<DOC>
<DOCNO>WT01-B23-1</DOCNO>
<DOCOLDNO>IA087-000632-B016-84</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/library/studies/nc/ncmenu.htm 206.61.184.43 19970122091456 text/html 14835
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:14:48 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:58:26 GMT
Content-length: 14617
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Marihuana, A Signal of Misunderstanding - Table of
Contents</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="61536" -->

<h1>The Report of the National Commission on Marihuana and Drug
Abuse </h1>

<h2>Marihuana: A Signal of Misunderstanding </h2>

<p><b>Commissioned by President Richard M. Nixon, March, 1972</b>
</p>

<hr>

<p><b><u>Table of Contents</u></b> </p>

<h3>The Report </h3>

<p>Letter of Transmittal </p>

<p><a href="misintro.htm">Introduction</a> </p>

<p><a href="mis2.htm"><b>I. Marihuana and the Problem of
Marihuana</b></a><b><u> </u></b></p>

<ul>
    <li>Origins of the Marihuana Problem <ul>
            <li>Visibility </li>
            <li>Perceived Threats </li>
            <li>Symbolism </li>
        </ul>
    </li>
    <li>The Need for Perspective <ul>
            <li>Historical Perspective </li>
            <li>Cultural Perspective <ul>
                    <li>The Search for Meaning </li>
                    <li>Skepticism </li>
                    <li>The Limits of Rationality </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Formulating Marihuana Policy <ul>
            <li>Scientific Oversimplification </li>
            <li>Philosophical Oversimplification </li>
            <li>Sociological Oversimplification </li>
            <li>Legal Oversimplification </li>
        </ul>
    </li>
    <li>The Report </li>
</ul>

<p><a href="ncchap2.htm"><b>II. Marihuana Use and Its Effects</b></a><b><u>
</u></b></p>

<ul>
    <li>The Marihuana User </li>
    <li>Demographic Characteristics </li>
    <li>Patterns of Use </li>
    <li>Profiles of Users <ul>
            <li>Experimental Users </li>
            <li>Intermittent Users </li>
            <li>Moderate and Heavy Users </li>
            <li>Very Heavy Users </li>
        </ul>
    </li>
    <li>Becoming a Marihuana User <ul>
            <li>Parental Influence </li>
            <li>Situational Factors and Behavioral Correlates </li>
            <li>Social Group Factors </li>
            <li>The Dynamics of Persistent Use </li>
        </ul>
    </li>
    <li>Becoming a Multidrug User <ul>
            <li>Epidemiologic Studies </li>
            <li>Profiles and Dynamics </li>
            <li>Sociocultural Factors </li>
        </ul>
    </li>
    <li>Effects of Marihuana on the User <ul>
            <li>Botany and Chemistry </li>
            <li>Factors Influencing Drug Effect <ul>
                    <li>Dosage </li>
                    <li>Method of Use </li>
                    <li>Metabolism </li>
                    <li>Set and Setting </li>
                    <li>Tolerance </li>
                    <li>Reverse Tolerance </li>
                    <li>Duration of Use </li>
                    <li>Patterns of Use </li>
                    <li>Definition of Dependence </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Effects Related to Pattern Use </li>
    <li>Immediate Drug Effects <ul>
            <li>Subjective Effects </li>
            <li>Bodv Function </li>
            <li>Mental Function </li>
            <li>The Intoxicated State </li>
            <li>Unpleasant Reactions </li>
            <li>Anxiety States </li>
            <li>Psychosis </li>
            <li>Conclusions </li>
        </ul>
    </li>
    <li>ShortTerm Effects </li>
    <li>Long Term Effects </li>
    <li>Very Long Term Effects <ul>
            <li>Tolerance and Dependence </li>
            <li>General Body Function </li>
            <li>Social Functioning </li>
            <li>Mental Functioning </li>
            <li>Motivation and Behavioral Change </li>
        </ul>
    </li>
    <li>Summary </li>
</ul>

<p><a href="ncc3.htm"><b>III. Social Impact of Marihuana Use</b></a><b><u>
</u></b></p>

<ul>
    <li>Marihuana and Public Safety <ul>
            <li>Marihuana and Crime <ul>
                    <li>The Issue of Cause and Effect </li>
                    <li>Marihuana and Violent Crime </li>
                    <li>Marihuana and Non Violent Crime </li>
                    <li>A Sociocultural Explanation </li>
                </ul>
            </li>
            <li>Marihuana and Driving </li>
        </ul>
    </li>
    <li>Marihuana, Public Health and Welfare <ul>
            <li>A Public Health Approach <ul>
                    <li>The Population at Risk </li>
                    <li>Confusion and Fact </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Assessment of Perceived Risks <ul>
            <li>Lethality </li>
            <li>Potential for Genetic Damage </li>
            <li>Immediate Effects </li>
            <li>Effects of LongTerm, Heavy Use </li>
            <li>Addiction Potential </li>
            <li>Progression to Other Drugs </li>
        </ul>
    </li>
    <li>Preventive Public Health Concerns <ul>
            <li>Summary </li>
        </ul>
    </li>
    <li>Marihuana and the Dominant Social Order <ul>
            <li>The Adult Marihuana User </li>
            <li>The Young Marihuana User </li>
        </ul>
    </li>
    <li>The World of Youth </li>
    <li>Why Society Feels Threatened <ul>
            <li>Dropping Out </li>
            <li>Dropping Down </li>
            <li>Youth and Radical Politics </li>
            <li>Youth and the Work Ethic </li>
        </ul>
    </li>
    <li>The Changing Social Scene </li>
</ul>

<p><a href="ncchp4.htm"><b>IV. Social Response to Marihuana Use </b></a></p>

<ul>
    <li>The Initial Social Response </li>
    <li>The Change </li>
    <li>The Current Response <ul>
            <li>The Criminal Justice System <ul>
                    <li>Law Enforcement Behavior </li>
                    <li>Law Enforcement Opinion </li>
                </ul>
            </li>
            <li>The Non Legal Institutions <ul>
                    <li>The Family </li>
                    <li>The Schools </li>
                    <li>The Churches </li>
                    <li>The Medical Community </li>
                    <li>Summary </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>The Public Response </li>
</ul>

<p><a href="ncrec.htm"><b>V. Marihuana and Social Policy</b></a><b><u>
</u></b></p>

<ul>
    <li><a href="ncrec1.htm">Drugs in a Free Society </a><ul>
            <li>Drugs and Social Responsibility </li>
        </ul>
    </li>
    <li><a href="ncrec2.htm">A Social Control Policy for
        Marihuana</a> <ul>
            <li>Approval of Use </li>
            <li>Elimination of Use </li>
            <li>Discouragement or Neutrality </li>
        </ul>
    </li>
    <li>Implementing the Discouragement Policy <ul>
            <li>The Role of Law in Effective Social Control </li>
            <li>Total Prohibition </li>
            <li>Regulation </li>
            <li>Partial Prohibition </li>
            <li>Recommendations for Federal Law </li>
            <li>Recommendations for State Law </li>
            <li>Discussion of Federal Recommendations </li>
            <li>Discussion of State Recommendations </li>
            <li>Discussion of Potential Objections </li>
        </ul>
    </li>
    <li>A Final Comment </li>
</ul>

<hr>

<p><a href="ncaddend.htm"><b>Addendum</b></a><b> </b></p>

<p>Ancillary Recommendations </p>

<p>Legal and Law Enforcement Recommendations </p>

<p>Medical Recommendations </p>

<p>Other Recommendations </p>

<p><b>Index of Contributors, Contractors and Consultants<br>
</b></p>

<hr>

<h3>The Appendix </h3>

<p>The Technical Papers of the First Report of the National
Commission on Marihuana and Drug Abuse, March, 1972 </p>

<p><a href="nc1let.htm">Letter of Transmittal </a></p>

<p><a href="ncstaff.htm">Members and Staff</a> </p>

<p><a href="nc1p.htm">Preface</a> </p>

<h3>Part One -- Biological Aspects </h3>

<h4>I. History of Marihuana Use: Medical and Intoxicant </h4>

<ul>
    <li><a href="nc1a.htm">History of the Medical Use</a> </li>
    <li><a href="nc1b.htm">History of the Intoxicant Use</a> </li>
</ul>

<h4>II. Biological Effects of Marihuana </h4>

<ul>
    <li><a href="nc1c.htm">Botanical and Chemical Considerations</a>
    </li>
    <li><a href="nc1d.htm">Factors Influencing
        Psychopharmacological Effect</a> </li>
    <li><a href="nc1e.htm">Acute Effects of Marihuana (Delta 9
        THC)</a> </li>
    <li><a href="nc1f.htm">Effects of Short-Term or Subacute Use</a>
    </li>
    <li><a href="nc1g.htm">Effects of Long-Term Cannabis Use</a> </li>
    <li><a href="nc1h.htm">Investigations of Very Heavy, Very
        Long-Term Cannabis Users</a> </li>
</ul>

<h4>III. Behavioral and Biological Concomitants of Chronic
Marihuana Smoking by Heavy and Casual Users </h4>

<h3>Part Two -- Social Aspects </h3>

<h4>I. Marihuana Use in American Society </h4>

<ul>
    <li>Surveys of Marihuana Use </li>
    <li>The Incidence and Prevalence of Marihuana Use </li>
    <li>The Future of Marihuana </li>
    <li>Why People Use Marihuana </li>
    <li>Becoming a Marihuana User </li>
    <li>Circumstances of First Marihuana Use </li>
    <li>The Marihuana User </li>
    <li>The Patterns of Marihuana Use </li>
    <li>Marihuana Use and the User: 1972 </li>
</ul>

<h4>II. Marihuana and the Use of Other Drugs </h4>

<ul>
    <li>Empirical Data on the Escalation Process </li>
    <li>Youth Drug Use Survey </li>
    <li>Summary </li>
</ul>

<h4>III. Marihuana and Public Safety </h4>

<ul>
    <li><a href="nc1i.htm">Problems in Assessing the Effects of
        Marihuana</a> </li>
    <li><a href="nc1j.htm">Marihuana and Violence</a> </li>
    <li><a href="nc1k.htm">Marihuana and Sexual Behavior</a> </li>
    <li><a href="nc1l.htm">Marihuana and (Non-Violent) Crime</a> </li>
    <li><a href="nc1m.htm">Summary and Conclusions: Marihuana and
        Crime</a> </li>
    <li><a href="nc1n.htm">Marihuana and Driving</a> </li>
</ul>

<h3>Part Three -- Legal Aspects </h3>

<h4>I. Control of Marihuana, Alcohol and Tobacco </h4>

<ul>
    <li><a href="nc2.htm">History of Marihuana Legislation</a> </li>
    <li><a href="nc2a.htm">History of Alcohol Prohibition</a> </li>
    <li><a href="nc2b.htm">History of Tobacco Regulation</a> </li>
</ul>

<h4>II. The Legal Status of Marihuana </h4>

<ul>
    <li>International Control </li>
    <li>The Control of Marihuana Under Federal Law </li>
    <li>Control of Marihuana at the State Level </li>
    <li>The Role of Ancillary Offenses and Constructive
        Possession in Controlling Marihuana </li>
    <li>Marihuana Control at the Local Level </li>
    <li>Analysis of Statutes Requiring Physicians to Report Drug
        Addiction </li>
</ul>

<h4>III. Trafficking Patterns of Marihuana and Hashish </h4>

<ul>
    <li>Marihuana Traffic From Mexico </li>
    <li>Marihuana Traffic From Jamaica </li>
    <li>The Growing Hashish Traffic </li>
</ul>

<h3>Part Four -- Response of the Criminal Justice System to
Marihuana Use </h3>

<h4>Introduction </h4>

<h4>I. Enforcement Behavior at the State Level </h4>

<h4>Enforcement Behavior at the Federal Level </h4>

<ul>
    <li>General Trends </li>
    <li>Federal Enforcement of the Marihuana Laws: 1970 </li>
</ul>

<h4>III. Opinion Within the Criminal Justice System </h4>

<ul>
    <li>Prosecutorial Opinion </li>
    <li>Opinion of Court Officials </li>
</ul>

<h3>Part Five -- National Survey </h3>

<h4>I. A Nationwide Study of Beliefs, Information and Experiences
</h4>

<ul>
    <li>Main Report </li>
    <li>Methods and Procedures </li>
</ul>

<h3>Part Six -- Social Policy Aspects </h3>

<h4>I. The Constitutional Dimensions of Marihuana Control </h4>

<ul>
    <li>Substantive Limitations on the Criminal Law </li>
    <li>Federal Preemption of Marihuana Control </li>
</ul>

<h4>II. Models and Statutory Schemes for Controlling Marihuana </h4>

<ul>
    <li>Law and Social Policy </li>
    <li>Legal Implementations of Marihuana Control Policies </li>
    <li>Formulating a Legal Scheme </li>
    <li>Implementation of Alcohol Prohibition </li>
</ul>

<h4>Marihuana and Education </h4>

<ul>
    <li>Drug Programs in American Education </li>
    <li>State Departments of Education Survey </li>
    <li>Commission Visits </li>
    <li>Drug Education Programs of Special Interest </li>
    <li>Marihuana Education in State Programs </li>
    <li>Surveys of College Drug Courses </li>
    <li>The Federal Government and Drug Education </li>
</ul>

<h4>Research Needs and Directions </h4>

<ul>
    <li>Biomedical </li>
    <li>Psychosocial </li>
    <li>Legal and Law Enforcement </li>
</ul>

<hr>

<p><b>Index of Contributors, Contractors and Consultants</b> </p>

<p><b>Research Papers Prepared for the Commission <br>
</b></p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="61536" -->

<p><br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-2</DOCNO>
<DOCOLDNO>IA087-000627-B013-271</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/cptstaff.htm 206.61.184.43 19970122050908 text/html 2676
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:08:46 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:01:16 GMT
Content-length: 2459
</DOCHDR>
<html>

<head>
<title>Cannabis Therapeutic Program Staff</title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<p> </p>
</body>

<body bgcolor="#ffffff">

<p><img src="../../graphics/blueline.gif"> <br>
</p>

<p> <b>California Research Advisory Panel</b> </p>

<p> <b>Cannabis Therapeutic Program</b> </p>

<p> <b>Panel Members</b> </p>

<p> <img src="../../graphics/blueline.gif"><br>
</p>

<p> <b><font size="2">Edward P. O'Brien, J.D.</font></b> </p>

<p> <font size="2">Panel Chairman</font> </p>

<p> <font size="2">Appointed <b>by </b>the Attorney General,<br>
</font> </p>

<p> <b><font size="2">Frederick H. Meyers, M.D.</font></b> </p>

<p> <font size="2">Panel Vice-Chairman</font> </p>

<p> <font size="2">Appointed <b>by </b>the University of
California <br>
</font> </p>

<p> <b><font size="2">Donald W. Holsten, Pharm.D.</font></b> </p>

<p> <font size="2">Appointed by the Department of Health Services<br>
</font> </p>

<p> <b><font size="2">Luis Icaza, Pharm.D.</font></b> </p>

<p> <font size="2">Appointed <b>by </b>the State Board of
Pharmacy<br>
</font> </p>

<p> <b><font size="2">Nancy C. Miller, R.N.</font></b> </p>

<p> <font size="2">Appointed by the Governor<br>
</font> </p>

<p> <b><font size="2">Carmel M. Roberts, Ph.D.</font></b> </p>

<p> <font size="2">Appointed by the University of Southern
California</font> </p>

<p> <font size="2">Designated private university<br>
</font> </p>

<p> <b><font size="2">Donald R. Wesson, M.D.</font></b> </p>

<p> <font size="2">Appointed <b>by </b>the California Medical
Association</font> </p>

<p> <font size="2">Designated professional medical society<br>
</font> </p>

<p> <b><font size="2">William Stanton, M.D.</font></b> </p>

<p> <font size="2">Appointed <b>by </b>the Research Advisory
Panel<br>
</font> </p>

<p> <b><font size="2">Allan J. Flach, M.D., Pharm.D.</font></b> </p>

<p> <font size="2">Appointed by the Research Advisory Panel<br>
<br>
Staff Members</font> </p>

<p> <b><font size="2">David W. Schieser, Ph.D.</font></b> </p>

<p> <font size="2">Executive Secretary</font> </p>

<p> <b><font size="2">Brenda J. Crommie</font></b> </p>

<p> <font size="2">Secretary<br>
</font> </p>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> <br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-3</DOCNO>
<DOCOLDNO>IA087-000627-B013-303</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ctpexec.htm 206.61.184.43 19970122050929 text/html 43246
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:09:18 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:00:48 GMT
Content-length: 43028
</DOCHDR>
<html>

<head>
<title>Cannabis Therapeutic Program EXECUTIVE SUMMARY</title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<p> </p>
</body>

<body bgcolor="#ffffff">

<p><img src="../../graphics/blueline.gif"> </p>

<p> <b><font size="5">California Research Advisory Program</font></b>
</p>

<p> <b><font size="5">Cannabis Therapeutic Program</font></b> </p>

<p> <b><font size="5">EXECUTIVE SUMMARY</font></b> </p>

<p> <img src="../../graphics/blueline.gif"> </p>

<h2>EXECUTIVE SUMMARY </h2>

<p> The nausea and vomiting caused by chemotherapy for cancer is
often so severe as to limit treatment. Drugs currently used to
combat that nausea and vomiting have very limited effectiveness
and unpleasant side effects. In 1979, the Legislature became
concerned that the status of marijuana as a stringently regulated
drug might be inhibiting research into its possible therapeutic
effects and that many cancer patients were being deprived of a
possibly effective treatment for nausea and vomiting. The
Legislature therefore directed the Research Advisory Panel,
created by the Legislature in 1969, to provide compassionate
access to marijuana, or its active component
delta-9-tetrahydrocannabinol (THC), by establishing a clinical
trial conforming to federal and ethical standards for research
using human subjects and a new drug. </p>

<p> The Panel recruited 486 oncologists from throughout the State
and 321 of these provided oral THC for 2,356 patients and
marijuana cigarettes for 119. The limited efficacy of THC was in
the meantime being established by double-blind studies carried
out elsewhere. The Panel study was a &quot;Phase III&quot; study
providing experience under conditions of actual practice.
Throughout the program over 1,716,000 dosage units of
investigational drug were provided without charge by the National
Cancer Institute (NCI) and the National Institute on Drug Abuse
(NIDA) to 114 approved pharmacies. The cost of the Cannabis
Therapeutic Program for the eight years was $400,000. </p>

<p> Oral THC has been shown to be clearly efficacious for relief
of nausea and vomiting in some patients, but not a total answer
to the terrible emetogenic effect of current anticancer
chemotherapy. Side effects were frequent but not serious, but
were a factor in limiting patient acceptance. The Panel
established a cumulative dose schedule for THC, not previously
studied, that provided the same efficacy with fewer troublesome
side effects. </p>

<p> In addition to the major study of smoked marijuana or oral
THC alone, the Panel sponsored research into an analogue of THC,
delta-8-tetrahydrocannabinol, combinations of THC with other
antiemetics and the use of THC for nausea and vomiting from
causes other than cancer. </p>

<p> In 1984, the Legislature added to its mandate a study of the
same drugs in the treatment of glaucoma. Only 9 patients from the
entire State received THC under the new program. The drug given
chronically is safe, but not demonstrably effective. </p>

<p> The program was effectively ended in October, 1986, when THC
was marketed as dronabinol (Marinol). The California experience
was a factor in the decisions of the U. S. Food and Drug
Administration (FDA) to permit its marketing. </p>

<p> The Research Advisory Panel does not recommend an extension
of Article 6 of Chapter 5 of Division 21 of the California Health
and Safety Code. California investigators can still carry out
research using human subjects and THC, but the Panel can no
longer provide the drug free. </p>

<p> The Research Advisory Panel wishes to express its
appreciation to the Legislature for directing the establishment
of a program which resulted in meeting the needs of that time for
compassionate access, as well as satisfying a continuing need for
research on the medicinal effects of such a controversial drug. </p>

<p> January 24, 1989 </p>

<hr>

<h2>CANCER CHEMOTHERAPY, NAUSEA AND VOMITING </h2>

<h3>The Problem </h3>

<p> With the development of effective cancer chemotherapeutic
agents and multi-drug regimens, the prognosis for many patients
with even advanced cancer has improved. However, the widely used
chemotherapeutic regimens induce nausea and vomiting with
regularity. as does radiation therapy to the abdominal area. In
some cases, the treatment for cancer may cause more immediate
discomfort than the disease itself, often leaving patients with
nausea and vomiting so severe as to impede their leading even a
semblance of normal life. For many patients, the mere
anticipation of chemotherapy induces vomiting and causes
depression, occasionally leading to the refusal to receive
further potentially life saving treatment. This nausea, vomiting
and loss of appetite may have not only a profound psychological
impact on the patient, but also produce significant weight loss.
Cancer itself may also produce significant anorexia and weight
loss and the problems are compounded by chemotherapy. </p>

<h3>Inadequacy of Drugs in Current Use </h3>

<p> Drugs to control the side effects of nausea and vomiting from
anticancer treatment have proved to be inadequate. When
administered with chemotherapy, phenothiazine derivatives such as
prochlorperazine (Compazine) and thiethylperazine (Torecan) have
been only partially successful in controlling the nausea and
vomiting caused by many anticancer drugs and their side effects,
especially a subjectively unpleasant sedation, are severe.
Patient compliance is therefore limited. Other drugs, e.g..
metoclopramide, loperamide, and high dose corticosteroids have
had brief vogues of extensive use.<br>
</p>

<h3>Early Experience with Marijuana and THC </h3>

<p> Anecdotal reports from cancer patients suggested that smoking
marijuana provided a significant antiemetic effect. In 1975,
Sallan and associates initiated a small controlled study to
evaluate the efficacy of delta-9-tetrahydrocannabinol (THC), a
principal active component of marijuana, as an antiemetic agent.
Additional small controlled trials2' including some carried out
in California and approved by the Research Advisory Panel, showed
that THC given by mouth provided some benefit to some patients
suffering from nausea and vomiting of chemotherapy. Although this
preliminary research partially confirmed the anecdotal findings,
the reported degree of effectiveness, as well as reported adverse
effects varied considerably among research studies. </p>

<p> The promising research studies furthered a widespread
interest in marijuana by patients undergoing chemotherapy.
However, marijuana was and is a Schedule I controlled substance
(i.e., a drug with a high abuse potential that lacks an approved
medical use under federal law) and only a very limited number of
people were eligible to legally use it and only at the few
locations of the ongoing research studies. Some very sick people
resorted to illegal use of this Schedule I controlled substance. </p>

<p> 1. Sallan SE. Zinberg RE. Frei NE 111. Antiemetic effect of
delta-9-tetrahydrocannabinol in patients receiving cancer
chemotherapy. M Engl J Ned 1975: 293: 795-7. </p>

<p> 2. Card S. Beers AL Jr. Bogard M. McMahan RT, Nangalik A.
Ashman AC. Levine S. Two-pronged study of tetrahydrocannabinol
(THC) prevention of vomiting from cancer chemotherapy. IRCS Ned
Sci 1980; 8: 203-4. </p>

<p> Orr LE. MKeran JF. Sloome S. Antiemetic affect or
tetrahydrocannabinal compared with placebo and prochlorperazine
in chemotherapy associated nausea and emesia. Arch Intern Ned
1980: 140: 1431-3. </p>

<p> Sallan SE. Cronin C. Zolen 14. Zinberg NE. Antiemetica in
patients receiving chemotherapy for cancer. New Engl J Ned 1980;
302: 135-8. </p>

<hr>

<h2>CANNABIS THERAPEUTIC PROGRAM </h2>

<h3>Legislative History </h3>

<p> The California Legislature found that the potential medicinal
value of Cannabis sativa had received Insufficient -study due to
a lack of financial incentives for the undertaking of appropriate
research by private drug manufacturing concerns. Individual
physicians could not utilize cannabis in their clinical practice
and it was not feasible for them to conduct research because of
governmental controls which include time consuming applications
with rigorous approval and monitoring procedures and reports. The
Legislature decided that 'compassionate access' to this
controversial drug should be provided for cancer patients. At the
same time, the Legislature recognized that treatment should be
provided under the general controls that apply to all new drug
research. To accomplish the two aims: 1) compassionate access 2)
achieved by research meeting the U.S. Food and Drug
Administration and ethical standards and without contributing to
the drug's availability through illicit channels, the Legislature
turned to the Research Advisory Panel, an agency established and
utilized by the Legislature since 1969. <br>
</p>

<h3>The Research Advisory Panel </h3>

<p> The Legislature established the Panel as an autonomous
multidisciplinary committee of experts with diverse backgrounds
who serve without pay and without vested interests in the matters
discussed. </p>

<p> Panel members are appointed, not by a single elected official
or State office, but by various public and private agencies: the
Attorney General, the University of California, the Department of
Health Services, the State Board of Pharmacy, a private
University designated by the Governor, the California Medical
Association, and the Governor. For the purposes of this
assignment, the Panel was authorized to appoint two additional
members with expertise in oncology or glaucoma. Appendix I
contains the sections of the California Health and Safety Code
pertaining to the Research Advisory Panel. </p>

<p> The Research Advisory Panel has existed since 1969 when it
was created by the Legislature to encourage research into the
nature and effects of abused drugs, to review and approve
research involving Schedules I and II controlled substances and
to function as a human subjects' protection committee in research
involving scheduled substances. The Panel established, approved
and monitored methadone maintenance programs, providing treatment
under the guise of research, until such programs became legal as
treatment. Because of its legislated mandate and the composition
of its membership, the Panel is in a unique position to provide a
level of control over research beyond that required of an
industrial sponsor or a University. Prior to the new assignment
which is the subject of this report, the Panel had sponsored a
symposium on marijuana research in California And provided seed
funds for twelve California investigators, two of whom have
subsequently developed comprehensive and influential programs
with federal funds. In 1978, the Panel was monitoring some twenty
four research projects involving marijuana or THC. </p>

<h3>Panel's Role in Development of Legislation </h3>

<p> In 1979, when Senator Presley and the Legislature began
consideration of the need to provide compassionate access to
marijuana, the Research Advisory Panel had approved five research
projects employing marijuana or THC and involving as many as five
hundred cancer patients suffering severe nausea and vomiting
caused by their cancer treatment. </p>

<p> The Panel counseled that State sponsored trials would be
required because the patent protection necessary to attract
industrial sponsorship was lacking. It was also pointed out that
standardized THC and marijuana cigarettes from the National
Institute on Drug Abuse (NIDA) be used rather than confiscated
marijuana that would be of variable and unknown potency and
generally unsuitable for oral use; that initial trials be limited
to patients receiving cancer chemotherapy; and that the treatment
of glaucoma, then seen as unpromising by available experience and
literature, be added later.<br>
</p>

<h3>Summary of Legislation </h3>

<p> The goals of the Legislature and of the Panel, to provide
compassionate access through a multicenter research-project that
complied with FDA regulation were incorporated into Senate Bill
184 (Appendix II) that became law on January 1, 1980, as Chapter
300, Statutes of 1979 (Therapeutic Marijuana Project. Article 6,
Chapter 5, Section 11260 et seq. of the Health and Safety Code).
The law mandated that the Research Advisory Panel establish a
4-year pilot research program into the medical use of cannabis
and its derivatives, particularly in treating patients suffering
from cancer. The law stated that making marijuana available to
individual physicians in a State-sponsored program for the
investigational use of cannabis and its derivatives would enable
qualified physicians and surgeons in the State to study the
benefits of the drug in a controlled clinical setting and to gain
additional knowledge with respect to dosage and effects. </p>

<p> In addition, the law required the Panel to develop guidelines
and protocols for the program and to approve physicians for
participation in the program. It authorized the Panel to contract
for pharmaceutical formulation, distribution and testing of
cannabis and cannabinoids, to obtain such substances from
designated sources, and to charge participating physicians for
the cost of obtaining the materials supplied. The Panel was
required to report ,annually to the Legislature on the status and
results of the program. </p>

<p> The legislation, with its mention of qualified physicians in
diverse geographic areas, was clearly intended to provide
patients with 'compassionate access, to these controlled,
investigational drugs. The intent was not to foster undisciplined
use of marijuana but rather to increase knowledge about the use
of this drug. Thus, both the legislation and the investigational
status of the drug enforced the Panel's obligation to conduct
useful clinical research and to investigate several still
unanswered questions about THC. </p>

<h3>Extension of Law and Provision for Glaucoma Studies </h3>

<p> At the end of 1983, with the Cannabis Therapeutic Program
underway, the Panel made an appraisal of the need for extending
the Program. At that time, because of the expressed need of
patients to continue having compassionate access to marijuana,
and because of the ongoing research into the use of THC with
other antiemetics, the Panel requested an extension of the
program. Noting that over 1700 patients had enrolled in the study
over the past four years, Legislation was introduced by Senator
Presley to extend the original statute. On July 11, 1984,
Governor Deukmejian signed SB 1765 (Chapter 417, Statutes of 1984
-Appendix III) into law. This legislation extended the Cannabis
Therapeutic Program four years beyond its previously scheduled
ending with a termination date of June 30, 1989. </p>

<p> This legislation also directed the Panel to establish another
statewide program to make marijuana and THC available to patients
undergoing treatment for glaucoma. </p>

<hr>

<h2>IMPLEMENTATION OF THE NEW LAW </h2>

<h3>Protocol Development </h3>

<p> The Panel immediately began to prepare an application for
Investigational New Drug Exemption (IND) to the FDA for approval
to study cannabis in humans. The Panel drafted a protocol for the
pilot project, appointed consultantoncology members, and
scheduled public meetings for comments from practicing
oncologists, pharmacists and nurses before finalizing the
protocols and submitting an IND to FDA. The Panel, through
negotiations with the National Cancer Institute (NCI) and the
National Institute on Drug Abuse (NIDA) arranged a supply of THC
capsules and marijuana cigarettes to approved pharmacies without
charge. </p>

<p> Before the Program was fully implemented, a number of
additional steps were taken: an Investigator's Brochure was
developed; an informed consent document was written and reviewed
by an outside human subjects' committee to assure patient
protection; a data processing unit was contracted to analyze
results of investigators' reports; and a uniform investigator
review and approval process was developed to assure that access
to ordering the drug was controlled. <br>
</p>

<h3>Drug Supply </h3>

<p> Marijuana is available as a raw plant, dried and minimally
processed for smoking or cooking. Its most active ingredient;
delta-9-tetrahydrocannabinol (THC) was available as a
synthetically derived chemical and formulated as a solution in
oil in a soft gelatin capsule. Although the California
legislation provided that seized illegal marijuana could be used,
the Panel decided that the only reliable source of standardized
marijuana would be NIDA and that NCI was the only economical
source of the encapsulated THC. </p>

<p> The investigational drugs would be made available by NCI and
NIDA at no cost to California participants. To further conserve
the limited State funds, the Panel arranged with NCI and NIDA to
ship drug supplies directly to designated pharmacies, a procedure
that cut costs to the State by eliminating warehousing and
distribution. The U.S. Drug Enforcement Administration (DEA)
retained its authority for accountability and to inspect storage
facilities. </p>

<p> Investigational THC and/or marijuana cigarettes were shipped
to 114 of the 132 approved California pharmacies during the life
of the Cannabis Therapeutic Program. The total quantities shipped
were as follows: </p>

<p> Marijuana cigarettes 27,650 </p>

<p> Tetrahydrocannabinol l0mg capsules 5,640 </p>

<p> Tetrahydrocannabinol 5mg capsules 1,033,300 </p>

<p> Tetrahydrocannabinol 2.5mg capsules 649,900 </p>

<p> Due to limitations of shelf life, the above quantities are
greater than the quantities actually administered to patients. </p>

<p> The Panel is pleased to report its investigators and
pharmacies maintained effective control of this large inventory
of controlled substances. The Panel received no reports of any
diversion, or even inventory discrepancies, of investigational
marijuana or THC capsules. </p>

<h3>Cost </h3>

<h4>The Cannabis Therapeutic </h4>

<p> Program was funded with an initial appropriation of $100,000
for the start-up costs and the first year of program operation.
Funding for subsequent years of this research project was through
the standard budgeting process of the State. Overall, the total
cost of the Cannabis Therapeutic Program from 1979 through 1988
was $400,000. The Principal items over those years were salaries
for one research project coordinator (Research Assistant II), a
parttime student research assistant, data analysis services and
consultation at critical junctures. Panel members or their
employing agencies volunteered their time. </p>

<h3>Investigator Eligibility </h3>

<p> Investigator status was granted to physicians who were board
eligible or board certified medical oncologists. radiation
oncologists, hematologists, or otherwise qualified physicians
(e.g., pediatric oncologists) and who: </p>

<p> a. completed an Investigator Application, </p>

<p> b. held a current license to practice medicine in California,
</p>

<p> c were otherwise qualified by their training and/or
experience, </p>

<p> d. completed the Federal FDA Investigator's Form (FD Form
1573), and </p>

<p> e. agreed and certified in writing that they would follow all
provisions of the protocol. </p>

<p> Participating investigators were required to assume full
responsibility for determining that their patients conformed to
the admission requirements. Continued participation was
conditioned upon the investigator's compliance with the protocol
including adequate record keeping on treatment outcome and timely
submission of data forms to the Panel. The Panel assured all
participants that it would carefully monitor this program, and a
number of site visits were made. </p>

<h3>Physician Enrollment </h3>

<p> The legislation directed that access be provided over
geographically wide areas of the State. The Panel made extensive
efforts to publicize the Cannabis Therapeutic Program throughout
the State to encourage qualified oncologists in diverse
geographical locations to apply. The Panel's program was
announced in the newsletter of the Board of Medical Quality
Assurance which is mailed to all California licensed physicians.
All acute are hospitals were provided with a notice announcing
the program and explaining the enrollment procedures. Recipient
hospitals were asked to circulate the notice to oncology
departments and to post a copy. At the meeting of the American
Society of Clinical Oncology in San Diego in May 1980, the Panel
announced the Cannabis Therapeutic Program to California
oncologists, provided application forms to them and answered
their questions; thus, the application review and approval
process continued through the spring and summer. </p>

<p> In July and September 1980, investigator training meetings
were held in San Francisco, Los Angeles, Sacramento, and San
Diego and two more held in April 1981, one in Los Angeles and one
in San Francisco. Ample time was allowed for questions and
answers. In addition to oncologists, these meetings were attended
by nurses, pharmacists, and data managers. </p>

<p> The agenda of these meetings included presentations on
problems on the clinical pharmacology of marijuana of potential
concern to the seriously ill, the elderly and the very young; a
review of the research procedures; information on drug ordering,
storage and dispensing; and a review of data collection and
reporting requirements. These meetings were considered crucial to
obtaining standardized protocol implementation, statewide, in
this large scale clinical study with only a small staff for
monitoring. Investigators, new to the State or new to practice,
who had no opportunity to attend the training meetings were
instructed individually by project staff. Although newspaper and
television interviews were used to inform the general public, the
Panel relied primarily on oncologists to inform patients of the
program's existence. </p>

<p> At the conclusion of the initial enrollment period in
September 1980, three hundred and twenty physicians applied for
participant status and 218 investigators from 21 counties
actually met all registration requirements by attending one of
the four investigator's seminars. By the time the program ended
in 1988, 486 investigators had registered and 321 had enrolled
patients. </p>

<p> At the conclusion of the enrollment-period in September 1980,
over 80 designated pharmacies were registered with DEA to
dispense Schedule I controlled substances, THC and marijuana. By
the end of the program, 132 pharmacies had been approved to
distribute THC and/or marijuana. </p>

<h3>Research Subjects </h3>

<p> Initially, eligible patients were males and non-pregnant
females, five years of age and older, with histologically
documented malignancies receiving chemotherapy or radiation and
experiencing nausea and vomiting which was not relieved by
treatment with conventional antiemetics. </p>

<p> Participation in the program was completely voluntary.
Therefore the study population was self-selected. The limitations
placed on the Panel by the conflicting aims of the program did
not permit the establishment of a control group. Each patient
acted as his/her own control, and previous experience with
conventional antiemetics was compared with the experience with
THC treatment. </p>

<h3>Research Subject Protection </h3>

<p> The use of either THC or marijuana for therapeutic purposes
was experimental; therefore. the Panel required investigators to
obtain a voluntary, informed consent before enrolling any cancer
patient into the program. The Panel prepared a written consent
form which disclosed the potential benefits as well as the
attendant risks of participation in the experiment. This document
was reviewed and approved by the Human Subjects' Protection
Committee of the California Department of Health Services. The
consent form, written in lay language without unnecessary
technical terms, ambiguous phrases or exculpatory clauses, made
clear, among other conditions, that participation, both initial
and continued, was entirely voluntary. </p>

<p> Pursuant to Section 24170 et seg of the Health and Safety
Code, the Rosenthal 'Protection of Human Subjects in Medical
Experimentation Act,' each subject also received a copy of the
'Research Subject's Bill of Rights.' Physicians practicing in
hospitals or other institutions were also subject to review by
their own research or human subjects committees. At the
investigators' meetings, the Panel stressed that informed consent
is not a mere formality. </p>

<p> English and Spanish versions of the consent form were
provided. Patients who did not speak either language were
enrolled only if a competent translator was available to explain
the consent form pointby-point and to attest in writing to the
patient's understanding of it. Patients aged 5 to 17 were
required to have parental consent before enrolling in the study
and must have joined with their parents in giving consent. </p>

<hr>

<h2>STUDY OBJECTIVES </h2>

<p> There were two objectives set forth in the statutes: </p>

<p> 1. to allow qualified oncologists in diverse geographical
locations to provide the drug on a compassionate basis to
seriously ill persons not responding to conventional treatment,
and </p>

<p> 2. to facilitate clinical trials of Cannabis and its
derivatives in cancer patients pursuant to the federal IND
procedures. </p>

<p> Both the legislation and the investigational status of the
drug under federal law obliged the Panel to conduct useful
clinical research to address several unanswered questions about
THC and marijuana effects. However, compassionate access made
some of the basic research processes unusable, e.g., a
double-blind controlled study. Therefore, to accomplish these two
potentially conflicting objectives, the Panel planned a large
collaborative Phase III3 trial. </p>

<p> At the time the Panel designed its protocols, several
controlled studies of THC's effect on nausea and vomiting had
been completed. Controlled studies demonstrating efficacy results
were variable and optimal dosage was not established. Individual
doses in most other studies were inflexible and ranged from 2.5
to 15mg THC/m2 body surface area. The time at which the first
dose of THC was administered in these studies varied from 1/2
hour to 24 hours prior to the initiation of chemotherapy. The
frequency of THC administration varied from every 2 .hours to
every 8 hours. Therefore, a major research objective was to
determine the optimal THC dose and dosing schedule. </p>

<p> Other research questions to be addressed were: 1) Does the
antiemetic effectiveness of THC (and marijuana) vary with the
anticancer agent? 2) What are the nature and incidence of the
side effects of THC ',,and marijuana) in typical oncological
patients7 3) What is the general acceptance of THC and marijuana
by practicing oncologists and by cancer patients7 4) Once an
effective dose has been established, does tolerance develop to
THC's antiemetic effect7 </p>

<p> 3. Among the safeguards for developing an investigational new
drug in a step-wise testing process: the drug is tested in
animals before humans. in normal volunteers before patients. and
in small groups of people before large groups. Preclinical refers
to non-human experiments. e.g.. toxicity and pharmacology
experiments in animals. Phase I is conducted in small numbers of
normal human volunteers to determine dosage levels and other
pharmacologic parameters. Phase 11 clinical trials typically
involve small numbers of patients and comparisons to other
treatment and must be controlled and almost always double blind.
Phase III is to confirm effectiveness and to assess adverse
effects in a large and diverse patient population. Usually these
studies are uncontrolled. represent the conditions of actual
practice, and evaluate toxicity rather than efficacy. Phase IV is
to report on drug safety and effectiveness after marketing. </p>

<h3>Protocol History </h3>

<p> With all of the above considered. protocols were prepared and
a comprehensive investigational new drug application (IND) was
submitted to the Federal Food and Drug Administration (FDA) March
28, 1980. The initial application included four protocols for THC
and marijuana administration. See Appendix IV. </p>

<p> Protocol I was the study of oral THC capsules as an
antiemetic in adult cancer patients receiving cyclic
chemotherapeutic agents known to produce nausea and vomiting.
(Cyclic chemotherapy was defined as single or multiple doses of
chemotherapeutic drugs given within a two-day period, with each
treatment cycle separated by one week or more.) To be eligible,
patients must have failed to benefit from conventional antiemetic
drugs such as Compazine or Tigan during at least one previous
treatment episode. </p>

<p> Protocol II was similar to Protocol I except that adult
patients would be receiving daily anticancer therapy which could
either be chemotherapy or radiation therapy. </p>

<p> Protocol III (Pediatric Protocol) was similar to Protocol I
except that it was designed for pediatric patients aged 5 through
14 years. Also, patients receiving up to five consecutive days of
chemotherapy could be enrolled provided that treatment episodes
were separated by three weeks or more. Special safeguards such as
the minimum age of 5 years, consent by both parents and by the
child. lower starting dosage of THC, and special mental health
evaluation, were incorporated into this protocol. </p>

<p> Protocol IV (Smoked Marijuana Protocol) was an evaluation of
smoked marijuana in adult cancer inpatients receiving one or more
of three extremely emetogenic chemotherapeutic agents, e.g.,
Cisplatin, dacarbazine or 5-azacytidine alone or in combination
with other agents. This protocol was initially limited to
patients 15 years of age or older who were marijuana experienced.
</p>

<p> The goal of these first four protocols was to obtain patient
data rapidly and as safely as possible on the critical issue of
THC dose and side effects. The plan was to quickly define a
practical safe dose and then modify, eliminate or add to the
protocols as necessary. </p>

<p> The above research protocols were modified several times
during the course of the Cannabis Therapeutic Program, to ensure
the broadest compassionate access and as much useful data as
possible. At the outset of the program, pediatric consultants
suggested that the usual treatment lasted for 48 hours or less
with treatment separated by one week or more. The duration of
chemotherapy allowed by Protocol III was limited accordingly.
However, the Panel soon learned that a regimen of 5 days of
chemotherapy repeated every 3 weeks was frequently used in
pediatric practice. Therefore, the Panel modified the criteria
for Protocol III to include those chemotherapy regimens lasting
for five consecutive days, provided that treatments are separated
by three weeks or more. </p>

<p> After the first 150 patients were treated with cannabis under
Protocols I and II, the data were scrutinized by Panel members,
staff and consultants. Two-thirds of patients reported benefit,
but the Panel noted that a large number of patients complained of
troubling, although not dangerous, side effects from THC. It also
appeared that these side effects influenced a patient's
continuation in the program with an initial dropout rate of 48
percent. Therefore, in August 1981, the Panel lowered the
starting dose of THC capsules from 7.5mg THC/m2 to 5mg THC/m2 in
Protocols II and III. The rationale for this change was a
continuation of the attempt to achieve an optimum dose of THC,
balancing antiemetic efficacy with troublesome side effects. </p>

<p> Oral THC Protocol. During site visits the Panel learned that
investigators perceived the Cannabis Therapeutic Program to be
much more complex than it actually was. Therefore, to encourage
the participation of cancer specialists and to provide greater
compassionate access of cancer patients to THC, the Panel revised
its protocols in July 1981. The three protocols for oral THC were
combined into one streamlined protocol to simplify the program
and to avoid investigator confusion. Also, the new unified
protocol, referred to subsequently as the Oral THC Protocol, was
modified to enable radiation patients who experienced nausea or
vomiting to receive THC. </p>

<p> Cumulative Dose Protocol. In September 1981, the Panel
hypothesized that small oral doses (e.g. 2.5mg/m2) of THC would
be more useful than larger doses (e.g. 5.0mg/m2) if the repeated
small doses were started sufficiently long enough before
chemotherapy (e.g. 4 doses prior to chemotherapy). THC is a long
acting drug with an appreciable latent period before its effect
develops. The development of side effects that caused patients to
discontinue THC could be predicted by the size of the single dose
of THC that was used. Given cumulatively, that is, in smaller
doses begun at a longer interval before chemotherapy, an
effective level should be achieved with fewer side effects than
if a single large dose is used in effort to achieve a rapid
effect. See Appendix VI. </p>

<p> Cumulative Protocol for Oral THC Adopted. in 1982, the
cumulative, low-dose regimen was adopted, for the Oral THC
Protocol to reduce the number of patients who stopped THC therapy
because of side effects that were discomforting rather than life
threatening. The lower initial dose (2.5mg/m2) beginning
approximately 24 hours prior to anticancer therapy allowed
patients to accommodate better to THC as an antiemetic. See
Appendix VII. </p>

<p> Combination Antiemetic Protocol. By 1983, it became apparent
that oncologists were prescribing several antiemetics in
combination in an effort to maximize the benefit. This approach
to treatment led investigators in the cannabis study to suggest
using THC in combination with other antiemetics. Only two studies
involving THC used in combination with another drug had been
conducted and in both cases, the other drug was a phenothiazine.
The effectiveness of THC tied in combination with a variety of
other antiemetics was not established and further clinical trials
were needed. Additive effects, particularly if the drugs had
different mechanisms of action, were expected to enhance the
effectiveness of THC. Appendix VIII includes the Combination
Antiemetic Protocol, consent form, patient package insert,
investigator brochure. and the combination protocol for pediatric
patients. </p>

<p> Smoked Marijuana Protocol. In March 1982, the Panel also
revised the protocol for smoked marijuana to broaden access.
Based on suggestions from oncologists and the absence of
associated problems, the protocol was expanded to include
outpatients and marijuana-naive patients who were taught a
standardized smoking technique. </p>

<p> In late 1982, the Panel further revised the Smoked Marijuana
Protocol. This protocol made any cancer patient receiving
radiation therapy or any chemotherapy drugs known to cause nausea
and vomiting eligible to participate, and permitted an
alternative smoking technique to humidify the smoke and reduce
the smoke's harshness by water filtration. Appendix IX contains
the initial versions of the Smoked Marijuana Protocol which
finally was also included in the Combination Protocol above. </p>

<p> Controlled Studies. In addition to the statewide open studies
described above, the Panel sponsored two double-blind, cross-over
controlled studies conducted by a small group of investigators. </p>

<p> THC in Combination with Scopolamine. One protocol was
intended to test the efficacy of THC use in combination with
Transderm V, a patch which is applied to the skin behind the ear
and releases an antinausea drug, scopolamine, through the skin
continuously over a period of two to three days (Appendix X).
Transderm V was supplied by CibaGeigy with double-blind labeling
and was to be randomly substituted with an identical placebo
patch. </p>

<p> THC in Combination with Dexamethasone. The second protocol,
also a double blind cross over study, was intended to test the
efficacy of THC used in combination with dexamethasone, an
antiinflammatory steroid which has been used as an antiemetic
(Appendix XI). Dexamethasone was supplied by Merck Sharp &amp;
Dohme Research Laboratories with double-blind labeling and was to
be randomly substituted with an identical placebo tablet. These
protocols began in late 1983 and continued to be available until
December 1987. </p>

<p> Delta-8-THC. Some reports in the medical literature claim
that delta-8-tetrahydrocannabinol (delta-8-THC), a synthetic
cannabinoid not present in natural marijuana, possesses actions
similar to those of delta-9-THC, but possibly caused fewer
central nervous system side effects. The Panel, with the
assistance of Marie Perez-Reyes, M.D., developed a pilot research
project to study the effects of delta-8-THC as an antiemetic. </p>

<p> In October 1983, the Panel submitted IND 124,094 to the U.S.
Food and Drug Administration (Appendix XII). Patients were first
enrolled in October 1983. The Pilot Protocol (protocol
exceptions) and the Glaucoma Protocol (Appendix XIV) are
discussed in detail later in the sections on findings. </p>

<p> Each protocol change was duly reported to FDA and discussed
as necessary with that agency's representatives. No revision
request was denied. </p>

<p> Table A provides a summary of the history of protocol changes
for the Cannabis Therapeutic Program. </p>

<h3>Data Collection </h3>

<p> Initially, data on patient history and the physician's
evaluation of treatment were collected at the time of treatment
using three standardized forms. The &quot;Chemotherapy and
Medical History Prior to THC&quot; form requested information
regarding patient characteristics and past chemotherapy and
antiemetic experience. The 'Physician's Treatment Episode Report'
included information on THC dosage, chemotherapy, performance
status of patient, overall THC effectiveness rating on a 4-point
scale, and ratings of the incidence and severity of 13 designated
THC side effects. Every day that patients received THC, they
completed a &quot;THC Evaluation Form,' rating nausea, vomiting,
food intake and overall effectiveness using 4- and 5-point
scales. If a patient dropped out of the study, the specific
reason was noted. Details of serious adverse reactions were
reported separately. </p>

<p> Much of the pilot testing and design of data collection forms
was conducted in collaboration with investigators and their
staff. The Cannabis Therapeutic Program paperwork, including the
Patient Package Insert and the Treatment Report forms were
thoroughly reviewed by many of these persons. </p>

<p> As protocols were changed, data forms were also revised in an
effort to increase enrollment by reducing the burden of paperwork
for investigators and patients. Revisions were color-coded for
easy identification. All data forms are attached to the protocols
included in the appendices. </p>

<p> The latest revision of the protocol (2/11/83) required
completion of only one data form for each treatment episode and
requested only that information which was considered essential. -
</p>

<p> For the purposes of evaluation and analysis, data from the
earlier forms were transcribed by Panel staff to the newer form
for consistency in coding. Independent contractors were utilized
for data entry and analysis for the first phases of the study.
Thereafter, Panel staff conducted the analysis for the concluding
phases. </p>

<h3>Data Quality Control </h3>

<p> In general, there were few problems with protocol compliance.
Physician cooperation was exemplary despite protocol details,
controlled substances prescription forms, and reports to be
completed. This is particularly noteworthy in view of the fact
that the funding usually provided by drug companies. </p>

<p> An important result from the site visits was the initiation
of Cannabis Therapeutic Program Newsletters designed to keep
investigators, nurses, and pharmacists abreast of program
developments and research findings. </p>

<h3>Dissemination of Findings and Results </h3>

<p> The Panel kept the Legislature, the medical community, and
the public informed about the program and its findings through
the Panel's Annual Reports to the Governor and Legislature,
newsletters and announcements to investigators, presentations at
professional meetings and publication in professional journals.
The FDA received quarterly reports as required. </p>

<p> By invitation of the Illinois Dangerous Drug Commission, the
preliminary results of the California Program were presented at
the National Conference on Marijuana and Cannabinoid Therapeutics
in Chicago in March 1982. The legal, administrative and
operational aspects of the California program were shared with
the professionals attending the meeting. </p>

<p> The Panel also published in scientific publications several
reports on research findings and program development: </p>

<p> Gordon J. Dow and Frederick H. Meyers, The California Program
for the Investigational Use of THC and Marijuana in Heterogeneous
Populations Experiencing Nausea and Vomiting from Anticancer
Therapy, Journal of Clinical Pharmacology, 21:128S-132S, 1981. </p>

<p> Dow, G.J. and others. Serious reactions to oral delta-9-THC
in cancer chemotherapy patients. Clinical Pharmacy 3:14, 1981. </p>

<p> Meyers, F. and others. Reduced adverse effects with optimal
anti-emetics dosage schedule of delta-9-THC. Proceedings of Am.
Soc. Clin. Oncology, p94, 1984. </p>

<p> Devine, M. and others. Adverse reactions to delta-9-THC given
as an antiemetic in a multi-center study. Clinical Pharmacy
6:319-22, 1987. </p>

<p> Flach, A. and others. </p>

<p> Experience on Treatment of Glaucoma with delta-9-THC,
presentation for meeting of American Academy of Ophthalmology, in
preparation. <br>
</p>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> <br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-4</DOCNO>
<DOCOLDNO>IA087-000627-B014-40</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ctp2.htm 206.61.184.43 19970122050945 text/html 64051
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:09:34 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:01:13 GMT
Content-length: 63833
</DOCHDR>
<html>

<head>
<title>Cannabis Therapeutic Program DETAILED PROTOCOL RESULTS </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<p> </p>
</body>

<body bgcolor="#ffffff">

<p><img src="../../graphics/blueline.gif"> </p>

<p> <b><font size="2">California Research Advisory Panel</font></b>
</p>

<h1>Cannabis Therapeutic Program</h1>

<p> <img src="../../graphics/blueline.gif"><br>
</p>

<p> <font size="1">DETAILED PROTOCOL RESULTS <br>
</font> </p>

<p> <font size="2">Interpretations of efficacy of THC are limited
by the fact that in this study no control group could be
established for comparison with the treatment group. Thus, some
of the findings are more anecdotal than quantitative. However,
the following results are clear, reasonable and documented. <br>
<br>
</font> </p>

<p> <font size="2">Number of Patients Treated <br>
</font> </p>

<p> <font size="2">A total of 2,475 patients were treated with
THC or smoked marijuana under one or more of the following
protocols: <br>
</font> </p>

<p> <font size="2">Smoked Marijuana Protocols 119<br>
</font> </p>

<p> <font size="2">The compassionate access</font> </p>

<p> <font size="2">THC protocols 2400<br>
</font> </p>

<p> <font size="2">Dexamethasone Protocol 4 <br>
</font> </p>

<p> <font size="2">Transderm-V Protocol 65<br>
</font> </p>

<p> <font size="2">Delta-8-THC Protocol 10<br>
</font> </p>

<p> <font size="2">Pilot Protocol (protocol</font> </p>

<p> <font size="2">exceptions) 19<br>
</font> </p>

<p> <font size="2">Glaucoma Protocol 9<br>
<br>
</font> </p>

<p> <font size="2">Because of the protocol revisions previously
described, data had to be tabulated separately for each of the
several compassionate access THC protocols (subjects who received
THC for nausea and vomiting associated with cancer chemotherapy):<br>
<br>
a) <u>Initial Trial</u> 856 patients enrolled in the initial
Protocols I, II, and III between November 1980 and April 1982,
and followed until October 1982. <br>
b) <u>Cumulative Dose Protocol </u>365 patients enrolled in the
Cumulative Dose Protocol.<br>
</font> </p>

<p> <font size="2">c) <u>Combination Antiemetic Protocol</u> 657
patients enrolled in the Combination Antiemetic Protocol, whose
treatment report forms were returned to RAP after January 1,
1984.<br>
</font> </p>

<p> <font size="2">Initial Trial<br>
<u>Summary</u>. These first results reflect data from an open
multisite cooperative study conducted to evaluate
delta-9-tetrahydrocannabinol (THC) in patients receiving
anticancer therapy who previously had been treated with other
antiemetics.<br>
</font> </p>

<p> <font size="2">Oral THC was found to be effective in reducing
nausea, vomiting and anorexia.</font> </p>

<p> <font size="2">Effectiveness was related to chemotherapeutic
regimen, generally being most effective with the less emetogenic
agents. <br>
Side effects were common. Serious adverse reactions were reported
by physicians for nine patients, but none of these were life
threatening. There was no significant difference between the
effectiveness of the 5mg/m2 and 7.5mg/m2 doses, but 5mg/M2 was
associated with fewer side effects, a lower dropout rate due to
side effects and a greater number of patients continuing THC
treatment. Thus, 5mg/m2 is the preferred dose. The incidence of
clinically serious adverse reactions to oral THC was less than
one percent.<br>
</font> </p>

<p> <u><font size="2">Patient and Investigator</font></u> </p>

<p> <u><font size="2">Demographics</font></u><font size="2"> Of
about 300 board certified and eligible oncologists, one hundred
seventy-nine enrolled 856 patients, of which 706 were evaluable.
Patients were enrolled between November 1980 and April 1982, and
were followed until October 1982, at which time a final
disposition was obtained on each patient. A total of 150 patients
were excluded from analysis due to incomplete report forms,
enrollment at dosages other than 5mg/m2 or 7.5mg/m and enrollment
by 26 investigators who did not adhere to the protocol.<br>
</font> </p>

<p> <font size="2">To avoid bias caused by selective
dropping-out, only results from the first treatment episode are
analyze in this report, although over half the patients received
THC in two or more discrete episodes for a total of 1622
treatments in this initial trial. Results of second and
subsequent episodes are statistically more favorable since
patients with disturbing side effects and those with good results
self-select for continuation or termination. <br>
</font> </p>

<p> <font size="2">Sixty percent entered the study at a THC dose
of 7.5m 2g/m2 ; 40% entered at the 5mg/ml dose level. Sixty-two
percent of the patients were female. The median age for women was
49, and for men was 38. Sixty-four percent of the patients had
breast, lung. ovarian, or hematopoietic neoplasms. Seventyseven
percent of the patients were able to carry on <u>normal</u>
activities despite their disease (Karnofsky <u>performance</u>
status of 80 or more). </font> </p>

<p> <font size="2">Ninety-nine percent of patients had failed to
benefit significantly from other antiemetics, which were
phenothiazines (87Z), butyrophenones (6%), metoclopramide (6%),
and others (3%). A wide variety of chemotherapeutic agents were
used, usually in combinations. The number of patients per
participating physician varied widely: 69 physicians or 41% of
them had one or two patients while 25 physicians (15%) had 10 or
more patients in the program (Table B).<br>
</font> </p>

<p> <font size="2">Proportionately, among men there were more
young persons than among women: 30% of the men compared with only
132 of the women were below 30 years. 44% of the men and 611 of
the women were in the age group 30-59 years. The age groups above
60 years were equally represented among men and women (26%)
(Table C). <br>
</font> </p>

<p> <font size="2">The tumor sites most commonly represented
among the patients in the THC program were, for women, carcinoma
of the breast (38%) and cancer of the ovary or uterus (21%). The
most common primary tumor sites among the men were Hodgkin's
lymphoma (18%) and lung carcinoma (18%) (Table D). It should be
emphasized, however, that the distribution of primary organ
locations is not representative of the prevalence by site in the
general population. <br>
</font> </p>

<p> <center><font size="2">Table B<br>
</font></center> </p>

<p> <font size="2">Frequency Distribution of 167 Physicians<br>
</font> </p>

<p> <font size="2">by Number of Patients Treated with THC
Capsules</font> </p>

<p> <font size="2">------------------------------------------------
<br>
</font> </p>

<p> <font size="2">Number Frequency Number Frequency</font> </p>

<p> <font size="2">of of of of</font> </p>

<p> <font size="2">Patients Physicians Patients Physicians</font>
</p>

<p> <font size="2">-------- ---------- -------- ----------</font>
</p>

<p> <font size="2">1 33 13 2</font> </p>

<p> <font size="2">2 36 14 3</font> </p>

<p> <font size="2">3 18 15 2</font> </p>

<p> <font size="2">4 18</font> </p>

<p> <font size="2">5 12 15 1</font> </p>

<p> <font size="2">6 5 1</font> </p>

<p> <font size="2">7 8 21 1</font> </p>

<p> <font size="2">8 5</font> </p>

<p> <font size="2">9 5 28 1</font> </p>

<p> <font size="2">10 6</font> </p>

<p> <font size="2">11 3 29 1</font> </p>

<p> <font size="2">12 5<br>
</font> </p>

<p> <font size="2">---------------------------------------------------------
<br>
</font> </p>

<p> <font size="2">167 physicians treated 809 patients with THC
capsules. <br>
<br>
<br>
<br>
</font> </p>

<p> <center><font size="2">Table C<br>
</font></center> </p>

<p> <center><font size="2">Characteristics of Study<br>
</font></center> </p>

<p> <center><font size="2">Population of the Initial Trial</font></center>
</p>

<p> <center><font size="2">------------------------------- <br>
</font></center> </p>

<p> <font size="2">Male Female<br>
</font> </p>

<p> <font size="2">No. Percent No. Percent</font> </p>

<p> <font size="2">--- ------- --- ------- <br>
</font> </p>

<p> <font size="2">Sex: 306 37.92 501 62.08 <br>
</font> </p>

<p> <font size="2">Age Distribution:<br>
</font> </p>

<p> <font size="2">19 yrs or less 23 7.52 29 5.79</font> </p>

<p> <font size="2">20 - 29 yrs 67 21.90 36 7.19</font> </p>

<p> <font size="2">30 - 39 yrs 57 18.63 81 16.17</font> </p>

<p> <font size="2">40 - 49 yrs 30 9.80 99 19.76</font> </p>

<p> <font size="2">50 - 59 yrs 44 14.38 125 24.95</font> </p>

<p> <font size="2">60 - 69 yrs 56 18.30 96 19.16</font> </p>

<p> <font size="2">70 yrs or more 23 7.52 32 6.39</font> </p>

<p> <font size="2">Unknown 6 1.96 3 0.60<br>
</font> </p>

<p> <font size="2">--------------------------------------------------------
<br>
</font> </p>

<p> <font size="2">Base: 890 patients receiving capsules.<br>
</font> </p>

<p> <font size="2">Exclusions: 2 patients with sex unreported.<br>
</font> </p>

<p> <center><font size="2">Table D<br>
</font></center> </p>

<p> <font size="2">Distribution of Primary Tumor Site by Sex</font>
</p>

<p> <font size="2">----------------------------------------- <br>
<br>
</font> </p>

<p> <font size="2">Primary Tumor Site Males Females<br>
</font> </p>

<p> <i><font size="2">No.</font></i><font size="2"> Percent No.
Percent <br>
</font> </p>

<p> <font size="2">Lip. Oral Cavity &amp; Pharynx 7 2.3 5 1.0<br>
</font> </p>

<p> <font size="2">Digestive Organs &amp;</font> </p>

<p> <font size="2">Peritoneum 36 12.0 21 4.2</font> </p>

<p> <font size="2">Examples:</font> </p>

<p> <font size="2">Stomach 6 2.0 1 0.2</font> </p>

<p> <font size="2">Colon, Caecum, 11 3.7 10 2.0</font> </p>

<p> <font size="2">Pancreas 6 2.0 4 0.8<br>
</font> </p>

<p> <font size="2">Respiratorv &amp; Intra-</font> </p>

<p> <font size="2">thoracic Organs 68 22.6 49 9.8</font> </p>

<p> <font size="2">Examples:</font> </p>

<p> <font size="2">Lung-Trachea 53 17.6 40 8.0 <br>
</font> </p>

<p> <font size="2">Thymus, Heart &amp;</font> </p>

<p> <font size="2">Mediastinum 12 4.0 6 1.2 <br>
</font> </p>

<p> <font size="2">Bone. Connective-Tissue,</font> </p>

<p> <font size="1">Skin </font><font size="2">&amp; breast 39
13.0 216 43.3</font> </p>

<p> <font size="2">Examples:</font> </p>

<p> <font size="2">Bone &amp; Articular</font> </p>

<p> <font size="2">Cartilage 20 6.6 10 2.0<br>
</font> </p>

<p> <font size="2">Connective &amp; Other</font> </p>

<p> <font size="2">Soft Tissue 10 3.3 11 2.2 <br>
</font> </p>

<p> <font size="2">Female Breast 191 38.3 <br>
</font> </p>

<p> <font size="2">Genitourinarv Organs 41 .13.6 124 .24.8</font>
</p>

<p> <font size="2">Examples:</font> </p>

<p> <font size="2">Uterus 6 1.2<br>
</font> </p>

<p> <font size="2">Ovary &amp; Other Uterine</font> </p>

<p> <font size="2">Adnexa 106 21.2<br>
</font> </p>

<p> <font size="2">Prostate 10 3.3</font> </p>

<p> <font size="2">Testis 24 8.0<br>
</font> </p>

<p> <font size="2">Lymphatic &amp; heamatopoeitic</font> </p>

<p> <b><font size="1">Tissue</font></b><font size="1"> </font><font
size="2">73 24.3 46 9.2</font> </p>

<p> <font size="2">Examples:</font> </p>

<p> <font size="2">Hodgkin's Disease 55 18.3 30 6.0</font> </p>

<p> <font size="2">Myeloid Leukemia 9 3.0 8 1.6<br>
</font> </p>

<p> <font size="2">Other unspecified sites 37 12.3 38 7.6<br>
</font> </p>

<p> <font size="2">-----------------------------------------------------------------</font>
</p>

<p> <font size="2">499 100.0<br>
</font> </p>

<p> <font size="2">Total (n-800)<br>
</font> </p>

<p> <font size="2">301 100.0<br>
</font> </p>

<p> <u><font size="2">Study design</font></u><font size="2">. The
California statute that established the cannabis program includes
the objective of providing 'compassionate access' to marijuana
for cancer patients receiving chemotherapy and radiotherapy.
Strict experimental control measures were thereby precluded.
Patients served as their own controls. however, through
comparison with previous antiemetic trials.<br>
</font> </p>

<p> <u><font size="2">Drug dose and schedule</font></u><font
size="2">. The drug was supplied by the National Cancer Institute
as soft gelatin capsules containing 2.5, 5 and 10mg
delta-9tetrahydrocannabinol dissolved in sesame oil. Based on
dosage, two cohorts of patients participated in this initial
study. Patients in the first cohort received 7.5mg THC/m2 every
four hours while awake starting six hours prior to anticancer
therapy, and continuing for 24 to 48 hours after its completion.
If severe side effects occurred, the physician had the option to
either delay, omit, or reduce the next dose, or discontinue THC
treatment. Preliminary results from the 7.5mg/m2 dose regimen
indicated that a lower starting dose of THC might be better
tolerated. Thus, patients in the second cohort were those given
5mg THC/m2 in the same manner. <br>
</font> </p>

<p> <u><font size="2">Efficacy</font></u><font size="2">. In 482
patients, the identical anticancer treatment was used with the
THC treatment episode and with the prior treatment episode,
allowing comparison of the efficacy of THC to a standard
antiemetic. As illustrated in Table E, nausea and vomiting were
better controlled by THC than by previous antiemetics in 752 and
731 of patients respectively. Fifty-five percent of patients
reported improved food intake. Although some nausea and vomiting
occurred in most patients during the THC trial, as shown in
Tables F and G, nausea was absent in 17% and mild in 38% of the
patients. Vomiting was absent in 30% of the population. and in
another 33% occurred an average of less than four times daily. As
illustrated in Table B. 62% of patients rated THC moderately to
very effective. Physicians' effectiveness ratings for THC used in
conjunction with various chemotherapy agents are summarized in
Table I. Depending on the anticancer agent used, THC was
effective in anywhere from 38% to 662 of the patients. No
statistically significant associations were found between
effectiveness and age, sex or primary tumor site.<br>
</font> </p>

<p> <u><font size="2">Effectiveness and Chemotherapeutic Drugs</font></u><font
size="2">. Because of the size of this statewide cooperative
study, assessment of effectiveness of THC was possible with
specific chemotherapeutic regimens. As rated by physicians THC
was most effective with chemotherapy regimens known as CMF5*,
FAC**, and AC***. Physicians rated THC as moderately or very
effective in 82 percent of the treatment episodes involving CMF,
76 percent of those involving FAC, and 75 percent of those
involving AC. THC was least effective with DTA**** and</font> </p>

<p> <font size="2">CISCA*****, yet over 40 percent of these
patients benefitted significantly.<br>
<br>
</font><font size="1">5. CMF Is Cyclophosphamide. nethotrexate
&amp; 5-FU<br>
FAC is 5-FU. Adriamycin &amp; cyclophosphamide</font> </p>

<p> <font size="1">*** AC Is Adriamycin &amp; cyclophosphaside<br>
*** DTA Is Decarbazine &amp; Adriamycin</font> </p>

<p> <font size="1">:**** CISCA in Cisplatin, cyclophosphamide
&amp; Adriemycin<br>
</font> </p>

<p> <center><font size="2">Table E<br>
</font></center> </p>

<p> <center><font size="2">Patient's Assessment of Symptoms:<br>
</font></center> </p>

<p> <center><font size="2">THC Compared to Previous Antiemetic*</font></center>
</p>

<p> <font size="2">----------------------------------- <br>
<br>
<br>
</font> </p>

<p> <font size="2">Severity of Nausea Vomiting Anorexia</font> </p>

<p> <font size="2">Symptoms No. No. % No.</font> </p>

<p> <font size="2">----------- ---------- -----------
------------<br>
</font> </p>

<p> <font size="2">Less with THC 363 75 350 73 264 55</font> </p>

<p> <font size="2">Same 78 16 61 13 119 25</font> </p>

<p> <font size="2">Greater with THC 41 9 67 14 93 20</font> </p>

<p> <font size="2">Total 482 100 478 100 476 100<br>
</font> </p>

<p> <font size="2">----------------------------------------------------------------Only
includes patients whose anticancer treatment was unchanged.<br>
<br>
<br>
<br>
<br>
<br>
</font> </p>

<p> <center><font size="2">Table F<br>
</font></center> </p>

<p> <center><font size="2">Nausea during THC Protected</font></center>
</p>

<p> <center><font size="2">Anticancer Treatment</font></center> </p>

<p> <center><font size="2">--------------------------- <br>
<br>
</font></center> </p>

<p> <font size="2">Nausea Rating Number of Patients Percent</font>
</p>

<p> <font size="2">------------- ------------------ -------<br>
</font> </p>

<p> <font size="2">None 112 17<br>
</font> </p>

<p> <font size="2">Mild 248 38<br>
</font> </p>

<p> <font size="2">Moderate 166 25<br>
</font> </p>

<p> <font size="2">Severe 130 20<br>
</font> </p>

<p> <font size="2">Total 656 100<br>
</font> </p>

<p> <font size="2">----------------------------------------------
<br>
</font> </p>

<p> <center><b><font size="2">Table </font></b><font size="2">G <br>
</font></center> </p>

<p> <center><font size="2">Vomiting during THC Protected</font></center>
</p>

<p> <center><font size="2">Anticancer Treatment <br>
</font></center> </p>

<p> <center><font size="2">----------------------------- <br>
<br>
</font></center> </p>

<p> <font size="2">Amount of Vomiting Number of Patients Percent</font>
</p>

<p> <font size="2">------------------ ------------------ -------<br>
</font> </p>

<p> <font size="2">None 197 30<br>
</font> </p>

<p> <font size="2">1-3 times 218 33<br>
</font> </p>

<p> <font size="2">4-6 times 83 13<br>
</font> </p>

<p> <font size="2">7 or more times 158 24<br>
</font> </p>

<p> <font size="2">Total 656 100<br>
</font> </p>

<p> <font size="2">-----------------------------------------------------
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
</font> </p>

<p> <center><font size="2">Table H<br>
</font></center> </p>

<p> <center><font size="2">Patient Overall Assessment <br>
</font></center> </p>

<p> <center><font size="2">of THC Effectiveness</font></center> </p>

<p> <center><font size="2">-------------------------- <br>
<br>
<br>
</font></center> </p>

<p> <font size="2">Degree of Effectiveness Number of Patients
Percent</font> </p>

<p> <font size="2">----------------------- ------------------
------- <br>
</font> </p>

<p> <font size="2">None 152 24<br>
</font> </p>

<p> <font size="2">Slight 92 14<br>
</font> </p>

<p> <font size="2">Moderate 196 30<br>
</font> </p>

<p> <font size="2">Very 203 32<br>
</font> </p>

<p> <font size="2">Total 643 100<br>
</font> </p>

<p> <center><font size="2">Table I<br>
<br>
</font></center> </p>

<p> <center><font size="2">Physician's Effectiveness Rating of</font></center>
</p>

<p> <center><font size="2">THC by Chemotherapy Regimen</font></center>
</p>

<p> <center><font size="2">----------------------------------- <br>
<br>
</font></center> </p>

<p> <font size="2">Chemotherapy Regimen Total Number Moderate or
Very</font> </p>

<p> <font size="2">of Patients Effective Rating</font> </p>

<p> <font size="2">-------------------- ------------
---------------- <br>
</font> </p>

<p> <font size="2">No.<br>
</font> </p>

<p> <font size="2">5 Fluorouracil, Adriamycin</font> </p>

<p> <font size="2">and cyclophosphamide 32 21 66<br>
<br>
</font> </p>

<p> <font size="2">Cyclophosphamide, metho-</font> </p>

<p> <font size="2">trexate and 5 fluorouracil 56 37 66<br>
<br>
</font> </p>

<p> <font size="2">Adriamycin and cyclophosphamide 90 57 63<br>
<br>
</font> </p>

<p> <font size="2">Cyclophosphamide, Adriamycin,</font> </p>

<p> <font size="2">vincristine and prednisone 51 28 55<br>
<br>
</font> </p>

<p> <font size="2">Cisplatin, cyclophosphamide</font> </p>

<p> <font size="2">and Adriamycin 50 20 40<br>
<br>
</font> </p>

<p> <font size="2">Dacarbazine and Adriamycin 34 13 38<br>
</font> </p>

<p> <u><font size="1">Safety</font></u><font size="1">.
Physicians were required to make a separate report of any
clinically serious adverse reaction, defined as a reaction while
taking THC that required the use of drugs or hospitalization of
the patient. During the course of this trial, five clinically
serious adverse reactions were reported among the first 856
patients treated with THC. There were two instances of severe
psychological distress (anxiety), and one case each of myoclonic
jerking, postural hypotension, and grand mal seizure.
Complicating factors, for example, brain metastasis associated
with the seizure, were present in three cases. All patients with
serious adverse reactions had the drug immediately discontinued
and recovered fully with no sequelae. Generally, no other drug
treatment was needed.<br>
</font> </p>

<p> <u><font size="1">Side Effects</font></u><font size="1">.
Side effects were common: even at the lower dose, about 80% of
patients had at least one side effect, and in 26% of those
patients, at least one side effect was considered severe. The
severe side effects with an incidence of 5% or greater were all
central nervous system effects. A significant difference between
the sexes was observed: nine percent of women reported severe
anxiety as compared to 4% of men (p=.025).<br>
</font> </p>

<p> <u><font size="1">Influence of Dose</font></u><font size="1">
Level. The THC dose level was found to influence the frequency of
side effects and drug-related reasons for dropping out of the
study, but did not influence drug effectiveness. <br>
</font> </p>

<p> <font size="1">The frequency and nature of various side
effects rated as moderate and severe for both THC </font><font
size="2">dose levels are listed in Table J. Dose level influenced
which side effects were reported most frequently as severe. At
7.5mg/m2, the two most common severe side effects were confusion
and anxiety. At 5mg/m2, these were sedation and confusion.
Patients receiving 5mg/m2 reported an average of 3.3 moderate and
severe side effects, compared with 4.4 per patient receiving
7.5mg/m2. Side effects were almost always less severe when the
lower dose of THC was used, and this difference was significant
for seven of the 13 categories of side effects. <br>
</font> </p>

<p> <font size="2">While there was no statistically significant
difference between the high overall dropout rates associated with
either dose level, patients receiving the higher dose were more
likely to drop out because of side effects than were those on the
lower dose. Forty seven percent of the patients receiving 5mg/m2
and 492 receiving 7.5mg/M2 dropped out of the study before
receiving a second THC treatment. Approximately 20% of patients
in both groups dropped out for non-drug reasons (e.g., moved,
died, completed chemotherapy). 2 Of the patients who received
5mg/m 682 dropped out because THC was ineffective, and 32%dropped
out because THC produced side effects judged by the patient to be
intolerable. In contrast, in the 7.5mg/m2 group, only 521 dropped
out due to drug ineffectiveness, and 48% dropped out due to
intolerable side effects, a significant difference between doses
(P&lt;.05). There was no difference in the overall drop-out rate
between the two dosage groups.<br>
</font> </p>

<p> <u><font size="2">Safety</font></u><font size="2">.
Physicians were required to make a separate report of any
clinically serious adverse reaction, defined as a reaction while
taking THC that required the use of drugs or hospitalization of
the patient. During the course of this trial, five clinically
serious adverse reactions were reported among the first 856
patients treated with THC. There were two instances of severe
psychological distress (anxiety), and one case each of myoclonic
jerking, postural hypotension, and grand mal seizure.
Complicating factors, for example, brain metastasis associated
with the seizure, were present in three cases. All patients with
serious adverse reactions had the drug immediately discontinued
and recovered fully with no sequelae. Generally, no other drug
treatment was needed.<br>
</font> </p>

<p> <u><font size="2">Side Effects</font></u><font size="2">.
Side effects were common: even at the lower dose, about 80% of
patients had at least one side effect, and in 262 of those
patients, at least one side effect was considered severe. The
severe side effects with an incidence of 5% or greater were all
central nervous system effects. A significant difference between
the sexes was observed: nine percent of women reported severe
anxiety as compared to 42 of men (p=.025).<br>
</font> </p>

<p> <u><font size="2">Influence of Dose</font></u><font size="2">
Level. The THC dose level was found to influence the frequency of
side effects and drug-related reasons for dropping out of the
study, but did not influence drug effectiveness. <br>
</font> </p>

<p> <font size="2">The frequency and nature of various side
effects rated as moderate and severe for both THC dose levels are
listed in Table J. Dose level influenced which side effects were
reported most frequently as severe. At 7.5mg/m2, the two most
common severe side effects were confusion and anxiety. At 5mg/m2,
these were sedation and confusion. Patients receiving 5mg/m2
reported an average of 3.3 moderate and severe side effects,
compared with 4.4 per patient receiving 7.5mg/m2. Side effects
were almost always less severe when the lower dose of THC was
used, and this difference was significant for seven of the 13
categories of side effects. <br>
</font> </p>

<p> <font size="2">While there was no statistically significant
difference between the high overall dropout rates associated with
either dose level, patients receiving the higher dose were more
likely to drop out because of side effects than were those on the
lower dose. Fortyseven percent of the patients receiving 5mg/m2
and 492 receiving 7.5mg/M2 dropped out of the study before
receiving a second THC treatment. Approximately 20% of patients
in both groups dropped out for non-drug reasons (e.g., moved,
died, completed chemotherapy). Of the patients who received
5mg/M2, 681 dropped out because THC was ineffective, and 32Z
dropped out because THC produced side effects judged by the
patient to be intolerable. In contrast, in the 7.5mg/m2 group,
only 52% dropped out due to drug ineffectiveness, and 482 dropped
out due to intolerable side effects, a significant difference
between doses (P&lt;.05). There was no difference in the overall
drop-out rate between the two dosage groups.<br>
</font> </p>

<p> <center><font size="2">Table J<br>
</font></center> </p>

<p> <center><font size="2">Comparison of the Incidence of Side<br>
</font></center> </p>

<p> <center><font size="2">Effects with 5/mg/m2 vs. 7.5mg/m2 THC</font></center>
</p>

<p> <center><font size="2">------------------------------------- <br>
<br>
</font></center> </p>

<p> <font size="2">Side Effect</font> </p>

<p> <font size="2">(Incidence as Moderate Severe</font> </p>

<p> <font size="2">percentage)</font> </p>

<p> <font size="2">7.5mg/m2 5mg/m2 7.5mg/m2 5mg/m2</font> </p>

<p> <font size="2">------------- ------ -------- ------<br>
</font> </p>

<p> <font size="2">Dry mouth** 46.5 35.4 3.9 3.2<br>
</font> </p>

<p> <font size="2">Tachycardia 12.0 10.9 2.0 1.1<br>
</font> </p>

<p> <font size="2">Ataxia** 21.9 18.3 5.4 1.1 <br>
</font> </p>

<p> <font size="2">Dizziness 41.7 27.1 8.7 4.6 <br>
</font> </p>

<p> <font size="2">Orthostatic</font> </p>

<p> <font size="2">hypotension 16.8 14.1 3.0 2.5.<br>
</font> </p>

<p> <font size="2">Anxiety** 22.3 14.4 3.8 <br>
</font> </p>

<p> <font size="2">Sedation* 56.9 47.7 6.8 7.0 <br>
</font> </p>

<p> <font size="2">Depressed mood*** 24.0 13.3 7.1 3.5<br>
</font> </p>

<p> <font size="2">Elated mood 31.1 35.4 4.1 3.9<br>
</font> </p>

<p> <font size="2">Panic 7.6 4.6 6.4 4.2<br>
</font> </p>

<p> <font size="2">Confusion** 34.4 27.5 10.4 5.6<br>
</font> </p>

<p> <font size="2">Distortion of</font> </p>

<p> <font size="2">perception 26.3 22.1 6.6 3.5<br>
</font> </p>

<p> <font size="2">Fantasizing 16.0 15.1 4.0 2.1<br>
</font> </p>

<p> <font size="2">----------------------------------------------------------------</font>
</p>

<p> <font size="2"> (5mg) - 285-285 n (7.5mg) - 404-413<br>
</font> </p>

<p> <font size="2">* P&lt;.05 ** P&lt;.Ol *** P&lt;.001<br>
</font> </p>

<p> <font size="2">However, in those patients reporting two or
more severe side effects isolated as separate groups, patients
receiving 5mg/m2 were more likely to continue on to a second THC
treatment, regardless of the number of severe side effects
reported. Forty-three percent of the patients who had experienced
two or more severe side effects continued on to a second THC
treatment when started at 5mg/m2. This compared with 29% of those
started at 7.5mg/m2. <br>
</font> </p>

<p> <u><font size="2">Discussion</font></u><font size="2">. This
first study included patients with a wide variety of cancer
types, covering a broad age range, and receiving treatment from
oncologists in community as well as university settings. It thus
served as a test of the antiemetic effect of THC under conditions
similar to those which would exist in clinical practice were the
drug generally available.<br>
</font> </p>

<p> <font size="2">Oral THC was found to be a safe and effective
antiemetic for most cancer chemotherapy patients. This study
shows that a single THC dose of 5mg/m2 causes fewer side effects
than 7.5mg/m2 while maintaining equal effectiveness. The larger
dose, 7.5mg/m2, should be considered for patients not deriving
sufficient protection from 5mg/m2<br>
</font> </p>

<p> <font size="2">The results of this study are particularly
noteworthy for two reasons:<br>
</font> </p>

<p> <font size="2">1) The large number of patients studied
strengthens conclusions reached regarding the effectiveness and
safety of THC. As of Cocchetto's 1981 review of the literature,
the largest sample size of the studies reported was only 116
patients. Ungerleider, et al., reported on 214 patients in 1982.
This Research Advisory Panel study, on the other hand, collected
detailed treatment reports and patient histories from 706
patients.<br>
</font> </p>

<p> <font size="2">2) Most of the patients enrolled in this
initial program had not responded to conventional antiemetics,
thus posing a more difficult therapeutic test than if THC had
been the first antiemetic drug used.<br>
<br>
The high drop-out rate and observations of individual patients
suggested that the rapid appearance of side effects in patients
with limited experience with disinhibiting drugs led to anxiety
and even panic. THC has an appreciable latent period, and, if the
drug is given immediately before chemotherapy a relatively large
single dose must be given to get a rapid effect. Such doses may
be effective but, when the effect is fully developed, will cause
more pronounced side effects. THC is known to have a long
half-life. Giving THC in a cumulative manner, that is, giving
repeated smaller doses at a longer time period prior to
chemotherapy, should allow more time for behavioral tolerance to
develop and achieve better patient acceptance but maintain
efficacy. To test that hypothesis a second trial was designed. <br>
</font> </p>

<p> <font size="2">Cumulative Dose Study<br>
<u>Summary</u>. The Cumulative Dose Protocol was designed to test
the above hypothesis, that the patient acceptance of oral THC
could be improved by using a cumulative dose schedule without the
lose of efficacy. The data below support that hypothesis. <br>
</font> </p>

<p> <u><font size="2">Patient and Investigator</font></u> </p>

<p> <u><font size="2">Demographics</font></u><font size="2">.
Patient demographics are similar to those of the first study and
are summarized for both protocols in Table K. Patients had a wide
variety of tumor types and received an assortment of
chemotherapeutic agents. In age, sex distribution, tumor types,
and anticancer treatment, the two cohorts did not differ
significantly. All patients had failed to achieve satisfactory
benefit from standard antiemetic before starting the study. The
most common antiemetic drug used prior to THC was
prochlorperazine.<br>
</font> </p>

<p> <u><font size="2">Study design</font></u><font size="2">.
Patients enrolled in the Cumulative Dose Protocol received 2.5mg
THC/m2 orally q4h, starting 4 doses prior to anticance treatment.
These patients were compared to a previous group of patients who
were treated under the standard protocol in which they received
5.Omg THC/m2 orally q4h, starting only 2 doses prior to
anticancer treatment. <br>
</font> </p>

<p> <font size="2">Results. The following is an analysis of the
results reported by California oncologists of their patients
enrolled in the Cumulative Dose Protocol. In this report, only
the first THC treatment was used in the comparative analysis of
the effectiveness and side effects to avoid bias due to over
representation of results from repeated trials on patients with
good response.<br>
</font> </p>

<p> <u><font size="2">Efficacy</font></u><font size="2">.
Physician ratings of nausea, vomiting and overall effectiveness
were similar in the initial and the cumulative protocols. Table L
compares the two cohorts as regards oncologists or nurses ratings
of nausea, vomiting and overall THC effectiveness. Although there
is a slight trend toward less nausea and less vomiting with
higher dose, with 952 confidence it is found that the
distribution of nausea and vomiting ratings are similar for both
protocols.' Similarly, 571 of patients rated THC as 'moderately'
or 'very' effective, exactly the same for the two dosage
schedules, indicating that side effects influence the overall
evaluation.<br>
</font> </p>

<p> <u><font size="2">Side Effects</font></u><font size="2">.
Table M summarizes the reports of moderate and severe THC side
effects and their severity as recorded by oncologists or nurses
on a standardized list. In no case was the percentage for a
moderate or severe side effect increased by the cumulative dosing
regimen; and the incidence of twelve of the thirteen side effects
listed was significantly reduced when compared to patients using
the initial THC protocol. <br>
</font> </p>

<p> <u><font size="2">THC Related Dropouts</font></u><font
size="2">. After the first treatment episode 27.5% of patients
receiving the cumulative dosing regimen and 22.9% of those
receiving the standard THC dosage dropped out of the trial. There
is no statistically significant difference in these dropout
rates.<br>
</font> </p>

<p> <u><font size="2">Conclusion</font></u><font size="2">. Based
on the preceding findings, it appears that prolonged exposure to
low dose THC is superior to standard THC therapy as an antiemetic
regimen for cancer chemotherapy patients. The cumulative dose
method decreases the number of moderate and severe side effects.
The cumulative dose method had no affect on the drug's reported
efficacy and had no affect on drop-out rate.<br>
</font> </p>

<p> <font size="2">Table K<br>
</font> </p>

<p> <font size="2">Patient Demographics</font> </p>

<p> <font size="2">--------------------<br>
Cumulative Dose Initial <br>
</font> </p>

<p> <font size="2">Protocol Protocol</font> </p>

<p> <font size="2">------------------ ---------------- <br>
</font> </p>

<p> <font size="2">(2.5mg THC/m2 with (5.Omg THC with<br>
</font> </p>

<p> <font size="2">4 loading doses) 2 loading doses)<br>
</font> </p>

<p> <font size="2">n - 134 n - 231<br>
<br>
</font> </p>

<p> <font size="2">Sex<br>
</font> </p>

<p> <font size="2">Males 38 % 46 %<br>
</font> </p>

<p> <font size="2">Females 62 % 54 %<br>
<br>
</font> </p>

<p> <font size="2">Age<br>
</font> </p>

<p> <font size="2">19 yrs or younger 7% 8%</font> </p>

<p> <font size="2">20 - 39 years 28% 34%</font> </p>

<p> <font size="2">40 - 59 years 44% 34%</font> </p>

<p> <font size="2">60 yrs or older 19% 23%<br>
</font> </p>

<p> <font size="2">--------------------------------------------------------------</font>
</p>

<p> <center><font size="2">Table L<br>
</font></center> </p>

<p> <font size="2">Comparison of Nausea, Vomiting and Overall
Effectiveness</font> </p>

<p> <font size="2">Between two THC Treatment Regimens<br>
</font> </p>

<p> <font size="2">--------------------------------------------------------
<br>
</font> </p>

<p> <font size="2">Ratings of Cumulative Single Dose</font> </p>

<p> <font size="2">---------- ---------- ----------- <br>
</font> </p>

<p> <font size="2">Nausea n - 124 n - 221<br>
</font> </p>

<p> <font size="2">None 17% 18%<br>
</font> </p>

<p> <font size="2">Mild 27% 32%<br>
</font> </p>

<p> <font size="2">Moderate 34% 31%<br>
</font> </p>

<p> <font size="2">Severe 22% 19%<br>
<br>
</font> </p>

<p> <font size="2">Vomiting n - 124 n - 221 <br>
</font> </p>

<p> <font size="2">None 32% 33%<br>
</font> </p>

<p> <font size="2">1 - 3 times 23% 29%<br>
</font> </p>

<p> <font size="2">3 - 4 times 14% 13%<br>
</font> </p>

<p> <font size="2">&gt; 4 times 31% 26%<br>
<br>
</font> </p>

<p> <font size="2">Overall Effectiveness n - 122 n - 221<br>
</font> </p>

<p> <font size="2">Not Effective 25% 20%<br>
</font> </p>

<p> <font size="2">Slightly 18% 23%<br>
</font> </p>

<p> <font size="2">Moderately 25% 25%<br>
</font> </p>

<p> <font size="2">Very 33% 32%<br>
</font> </p>

<p> <center><font size="2">Table M<br>
</font></center> </p>

<p> <font size="2">Comparison of the Incidence &amp; Severity of
Side Effects from THC</font> </p>

<p> <font size="2">Using Two Different Dosing Methods</font> </p>

<p> <font size="2">---------------------------------------------------------------
<br>
</font> </p>

<p> <font size="2">Side Effect Rated as Moderate Rated as Severe</font>
</p>

<p> <font size="2">(Incidence</font> </p>

<p> <font size="2">as Cumulative* Single Cumulative* Single</font>
</p>

<p> <font size="2">percentage) Dose** Dose**</font> </p>

<p> <font size="2">----------- ---------- ------ ----------
------<br>
</font> </p>

<p> <font size="2">Dry mouth** 19 40 3 6<br>
</font> </p>

<p> <font size="2">Tachycardia 2 5 0 1<br>
</font> </p>

<p> <font size="2">Ataxia** 2 15 2 1<br>
</font> </p>

<p> <font size="2">Dizziness 11 19 6 5<br>
</font> </p>

<p> <font size="2">Orthostatic</font> </p>

<p> <font size="2">hypotension 3 8 2 5<br>
</font> </p>

<p> <font size="2">Anxiety** 2 8 2 2<br>
</font> </p>

<p> <font size="2">Sedation* 19 46 9 9<br>
</font> </p>

<p> <font size="2">Elated mood 5 20 0 7<br>
</font> </p>

<p> <font size="2">Confusion** 8 24 2 5<br>
</font> </p>

<p> <font size="2">Distortion of</font> </p>

<p> <font size="2">perception 5 14 0 2<br>
</font> </p>

<p> <font size="2">Fantasizing 6 13 0 C<br>
</font> </p>

<p> <font size="2">Depressed mood 5 7 0 4<br>
</font> </p>

<p> <font size="2">Panic or fear 2 0 0 4<br>
</font> </p>

<p> <font size="2">-------------------------------------------------------------
<br>
</font> </p>

<p> <font size="2">* Cumulative N - 134 ** Single Dose N - 224<br>
</font> </p>

<p> <font size="2">Combination Protocol<br>
</font> </p>

<p> <u><font size="2">Summary</font></u><font size="2">. To
provide a more systematic and structured approach to the common
practice of combination antiemetic therapy, the Panel offered a
protocol for the optional use of THC alone or THC in combination
with prochlorperazine or other antiemetics. The Panel hoped that
required reporting of combinations of antiemetics used. would
provide additional information about efficacy and side effects of
various combinations. Under the Combination Protocol, the
majority of investigators either chose to use THC alone or THC in
combination with prochlorperazine. <br>
</font> </p>

<p> <font size="2">The results of the Combination Protocol study
support prior Cannabis Therapeutic Program studies in terms of
effectiveness and side effects. Only one clinically serious
adverse reaction was reported during the treatment of an
additional 657 patients with THC. Also, tabulation of the data
demonstrates no significant differences in reports of efficacy or
side effects between those cases where THC was used alone, cases
where THC was used in combination with prochlorperazine or other
antiemetics. Too few treatment reports alluded to combined use of
THC with other antiemetics to draw conclusions on the individual
combinations.<br>
</font> </p>

<p> <u><font size="2">Patient Demographics</font></u><font
size="2">. The Panel tabulated 2,263-reports of treatment
episodes on a total of 657 patients treated after January 1,
1984, the effective date for the combination protocol. These
numbers include treatment reports for 98 patients who were
administered marijuana cigarettes (including all prior protocols
which permitted use of smoked marijuana) and records for 70
patients who had received prior treatments with THC capsules
pursuant to protocols other than the Combination Protocol. There
were 489 patients who had not been previously treated with THC
under a prior protocol and who first received oral THC under the
Combination Protocol. A total of 1,674 discrete treatment
episodes were reported for these 489 patients. See Table N for a
description of patient characteristics. Table 0 tabulates the
emetogenicity ratings of the chemotherapy for the first treatment
episodes and Table P presents the distribution of types of tumors
treated. </font> </p>

<p> <u><font size="2">Study design</font></u><font size="2">. The
Panel had indications that some physicians were using other
antiemetics in combination with oral THC but not informing the
Panel or including such data on the treatment report forms. Aside
from THC as an antiemetic, it was clear that many oncologists
were now using poly<u>pharmacy</u> antiemetic therapy, with some
of the cocktails ranging up to 5 or 6 antiemetic drugs. The
combination protocol gave oncologists the option to start
patients either on THC alone or in combination with
prochlorperazine or dexamethasone. These combinations were
encouraged by the protocol but other combinations were permitted.<br>
</font> </p>

<p> <center><font size="2">Table N<br>
</font></center> </p>

<p> <center><font size="2">Patient Demographics</font></center> </p>

<p> <center><font size="2">-------------------- <br>
<br>
</font></center> </p>

<p> <font size="2">THC THC and Combination</font> </p>

<p> <font size="2">used other Protocol</font> </p>

<p> <font size="2">alone Antiemetics Totals <br>
</font> </p>

<p> <font size="2">n - 257 n - 232 n - 489<br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">--- ----- --- ----- --- -----<br>
</font> </p>

<p> <font size="2">Sex<br>
</font> </p>

<p> <font size="2">Males 118 45.9 104 44.8 222 45.4<br>
</font> </p>

<p> <font size="2">Females 139 54.1 128 55.2 267 54.6<br>
<br>
</font> </p>

<p> <font size="2">Age 19 yrs or younger 31 12.1 31 13.4 62 12.7</font>
</p>

<p> <font size="2">20 - 39 yrs 74 28.8 101 43.5 175 35.8</font> </p>

<p> <font size="2">40 - 59 yrs 85 33.1 63 27.2 148 30.3</font> </p>

<p> <font size="2">60 yrs or more 67 26.1 37 15.9 104 21.3<br>
</font> </p>

<p> <font size="2">---------------------------------------------------------------------
<br>
<br>
<br>
</font> </p>

<p> <center><font size="2">Table 0<br>
</font></center> </p>

<p> <center><font size="2">Comparative Ratings of Emetogenicity<br>
</font></center> </p>

<p> <center><font size="2">of the Chemotherapy</font></center> </p>

<p> <center><font size="2">------------------------------------ <br>
<br>
</font></center> </p>

<p> <font size="2">THC THC and Combination</font> </p>

<p> <font size="2">used other Protocol</font> </p>

<p> <font size="2">alone Antiemetics Totals <br>
</font> </p>

<p> <font size="2">n - 257 n - 232 n - 489<br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">----- --- -----<br>
</font> </p>

<p> <font size="2">Emetogenicity Rating<br>
</font> </p>

<p> <font size="2">Mild 17 6.7 13 5.6 30 6.1 <br>
</font> </p>

<p> <font size="2">Moderate 138 54.1 95 41.1 233 47.6<br>
</font> </p>

<p> <font size="2">Severe 61 23.9 85 36.8 146 29.9<br>
</font> </p>

<p> <font size="2">Radiation 22 8.6 25 10.8 47 9.6<br>
</font> </p>

<p> <font size="2">Unknown 19 8.5 14 6.0 33 6.7</font> </p>

<p> <font size="2">-----------------------------------------------------------------------
<br>
</font> </p>

<p> <center><font size="2">Table P<br>
</font></center> </p>

<p> <font size="2">Distribution of Tumor Types</font> </p>

<p> <font size="2">--------------------------- <br>
<br>
<br>
<br>
</font> </p>

<p> <font size="2">THC THC and Combination</font> </p>

<p> <font size="2">used other Protocol</font> </p>

<p> <font size="2">alone Antiemetics Totals <br>
</font> </p>

<p> <font size="2">n 257 n 232 n 489<br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">--- ----- --- ----- --- -----<br>
</font> </p>

<p> <font size="2">Primary Tumor Site<br>
</font> </p>

<p> <font size="2">01 Hodgkins 24 9.3 44 19.0 68 13.9</font> </p>

<p> <font size="2">02 Other lymphomas 15 5.8 32 13.8 47 9.6</font>
</p>

<p> <font size="2">04 Lymphoid leukemia 7 2.7 6 2.6 13 2.7</font>
</p>

<p> <font size="2">05 Myeloid leukemia 3 1.2 2 0.9 5 1.0</font> </p>

<p> <font size="2">07 Other leukemia 2 0.8 2 0.4</font> </p>

<p> <font size="2">08 Leukemia unspec. 2 0.9 2 0.4</font> </p>

<p> <font size="2">09 Lymphosarcoma 5 1.9 5 2.2 10 2.0</font> </p>

<p> <font size="2">41 Tongue 2 0.9 2 0.4</font> </p>

<p> <font size="2">47 Nasopharynx 2 0.8 1 0.4 3 0.6</font> </p>

<p> <font size="2">49 Other oral cav. 1 0.4 1 0.2</font> </p>

<p> <font size="2">50 Esophagus 1 0.4 1 0.4 2 0.4</font> </p>

<p> <font size="2">51 Stomach 4 1.6 3 1.3 7 1.4</font> </p>

<p> <font size="2">53 Colon 11 4.3 1 0.4 12 2.5</font> </p>

<p> <font size="2">54 Rectum, rectosigmoid 2 0.8 1 0.4 3 0.6</font>
</p>

<p> <font size="2">55 Liver and intra 3 1.2 3 1.3 6 1.2</font> </p>

<p> <font size="2">56 Gallbladder ... 1 0.4 1 0.2</font> </p>

<p> <font size="2">57 Pancreas 3 1.2 5 2.2 8 1.6</font> </p>

<p> <font size="2">59 Other dig,torg. 3 1.2 3 0.6</font> </p>

<p> <font size="2">60 Nasal cavities ... 1 0.4 1 0.2</font> </p>

<p> <font size="2">62 Trachea, bronchi 40 15.6 18 7.8 58 11.9</font>
</p>

<p> <font size="2">64 Thymus, heart ... 2 0.8 8 3.4 10 2.0</font>
</p>

<p> <font size="2">70 Bone and articul 12 4.7 6 2.6 18 3.7</font>
</p>

<p> <font size="2">71 Connective, other 12 4.7 4 1.7 16 3.3</font>
</p>

<p> <font size="2">72 Melanoma of skin 3 1.2 2 0.9 5 1.0</font> </p>

<p> <font size="2">74 Female breast 58 22.6 41 17.7 99 20.2</font>
</p>

<p> <font size="2">79 Uterus ... 2 0.8 1 0.4 3 0.6</font> </p>

<p> <font size="2">80 Cervex, uteri ... 2 0.9 2 0.4</font> </p>

<p> <font size="2">83 Ovary... 24 9.3 19 8.2 43 8.8</font> </p>

<p> <font size="2">85 Prostate 3 1.2 1 0.4 4 0.8</font> </p>

<p> <font size="2">86 Testis 4 1.6 5 2.2 9 1.8</font> </p>

<p> <font size="2">88 Bladder 2 0.9 2 0.4</font> </p>

<p> <font size="2">89 Kidney and .... 2 0.8 2 0.9 4 0.8</font> </p>

<p> <font size="2">90 Eye 1 0.4 1 0.2</font> </p>

<p> <font size="2">91 Brain 2 0.8 5 2.2 7 1.4</font> </p>

<p> <font size="2">95 Other and ill-def 3 1.2 2 0.9 5 1.0</font> </p>

<p> <font size="2">96 Secondary... lymph 1 0.4 1 0.2</font> </p>

<p> <font size="2">99 Without spec. o 3 1.2 3 0.6</font> </p>

<p> <font size="2">Missing 3 1.3 3 0.6<br>
----------------------------------------------------------------------
<br>
</font> </p>

<p> <font size="2">Objectives of the study included: <br>
</font> </p>

<p> <font size="2">1. Does THC have a greater therapeutic effect
when used in combination with other standard antiemetics?<br>
</font> </p>

<p> <font size="2">2. Are THC/Compazine, THC/dexamethasone and
THC/Compazine/ dexamethasone combinations safe and free from
intolerable side effects?<br>
</font> </p>

<p> <font size="2">3. Which THC antiemetic combination is
preferred by cancer patients?<br>
</font> </p>

<p> <u><font size="2">Drug Dose and</font></u><font size="2">
Schedule. THC was to be given using the cumulative dose method.
Prochlorperazine, at a dose of 10mg orally, was to be
administered at the same time as the THC. Dexamethasone was to be
given 2 hours prior to chemotherapy as a single oral dose of
20mg. If a patient had not received a good response from the
THC/prochlorperazine or THC/dexamethasone combinations, in
subsequent treatment episodes the patient could be given THC,
plus both prochlorperazine and dexamethasone (at the dosage and
schedule outlined above.) <u>Results</u> from first treatment
episodes are emphasized because of the self-selection bias
expected in results from subsequent treatment episodes.<br>
</font> </p>

<p> <font size="2">Approximately one half of the treatment
reports indicated that the physician investigator chose to use
THC alone. Thus, in the tabulation of these reports &quot;THC
alone' serves as a 'control' for presentation of data for the
'THC used in combinations group. Little or no differences are
noted.<br>
</font> </p>

<p> <font size="2">The results of the Combination Protocol study
support prior Cannabis Therapeutic Program studies in terms of
effectiveness and side effects.<br>
</font> </p>

<p> <font size="2">Tabulation of data did not provide an answer
to the question of which THC antiemetic combination is preferred
by cancer patients. This is due in part to the small numbers of
reports on many of the antiemetic combinations. Also, in general,
the reports of efficacy and side effects are very similar
regardless of 'THC used alone' or 'THC used in all combinations'.
<br>
</font> </p>

<p> <font size="2">Tabulation of this data also did not
demonstrate any significant differences when results reported for
women were compared to results reported for men, nor for young
vs. old subjects. <br>
</font> </p>

<p> <u><font size="2">Efficacy</font></u><font size="2">. Table Q
provides a <u>summary</u> of nausea and vomiting ratings for the
first treatment episodes which were protected by THC alone, THC
combined with other antiemetics and as a total for the overall
experience with the 489 patients analyzed for this phase of the
Cannabis Therapeutic Program. Table R similarly summarizes the
overall effectiveness ratings.<br>
</font> </p>

<p> <u><font size="2">Side</font></u><font size="2"> Effects.
Overall, side effects do not constitute a major problem in the
therapeutic use of THC. This study not only confirms the first
study, but serious side effects ceased being reported as
physicians learned better how to use THC, lower doses, and
cumulative doses, and not on persons with brain damage. Table S
tabulates side effects reported for the first treatment episode
for patients treated with THC, treated with various combinations
of THC and other antiemetics, as well as the totals for the
Combination Protocol Study.<br>
</font> </p>

<p> <u><font size="2">Dropout</font></u><font size="2"> Rate.
Table T summarizes the reasons for dropping out from the study
after the first treatment episode.<br>
</font> </p>

<p> <u><font size="2">Discussion</font></u><font size="2">. The
only significant difference between this and the first THC study
is the use of combinations of antiemetics. Data on subjects
receiving polypharmacy have been compared with data on subjects
receiving THC alone. The similarities of results of the two
groups is remarkable. The only apparent difference is percent of
subjects willing to continue to additional treatment episodes
using combinations of antiemetics (70%) as opposed to those
treated with THC alone (46%).<br>
</font> </p>

<p> <font size="2">This study tended to confirm the findings of
the first study. An additional 657 patients were treated with THC
and their reports of impression of efficacy were similar to those
of the first study. Similar side effects were noted and only one
serious adverse reaction was reported. The lower dose, and to a
large extent, the cumulative dosing was being used.<br>
</font> </p>

<p> <u><font size="2">Additional information</font></u><font
size="2">. The popular polypharmacy does not appear to offer any
advantage in terms of effectiveness and little if any advantage
in terms of side effects. Again, no differences were found when
these data were analyzed by sex, or age.<br>
</font> </p>

<p> <center><font size="2">Table Q<br>
</font></center> </p>

<p> <center><font size="2">Comparative Ratings of Nausea and
Vomiting</font></center> </p>

<p> <center><font size="2">------------------------------------------
<br>
</font></center> </p>

<p> <font size="2">THC THC and Combination</font> </p>

<p> <font size="2">used other Protocol</font> </p>

<p> <font size="2">alone Antiemetics Totals <br>
</font> </p>

<p> <font size="2">n 257 n 232 n 489<br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">----- --- ----- --- ----</font> </p>

<p> <font size="2">Nausea Rating<br>
</font> </p>

<p> <font size="2">None 38 15.1 50 21.7 88 18.0</font> </p>

<p> <font size="2">Mild 85 33.9 71 30.9 156 31.9</font> </p>

<p> <font size="2">Moderate 73 29.1 57 24.8 130 26.6</font> </p>

<p> <font size="2">Severe 55 21.9 52 22.6 107 21.9</font> </p>

<p> <font size="2">Missing 6 2 8 1.6<br>
<br>
</font> </p>

<p> <font size="2">Vomiting Rating<br>
</font> </p>

<p> <font size="2">None 89 35.3 70 30.4 159 32.5</font> </p>

<p> <font size="2">1 - 3 times 69 27.4 58 25.2 127 26.0</font> </p>

<p> <font size="2">4 - 6 times 35 13.9 40 17.4 75 15.3</font> </p>

<p> <font size="2">&gt; 6 times 59 23.4 62 27.0 121 24.7</font> </p>

<p> <font size="2">Missing 5 2 7 1.4<br>
</font> </p>

<p> <font size="2">----------------------------------------------------------------------
<br>
<br>
</font> </p>

<p> <center><font size="2">Table R<br>
</font></center> </p>

<p> <center><font size="2">Comparative Ratings of Overall
Effectiveness</font></center> </p>

<p> <center><font size="2">--------------------------------------------
<br>
</font></center> </p>

<p> <font size="2">THC THC and Combination</font> </p>

<p> <font size="2">used other Protocol</font> </p>

<p> <font size="2">alone Antiemetics Totals <br>
</font> </p>

<p> <font size="2">n - 257 n - 232 n - 489 <br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">--- ----- --- ----- --- -----</font> </p>

<p> <font size="2">Overall Effectiveness<br>
</font> </p>

<p> <font size="2">Not effective 62 24.7 35 15.2 97 19.8</font> </p>

<p> <font size="2">Slightly 45 17.9 55 23.8 100 20.4</font> </p>

<p> <font size="2">Moderately 68 27.1 60 26.0 128 26.2</font> </p>

<p> <font size="2">Very 76 30.3 81 35.1 157 32.1</font> </p>

<p> <font size="2">Missing 6 1 7 1.4<br>
</font> </p>

<p> <font size="2">----------------------------------------------------------------------
<br>
</font> </p>

<p> <center><font size="2">Table S<br>
</font></center> </p>

<p> <center><font size="2">Comparative Ratings of Side Effects</font></center>
</p>

<p> <center><font size="2">----------------------------------- <br>
</font></center> </p>

<p> <font size="2">THC THC and Combination</font> </p>

<p> <font size="2">used other Protocol</font> </p>

<p> <font size="2">alone Antiemetics Totals <br>
</font> </p>

<p> <font size="2">n 257 n - 232 n 489<br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">--- ----- --- ----- --- -----</font> </p>

<p> <font size="2">Incidence of</font> </p>

<p> <font size="2">Side Effects<br>
</font> </p>

<p> <font size="2">Dry mouth<br>
</font> </p>

<p> <font size="2">Severe 4 1.6 4 1.7 8 1.6</font> </p>

<p> <font size="2">Moderate 31 12.4 31 13.5 62 12.7</font> </p>

<p> <font size="2">Mild 77 30.8 57 24.8 134 27.4</font> </p>

<p> <font size="2">None 138 55.2 138 60 276 56.4</font> </p>

<p> <font size="2">Missing 7 2 9 1.8<br>
</font> </p>

<p> <font size="2">Tachycardia<br>
</font> </p>

<p> <font size="2">Severe 0 0.0</font> </p>

<p> <font size="2">Moderate 6 2.4 3 1.3 9 1.8</font> </p>

<p> <font size="2">Mild 19 7.6 14 6.1 33 6.7</font> </p>

<p> <font size="2">None 225 90 213 92.6 438 89.6</font> </p>

<p> <font size="2">Missing 7 2 9 1.8<br>
</font> </p>

<p> <font size="2">Ataxia<br>
</font> </p>

<p> <font size="2">Severe 1 0.4 1 0.2</font> </p>

<p> <font size="2">Moderate 4 1.6 7 3 11 2.2</font> </p>

<p> <font size="2">Mild 26 10.4 23 10 49 10.0</font> </p>

<p> <font size="2">None 219 87.6 200 87 419 85.7</font> </p>

<p> <font size="2">Missing 7 2 9 1.8<br>
</font> </p>

<p> <font size="2">Dizziness<br>
</font> </p>

<p> <font size="2">Severe 5 2 1 0.4 6 1.2</font> </p>

<p> <font size="2">Moderate 16 6.4 19 8.3 35 7.2</font> </p>

<p> <font size="2">Mild 46 18.4 50 21.7 96 19.6</font> </p>

<p> <font size="2">None 183 73.2 160 69.6 343 70.1</font> </p>

<p> <font size="2">Missing 7 2 9 1.8<br>
</font> </p>

<p> <font size="2">Orthostatic</font> </p>

<p> <font size="2">hypotension<br>
</font> </p>

<p> <font size="2">Severe 1 0.4 1 0.4 2 0.4</font> </p>

<p> <font size="2">Moderate 4 1.6 10 4.3 14 2.9</font> </p>

<p> <font size="2">Mild 27 10.8 31 13.5 58 11.9</font> </p>

<p> <font size="2">None 218 87.2 188 81.7 406 83.0</font> </p>

<p> <font size="2">Missing 7 2 9 1.8<br>
</font> </p>

<p> <font size="2">Anxiety<br>
</font> </p>

<p> <font size="2">Severe 7 2.8 1 0.4 8 1.6</font> </p>

<p> <font size="2">Moderate 8 3.2 15 6.6 23 4.7</font> </p>

<p> <font size="2">Mild 32 12.8 34 14.8 66 13.5</font> </p>

<p> <font size="2">None 203 81.2 179 78.2 382 78.1</font> </p>

<p> <font size="2">Missing 7 3 10 2.0<br>
</font> </p>

<p> <center><font size="1">Table S (Cont.)<br>
</font></center> </p>

<p> <font size="1">THC THC and Combination</font> </p>

<p> <font size="1">used other Protocol</font> </p>

<p> <font size="1">alone Antiemetics Totals <br>
</font> </p>

<p> <font size="1">No. % No. % No. %</font> </p>

<p> <font size="1">--- ----- --- ----- --- -----</font> </p>

<p> <font size="1">Sedation<br>
</font> </p>

<p> <font size="1">Severe 13 5.2 15 6.6 28 5.7</font> </p>

<p> <font size="1">Moderate 46 18.4 54 23.6 100 20.4</font> </p>

<p> <font size="1">Mild 101 40.4 74 32.3 175 35.8</font> </p>

<p> <font size="1">None 90 36 86 37.6 176 36.0</font> </p>

<p> <font size="1">Missing 7 3 10 2.0<br>
</font> </p>

<p> <font size="1">Elated mood<br>
</font> </p>

<p> <font size="1">Severe 6 2.4 8 3.5 14 2.9</font> </p>

<p> <font size="1">Moderate 22 8.8 20 8.7 42 8.6</font> </p>

<p> <font size="1">Mild 33 13.2 49 21.3 82 16.8</font> </p>

<p> <font size="1">None 189 75.6 153 66.5 342 69.9</font> </p>

<p> <font size="1">missing 7 2 9 1.8<br>
</font> </p>

<p> <font size="1">Confusion<br>
</font> </p>

<p> <font size="1">Severe 2 0.8 5 2.2 7 1.4</font> </p>

<p> <font size="1">Moderate 30 12 19 8.3 49 10.0</font> </p>

<p> <font size="1">Mild 47 18.8 65 28.4 112 22.9</font> </p>

<p> <font size="1">None 171 68.4 140 61.1 311 63.6</font> </p>

<p> <font size="1">Missing 7 3 10 2.0<br>
</font> </p>

<p> <font size="1">Distortion of</font> </p>

<p> <font size="1">perception<br>
</font> </p>

<p> <font size="1">Severe 2 0.8 1 0.4 3 0.6</font> </p>

<p> <font size="1">Moderate 12 4.8 13 5.7 25 5.1</font> </p>

<p> <font size="1">'Mild 43 17.2 32 13.9 75 15.3</font> </p>

<p> <font size="1">None 193 77.2 184 80 377 77.1</font> </p>

<p> <font size="1">Missing 7 2 9 1.8<br>
</font> </p>

<p> <font size="1">Fantasizing<br>
</font> </p>

<p> <font size="1">Severe 3 1.3 3 0.6</font> </p>

<p> <font size="1">Moderate 7 2.8 7 3 14 2.9</font> </p>

<p> <font size="1">Mild 22 8.8 15 6.5 37 7.6</font> </p>

<p> <font size="1">None 221 88.4 205 89.1 426 87.1</font> </p>

<p> <font size="1">Missing 7 2 9 1.8<br>
</font> </p>

<p> <font size="1">Depressed mood<br>
</font> </p>

<p> <font size="1">Severe 3 1.2 1 0.4 4 0.8</font> </p>

<p> <font size="1">Moderate 11 4.4 8 3.5 19 3.9</font> </p>

<p> <font size="1">Mild 19 7.6 18 7.9 37 7.6</font> </p>

<p> <font size="1">None 217 86.8 202 88.2 419 85.7</font> </p>

<p> <font size="1">Missing 7 3 10 2.0<br>
</font> </p>

<p> <font size="1">Panic or fear<br>
</font> </p>

<p> <font size="1">Severe 3 1.2 3 1.3 6 1.2</font> </p>

<p> <font size="1">Moderate 4 1.6 2 0.9 6 1.2</font> </p>

<p> <font size="1">Mild 12 4.8 13 5.7 25 5.1</font> </p>

<p> <font size="1">None. 231 92.4 212 92.2 443 90.6</font> </p>

<p> <font size="1">Missing 7 7 1.4<br>
</font> </p>

<p> <font size="1">-----------------------------------------------------------------------
<br>
</font> </p>

<p> <center><font size="2">Table T<br>
</font></center> </p>

<p> <center><font size="2">Comparison of Reasons for Termination</font></center>
</p>

<p> <center><font size="2">------------------------------------- <br>
<br>
</font></center> </p>

<p> <font size="2">THC THC and Combination</font> </p>

<p> <font size="2">used other Protocol</font> </p>

<p> <font size="2">alone Antiemetics Totals <br>
</font> </p>

<p> <font size="2">n 257 n - 232 n - 489<br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">--- ----- --- ----- --- <br>
</font> </p>

<p> <font size="2">Reasons for</font> </p>

<p> <font size="2">Termination<br>
</font> </p>

<p> <font size="2">Ineffective as</font> </p>

<p> <font size="2">an antiemetic 40 15.6 20 8.6 60 12.3<br>
</font> </p>

<p> <font size="2">Side effects</font> </p>

<p> <font size="2">too severe 23 8.9 13 5.6 36 7.4<br>
</font> </p>

<p> <font size="2">Expired or</font> </p>

<p> <font size="2">completed treatment 69 26.8 26 11.2 95 19.4<br>
</font> </p>

<p> <font size="2">Other 6 2.3 11 4.7 17 3.5 <br>
</font> </p>

<p> <font size="2">Continued study 119 46.3 162 69.8 281 57.5<br>
<br>
</font> </p>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> <br>
<br>
<br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-5</DOCNO>
<DOCOLDNO>IA087-000627-B014-86</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ctp3.htm 206.61.184.43 19970122051022 text/html 47214
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:10:00 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:00:59 GMT
Content-length: 46996
</DOCHDR>
<html>

<head>
<title>Cannabis Therapeutic Program Results of Study with Smoked
Marij </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<p> </p>
</body>

<body bgcolor="#ffffff">

<p><img src="../../graphics/blueline.gif"> </p>

<p> <b><font size="2">California Research Advisory Panel</font></b>
</p>

<h1>Cannabis Therapeutic Program</h1>

<p> <img src="../../graphics/blueline.gif"><br>
</p>

<p> <b>Results of Study with Smoked Marijuana<br>
</b> </p>

<p> <u><font size="2">The Protocols</font></u><font size="2">.
Three protocols were developed based on experiences since March
of 1980: Protocol IV, Revised Operational Protocol for Smoked
Marijuana, and Revised Protocol for Smoked Marijuana (Appendix
IX).<br>
</font> </p>

<p> <font size="2">The initial Smoked Marijuana Protocol
(Protocol IV) was limited to inpatients who were experienced
marijuana smokers and receiving Cisplatin, Dacarbazine and/or
5-Azacytadine.<br>
</font> </p>

<p> <font size="2">In 1981, the Smoked Marijuana Protocol was
modified to permit outpatients and marijuana naive' patients to
participate. In addition, patients receiving radiation therapy
were then allowed to use smoked marijuana.<br>
</font> </p>

<p> <font size="2">In 1983, another revision was made to adapt to
the limited number of patients choosing to use smoked marijuana.
This protocol allowed all patients, regardless of their
anticancer treatment, to have access to smoked marijuana. A
standardized smoking technique was described and the use of a
water pipe was encouraged to modify the harshness of the smoke
which was a deterrent for patients using smoked marijuana in the
previous protocols. <br>
</font> </p>

<p> <u>Minimal Accrual</u>. The marijuana cigarette protocol
attracted only 119 patients, less than five percent of the total
number enrolled in the Cannabis Therapeutic Program. Anecdotal
reports suggested that reasons for the low accrual included a
general objection to smoking on the part of some patients, their
oncologists, or their hospitals, and some reluctance to use a
drug associated with street use.<br>
</p>

<p> The characteristics of the NIDA cigarettes may have been a
factor in discouraging further use by experieced marijuana
smokers. The cigarettes, even after proper storage, were dry and
gave an acrid smoke. Their potency was noticeably low at a time
when street marijuana was increasing greatly in potency and
availability. <br>
</p>

<p> <u><font size="2">Data Collection</font></u><font size="2">.
As each protocol was changed data forms were also <b>revised </b>in
an effort to increase enrollment by reducing any burden of
paperwork for investigators and patients. <b>All </b>data forms
associated with the various protocols are included in the
appendices.<br>
</font> </p>

<p> <font size="2">The report form included with the latest
revision of the protocol <b>(2/11/83) </b>requested only
information which <b>was </b>considered essential and, for the
purpose of this evaluation, data from the previous forms <b>were </b>transcribed
to the newer form for consistency in coding. This point is
elaborated in <b>a </b>following section on validity of results.<br>
</font> </p>

<p> <u><font size="2">Potency Increase</font></u><font size="2">.
The potency of the marijuana cigarettes being used <b>was </b>changed
in April of 1983 from <b>1.2% </b>to <b>2.8% THC </b>content.
This increase <b>was not </b>considered in our <b>analysis.<br>
</b></font> </p>

<p> <u><font size="2">Patients</font></u><font size="2">. The
Panel received 218 treatment episode reports for 119 total
patients treated with smoked marijuana. Eight reports were
received for 3 patients treated with both smoked marijuana and
THC capsules. Twenty-one of the 119 patients had been previously
treated under other Cannabis Therapeutic Program protocols.
Reports on 98 patients are therefore available for analysis of
the 'first treatment episode' on the Cannabis Therapeutic
Program. Table U reflects characteristics of the 98 patients
whose reports are analyzed and Table V summarizes the primary
tumor sites.<br>
</font> </p>

<p> <u><font size="2">Evaluation of the Antiemetic Properties</font></u><font
size="2">. As shown in Table W, only 4.1% of the patients
reported mild or no nausea during their first smoked marijuana
protected treatment episode. And, 46.72 reported vomiting of 3
times or less during their first treatment episode.<br>
</font> </p>

<p> <font size="2">Overall assessment of the effectiveness was
rated very or moderately successful by 58.7%. The relative
effectiveness of smoked and orally ingested THC are similar.
Table X includes the column on THC capsules from Table R for
comparison. Anecdotal reports by a few patients who had used both
marijuana cigarettes and THC, rated the effectiveness of the
smoked marijuana as comparable to that of the oral THC used in
this study. </font> </p>

<p> <u><font size="2">Side Effects</font></u><font size="2">.
Side effects are reported in Table Y which also presents the data
on THC alone (from Table S) for comparison. The slightly more
intense side effects after smoked marijuana are not surprising in
view of its more rapid onset. <u>Presumably</u>, they persisted
for a shorter time but no such measurements were recorded in this
study.<br>
<br>
</font> </p>

<p> <center><font size="2">Table U<br>
</font></center> </p>

<p> <font size="2">Characteristics of Study Population</font> </p>

<p> <font size="2">------------------------------------ <br>
</font> </p>

<p> <font size="2">n - 98</font> </p>

<p> <font size="2">No. Percent</font> </p>

<p> <font size="2">Sex ---- -------<br>
</font> </p>

<p> <font size="2">Male 56 57.1<br>
</font> </p>

<p> <font size="2">Female 42 42.9<br>
</font> </p>

<p> <font size="2">Age Distribution<br>
</font> </p>

<p> <font size="2">19 yrs or less 1 1.0<br>
</font> </p>

<p> <font size="2">20 - 39 yrs 38 38.8<br>
</font> </p>

<p> <font size="2">40 - 59 yrs 32 32.7<br>
</font> </p>

<p> <font size="2">60 yrs or more 27 27.6<br>
</font> </p>

<p> <font size="2">--------------------------------------------- <br>
</font> </p>

<p> <center><font size="2">Table V<br>
</font></center> </p>

<p> <center><font size="2">Distribution of Patient Cancer History<br>
</font></center> </p>

<p> <center><font size="2">by Primary Site</font></center> </p>

<p> <center><font size="2">--------------------------------------
<br>
</font></center> </p>

<p> <font size="2">n 98<br>
<br>
</font> </p>

<p> <font size="2">Primary Cancer Site Number Percent</font> </p>

<p> <font size="2">------------------- ------ -------<br>
</font> </p>

<p> <font size="2">Hodgkin's 5 5.1<br>
</font> </p>

<p> <font size="2">Other lymphomas 3 3.1<br>
</font> </p>

<p> <font size="2">Myeloid leukemia 2 2.0 <br>
</font> </p>

<p> <font size="2">Tongue 1 1.0<br>
</font> </p>

<p> <font size="2">Esophagus 1 1.0<br>
</font> </p>

<p> <font size="2">Liver and intrahepatic ... 3 3.1</font> </p>

<p> <font size="2">Gallbladder and ducts 1 1.0</font> </p>

<p> <font size="2">Pancreas 1 1.0</font> </p>

<p> <font size="2">Retroperitoneal 2 2.0</font> </p>

<p> <font size="2">Other and ill defined 1 1.0</font> </p>

<p> <font size="2">Nasal cavities 1 1.0</font> </p>

<p> <font size="2">Trachea, bronchi 18 18.4</font> </p>

<p> <font size="2">Thymus, heart 3 3.1</font> </p>

<p> <font size="2">Bone and articulations 5 5.1</font> </p>

<p> <font size="2">Connective and .... 2 2.0</font> </p>

<p> <font size="2">Melanoma of skin 4 4.1</font> </p>

<p> <font size="2">Female breast 5 5.1</font> </p>

<p> <font size="2">Ovary and other .... 14 14.3</font> </p>

<p> <font size="2">Prostate 4 4.1</font> </p>

<p> <font size="2">Testis 18 18.4</font> </p>

<p> <font size="2">Bladder 2 2.0</font> </p>

<p> <font size="2">Without specific 2 2.0<br>
</font> </p>

<p> <center><font size="2">Table W<br>
</font></center> </p>

<p> <center><font size="2">Comparative Ratings of Nausea and
Vomiting</font></center> </p>

<p> <center><font size="2">------------------------------------------
<br>
</font></center> </p>

<p> <font size="2">Smoked Marijuana THC used alone</font> </p>

<p> <font size="2">n 98 n 257</font> </p>

<p> <font size="2">Ratings of No. % No. %<br>
</font> </p>

<p> <font size="2">Nausea<br>
</font> </p>

<p> <font size="2">None 9 9.2 38 15.1</font> </p>

<p> <font size="2">Mild 34 34.7 85 33.9<br>
</font> </p>

<p> <font size="2">Moderate 36 36.7 73 29.1</font> </p>

<p> <font size="2">Severe 17 17.3 55 21.9</font> </p>

<p> <font size="2">Missing 2 2.0 6 2.3<br>
</font> </p>

<p> <font size="2">Vomiting<br>
</font> </p>

<p> <font size="2">None 19 19.4 89 35.3</font> </p>

<p> <font size="2">1 - 3 times 36 36.7 69 27.4</font> </p>

<p> <font size="2">4 - 6 times 18 18.4 35 13.9</font> </p>

<p> <font size="2">&gt; 6 times 24 24.5 59 23.4</font> </p>

<p> <font size="2">Missing 1 1.0 5 1.9<br>
</font> </p>

<p> <font size="2">-------------------------------------------------------
<br>
<br>
<br>
<br>
<br>
</font> </p>

<p> <center><font size="2">Table X<br>
</font></center> </p>

<p> <font size="2">Comparative Ratings of Overall Effectiveness</font>
</p>

<p> <font size="2">------------------------------------------- <br>
</font> </p>

<p> <font size="2">Smoked Marijuana THC used alone</font> </p>

<p> <font size="2">n - 98 n - 257</font> </p>

<p> <font size="2">No. % No. %</font> </p>

<p> <font size="2">--- ----- --- -----<br>
<br>
</font> </p>

<p> <font size="2">Not effective 26 26.8 62 24.7</font> </p>

<p> <font size="2">Slightly 14 14.4 45 17.9</font> </p>

<p> <font size="2">Moderately 40 41.2 68 27.1</font> </p>

<p> <font size="2">Very 17 17.5 76 30.3</font> </p>

<p> <font size="2">Missing 1 1.0 6 2.3<br>
</font> </p>

<p> <font size="2">-------------------------------------------------------
<br>
</font> </p>

<p> <font size="2">Table Y<br>
</font> </p>

<p> <font size="2">Comparative Ratings of Side Effects</font> </p>

<p> <font size="2">---------------------------------- <br>
</font> </p>

<p> <font size="2">Smoked THC</font> </p>

<p> <font size="2">Marijuana used</font> </p>

<p> <font size="2">alone<br>
</font> </p>

<p> <font size="2">n 98 n 257<br>
</font> </p>

<p> <font size="2">No. No.</font> </p>

<p> <font size="2">--- ----- --- -----</font> </p>

<p> <font size="2">Incidence of</font> </p>

<p> <font size="2">Side Effects<br>
</font> </p>

<p> <font size="2">Dry mouth<br>
</font> </p>

<p> <font size="2">Severe 4 4.3 4 1.6</font> </p>

<p> <font size="2">Moderate 26 27.7 31 12.4</font> </p>

<p> <font size="2">Mild 23 24.5 77 30.8</font> </p>

<p> <font size="2">None 41 43.6 138 55.2</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Tachycardia<br>
</font> </p>

<p> <font size="2">Severe 2 2.1</font> </p>

<p> <font size="2">Moderate 1 1.1 6 2.4</font> </p>

<p> <font size="2">Mild 3 3.2 19 7.6</font> </p>

<p> <font size="2">None 88 93.6 225 90</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Ataxia<br>
</font> </p>

<p> <font size="2">Severe 1 1.1 1 0.4</font> </p>

<p> <font size="2">Moderate 9 9.6 4 1.6</font> </p>

<p> <font size="2">Mild 6 6.4 26 10.4</font> </p>

<p> <font size="2">None 78 83.0 219 87.6</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Dizziness<br>
</font> </p>

<p> <font size="2">Severe 4 4.3 5 2</font> </p>

<p> <font size="2">Moderate 12 12.8 16 6.4</font> </p>

<p> <font size="2">Mild 15 16.0 46 18.4</font> </p>

<p> <font size="2">None 63 67.0 183 73.2</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Orthostatic</font> </p>

<p> <font size="2">hypotension<br>
</font> </p>

<p> <font size="2">Severe 2 2.1 1 0.4</font> </p>

<p> <font size="2">Moderate 2 2.1 4 1.6</font> </p>

<p> <font size="2">Mild 3 3.2 27 10.8</font> </p>

<p> <font size="2">None 67 71.3 218 87.2</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Anxiety<br>
</font> </p>

<p> <font size="2">Severe 3 3.2 7 2.8</font> </p>

<p> <font size="2">Moderate 8 8.5 8 3.2</font> </p>

<p> <font size="2">Mild 8 8.5 32 12.8</font> </p>

<p> <font size="2">None 75 79.8 203 81.2</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Table Y (Cont.)<br>
</font> </p>

<p> <font size="2">Smoked THC</font> </p>

<p> <font size="2">Marijuana used</font> </p>

<p> <font size="2">alone</font> </p>

<p> <font size="2">No. No.<br>
</font> </p>

<p> <font size="2">--- ----- --- -----<br>
</font> </p>

<p> <font size="2">Sedation<br>
</font> </p>

<p> <font size="2">Severe 2 2.1 13 5.2</font> </p>

<p> <font size="2">Moderate 25 26.6 46 18.4</font> </p>

<p> <font size="2">Mild 22 23.4 101 40.4</font> </p>

<p> <font size="2">None 45 47.9 90 36</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Elated mood<br>
</font> </p>

<p> <font size="2">Severe 1 1.1 6 2.4</font> </p>

<p> <font size="2">Moderate 10 10.6 22 8.8</font> </p>

<p> <font size="2">Mild 14 14.9 33 13.2</font> </p>

<p> <font size="2">None 61 64.9 189 75.6</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Confusion<br>
</font> </p>

<p> <font size="2">Severe 4 4.3 2 0.8</font> </p>

<p> <font size="2">Moderate 10 10.6 30 12</font> </p>

<p> <font size="2">Mild 9 9.6 47 18.8</font> </p>

<p> <font size="2">None 71 75.5 171 68.4</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Distortion of</font> </p>

<p> <font size="2">perception<br>
</font> </p>

<p> <font size="2">Severe 3 3.2 2 0.8</font> </p>

<p> <font size="2">Moderate 7 7.4 12 4.8</font> </p>

<p> <font size="2">Mild 5 5.3 43 17.2</font> </p>

<p> <font size="2">None 79 84.0 193 77.2</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Fantasizing<br>
</font> </p>

<p> <font size="2">Severe</font> </p>

<p> <font size="2">Moderate 4 4.3 7 2.8</font> </p>

<p> <font size="2">Mild 6 6.4 22 8.8</font> </p>

<p> <font size="2">None 84 89.4 221 88.4</font> </p>

<p> <font size="2">Missing 4 4.3 7<br>
</font> </p>

<p> <font size="2">Depressed mood<br>
</font> </p>

<p> <font size="2">Severe 3 3.2 3 1.2</font> </p>

<p> <font size="2">Moderate 4 4.3 11 4.4</font> </p>

<p> <font size="2">Mild 10 10.6 19 7.6</font> </p>

<p> <font size="2">None 77 81.9 217 86.8</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">Panic or fear<br>
</font> </p>

<p> <font size="2">Severe 3 3.2 3 1.2</font> </p>

<p> <font size="2">Moderate 3 3.2 4 1.6</font> </p>

<p> <font size="2">Mild 1 1.1 12 4.8</font> </p>

<p> <font size="2">None 87 92.6 231 92.4</font> </p>

<p> <font size="2">Missing 4 7<br>
</font> </p>

<p> <font size="2">-------------------------------------------------------------------
<br>
</font> </p>

<p> <u><font size="2">Patient Drop-out Rates</font></u><font
size="2">. Thirtyfour patients continued on to two or more
treatment episodes using smoked marijuana. Sixty-four patients
dropped from the study. The reasons for dropping are detailed
below in Table Z. <br>
</font> </p>

<p> <u><font size="2">Reliability Estimate of Results</font></u><font
size="2">. There were three basic concerns regarding the
reliability of the marijuana protocol results: 1) the change in
the data forms, 2) the change in the protocols themselves, and 3)
the change in the potency of the marijuana cigarettes. Each of
these may influence the kind of data reported.<br>
</font> </p>

<p> <font size="2">Since the potency changed from 1.2% to 2.8%
THC, any patients smoking marijuana after April 1983, were
smoking marijuana that was roughly twice as potent. This may or
may not have been considered by the prescribing physician and/or
pharmacist in calculating and marking the dosage. There was
general confusion about how to calculate dose. Sometimes the
number of cigarettes used was listed. Also, patients not smoking
the entire dose may not have had this fact recorded, and there
was variation in smoking technique. <br>
</font> </p>

<p> <font size="2">In 1983, eligibility requirements were changed
to permit outpatients and inexperienced marijuana smokers to
participate. The smoking method was changed, increasing the
amount of time the smoke is held in the lungs. Water pipes were
also permitted. <br>
</font> </p>

<p> <font size="2">With each protocol change there were changes
in the data forms. The original data form had different labels on
the side effect<br>
<br>
<br>
</font> </p>

<p> <center><b><font size="2">Table Z<br>
</font></b></center> </p>

<p> <b><font size="2">Reasons for </font></b><font size="2">Termination
<br>
</font> </p>

<p> <b><font size="2">After </font></b><font size="2">First
Treatment Episode</font> </p>

<p> <font size="2">-------------------------- <br>
</font> </p>

<p> <font size="2">n - <b>64<br>
<br>
</b></font> </p>

<p> <b><font size="2">No. of Patients</font></b><font size="2"> <b>Percent</b></font>
</p>

<p> <b><font size="2">---------------</font></b><font size="2"> <b>-------</b></font>
</p>

<p> <b><font size="2">Ineffective as</font></b> </p>

<p> <b><font size="2">an antiemetic</font></b><font size="2"> <b>17</b>
<b>26.6<br>
</b></font> </p>

<p> <b><font size="2">Side effects</font></b> </p>

<p> <b><font size="2">too severe</font></b><font size="2"> <b>7</b>
<b>10.9 <br>
</b></font> </p>

<p> <b><font size="2">Expired or</font></b> </p>

<p> <b><font size="2">completed treatment</font></b><font
size="2"> <b>32</b> <b>50<br>
</b></font> </p>

<p> <b><font size="2">Other</font></b><font size="2"> <b>8</b> <b>12.5
<br>
</b></font> </p>

<p> <b><font size="2">------------------------------------------------------</font></b><font
size="2">- <br>
</font> </p>

<p> <font size="2">categories (none, tolerable, intolerable).
More than one treatment episode could be reported on one form.
Also, the patient reports had categories dealing with mood. The
next data form revision changed the category labels of side
effects to none, moderate and severe. One treatment episode was
reported per form. Mood was deleted from the patient reports. The
final revision is the one sheet form.<br>
</font> </p>

<p> <font size="2">The protocol directed that four doses of
marijuana should be administered prior to chemotherapy, but the
data form also provided a place to enter the actual number of
'doses prior' as 'other.' The patient evaluation form was
discontinued and the investigator (or his/her staff) evaluated
the nausea, vomiting and overall effectiveness. In tabulating the
data the physician's assessment was used. The number of side
effect categories was increased to four: none, mild, moderate,
and severe. The mean value of patient reports was used. If it
fell between categories, it was rounded up when converted to the
new form. The dosage level was a fixed choice.<br>
</font> </p>

<p> <font size="2">The coding process attempted to take into
consideration these changes and standardized the data onto the
one page data collection form (Treatment Report Form A).<br>
</font> </p>

<p> <font size="2">Protocol Exceptions (Pilot Protocols)<br>
</font> </p>

<p> <font size="2">Protocols initially available under the
Cannabis Therapeutic Program were limited to antinauseant use of
delta-9-tetrahydrocannabinol (THC) to patients undergoing
chemotherapy for cancer. In 1983, the Panel began to receive
requests for THC from physicians with patients who suffered
intractable nausea and vomiting from conditions <u>other than
chemotherapy</u>. These patients did not meet the strict criteria
of the Panel's other protocols, but needed an alternative to the
standard treatments available for nausea and vomiting. THC was
considered to be their antiemetic of last resort. The &quot;pilot
protocols' provided a treatment option for desperate patients
unresponsive to standard treatments.<br>
</font> </p>

<p> <font size="2">By the end of the study, 29 patients, all
seriously ill, had been approved to receive THC as an antiemetic
treatment of last resort. Two patients did not receive drug
treatment.. A total of 28 reports of treatment episodes were
received; one patient received two THC treatments. Conditions for
which THC was tried as an antiemetic included acute leukemia,
acute myelocytic leukemia, bone marrow transplant, terminal
melanoma, terminal breast cancer, AIDS, multiple sclerosis, etc.<br>
</font> </p>

<p> <font size="2">In summary, physicians rated the overall
antiemetic effectiveness of THC as very effective for fourteen
treatments, moderately effective for five treatments, slightly
effective for two treatments and not effective for seven
treatments. Other notable THC benefits reported included improved
appetites, an increased ability to participate in family
functions and an overall improvement in spirits. No serious side
effects were reported.<br>
</font> </p>

<p> <font size="2">Results of the Controlled Study Protocols<br>
</font> </p>

<p> <u><font size="2">THC plus Transdermal Scopolamine</font></u><font
size="2">. A two arm placebo controlled study was intended to
test the hypothesis that antiemetic therapy with THC would be
optimized by combining its use with transdermal scopolamine,
(Transderm V). The purpose of the study was to determine
antiemetic efficacy, side effects and drop out rate of the
combination regimen versu's THC alone using the cumulative, low
dose regimen. The investigation was limited to 5 investigators at
selected clinical sites. The Panel hoped to establish statistical
significance early by means of sequential analysis, anticipating
30 to 50 patients.<br>
</font> </p>

<p> <font size="2">The Transderm V Protocol began in late 1983,
and continued into 1986. Sixty-five patients were enrolled in
this study. However, no conclusion about efficacy was possible by
the end of the Cannabis Therapeutic Program, since only ten of
the 65 patients who enrolled met the stringent study criteria and
completed both arms of the study.<br>
</font> </p>

<p> <u><font size="2">THC in Combination with Dexamethasone</font></u><font
size="2">. The Dexamethasone Protocol like the Transderm Protocol
above was also a two arm placebo controlled study. It was
intended to test the hypothesis that antiemetic therapy with THC
would be optimized by combining its use with dexamethasone.<br>
</font> </p>

<p> <font size="2">The Dexamethasone Protocol also was initiated
in late 1983, and continued into 1984; however, of the four
patients who entered the study only one patient completed the
necessary two trials.<br>
</font> </p>

<p> <u><font size="2">Delta-8-tetrahydrocannabinol </font></u><font
size="2">(delta-8-THC), a synthetic cannabinoid, is not present
in natural marijuana. It is similar in action to delta-9-THC, the
oral THC administered in the Cannabis Therapeutic Program, but
some reports in the medical literature suggested that it caused
fewer central nervous system side effects than delta-9-THC.
Because side effects may limit the maximum tolerated dose and may
deter some patients from continuing THC therapy even though it
may be relieving nausea and vomiting, such properties of
delta-8-THC could offer a major advantage. The Panel was
encouraged in the effort by Dr. Perez-Reyes, author of some of
the studies referred to above.<br>
</font> </p>

<p> <font size="2">The Panel engaged Dr. Perez Reyes to consult
in developing a pilot research project on the effects of
delta-8-THC as an., antiemetic. 'In October 1983, the Panel
submitted an investigational New Drug Application (IND 124,094)
to the U.S. Food and Drug Administration. Patients were first
enrolled in October 1983.<br>
</font> </p>

<p> <font size="2">Only ten patients were enrolled in this study.
Results on this small number cannot be interpreted except
anecdotally. The drug was used on two patients over a longterm
period resulting in the following comments:<br>
</font> </p>

<p> <font size="2">Patient D received 26 treatment episodes over
a 10 month period. After her initial three treatments, during
which the patient rated delta-8-THC moderately or very effective,
the drug dosing schedule was modified to a single 20mg. dose. The
patient continued to benefit. For the next 20 treatment episodes
with this modified dose, she rated the drug very effective for 17
treatments, had no or only mild nausea and vomiting, and suffered
only dry mouth and sedation as side effects. (Overall
effectiveness ratings were missing from three treatment
episodes.) However, during treatment episode number 23, the
patient experienced anxiety and said she felt 'funny or crazy.'
To minimize these effects, the dose was lowered to 10mg. for
treatments 24 to 26. The-drug was rated very effective for
treatment 24 but not effective for treatments 25 and 26. The
protocol nurse had not indicated any change in the patient's
chemotherapy regimen or concurrent medications during those
treatment episodes. The patient elected not to take further
delta-8-THC.<br>
</font> </p>

<p> <font size="2">Patient Z received twelve treatments over a
total of 5 months (2 months with delta-8-THC, 2 months off the
drug while undergoing radiation therapy, then a return to 3
months with delta-8-THC). Delta8-THC was rated as beneficial with
a variety of combinations of chemotherapy agents (BCKU + CYC +
VCR; ADR; CYC + VCR). The patient rated the drug very effective
for 5 treatment episodes and moderately effective for 6. Several
side effects were experienced during all treatment episodes, but
all were reported as mild. However, on the patient's last
treatment, he began a new chemotherapy regimen (ARA-C + MTX) and
found delta-8-THC not effective.<br>
</font> </p>

<p> <font size="2">Glaucoma Protocol<br>
</font> </p>

<p> <font size="2">In 1983, the Legislature considered anecdotal
reports from a few patients with glaucoma, and other individuals,
and noted the evidence that oral THC and smoked marijuana lowered
intra-ocular pressure. In response, the legislation that extended
the Cannabis Therapeutic Program also mandated exploration of the
therapeutic potential of cannabinoids in glaucoma, an assignment
with complexities beyond those encountered in the cancer
chemotherapy program.<br>
</font> </p>

<p> <font size="2">Prior to designing a clinical trial, the Panel
co-opted the services of an ophthalmologist and distributed a
questionnaire that queried every ophthalmologist in the State
about the probable availability of patients and for their
suggestions. The Panel then prepared-and submitted an application
for an Investigational New Drug Exemption (IND), accepted by the
Food and Drug Administration as 123,373, that included a protocol
(Appendix XIII) for the evaluation of oral-THC and smoked
marijuana in the treatment of open-angle glaucoma.<br>
</font> </p>

<p> <font size="2">In preparing this protocol, the Panel
considered the nature of the disease and the availability of
other treatment in establishing criteria for the acceptance of
patients into the program.<br>
</font> </p>

<p> <font size="2">There are several variants of glaucoma. All
are characterized by an elevation of the pressure within the
eyeball, where pressure is transmitted to the optic nerve with,
consequently, a possible loss of vision. However, the rate of
progression, threat to vision and modes of treatment differ for
different types of glaucoma. Moreover, effective treatment with
drugs or, in a few situations, surgery, is available for most
patients, a contrast with the nausea and vomiting of cancer
chemotherapy.<br>
</font> </p>

<p> <font size="2">To be certain that no patient was deprived of
treatment of established efficacy by the research needs of the
Panel, patients were accepted only if they had open-angle
glaucoma inadequately controlled by conventional,
non-investigational treatment. To be certain that the desire of
the patient to use THC was not generated by emotion or by
proselytizing efforts directed toward 'legalized' marijuana, a
&quot;Patient Qualification Review Board' was established to
scrutinize the medical history of each prospective patient to
ensure that their enrollment was appropriate. <br>
</font> </p>

<p> <font size="2">In 1984, the Panel conducted a vigorous
program to publicize the Panel's investigational glaucoma
treatment to ophthalmologists and prospective patients. In
addition to the usual press releases, every ophthalmologist
received a mailing. The Panel arranged a program at Grand Rounds
at the University of California Medical School in San Francisco
for 200 ophthalmologists in Northern California and contacted
individual doctors known for their special interest or influence.<br>
</font> </p>

<p> <font size="2">Nevertheless, by the end of the program, only
twenty ophthalmologists were approved as investigators and, of
the twelve patients who expressed interest, only nine received
treatment. All nine were Mend-stage glaucoma' for whom it was
felt that no other treatment alternatives could be offered. All
nine chose oral THC rather than smoked marijuana.<br>
</font> </p>

<p> <u><font size="2">Results</font></u><font size="2">. The
results of treatment can be quickly summarized because all nine
patients withdrew from treatment. Four withdrew because of side
effects at 3 weeks, 2 months, and five months (2); one for lack
of efficacy (4 months); two progressed to cataract extraction and
did not resume treatment (5 months, 9 months); one changed
doctors (15 months) and one concluded after 7 months that the
drug was no longer needed, a conclusion not shared by the doctor.<br>
</font> </p>

<p> <font size="2">These patients did, however, contribute
information in two areas.<br>
</font> </p>

<p> <u><font size="2">Side Effects</font></u><font size="2">.
These patients provided reassurance about chronically
administered THC in that they took doses ranging from 2.5 to
17.5mg four tim es each day for 1-9 months. The patient who took
THC for 9 months used gradually increasing amounts until she was
taking 17.5mg four times each day. The most frequent side effects
were dry mouth, sedation, ataxia and dizziness. The impression
was that the side effects lessened with continued treatment. No
serious or unexpected reactions were seen...<br>
</font> </p>

<p> <u><font size="2">Effect on Intra-ocular</font></u> </p>

<p> <u><font size="2">Pressure</font></u><font size="2">. The
doctor's judgement of the patient's clinical status did not
provide any evidence of effectiveness although some initial, but
not lasting, improvement was claimed.<br>
</font> </p>

<p> <font size="2">The measurement of intra-ocular pressure (IOP)
should provide an objective measure of drug effect, but
variability was somewhat greater than expected, possibly because
the measurement was made at varying times after the application
of the standard treatment, which was continued when the THC was
started. Some of the patients showed an initial decrease in IOP
from base line levels, but this lowering was sustained in only
two patients. Even in these two patients, the possibility is that
THC, an anxiety relieving drug, or the increased attention of the
drug trial increased patient compliance with their standard
treatment.<br>
</font> </p>

<p> <font size="2">Post Marketing Survey of Investigators<br>
</font> </p>

<p> <font size="2">Eighteen months after dronabinol reached the
market, the Panel decided to audit its function and survey the
use of THC as a marketed drug. To accomplish these goals, a
survey was mailed to 237 oncologists-investigators. A reminder
postcard was mailed one week later and a 622 (n-148) response
rate was achieved. <br>
</font> </p>

<p> <u><font size="2">Prescribing of Dronabinol</font></u><font
size="2">. The survey asked to what extent dronabinol had been
prescribed over the 18 months since it became available. Of the
respondents, 103 (70%) indicated that they had continued to
prescribe tetrahydrocannabinol as dronabinol. The other 45 (302)
indicated they had not ordered THC since they prescribed it under
the Cannabis Therapeutic Program. <br>
</font> </p>

<p> <font size="2">Those investigators who reported that they had
not used commercial dronabinol were also the investigators who
had treated fewer patients with investigational THC during the
program. The 45 investigators who are not using THC had treated
only 304 patients during the Cannabis Therapeutic Program
(average of 6.8 patients each). The 103 who now use dronabinol
had treated 1163 patients during the Cannabis Therapeutic Program
(average of 11.3 patients each). The survey shows a tendency for
those oncologists who used experimental THC more extensively
during the Panel's compassionate access program to continue to
prescribe dronabinol. <br>
</font> </p>

<p> <font size="2">The survey instrument was intended to
establish the factors responsible for restricted use: efficacy,
undesirable side effects, price, the triplicate prescription form
requirement, and the strict limitations of the FDA approved
package insert. <br>
</font> </p>

<p> <font size="2">Table A&amp; <u>summarizes</u> the
respondents' responses to this question. Physicians who did not
order THC cited side effects, ineffectiveness and availability of
other effective antiemetics (reported most often as a comment) as
reasons for not prescribing dronabinol. Those using THC for their
patients included cost and triplicate form requirement as the
primary concerns and causes of limited use.<br>
</font> </p>

<p> <font size="2">The influence of patient demand on prescribers
is reported in Table AB. Those who do not order THC are not
influenced by patient demand.<br>
</font> </p>

<p> <u><font size="2">Impressions of Efficacy</font></u><font
size="2">. There was no significant difference between those who
order and those who do not in reports of the number of
antiemetics that would be tried first before prescribing
dronabinol. See Table AC.<br>
</font> </p>

<p> <font size="2">Polypharmacy is still popular. Of those using
dronabinol 58.3% (n - 60) used it in combination with other
antiemetics. (Note that in our analysis of the combination study,
little or no advantage in combination antiemetic therapy was
actually found. See page 36.<br>
</font> </p>

<p> <font size="2">The dronabinol prescribers have somewhat more
favorable opinion of dronabinol's efficacy for nausea than have
the non-prescribers in this survey. See figures I and 2.<br>
</font> </p>

<p> <font size="2">The difference in opinion between the two
groups of dronabinol's efficacy for vomiting is somewhat less.
See figures 3 and 4.<br>
</font> </p>

<p> <font size="2">Reasons to Hesitate to Prescribe Dronabinol</font>
</p>

<p> <font size="2">------------------------------------------- <br>
</font> </p>

<p> <font size="2">Non-prescribers Prescribers Total</font> </p>

<p> <font size="2">n - 45 n - 103 n - 148<br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">---- ----- ---- ----- ---- -----<br>
</font> </p>

<p> <font size="2">Side effects too severe 17 37.8 38 36.9 55
37.2<br>
</font> </p>

<p> <font size="2">Not effective 14 31.1 26 25.2 40 27.0<br>
</font> </p>

<p> <font size="2">Indications too limited 1 2.2 8 7.8 9 6.1<br>
</font> </p>

<p> <font size="2">Requires Triplicate 3 6.7 22 21.4 25 16.9<br>
</font> </p>

<p> <font size="2">Cost too high 6 13.3 27 26.2 33 22.3<br>
</font> </p>

<p> <font size="2">Other 15 33.3 16 15.5 31 20.9<br>
</font> </p>

<p> <font size="2">No response 5 11.1 15 14.6 20 13.5<br>
</font> </p>

<p> <font size="2">---------------------------------------------------------------------
<br>
<br>
</font> </p>

<p> <center><font size="2">Table AB<br>
</font></center> </p>

<p> <center><font size="2">Main Reason for Participation in</font></center>
</p>

<p> <center><u><font size="2">Cannabis-Therapeutic-program <br>
</font></u></center> </p>

<p> <font size="2">Prescribers Non-prescribers Total</font> </p>

<p> <font size="2">n - 103 n - 45 n - 148</font> </p>

<p> <font size="2">No. % No. % No. %<br>
</font> </p>

<p> <font size="2">---- ----- ---- ----- ---- -----<br>
</font> </p>

<p> <font size="2">Contribute to</font> </p>

<p> <font size="2">research 27 26.2 12 26.7 39 26.4<br>
</font> </p>

<p> <font size="2">Patient demand 23 22.3 4 8.9 27 18.2<br>
</font> </p>

<p> <font size="2">Provide compassionate</font> </p>

<p> <font size="2">access 44 42.7 23 51.1 67 45.3<br>
</font> </p>

<p> <font size="2">Other 1 1.0 2 4.4 3 2.0<br>
</font> </p>

<p> <font size="2">No response 6 5.8 4 8.9 10 6.8<br>
</font> </p>

<p> <font size="2">-------------------------------------------------------------------
<br>
</font> </p>

<p> <center><font size="2">Table AC<br>
</font></center> </p>

<p> <font size="2">Number of Antiemetics Prescribed</font> </p>

<p> <font size="2">Before Prescribing Dronabinol</font> </p>

<p> <font size="2">--------------------------- <br>
</font> </p>

<p> <font size="2">Prescribers Non-prescribers Total</font> </p>

<p> <font size="2">n - 103 n - 45 n - 148<br>
</font> </p>

<p> <font size="2">No. % No. % No. %</font> </p>

<p> <font size="2">---- ----- ---- ----- ---- -----<br>
</font> </p>

<p> <font size="2">None 0 0 0<br>
</font> </p>

<p> <font size="2">1 7 6.8 0 7 4.7</font> </p>

<p> <font size="2">2 31 30.1 7 15.6 38 25.7</font> </p>

<p> <font size="2">3 47 45.6 15 33.3 62 41.9</font> </p>

<p> <font size="2">4 or more 17 16.5 14 31.1 31 20.9</font> </p>

<p> <font size="2">No response 1 1.0 9 20.0 10 6.8<br>
</font> </p>

<hr>

<p> Evaluation of the Cannabis Therapeutic Program. </p>

<p> In general, our investigators were favorably disposed toward
the Panel's efforts to carry out the objectives of the Cannabis
Therapeutic Program. See figure 5.<br>
<br>
<font size="2">Discussion of Results of <u>Cannabis </u>Therapeutic
Program<br>
</font> </p>

<p> <font size="2">A general consistency was noted in results of
impression of effectiveness of THC and smoked marijuana as an
antiemetic throughout the various protocols.<br>
</font> </p>

<p> <font size="2">Side effects are significant, but were never
observed to be life threatening. Clinically serious adverse
reactions, defined as reactions while taking THC or marijuana
that required the use of drugs or hospitalization of the patient,
were observed primarily at the beginning of the study. Nine cases
were reported during the first 1569 patients and only one
throughout the balance of the study. This great reduction in
severe side effects may be due to several factors: 1) The
recommended initial dosage was first lowered from 7.5 to 5mg/m2.
2) Then, cumulative dosing technique was recommended. 3) Patients
with metastes to the brain were excluded from the study. 4)
Perhaps as the hospital staff became more familiar with the
clinical use of this disinhibiting drug, they were better able to
allay a feeling of panic in the inexperienced subjects. <br>
</font> </p>

<p> <font size="2">The Panel noted a number of problems in the
conduct of such a large multi-investigator study. </font> </p>

<p> <font size="2">It is difficult to determine the degree of
uniformity among investigators in their interpretation of 'Mild,'
'Moderate,&amp; or 'Severe.In some cases the reports received
from investigators were incomplete. In a few cases it was
apparent that second and subsequent treatment reports were merely
copies of prior reports. Treatment reports beyond the first were
not extensively utilized in the Panel's analysis of data.<br>
</font> </p>

<p> <font size="2">The requirements for compassionate access to
THC and smoked marijuana made the use of a true control group
impossible. The publicity given compassionate access somewhat
reduced investigator compliance and reduced the strictness of
Panel requirements. Nevertheless, a few investigators were
dropped from the study due to lack of cooperation.<br>
</font> </p>

<p> <font size="2">The attempt by the Panel to conduct smaller
controlled studies within the overall Cannabis Therapeutic
Program was inhibited by the lack of funds to provide physician
investigators the financial incentive usually offered by
industrial sponsors of new drug investigations. <br>
</font> </p>

<p> <font size="2">In spite of the problems, the Panel has been
able to gather valuable information on side effects of THC
therapy and dosing approaches which will minimize these side
effects. Also, even though this was not a formal, blinded,
efficacy study the tabulation of reports of impression of
effectiveness is a valuable predictor of the clinical future for
this drug.<br>
</font> </p>

<p> <center><font size="2">APPROVAL BY FDA FOR MARKETING OF THC</font></center>
</p>

<p> <center><font size="2">AND CONCLUSION</font></center> </p>

<p> <center><font size="2">OF THE CANNABIS THERAPEUTIC PROGRAM<br>
<br>
<br>
</font></center> </p>

<p> <font size="2">Approval and Rescheduling <br>
</font> </p>

<p> <font size="2">The Federal Food and Drug Administration (FDA)
required the same sequence of pre-marketing human trial a to
demonstrate safety and effectiveness for THC as for any new drug.
The Phase II, or controlled, double-blind studies, were
previously reported in the literature. The Phase III studies that
are represented by the Cannabis</font> </p>

<p> <font size="2">Therapeutic Program's trials are uncontrolled,
but involve a large number of patients. In this phase, the Panel
provided the largest experience simulating conditions of actual
practice, that is, the California Program was a successful Phase
III study useful to the FDA. The Research Advisory Panel, its
cooperative investigators and NCI's supply of investigational
drug subsidized the marketing of dronabinol. Under the usual
circumstances the cost for the data provided in such a study
would have exceeded $1.5 million.<br>
</font> </p>

<p> <font size="2">In 1985, the FDA concluded that the efficacy
and safety of THC were well enough established to justify
approval of dronabinol for marketing under highly restricted
conditions. This action by the FDA did not immediately terminate
the need for the compassionate access protocol. Approval jointly
by the FDA and DEA of the use of THC for a single application and
in a single dose form, i.e.. the oral capsule, did not override
existing California laws and regulations.<br>
<br>
In October 1986, both Federal and State laws and regulations were
changed and THC, now classed as a Schedule II controlled
substance and requiring the use of the California Triplicate
Prescription Form, became available as a prescription drug
marketed as dronabinol (Marinol). Thus, much of the need for the
Cannabis Therapeutic Program ended.<br>
</font> </p>

<p> <font size="2">During the transition period between FDA
approval and the ultimate rescheduling of dronabinol (Marinol,
THC) in California, the Panel minimized confusion by publishing
pertinent information in the newsletters of various California
licensing authorities and professional societies. <br>
<br>
Investigational THC No Longer Supplied by NCI<br>
</font> </p>

<p> <font size="2">The National Cancer Institute stopped
supplying investigational THC after September 30, 1986; however,
any investigational THC remaining in California pharmacies was
available to approved investigators. The Panel monitored the use
through August 1987, and audited the return to the DEA of unused
supplies. At no time during the program were there any
discrepancies in inventory or suspicion of diversion. It was
occasionally necessary to require some investigators to file
missing treatment reports (discovered by review of pharmacy
records) by considering denial of investigational privileges. <br>
</font> </p>

<p> <font size="2">Dronabinol finally became available as a
Schedule II drug in California on October 1, 1986. It is
important to note that only synthetic THC in sesame oil and
encapsulated in a soft gelatin capsule has been rescheduled.
Other forms of marijuana and THC remain Schedule I under both
California and federal Controlled Substances laws.<br>
</font> </p>

<p> <font size="2">The U.S. Drug Enforcement Administration has
stressed that dronabinol should be prescribed only for its
FDA-approved use: the <u>treatment</u> of nausea and vomiting
associated with <u>cancer chemotherapy </u>in patients who have
failed to respond adequately to conventional antiemetics. FDA
labeling states that this restriction is required because a
substantial proportion of patients treated with dronabinol can be
expected to experience disturbing psychotomimetic reactions not
observed with other antiemetic agents. The FDA-approved labeling
also declares that dronabinol is <u>contraindicated</u> in
patients whose nausea and vomiting arises from any cause other
than cancer chemotherapy. DEA warned in its regulation which
rescheduled dronabinol, that it may revoke a registrant's
Schedule II license and pursue any criminal sanctions warranted
under the Controlled Substances Act if a practitioner distributes
or dispenses dronabinol in a manner that constitutes a threat to
the public safety.<br>
</font> </p>

<p> <font size="2">Investigators and pharmacies had been advised
that marijuana cigarettes would continue to be available through
the Panel's Smoked Marijuana Protocol at least through the end of
1988. In spite of this continued availability, there has been
little or no interest in continued study of marijuana cigarettes
by the Panel's investigators.<br>
<br>
</font> </p>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> <br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-6</DOCNO>
<DOCOLDNO>IA087-000627-B015-282</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch1.htm 206.61.184.43 19970122051514 text/html 91696
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:14:15 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:06:41 GMT
Content-length: 91478
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>The health and psychological consequences of cannabis use:
chapter 1 </title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_hemp_medical_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a> | <a
href="medical.htm">Medical Information</a> </p>
<!--webbot bot="Include" endspan i-checksum="55454" -->

<p>The health and psychological consequences of cannabis use
chapter 1 </p>

<h3>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
</h3>

<hr>

<ol>
    <li><font size="2" face="Courier New">Summary of report<br>
        <br>
        <br>
        <br>
        Introduction <br>
        <br>
        This review of the literature on the health and
        psychological effects<br>
        of cannabis was undertaken at the initiative of the
        former Federal <br>
        Justice Minister, Senator Michael Tate, who requested a
        review of<br>
        knowledge relating to cannabis, to inform policy
        decisions. At Senator<br>
        Tate's urging, a National Task Force on Cannabis was
        established on 25<br>
        May 1992. The Task Force commissioned this review of the
        evidence on<br>
        the health and psychological effects of cannabis use. A
        new and <br>
        independent review was thought necessary because there
        has not been<br>
        any major international review of the literature on the
        health and<br>
        psychological effects of cannabis since 1981, when the
        Addiction <br>
        Research Foundation and World Health Organization jointly
        reviewed the<br>
        literature. The purpose of this review was to update the
        conclusions <br>
        of earlier reviews in the light of research undertaken
        during the past<br>
        decade.<br>
        <br>
        <br>
        <br>
        Our approach to the literature<br>
        <br>
        Our review of the literature was not intended to be as
        comprehensive <br>
        as the major review undertaken by the Addiction Research
        Foundation <br>
        and the World Health Organization. The literature is too
        large, and<br>
        the diversity of relevant disciplines represented in it
        beyond the<br>
        expertise we had available for the task. Unavoidably, we
        have relied<br>
        upon expert opinion in the areas that lie outside the
        authors' <br>
        collective expertise which is primarily in areas of
        epidemiology, <br>
        psychiatry, psychopharmacology, neurophysiology and
        neuropsychology. <br>
        <br>
        In order to minimise the effects of our lack of expertise
        in certain <br>
        areas we have relied upon the consensus views expressed
        in the <br>
        literature by experts in the relevant fields. When there
        has been <br>
        controversy between the experts we have explicitly
        acknowledged areas<br>
        of disagreement. We have checked our understanding and
        representation <br>
        of these expert views by asking Australian and overseas
        researchers <br>
        with expertise in the relevant fields to critically
        review what we<br>
        have written. <br>
        <br>
        <br>
        <br>
        Our approach to assessing the health effects of cannabis <br>
        <br>
        The evaluation of the health hazards of any drug is
        difficult for a<br>
        number of reasons. First, causal inferences about the
        effects of drugs<br>
        on human health are difficult to make, especially when
        the interval <br>
        between use and alleged ill effects is a long one. It
        takes time for<br>
        adverse effects to develop and for research to identify
        such effects. <br>
        <br>
        Second, in making causal inferences there is a tension
        between the<br>
        rigour and relevance of the evidence. The most rigorous
        evidence is<br>
        provided by laboratory investigations using animals or in
        vitro <br>
        preparations (e.g. cell preparations in a test tube) in
        which well<br>
        controlled drug doses are related to precisely specified
        biological <br>
        outcomes. The relevance of this evidence to human disease
        is<br>
        uncertain, however, because many inferences have to be
        made in linking<br>
        the occurrence of specific biological effects in
        laboratory animals to<br>
        the likely effects of human use. Epidemiological studies
        of<br>
        relationships between drug use and human disease are of
        greater <br>
        relevance to the appraisal of the health risks of human
        drug use, but<br>
        their relevance is purchased at the price of reduced
        rigour. Doses of<br>
        illicit drugs over periods of years are difficult to
        quantify because<br>
        of the varied dosages of blackmarket drugs and the stigma
        in admitting <br>
        to illicit drug use. Interpretation is further
        complicated by <br>
        correlations between cannabis use and alcohol, tobacco
        and other <br>
        illicit drug use. <br>
        <br>
        Third, appraisals of the hazards of drug use are affected
        by the <br>
        social approval of the drugs in question. The
        countercultural <br>
        symbolism of cannabis use in the late 1960s has
        introduced an <br>
        unavoidable sociopolitical dimension to the debate about
        the severity <br>
        of its adverse health effects. Politically conservative
        opponents of<br>
        cannabis use justify continued prohibition by citing
        evidence of the<br>
        personal and social harms of cannabis use. When the
        evidence is <br>
        uncertain they resolve uncertainty by assuming that the
        drug is unsafe<br>
        until proven safe. Complementary behaviour is exhibited
        by proponents <br>
        of cannabis use. Evidence of harm is discounted and
        uncertainties <br>
        about the ill-effects of chronic cannabis use resolved by
        demanding <br>
        better evidence, arguing that until such evidence is
        available <br>
        individuals should be allowed to choose whether or not
        they use the<br>
        drug.<br>
        <br>
        Such evidential standards are rarely applied
        consistently. The <br>
        politically conservative would reject a similar approach
        to the <br>
        appraisal of the health hazards of industrial processes.
        Similarly, <br>
        proponents of cannabis liberalisation rarely apply the
        principles used<br>
        in their risk assessment of cannabis to the appraisal of
        the health <br>
        effects of pharmaceutical drugs, industrial processes,
        and pesticides. <br>
        To guard against such double evidential standards we will
        be as <br>
        explicit as possible about the evidential standards we
        have used, and<br>
        attempt to be as even-handed as we can in their
        application.<br>
        <br>
        <br>
        <br>
        Evidential desiderata<br>
        <br>
        The burden of proof concerns who bears the responsibility
        for making a<br>
        case: those who make a claim of adverse health effects of
        cannabis, or<br>
        those who doubt it. If the burden falls on those who
        claim that it is<br>
        safe, uncertainty will be resolved by assuming that it is
        unsafe until<br>
        proved otherwise; conversely, if the burden falls on
        those who claim<br>
        that the drug is unsafe, then it will be assumed to be
        safe until <br>
        proven otherwise. <br>
        <br>
        It is by no means agreed who bears the burden of proof in
        the debate<br>
        about the health effects of cannabis use. Proponents of
        continued <br>
        prohibition appeal to established practice, arguing that
        since the<br>
        drug is illegal the burden of proof falls upon those who
        want to<br>
        legalise it; opponents of existing policies argue that
        the burden of<br>
        proof falls upon those who wish to use the criminal law
        to prevent <br>
        adults from freely choosing to use a drug.<br>
        <br>
        We will vary the burden of proof depending upon the state
        of the <br>
        evidence and argument. Once a prima facie case of harm
        has been made,<br>
        positive evidence of safety is required rather than the
        simple absence<br>
        of any evidence of ill effect. We will assume that a
        prima facie case<br>
        has been made when there is either direct evidence that
        the drug has<br>
        ill effects in humans or animals (e.g. from a
        case-control study), or<br>
        there is a compelling argument that it could, e.g. since
        tobacco <br>
        smoking causes lung cancer, and since cannabis and
        tobacco smoke are<br>
        similar in their constituents, it is probable that heavy
        cannabis <br>
        smoking also causes lung cancer. <br>
        <br>
        Standard of proof reflects the degree of confidence
        required in an<br>
        inference that there is a causal connection between drug
        use and harm.<br>
        In courts of law, the standard of proof demanded depends
        upon the<br>
        seriousness of the offence at issue and the consequences
        of a verdict,<br>
        with a higher standard of proof, &quot;beyond reasonable
        doubt&quot;, being<br>
        demanded in criminal cases, and the &quot;balance of
        probabilities&quot; being<br>
        acceptable in civil cases. Scientists generally require
        something <br>
        closer to the standard of &quot;beyond reasonable
        doubt&quot; than the balance<br>
        of probabilities before they draw confident conclusions
        of harm. <br>
        However, since there are few adverse health effects of
        cannabis use<br>
        which meet this standard, we will indicate when the
        evidence permits <br>
        an inference to be made on the balance of probabilities.<br>
        <br>
        The criteria for causal inference that we will use are
        standard ones.<br>
        These are: (1) evidence that there is a relationship
        between cannabis <br>
        use and a health outcome provided by one of the accepted
        types of<br>
        research design (namely, case-control, cross-sectional,
        cohort, or<br>
        experiment); (2) evidence provided by a statistical test
        or confidence <br>
        interval that the relationship is unlikely to be due to
        chance; (3)<br>
        good evidence that drug use precedes the adverse effect
        (e.g. from a<br>
        cohort study); and (4) evidence either from experiment,
        or<br>
        observational studies with statistical or other form of
        control, which<br>
        makes it unlikely that the relationship is due to some
        other variable <br>
        which is related to both cannabis use and the adverse
        health effect. <br>
        <br>
        In the trade-off between relevance and rigour, our
        preference will be<br>
        for human evidence, both experimental and
        epidemiological, over animal<br>
        and in vitro studies. In the absence of human evidence,
        in vitro and<br>
        animal experiments will be regarded as raising a
        suspicion that drug<br>
        use has an adverse effects on human health, with the
        degree of <br>
        suspicion being in proportion to the number of such
        studies, the <br>
        consistency of their results across different species and
        experimental <br>
        preparations, and the degree of expert consensus on the<br>
        trustworthiness of the inferences from effects in vitro
        and in vivo to<br>
        adverse effects on human health under existing patterns
        of usage. <br>
        <br>
        Ideally, it would be desirable to quantify the magnitude
        of risk posed<br>
        by cannabis use by estimating both the relative and
        attributable risks<br>
        of specific health effects. However, since there is
        generally <br>
        insufficient evidence to estimate these risks for many
        putative <br>
        adverse effects of cannabis, the magnitude of a health
        risk posed by<br>
        cannabis use will be qualitatively assessed by a
        comparison of its<br>
        probable health effects with those of two other widely
        used<br>
        recreational drugs, alcohol and tobacco. The motive for
        such a <br>
        comparison is to minimise double standards in the
        appraisal of the<br>
        health effects of cannabis use by providing some kind of
        common <br>
        standard, however approximate, for making societal
        decisions about <br>
        cannabis use.<br>
        <br>
        <br>
        <br>
        Cannabis the drug <br>
        <br>
        Cannabis is a generic name for a variety of preparations
        derived from<br>
        the plant Cannabis sativa. A sticky resin which covers
        the flowering <br>
        tops and upper leaves, most abundantly in the female
        plant, contains <br>
        more than 60 cannabinoid substances. Laboratory research
        on animals <br>
        and humans has demonstrated that the primary psychoactive
        constituent <br>
        in cannabis is the cannabinoid,
        delta-9-tetrahydrocannabinol or THC.<br>
        <br>
        <br>
        <br>
        The cannabinoid receptor<br>
        <br>
        Cannabis resembles the opioid drugs in acting upon
        specific receptors <br>
        in the brain. In this respect it differs from alcohol,
        cocaine and<br>
        other illicit drugs which act by disrupting brain
        processes. The <br>
        determination and characterisation of a specific
        cannabinoid receptor <br>
        has made it possible to map its distribution in the
        brain, and to<br>
        demonstrate that its well-known psychoactive effects are
        receptor <br>
        mediated. Very recently an endogenous brain molecule has
        been <br>
        discovered which binds to the cannabinoid receptor and
        mimics the<br>
        action of cannabinoids. It has been called
        &quot;anandamide&quot;, from the<br>
        Sanskrit word for bliss. Its discovery promises to
        stimulate a great<br>
        deal of research which will improve our understanding of
        the role <br>
        played by a cannabinoid-like system of the brain, and
        elucidate the<br>
        mechanism of action of cannabis.<br>
        <br>
        <br>
        <br>
        Forms of cannabis<br>
        <br>
        The concentration of THC varies between the three most
        common forms of<br>
        cannabis: marijuana, hashish and hash oil. Marijuana is
        prepared from<br>
        the dried flowering tops and leaves of the harvested
        plant. The <br>
        potency of the marijuana depends upon the growing
        conditions, the<br>
        genetic characteristics of the plant and the proportions
        of plant <br>
        matter. The flowering tops and bracts are highest in THC<br>
        concentration, with potency descending through the upper
        leaves, lower<br>
        leaves, stems and seeds. The concentration of THC in a
        batch of <br>
        marijuana containing mostly leaves and stems may range
        from 0.5-5 per<br>
        cent, while the &quot;sinsemilla&quot; variety with
        &quot;heads&quot; may have THC<br>
        concentrations of 7-14 per cent. <br>
        <br>
        Hashish or hash consists of dried cannabis resin and
        compressed <br>
        flowers. The concentration of THC in hashish generally
        ranges from 2-8<br>
        per cent, although it can be as high as 10-20 per cent.
        Hash oil is a<br>
        highly potent and viscous substance obtained by
        extracting THC from<br>
        hashish (or marijuana) with an organic solvent,
        concentrating the<br>
        filtered extract, and in some cases subjecting it to
        further<br>
        purification. The concentration of the THC in hash oil is
        generally <br>
        between 15 per cent and 50 per cent.<br>
        <br>
        <br>
        <br>
        Routes of administration<br>
        <br>
        Almost all possible routes of administration have been
        used, but by<br>
        far the most common method is smoking (inhaling).
        Marijuana is most<br>
        often smoked as a hand-rolled &quot;joint&quot;, the size
        of a cigarette or<br>
        larger. Tobacco is often added to assist burning, and a
        filter is<br>
        sometimes inserted. Hashish may also be mixed with
        tobacco and smoked<br>
        as a joint, but it is probably more frequently smoked
        through a pipe,<br>
        with or without tobacco. A water pipe known as a
        &quot;bong&quot; is a popular<br>
        implement for all cannabis preparations because the water
        cools the<br>
        hot smoke before it is inhaled and there is little loss
        of the drug<br>
        through sidestream smoke. Hash oil is used sparingly
        because of its<br>
        extremely high psychoactive potency; a few drops may be
        applied to a<br>
        cigarette or a joint, to the mixture in the pipe, or the
        oil may be<br>
        heated and the vapours inhaled. Whatever method is used,
        smokers <br>
        inhale deeply and hold their breath for several seconds
        in order to<br>
        ensure maximum absorption of THC by the lungs. <br>
        <br>
        Hashish may also be cooked or baked in foods and eaten.
        When ingested <br>
        orally the onset of the psychoactive effects is delayed
        by about an<br>
        hour. The &quot;high&quot; may be of lesser intensity but
        the duration of<br>
        intoxication is longer by several hours. It is easier to
        titrate the<br>
        dose and achieve the desired level of intoxication by
        smoking than by<br>
        ingestion, since the effects from smoking are more
        immediate. Crude<br>
        aqueous extracts of cannabis have been very rarely
        injected<br>
        intravenously, but this route is unpopular since THC is
        insoluble in<br>
        water, and hence, little or no drug is actually present
        in these <br>
        extracts. Moreover, the injection of tiny undissolved
        particles may<br>
        cause severe pain and inflammation at the site of
        injection, and a<br>
        variety of toxic systemic effects. <br>
        <br>
        <br>
        <br>
        Dosage<br>
        <br>
        A typical joint contains between 0.5g and 1.0g of
        cannabis plant <br>
        matter, which may vary in THC content between 5mg and
        150mg (i.e. <br>
        typically between 1 per cent and 15 per cent). The actual
        amount of<br>
        THC delivered in the smoke has been estimated at 20-70
        per cent, the<br>
        rest being lost through combustion or sidestream smoke.
        The<br>
        bioavailability of THC (the fraction of THC in the
        cigarette which <br>
        reaches the bloodstream) from marijuana cigarettes in
        human subjects <br>
        has been reported to range from 5-24 per cent. Given all
        of these <br>
        variables, the actual dose of THC absorbed when cannabis
        is smoked is<br>
        not easily quantified. <br>
        <br>
        In general, only a small amount of cannabis (e.g. 2-3mg
        of available <br>
        THC) is required to produce a brief pleasurable high for
        the<br>
        occasional user, and a single joint may be sufficient for
        two or three<br>
        individuals. A heavy smoker may consume five or more
        joints per day,<br>
        while heavy users in Jamaica, for example, may consume up
        to 420mg THC<br>
        per day. In clinical trials designed to assess the
        therapeutic <br>
        potential of THC, single doses have ranged up to 20mg in
        capsule form.<br>
        In human experimental research, THC doses of 10mg, 20mg
        and 25mg have<br>
        been administered as low, medium and high doses.<br>
        <br>
        <br>
        <br>
        Patterns of use<br>
        <br>
        Cannabis is the most widely used illicit drug in
        Australia, having <br>
        been tried by a third of the adult population, and by the
        majority of<br>
        young adults between the ages of 18 and 25. The most
        common route of<br>
        administration is by smoking, and the most widely used
        form of the<br>
        drug is marijuana. In the majority of cases cannabis use
        is<br>
        &quot;experimental&quot;, that is, most users use the
        drug on a small number of<br>
        occasions, and either discontinue their use, or use
        intermittently and<br>
        episodically after first trying it. Even among those who
        continue to<br>
        use the drug over longer periods, the majority
        discontinue their use<br>
        in their mid to late 20s. <br>
        <br>
        Only a small proportion of those who ever use cannabis
        use it on a<br>
        daily basis over an extended period such as several
        years. Because of<br>
        uncertainties about the dose received, there is no good
        information on<br>
        the amount of THC ingested by such regular users.
        &quot;Heavy&quot; use is<br>
        consequently defined approximately in terms of frequency
        of use rather<br>
        than the estimated average dose of THC received. The
        daily or near<br>
        daily use pattern over a period of years is the pattern
        that probably <br>
        places cannabis users at greatest risk of experiencing
        long-term <br>
        health and psychological consequences of use. Daily
        cannabis users are<br>
        more likely to be male and less well educated; they are
        also more <br>
        likely to regularly use alcohol and to have experimented
        with a<br>
        variety of other illicit drugs, such as, amphetamines,
        hallucinogens, <br>
        psychostimulants, sedatives and opioids.<br>
        <br>
        <br>
        <br>
        Metabolism of cannabinoids <br>
        <br>
        Different methods of ingesting cannabis give rise to
        differing <br>
        pharmacokinetics, i.e. patterns of absorption, metabolism
        and <br>
        excretion of the active agent. Upon inhalation, THC is
        absorbed from<br>
        the lungs into the bloodstream within minutes. After oral<br>
        administration absorption is much slower, taking one to
        three hours<br>
        for THC to enter the bloodstream, and delaying the onset
        of<br>
        psychoactive effects. When cannabis is smoked, the
        initial metabolism <br>
        of THC takes place in the lungs, followed by more
        extensive metabolism <br>
        by liver enzymes, with the transformation of THC to a
        number of <br>
        metabolites. The most rapidly produced metabolite is
        9-carboxy-THC, <br>
        which is detectable in blood within minutes of smoking.
        Another major<br>
        metabolite produced is 11-hydroxy-THC, which is
        approximately 20 per<br>
        cent more potent than THC, and penetrates the blood-brain
        barrier more<br>
        rapidly. It is present at very low concentrations in the
        blood after<br>
        smoking, but at high concentrations after the oral route.
        THC and its<br>
        hydroxylated metabolites account for most of the observed
        effects of<br>
        the cannabinoids.<br>
        <br>
        Peak blood levels of THC are usually reached within 10
        minutes of<br>
        smoking, and decline rapidly thereafter to about 5-10 per
        cent of<br>
        their initial level within the first hour. This initial
        rapid decline<br>
        reflects both rapid conversion to its metabolites, as
        well as the<br>
        distribution of unchanged THC to lipid-rich tissues,
        including perhaps<br>
        the brain. <br>
        <br>
        THC and its metabolites are highly fat soluble and may
        remain for long<br>
        periods in the fatty tissues of the body, from which they
        are slowly<br>
        released back into the bloodstream. The terminal
        half-life of THC (the<br>
        time required to clear half of the administered dose from
        the body) is<br>
        significantly shorter for experienced or daily users
        (19-27 hours) <br>
        than for inexperienced users (50-57 hours). Since tissue
        distribution <br>
        is similar for both users and non-users, it is the
        immediate and <br>
        subsequent metabolism that occurs more rapidly in
        experienced users.<br>
        Given the slow clearance of THC, repeated administration
        results in<br>
        the accumulation of THC and its metabolites in the body.
        Because of<br>
        its slow release from fatty tissues back into the
        bloodstream, THC and<br>
        its metabolites may be detectable in blood for several
        days, and <br>
        traces may persist for several weeks. Several studies
        have examined <br>
        measures of cannabinoids in fat, confirming that THC may
        be stored for<br>
        at least 28 days. <br>
        <br>
        <br>
        <br>
        Detection of cannabinoids in body fluids<br>
        <br>
        Cannabinoid levels in the body depend on both the dose
        given and the<br>
        smoking history of the individual, but are subject to a
        vast degree of<br>
        individual variability. Plasma levels of THC in man may
        range between<br>
        0-500ng/ml, depending on the potency of the cannabis
        ingested and the<br>
        time since smoking. The detection of THC in blood above
        10-15ng/ml <br>
        provides evidence of recent consumption of the drug,
        although how<br>
        recent is not possible to determine. A more precise
        estimate of time<br>
        of consumption may be obtained from the ratio of THC to
        9-carboxy-THC: <br>
        similar concentrations of both in blood indicate very
        recent use (in<br>
        the vicinity of 20-40 minutes) and a high probability of
        intoxication. <br>
        When the levels of 9-carboxy-THC are substantially higher
        than those<br>
        of THC itself, ingestion could be estimated to have
        occurred more than<br>
        half an hour ago. It is very difficult to determine the
        time of <br>
        administration from blood concentrations even if the
        smoking habits of<br>
        the individual and the exact dose consumed were known.
        Therefore, the<br>
        results of blood analyses are not easily interpreted and,
        at best, <br>
        only confirm the &quot;recent&quot; use of cannabis.<br>
        <br>
        <br>
        <br>
        Intoxication and levels of cannabinoids<br>
        <br>
        Since there is evidence that cannabis intoxication
        adversely affects <br>
        skills required to drive a motor vehicle (see below), it
        would be<br>
        desirable to have a reliable measure of impairment due to
        cannabis <br>
        intoxication that was comparable to the breath test of
        alcohol <br>
        intoxication. However, there is no clear relationship
        between blood<br>
        levels of THC or its metabolites and degree of either
        impairment or<br>
        subjective intoxication. A general consensus of forensic
        toxicologists <br>
        is that blood concentrations associated with impairment
        after smoking<br>
        cannabis have not been sufficiently established to
        provide a basis for<br>
        legal testimony in cases concerning driving a motor
        vehicle while <br>
        under the influence of cannabis. <br>
        <br>
        <br>
        <br>
        Acute psychological and health effects<br>
        <br>
        The major reason for the widespread recreational use of
        cannabis is<br>
        that it produces a &quot;high&quot;, an altered state of
        consciousness which is<br>
        characterised by mild euphoria, relaxation, and
        perceptual<br>
        alterations, including time distortion and the
        intensification of<br>
        ordinary sensory experiences, such as eating, watching
        films, and<br>
        listening to music. When used in a social setting the
        high is often<br>
        accompanied by infectious laughter, and talkativeness.
        Cognitive <br>
        effects are also marked. They include impaired short-term
        memory, and<br>
        a loosening of associations, which make it possible for
        the user to<br>
        become lost in pleasant reverie and fantasy. Motor skills
        and reaction<br>
        time are also impaired, so skilled activity of various
        kinds is <br>
        frequently disrupted.<br>
        <br>
        Not all the acute psychological effects of cannabis are
        welcomed by<br>
        users. The most common unpleasant psychological effects
        are anxiety, <br>
        sometimes producing frank panic reactions, or a fear of
        going mad, and<br>
        dysphoric or unpleasant depressive feelings. Psychotic
        symptoms such<br>
        as delusions and hallucinations may be more rarely
        experienced at very<br>
        high doses. These effects are most often reported by
        naive users who<br>
        are unfamiliar with the drug's effects, and by patients
        who have been<br>
        given oral THC for therapeutic purposes. More experienced
        users may<br>
        occasionally report these effects after oral ingestion of
        cannabis, <br>
        when the effects may be more pronounced and of longer
        duration than<br>
        those usually experienced after smoking cannabis. These
        effects can<br>
        usually be prevented by adequately informing users about
        the type of<br>
        effects they may experience, and once developed can be
        readily managed<br>
        by reassurance and support.<br>
        <br>
        The inhalation of marijuana smoke, or the ingestion of
        THC has a<br>
        number of bodily effects. Among these the most dependable
        is an <br>
        increase in heart rate of 20-50 per cent over baseline,
        which occurs<br>
        within a few minutes to a quarter of an hour, and lasts
        for up to<br>
        three hours. Changes in blood pressure also occur, which
        depend upon<br>
        posture: blood pressure is increased while the person is
        sitting, and<br>
        decreases while standing. In healthy young users these
        cardiovascular <br>
        effects are unlikely to be of any clinical significance
        because <br>
        tolerance develops to the effects of THC, and young,
        healthy hearts <br>
        will only be mildly stressed.<br>
        <br>
        The acute toxicity of cannabis, and cannabinoids more
        generally, is<br>
        very low. There are no confirmed cases of human deaths
        from cannabis <br>
        poisoning in the world medical literature. This is
        unlikely to be due<br>
        to a failure to detect such deaths, because animal
        studies indicate <br>
        that the dose of THC required to produce 50 per cent
        mortality in<br>
        rodents is extremely high by comparison with other
        commonly used <br>
        pharmaceutical and recreational drugs. The lethal dose
        also increases <br>
        as one moves up the phylogenetic tree, suggesting by
        extrapolation <br>
        that the lethal dose in humans could not be achieved by
        either smoking<br>
        or ingesting the drug. <br>
        <br>
        <br>
        <br>
        Psychomotor effects and driving<br>
        <br>
        The major potential health risk from the acute use of
        cannabis arises<br>
        from its effects on psychomotor performance. Intoxication
        produces <br>
        dose-related impairments in a wide range of cognitive and
        behavioural <br>
        functions that are involved in skilled performances like
        driving an<br>
        automobile or operating machinery. The negative effects
        of cannabis on<br>
        the performance of psychomotor tasks is almost always
        related to dose.<br>
        The effects are generally larger, more consistent and of
        increased <br>
        persistence in difficult tasks which involve sustained
        attention. The<br>
        acute effects of doses of cannabis which are subjectively
        equivalent <br>
        to or higher than usual recreational doses on driving
        performance in<br>
        laboratory simulators and over standardised driving
        courses, are <br>
        similar to those of doses of alcohol that achieve blood
        alchol <br>
        concentrations between 0.07 per cent and 0.10 per cent. <br>
        <br>
        While cannabis impairs performance in laboratory and
        simulated driving<br>
        settings, it is difficult to relate the magnitude of
        these impairments <br>
        to the risk of being involved in motor vehicle accidents.
        Studies of<br>
        the effects of cannabis on on-road driving performance
        have found at<br>
        most modest impairments. Cannabis intoxicated persons
        drive more <br>
        slowly, and generally take fewer risks, than alcohol
        intoxicated <br>
        drinkers, probably because they are more aware of their
        level of<br>
        psychomotor impairment.<br>
        <br>
        There is no controlled epidemiological evidence that
        cannabis users<br>
        are at increased risk of being involved in motor vehicle
        or other <br>
        accidents. This is in contrast to the case of alcohol use
        and <br>
        accidents, where case-control studies have shown that
        persons with<br>
        blood alcohol levels indicative of intoxication are
        over-represented <br>
        among accident victims. All that is available are studies
        of the <br>
        prevalence of cannabinoids in the blood of motor vehicle
        and other <br>
        accident victims, which have found that between 4 per
        cent and 37 per<br>
        cent of such blood samples have contained cannabinoids,
        typically in<br>
        association with blood alcohol levels indicative of
        intoxication. <br>
        These studies are difficult to evaluate for a number of
        reasons. <br>
        <br>
        First, in the absence of information on the prevalence of
        cannabinoids <br>
        in the blood of non-accident victims, we do not know
        whether persons <br>
        with cannabinoids are over-represented among accident
        victims. Second,<br>
        the presence of cannabinoids in blood indicates only
        recent use, not<br>
        necessarily intoxication at the time of the accident.
        Third, there are<br>
        also serious problems of causal attribution, since more
        than 75 per<br>
        cent of drivers with cannabinoids in their blood also
        have blood <br>
        levels indicative of alcohol intoxication. <br>
        <br>
        Attempts have been made to circumvent the first
        difficulty by using<br>
        NIDA Household survey data (from the United States) to
        estimate what<br>
        proportion of drivers might be expected to have
        cannabinoids in their<br>
        blood and urine. These suggest that cannabis users are
        two to four<br>
        times more likely to be represented among accident
        victims than <br>
        non-cannabis users; cannabis users who also use alcohol,
        rather than<br>
        cannabis only users, are even more likely to be
        over-represented among<br>
        accident victims. Other indirect support for an increased
        risk of<br>
        accidental death associated with cannabis use comes from
        surveys of<br>
        self-reported accidents among adolescent drug users, and
        from <br>
        epidemiological studies of the relationships between
        cannabis use and<br>
        mortality, and health service utilisation. <br>
        <br>
        The known effects of interactions between cannabis and
        other drugs on<br>
        psychomotor performance are what would be predicted from
        their <br>
        separate effects. The drug most often used in combination
        with <br>
        cannabis is alcohol. The separate effects of alcohol and
        cannabis on<br>
        psychomotor impairment and driving performance are
        approximately <br>
        additive. <br>
        <br>
        <br>
        <br>
        The effects of chronic cannabis use<br>
        <br>
        <br>
        <br>
        Cellular effects and the immune system <br>
        <br>
        There is reasonably consistent evidence that some
        cannabinoids, most<br>
        especially THC, can produce a variety of cellular
        changes, such as<br>
        alterations to cell metabolism, and DNA synthesis, in
        vitro (i.e. in<br>
        the test tube). There is stronger and more consistent
        evidence that<br>
        cannabis smoke is mutagenic in vitro, and in vivo (i.e.
        in live <br>
        animals), and hence, that it is potentially carcinogenic.
        If cannabis <br>
        smoke is carcinogenic then it is probably for the same
        reasons that<br>
        cigarette smoke is, rather than because it contains
        cannabinoids. <br>
        Hence, if chronic cannabis smoking causes cancer, it is
        most likely to<br>
        develop after long-term exposure at those sites which
        receive maximum<br>
        exposure, namely, the lung and upper aerodigestive tract
        (see below). <br>
        <br>
        There is reasonably consistent evidence that cannabinoids
        impair both<br>
        the cell-mediated and humoral immune systems in rodents.
        Humoral <br>
        immune suppression is seen in decreased antibody
        formation responses <br>
        to antigens, and decreased lymphocyte response to B-cell
        mitogens. <br>
        Cell-mediated immune suppression is revealed by a
        reduction in <br>
        lymphocyte response to T-cell mitogens. These changes
        have produced <br>
        decreased resistance to infection by a bacteria and a
        virus. There is<br>
        also evidence that the non-cannabinoid components of
        cannabis smoke<br>
        impair the functioning of alveolar macrophages, the first
        line of the<br>
        body's defence system in the lungs. The clinical
        relevance of these<br>
        findings is uncertain, however. The doses required to
        produce these<br>
        effects have generally been very high, and the problem of<br>
        extrapolating to the effects of doses used by humans is
        complicated by<br>
        the possibility that tolerance may also develop to such
        effects. <br>
        <br>
        The limited experimental and clinical evidence in humans
        is mixed, <br>
        with a small number of studies suggesting adverse effects
        that have<br>
        not been replicated by others. At present, there is no
        conclusive <br>
        evidence that consumption of cannabinoids predisposes man
        to immune <br>
        dysfunction, as measured by reduced numbers or impaired
        functioning of<br>
        T-lymphocytes, B-lymphocytes or macrophages, or reduced
        immunoglobulin <br>
        levels. There is suggestive evidence that THC impairs
        T-lymphocyte <br>
        responses to mitogens and allogenic lymphocytes.<br>
        <br>
        The clinical and biological significance of these
        possible<br>
        immunological impairments in chronic cannabis users is
        uncertain. To<br>
        date there has been no epidemiological, or even
        anecdotal, evidence of<br>
        increased rates of disease among chronic heavy cannabis
        users, such as<br>
        was seen among young homosexual men in the early 1980s
        when the <br>
        Acquired Immune Deficiency Syndrome was first recognised.
        There is one<br>
        large prospective study of HIV-positive homosexual men
        which indicates <br>
        that continued cannabis use did not increase the risk of
        progression <br>
        to AIDS. Given the duration of large-scale cannabis use
        by young <br>
        adults in Western societies, the absence of any epidemics
        of<br>
        infectious disease makes it unlikely that cannabis
        smoking produces <br>
        major impairments in the immune system. <br>
        <br>
        It is more difficult to exclude the possibility that
        chronic heavy <br>
        cannabis use produces a minor impairment in immunity.
        Such an effect<br>
        would be manifest in small increases in the rate of
        occurrence of<br>
        common bacterial and viral illnesses among chronic users
        which could<br>
        have escaped detection in the few studies that have
        attempted to<br>
        address the issue. Such an increase could nonetheless be
        of public <br>
        health significance because of the increased expenditure
        on health <br>
        services, and the loss of productivity that it would
        cause among the<br>
        young adults who are the heaviest users of cannabis. <br>
        <br>
        The possibility that cannabinoids may produce minor
        impairments in the<br>
        immune system would also raise doubts about the
        therapeutic usefulness <br>
        of cannabinoids in immunologically compromised patients,
        such as those<br>
        undergoing cancer chemotherapy, or those with AIDS. AIDS
        patients may<br>
        provide one of the best populations in which to detect
        any such <br>
        effects. If it was ethical to conduct clinical trials of
        cannabinoids <br>
        to improve appetite and well-being in AIDS patients, then
        studies of<br>
        the impact of cannabis use on their compromised immune
        systems would<br>
        provide one way of evaluating the seriousness of this
        concern. <br>
        <br>
        <br>
        <br>
        The cardiovascular system<br>
        <br>
        There is insufficient new evidence to change the
        conclusions reached <br>
        by the Institute of Medicine in 1982, namely, that
        although the <br>
        smoking of marijuana &quot;causes changes to the heart
        and circulation that<br>
        are characteristic of stress ... there is no evidence ...
        that it<br>
        exerts a permanently deleterious effect on the normal
        cardiovascular <br>
        system...&quot; (p72). The situation may be less benign
        for patients with<br>
        hypertension, cerebrovascular disease and coronary
        atherosclerosis, in<br>
        which case there is evidence that marijuana poses a
        threat because it<br>
        increases the work of the heart. The &quot;magnitude and
        incidence&quot; of the<br>
        threat remains to be determined as the cohort of chronic
        cannabis <br>
        users of the late 1960s enters the age of maximum risk
        for<br>
        complications of atherosclerosis in the heart, brain and
        peripheral <br>
        blood vessels. In the interim, because any such effects
        could be life<br>
        threatening in patients with significant occlusion of the
        coronary <br>
        arteries or other cerebrovascular disease, patients with<br>
        cardiovascular disease should be advised not to consume
        cannabis, and<br>
        perhaps not to use THC therapeutically.<br>
        <br>
        <br>
        <br>
        The respiratory system<br>
        <br>
        Chronic heavy cannabis smoking impairs the functioning of
        the large<br>
        airways, and probably causes symptoms of chronic
        bronchitis such as<br>
        coughing, sputum production, and wheezing. Given the
        adverse effects <br>
        of tobacco smoke, which is qualitatively very similar in
        composition <br>
        to cannabis smoke, it is likely that chronic cannabis use
        predisposes <br>
        individuals to develop chronic bronchitis and respiratory
        cancer. <br>
        There is reasonable evidence for an increased risk of
        chronic <br>
        bronchitis, and evidence that chronic cannabis smoking
        may produce <br>
        histopathological changes in lung tissues of the kind
        that precede the<br>
        development of lung cancer.<br>
        <br>
        More recently, concern about the possibility of cancers
        being induced<br>
        by chronic cannabis smoking has been heightened by case
        reports of<br>
        cancers of the aerodigestive tract in young adults with a
        history of<br>
        heavy cannabis use. Although these reports fall short of
        providing <br>
        convincing evidence because many of the cases
        concurrently used <br>
        alcohol and tobacco, they are clearly a major cause for
        concern, since<br>
        such cancers are usually rare in adults under the age of
        60, even <br>
        among those who smoke tobacco and drink alcohol. The
        conduct of <br>
        case-control studies of these cancers should be a high
        priority for<br>
        research which aims to identify the possible adverse
        health effects of<br>
        chronic cannabis use.<br>
        <br>
        <br>
        <br>
        Reproductive effects<br>
        <br>
        Chronic cannabis use probably disrupts the male and
        female<br>
        reproductive systems in animals, reducing testosterone
        secretion, and<br>
        sperm production, motility, and viability in males, and
        disrupting the<br>
        ovulatory cycle in females. It is uncertain whether it is
        likely to<br>
        have these effects in humans, given the inconsistency in
        the limited <br>
        literature on human males, and the lack of research in
        the case of<br>
        human females. There is also uncertainty about the
        clinical<br>
        significance of these effects in normal healthy young
        adults. They may<br>
        be of greater concern among young adolescents, and among
        males with<br>
        fertility impaired for other reasons.<br>
        <br>
        Cannabis use during pregnancy probably impairs foetal
        development, <br>
        leading to smaller birthweight, perhaps as a consequence
        of shorter <br>
        gestation, and probably by the same mechanism as
        cigarette smoking, <br>
        namely, foetal hypoxia. There is uncertainty about
        whether cannabis <br>
        use during pregnancy produces a small increase in the
        risk of birth<br>
        defects as a result of exposure of the foetus in utero.
        Prudence <br>
        demands that until this issue is resolved, women should
        be advised not<br>
        to use cannabis during pregnancy, or when attempting to
        conceive. <br>
        <br>
        There is not a great deal of evidence that cannabis use
        can produce <br>
        chromosomal or genetic abnormalities in either parent
        which could be<br>
        transmitted to offspring. Such animal and in vitro
        evidence as exists<br>
        suggests that the mutagenic capacities of cannabis smoke
        are greater <br>
        than those of THC, and are probably of greater relevance
        to the risk<br>
        of users developing cancer than to the transmission of
        genetic defects<br>
        to children.<br>
        <br>
        There is suggestive evidence that infants exposed in
        utero to cannabis<br>
        may experience transient behavioural and developmental
        effects during<br>
        the first few months after birth. There is a single study
        which <br>
        suggests an increased risk of childhood leukemia
        occurring among the<br>
        children born to women who used cannabis during their
        pregnancies. Its<br>
        replication is of some urgency. <br>
        <br>
        <br>
        <br>
        Psychological effects of chronic cannabis use<br>
        <br>
        <br>
        <br>
        Adolescent development <br>
        <br>
        There is strong continuity of development from
        adolescence into early<br>
        adult life in which many indicators of adverse
        development which have<br>
        been attributed to cannabis use precede its use, and
        increase the<br>
        likelihood of using cannabis. These include minor
        delinquency, poor<br>
        educational performance, nonconformity, and poor
        adjustment. A <br>
        predictable sequence of initiation into the use of
        illicit drugs was<br>
        identified among American adolescents in the 1970s, in
        which the use<br>
        of licit drugs preceded experimentation with cannabis,
        which preceded <br>
        the use of hallucinogens and &quot;pills&quot;, which in
        turn preceded the use<br>
        of heroin and cocaine. Generally, the earlier the age of
        initiation <br>
        into drug use, and the greater the involvement with any
        drug in the<br>
        sequence, the greater the likelihood of progression to
        the next drug<br>
        in the sequence.<br>
        <br>
        The causal significance of these findings, and especially
        the role of<br>
        cannabis in the sequence of illicit drug use, remains
        controversial. <br>
        The hypothesis that the sequence of use represents a
        direct<br>
        pharmacological effect of cannabis use upon the use of
        later drugs in<br>
        the sequence is the least compelling. A more plausible
        and better <br>
        supported explanation is that it reflects a combination
        of two <br>
        processes: the selective recruitment into cannabis use of<br>
        nonconforming and deviant adolescents who have a
        propensity to use<br>
        illicit drugs; and the socialisation of cannabis users
        within an<br>
        illicit drug using subculture which increases the
        exposure,<br>
        opportunity, and encouragement to use other illicit
        drugs.<br>
        <br>
        Although strong conclusions cannot be drawn, on the
        evidence from <br>
        cross-sectional and longitudinal studies of cohorts of
        American <br>
        adolescents in the 1970s and 1980s, there are suggestions
        that chronic<br>
        heavy cannabis use can adversely affect adolescent
        development in a<br>
        number of ways.<br>
        <br>
        There has been suggestive support for the hypothesis that
        heavy <br>
        adolescent use of cannabis impairs educational
        performance. In <br>
        cross-sectional surveys, cannabis use is related to an
        increased risk<br>
        of failing to complete a high school education, and of
        job instability <br>
        in young adulthood. These relationships in
        cross-sectional studies are<br>
        exaggerated because those who are most likely to use
        cannabis have<br>
        lower pre-existing academic aspirations and high school
        performance <br>
        than those who do not use it. When pre-existing academic
        aptitude and<br>
        interest are taken into account, the relationship between
        cannabis use<br>
        and educational and occupational performance is much more
        modest. Even<br>
        though modest, the suggestive adverse effects of cannabis
        and other<br>
        drug use upon educational performance are important
        because they may<br>
        cascade throughout young adult life, affecting choice of
        occupation, <br>
        level of income, choice of mate, and quality of life of
        the user and<br>
        his or her children. <br>
        <br>
        There is weaker but suggestive evidence that heavy
        cannabis use has<br>
        adverse effects upon family formation, mental health, and
        involvement <br>
        in drug-related (but not other types of) crime. In the
        case of each of<br>
        these outcomes, the apparently strong associations
        revealed in <br>
        cross-sectional data are much more modest in longitudinal
        studies, <br>
        after statistically controlling for associations between
        cannabis use<br>
        and other variables which predict these adverse outcomes.
        <br>
        <br>
        On balance, there are sufficient indications that
        cannabis use in<br>
        adolescence probably adversely affects adolescent
        development to<br>
        conclude that it is desirable to discourage adolescent
        cannabis use,<br>
        and especially regular cannabis use. <br>
        <br>
        <br>
        <br>
        Adult adjustment<br>
        <br>
        The evidence that chronic heavy cannabis use produces an
        amotivational <br>
        syndrome among adults is equivocal. The positive evidence
        largely <br>
        consists of case histories, and observational reports.
        The small <br>
        number of controlled field and laboratory studies have
        not found <br>
        compelling evidence for such a syndrome, although their
        evidential <br>
        value is limited by the small sample sizes and limited<br>
        sociodemographic characteristics of the field studies,
        and by the<br>
        short periods of drug use, and the youthful good health
        and minimal <br>
        demands made of the volunteers observed in the laboratory
        studies. If<br>
        there is such a syndrome, it is a relatively rare
        occurrence, even<br>
        among heavy, chronic cannabis users. <br>
        <br>
        <br>
        <br>
        A dependence syndrome<br>
        <br>
        A cannabis dependence syndrome like that defined in
        DSM-III-R probably<br>
        occurs in heavy, chronic users of cannabis. There is good
        experimental <br>
        evidence that chronic heavy cannabis users can develop
        tolerance to<br>
        its subjective and cardiovascular effects, and there is
        suggestive <br>
        evidence that some users may experience a withdrawal
        syndrome on the<br>
        abrupt cessation of cannabis use. There is clinical and<br>
        epidemiological evidence that some heavy cannabis users
        experience <br>
        problems in controlling their cannabis use, and continue
        to use the<br>
        drug despite experiencing adverse personal consequences
        of use. There<br>
        is limited evidence in favour of a cannabis dependence
        syndrome <br>
        analogous to the alcohol dependence syndrome. If the
        estimates of the<br>
        community prevalence of drug dependence provided by the
        Epidemiologic <br>
        Catchment Area study are correct, then cannabis
        dependence is the most<br>
        common form of dependence on illicit drugs. <br>
        <br>
        Recognition of the cannabis dependence syndrome has been
        delayed by a<br>
        number of factors. First, heavy daily cannabis use has
        been relatively <br>
        uncommon, and there have been few individuals who have
        requested <br>
        assistance in stopping their cannabis use. Second, an
        overemphasis on<br>
        evidence of tolerance and a withdrawal syndrome has
        hindered the <br>
        recognition of the syndrome among individuals who have
        presented for<br>
        treatment. Third, the occurrence of cannabis dependence
        has probably <br>
        been overshadowed because it is most common among persons
        who are<br>
        dependent on alcohol and opioids, forms of drug
        dependence which have<br>
        understandably been given higher treatment priority. <br>
        <br>
        Given the widespread use of cannabis, and its continued
        reputation as<br>
        a drug free of the risk of dependence, the clinical
        features of <br>
        cannabis dependence deserve to be better defined. This
        would enable <br>
        the prevalence of a dependence syndrome to be better
        estimated and<br>
        individuals who are dependent on cannabis to be better
        recognised and<br>
        treated. Treatment should probably be on the same
        principles as other<br>
        forms of dependence, although this issue is also in need
        of research. <br>
        <br>
        Although cannabis dependence is likely to be a larger
        problem than<br>
        previously thought, we should be wary of over-estimating
        its social <br>
        and public health importance. Estimates of the risk of
        users becoming <br>
        dependent suggest that it may be similar to that of
        alcohol, that it<br>
        will be highest among the minority of daily cannabis
        users, and that<br>
        even in this group the prevalence of drug-related
        problems may be<br>
        relatively low by comparison with those of alcohol
        dependence. There<br>
        is likely to be a high rate of remission of cannabis
        dependence <br>
        without formal treatment. While acknowledging the
        existence of the<br>
        syndrome, we should avoid exaggerating its prevalence and
        the severity<br>
        of its adverse effects on individuals. Better research on
        the <br>
        experiences of long-term cannabis users should provide
        more precise <br>
        estimates of the risk. <br>
        <br>
        <br>
        <br>
        Cognitive effects<br>
        <br>
        The weight of the available evidence suggests that the
        long-term heavy<br>
        use of cannabis does not produce any severe impairment of
        cognitive <br>
        function. There is reasonable clinical and experimental
        evidence, <br>
        however, that the long-term use of cannabis may produce
        more subtle <br>
        cognitive impairment in the higher cognitive functions of
        memory, <br>
        attention and organisation and integration of complex
        information. <br>
        While subtle, these impairments may affect everyday
        functioning, <br>
        particularly in adolescents with marginal educational
        aptitude, and<br>
        among adults in occupations that require high levels of
        cognitive <br>
        capacity. The evidence suggests that the longer the
        period that <br>
        cannabis has been used, the more pronounced is the
        cognitive<br>
        impairment. It remains to be seen whether the impairment
        can be <br>
        reversed by an extended period of abstinence from
        cannabis.<br>
        <br>
        There is a need for research to identify the specific
        cognitive <br>
        functions affected by long-term cannabis use, to identify
        the precise<br>
        mechanisms that produce impairment and to relate them to
        biological <br>
        mechanisms, including the cannabinoid receptors and the
        endogenous <br>
        cannabinoid, anandamide. Such research also needs to
        investigate <br>
        individual differences in susceptibility to such effects,
        and the<br>
        impact of long-term cannabis use on adolescents and young
        adults. <br>
        Appropriate treatment programs for long-term dependent
        cannabis users<br>
        will also need to address the subtle cognitive
        impairments likely to<br>
        be found in this population.<br>
        <br>
        <br>
        <br>
        Brain damage<br>
        <br>
        A suspicion that chronic heavy cannabis use may cause
        gross structural <br>
        brain damage was provoked by a single poorly controlled
        study using an<br>
        outmoded method of investigation, which reported that
        cannabis users<br>
        had enlarged cerebral ventricles. This finding was widely
        and <br>
        uncritically publicised. Since then a number of better
        controlled <br>
        studies using more sophisticated methods of investigation
        have <br>
        consistently failed to demonstrate evidence of structural
        change in<br>
        the brains of heavy, long-term cannabis users. These
        negative results<br>
        are consistent with the evidence that any cognitive
        effects of chronic<br>
        cannabis use are subtle, and hence unlikely to be
        manifest as gross<br>
        structural changes in the brain. They do not exclude the
        possibility <br>
        that chronic, heavy cannabis use may cause
        ultrastructural changes at<br>
        the receptor level.<br>
        <br>
        <br>
        <br>
        Psychotic disorders<br>
        <br>
        There is suggestive evidence that heavy cannabis use can
        produce an<br>
        acute toxic psychosis in which confusion, amnesia,
        delusions, <br>
        hallucinations, anxiety, agitation and hypomanic symptoms
        predominate. <br>
        The evidence for an acute toxic cannabis psychosis comes
        from <br>
        laboratory studies of the effects of THC on normal
        volunteers and<br>
        clinical observations of psychotic symptoms in heavy
        cannabis users<br>
        which seem to resemble those of other toxic psychoses,
        and which remit<br>
        rapidly following abstinence. <br>
        <br>
        There is less support for the hypothesis that cannabis
        use can cause<br>
        either an acute or a chronic functional psychosis which
        persists <br>
        beyond the period of intoxication. Such a possibility is
        difficult to<br>
        study because of the rarity of such psychoses, and the
        near<br>
        impossibility of distinguishing them from schizophrenia
        and manic <br>
        depressive psychoses occurring in individuals who also
        abuse cannabis. <br>
        <br>
        There is strongly suggestive evidence that chronic
        cannabis use may<br>
        precipitate a latent psychosis in vulnerable individuals.
        This is only<br>
        strongly suggestive because in the best study conducted
        to date, the<br>
        use of cannabis was not documented at the time of
        diagnosis, there was<br>
        a possibility that cannabis use was confounded by
        amphetamine use, and<br>
        there are doubts about whether the study could reliably
        distinguish <br>
        between schizophrenia and acute cannabis-induced, or
        other<br>
        drug-induced, psychoses. Even if this relationship is
        causal, its<br>
        public health significance should not be overstated: the
        estimated <br>
        attributable risk of cannabis use is small (less than 10
        per cent), <br>
        and even this seems an overestimate, since the incidence
        of<br>
        schizophrenia declined over the period when cannabis use
        increased <br>
        among young adults. <br>
        <br>
        <br>
        <br>
        Therapeutic effects of cannabinoids<br>
        <br>
        There is reasonable evidence that THC is an effective
        anti-emetic <br>
        agent for patients undergoing cancer chemotherapy,
        especially those<br>
        whose nausea has proven resistant to the anti-emetic
        drugs that were<br>
        widely used in the late 1970s and early 1980s, when most
        of the <br>
        research was conducted. It is uncertain whether THC is as
        effective as<br>
        newer anti-emetic drugs. Uncertainty also exists about
        the most <br>
        optimal method of dosing and the advantages and
        disadvantages of<br>
        different routes of administration. Nonetheless, there is
        probably <br>
        sufficient evidence to justify THC being made available
        in synthetic <br>
        form to cancer patients whose nausea has proven resistant
        to<br>
        conventional treatment. <br>
        <br>
        There is also reasonable evidence for the potential
        efficacy of THC<br>
        and marijuana in the treatment of glaucoma, especially in
        cases which<br>
        have proved resistant to existing anti-glaucoma agents.
        Further <br>
        research is required to establish the effectiveness and
        safety of<br>
        long-term use, but this should not prevent its use under
        medical <br>
        supervision in individuals with poorly controlled
        glaucoma. <br>
        <br>
        There is sufficient suggestive evidence of the potential
        usefulness of<br>
        various cannabinoids as anti-spasmodic, and
        anti-convulsant agents to<br>
        warrant further clinical research into their
        effectiveness. There are<br>
        other potential therapeutic uses which require more basic<br>
        pharmacological and experimental investigation, e.g.
        cannabinoids as<br>
        possible analgesic and anti-asthma agents. <br>
        <br>
        There is a need for further research into the
        effectiveness of <br>
        cannabis and its derivatives in assisting patients with<br>
        HIV/AIDS-related conditions, and in particular, their
        value in <br>
        counteracting weight loss associated with these
        conditions, improving <br>
        mood and easing pain. Case reports have suggested that
        synthetic THC<br>
        may be effective in reducing nausea and stimulating
        appetite in <br>
        symptomatic AIDS patients. While there is a potential
        concern that<br>
        possible effects of cannabinoids on the immune system may
        have more<br>
        serious consequences for HIV positive individuals and
        AIDS patients, a<br>
        recent study has failed to find a relationship between
        the use of<br>
        cannabis, or any other psychoactive drugs, and the rate
        at which HIV<br>
        positive people progress to clinical AIDS.<br>
        <br>
        Despite the basic and clinical research work which was
        undertaken in<br>
        late 1970s and early 1980s, the cannabinoids have not
        been widely used<br>
        therapeutically, nor has further investigation been
        conducted along<br>
        the lines suggested by the Institute of Medicine in 1982.
        This seems<br>
        attributable to the fact that, in the United States,
        where most <br>
        cannabis research has been conducted, clinical research
        on<br>
        cannabinoids has been discouraged by regulation and a
        lack of funding.<br>
        The discouragement of clinical cannabis research, in
        turn, derives <br>
        from the fact that THC, the most therapeutically
        effective<br>
        cannabinoid, is the one that produces the psychoactive
        effects sought<br>
        by recreational users. An unreasonable fear that the
        therapeutic use<br>
        of THC would send &quot;mixed messages&quot; to youth has
        motivated the<br>
        discouragement of research into the therapeutic effects
        of<br>
        cannabinoids. <br>
        <br>
        The recent discovery of a specific cannabinoid receptor
        and the <br>
        endogenous cannabinoid-like substance anandamide may
        change this <br>
        situation by encouraging more basic research on the
        biology of <br>
        cannabinoids which may have therapeutic consequences. It
        may prove <br>
        possible to separate the psychoactive and therapeutic
        effects of<br>
        cannabis, fulfilling the ancient promise of
        &quot;marijuana as medicine&quot;.<br>
        <br>
        <br>
        <br>
        Overall appraisal of the health and psychological risks
        of cannabis <br>
        use <br>
        <br>
        The following is a summary of the major adverse health
        and<br>
        psychological effects of acute and chronic cannabis use,
        classified by<br>
        the degree of confidence about the relationship between
        cannabis use<br>
        and the adverse effect.<br>
        <br>
        <br>
        <br>
        Acute effects <br>
        <br>
        The major acute adverse psychological and health effects
        of cannabis <br>
        intoxication are:<br>
        <br>
        anxiety, dysphoria, panic and paranoia, especially in
        naive<br>
        users;<br>
        <br>
        cognitive impairment, especially of attention and memory;
        <br>
        <br>
        psychomotor impairment, and possibly an increased risk of<br>
        accident if an intoxicated person attempts to drive a
        motor vehicle; <br>
        <br>
        an increased risk of experiencing psychotic symptoms
        among those<br>
        who are vulnerable because of personal or family history
        of psychosis; <br>
        and<br>
        <br>
        an increased risk of low birth weight babies if cannabis
        is used<br>
        during pregnancy.<br>
        <br>
        <br>
        <br>
        Chronic effects<br>
        <br>
        The major health and psychological effects of chronic
        heavy cannabis <br>
        use, especially daily use, over many years, remain
        uncertain. On the<br>
        available evidence, the major probable adverse effects
        appear to be:<br>
        <br>
        respiratory diseases associated with smoking as the
        method of<br>
        administration, such as chronic bronchitis, and the
        occurrence of<br>
        histopathological changes that may be precursors to the
        development of<br>
        malignancy;<br>
        <br>
        development of a cannabis dependence syndrome,
        characterised by<br>
        an inability to abstain from or to control cannabis use;
        and<br>
        <br>
        subtle forms of cognitive impairment, most particularly
        of<br>
        attention and memory, which persist while the user
        remains chronically <br>
        intoxicated, and may or may not be reversible after
        prolonged <br>
        abstinence from cannabis.<br>
        <br>
        The following are the major possible adverse effects of
        chronic, heavy<br>
        cannabis use which remain to be confirmed by further
        research: <br>
        <br>
        an increased risk of developing cancers of the
        aerodigestive <br>
        tract, i.e. oral cavity, pharynx, and oesophagus; <br>
        <br>
        an increased risk of leukemia among offspring exposed in
        utero; <br>
        <br>
        a decline in occupational performance marked by
        underachievement <br>
        in adults in occupations requiring high level cognitive
        skills, and<br>
        impaired educational attainment in adolescents; and<br>
        <br>
        birth defects occurring among children of women who used
        cannabis<br>
        during their pregnancies.<br>
        <br>
        <br>
        <br>
        High risk groups<br>
        <br>
        A number of groups can be identified as being at
        increased risk of<br>
        experiencing some of these adverse effects. <br>
        <br>
        <br>
        <br>
        Adolescents<br>
        <br>
        Adolescents with a history of poor school performance may
        have<br>
        their educational achievement further limited by the
        cognitive <br>
        impairments produced by chronic intoxication with
        cannabis. <br>
        <br>
        Adolescents who initiate cannabis use in the early teens
        are at<br>
        higher risk of progressing to heavy cannabis use and
        other illicit<br>
        drug use, and to the development of dependence on
        cannabis. <br>
        <br>
        <br>
        <br>
        Women of childbearing age<br>
        <br>
        Pregnant women who continue to smoke cannabis are
        probably at<br>
        increased risk of giving birth to low birth weight
        babies, and perhaps<br>
        of shortening their period of gestation.<br>
        <br>
        Women of childbearing age who smoke cannabis at the time
        of<br>
        conception or while pregnant possibly increase the risk
        of their<br>
        children being born with birth defects. <br>
        <br>
        <br>
        <br>
        Persons with pre-existing diseases<br>
        <br>
        Persons with a number of pre-existing diseases who smoke
        cannabis are<br>
        probably at an increased risk of precipitating or
        exacerbating <br>
        symptoms of their diseases. These include: <br>
        <br>
        individuals with cardiovascular diseases, such as
        coronary artery<br>
        disease, cerebrovascular disease and hypertension; <br>
        <br>
        individuals with respiratory diseases, such as asthma,
        bronchitis<br>
        and emphysema; <br>
        <br>
        individuals with schizophrenia who are at increased risk
        of<br>
        precipitating or of exacerbating schizophrenic symptoms;
        and<br>
        <br>
        individuals who are dependent on alcohol and other drugs,
        who are<br>
        probably at an increased risk of developing dependence on
        cannabis.<br>
        <br>
        <br>
        <br>
        Two special concerns<br>
        <br>
        <br>
        <br>
        Storage of THC<br>
        <br>
        There is good evidence that with repeated dosing of
        cannabis at <br>
        frequent intervals, THC can accumulate in fatty tissues
        in the human<br>
        body where it may remain for considerable periods of
        time. The health<br>
        significance of this fact is unclear. The storage of
        cannabinoids <br>
        would be serious cause for concern if THC were a highly
        toxic <br>
        substance which remained physiologically active while
        stored in body<br>
        fat. The evidence that THC is a highly toxic substance is
        weak and its<br>
        degree of activity while stored has not been
        investigated. One <br>
        potential health implication of THC storage is that
        stored<br>
        cannabinoids could be released into blood, producing a
        &quot;flashback&quot;, <br>
        although this is likely to be a very rare event, if it
        occurs at all.<br>
        Whatever the uncertainties about health implications of
        THC storage, <br>
        all potential users of cannabis should be aware that it
        occurs. <br>
        <br>
        <br>
        <br>
        Increases in the potency of cannabis? <br>
        <br>
        It has been claimed that the existing medical literature
        on the health<br>
        effects of cannabis underestimates its adverse effects,
        because it was<br>
        based upon research conducted on less potent forms of
        marijuana than<br>
        became available in the USA in the past decade. This
        claim has been<br>
        repeated and interpreted in an alarmist fashion in the
        popular media<br>
        on the assumption that an increase in the THC potency of
        cannabis <br>
        necessarily means a substantial increase in the health
        risks of <br>
        cannabis use. <br>
        <br>
        It is far from established that the average THC potency
        of cannabis <br>
        products has substantially increased over recent decades.
        If potency <br>
        has increased, it is even less certain that the average
        health risks<br>
        of cannabis use have materially changed as a consequence,
        since users<br>
        may titrate their dose to achieve the desired effects.
        Even if the<br>
        users are inefficient in titrating their dose of THC, it
        is not clear<br>
        that the probability of all adverse health effects will
        be thereby <br>
        increased. Given the existence of these concerns about
        THC potency, it<br>
        would be preferable to conduct some research on the issue
        rather than<br>
        to rely upon inferences about the likely effects of
        increased cannabis<br>
        potency. Studies of the ability of experienced users to
        titrate their<br>
        dose of THC would contribute to an evaluation of this
        issue.<br>
        <br>
        <br>
        <br>
        A comparative appraisal of health risks: alcohol, tobacco
        and cannabis<br>
        use<br>
        <br>
        The probable and possible adverse health and
        psychological effects of<br>
        cannabis need to be placed in comparative perspective to
        be fully <br>
        appreciated. A useful standard for such a comparison is
        what is known<br>
        about the health effects of alcohol and tobacco, two
        other widely used<br>
        psychoactive drugs. Cannabis shares with tobacco, smoking
        as the usual<br>
        route of administration, and resembles alcohol in being
        used for its<br>
        intoxicating and euphoriant effects. Although allowance
        has to be made<br>
        for the very different prevalence of use of the two
        drugs, and for the<br>
        fact that we know a great deal more about the adverse
        effects of<br>
        alcohol and tobacco use, the comparison serves the useful
        purpose of<br>
        reminding us of the risks we currently tolerate with our
        favourite <br>
        psychoactive drugs. <br>
        <br>
        <br>
        <br>
        Acute effects<br>
        <br>
        Alcohol. The major risks of acute cannabis use are
        similar to the<br>
        acute risks of alcohol intoxication in a number of
        respects. First, <br>
        both drugs produce psychomotor and cognitive impairment,
        especially of<br>
        memory and planning. The impairment produced by alcohol
        increases <br>
        risks of various kinds of accident, and the likelihood of
        engaging in<br>
        risky behaviour, such as dangerous driving, and unsafe
        sexual <br>
        practices. It remains to be determined whether cannabis
        intoxication <br>
        produces similar increases in accidental injury and
        death, although on<br>
        the balance of probability it does.<br>
        <br>
        Second, there is good evidence that substantial doses of
        alcohol taken<br>
        during the first trimester of pregnancy can produce a
        foetal alcohol <br>
        syndrome. There is suggestive but far from conclusive
        evidence that<br>
        cannabis used during pregnancy may have similar adverse
        effects. <br>
        <br>
        Third, there is a major health risk of acute alcohol use
        that is not<br>
        shared with cannabis. In large doses alcohol can cause
        death by <br>
        asphyxiation, alcohol poisoning, cardiomyopathy and
        cardiac infarct, <br>
        whereas there are no recorded cases of fatalities
        attributable to<br>
        cannabis.<br>
        <br>
        Tobacco. The major acute health risks that cannabis share
        with tobacco<br>
        are the irritant effects of smoke upon the respiratory
        system, and the<br>
        stimulating effects of both THC and nicotine on the
        cardiovascular <br>
        system, both of which can be detrimental to persons with<br>
        cardiovascular disease.<br>
        <br>
        <br>
        <br>
        Chronic effects<br>
        <br>
        Alcohol. There are a number of risks of heavy chronic
        alcohol use,<br>
        some of which may be shared by chronic cannabis use.
        First, heavy use<br>
        of either drug increases the risk of developing a
        dependence syndrome <br>
        in which users experience difficulty in stopping or
        controlling their<br>
        use. There is strong evidence for such a syndrome in the
        case of<br>
        alcohol and reasonable evidence in the case of cannabis.
        A major <br>
        difference between the two is that it is uncertain
        whether a<br>
        withdrawal syndrome reliably occurs after dependent
        cannabis users <br>
        abruptly stop their cannabis use, whereas the abrupt
        cessation of<br>
        alcohol use in severely dependent drinkers produces a
        well defined <br>
        withdrawal syndrome which can be potentially fatal. <br>
        <br>
        Second, there is reasonable clinical evidence that the
        chronic heavy<br>
        use of alcohol can produce psychotic symptoms and
        psychoses in some<br>
        individuals. There is suggestive evidence that chronic
        heavy cannabis <br>
        use may produce a toxic psychosis, precipitate psychotic
        illnesses in<br>
        predisposed individuals, and exacerbate psychotic
        symptoms in <br>
        individuals with schizophrenia.<br>
        <br>
        Third, there is good evidence that chronic heavy alcohol
        use can <br>
        indirectly cause brain injury - the Wernicke-Korsakov
        syndrome - with<br>
        symptoms of severe memory defect and an impaired ability
        to plan and<br>
        organise. With continued heavy drinking, and in the
        absence of vitamin<br>
        supplementation, this injury may produce severe
        irreversible cognitive <br>
        impairment. There is good reason for concluding that
        chronic cannabis <br>
        use does not produce cognitive impairment of comparable
        severity. <br>
        There is suggestive evidence that chronic cannabis use
        may produce <br>
        subtle defects in cognitive functioning, that may or may
        not be <br>
        reversible after abstinence. <br>
        <br>
        Fourth, there is reasonable evidence that chronic heavy
        alcohol use<br>
        produces impaired occupational performance in adults, and
        lowered <br>
        educational achievements in adolescents. There is at most
        suggestive <br>
        evidence that chronic heavy cannabis use produces
        similar, albeit more<br>
        subtle impairments in occupational and educational
        performance of<br>
        adults. <br>
        <br>
        Fifth, there is good evidence that chronic, heavy alcohol
        use <br>
        increases the risk of premature mortality from accidents,
        suicide and<br>
        violence. There is no comparable evidence for chronic
        cannabis use,<br>
        although it is likely that dependent cannabis users who
        frequently <br>
        drive while intoxicated with cannabis increase their risk
        of<br>
        accidental injury or death.<br>
        <br>
        Sixth, alcohol use has been accepted as a contributory
        cause of cancer<br>
        of the oropharangeal organs in men and women. There is
        suggestive <br>
        evidence that chronic cannabis smoking may also be a
        contributory <br>
        cause of cancers of the aerodigestive tract (i.e. the
        mouth, tongue, <br>
        throat, oesophagus, lungs).<br>
        <br>
        Tobacco. The major adverse health effects shared by
        chronic cannabis <br>
        and tobacco smokers are chronic respiratory diseases,
        such as chronic<br>
        bronchitis, and probably, cancers of the aerodigestive
        tract. The<br>
        increased risk of cancer in the respiratory tract is a
        consequence of<br>
        the shared route of administration by smoking. It is
        possible that<br>
        chronic cannabis smoking also shares the cardiotoxic
        properties of<br>
        tobacco smoking, although this possibility remains to be
        investigated. <br>
        <br>
        <br>
        <br>
        Implications for harm reduction <br>
        <br>
        Anyone who wishes to avoid the probable acute and chronic
        adverse <br>
        health effects of cannabis should abstain from using the
        drug. This<br>
        advice is especially pertinent for persons with any of
        the diseases <br>
        (e.g. cardiovascular) or conditions (e.g. pregnancy)
        which would make<br>
        them more vulnerable to the adverse effects of cannabis. <br>
        <br>
        Current cannabis users should be aware of the following
        risks of using<br>
        the drug. First, the risk of being involved in a motor
        vehicle <br>
        accident is likely to be increased when cannabis users
        drive while <br>
        intoxicated by cannabis. The combination of alcohol and
        cannabis <br>
        intoxication will substantially increase this risk.
        Second, the <br>
        chronic smoking of cannabis poses significant risks to
        the respiratory <br>
        system, apart from any specific effects of THC. Third,
        the respiratory <br>
        risks of cannabis smoking are amplified if deep
        inhalation and <br>
        breath-holding are used to maximise the absorption of THC
        in the <br>
        lungs. This technique greatly increases the delive<br>
        1. Summary of repo<br>
        particulate matter and tar. Fourth, daily or near daily
        use of <br>
        cannabis is to be avoided, as it has a high risk of
        producing <br>
        dependence. <br>
        </font></li>
</ol>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_medical_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a> | <a
href="medical.htm">Medical Information</a> </p>
<!--webbot bot="Include" endspan i-checksum="55454" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-7</DOCNO>
<DOCOLDNO>IA087-000627-B016-1</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch2.htm 206.61.184.43 19970122051547 text/html 4663
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:15:41 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 19-Jan-97 11:04:27 GMT
Content-length: 4448
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>The health and psychological consequences of cannabis
use:chapter 2 </title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_hemp_medical_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a> | <a
href="medical.htm">Medical Information</a> </p>
<!--webbot bot="Include" endspan i-checksum="55454" -->

<p>The health and psychological consequences of cannabis use
chapter 2 </p>

<p>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
<br>
</p>

<p>2. Introduction <br>
</p>

<p>This review of the literature on the health and psychological
effects of cannabis was undertaken at the initiative of the
former Federal Justice Minister, Senator Michael Tate, who
requested a review of knowledge relating to cannabis, to inform
policy decisions. At Senator Tate's urging, a National Task Force
on Cannabis was established on 25 May 1992. The Task Force
commissioned this review of the evidence on the health and
psychological effects of cannabis use. A new and independent
review was thought necessary because there has not been any major
international review of the literature on the health and
psychological effects of cannabis since 1981, when the Addiction
Research Foundation and World Health Organization jointly
reviewed the literature. The purpose of this review was to update
the conclusions of earlier reviews in the light of research
undertaken during the past decade (ARF/WHO, 1981; Fehr and
Kalant, 1983). <br>
</p>

<p>2.1 Our approach to the literature </p>

<p>Our review of the literature was not intended to be, and could
not hope to be, as comprehensive as the major review undertaken
by the Addiction Research Foundation and the World Health
Organization. The literature is too large, and the diversity of
relevant disciplines represented in it beyond the expertise we
had available for the task. Unavoidably, we have relied upon
published expert opinion in the very many areas which lie outside
the authors' collective expertise, which is primarily in
epidemiology, psychopharmacology, neurophysiology and
neuropsychology. This fact is inevitably reflected in the
relative attention given to the literatures that lie within and
beyond our expertise. The literatures on the psychological
consequences of acute and chronic cannabis use, for example, are
much more comprehensively and critically reviewed than those
pertaining to effects on the reproductive and immune systems. In
reviewing the literature that lies outside our expertise, we have
relied upon the consensus views expressed in the literature by
experts in the relevant fields. When there has been controversy
between the experts we have explicitly acknowledged it. We have
checked our understanding and representation of these expert
views by asking Australian and international researchers with
expertise in the relevant fields to critically review what we
have written. <br>
<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_medical_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a> | <a
href="medical.htm">Medical Information</a> </p>
<!--webbot bot="Include" endspan i-checksum="55454" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-8</DOCNO>
<DOCOLDNO>IA087-000627-B016-31</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch3.htm 206.61.184.43 19970122051558 text/html 17729
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:15:51 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:03:35 GMT
Content-length: 17511
</DOCHDR>
<html>

<head>
<title>The health and psychological consequences of cannabis use:
chapter 3 </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<h1></h1>
</body>

<body bgcolor="#ffffff">

<p>The health and psychological consequences of cannabis use
chapter 3 </p>

<h3>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
</h3>

<hr>

<pre>
<font size="2">3. Evidential principles 



3.1 Issues in appraising health hazards

The evaluation of the health hazards of any drug is difficult for a
variety of scientific and sociopolitical reasons. First, causal
inferences about the effects of drugs on human health are not easy to
make (ARF/WHO, 1981). Even inferences about the relatively direct and
transient effects of acute drug use may be complicated by individual
variability in response to a standard dose of a drug, and by the fact
that serious adverse effects are relatively rare. Inference becomes
more difficult the longer the interval between use and alleged ill
effects: it takes time for such effects to develop, and it may take
considerably longer for the research technology to be developed that
enables these effects to be identified and confidently attributed to
the drug use rather than some other factor (Institute of Medicine,
1982). In the case of chronic tobacco use, for example, it has taken
over three hundred years to discover that it increases premature
mortality from cancer, and heart disease. Moreover, new health hazards
of tobacco use, such as passive smoking, continue to be discovered. 

Second, in making causal inferences about drug use and its
consequences there is a tension between the rigour and relevance of
the evidence. The most rigorous evidence is provided by laboratory
investigations using experimental animals, or in vitro preparations of
animal cells and micro-organisms in which well controlled drug doses
are related to precisely measured biological outcomes. The relevance
of such research to human disease, however, is often problematic. A
great many inferences have to be made in linking the occurrence of
specific biological effects in laboratory animals or cell cultures to
the likely effects of the drug under existing patterns of human use. 

Epidemiological studies of relationships between drug use and human
disease have manifestly greater relevance to the appraisal of the
health risks of human drug use, but this is purchased at the price of
reduced rigour. Doses of drugs over periods of years are difficult to
quantify in the best of circumstances. The vagaries of human memory
which make quantification of consumption difficult in the case of
tobacco and alcohol are magnified in the case of illicit drugs by the
non-standard doses and contaminants in blackmarket drugs, and the
reluctance of users to report illicit drug use. The fact that
different patterns of drug use and other life-style factors are often
correlated (e.g. alcohol and tobacco), makes attribution of
ill-effects to particular drugs even more difficult (Task Force on
Health Risk Assessment, 1986).

Third, appraisals of the hazards of recreational drug use are
unavoidably affected by the societal approval or disapproval of the
drug in question. As Room (1984) has observed, when evaluating the
impact of alcohol on non-industrialised societies, anthropologists
have often engaged in problem deflation in response to the problem
inflation of missionaries and colonial authorities. In our own
culture, the economic interests of tobacco and alcohol industries
provide a potent reason for problem deflation with these drugs. Such
problem deflationists often discount the adverse effects of alcohol
use, either by contesting the evidence for adverse effects, or by
denying that there is a causal connection between alcohol use and
particular adverse health effects.

Similar processes have been at work in the appraisal of the health
effects of recreational cannabis use. The countercultural symbolism of
cannabis use in the late 1960s has introduced a strong sociopolitical
dimension to the debate about the adverse health effects of cannabis.
Politically conservative opponents of cannabis use, for example,
justify its continued prohibition by citing evidence of the personal
and social harms of its use. When the evidence is uncertain, as it is
with many of the alleged effects of chronic use, they resolve the
uncertainty by assuming that the cannabis is unsafe until proven safe.
Complementary behaviour is exhibited by some proponents of
decriminalisation. Evidence of harm is discounted or discredited, and
uncertainties about the ill-effects of chronic cannabis use are
resolved by demanding more and better evidence, arguing that until
this uncertainty is resolved individuals should be allowed to exercise
their free choice about whether or not they use the drug. 

Such approaches to the appraisal of evidence have not always been
consistently applied. Both sides of the debate would reject the
application of their own approaches to the appraisal of cannabis to
the appraisal of the health hazards of alcohol, pesticides,
herbicides, or chemical residues in food. While we do not claim to be
unaffected by these processes, we will be as explicit as possible
about the evidential standards that we have used, and as even-handed
as we can in their application.



3.2 Evidential desiderata

The following issues must be addressed in specifying what we have
taken to be the evidential desiderata in our appraisal of the health
risk of cannabis use: the burden of proof; standard of proof; criteria
for causal inference; preference for relevance or rigour; approaches
to estimating the magnitude of risk; and the desirability of a
comparative appraisal of the risks.

The burden of proof concerns who bears the responsibility for making a
case; those who make a claim of adverse health effects, or those who
doubt it (see Rescher, 1977, chapter XII). Who bears the burden of
proof determines the way in which an issue is decided in the face of
uncertainty: if the burden falls on those who claim that the drug is
safe, uncertainty will be resolved by assuming that it is unsafe until
proved otherwise; conversely, if the burden falls on those who claim
that the drug is unsafe, then it will be assumed to be safe until
proven otherwise.

It is by no means agreed who bears the burden of proof in the debate
about the health effects of cannabis use. Proponents of continued
prohibition appeal to established practice (Whately, 1846), arguing
that since the drug is illegal, the burden of proof falls upon those
who want to legalise it. Some proponents of its legalisation counter
that this begs the question, since there was no evidence, they argue,
that cannabis was harmful when its use was first made a criminal
offence. Others argue that the burden of proof falls upon those who
wish to use the criminal law to prevent adults from freely choosing to
use a drug (e.g. Husak, 1992).

We will vary the burden of proof on the basis of the state of the
evidence and argument. Once a prima facie case of harm has been made,
positive evidence of safety will be required rather than the simple
absence of any evidence of ill effect. We will assume that a prima
facie case has been made either when there is direct evidence that the
drug has ill effects in animals or humans (e.g. from a case-control
study), or when there is some compelling argument that it could, e.g.
the inference that since tobacco smoking causes lung cancer and
cannabis and tobacco smoke are similar in their constituents, it is
probable that heavy cannabis smoking also causes lung cancer. 

The standard of proof reflects the degree of confidence required in an
inference that there is a causal connection between drug use and harm.
In courts of law, the standard of proof demanded depends upon the
seriousness of the offence at issue and the consequences of a verdict,
with a higher standard of proof, &quot;beyond reasonable doubt&quot;, being
demanded in criminal cases, while the &quot;balance of probabilities&quot; is
acceptable in civil cases. Although these legal standards are not
directly translatable into scientific practice, scientists generally
require something closer to the standard of &quot;beyond reasonable doubt&quot;
than the balance of probabilities before drawing confident conclusions
that a drug causes harm. 

If we were to demand that such a standard be met for the health
effects of cannabis, this review would be exceedingly brief.
Consequently, we will relax the criteria and indicate when the
evidence permits a causal inference to be made on the balance of
probabilities. We will take this standard to be exemplified in the
consensus of informed scientific opinion that sufficient evidence has
been provided to infer a probable causal connection between drug use
and a harm (e.g. Fehr and Kalant, 1983; Institute of Medicine, 1982). 

In the trade-off between relevance and rigour, our preference will be
for human evidence, both experimental and epidemiological, rather than
animal and in vitro studies. In the absence of human evidence, in
vitro and animal experiments will be taken as raising a suspicion that
drug use has an adverse effects on human health. The degree of
suspicion raised will be in proportion to the number of such animal
studies, the consistency of their results across different species and
experimental preparations (Task Force on Health Risk Assessment,
1986), and the degree of expert consensus that the inferences from
effects in vitro and in vivo to adverse effects under existing
patterns of human use are valid. The degree of consensus on the latter
point will be indicated by the views expressed in authoritative
reviews in peer reviewed journals or contributions to international
consensus conferences (e.g. Fehr and Kalant, 1983; Institute of
Medicine, 1982).

The criteria for causal inference that we will use are standard ones
(see Hall, 1987), namely:

1.      Evidence that there is a relationship between drug use and a
        health outcome provided by one of the accepted types of
        epidemiological research design (namely, case-control,
        cross-sectional, cohort, or experiment).

2.      Evidence (usually provided by a statistical significance test or
        the construction of a confidence interval) that the relationship is
        unlikely to be due to chance.

3.      Good evidence that drug use precedes the adverse effect (e.g. a
        cohort study).

4.      Evidence either from experiment, or statistical or other form of
        control, which makes it unlikely that the relationship is due to some
        other variable which is related to both drug use and the adverse
        effect. 

In appraising a body of literature as a whole we determine the extent
to which the evidence meets the criteria outlined by Hill (1977). 

Ideally, once a strong case has been made for a causal connection
between drug use and an adverse health effect, the magnitude of risk
needs to be estimated so the seriousness of the risk can be
quantified. For example, the consumption of large amounts of water
over a short period of time can kill human beings, but this is not a
good reason for counselling people against drinking water. The
quantities required to produce intoxication and death are so large
(e.g. 30 or more litres) that only diseased or psychotic individuals
consume them.

The standard epidemiological measures of risk magnitude are relative
risk and population attributable risk. The relative risk is the
increase in the odds of experiencing an adverse health outcome among
those who use the drug compared to those who do not (that is, the
number of times greater the risk of experiencing an effect is among
those who use the drug compared with those who do not). The population
attributable risk represents that proportion of cases with an adverse
outcome which is attributable to drug use. The two measures of risk
magnitude have different uses and implications. Relative risk is of
greatest relevance to individuals attempting to estimate the increase
in their risk of experiencing an adverse outcome if they use a drug.
Attributable risk is of most relevance to a societal appraisal of the
harms of drug use. 

The importance of the two measures of risk magnitude depends upon the
prevalence of drug use and the base rate of the adverse outcome. An
exposure with a low relative risk may have a large public health
impact if a large proportion of the population is exposed (e.g.
cigarette smoking and heart disease). Conversely, an exposure with a
high relative risk may have little public health importance because
very few people are exposed to it. Accordingly, an appraisal of the
public health importance of illicit drug use must take some account
not only of the relative risk of harm, but also the prevalence of use
and the base rate of the adverse effect. As will become apparent in
the course of this review, it is very difficult to estimate either
relative or attributable risk of any probable adverse health effects
of cannabis use because few epidemiological studies have been
conducted.

A different way of assessing the health risk posed by cannabis use has
had to be used: a comparative qualitative appraisal of its risks with
those of other widely used recreational drugs such as alcohol and
tobacco (ARF/WHO, 1981). The motive for such comparisons is that they
reduce the operation of double-standards in the health appraisal of
drug use by reminding us that the drugs we currently tolerate pose
major health risks. They also help to put the risk of newer drugs into
perspective, so that we can use a common standard when making societal
decisions about whether or not to tolerate such drug use. The task of
comparison, however, is more difficult than it seems at first. 

First, we know much more about the quantitative risks of acute and
chronic tobacco and alcohol use than we know about the health risks of
currently illicit drugs. This is largely because the legal drugs have
been consumed by substantial proportions of the population, over
centuries in the case of tobacco, and millennia in the case of
alcohol, and there have been more than 40 years of scientific studies
of the health consequences of their use. The contemporary illicit
drugs, by contrast, have been much less widely used in Western
society, and for a shorter period, primarily by healthy young adults;
there have also been few studies of their adverse health effects, and
there have been even fewer attempts to quantify the risks of their
use.

Second, the prevalence of use of currently legal and illegal drugs is
so different that any comparison based upon existing patterns of use
will disadvantage the legal drugs (Peterson, 1980). In principle, this
problem could be addressed by estimating what the health risks of
cannabis use might be if its prevalence was to approach that of
alcohol and tobacco. This approach has not been adopted here because
in the absence of good data on the quantitative risks of cannabis use,
a large number of contestable assumptions would have to be made to
permit such estimates to be made. 

These obstacles provide strong reasons for cautiously interpreting
comparisons of the health hazards of cannabis with those of alcohol
and tobacco. They do not, however, provide insurmountable objections
to such comparisons. We will accordingly make some qualitative
comparisons with the health risks of alcohol and tobacco after we have
considered the evidence on the adverse health effects of cannabis. 



References

Addiction Research Foundation/World Health Organization (1981) Report
of an ARF/WHO Scientific Meeting on the Adverse Health and Behavioral
Consequences of Cannabis Use. Toronto: Addiction Research Foundation,
.

Fehr, K.O. and Kalant, H. (1983) (eds) Cannabis and Health Hazards.
Toronto: Addiction Research Foundation.

Hall, W. (1987) A simplified logic of causal inference. Australian and
New Zealand Journal of Psychiatry, 1987, 21, 507-513.

Hill, A.B. (1977). A Short Textbook of Statistics. London: Hodder and
Stoughton.

Husak, D.N. (1992) Drugs and Rights. Cambridge: Cambridge University
Press.

Institute of Medicine. (1982) Marijuana and Health. Washington DC:
National Academy Press.

Peterson, R (1980) (ed) Marijuana Research Findings: 1980 National
Institute on Drug Abuse Research Monograph Number 31. Rockville, MD:
U.S. Department of Health and Human Services.

Rescher, N. (1977) Methodological Pragmatism. Oxford, Blackwell.

Room, R. (1984) Alcohol and ethnography: A case of problem deflation?
Current Anthropology, 25, 169- 191.

Task Force on Health Risk Assessment, United States Department of
Health and Human Services (1986) Determining Risks to Health: Federal
Policy and Practice. Dover, MA: Auburn House Publishing Company.

Whately, R. (1846) Elements of Rhetoric. Originally published 1846.
(ed) D. Ehninger. Carnondale, Illinois: Illinois University Press,
1963.


</font>
</pre>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-9</DOCNO>
<DOCOLDNO>IA087-000627-B016-62</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch4.htm 206.61.184.43 19970122051616 text/html 42264
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:16:02 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:03:29 GMT
Content-length: 42046
</DOCHDR>
<html>

<head>
<title>The health and psychological consequences of cannabis use:
chapter 4 </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<h1></h1>
</body>

<body bgcolor="#ffffff">

<p>The health and psychological consequences of cannabis use
chapter 4 </p>

<h3>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
</h3>

<hr>

<pre>
<font size="2">4. Cannabis the drug 



4.1 Cannabis the drug

Cannabis is the material derived from the herbaceous plant Cannabis
sativa, which grows vigorously throughout many regions of the world.
It occurs in male and female forms, with both sexes having large
leaves which consist of five to 11 leaflets with serrated margins. A
sticky resin which covers the flowering tops and upper leaves is
secreted most abundantly by the female plant and this resin contains
the active agents of the plant. While the cannabis plant contains more
than 60 cannabinoid compounds, such as cannabidiol and cannabinol, the
primary psychoactive constituent is delta-9-tetrahydrocannabinol or
THC (Gaoni and Mechoulam, 1964), the concentration of which largely
determines the potency of the cannabis preparation. Most of the other
cannabinoids are either inactive or only weakly active, although they
may increase or decrease potency by interacting with THC (Abood and
Martin, 1992).

Cannabis has been erroneously classified as a narcotic, as a sedative
and most recently as an hallucinogen. While the cannabinoids do
possess hallucinogenic properties, together with stimulant and
sedative effects, they in fact represent a unique pharmacological
class of compounds. Unlike many other drugs of abuse, cannabis acts
upon specific receptors in the brain and periphery. The discovery of
the receptors and the naturally occurring substances in the brain that
bind to these receptors is of great importance, in that it signifies
an entirely new pathway system in the brain.



4.2 The cannabinoid receptor

The desire to identify a specific biochemical pathway responsible for
the expression of the psychoactive effects of cannabis has prompted a
prodigious amount of cannabinoid research (Martin, 1986). Early
studies found that radioactively labelled THC would non-specifically
attach to all neural surfaces, suggesting that it produced its effects
by perturbing cell membranes (Martin, 1986). However, the work of
Howlett and colleagues (Howlett et al 1986; 1987; 1988) showed that
cannabinoids inhibit the enzyme that synthesizes cyclic AMP in
cultured nerve cells, and that the degree of inhibition was correlated
with the potency of the cannabinoid. Since many receptors relay their
signals to the cell interior by changing cellular cyclic AMP, this
finding strongly suggested that cannabinoids were not just dissolving
non-specifically in membranes. After eliminating all the known
receptors that act by inhibiting adenylate cyclase, it was concluded
that cannabinoids acted through their own receptor. The determination
and characterisation of a specific cannabinoid receptor in brain
followed soon after (Devane et al, 1988), paving the way for its
distribution in brain to be mapped (Bidaut-Russell et al, 1990;
Herkenham et al, 1990). 

It is now accepted that cannabis acts on specific cannabinoid
receptors in the brain, conclusive evidence for which was provided by
the cloning of the gene for the cannabinoid receptor in rat brain
(Matsuda et al, 1990). A cDNA which encodes the human cannabinoid
receptor was also cloned (Gerard et al, 1991) and the human receptor
was found to exhibit more than 97 per cent identity with the rat
receptor. Cannabinoid receptors have also been found in the nervous
system of lower vertebrates, including chickens, turtles and trout
(Howlett et al, 1990) and there is preliminary evidence that they
exist in low concentration in fruit flies (Bonner quoted in Abbott,
1990; Howlett, Evans and Houston, 1992). This phylogenetic
distribution suggests that the gene must have been present early in
evolution, and its conservation implies that the receptor serves an
important biological function. 

The localisation of cannabinoid receptors in the brain has elucidated
the pharmacology of the cannabinoids. Herkenham and colleagues
(Herkenham, et al 1990; 1991a; 1991b; 1992) used autoradiography to
localise receptors in fresh cut brain sections of a number of species,
including humans. Dense binding was detected in the cerebral cortex,
hippocampus, cerebellum and in outflow nuclei of the basal ganglia,
particularly the substantia nigra pars reticulata and globus pallidus.
Few receptors were present in the brainstem and spinal cord.
Bidaut-Russell and colleagues (Bidaut-Russell et al, 1990) located
cannabinoid receptors in greatest abundance in the rat cortex,
cerebellum, hippocampus and striatum, with smaller but significant
binding in the hypothalamus, brainstem and spinal cord. 

High densities of receptors in the hippocampus and cortex suggest
roles for the cannabinoid receptor in cognitive functions. This is
consistent with evidence in humans that the dominant effects of
cannabis are cognitive: loosening of associations, fragmentation of
thought, and confusion on attempting to remember recent occurrences
(Hollister, 1986; Miller and Branconnier, 1983). High densities of
receptors in the basal ganglia and cerebellum suggested a role for the
cannabinoid receptor in movement control, a finding which is also
consistent with the ability of cannabinoids to interfere with
coordinated movements. 

Cannabis has a mild effect on cardiovascular and respiratory function
in humans (Hollister, 1986) which is consistent with the observation
that the lower brainstem area has few cannabinoid receptors. The
absence of sites in the lower brainstem may in fact explain why high
doses of THC are not lethal. Cannabinoid receptors do not appear to
reside in the dopaminergic neurons or the mesolimbic dopamine cells
that have been suggested as a possible &quot;reward&quot; system in the brain. 

These mappings of receptors have been broadly confirmed in recent work
by Matsuda and colleagues (1992, 1993) using a histochemistry
technique to neuroanatomically localise cannabinoid receptor mRNA.
Labelling intensities were highest in forebrain regions (olfactory
areas, caudate nucleus, hippocampus) and in the cerebellar cortex.
Clear labelling observed in the rat forebrain suggests several
potential sites in the human brain that could mediate an impairment of
memory function (Miller and Branconnier, 1983), such as the
hippocampus, medial septal complex, lateral nucleus of the mamillary
body, and the amygdaloid complex. Similarly, labelling was detected
clearly in rat forebrain regions that correspond to those that could
mediate cannabis-induced effects on human appetite and mood (namely,
the hypothalamus, amygdaloid complex, and anterior cingulate cortex).
It should be borne in mind that the regions where cannabinoid
receptors occur may have long projections to other areas, contributing
to the multiplicity of effects of the cannabinoids.

Since THC is not a naturally occurring substance within the brain, the
existence of a cannabinoid receptor implied the existence of a
naturally occurring or &quot;endogenous&quot; cannabinoid-like substance. Devane
and colleagues (1992) recently identified a brain molecule which binds
to the receptor and mimics the action of cannabinoids. The molecule,
arachidonylethanolamide, which is fat soluble like THC, has been named
&quot;anandamide&quot; from a Sanskrit word meaning &quot;bliss&quot;. Anandamide has been
found to act on cells that express the cannabinoid receptor, but it
has no effect on identical cells which lack the receptor. Further
research is necessary to determine which neurons are responsible for
producing anandamide molecules and to determine what their role is.  

The unique psychoactivity of cannabinoids may be described as a
composite of numerous effects which would not arise from a single
biochemical alteration, but rather from multiple actions (Martin,
1986). Thus, the diverse pharmacological actions of the various
cannabinoids implies the existence of receptor subtypes. Cannabinoid
receptor cDNA can be used to search for other members of the
hypothesised receptor family (Snyder, 1990). If the receptors with the
potential for mediating the therapeutic uses of cannabis are different
from those responsible for their psychoactive effects, cannabinoid
receptor cDNA cloning and new synthetic cannabinoids modelled on
anandamide may help to uncover the receptor subtypes and develop drugs
to target them, thus fulfilling the ancient promise of &quot;marijuana as
medicine&quot;. If, however, it were the case that there was only one type
of cannabinoid receptor, then the psychoactive and therapeutic effects
would be inseparable. The evidence against this proposition mounts
with the recent cloning of a cannabinoid receptor in spleen that does
not exist in brain (Munro et al, 1993).



4.3 Forms of cannabis

The concentration of THC varies with the forms in which cannabis is
prepared for ingestion, the most common of which are marijuana,
hashish and hash oil. Marijuana is prepared from the dried flowering
tops and leaves of the harvested plant. Its potency depends upon the
growing conditions, the genetic characteristics of the plant and the
proportions of plant matter. The flowering tops and bracts (known as
&quot;heads&quot;) are highest in THC concentration, with potency descending
through the upper leaves, lower leaves, stems and seeds. Some
varieties of the cannabis plant contain little or no THC, such as the
hemp varieties used for making rope, while others have been
specifically cultivated for their high THC content, such as
&quot;sinsemilla&quot;. 

Marijuana may range in colour from green to grey or brown, depending
on the variety and where it was grown, and in texture from a dry
powder or finely divided tea-like substance to a dry leafy material.
The concentration of THC in a batch of marijuana containing mostly
leaves and stems may range from 0.5-5 per cent, while the &quot;sinsemilla&quot;
variety with &quot;heads&quot; may result in concentrations from 7-14 per cent.
The potency of marijuana preparations being sold has probably
increased in the past decade (Jones, 1987), although the evidence for
this has been contested (Mikuriya and Aldrich, 1988).

Hashish or hash consists of dried cannabis resin and compressed
flowers. It ranges in colour from light blonde/brown to almost black,
and is usually sold in the form of hard chunks or cubes. The
concentration of THC in hashish generally ranges from 2-8 per cent,
although it can be as high as 10-20 per cent. Hash oil is a highly
potent and viscous substance obtained by using an organic solvent to
extract THC from hashish (or marijuana), concentrating the filtered
extract, and, in some cases, subjecting it to further purification.
The colour may range from clear to pale yellow/green, through brown to
black. The concentration of the THC in hash oil is generally between
15 per cent and 50 per cent, although samples as high as 70 per cent
have been detected.



4.4 Routes of administration

Almost all possible routes of administration have been used, but by
far the most common method is smoking (inhaling). Marijuana is most
often smoked as a hand-rolled &quot;joint&quot; the size of a cigarette or
larger, and usually thicker. Tobacco is often added to marijuana to
assist burning and &quot;make it go further&quot;, and a filter may be inserted.
Hashish may be mixed with tobacco and smoked as a joint, but is more
often smoked through a pipe, either with or without tobacco. A water
pipe known as &quot;bong&quot; is a popular implement for all cannabis
preparations, because the water cools the hot smoke before it is
inhaled and there is little loss of the drug through sidestream smoke.
Hash oil is used sparingly because of its extremely high psychoactive
potency; a few drops may be applied to a cigarette or a joint, to the
mixture in the pipe, or the oil may be heated and the vapours inhaled.
Whatever method is used, smokers usually inhale deeply and hold their
breath for several seconds in order to ensure maximum absorption of
THC by the lungs. 

Hashish may also be cooked or baked in foods and eaten. When ingested
orally the onset of the psychoactive effects is delayed by about an
hour. In clinical and experimental research, THC has often been
prepared in gelatine capsules and administered orally. In India, a
popular method of ingestion is in the form of a tea-like brew of the
leaves and stems, known as &quot;bhang&quot;. The &quot;high&quot; is of lesser intensity
but the duration of intoxication is longer by several hours. It is
easier to titrate the dose and achieve the desired level of
intoxication by smoking than by oral ingestion since the effects are
more immediate. 

Crude aqueous extracts of cannabis have on very rare occasions been
injected intravenously. THC is insoluble in water, so little or no
drug is actually present in these extracts, and the injection of tiny
undissolved particles may cause severe pain and inflammation at the
site of injection and a variety of toxic systemic effects. Injection
should not be considered as a route of cannabis administration, but
has been used in research to investigate pharmacokinetics.

Since different routes of administration give rise to differing
pharmacokinetics (see below), the reader should assume for the
remainder of this document that the method of ingestion is smoking
unless stated otherwise.



4.5 Dosage

A typical joint contains between 0.5g and 1.0g of cannabis plant
matter, which varies in THC content between 5mg and 150mg (i.e.
typically between 1 per cent and 15 per cent THC). Not all of the
available THC is ingested; the actual amount of THC delivered in the
smoke has been estimated at 20 per cent to 70 per cent of that in the
cigarette (Hawks, 1982), with the rest being lost through combustion
or escaping in sidestream smoke. The bioavailability of THC from
marijuana cigarettes (the fraction of THC in the cigarette which
reaches the bloodstream) has been reported to range between 5 per cent
and 24 per cent (mean 18.6 per cent) (Ohlsson et al, 1980). For all
these reasons, the actual dose of THC that is absorbed when cannabis
is smoked is not easily estimated. 

In general, only a small amount of smoked cannabis (e.g. 2mg to 3mg of
available THC) is required to produce a brief pleasurable high for the
occasional user, and a single joint may be sufficient for two or three
individuals. A heavy smoker may consume five or more joints per day,
while heavy users in Jamaica, for example, may consume up to 420mg THC
per day (Ghodse, 1986). In clinical trials designed to assess the
therapeutic potential of THC, single doses have ranged up to 20mg in
capsule form. In human experimental research, THC doses of 10mg, 20mg
and 25mg have been administered as low, medium and high doses (Barnett
et al 1985; Perez-Reyes et al 1982).

Perez-Reyes et al (1974) determined the amount of THC required to
produce the desired effects by slow intravenous administration. They
estimated that the threshold for perception of an effect was 1.5mg
while a peak social &quot;high&quot; required 2-3mg THC. These levels did not
differ between frequent and infrequent users, so Perez-Reyes et al
concluded that tolerance or sensitivity to the perceived high does not
develop. 



4.6 Patterns of use

Cannabis is the most widely used illicit drug in Australia, having
been tried by a third of the adult population, and by the majority of
young adults between the ages of 18 and 25 (see Donnelly and Hall,
1994). The most common route of administration is by smoking, and the
most widely used form of the drug is marijuana. 

The majority of cannabis use in Australia and elsewhere is
&quot;recreational&quot;. That is, most users use the drug to experience its
euphoric and relaxing effects rather than for its recognised
therapeutic effects. Unless explicitly stated to the contrary (as in
chapter 8) it should be assumed that the phrase &quot;cannabis use&quot; is a
short-hand term for the recreational use of cannabis products.

The majority of cannabis use is also &quot;experimental&quot; in that most of
those who have ever used cannabis either discontinue their use after a
number of uses, or if they continue to use, do so intermittently and
episodically whenever the drug is available. Only a small proportion
of those who ever use cannabis become regular cannabis users. The best
estimate from the available survey data is that about 10 per cent of
those who ever use cannabis become daily users, and a further 20-30
per cent use on a weekly basis (see Queensland Criminal Justice
Commission, 1993; Donnelly and Hall, 1994). Among those who continue
to use cannabis, the majority discontinue their use in their mid to
late 20s. 

Because of uncertainties about the dose of THC contained in illicit
marijuana, there is no information on the amount of THC ingested by
regular Australian cannabis users. &quot;Heavy&quot; cannabis use is typically
defined in terms of the frequency of use rather than average dose of
THC received. Although it is possible that daily users could use small
quantities per day, this is unlikely to be true of the majority of
regular users because of the tolerance to drug effects which develops
with regular use. Evidence collected on chronic long-term users at the
National Drug and Alcohol Research Centre (Solowij, 1994), indicated
that they typically used more potent forms of cannabis (namely,
&quot;heads&quot; and hashish). 

The daily or near daily use pattern is the pattern that probably
places users at greatest risk of experiencing long-term health and
psychological consequences of use. Such users are more likely to be
male and less well educated, and are more likely to regularly use
alcohol, and to have experimented with a variety of other illicit
drugs, such as amphetamines, hallucinogens, psychostimulants,
sedatives and opioids.



4.7 Metabolism of cannabinoids

&quot;Cannabinoids&quot; is the collective term for a variety of compounds which
can be extracted from the cannabis plant or are produced within the
body after ingestion and metabolism of cannabis. Some of these
compounds are psychoactive, that is, they have an effect upon the mind
of the users; others are pharmacologically or biologically active,
that is, have an effect upon cells or the function of other bodily
tissues and organs, but are not psychoactive. Animal and human
experimentation indicates that delta-9-tetrahydrocannabinol (THC) is
the major psychoactive constituent of cannabis.

THC is rapidly and extensively metabolised in humans. Different
methods of ingesting cannabis give rise to different patterns of
absorption, metabolism and excretion of THC. Upon inhalation, THC is
absorbed within minutes from the lungs into the bloodstream.
Absorption of THC is much slower after oral administration, entering
the bloodstream within one to three hours, and delaying the onset of
psychoactive effects. 

After smoking, the initial metabolism of THC takes place in the lungs,
followed by more extensive metabolism by liver enzymes which transform
THC to a number of metabolites. The most rapidly produced metabolite
is 9-carboxy-THC (or THC-COOH) which is detectable in blood within
minutes of smoking cannabis. It is not psychoactive. Another major
metabolite of THC is 11-hydroxy-THC, which is approximately 20 per
cent more potent than THC, and which penetrates the blood-brain
barrier more rapidly than THC. 11-hydroxy-THC is only present at very
low concentrations in the blood after smoking, but at high
concentrations after the oral route (Hawks, 1982). THC and its
hydroxylated metabolites account for most of the psychoactive effects
of the cannabinoids.

Peak blood levels of THC are reached very rapidly, usually within 10
minutes of smoking and before a joint is fully smoked, and decline
rapidly to about 5-10 per cent of their initial level within the first
hour. This initial rapid decline reflects the rapid conversion of THC
to its metabolites, as well as the distribution of THC to lipid-rich
tissues, including the brain (Fehr and Kalant, 1983; Jones, 1980;
1987). THC and its metabolites are highly fat soluble and may remain
for long periods of time in the fatty tissues of the body, from which
they are slowly released back into the bloodstream. This phenomenon
slows the elimination of cannabinoids from the body. 

The time required to clear half of the administered dose of THC from
the body has been found to be shorter for experienced or daily users
(19-27 hours) than for inexperienced users (50-57 hours) (Agurell, et
al 1986; Hunt and Jones, 1980; Lemberger et al, 1970; 1978; Ohlsson,
et al, 1980). Recent research using more sensitive detection
techniques suggests that the half-life in chronic users may be closer
to three to five days (Johansson et al, 1988). It is the immediate and
subsequent metabolism of THC that occurs more rapidly in experienced
users (Blum, 1984). Given the slow clearance, repeated administration
of cannabis results in the accumulation of THC and its metabolites in
the body. Because of its slow release from fatty tissues into the
bloodstream, THC and its metabolites may be detectable in blood for
several days, and traces may persist for several weeks. 

While blood levels of THC peak within a few minutes, 9-carboxy-THC
levels peak approximately 20 minutes after commencing smoking and then
decline slowly. The elimination curve for THC crosses the
9-carboxy-THC curve around the time of the peak of the latter and
subjective intoxication also peaks around this time (i.e., 20-30
minutes later than peak THC blood levels), with acute effects
persisting for approximately two to three hours. 



4.8 Detection of cannabinoids in body fluids

Cannabinoid levels in the body, which depend on both the dose given
and the smoking history of the individual, are subject to substantial
individual variability. Plasma levels of THC in man may range between
0-500ng/ml, depending on the potency of the cannabis ingested and the
time since smoking. For example, blood levels of THC may decline to
2ng/ml one hour after smoking a low potency cannabis cigarette, a
level that may be achieved only nine hours after smoking a high
potency cannabis cigarette. In habitual and chronic users such levels
may persist for several days after use because of the slow release of
accumulated THC. 

The detection of THC in blood above 10-15ng/ml provides presumptive
evidence of &quot;recent&quot; consumption of cannabis, but it is not possible
to determine how recently it was consumed. A somewhat more precise
estimate of the time of consumption may be obtained from the ratio of
THC to 9-carboxy-THC: similar concentrations of each in blood could be
an indication of use within the last 20-40 minutes, and would predict
a high probability of the user being intoxicated. When the levels of
9-carboxy-THC are substantially higher than those of THC, ingestion
can be estimated to have occurred more than half an hour ago (Hawks,
1982; Perez-Reyes et al, 1982). However, such an interpretation
probably applies only to the naive users who have resting levels of
zero. Background levels of cannabinoids (particularly 9-carboxy-THC)
in habitual users make the estimation of time of ingestion almost
impossible. It is very difficult to determine the time of
administration from blood concentrations of THC and its metabolites,
even if the smoking habits of the individual and the exact dose
consumed are known. The results of blood analyses indicate, at best,
the &quot;recent&quot; use of cannabis.

Urinary cannabinoid levels provide an even weaker indicator of current
cannabis intake. In general, the greater the level of cannabinoid
metabolites in urine, the greater the possibility of recent use, but
it is impossible to be precise about how &quot;recent&quot; use has been (Hawks,
1982). Only minute traces of THC itself appear in the urine due to its
extensive metabolism, and most of the administered dose is excreted in
the form of metabolites in faeces and urine (Hunt and Jones, 1980).
9-carboxy-THC is detectable in urine within 30 minutes of smoking.
This and other metabolites may be present for several days in first
time or irregular cannabis users, while frequent users may continue to
excrete metabolites for weeks or months after last use because of the
accumulation and slow elimination of these compounds (Dackis et al,
1982; Ellis et al, 1985). As with blood levels, there is substantial
human variability in the metabolism of THC, and no simple relationship
between urinary levels of THC metabolites and time of consumption.
Hence, urinalyses results cannot be used to distinguish between use
within the last 24 hours and use more than a month ago. 

Several studies have examined measures of cannabinoids in fat and
saliva. Analyses of human fat biopsies confirm storage of the drug for
at least 28 days (Johansson, et al, 1987). Detection of cannabinoids
in saliva holds more promise for forensic purposes, since it has the
capacity to reduce the time frame of &quot;recent&quot; use from days and weeks
to hours (Hawks, 1982; Gross et al 1985; Thompson and Cone, 1987).
Salivary THC levels have also been shown to correlate with subjective
intoxication and heart rate changes (Menkes et al, 1991). 



4.9 Intoxication and levels of cannabinoids

Ingestion of cannabis produces a dose related impairment of a wide
range of cognitive and behavioural functions. Since there is evidence
that cannabis intoxication adversely affects skills required to drive
a motor vehicle (see below), it would be desirable to have a reliable
measure of impairment due to cannabis intoxication that was comparable
to the breath test of alcohol intoxication. For this reason, a
reliable measure for determining the degree of impairment due to
cannabis has been particularly sought after.

While the degree of impairment from alcohol can be determined from a
single blood alcohol estimate, a clear relationship between blood
levels of THC or its metabolites and degree of either impairment or
subjective intoxication has not been demonstrated (Agurell et al,
1986). The estimation of the degree of intoxication from a single
value of blood THC level is difficult, not only because of the time
delay between subjective high and blood THC, but also because of large
individual variations in the effects experienced at the same blood
levels. The difficulty is compounded by the distribution of THC to
body tissues, and its metabolism to other psychoactive compounds. 

Blood levels of THC metabolites, such as 11-hydroxy-THC, correlate
temporally with subjective effects but are not readily detectable in
blood after smoking cannabis, while blood levels of THC correlate only
modestly with cannabis intoxication, in part because of its lipid
solubility (Barnett et al, 1985; McBay 1988; Ohlsson et al 1980). The
level of intoxication could only realistically be related to the total
sum of all the psychoactive cannabinoids present in body fluids and in
the brain and various tissues. 

Due to large human variability, no realistic limit of cannabinoid
levels in blood has been set which can be related to an undesirable
level of intoxication. Tolerance also develops to many of the effects
of cannabis. Hence, a given dose consumed by a naive individual may
produce greater impairment on a task than the same dose consumed by a
chronic heavy user. THC may also be active in the nervous system long
after it is no longer detectable in the blood, so there may be
long-term subtle effects of cannabis on the cognitive functioning of
chronic users even in the unintoxicated state. To date, there is no
consistently demonstrated correlation between blood levels of THC and
its effect on human mind and performance. Thus, no practical method
has been developed as a forensic tool for determining levels of
intoxication based on detectable cannabinoids. A consensus conference
of forensic toxicologists has concluded that blood concentrations of
THC which cause impairment have not been sufficiently established to
provide a basis for legal testimony in cases concerning driving a
motor vehicle while under the influence of cannabis (Consensus Report,
1985). 



4.10 Passive inhalation

In the United States, urine testing for drug traces and metabolites is
increasingly used to identify illicit drug users in the workplace
(Hayden, 1991). A technical concern raised by the opponents of this
practice has been the possibility of a person having a urine positive
for cannabinoids as the result of the passive inhalation of marijuana
smoke at a social event immediately prior to the provision of the
urine sample. A number of research studies have attempted to determine
the relationship between passive inhalation of marijuana smoke and
consequent production of urinary cannabinoids (Hayden, 1991).

In one of the first studies on passive inhalation, Perez-Reyes and
colleagues (1983) found that non-smokers who had been confined for
over an hour in a very small unventilated space containing the smoke
of at least eight cannabis cigarettes over three consecutive days had
insignificant amounts of urinary cannabinoids. Law and colleagues
(1984) and Mule et al (1988) also showed that passive inhalation
produced urinary cannabinoid concentrations well below the detection
limit of 20ng/ml 9-carboxy-THC used in workplace drug screens. 

Morland et al (1985) produced urinary cannabinoid levels above 20ng/ml
in non-smokers but the conditions were extreme, namely, confinement in
a space the size of a packing box with exposure to the smoke of six
cannabis cigarettes. The studies of Cone and colleagues (1986; 1987a,
1987b) confirmed the necessity to apply extreme experimental
conditions, which they claimed non-smokers were unlikely to submit
themselves to for the long periods of time required to produce urinary
metabolites above 20ng/ml. They also showed that non-smokers with
significant amounts of cannabinoids in their urine experienced the
subjective effects of intoxication. 



References

Abbott, A. (1990) The switch that turns the brain on to cannabis. New
Scientist, 11 Aug, 19.

Abood, M.E. and Martin, B.R. (1992) Neurobiology of marijuana abuse.
Trends in Pharmacological Science, 13(5), 201-206.

Agurell, S., Halldin, M., Lindgren, J., Ohlsson, A., Widman, M.,
Gillespie, H. and Hollister, L. (1986) Pharmacokinetics and metabolism
of 1-Tetrahydrocannabinol and other cannabinoids with emphasis on
man. Pharmacological Reviews, 38(1), 21-43.

Barnett, G., Licko,V. and Thompson, T. (1985) Behavioral
pharmacokinetics of marijuana. Psychopharmacology, 85, 51-56.

Bidaut-Russell, M., Devane, W.A. and Howlett, A (1990) Cannabinoid
receptors and modulation of cyclic AMP accumulation in the rat brain.
Journal of Neurochemistry, 55, 21-55.

Blum, K. (1984) Handbook of Abusable Drugs. New York: Gardner Press.

Cone, E.J. and Johnson, R.E. (1986) Contact highs and urinary
cannabinoid excretion after passive exposure to marijuana smoke.
Clinical Pharmacology and Therapeutics, 40(3), 247-256.

Cone, E.J., Roache, J.D. and Johnson, R.E. (1987a) Effects of passive
exposure to marijuana smoke. National Institute on Drug Abuse Research
Monograph Series, 76, 150-156. 

Cone, E.J., Johnson, R.E., Darwin, W.D., Yousefnajed, D., Mell, L.D.,
Paul, B.D. and Mitchell, J. (1987b) Passive inhalation of marijuana
smoke: Urinalysis and room air levels of delta-9-tetrahydrocannabinol.
Journal of Analytical Toxicology, 11, 89-96.

Consensus Report, C.D.P. Research Technology Branch, National
Institute on Drug Abuse. (1985) Drug concentrations and driving
impairment. Journal of the American Medical Association, 254(18),
2618-2621.

Dackis, C.A., Pottash, A.L.C., Annitto, W. and Gold, M.S. (1982)
Persistence of urinary marijuana levels after supervised abstinence.
American Journal of Psychiatry, 139(9), 1196-1198.

Devane, W.A., Dysarz, F.A., Johnson, M.R., Melvin, L.S. and Howlett, A
(1988) Determination and characterization of a cannabinoid receptor in
rat brain. Molecular Pharmacology, 34, 605-613.

Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A.,
Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R.
(1992) Isolation and structure of a brain constituent that binds to
the cannabinoid receptor. Science, 258, 1946-1949.

Donnelly, N. and Hall, W. (1994) Patterns of Cannabis Use in
Australia. Paper prepared for the National Task Force on
Cannabis.National Drug Strategy Monograph Series No. 27. Canberra:
Australian Government Publishing Service.

Ellis, G.M., Mann, M.A., Judson, B.A., Schramm, N.T. and Tashchian, A.
(1985) Excretion patterns of cannabinoid metabolites after last use in
a group of chronic users. Clinical Pharmacology and Therapeutics, 38,
572-578.

Fehr, K.O. and Kalant, H. (Eds) (1983) Cannabis and Health Hazards.
Toronto: Addiction Research Foundation.

Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure and partial
synthesis of an active constituent of hashish. Journal of the American
Chemistry Society, 86, 1646-1647.

Gerard, C.M., Mollereau, C., Vassart, G. and Parmentier, M. (1991)
Molecular cloning of a human cannabinoid receptor which is also
expressed in testis. Biochemistry Journal, 279, 129-134.

Ghodse, A.H. (1986) Cannabis psychosis. British Journal of Addiction,
81, 473-478.

Gross, S.J., Worthy, T.E., Nerder, L., Zimmermann, E.G., Soares, J.R.
and Lomax, P. (1985) The detection of recent cannabis use by saliva
delta-9 THC radioimmune quantitation. Journal of Analytical
Toxicology, 2, 98-100.

Hawks, R.L. (1982) The constituents of cannabis and the disposition
and metabolism of cannabinoids. In Hawks, R.L. (Ed) The Analysis of
Cannabinoids in Biological Fluids, National Institute on Drug Abuse
Research Monograph No. 42 (pp125-137). Rockville, MD: U.S. Department
of Health and Human Services.

Hayden, J.W. (1991) Passive inhalation of marijuana smoke: a critical
review. Journal of Substance Abuse, 3(1), 85-90.

Herkenham, M. (1992) Cannabinoid receptor localization in brain:
relationship to motor and reward systems. Annals of the New York
Academy of Sciences. [Kalivas, P.W. and Samson, H.H. (Eds) The
Neurobiology of Drug and Alcohol Addiction], 19-32.

Herkenham, M., Lynn, A.B., de Costa, B.R. and Richfield, E.K. (1991a)
Neuronal localization of cannabinoid receptors in the basal ganglia of
the rat. Brain Research, 547, 267-274.

Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R.
and Rice, K (1991b) Characterization and localization of cannabinoid
receptors in rat brain: A quantitative in vitro autoradiographic
study. Journal of Neuroscience, 11(2), 563-583.

Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S.,
De Costa, B.R. and Rice, K (1990) Cannabinoid receptor localization in
brain. Proceedings of the National Academy of Sciences, USA, 87,
1932-1936.

Hollister, L.E. (1986) Health Aspects of Cannabis. Pharmacological
Reviews, 38(1), 1-20.

Howlett, A (1987) Cannabinoid inhibition of adenylate cyclase:
relative activity of constituents and metabolites of marihuana.
Neuropharmacology, 26(5), 507-512.

Howlett, A.C., Qualy, J.M. and Khatchatrian, L.L. (1986) Involvement
of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
Molecular Pharmacology, 29, 307-313.

Howlett, A.C., Johnson, M.R., Melvin, L.S. and Milne, G.M. (1988)
Nonclassical cannabinoid analgetics inhibit adenylate cyclase:
development of a cannabinoid receptor model. Molecular Pharmacology,
33, 297-302.

Howlett, A.C., Bidaut-Russell, M., Devane, W.A., Melvin, L.S.,
Johnson, M.R. and Herkenham, M. (1990) The cannabinoid receptor:
biochemical, anatomical and behavioral characterization. Trends in
Neuroscience, 13(10), 420-423.

Howlett, A.C., Evans, D.M. and Houston, D.B. (1992) The cannabinoid
receptor. In Murphy, L. and Bartke, A. (Eds) Marijuana/Cannabinoids:
Neurobiology and Neurophysiology (pp. 35-72). Boca Raton, FL: CRC
Press.

Hunt, C.A. and Jones, R.T. (1980) Tolerance and disposition of
tetrahydrocannabinol in man. The Journal of Pharmacology and
Experimental Therapeutics, 215(1), 35-44.

Johansson, E., Sjovall, J., Noren, K., Agurell, S., Hollister. L.E.
and Halldin, M.M. (1987) Analysis of 1-Tetrahydrocannabinol (1-THC)
in human plasma and fat after smoking. In Chesher, G., Consroe, P. and
Musty, R. (Eds) Marijuana: An International Research Report (pp.
291-296). 

Johansson, E., Agurell, S., Hollister, L.E. and Halldin, M.M. (1988)
Prolonged apparent half-life of 1-tetrahydrocannabinol in plasma of
chronic marijuana users. Journal of Pharmacy and Pharmacology, 40,
374-375.

Jones, R.T. (1980) Human effects: An overview. In Petersen, R (Ed),
Marijuana Research Findings: 1980, National Institute on Drug Abuse
Research Monograph No. 31 (pp. 54-80). Rockville, MD: U.S. Department
of Health and Human Services.

Jones, R.T. (1987) Drug of abuse profile: cannabis. Clinical
Chemistry, 33(11(B)), 72B-81B.

Law, B., Mason, P.A., Moffat, A.C., King. L.J. and Marks, V. (1984)
Passive inhalation of cannabis smoke. Journal of Pharmacy and
Pharmacology, 36, 578-581.

Lemberger, L. and Rubin, A. (1978) Cannabis: the role of metabolism in
the development of tolerance. Drug Metabolism Reviews, 8, 59-68.

Lemberger, L., Silberstein, S.D., Axelrod, J. and Kopin, I.J. (1970)
Marihuana: Studies on the disposition and metabolism of
delta-9-tetrahydrocannabinol in man. Science, 170, 1320-1321.

Martin, B.R. (1986) Cellular effects of cannabinoids. Pharmacological
Reviews, 38(1), 45-74.

Matsuda, L.A., Lolait, S.J., Brownstein, M., Young, A. and Bonner,
T.I. (1990) Structure of a cannabinoid receptor and functional
expression of the cloned cDNA. Nature, 346, 561-564.

Matsuda, L.A., Bonner, T.I. and Lolait, S.J. (1992) Cannabinoid
receptors: which cells, where, how, and why? In T. N. H. Lee (Ed.),
Molecular Approaches to Drug Abuse Research Volume II: Structure,
Function, and Expression. (pp. 48-56). Rockville: US Department of
Health and Human Services.

Matsuda, L.A., Bonner, T.I. and Lolait, S.J. (1993) Localization of
cannabinoid receptor mRNA in rat brain. The Journal of Comparative
Neurology, 327, 535-550.

McBay, A.J. (1988) Interpretation of blood and urine cannabinoid
concentrations. Journal of Forensic Science, 33, 875-883.

Menkes, D.B., Howard, R.C., Spears, G.F.S. and Cairns, E.R. (1991)
Salivary THC following cannabis smoking correlates with subjective
intoxication and heart rate. Psychopharmacology, 103, 277-279.

Mikuriya, T.H. and Aldrich, M.R. (1988) Cannabis 1988: old drug, new
dangers - the potency question. Journal of Psychoactive Drugs, 20(1),
47-55. 

Miller, L.L. and Branconnier, R.J. (1983) Cannabis: effects on memory
and the cholinergic limbic system. Psychological Bulletin, 93(3),
441-456.

Morland, J., Bugge, A., Skuterud, B., Steen, A., Wethe, G.H. and
Kjeldsen, T. (1985) Cannabinoids in blood and urine after passive
inhalation of cannabis smoke. Journal of Forensic Sciences, 30,
997-1002.

Mule, S.J., Lomax, P. and Gross, S.J. (1988) Active and realistic
passive marijuana exposure tested by three immunoassays and GC/MS in
urine. Journal of Analytical Toxicology, 12, 113-116.

Munro, S., Thomas, K.L. and Abu-Shaar, M. (1993) Molecular
characterization of a peripheral receptor for cannabinoids. Nature,
365, 61-65.

Ohlsson, A., Lindgren, J-E., Wahlen, A., Agurell, S., Hollister, L.E.
and Gillespie, H.K. (1980) Plasma delta-9-tetrahydrocannabinol
concentrations and clinical effects after oral and intravenous
administration and smoking. Clinical Pharmacology and Therapeutics,
28(3), 409-416.

Perez-Reyes, M., Timmons, M and Wall, M.E. (1974) Long-term use of
marijuana and the development of tolerance or sensitivity to
9Tetrahydrocannabinol. Archives of General Psychiatry, 31, 89-91.

Perez-Reyes, M., Di Guiseppi, S., Davis, K.H., Schindler, V.H. and
Cook, C.E. (1982) Comparison of effects of marihuana cigarettes of
three different potencies. Clinical Pharmacology and Therapeutics,
31(5), 617-624.

Perez-Reyes, M., Di Guiseppi, S., Mason, A.M. and Davis, K.H. (1983)
Passive inhalation of marihuana smoke and urinary excretion of
cannabinoids. Clinical Pharmacology and Therapeutics, 34(1), 36-41.

Queensland Criminal Justice Commission (1993) Cannabis and the Law in
Queensland. Queensland Criminal Justice Commission, Brisbane.

Snyder, S. (1990) Planning for serendipity. Nature, 346, 508.

Solowij, N. (1994) Event-related potential indices of cognitive
functioning in long term cannabis users. Ph.D. Department of Community
Medicine, University of New South Wales.

Thompson, L.K. and Cone, E.J. (1987) Determination of
delta-9-tetrahydrocannabinol in human blood and saliva by
high-performance liquid chromatography with amperometric detection.
Journal of Chromatography, 421, 91-97.


</font>
</pre>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-10</DOCNO>
<DOCOLDNO>IA087-000627-B016-89</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch5.htm 206.61.184.43 19970122051627 text/html 69209
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:16:20 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:03:19 GMT
Content-length: 68991
</DOCHDR>
<html>

<head>
<title>The health and psychological consequences of cannabis use:
chapter 5 </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<h1></h1>
</body>

<body bgcolor="#ffffff">

<p>The health and psychological consequences of cannabis use
chapter 5 </p>

<h3>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
</h3>

<hr>

<pre>
<font size="2">5. The acute effects of cannabis intoxication 



5.1  Psychological and physical effects

Any attempt to summarise the acute effects of cannabis, or of any
psychoactive drug, is necessarily an oversimplification. The effects
experienced by the user will depend upon: the dose, the mode of
administration, the user's prior experience with the drug, any
concurrent drug use, and the &quot;set&quot; - the user's expectations, mood
state and attitudes towards drug effects - and &quot;setting&quot; - the social
environment in which the drug is used (Jaffe, 1985). The following
descriptions of the typical effects of cannabis are made with this
qualification in mind.

The major motive for the widespread recreational use of cannabis is
the experience of a subjective &quot;high&quot;, an altered state of
consciousness which is characterised by: emotional changes, such as
mild euphoria and relaxation; perceptual alterations, such as time
distortion, and; intensification of ordinary sensory experiences, such
as eating, watching films, listening to music, and engaging in sex
(Jaffe, 1985; Tart, 1970). When used in a social setting, the &quot;high&quot;
is often accompanied by infectious laughter, talkativeness, and
increased sociability. 

Cognitive changes are usually marked during a &quot;high&quot;. These include an
impaired short-term memory, and a loosening of associations, which
make it possible for the user to become lost in pleasant reverie and
fantasy, while making it difficult for the user to sustain
goal-directed mental activity. Motor skills, reaction time and motor
coordination are also affected, so many forms of skilled psychomotor
activity are impaired while the user is intoxicated (Jaffe, 1985).

Not all the effects of cannabis intoxication are welcomed by users.
Some users report unpleasant psychological reactions, ranging from a
feeling of anxiety to frank panic reactions, and a fear of going mad
to depressed mood (Smith, 1968; Weil, 1970; Thomas, 1993). These
effects are most often reported by naive users who are unfamiliar with
the effects of cannabis, and by some patients given THC for
therapeutic purposes. More experienced users may also report these
effects on occasion, especially after the oral ingestion of cannabis
when the effects may be more pronounced and of longer duration than
those usually experienced after smoking cannabis. These effects can
usually be successfully prevented by adequate preparation of users
about the type of effects they may experience. If these effects
develop they can be managed by reassurance and support (Smith, 1968;
Weil, 1970). Psychotic symptoms, such as delusions and hallucinations,
are very rare experiences that occur at very high doses of THC, and
perhaps in susceptible individuals at lower doses (Smith, 1968;
Thomas, 1993; Weil, 1970). 

The inhalation of marijuana smoke, or the ingestion of THC, the
psychoactive derivative of cannabis, has a number of bodily effects.
Among these the most dependable are the effects on the heart and
vascular system. The most immediate effect of cannabis use by all
routes of administration is an increase in heart rate of 20-50 per
cent over baseline which occurs within a few minutes to a quarter of
an hour and lasts for up to three hours (Huber et al, 1988; Jones,
1984). Changes in blood pressure also occur which depend upon posture:
blood pressure is increased while the person is sitting, and decreases
while standing. A sudden change from a recumbent posture may produce
postural hypotension and fainting, an effect which may explain the
feeling of &quot;light-headedness&quot; and faintness that is often the earliest
indication of intoxication in naive users (Maykut, 1984). Increases
are also observed in the production of the catecholamine
norepinephrine, although these lag behind the cardiovascular changes,
and their mechanisms are not well understood (Hardman and Hosko,
1976).

In healthy young users these cardiovascular effects are unlikely to be
of any clinical significance. They may, however, magnify anxiety in
naive users. The cannabis-induced tachycardia and postural hypotension
may contribute to the panic attacks sometimes experienced by naive
users (Weil, 1970) who may mistakenly interpret the palpitations, and
the feeling of faintness, as symptoms of serious misadventure,
magnifying pre-existing anxiety in a positive feedback cycle that
leads to a panic attack. 



5.2  Toxic dose levels

THC appears to be the component of cannabis which has the highest
direct toxicity in all animals so far tested. The toxic effects of
cannabis are mediated through its effects on neural systems. The cause
of death in experimental animals is almost invariably apnoea or
cardiac arrest, if apnoea is prevented (Rosencrantz, 1983). Due to the
development of tolerance, toxic doses depend upon the amount by which
they exceed the customary dose. In contrast to the increase in toxic
dose typical of many drugs when moving from primates to lower animals,
it appears that phylogenetically higher animals are less susceptible
to the acute toxicity of THC. Thus, the dose of THC which kills 50 per
cent of animals (LD50) when administered intravenously is 40mg/kg in
the rat but 130mg/kg in the dog and monkey (Rosencrantz, 1983). 

For obvious ethical reasons there is no experimental evidence to
determine a lethal dose in humans. Nor is there any clinical evidence,
since there have been no reported cases of death attributable to
cannabis in the world medical literature (Blum, 1984; Nahas, 1984).
Extrapolation from the animal evidence suggests that the lethal human
dose of THC is at least as high as, and probably higher than, that
observed in the monkey. If this is so, then the toxic dose of THC in a
65kg adult would be 8.45kg.

A number of non-fatal toxic reactions occur in humans with higher than
normal doses. The tachycardia almost invariably produced in acute
intoxication, combined with the sensory alterations and increased
tremor commonly reported, probably contribute to the affective
components of these reactions. CNS and respiratory depression are
noted with high doses, which in severe overdose may be
life-threatening (Rosencrantz, 1983). These effects are, of course,
more dangerous to those with pre-existing cardiac irregularities.
Because of the large effective to lethal dose ratio in humans
(probably in excess of 1:1000 in non-tolerant users) the risk of
experiencing severe toxic effects of cannabis is limited by the
aversive psychotropic effects of high doses, which usually lead to
cessation of use before the onset of dangerous physical consequences.



5.3 Tolerance to acute effects

In animals, tolerance develops to the lethal, hypothermic and some of
the behavioural effects of cannabinoids. This has been attributed to
functional or pharmacodynamic adaptations of the CNS rather than to a
more rapid metabolic disposition (Jaffe, 1985). Laboratory studies in
humans involving daily dosing at high levels over periods of weeks
have demonstrated tolerance to mood effects, tachycardia, decrease in
skin temperature, increased body temperature, and impaired performance
on psychomotor tests. Abrupt discontinuation in these studies usually
produces a mild withdrawal syndrome (see below pp111-113). 



5.4 Psychomotor effects

A major societal concern about cannabis intoxication is its potential
to impair psychomotor performance in ways which may directly affect
the well-being of non-users of cannabis. The prototype outcome is an
automobile accident caused by a cannabis user driving while
intoxicated. It is well known that individuals who drive while
intoxicated with alcohol are dangerous to others in proportion to
their level of intoxication. Is there evidence that intoxication with
cannabis produces impaired psychomotor performance of a nature and
degree sufficient to warrant restrictions upon its use by automobile
drivers? To what extent has cannabis intoxication contributed to road
accidents?

Psychoactive substances typically have both acute and chronic effects
on performance of a variety of tasks. Given the fact that most tasks
of interest to researchers require effort and concentration, only
those substances which enhance these very general abilities typically
improve performance. Recreational drugs are usually valued for effects
which remove the user from mundane concerns, produce relaxation, and
enhance experiences which would normally interfere with concentration
on a skilled task. Consequently, many societies enact restrictions on
the use of such drugs, either during specific tasks such as motor
vehicle driving, or at any time, as is the case with cannabis in most
Western societies, and with alcohol in many Islamic societies.

The subjective effects of cannabis include feelings of well-being and
relaxation, and sensory and temporal distortions which might be
expected to decrease performance in situations where perceptual
accuracy and attention are important. In deciding whether the
recreational use of cannabis presents a danger to the user and others
we need to consider two things: (1) the extent to which its use
disrupts the performance of potentially dangerous tasks such as motor
vehicle driving or the operation of machinery, and (2) the effect that
the drug has on the user's compliance with restrictions upon its use.
The second point refers to any disinhibitory effects of the drug which
might predispose users to ignore prohibitions on driving, or may
increase their willingness to take risks while intoxicated. 

The risks of cannabis intoxication and driving will be assessed in the
following way. First, laboratory evidence on the effects of cannabis
on various psychomotor tasks will be reviewed. In the following review
of this evidence, when a number of studies have produced similar
results, only the most typical studies will be cited. (For a more
complete review of such studies see Chait and Pierri, 1992). Second,
the possible mechanisms of the psychomotor effects of cannabis will be
briefly discussed. Third, the literature on the effects of cannabis on
performance in driving and flying simulators will be briefly reviewed.
Fourth, the experimental literature on the effects of cannabis
intoxication on on-road driving will be reviewed. Finally, the limited
epidemiological evidence on the contribution of cannabis to motor
vehicle accidents will be considered.



5.4.1 Effects of cannabis on psychomotor tasks

Muscle control. Standing steadiness (Kiplinger et al, 1971) and hand
steadiness (Klonoff et al, 1973) are both adversely affected by
cannabis. Finger or toe tapping speed does not appear to be reliably
affected (Weckowicz et al, 1975; Evans et al, 1976; Milstein et al,
1975; Dalton et al, 1975), as only one study (Klonoff et al, 1973)
found a decrement in finger tapping.



Reaction time. Simple reaction time does not appear to be reliably
affected by cannabis. Some studies have reported decrements in mean
reaction time (Borg et al, 1975; Dornbush et al, 1971), or the
variability of reaction time (Braden et al, 1974), while others have
found no difference (Evans et al, 1973). Choice reaction time tasks,
in which the response is conditional not only upon the occurrence of a
stimulus, but also the presence of some other discriminant (such as
the pitch of a tone or the colour of a visual stimulus), have been
administered to determine the effect of cannabis. In a number of these
studies, reaction time was indeed slower after cannabis use (Borg et
al, 1975; Block &amp; Wittenborn, 1984; 1986), although there were some
studies which found no change (Peeke et al, 1976; Block &amp; Wittenborn,
1984). With only one exception (Low et al, 1973), errors in choice
reaction time were not increased by cannabis.



Single tasks of manual dexterity. Pursuit rotor tasks, in which the
subject attempts to follow a rotating target with a pointer, are
generally performed worse after cannabis use (Manno et al, 1971; Manno
et al, 1970), although studies employing regular users (Salvendy &amp;
McCabe, 1975; Carlin et al, 1972) have found no effect, suggesting
that the regular users developed tolerance to the effects of cannabis.
Other tracking tasks are generally not affected (Zacny &amp; Chait, 1991;
Heishman et al, 1989). Tests in which the subject must manipulate and
accurately place small items (Dalton et al, 1975; 1976; Evans et al,
1973) are usually affected, while sorting tasks may (Chait et al,
1985) or may not (Kelly et al, 1990) be performed less well. 



Concurrent tasks. Most concurrent task studies use one task which
requires almost continuous attention, typically tracking, and one in
which significant stimuli occur sporadically, often within a larger
number of non-significant stimuli. The tasks are often referred to as
the central and peripheral tasks respectively. The performance of
concurrent tasks is almost always affected negatively by cannabis,
although the effects on the component tasks are not consistent. Number
or proportion of peripheral targets missed (MacAvoy &amp; Marks, 1975;
Marks &amp; MacAvoy, 1989; Casswell &amp; Marks, 1973; Moskowitz et al, 1972),
proportion of hits (Moskowitz, Sharma &amp; McGlothlin, 1972), false
alarms (Chait et al, 1988, MacAvoy &amp; Marks, 1975; Moskowitz &amp;
McGlothlin, 1974) or reaction time to peripheral targets (Perez-Reyes
et al, 1988; Evans et al, 1976; Moskowitz et al, 1976) may suffer, but
no interpretable pattern of decrements has emerged. It may be the case
that while overall performance on concurrent tasks is decreased during
cannabis intoxication, differences in the tasks used produce various
patterns of effect. While there has been some speculation as to
whether the effects of cannabis in concurrent tasks might be
concentrated on the central or peripheral tasks (Moskowitz, 1985), no
observed pattern has emerged to clearly support these conjectures.



5.4.2 Possible mechanisms of psychomotor effects

Sensory disturbances. Reports of the subjective experience of cannabis
intoxication include altered experience in all sensory modalities, as
well as in the perception of space and time (Tart, 1970). Since almost
all tasks of psychomotor performance include important visual and
auditory components, sensory disturbances might well affect the
ability to perform such tasks. Studies of the ability to discover
embedded figures within complex designs have shown that this is
impaired by cannabis (Carlin et al, 1972; Carlin et al, 1974; Pearl et
al, 1973). Performance decrements due to cannabis in the Stroop colour
naming test have been reported (Carlin et al, 1972; 1974), although it
is not clear whether disturbed perception has any significant effect
upon this task.



Central Nervous System depression. Both the toxic and behavioural
effects of cannabis indicate that it acts as a CNS depressant, at
least in moderate to high doses. It might seem reasonable to
hypothesise that this general effect might contribute to slowed
reaction times, inability to maintain concentration, and lapses in
attention. This is certainly the case with alcohol and other CNS
depressants. When compared to the relatively large and reliable
depressant effects of moderate doses of alcohol, it is clear that this
effect of cannabis is not the primary mediator of performance changes.
It must be stressed, however, that high doses of cannabis would make
this aspect of its action on psychomotor skills more important.



Motivational changes. A great deal has been written about the supposed
effects of cannabis on human motivation. Hypotheses concerning the
motivational effects of chronic cannabis use have been reviewed
separately (see chapter 7.2). Cannabis users routinely report reduced
desire for physical activity and increased difficulty of concentrating
on intellectually demanding tasks such as reading for study (Tart,
1970). Studies designed to test the effect of cannabis on the
willingness to perform laboratory &quot;work&quot; have found no striking
decrements (Mendelson, 1983). This is consistent with comparisons of
manual workers who used cannabis with those who did not (Rubin &amp;
Comitas, 1975; Stefanis et al, 1977). Indeed, the counter-argument
that cannabis users can voluntarily compensate for some of the
impairing effects of the drug has received experimental support
(Cappell &amp; Pliner, 1973; Robbe &amp; O'Hanlon, 1993). As discussed below,
motivational changes are surely important in decisions made outside
the laboratory, but there appears to be no reliable evidence that
motivational changes are responsible for any major proportion of the
psychomotor effects of cannabis.



5.4.3 Effects of cannabis on simulated driving and flying

Simulated driving tasks. As the previous sections have shown, there is
considerable evidence that cannabis intoxication has some negative
effects upon performance which become more pronounced with increasing
task difficulty. Motor vehicle driving is a complex task, especially
in conditions of heavy traffic or poor road or weather conditions, and
as such, it might be expected to be adversely affected by cannabis.
Simulated driving tasks require skills which are similar to those
involved in driving, which can be performed under controlled
laboratory conditions. When special efforts are made to simulate the
performance characteristics of a car, simulations have two major
advantages (Smiley, 1986). First, cannabis users an be tested after
taking doses of cannabis which it would be unethical to use on the
road. Second, they can be placed in simulated emergency situations
which test their level of impairment in ways that would be
impermissible on the road. The disadvantage of simulator studies
derives from the difficulty of achieving sufficient fidelity to
on-road driving tasks.

One of the earliest studies by Crancer et al, (1969) found only that
&quot;speedometer errors&quot; increased in simulated driving after cannabis
use. In one of the more influential studies, Dott (1972) reported an
apparent decrease in the willingness to take risks in simulated
passing of another vehicle after cannabis use, while alcohol had the
opposite effect. Alcohol also tended to hamper the subjects' response
to stimuli signalling an emergency condition, while cannabis had
little effect on this response. Both, however, increased reaction time
to a more routine signal. A similar dissociation of the effects of
alcohol and cannabis was reported by Ellingstad, et al, (1973) who
found that cannabis did not appear to increase risk-taking, whereas
alcohol did. Cannabis affected the ability to judge the time taken to
pass another vehicle, while alcohol did not. Moskowitz et al (1976)
found that alcohol altered the visual search patterns of subjects
performing a simulated driving task, while cannabis did not. The
alterations found with alcohol were, in theory, consistent with a
reduced ability to scan for hazardous events, but no reliable
difference in task performance was found with either drug.

Smiley (1986) critically reviewed the research on the effects of
cannabis intoxication on simulated driving. She argued that the
earlier studies which showed fewer effects on car control than later
studies suffered because of their unrealistic car dynamics. Later
studies which used driving simulators with more realistic car dynamics
have shown impairments of lane control after cannabis use. Some of the
studies have also shown reductions in risk-taking as manifested in
slower speeds, and maintenance of a larger distance from the car in
front in following tasks (Smiley, 1986).



Simulated flying. Janowsky et al (1976) found substantial increases in
the number and magnitude of errors during a simulated flight after
taking cannabis. These were principally in keeping the plane at the
proper altitude and heading. Yesavage et al (1985) originally reported
negative effects of cannabis on some components of a simulated flying
task up to 24 hours after smoking, but this study did not include a
control group. A later study (Leirer et al, 1989) which attempted to
replicate this result with a control group found only an effect one to
four hours after smoking. A third study which also included a control
group (Leirer et al, 1991) again demonstrated decrements in the
composite performance score up to 24 hours after smoking cannabis.
Much has been made of these findings by critics of cannabis use, but
the effects are very small and of uncertain significance for flying
safety. Jones (1987) has argued that the use of cannabis by pilots in
the 24 hours preceding flying may be more an indicator of poor
judgment, rather than a cause for concern about the residual
psychomotor effects of cannabis.



5.4.4 Effects of cannabis on on-road driving

It is often remarked that the activity most often cited as dangerous
when performed under the influence of recreational drugs - motor
vehicle driving - is one of the least studied. Given the concern about
the safety of the experimental subject in drug and driving
experimentation, it is understandable that such studies have been
relatively uncommon. A review by Nichols (1971) found that there were
no well controlled observations of the effects of cannabis on driving
performance. This situation changed with research commissioned by the
Canadian Commission of Inquiry into the Non-Medical use of Drugs. A
comprehensive report published by Hansteen et al (1976) showed that a
moderate dose of alcohol (approximately 0.07 BAC) or THC (5.9mg)
impaired driving on a traffic-free course (as measured by the number
of times the lane-defining cones (&quot;witch's hats&quot;) were struck).
Driving speed was decreased after cannabis but not after alcohol use. 

Smiley et al (1975), using a different type of course, found that
reaction time to signal stimuli was increased with the combination of
cannabis and alcohol. Klonoff (1974) studied driving on a closed
course, and in city traffic, after a placebo and two doses of smoked
cannabis (4.9mg and 8.4mg THC). Closed course driving was scored by
the number of cones hit on a precisely laid out path. Driving in
traffic was scored by observation of eleven categories of driving
skill, similar to those used in some driving tests. Driving on the
closed course was impaired by both doses, as indicated by a higher
proportion of subjects whose performance declined after cannabis use.
Driving in traffic, however, while showing a trend toward poorer
performance, was not significantly affected, and the effects of
cannabis were much more variable. Sutton (1983) also found that
cannabis had little effect on actual driving performance. Peck et al
(1986) recorded performance on a range of driving tasks on a closed
circuit on four occasions after the administration of placebo, up to
19mg of smoked THC, 0.84g/kg of alcohol, and the combination of both
drugs. On most individual and derived composite measures, cannabis
impaired performance. This study is important in that there was a high
degree of concordance between objective performance measures (e.g.
number of traffic markers hit during manoeuvres), subjective estimates
of performance by the drivers, and ratings by police observers.
However, the conclusion reached was that the effects of cannabis on
driving performance were somewhat less than those of alcohol. Robbe
and O'Hanlon (1993), have reported the methodology, but not the
detailed results, of a study of driving in traffic. Their brief report
suggests that their results also indicated little impairment of actual
driving skills after cannabis. They speculated that since drivers were
aware of their intoxication, they had successfully attempted to
counter the impairment. 

Overall, the effects of cannabis use on on-road driving have been
smaller than the comparable effects of intoxicating doses of alcohol
in the same settings (Smiley, 1986). The most consistent cannabis
effect has been that drivers reduce their risk by slowing down; a
finding that contrasts with the consistent finding that subjects
typically increase their speed when intoxicated with alcohol. It is
probably this compensatory behaviour by cannabis users that explains
the comparatively small effects of cannabis intoxication in on road
studies. For ethical reasons such studies have not been able to
adequately test the response of cannabis intoxicated drivers to
situations that require emergency decision, in which there is less
opportunity to compensate for impairment. The few studies which have
attempted to simulate this situation (e.g. by using subsidiary
reaction tasks in addition to driving) have shown that cannabis
intoxication impairs emergency decision-making (Smiley, 1986).

The small effects of cannabis on driving performance seem at odds with
its effects on laboratory tasks requiring divided attention. Peck et
al (1986) have pointed out, however, that the subtle performance
effects of drugs in laboratory divided attention tasks may be poor
predictors of driving performance. While the combination of
performance abilities which is tapped by the typical divided attention
task, such as concurrent pursuit tracking and visual discrimination,
is plausibly related to driving, the tracking task is usually a much
more difficult task than driving under normal conditions. Much more
attention must be allocated to the central task in most divided
attention tests, for example, leading to a substantial decrease in
performance when drugs such as cannabis are taken. In addition, in the
laboratory the subject is unable to vary a key task parameter, such as
driving speed, in order to compensate for any perceived impairment.
Hence, while laboratory divided attention tasks may be ideal for
detecting small drug effects, they may over-estimate the effects of
drugs on actual driving. It is not surprising then that many studies
which have used both types of test have reported less effect on actual
driving than on laboratory tasks or simulated driving.

5.4.5 Studies of cannabis use and accident risk 

While cannabis produces decrements in psychomotor performance in
laboratory and controlled settings, it does not necessarily follow
that these decrements will increase the risk of being involved in
accidents. It may be, for example, that cannabis users are less likely
to drive than drinkers because they are more aware of their
intoxication. The survey evidence suggests that this is not the case.
Several surveys (e.g. Dalton et al, 1975; Thompson, 1975; Klonoff,
1974; Robbe &amp; O'Hanlon, 1993) have found that cannabis users are
generally aware that their driving is impaired after using cannabis
but the majority had driven, or would drive, after using cannabis,
despite this recognition of impairment (Klonoff, 1974). This finding
is consistent with observations on the recreational use of alcohol
when driving (Smart, 1974).

Even if cannabis users drive when intoxicated it does not necessarily
follow that they will be over-represented among drivers involved in
accidents. It could be, for example, that cannabis users take special
care and avoid risk-taking when driving while intoxicated. This
possibility is difficult to investigate because there have been no
controlled epidemiological studies conducted to establish whether
cannabis users are at increased risk of being involved in motor
vehicle or other accidents. This is in contrast to the instance of
alcohol use and accidents, where case-control studies have shown that
persons with blood alcohol levels indicative of intoxication are
over-represented among accident victims (Holman et al, 1988). 

In the case of cannabis, all that is available are studies of the
prevalence of cannabinoids in the blood of motor vehicle and other
accident victims (see McBay, 1986 for a review). Most often these have
been retrospective studies of the prevalence of cannabinoids in blood
tested post-mortem, which have found that between 4 per cent and 37
per cent of blood samples have contained cannabinoids, typically in
association with blood alcohol levels indicative of intoxication (e.g.
Cimbura et al, 1982; Mason and McBay, 1984; Williams et al, 1985).
Zimmerman et al (1983) have reported similar prevalence data on blood
cannabinoid levels among Californian motorists tested because of
suspicion of impairment by the Highway patrol. Soderstrom et al (1988)
have conducted one of the few prospective studies among trauma
patients rather than accident fatalities, which showed a high
prevalence of bloods positive for cannabinoids (35 per cent). 

These studies are difficult to evaluate for a number of reasons.
First, in the absence of information on the prevalence of cannabinoids
in the blood of non-accident victims, we do not know whether persons
with cannabinoids are over-represented among accident victims
(Terhune, 1986). Although a prevalence of 35 per cent may seem high,
this is of the order of the prevalence of cannabis use among young
males who are at highest risk of involvement in motor vehicle and
other accidents (Soderstrom et al, 1988). Second, there are major
problems in using cannabinoid blood levels to determine whether a
driver or pedestrian was intoxicated with cannabis at the time of an
accident (Consensus Development Panel, 1985). The simple presence of
cannabinoids indicates only recent use, not necessarily intoxication
at the time of the accident (see above pp35-36). Third, there are also
serious problems of causal attribution, since more than 75 per cent of
drivers with cannabinoids in their blood also have blood levels
indicative of alcohol intoxication (McBay, 1986). On the basis of the
available evidence, it is accordingly difficult to draw any
conclusions about the contribution that cannabis intoxication may make
to the occurrence of motor vehicle accidents (Terhune, 1986).

One approach that has been used in an attempt to get around the
absence of data on the prevalence of cannabis use among drivers not
involved in accidents has been to perform &quot;culpability analyses&quot;
(Terhune, 1986). In such analyses, decisions are made as to which
drivers killed in fatal accidents are culpable (i.e. responsible for
the accident). Drivers with no alcohol or other drugs in their blood
are then used as the control group in analyses of the relationship
between the presence of drugs in blood and degree of culpability.
These studies have their problems: the culpability of the drug-free
drivers is usually high thereby reducing the ability to detect an
increase in culpability among drivers with alcohol and cannabis;
different studies use different criteria for deciding that when a
driver was intoxicated with cannabis; and as a consequence, different
studies have produced very different estimates of the relationship
between cannabinoids in blood and driver culpability (although most
have shown an increased culpability for drivers with intoxicating
levels of alcohol in their blood). As Simpson (1986) concluded after
reviewing the culpability literature: &quot;the results are mixed and
inconclusive&quot; (p28).

Gieringer (1988) used a different approach to circumvent the absence
of data on the prevalence of cannabinoids in drivers not involved in
accidents. He used data from a National Institute of Drug Abuse (NIDA)
household survey of drug abuse in the United States to estimate the
proportion of all drivers who might be expected to have blood and
urine samples positive for cannabinoids. On the basis of these data,
he estimated that cannabis users are two to four times more likely to
be represented among accident victims than non-cannabis users, and
that cannabis users who also used alcohol were even more likely to be
over-represented among the victims of motor vehicle accidents. 

Gieringer's inference about the risks of combining alcohol and
cannabis when driving receive some support from the studies of Mason
and McBay (1984) and Williams et al (1985). Mason and McBay estimated
that at most one driver in their series of 600 drivers killed in
single-vehicle accidents was significantly impaired by cannabis use
alone, compared with between nine and 28 drivers who were impaired by
marijuana and alcohol, and 476 drivers who had blood alcohol
contentrations (BACs) greater than 0.10. Williams et al (1985)
investigated the relationship between alcohol and cannabis use and
driver responsibility for fatal accidents (as judged from police
investigations of each accident) involving young men in California.
Using the small drug-free group as the comparison, they found that
both alcohol (OR=4.7 [95 per cent CI: 2.1, 10.3]) and alcohol and
marijuana in combination (OR=8.6 [95 per cent CI: 3.3, 22.2])
significantly increased the odds of the driver being adjudged to be
responsible for the accident. Marijuana-only drivers, however, were
less likely to be adjudged responsible for their accident (OR=0.5 [95
per cent CI: 0.2, 1.3]), although numbers were small (N=19).

There is also indirect evidence that cannabis use produces an increase
in the risk of accidents, from surveys of self-reported accidents
among adolescent drug users. Two such surveys have found a
statistically significant relationship between marijuana use and
self-reported involvement in accidents, with marijuana smokers having
approximately twice the risk of being involved in accidents of
non-marijuana smokers (Hingson et al, 1982; Smart and Fejer, 1976). 

More direct evidence of an association between cannabis use and
accidents is provided by two epidemiological studies, one of cannabis
use and mortality (Andreasson and Allebeck, 1990), and the other of
cannabis use and health service utilisation (Polen et al, 1993).
Andreasson and Allebeck reported a prospective study of mortality over
15 years among 50,465 Swedish military conscripts. They found an
increased risk of premature mortality among men who had smoked
cannabis 50 or more times by age 18 (RR=4.6, 95 per cent CI: 2.4,
8.5). Violent deaths were the major cause of death contributing to
this excess mortality, with 26 per cent of deaths being motor vehicle
and 7 per cent other accidents (e.g. drownings and falls). The
increased risk was no longer statistically significant (RR=1.2 [95 per
cent CI: 0.7, 1.9]) after multivariate statistical adjustment for
confounding variables such as anti-social behaviour, and alcohol and
other drug use in adolescence (Andreasson and Allebeck, 1990),
reinforcing Gieringer's suggestion that the combination of cannabis
and alcohol may be the important risk factor for accidents. 

Polen et al (1993) compared health service utilisation by non-smokers
(N=450) and daily cannabis-only smokers (N=450) screened at Kaiser
Permanente Medical centres between July, 1979 and December, 1985. They
reported an increased rate of medical care utilisation by
cannabis-only smokers for respiratory conditions and accidental injury
over a one to two-year follow-up. There was also an interaction
between cannabis and alcohol use, in which cannabis users who were the
heaviest alcohol users showed the highest rates of utilisation. This
result is suggestive but minimally informative about the risks of
motor vehicle accidents, because all forms of accidental injury were
aggregated. 



5.4.6 Conclusions on cannabis and driving

There is no doubt that cannabis adversely affects the performance of a
number of psychomotor tasks, an effect which is related to dose, and
which is larger, more consistent and persistent in difficult tasks
involving sustained attention. The acute effects on performance of
typical recreational doses of cannabis are similar to, if smaller
than, those of intoxicating doses of alcohol. Alcohol and cannabis
differ in their effects on the apparent willingness of intoxicated
users to take risks when driving, with persons intoxicated by cannabis
engaging in less risky behaviour than persons intoxicated by alcohol. 

While cannabis produces decrements in performance under laboratory and
controlled on-road conditions, it has been difficult, for technical
and ethical reasons, to establish conclusively whether cannabis
intoxication increases the risk of involvement in motor vehicle
accidents. There is sufficient consistency and coherence in the
evidence from studies of cannabinoid levels among accident victims,
and a small number of epidemiological studies, to infer that there
probably is an increased risk of motor vehicle accidents among persons
who drive when intoxicated with cannabis. A crude estimate of the risk
is of the order of two to four times for persons driving under the
influence of cannabis. This increased risk may be largely explained by
the combined use of cannabis with intoxicating doses of alcohol.
Further research is required to elucidate this issue, although it will
not be easily resolved because of the technical obstacles to such
research. In the meantime, cannabis users should be urged not to drive
while intoxicated by cannabis, and they should be particularly warned
of the dangers of driving after combining alcohol and cannabis use. 



5.5 Interactions between cannabis and other drugs 

Cannabis is often taken in combination with other drugs. This is most
likely among those who use it frequently and in large quantities (Tec,
1973). The predominant drug of choice for use with cannabis is alcohol
(e.g. Carlin &amp; Post, 1971; Hochhauser, 1977; McGlothlin et al, 1970;
Norton and Colliver, 1988) which supports the popular notion that this
combination enhances the degree of intoxication. Barbiturates, in
contrast, appear to produce an aversive intoxication when combined
with cannabis (Johnstone et al, 1975). The interactions of cannabis
with each type of drug will be considered in three ways; interactions
of toxicity, psychotropic effects and psychomotor impairment.



5.5.1 Other cannabinoids

There are slight interactions of THC with other cannabinoids found in
cannabis preparations. The two major cannabinoids other than THC which
have been extensively tested for interactions with THC and other drugs
are cannabidiol and cannabinol. Both of these compounds have been
found to have little psychoactivity when administered alone
(Hollister, 1986). In rather high doses (15-60mg), cannabidiol has
been reported to abolish the effects of 30mg of oral THC (Karniol et
al, 1975), whereas cannabinol had no apparent effect (Hollister &amp;
Gillespie, 1975). Comparisons of smoked THC and smoked cannabis, the
latter containing the usual small amounts of cannabinol and
cannabidiol, indicate that there is, if anything, a slightly greater
psychoactive effect from the cannabis than from THC (Galanter et al,
1973; Lemberger et al, 1976). The psychotropic effects of THC also
appear to be slightly enhanced by the minor constituent cannabinoids
found in natural products when smoked (Galanter et al, 1973). No such
differences have been reported in the behavioural effects of smoked
cannabis.



5.5.2 Alcohol 

Alcohol and cannabis have a number of effects in common, although the
mechanisms of these actions appear to be different. The recent
identification of the cannabinoid receptor (Howlett et al, 1990), and
an endogenous ligand for that receptor, have confirmed the hypothesis
that the central activity of cannabis is receptor-mediated (see pp
29-31 above). While the mechanism of action of alcohol is still in
question, most explanations are concerned with the effects of alcohol
upon the structure and chemistry of the cell membrane. Both drugs are
considered to be CNS depressants, especially in high doses, and both
have substantial analgesic properties. Since these effects of the two
drugs appear to be approximately additive (Siemens, 1980) it is
possible that the toxicity of high doses of 9-tetrahydrocannabinol
(THC) (Rosencrantz, 1983) may be potentiated by alcohol, although
there is very little evidence to support this conjecture. Neither the
metabolism of alcohol nor that of THC appears to be altered by the
presence of the other drug (Siemens &amp; Khanna, 1977).

Alcohol and THC also appear to have similar psychotropic effects. The
perceived stimulation and euphoria at low doses are common effects, as
well as a tendency toward behavioural disinhibition over a range of
doses (Hollister &amp; Gillespie, 1970). This interaction is generally
perceived by users as enhancing the intoxication produced by either
drug alone (Chesher et al, 1976), although contrary results have been
reported (Manno et al, 1971). However, larger doses in combination are
often reported to be aversive (Sulkowski &amp; Vachon, 1977; Chesher et
al, 1986).

The effects of alcohol and cannabis combinations on psychomotor
performance are more complex. The majority of studies have reported
that both drugs produce impairment on a variety of psychomotor tasks,
and that the interaction is approximately additive. However, a number
of studies have reported that at low doses there is less than an
additive effect. Chesher et al (1976, 1977) found a reduction in
impairment late in intoxication after a combination of oral THC
(0.14-0.21mg/kg) and alcohol (0.5-0.6g/kg). A further study in which
the THC (0.32mg/kg) was administered one hour before the alcohol
(0.54g/kg) found no apparent antagonism (Belgrave et al, 1979).
Another study using three doses of smoked marijuana in combination
with alcohol showed a lower-than-expected impairment in the group
which received the lowest dose of THC (5mg) and the lowest dose of
alcohol (0.54g.kg) (Chesher et al, 1986). Peck et al (1986) also
reported an apparent antagonism, but only on a composite &quot;stopping&quot;
variable derived from driving performance. In most of their measures,
the combination of alcohol and cannabis produced additive impairments.


Siemens (1980) has proposed that alcohol may reduce the availability
of THC through a pharmacokinetic interaction demonstrated in animals
(Siemens &amp; Khanna, 1977). Given that there is substantial evidence for
cross-tolerance between alcohol and THC (Newman et al, 1972), it is
possible that low doses of THC and alcohol in combination may enhance
the acute tolerance to alcohol (Hurst &amp; Bagley, 1972) late in
intoxication.



5.5.3 Psychostimulants

The most characteristic effect of psychostimulants such as amphetamine
and cocaine is their activation of the sympathetic branch of the
autonomic nervous system, as indicated by increases in arousal, blood
pressure and respiratory rate. There are few actions which appear to
be common between cannabis and stimulants. The few effects on the
cardiovascular system, such as amphetamine-induced hypertension, and
THC-induced tachycardia, seem to occur independently (Zalcman et al,
1973). It is in the combined effect upon cardiac action that toxic
interactions of THC and stimulants could be dangerous, but there are
no clear indications in the literature for humans, and the evidence
from animal studies is mixed (Siemens, 1980).

The psychotropic effects of the combination of 0.14mg/kg amphetamine
and 0.05mg/kg THC have been reported as a longer and more intense
&quot;high&quot; (Evans et al, 1976), although a similar study using only
0.025mg/kg THC found no effect of the combination (Forney et al 1976).
While the concurrent use of cannabis and cocaine is often reported
(Miller et al, 1990), systematic study of their interaction is
lacking. 

There is some evidence that amphetamine may antagonise the behavioural
impairments produced by cannabis (Zalcman et al, 1973), as a number of
stimulants appear to do in some animals (Consroe et al, 1976). The
infrequency of stimulant/cannabis combinations in recreational use
(Hollister, 1986) may be due to as yet unspecified negative
interactions experienced by users. It may be, for example, that
stimulants increase the probability of occurrence, or severity of the
acute panic reaction which sometimes occurs after cannabis use.



5.5.4 Depressants

A great deal of experimentation in animals has shown that cannabis in
general increases the depressant action of drugs such as the
barbiturates over a range of doses (Siemens, 1980). This is also the
case with oxymorphone (Johnstone et al, 1975) and diazepam (Smith &amp;
Kulp, 1976). As with alcohol, it is likely that interactions between
these acute effects of depressant drugs would lead to the greatest
danger of acute toxicity. There is little human evidence at present,
however, to support this speculation. 

The psychotropic effects produced by combinations of barbiturates with
cannabis appear to be additive (Dalton et al, 1975). As mentioned
previously, this intoxication is more likely to be aversive to the
user (Johnstone et al, 1975). The behavioural effects of the
interaction of depressant drugs with cannabis are, in almost all
reports, also additive.



5.5.5 Miscellaneous drugs

A number of other substances have been reported to antagonise various
effects of cannabis in animals, including phenitrone (Kudrin &amp;
Davydova, 1968), pemoline (Howes, 1973) and even tamarind (Hollister,
1986). Only pemoline is acknowledged to counter the reduced motor
activity and hypoalgesia due to THC. Physostigmine has shown a complex
interaction which includes increasing the motor depression produced by
THC and antagonising the tachycardia (Freemon et al, 1975).
Propanolol, which would be expected to antagonise the tachycardia
characteristic of cannabis intoxication, also appears to abolish the
reduction in learning capacity produced by cannabis (Sulkowski et al,
1977), although an earlier study using smaller, spaced doses found no
effect (Drew et al, 1972). Recently, it has been reported that
indomethacin, a non-steroidal anti-inflammatory, reduced or eliminated
a number of physiological effects of THC, and attenuated the &quot;high&quot;,
but did not affect the acute memory impairment (Perez-Reyes et al,
1991).



5.5.6 Conclusions on drug interactions

At present, the interactions between the effects of cannabis and other
drugs are what would be predicted from their separate actions, and are
generally relatively innocuous in recreational doses. There have been
a number of reports in which cannabis use has accompanied serious
consequences, typically when used in combination with one or more
other drugs in high doses, or over extended periods of intoxication.
However, there appears to be no evidence that cannabis is particularly
implicated in cases of heavy intoxication with other drugs. The
concurrent intoxication with alcohol and cannabis, which is the most
common combination of drugs, may have greatest relevance in motor
vehicle accidents. The separate impairments induced by the two drugs
appear to be approximately additive, and there are indications that
users of both drugs are over-represented among motor vehicle
accidents.



References

Andreasson, S. and Allebeck, P. (1990) Cannabis and mortality among
young men: A longitudinal study of Swedish conscripts. Scandinavian
Journal of Social Medicine, 
18, 9-15.

Belgrave, B. E., Bird, K. D., Chesher, G. B., Jackson, D. M., Lubbe,
K. E., Starmer, G. A. &amp; Teo, R. K. C. (1979) The effect of (-)
trans-9-tetrahydrocannabinol, alone and in combination with ethanol,
on human performance. Psychopharmacology, 62, 53-60.

Block, R. I. &amp; Wittenborn, J. R. (1984) Marijuana effects on semantic
memory: verification of common and uncommon category members.
Psychological Reports, 55, 503-512.

Block, R. I. &amp; Wittenborn, J. R., (1986) Marijuana effects on the
speed of memory retrieval in the letter-matching task. International
Journal of Addiction, 21, 281-285.

Blum, K. (1984) Handbook of Abusable Drugs. New York: Gardner Press.

Borg, J, Gershon, S. &amp; Alpert, M. (1975) Dose effects of smoked
marihuana on human cognitive and motor functions. Psychopharmacologia,
42, 211-218.

Braden, W., Stillman, R. C. &amp; Wyatt, R. J. (1974) Effects of marihuana
on contingent negative variation and reaction time. Archives of
General Psychiatry, 31, 537-541.

Cappell, H. D. &amp; Pliner, P. L. (1973) Volitional control of marijuana
intoxication: A study of the ability to &quot;come down&quot; on command.
Journal of Abnormal Psychology, 
82, 428-434.

Carlin, A. S. &amp; Post, R. D. (1971) Patterns of drug use among
marijuana smokers. Journal of the American Medical Association, 218,
867-868.

Carlin, A. S., Bakker, C. B., Halpern, L. &amp; Post, R. D. (1972) Social
facilitation of ,marijuana intoxication: impact of social set and
pharmacological activity. Journal of Abnormal Psychology, 80, 132-140.

Carlin, A. S., Post, R. D., Bakker, C. B. &amp; Halpern, L. M. (1974) The
role of modeling and previous experience in the facilitation of
marijuana intoxication. Journal of Nervous and Mental Disease, 159,
275-281.

Casswell, S. &amp; Marks, D. F. (1973) Cannabis induced impairment of
performance of a divided attention task. Nature (London), 241, 60.

Chait, L. D., Corwin, R. L. &amp; Johanson, C. E. (1988) A cumulative
dosing procedure for administering marijuana smoke to humans.
Pharmacology, Biochemistry and Behavior, 29, 553-557.

Chait, L. D., Fischman, M. W. &amp; Schuster, C. R. (1985) Hangover
effects the morning after marijuana smoking. Drug and Alcohol
Dependence, 15, 229-238.

Chait, L. D. &amp; Pierri, J. (1992) Effects of smoked marijuana on human
performance: A critical review. in A. Murphy &amp; J. Bartke (Eds)
Marijuana/Cannabinoids: Neurobiology and Neurophysiology, Boca Raton:
CRC Press. 

Chesher, G. B., Franks, H. M., Hensley, V. R., Hensley, W. J.,
Jackson, D. M., Starmer, G. A. &amp; Teo, R. K. C. (1976) The interaction
of ethanol and 9-tetrahydrocannabinol in man. Effects on perceptual,
cognitive and motor functions. Medical Journal of Australia, 2,
159-163.

Chesher, G. B., Franks, H. M., Jackson, D. M., Starmer, G. A. &amp; Teo,
R. K. C. (1977) Ethanol and 9-tetrahydrocannabinol. Interactive
effects on human perceptual, cognitive and motor functions. Medical
Journal of Australia, 1, 478-481.

Chesher, G. B., Dauncey, H., Crawford, J. C. &amp; Horn, K. (1986) The
interaction of alcohol and marijuana: A dose dependent study of
effects on human moods and performance skills. Canberra: Federal
Office of Road Safety.

Cimbura, G., Lucas, D.M., Bennet, R.C., Warren, R.A. and Simpson, H.M.
(1982) Incidence and toxicological aspects of drugs detected in 484
fatally injured drivers and pedestrians in Ontario. Journal of
Forensic Science, 27, 855-867.

Consensus Development Panel (1985) Drug concentrations and driving
impairment. Journal of the American Medical Association, 254,
2618-2621.

Consroe, P. F., Jones, B. &amp; Laird, H. (1976) EEG and behavioral
effects of 9-tetrahydrocannabinol in combination with stimulant drugs
in rabbits. Psychopharmacology, 50, 47-52.

Crancer, A. Jr., Dille, J. M., Delay, J. C., Wallace, J. E. &amp; Haykin,
M. D. (1969) Comparison of the effects of marihuana and alcohol on
simulated driving performance. Science, 163, 851-854.

Dalton, W. S., Martz, R., Lemberger, L., Rodda, B. E. &amp; Forney, R. B.
(1975) Effects of marijuana combined with secobarbitol. Clinical
Pharmacology and Therapeutics, 14, 298-304.

Dornbush, R. L., Fink M. &amp; Freedman, A. M. (1971) Marijuana, memory,
and perception. American Journal of Psychiatry, 128, 194-197.

Dott, A. (1972) Effect of marihuana on risk acceptance in a simulated
passing task. DHEW Publication HSM-72-10010, Washington: DHEW.

Drew, W. G., Kiplinger, G. F., Miller, L. L. &amp; Marx, M. (1972) Effects
of propanolol on marijuana-induced cognitive dysfunctioning. Clinical
Pharmacology and Therapeutics, 13, 526-533.

Ellingstad, V., McFarling, L. &amp; Struckman, D. (1973) Alcohol,
marijuana and risk-taking. DOT-HS-191-2-301, Vermillion: University of
South Dakota, 

Evans, M. A., Martz, R., Brown, D. J., Rodda, B. E., Kiplinger, G. F.,
Lemberger, L. &amp; Forney, R. B. (1973) Impairment of performance with
low doses of marihuana. Clinical Pharmacology and Therapeutics, 14,
936-940.

Evans, M. A., Martz, R., Rodda, B. E., Lemberger, L. &amp; Forney, R. B.
(1976) Effects of marihuana-dextroamphetamine combination. Clinical
Pharmacology and Therapeutics, 20, 350-358.

Forney, R. B., Martz, R., Lemberger, L. &amp; Rodda, B. (1976) The
combined effect of marijuana and dextroamphetamine. Annals of the New
York Academy of Science, 
281, 172-170.

Freemon, F. R., Rosenblatt, J. E. &amp; El-Yousef, M. K. (1975)
Interaction of physostigmine and delta-9-tetrahydrocannabinol in man.
Clinical Pharmacology and Therapeutics, 
17, 121-126.

Galanter, M., Weingartner, H., Vaughan, T. B., Roth, W. T. &amp; Wyatt, R.
J. (1973) 
9-Tetrahydrocannabinol and natural marijuana. Archives of General
Psychiatry, 
28, 278-281

Gieringer, D.H. (1988) Marijuana, driving and accident safety. Journal
of Psychoactive Drugs, 20, 93-101.

Hansteen, R. W., Miller, R. D., Lonero, L., Reid, L. D. &amp; Jones, B.
(1976) Effects of cannabis and alcohol on automobile driving and
psychomotor tracking. Annals of the New York Academy of Science, 282,
240-256.

Hardman, H.F. and Hosko, M.J. (1976) An overview of the
cardiovascular-autonomic actions of cannabis. In M Braude and S. Szara
(eds) Pharmacology of Marihuana, Volume 1. New York: Raven Press.

Heishman, S. J., Stitzer, M. L. &amp; Bigelow, G. E. (1989) Alcohol and
marijuana: comparative dose effect profiles in humans. Pharmacology,
Biochemistry and Behavior, 31, 649-655.

Hingson, R., Heeren, T., Mangione, T., Morelock, S. and Mucatel, M.
(1982) Teenage driving after using marijuana or drinking and traffic
accident involvement. Journal of Safety Research, 13, 33-37.

Hochhauser, M. (1977) Alcohol and marijuana consumption among
undergraduate polydrug users. American Journal of Drug and Alcohol
Abuse, 4, 65-76.

Hollister, L. (1986) Interactions of cannabis with other drugs in man.
in M. C. Braude &amp; H. M. Ginzburg (Eds.) Strategies for research on the
interactions of drugs of abuse. Rockville, MD: National Institute on
Drug Abuse.

Hollister, L. &amp; Gillespie, H. K. (1970) Marihuana, ethanol and
dextroamphetamine; mood and mental function alterations. Archives of
General Psychiatry, 23, 199-203.

Hollister, L. &amp; Gillespie, H. K. (1975) Interactions in man of
delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol. Clinical
Pharmacology and Therapeutics, 18, 80-83.

Holman, C.D., Armstrong, B. et al (1988). The Quantification of
Drug-Caused Morbidity and Mortality in Australia. Canberra:
Commonwealth Department of Community Services and Health. 

Howes, J. F. (1973) Antagonism of the effects of
9-tetrahydrocannabinol by pemoline (CylertR). Research Communications
in Chemical Pathology and Pharmacology, 
6, 901-908.

Howlett, A. C., Bidaut-Russell, M., Devane, W. A., Melvin, L. S.,
Johnson, M. R. &amp; Herkenham, M. (1990) The cannabinoid receptor:
Biochemical, anatomical and behavioral characterization. Trends in
Neuroscience, 13, 420-423.

Huber, G.L., Griffith, D.L. and Langsjoen, P.M. (1988) The effects of
marihuana on the respiratory and cardiovascular systems. In G.
Chesher, P. Consroe, and R. Musty (eds) Marijuana: An International
Research Report. National Campaign Against Drug Abuse Monograph Number
7, Canberra: Australian Government Publishing Service.

Hurst, P. M., &amp; Bagley, S. K.. (1972) Acute adaptation to the effects
of alcohol. Quarterly Journal of Studies on Alcohol, 33, 358-378.

Jaffe, J.H. (1985) Drug addiction and drug abuse. In A.G. Gilman, L.S.
Goodman &amp; F. Murad (Eds) The Pharmacological Basis of Therapeutics.
(7th Edition) USA: Macmillan.

Janowsky, D. S., Meacham, M. P., Blaine, J. D., Schoor, M. &amp; Bozzetti,
L. P. (1976) Marijuana effects on simulated flying ability. American
Journal of Psychiatry, 133, 384-388.

Jones, R.T. (1984) Cardiovascular effects of cannabinoids. In D.J.
Harvey, W. Paton and G.G. Nahas (eds) Marihuana '84: Proceedings of
the Oxford Symposium on Cannabis. Oxford:IRL Press.

Jones, R. T. (1987) Drug of abuse profile: cannabis. Clinical
Chemistry, 33, 72B-81B.

Johnstone, R. E., Lief, P. L., Kulp, R. A. &amp; Smith, T. C. (1975)
Combination of delta-9-tetrahydrocannabinol with oxymorphone or
pentobarbitol: Effects on ventilatory control and cardiovascular
dynamics. Anesthesiology, 42, 674-684.

Karniol, I. G., Shirakawa, I., Kasinski, N., Pfeferman, A. &amp; Carlini,
E. A. (1975) Cannabidiol interferes with the effects of
delta-9-tetrahydrocannabinol in man. European Journal of Pharmacology,
28, 172-177.

Kelly, T. H., Foltin, R. W., Emurian, C. S. &amp; Fischman, M. W. (1990)
Multidimensional behavioral effects of marijuana. Progress in
Neuro-Psychopharmacology, Biology and Psychiatry, 14, 885-902.

Kiplinger, G. F., Manno, J. E., Rodda, B. E., &amp; Forney, R. B. (1971)
Dose-response analysis of the effects of tetrahydrocannabinol in man.
Clinical Pharmacology and Therapeutics, 12, 650-657.

Klonoff, H. (1974) Effects of marijuana on driving in a restricted
area and on city streets: Driving performance and physiological
changes. in L. Miller (Ed.) Marijuana: Effects on Human Behavior, New
York: Academic Press.

Klonoff, H., Low, M. &amp; Marcus, A. (1973) Neuropsychological effects of
marijuana. Canadian Medical Association Journal, 108, 157-164.

Kudrin, A. N. &amp; Davydova, O. N. (1968) Elimination of hashish effect
with phenitrone in dogs. Farmakologiia i Toksikologiia, 31, 549-552.

Leirer, v.-O., Yesavage, J. A. &amp; Morrow, D. G. (1989) Marijuana, aging
and task difficulty effects on pilot performance. Aviation, Space and
Environmental Medicine, 
60, 1145-1152.

Leirer, v.-O.,Yesavage, J. A. &amp; Morrow, D. G. (1991) Marijuana
carry-over effects on aircraft pilot performance. Aviation, Space and
Environmental Medicine, 62, 221-227.

Lemberger, L., Dalton, B., Martz, R., Rodda, B. &amp; Forney, R. (1976).
Clinical studies of the interaction of psychopharmacologic agents with
marijuana. Annals of the New York Academy of Science, 281, 219-228.

Low, M., Klonoff, H. &amp; Marcus, A. (1973) The neuropsychological basis
of the marijuana experience. Canadian Medical Journal Association,
108, 157-164.

MacAvoy, M. G. &amp; Marks, D. F. (1975) Divided attention performance of
cannabis users and non-users following cannabis and alcohol.
Psychopharmacologia, 44, 147-152.

Maykut, M.O. (1984) Health Consequences of Acute and Chronic Marihuana
Use. Oxford: Pergamon Press.

McBay, A.J. (1986) Drug concentrations and traffic safety. Alcohol,
Drugs and Driving, 
2, 51-59.

McGlothlin, W., Jamison, K. &amp; Rosenblatt, S. (1970) Marijuana and the
use of other drugs. Nature, 228, 1227-1228.

Manno, J. E., Kiplinger, G. F., Haine, S. E., Bennett, I. F. &amp; Forney,
R. B. (1970) Comparative effects of smoking marihuana or placebo on
human motor and mental performance. Clinical Pharmacology and
Therapeutics, 11, 808-815.

Manno, J. E., Kiplinger, G. F., Scholz, N. &amp; Forney, R. B. (1971) The
influence of alcohol and marihuana on motor and mental performance.
Clinical Pharmacology and Therapeutics, 12, 202-211.

Marks, D. F. &amp; MacAvoy, M. G. (1989) Divided attention performance in
cannabis users and non-users following alcohol and cannabis separately
and in combination. Psychopharmacology, 99, 397-401.

Mason, A.P, &amp; McBay, A.J. (1984) Ethanol, marijuana and other drug use
in 600 drivers killed in single-vehicle crashes in North Carolina
1978-1981. Journal of Forensic Science, 29, 987-1026.

Mendelson, J. (1983) Chronic effects of cannabis on human brain
function and behavior. in K. O. Fehr &amp; H. Kalant (Eds) Cannabis and
Health Hazards, Toronto: Addiction Research Foundation.

Miller, N. S., Klahr, A. L., Gold, M. S., Sweeney, K. &amp; Corcores, J.
A. (1990) The prevalence of marijuana (cannabis) use and dependence in
cocaine dependence. New York State Journal of Medicine, 90, 491-492.

Milstein, S. L., MacCannell, K., Karr, G. &amp; Clark, S. (1975)
Marijuana-produced impairments in coordination. Journal of Nervous and
Mental Disease, 161, 26-31.

Moskowitz, H. (1985) Marijuana and driving. Accident Analysis and
Prevention, 
17, 323-345.

Moskowitz, H., Hulbert, S. &amp; McGlothlin, W. H. (1976) Marijuana:
Effects on simulated driving performance. Accident Analysis and
Prevention, 8, 45-50.

Moskowitz, H. &amp; McGlothlin, W. (1974) Effects of marijuana on auditory
signal detection. Psychopharmacologia, 40, 137-145.

Moskowitz, H., Sharma, S. &amp; McGlothlin, W. (1972) Effect of marijuana
upon peripheral vision as a function of the information processing
demands in central vision. Perceptual and Motor Skills, 35, 875-882.

Nahas, G.G. (1984) Toxicology and pharmacology. In G.G. Nahas
Marihuana in Science and Medicine New York: Raven Press.

Newman, L. M., Lutz, M. P., Gould, M. H. &amp; Domino, E. F. (1972) 
9-Tetrahydrocannabinol and ethyl alcohol: Evidence for
cross-tolerance in the rat. Science, 175, 1022-1023.

Nichols, J. L. (1971) Drug use and highway safety: A review of the
literature. DOT-HS-0.2-1-019, Washington: National Highway Traffic
Safety Administration.

Norton, R. and Colliver, J. (1988) Prevalence and patterns of combined
alcohol and marijuana use. Journal of Studies in Alcohol, 49, 378-380.

Pearl, J. H., Domino, E. F. &amp; Rennick, P. (1973) Short-term effects of
marijuana smoking on cognitive behavior in experienced male users.
Psychopharmacologia, 31, 13-24.

Peck, R. C., Biasotti, A., Boland, P. N., Mallory, C. &amp; Reeve, V.
(1986) The Effects of marijuana and alcohol on actual driving
performance. Alcohol, Drugs and Driving, 
2, 135-154.

Peeke, S. D., Jones, R. T. &amp; Stone, G. C. (1976) Effects of practice
on marijuana-induced changes in reaction time. Psychopharmacology, 48,
159-163.

Perez-Reyes, M., Burstein, S. H., White, W. R.., McDonald, S. A. &amp;
Hicks, R. E. (1991) Antagonism of marihuana effects by indomethacin in
humans. Life Sciences, 
48, 507-515.

Perez-Reyes, M., Hicks, R. E., Bumberry, J., Jeffcoat, A. R. &amp; Cook,
C. E. (1988) Interaction between marihuana and ethanol: Effects on
psychomotor performance. Alcoholism, 12, 268-276.

Polen, M.R., Sidney, S., Tekawa, I.S., Sadler, M. and Friedman, G.D.
(1993) Health care use by frequent marijuana smokers who do not smoke
tobacco. Western Journal of Medicine, 158, 596-601.

Robbe, H. W. J. &amp; O'Hanlon, J. F. (1993) Marijuana's effect on actual
driving: Summary of a 3-year experimental program. in H.-D. Utzelmann,
G. Berghaus &amp; G. Kroj (Eds) Alcohol, Drugs and Traffic Safety - T92
(Vol. 2), K&quot;ln: Verlag T&#154;V Rheinland.

Rosencrantz, H. (1983) Cannabis, marihuana and cannabinoid
toxicological manifestations in man and animals. in K. O. Fehr &amp; H.
Kalant (Eds.) Cannabis and Health Hazards. Toronto: Addiction Research
Foundation.

Rubin, V. &amp; Comitas, L. (1975) Ganja in Jamaica. The Hague: Mouton
Publishers.

Salvendy, G. &amp; McCabe, G. P. (1975) Marihuana and human performance.
Human Factors, 17, 229-235.

Siemens, A. J. (1980) Effects of cannabis in combination with ethanol
and other drugs. in Petersen, R. C. (Ed.) Marijuana Research Findings:
1980. National Institute on Drug Abuse Research Monograph No. 31.
Rockville, MD: U.S. Department of Health and Human Services.

Siemens, A. J. &amp; Khanna, J. M. (1977) Acute metabolic interactions
between ethanol and cannabis. Alcoholism: Clinical and Experimental
Research, 1, 343-348.

Simpson, H.M. (1986) Epidemiology of road accidents involving
marijuana. Alcohol, Drugs and Driving, 2, 15-30.

Smart, R. G. (1974) Marijuana and driving risk among college students.
Journal of Safety Research, 6, 155-158.

Smart, R. G. and Fejer, D. (1976) Drug use and driving risk among high
school students. Accident Analysis and Prevention, 8, 33-38.

Smiley, A. (1986) Marijuana: on-road and driving simulator studies.
Alcohol, Drugs and Driving, 2, 121-134.

Smiley, A., LeBlanc, A. E., French, I. W. and Burford, R. (1975) The
combined effects of alcohol and common psychoactive drugs: 11 field
studies with an instrumented automobile. in S. Israelstam &amp; S. Lambert
(Eds.) Alcohol, Drugs and Traffic Safety. Proceedings of the Sixth
International Conference on Alcohol, Drugs and Traffic Safety.
Toronto: Addiction Research Foundation.

Smith, D.E. (1968) Acute and chronic toxicity of marijuana. Journal of
Psychedelic Drugs, 2, 37-47.

Smith, T. C. &amp; Kulp, R. A. (1976) Respiratory and cardiovascular
effects of delta-9-tetrahydrocannabinol alone and in combination with
oxymorphone, pentobarbitol and diazepam. in S. Cohen &amp; R. G. Stillman
(Eds.) The Therapeutic Potential of Marijuana. New York: Plenum Press.

Soderstrom, C.A., Triffilis, A.L., Shankar, B.S., Clark, W.E., Cowley,
R.A. (1988) Marijuana and alcohol use among 1023 trauma patients.
Archives of Surgery, 123, 733-737.

Stefanis, C., Dornbush, R. &amp; Fink, M. (Eds.) (1977) Ha
5. The acute 
of Long-term Use. New York: Raven Press.

Sulkowski, A. &amp; Vachon, L. (1977) Propanolol effects on acute
marijuana intoxication in man. Psychopharmacology, 52, 47-53.

Sulkowski, A. Vachon, L. &amp; Rich, E.S. (1977) Propanolol effects on
acute marijuana intoxication in man. Psychopharmacology, 52, 47-53.

Sutton, L. R. (1983) The effects of alcohol, marihuana and their
combination on driving ability. Journal of Studies on Alcohol, 44,
438-445.

Tart, C. (1970) Marijuana intoxication: Common experiences. Nature,
226, 701-704.

Tec, N. (1973) A clarification of the relationship between alcohol and
marijuana. British Journal of Addiction, 68, 191-195.

Terhune, K.W. (1986) Problems and methods in studying drug crash
effects. Alcohol, Drugs and Driving, 2, 1-13.

Thomas, H. (1993) Psychiatric symptoms in cannabis users. British
Journal of Psychiatry, 163, 141-149.

Thompson, P. (1975) &quot;Stoned&quot; driving is unpleasant, say marijuana
smokers. The Journal (Addiction Research Foundation), 4, 13.

Weckowicz, T. E., Fedora, O., Mason, J., Radstaak, D., Bay, K. S. &amp;
Yonge, K. A. (1975) Effect of marijuana on divergent and convergent
production cognitive tests. Journal of Abnormal Psychology, 84,
386-398.

Weil, A. (1970) Adverse reactions to marihuana. New England Journal of
Medicine, 282, 997-1000.

Williams, A.G., Peat, M.A., Crouch, D.J., Wells, J.K. and Finkle, B.S.
(1985) Drugs in fatally injured young male drivers. Public Health
Reports, 100, 19-25.

Yesavage, J. A., Leirer, v.-O., Denari, M. &amp; Hollister, L. E. (1985)
Carry-over effects of marijuana intoxication on aircraft pilot
performance: A preliminary report. American Journal of Psychiatry,
142, 1325-1329.

Zacny, J. P. &amp; Chait, L. D. (1991) Response to marijuana as a function
of potency and breathhold duration. Psychopharmacology, 103, 223-226.

Zalcman, S., Liskow, B., Cadoret, R. &amp; Goodwin, (1973) Marijuana and
amphetamine: The question of interaction. American Journal of
Psychiatry, 130, 707-708.

Zimmerman, E.G., Yaeger, E.P., Soares, J.R., Hollister, L. and Reeve,
V (1983) Measurement of Delta-9-Tetrahydrocannabinol (THC) in whole
blood samples from impaired motorists. Journal of Forensic Sciences,
28, 957-962.


</font>
</pre>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-11</DOCNO>
<DOCOLDNO>IA087-000627-B016-129</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch6.htm 206.61.184.43 19970122051644 text/html 107749
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:16:35 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:03:03 GMT
Content-length: 107530
</DOCHDR>
<html>

<head>
<title>The health and psychological consequences of cannabis use:
chapter 6 </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<h1></h1>
</body>

<body bgcolor="#ffffff">

<p>The health and psychological consequences of cannabis use
chapter 6 </p>

<h3>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
</h3>

<hr>

<pre>
<font size="2">6. The chronic effects of cannabis use on health 



Cellular and immunological effects

The possible effects of chronic cannabis use on cellular processes and
the immune system are considered together because both effects may
influence a cannabis user's susceptibility to diseases. If cannabis
use affects cellular processes then users may be at increased risk of
developing various types of cancer, and if it affects the immune
system then cannabis users may be at increased risk of contracting
infectious diseases and developing cancer. 



6.1 Mutagenicity and carcinogenicity 

A major reason for research into the effects of cannabinoids on
cellular processes is to discover whether cannabinoids are mutagenic,
i.e. whether they may produce mutations in the genetic material in the
somatic and germ cells of users. If cannabinoid exposure affects the
genetic material of a user's somatic or bodily cells (such as those of
the lung, for example) then chronic cannabis use may cause cancer. If
it affects the genetic material of germ cells (the sperm and ova),
then genetic mutations could be transmitted to the children of
cannabis users. 

There is experimental evidence from in vitro studies of animal cells
that some cannabinoids, including THC, can produce a variety of
changes in cellular processes in vitro (i.e. in the test tube). These
include alterations to cell metabolism, DNA synthesis, and cell
division (Nahas, 1984). The potential for cannabinoids to produce
genetic change in humans or animals is unclear. There is, at most,
mixed evidence that THC and other cannabinoids are mutagenic in
standard microbial assays, such as the Ames test, and there is
contradictory evidence on whether the cannabinoids are clastogenic,
i.e. produce breaks in chromosomes. According to Bloch (1983) who
reviewed the literature for the World Health Organisation: &quot;in vivo
and in vitro exposure to purified cannabinoids or cannabis resin
failed to increase the frequency of chromosomal damage or mutagenesis&quot;
(p412). Nahas (1984) reviewed the same evidence and concluded that
&quot;cannabinoids and marihuana may exert a weak mutagenic effect&quot; (p117).
More recently, Zimmerman and Zimmerman (1990/1991) concluded that
&quot;cannabis mutagenicity remains unclear&quot;, but argued that there was
evidence that &quot;cannabinoids induce chromosome aberrations in both in
vivo and in vitro studies&quot; (p19).

There is stronger and more consistent evidence that cannabis smoke,
like smoke produced by most burning plant material, is mutagenic in
vitro, and hence, is potentially carcinogenic (Leuchtenberger, 1983).
According to Bloch (1983) &quot;marijuana smoke exposure has been reported
to be associated with chromosomal aberrations ... [such as]
hypoploidy, mutagenicity in the Ames test ... &quot; (Bloch, 1983, p413).
This is consistent with research indicating that cannabis smoke
contains many of the same carcinogens as cigarette smoke (Institute of
Medicine, 1982; Leuchtenberger, 1983), suggesting that if cannabis
smoke is carcinogenic it is more likely to be because of the
carcinogens it shares with cigarette smoke rather than because of the
cannabinoids it contains. If it is the non-cannabinoid components of
cannabis smoke that are mutagenic, then any cancers caused by cannabis
smoking are most likely to develop after long-term exposure to
cannabis smoke, and they are most likely to develop at sites which
have had the maximum exposure to that smoke, namely, the upper
aerodigestive tract and lung. This possibility is considered in more
detail below (see pp49-50). 



6.2 Immunological effects 

The possibility that cannabis reduces immune system function is
important for several reasons. First, tobacco smoking suppresses both
the humoral and cell-mediated immune systems. Given the similarities
between the constituents of cigarette and cannabis smoke (Institute of
Medicine, 1982; Leuchtenberger, 1983) it is reasonable to suspect that
cannabis may also be an immunosuppressant (Nahas, 1984). Second, even
a modest reduction in immunity caused by cannabis use could have
public health significance because of the relatively large number of
young adults who have used the drug (Munson and Fehr, 1983). Third, if
cannabinoids have immunosuppressive effects, then this would have
mixed implications for their therapeutic use. On the one hand, they
could be therapeutically useful as immunosuppressant drugs in patients
undergoing organ transplants. On the other hand, their therapeutic use
for other purposes would be limited in patients with impaired immune
systems, a restriction which would potentially preclude their use as
anti-emetic agents in cancer chemotherapy, or as appetite stimulants
and mood enhancers in patients with AIDS.

There are a number of difficulties in deciding whether cannabis
impairs the functioning of the immune system. First, the majority of
studies that have been conducted have been either in vitro studies in
which animal and human cell cultures have been exposed to cannabis
smoke or cannabinoids, or in vivo animal studies in which the effects
of cannabis and cannabinoid exposure on immune system function have
been assessed in live animals. The usual problems of extrapolation
from in vivo and in vitro studies to human users are complicated by
the fact that many of the effects of cannabinoids on the immune system
of animals are only obtained at very high doses which are rarely taken
by human beings. Second, the difficulties in interpreting these
studies are exacerbated because the results of the small number of
human in vivo studies have been conflicting. Third, there have been
very few epidemiological studies of immune system functioning and
disease susceptibility in heavy chronic cannabis users.

Given that the majority of the in vitro and in vivo animal work was
undertaken in the 1970s, we have relied upon the summary of findings
provided in the authoritative reviews of this literature undertaken by
the Addiction Research Foundation and World Health Organization
(Leuchtenberger, 1983; Munson and Fehr, 1983). This enables the
present review to focus upon on the clinical and public health
significance of the immunological effects observed in the experimental
studies. Before doing so, a brief and schematic review will be
provided of the components of the human immune system.



6.2.1 The immune system

The immune system in mammals is &quot;an adaptive and a protective
mechanism against noxious foreign materials including pathogens and
cancer cells&quot; (Munson and Fehr, 1983). Its multiple components
include: lymphoid tissues such as the spleen and lymph nodes; the bone
marrow and thymus, where lymphocytes and other important cells in the
immune system are manufactured; and the recirculating lymphocytes that
mediate cellular and humoral immunity (see Grossman and Wilson, 1992;
and Nossal, 1993). 

Immunity may be either innate or acquired. Innate immunity consists of
those responses to foreign substances that do not require
sensitisation from previous exposure, such as the ingestion of
bacteria by macrophages, and the killing of tumour cells by natural
killer cells. Acquired immunity is that form of immunity in which the
recognition and destruction of foreign material depends upon processes
produced by a previous exposure to the material. It is mediated by the
cooperative functioning of two major systems of lymphocyte cells: the
B-cells (Thymus-independent lymphocytes) which control humoral
immunity, and T-cells (Thymus-dependent lymphocytes) the activity of
which controls cell-mediated immunity.

Humoral immunity involves the production of antibodies in response to
antigens, usually proteins, which are attached to the surface of
foreign cells. Antigens are recognised by the B-cells which
proliferate and differentiate into two types of cells, the first of
which synthesises and releases antibody, and the second of which
remains as antigen-sensitised cells that are able to respond to
subsequent exposure to the antigen by rapidly releasing large amounts
of antibody. The antibodies can act directly to inactivate the
pathogens or toxins by damaging cell membranes, or they can work
cooperatively with the cell-mediated immune system by enabling cells
called macrophages to recognise and destroy the foreign cells, either
by ingesting those cells which have antibodies attached, or by
releasing toxins which kill the cells. Cell-mediated immunity is
directed against foreign cells including many bacteria, viruses and
fungi. Macrophages are intimately involved in the early removal of
foreign materials directly by ingestion, or indirectly by altering
their antigens and presenting them to the T- and B-cells for the
further development of the immune response. They work in concert with
the humoral immune system to protect the organism from all pathogens
in its environment.



6.2.2 Effects of cannabinoids on lymphoid organs

A non-specific indication of an effect of cannabinoids on the immune
system would be a reduction in the weight of lymphoid organs, such as
the thymus and spleen, or a decrease in the number of circulating
lymphocytes. A substantial body of anatomical and histological studies
in animals bearing upon this possibility has been reviewed by Munson
and Fehr (1983). These studies reveal that cannabinoids in high doses
can affect the function of the stem cells which produce lymphocytes,
and can reduce the size of the spleen in rodents. It is uncertain what
the implications are for immune system competence because these
effects all occur after acute exposure, typically in response to very
high doses of cannabinoids. It is also unknown whether these effects
occur as the direct result of cannabinoids acting upon the lymphoid
cells, or whether they are an indirect effect of cannabinoids acting
on the adrenal-pituitary axis to increase the release of
corticosteroids which in turn shrink the spleen.



6.2.3 Effects of cannabinoids on humoral immunity 

The effect of cannabinoids on humoral immunity has been assessed in
vitro by measuring the effect of cannabinoids on the number and
functioning of animal and human B-cells produced in response to the
presence of sheep red blood cells. Cannabinoids do not consistently
alter the number or percentage of B-cells (Munson and Fehr, 1983). 

B-cell function has also been assessed in vitro by measuring the
proliferation of B-cells in response to chemicals which stimulate the
cells to divide, and by assessing antibody production in B-cells that
have previously been exposed to cannabinoids. While cannabinoids have
been consistently shown to impair the B-cell responses in mice, no
such effects have been consistently observed in humans, and the few
positive studies have produced results which are still within the
normal range (Munson and Fehr, 1983).

Antibody formation to THC has been demonstrated in animals. There are
also clinical reports in humans that cannabinoids can exacerbate
existing allergies, and there are several reports of demonstrated
allergy to cannabinoids in humans (e.g. Freeman, 1983). Munson and
Fehr (1983) concluded that: &quot;it appears that cannabinoids can elicit
the formation of specific antibodies ... [and that THC] or a
metabolite is probably acting as a hapten, combining with a protein to
form an antigenic complex&quot; (p289).

Hollister (1992), however, has questioned the clinical significance of
this evidence, arguing that:

While it is possible that a few persons may become truly allergic to
cannabinoids, it is far more likely that allergic reactions, which
have been extremely rare following the use of marijuana, are due to
contaminants .. (e.g. bacteria, fungi, molds, parasites, worms,
chemicals) that may be found in such field plants. That such impure
material, when smoked and inhaled into the lungs, causes so little
trouble is really a marvel (p163).



6.2.4 Effects of cannabinoids on cell-mediated immunity

Researchers have examined the effects of cannabinoids on both the
numbers and functioning of T-cells and macrophages. There are
considerable inconsistencies in the results of studies on the effects
of cannabinoids on T-cell numbers in humans, with some studies showing
reductions (e.g. Nahas et al, 1974) while others have not (e.g. Dax et
al, 1989). There is also mixed evidence on the effect of cannabinoids
on T-cell functioning as assessed by response to allogenic cells and
mitogens, chemicals which stimulate the cells to divide. A number of
the earliest studies suggested that T-cells from chronic cannabis
users showed a decreased responsiveness to such stimulation, but later
studies, including laboratory studies of chronic heavy dosing in
humans (e.g. Lau et al, 1976), have failed to replicate these results.
Studies of in vitro exposure of T-cells to cannabinoids have also
produced mixed results, while animal studies have showed a decreased
T-cell response to mitogens (Munson and Fehr, 1983).

Interpretations of this literature differ. Munson and Fehr (1983)
concluded that the fact that cannabinoids can affect T-cell function
in several species of animals &quot;suggests that the same effects could
occur in humans given exposure to these substances&quot; (pp306-307). Nahas
(1984) concluded that &quot;there is only suggestive&quot; evidence that
cannabinoids &quot;exert an immunodepressive effect&quot; (p156). Hollister
(1986) argued that even if there were such effects, they were of
limited clinical significance because they were probably transient
effects in healthy young adults, and there was no evidence of
increased susceptibility to disease in cannabis smokers. More
recently, Hollister (1992) has concluded that &quot;... the effects of
cannabinoids on cell-mediated immunity are contradictory. Such
evidence as has been obtained to support such an effect has usually
involved doses and concentrations that are orders of magnitude greater
than those obtained when marijuana is used by human subjects. (p161)&quot;



6.2.5 Effects of cannabinoids on host resistance

It is one thing to decide that in vitro exposure of the immune system
to high doses of cannabinoids impairs its functioning in various ways;
it is much more difficult to decide whether the small impairments in
immunity predicted by in vitro studies is likely to impair host
resistance to pathogens and infection with micro-organisms among human
cannabis users. There is a very small animal, and almost no human,
literature on which to make such a decision. 

A small number of studies in rodents (mice and guinea pigs) has
suggested that high doses (200mg/kg) of cannabinoids decrease
resistance to infection (Friedman, 1991), e.g. with Lysteria
monocytogenes (Morahan et al, 1979), and herpes simplex type 2 virus
(Cabral et al, 1986; Mishkin and Cabral, 1985; Morahan et al, 1979). A
reasonably consistent finding in humans has been that exposure to
cannabis smoke adversely affects alveolar macrophages, cells in the
respiratory system that constitute a first line of bodily defence
against many pathogens and micro-organisms which enter the body via
the lungs (Leuchtenberger, 1983). Studies of these cells obtained from
cannabis smokers have demonstrated ultrastructural abnormalities
(Tennant, 1980), and studies of the in vitro exposure of alveolar
macrophages to cannabis smoke have demonstrated that their ability to
inactivate Staphylococcus aureus (Leuchtenberger, 1983; Munson and
Fehr, 1983), and more recently the fungus Candida albicans (Sherman et
al, 1991) has been impaired. In this case, however, it seems to be the
non-cannabinoid components of cannabis smoke that produce the effect
(Leuchtenbeger, 1983). 



6.2.6 Human significance of immunological effects of cannabinoids 

The animal evidence is reasonably consistent that cannabinoids produce
impairments of the cell-mediated and humoral immune systems, and in
several studies these changes have been reflected in decreased
resistance to bacteria and viruses. There is also evidence that the
non-cannabinoid components of cannabis smoke can impair the
functioning of alveolar macrophages, the first line of the body's
defence system. However, the doses required to produce these
immunological effects have varied from the behaviourally relevant to
very high doses. This raises the issue of whether their findings can
be extrapolated to the doses used by humans.

The possibility of tolerance developing to any immunological effects
of cannabinoids also makes the human significance of the results of in
vitro studies uncertain. If immunological tolerance develops with
chronic use, then the possibility of observing even the small effects
projected from the in vitro studies would be substantially reduced.
There have been no demonstrations that such tolerance occurs in
animals, in part because most studies have used short duration, high
dosing schedules rather than chronic high dosing required for
tolerance to be demonstrated. Given the large number of cannabinoid
effects to which tolerance has been shown to develop, it would not be
surprising if this were also true of its immunological effects. 

The very limited human evidence from experimental studies of immune
function is mixed, with a small number of studies suggesting
immunosuppressant effects that have not been replicated by others. As
Munson and Fehr (1983) concluded: &quot;At present, there is no conclusive
evidence that consumption of cannabinoids predisposes man to immune
dysfunction&quot; (p338), as measured by reduced numbers or impaired
functioning of T-lymphocytes, B-lymphocytes or macrophages, or reduced
immunoglobulin levels. There was &quot;suggestive evidence&quot; of impaired
T-lymphocyte functioning reflected in an impaired reaction to mitogens
and allogenic lymphocytes (Munson and Fehr, 1983). More recently,
Wallace et al (1988, 1993 in press) have failed to find any impairment
of lymphocyte function in alveolar macrophages in marijuana smokers,
although they did find such impairment in tobacco smokers.

The clinical significance of these possible immunological impairments
in chronic cannabis users is uncertain. There have been sporadic
reports of ill health, including decreased resistance to disease,
among chronic heavy cannabis users in Asia and Africa (Munson and
Fehr, 1983). These reports are difficult to evaluate because of the
confounding effects of poor living conditions and nutritional status,
although it may be that the small human immunological impairment
predicted from the animal literature is most likely to be seen among
such populations (Munson and Fehr, 1983).

Three field studies of the effects of chronic cannabis use in Costa
Rica (Carter et al, 1980), Greece (Stefanis et al, 1977), and Jamaica
(Rubin and Costas, 1975), have failed to demonstrate any evidence of
increased susceptibility to infectious diseases among chronic cannabis
users. However, these negative findings are not very convincing. Less
than 100 users were studied overall, which is too small a sample in
which to detect a small increase in the incidence of common infectious
and bacterial diseases. While it is difficult to detect a small
increase in the incidence of infections in an individual or among a
small sample of people, such an increase may have great public health
significance. The type of large-scale epidemiological studies that are
needed to explore this issue have not been conducted until very
recently. 

A recent study by Polen et al (1993) compared health service
utilisation by non-smokers and daily cannabis only smokers enrolled in
a health maintenance organisation. Their results provided the first
suggestive evidence of an increased rate of presentation for
respiratory conditions among cannabis-only smokers, although its
significance remains uncertain because infectious and non-infectious
respiratory conditions were aggregated. Nevertheless, further studies
of this type may enable a more informed decision to be made about the
seriousness of the risk that chronic heavy cannabis smoking poses to
the immune and respiratory systems. 

Hollister (1992) has expressed a sceptical attitude towards the human
health implications of the literature on the immunological effects of
cannabis, arguing that: 

... Clinically, one might assume that sustained impairment of
cell-mediated immunity might lead to an increased prevalence of
malignancy. No such clinical evidence has been discovered or has any
direct epidemiological data incriminated marijuana use with the
acquisition of human immunodeficiency virus or the clinical
development of AIDS. (p161)

Given the duration of large-scale cannabis use by young adults in
Western societies, the absence of an epidemic of infectious disease is
arguably sufficient to rule out the hypothesis that cannabis smoking
produces major impairments in the immune systems of users comparable
to those caused by AIDS. The absence of such epidemics among cannabis
users does not, however, exclude the possibility that chronic heavy
use may produce minor impairments in immunity, since this would
produce small increases in the rate of occurrence of common bacterial
and viral illnesses (Munson and Fehr, 1983) that would have escaped
the notice of clinical observers. Such an increase could nonetheless
be of public health significance because of the increased expenditure
on health services, and the loss of productivity among the young
adults who are the heaviest users of cannabis. 

Clinical studies of patients with immune systems compromised by AIDS
may provide one of the best ways of detecting any adverse
immunological effects of cannabinoids. AIDS patients and gay advocacy
groups have proposed that cannabinoids should be used therapeutically
to improve appetite and well-being in AIDS patients (see below p195).
If it was ethical to conduct trials of the therapeutic use of
cannabinoids in AIDS patients, then monitoring the impact on immune
functioning would provide one way of evaluating the seriousness of the
immunological effects of cannabinoids, not only for AIDS patients, but
also for other immunologically compromised patients using cannabinoids
for therapeutic purposes. If there were no effects in patients with
compromised immune systems, it would also be a reasonable to infer
that there was little risk of immunological effects in long-term
recreational users. 

An epidemiological study of predictors of progression to AIDS among
HIV positive homosexual men suggests that the risks may be
sufficiently small in the case of HIV positive patients to warrant
further research. Kaslow et al (1989) conducted a prospective study of
progression to AIDS among HIV positive men in a cohort of 4,954
homosexual and bisexual men. Among the predictor variables studied
were licit and illicit drug use, including cannabis use. Illicit drug
use predicted an increased risk of infection with HIV, as has been
consistently found in studies of risk factors for HIV infection.
However, neither cannabis use, nor any other psychoactive drug use,
predicted an increased rate of progression to AIDS among men who were
HIV positive. Nor was cannabis use related to changes in a limited
number of measures of immunological functioning. 



6.2.7 Conclusions

There is reasonable evidence that cannabis smoke is mutagenic, and
hence, potentially carcinogenic, because of the many mutagenic and
carcinogenic substances it shares with tobacco smoke. THC is at most
weakly mutagenic. This suggests that the major cancer risk from
cannabis use is the development of cancers of the respiratory tract
arising from smoking as a route of administration, rather than from
the mutagenicity of the psychoactive components of cannabis.

There is reasonably consistent animal evidence that THC can impair
both the cell-mediated and humoral immune systems, producing decreased
resistance to infection by bacteria and viruses. The relevance of
these findings to human health is uncertain: the doses required to
produce these effects are often very high, and the problem of
extrapolating from the effects of these doses to those used by humans
is complicated by the possibility that tolerance develops to the
effects on the immune system.

The limited experimental evidence on immune effects in humans is
conflicting, with the small number of studies producing adverse
effects not being replicated. Even studies that have produced evidence
of adverse effects observe small changes that are still within the
normal range. The clinical and biological significance of even the
small positive effects in chronic cannabis users is uncertain. There
has not been any evidence of increased rates of disease among chronic
heavy cannabis users analogous to that seen among homosexual men in
the early 1980s. Given the duration of large-scale cannabis use by
young adults in Western societies, the absence of such epidemics makes
it unlikely that cannabis smoking produces major impairments in the
immune system. 

It is more difficult to exclude the possibility that chronic heavy
cannabis use produces minor impairments in immunity. Such effects
would produce small increases in the rates of infectious diseases of
public health significance, because of the increased expenditure on
health services, and the loss of productivity among the young adults
who are the heaviest users. There is one large prospective study of
HIV-positive homosexual men which indicates that continued cannabis
use did not increase the risk of progression to AIDS (Kaslow et al,
1989). A recent epidemiological study by Polen et al (1993) which
compared health service utilisation by non-smokers and daily
cannabis-only smokers provided the first suggestive evidence of an
increased rate of medical care utilisation for respiratory conditions
among cannabis smokers. This remains suggestive, however, because
infectious and non-infectious respiratory conditions were not
distinguished. The most sensitive assay of any small immunological
effects of cannabis may come from studies of the therapeutic
usefulness of cannabinoids in immunologically compromised patients,
such as those undergoing cancer chemotherapy, or those with AIDS. 



6.3 Cardiovascular effects 

Both the inhalation of marijuana smoke and the ingestion of THC
reliably produces an increase in heart rate of 20 per cent to 50 per
cent over baseline (Huber et al, 1988; Jones, 1984). When cannabis is
smoked, the heart rate increases within two to three minutes, peaks
within 15 to 30 minutes, and may remain elevated for up to two hours.
When ingested, these effects are delayed for several hours, and last
for four to five hours (Maykut, 1984). There are also complex changes
in blood pressure which depend upon posture: blood pressure is
increased while the person is sitting or lying, but decreases on
standing, so that a sudden change from a recumbent to an upright
position may produce postural hypotension and, in extreme cases,
fainting (Maykut, 1984). 

Young, healthy hearts are likely to be only mildly stressed by these
acute effects of cannabis (Tennant, 1983). The clinical significance
of the repeated occurrence of these effects in chronic heavy cannabis
users remains uncertain, because there is evidence from clinical and
experimental studies (Benowitz and Jones, 1975; Jones and Benowitz,
1976; Nowlan and Cohen, 1977) that tolerance develops to the acute
cardiovascular effects of cannabis. Clinical studies employing chronic
dosing over periods of up to nine weeks show that the increased heart
rate all but disappears, while the blood pressure increase is much
attenuated. Tolerance to the cardiovascular effects develops within
seven to 10 days in persons receiving high daily doses by the oral
route (Jones, 1984). 

The field studies of chronic heavy users in Costa Rica (Carter et al,
1980), Greece (Stefanis et al, 1977), and Jamaica (Rubin and Costas,
1975) failed to disclose any evidence of cardiac toxicity, even in
those subjects with heart disease that was unrelated to their cannabis
use. The findings of the field studies have been supported by the fact
that electrocardiographic studies in conditions of both acute and
prolonged administration have rarely revealed pathological changes
(Benowitz and Jones, 1975; Jones, 1984). It seems reasonable to
conclude then that among healthy young adults who use cannabis
intermittently, cannabis use is not a major risk factor for
life-threatening cardiovascular events in the way that the use of
cocaine and other psychostimulants can be (Gawin and Ellinwood, 1988).
There is suggestive evidence of a small risk, however, since there
have been a number of case reports of myocardial infarction in young
men who were heavy cannabis smokers and had no personal history of
heart disease (Tennant, 1983; Choi and Pearl, 1989; Pearl and Choi,
1992; Podczeck et al, 1990). Such cases deserve close investigation to
exclude the role of other cardiotoxic drugs.

The possibility remains that chronic heavy cannabis smoking may have
more subtle effects on the cardiovascular system. Jones (1984) has
suggested, for example, that there is a possibility that &quot;after years
of repeated exposure&quot; there may be &quot;lasting, perhaps even permanent,
alterations of the cardiovascular system function&quot; (p331). Arguing by
analogy with the long-term cardiotoxic effects of tobacco smoking, he
suggests that there are &quot;enough similarities between THC and nicotine
cardiovascular effects to make the possibility plausible&quot; (p331).
Moreover, since many cannabis smokers are also cigarette smokers,
there is the possibility that there may be adverse interactions
between nicotine and cannabinoids in their effects on the
cardiovascular system. 



6.3.1 Effects on patients with cardiovascular disease

The cardiovascular effects of cannabis may adversely affect patients
with pre-existing cardiovascular disease. As the Institute of Medicine
observed: 

the possibility is great that the abnormal heart and circulation will
not be as tolerant of an agent that speeds up the heart, sometimes
unpredictably raises or drops blood pressure, and modifies the
activities of the autonomic nervous system (pp69-70). 

There are a number of concerns about the potentially deleterious
effects of cannabis use on patients with ischaemic heart disease,
hypertension, and cerebrovascular disease (Jones, 1984; National
Academy of Science, 1982). First, THC appears to increase the
production of catecholamines which stimulate the activity of the
heart, thereby increasing the risk of cardiac arrhythmias in
susceptible patients. Second, THC increases heart rate, thereby
producing chest pain (angina pectoris) in patients with ischaemic
heart disease, and perhaps increasing the risk of a myocardial
infarction. Third, THC also has analgesic properties (see below p194)
which may attenuate chest pain, delaying treatment seeking, and
thereby perhaps increasing the risk of fatal arrhythmias. Fourth,
marijuana smoking increases the level of carboxyhaemoglobin, thereby
decreasing oxygen delivery to the heart, increasing the work of the
heart and, perhaps, the risk of atheroma formation. Moreover, the
reduced delivery of oxygen to the heart is compounded by a concomitant
increase in the work of the heart - and therefore its oxygen
requirements - because of the tachycardia induced by THC. Fifth,
patients with cerebrovascular disease may be put at risk of
experiencing strokes by unpredictable changes in blood pressure, and
patients with hypertension may experience exacerbations of their
disease for the same reason.

After considering the known cardiovascular effects of THC, and their
likely interactions with cardiovascular disease, the Institute of
Medicine (1982) concluded that it: &quot; ... seems inescapable that this
increased work, coupled with stimulation by catecholamines, may tax
the heart to the point of clinical hazard&quot; (p70). Despite the
plausibility of the reasoning, there is very little direct evidence of
the adverse effects of cannabis on persons with heart disease (Jones,
1984). Among the few relevant pieces of research evidence are two
laboratory studies of the acute cardiovascular effects of smoking
marijuana cigarettes on patients with occlusive heart disease. Aronow
and Cassidy (1974) conducted a double blind placebo control study
comparing the effect on heart rate and the time required to induce
chest pain during an exercise tolerance test, of smoking a single
marijuana cigarette containing 20mg of THC, with the effect of a
placebo marijuana cigarette. Heart rate increased by 43 per cent, and
the time taken to produce chest pain was approximately halved, after
smoking a marijuana cigarette. It appeared that cannabis increased the
myocardial oxygen demand while reducing the amount of oxygen delivered
to the heart (Aronow and Cassidy, 1974). 

Aronow and Cassidy (1975) compared the effects of smoking a single
marijuana cigarette and a high nicotine cigarette in 10 men with
occlusive heart disease, all of whom were 20 a day cigarette smokers.
A 42 per cent increase in heart rate was observed after smoking the
marijuana cigarette compared with a 21 per cent increase after smoking
the tobacco cigarette. Exercise tolerance time was halved (49 per
cent) after smoking a marijuana cigarette by comparison with a 23 per
cent decline after smoking a tobacco cigarette. 

Apart from these studies, there is very little direct evidence on the
risks of cannabis use by persons with cardiovascular disease. The
reasons for the absence of adverse effects of chronic cannabis use on
diseased cardiovascular systems are unclear. It should not be assumed
in the absence of evidence, however, that such effects do not exist.
The absence of evidence may simply reflect the lack of systematic
study. It may be that the development of tolerance to the
cardiovascular effects with chronic heavy dosing has protected the
heaviest users from experiencing such effects: it may be that there
has been an insufficient exposure to cannabis smoking of a
sufficiently large number of vulnerable individuals (National Academy
of Science, 1982); or it may be that cardiologists have missed any
such evidence because they have not inquired about cannabis use among
their patients.

On the face of it, the possibility of cannabis smokers developing
heart disease may seem &quot;theoretical&quot;. Most cannabis users are healthy
young adults who smoke intermittently, most discontinue their use by
their late 20s, and very few of the minority who become heavy cannabis
users are likely to have clinical occlusive heart disease or other
atherosclerotic disease. But the possibility of such adverse effects
is not entirely theoretical. 

First, any such effects would contraindicate the therapeutic uses of
cannabinoids among older patients, such as those with cancer and
glaucoma, who are at higher risk, because they are older, of having
significant heart disease (Jones, 1984). 

Second, the chronic heavy cannabis users who were inducted into
cannabis use in the late 1960s and early 1970s are now entering the
period in which that minority who have continued to smoke cannabis are
at risk of experiencing symptoms of clinical heart disease. Among this
group cannabis use may contribute to an earlier expression of heart
disease, especially, if they have also been heavy cigarette smokers.
Because of the high rates of cessation of cannabis use with age,
however, this may be such a small number of persons that the effect is
difficult to detect clinically, especially if cannabis use is not
considered to be a risk factor about which cardiologists
systematically inquire. It may be worth exploring this possibility by
including questions on cannabis use in case-control studies of
cardiovascular disease among middle-aged adults.



6.3.2 Conclusions 

On the available evidence, it is still appropriate to endorse the
conclusions reached by the expert committee appointed by the National
Academy of Science in 1982 that, although the smoking of marijuana
&quot;causes changes to the heart and circulation that are characteristic
of stress ... there is no evidence ... that it exerts a permanently
deleterious effect on the normal cardiovascular system...&quot; (p72). The
situation may be less benign for those with &quot;abnormal heart or
circulation&quot; since there is evidence that marijuana poses &quot;a threat to
patients with hypertension, cerebrovascular disease and coronary
atherosclerosis&quot; (p72) by increasing the work of the heart. The
&quot;magnitude and incidence&quot; of the threat remains to be determined as
the cohort of chronic cannabis users of the late 1960s enters the age
of maximum risk for complications of atherosclerosis of the cardiac,
brain and peripheral vessels. In the interim, because any such effects
could be life threatening in patients with significant occlusion of
the coronary arteries or other cerebrovascular disease, such persons
should be advised not to smoke cannabis (Tennant, 1983).



6.4 Effects on the respiratory system 

The most reliable acute effect of exposure to cannabis smoke is
bronchodilation (National Academy of Science, 1982), which has
principally been of interest because of its possible therapeutic
effect upon asthma (see below pp193-194). Other than bronchodilation,
it has proved difficult to demonstrate any effects of acute cannabis
smoking on breathing &quot;as measured by conventional pulmonary tests&quot;
(National Academy of Science, 1982, p58). 

The major concerns about the respiratory effects of cannabis use have
been the possible adverse effects of chronic, heavy cannabis smoking
(Tashkin, 1993). The two largest issues of concern have been the
production of chronic bronchitis as a precursor of irreversible
obstructive lung disease, and the possible causation of cancers of the
aerodigestive tract (including the lungs, mouth, pharynx, larynx, and
trachea) after 20 to 30 years of regular cannabis smoking. These risks
are the primary focus of this section of the review.

There is good reason to expect that chronic heavy cannabis smoking may
have adverse effects upon the respiratory system (Tashkin, 1993).
Cannabis smoke is similar in constitution to tobacco smoke, and
contains a substantially higher proportion of particulate matter and
of some carcinogens (e.g. benzpyrene) than does tobacco smoke
(Leuchtenberger, 1983; National Academy of Science, 1982). Hence, the
inhalation of cannabis smoke deposits irritating and potentially
carcinogenic particulate matter onto lung surfaces. Cigarette smoking
is known to cause diseases of the respiratory system, such as
bronchitis, emphysema, and various forms of cancer affecting the lung,
oral cavity, trachea, and oesophagus (Holman et al, 1988). Although
tobacco smokers smoke many more cigarettes than cannabis smokers,
cannabis smoke is typically inhaled more deeply, and the breath held
for longer, than tobacco smoke, thereby permitting greater deposition
of particulate matter on the lung surface (Hollister, 1986). It
therefore seems a reasonable inference that chronic daily cannabis
smoking may cause diseases of the respiratory system.

Despite the reasonableness of this hypothesis, it has nonetheless been
difficult to investigate the contribution of chronic heavy cannabis
smoking to diseases of the respiratory system (Huber et al, 1988;
National Academy of Science, 1982). A major problem is that most
marijuana smokers also smoke tobacco, which makes it difficult to
disentangle the effects of cannabis from those of tobacco smoking. The
problems in quantifying current and lifetime exposure to cannabis,
because of variations in quality and potency, make it difficult to
examine dose-response relationships between cannabis use and the risk
of developing various respiratory diseases. There is also likely to be
a long latency period between exposure and the development of these
diseases, especially in the case of cancers of the aerodigestive
tract. This period is approximately the length of time since cannabis
smoking became widespread in Western societies. There are also
technical difficulties in designing studies which are sufficiently
sensitive to detect increased risks of diseases arising from
relatively rare exposures, such as chronic daily cannabis use.



6.4.1 Bronchitis and airways obstruction

There is a small clinical literature containing case reports of acute
lung diseases among heavy cannabis smokers in the US military
stationed in West Germany during the early 1970s, when hashish was
cheap and freely available (Henderson et al, 1972; Tennant et al,
1971). Tennant et al studied 31 soldiers who had smoked 100g or more
of hashish monthly for six to 21 months, 21 of whom were also tobacco
smokers. Nine complained of bronchitis which had its onset three to
four months after they began to smoke hashish. Pulmonary function
tests of five cases (two of whom did not smoke tobacco) revealed mild
airflow obstruction that partially remitted after a reduction or
cessation of hashish use. Tennant (1980) also reported
histopathological studies of 23 of these patients in which all
patients were found to have atypical cells of the type (squamous
metaplasia in 21 cases) associated with chronic bronchitis and
carcinoma of the lung.

Henderson et al (1972) reported on 200 servicemen who sought treatment
for problems related to hashish use, 90 per cent of whom were also
cigarette smokers. Twenty men who smoked large doses of hashish on a
weekly basis presented with symptoms of chronic bronchitis, and on
testing had vital capacity that was 15-40 per cent below normal. Six
had a bronchoscopic examination which showed epithelial abnormalities.
The interpretation of these findings was complicated by the fact that
the majority of these hashish smokers were also tobacco smokers, as
were Tennant et al's subjects, and there was no adequate comparison
group. 

The field studies of chronic cannabis smokers in Costa Rica (Carter et
al, 1980) and Jamaica (Rubin and Comitas, 1975), which included
comparison groups, have failed to support the clinical findings of
Henderson et al, and Tennant et al. Neither of these studies found any
statistically significant differences in lung function, or in the
prevalence of respiratory symptoms, between chronic cannabis users and
non-cannabis smoking controls. In both studies, however, the measures
of respiratory function were relatively unsophisticated, the sample
sizes were small, making it difficult to detect all but very large
differences, and the comparisons were often confounded by a failure to
control for tobacco smoking. 

The most convincing evidence that chronic cannabis use may be a
contributory cause of impaired lung function and symptoms of
respiratory disease comes from a series of controlled studies which
have been conducted by Tashkin and his colleagues since the mid-1970s.
One of their early studies evaluated the subacute effects of heavy
daily marijuana smoking on respiratory function. The subjects were
young male marijuana smokers who were studied in a closed hospital
ward where they were allowed ad libitum access to marijuana for 47 to
59 days. The results of lung function tests showed a statistically
significant decrease in the function of large and medium-sized airways
over the course of the study. The degree of impairment was positively
correlated with the number of marijuana cigarettes smoked, suggesting
that the quantity of inhaled irritants was the important factor,
perhaps by producing an inflammatory reaction in the tracheobronchial
epithelium. Although the impairment was apparently small and values
were still within the normal range, these changes were of clinical
significance. If continued over a year, for example, the rate of
decline in lung function would be several times greater than the
normal rate.

Tashkin and his colleagues (1987) subsequently recruited a volunteer
sample of marijuana only smokers (MS, n=144), marijuana and tobacco
smokers (MTS, n=135), tobacco only smokers (TS, n=70), and non-smoking
controls (NS, n=97). A subset of these subjects were followed to
examine changes in lung function, signs and symptoms of respiratory
disease, and the occurrence of histopathological changes that may
precede the development of carcinoma. 

In the baseline observations of their cohort, Tashkin et al (1987)
found significant differences in the prevalence of symptoms of
bronchitis (such as cough, bronchitic sputum production, wheeze and
shortness of breath) between all types of smokers (MS, MTS, TS) and
controls. There were no differences between cannabis and tobacco
smokers in the prevalence of these symptoms. Lung function tests
showed significantly poorer functioning and significantly greater
abnormalities in small airways among tobacco smokers (regardless of
concomitant cannabis use) while marijuana smokers showed poorer large
airways functioning than non-marijuana smokers (regardless of
concomitant tobacco use). These findings suggest that &quot;habitual
smoking of marijuana or tobacco causes functional alterations at
different sites in the respiratory tract, with marijuana affecting
mainly the large airways and tobacco predominantly the peripheral
airways and alveolated regions of the lung&quot; (Tashkin et al, 1990,
p67).

Follow-up studies of a subsample of this cohort have broadly supported
the results of the cross-sectional baseline study, while providing
more detail on some differences between marijuana and tobacco smoking
in their effects on lung function (Tashkin et al, 1990). The first
follow-up study was conducted two to three years after the baseline
study. Approximately half of these subjects were retested and most
remained in the same smoking categories as at baseline, namely, 40 of
the 54 MTS, 60 of the 71 MS, 30 of the 32 TS, and 56 of 58 NS,
respectively of those who were followed up. 

The prevalence of bronchitic symptoms of cough, sputum, and wheeze was
higher in all smoking groups than among non-smokers at both time one
and time two, and there was no significant change in the respiratory
status of any of the smoking groups from time one to time two when
those individuals who ceased smoking were excluded. Substantially the
same results were obtained when the subjects were followed up three to
four years after initial assessment. In addition, there was evidence
of an additive adverse effect of marijuana and cigarette smoking, in
that the MTS group showed effects of both types of damage attributable
to marijuana and tobacco smoking alone.

Tashkin and his colleagues (Fligiel et al, 1988; Gong et al, 1987)
undertook histopathological studies of the lungs of a subsample of
their cohort. Fligiel et al (1988) compared the bronchial morphology
of males aged 25 to 49 years who were heavy smokers of marijuana only
(n=30), marijuana and tobacco (n=17), tobacco only (n=15) and
non-smoking controls (n=11). Bronchial biopsies were examined by
pathologists who were &quot;blind&quot; as to their smoking status, and analyses
were made of cellular inflammation. All subjects who smoked (whether
cannabis, tobacco or both) showed more prevalent and severe
histopathological abnormalities than non-smokers. Many of these
abnormalities were more prevalent in marijuana smokers, and they were
most marked in those who smoked both marijuana and tobacco. 

These findings were especially striking because they were observed in
young adults who did not have respiratory symptoms, and they occurred
at a younger age on average in marijuana than tobacco smokers, despite
the fact that the marijuana smokers smoked less than a quarter as many
&quot;joints&quot; as the tobacco smokers smoked cigarettes. Fliegel et al
concluded that &quot;marijuana smoking may be as damaging or perhaps even
more damaging to the respiratory epithelium than smoking of tobacco&quot;
(p46), and there was &quot;a very good possibility ... that marijuana
smoking combined with smoking of tobacco, leads to a more significant
mucosal alteration than either of these substances smoked alone&quot;
(p47). 

Evidence of inflammation was sought by examining the presence of
alveolar macrophages, lymphocytes, neutrophils and eosinophils in the
bronchial lavage of the same subjects. This examination revealed that
marijuana and tobacco smoking induced an inflammatory cellular
response in the alveoli, and that the combination of marijuana and
tobacco smoking produced the largest inflammatory response, &quot;implying
an adverse effect of marijuana smoking on the lung that is independent
of and additive to that of tobacco&quot; (Tashkin et al, 1990, p74).

Additional research by Tashkin and his colleagues (Tashkin et al,
1988; Wu et al, 1988) suggests that the most likely explanations of
the apparently greater toxicity of marijuana smoking are major
differences in the topography of marijuana and tobacco smoking.
Laboratory studies of the volume of inhaled smoke from tobacco and
marijuana, and analyses of its particulate content, indicated that
marijuana smokers inhaled a larger volume of smoke (40-54 per cent
more), inhaled more deeply, took in more particulate matter per puff,
and held their breath about four to five times longer, thereby
retaining more particulate matter, and absorbing three times more
carbon monoxide, than cigarette smokers (Wu et al, 1988).

Bloom et al (1987) have recently reported findings that broadly
confirm those of Tashkin and his colleagues. Bloom et al conducted a
cross-sectional study in a general population of the relationship
between smoking &quot;non-tobacco&quot; cigarettes and respiratory symptoms and
respiratory function. Their study sample was a community sample of 990
individuals aged under 40 years who were being followed as part of a
prospective community study of obstructive airways disease. Subjects
were asked about symptoms of cough, phlegm, wheeze and shortness of
breath, and they were also measured on a number of indicators of
respiratory function, including forced expiratory volume and forced
vital capacity.

The prevalence of ever having smoked a &quot;non-tobacco&quot; cigarette was 14
per cent (the same as the prevalence of marijuana smoking in general
population surveys), with 9 per cent being current smokers and 5 per
cent ex-smokers. Non-tobacco smokers were younger and more likely to
be male than non-smokers of non-tobacco. The mean frequency of current
non-tobacco smoking was seven times per week, and the average duration
of use was nine years. Non-tobacco smokers were more likely than
non-tobacco non-smokers to have smoked tobacco, and more likely to
inhale deeply than tobacco smokers.

Non-tobacco smoking was related to the prevalence of the self-reported
respiratory symptoms of cough, phlegm, and wheeze, regardless of
whether the person smoked tobacco or not. There were also mean
differences in forced expiratory volume and forced vital capacity,
with those who had never smoked having the best functioning, followed
in decreasing order of function by current cigarette smokers, current
non-tobacco smokers, and current smokers of both tobacco and
non-tobacco cigarettes. Non-tobacco smoking alone had a larger effect
on all flow indices than tobacco smoking alone, and the effect of both
types of smoking was additive.

Although there were some inconsistencies between the studies of
Tashkin and colleagues and those of Bloom and colleagues, there is
reasonable coherence in the available evidence on the respiratory
effects of cannabis use. Taken as a whole, it suggests that chronic
cannabis smoking increases the prevalence of bronchitic symptoms,
reduces respiratory function, and in very heavy smokers produces
histopathological changes that may portend the subsequent development
of bronchogenic carcinoma, a well known consequence of heavy tobacco
smoking. Although, &quot;there is still no conclusive evidence in man of
clinically important pulmonary dysfunction produced by smoking
marihuana&quot; (Huber et al, 1988; p8), it is nonetheless a reasonable
inference that chronic heavy cannabis smoking probably increases the
risk of developing respiratory tract cancer, and possibly influences
the development of irreversible obstructive pulmonary disease. Persons
who wish to reduce their risks of developing these diseases would be
wise to desist from cannabis smoking (Tashkin, 1993). 



6.4.2 Cancers of the aerodigestive tract 

Although &quot;not a single case of bronchogenic carcinoma in man has been
directly attributable to marijuana&quot; (Tashkin, 1988), it would be
unwise to infer from the absence of such cases that there is no such
an effect (Huber et al, 1988; National Academy of Science, 1982).
There is a 20 to 30-year latency period between the initiation of
regular smoking and the development of cancer, and cannabis smoking
only became widespread in Western societies in the early 1970s
(National Academy of Science, 1982). There has also been a lack of
clinical and epidemiological research on this question. Patients with
lung or of other types of cancer, for example, have rarely been asked
about their cannabis use as part of the clinical history-taking. No
cohort or case-control studies of cancers among cannabis smokers have
been reported, because the illegality of cannabis has made it
difficult to obtain reliable information on habits of the large
samples required, while the proportion of cannabis users who become
long-term heavy users is likely to be small (Huber et al, 1988). 

Despite the absence of such evidence, there are good reasons for
suspecting that cannabis may contribute to the development of lung
cancer and cancers of the aerodigestive tract (the oropharynx, nasal
and sinus epithelium, and the larynx). A major reason is the
similarity between the constituents of cannabis and tobacco smoke, an
accepted cause of cancers in these organs (Doll and Peto, 1980;
International Agency for Research on Cancer, 1990). The major
qualitative differences between tobacco and cannabis smoke are the
presence of cannabinoids in cannabis smoke and of nicotine in tobacco.
There are also some quantitative differences in the amount of various
carcinogens with cannabis smoke typically containing higher levels
than tobacco smoke (Leuchtenberger, 1983; National Academy of Science,
1982). 

The work of Fligiel et al (1988) has indicated that histopathological
changes of the type that are believed to be precursors of carcinoma
can be observed in the lung tissue of chronic marijuana smokers. These
results confirmed the earlier finding of Tennant (1980), who performed
bronchoscopies on 30 US servicemen stationed in Europe who had smoked
large quantities of hashish and experienced symptoms of bronchitis. He
found that 23 of these who also smoked tobacco had one or more
pathological changes &quot;identical to those associated with the later
development of carcinoma of the lung when it occurs in tobacco
smokers&quot; (Tennant, 1983, p78).

The results of these clinical and laboratory studies have recently
received suggestive support from case reports of cancers of the upper
aerodigestive tract in young adults who have been chronic cannabis
smokers. Donald (1991a, b) reported 13 cases of advanced head and neck
cancer occurring in young adults under 40 years of age among 3,000 of
his cancer patients. Their average age was 26 years (range 19-38
years), compared with an average age of 65 years among his other
patients. Eleven of the 13 had been daily cannabis smokers.
Interpretation is complicated by the fact that at least five of these
patients also smoked tobacco, and at least three were heavy alcohol
consumers, both known risk factors for cancers of the upper
aerodigestive tract (Holman et al, 1988; Vokes et al, 1993). Donald
acknowledged these facts, but emphasised that half of his cases
neither smoked tobacco nor consumed alcohol. Moreover, he argued, the
implication of marijuana as a cause of cancers of the upper
aerodigestive tract was strengthened by the observation that such
cancers are rare under the age of 40 years, even among tobacco smokers
who consume alcohol.

Similar findings have been reported by Taylor (1988) in a
retrospective analysis of cases of upper respiratory tract cancer
occurring in adults under the age of 40 years over a four-year period.
Because the medical records did not routinely report the patients' use
of cannabis, Taylor asked the attending clinicians to make judgments
about their patients' cannabis and other drug use. He found 10 cases
among the 887 cases of cancer that were treated over the study period.
They consisted of six males and four females with an average age of
33.5 years. Nine were cases of squamous cell carcinomas (of the
tongue, the larynx, and the lung). Five cases had a documented history
of heavy cannabis smoking, two patients were described as &quot;regular&quot;
cannabis users, one was classified as a &quot;possible&quot; cannabis user
because he was known to abuse other drugs, and two were judged not to
be cannabis users. As with Donald's case series, interpretation was
complicated by the fact that six out of 10 were heavy alcohol
consumers, and six were cigarette smokers (four out of the five heavy
cannabis users in each case). 

Taylor argued &quot;that the regular use of marijuana is a potent etiologic
factor, particularly in the presence of other risk factors, in
hastening the development of respiratory tract carcinomas&quot; (p1216).
While he allowed that alcohol and tobacco use may have contributed to
the development of these cancer, he discounted their importance,
arguing like Donald, that the patients were well under 40 years of
age, while the peak incidence of such cancers in drinkers and smokers
is in the seventh decade of life. 

Other investigators (e.g. Caplan and Brigham, 1989; Endicott and
Skipper, 1991, cited by Nahas and Latour, 1992) have also reported
cases of upper respiratory tract cancers in young adults with
histories of heavy cannabis use. Caplan and Brigham's (1989) report of
two cases of squamous cell carcinoma of the tongue in men aged 37 and
52 years was especially noteworthy because neither of their cases
smoked tobacco or consumed alcohol; a history of long-term daily
cannabis use was their only shared risk factor. 

These case reports provide limited support for the hypothesis that
cannabis use is a cause of upper respiratory tract cancers. They did
not compare the prevalence of cannabis use in cases with that in a
control sample, and cannabis exposure was not assessed in a
standardised way or in ignorance of the case or control status, all of
which are standard controls to minimise bias in case-control studies
of cancer aetiology. Nonetheless, there is a worrying consistency
about the reports that should be addressed by case-control studies
which compare the proportions of cannabis smokers among patients with
cancers of the upper aerodigestive tract and appropriate controls
(National Academy of Science, 1982). Now may be the time to conduct
such studies, since chronic cannabis smokers who began their use in
early 1970s are now entering the period of risk for such cancers. If
carcinomatous changes occur earlier in heavy cannabis smokers, it may
be better to restrict attention to early onset cases (e.g. cases
occurring in individuals under 50 years of age). Information on
cannabis use should also be obtained prospectively in newly diagnosed
cases, because of the problems with retrospective assessment of
cannabis and other drug use from either clinical records or the
relatives of those who have died.



6.4.3 Conclusions

Chronic heavy cannabis smoking probably causes chronic bronchitis, and
impairs functioning of the large airways. Given the documented adverse
effects of cigarette smoking, it is likely that chronic cannabis use
predisposes individuals to develop irreversible obstructive lung
diseases. There is suggestive evidence that chronic cannabis smoking
produces histopathogical changes in lung tissues that are precursors
of lung cancer. Case studies raise a strong suspicion that cannabis
may cause cancers of the aerodigestive tract. The conduct of
case-control studies of these cancers is a high priority for research
into the possible adverse health effects of chronic cannabis smoking. 



6.5 Reproductive effects of cannabis 

In the mid-1970s there seemed to be good reason to suspect that
cannabis use had adverse effects on the human reproductive system.
There was some animal experimentation which suggested that cannabis
adversely affected the secretion of gonadal hormones in both sexes,
and the foetal development of animals administered crude marijuana
extract or THC during pregnancy (Bloch, 1983; Institute of Medicine,
1982; Nahas, 1984; Nahas and Frick, 1987; Wenger et al, 1992).
Cannabis was being widely used by adolescents who were undergoing
sexual maturation, and by young adults who were entering the peak age
for reproduction (Linn et al, 1983). The suspicion that cannabinoids
had adverse effects on the human reproductive system was first raised
by case reports of breast development (gynecomastia) in young men aged
23 to 26 years of age, all of whom had a history of heavy cannabis use
(Harman and Aliapoulios, 1972). The suspicion seemed confirmed by
human observations published shortly after by Kolodny et al (1974),
who reported that males who were chronic cannabis users had reduced
plasma testosterone, reduced sperm count and motility, and an
increased prevalence of abnormal sperm. 

In the light of these observations, the widespread use of cannabis
among young adults which began in the early 1970s and continued well
into the mid-1980s raised understandable fears that fertility would be
impaired in men, and the rates of unfavourable pregnancy outcomes
would increase among women using cannabis during in their reproductive
years. These outcomes could possibly include greater foetal loss,
lower birth weight, and an increased risk of birth defects and
perinatal deaths. Later, concerns were also raised about the
possibility of adverse effects upon the subsequent behavioural
development and health of children exposed to marijuana in utero.
Evidence relevant to each of these concerns will be reviewed in this
section.



6.5.1 Effects on the male reproductive system

In animals, marijuana, crude marijuana extracts, THC and certain other
purified cannabinoids have been shown to &quot;depress the functioning of
the male reproductive endocrine system&quot; (Bloch, 1983, p355). If used
chronically, cannabis reduces plasma testosterone levels, retards
sperm maturation, reducing the sperm count and sperm motility, and
increasing the rate of abnormal sperm (Bloch, 1983, National Academy
of Science, 1982; Wenger et al, 1992). Although the mechanisms by
which cannabis produces these effects are uncertain, it is likely that
they occur both directly as a result of action of THC on the testis,
and indirectly via effects on the hypothalamic secretion of the
hormones that stimulate the testis to produce testosterone (Wenger et
al, 1992).

The small number of human studies on the effects of cannabis on male
reproductive function have produced mixed results. The findings of the
early study by Kolodny et al (1974) which reported reduced
testosterone, sperm production, and sperm motility and increased
abnormalities in sperm were contradicted shortly thereafter by the
results of a larger, well controlled study of chronic heavy users,
which failed to find any difference in plasma testosterone at study
entry, or after three weeks of heavy daily cannabis use (Mendelson et
al, 1974). Other studies have produced both positive and negative
evidence of an effect of cannabinoids on testosterone, for reasons
that are not well understood (Institute of Medicine, 1982). Hollister
(1986) has conjectured that reductions in testosterone and
spermatogenesis probably require long-term exposure. Even if there are
such effects of cannabis on male reproductive functioning, their
clinical significance in humans is uncertain (Institute of Medicine,
1982) since testosterone levels in the studies which have found
effects have generally remained within the normal range (Hollister,
1986). 

The putative relationship between cannabis use and gynecomastia now
seems very doubtful. The magnitude of reductions observed in the
positive studies are too small to explain the case reports of
gynecomastia among heavy male cannabis smokers (Harman and
Aliapoulios, 1972), and a small case-control study failed to find any
relationship between cannabis use and gynecomastia in 11 cases and
controls (Cates and Pope, 1977). Altho

6. The chronic effects o
this study did not exclude a four-fold higher risk of gynecomastia
among cannabis smokers, studies in humans and animals have not shown
any increased secretion of the hormone prolactin, the most likely
mechanism of such effects in males. As Mendelson et al (1984) have
argued, if chronic cannabis use caused gynecomastia, one would expect
many more cases to have been reported in the clinical literature,
given the widespread use of cannabis among young males during the past
few decades.

Hollister has argued that the reductions in testosterone and
spermatogenesis observed in the positive studies are probably of
&quot;little consequence in adults&quot;, although he conceded that they could
be of &quot;major importance in the prepubertal male who may use cannabis&quot;
(p10). He cited a case of growth arrest in a 16-year-old male who
began heavy cannabis use at the age of 11, and who experienced a
retardation of growth and the development of secondary sexual
characteristics which partially remitted after three months abstinence
from cannabis (Copeland, Underwood and Van Wyck, 1980). The possible
effects of cannabis use on testosterone and spermatogenesis may
therefore be most relevant to males whose fertility is already
impaired for other reasons, e.g. a low sperm count. 



6.5.2 Effects on the female reproductive system 

The experimental animal studies suggests that cannabis use has similar
effects on female reproductive system to those found in males. The
acute effects of cannabis or THC exposure in the non-pregnant female
animal is to transiently interfere with the
hypothalamic-pituitary-gonadal axis (Bloch, 1983). Chronic cannabis
exposure delays oestrous and ovulation by reducing leutinising hormone
and increasing prolactin secretion. 

There have been very few human studies of the effects of cannabis on
the female reproductive system because of fears that cannabis use may
produce teratogenic and genotoxic effects in women of childbearing age
who would be the experimental subjects in such studies (Rosenkrantz,
1985). Two studies have been reported with conflicting results. In an
unpublished study, Bauman (1980 cited by Nahas, 1984) compared the
menstrual cycles of 26 cannabis smokers with those of 17 controls, and
found a higher rate of anovulatory cycles among the cannabis users.
Mendelson and Mello (1984) observed hormonal levels in a group of
female cannabis users (all of whom had undergone a tubal ligation)
under controlled laboratory conditions. They failed to find any
evidence that sub-chronic cannabis use affected the cycling of the sex
hormones, or the duration of the cycle. In the absence of any other
human evidence, both Bloch (1983) and the Institute of Medicine (1982)
argued on the basis of the animal literature that cannabis use
probably had an inhibitory effect on human female reproductive
function which was similar to that which occurs in males.



6.5.3 Foetal development and birth defects 

Given evidence that THC affects female reproductive function, one
might expect it to have a potentially adverse effect on the outcome of
pregnancy. The possibility of adverse pregnancy outcomes is increased
by evidence that THC crosses the placenta in animals (Bloch, 1983) and
humans (Blackard and Tennes, 1984). This raises the possibility that
THC, and possibly other cannabinoids, are teratogens, i.e. substances
that may interfere with the normal development of the foetus in utero.

The animal evidence indicates that in sufficient dosage cannabis can
&quot;produce resorption, growth retardation, and malformations&quot; in mice,
rats, rabbits, and hamsters (Bloch, 1983, p406). Growth resorption and
growth retardation have been more consistently reported than birth
malformations (Abel, 1985). There are also several caveats on the
evidence that cannabis increases rates of malformations. The doses
required to reliably produce malformations have been very high (Abel,
1985), and such effects have been observed more often after the
administration of crude marijuana extract than pure THC, suggesting
that other cannabinoids may be involved in producing any teratogenic
effects. There have also been doubts expressed about whether these
teratogenic effects can be directly attributed to THC. Some have
argued, for example, that the malformations may be a consequence of
reduced nutrition caused by the aversive properties of the large doses
of cannabis used in these studies (Abel, 1985; Bloch, 1983). 

Hollister (1986) has also discounted the animal research data, arguing
that &quot;virtually every drug that has ever been studied for
dysmorphogenic effects has been found to have them if the doses are
high enough, if enough species are tested, or if treatment is
prolonged&quot; (p4). Similar views have been expressed by Abel (1985) and
by Bloch (1983), who concluded that THC was unlikely to be teratogenic
in humans because &quot;the few reports of teratogenicity in rodents and
rabbits indicate that cannabinoids are, at most, weakly teratogenic in
these species&quot; (p416).



6.5.3.1 Human studies

The findings from the small number of epidemiological studies of the
effects of cannabis use on human foetal development have been mixed
for a number of reasons. First, both the adverse reproductive outcomes
and the prevalence of heavy cannabis use during pregnancy are
relatively rare events. Hence, unless cannabis use produces a large
increase in the risk of abnormalities, very large sample sizes will be
required to detect adverse effects of cannabis use on foetal
development. Many of the studies that have been conducted to date have
been too small to detect effects of this size (e.g. Greenland et al,
1982 a,b; Fried, 1980). 

There are also likely to be difficulties in identifying cannabis users
among pregnant women. The stigma associated with illicit drug use,
especially during pregnancy, may discourage honest reporting,
compounding the usual problem of women accurately recalling drug use
in early pregnancy, when they are asked about it late in their
pregnancy, or after the birth (Day et al, 1985). If, as seems likely,
a substantial proportion of cannabis users are misclassified as
non-users, any relationship between cannabis use and adverse outcomes
will be attenuated, requiring even larger samples to detect it
(Zuckerman, 1985). 

Even when large sample sizes have been obtained, there are
difficulties in interpreting any associations found between adverse
pregnancy outcomes and cannabis use. Cannabis users are more likely to
use tobacco, alcohol and other illicit drugs during their pregnancy.
They also differ from non-users in social class, education, nutrition,
and other factors which predict an increased risk of experiencing an
adverse outcome of pregnancy (Fried, 1980, 1982; National Academy of
Science, 1982; Tennes et al, 1985). These sources of confounding make
it difficult to unequivocally attribute any relationship between
reproductive outcomes and cannabis use to cannabis use per se, rather
than to other drug use, or other variables correlated with cannabis
use, such as poor maternal nutrition, and lack of prenatal care.
Sophisticated forms of statistical control provide the only way of
assessing to what degree this may be the case, but its application is
limited by the small number of cannabis smokers identified in most
studies.

Given these difficulties, and the marked variation between studies in
the proportion of women who report cannabis use during pregnancy, the
degree of agreement between the small number of studies is more
impressive than the disagreement that seems at first sight to such be
a feature of this literature. There is reasonable consistency
(although not unanimity) in the finding that cannabis use in pregnancy
is associated with foetal growth retardation, as shown by reduced
birth weight (e.g. Gibson et al, 1983; Hatch and Bracken, 1986;
Zuckerman et al, 1989), and length at birth (Tennes et al, 1985). This
relationship has been found in the best controlled studies, and it has
persisted after statistically controlling for potential confounding
variables by sophisticated forms of statistical analysis (e.g. Hatch
and Bracken, 1986; Zuckerman et al, 1989). 

Uncertainty remains about the interpretation of this finding. Is it
because the &quot;marijuana products were toxic to foetal development&quot;, as
argued by Nahas and Latour (1992)? Is it because THC interferes with
the hormonal control of pregnancy shortening the gestation period, as
has been reported by Gibson et al (1983) and Zuckerman et al (1989)?
The fact that the lower birth weight among the children of women who
used cannabis disappears after controlling for gestation length is
supportive of the latter hypothesis. Is it because cannabis is
primarily smoked, since tobacco smoking has been consistently shown to
be associated with reduced birth weight (Fried, 1993)?

The findings on the relationship between cannabis use and birth
abnormalities are more mixed, and conclusions accordingly less
certain. Early case reports of children with features akin to the
Foetal Alcohol Syndrome born to women who had smoked cannabis but not
used alcohol during pregnancy (e.g. Milman, 1982, p42) suggested that
cannabis may increase the risk of birth defects. Subsequent controlled
studies have produced mixed results. Four studies have reported no
increased rate of major congenital abnormalities among children born
to women who use cannabis (Gibson et al, 1983; Hingson et al, 1982;
Tennes et al, 1985; Zuckerman et al, 1989). 

One study has reported a five-fold increased risk of children with
foetal alcohol like features being born to women who reported using
cannabis (Hingson et al, 1982). The significance of this finding is
uncertain because the same study also found no relationship between
self-reported alcohol use and &quot;foetal alcohol syndrome&quot; features. This
is doubly surprising because of other evidence on the adverse effects
of alcohol, and because the epidemiological data indicates that
cannabis and alcohol use are associated (Norton and Colliver, 1988).
An additional study reported an increase in the crude rate of birth
abnormalities among children born to women who reported using
cannabis. This result was no longer statistically significant after
adjustment for confounders (Linn et al, 1983), although the confidence
interval around this adjusted risk (OR=1.36) only narrowly included
the null value (95 per cent CI: 0.97, 1.91). 

The study by Zuckerman et al provides the most convincing failure to
find an increased risk of birth defects among women who used cannabis
during pregnancy. A large sample of women was obtained, among which
there was a substantial prevalence of cannabis use that was verified
by urinalysis. There was a low rate of birth abnormalities among the
cannabis users, and no suggestion of an increase by comparison with
the controls. On this finding, one might be tempted to attribute the
small increased risk in the positive study (Linn et al, 1983) to
recall bias, since the report of cannabis use during pregnancy was
obtained retrospectively after birth, when women who had given birth
to children with malformations may have been more likely to recall
cannabis use than those who did not. However, given the uncertainty
about the validity of self-reported cannabis use in many of the null
studies, it would be unwise to exonerate cannabis as a cause of birth
defects until larger, better controlled studies have been conducted. 



6.5.4 Chromosomal abnormalities and genetic effects

Teratogenesis - interference with normal foetal development - is not
the only way in which cannabis use might adversely affect human
reproduction. Cannabis use could conceivably produce chromosomal
abnormalities or genetic change in either parent which could be
transmitted to their progeny. Although possible, there is no animal or
human evidence that such events occur. The experimental evidence
indicates that &quot;in vivo and in vitro exposure to purified cannabinoids
or cannabis resin failed to increase the frequency of chromosomal
damage or mutagenesis&quot; (Bloch, 1983, p412). Marijuana smoke exposure,
by contrast, &quot;has been ... associated with chromosomal aberrations ...
[such as] hypoploidy, mutagenicity in the Ames test ... &quot; (Bloch,
1983, p413). The latter fact is more relevant to an appraisal of the
risk of cannabis users developing cancers from exposure to cannabis
smoke rather than to the risks of transmissible genetic defects in
their offspring. 

Hollister (1986) discounted the evidence from cytogenetic studies that
cannabinoids may be mutagenic, as did the Institute of Medicine
(1982). He also argued that assessing chromosomal damage was &quot;more of
an art than a science&quot;, as indicated by poor inter-observer agreement,
and that the clinical significance remained unclear because &quot;similar
types and degrees of chromosomal changes have been reported in
association with other drugs commonly used in medical practice without
any clinical evidence of harm ...&quot; (p4). Hollister concluded that
&quot;even if a small increase in chromosomal abnormalities is produced by
cannabis, the clinical significance is doubtful&quot; (p4).



6.5.5 Post-natal development

A further possibility which needs to be considered is that cannabis
use by the mother during pregnancy and breast feeding may affect the
post-natal development of the child. This could occur either because
of the enduring effects of developmental impairment arising from in
utero exposure, or because the infant continued to be exposed to
cannabinoids via breast milk. These are not well investigated
possibilities, although there are a small number of animal studies
which provide suggestive evidence of such effects (Nahas, 1984; Nahas
and Frick, 1987).

The most extensive research evidence in humans comes from the Ottawa
Prospective Prenatal Study (OPPS), which studied developmental and
behavioural abnormalities in children born to women who reported using
cannabis during pregnancy (Fried and colleagues, 1980, 1982, 1983,
1985, 1986, 1989, 1990, 1992). In this study, mothers were assessed
about their drug use during pregnancy and their children were measured
on the Brazelton scales after birth, neurologically assessed at one
month, and assessed again by standardised scales of ability at six and
12 months. The results indicated that there was some developmental
delay shortly after birth in the infants' visual system, and there was
also an increased rate of tremors and startle among the children of
cannabis users. 

The behavioural effects discernible after birth had faded by one
month, and no effects were detectable in performance on standardised
ability tests at six and 12 months. Effects were subsequently reported
at 36 and 48-month follow-ups (Fried and Watkinson, 1990) but these
did not persist in a more recent follow-up at 60 and 72 months (Fried,
O'Connell, and Watkinson, 1992). These results are suggestive of a
transient developmental impairment occurring among children who had
experienced a shorter gestation and prematurity. There is a
possibility that the tests used in later follow-ups are insufficiently
sensitive to the subtle effects of prenatal cannabis exposure,
although they were able to detect effects of maternal tobacco smoking
during pregnancy on behavioural development at 60 and 72 months (Fried
and Watkins, 1990, 1992). 

Attempts to replicate the OPPS findings have been mixed. Tennes et al
(1985) conducted a prospective study of the relationship between
cannabis use during pregnancy and postnatal development in 756 women,
a third of whom reported using cannabis during pregnancy. The children
were assessed shortly after birth using the same measurement
instruments as Fried (1980), and a subset were followed up and
assessed at one year of age. The findings failed to detect any
differences in behavioural development between the children of users
and non-users after birth; i.e. there was no evidence of impaired
development of the visual system, and no increased risk of tremor or
startle among the children of users. There was also no evidence of any
differences at one year. More recently, Day et al (in press), have
followed up children at age three born to 655 women who were
questioned about their substance use during pregnancy. They found a
relationship between the mothers' cannabis use during pregnancy and
the children's performances on memory and verbal scales of the
Stanford-Binet Intelligence Scale. 

There is suggestive evidence that cannabis use during pregnancy may
have a more serious and life threatening effect on post-natal
development. This emerged from a case-control study of Acute
Nonlymphoblastic Leukemia (ANLL), a rare form of childhood cancer
(Neglia et al, 1991; Robinson et al, 1989). The study was not designed
as a test of relationship between cannabis use and ANLL; it was
designed to examine the possible aetiological role of maternal and
paternal environmental exposures to petrochemicals, pesticides and
radiation. Maternal drug use, including marijuana use before and
during pregnancy, were assessed as possible covariates to be
statistically controlled in any relationships observed between ANLL
and environmental exposures. 

An unexpected but strong association was observed between maternal
cannabis use and ANLL. The mothers of cases were 11 times more likely
to have used cannabis before and during their pregnancy than were the
mothers of controls. The relationship persisted after statistical
adjustment for many other risk factors. Comparisons of cases whose
mothers did and did not use cannabis during their pregnancies showed
that cases with cannabis exposure were younger, and had a higher
frequency of ANLL with cell types of a specific pathological origin
than did the cases without such exposure. The authors argued that
these differences made it unlikely that the relationship was due to
chance. 

Reporting bias on the part of the mothers of cases is an alternative
explanation of the finding that is harder to discount. The reports of
cannabis use were obtained retrospectively after diagnosis of the
ANLL, so it is possible that the mothers of children who developed
ANLL were more likely to seek an explanation in something they did
during their pregnancies, and hence, may have been more likely to
report cannabis use than were mothers of controls. The authors
investigated this possibility by comparing the rates of cannabis use
reported in this study with the rates reported in several earlier
case-control studies of other childhood cancers that they had
conducted using the same methods. The rate was lower among controls in
the ANLL study, but even when the rate of cannabis use among the
controls in these other studies was used the odds ratio was still
greater than three and statistically significant. Nonetheless, since
this was an unexpected finding which emerged from a large number of
exploratory analyses conducted in a single study, it should be
replicated as a matter of some urgency. 



6.5.6 Conclusions

On the balance of probabilities, high doses of THC probably disrupt
the male and female reproductive systems in animals by interfering
with hypothalamo-pituitary-gonadal system, reducing secretion of
testosterone, and hence reducing sperm production, motility, and
viability in males, and interfering with the ovulatory cycle in
females. It is uncertain whether these effects also occur in humans,
given the dose differences, the inconsistency in the literature on
human males and the absence of research on human females. Even if
cannabinoids have such effects in humans, their clinical significance
in normal healthy young adults is unclear. They may be of greater
concern among young adolescents who are now more likely to use, and
among males with fertility impaired for other reasons.

Cannabis use during pregnancy probably impairs foetal development,
leading to smaller birthweight, perhaps as a consequence of a shorter
period of gestation. It is possible although far from certain that
cannabis use during pregnancy produces a small increase in the risk of
birth defects as a result of exposure of the foetus in utero. Prudence
suggests that until this issue is resolved, we should err in the
conservative direction by recommending that women not use cannabis
during pregnancy, or when attempting to conceive (Hollister, 1986).

There is not a great deal of evidence that cannabis use can produce
chromosomal or genetic abnormalities in either parent which could be
transmitted to offspring. The available animal and in vitro evidence
suggests that the mutagenic properties of cannabis smoke are greater
than those of THC, and are probably of greater relevance to the risk
of users developing cancer than to the transmission of genetic defects
to children. There is suggestive evidence that infants exposed in
utero to cannabis may experience transient behavioural and
developmental effects during the first few months after birth. There
is also a single study which raises concern about an increased risk of
childhood leukemia occurring among the children born to women who used
cannabis during their pregnancies. 



References

Abel, E.L. (1985) Effects of prenatal exposure to cannabinoids. In
T.M. Pinkert (ed) Current Research on the Consequences of Maternal
Drug Abuse. National Institute on Drug Abuse Research Monograph No.
59. Rockville, MD: U.S. Department of Health and Human Services.

Aronow, W.S. and Cassidy, J. (1974) Effect of marijuana and
placebo-marijuana smoking on angina pectoris. New England Journal of
Medicine, 291, 65-67.

Aronow, W.S. and Cassidy, J. (1975) Effect of smoking marijuana and a
high-nicotine cigarette on angina pectoris. Clinical Pharmacology and
Therapeutics, 17, 549-554.

Benowitz, N.L. and Jones, R.T. (1975) Cardiovascular effects of
prolonged delta-9-tetrahydrocannabinol ingestion. Clinical
Pharmacology and Therapeutics,18, 287-297.

Blackard, C. and Tennes, K. (1984) Human placental transfer of
cannabinoids. New England Journal of Medicine, 311, 797.

Bloch, E. (1983) Effects of marijuana and cannabinoids on
reproduction, endocrine function, development and chromosomes. In K.O.
Fehr and H. Kalant (eds) Cannabis and Health Hazards. Toronto:
Addiction Research Foundation.

Bloom, J.W., Kaltenborn, W.T., Paoletti, P., Camilli, A. and Lebowitz,
M.D. (1987) Respiratory effects of non-tobacco cigarettes. British
Medical Journal, 295, 1516-1518.

Cabral, G.A., Mishkin, E.M., Marciano-Cabral, F., Coleman, P., Harris,
L. and Munson, A.E. (1986) Effect of delta-9-tetrahydrocannabinol on
Herpes Simplex Virus Type 2 Vaginal Infection in the guinea pig
(42325). Proceedings of the Society for Experimental Biology and
Medicine, 182, 181-186.

Caplan, G.A. and Brigham, B.A. (1989) Marijuana smoking and carcinoma
of the tongue. Is there an association? Cancer, 66, 1005-1006.

Carter, W. E, Coggins, W. and Doughty, P.L. (1980) Cannabis in Costa
Rica: A study of chronic marihuana use. Philadelphia: Institute for
the Study of Human Issues.

Cates, W. and Pope, J.N. (1977) Gynecomastia and cannabis smoking: A
nonassociation among US Army soldiers. American Journal of Surgery,
134, 613-615.

Choi, Y.S. and Perl, W.R. Cardiovascular effects of adolescent drug
abuse. Journal of Adolescent Health Care, 1989, 10, 332-337.

Copeland, K.C., Underwood, L.E., and Van Wyk, J.J. (1980) Marihuana
smoking and prepubertal arrest. Journal of Pediatrics, 96, 1079-1080.

Dax, E.M., Pilotte, N.S., Adler, W.H., Nagel, J.E. and Lange, W.R.
(1989) The effects of 
9-ENE-Tetrahydrocannabinol on hormone release and immune function.
Journal of Steroid Biochemistry, 34, 263-270.

Day, N.L., Wagener, D.K. and Taylor, P.M. (1985) Measurement of
substance use during pregnancy: methodologic issues. In T.M. Pinkert
(ed) Current Research on the Consequences of Maternal Drug Abuse.
National Institute on Drug Abuse Research Monograph No. 59. Rockville,
MD: U.S. Department of Health and Human Services.

Day, N.L., Richardson, G.A., Goldschmidt, L, Robles, N., Taylor, P.M.,
Stoffer, D.S., Cornelius, M.D. and Geva, D.D. (in press) The effect of
prenatal marijuana exposure in the cognitive development of offspring
at age three. Neonatology and Teratology.

Doll, R. and Peto, R. (1980) The Causes of Cancer. Oxford University
Press.

Donald, P.J. (1991a) Marijuana and upper aerodigestive tract
malignancy in young patients. In G. Nahas and C. Latour (eds)
Physiopathology of Illicit Drugs: Cannabis, Cocaine, Opiates. Oxford:
Pergamon Press.

Donald, P.J. (1991b) Advanced malignancy in the young marijuana
smoker. In H. Freidman, S. Specter, and T.W. Klein (eds) Drugs of
Abuse, Immunity, and Immunodeficiency. London: Plenum Press.

Fligiel, S.E.G., Beals, T.F., Venkat, H., Stuth, S. Gong, H. and
Tashkin, D.P. (1988) Pulmonary pathology in marijuana smokers. In G.
Chesher, P. Consroe, and R. Musty (eds) Marijuana: An International
Research Report. National Campaign Against Drug Abuse Monograph Number
7. Canberra: Australian Government Publishing Service.

Freeman, G.L. (1983) Allergic skin test reactivity to marijuana in the
southwest. The Western Journal of Medicine, 138, 829-831.

Fried, P.A. (1980) Marihuana use by pregnant women: Neurobehavioural
effects in neonates. Drug and Alcohol Dependence, 6, 415-424.

Fried, P.A. (1982) Marihuana use by pregnant women and effects on
offspring: an update. Neurobehavioral Toxicology and Teratology, 4,
451-454.

Fried, P.A. (1985) Postnatal consequences of maternal marijuana use.
In T.M. Pinkert (ed) Current Research on the Consequences of Maternal
Drug Abuse. National Institute on Drug Abuse Research Monograph No.
59. Rockville, MD: U.S. Department of Health and Human Services.

Fried, P.A. (1986) Marijuana and human pregnancy. In I. Chasnoff (ed)
Drug Use in Pregnancy: Mother and Child. Lancaster: MTP Press.

Fried, P.A. (1989) Postnatal consequences of maternal marijuana use in
humans. Annals of the New York Academy of Sciences, 562, 123-132.

Fried, P.A. (1993) Prenatal exposure to tobacco and marijuana: Effects
during pregnancy, infancy, and early childhood. Clinical Obstetrics
and Gynecology, 36, 319-337.

Fried, P.A. and Watkinson, B. (1990) 36- and 48-month neurobehavioral
follow-up of children prenatally exposed to marijuana, cigarettes and
alcohol. Developmental and Behavioral Pediatrics, 11, 49-58.

Fried, P.A., Buckingham, M. and Von Kulmiz, P. (1983) Marihuana use
during pregnancy and perinatal risk factors. American Journal of
Obstetrics and Gynecology, 146, 992-994. 

Fried, P.A., O'Connell, Watkinson, B. (1992) 60- and 72-month
follow-up of children prenatally exposed to marijuana, cigarettes, and
alcohol: cognitive and language assessment. Developmental and
Behavioral Pediatrics, 13, 383-391. 

Friedman, H. (1991) Cannabis and immunity. In G. Nahas and C. Latour
(eds) Physiopathology of Illicit Drugs: Cannabis, Cocaine, Opiates.
Oxford: Pergamon Press. 

Gawin, F.H. and Ellinwood, E.H. (1988) Cocaine and other stimulants:
Actions, abuse and treatment. New England Journal of Medicine, 318,
1173-1182.

Gibson, G.T., Baghurst, P.A. and Colley, D.P. (1983) Maternal alcohol,
tobacco and cannabis consumption and the outcome of pregnancy.
Australian and New Zealand Journal of Obstetrics and Gynaecology, 23,
15-19.

Gong, H., Fliegel, S., Tashkin, D.P. and Barbers, R.G. (1987)
Tracheobronchial changes in habitual, heavy smokers of marijuana with
and without tobacco. American Review of Respiratory Disease, 136,
142-149.

Greenland, S., Staisch, K.J., Brown, N. and Gross, S.J. (1982a) The
effects of marijuana use during pregnancy. I. A preliminary
epidemiologic study. American Journal of Obstetrics and Gynecology,
143, 408-413. (a)

Greenland, S., Staisch, K.J., Brown, N. and Gross, S.J. (1982b)
Effects of marijuana on human pregnancy, labor and delivery.
Neurobehavioral Toxicology and Teratology, 
4, 447-450. (b)

Grossman, C.J. and Wilson, E.J. (1992) The immune system: mechanisms
that counteract disease. Alcohol Health and Research World, 16, 5-14.

Harmon, J. and Aliapoulios, M.A. (1972) Gynecomastia in marihuana
users. New England Journal of Medicine, 287, 936.

Hatch, E.E. and Bracken, M.B. (1986) Effect of marijuana use in
pregnancy on fetal growth. American Journal of Epidemiology, 124,
986-993.

Hembree, W.C., Nahas, G.G., Zeidenberg, P. and Huang, H.F.S. (1991) In
G. Nahas and C. Latour (eds) G. Nahas and C. Latour (eds)
Physiopathology of Illicit Drugs: Cannabis, Cocaine, Opiates. Oxford:
Pergamon Press. 

Henderson, R.L., Tennant, F.S., and Guerry, R. (1972) Respiratory
manifestations of hashish smoking. Archives of Otolaryngology, 95,
248-251.

Hingson, R., Alpert, J., Day, N., Dooling, E., Kayne, H., Morelock,
S., Oppenheimer, E. and Zuckerman, B. (1982) Effects of maternal
drinking and marijuana use on fetal growth and development.
Pediatrics, 70, 539-546.

Hollister, L.E. (1986) Health aspects of cannabis. Pharmacological
Reviews, 38, 1-20.

Hollister, L.E. (1992) Marijuana and immunity. Journal of Psychoactive
Drugs, 24, 159-164.

Holman, C.D., Armstrong, B. et al (1988).The Quantification of
Drug-Caused Morbidity and Mortality in Australia. Canberra:
Commonwealth Department of Community Services and Health. 

Huber, G.L., Griffith, D.L. and Langsjoen, P.M. (1988) The effects of
marihuana on the respiratory and cardiovascular systems. In G.
Chesher, P. Consroe, and R. Musty (eds) Marijuana: An International
Research Report. National Campaign Against Drug Abuse Monograph Number
7, Canberra: Australian Government Publishing Service. 

Institute of Medicine. (1982) Marijuana and Health. Washington, DC:
Institute of Medicine, National Academy Press 

International Agency on Cancer (1990) Cancer: Causes, Occurrence and
Control. (Ed) 
L. Tomatis. Lyon: International Agency on Cancer.

Jones, R.T. and Benowitz, N. (1976) The 30-day trip - clinical studies
of cannabis tolerance and dependence. In M Braude and S. Szara (eds)
Pharmacology of Marijuana. Volume 2. New York: Academic Press.

Jones, R.T. (1984) Cardiovascular effects of cannabinoids. In D.J.
Harvey, W. Paton and G.G. Nahas (eds) Marihuana '84: Proceedings of
the Oxford Symposium on Cannabis. Oxford: IRL Press.

Kaslow, R.A., Blackwelder, W.C., Ostrow, D.G., Yerg, D., Palenick, J.,
Coulson, A.H., and Valdiserri, R.O. (1989) No evidence for a role of
alcohol or other psychoactive drugs in accelerating immunodeficiency
in HIV-1-positive individuals: A report from the Multicenter AIDS
Cohort Study. Journal of the American Medical Association, 261,
3424-3429.

Kolodny, R.C., Masters, W.H., Kolodner, R.M., and Toro, G. (1974)
Depression of plasma testosterone levels after chronic intensive
marihuana use. New England Journal of Medicine, 290, 872-874. 

Lau, R.J., Tubergen, D.G., Barr, M., Domino, E.F., Benowitz, N. and
Jones, R.T. (1976) Phytohemagglutinin-induced lymphocyte
transformation in humans receiving delta-9-tetrahydrocannabinol.
Science, 192, 805-807.

Leuchtenberger, C. (1983) Effects of marihuana (cannabis) smoke on
cellular biochemistry of in vitro test systems. In K.O. Fehr and H.
Kalant (Eds) Cannabis and Health Hazards. Toronto: Addiction Research
Foundation.

Linn, S., Schoenbaum, S., Monson, R., Rosner, R., Stubblefield, P.C.,
and Ryan, K.J. (1983) The association of marijuana use with outcome of
pregnancy. American Journal of Public Health, 73, 1161-1164.

Maykut, M.O. (1984) Health Consequences of Acute and Chronic Marihuana
Use. Oxford: Pergamon Press.

Mendelson, J.H., Kuehnle, J., Ellingboe, J. and Babor, T.F. (1974)
Plasma testosterone levels before, during, and after chronic marihuana
smoking. New England Journal of Medicine, 291, 1051-1055. 

Mendelson, J.H. and Mello, N.K. (1984) Effects of marijuana on
neuroendocrine hormones in human males and females. In M Braude and
J.P. Ludford (eds) Marijuana Effects on the Endocrine and Reproductive
Systems. Rockville, Maryland: National Institute on Drug Abuse.

Milman, D.H. (1982) Psychological effects of cannabis in adolescence.
In National Institute on Drug Abuse. Marijuana and Youth: Clinical
Observations on Motivation and Learning. Rockville, Maryland: National
Institute on Drug Abuse. . 

Mishkin, E.M., and Cabral, G.A. (1985) Delta-9-Tetrahydrocannabinol
decreases host resistance to herpes simplex virus 2 vaginal infection
in the B6C3F1 mouse. Journal of General Virology, 66, 2539-2549.

Morahan, P.S., Klykken, P.C., Smith, S.H., Harris, L.S. and Munson,
A.E. (1979) Effects of cannabinoids on host resistance to Listeria
monocytogenes and Herpes Simplex Virus. Infection and Immunity, 23,
670-674.

Munson, A.E., and Fehr, K.O. (1983) Immunological effects of cannabis.
In K.O. Fehr and H. Kalant (Eds) Cannabis and Health Hazards. Toronto:
Addiction Research Foundation 

Nahas, G.G. (1984) Toxicology and pharmacology. In G.G. Nahas
Marihuana in Science and Medicine New York: Raven Press.

Nahas, G.G. and Frick, H (1987) Developmental effects of cannabis.
Neurotoxicology, 7, 381-395.

Nahas, G. and Latour, C. (1992) The human toxicity of marijuana.
Medical Journal of Australia, 156, 495-497.

Nahas, G.G., Desoize, J.P., Armand, J.P., Hsu, J. and Morishima A.
(1976) Natural cannabinoids: apparent depression of nucleic acids and
protein synthesis in cultured human lymphocytes. In M Braude and S.
Szara (Eds) The Pharmacology of Marihuana. New York: Raven Press.

National Academy of Science. (1982) Marijuana and Health. Washington,
DC: Institute of Medicine, National Academy Press.

Neglia, J.P., Buckley, J.D. and Robinson, L.L. (1991) Maternal
marijuana use and leukemia in offspring. In G. Nahas and C. Latour
(eds) Physiopathology of Illicit Drugs: Cannabis, Cocaine, Opiates.
Oxford: Pergamon Press. 

Norton, R. and Colliver, J. (1988) Prevalence and patterns of combined
alcohol and marijuana use. Journal of Studies in Alcohol, 49, 378-380.

Nossal, G. (1993) Life, death and the immune system. Scientific
American, 269, 21-30.

Nowlan, R. and Cohen, S. (1977) Tolerance to marijuana: heart rate and
subjective &quot;high&quot;. Clinical Pharmacology and Therapeutics, 22,
550-556.

Pearl, W. and Choi, Y.S. (1992) Marijuana as a cause of myocardial
infarction. International Journal of Cardiology, 34, 353-354.

Podczeck, A, Frohmer, K. and Steinbach, K. (1990) Acute myocardial
infarction in juvenile patients with normal coronary arteries.
International Journal of Cardiology, 30, 359-361. 

Polen, M.R., Sidney, S., Tekawa, I.S., Sadler, M. and Friedman, G.D.
(1993) Health care use by frequent marijuana smokers who do not smoke
tobacco. Western Journal of Medicine, 158, 596-601.

Robinson, L.I., Buckley, J.D., Daigle, A.E., Wells, R., Benjamin, D.,
Arthur, D and Hammond, G.D. (1989) Maternal drug use and the risk of
childhood nonlymphoblastic leukemia among offspring: An epidemiologic
investigation implicating marijuana. Cancer, 63, 1904-1911.

Rosenkrantz, H. (1985) Cannabis components and responses of
neuroendochrine-reproductive targets: an overview. In D.J. Harvey, W.
Paton and G.G. Nahas (eds) Marihuana '84: Proceedings of the Oxford
Symposium on Cannabis. Oxford: IRL Press.

Rubin, V. and Comitas, L. (1975) Ganja in Jamaica: A Medical
Anthropological Study of Chronic Marihuana Use. The Hague: Mouton
Publishers.

Sherman, M.P., Campbell, L.A., Gong, H., Roth, M.D. and Tashkin, D.
(1991) Antimicrobial and respiratory burst characteristics of
pulmonary alveolar macrophages recovered from smokers of marijuana
alone, smokers of tobacco alone, smokers of marijuana and tobacco, and
nonsmokers. American Review of Respiratory Disease, 144, 1351-1356.

Stefanis, C., Dornbush, R. and Fink, M. (eds) (1977) Hashish: Studies
of Long-Term Use. New York: Raven Press.

Tashkin, D.P. (1988) Summary of the Session on Pulmonary Effects. In
G. Chesher, P. Consroe, and R. Musty (eds) Marijuana: An International
Research Report. National Campaign Against Drug Abuse Monograph Number
7. Canberra: Australian Government Publishing Service.

Tashkin, D.P. (1993) Is frequent marijuana smoking harmful to health?
Western Journal of Medicine, 158, 635-637.

Tashkin, D.P., Coulson, A.H., Clark, V.A., Simmons, M., Bourque, L.B.,
Duann, S., Spivey, G.H. and Gong, H. (1987) Respiratory symptoms and
lung function in habitual heavy smokers of marijuana alone, smokers of
marijuana and tobacco, smokers of tobacco alone, and nonsmokers.
American Review of Respiratory Diseases, 135, 209-216.

Tashkin, D.P., Wu, T.C., Djahed, B., and Rose, J.E. (1988) Smoking
topography and delivery of insoluble particulates and carbon monoxide
to the lung during the smoking of tobacco and marihuana of varying
potency in habitual smokers of both substances. In G. Chesher, P.
Consroe, and R. Musty (eds) Marijuana: An International Research
Report. National Campaign Against Drug Abuse Monograph Number 7.
Canberra: Australian Government Publishing Service.

Tashkin, D.P., Fligiel, S., Wu, T.C., Gong, H., Barbers, R.G.,
Coulson, A.H., Simmons, M.S., and Beals, T.F. (1990) Effects of
habitual use of marijuana and/or cocaine on the lung. In C.N. Chiang
and R.L. Hawks (Eds) Research Findings on Smoking of Abused
Substances. National Institute on Drug Abuse Research Monograph No.
99, Rockville, Maryland: U.S. Department of Health and Human Services.

Taylor, F.M. (1988) Marijuana as a potential respiratory tract
carcinogen: a retrospective analysis of a community hospital
population. Southern Medical Journal, 81, 1213-1216.

Tennant, F.S., Preble, M., Prendergast, T.J. and Ventry, P. (1971)
Medical manifestations associated with hashish. Journal of the
American Medical Association, 216, 1965-1969.

Tennant, F.S. (1980) Histopathologic and clinical abnormalities of the
respiratory system in chronic hashish smokers. In L.S. Harris (ed)
Problems of Drug Dependence, 1979, Volume 127. Rockville, Maryland:
National Institute on Drug Abuse 

Tennant, F.S. (1983) Clinical toxicology of cannabis use. In K.O. Fehr
and H. Kalant (eds) Cannabis and Health Hazards. Toronto: Addiction
Research Foundation.

Tennes, K., Aritable, N., Blackard, C., Boyles, C., Hassoun, B.,
Holmes, L., and Kreye, M. (1985) Marihuana: prenatal and postnatal
exposure in the human. In T.M. Pinkert (ed) Current Research on the
Consequences of Maternal Drug Abuse. National Institute on Drug Abuse
Research Monograph No. 59. Rockville, MD: U.S. Department of Health
and Human Services.

Vokes, E.E., Weichelsbaum, R.R., Lippman, S.M., and Hong, W.K. (1993)
Head and neck cancer. New England Journal of Medicine, 328, 183-194.

Wallace, J.M., Tashkin, D., Oishi, J.S. and Barbers, R.G. (1988)
Peripheral blood lymphocyte subpopulations and mitogen responsiveness
in tobacco and marijuana smokers. Journal of Psychoactive Drugs, 1988,
20, 9-14.

Wallace, J.M., Oishsi, J.S., Barbers, R.G., Simmons, M.S. and Tashkin,
D.P. (1993) Lymphocytic subpopulation profiles in bronchoalveolar
lavage fluid and peripheral blood from tobacco and marijuana smokers.
Chest (in press).

Wenger, T., Croix, D., Tramu, G., and Leonardeli, J. (1992) Effects of
delta-9-tetrahydrocannabinol on pregnancy, puberty and the
neuroendocrine system. In L. Murphy and A. Bartke (eds)
Marijuana/Cannabinoids: Neurobiology and Neurophysiology. Boca Raton:
CRC Press.

Wu, T., Tashkin, D.P., Djahed, B. and Rose, J.E. (1988) Pulmonary
hazards of smoking marijuana as compared with tobacco. New England
Journal of Medicine, 318, 347-351.

Zimmerman, S. and Zimmerman, A.M. (1990/1991) Genetic effects of
marijuana. International Journal of the Addictions, 25, 19-33.

Zuckerman, B. (1985) Developmental consequences of maternal drug use
during pregnancy. In T.M. Pinkert (ed) Current Research on the
Consequences of Maternal Drug Abuse. NIDA Research Monograph No. 59,
Department of Health and Human Services.

Zuckerman, B., Frank, D., Hingson, R., Amaro, H., Levenson, S., Kayne,
H., Parker, S., Vinci, R., Aboagye, K., Fried, L., Cabral, H.,
Timperi, R., and Bauchner, H. (1989) Effects of maternal marijuana and
cocaine use on fetal growth. New England Journal of Medicine, 320,
762-768.


</font>
</pre>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-12</DOCNO>
<DOCOLDNO>IA087-000627-B016-196</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch7.htm 206.61.184.43 19970122051756 text/html 335169
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:16:53 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:02:41 GMT
Content-length: 334950
</DOCHDR>
<html>

<head>
<title>The health and psychological consequences of cannabis use:
chapter 7 </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<h1></h1>
</body>

<body bgcolor="#ffffff">

<p>The health and psychological consequences of cannabis use
chapter 7 </p>

<h3>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
</h3>

<hr>

<pre>
<font size="2">7. The psychological effects of chronic cannabis use 

A major concern about the psychological consequences of cannabis use
has been the possible effects of its chronic use on psychological
adjustment in general, and its impact upon motivation and performance
in occupational and social roles in particular. There have been two
variations on this concern depending upon the age of the cannabis
user. Among adults, an &quot;amotivational syndrome&quot; has been described, in
which chronic cannabis users become apathetic, socially withdrawn, and
perform at a level of everyday functioning well below their capacity
prior to their cannabis use. Among adolescents, the concern has been
about the effects of heavy cannabis use on motivation to undertake the
educational and other psychological tasks that are an essential part
of the transition from childhood to adulthood. The evidence for each
of these adverse outcomes of heavy cannabis use will be considered
separately, beginning with the effects on adolescent development,
which have understandably provoked the greatest concern, and prompted
the most research.



7.1 Effects on adolescent development 

The effects of heavy cannabis use on adolescent development are of
special concern for a number of reasons. First, adolescents are minors
whose decisions about whether or not to use drugs are not
conventionally regarded as free and informed in the way that adult
choices are (Kleiman, 1989). Second, adolescence is an important
period of transition from childhood to adulthood, in which regular
cannabis intoxication may be expected to interfere with educational
achievement, the process of disengagement from dependence upon
parents, the development of relationships with peers, and making
important life choices, such as whether, whom and when to marry, and
what occupation to pursue (Baumrind and Moselle, 1985; Polich,
Ellickson, Reuter and Kahan, 1984). Third, the age at which drug use
begins has implications for subsequent drug use and health and
well-being. Early initiation of cannabis use predicts an increased
risk of escalation to heavier cannabis use, and to the use of other
illicit drugs. It also means a longer period of heavy use, and hence,
an increased risk of experiencing any adverse health effects that
chronic cannabis use may have in later adult life (Kleiman, 1989;
Polich, Ellickson, Reuter and Kahan, 1984). Fourth, since adolescence
is a time of risk-taking, the use of any intoxicant, whether alcohol
or cannabis while driving a car, increases the risks of accidental
injury, and hence of premature death (Kleiman, 1989; Polich,
Ellickson, Reuter and Kahan, 1984). 

The type of evidence that initially excited concern about the effects
of chronic cannabis use on adolescents came from clinical case studies
in which bright adolescents' use of cannabis escalated to daily
cannabis use, and the use of other illicit drugs, leading to declining
social and educational performance, as evidenced by high school
drop-out, and immersion in the illicit drug subculture (e.g. Kolansky
and Moore, 1971; Lantner, 1982; Milman, 1982; Smith and Seymour,
1982). In some of these cases, the syndrome remitted after the
adolescent had been abstinent from cannabis for some months (Meeks,
1982; Smith and Seymour, 1982). Nonetheless, the evidence was largely
anecdotal and so of limited value in making causal inferences about
the contribution that cannabis made to the development of these
outcomes. It did not, that is, permit a decision to be made as to what
extent cannabis use was a symptom rather than a cause of personality,
or other psychiatric disorders, or a form of adolescent rebellion
against parental values.

The concern about the adverse effects of cannabis use on adolescent
development in the late 1970s prompted a number of large-scale
prospective epidemiological studies of the antecedents, and to a
limited degree, the consequences of adolescent drug use (e.g. Kandel,
1988; Kaplan, Martin and Robbins, 1982; Newcombe and Bentler, 1988).
These studies have attempted to tease out the contributions of the
users' pre-existing personal and social characteristics from the
specific effects of drug use. Some of these studies have also
attempted to examine the impact of illicit drug use in adolescence
upon a number of social and personal outcomes in early adult life
(e.g. Kandel, 1988; Newcombe and Bentler, 1988). The most important of
these studies are reviewed below. 



7.1.1 Is cannabis a gateway drug?

A major concern about cannabis has been that its use in adolescence
may lead to, or increase the risk of using other more dangerous
illicit drugs, such as cocaine and heroin (DuPont, 1984; Goode, 1974;
Kleiman, 1992). The most popular evidence for this hypothesis is the
fact that the majority of heroin and cocaine users used cannabis
before heroin and cocaine. Such evidence is weak. In the absence of
comparative data on the prevalence of cannabis use by non-heroin
addicts we are unable to decide if there is an association between
cannabis and heroin use. Even if there is an association, alternative
explanations of its possible causal significance have to be evaluated
and excluded (Goode, 1974). 

There is now abundant evidence of an association between cannabis and
heroin use from a series of cross-sectional studies of adolescent drug
use in the United States and elsewhere, including Australia. In the
late 1970s and into the 1990s in the United States there was a strong
relationship between degree of current involvement with cannabis and
the use of other illicit drugs such as heroin and cocaine users.
Kandel (1984), for example, found that the prevalence of other illicit
drug use increased with current degree of marijuana involvement: 7 per
cent of those who had never used marijuana, 33 per cent of those who
had used in the past, and 84 per cent of those who were currently
daily cannabis users, had used other illicit drugs. Current cannabis
users were also likely to have used a larger number of different types
of illicit drugs. 

Cross-sectional data on drug use among Australian adults in 1993 have
also shown that those who have tried cannabis are more likely to have
used heroin, and the greater the frequency of cannabis use, the higher
the probability of their having tried heroin (see Donnelly and Hall,
1994). In the 1993 NCADA survey of drug use in Australia, for example,
the crude risk of using heroin was approximately 30 times higher among
those who have used cannabis than those who have not (even though 96
per cent of cannabis users had not used heroin) (see Donnelly and
Hall, 1994).

The relationships between cannabis and heroin use observed in the
cross-sectional studies have also been observed in the small number of
longitudinal studies of drug use. In one of the first such studies
Robins, Darvish and Murphy (1970) followed up a cohort of 222
African-American adolescents identified from school records at age 33,
and interviewed them retrospectively about their drug use in
adolescence and young adulthood, and their adult adjustment. They
found a higher rate of progression to heroin use among the young men
who had used cannabis before age 20. 

These early results have been confirmed and elaborated upon in the
extensive research on adolescent drug use by Kandel and her colleagues
(e.g. Kandel et al, 1986). These investigators have identified a
predictable sequence of involvement with licit and illicit drugs among
American adolescents, in which progressively fewer adolescents tried
each drug class, but in which almost all of those who tried drug types
later in the sequence had used all drugs earlier in the sequence
(Kandel and Faust, 1975). Typically, psychoactive drug use began with
the use of the legal drugs alcohol and tobacco, which were almost
universally used. A smaller group of the alcohol and tobacco users
(although often the majority of adolescents) initiated cannabis use,
and those whose progressed to regular cannabis use were more likely to
use the hallucinogens and &quot;pills&quot; (amphetamines and tranquillisers).
The heaviest users of &quot;pills&quot;, in turn, were more likely to use
cocaine and heroin. Generally, the earlier the initiation of any drug
use, and the heavier the use of any particular drug in the sequence,
the more likely the user was to use the next drug type in the sequence
(Kandel, 1978; Kandel et al, 1984; Kandel, 1988). 

This sequence of drug involvement has largely been confirmed by other
researchers. Donovan and Jessor (1983), for example, found much the
same sequence of initiation, with the variation that when problematic
alcohol use was distinguished from non-problem alcohol use, then
marijuana use preceded problem drinking in the sequence of
progression. These sequences have also been observed in the small
number of prospective studies which have followed a cohort of
adolescents into early adulthood and examined the patterns of
progression in drug use (e.g. Kaplan et al, 1982; Yamaguchi and
Kandel, 1984a, b). For the majority (87 per cent) of men &quot;the pattern
of progression is one in which the use of alcohol precedes marijuana;
alcohol and marijuana precede other illicit drugs; and alcohol,
cigarettes and marijuana precede the use of prescribed psychoactive
drugs&quot; (Yamaguchi and Kandel, 1984a, p671). Among the majority of
women (86 per cent) the sequence was such that &quot;either alcohol or
cigarettes precedes marijuana; alcohol, cigarettes and marijuana
precede other illicit drugs; alcohol and either cigarettes or
marijuana precede prescribed psychoactive drugs&quot; (Yamaguchi and
Kandel, 1984a, p671).

Yamaguchi and Kandel (1984b) also examined variables which predicted
progression to illicit drug use beyond cannabis use. They were
specifically interested in &quot;whether the use of certain drugs lower in
the sequence influences the initiation of higher drugs&quot; (p673) and
used sophisticated statistical methods to discover if the statistical
relationship between cannabis use and subsequent illicit drug use
persisted after controlling for temporally prior variables, such as
pre-existing adolescent behaviours and attitudes, interpersonal
factors, and age of initiation into drug use. If the relationship
persisted after controlling for these variables, confidence was
increased that the relationship was a causal one. 

Yamaguchi and Kandel found that the relationship between marijuana use
and progression to the use of other illicit drugs was not only
explained by friends' marijuana use (which also predicted
progression). Among men, the age of initiation of marijuana was an
important modifier of this relationship: men who initiated marijuana
use under the age of 16, were &quot;even more likely to initiate other
illicit drugs than is expected from the longer period of risk
resulting from an early age of onset&quot; (p677). Most importantly,
&quot;persons who have not used marijuana have very small probabilities of
initiating other drugs, ranging from 0.01 to 0.03 (men) or 0.02
(women)&quot; indicating that in their cohort, &quot;marijuana appears to be a
necessary condition for the initiation of other illicit drugs&quot; (p677).

The work of Kandel and her colleagues and that of other researchers
(e.g. O'Donnell and Clayton, 1982) has been interpreted by some as
confirming the &quot;gateway drug&quot; hypothesis or &quot;the stepping stone theory
of drug use&quot; (DuPont, 1984). Although it is not always clear what is
being claimed by proponents of this hypothesis, it does not imply that
a high proportion of those who experiment with marijuana will go on to
use heroin. Indeed, the overwhelming majority of cannabis users do not
use harder drugs like heroin. Kandel has explicitly disavowed this
interpretation of her work: 

The notion of stages in drug behavior does not imply that these stages
are either obligatory or universal ... the model is not meant to be a
variant of the controversial `stepping-stone' theory of drug addiction
in which use of marijuana was assumed inexorably to lead to the use of
other illicit 'hard' drugs, especially heroin (Kandel, 1988, pp58-61).


The view that cannabis use generally leads to the use of other illicit
drugs is contradicted by the evidence from the studies of Kandel and
her colleagues. Cannabis use is largely a behaviour of late
adolescence and early adulthood. Kandel's research has shown that it
has been initiated by the age of 19 in 90 per cent of those who ever
used cannabis, and initiation is rare after 20 years. The frequency of
its use peaks in the early 20s, when 50 per cent of males and 33 per
cent of females reported using, and rapidly declines by age 23, with
&quot;the assumption of the roles of adulthood .. getting married, entering
the labor force, or becoming a parent .. that may be incompatible with
involvement in illicit drugs and deviant lifestyles&quot; (Kandel and
Logan, 1984, p665). Hence, although those who use cannabis are more
likely to use other illicit drugs than those who do not, it is more
usual for cannabis use to decline in early adult life, with only a
minority continuing to use regularly, or progressing to the use of
more dangerous illicit drugs. Even in the case of the minority (about
one in four) who progress to daily cannabis use, the majority cease
their use by the mid to late 20s (Kandel and Davies, 1992).

A better supported hypothesis is that cannabis use, especially heavy
cannabis use, greatly increases the chances of progressing to the use
of other illicit drugs. But even this type of relationship does not
necessarily mean that cannabis use &quot;causes&quot; heroin use. As Kandel
(1988) has stressed, the existence of sequential stages of progression
does not &quot;necessarily imply causal linkages among different drugs&quot;.
The sequences &quot;could simply reflect the association of each class of
drugs with different ages of initiation or [with pre-existing]
individual attributes, rather than the specific effects of the use of
one class of drug on the use of another&quot; (Kandel, 1988, p61). 

A plausible alternative hypothesis is that of selective recruitment.
That is, there is a selective recruitment to cannabis use of deviant
and nonconformist persons with a predilection for the use of
intoxicating substances. On this hypothesis, the sequence in which
drugs are typically used reflects their differential availability and
societal disapproval (e.g. Donovan and Jessor, 1983). Further, the
sequence of initiation into drug use is held to be a consequence of
the availability of different drugs at different ages, with the use of
the least available, and most strongly socially disapproved &quot;hard&quot;
drugs being last. This hypothesis exculpates cannabis use as a cause
of progression to other illicit drug use, since cannabis use and other
illicit drug use are the common consequences of adolescent deviance
and nonconformity (Kaplan et al, 1982; Newcombe and Bentler, 1988). 

The selective recruitment hypothesis has received support from a
number of studies. There are substantial correlations between various
forms of nonconforming adolescent behaviour, such as, high school
drop-out, early premarital sexual experience and pregnancy,
delinquency, and alcohol and illicit drug use (Jessor and Jessor,
1977; Osgood et al, 1988). All such behaviours are correlated with
nonconformist and rebellious attitudes and anti-social conduct in
childhood (Shedler and Block, 1990) and early adolescence (Jessor and
Jessor, 1977; Newcombe and Bentler, 1988). Recent research indicates
that those who are most likely to use other illicit drugs, namely,
those who become regular cannabis users (Kandel and Davies, 1992), are
more likely to have a history of anti-social behaviour (Brook et al,
1992; McGee and Feehan, 1993), nonconformity and alienation (Brook et
al, 1992; Jessor and Jessor, 1978; Shedler and Block, 1990), perform
more poorly at school (Bailey et al, 1992; Hawkins et al, 1992; Kandel
and Davies, 1992), and use drugs to deal with personal distress and
negative affect (Kaplan and Johnson, 1992; Shedler and Block, 1990).
In general, the more of these risk factors that adolescents have, the
more likely they are to progress to more intensive involvement with
cannabis, and hence, to use other illicit drugs (Brook et al, 1992;
Newcombe, 1992; Scheier and Newcombe, 1991). 

One way of testing the selective recruitment hypothesis is to discover
whether cannabis use continues to predict progression to &quot;harder&quot;
illicit drugs after statistically controlling for pre-existing
differences in personality and other characteristics (e.g. deviance)
between cannabis users and non-users. In several such studies (e.g.
Kandel et al, 1986; O'Donnell and Clayton, 1982; Robins et al, 1970)
the relationship between cannabis and heroin use has been reduced when
pre-existing differences have been controlled for, but in all cases
the relationship has persisted, albeit in attenuated form. O'Donnell
and Clayton (1982) have interpreted this type of finding as strong
evidence in favour of a causal connection between cannabis and heroin
use. 

The credibility of such an argument for a causal interpretation of the
relationship between cannabis and heroin use depends upon whether the
most important prior characteristics have been adequately measured and
statistically controlled for in these studies. It would be difficult
to argue that this has been the case. Kandel et al (1986), for
example, were unable to measure the users' attitudes and family
characteristics at the time of drug initiation, or differential drug
availability, either or both of which &quot;may account for the observed
relationships between the early and late stage drugs&quot; (p679). In both
the studies of O'Donnell and Clayton (1982) and Robins et al (1970)
the measures of deviance &quot;prior&quot; to drug use were assessed
retrospectively with unknown validity. Baumrind (1983) has contested
the ability of these studies to exclude the alternative hypothesis
that personality differences which preceded cannabis use were the
causes of the progression to heroin use. She has argued that &quot;it is
safer in the absence of evidence of external validity&quot; of these
measures to assume that the relationship between marijuana use and
heroin use is spurious.

Even if we assume for the purpose of argument that the association
between cannabis and heroin use is not wholly explained by
pre-existing differences in deviant behaviour between cannabis users
and non-users, it remains to be explained how cannabis use &quot;causes&quot;
heroin use. It may seem superficially plausible to suggest that there
is something about the pharmacological effect of cannabis which
predisposes heavy users to progress to the use of other intoxicants,
but there is no obvious pharmacological mechanism for such
progression. Is it the development of tolerance to the positive
effects of cannabis, or to some form of experiential satiation with
its effects? Does the euphoria of cannabis awaken appetite for
intoxication by other drugs? These possibilities are difficult to
test. 

Any pharmacological explanation in which more potent illicit drugs
serve as &quot;substitutes&quot; for less potent drugs like alcohol and cannabis
has to contend with a number of facts. As already indicated, there are
relatively low rates of progression from cannabis use to the sustained
use of other illicit drugs; experimentation and abandonment is more
the norm. Even those heavy cannabis users who use other illicit drugs
continue to use cannabis as well as the new illicit drugs. As Donovan
and Jessor (1983) have noted: &quot;...`harder' drugs do not serve as
substitutes for `softer' drugs. Rather, a deepening of regular
substance use appears to go along with a widening of experience in the
drug domain&quot; (p548-549). 

There is also good reason for believing that the pattern of
progression observed among American adolescents in the 1970s was
conditioned by historical differences in drug availability (Kandel,
1978). Historical evidence from among earlier cohorts of heroin users
indicated that prior involvement with cannabis was confined to those
geographic areas of the US in which it was readily available (Goode,
1974). Research on African-American adolescents also showed a
variation in the sequence of drug use, with the use of more readily
available cocaine and heroin preceding the use of the less readily
available hallucinogens and &quot;pills&quot; (Kandel, 1978). Most dramatically,
American soldiers in Vietnam were more likely to use heroin than
alcohol because heroin was cheaper and more freely available than
alcohol to most American troops who were younger than the minimum
drinking age of 21 (Robins, 1993).

The historical and geographical variations in sequencing of illicit
drug use suggest a sociological explanation of both the sequencing of
illicit drug use and the higher rates of progression to heroin use
among heavy cannabis users. One of the most popular sociological
hypotheses is that cannabis use increases the chance of using other
illicit drugs by increasing contact with other drug users as part of a
drug using subculture. On this hypothesis, heavy cannabis use leads to
greater involvement in a drug using subculture which, in turn, exposes
cannabis users to the example of peers who have used other illicit
drugs. Such exposure also increases opportunities to use other illicit
drugs because of their increased availability within their social
circle, and places the individual in a social context in which illicit
drug use is encouraged and approved (e.g. Goode, 1974). 

Although plausible, there is surprisingly little direct evidence on
the drug subculture hypothesis. Goode (1974) presented data from the
late 1960s indicating that the number of friends who used heroin was a
stronger predictor of heroin use than was frequency of cannabis use,
arguing that the &quot;correlation between frequency of use and the use of
dangerous drugs ... [is] the result of interaction and involvement
with others who use&quot; (p332). These observations have been supported by
Kandel's (1984) finding that the strongest predictor of continued
cannabis use in early adulthood was the number of friends who were
cannabis users. 

The hypotheses of selective recruitment and socialisation in a
drug-using subculture are not mutually exclusive; both processes could
independently contribute to the relationship between regular marijuana
use and progression to heroin use (Goode, 1974). As already noted, the
selective recruitment hypothesis is supported by the consistent
finding of pre-existing differences between those who use marijuana
and those who do not, which are most marked in those whose continued
use of cannabis predicts their use of other illicit drugs. Once
initiated into cannabis use, heavy users become further distinguished
from non-users and those who have discontinued their use by the
intensity of their social relations and activities which involve the
use of marijuana, such as mixing with other drug users, and buying and
selling illicit drugs. The illegality of these activities confers on
the use, possession and sale of cannabis a socialising and subcultural
influence not possessed by the possession and use of the legal drugs
(Goode, 1974).

On the available evidence, the case for a pharmacological explanation
of the role of cannabis use in progression to other illicit drug use
is weak. A sociological explanation is more plausible than a
pharmacological one. The predictive value of cannabis use is more
likely to reflect a combination of: the selective recruitment to heavy
cannabis use of persons with combination of pre-existing personality
and attitudinal traits that predispose to the use of other
intoxicants; and the effects of socialisation into an illicit drug
subculture in which there is an increased availability of, and
encouragement to use, other illicit drugs. 



7.1.2 Educational performance 

A major concern about the effects of adolescent cannabis use has been
the possibility that its use impairs educational performance, and
increases the chances of students discontinuing their education. Such
a possibility is plausible: heavy cannabis use in the high school
years would impair memory and attention, thereby interfering with
learning in and out of the classroom (Baumrind and Moselle, 1985). If
use became chronic, persistently impaired learning would produce
poorer performance in high school and later in college, and increase
the chance of a student dropping out of school. If the adolescent's
school performance was marginal to begin with, as research reviewed
above suggests it is more likely to be among marijuana users, then
regular use could increase the pre-existing risk of high school
failure. Because of the importance of high school education to
occupational choice, this potential effect of adolescent cannabis use
could have consequences which ramified throughout the affected
individual's adult life.

Such a possibility has been supported by cross-sectional studies (e.g.
Kandel, 1984; Robins et al, 1970). These and other studies (see
Hawkins et al, 1992) have found a positive relationship between degree
of involvement with cannabis as an adult and the risk of dropping out
of high school. Studies of relationships between performance in
college and marijuana smoking have produced more equivocal results
(see below), usually failing to find consistent evidence that the
performance of cannabis users was more impaired than would be
predicted by their performance prior to cannabis use. These studies
have been criticised (Baumrind and Moselle, 1985; Cohen, 1982),
however. Baumrind and Moselle have argued that grade point average is
an insensitive measure of adverse educational effects among bright
high school and college students, while Cohen has argued that students
whose learning has been most adversely affected by their chronic heavy
cannabis use would not be found in college samples (Cohen, 1982).

Longitudinal studies of the effect of cannabis use on educational
achievement have produced mixed support for the hypothesis (e.g.
Kandel et al, 1986; Newcombe and Bentler, 1988). Kandel et al (1986),
for example, analysed the follow-up data from the cohort on which
their earlier cross-sectional finding of a relationship between
cannabis use and high school drop-out had been reported. They reported
a negative relationship between marijuana use in adolescence and years
of education completed in early adulthood but this relationship
disappeared once account was taken of the fact that those who used
cannabis in adolescence had much lower educational aspirations than
those who did not. 

Newcombe and Bentler (1988) used a different approach to analysis in
their study of the effects of adolescent drug use on educational
pursuits in early adulthood. They used a composite measure of degree
of drug involvement, which measured frequency of use of alcohol,
cannabis and &quot;hard drugs&quot;, and a measure of social conformity in
adolescence as a control variable in the analyses, which examined the
relationships between adolescent drug use and educational pursuits in
early adulthood. They found negative correlations between adolescent
drug use and high school completion, but after controlling for the
higher nonconformity and lower academic potential among adolescent
drug users, there was only a modest negative relationship between drug
use and college involvement. The only specific effect of any
particular type of drug use, over and above their measure of drug use
involvement, was a negative relationship between hard drug use in
adolescence and high school completion.

On the whole then, the available evidence from the longitudinal
studies suggests that there may be a modest statistical relationship
between cannabis and other illicit drug use in adolescence and poor
educational performance. The apparently strong relationship between
cannabis use and high school drop-out observed in cross-sectional
studies exaggerates the adverse impact of cannabis use on school
performance because adolescents who perform less well at school, and
have lower academic aspirations, are more likely to use cannabis. But
even if the relationship is statistically small, it may be
substantively important, especially among those whose educational
performance was marginal to begin with, because of the adverse effects
that educational underachievement has on subsequent life choices, such
as occupation, and the opportunities that they provide or exclude.



7.1.3 Occupational performance

Among those young adult cannabis users who enter the work-force, the
continued use of cannabis and other illicit drugs in young adulthood
might impair job performance for the same reasons that it has been
suspected of impairing school performance, namely, that chronic
intoxication impairs work performance. There is some suggestive
support for this expectation, in that cannabis users report higher
rates of unemployment than non-users (e.g. Kandel, 1984; Robins et al,
1970), but this comparison is likely to be confounded by the different
educational qualifications of the two groups. Longitudinal studies
have suggested that there is a relationship between adolescent
marijuana use and job instability among young adults which is not
explained by differences in education and other characteristics which
precede cannabis use (e.g. Kandel et al, 1986). Newcombe and Bentler
(1988) provided a more extensive analysis of the effects of adolescent
drug use on occupational performance in young adulthood. They examined
the relationships between adolescent drug use and income, job
instability, job satisfaction, and resort to public assistance in
young adulthood, while controlling for differences between users and
non-users in social conformity, academic potential and income in
adolescence. Their findings supported those of Kandel and colleagues
in that adolescent drug users had a larger number of changes of job
than non-drug users. Newcombe and Bentler conjectured that this
reflects either impaired work performance, or a failure of illicit
drug users to develop responsible employment behaviours such as
conscientiousness, thoroughness, and reliability. 



7.1.4 Interpersonal relationships

There are developmental and empirical reasons for suspecting that
cannabis use may adversely affect interpersonal relationships. The
developmental reason is that heavy adolescent drug use may produce a
developmental lag, entrenching adolescent styles of thinking and
coping which would impair the ability to form adult interpersonal
relationships (Baumrind and Moselle, 1985). The empirical reason is
the strong positive correlation between drug use, precocious sexual
activity, and early marriage, which in turn predicts a high rate of
relationship failure (Newcombe and Bentler, 1988). 

Cross-sectional studies of drug use in young adults have indicated
that a high degree of involvement with marijuana predicts a reduced
probability of marriage, an increased rate of cohabiting, an increased
risk of divorce or terminated de facto relationships, and a higher
rate of unplanned parenthood and pregnancy termination (Kandel, 1984;
Robins et al, 1970). Kandel (1984) also found that heavy cannabis
users were more likely to have a social network in which friends and
the spouse or partner were also cannabis users (Kandel, 1984). These
findings have been largely confirmed in analyses of the longitudinal
data from this cohort of young adults (Kandel et al, 1986). 

Newcombe and Bentler (1988) found similar relationships between drug
use and early marriage in their analysis of the cross-sectional data
from their cohort of young adults in Los Angeles. Drug use in
adolescence predicted an increased rate of early family formation in
late adolescence and of divorce in early adulthood, which they
interpreted as evidence that: &quot;early drug involvement leads to early
marriage and having children which then results in divorce&quot; (p97).
Newcombe and Bentler argued that this finding provided evidence for
their theory of &quot;precocious development&quot;, according to which drug use
accelerates development and &quot;... drug users tend to bypass or
circumvent the typical maturational sequence of school, work and
marriage and become engaged in adult roles of jobs and family
prematurely without the necessary growth and development to enhance
success with these roles ... [developing] a pseudomaturity that ill
prepares them for the real difficulties of adult life&quot; (pp35-36).

Less attention has been paid to the possibility that cannabis use has
adverse effects on the development of social relationships outside
marriage. Newcombe and Bentler (1988) have reported one of the few
such studies. They investigated the relationship between adolescent
drug use and degree of social support and the experience of loneliness
reported in young adulthood. Cross-sectional analyses of data on drug
use and degree of social support in adolescence showed that drug users
reported having less social support than non-users (Newcombe and
Bentler, 1988). But the effects of adolescent drug use on social
support and loneliness in young adulthood were minor. Alcohol use in
adolescence was associated with decreased loneliness in adulthood,
while only hard drug use in adolescence was associated with decreased
social support and increased loneliness in early adulthood.



7.1.5 Mental health

The impact of adolescent cannabis and other drug use on general health
in early adult life has not been investigated, in large part because
it will be difficult to detect any adverse effects of adolescent drug
use on adult health in the longitudinal studies that have been
conducted. In such cohorts, heavy cannabis use - the riskiest pattern
of use from the perspective of health effects - has generally been
observed to occur at low rates. In any case, young adulthood is too
soon to expect any adverse health effects to be evident, because of
the relatively short period of use by young adults. 

For good reasons, the effects of cannabis use on mental health have
been the health outcomes most studied. Cannabis is a psychoactive drug
which effects the users' mood and feeling, so chronic heavy use could
possibly adversely affect mental health, especially among those whose
adjustment prior to their cannabis use was poor and who use cannabis
to modulate and control their negative mood states and emotions. The
relationships between cannabis use and the risks of developing
dependence upon cannabis or major mental illnesses such as
schizophrenia, are reviewed below (see pp110-122 and pp173-178
respectively). In this section attention is confined to non-psychotic
symptoms of depression and distress. 

A number of studies have suggested an association between cannabis use
and poor mental health. Kandel's (1984) cross-sectional study found an
inverse association between the intensity of marijuana involvement and
degree of satisfaction with life, and a positive association between
marijuana involvement and a greater likelihood of having consulted a
mental health professional, and having been hospitalised for a
psychiatric disorder (Kandel, 1984). Longitudinal analyses of this
same cohort, however, found only weak associations between adolescent
drug use and these adult outcomes; the strongest relationship between
adolescent drug use and mental health, was a positive relationship
between cigarette smoking in adolescence and increased symptoms of
depression in adulthood (Kandel et al, 1986). 

The cross sectional adult data in Newcombe and Bentler's (1988) study
showed strong relationships between adolescent drug use and emotional
distress, psychoticism and lack of a purpose in life. Emotional
distress in adolescence predicted emotional distress in young
adulthood, but there were no relationships between adolescent drug use
and the experience of emotional distress, depression and lack of a
sense of purpose in life in young adulthood. There were a number of
small but substantively significant effects of adolescent drug use on
mental health in young adulthood. Adolescent drug use predicted
psychotic symptoms in young adulthood, and hard drug use in
adolescence predicted increased suicidal ideation in young adulthood,
after controlling for general drug use and earlier emotional distress.
Newcombe and Bentler interpreted these findings as evidence that
adolescent drug use &quot;interferes with organised cognitive functioning
and increases thought disorganisation into young adulthood&quot; (p180).



7.1.6 Delinquency and crime

Since initiation into illicit drug use and the maintenance of regular
illicit drug use are both strongly related to degree of social
nonconformity or deviance (e.g. Donovan and Jessor, 1980; Newcombe and
Bentler, 1988; Polich et al, 1984) it is reasonable to expect
adolescent illicit drug use to predict social nonconformity and
various forms of delinquency and crime in young adulthood.
Cross-sectional studies of adult drug users seem to support this
hypothesis: they indicate that there is a relationship between the
extent of marijuana use as an adult and a history of lifetime
delinquency (e.g. Kandel, 1984; Robins et al, 1970), having been
convicted of an offence, and having had a motor vehicle accident while
intoxicated (Kandel, 1984). 

Johnston et al (1978) reported a detailed analysis of the relationship
between intensity of drug use and delinquency across two waves of
interviews of adolescent males undertaken as part of the &quot;Youth in
Transition&quot; study. They found in their cross-sectional data that there
was a strong relationship between involvement in delinquency and
degree of involvement with illicit drugs, that is, self-reported rates
of delinquent activity increased steadily with increasing degree of
drug involvement. However, a series of analyses looking at changes in
drug use and crime over time indicated that the groups defined on
intensity of drug involvement differed strongly in their rate of
delinquent acts before their drug use. Moreover, the onset of illicit
drug use (including cannabis) had little effect on delinquent acts,
except perhaps among those who used heroin, among whom there was a
suggestion that the rates of delinquency increased. Finally, rates of
delinquent acts declined over time in all drug use groups and at about
the same rate. The findings were interpreted as delivering &quot;a
substantial, if not mortal, blow&quot; to the hypothesis that &quot;drug use
somehow causes other kinds of delinquency&quot; (p156).

Newcombe and Bentler (1988) reported a somewhat more complicated
although no less plausible picture in their longitudinal study. They
reported a positive relationship between drug use and criminal
involvement in adolescence, but found more mixed results in the
relationship between adolescent drug use and criminal activity in
young adulthood. Adolescent drug use predicted drug crime involvement
in young adulthood; but after controlling for other variables, it was
negatively correlated with violent crime, and general criminal
activities in young adulthood. Newcombe and Bentler argued that these
negative correlations indicated that the correlation between different
forms of delinquency in adolescence decreases with age, as criminal
activities become differentiated into drug-related and
non-drug-related offences. Hard drug use in adolescence also had a
specific effect on young adult crime over and above that of drug use
in general: it predicted an increased rate of criminal assaults in
young adulthood. 



7.1.7 Conclusions

There are a number of clear outcomes of research on adolescent
cannabis and other illicit drug use. First, there is strong continuity
of development from adolescence into early adult life in which many of
the indicators of adverse development which have been attributed to
cannabis use precede its first use (Kandel, 1978). These include minor
delinquency, poor educational performance, nonconformity, and poor
adjustment. Second, there was a predictable sequence of initiation
into the use of illicit drugs among American adolescents in the 1970s
in which the use of licit drugs preceded experimentation with
cannabis, which preceded the use of hallucinogens and &quot;pills&quot;, which
in turn preceded the use of heroin and cocaine. Generally, the earlier
the age of initiation into drug use, and the greater the involvement
with any drug in the sequence, the greater the likelihood of
progression to the next drug in sequence.

The causal significance of these findings, and especially the role of
cannabis in the sequence of illicit drug use, remains controversial.
The hypothesis that the sequence of use represents a direct
pharmacological effect of cannabis use upon the use of later drugs in
the sequence is the least compelling. A more plausible and better
supported explanation is that it reflects a combination of the
selective recruitment into cannabis use of nonconforming and deviant
adolescents who have a propensity to use illicit drugs, and the
socialisation of cannabis users within an illicit drug using
subculture which increases the exposure, opportunity, and
encouragement to use other illicit drugs.

There has been some support for the hypothesis that heavy adolescent
use of cannabis impairs educational performance. Cannabis use appears
to increase the risk of failing to complete a high school education,
and of job instability in young adulthood. The apparent strength of
these relationships in cross-sectional studies has been exaggerated
because those who are most likely to use cannabis have lower
pre-existing academic aspirations and high school performance than
those who do not. Even though more modest than has sometimes been
supposed, the apparently adverse effects of cannabis and other drug
use upon educational performance may cascade throughout young adult
life, affecting choice of occupation, level of income, choice of mate,
and quality of life of the user and his or her children. 

There is weaker but suggestive evidence that heavy cannabis use has
adverse effects upon family formation, mental health, and involvement
in drug-related (but not other types of) crime. In the case of each of
these outcomes, the apparently strong associations revealed in
cross-sectional data are much more modest in longitudinal studies
after statistically controlling for associations between cannabis use
and other variables which predict these adverse outcomes. 

On balance, there are sufficient indications that cannabis use in
adolescence adversely affects adolescent development to conclude that
it is a socially desirable goal to discourage adolescent cannabis use,
and especially regular cannabis use. 



7.2 Psychological adjustment in adults 



7.2.1 Is there an amotivational syndrome?

Anecdotal reports that chronic heavy cannabis use impairs motivation
and social performance have been described in the older literature on
cannabis use in societies with a long history of use, such as Egypt,
the Carribean and elsewhere (e.g. Brill and Nahas, 1984). In these
societies, heavy cannabis use is the prerogative of the poor,
impoverished and unemployed. With the increase of cannabis use among
young adults in the USA in the early 1970s, there were clinical
reports of a similar syndrome occurring among heavy cannabis users
(e.g. Kolansky and Moore, 1971; Millman and Sbriglio, 1986; Tennant
and Groesbeck, 1972). These investigators have typically described a
state among chronic, heavy cannabis users in which the users' focus of
interest narrowed, they became apathetic, withdrawn, lethargic,
unmotivated, and showed evidence of impaired memory, concentration and
judgment (Brill and Nahas, 1984; McGlothin and West, 1968). This
constellation of symptoms has been described as an &quot;amotivational
syndrome&quot; (e.g. McGlothin and West, 1968; Smith, 1968), which some
have claimed is an organic brain syndrome caused by the effects of
chronic cannabis intoxication (Tennant and Groesbeck, 1972). All these
reports have been uncontrolled, and often poorly documented, so that
it has not been possible to disentangle the effects of chronic
cannabis use from those of poverty and low socioeconomic status, or
pre-existing personality and other psychiatric disorders (Edwards,
1976; Millman and Sbriglio, 1986; National Academy of Science, 1982;
Negrete, 1983).

There is no research evidence which unequivocally demonstrates that
cannabis does or does not adversely affect the motivation of chronic
heavy adult cannabis users. It has proved singularly difficult to
provide better controlled research evidence which has permitted a
consensus to emerge upon the issue. Two types of investigation have
been carried out in an attempt to assess the motivational effects of
chronic heavy cannabis use: field studies of chronic heavy cannabis
using adults in societies with a tradition of such use, e.g. Costa
Rica (Carter et al, 1980) and Jamaica (Rubin and Comitas, 1975); and
laboratory studies of the effects on the motivation and performance of
volunteers who have been administered heavy doses of cannabis over
periods of up to 21 days (e.g. Mendelson et al, 1974). There has also
been some evidence on the prevalence of adverse psychological effects
of cannabis from a small number of studies of chronic cannabis users
(e.g. Halikas et al, 1982). 



7.2.2 Field studies of motivation and performance

Rubin and Comitas (1975) examined the effects of ganja smoking on the
performance of Jamaican farmers who regularly smoked cannabis in the
belief that it enhanced their physical energy and work productivity.
They used videotapes to measure movement and biochemical measures of
exhaled breath to assess caloric expenditure before and after ganja
smoking. Four case histories were reported which indicated that the
level of physical activity increased immediately after smoking ganja,
as did caloric expenditure, but not productivity. It seemed to be that
after smoking ganja the workers engaged in more intense and
concentrated labour, but this was done less efficiently, especially by
heavy users. Contrary to the hypothesis that cannabis use produced an
impairment in motivation, they concluded: &quot;In all Jamaican settings
observed, the workers are motivated to carry out difficult tasks with
no decrease in heavy physical exertion, and their [mistaken]
perception of increased output is a significant factor in bolstering
their motivation to work.&quot; (p79).

A study of Costa Rican cannabis smokers produced mixed evidence on the
impact of chronic cannabis use on job performance (Carter et al,
1980). A comparison was made of the employment histories of 41 pairs
of heavy users (10 marijuana cigarettes per day for 10 or more years)
and non-users who had been matched on age, marital status, education,
occupation, and alcohol and tobacco consumption. The comparison
indicated that non-users were more likely than users to have attained
a stable employment history, to have received promotions and raises,
and to be in full-time employment. Users were also more likely to
spend all or more than their incomes, and to be in debt. Among users,
however, the relationship between average daily marijuana consumption
and employment was the obverse of what the amotivational hypothesis
would predict, that is, those &quot;who had steady jobs or who were
self-employed were smoking more than twice as many marijuana
cigarettes per day as those with more frequent job changes, or those
who were chronically unemployed&quot; (p153), indicating that &quot;the level of
consumption was related more to relative access than to individual
preference&quot; (p154).

Evidence from these field studies is usually interpreted as failing to
demonstrate the existence of the amotivational syndrome (e.g.
Dornbush, 1974; Hollister, 1986; Negrete, 1988). There are critics,
however, who raise doubts about how convincing such apparently
negative evidence is. Cohen (1982), for example, has argued that the
chronic users in three field studies have come from socially marginal
groups, so that the cognitive and motivational demands of their
everyday lives were insufficient to detect any impairment caused by
chronic cannabis use. Moreover, the sample sizes of these studies have
been too small to exclude the possibility of an effect occurring among
a minority of heavy users. 

Other evidence suggests that an amotivational syndrome is likely to be
a rare occurrence, if it exists. Halikas et al (1982), for example,
followed up 100 regular cannabis users six to eight years after
initially recruiting them and asked them about the experience of
symptoms suggestive of an amotivational syndrome. They found only
three individuals who had ever experienced such a cluster of symptoms
in the absence of significant symptoms of depression. These
individuals were not distinguished from the other smokers by their
heaviness of use. Nor was their experience of these symptoms obviously
related to changes in pattern of use; they seemed to come and go
independently of continued heavy cannabis use. 



7.2.3 Laboratory studies of motivation and performance

In the light of Halikas et al's low estimate of the prevalence of
amotivational symptoms among chronic heavy cannabis users, it is
perhaps not surprising that the small number of laboratory studies of
long-term heavy cannabis use have failed to provide unequivocal
evidence of impaired motivation (Edwards, 1976). The early studies
conducted as part of the LaGuardia Commission inquiry (see Mendelson
et al, 1974) reported deterioration in behaviour among prisoners given
daily doses of cannabis over a period of some weeks, but these reports
were based upon largely uncontrolled observation. So too was the more
recent study of Georgotas and Zeidenberg (1979) in which it was
reported that five healthy male marijuana users who were placed on a
dose regimen of 210mg of THC per day for a month appeared &quot;moderately
depressed, apathetic, at times dull and alienated from their
environment and with impaired concentration&quot; (p430). 

A study which used standardised measures of performance rather than
relying on observational data failed to observe such effects
(Mendelson et al, 1974). In this study 10 casual and 10 heavy cannabis
smokers were observed over a 31 days study period in a research
laboratory. For 21 of these days, subjects were given access to as
many marijuana cigarettes as they earned by performing a simple
operant task which involved pressing a button to move a counter. The
points could be exchanged for money (60 points equal to a cent),
packets of cigarettes (3,000 each), and marijuana cigarettes (6,000
each). Mendelson et al found that all subjects earned the maximum
number of points allowed per day (60,000) throughout the study and
that output was unaffected by marijuana smoking whereas ad libitum
access to alcohol by heavy drinking subjects in the same setting
profoundly disrupted performance of the same task. Mendelson et al
concluded that: &quot;our data disclosed no indication of a relationship
between decrease in motivation to work at an operant task and acute or
repeat dose effects of marihuana&quot; (p176).

A number of criticisms can be made of this study. First, the period of
heavy use was only 21 days by comparison with the life histories of 15
or more years daily use in heavy cannabis users in the field studies.
Second, the subjects in the study were volunteers who were all
healthy, young cannabis users with a mean IQ of 120 and nearly three
years of college education, and some of whom reported during
debriefing that they were motivated to perform well so as to
demonstrate that their cannabis use did not have any adverse effect on
their performance (Mendelson et al, 1974). Third, the tasks that users
were asked to perform (button presses) were undemanding. Mendelson et
al countered that these tasks had nonetheless been shown to detect the
deleterious effects of heavy alcohol use. Moreover, they argued, there
were other indicators that their subjects' performance and motivation
was unimpaired while using cannabis, namely, all subjects completed
the study, most undertook the daily assessments conducted throughout,
all complied with a roster for cleaning and house-keeping duties, and
all kept up their preferred recreational activities throughout the
study period. 

A similar study was completed at the Addiction Research Foundation,
the results of which have not been fully published, although Campbell
(1976) has provided a brief account of its findings. In this study,
young cannabis users were studied in a residential token economy in
which they could earn tokens that could be exchanged for money and
other goods by manufacturing woven woollen belts. Unlike the Mendelson
study, subjects' cannabis doses were under the experimenters' control
and subjects were given mandatory high doses. The subjects showed no
gross behavioural changes, no social deterioration, and no alterations
in intellectual functioning, but the results suggested, contrary to
those of Mendleson et al, that chronic heavy cannabis use reduced
productivity, especially during the period of mandatory high dosing
(30mg of THC per day) which many subjects found aversive. It remains
unclear how applicable the results of performance with mandatory high
dosing are to the situation where users have control over their own
dose.



7.2.4 Discussion

The status of the amotivational syndrome remains contentious, in part
because of differences in the appraisal of evidence from clinical
observations and controlled studies. On the one hand, there are those
who find the small number of cases of &quot;amotivational syndrome&quot;
compelling clinical evidence of the marked deterioration in
functioning that chronic heavy cannabis use can produce. On the other,
there are those who are more impressed by the largely unsupportive
findings of the small number of field and laboratory studies. Although
the controlled studies have largely been interpreted as failing to
substantiate the clinical observations (e.g. Millman and Sbriglio,
1986), the possibility has been kept alive by suggestive reports that
regular cannabis users experience a loss of ambition and impaired
school and occupational performance as adverse effects of their use
(e.g. Hendin et al, 1987), and that some ex-cannabis users give
impaired occupational performance as a reason for stopping (Jones,
1984). It seems reasonable to conclude that if there is an
amotivational syndrome, it is a relatively rare consequence of
prolonged heavy cannabis use. If this is the case, then studies of
motivation and performance among dependent cannabis users may be the
most promising place to look for examples of the syndrome. 

Even if we assume that chronic heavy cannabis use impairs adult
motivation and performance, there remains the question of mechanism
(Baumrind, 1983). Is there a specific amotivational syndrome caused by
the chronic intake of cannabinoids, or are we mistaking it for the
impaired cognitive and psychomotor performance of chronically
intoxicated dependent cannabis users (Edwards, 1976)? Are we perhaps
mistaking a depressive syndrome among heavy cannabis users for the
amotivational syndrome? (Cohen, 1982) Assuming that cases can be
identified, how easy is it to reverse the syndrome or behaviour
pattern after a period of abstinence from cannabis?



7.2.5 Conclusions 

The evidence for an amotivational syndrome among adults is, at best,
equivocal. The positive evidence largely consists of case histories,
and observational reports. The small number of controlled field and
laboratory studies have not found compelling evidence for such a
syndrome, although their evidential value is limited by the small
sample sizes and limited sociodemographic characteristics of the field
studies, by the short periods of drug use, and the youthful good
health and minimal demands made of the volunteers observed in the
laboratory studies. It nonetheless is reasonable to conclude that if
there is such a syndrome, it is a relatively rare occurrence, even
among heavy, chronic cannabis users.



References

Bailey, S.L., Flewelling, J.V., and Rachal, J.V. (1992) Predicting
continued use of marijuana among adolescents: the relative influence
of drug-specific and social context factors. Journal of Health and
Social Behavior, 33, 51-66.

Baumrind, D. (1983) Specious causal attribution in the social
sciences: the reformulated stepping stone hypothesis as exemplar.
Journal of Personality and Social Psychology, 45, 1289-1298.

Baumrind, D. and Moselle, K.A. (1985) A developmental perspective on
adolescent drug abuse. Advances in Alcohol and Substance Abuse, 5,
41-67.

Brill, H. and Nahas, G.G. (1984) Cannabis intoxication and mental
illness. In G.G. Nahas Marihuana in Science and Medicine. New York:
Raven Press.

Brook, J.S., Cohen, P., Whiteman, M. and Gordon, A.S. (1992)
Psychosocial risk factors in the transition from moderate to heavy use
or abuse of drugs. In M. Glantz and R. Pickens (eds) Vulnerability to
Drug Abuse. Washington: American Psychological Association.

Campbell, I. (1976) The amotivational syndrome and cannabis use with
emphasis on the Canadian Scene. Annals of New York Academy of
Sciences, 282, 33-36.

Carter, W. E, Coggins, W. and Doughty, P.L. (1980) Cannabis in Costa
Rica: A study of chronic marihuana use. Philadelphia: Institute for
the Study of Human Issues.

Cohen, S. (1982) Cannabis effects upon adolescent motivation. In
National Institute on Drug Abuse. Marijuana and Youth: Clinical
Observations on Motivation and Learning. Rockville, Maryland: National
Institute on Drug Abuse.

Donnelly, N. and Hall, W. (1994) Patterns of Cannabis Use in
Australia. Paper prepared for the National Task Force on Cannabis.
National Drug Strategy Monograph Series No. 27. Canberra: Australian
Government Publishing Service.

Donovan, J.E. and Jessor, R. (1983) Problem drinking and the dimension
of involvement with drugs: A Guttman Scalogram analysis of adolescent
drug use. American Journal of Public Health, 73, 543-552.

Dornbush, R.L. (1974) The long-term effects of cannabis use. In L.L.
Miller (ed) Marijuana: Effects on Behavior. New York: Academic Press.

DuPont, R. (1984) Getting Tough on Gateway Drugs. Washington, DC,
American Psychiatric Press.

Edwards, G. (1976) Cannabis and the psychiatric position. In J.D.P.
Graham (ed) Cannabis and Health. London: Academic Press.

Georgotas, A. and Zeidenberg, P. (1979) Observations on the effects of
four weeks of heavy marijuana smoking on group interaction and
individual behavior. Comprehensive Psychiatry, 20, 427-432.

Goode, E. (1974) Marijuana use and the progression to dangerous drugs.
In L.L. Miller (Ed) Marijuana: Effects on Human Behavior. New York:
Academic Press.

Halikas, J.A., Weller, R.A., Morse, C. and Shapiro, T. (1982)
Incidence and characteristics of amotivational syndrome, including
associated findings, among chronic marijuana users. In National
Institute on Drug Abuse. Marijuana and Youth: Clinical Observations on
Motivation and Learning. Rockville, Maryland: National Institute on
Drug Abuse.

Hawkins, J.D., Catalano, R.F. and Miller, J.Y. (1992) Risk and
protective factors for alcohol and other drug problems in adolescence
and early adulthood: implications for substance abuse prevention.
Psychological Bulletin, 112, 64-105.

Hendin, H., Haas, A.P., Singer, P., Eller, M. and Ulman, R. (1987)
Living High: Daily Marijuana Use Among Adults. New York: Human
Sciences Press.

Hollister, L.E. (1986) Health aspects of cannabis. Pharmacological
Reviews, 38, 1-20.

Jessor, R. and Jessor, S.L. (1977) Problem Behavior and Psychosocial
Development: A Longitudinal Study of Youth. New York: Academic Press.

Jessor, R. and Jessor, S.L. (1978) Theory testing in longitudinal
research on marihuana use. In D.B. Kandel (ed) Longitudinal Research
on Drug Use: Empirical Findings and Methodological Issues. New York:
John Wiley and Sons.

Johnston, L.D., O'Maley, P.M. and Eveland, L.K. (1978) Drugs and
delinquency: A search for causal connections. In D.B. Kandel (ed)
Longitudinal Research on Drug Use: Empirical Findings and
Methodological Issues. New York: John Wiley and Sons.

Jones, R.T. (1984) Marijuana: Health and treatment issues. Psychiatric
Clinics of North America, 7, 703-712.

Kandel, D.B. (1978) Convergences in prospective longtudinal surveys of
drug use in normal populations. In D.B. Kandel (ed) Longitudinal
Research on Drug Use: Empirical Findings and Methodological Issues.
New York: John Wiley and Sons.

Kandel, D.B. (1984) Marijuana users in young adulthood. Archives of
General Psychiatry, 41, 200-209.

Kandel, D.B. (1988) Issues of sequencing of adolescent drug use and
other problem behaviors. Drugs and Society, 3, 55-76.

Kandel, D.B. and Davies, M. (1992) Progression to regular marijuana
involvement: Phenomenology and risk factors for near daily use. In M.
Glantz and R. Pickens (eds) Vulnerability to Drug Abuse. Washington:
American Psychological Association.

Kandel, D. and Faust, R. (1975) Sequence and stages in patterns of
adolescent drug use. Archives of General Psychiatry, 32, 923-932.

Kandel, D.B. and Logan, J.A. (1984) Patterns of drug use from
adolescence to young adulthood: I. Periods of risk for initiation,
continued use and discontinuation. American Journal of Public Health,
1984, 74, 660-666.

Kandel, D.B., Davies, M., Karus, D. and Yamaguchi, K. (1986) The
consequences in young adulthood of adolescent drug involvement.
Archives of General Psychiatry, 1986, 43, 746-754.

Kaplan, H.B., Martin, S. and Robbins, C. (1982) Pathways to adolescent
drug use: self-derogation, peer influence, weakening of social
controls, and early substance use. Journal of Health and Social
Behavior, 25, 270-289.

Kaplan, H.B. and Johnson, R.J. (1992) relationships between
circumstances surrounding initial drug use and escalation of drug use:
moderating effects of gender and early adolescent experiences. In M.
Glantz and R. Pickens (eds) Vulnerability to Drug Abuse. Washington:
American Psychological Association.

Kleiman, M.A.R. (1989) Marijuana: Costs of Abuse, Costs of Control.
New York: Greenwood Press.

Kleiman, M.A.R. (1992) Against Excess: Drug Policy for Results. New
York: Basic Books.

Kolansky, H. and Moore, W.T. (1971) Effects  of marihuana on
adolescents and young adults. Journal of the American Medical
Association, 216, 486-492.

Lantner, I.L. (1982) Marijuana abuse by children and teenagers: a
pediatrician's view. Cohen, S. (1982) Cannabis effects upon adolescent
motivation. In National Institute on Drug Abuse. Marijuana and Youth:
Clinical Observations on Motivation and Learning. Rockville, Maryland:
National Institute on Drug Abuse.

McGee, R.O. and Feehan, M. (1993) Cannabis use among New Zealand
adolescents. New Zealand Medical Journal, 106, 345.

McGlothin, W.H. and West, L.J. (1968) The marijuana problem: An
overview. American Journal of Psychiatry, 125, 370-378.

Meeks, J.E. (1982) Some clinical comments on chronic marijuana use in
adolescent psychiatric patients. In National Institute on Drug Abuse.
Marijuana and Youth: Clinical Observations on Motivation and Learning.
Rockville, Maryland: National Institute on Drug Abuse.

Mendelson, J.H., Rossi, A.M., and Meyer, R.E. (1974) The Use of
Marihuana: A Psychological and Physiological Inquiry. New York: Plenum
Press.

Millman, R.B. and Sbriglio, R. (1986) Patterns of use and
psychopathology in chronic marijuana users. Psychiatric Clinics of
North America, 9, 533-545.

National Academy of Science. (1982) Marijuana and Health. Washington,
DC: Institute of Medicine, National Academy Press.

Milman, D.H. (1982) Psychological effects of cannabis in adolescence.
In National Institute on Drug Abuse. Marijuana and Youth: Clinical
Observations on Motivation and Learning. Rockville, Maryland: National
Institute on Drug Abuse.

National Academy of Science, Institute of Medicine. (1982) Marijuana
and Health. Washington, DC: National Academy Press.

Negrete, J (1983) Psychiatric aspects of cannabis use. In K.O. Fehr
and H. Kalant (eds) Cannabis and Health Hazards. Toronto: Addiction
Research Foundation.

Negrete, J (1988) What's happened to the cannabis debate? British
Journal of Addiction, 83, 359-372.

Newcombe, M.D. (1992) Understanding the multidimensional nature of
drug use and abuse: The role of consumption, risk factors and
protective factors. In M. Glantz and R. Pickens (eds) Vuln

7. The ps
Drug Abuse. Washington: American Psychological Association.

Newcombe, M.D. and Bentler, P. (1988) Consequences of Adolescent Drug
Use: Impact on the Lives of Young Adults. Newbury Park, California:
Sage Publications.

O'Donnell, J.A. and Clayton, R.R. (1982) The stepping stone hypothesis
- marijuana, heroin and causality. Chemical Dependencies, 4, 229-241.

Osgood, D.W., Johnston, L.D., O'Malley, P.M., and Bachman, J.G. (1988)
The generality of deviance in late adolescence and early adulthood.
American Sociological Review, 53, 81-93.

Polich, J.M., Ellickson, P.L., Reuter, P., and Kahan, J.P. (1984)
Strategies for Controlling Adolescent Drug Use. Santa Monica,
California: The Rand Corporation.

Robins, L., Darvish, H.S., and Murphy, G.E. (1970) The long-term
outcome for adolescent drug users: A follow-up study of 76 users and
146 nonusers. In J. Zubin and A.M. Freedman (eds) The Psychopathology
of Adolescence. New York: Grune and Stratton.

Robins, L. (1993) Vietnam veterans' rapid recovery from heroin
addiction: a fluke or normal expectation? Addiction, 88, 1041-1054.

Rubin, V. and Comitas, L. (1975) Ganja in Jamaica: A Medical
Anthropological Study of Chronic Marihuana Use. The Hague: Mouton
Publishers.

Scheier, L.M. and Newcombe, M.D. (1991) Psychosocial predictors of
drug use initiation and escalation: an expansion of the multiple risk
factors hypothesis using longitudinal data. Contemporary Drug
Problems, 18, 31-73.

Shedler, J. and Block, J. (1990) Adolescent drug use and psychological
health. American Psychologist, 45, 612-630.

Smith, D.E. (1968) Acute and chronic toxicity of marijuana. Journal of
Psychedelic Drugs, 2, 37-47.

Smith, D.E. and Seymour, R.B. (1982) Clinical perspectives on the
toxicity of marijuana: 1967-1981. In National Institute on Drug Abuse.
Marijuana and Youth: Clinical Observations on Motivation and Learning.
Rockville, Maryland: National Institute on Drug Abuse.

Tennant, F.S. and Groesbeck, C.J. (1972) Psychiatric effects of
hashish. Archives of General Psychiatry, 33, 383-386.

Yamaguchi, K. and Kandel, D.B. (1984a) Patterns of drug use from
adolescence to adulthood. II Sequences of progression. American
Journal of Public Health, 1984, 74, 668-672.

Yamaguchi, K. and Kandel, D.B. (1984b) Patterns of drug use from
adolescence to adulthood. III Predictors of progression. American
Journal of Public Health, 1984, 74, 673-681.



7.3 Is there a cannabis dependence syndrome? 



7.3.1 The significance of dependence

If there is a cannabis dependence syndrome, it has important
implications for both cannabis users and public health (Edwards,
1982). First, people who currently use cannabis, and young adults who
are considering whether to use it, should make decisions which are
informed by an appraisal of the risk of their becoming dependent on
the drug. If there is a risk of dependence, and cannabis continues to
be regarded as a drug that does not produce dependence, such decisions
cannot be informed.

Second, if there is a cannabis dependence syndrome, then persons who
become dependent on cannabis place themselves at an increased risk of
experiencing any adverse health effects attributable to cannabis use.
Dependent cannabis users typically smoke two or more cannabis
cigarettes daily over many years, putting themselves at risk of the
pulmonary hazards of smoking. A chronic state of cannabis intoxication
could place them at increased risk of accidents, and the THC they
absorb may accumulate in their bodies, placing them at increased risk
of experiencing any adverse health effects of THC (Edwards, 1982). 

Third, although a dependent pattern of cannabis use may be rare in
comparison with the more prevalent pattern of experimental and
intermittent use, it may nonetheless have public health significance
because of the widespread experimentation with cannabis in many
Western societies. The public health significance of cannabis
dependence would also increase if the prevalence of use substantially
increased as a result of changes in the availability of the drug.



7.3.2 The nature of dependence

For much of the 1960s and 1970s the apparent absence of tolerance to
the effects of cannabis, and of a withdrawal syndrome analogous to
that seen in alcohol and opioid dependence, supported the consensus of
informed opinion that cannabis was not a drug of dependence. Expert
views on the nature of dependence changed during the late 1970s and
early 1980s, when the more liberal definition of drug dependence
embodied in Edwards and Gross's (1976) alcohol dependence syndrome was
extended to all psychoactive drugs (Edwards et al, 1981). The drug
dependence syndrome reduced the emphasis upon tolerance and
withdrawal, and attached greater importance to symptoms of a
compulsion to use, a narrowing of the drug using repertoire, rapid
reinstatement of dependence after abstinence, and the high salience of
drug use in the user's life. This new conception influenced the
development of the Third Revised Edition of the Diagnostic and
Statistical Manual of the American Psychiatric Association (1987)
(DSM-III-R), which reduced the importance of tolerance and withdrawal
symptoms in favour of a greater emphasis upon continued use of a drug
in the face of its adverse effects. 



7.3.2.1 Drug dependence in DSM-III-R

&quot;Psychoactive substance use disorders&quot; include all forms of drug and
alcohol dependence in DSM-III-R (American Psychiatric Association,
1987; Kosten et al, 1987). &quot;The essential feature of this disorder is
a cluster of cognitive, behavioral and physiologic symptoms that
indicate that the person has impaired control of psychoactive
substance use and continues use of the substance despite adverse
consequences&quot; (p166). A diagnosis of psychoactive substance dependence
is made if any three of the nine criteria listed below have been
present for one month or longer:

1.  the substance is often taken in larger amounts or over a longer
period than the person intended;

2.  there is a persistent desire or one or more unsuccessful efforts
to cut down or control substance use;

3. a great deal of time is spent in activities necessary to get the
substance (e.g., theft), taking the substance..., or recovering from
its effects;

4.  frequent intoxication or withdrawal symptoms when expected to
fulfil major role obligations at work, school, or home..., or when
substance use is physically hazardous...;

5.  important social, occupational, or recreational activities given
up or reduced because of substance use;

6. continued substance use despite knowledge of having a persistent or
recurrent social, psychological, or physical problem that is caused or
exacerbated by the use of the substance;

7. marked tolerance;

8. characteristic withdrawal symptoms;

9. substance often taken to relieve or avoid withdrawal symptoms&quot;
(American Psychiatric Association, 1987, pp167-8).

Criteria 8 and 9, are not required for the dependence syndromes of
cannabis, hallucinogens and PCP to be diagnosed. 

These criteria may seem to conflict with community conceptions of drug
dependence, in that they explicitly include tobacco smoking as a form
of drug dependence, and could conceivably include caffeine dependence
(among heavy coffee drinkers). The fact that these forms of drug
taking are not usually be regarded as producing drug dependence is
less a reason for rejecting these diagnostic criteria than a signal of
the need to persuade the community to adopt a broader conception of
drug dependence, which reduces the emphasis upon &quot;physical&quot; dependence
as evidenced by the occurrence of a marked withdrawal syndrome on
abstinence.



7.3.2.2 Cannabis tolerance and withdrawal: experimental evidence

Although tolerance and withdrawal symptoms are not required within
DSM-III-R, there is evidence that both can occur under certain
conditions of dosing with cannabinoids. This should not be surprising
since, as Hollister (1986) has observed, cannabis &quot;would have been an
exceptional centrally acting drug if tolerance/dependence were not one
of its properties&quot; (p9). Yet for many years it was believed that there
was little tolerance to cannabis and no withdrawal syndrome. The
predominant recreational pattern of intermittent use in the community,
and the use of low doses of THC and short dosage schedules in
laboratory studies, contributed to this belief (Hollister, 1986), as
did the expectation that if there was a cannabis withdrawal syndrome,
it would be as readily recognised as the opioid withdrawal syndrome
(Edwards, 1982).

Since the middle 1970s evidence has emerged from human and animal
studies that chronic administration of high doses of THC results in
the development of marked tolerance to a wide variety of cannabinoid
effects, such as cardiovascular effects, and to the subjective high in
humans (Compton, Dewey, and Martin, 1990; Fehr and Kalant, 1983;
Hollister, 1986; Jones, Benowitz, and Herning, 1981; National Academy
of Science, 1982). Moreover, the abrupt cessation of chronic high
doses of THC generally produces a mild withdrawal syndrome like that
produced by other long-acting sedative drugs (Compton et al, 1990;
Jones and Benowitz, 1976; Jones et al, 1981). 

Jones and Benowitz (1976) provided convincing evidence in humans of
the development of tolerance to the cardiovascular and subjective
effects of THC. They conducted human laboratory studies of the effects
of high doses of THC (210 mg per day) administered orally over a
period of 30 days on a fixed dosing schedule to healthy male
volunteers who had an extensive history of cannabis use. Clinical
observations of the subjects showed that as the duration of the high
dose regimen increased, there was a decline in the positive effects of
intoxication, and in the subjects' ratings of the &quot;high&quot;. There was a
marked deterioration in the subjects' social functioning according to
nurses' ratings during the early days of the high dose regimen, but
there was almost complete recovery to baseline levels by the end of
the dosing period. There was similar evidence of recovery in cognitive
and psychomotor performance in the course of the high dose regimen.

The most convincing evidence of tolerance came from observations of
the cardiovascular and subjective effects of smoking a marijuana
cigarette at various points during the study. The magnitude of both
the cardiovascular and subjective responses to smoking a single
&quot;joint&quot; decreased with the length of time subjects had received a high
dose of THC. After a few days of high doses of THC, the increased
heart rate was replaced by a normal, and in some cases a slowed, heart
rate. Similarly, self-ratings indicated that the &quot;high&quot; produced by
the cigarette all but disappeared in the course of the high dose
regimen. 

Similar observations of tolerance to the subjective effects of
cannabis have been made by Georgotas and Zeidenberg (1979). They
studied five healthy male marijuana smokers over a four-week period,
in which they smoked an average of 10 joints per day, providing an
average daily dose of 210mg of THC. In the course of this experiment,
subjects rapidly developed tolerance to the drug's effects: 

Although initially they found the marijuana to be of good quality,
they now found it much weaker and inferior to what they were getting
outside. They felt it did not make them as high as often as they were
accustomed (p429). 

An abstinence syndrome has been observed in monkeys maintained on a
schedule of chronic high doses of THC. Its symptoms consisted of:
&quot;yawning, anorexia, piloerection, irritability, tremors and
photophobia&quot; (Jones and Benowtiz, 1976). Similar symptoms were
observed by Jones and Benowitz (1976) after their subjects were
abruptly withdrawn from high doses of THC. Within six hours of
withdrawal subjects complained of &quot;inner unrest&quot;, and by 12 hours,
&quot;increased activity, irritability, insomnia, and restlessness were
reported by the subjects and obvious to staff&quot; (p632). Common symptoms
reported were &quot; `hot flashes', sweating, rhinorrhea, loose stools,
hiccups and anorexia&quot; (p632) which many subjects compared to a bout of
influenza. These symptoms were reduced by the resumption of marijuana
use (Jones et al, 1981).

Georgotas and Zeidenberg (1979) reported similar withdrawal phenomena
in their long-term dosing study. During the first week of a four-week
wash-out period after four weeks of receiving 210mg of cannabis a day,
the subjects &quot;became very irritable, uncooperative, resistant, and at
times hostile ... their desire for food decreased dramatically and
they had serious sleeping difficulties&quot; (p430). These effects
disappeared during the final three weeks of the wash out. These
studies suggest that tolerance can develop to cannabis's effects and
that a withdrawal syndrome can occur on abstinence under certain
conditions, namely, chronic administration of doses as low as 10 mg
per day for 10 days (Jones et al, 1981). 

The results of laboratory studies have received suggestive support
from a small number of studies of heavy cannabis users. Weller and
Halikas (1982), for example, found that the self-reported positive
effects of cannabis use diminished over a five to six-year period in
regular users of cannabis. The average reduction in the frequency of
experiencing the positive effects was small, perhaps because only 27
per cent were daily users, but they were consistent and included some
of the symptoms reported in laboratory studies. 

The laboratory and observational studies raise the following
questions: How relevant are these observations to contemporary
cannabis users? How often does sufficient tolerance to cannabis
develop for users to experience a withdrawal syndrome? How often is
cannabis used to relieve or avoid withdrawal symptoms, and if so, does
such behaviour play any role in maintaining use and producing
dependence? These questions remain unanswered (Edwards, 1982; Jones,
1984), although (as will be seen below) there is clinical and
observational evidence that some heavy chronic users experience
tolerance and withdrawal symptoms, and that some use cannabis to
control these symptoms.



7.3.3 Clinical and observational evidence on dependence

There has not been an organised program of research on the cannabis
dependence syndrome comparable to that undertaken on the alcohol and
the opiate dependence syndromes. Instead, its existence and
characteristics have had to be inferred from a diverse body of
research studies. This comprises: limited data on the prevalence and
characteristics of persons seeking professional help in dealing with
their cannabis use and associated problems; a small number of
observational studies of problems reported by non-treatment samples of
long-term cannabis users; and a very small and recent literature
examining the validity of the cannabis dependence syndrome, usually as
part of larger investigations of the validity of the substance
dependence syndromes embodied in DSM-III-R and other classification
systems.

During the 1980s evidence began to emerge that there had been an
increase in the number of persons seeking help with cannabis as their
major drug problem. Jones (1984), for example, reported that 35,000
patients sought treatment in the United States in 1981 for drug
problems in which &quot;cannabis was their primary drug&quot; (p703), an
increase of 50 per cent over three years. Many of these patients
behaved &quot;as if they were addicted to cannabis&quot; and they presented
&quot;some of the same problems as do compulsive users of other drugs&quot;
(p711). More recently, Roffman and colleagues (1988) have reported a
strong response to a series of community advertisements offering help
to people who wanted to stop using marijuana.

Sweden, which has had a long history of hashish use, has also
experienced an increase in numbers of heavy hashish users presenting
to treatment services for assistance with problems caused by its use
(Engstrom et al, 1985). Tunving et al (1988) have described their
experience treating approximately 100 individuals per year who
presented to Swedish treatment services requesting help in controlling
their cannabis use. Although no data were reported on the proportion
of these individuals who satisfied the 
DSM-III-R criteria for cannabis dependence, these patients typically
complained of symptoms which arguably would meet some of its criteria.
They reported, for example, that they had been unable to stop using
cannabis after having made several unsuccessful attempts to stop or
cut down, that they were frequently intoxicated, often every day, and
that they continued to use despite suffering adverse effects which
they recognised were connected with their cannabis use, such as
sleeplessness, depression, diminished ability to concentrate and
memorise, and blunting of emotions. Hannifin (1988) and Miller and
Gold (1989) have reported similar behaviour patterns among cannabis
users who have sought assistance. 

In Australia, there are indications that some heavy cannabis users
request help in controlling their use. Didcott et al (1988), for
example, reported on the characteristics of 3,462 clients seen in 12
residential treatment services in New South Wales in 1985 and 1986.
They found that cannabis was identified as the &quot;primary drug problem&quot;
by 25 per cent of clients seen, second only to the opioid drugs, which
were so identified by 73 per cent of clients. Just over half of all
clients (52 per cent), the majority of whom were polydrug users,
identified their cannabis use as &quot;a problem&quot;. The prevalence of
cannabis use as a principal drug problem was lower in a 1992 National
Census of Clients of Australian Treatment Service Agencies (Chen,
Mattick and Bailey, 1993). In this census cannabis use was the main
drug problem for 6 per cent of the 5,259 clients, fifth in order of
importance behind alcohol (52 per cent), opiates (26 per cent),
tobacco (9 per cent) and opiate/polydrug problems (7 per cent). 

Suggestive evidence of cannabis dependence has emerged from a small
number of observational studies of regular cannabis users. Weller,
Halikas and Morse (1984), for example, followed up a cohort of 100
regular marijuana users who were first identified in 1970-1971, and
assessed them for alcohol and marijuana abuse using Feighner's
criteria for alcoholism and an analogous set of criteria for marijuana
(see Weller and Halikas, 1980). Their concept of abuse would arguably
have included most cases of dependence. They were able to interview 97
of their subjects about the amount and frequency of alcohol and
marijuana use, and their experience of problems related to the use of
both drugs. According to Feighner's criteria, 9 per cent of subjects
were alcoholic and 9 per cent were &quot;abusers&quot; of marijuana, with 2 per
cent qualifying for both diagnoses. The most common symptoms reported
among those classified as marijuana abusers were feeling &quot;addicted&quot;, a
history of failed attempts to limit use, early morning use, and
traffic arrests related to marijuana use.

Hendin et al (1987) reported on the experiences of 150 long-term daily
cannabis users who had been recruited through newspaper
advertisements. Although they did not explicitly inquire about the
symptoms of a cannabis dependence syndrome, substantial proportions of
their sample reported experiencing various adverse effects of
long-term use, despite which they continued to use cannabis. These
included: impaired memory (67 per cent); an impaired ability to
concentrate on complex tasks (49 per cent); difficulty getting things
done (48 per cent); or thinking clearly (43 per cent); reduced energy
(43 per cent); ill health (36 per cent); and accidents (23 per cent).
Substantial minorities reported that it had impeded their educational
(31 per cent), and career achievements (28 per cent), and half of the
sample reported that they would like to cut down or stop their use.

These findings have been broadly supported by Kandel and Davies (1992)
and by Stephens and Roffman (1993). Kandel and Davies reported on the
characteristic problems reported by near daily cannabis users (aged
28-29 years) who were identified in a prospective study of the
consequences of adolescent drug use. The major adverse consequences of
use were: subjectively experienced cognitive deficits; reduced energy;
depression; and problems with spouse. Stephens and Roffman's sample of
users answering an advertisement offering assistance in quitting
cannabis complained of: &quot;feeling bad about using&quot;; procrastinating
because of their use; memory impairment; loss of self-esteem;
withdrawal symptoms; and spouse complaints about their use. In the
absence of control groups, however, it is impossible to be certain
that the prevalence of these symptoms is higher than in the community,
and that they were not present prior to cannabis use, as has been
reported in some longitudinal studies (e.g. Shedler and Block, 1990).

The most direct support for the validity of the cannabis abuse
dependence syndrome comes from a series of studies of the validity of
diagnostic criteria for substance dependence. Kosten et al (1987)
tested the extent to which the DSM-III-R psychoactive substance
dependence disorders for alcohol, cannabis, cocaine, hallucinogens,
opioids, sedatives and stimulants constituted syndromes. A sample of
83 persons (41 from an inpatient psychiatric unit and 42 from an
outpatient substance abuse treatment unit) was interviewed using a
standardised psychiatric interview schedule to elicit the symptoms of
drug dependence as defined in DSM-III-R for each of the drug classes.
Multiple diagnoses were allowed, so many individuals qualified for
more than one type of drug dependence.

There was consistent support for a unidimensional dependence syndrome
for alcohol, cocaine and opiates. The results were more equivocal in
the case of the cannabis dependence syndrome. All the items were
moderately positively correlated, had good internal consistency, and
seemed to comprise a Guttman scale, but a Principal Components
Analysis of the cannabis items suggested that (unlike alcohol, cocaine
and heroin, all of which had a single underlying factor) there seemed
to be three independent dimensions of dependence: compulsion indicated
by impaired social activity attributable to drug use, preoccupation
with drug use, giving up other interests, and using more than
intended; inability to stop use, indicated by not being able to cut
down the amount used, rapid reinstatement after abstinence, and
tolerance to drug effects; and withdrawal identified by withdrawal
symptoms, use of cannabis to relieve withdrawal symptoms, and
continued use despite problems.

Two more recent studies on much larger samples have provided stronger
support for the concept of a cannabis dependence syndrome. Newcombe
(1992) reported factor analyses of 29 questionnaire items designed to
measure DSM-III-R abuse and dependence for a community sample of 614
young adults reporting on their use of alcohol, cocaine, and cannabis.
He reported a strong common factor for all three drug types which
accounted for 36 per cent to 40 per cent of the item variance.
Rounsaville, Bryant, Babor, Kranzler and Kadden (1993) report the
results of factor analyses of items designed to assess dependence in
each of three diagnostic systems (DSM-III-R. DSM-IV and ICD-10) for
each of six drug classes (alcohol, cocaine, marijuana, opiates,
sedatives and stimulants). Their sample comprised 521 persons
recruited from inpatient and outpatient drug treatment, psychiatric
treatment services, and the general community. They found that a
single common factor explained the variation between diagnostic
criteria for all diagnostic systems, and for all drug types.



7.3.4 Epidemiological evidence on cannabis abuse and dependence 

The best evidence on the prevalence of cannabis abuse and dependence
in the community comes from the Epidemiological Catchment Area (ECA)
study (Robins and Regier, 1991) which involved face-to-face interviews
with 20,000 Americans in five catchment areas: Baltimore, Maryland;
Los Angeles, California; New Haven, Connecticut; Durham, North
Carolina; and St Louis, Missouri. A standardised and validated
clinical interview schedule was used to elicit a history of
psychiatric symptoms found in 40 major psychiatric diagnoses,
including drug abuse and dependence. This information was used to
diagnose the presence or absence of a DSM-III diagnosis of drug
dependence (Anthony and Helzer, 1991). Although not a true random
sample of the American population, it is the best available data on
the prevalence of different types of drug dependence and their
correlates in a non-treatment population. 

Illicit drug use was defined as &quot;any non-prescription psychoactive
agents other than tobacco, alcohol and caffeine, or inappropriate use
of prescription drugs&quot; (Anthony and Helzer, 1991, p116). To exclude
individuals who had only briefly experimented with illicit drugs,
individuals had to have used an illicit drug on more than five
occasions before they were asked about any symptoms of drug
dependence. The focus of the interview schedule was on the &quot;consequent
psychiatric symptoms and behavioral changes that constitute the
syndromes of drug abuse and dependence&quot; (p117). 

The criteria used to define drug abuse and dependence were derived
from the DSM-III, which divided symptoms of abuse and dependence into
four main groups: (1) tolerance to drug effects; (2) withdrawal
symptoms; (3) pathological patterns of use; and (4) impairments in
social and occupational functioning due to drug use. Drug abuse
required a pattern of pathological use and impaired functioning. In
the case of cannabis, a diagnosis of dependence required pathological
use, or impaired social functioning, in addition to either signs of
tolerance or withdrawal. The problem had to have been present for at
least one month, although there was no requirement that all criteria
had to be met within the same period of time. In reporting the results
Anthony and Helzer report the prevalence of abuse and/or dependence
combined for all drug types. 

Illicit drug use was relatively common in the sample, with 36 per cent
of persons having used at least one illicit drug. Cannabis was the
most commonly used illicit drug, having been used by 76 per cent of
those who had used any illicit drug more than five times. Drug abuse
and dependence were relatively common, with 6.2 per cent of the
population qualifying for such a diagnosis. Cannabis abuse and/or
dependence was the most common form of abuse and/or dependence, with
4.4 per cent of the population being so diagnosed compared with 1.7
per cent for stimulants, 1.2 per cent for sedatives, and 0.7 per cent
for opioid drugs. Two-thirds of cases of cannabis abuse and/or
dependence had used cannabis within the past year, and half had used
within the past month. &quot;Almost two-fifths (38 per cent) of those with
a lifetime history of cannabis abuse and/or dependence reported active
problems in the prior year&quot; (Anthony and Helzer, 1991, p123)

When DSM-III-R diagnoses of dependence and abuse were approximated,
three fifths of those with a diagnosis of dependence and/or abuse met
the criteria for dependence. The proportion of current users who were
dependent increased with age, from 57 per cent in the 18-29 year age
group to 82 per cent in the 45-64 year age group, reflecting the
remission of less severe drug abuse problems with age. Only a minority
of those who had a diagnosis of abuse and/or dependence (20 per cent
of men and 28 per cent of women) had mentioned their drug problem to a
health professional, even though 60-70 per cent had sought medical
treatment in the previous month. There were predictable age and gender
differentials in prevalence of drug abuse and/or dependence. Men had
higher prevalence than women (7.7 per cent versus 4.8 per cent). This
was largely due to differences in exposure to illicit drugs, since the
prevalence of a diagnosis of abuse and/or dependence among persons who
had used an illicit drug more than five times was the about the same
for men and women (21 per cent and 19 per cent). The highest
prevalence of abuse and/or dependence (13.5 per cent) was in the 18-29
year age group (16.0 per cent among men and 10.9 per cent among
women), declining steeply thereafter in both sexes. 

It is difficult to make clear inferences about the prevalence of
cannabis dependence in the community from the ECA study, because
DSM-III rather than DSM-III-R criteria were used, and the data on the
prevalence of drug abuse and/or dependence have not been broken down
either by abuse and dependence or by drug class. The first of these
problems may not be too serious, since studies comparing DSM-III and
DSM-III-R criteria (e.g. Rounsaville et al, 1987) suggest that there
is reasonable agreement between a DSM-III diagnosis of abuse or
dependence and DSM-III-R dependence, in the case of cannabis
dependence. Any disagreements in diagnosis seem to be in the direction
of DSM-III-R identifying more cases as dependent than DSM-III,
suggesting that any errors in the prevalence of drug abuse in the ECA
study will be in the direction of underestimation.

The absence of detailed ECA reports on the separate prevalence of drug
abuse and dependence is more difficult to circumvent. If we assume
that any differences between drug types in the proportion of users who
became dependent would have been reported (and hence that the ratio of
cases of dependence to abuse for cannabis is 3:2), then the prevalence
of cannabis dependence in the USA in 1982-1983 would have been 2.6 per
cent of the population. If we also assume that the ratio of cases of
cannabis dependence to cases of cannabis abuse was the same for men
and women, then 3.2 per cent of men and 2.0 per cent of women would
have been diagnosed as cannabis dependent. 

Similar estimates of the population prevalence of cannabis dependence
were produced by a community survey of psychiatric disorder conducted
in Christchurch, New Zealand, in 1986, using the same sampling
strategy and diagnostic interview as the ECA study (Wells et al,
1992). This survey used the DIS to diagnose a restricted range of
DSM-III diagnoses in a community sample of 1,498 adults aged 18-64
years of age. The prevalence of having used cannabis on five or more
occasions was 15.5 per cent, remarkably close to that of the ECA
estimate, as was the proportion who met DSM-III criteria for marijuana
abuse or dependence, namely 4.7 per cent. The fact that this survey
largely replicated the ECA findings for most other diagnoses,
including alcohol abuse and dependence, enhances confidence in the
validity of the ECA study findings. 



7.3.5 The risk of cannabis dependence

It is important to put the existence of a cannabis dependence syndrome
into perspective to avoid a falsely alarmist impression that all
cannabis users run a high risk of becoming dependent upon cannabis. A
variety of estimates suggest that the crude risk is small, and
probably more like that for alcohol rather than nicotine or the
opioids. Other data suggests that certain characteristics of users
increase the risk of dependence developing, although in most cases it
is impossible to place quantitative estimates on the latter risks. 

As with all drugs of dependence, persons who use cannabis on a daily
basis over periods of weeks to months are at greatest risk of becoming
dependent upon it. The ECA data suggested that approximately half of
those who used any illicit drug on a daily basis satisfied DSM-III
criteria for abuse or dependence (Anthony and Helzer, 1991). Since
this estimate was based upon drug abuse and dependence for all drug
types, including opioids, it probably overestimates the risks of
dependence among daily cannabis users. Kandel and Davis (1992)
estimated the risk of dependence among near daily cannabis (according
to approximated DSM-III criteria) at one in three. 

The risk of developing dependence among less frequent users of
cannabis, including experimental and occasional users, would be
substantially less than that for daily users. A number of reasonably
consistent estimates of the risks of a broader spectrum of users
becoming dependent on cannabis can be obtained from recent studies. A
crude estimate from the ECA study was that approximately 20 per cent
of persons who used any illicit drug more than five times met DSM-III
criteria for drug abuse and dependence at some time. The specific rate
of abuse and dependence for cannabis (calculated by dividing the
proportion who met criteria for abuse and dependence by the proportion
who had used the drug more than five times) was 29 per cent. A more
conservative estimate which removed cases of abuse (40 per cent) from
the overall estimate of cannabis abuse and dependence would be that 17
per cent of those who used cannabis more than five times would meet
DSM-III criteria for dependence. 

Estimates derived from a number of other studies suggest that the ECA
estimates of the risk of dependence are reasonable. The crude
percentage of cases of dependence and abuse among persons who had used
cannabis five or more times in the Christchurch epidemiology study
(Wells et al, 1992) was 30 per cent, while an estimate derived from
Newcombe's community survey of young adults was 25 per cent of those
who had ever used cannabis. A comparable estimate can be derived from
Kandel and Davies' (1992) study of near daily cannabis users. [This
was done by multiplying the ECA estimate of the proportion of daily
users who met criteria for abuse and dependence (50 per cent) by the
proportion of near daily users in Kandel and Davis sample (44 per
cent), and adding this to the ECA estimate of the proportion of
non-daily illicit drug users who met the criteria (30 per cent)
multiplied by their proportion in the Kandel and Davies sample (55 per
cent)]. On Kandel and Davies data the estimated rate of abuse and
dependence among those who had used cannabis 10 or more times was 39
per cent, the higher rate reflecting the higher number of times of use
required to be counted as a cannabis user in Kandel and Davies study
(10 times versus five times in ECA). A lower estimate of 12 per cent
for DSM-III-R cannabis dependence was obtained by McGee and colleagues
(1993) in a prospective study of 18-year-old youth in Dunedin, New
Zealand. A lower estimate was to be expected given the youth of the
sample, and the fact that the estimate is the proportion of dependent
users among those who had ever used cannabis.

Although one would not want to claim a great deal of precision for any
of these individual estimates of the risk of cannabis dependence, it
is reassuring that they are within a range of 12-37 per cent, and that
the estimates vary in predictable ways with the ages of the samples
and the stringency of the criteria used in defining cannabis use. The
reasonable consistency of the estimates suggests the following rules
of thumb about the risks of cannabis dependence. For those who have
ever used cannabis, the risks of developing dependence is probably of
the order of one chance in 10. The risk of dependence rises with the
frequency of cannabis use, as it does with all drugs, so that among
those who use the drug more than a few times the risk of developing
dependence is in the range of from one in five to one in three. The
range of the estimates reflects variations in the number of occasions
of use that is taken to reflect more than simple experimentation, with
the general rule being that the more often the drug has been used, and
the longer the period of use, the higher is the risk of becoming
dependent. Although there have been few formal comparisons of the
dependence potential of cannabis with that of other drugs, these risks
are probably more like those associated with alcohol than those
associated with tobacco and opiates (Woody, Cottler and Cacciola,
1993).

Apart from frequency of use, other risk factors have been identified
in the series of prospective studies of adolescent illicit drug use
reviewed above. These include the following factors which have been
shown to predict continued use and more intensive involvement with
illicit drugs: poor academic achievement; deviant behaviour in
childhood and adolescence; nonconformity and rebelliousness; personal
distress and maladjustment; poor parental relationships; earlier use;
and a parental history of drug and alcohol problems (Brook et al,
1992; Kandel and Davies, 1992; Newcombe, 1992; Shedler and Block,
1990). For most of these variables it is difficult to attach any
quantitative estimates to the increased risk of dependence, because
they have been measured in different ways in different studies.

These overall statements of the risks of cannabis dependence ignore
the fact that the risk of dependence is not equally distributed in the
population. The ECA study suggested that men have a higher risk of
developing dependence than women, and that the risk was highest among
the younger 18-29 year old cohort. In both cases, however, the most
likely explanation was the different rates of exposure to cannabis
among men and women, and among younger and older persons (Anthony and
Helzer, 1991). When this was controlled by looking at the rates of
dependence among daily users of the drug among men and women and
younger and older persons, the differences in the risk of dependence
largely disappeared (Anthony and Helzer, 1991).



7.3.6 The consequences of cannabis dependence

Another important issue that needs to be considered when placing the
risks of cannabis dependence into perspective is that of the
consequences of developing dependence. How easy or difficult is it for
those who decide to stop using cannabis to achieve and maintain
abstinence? This question is difficult to answer in the absence of
systematic research on the natural history of cannabis dependence. The
following are reasonable inferences about what the rate of remission
might be. First, cannabis dependence resembles alcohol dependence in
the risk of dependence, and the similarity in the age and gender
distributions of heaviest use, and abuse, and dependence. It seems
reasonable then to suppose that there is likely to be a high rate of
remission without treatment in cannabis dependence, as there is in as
in alcohol dependence in the community (Helzer, Burnham and McEvoy,
1991). The large discrepancy between the ECA estimates of cannabis
abuse and dependence in the community, and the proportions of cannabis
users among drug users seeking treatment provides indirect support for
this inference. Kandel and Davies' (1992) findings provide more direct
support. They found that 44 per cent of those who had used cannabis
more than 10 times became near daily users for an average period of
three years. Yet by age 28-29, less than 15 per cent of those who had
ever been daily users were still daily users, indicating a very high
rate of remission during the 20s.

Among those who develop cannabis dependence, how disruptive to
everyday life and functioning is it? This is even more difficult to
answer. All that can be said with confidence is that there are some
cannabis users who are sufficiently troubled by the consequences of
their dependence to seek assistance. The experience of Roffman and
colleagues suggests that this number may be increased if more effort
was made to attract dependent cannabis users into treatment. Among the
population of cannabis dependent persons seeking treatment, the major
complaints have been the loss of control over their drug use,
cognitive and motivational impairments which interfere with
occupational performance, lowered self-esteem and depression, and the
complaints of spouses and partners (see above). There is no doubt that
some dependent cannabis users report impaired performance and a
reduced enjoyment of everyday life, but more detailed research is
necessary to make a better judgment about how common this is, and how
severe the impairment typically produced by cannabis dependence is. 

7.3.7   The treatment of cannabis dependence 

Given the widespread scepticism about the existence of a cannabis
dependence syndrome, the question of what should be done to assist
those who present for help with their cannabis use has largely been
ignored (see Kleber, 1989). Indeed, Stephens and Roffman (1993) have
suggested that there is a widespread view among drug and alcohol
treatment practitioners that cannabis dependence does not require
treatment because the withdrawal syndrome is so mild that most users
can quit without assistance. Although, as argued above, it is likely
that rates of remission without treatment are substantial, the fact
that many users succeed without professional assistance does not mean
we should ignore requests for assistance from those who are unable to
stop on their own. As with persons who are nicotine dependent, those
dependent cannabis users who have repeatedly failed in attempts to
stop their cannabis use need professional assistance to do so. But
what types of treatment should be offered?

There is not a lot of information on which to base useful
recommendations. The available literature largely consists of
treatment suggestions based upon personal experience, or upon clinical
wisdom derived from opinions about the best forms of treatment for
other related forms of dependence, such as alcohol and tobacco (e.g.
de Silva, DuPont, and Russell, 1981). Jones (1984), for example,
suggested that because cannabis was usually smoked in social settings,
the treatment for cannabis dependence should be based upon principles
derived from successful forms of treatment for nicotine dependence.
Such treatment would include: assisted cessation of cannabis use
accompanied by education about the acute and chronic effects of the
drug; social skills training in resisting the social cues for cannabis
use; and the mobilisation of peer support to maintain abstinence
through self-help groups. 

Others have preferred to adopt approaches adapted from those developed
to treat alcohol dependence. Hannifin (1988), in arguing for the
concept of &quot;cannabism&quot; by analogy to &quot;alcoholism&quot;, implied that it be
managed in much the same way. Miller and his colleagues (Miller and
Gold, 1989; Miller, Gold and Pottash, 1989) have recommended a
treatment model based upon the preferred form of treatment for alcohol
dependence in the United States, namely, detoxification, a 12-step
program delivered during an extended inpatient stay, and enrolment in
Alcoholics Anonymous or Narcotics Anonymous after discharge. Stephens
and Roffman (1993) and Zweben and O'Connell (1992) have suggested
eclectic approaches combining management of withdrawal, relapse
prevention methods, and enrolment in 12-step programs. Tunving et al
(1988) have described their experience with a similar eclectic
outpatient program for cannabis users in Sweden. De Silva et al (1981)
provide short accounts of a variety of treatment approaches for
marijuana dependent adolescents.

There have been very few controlled evaluations of the effectiveness
of these recommendations. Smith et al (1988) reported a simple
pre-treatment and post-treatment comparison of cannabis use among
patients who received outpatient aversion therapy and group
self-management counselling. They found good self-reported rates of
abstinence, but these were obtained from telephone interviews
conducted by the therapists who delivered the treatment. Roffman et al
(1988) have reported a randomised controlled trial comparing group
based relapse prevention or social support. Subjects were 120 men and
women (average age 32 years with an average history of 16 years
marijuana use) who had answered advertisements publicising a treatment
program for adults seeking help to stop using marijuana. Their results
at one month follow-up were much less positive than those of Smith et
al: only 30 per cent of their patients were still abstinent, although
75 per cent had set abstinence as a treatment goal. By the end of a
year the abstinence rate had dropped to 17 per cent. Results were a
little more positive when evaluated in terms of average number of days
of use, and in problems experienced, suggesting that the outcome of
cannabis cessation treatment is much like that for alcohol and tobacco
(Heather and Tebbutt, 1989).

Much more research is clearly required before sensible advice can be
given about the best ways to achieve abstinence from cannabis. In the
absence of better evidence of treatment effectiveness, those who offer
treatment for cannabis dependence should avoid replicating experience
in the alcohol field, where intensive and expensive forms of inpatient
treatment have been widely adopted in the absence of any good evidence
that they are more effective than less intensive outpatient forms of
treatment (Heather and Tebbut, 1989; Miller and Hester, 1986).



7.3.8 Conclusions

In 1982 Edwards reviewed the available evidence on the question of
whether there was a cannabis dependence syndrome as defined by the
1981 World Health Organisation criteria. Although he argued that there
was good evidence of tolerance and a withdrawal syndrome, there was
insufficient evidence bearing on the criteria of compulsion, narrowing
of repertoire, reinstatement after abstinence, use to relieve or
prevent withdrawal symptoms and salience of cannabis use. He added
that although tolerance and withdrawal were insufficient to prove the
existence of a dependence syndrome, they nonetheless constituted
&quot;grounds for believing that such a syndrome may exist&quot; (p38). Until
these issues were resolved, he concluded, the question remained &quot;very
open&quot;.

On the basis of evidence gathered since Edwards wrote, we conclude
that there probably is a cannabis dependence syndrome like that
defined in DSM-III-R which occurs in heavy chronic users of cannabis.
There is good experimental evidence that chronic heavy cannabis use
can produce tolerance and withdrawal symptoms, and some clinical and
epidemiological evidence that some heavy cannabis users experience
problems controlling their cannabis use, and continue to use despite
the experience of adverse personal consequences of use. There is
reasonable observational evidence that there is a cannabis dependence
syndrome like that for alcohol, cocaine and opioid dependence. If the
estimates of drug dependence from the ECA study are approximately
correct, cannabis dependence is the most common form of dependence on
illicit drugs, reflecting its high prevalence of use in the community.
The risk of developing the syndrome is probably of the order of: one
chance in ten among those who ever use the drug; between one in five
and one in three among those who use more than a few times; and around
one in two among those who become daily users of the drug. 

Recognition of the cannabis dependence syndrome has been delayed
because of its apparent rarity in Western societies, which reflects a
number of factors. First, heavy daily cannabis use has been relatively
uncommon by comparison with the intermittent use of small quantities
of cannabis. Second, until recently there have been few individuals
who have presented requesting assistance for cannabis related
problems. This may have been because it is easier to stop using
cannabis than opioids or alcohol without specialist assistance, or it
may be that the impact of cannabis dependence on the user is not as
transparently adverse as that of alcohol or opioid problems to users
and their families. Third, an overemphasis on the occurrence of
tolerance and a withdrawal syndrome in the past has hindered its
recognition in those individuals who have presented for treatment.
Fourth, cannabis dependence (which is widespread among opioid
dependent persons) has been perceived to be a less serious problem
than dependence on alcohol, opioids and stimulants, which have
accordingly been given priority in treatment (Hannifin, 1988).

Given the widespread use of cannabis, and its continued reputation as
a drug which is free of the risk of dependence, the clinical features
of cannabis dependence deserve to be better delineated and studied.
This would enable its prevalence to be better estimated, and
individuals with this dependence to be better recognised and treated.
Treatment should probably be on the same principles as what is
effective for other forms of dependence. Treatment for tobacco
dependence may provide a better model than treatment for alcohol
dependence, although this area is in need of research. 

Although cannabis dependence is likely to be a larger problem than
previously thought, we should be wary of over-estimating its social
and public health importance. It will be most common in the minority
of heavy chronic cannabis users. Even in this group, the prevalence of
drug-related problems may be relatively low by comparison with those
of alcohol dependence, and the rate of remission without formal
treatment is likely to be high. While acknowledging the existence of
the syndrome, we should avoid exaggerating its prevalence and the
severity of its adverse effects on individuals. Better research on the
experiences of long-term cannabis users should provide more precise
estimates of the risk.



References

American Psychiatric Association. (1987) Diagnostic and Statistical
Manual of Mental Disorders (DSM-III-R). (3rd Edition, Revised)
Washington: American Psychiatric Association.

Anthony, J and Helzer, J.E. (1991) Syndromes of drug abuse and
dependence. In L.N. Robins and D.A. Regier (eds) Psychiatric Disorders
in America. New York: Free Press, MacMillan.

Brook, J.S., Cohen, P., Whiteman, M. and Gordon, A.S. (1992)
Psychosocial risk factors in the transition from moderate to heavy use
or abuse of drugs. In M. Glantz and R. Pickens (eds) Vulnerability to
Drug Abuse. Washington: American Psychological Association.

Chen, R., Mattick, R.P and Baillie, A. (1993) Clients of Treatment
Service Agencies. March, 1992 Census Findings. Canberra: Australian
Government Publishing Service.

Compton, D.R., Dewey, W.L. and Martin, B.R. (1990) Cannabis dependence
and tolerance production. Advances in Alcohol and Substance Abuse, 9,
128-147.

De Silva, R., DuPont, R.L. and Russell, G.K. (eds) (1981) Treating the
Marijuana-Dependent Person. New York: The American Council on
Marijuana and Other Psychoactive Drugs, Inc.

Didcott, P., Flaherty, B. and Muir, C. (1988) A profile of addicts in
residential treatment in New South Wales. Directorate of the Drug
Offensive, In House Report Series. Sydney: New South Wales Department
of Health.

Edwards, G. (1982) Cannabis and the question of dependence. Advisory
Council on the Misuse of Drugs. Report of the Expert Group on the
Effects of Cannabis Use. London: Home Office.

Edwards, G.  and Gross, M.M. (1976) Alcohol dependence: provisional
description of a clinical syndrome. British Medical Journal, 1,
1058-1061.

Edwards, G., Arif, A. &amp; Hodgson, R. (1981) Nomenclature and
classification of drug-and alcohol-related problems: A WHO memorandum.
Bulletin of the World Health Organization, 59 (2), 225-242.  

Engstrom, A., Allebeck, P., Rodwall, Y. and Rydberg, U. (1985) Adverse
psychic effects of cannabis - with special focus on Sweden. In D.J.
Harvey, W. Paton and G. Nahas (Eds) Marihuana '84: Proceedings of the
Oxford Symposium on Cannabis. Oxford: IRL Press.

Fehr, K.O. and Kalant, H. (1983) (Eds) Cannabis and Health Hazards.
Toronto: Addiction Research Foundation.

Georgotas, A. and Zeidenberg, P. (1979) Observations on the effects of
four weeks of heavy marijuana smoking on group interaction and
individual behavior. Comprehensive Psychiatry, 20, 427-432.

Hanniffin, J. (1988) The ownership debate: Cannabis and the concept of
&quot;cannabism&quot;. In G. Chesher, P. Consroe, and R. Musty (eds) Marijuana:
An International Research Report. Canberra: Australian Government
Publishing Service. 

Heather, N. and Tebbut, J. (eds) (1989) An Overview of the
Effectiveness of Treatment for Drug and Alcohol Problems. National
Campaign Against Drug Abuse Monograph Series Number 11. Canberra:
Australian Government Publishing Service.

Helzer, J.E., Burnham, A. and McEvoy, L.T. (1991) Alcohol abuse and
dependence. In L.N. Robins and D.A. Regier (eds) Psychiatric Disorders
in America. New York: Free Press, MacMillan.

Hendin, H., Haas, A.P., Singer, P., Eller, M. and Ulman, R. (1987)
Living High: Daily Marijuana Use Among Adults. New York: Human
Sciences Press.

Hollister, L.E. (1986) Health aspects of cannabis. Pharmacological
Reviews, 38, 1-20.

Jones, R.T. (1984) Marijuana: Health and treatment issues. Psychiatric
Clinics of North America, 7, 703-712.

Jones, R.T. and Benowitz, N. (1976) The 30-day trip - clinical studies
of cannabis tolerance and dependence. In M Braude and S. Szara (eds)
Pharmacology of Marijuana. 
Volume 2. New York: Academic Press.

Jones, R.T., Benowitz, N. and Herning, R.I. (1981) The clinical
relevance of cannabis tolerance and dependence. Journal of Clinical
Pharmacology, 21, 143S-152S.

Kandel, D.B. and Davies, M. (1992) Progression to regular marijuana
involvement: Phenomenology and risk factors for near daily use. In M.
Glantz and R. Pickens (eds) Vulnerability to Drug Abuse. Washington:
American Psychological Association.

Kleber, H.D. (1989) Treatment of drug dependence: What works?
International Review of Psychiatry, 1, 81-100.

Kosten, T.R., Rounsaville, B.J., Babor, T.F., Spitzer, R.L. and
Williams, J.B.W. (1987) Substance-use disorders in DSM-III-R. British
Journal of Psychiatry, 151, 834-843.

McGee, R.O. and Feehan, M. (1993) Cannabis use among New Zealand
adolescents. New Zealand Medical Journal, 106, 345.

Miller, N.S. and Gold, M.S. (1989) The diagnosis of marijuana
(Cannabis) dependence. Journal of Substance Abuse Treatment, 6,
183-192.

Miller, N.S., Gold, M. and Pottash, A (1989) A 12-step treatment
approach for marijuana (Cannabis) dependence. Journal of Substance
Abuse Treatment, 6, 241-250. 

Miller, W.M. and Hester, R.K. (1986) The effectiveness of alcoholism
treatment: what research reveals. In Miller, W.M. and Heather, N.
(eds) Treating Addictive Behaviors: Processes of Change. New York:
Plenum Press.

National Academy of Science, Institute of Medicine. (1982) Marijuana
and Health. Washington, DC: National Academy Press.

Newcombe, M.D. (1992) Understanding the multidimensional nature of
drug use an abuse: The role of consumption, risk factors and
protective factors. In M. Glantz and R. Pickens (eds) Vulnerability to
Drug Abuse. Washington: American Psychological Association.

Robins, L.N.  and Regier, D.A. (1991) (Eds) Psychiatric Disorders in
America. New York: Free Press, MacMillan.

Roffman, R.A., Stephens, R.S., Simpson, E.E. and Whitaker, D.L. (1988)
Treatment of marijuana dependence: preliminary results. Journal of
Psychoactive Drugs, 
20, 129-137.

Rounsaville, B.J., Kosten, T.R., Williams, J.B.W. and Spitzer, R.L.
(1987) A field trial of DSM-III-R psychoactive substance dependence
disorders. American Journal of Psychiatry, 144, 351-355. 

Rounsaville, B.J., Bryant, K., Babor, T., Kranzler, H. and Kadden, R.
(1993) Cross-system agreement for substance use disorders. Addiction,
88, 337-348.

Shedler, J. and Block, J. (1990) Adolescent drug use and psychological
health. American Psychologist, 45, 612-630.

Smith, J.W., Schmeling, G. and Knowles, P.L. (1988) A marijuana
smoking cessation clinical trial utilizing THC-free marijuana,
aversion therapy, and self-management counseling. Journal of Substance
Abuse Treatment, 5, 89-98.

Stephens, R.S. and Roffman, R.A. (1993) Adult marijuana dependence. In
J.S. Baer, G.A. Marlatt, and R.J. MacMahon (eds) Addictive Behaviors
Across the Lifespan: Prevention, Treatment and Policy Issues. Newbury
Park, California: Sage Publications.

Tunving, K., Lundquist, T., and Eriksson, D. (1988) &quot;A way out of the
fog&quot;: An outpatient program for cannabis users. In G. Chesher, P.
Consroe, and R. Musty (eds) Marijuana: An International Research
Report. Canberra: Australian Government Publishing Service.

Weller, R.A. and Halikas, J. (1980) Objective criteria for the
diagnosis of marijuana abuse. Journal of Nervous and Mental Disease,
168, 98-103.

Weller, R.A. and Halikas, J. (1982) Changes in effects of marijuana: a
five- to six-year follow-up. Journal of Clinical Psychiatry, 43,
362-365.

Weller, R.A., Halikas, J. and Morse, C. (1984) Alcohol and marijuana:
comparison of use and abuse in regular marijuana users. Journal of
Clinical Psychiatry, 45, 377-379.

Wells, J.E., Bushnell, J.A., Joyce, P.R., Oakley-Browne, M.A. and
Hornblow, A.R. (1992) Problems with alcohol, drugs and gambling in
Christchurch, New Zealand. In M. Abbot and K. Evans (eds) Alcohol and
Drug Dependence and Disorders of Impulse Control. Auckland: Alcohol
Liquor Advisory Council.

Woody, G.E., Cottler, L.B. and Caciola, J. (1993) Severity of
dependence: data from the DSM-IV field trials. Addiction, 88,
1573-1579.

Zweben, J.E. and O'Connell, K. (1992) Strategies for breaking
marijuana dependence. Journal of Psychoactive Drugs, 24, 165-171.



7.4 Effects of chronic cannabis use on cognitive functioning

Because cannabis use acutely impairs cognitive processes, a concern
has arisen that chronic cannabis use may cause chronic cognitive
impairment. Such a chronic effect need not necessarily be permanent,
but it would persist beyond the elimination of cannabinoids from the
body, and hence would be the result of secondary changes induced by
cumulative exposure to cannabinoids. Such chronic effects could
produce relatively enduring behavioural deficits which presumably
reflect changes in brain function. 

This chapter deals with the evidence from a variety of different types
of study about the cognitive effects of chronic cannabis use. The
caveats mentioned in the introduction must be born in mind whilst
critically assessing this evidence: many other factors must be
controlled in order to confidently attribute any cognitive effects to
cannabis use. Among these, the most important are ensuring that the
cognitive impairment did not precede cannabis use, and ensuring that
the cognitive effects are not the result of the multiple drug use that
is especially common among heavy cannabis users (Carlin, 1986).



7.4.1 Clinical observations

Concerns about the cognitive effects of chronic cannabis use during
the early 1970s were first prompted by clinical reports of mental
deterioration in persons who had used cannabis heavily (at least
daily) for more than one year (Fehr and Kalant, 1983). Kolansky and
Moore (1971, 1972), for example, reported cases of psychiatric
disorder in adolescents and young adults (38 cases) and among adults
(13 cases) who had used marijuana at least twice per week. The
clinical picture was one of &quot;very poor social judgment, poor attention
span, poor concentration, confusion, anxiety, depression, apathy,
passivity, indifference and often slowed and slurred speech&quot; (Kolansky
and Moore, 1971). Cognitive symptoms included: apathetic and sluggish
mental and physical responses; mental confusion; difficulties with
recent memory; and incapability of completing thoughts during verbal
communication. These symptoms typically began after cannabis use and
disappeared within three to 24 months of abstinence. The course and
remission of symptoms also appeared to be correlated with past
frequency and duration of cannabis smoking. Those with a history of
less intensive use showed complete remission of symptoms within six
months; those with more intensive use took between six and nine months
to recover; while those with chronic intensive use were still
symptomatic nine months after discontinuation of drug use. 

These clinical reports, similar observations by Tennant and Groesbeck
(1972) among hashish smoking US soldiers in West Germany, and a report
of cerebral atrophy in young cannabis users (Campbell et al, 1971)
excited substantial controversy about the cognitive effects of chronic
cannabis use. Critics were quick to object to the lack of objective
measures of impairment and the biased sampling from psychiatric
patient populations. It was also difficult to rule out alternative
explanations of the apparent association between cannabis use and
cognitive impairment, namely, that many of these effects either
preceded cannabis use, or were the result of other drug use. Whatever
their limitations, these clinical reports alerted the community to the
possible risks of using cannabis when it was becoming popular among
the young in Western countries; they also prompted better controlled
empirical research on the issue. 



7.4.2 Cross-cultural studies

In response to public anxiety about the increase in marijuana use in
the late 1960s, the National Institute on Drug Abuse (NIDA) in the
United States commissioned three cross-cultural studies in Jamaica,
Greece and Costa Rica to assess the effects of chronic cannabis use on
cognitive functioning (among other things). The rationale for these
studies was that any cognitive effects of chronic daily cannabis use
would be most apparent in cultures with a long-standing tradition of
heavy cannabis use.



7.4.2.1 Jamaica

Bowman and Pihl (1973) conducted two field studies of chronic cannabis
use in Jamaica, one with a small sample of 16 users and 10 controls
from rural and semi-rural areas, and the other with a small urban slum
sample of 14 users and controls. Users had consumed cannabis daily for
a minimum of 10 years (current use of about 23 high potency
joints/day), while controls had no previous experience with cannabis.
Tests were selected on the basis of having previously been shown to be
sensitive to impairment following chronic heavy alcohol use (Bowman
and Pihl, 1973). The groups were matched for age, sex, social class,
alcohol use, education and &quot;intelligence&quot;, but most subjects were
illiterate or semi-literate, with an average age of 30. No differences
were found between the users and non-users in either study, even when
the rural and urban samples were combined. 

Soueif (1976b) argued that a null result would be expected according
to his hypothesis that cannabis-induced impairments require a minimum
level of literacy to be detected. Bowman and Pihl replied that the
controls were sufficiently literate to enable any impairment in the
users to manifest. Moreover, their study required only a minimum of
four hours abstinence prior to testing, which meant that some subjects
were still intoxicated at the time of testing. This possibility would
have biased the test results in favour of finding poorer performance
among the users. 

A more extensive study of 60 working class males in Jamaica (Rubin and
Comitas, 1975) compared 30 users and 30 non-users matched on age,
socioeconomic status and residence. The users who were aged between 23
and 53 years with a mean age of 34 years, had used cannabis for an
average of 17.5 years (range seven to 37 years) at around seven joints
per day (range one to 24) containing an estimated 60mg of THC. They
had not used any other substances other than alcohol and tobacco.
While no control subject had used cannabis heavily in recent years,
nine were current &quot;occasional&quot; users of cannabis and all but 12 of the
controls had some experience with cannabis. 

A battery of 19 psychological tests were administered after three days
of abstinence, as part of a six-day inpatient stay. The psychological
tests included three tests of intellectual and verbal abilities, and
15 neuropsychological tests measuring abilities previously shown to be
affected by acute cannabis intoxication. Comparisons of the users and
non-users on 47 test scores failed to reveal any consistent
significant differences. There were three statistically significant
results which were not easily interpreted and were considered chance
findings. There was no strong suggestion of differences that failed to
be detected because of a small sample size, since the user group
scored better than the non-user group on 29 variables, albeit
non-significantly. 

The interpretation of these null results must be qualified because
several factors may have attenuated differences between users and
non-users. First, the tests used were not standardised for use in
Jamaica. The authors' arguednerability to
Drug Abuse. Washington: Am
for both users and controls and therefore would not obscure any group
differences (Rubin and Comitas, 1975, p111). Second, the Weschler
Adult Intelligence Scale (WAIS) subtests may have been too easy or too
difficult to allow detection of group differences. Third, the
inclusion of cannabis users in the control group may have further
reduced the chance of detecting group differences. Fourth, the
Jamaican sample were primarily farmers, fishermen and artisans from
rural areas, or casual urban labourers. The failure of cannabis to
impair their cognitive performance does not exclude the possibility
that the long-term use of cannabis may impair the performance of
persons required to perform at a cognitively more demanding level.



7.4.2.2 Greece

The Greek NIDA study (Stefanis et al 1976, 1977) compared the
cognitive performance of a sample of 47 chronic hashish users and 40
controls matched for age, sex, education, demographic region,
socioeconomic status and alcohol consumption. The subjects were mostly
refugees from Asia Minor, residing in a low income, working class area
of Athens. The average duration of hashish use was 23 years of 200mg
per day. Most users had smoked hashish on the day before testing, and
some had smoked several hours before the test session. Controls were
slightly better educated than users. 

These researchers administered the Weschler Adult Intelligence Scale
(WAIS) and Raven's Progressive Matrices to assess general intelligence
and mental functioning (Kokkevi and Dornbush, 1977). Subtests of the
WAIS were used to evaluate impairment in specific cognitive and
perceptual functions. The Raven's test was considered to be a more
culture-free assessment of intelligence and was used for reliability
and validity purposes. The groups did not differ in global IQ score on
either the WAIS or Raven's Progressive Matrices, but non-users
obtained a higher verbal IQ score than users. The users' performance
was worse than controls on all but one of the subtests of the WAIS,
even if not significantly so. Significant differences in performance
between the two groups were obtained in three subtests of the WAIS,
indicating possible defects in verbal comprehension and expression,
verbal memory, abstraction and associative thinking, visual-motor
coordination and memorising capacity, and logical sequential thought. 

The interpretation of these results was complicated by the lack of a
requirement that subjects abstain from hashish prior to testing.
Consequently, it was not clear whether the impairments found on these
subtests were related to long-term use of hashish, or were due to the
persistence of an acute drug effect at the time of testing. Because
the differences between verbal and performance IQ were similar in both
groups, the authors argued that there was no evidence of deterioration
in mental abilities in the hashish users. 



7.4.2.3 Costa Rica

The NIDA study of chronic heavy cannabis users in Costa Rica was
modelled upon the Jamaican project, but with greater sensitivity to
cross-cultural issues. It involved an intensive physiological,
psychological, sociological and anthropological study of matched pairs
of users and non-users (Carter, 1980). Satz, Fletcher and Sutker
(1976) compared 41 male long-term heavy cannabis users (9.6 joints per
day for 17 years) with matched controls on an extensive test battery
designed to assess the impact of chronic cannabis use on
neuropsychological, intellectual and personality variables. The
educational level of the Costa Rican sample was slightly higher than
that of either the Greek or the Jamaican samples, although more than
half of the user group had not completed primary school, and both
users and non-users had left school at 12 years of age. The users were
working class, mostly tradesmen with lower than average income, who
reported that they often used cannabis to improve their work
performance.

Despite their long duration and heavy use, the Costa Rican users did
not differ significantly from controls on any test. Users scored
consistently lower, if not significantly so, than non-users on 11 of
16 neuropsychological tests. Although users' performance was poorer,
particularly in the mean number of errors made, learning curves were
similar for both groups. The authors concluded that there was
insufficient evidence for significant impairment of memory function in
the chronic cannabis users. Users performed slightly better on six of
the 11 WAIS subtests and had a slightly higher verbal and full-scale
IQ. There were no correlations between test results and the level of
marijuana use. 

A 10-year follow-up of the Costa Rican sample was conducted by Page,
Fletcher and True (1988). By the time of follow-up, the users had an
average 30 years experience with cannabis, but the sample size had
dropped to 27 of the 41 original users and 30 of the 41 controls. The
test protocol included some of the original tests, as well as
additional tests which measured short-term memory and attention, and
which had been selected for their sensitivity in detecting subtle
changes in cognitive functioning. 

No differences were detected on any of the original tests, but three
tests from the new battery yielded significant differences between
users and controls. In Buschke's Selective Reminding Test, the user
group retrieved significantly fewer words from long-term storage than
the non-user group, although the groups did not differ on a measure of
storage. Users performed more slowly than non-users in the Underlining
Test, with particularly poor performance in the most complex subtest.
The Continuous Performance Test also revealed users to be slower than
controls on measures requiring sustained attention and effortful
processing, although there were no differences in performance. 

Page et al (1988) interpreted their results as evidence that long-term
consumption of cannabis was associated with difficulties in sustained
attention and short-term memory. They hypothesised that such tests
require more mental effort than the tests used in the original study,
and, as such, that long-term users of cannabis experience greater
difficulties with effortful processing. This study differs from
previous cross-cultural investigations in that it found differences
between users and non-users in tests of information processing,
sustained attention and short-term memory. Nevertheless, Page et al
(1988) emphasised that the differences they found were &quot;quite subtle&quot;
and &quot;subclinical&quot;, with only a small number of subjects being
clinically impaired. Because the differences are so small and subtle,
it was difficult to exclude the alternative explanation that the
differences were due to acute intoxication or recent use, since
24-hour abstinence was requested but not verified. 



7.4.2.4 Egypt

Soueif (1971) studied 850 Egyptian hashish smokers and 839 controls
obtained from a male prison population which was poorly educated,
largely illiterate and of low socioeconomic status. Significant
differences were found between users and controls on 10 out of 16
measures of perceptual speed and accuracy, distance and time
estimation, immediate memory, reaction time and visual-motor abilities
(Soueif, 1971; 1975; 1976a; 1976b). These differences were more marked
in those under 25 years and among the best educated urban users. 

Soueif's study was subsequently criticised for methodological reasons
(Fletcher and Satz, 1977). A major criticism was that the groups
differed on a number of variables that were relevant to cognitive
performance, including education (with literate non-users being better
educated than illiterate users). There were also higher rates of
opiate and alcohol use among the cannabis users. Soueif (1977) later
reported that in his sample, differences between users and non-users
were not explained by education or polydrug use (Soueif, 1977). The
validity of these findings remain under doubt, however, because some
of the tests used did not have established neuropsychological validity
(Carlin, 1986).



7.4.2.5 India

Agarwal et al (1975) studied 40 subjects who had used bhang (a
tea-like infusion of cannabis leaves and stems) daily for about five
years. These users were less than 45 years of age, and reasonably well
educated: none were illiterate and 65 per cent had completed high
school. There was no control group, so scores were compared to
normative data on the tests used. By comparison with these norms, 18
per cent of the bhang users had memory impairment, 28 per cent showed
mild intellectual impairment on an intelligence test (IQs less than
90) and 20 per cent showed substantial cognitive disturbances on the
Bender-Gestalt Visuo-Motor Test. Wig and Varma (1977) substantially
replicated these results. 

Mendhiratta, Wig and Verma (1978) compared 50 heavy cannabis users
(half bhang drinkers, half charas smokers of at least 25 days per
month for a mean of 10 years) with matched controls. The entire sample
was of low socioeconomic status. Tests were administered after 12
hours abstinence which was verified by overnight admission to a
hospital ward. The cannabis users reacted more slowly, and performed
more poorly in concentration and time estimation. The charas smokers
were the poorest performers, showing impaired memory function, lowered
psychomotor activity and poor size estimation. A follow-up of 11 of
the original bhang drinkers, 19 charas smokers and 15 controls nine to
10 years later (Mendhiratta et al, 1988) showed significant
deterioration on several of the tests.

Ray et al (1978) assessed the cognitive functioning of 30 chronic
cannabis users (aged 25-46) who had used bhang, ganja or charas for a
minimum of 11 times/month for at least five years. They compared their
performance to 50 randomly selected non-user controls of similar age,
occupation, socioeconomic status and educational background. Few
differences were found on tests of attention, visuomotor coordination,
or memory. Cannabis users' performance was impaired on one of the
subtests of the memory scale. However, the matching of subjects was
not rigorous, and the fact that all subjects were illiterate may have
produced a floor effect masking differences between groups. 

Varma et al (1988) administered 13 psychological tests selected to
assess intelligence, memory and other cognitive functions, to 26 heavy
marijuana smokers and 26 controls matched on age, education and
occupation. The average daily intake of the cannabis users was
estimated as 150mg THC, with a frequency of at least 20 times per
month, and a mean duration of use 6.8 years (minimum five years).
Twelve hours abstinence was ensured by overnight hospitalisation.
Cannabis users were found to react more slowly on perceptuomotor
tasks, but did not differ from controls on the tests of intelligence.
When the scores of all the memory tests were combined, there was no
difference between the total scores of cannabis users and controls,
although cannabis users scored significantly more poorly on a subtest
of recent memory. There were trends toward poorer performance on
subtests of remote memory, immediate and delayed recall, retention and
recognition. 



7.4.2.6 Summary

The results of the cross-cultural studies of long-term heavy cannabis
users provided at most equivocal evidence of an association between
cannabis use and more subtle long-term cognitive impairments. Given
that cognitive impairments are most likely to be found in subjects
with a long history of heavy use, it is reassuring that most such
studies have found few and typically small differences. It is unlikely
that the negative results of these studies can be attributed to an
insufficient duration or intensity of cannabis use within the samples
studied, since the duration of cannabis use ranged between 16.9-23
years, and the estimated amount of THC consumed daily ranged from
20-90mg daily in Rubin and Comitas's Jamaican study to 120-200mg daily
in the Greek sample.

The absence of differences is all the more surprising, since a number
of factors may have biased these studies toward finding poorer
performance among cannabis users. These include: higher rates of
polydrug use, poor nutrition, poor medical care, and illiteracy among
users; and the failure in many studies to ensure that subjects were
not intoxicated at the time of testing. Given the generally positive
biases in these studies, it has been argued that if cannabis use did
produce cognitive impairment, then these studies should have shown
positive results (Wert and Raulin, 1986b).

The force of this argument is weakened by the fact that most of these
studies also suffered from methodological difficulties which may have
operated against finding a difference. First, the instruments used
have been developed and standardised on Western populations. Second,
many of these studies were based on small samples of questionable
representativeness. Third, a number of studies failed to include a
control group, while others used inappropriate controls. Fourth,
generalisation of the results of these studies to users in the West or
other cultures is difficult, given the predominance of illiterate,
rural, older and less intelligent or less educated subjects in these
studies. Fifth, the studies were only capable of detecting gross
deficits. Sixth, few attempts were made to examine relationships
between neuropsychological test performance and frequency and duration
of cannabis use. 

Despite all these problems, there was nonetheless suggestive evidence
of more subtle cognitive deficits. Slower psychomotor performance,
poorer perceptual motor coordination, and memory dysfunction were the
most consistently reported deficits. In terms of memory function, four
studies detected persistent short-term memory and attentional deficits
(Page et al, 1988; Soueif, 1976a; Varma et al, 1988; Wig and Varma,
1977), while three failed to detect such deficits (Bowman et al, 1973;
Satz et al, 1976; Mendhiratta et al, 1978). The measures of short-term
memory were often inadequate, failing to determine which processes may
be impaired (e.g. acquisition, storage, encoding, retrieval) and often
excluded higher mental loads and conditions of distraction. A proper
evaluation of the complexity of effects of long-term cannabis use on
higher cognitive functions requires greater specificity in the
selection of assessment methods, as well as the use of more sensitive
tests.



7.4.3 Studies of young Western users 

A number of studies have been conducted on the cognitive performance
of American or Canadian cannabis users. These samples have generally
been young and well educated college students with relatively
short-term exposure to cannabis, by comparison with the long history
of use among chronic users in the cross-cultural studies. 

In one of the earliest studies, Hochman and Brill (1973) surveyed
1,400 college students and compared the performance of non-users (66
per cent), occasional users (26 per cent) and chronic users (9 per
cent: defined as having used three times/week for three years or, had
used daily for two years). They found no relationship between either
frequency or duration of use and academic achievement. In about 1 per
cent of marijuana users there was impaired ability to function. In a
follow-up of the original sample over two consecutive years (1971:
N=1,133; 1972: N=901), Brill and Christie (1974) compared non-users,
occasional users (<2 times per week), frequent (2-4/week), and regular users
(&ograve;5/week) by a self-report questionnaire. the majority of
users reported no effect of cannabis use on psychosocial
adjustment. a small proportion (12 per cent) who reported that
their academic performance had declined were likely to have
either reduced their frequency of use or quit. there were no
significant differences between users, non-users or former users
in grade point average. a series of studies conducted since then
has largely confirmed the results of hochman and brill's studies.
grant et al (1973), for example, studied the effects of cannabis
use on psychological test performance on eight measures from the
halstead-reitan battery among medical students. they found no
differences between 29 cannabis users (of median duration, four
years and median frequency of use, three times per month) and 29
age and intelligence matched non-users on seven of the eight
measures. the failure to find any difference in sensory-motor
integration or immediate sensory memory was later replicated by
rochford, grant and lavigne (1977) in a comparison of 25 users
(of at least 50 times over a mean 3.7 years) and 26 controls
matched on sex, age and scholastic aptitude scores. weckowicz and
janssen (1973) compared eleven male college students who smoked
cannabis three to five times per week for at least three years
with non-users who were matched on age, education and
socioeconomic and cultural backgrounds. they were assessed on a
variety of tests of cognitive function. users performed better
than controls on eight of the 11 cognitive tests but performed
more poorly on one which suggested that chronic use may affect
sequential information processing. otherwise, there was no
evidence of gross impairment of cognitive functioning. weckowicz,
collier and spreng (1977) largely replicated these findings in a
comparison of 24 heavy smokers (at least daily for three years)
belonging to the "hippie subculture" with non-user controls
matched for age, education, and social background. similar
results were reported by culver and king (1974) in a comparison
of the neuropsychological performance of three groups of
undergraduates (n="14)" from classes in two successive years:
marijuana users (at least twice/month for 12 months); marijuana
plus lsd users (lsd use at least once/month for 12 months); and
non-drug users. there were no consistent differences between the
groups across the different years. in 1981, schaeffer et al
(1981) reported no impairment of cognitive function in one of the
first studies of a prolonged heavy cannabis using population in
the united states, who used the drug for religious reasons. they
assessed 10 long-term heavy users of ganja, aged between 25 and
36 years, all of whom were caucasian, and had been born, raised
and educated in the usa. all had smoked between 30gm and 60gm of
marijuana (>8 per cent THC) per day for a mean of 7.4 years. They had
not consumed alcohol or other psychoactive substances. This study was
also used a laboratory test to detect recent ingestion of cannabis.
Schaeffer et al reported that at the time of testing, all subjects had
at least 50ng/ml cannabinoids in their urines. Performance on a series
of tests of cognitive ability was compared with the
standardised-normative information available for each test. Overall,
WAIS IQ scores were in the superior to very superior range, and the
scores of all other tests were within normal limits. Despite the heavy
and prolonged use of cannabis, there was no evidence of impairment in
the cognitive functions assessed, namely, language function,
non-language function, auditory and visual memory, remote, recent and
immediate memory, or complex multimodal learning. 

Carlin and Trupin (1977) assessed 10 normal subjects (mean age 24
years) who smoked marijuana daily for at least two years (mean five
years) and who denied other drug use. They administered the Halstead
Neuropsychological Test Battery after 24 hours abstinence. No
significant impairment was found by comparison with non-smoking
subjects matched for age, education and full-scale IQ. Cannabis users
performed better on a test sensitive to cerebral impairment than
non-users. 

Not all studies have produced null results, however. Gianutsos and
Litwack (1976), for example, compared the verbal memory performance of
25 cannabis smokers who had used for two to six years and at least
twice/week for the last three months, with 25 non-smokers who had
never smoked cannabis. Subjects were drawn from an undergraduate
university student population and were matched on age, sex, year at
university, major and grade point average. Cannabis users reported
that they had not smoked prior to testing, although the length of
abstinence was not reported. Cannabis users recalled significantly
fewer words overall than non-users, and the difference in performance
increased as a function of the number of words they were required to
learn. 

Entin and Goldzung (1973) also found evidence of impairment in two
studies of the residual impact of cannabis use on memory processes. In
the first study, verbal memory was assessed by the use of
paired-associate nonsense syllable learning lists. Twenty-six cannabis
users (defined as daily for at least six months) were compared to 37
non-users drawn from a student population. Cannabis users scored
significantly more poorly on both free recall (the number of words
recalled after a delay) and on acquisition, measured as improvement in
recall over repeated trials. In the second study, verbal and numerical
memory were tested by the presentation of word lists, interspersed
with arithmetic problems prior to recall. Cannabis users (N=37)
recalled significantly fewer words than non-users (N=37), but did not
differ from controls on arithmetic test scores. These findings were
interpreted as residual impairment of both the acquisition and recall
phases of long-term memory processes. The authors attributed the
impairments to either an enduring residual pharmacological effect on
the nervous system, or to an altered learning or attention pattern due
to repeated exposure to cannabis. 



7.4.3.1 Summary

The results of these empirical studies served to allay fears that
cannabis smoking caused gross impairment of cognition and cerebral
function in young adults. The lack of consistent findings failed to
support Kolansky and Moore's (1971, 1972) clinical reports of an
organic impairment, although some critics (e.g. Cohen, 1982) argued
that the value of these studies was weakened by their small sample
sizes and the fact that by studying college students, they had sampled
from a population unlikely to contain many impaired persons. On
Cohen's hypothesis, the younger, brighter college cannabis users may
reflect the survivors, whereas Kolansky and Moore sampled the
casualties. Such an hypothesis conflicts with the explanations
provided for the failure to find impairment in the cross cultural
studies. Soueif's hypothesis, for example, was that the lower the
non-drug level of proficiency, the smaller the size of functional
deficit associated with drug usage. This would imply maximal
differences at the high end of cognitive ability. 

A more pertinent explanation for the lack of impairment is that the
duration of cannabis use in these samples was quite brief, generally
less than five years. It has been argued that cannabis has not been
smoked long enough in Western countries for impairments to emerge.
Further, when psychometric testing was used as a metric of cognitive
function as opposed to self-report questionnaires, sample sizes were
often too small to permit the detection of all but very large
differences between groups. 

Not all studies found negative results. A small number of studies did
find significant impairments in their cannabis users. It is noteworthy
that these studies selected tests to assess a specific cognitive
function (memory), and attempted to determine the specific stages of
processing where dysfunction occurred. Entin and Goldzung (1973), for
example, found that users were impaired on both verbal recall and
acquisition of long-term storage memory tasks, but not on arithmetic
manipulations which require short-term storage of information. 



7.4.4 Controlled laboratory studies

A different approach to the investigation of the cognitive
consequences of chronic cannabis use is to examine the cognitive
effects of daily cannabis use over periods of weeks to months. Such
studies have attempted to control for variation in quantity, frequency
and duration of use, as well as other factors such as nutrition and
other drug use, by having subjects reside in a hospital ward while
receiving known quantities of cannabis. All such studies employed pre-
and post-drug observation periods. Because of their expense, sample
sizes in these studies have been small and the duration of cannabis
administration has ranged from 21 to 64 consecutive days.

Dornbush et al (1972) administered 1g of marijuana containing 14mg THC
to five regular smokers (all healthy young students) for 21
consecutive days. The subjects were tested immediately before and 60
minutes after drug administration. Data were collected on short-term
memory and digit symbol substitution tests. Performance on the
short-term memory test decreased on the first day of drug
administration but gradually improved until by the last day of the
study, performance had returned to baseline levels. On the
post-experimental day baseline performance was surpassed. Performance
on the digit symbol substitution test was unaffected by drug
administration and also improved with time, suggesting a practice
effect. 

Mendelson, Rossi and Meyer (1974) reported a 31-day cannabis
administration study in which 20 healthy, young male subjects (10
casual and 10 heavy users, mean age 23) were confined in a research
ward and allowed 21 days of ad libitum marijuana smoking.
Psychological tests were administered during a five-day drug-free
baseline phase, the 21 day smoking period and a five-day drug-free
recovery phase. Acute and repeat dose effects of marijuana on
cognitive function were studied with a battery of psychological tests
known to be sensitive to organic brain dysfunction. There was no overt
impairment of performance prior to or following cannabis smoking, nor
was there any difference between the performance of the heavy and the
casual users. Short-term memory function, as assessed by digit span
forwards and backwards, was impaired while intoxicated, and there was
a relationship between performance and time elapsed since smoking.

Similar failures to detect cognitive effects have been reported by
three other groups of investigators. Frank et al (1976) assessed
short-term memory and goal directed serial alternation and computation
in healthy young males over 28 days of cannabis administration.
Harshman et al (1976) and Cohen (1976) conducted a 94-day cannabis
study in which 30 healthy moderate to heavy male cannabis users, aged
21-35, were administered on average 5.2 joints per day (mean 103mg
THC, range 35-198mg) for 64 days, and were assessed on brain
hemisphere dominance before, during and after cannabis administration.
Psychometric testing was not employed, but subjects were given two
work assignments with financial incentive: a &quot;psychomotor&quot; task
involving the addition of two columns of figures on a calculator, and
a &quot;cognitive task&quot; of learning a foreign language. No long-term
impairments were detected with these somewhat inadequate assessment
methods. 



7.4.4.1 Summary

The experimental studies of daily cannabis usage for periods of up to
three months in young adult male volunteers have consistently failed
to demonstrate a relationship between marijuana use and
neuropsychological dysfunction. This is not surprising given the short
periods of exposure to the drug in these studies. Furthermore, since
subjects served as their own controls, and had all used cannabis for
at least one year prior to the study, it would be surprising if a few
additional weeks of cannabis use produced any significant decrements
in performance. 



7.4.5 Recent research 

The equivocal results of the early investigations into long-term
effects of cannabis on cognitive function led to something of a hiatus
in research on the cognitive effects of cannabis in the 1980s.
Although the accumulated evidence indicated that cannabis did not
severely affect intellectual functioning, uncertainty remained about
more subtle impairments. Their study required advances in methodology
and assessment techniques which were made in the field of cognitive
psychology and neuropsychology in the 1980s. Modern theories of
cognition, memory function and information processing were developed,
as were more sensitive measures of cognitive processes. By the late
1980s, interest in the cognitive effects of cannabis revived at a time
when cannabis had been widely used for more than 15 years, its use was
widespread and initiated at a progressively younger age among young
Americans. 

Research from the late 1980s through the 1990s improved upon the
design and methodology of previous studies by using adequate control
groups, verifying abstinence from cannabis prior to testing, and
precisely measuring the quantity, frequency and duration of cannabis
use. In addition, greater attention was paid to investigating specific
cognitive processes and relating impairments in them to the quantity,
frequency and duration of cannabis use. 

The greater specificity in study focus was made possible by
accumulating evidence that cannabis primarily exerts its effect upon
those areas of the brain responsible for attention and memory. Miller
and Branconnier (1983), for example, reviewed the literature and
concluded that impaired memory was the single most consistently
reported psychological deficit produced by cannabinoids acutely, and
the most consistently detected impairment in long-term cannabis use.
Intrusion errors were one of the most robust type of cannabis-induced
memory deficits in both recall and recognition (Miller and
Branconnier, 1983). Such errors involve the introduction of extraneous
items, word associations or new material during free recall of words,
or the false identification of previously unseen items in recognition
tasks. Miller and Branconnier conjectured that these intrusion errors
occurred because cannabis users were unable to exclude irrelevant
associations or extraneous stimuli during concentration of attention,
a process in which the hippocampus plays a major role. The finding of
high densities of the cannabinoid receptor in the cerebral cortex and
hippocampus (Herkenham et al, 1990) supports the hypothesis that
cannabinoids are involved in attentional and memory processes. 



7.4.5.1 Studies of long-term adult users

Solowij et al (1991; 1992; 1993) conducted a series of studies of the
effects of long-term cannabis use on specific stages of information
processing. In keeping with Miller and Branconnier's hypothesis,
Solowij et al assessed the integrity of attentional processes in
long-term cannabis users using a combination of performance and brain
event-related potential measures. Event-related potential (ERP)
measures are sensitive markers of covert cognitive processes
underlying overt behaviour; the amplitude and latency of various ERP
components have been shown to reflect various stages of information
processing.

Solowij et al, (1991) studied a small and heterogeneous group of
long-term cannabis users (N=9), aged 19-40, who had used cannabis for
a mean of 11.2 years at the level of 4.8 days per week. The cannabis
users were matched on age, sex, years of education and alcohol
consumption with nine non-user controls who had either never used or
had limited experience with cannabis (maximum use 15 times). Strict
exclusion criteria were applied to any subjects with a history of head
injury, neurological or psychiatric illness, significant use of other
drugs, or high levels of alcohol consumption. The groups did not
differ in premorbid IQ, as estimated by the NART score (Nelson, 1984).

Subjects were instructed to abstain from cannabis and alcohol for 24
hours prior to testing and two urine samples were analysed to ensure
that subjects were not acutely intoxicated at the time of testing.
Subjects completed a multidimensional auditory selective attention
task in which random sequences of tones varying in location, pitch and
duration were delivered through headphones while brain electrical
activity (EEG) was recorded. They were instructed to attend to a
particular ear and a particular pitch, and to respond to the long
duration tones with a button press. This procedure enabled an
examination of the brain's response to attended and unattended tones.

Cannabis users performed significantly more poorly than controls, with
fewer correct detections, more errors and slightly longer reaction
times. Analysis of the ERP measures showed that cannabis users had
reduced P300 amplitudes compared to controls, reflecting dysfunction
in the allocation of attentional resources and stimulus evaluation
strategies. Further, cannabis users showed an inability to filter out
irrelevant information, while controls were able to reject this
irrelevant information from further processing at an early stage.
These results suggested that long-term cannabis use impairs the
ability to efficiently process complex information.

Solowij et al (1992; 1993) conducted a second study with a larger
sample to examine the relationships between degree of impairment and
the frequency and duration of use. Thirty-two cannabis users recruited
from the general community were split into four groups of equal size
(N=8) defined by frequency (light:  twice/week vs heavy:  three
times/week) and duration (short: 3-4 years vs long:  five years) of
cannabis use. The mean number of years of use for the long duration
users was 10.1, and 3.3 for short duration users (range three to 28
years). The mean frequency of use was 18 days per month for the heavy
group and six for the light group (range: once/month to daily use).
Subjects were matched to a group of non-user controls (N=16) as in the
first study, and a similar methodology was employed. 

Once again cannabis users performed worse than the controls, with the
greatest impairment observed in the heavy user group, thereby
replicating the earlier ERP findings. In addition, different cognitive
processes were differentially affected by frequency and duration of
cannabis use. The long duration user group showed significantly larger
processing negativity to irrelevant stimuli than did short duration
users and controls, who did not differ from each other. There were no
differences between groups defined on frequency of use. A significant
correlation between the ERP measure and duration of cannabis use
indicated that the ability to focus attention and filter out
irrelevant information was progressively impaired with the number of
years of use, but was unrelated to frequency of use. Frequency of use
affected the speed of information processing, as reflected in a
delayed P300 latency in the heavy user group compared to light users
and controls. There was a significant correlation between P300 latency
and increasing frequency of use, while this measure was unrelated to
duration of use. 

These results suggest that different mechanisms underlie the
short-term and long-lasting actions of cannabinoids. The slowing of
information processing suggests a chronic build up of cannabinoids,
and reflected a residual effect which could be eliminated by reducing
the frequency of use. The inability to focus attention and reject
irrelevant information possibly reflected long-term changes at the
cannabinoid receptor site. The consequences of these impairments may
be apparent in high levels of distractability when driving, operating
complex machinery, and learning in the classroom situation, and
interference with efficient memory and general cognitive functions.

Solowij et al also conducted specific analyses to disentangle the
relationship between duration of cannabis use and age. The results of
these analyses indicated that impairment was greatest in younger
subjects. Further, the studies demonstrated the insensitivity of
performance measures to cannabinoid effects, emphasising the need to
use more sensitive measures to examine otherwise inaccessible, covert
cognitive processes. 

Supportive evidence has emerged from a project funded by the National
Institute on Drug Abuse (NIDA) in the U.S. (principal investigator F.
Struve) that investigated persistent central nervous system sequelae
of chronic cannabis exposure. This research, which has focused upon
quantitative EEG, has found evidence of larger changes in EEG
frequency, primarily in frontal-central cortex, in daily cannabis
users of up to 30 years duration compared to short-term users and
non-users (e.g. Struve et al, 1993). The results also suggest a
dose-response relationship between EEG changes and the total
cumulative exposure (duration in years) of daily cannabis use which
may indicate organic changes. The major limitation of this research is
that changes in frequency of EEG spectra have not been shown to be
related to cognitive events. 

One study from this research group has used cognitive event-related
potential measures. It found smaller P2 and N2 amplitudes in long-term
cannabis users (&gt;15 years) compared to moderate users (of three to six
years). Cannabis users overall showed significantly smaller auditory
and visual P300 amplitudes than controls, but no significant latency
differences (Straumanis et al, 1992). Unfortunately, this study has
only been reported in abstract form, and results have not been
examined as a function of frequency of cannabis use. 

This research group has also assessed cognitive functioning by
neuropsychological tests (e.g. Leavitt et al, 1991; 1992; 1993). These
investigations have been well controlled. Subjects were extensively
screened for current or past psychiatric or medical disease or CNS
injury, and underwent extensive drug history assessments, with eight
weeks of twice weekly drug screens. Groups were matched for age and
sex. Daily cannabis users who had at least three years to six years of
use were compared to a group who had used for six to 14 years, a group
who had used on a daily basis for 15 years or more, and a non-user
control group. Sample sizes varied from study to study, but averaged
15 per group. 

An extensive battery of psychological tests included measures of
simple and complex reaction time, attention and memory span, language
and comprehension tasks, construction, verbal and visual learning and
memory, and mental abilities such as concept formation and logical
reasoning. The effects of age and education have been statistically
controlled for by multiple regression. Preliminary analyses have shown
a dose-response relationship between test performance and intensity of
cannabis use, with the best performance characterising controls,
followed by the daily cannabis users, and the worst mean scores
occurring in the very long-term group (Leavitt et al, 1991; 1992;
1993; Leavitt, personal communication). Tests sensitive to mild
cortical dysfunction were those most affected in the long-term user
groups. 

The authors acknowledge that small sample sizes dictate caution, and
that there were no data available to assess premorbid cognitive
capacity of these subjects. Nevertheless, the results suggested that
long duration users seem to process some kinds of information more
slowly than non-users, and that the effects of long-term cannabis use
are most likely to surface under conditions of moderately heavy
cognitive load. 

One crucial requirement for evaluating the performance of chronic
marijuana users is comparison with an appropriately matched group of
non-using subjects. Although the studies described have made
substantial progress in this regard, one concern remains that some of
these impairments may have been present in the cannabis users prior to
their cannabis use. Block et al (1990) used scores on the Iowa Tests
of Basic Skills collected in the fourth grade of grammar school as a
measure of premorbid cognitive ability. Block et al matched their user
and non-user samples on this test to ensure that they were comparable
in intellectual functioning before they began using marijuana. The
study aim was to determine whether chronic marijuana use produced
specific cognitive impairments, and if so, whether these impairments
depend on the frequency of use. Block and colleagues assessed: 144
cannabis users, 64 of whom were light users (one to four/week for 5.5
years) and 80 heavy users (five/week for 6.0 years), and compared
them with 72 controls. Subjects were aged 18-42. Twenty-four hours of
abstinence were required prior to testing. 

Subjects participated in two sessions. In the first session they
completed the 12th grade version of the Iowa Tests of Educational
Development, which emphasise basic, general intellectual abilities and
academic skills and effective utilisation of previously acquired
information in verbal and mathematical areas. In the second session,
subjects were administered computerised tests that emphasise learning
and remembering new information, associative processes and semantic
memory retrieval, concept formation and psychomotor performance. These
tasks had been previously shown to be sensitive to the acute and
chronic effects of cannabis, and to relevant skills required in school
and work performance. The results showed that heavy users who were
matched to controls on fourth-grade Iowa scores, showed impairment on
two tests of verbal expression and mathematical skills when tested on
the 12th-grade Iowa test. No results have been reported to date from
the computerised tests.  



7.4.5.2 Studies in children and adolescents

A very different approach to assessing the long-term consequences of
exposure to cannabis has been taken in a well controlled longitudinal
study of children who were exposed to cannabis in utero (Fried, 1993).
The levels of exposure to cannabis in the sample were approximately as
follows: 60 per cent of the mothers used cannabis irregularly, 10 per
cent reported smoking two to five joints per week, and 30 per cent
smoked a greater amount during each trimester of pregnancy. Prenatal
exposure to cannabis was associated with high pitched cries, disturbed
sleep cycles, increased tremors and exaggerated startles in response
to minimal stimulation in newborn to 30-day-old babies. The babies
showed poorer habituation to visual stimuli, consistent with the
sensitivity of the visual system to the teratogenic effects of
cannabis demonstrated in rhesus monkeys and rats. Fried hypothesised
that exposure to cannabis may affect the rate of development of the
central nervous system, slowing the maturation of the visual system.
This hypothesis was supported by visual evoked potential studies of
the children at four years of age, when children who had been exposed
to cannabis in utero showed greater variability and longer latency of
the evoked potential components, indicating immaturity in the system. 

From one to three years of age, no adverse effects of prenatal
exposure were found. At two years it appeared that the children were
impaired on tests of language comprehension, but this effect did not
persist after controlling for other factors such as ratings of home
environment. At four years of age, however, the children of cannabis
using mothers were significantly inferior to controls on tests of
verbal ability and memory. The explanation for the failure to detect
impairments in the preceding age group was that the degree and types
of deficits observed may only be identifiable when cognitive
development has proceeded to a certain level of maturity. 

At five and six years of age, the children were not impaired on global
tests of cognition and language. By age six, however, there was a
deficit in sustained attention on a task that differentiated between
impulsivity and vigilance. Fried proposed that &quot;instruments that
provide a general description of cognitive abilities may be incapable
of identifying nuances in neurobehavior that may discriminate between
the marijuana-exposed and non-marijuana exposed children&quot; (p332). He
suggested the need for tests which examine specific cognitive
characteristics and strategies, such as the test of sustained
attention. Fried concluded that cannabis &quot;may affect a number of
neonatal behaviours and facets of cognitive behavior under conditions
in which complex demands are placed on nervous system functions&quot;.

The effects of long-term cannabis use on adolescents have not been
adequately addressed. This issue is of greater relevance with an
increase in the prevalence of cannabis use among adolescents and young
adults in Western society. In the first study of its kind with
adolescents, Schwartz et al (1989) reported the results of a small
controlled pilot study of persistent short-term memory impairment in
10 cannabis-dependent adolescents (aged 14-16 years). Schwartz's
clinical observations of adolescents in a drug-abuse treatment program
suggested that memory deficits were a major problem, which according
to the adolescents persisted for at least three to four weeks after
cessation of cannabis use. His sample was middle-class, North
American, matched for age, IQ and history of learning disabilities
with 17 controls, eight of whom were drug abusers who had not been
long-term users of cannabis, and another nine whom had never abused
any drug. The cannabis users consumed approximately 18g per week,
smoking at a frequency of at least four days per week (mean 5.9) for
at least four consecutive months (mean 7.6 months). Subjects with a
history of excessive alcohol or phencyclidine use were excluded from
the study. Cannabinoids were detected in the urines of eight of the 10
users over two to nine days. 

Users were initially tested between two and five days after entry to
the treatment program, this length of time allowing for dissipation of
any short-term effects of cannabis intoxication on cognition and
memory. Subjects were assessed by a neuropsychological battery which
included the Wechsler Intelligence Scale for Children, and six tests
&quot;to measure auditory/verbal and visual/spatial immediate and
short-term (delayed) memory and praxis (construction ability)&quot;
(p1215). After six weeks of supervised abstinence with bi-weekly urine
screens for drugs of abuse, they were administered a parallel test
battery. 

On the initial testing, there were statistically significant
differences between groups on two tests: cannabis users were
selectively impaired on the Benton Visual Retention Test and the
Wechsler Memory Scale Prose Passages. The differences were smaller but
were still detectable six weeks later. Cannabis users committed
significantly more errors than controls initially on the Benton Visual
Retention Test for both immediate and delayed conditions, but
differences in the six-week post-test were not significant. Users
scored lower than controls on both immediate and delayed recall in the
Wechsler Memory Prose Passages Test in both test sessions. The fact
that there was a trend toward improvement in the scores of cannabis
users suggests that the deficits observed were related to their past
cannabis use and that functioning may return to normal following a
longer period of abstinence. 

Schwartz's study was the first controlled study to demonstrate
cognitive dysfunction in cannabis-using adolescents with a relatively
brief duration of use. The implications of these results are that
young people may be more vulnerable to any impairments resulting from
cannabis use. Unfortunately, like many of its predecessors, Schwartz's
team made little effort to interpret the significance of the
selectivity of their results. There was nothing to indicate which
specific elements of memory formation or retrieval were disrupted. 



7.4.6 Discussion

Previous reviewers have generally concluded that there is insufficient
evidence that cannabis produces long-term cognitive deficits (e.g.
Wert and Raulin, 1986a; 1986b). This is a reasonable conclusion when
gross deficits are considered. However, the findings from recent, more
methodologically rigorous studies provide evidence of subtle cognitive
impairments which appear to increase with duration of cannabis use.
The evidence suggests that impairment on some neuropsychological tests
may become apparent only after 10-15 years of use, but very sensitive
measures of brain function are capable of detecting specific
impairments after five years of use.

Impairments appear to be specific to the organisation and integration
of complex information, involving various mechanisms of attention and
memory processes. The similarity between the kinds of subtle
impairments associated with long-term cannabis use and frontal lobe
dysfunction is becoming more apparent (e.g. short-term memory
deficits, increased susceptibility to interference, lack of impairment
on general tests of intelligence or IQ). Frontal lobe function is
difficult to measure, as indicated by the fact that patients with
known frontal lobe lesions do not differ from controls on a variety of
neuropsychological tests (Stuss, 1991), so the difficulty of assessing
frontal lobe functions is not unique to research into the long-term
effects of cannabis. 

One of the functions of the frontal lobes is the temporal organisation
of behaviour, a key process in efficient memory function,
self-awareness and planning. The frontal lobe hypothesis of
impairments due to long-term use of cannabis is consistent with the
altered perception of time demonstrated in cannabis users and with
cerebral blood flow studies which demonstrate greatest alterations in
the region of the frontal lobes (see Section 7.5 brain damage).

The equivocal results of previous studies may be due primarily to poor
methodology and insensitive test measures. Wert and Raulin (1986b) had
rejected the possibility that tests used previously were not sensitive
enough to detect impairments, on the grounds that the same tests have
demonstrated impairment in alcoholics and heavy social drinkers.
However, the cognitive deficits produced by chronic alcohol
consumption may be very different to those produced by cannabis. The
mechanisms of action of the two substances are different, with
cannabis acting on its own specific receptor, and Solowij et al (1993)
showed that the attentional impairments detected in their long-term
cannabis users were not related to their alcohol consumption.
Furthermore, tests may have been selected inappropriately because they
were previously shown to be affected by acute intoxication, when the
consequences of chronic use may be very different. A priority for
future research is the identification of specific mechanisms of
impairment by making direct comparisons with the effects of a variety
of other substances. 

Recent research has aimed at identifying specific cannabis effects by
using strict exclusion criteria, and carefully matching control groups
to ensure that any deficits observed are attributable to cannabis.
However, interactions between the effects of long-term cannabis use
concurrent with use of other substances need to be further explored.
Subjects have also been excluded if they have had a history of
childhood illness, learning disabilities, brain trauma or other
neurological or psychiatric illness. The effects of long-term cannabis
use on such individuals may be worthy of further investigation.

Cognitive deficits may not be an inevitable consequence of cannabis
use. The long-term effects of cannabis on healthy individuals may
differ from those in individuals with co-existing mental illness or
pre-existing cognitive impairments. On the other hand, some
individuals appear to function well even in cognitively demanding
occupations despite long-term cannabis use. Wert and Raulin (1986b)
suggested that some individuals may adapt and overcome some forms of
cognitive impairment by a process of relearning. 

When users and non-users are compared, differences may not always
reach statistical significance due to large individual variability,
particularly when small sample sizes are used. Carlin (1986) proposed
that &quot;studies that rely upon analysis of central tendency are likely
to overlook impairment by averaging away the differences among
subjects who have very different patterns of disability&quot;. Individual
differences in vulnerability to the acute effects of cannabis are well
recognised and are likely to be a factor in determining susceptibility
to a variety of cognitive dysfunctions associated with prolonged use
of cannabis. 

There has been no research designed to identify individual differences
in susceptibility to the adverse effects of cannabis. A susceptibility
may be due to structural, biochemical or psychological factors, or as
Wert and Raulin suggested, to lack of the &quot;cerebral reserve that most
of us call on when we experience mild cerebral damage&quot;, for example,
after a night of heavy drinking. Wert and Raulin suggested that
prospective studies are the ideal way to identify those subjects who
show real impairment in functioning by comparing pre- and post-
cannabis performance scores. However, even in a retrospective design
it is possible to compare the characteristics of subjects who show
impairment with those who do not, thereby identifying possible risk
factors. Insufficient consideration has been given to gender, age, IQ
and personality differences in the long-term consequences of cannabis
use. 

Almost all of the studies reviewed have been retrospective studies of
naturally occurring groups (users vs. non-users). Although the
matching of control groups has become more stringent, and attempts to
obtain estimates of premorbid functioning have increased, prospective
studies where each subject is used as his/her own control would
eliminate the possibility of cannabis users having demonstrated poorer
performance before commencing their use of cannabis. A longitudinal
study in which several cohorts at risk for drug abuse are followed
over time would be the best way to assess the detrimental effects of
long-term cannabis use on cognition and behaviour. 

Given the growing prevalence of cannabis use, and proposals to reduce
legal restrictions on cannabis use, it is essential that research into
cognitive effects of long-term cannabis use continues. According to US
survey data (Deahl, 1991), more than 29 million people in the United
States may be using cannabis, and more than seven million of these use
on a daily basis. While there is some controversy surrounding the
issue, it seems likely that the potency of cannabis has increased over
the years, as more potent strains have been developed for the black
market. Increased THC potency combined with decreased age of first use
may result in the more marked cognitive impairments in larger numbers
of individuals in the future. 

Future research should adhere to rigorous methodology. This should
include the use of the best available techniques for detecting
cannabinoids in the body to provide greater precision in the
investigation of the effects of abstinence on performance. This would
permit a distinction to be made between those impairments which are
residual, and likely to resolve with abstinence over time, from those
of a more enduring or chronic nature, which would be associated with
cumulative exposure. 

Given that recent research has identified cognitive impairments that
are associated with cumulative exposure, it is a priority to
investigate the extent and rate of recovery of function following
cessation of cannabis use. Furthermore, the parameters of drug use
require careful scrutiny in terms of evaluating how much cannabis must
be smoked and for how long, before impairments are manifest in
different kinds of individuals. One of the problems in assessing the
cannabis literature is the arbitrariness with which various groups of
users have been described as &quot;heavy&quot;, &quot;moderate&quot; or &quot;light&quot;,
&quot;long-term&quot;, &quot;moderate&quot; or &quot;short-term&quot;. 

The use of very sensitive measures of cognitive function is important
for the detection of early signs of impairment, which may permit a
harm minimisation approach to be applied to cannabis use. With further
research, it may be possible to specify levels of cannabis use that
are &quot;safe&quot;, &quot;hazardous&quot; and &quot;harmful&quot; in terms of the risk of
cognitive impairment. Further research examining the consequences of
cannabis use in comparison to other substances could provide users
with the ability to make an informed decision about whether or not to
use the drug, and if they use, how much and how often to use.



7.4.7 Conclusion

The weight of evidence suggests that the long-term use of cannabis
does not result in any severe or grossly debilitating impairment of
cognitive function. However, there is clinical and experimental
evidence which suggests that long-term use of cannabis produces more
subtle cognitive impairments in specific aspects of memory, attention
and the organisation and integration of complex information. While
these impairments may be subtle, they could potentially affect
functioning in daily life. The evidence suggests that increasing
duration of use leads to progressively greater impairment. It is not
known to what extent such impairment may recover with prolonged
abstinence.

It is apparent that not all individuals are affected equally by
prolonged exposure to cannabis. Individual differences in
susceptibility need to be identified and examined. For those who are
dysfunctional, there is a need to develop appropriate treatment
programs which address the subtle impairments in cognition and work
toward their resolution. There has been insufficient research on the
impact of long-term cannabis use on cognitive functioning in
adolescents and young adults, or on the effects of chronic use on the
cognitive decline that occurs with normal aging. Gender differences
have not been examined to date and may be important, given that such
differences have become apparent in differential responses to alcohol.


Future research should aim to identify with greater specificity those
aspects of cognitive functioning which are affected by long-term use
of cannabis, and to examine the degree to which they are reversible.
There is converging evidence that dysfunction due to chronic cannabis
use lies in the higher cognitive functions that are subserved by the
frontal lobes and which are important in organising, manipulating and
integrating a variety of information, and in structuring and
segregating events in memory. 

Until better measures have been developed to investigate the
subtleties of dysfunction produced by chronic cannabis use, cannabis
may be viewed as posing a lesser threat to cognitive function than
other psychoactive substances such as alcohol. Nevertheless, the fact
remains that in spite of its illegal status, cannabis use is
widespread. We therefore have a continuing responsibility to minimise
drug-related harm by identifying potential risks, subtle though they
may be, and communicating the necessary information to the community.



References

Agarwal, A.K., Sethi, B.B. and Gupta, S (1975). Physical and cognitive
effects of chronic bhang (cannabis) intake. Indian Journal of
Psychiatry, 17(1), 1-7.

Block, R.I., Farnham, S., Braverman, K., Noyes, R., Jr. and Ghoneim,
M.M. (1990). Long-term marijuana use and subsequent effects on
learning and cognitive functions related to school achievement:
preliminary study. In J.W. Spencer and J.J. Boren (Ed.), Residual
Effects of Abused Drugs on Behavior, National Institute on Drug Abuse
Research Monograph No. 101. Rockville, MD: U.S. Department of Health
and Human Services.

Bowman, M. and Pihl, R.O. (1973). Cannabis: Psychological effects of
chronic heavy use. A controlled study of intellectual functioning in
chronic users of high potency cannabis. Psychopharmacologia (Berl.),
29, 159-170.

Brill, N.Q. and Christie, R.L. (1974). Marihuana use and psychosocial
adaptation: Follow-up study of a collegiate population. Archives of
General Psychiatry, 31, 713-719.

Campbell, A.M.G., Evans, M., Thomson, J.L.G. and Williams, M.J.
(1971). Cerebral atrophy in young cannabis smokers. The Lancet, 2,
1219-1224.

Carlin, A.S. (1986). Neuropsychological consequences of drug abuse. In
I. Grant and. K.M. Adams (Eds.), Neuropsychological Assessment of
Neuropsychiatric Disorders (pp. 478-497). New York: Oxford University
Press.

Carlin, A.S. and Trupin, E.W. (1977). The effect of long-term chronic
marijuana use on neuropsychological functioning. International Journal
of the Addictions, 12(5), 617-624.

Carter, W.E., Coggins, W. and Doughty, P.L. (1980). Cannabis in Costa
Rica: A Study of Chronic Marihuana Use. Philadelphia: Institute for
the Study of Human Issues.

Cohen, S. (1976). The 94-day cannabis study. Annals of the New York
Academy of Sciences 282 (pp. 211-220). 

Cohen, S. (1982) Cannabis effects upon adolescent motivation. In
National Institute on Drug Abuse. Marijuana and Youth: Clinical
Observations on Motivation and Learning. Rockville, Maryland: National
Institute on Drug Abuse.

Culver, C.M. and King, F.W. (1974). Neuropsychological assessment of
undergraduate marihuana and LSD users. Archives of General Psychiatry,
31(5), 707-711.

Deahl, M. (1991). Cannabis and memory loss. British Journal of
Addiction, 86, 249-252.

Dornbush, R.L., Clare, G., Zaks, A., Crown, P., Volavka, J. and Fink,
M. (1972). Twenty-one day administration of marijuana in male
volunteers. In M. F. Lewis (Ed.), Current Research in Marihuana (pp.
115-127). New York: Academic Press.

Entin, E.E. and Goldzung, P.J. (1973). Residual effects of marihuana
use on learning and memory. Psychological Record, 23(2), 169-178.

Fehr, K.O. and Kalant, H. (1983). Long-term effects of cannabis on
cerebral function: A review of the clinical and experiemntal
literature. In Fehr, K.O. and Kalant, H. (Eds), Cannabis and Health
Hazards (pp. 501-576). Toronto: Addiction Research Foundation.

Fletcher, J.M. and Satz, P. (1977). A methodological commentary on the
Egyptian study of chronic hashish use. Bulletin on Narcotics, 29(2),
29-34.

Frank, I.M., Lessin, P.J., Tyrell, E.D., Hahn, P.M. and Szara, S.
(1976) Acute and cumulative effects of marihuana smoking in
hospitalized subjects: A 36 day study. In M Braude and S. Szara (Eds)
Pharmacology of Marihuana, Volume 2. New York: Raven Press.

Fried, P. (1993) Prenatal exposure to tobacco and marijuana: Effects
during pregnancy, infancy, and early childhood. Clinical Obstetrics
and Gynaecology, 36(2), 319-337.

Gianutsos, R. and Litwack, A.R. (1976). Chronic marijauna smokers show
reduced coding into long-term storage. Bulletin of the Psychonomic
Society, 7(3), 277-279.

Grant, I., Rochford, J., Fleming, T. and Stunkard, A. (1973). A
neuropsychological assessment of the effects of moderate marihuana
use. Journal of Nervous and Mental Disease, 156(4), 278-280.

Harshman, R.A., Crawford, H.J. and Hecht, E. (1976) Marihuana,
cognitive style, and lateralized hemisphere. In S. Cohen and R
Stillman (Eds) The Therapeutic Potential of Marihuana. New York:
Plenum Press.

Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S.,
De Costa, B.R. and Rice, K (1990). Cannabinoid receptor localization
in brain. Proceedings of the National Academy of Sciences, USA, 87,
1932-1936.

Hochman, J.S. and Brill, N.Q. (1973). Chronic marijuana use and
psychosocial adaptation. American Journal of Psychiatry, 130(2),
132-140.

Kokkevi, A. and Dornbush, R. (1977). Psychological test
characteristics of long-term hashish users. In C. Stefanis, R.
Dornbush, and M. Fink (Eds), Hashish: Studies of Long-Term Use. New
York: Raven Press.

Kolansky, H. and Moore, R.T. (1971). Effects of marihuana on
adolescents and young adults. Journal of the American Medical
Association, 216(3), 486-492.

Kolansky, H. and Moore, R.T. (1972). Toxic effects of chronic
marihuana use. Journal of the American Medical Association, 222(1),
35-41.

Leavitt, J., Webb, P., Norris, G., Struve, F., Straumanis, J.,
Patrick, G., Fitz-Gerald, J. and Nixon, F. (1991). Differences in
complex reaction time between chronic heavy THC users and non-user
controls. Poster presented at the 53rd Annual Scientific Meeting of
the College on Problems of Drug Dependence, Palm Beach, Florida, 10-17
June.

Leavitt, J., Webb, P., Norris, G., Struve, F., Straumanis, J.,
Fitz-Gerald, M., Nixon, F., Patrick, G. and Manno, J. (1992).
Performance of chronic daily marijuana users on neuropsychological
tests. Poster presented at the 54th Annual Scientific Meetthat any c
College on Problems of Drug Dependence, Keystone, Colorado, 20-25
June.

Leavitt, J., Webb, P., Norris, G., Struve, F., Patrick, G.,
Fitz-Gerald, M. and Nixon, F. (1993). Performance of long-term THC
users on tests of reaction time using Sternberg's procedure. Poster
presented at the 55th Annual Scientific Meeting of the College on
Problems of Drug Dependence, Toronto, Canada, 12-17 June.

Mendelson, J.H., Rossi, M.A., Meyer, R.E. (Eds). (1974). The Use of
Marihuana: A psychological and physiological inquiry. New York: Plenum
Press.

Mendhiratta, S.S., Wig, N.N. and Verma, S.K. (1978). Some
psychological correlates of long-term heavy cannabis users. British
Journal of Psychiatry, 132, 482-486.

Mendhiratta, S.S., Varma, V.K., Dang, R., Malhatra, A.K., Das, K., and
Neha, R. (1988) Cannabis and cognitive functions. British Journal of
Addiction, 83, 749-753.

Miller, L.L. and Branconnier, R.J. (1983). Cannabis: effects on memory
and the cholinergic limbic system. Psychological Bulletin, 93(3),
441-456.

NIDA. (1982). Marijuana and Youth: Clinical Observations on Motivation
and Learning. Rockville, MD: National Institute on Drug Abuse.

Nelson, N. (1984). The National Adult Reading Test. NFER.

Page, J.B., Fletcher, J. and True, W.R. (1988). Psychosociocxultural
persepctives on chronic cannabis use: The Costa Rican follow-up.
Journal of Psychoactive Drugs, 20(1), 57-65.

Ray, R., Prabhu, G.G., Mohan, D., Nath, L.M. and Neki, J.S. (1978).
The association between chronic cannabis use and cognitive functions.
Drug and Alcohol Dependence, 3(5), 365-368.

Rochford, J., Grant, I. and LaVigne, G. (1977). Medical students and
drugs: Further neuropsychological and use pattern considerations.
International Journal of the Addictions, 12(8), 1057-1065.

Rubin, V. and Comitas, L. (1975) Ganja in Jamaica: A medical
anthropological study of chronic marihuana use. The Hague: Mouton
Publishers.

Satz, P., Fletcher, J.M. and Sutker, L.S. (1976). Neuropsychologic,
intellectual and personality correlates of chronic marijuana use in
native Costa Ricans. Annals of the New York Academy of Sciences, 282,
266-306.

Schaeffer, J., Andrysiak, T. and Ungerleider, J.T. (1981). Cognition
amd long-term use of Ganja (cannabis). Science, 213(4506), 465-466.

Schwartz, R.H., Gruenewald, P.J., Klitzner, M. and Fedio, P. (1989).
Short-term memory impairment in cannabis-dependent adolescents.
American Journal of Disorders of Childhood, 143, 1214-1219.

Solowij, N., Michie, P.T. and Fox, A.M. (1991). Effects of long-term
cannabis use on selective attention: An event-related potential study.
Pharmacology Biochemistry and Behavior, 40, 683-688.

Solowij, N., Michie, P.T. and Fox, A.M. (1992). Frequency and duration
of cannabis use differentially affect brain function in a selective
attention task. Paper presented at the 10th International Australasian
Winter Conference on Brain Research (AWCBR), Queenstown, New Zealand,
16-21 August; and at the National Drug and Alcohol Research Centre
Fifth Anniversary Annual Symposium on the Correlates and Consequences
of Excessive Drug Use, University of New South Wales, Sydney
Australia, 4 December.

Solowij, N., Michie, P.T. and Fox, A.M. (1993). Differential
impairments of selective attention due to frequency and duration of
cannabis use. Paper presented at the International Cannabis Research
Society Annual Meeting, Satellite to the 55th Annual Scientific
Meeting of the College on Problems of Drug Dependence, Toronto,
Cannada, 10-17 June.

Soueif, M.I. (1971). The use of cannabis in Egypt: A behavioural
study. Bulletin on Narcotics, 23(4), 17-28.

Soueif, M.I. (1975). Chronic cannabis users: Further analysis of
objective test results. Bulletin on Narcotics, 27(4), 1-26.

Soueif, M.I. (1976a). Differential association between chronic
cannabis use and brain function deficits. Annals of the New York
Acadamy of Sciences, 282, 323-343.

Soueif, M.I. (1976b). Some determinants of psychological deficits
associated with chronic cannabis consumption. Bulletin on Narcotics,
28(1), 25-42.

Soueif, M.I. (1977). The Egyptian study of chronic cannabis use: A
reply to Fletcher and Satz. Bulletin on Narcotics, 29(2), 35-43.

Stefanis, C., Boulougouris, J. and Liakos, A. (1976). Clinical and
psychophysiological effects of cannabis in long-term users. In Braude,
M and Szara, S. (Eds.), Pharmacology of Marihuana. New York: Raven
Press, pp. 659-665.

Stefanis, C., Dornbush, R. and Fink, M. (1977). Hashish: Studies of
Long-Term Use. New York: Raven Press.

Straumanis, J., Struve, F. and Patrick, G. (1992). Cerebral evoked
potentials in chronic marihuana users. Poster presented at the 54th
Annual Scientific Meeting of the College on Problems of Drug
Dependence, Keystone, Colorado, 20-25 June. 

Struve, F., Straumanis, J., Patrick, G., Norris, G., Nixon, F.,
Fitz-Gerald, M., Manno, J., Leavitt, J. and Webb, P. (1993).
Topographic quantitative EEG sequelae of chronic cumulative THC
exposure: Recent and continuing studies. Paper presented at the
International Cannabis Research Society Annual Meeting, Satellite to
the 55th Annual Scientific Meeting of the College on Problems of Drug
Dependence, Toronto, Canada, 10-17 June.

Stuss, D.T. (1991) Interference effects on memory function in
postleukotomy patients: An attentional perspective. In Levin, H.S.,
Eisenberg, H.M. and Benton, A.L.(Eds) Frontal lobe function and
dysfunction. New York: Oxford University Press, pp 157-172.

Tennant, F.S. and Groesbeck, C.J. (1972). Psychiatric effects of
hashish. Archives of General Psychiatry, 27(1), 133-136.

Varma, V.J., Malhotra, A.K., Dang, R., Das, K. and Nehra, R. (1988).
Cannabis and cognitive functions: a prospective study. Drug and
Alcohol Dependence, 21, 147-152.

Weckowicz, T.E. and Janssen, D.V. (1973). Cognitive functions,
personality traits, and social values in heavy marijuana smokers ans
nonsmoker controls. Journal of Abnormal Psychology, 81(3), 264-269.

Weckowicz, T.E., Collier, G. and Spreng, L. (1977). Field dependence,
cognitive functions, personality traits, and social values in heavy
cannabis users and nonuser controls. Psychological Reports, 41,
291-302.

Wert, R and Raulin, M.L. (1986a) The chronic cerebral effects of
cannabis use. I. Methodological issues and neurological findings. The
International Journal of the Addictions, 21(6), 605-628.

Wert, R and Raulin, M.L. (1986b) The chronic cerebral effects of
cannabis use. II. Psychological findings and conclusions. The
International Journal of the Addictions, 21(6), 629-642.

Wig, N.N. and Varma, V.K. (1977). Patterns of long-term heavy cannabis
use in North India and its effects on cognitive functions: a
preliminary report. Drug and Alcohol Dependence, 2(3), 211-219.



7.5 Chronic cannabis use and brain damage 

A major concern about the recreational use of cannabis has been
whether it may lead to functional or structural neurotoxicity, or
&quot;brain damage&quot; in ordinary language. Fehr and Kalant (1983) defined
neurotoxicity as &quot;functional aberrations qualitatively distinct from
the characteristic usual pattern of reversible acute and chronic
effects, and that may be caused by identified or identifiable neuronal
damage&quot; (p27). On this definition, an enduring impairment of cognitive
functioning may be interpreted as a manifestation of neurotoxicity.
Since such impairments are discussed in the previous chapter on
chronic effects on cognitive functioning, this chapter will
concentrate on direct investigations of neurological function and
structural brain damage arising from exposure to cannabinoids. The
review begins with an examination of the evidence for behavioural
neurotoxicity from animal studies. Neurochemical, electrophysiological
and brain substrate investigations of functionality follow, and the
chapter concludes with the findings of more invasive examinations of
brain structure and morphology in animals, and of less invasive
techniques for imaging the human brain.



7.5.1 Behavioural neurotoxicity in animals

Animal research provides the ultimate degree of control over
extraneous variables; it is possible to eliminate factors known to
influence research findings in humans, e.g. nutritional status, age,
sex, previous drug history, and concurrent drug use. The results,
however, are often difficult to extrapolate to humans because of
between-species differences in brain and behaviour and in drug dose,
patterns of use, routes of administration and methods of assessment. 

Animal research on the effects of cannabis on brain function has
typically administered known quantities of cannabinoids to animals for
an extended period of time and then examined performance on various
tasks assessing brain function, before using histological and
morphometric methods to study the brains of the exposed animals. In
general, the results of studies with primates produce results that
most closely resemble the likely effects in humans; the monkey is
physiologically similar to humans, while rats, for example, metabolise
drugs in a different way; and monkeys are able to perform complex
behavioural tasks. Nevertheless, every animal species examined to date
has been found to have cannabinoid receptors in the brain. In animal
models, non-targeted staring into space following administration of
cannabinoids is suggestive of psychoactivity comparable to that in
humans. The most characteristic responses to cannabinoids in animals
are mild behavioural aberrations following small doses, and signs of
gross neurotoxicity manifested by tremors and convulsions following
excessively large doses. Where small doses are given for a prolonged
period of time, evidence of behavioural neurotoxicity has emerged (see
Rosenkrantz, 1983). Chronic exposure produces lethargy, sedation and
depression in many species, and/or aggressive irritability in monkeys.


A clear manifestation of neurotoxicity in rats is what has been called
the &quot;popcorn reaction&quot; (Luthra, Rosenkrantz and Braude, 1976),
characterised by a pattern of sudden vertical jumping in rats exposed
to cannabinoids for five weeks or longer. It is also seen in young
animals exposed to cannabinoids in utero and then given a small dose
challenge at 30 days of age. Several studies of prenatal exposure
indicate that the offspring of cannabis treated animals show small
delays in various stages of post-natal development, such as eye
opening, various reflexes and open field exploration, although after
several weeks or months their development is indistinguishable from
normal (e.g. Fried and Charlebois, 1979). This means that either the
developmental delay was not chronic, the remaining damage is too
subtle to be detected by available measures, or the &quot;plasticity of
nervous system organisation in the newborn permitted adequate
compensation for the loss of function of any damaged cells&quot; (Fehr and
Kalant, 1983, p29). 

Behavioural tests in rodents have included conventional and radial arm
maze learning, operant behaviour involving time discriminations, open
field exploration and two-way shuttle box avoidance learning. Correct
performance on these tests is dependent on spatial orientation or on
response inhibition, both of which are believed to depend heavily on
intact hippocampal functioning. Some studies have found decreased
learning ability on such tasks several months after long-term
treatment with cannabinoids (see Fehr and Kalant, 1983). For example,
Stiglick and Kalant (1982a, 1982b) reported altered learning behaviour
in rats one to six months after a three-month oral dosing regimen of
marijuana extract or THC. They claimed that the deficits were
reminiscent of behavioural changes seen after damage to the
hippocampus. Long lasting impairment of learning ability and
hippocampal dysfunction suggests that long-lasting damage may result
from exposure to cannabis. However, some studies have been carried out
too soon after last drug administration to exclude the possibility
that the observed effects are residual effects, that is, due to the
continued action of accumulated cannabinoids. 

Memory function in monkeys has often been assessed by delayed
matching-to-sample tasks. In a recent study (Slikker et al, 1992),
rhesus monkeys were trained for one year to perform five operant tasks
before one year of chronic administration of cannabis commenced. One
group was exposed daily to the smoke of one standard joint, another on
weekends only, and control groups received sham smoke exposure (N=15
or 16 per group). Performance on the tasks indicated the induction of
an &quot;amotivational syndrome&quot; during chronic exposure to cannabis, as
manifested in a decrease in motivation to respond, regardless of
whether the monkeys were exposed daily or only on weekends. This led
the authors to suggest that motivational problems can occur at
relatively low or recreational levels of use (in fact the effect was
maximal with intermittent exposure). Task performance was grossly
impaired for more than a week following last exposure, although
performance returned to baseline levels two to three months after
cessation of use. Thus, the effects of chronic exposure were slowly
reversible with no long-term behavioural effects, and the authors
concluded that persistent exposure to compounds that are very slowly
cleared from the brain could account for their results. This
hypothesis is consistent with the long half life of THC in the body
(see Section 4.7 on metabolism).

One of the problems with these studies is that animals are often only
exposed for a relatively short period of time, for example, one year
or less. Slikker and colleagues acknowledge that it remains to be
determined whether longer or greater exposures would cause more severe
or additional behavioural effects. It may be that chronic dysfunction
becomes manifest only after many years of exposure. Nevertheless, it
is of concern that behavioural impairments have been shown to last for
several months after exposure, but reassuring that they have generally
resolved over time. 

A further difficulty with animal studies is a consequence of
differences between animals and humans in route of cannabinoid
administration. In humans, the most common route of exposure to THC is
via the inhalation of marijuana smoke, whereas most animals studies
have relied upon the oral administration or injection of THC because
of the difficulty in efficiently delivering smoke to animals and the
concern about the complications introduced by carbon monoxide
toxicity. While it may well be impossible to evaluate the
pharmacological and toxicological consequences of exposure to the
hundreds of compounds in cannabis simultaneously, it is arguably
inappropriate to assess the long-term consequences of human cannabis
smoking by administering THC alone. Hundreds of additional compounds
are produced by pyrolysis when marijuana is smoked, which may
contribute either to acute effects or to long-term toxicity. Future
studies need to address these issues for comparability to human usage.
Appropriate controls, including those which mimic the carbon monoxide
exposure experienced during the smoking of marijuana may be necessary.




7.5.2 Neurochemistry

The discovery of the cannabinoid receptor and its endogenous ligand
anandamide revolutionised previous conceptions of the mode of action
of the cannabinoids. However, much further research is required before
the interactions between ingested cannabis, anandamide and the
cannabinoid receptor are fully understood. Nor should the anandamide
pathways be seen as responsible for all of the central effects of the
psychoactive cannabinoids. There is good evidence that cannabinoids
affect the concentration, turnover, or release of endogenous
substances (see Pertwee, 1988). Much research has been devoted to
examining the interactions between cannabinoids and several
neurotransmitter receptor systems (e.g. norepinephrine, dopamine,
5-hydroxytryptamine, acetylcholine, gamma-aminobutyric acid (GABA),
histamine, opioid peptides, and prostaglandins). The results suggest
that all these substances have some role in the neuropharmacology of
cannabinoids, although little is known about the precise nature of
this involvement. Cannabinoids may alter the activities of
neurochemical systems in the central nervous system by altering the
synaptic concentrations of these mediators through an effect on their
synthesis, release, or metabolism, and/or by modulating
mediator-receptor interactions. There have been numerous reports of
neurotransmitter perturbations in vitro and after short-term
administration (see Martin, 1986; Pertwee, 1988).

Domino (1981) demonstrated in cats that large doses of THC elevate
brain acetylcholine and reduce its turnover by producing a decrease in
acetylcholine release from the neocortex. At large doses, THC may
depress the brain stem activating system. With lower doses, brain
acetylcholine utilisation was reduced primarily only in the
hippocampus. Some of the potential undesirable side effects of
cannabinoids may be related to a decrease in acetylcholine release and
turnover. Domino also reported that THC decreased EEG activation and
induced slow wave activity: high voltage slow waves in neocortical EEG
were produced in frontal regions and tended to be exaggerated by small
doses but reduced by larger doses. These findings support the general
observation made in a variety of studies, that low doses of THC
stimulate, while high doses depress the noradrenergic and dopaminergic
system. 

Bloom (1984) reported that cannabinoids increase the synthesis and
turnover of dopamine and norepinephrine in rat and mouse brain, while
producing little or no change in endogenous levels of catecholamines.
However, THC and other cannabinoids were reported to alter functional
aspects of catecholaminergic neurotransmission. THC was found to
increase the utilisation of the catecholamine neurotransmitters, to
alter the active uptake of biogenic amine neurotransmitters and their
precursors into synaptosomes, and to alter transmitter release from
synaptosomes. Further, THC was reported to alter the activity of
enzymes involved in the synthesis and degradation of the
catecholamines. THC and other cannabinoids can selectively alter the
binding of ligands to several different membrane-bound
neurotransmitter receptors.

Relatively few studies have examined whether long-term exposure to
cannabinoids results in lasting changes in brain neurotransmitter and
neuromodulator levels. An early study examined cerebral and cerebellar
neurochemical changes accompanying behavioural manifestations of
neurotoxicity (involuntary vertical jumping) in rats exposed to
marijuana smoke for up to 87 days (Luthra, Rosenkrantz and Braude,
1976). Sex differences emerged in the neurochemical consequences of
chronic exposure: in females, AChE showed a cyclic increase and
cerebellar enzyme activity declined. For both sexes cerebellar RNA
increased, but at different times for each sex, and at 87 days
remained elevated only in females. Some of these neurochemical changes
persisted during a 20-day recovery period, but the authors predicted
the return to normality after a much longer recovery period.
Cannabinoids administered prenatally not only impaired developmental
processes in rats, but produced significant decrements in RNA, DNA and
protein concentrations and reductions in amine concentrations
(dopamine, norepinephrine) in mice, which could be important in the
role of protein and nucleic acids in learning and memory (see Fehr and
Kalant, 1983). Bloom (1984) reported that chronic exposure to
cannabinoids has been shown to lead to increased activity of tyrosine
in rat brain. 

However, recent evidence suggests that there are few, if any,
irreversible effects of THC on known brain chemistry. Ali and
colleagues (1989) administered various doses of THC to rats for 90
days and then assessed several brain neurotransmitter systems 24 hours
or two months after the last drug dose. Examination of dopamine,
serotonin, acetylcholine, GABA, benzodiazepine and opioid
neurotransmitter systems revealed that no significant changes
occurred. A larger study with both rats and monkeys examined receptor
binding of the above neurotransmitters and the tissue levels of
monoamines and their metabolites (Ali et al, 1991). No significant
irreversible changes were demonstrated in the rats chronically treated
with THC. Monkeys exposed to a chronic treatment of marijuana smoke
for one year and then sacrificed after a seven-month recovery period
were found to have no changes in neurotransmitter concentration in
caudate, frontal cortex, hypothalamus, or brainstem regions. The
authors concluded that there are no significant irreversible
alterations in major neuromodulator pathways in the rat and monkey
brain following long-term exposure to the active compounds in
marijuana. 

Slikker et al (1992), reporting on the same series of studies, noted
that there were virtually no differences between placebo, low dose or
high dose groups of monkeys in blood chemistry values. The general
health of the monkeys was unaffected, but the exposure served as a
chronic physiological stressor, evidenced by increases in urinary
cortisol levels which were not subject to tolerance (although plasma
cortisol levels did not differ). Urinary cortisol elevation has not
been demonstrated in other studies with monkeys. Slikker et al
reported a 50 per cent reduction in circulating testosterone levels in
the high dosed group, with a dramatic (albeit non-significant) rebound
one to four weeks after cessation of treatment. It is worth noting
that these monkeys were three years of age at the commencement of the
study and would have experienced hormonal changes over the course of
entering adolescence during the study.

A recent pilot study compared monoamine levels in cerebrospinal fluid
(CSF) in a small sample of human cannabis users and age and
sex-matched normal controls (Musselman et al, 1993). The justification
for the study was that THC administered to animals has been shown to
produce increases in serotonin and decreases in dopamine activity. No
differences were found between the user and non-user groups in the CSF
concentration of HVA, 5HIAA, MHPG, ACTH and CRH. The authors proposed
a number of explanations for these results: (1) cannabis use has no
chronic effect on levels of brain monoamines; (2) those who use
cannabis have abnormal levels of brain monoamines which are normalised
over long periods of time by cannabis use; or (3) those who use
cannabis have normal levels of brain monoamines which are transiently
altered with cannabis use and then return to normal. However, there is
insufficient data from this study to permit a choice between these
hypotheses to be made. The frequency and duration of cannabis use, and
the time since last use in the user group could not be determined. All
users had denied using cannabis, having been drawn from a larger
normative sample and identified as cannabis users by the detection of
substantial levels of cannabinoids in urine screens. Furthermore, the
&quot;normal&quot; controls were assumed to be non-users on the basis of their
drug free urines, a far from adequate source of evidence for or
against cannabis use. Thus, the small sample size and faulty
methodology preclude any conclusions to be drawn from this study about
possible alterations in monoamine levels in cannabis users.



7.5.3 Electrophysiological effects

Cannabis is clearly capable of causing marked changes in brain
electrophysiology as determined by electroencephalographic (EEG)
recordings. Long-term residual abnormalities in EEG tracings from
cortex and hippocampus have been shown in cats (Barratt &amp; Adams, 1972;
Domino, 1981; Hockman et al, 1971), rats (see Fehr and Kalant, 1983)
and monkeys (Heath et al, 1980) exposed to cannabinoids. Withdrawal
effects are also apparent in the EEG (see Fehr and Kalant, 1983), with
epileptiform and spike-like activity most often seen. 

Shannon and Fried (1972) related EEG changes in rat to the
distribution of bound and unbound radioactive THC. Disposition of the
tracer was primarily in the extra-pyramidal motor system and some
limbic structures, and 0.8 per cent of the total injected drug which
was weakly bound in the brain accounted for the EEG changes. In
monkeys, serious subcortical EEG anomalies were observed in those
exposed to marijuana smoke for six months (Heath et al, 1980). The
septal region, hippocampus and amygdala were most profoundly affected,
showing bursts of high amplitude spindles and slow wave activity. Such
early studies often lacked critical quantitative analysis. The
definition of abnormal spike-like waveforms in EEG were not made to
rigorous criteria,and EEG frequency was not assessed quantitatively. 

More recent studies have examined the effects of THC on extracellular
action potentials recorded from the dentate gyrus of the rat
hippocampus (Campbell et al, 1986a; 1986b). THC produced a suppression
of cell firing patterns and a decrease in the amplitude of
sensory-evoked potentials, also impairing performance on a tone
discrimination task. The evoked-potential changes recovered rapidly
(within four hours), but the spontaneous and tone-evoked cellular
activity remained significantly depressed, indicating an abnormal
state of hippocampal/limbic system operation. The authors proposed
that such changes accounted for decreased learning, memory function
and general cognitive performance following exposure to cannabis. The
long-lasting effects of prolonged cannabis administration on animal
electrophysiology has not been investigated to any degree of
specificity.

The waking or sleep EEG is increasingly recognised as a particularly
sensitive tool for evaluating the effects of drugs, especially drugs
that affect the CNS, since EEG signals are sensitive to variables
affecting the brain's neurophysiological substrate. The recording of
the EEG is one of the few reasonably direct, non-intrusive methods of
monitoring CNS activity in man. However, alterations in EEG activity
are difficult to interpret in a functional sense. Struve and
Straumanis (1990) provide a review of the human research dating from
1945 on the EEG and evoked potential studies of acute and chronic
effects of cannabis use. While the data have often been contradictory,
the most typical human alterations in EEG patterns include an increase
in alpha activity and a slowing of alpha waves with decreased peak
frequency of the alpha rhythm, and a decrease in beta activity (Fink,
1976; Fink et al, 1976). In general, this is consistent with a state
of drowsiness. Desynchronisation, variable changes in theta activity,
abnormal sleep EEG profiles and abnormal evoked responses have also
been reported (see Fehr and Kalant, 1983). Clinical reports have
associated cannabis with triggering seizures in epileptics (Feeney,
1979) and experimental studies have shown THC to trigger abnormal
spike waveforms in the hippocampus, whereas cannabidiol has an
opposite effect. Yet there is suggestive evidence that cannabis may be
useful in the treatment of convulsions. Feeney (1979) discusses these
paradoxical effects.

A number of studies have investigated EEG in chronic cannabis users.
The early cross-cultural studies were flawed in many respects (see
Section 7.4 on cognitive functioning) and also failed to used
quantitative techniques in analysing EEG spectra. No EEG abnormalities
were found in the resting EEG of chronic users from Greek, Jamaican or
Costa Rican populations compared to controls (Karacan et al, 1976;
Rubin and Comitas, 1975; Stefanis, 1976). In all of these studies,
only subjects who were in good health and who were functioning
adequately in the community, were selected, thereby systematically
eliminating subjects who may have been adversely affected by cannabis
use and who may therefore have shown residual EEG changes. The
evidence from many studies has been contradictory: users have been
found to show either higher or lower percentages of alpha-components
than non-users, and to have higher or lower visual evoked response
amplitudes (Richmon et al, 1974). Subjects in a 94-day cannabis
administration study (Cohen, 1976) showed lasting EEG changes. The
abnormalities were more marked in subjects who had taken heavier
doses, but it was observed that even in abstinence, cannabis users had
more EEG irregularities than non-using controls. It was not determined
for how long after cessation of use the EEG changes persisted. It has
also been reported that chronic users develop tolerance to some of the
acute EEG changes caused by cannabis (Feinberg et al, 1976). The
question as to why chronic cannabis users can continue to display
changes in EEG when tolerance is known to develop to such alterations
remains unanswered.

In a series of well controlled ongoing studies, Struve and colleagues
(1991, 1993) have been using quantitative techniques to investigate
persistent EEG changes in long-term cannabis users, characterised by a
&quot;hyperfrontality of alpha&quot;. Significant increases in absolute power,
relative power and interhemispheric coherence of EEG alpha activity
over the bilateral frontal-central cortex in daily THC users compared
to non-users were demonstrated and replicated several times. The
quantitative EEGs of subjects with excessively long cumulative THC
exposures (&gt;15 years) appear to be characterised by increases in
frontal-central theta activity in addition to the hyperfrontality of
alpha found in THC users in general (or those with much shorter
durations of use). Ultra-long-term users have shown significant
elevations of theta absolute power over frontal-central cortex
compared to short-term users and controls, and significant elevations
in relative power of frontal-central theta in comparison to short-term
users. Over most cortical regions, ultra-long-term users had
significantly higher levels of theta interhemispheric coherence than
short-term users or controls. Thus, excessively long duration of THC
exposure (15-30 years) appears to be associated with additional
topographic quantitative EEG features not seen with subjects using THC
for short to moderately long time periods. 

These findings have led to the suspicion that there may be a gradient
of quantitative EEG change associated with progressive increases in
the total cumulative exposure (duration in years) of daily THC use.
Infrequent, sporadic or occasional THC use does not seem to be
associated with persistent quantitative EEG change. As daily THC use
begins and continues, the topographic quantitative EEG becomes
characterised by the hyperfrontality of alpha. While it is not known
at what point during cumulative exposure it occurs, at some stage
substantial durations of daily THC use become associated with a
downward shift in maximal EEG spectral power from the mid alpha range
to the upper theta/low alpha range. Excessively long duration
cumulative exposure of 15-30 years may be associated with increases of
absolute power, relative power and coherence of theta activity over
frontal-central cortex. One conjecture is that the EEG shift toward
theta frequencies, if confirmed, may suggest organic change. These
data are supplemented by neuropsychological test performance features
separating long-term users from moderate users and non-users, however
the relationship between neuropsychological test performance and EEG
changes has not been investigated.

While the EEG provides little interpretable information about brain
function, brain event-related potential measures are direct
electrophysiological markers of cognitive processes. Studies by
Herning et al (1979) demonstrated that THC administered orally to
volunteers alters event-related potentials according to dose, duration
of administration, and complexity of the task. Event-related potential
studies of chronic cannabis users in the unintoxicated state have
provided evidence for long-lasting functional brain impairment and
subtle cognitive deficits (see Section 7.4 on cognitive functioning).



7.5.4  Cerebral blood flow studies

Brain cerebral blood flow (CBF) is closely related to brain function.
The use of CBF may help to identify brain regions responsible for the
behavioural changes associated with drug intoxication. Since, however,
psychoactive drugs may induce CBF changes through mechanisms other
than alteration in brain function (e.g. by increasing carbon monoxide
levels, changing blood gases or vasoactive properties, affecting blood
viscosity, autonomic activation or inhibition of intraparenchymal
innervation, acting on vasoactive neuropeptides), any conclusions
drawn from drug-induced CBF changes must be treated with caution.

Mathew and Wilson (1992) report several studies of cannabis effects on
cerebral blood flow. Acutely, cannabis administration to inexperienced
users produced global CBF decreases, while acute intoxication
increased CBF in both hemispheres, at frontal and the left temporal
regions, in experienced users. There was an inverse relationship
between anxiety and CBF. The authors attributed the decrease in CBF in
naive subjects to their increased anxiety after cannabis
administration, while the increased CBF in experienced users was
attributed to the behavioural effects of cannabis. A further study
showed that the largest increases in CBF occurred 30 minutes after
smoking. The authors concluded that cannabis causes a dose related
increase in global CBF, but also appears to have regional effects,
with a greater increase in the frontal region and in particular in the
right hemisphere. CBF increases were correlated with the &quot;high&quot;,
plasma THC levels and pulse rate, loss of time sense,
depersonalisation, anxiety and somatisation scores (positively with
frontal flow and inversely with parietal flow).

The authors claimed their results suggested that altered brain
function was mainly, if not exclusively, responsible for the CBF
changes. Carbon monoxide increased after both cannabis and placebo but
did not correlate with CBF. Cannabis induced &quot;red eye&quot; lasted for
several hours, but the CBF increases declined significantly within two
hours of smoking. Nevertheless, the possibility remains that the CBF
changes reflected drug-induced vascular (cerebral) change. Continued
reduction in cerebral blood velocity was demonstrated following
cannabis administration, and reports of dizziness but with normal
blood pressure suggested that cannabis may impair cerebral
autoregulation.

The time course of CBF changes resembled that of mood changes more
closely than plasma THC levels. Global CBF was closely related to
levels of arousal mediated by the reticular activating system. High
arousal states generally show CBF increases while low arousal states
show CBF decreases. Of all cortical regions, the frontal lobe has the
most intimate connections with the thalamus which mediates arousal,
and CBF increases after cannabis use were most pronounced in frontal
lobe regions. The right hemisphere is known to mediate emotions, and
the most marked changes after cannabis were seen there. Time sense and
depersonalisation, which are associated with the temporal lobe, were
severely affected, but there were no significant correlations between
these scores and temporal flow. Perhaps CBF techniques are not
sensitive enough in terms of spatial resolution to detect such
effects. The parietal lobes are associated with perception and
cognition. Cannabis reduces perceptual acuity, but during intoxication
subjects report increased awareness of tactile, visual and auditory
stimuli. Maybe their altered time sense and depersonalisation are
related to such altered awareness.

There have been a few investigations of chronic effects of cannabis on
CBF. Tunving et al, (1986) demonstrated globally reduced resting
levels of CBF in chronic heavy users of 10 years compared to non-user
controls, but no regional flow differences were observed. CBF
increased by 12 per cent between nine and 60 days later, indicating
reduced CBF in heavy users immediately after cessation of cannabis
use, with a return to normal levels with abstinence. This study was
flawed in that some subjects were given benzodiazepines (which are
known to lower CBF) prior to the first measurement. Mathew and
colleagues (1986) assessed chronic users of at least six months (mean
83 months) after two weeks of abstinence. No differences in CBF levels
were found between users and non-user controls. The number of studies
available on the effects of cannabis on CBF are relatively small. Use
of techniques with better spatial resolution and the ability to
quantify subcortical flow, such as positron emission tomography (PET),
would yield more useful findings.



7.5.5 Positron emission tomography (PET) studies

Positron emission tomography (PET) is a nuclear imaging technique
which allows the concentration of a positron-labelled tracer to be
imaged in the human brain. PET can measure the time course and
regional distribution of positron-labelled compounds in the living
human brain. Most PET studies have utilised an analog of glucose to
measure regional brain glucose metabolism, since nervous tissue uses
glucose as its main source of energy. Measurement of glucose
metabolism reflects brain function, since activation of a given brain
area is indicated by an increase in glucose consumption. PET may be
used to assess the effects of acute drug administration by using
regional brain glucose metabolism to determine the areas of the brain
which are activated by a given drug. Assessment of brain glucose
metabolism has been useful in identifying patterns of brain
dysfunction in patients with psychiatric and neurological diseases. It
is a direct and sensitive technique for identifying brain pathology,
since it can detect abnormalities in the functioning of brain regions
in the absence of structural changes, such as is likely to occur with
the neurotoxic effects of chronic drug use. It is accordingly more
sensitive than either computer-assisted tomography (CAT) scans or
magnetic resonance imaging (MRI) in detecting early pathological
changes in the brain.

Only one study to date has used the PET technique to investigate the
effects of cannabis use. Volkow et al (1991) reported preliminary data
from an investigation comparing the acute effects of cannabis in three
normal subjects (who had used cannabis no more than once or twice per
year) and in three chronic users (who had used at least twice a week
for at least 10 years). The regions of interest were the prefrontal
cortex, the left and right dorsolateral, temporal, and somatosensory
parietal cortices, the occipital cortex, basal ganglia, thalamus and
cerebellum. A measure of global brain metabolism was obtained using
the average for the five central brain slices, and relative measures
for each region were obtained using the ratios of region/global brain
metabolism. Due to the small number of subjects, descriptive rather
than inferential statistical procedures were used for comparison. The
relation between changes in metabolism due to cannabis and the
subjective sense of intoxication was tested with a regression
analysis. 

In the normal subjects, administration of cannabis led to an increase
in metabolic activity in the prefrontal cortex and cerebellum; the
largest relative increase was in the cerebellum and the largest
relative decrease was in the occipital cortex. The degree of increase
in metabolism in the cerebellar cortex was highly correlated with the
subjective sense of intoxication. The cannabis users reported less
subjective effects than the normal controls and showed less changes in
regional brain metabolism, reflecting tolerance to the actions of
cannabis. However, the authors did not report comparisons of baseline
levels of activity in the users and controls, perhaps due to the
limitations of the small sample size. Such a comparison would have
enabled some evaluation of the consequences of long-term cannabis use
on resting levels of glucose metabolism. The increases in regional
metabolism are in accord with the increases in cerebral blood flow
reported by Mathew and Wilson (1992). The regional pattern of response
to cannabis in this study is consistent with the localisation of
cannabinoid receptors in brain. A further application of PET would be
to label cannabinoids themselves: labelling of cannabis with a
positron emitter has been achieved and preliminary biodistribution
studies have been carried out in mice and in the baboon (Charalambous
et al, 1991; Marciniak et al, 1991). The use of PET in future human
studies is promising.



7.5.6 Brain morphology



7.5.6.1 Animal studies

Early attempts to investigate the effects of chronic cannabinoid
exposure on brain morphology in animals failed to demonstrate any
effect on brain weight or histology under the light microscope.
Electron microscopic examination, however, has revealed alterations in
septal, hippocampal and amygdaloid morphology in monkeys after chronic
treatment with THC or cannabis. A series of studies from the same
laboratory (Harper et al, 1977; Myers and Heath, 1979; Heath et al,
1980 discussed below) reported widening of the synaptic cleft,
clumping of synaptic vesicles in axon terminals, and an increase in
intranuclear inclusions in the septum, hippocampus and amygdala. These
findings incited a great deal of controversy, and the studies were
criticised for possible technical flaws (Institute of Medicine, 1982),
with claims that such alterations are not easily quantifiable. 

Harper et al (1977) examined the brains of three rhesus monkeys six
months after exposure to marijuana, THC or placebo, and two
non-exposed control monkeys. In the treated group, one monkey was
exposed to marijuana smoke three times each day, five days per week;
another was injected with THC once each day and the third was exposed
to placebo smoke conditions. The latter two had electrode implants for
EEG recording and had shown persistent EEG abnormalities following
their exposure to cannabis. Morphological differences were not
observed by light microscopy, but electron microscopy revealed a
widening of the synaptic cleft in the marijuana and THC treated
animals, with no abnormalities detected in the placebo or control
monkeys. Further, &quot;clumping&quot; of synaptic vesicles was observed in pre-
and post-synaptic regions in the cannabinoid treated monkeys, and
opaque granular material was present within the synaptic cleft. The
authors concluded that chronic heavy use of cannabis alters the
ultrastructure of the synapse, and proposed that the observed EEG
abnormalities may have been related to these changes.

Myers and Heath (1979) examined the septal region of the same two
cannabinoid treated monkeys, and found the volume density of the
organised rough endoplasmic reticulum to be significantly lower than
that of the controls, and fragmentation and disorganisation of the
rough endoplasmic reticulum patterns, free ribosomal clusters in the
cytoplasm, and swelling of the cisternal membranes was observed. The
authors noted that similar lesions have been observed following
administration of various toxins or after axonal damage, reflecting
disruptions in protein synthesis. 

Heath et al (1980) extended the above findings by examining a larger
sample of rhesus monkeys (N=21) to determine the effects of marijuana
on brain function and ultrastructure. Some animals were exposed to
smoke of active marijuana, some were injected with THC and some were
exposed to inactive marijuana smoke. After two to three months of
exposure, those monkeys that were given moderate or heavy exposure to
marijuana smoke developed chronic EEG changes at deep brain sites,
which were most marked in the septal, hippocampal and amygdaloid
regions. These changes persisted throughout the six to eight month
exposure period, as well as the postexposure observation period of
between one and eight months. Brain ultrastructural alterations were
characterised by changes at the synapse, destruction of rough
endoplasmic reticulum and development of nuclear inclusion bodies. The
brains of the placebo and control monkeys showed no ultrastructural
changes. The authors claimed that at the doses used, which were
comparable to human usage, permanent alterations in brain function and
ultrastructure were observed in these monkeys.

Brain atrophy is a major non-specific organic alteration which must be
preceded by more subtle cellular and molecular changes. Rumbaugh et al
(1980) observed six human cases of cerebral atrophy in young male
substance abusers of primarily alcohol and amphetamines. They then
conducted an experimental study of six rhesus monkeys treated
chronically with various doses of cannabis extracts orally for eight
months and compared them to groups that were treated with barbiturates
or amphetamines, or untreated. No signs of cerebral atrophy were
demonstrated in the cannabis exposed group, and light microscopy
revealed no histological abnormalities in four of the animals, but
&quot;equivocal&quot; results for the other two. Brains were not examined under
the electron microscope. The amphetamine treated group showed the
greatest histological, cerebrovascular and atrophic changes.

More recently, McGahan et al (1984) used high resolution computerised
tomography scans in three groups of four rhesus monkeys. One was a
control group, a second was given 2.4mg/kg of oral THC per day for two
to 10 months, and a third group received a similar daily dose over a
five-year period. The dosage was considered the equivalent of smoking
one joint a day. The groups receiving THC were studied one year after
discontinuing the drug. There was a statistically significant
enlargement of the frontal horns and the bicaudate distance in the
brains of the five-year treated monkeys as compared to the control and
short-term THC groups. This finding suggests that the head of the
caudate nucleus and the frontal areas of the brain can atrophy after
long-term administration of THC in doses relevant to human exposure.

A number of rat studies have found similar results to those in rhesus
monkeys described above. Investigators have reported that after high
dose cannabinoid administration, there is a decrease in the mean
volume of rat hippocampal neurons and their nuclei, and that after low
dose administration, there is a shortening of hippocampal dendritic
spines. Scallet and coworkers (1987) used quantitative
neuropathological techniques to examine the brains of rats seven to
eight months after 90-day oral administration of THC. The anatomical
integrity of the CA3 area of rat hippocampus was examined using light
and electron microscopy. High doses of THC resulted in striking
ultrastructural alterations, with a significant reduction in
hippocampal neuronal and cytoplasmic volume, detached axodendritic
elements, disrupted membranes, increased extracellular space and a
reduction in the number of synapses per unit volume (i.e. decreased
synaptic density). These structural changes were present up to seven
months following treatment. Lower doses of THC produced a reduction in
the dendritic length of hippocampal pyramidal neurons two months after
the last dose, and a reduction in GABA receptor binding in the
hippocampus, although the ultrastructural appearance and synaptic
density appeared normal. The authors suggested that such hippocampal
changes may constitute a morphological basis for the persistent
behavioural effects demonstrated following chronic exposure to THC in
rats, effects which resemble those of hippocampal brain lesions. These
findings are in accord with those of Heath et al (1980) with rhesus
monkeys, and the doses administered correspond to daily use of
approximately six joints in humans.

A study by Landfield et al (1988) showed that chronic exposure to THC
reduced the number of nucleoli per unit length of the CA1 pyramidal
cell somal layer in the rat hippocampus. The brains of rats treated
five times per week for four or eight months with 4-10mg/kg injected
subcutaneously were examined by light and electron microscopy.
Significant THC-induced changes were found in hippocampal structure;
pyramidal neuronal cell density decreased and there was an increase in
glial reactivity, reflected by cytoplasmic inclusions similar to that
seen during normal aging or following experimentally induced brain
lesions. However, no effects were observed on ultrastructural
variables such as synaptic density. Adrenal-pituitary activity
increased, resulting in elevated ACTH and corticosterone elevations
during acute stress. The authors claimed that the observed hippocampal
morphometric changes produced by THC exposure were similar to
glucocorticoid-dependent changes that develop in rat hippocampus
during normal aging. They proposed that, given the chemical structural
similarity between cannabinoids and steroids, chronic exposure to THC
may alter hippocampal anatomical structure by interacting with adrenal
steroid activity. More recently, Eldridge et al (1992) reported that
delta-8-THC bound with the glucocorticoid receptors in the rat
hippocampus, and was displaced by corticosterone or delta-9-THC. A
glucocorticoid agonist action of delta-9-THC injections was
demonstrated. Injection of corticosterone increased hippocampal
cannabinoid receptor binding. These interactions suggest that
cannabinoids may accelerate brain aging.

It should be noted that where THC has been administered to monkeys for
six months, this represents only 2 per cent of their life span and may
not have been long enough to detect the gradual effects that could
arise from interactions with steroid systems (and affect the aging
process). In contrast, eight months administration to rats represents
approximately 30 per cent of their life span. The differences in the
ultrastructural findings of Landfield's and Scallet's studies may be
due to the largely different doses administered; the 8mg/kg of
Landfield's study was not sufficient to produce any marked behavioural
effects. Further, the two studies examined slightly different
hippocampal areas (CA1 or CA3).

Most recently, Slikker and colleagues (1992) reported the results of
their neurohistochemical and electronmicroscopic evaluation of the
rhesus monkeys whose dosing regime, behavioural and histochemical data
were reported above. They failed to replicate earlier findings: no
effects of drug exposure were found on the total area of hippocampus,
or any of its subfields; there were no differences in hippocampal
volume, neuronal size, number, length or degree of branching of CA3
pyramidal cell dendrites. Nor were there effects on synaptic length or
width, but there were trends toward increased synaptic density (the
number of synapses per cubic mm), increased soma size, and decreased
basilar dendrite number in the CA3 region with marijuana treatment.
Slikker et al (1992) were able to demonstrate an effect of enriched
environments upon neuroanatomy: daily performance of operant tasks
increased the total area of hippocampus and particularly the CA3
stratum oriens, producing longer, more highly branched dendrites and
less synaptic density, while the reverse occurred in the animals
deprived of the daily operant tasks. The extent of drug interaction
with these changes was not clear and may explain some of the
inconsistencies between this study and those described above. Clearly,
the question of whether prolonged exposure to cannabis results in
structural brain damage has not been fully resolved.

The development of tolerance following chronic administration of
psychoactive compounds is often mediated by a down-regulation of
receptors. Thus, chronic exposure to THC could result in a decreased
number of cannabinoid receptors in the brain. Such receptor
down-regulation and reduced binding has recently been demonstrated in
rats (Oviedo, Glowa and Herkenham, 1993). However, previously Westlake
et al (1991) found that cannabinoid receptor properties were not
irreversibly altered in rat brain 60 days following 90-day
administration of THC, nor in monkey brain seven months after one year
of exposure to marijuana smoke. It was argued that these recovery
periods were sufficient to allow the full recovery of any receptors
that would have been lost during treatment. Nevertheless, studies have
not yet confirmed the parameters of any alterations in cannabinoid
receptor number and function that may result from chronic exposure to
cannabinoids, and the extent of reversibility following longer
exposures has not been determined.

7.5.6.2 Human studies

There is very little evidence from human studies of structural brain
damage. In their controversial paper, Campbell et al (1971) were the
first to present evidence suggesting that structural/morphological
brain damage was associated with cannabis use. They used air
encephalography to measure cerebral ventricular size, and claimed to
have demonstrated evidence of cerebral atrophy in ten young males who
had used cannabis for three to 11 years, and who complained of
neurological symptoms, including headaches, memory dysfunction and
other cognitive impairment. Compared to controls, the cannabis users
showed significantly enlarged lateral and third ventricular areas.
Although this study was widely publicised in the media because of its
serious implications, it was heavily criticised on methodological
grounds. Most subjects had also used significant quantities of LSD and
amphetamines, and the measurement technique was claimed to be
inaccurate, particularly since there were great difficulties in
assessing ventricular size and volume to any degree of accuracy (e.g.
Bull, 1971; Susser, 1972; Brewer, 1972). Moreover, the findings could
not be replicated. Stefanis (1976) reported that echoencephalographic
measurements of the third ventricle in 14 chronic hashish users and 21
non-users did not support Campbell et al's pneumoencephalographic
findings of ventricular dilation.

The introduction of more accurate and non-invasive techniques, in the
form of computerised tomographic (CT) scans, (also known as
computer-assisted tomographic (CAT) scans), permitted better studies
of possible cerebral atrophy in chronic cannabis users (Co et al,
1977; Kuehnle et al, 1977). Co et al (1977), for example, compared 12
cannabis users recruited from the general community, with 34 non-drug
using controls, all within the ages of 20-30. The cannabis users had
used cannabis for at least five years at the level of at least five
joints per day, and most had also consumed significant quantities of a
variety of other drugs, particularly LSD. Kuehnle et al's (1977)
subjects were 19 heavy users aged 21-27 years, also recruited from the
general community who had used on average between 25 and 62 joints per
month in the preceding year, although their duration of use was not
reported. CT scans were obtained presumably at the end of a 31-day
study, which included 21 days of ad libitum smoking of marijuana
(generally five joints per day), and were compared against a separate
normative sample. No evidence for cerebral atrophy in terms of
ventricular size and subarachnoid space was found in either study.
Although these studies could also be criticised for their research
design (e.g. inappropriate control groups, and the fact that cannabis
users had used other drugs), these flaws would only have biased the
studies in the direction of detecting significant differences between
groups, yet none were found. The results were interpreted as a
refutation of Campbell's findings, and supporting the absence of
cortical atrophy demonstrated by Rumbaugh et al's (1980) CAT scans of
monkeys. A further study (Hannerz and Hindmarsh, 1983) investigated 12
subjects who had smoked on average 1g of cannabis daily for between
six and 20 years, by thorough clinical neurological examination and CT
scans. As in the studies above, no cannabis related abnormalities were
found on any assessment measure. 

7.5.7   Discussion

Surprisingly few studies of neurotoxicity have been published, and the
results have been equivocal. There is convincing evidence that chronic
administration of large doses of THC leads to residual changes in
rodent behaviours which are believed to depend upon hippocampal
function. There is evidence for long-term changes in hippocampal
ultrastructure and morphology in rodents and monkeys. Animal
neurobehavioural toxicity is characterised by residual impairment in
learning, EEG and biochemical alterations, impaired motivation and
impaired ability to exhibit appropriate adaptive behaviour. Although
extrapolation to man is not possible, the results of these
experimental studies have demonstrated cannabinoid toxicity at doses
comparable to those consumed by humans using cannabis several times a
day. There is sufficient evidence from human research to suggest that
the cannabinoids act on the hippocampal region, producing behavioural
changes similar to those caused by traumatic injury to that region.

The cognitive, behavioural and functional responses to long-term
cannabis consumption in animals and man appear to be the most
consistent manifestation of its potential neurotoxicity. The extent of
damage appears to be more pronounced at two critical stages of central
nervous system development: in neonates when exposed to cannabis
during intrauterine life; and in adolescence, during puberty when
neuroendocrine, cognitive and affective functions and structures of
the brain are in the process of integration. As discussed in Section
7.4 on cognitive functioning, research needs to investigate the
possibility that more severe consequences may occur in adolescents
exposed to cannabinoids. Human research has defined a pattern of acute
CNS changes following cannabis administration; there is convincing
evidence for long-lasting changes in brain function after long-term
heavy use; whether or not these changes are permanent has not been
established. 

Human studies of brain morphology have yielded generally negative
results, failing to find gross signs of &quot;brain damage&quot; after chronic
exposure to cannabis. Nevertheless, the results of many human studies
are indicative of more subtle brain dysfunction. It may be that
existing methods of brain imaging are not sensitive enough to
establish subcellular alterations produced in the CNS. Many
psychoactive substances exert their action through molecular
biochemical mechanisms which do not distort gross cell architecture.
The most convincing evidence on brain damage would come from
postmortem studies, but this type of information has not been
available.

In 1983, Fehr and Kalant concluded that &quot;The state of the evidence at
the present time does not permit one either to conclude that cannabis
produces structural brain damage or to rule it out&quot; (p602). Nahas
(1984) wrote &quot;The brain is the organ of the mind. Can one repetitively
disturb the mental function without impairing brain mechanisms? The
brain, like all other organs of the human body, has very large
functional reserves which allow it to resist and adapt to stressful
abnormal demands. It seems that chronic use of cannabis derivatives
slowly erodes these reserves&quot; (p299). In 1986, Wert and Raulin (1986)
proposed, that on the available evidence &quot;there are no gross
structural or neurological deficits in marijuana-using subjects,
although subtle neurological features may be present. However, the
type of deficit most likely to occur would be a subtle, functional
deficit which could be assessed more easily with either psychological
or neuropsychological assessment techniques.&quot; (p624). In 1993, little
further evidence has emerged to challenge or refute these earlier
conclusions. 

This conclusion was anticipated by the Parisian physician Moreau as
early as 1845 when he observed: 

 ...unquestionably there are modifications (I do not dare use the word
&quot;lesion&quot;) in the organ which is in charge of mental functions. But
these modifications are not those one would generally expect. They
will always escape the investigations of the researchers seeking
alleged or imagined structural changes. One must not look for
particular, abnormal changes in either the gross anatomical or the
fine histological structure of the brain; but one must look for any
alterations of its sensibility, that is to say, for an irregular,
enhanced, diminished or distorted activity of the specific mechanisms
upon which depends the performance of mental functions. (Moreau (de
Tours), 1845).



References

Ali, S.F., Newport, G.D., Scallet, A.C., Gee, K.W., Paule, M.G.,
Brown, R.M. and Slikker, W., Jr. (1989) Effects of chronic
delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter
concentrations and receptor binding in the rat brain. Neurotoxicology,
10, 491-500.

Ali, S.F., Newport, G.D., Scallet, A.C., Paule, M.G., Bailey, J.R. and
Slikker, W., Jr. (1991) Chronic marijuana smoke exposure in the rhesus
monkey. IV: Neurochemical effects and comparison to acute and chronic
exposure to delta-9-tetrahydrocannabinol (THC) in rats. Pharmacology
Biochemistry and Behavior, 40(3), 677-682.

Barrat, E.S. and Adams, P.M. (1972) The effects of chronic marijuana
administration on brain functioning in cats. Clinical Toxicology,
5(1), 36.

Bloom, A.S. (1984) Effects of cannabinoids on neurotransmitter
receptors in the brain. In Agurell, S., Dewey, W.L. and Willette, R.E.
(Eds), The Cannabinoids: Chemical, Pharmacological and Therapeutic
Aspects (pp. 575-589). New York: Academic Press.

Brewer, C. (1972) Cerebral atrophy in young cannabis smokers. Lancet,
(January 15), 143.

Bull, J. (1971) Cerebral atrophy in young cannabis smokers. Lancet,
(December 25), 1420.

Campbell, A.M.G., Evans, M., Thomson, J.L.G. and Williams, M.J. (1971)
Cerebral atrophy in young cannabis smokers. Lancet, 2, 1219-1224.

Campbell, K.A., Foster, T.C., Hampson, R.E. and Deadwyler, S.A.
(1986a) Effects of 9-tetrahydrocannabinol on sensory-evoked
discharges of granule cells in the dentate gyrus of behaving rats. The
Journal of Pharmacology and Experimental Therapeutics, 239(3),
941-945.

Campbell, K.A., Foster, T.C., Hampson, R.E. and Deadwyler, S.A.
(1986b) 9-Tetrahydrocannabinol differentially affects sensory-evoked
potentials in the rat dentate gyrus. The Journal of Pharmacology and
Experimental Therapeutics, 239(3), 
936-940.

Charalambous, A., Marciniak, G., Shiue, C.-Y., Dewey, S.L., Schlyer,
D.J., Wolf, A.P. and Makriyannis, A. (1991) PET studies in the primate
brain and biodistribution in mice using (-)-5'-18F-8-THC.
Pharmacology Biochemistry and Behavior, 40(3), 503-507.

Co, B.T., Goodwin, D.W., Gado, M., Mikhael, M. and Hill, S.Y. (1977)
Absence of cerebral atrophy in chronic cannabis users: Evaluation by
computerized transaxial tomography. Journal of the American Medical
Association, 237(12), 1229-1230.

Cohen, S. (1976) The 94-day cannabis study. Annals of the New York
Academy of Sciences, 282 (R.L. Dornbush, A.M. Freedman and M. Fink
(Eds) Chronic Cannabis Use), 
211-220.

Domino, E.F. (1981) Cannabinoids and the cholinergic system. Journal
of Clinical Pharmacology, 21, 249s-255s.

Feeney, D.M. (1979) Marihuana and epilepsy: Paradoxical anticonvulsant
and convulsant effects. In G.G. Nahas and W.D.M. Paton (Eds),
Marihuana: Biological Effects. Analysis, metabolism, cellular
responses, reproduction and brain (pp. 643-657). Oxford: Pergamon
Press.

Fehr, K.O. and Kalant, H. (Eds) (1983) Cannabis and Health Hazards.
Toronto: Addiction Research Foundation.

Feinberg, I., Jones, R., Walker, J., Cavness, C. and Floyd, T. (1976)
Effects of marijuana extract and tetrahydrocannabinol on
electroencephalographic sleep patterns. Clinical Pharmacology and
Therapeutics, 19(6), 782-794.

Fink, M. (1976) Effects of acute and chronic inhalation of hashish,
marijuana, and 9-tetrahydrocannabinol on brain electrical activity in
man: Evidence for tissue tolerance. Annals of the New York Academy of
Sciences, 282 (R.L. Dornbush, A.M. Freedman and M. Fink (Eds) Chronic
Cannabis Use), 387-398.

Fink, M., Volavka, J., Panayiotopoulos, C.P. and Stefanis, C. (1976)
Quantitative EEG studies of marijuana, 9-tetrahydrocannabinol, and
hashish in man. In M Braude and Szara, S. (Eds), Pharmacology of
Marihuana (pp. 383-391). New York: Raven Press.

Fried, P.A. and Charlebois, A.T. (1979) Canning of the
College on P
pregnancy: First and second generation effects in rats. Physiological
Psychology, 7, 307-310.

Hannerz, J. and Hindmarsh, T. (1983) Neurological and
neuroradiological examination of chronic cannabis smokers. Annals of
Neurology, 13(2), 207-210.

Harper, J.W., Heath, R.G. and Myers, W.A. (1977) Effects of cannabis
sativa on ultrastructure of the synapse in monkey brain. Journal of
Neuroscience Research, 3(2), 87-93.

Heath, R.G., Fitzjarrell, A.T., Fontana, C.J. and Garey, R.E. (1980)
Cannabis sativa: effects on brain function and ultrastructure in
rhesus monkeys. Biological Psychiatry, 15(5), 657-690.

Herning, R.I., Jones, R.T. and Peltzman, D.J. (1979) Changes in human
event-related potentials with prolonged delta-9-tetrahydrocannabinol
(THC) use. Electroencephalography and Clinical Neurophysiology, 47,
556-570.

Hockman, C.H., Perrin, R.G. and Kalant, H. (1971)
Electroencephalographic and behavioral alterations produced by
1-tetrahydrocannabinol. Science, 172, 968-970.

Institute of Medicine. (1982) Marijuana and Health. Washington, DC:
National Academy Press.

Karacan, I., Fernandez-Salas, A., Coggins, W.J., Carter, W.E.,
Wiliams, R.L., Thornby, J.I., Salis, P.J., Okawa, M. and Villaume,
J.P. (1976) Sleep electroencephalographic -electrooculographic
characteristics of chronic marijuana users. Annals of the New York
Academy of Sciences, 282 (R.L. Dornbush, A.M. Freedman and M. Fink
(Eds) Chronic Cannabis Use), 348-374.

Kuehnle, J., Mendelson, J.H. and David, K.R. (1977) Computed
tomographic examination of heavy marijuana users. Journal of the
American Medical Association, 237(1231-1232), 

Landfield, P.W., Cadwallader, L.B. and Vinsant, S. (1988) Quantitative
changes in hippocampal structure following long-term exposure to
9-tetrahydrocannabinol: possible mediation by glucocorticoid systems.
Brain Research, 443, 47-62.

Luthra, Y.K., Rosenkrantz, H. and Braude, M (1976) Cerebral and
cerebellar neurochemical changes and behavioral manifestations in rats
chronically exposed to marijuana smoke. Toxicology and Applied
Pharmacology, 35, 455-465.

Marciniak, G., Charalambous, A., Shiue, C.-Y., Dewey, S.L., Schlyer,
D.J., Makriyannis, A. and Wolf, A.P. (1991) 18F-Labeled
tetrahydrocannabinol: synthesis; and PET studies in a baboon. Journal
of Laboratory and Comparative Radiophysiology, 30, 413-415. 

Martin, B.R. (1986) Cellular effects of cannabinoids. Pharmacological
Reviews, 38(1), 45-74.

Mathew, R.J., Tant, S. and Berger, C. (1986) Regional cerebral blood
flow in marijuana smokers. British Journal of Addiction, 81, 567-571.

Mathew, R.J. and Wilson, W.H. (1992) The effects of marijuana on
cerebral blood flow and metabolism. In L. Murphy and A. Bartke (Ed.)
Marijuana/Cannabinoids: Neurobiology and neurophysiology (pp.
337-386). Boca Raton, Fl.: CRC Press.

McGahan, J.P., Dublin, A.B. and Sassenrath, E. (1984) Long-term
delta-9-tetrahydrocannabinol treatment: Computed tomography of the
brains of rhesus monkeys. AJDC, 138, 1109-1112.

Moreau (de Tours), J.J. (1845) Du Hachisch et de l'Alienation Mentale:
Etudes Psychologiques. Paris: Libraire de Fortin, Masson. (English
edition: New York: Raven Press 1972).

Musselman, D.L., Haden, C., Caudle, J., Lewine, R.R.J. and Risch, S
(1993) Cerebrospinal fluid study of cannabinoid users and normal
controls. Presented at the 55th Annual Scientific Meeting of the
College on Problems of Drug Dependence, Toronto, Canada, June 12-17.

Myers, W.A. and Heath, R.G. (1979) Cannabis sativa: Ultrastructural
changes in organelles of neurons in brain septal region of monkeys.
Journal of Neuroscience Research, 4(1), 9-17.

Nahas, G.G. (Ed) (1984) Marihuana in Science and Medicine. New York:
Raven Press.

Oviedo, A., Glowa, J. and Herkenham, M. (1993) Chronic cannabinoid
administration alters cannabinoid receptor binding in rat brain: a
quantitative autoradiographic study. Brain Research, 616, 293-302.

Pertwee, R.G. (1988) The central neuropharmacology of psychotropic
cannabinoids. Pharmacol Ther, 36, 189-261.

Richmon, J., Murawski, B., Matsumiya, Y., Duffy, F.H. and Lombroso,
C.T. (1974) Long term effects of chronic marihuana smoking.
Electroencephalography and Clinical Neurophysiology, 36(2), 223-224.

Rosenkrantz, H. (1983) Cannabis, marihuana, and cannabinoid
toxicological manifestations in man and animals. In K.O. Fehr and H.
Kalant (Eds), Cannabis and Health Hazards: Proceedings of an ARF/WHO
Scientific Meeting on Adverse Health and Behavioral Consequences of
Cannabis Use (pp. 91-175). Toronto: Addiction Research Foundation.

Rubin, V. and Comitas, L. (1975) Ganja in Jamaica: A medical
anthropological study of chronic marihuana use. The Hague: Mouton
Publishers.

Rumbaugh, C.L., Fang, HH., Wilson, G.H., Higgins, R.E. and Mestek,
M.F. (1980) Cerebral CT findings in drug abuse: Clinical and
experimental observations. Journal of Computer Assisted Tomography,
4(3), 330-334.

Scallett, A.C., Uemura, E., Andrews, A., Ali, S.F., McMillan, D.E.,
Paule, M.G., Brown, R.M. and Slikker, W., Jr. (1987) Morphometric
studies of the rat hippocampus following chronic
delta-9-tetrahydrocannabinol (THC). Brain Research, 436, 193-198.

Shannon, M.E. and Fried, P.A. (1972) The macro- and microdistribution
and polymorphic electroencephalographic effects of
9-tetrahydrocannabinol in the rat. Psychopharmacologia (Berl.), 27,
141-156.

Slikker, W., Jr., Paule, M.G., Ali, S.F., Scallet, A and Bailey, J.R.
(1992) Behavioral, neurochemical, and neurohistological effects of
chronic marijuana smoke exposure in the nonhuman primate. In L. Murphy
and A. Bartke (Ed.), Marijuana/Cannabinoids: Neurobiology and
Neurophysiology (pp. 219-273). Boca Raton, Fl.: CRC Press.

Stefanis, C. (1976) Biological aspects of cannabis use. In R Petersen
(Ed.), The International Challenge of Drug Abuse (pp. 149-178).
Rockville, MD: National Institute on Drug Abuse.

Stiglick, A. and Kalant, H. (1982a) Learning impairment in the
radial-arm maze following prolonged cannabis treatment in rats.
Psychopharmacology, 77(2), 117-123.

Stiglick, A. and Kalant, H. (1982b) Residual effects of prolonged
cannabis administration on exploration and DRL performance in rats.
Psychopharmacology, 77(2), 124-128.

Struve, F.A. and Straumanis, J.J. (1990) Electroencephalographic and
evoked potential methods in human marihuana research: Historical
review and future trends. Drug Development Research, 20, 369-388.

Struve, F., Straumanis, J., Patrick, G., Norris, G., Leavitt, J. and
Webb, P. (1991). Topographic quantitative EEG findings in subjects
with 18+ years of cumulative daily THC exposure. 53rd Scientific
Meeting of the College on Problems of Drug Dependence, Palm Beach,
Florida USA, June.

Struve, F., Straumanis, J., Patrick, G., Norris, G., Nixon, F.,
Fitz-Gerald, M., Manno, J., Leavitt, J. and Webb, P. (1993)
Topographic quantitative EEG sequelae of chronic cumulative THC
exposure: recent and continuing studies. 55th Annual Scientific
Meeting of the College on Problems of Drug Dependence, Toronto,
Canada, June 10-17. 

Susser, M. (1972) Cerebral atrophy in young cannabis smokers. Lancet,
(January 1), 41-42.

Tunving, K., Thulin, O., Risberg, J. and Warkentin, S. (1986) Regional
cerebral blood flow in long-term heavy cannabis use. Psychiatry
Research, 17, 15-21.

Volkow, N.D., Gillespi, H., Mullani, N., Tancredi, L., Hollister, L.,
Ivanovic, M., and Grant, C. (1991) Use of positron emission tomography
to investigate the action of marihuana in the human brain. In G. Nahas
and C. Latour (Eds), Physiopathology of Illicit Drugs: Cannabis,
Cocaine, Opiates (pp. 3-11). Oxford: Pergamon Press.

Wert, R and Raulin, M.L. (1986) The chronic cerebral effects of
cannabis use. I. Methodological issues and neurological findings. The
International Journal of the Addictions, 21(6), 605-628.

Westlake, T.M., Howlett, A.C., Ali, S.F., Paule, M.G. and Scallett, W.
Jr. (1991) Chronic exposure to delta-9-tetrahydrocannabinol fails to
irreversibly alter brain cannabinoid receptors. Brain Research, 544,
145-149.



7.6 Does cannabis use cause psychotic disorders? 

There is a prima facie case for believing that cannabis use may in
certain circumstances be a contributory cause of major psychological
disorders such as psychotic disorders, i.e. illnesses in which
symptoms of hallucinations, delusions and impaired reality testing are
predominant features. First, THC is a psychoactive substance which
produces some of the symptoms found in psychotic disorders, namely,
euphoria, distorted time perception, cognitive and memory impairments
(Brill and Nahas, 1984; Halikas et al, 1971; Thornicroft, 1990).
Second, under controlled laboratory conditions with normal volunteers,
THC has been shown at high doses to produce psychotic symptoms which
include visual and auditory hallucinations, delusional ideas, thought
disorder, and symptoms of hypomania (Georgotas and Zeidenberg, 1979;
National Academy of Science, 1982). Third, a putative &quot;cannabis
psychosis&quot; has been identified by clinical observers in regions of the
world with a long history of chronic, heavy cannabis use, e.g. India,
Egypt, and the Carribean (Brill and Nahas, 1984; Ghodse, 1986). 



7.6.1 The nature of the relationship

How might cannabis use causally contribute to the development of
psychosis? The following are the major mechanisms that have been
suggested by proponents of a relationship between cannabis use and
severe psychological disorder (Thornicroft, 1990). 



7.6.1.1 Is there a 'cannabis psychosis'?

The first possibility is that acute or chronic cannabis use may
produce a &quot;cannabis psychosis&quot;. Four possible variants of this
hypothesis can be distinguished. The first hypothesis is that the
acute use of large doses of cannabis may induce a &quot;toxic&quot; or organic
psychosis with prominent symptoms of confusion and hallucination,
which remit with abstinence from cannabis. The second hypothesis is
that cannabis use may produce an acute functional psychosis, similar
in its clinical presentation to paranoid schizophrenia, and lacking
the organic features of a toxic psychosis which remits after
abstinence from cannabis. A third hypothesis is that chronic cannabis
use may produce a chronic psychosis, i.e. a psychotic disorder which
persists beyond the period of intoxication. The fourth hypothesis (a
variant of the third) is that chronic cannabis use may induce an
organic psychosis which only partially remits with abstinence, leaving
in its train a residual deficit state with symptoms that are analogous
to the negative symptoms of schizophrenia, or a mild chronic brain
syndrome. This has also been described as &quot;an amotivational syndrome&quot;
which is characterised by withdrawal, lack of interest in others,
impaired performance and lack of motivation to perform one's social
responsibilities. 



7.6.1.2 Does cannabis use precipitate a latent psychosis?

Cannabis use could conceivably precipitate a latent psychosis, i.e.
bring forward an episode of schizophrenia or manic depressive
psychosis in a vulnerable or predisposed individual. This could occur
either as a result of a specific pharmacological effect of THC (or
other constituents of cannabis preparations), or as the result of
stressful experiences while intoxicated, such as a panic attack or a
paranoid reaction to the acute effects of cannabis (Edwards, 1976).
Schizophrenia is the disorder about which concern has been most often
expressed in the case of cannabis use.

A related hypothesis would be that cannabis use exacerbates the
symptoms of a functional psychosis such as schizophrenia or manic
depressive psychosis. This could occur if cannabis use precipitated a
relapse in the same way that it has been hypothesised to precipitate
the onset of a latent psychosis. Alternatively, the pharmacological
effects of cannabis might impair the effectiveness of the neuroleptic
drugs used to treat major psychoses.



7.6.2 Methodological issues 

Until recently, our ability to test these hypotheses has been hampered
by a lack of sophistication in research design (Mueser et al, 1990;
Thornicroft, 1990; Turner and Tsuang, 1990). First, the possible
mechanisms for a causal relationship between cannabis use and
psychosis have not always been clearly distinguished, and so have not
often informed the design of research studies purporting to test them.
Second, studies of the relationships between cannabis use and
psychological disorder have often been uncontrolled. Only rarely have
they compared cannabis use in psychotic patients and controls, or
compared the clinical characteristics and course of psychotic patients
who have and have not used cannabis. Third, the extent of cannabis and
other drug use, and its relationship to the onset of psychotic
symptoms, has often been poorly documented. There has been a heavy
reliance upon self-reported use, and few attempts have been made to
distinguish between use, abuse and dependence (Mueser et al, 1990).
Fourth, the diagnosis of a psychotic disorder, or of psychotic
symptoms, has only rarely used standardised diagnostic criteria such
DSM-III-R or ICD-9. Fifth, many studies have used small samples,
reducing the chances of detecting any association between cannabis use
and psychotic disorder. As a consequence of these deficiencies, many
studies have failed to provide convincing evidence of even an
association between cannabis use and psychotic symptoms or psychotic
syndromes. 

Even when an association between cannabis use and psychosis has been
demonstrated, it has proved difficult to distinguish between
alternative explanations of it. There has been a readiness to assume
that the data supports the hypothesis that cannabis use is a
contributory cause of psychosis (whether that is a specific &quot;cannabis
psychosis&quot; or a functional psychosis such as schizophrenia). Only
recently have other hypotheses been acknowledged, and attempts made to
test them (e.g. Dixon et al, 1990, 1991; Turner and Tsuang, 1990). 

There are a number of ways in which cannabis use could be associated
with psychotic disorders without being a contributory cause of such
disorders. One possibility is that the psychosis is a contributory
cause of cannabis use, and that cannabis is used to self-medicate
depression, anxiety, negative psychotic symptoms, or the side effects
of neuroleptic drugs. Another possibility is that drug use among
schizophrenic individuals is a consequence of pre-existing personality
characteristics which predispose them to use illicit drugs and to
develop schizophrenia. A third possibility is that heavy cannabis use
may be a marker of the use of amphetamine and cocaine for which there
is strong evidence for causing acute paranoid psychoses (Angrist,
1983; Bell, 1973; Connell, 1959). 

In the review that follows, the best available clinical and
epidemiological studies bearing on these issues is reviewed. Although
we have preferred to cite controlled studies, we have not excluded all
the early uncontrolled studies which have been most often cited.
Attempts will also be made to distinguish the very different
non-causal explanations of the apparent association between cannabis
use and psychosis.



7.6.3 'Cannabis psychoses'



7.6.3.1 Toxic psychosis

Much of the literature on cannabis psychoses consists of case studies
(e.g. Carney, Bacelle and Robinson, 1984; Drummond, 1986; Edwards,
1983; Weil, 1970), case series (e.g. Bernardson and Gunne, 1972; Cohen
and Johnson, 1988; Kolansky and Moore, 1971; Onyango, 1986) and
reviews of such reports (e.g. Tunving, 1985) which often suffer from a
circularity in their argument (Thornicroft, 1990). Typically a group
of patients have been identified as having a toxic &quot;cannabis
psychosis&quot; (with little information given on how they came to be so
identified) and their behaviour and clinical history are then
presented as evidence for the existence of the diagnostic entity they
were meant to be testing. The better examples of these reports have
attempted to justify their inclusion of cases within this diagnosis,
and have attempted to assess the contribution of predisposition and
drug use to the development of the psychosis. 

Chopra and Smith (1974) have presented one of the largest case series
of a toxic &quot;cannabis psychosis&quot;. They described the characteristics of
200 East Indian patients who were admitted to a psychiatric hospital
in Calcutta between 1963 and 1968 with &quot;psychotic symptoms following
the use of cannabis preparations&quot; (p24). Their cases resembled cases
of acute organic brain disorder in that their major symptoms included
confusion and amnesia. The most common symptoms &quot;were sudden onset of
confusion, generally associated with delusions, hallucinations
(usually visual) and emotional lability ... amnesia, disorientation,
depersonalisation and paranoid symptoms&quot; (p24). Most psychoses were
preceded by the ingestion of a large dose of cannabis which produced
intoxication and amnesia for the period between ingestion and
hospitalisation.

Patients were classified into three groups on the basis of their
history of previous psychiatric disorder. The first consisted of a
third of patients who had no previous personality problems or
psychiatric disorder, whose only constant feature was &quot;recent use of
cannabis preparations as the apparent precipitant of the psychotic
episode&quot; (p25). They exhibited symptoms of excitement, confusion,
disorientation, delusions, visual hallucinations, depersonalisation,
emotional instability and delirium. These symptoms were usually of
short duration, varying between a few hours and several days, and all
these patients returned to their normal state after remission. 

The second group consisted of 61 per cent of patients who did not have
a prior history of psychosis but had a history of schizoid,
sociopathic, and unstable personalities. Their clinical picture was
much like that of the first group, and they also had a high
probability of remission within a few days of admission. The third
group consisted of 10 patients with a prior history of psychosis (most
often schizophrenia) who rarely experienced a short remission and
usually required continued hospitalisation and treatment. 

Chopra and Smith argued that their case series provided evidence for
the existence of the clinical entity of &quot;cannabis psychosis&quot;. Although
they conceded that excessive drug use could be a sign of pre-existing
psychopathology, they argued that this was an unlikely explanation of
their findings, because at least a third of their cases had no prior
psychiatric history, the symptoms reported were remarkably uniform
regardless of prior psychiatric history, and there was evidence of a
dose-time relationship in that those who used the most potent cannabis
preparations experienced psychotic reactions after the shortest period
of use.

The findings of Chopra and Smith have received some support from case
series published in other countries (e.g. Bernardson and Gunne, 1972;
Onyango, 1986; Tennant and Groesbeck, 1972). Bernardson and Gunne
(1972) reported on 46 cases of putative cannabis psychosis admitted to
Swedish psychiatric hospitals between 1966 and 1970. These were
primary cannabis users who had no history of psychosis prior to their
cannabis use, and who presented with a clinical picture of paranoid
delusions, motor restlessness, auditory and visual hallucinations,
hypomania, aggression, anxiety and clouded consciousness. Their
symptoms usually remitted within five weeks of admission, and those
who returned to cannabis use after discharge were most likely to
relapse. 

Tennant and Groesbeck (1972) report on psychoses they had treated
among US servicemen stationed in Germany between 1968 and 1971. During
this period, potent hashish was cheap and readily available and widely
used, with 46 per cent of servicemen reporting that they had used
hashish, and 16 per cent reporting using it three or more times per
week. They reported 18 cases of a short-term panic reaction or toxic
psychosis developing after a single high dose of hashish, and 85 cases
of toxic psychoses developing after the simultaneous consumption of
cannabis and other drugs. The toxic psychoses usually resolved within
three days on neuroleptic medication. 

Onyango (1986) reported one of the few case series which used
biochemical measures of recent cannabis use to identify possible cases
of toxic cannabis psychosis among young adults who presented to a
London psychiatric hospital with psychotic symptoms. He screened the
urines of 25 such admissions and found that, although half reported
having used cannabis at some time, only four had cannabinoid
metabolites in their urines at the time of presentation. In three
cases the patients had a prior history of psychosis, their
phenomenology was unremarkable, and they did not respond rapidly to
treatment. Only one case seemed to fit the picture of a cannabis
psychosis. He had no prior history of psychosis, and a history of
chronic, heavy cannabis use prior to admission. He presented with
hallucinations, delusions, and labile, elated mood which responded
rapidly to haloperidol, and he had no further episodes during a
two-year follow-up.

All considered, there is a reasonable case for believing that large
doses of potent cannabis products can produce a toxic psychotic
illness in persons who do not have a personal history of psychotic
illness (Edwards, 1976; Negrete, 1983; Thomas, 1993). Such psychoses
are characterised by symptoms of confusion and amnesia, paranoid
delusions, and auditory and visual hallucinations, and they have a
relatively benign course in that they typically remit within a week of
abstinence (Chaudry et al, 1991; Thomas, 1993). They seem most likely
to occur in populations which use high doses of THC, and probably
occur rarely otherwise (Smith, 1968). Given the poor standards of
research design and lack of adequate controls in all but a few of
these studies, and the failure to use standardised diagnostic
criteria, it would be premature to claim that the existence of a toxic
&quot;cannabis psychosis&quot; has been established beyond reasonable doubt.



7.6.3.2 An acute functional psychosis 

Other investigators have argued that heavy cannabis use may produce an
acute functional psychosis. That is, it produces an illness which does
not reflect an organic state produced by drug intoxication, but rather
a psychotic illness that resembles schizophrenia. Thacore and Shukla
(1976), for example, reported a case control study comparing cases
with a putatively functional cannabis psychosis with controls
diagnosed as having paranoid schizophrenia. Their 25 cases of cannabis
psychosis had a paranoid psychosis resembling schizophrenia, in which
&quot;a clear temporal relationship between the prolonged use of cannabis
[longer than five years in all but one case] and the development of
psychosis has been observed on more than two occasions&quot; (p384). Their
25 age and sex-matched controls were individuals with paranoid
schizophrenia who had no history of cannabis use. 

The comparison revealed that the patients with a cannabis psychosis
displayed more odd and bizarre behaviour, violence, panic affect, and
insight and less evidence of thought disorder. They also responded
swiftly to neuroleptic drugs and recovered completely. According to
Thacore and Shukla, this functional psychotic disorder could be
distinguished from the toxic &quot;cannabis psychosis&quot; reported by Chopra
and Smith (1974), because there was no evidence of confusion and
amnesia, and the major presenting symptoms were delusions of
persecution, and auditory and visual hallucinations occurring in a
state of clear consciousness. 

Rottanburg et al (1982) provide one of the most convincing research
studies in favour of the hypothesis that cannabis can produce an acute
functional psychosis. They conducted a case-control study in which
psychotic patients with cannabinoids in their urines were compared
with psychotic patients who did not have cannabinoids in their urines.
Both groups were assessed shortly after admission, and seven days
later, by psychiatrists who used a standardised psychiatric interview
schedule (PSE) and who were blind as to presence or absence of
cannabinoids in the patients' urine. 

Every third admission of a Cape coloured man during a period of a year
(n=117) were screened for cannabinoids, alcohol and other toxins.
Sixty per cent (N=70) had urines that were positive for cannabinoids,
and 36 cases had levels which suggested heavy cannabis use prior to
admission. Sixteen patients left hospital before the study was
completed, leaving a group of 20 cases with psychoses and cannabinoids
only in their urines. They were compared with 20 psychotic controls,
matched for age and clinical diagnosis, whose urines were negative for
cannabinoids and other drugs and toxins. 

The results showed that psychotic patients with cannabinoids in their
urine had more symptoms of hypomania and agitation, and less auditory
hallucinations, flattening of affect, incoherent speech and hysteria
than controls. They also showed strong improvements in symptoms by the
end of a week, as against no change in the controls despite receiving
comparable amounts of anti-psychotic drugs. They concluded that &quot;heavy
cannabis intake is associated with a rapidly resolving psychotic
illness characterised by marked hypomanic features&quot; (p1366). 

Imade and Ebie (1991) conducted a retrospective comparison of the
symptoms reported by 70 patients with putatively cannabis-induced
psychosis, 163 patients with schizophrenia, and 39 patients with
mania. No details were provided on how these diagnoses were made, and
the ratings of symptoms were made retrospectively from case records by
psychiatrists who were not blind as to the patients' diagnoses. A
large number of statistical comparisons produced a number of
statistically significant differences in individual symptoms between
the three patient groups, although they did not differ in symptoms of
violence, panic and bizarre behaviour. Imade and Ebie argued that
there were no symptoms that were unique to cannabis psychosis, and
that there was no consistency of clinical picture that enabled them to
distinguish a &quot;cannabis psychosis&quot; from schizophrenia. This negative
study is unconvincing. The symptom ratings were made retrospectively
from clinical records of unknown quality, and the patients' diagnoses
were not made using standardised diagnostic criteria. There was no
information on how &quot;cannabis psychosis&quot; was diagnosed, or on the
clinical course of the psychoses. The authors also failed to use
appropriate statistical methods to test the claim that cannabis
psychosis can be distinguished from schizophrenia.

A number of cohort studies have been conducted on the prevalence of
psychotic symptoms in chronic cannabis users and controls. Beaubruhn
and Knight (1973) conducted a small study comparing the psychiatric
history and symptoms of 30 chronic daily Jamaican cannabis users (with
a history of at least seven years use) with that of 30 non-cannabis
using controls matched on social class, income, age and sex. Both
cases and controls were assessed by personal psychiatric interview and
personality questionnaires during a six day hospitalisation. There
were few statistically significant differences between the two groups,
only a higher rate of family history of psychiatric disorder and of
hallucinatory experiences in the cannabis users. Only one user and one
non-user reported a personal history of psychiatric disorder. 

Similar results have been reported by Stefanis et al (1976) in a study
of 47 chronic cannabis users in Greece and 40 controls matched for
age, family origin, residence at birth and upbringing. They found a
higher incidence of personality disorders among their cannabis users,
but no statistically significant difference in the rates of
psychiatric disorder diagnosed by a personal interview with a
psychiatrist. Three cases of schizophrenia were diagnosed in the
cannabis using group, but a connection with cannabis use was
discounted on the ground that two of the three had a family history of
schizophrenia.

The small number of cases and the relative rarity of psychosis makes
these studies unconvincing. The authors interpreted their results far
too strongly, by inferring that a failure to find a difference in
rates of psychiatric disorder in sample sizes of 30 and 47 indicated
that there was no difference in prevalence between chronic cannabis
users and controls. In Beaubruhn and Knight's study (1973), for
example, the failure to detect a difference in the rate of psychosis
between 30 cannabis users and 30 controls does not rule out a 17 fold
higher rate of psychiatric disorder among cannabis users (as shown by
the upper limit of a 95 per cent confidence interval around the odds
ratio).

All considered, the case for believing that cannabis use can produce a
functional paranoid illness is much less compelling than that for a
toxic psychosis (Thomas, 1993; Thornicroft, 1990). The research
designs for studies of this diagnosis have more often included control
groups, but proponents of this hypothesis have not presented evidence
that satisfactorily distinguishes it from other functional psychoses
(Thornicroft, 1990). 

If there is a toxic cannabis psychosis, then a strong case has not
been made for distinguishing it from the putatively functional
cannabis psychosis. Thacore and Shukla (1976) emphasised the history
of chronic heavy cannabis use among their cases of functional cannabis
psychoses, and the absence of the confusion and amnesia reported in
persons with the toxic psychosis. 

The differentiation in terms of chronicity of drug use is
unconvincing. Some of the cases of the toxic cannabis psychosis
described by Chopra and Smith (1974), for example, had a long history
of heavy cannabis use. The hypothesised difference in symptoms is more
difficult to evaluate. Because few of the studies used standardised
assessments of symptoms, the absence of reports of confusion and
amnesia in the functional cases may indicate differences in diagnostic
practice. There are also strong similarities between the putatively
toxic and functional psychoses, namely, the occurrence of delusions,
and auditory and visual hallucinations, and a relatively benign
course, typically remitting within a week. 

There is some recent support for the distinction between toxic and
functional cannabis-induced psychoses. Tsuang et al, (1982) compared
the demographic and clinical characteristics, and family histories of
four groups of patients: those with drug abuse who had experienced a
psychotic illness (DAP), those with diagnoses of drug abuse alone
(DA), those with schizophrenia (SC), and those with diagnoses of
atypical schizophrenia (AS). They subdivided the patients with drug
abuse and psychosis into those with shorter and longer duration of
symptoms. They found that the DAP patients were more likely to have
abused hallucinogens and cannabis, and less likely to have abused
sedative-hypnotics and opiates, than DA patients. The DAP patients
also had an earlier onset of illness, and better premorbid
personalities than the SC patients. 

Comparisons of the DAP patients with short and long duration of
illness produced some interesting results. The patients with short
duration disorders had better premorbid personalties, fewer psychotic
symptoms, and fewer core schizophrenic symptoms, such as poor insight,
shallow and inappropriate affect, thought disorder, delusions and
Schneiderian &quot;first rank symptoms&quot;. They were more likely to have
presented with &quot;organic&quot; symptoms such as confusion, disorientation,
visual hallucinations, and amnesia than the patients with long
duration disorders. By definition, the shorter duration patients had
shorter periods of admission; they also had shorter duration of drug
treatment, and more were discharged without being referred for further
treatment. The prevalence of family histories of schizophrenia among
the longer duration DAP patients was similar to that of the SC, while
the shorter duration DAP patients had no such family history. 

On the basis of their comparisons, Tsuang et al argued that the short
duration disorders were drug-induced toxic psychoses, while the longer
duration disorders reflected functional psychoses precipitated by drug
use in predisposed individuals. If these findings are accepted, the
simplest explanation of the allegedly functional &quot;cannabis psychoses&quot;
is that they are functional psychoses occurring in heavy cannabis
users. 



7.6.3.3 Chronic psychoses 

If cannabis can produce an acute organic psychosis, the possibility
must be considered that chronic cannabis use may produce a chronic
psychosis in much the same way as chronic alcohol heavy use can
produce a chronic organic brain syndrome. As Ghodse (1986) has
suggested, it is &quot;theoretically possible in a situation of easy
availability of cannabis, that regular, heavy users may suffer
repeated, short episodes of psychosis and effectively `maintain'
themselves in a chronic, psychotic state&quot; (p477). 

Although this is a possibility, there is no good evidence that chronic
cannabis use causes a psychotic illness which persists after
abstinence from cannabis (Thomas, 1993). This possibility is difficult
to study because of the near impossibility of distinguishing a chronic
cannabis psychosis from a functional psychosis such as schizophrenia
in which there is concurrent cannabis use (Negrete, 1983). Certainly
the findings of Tsuang et al (1982) suggest that the strong
presumption must be that individuals with a history of drug abuse and
a psychotic illness have a functional psychosis which has been
precipitated or exacerbated by drug use. Follow-up studies of patients
with acute cannabis psychoses, if they could be reliably identified,
would be the best way of throwing some light on this issue. 



7.6.3.4 A residual state

A number of investigators have described a state among chronic, heavy
cannabis users in which the users' focus of interest narrows, they
become apathetic, withdrawn, lethargic, and unmotivated, and they have
impaired memory, concentration and judgment (Brill and Nahas, 1984;
McGlothin and West, 1968). This has been described as an
&quot;amotivational state&quot;, which some have attributed to an organic
syndrome caused by the effects of chronic cannabis intoxication, from
which there is incomplete recovery after prolonged abstinence (Tennant
and Groesbeck, 1972). 

The major clinical evidence in favour of such a hypothesis consists of
case series among contemporary chronic cannabis users (e.g. Kolansky
and Moore, 1971; Millman and Sbriglio, 1986), and historical reports
of the syndrome among chronic, heavy users in countries such as Egypt,
Greece, and the Carribean, where there has been a tradition of chronic
heavy cannabis use among the lower socioeconomic groups (Brill and
Nahas, 1984). These reports are often poorly documented and
uncontrolled, and do not permit the effects of chronic drug use to be
easily disentangled from those of poverty and low socioeconomic
status, or pre-existing personality disorders (Edwards, 1976; Millman
and Sbriglio, 1986; Negrete, 1983).

A small number of controlled studies of heavy chronic users in other
cultures have largely failed to substantiate the clinical observations
(Millman and Sbriglio, 1986), although there are enough reports of
regular users complaining of loss of ambition and impaired school and
occupational performance (e.g. Hendin et al, 1987), and of ex-users
giving this as a reason for stopping (Jones, 1984), to keep the
possibility alive. The small number of laboratory studies of long-term
heavy use have produced mixed evidence (Edwards, 1976). Georgotas and
Zeidenberg (1979), for example, reported that five healthy male
marijuana users on a dose regimen of 210mg of THC per day for a month
appeared &quot;moderately depressed, apathetic, at times dull and alienated
from their environment and with impaired concentration&quot; (p430). Others
have failed to observe such effects (e.g. Mendelson et al, 1974). The
status of the amotivational syndrome consequently remains uncertain
(see pp102-105). 



7.6.4 Cannabis and schizophrenia



7.6.4.1 Precipitation

The possibility that heavy, chronic cannabis use may precipitate
schizophrenia was raised by Tennant and Groesbeck (1972) in their
study of the consequences of chronic heavy hashish use among American
servicemen in Germany between 1968 and 1971. They reported 112 cases
of &quot;persistent schizophrenic reactions following prolonged hashish
use&quot; (p134), and they presented evidence that there had been a four
fold increase in the incidence of schizophrenia among American
servicemen during the period in which hashish use became endemic. As
with all ecological evidence, a causal relationship is only one of the
possible explanations of the apparently concurrent increase in the
prevalence of hashish use and schizophrenia among American servicemen
in Germany. The attribution of the increase to hashish use alone was
also complicated by fact that many of their cases of schizophrenia
also used hallucinogens, amphetamines, and alcohol. 

The precipitation hypothesis has received some support from a series
of case-control studies of cannabis and other psychoactive drug use
among schizophrenic patients (Schneier and Siris, 1987). The usual
finding has been that schizophrenic patients have higher rates of use
of psychomimetic drugs such as amphetamines, cocaine, and
hallucinogens than other patients (Dixon et al, 1990; Schneier and
Siris, 1987; Weller et al, 1988) or normal controls (Breakey et al,
1974; Rolfe et al, 1993). The results for cannabis use have been more
mixed, with some finding a higher prevalence of use or abuse (e.g.
Mathers et al, 1991) and others not having done so (Dixon et al, 1990;
Mueser et al, 1990; Schneier and Siris, 1987). 

There is also good epidemiological evidence for an association between
schizophrenia and drug abuse and dependence in the Epidemiological
Catchment Area (ECA) study. In this study (Anthony and Helzer, 1991)
there was an increased risk of schizophrenia among men and women with
a diagnosis of any form of drug abuse and dependence: the excess risk
of schizophrenia was 6.2 for men and 6.4 for women. Although separate
estimates were not provided for cannabis abuse and dependence, it
seems reasonable to assume that the same sort of relationship applied.
Bland, Norman and Orn, (1987) have obtained a similar finding in a
population survey of the prevalence of psychiatric disorder in
Edmonton Alberta, using the same ECA interview schedule and diagnostic
criteria. They found that the odds of receiving a diagnosis of drug
abuse and dependence were 11.9 times higher among persons with
schizophrenia. 

Many researchers have favoured a causal interpretation of the
increased prevalence of psychoactive drug use among schizophrenics,
that is, they have concluded that cannabis and other drug use
precipitates schizophrenic disorders in persons who may not otherwise
have experienced them. In support of this hypothesis are the common
findings that drug abusing schizophrenic patients have an earlier age
of onset of psychotic symptoms (with their drug use typically
preceding the onset of symptoms), a better premorbid adjustment, fewer
negative symptoms (e.g. withdrawal, anhedonia, lethargy), and a better
response to treatment and outcome than schizophrenic patients who do
not use drugs (Allebeck et al, 1993; Dixon et al, 1990; Schneier and
Siris, 1987). 

There are other interpretations of these findings, however. Arndt et
al (1992), for example, have suggested that the association between
cannabis use and an early onset of schizophrenia in persons with a
good premorbid personality and outcome is spurious. According to Arndt
et al, schizophrenics with a better premorbid personality were simply
more likely to be exposed to illicit drug use among peers than those
with a withdrawn and socially inept premorbid personality, and because
of this prior exposure to drugs, they were also more likely to use
drugs to cope with the symptoms of an emerging psychosis. On this
account, cannabis and other illicit drug use is a correlate of a good
prognosis in schizophrenia, and pathological drug use is a response to
the unrelated emergence of psychotic symptoms. 

A further possibility is that cannabis and other illicit drug use is a
consequence of schizophrenia. That is, such illicit drug use is a form
of self-medication to deal with some of the unpleasant symptoms of
schizophrenia, such as depression, anxiety, lethargy, and anhedonia,
and the side effects of the neuroleptic drugs used to treat it (Dixon
et al, 1990). There is some support for this hypothesis in the work of
Dixon et al (1990), who surveyed 83 patients with schizophrenia or
schizophreniform psychoses about the effects of various illicit drugs
on their mood and symptoms. Their patients reported that cannabis
reduced anxiety and depression, and increased a sense of calm, at the
cost of some increase in suspiciousness, and with mixed effects on
hallucinations and energy. 

Prospective evidence. The most convincing evidence of an association
between cannabis use and the precipitation of schizophrenia has been
provided by a prospective study of cannabis use and schizophrenia in
Swedish conscripts undertaken by Andreasson et al (1987). These
investigators used data from a 15-year prospective study of 50,465
Swedish conscripts to investigate the relationship between
self-reported cannabis use at age 18 and the risk of receiving a
diagnosis of schizophrenia in the subsequent 15 years, as indicated by
inclusion in the Swedish psychiatric case register. Substantial data
were collected on the conscripts (such as family circumstances,
personal psychiatric disorder and other drug use) and statistical
methods were used to examine the effect of these potentially
confounding variables on the association between cannabis and
schizophrenia. 

Their results showed that the relative risk of receiving a diagnosis
of schizophrenia was 2.4 times higher [95 per cent confidence interval
1.8, 3.3] for those who had ever tried cannabis compared to those who
had not. There was also a dose-response relationship between the risk
of a diagnosis of schizophrenia and the number of times that the
conscript had tried cannabis by age 18. The crude relative risk of
developing schizophrenia was 1.3 times higher [95 per cent confidence
interval 0.8, 2.3] for those who had used cannabis one to ten times,
3.0 times higher [95 per cent confidence interval 1.6, 5.5] for those
who had used cannabis between one and 50 times, and 6.0 times higher
[95 per cent confidence interval 4.0, 8.9] for those who had used
cannabis more than fifty times (compared in each case to those who had
not used cannabis). 

The size of the risk was substantially reduced by statistical
adjustment for variables that were independently related to the risk
of developing schizophrenia (namely, having a psychiatric diagnosis at
conscription, and having parents who had divorced). Nevertheless, the
relationship between cannabis use and schizophrenia remained
statistically significant and still showed a dose response
relationship. The risk of a diagnosis of schizophrenia for those who
had smoked cannabis from one to ten times was 1.5 times that of those
who had never used, and the relative risk for those who had used 10 or
more times was 2.3 times that for those who had never used [95 per
cent confidence interval 1.0, 5.3].

Andreasson et al (1987) carefully scrutinised the validity of their
data on cannabis use and the diagnosis of schizophrenia. They
acknowledged that cannabis use was likely to have been under-reported
because the information was not confidential, but they argued this was
most likely to have under-estimated the relative risk of developing
schizophrenia among users and non-users. Self-reported cannabis use at
age 18 showed a strong dose-response relationship to the risk of
receiving a diagnosis of drug abuse in the subsequent 15 years. Data
from a small validity study indicated that 80 per cent of those
diagnosed as schizophrenic in the case register met the DSM-III
criteria for schizophrenia (which include a minimum duration of six
months).

Andreasson et al (1987) and Allebeck (1991) argued for a causal
interpretation of the association, conjecturing that cannabis use
precipitated schizophrenia in vulnerable individuals. They rejected as
implausible the hypothesis that cannabis consumption was a consequence
of emerging schizophrenia. The cannabis users who developed
schizophrenia had better premorbid personalities, a more abrupt onset,
and more positive symptoms than the non-users who developed
schizophrenia (Andreasson et al, 1989). Although over half of the
heavy cannabis users (58 per cent) had a psychiatric diagnosis at the
time of conscription, there was still a dose-response relationship
between cannabis use and schizophrenia among those conscripts who did
not have such a history. They stressed that cannabis use &quot;only
accounts for a minority of all cases&quot; (p1485) since most of the 274
conscripts who developed schizophrenia had not used cannabis, and only
21 of them were heavy cannabis users. 

No single study ever settles an issue. Even a prospective study as
well designed, and as carefully interpreted as that of Andreasson et
al has been criticised (Johnson, Smith and Taylor, 1988; Negrete,
1989). Among these criticisms are the following, which raise a number
of alternative explanations to the causal one proposed by Andreasson
and his colleagues. 

First, there was a large temporal gap between self-reported cannabis
use at age 18-20 and the development of schizophrenia over the next 15
years or so (Johnson, Smith and Taylor, 1988; Negrete, 1989). Because
the diagnosis was based upon a case register, there was no information
on whether the individuals continued to use cannabis up until the time
that their schizophrenia was diagnosed. Andreasson et al (1987)
anticipated and dealt with this criticism by showing that
self-reported cannabis use at age 18 was strongly related to the risk
of subsequently attracting a diagnosis of drug abuse. This suggests
that cannabis use at age 18 was predictive of continued drug use, and
the more so the more frequently it had been used by age 18. 

A second possibility is that the excess rate of &quot;schizophrenia&quot; among
the heavy cannabis users was due to acute cannabis-induced toxic
psychoses which were mistakenly diagnosed as schizophrenia (Johnson et
al, 1988; Negrete, 1989). Andreasson et al (1989) attempted to address
this criticism by a study of the validity of the schizophrenia
diagnoses in 21 conscripts in the case register (8 of whom had used
cannabis and 13 of whom had not). This study indicated that 80 per
cent of these cases met the DSM-III requirement that the symptoms had
been present for at least six months, to exclude transient psychotic
symptoms. This sample size (21 case) was small, however, and the
confidence interval around a 20 per cent rate of misdiagnosis of
schizophrenia is between 3 per cent and 37 per cent. Even if the rate
of misdiagnosis was only 20 per cent, this could, if it varied between
cannabis and non-cannabis users, be large enough to explain the
relationship they observed.

A third, more serious concern about the causal interpretation of the
relationship between cannabis use and schizophrenia is that the
relationship may be a consequence of the use of other illicit
psychoactive drugs. Longitudinal studies of illicit drug use indicate
that intensity of cannabis use in late adolescence predicts the later
use of other illicit drugs. These drugs include amphetamine and
cocaine (Johnson, 1988; Kandel and Faust, 1975) which can produce an
acute paranoid psychosis (Angrist, 1983; Bell, 1973; Connell, 1959;
Gawin and Ellinwood, 1988; Grinspoon and Hedblom, 1975). There is also
good evidence that amphetamine was the major illicit drug of abuse in
Sweden during the study period (Inghe, 1969; Goldberg, 1968 a, b),
which suggests that intervening amphetamine use may have produced the
correlation between cannabis use and schizophrenia. Andreasson et al's
(1989) study reported that only two of their eight schizophrenic
cannabis users had also been abusers of amphetamines prior to the
diagnosis of their schizophrenia, but with a sample size as small as
this, the true rate (indicated by a 95 per cent confidence interval)
could be anywhere between 0 per cent and 55 per cent.

A fourth concern is that Andreasson et al (1987) have not ruled out
the possibility that cannabis use at age 18 was a symptom of emerging
schizophrenia. Statistical adjustment for a psychiatric diagnosis at
conscription did not eliminate the relationship between cannabis use
and schizophrenia, but it substantially reduced the size of the
relative risk, because over half of the heavy users of cannabis had
received a psychiatric diagnosis by age 18. Andreasson et al argued
that this hypothesis was implausible because the dose response
relationship between cannabis use and the risk of a schizophrenia
diagnosis held up among those who did not have a psychiatric history.
The persuasiveness of this argument depends upon how credible the
screening for psychiatric diagnosis was at the time of conscription,
and in particular, how confident we can be that a failure to identify
a psychiatric disorder at conscription means that no disorder was
present. This is difficult to evaluate.

The fifth and final criticism relates to the validity of self-reported
cannabis use at conscription. Andreasson et al (1987) acknowledged
that there was likely to be under-reporting of cannabis use because
this information was not collected anonymously, but they argued that
this was most likely to lead to an under-estimation of the
relationship between cannabis use and the risk of schizophrenia. This
will only be true, however, if the schizophrenic and
non-schizophrenics conscripts were equally likely to under-report. If,
however, pre-schizophrenic subjects were more candid about their drug
use, the apparent relationship between cannabis use and schizophrenia
would be due to response bias (Negrete, 1989). Although a possibility,
this seems unlikely in view of the strong dose-response relationship
with frequency of cannabis use, and the large size of the unadjusted
relative risk of schizophrenia among heavy users.

When all these criticisms are considered, the Andreasson et al (1987)
study still provides strong evidence of an association between
cannabis use and schizophrenia which is not completely explained by
prior psychiatric history. Uncertainty remains about the causal
significance of the association because it is unclear to what extent
the relationship is a result of drug-induced psychoses being mistaken
for schizophrenia, and to what extent it is attributable to
amphetamine rather than cannabis use.

Even if the relationship is causal, its public health significance
needs to be kept in perspective. Although they did not report
calculations of attributable risk, an estimate based upon the relative
risk adjusted for psychiatric disorder (Feinstein, 1985) indicates
that even if their association is causal, at most 7 per cent of cases
of schizophrenia would be attributable to cannabis use. That is, on
the prevalence rate of cannabis use reported by Andreasson et al,
cannabis use would have explained 7 per cent (at most) of cases of
schizophrenia occurring in Sweden during the period of study. Even
this small potential contribution to an increased incidence of
schizophrenia seems difficult to accept, since there is good
independent evidence that the incidence of schizophrenia, and
particularly of early onset, acute cases, declined during the 1970s,
the period when the prevalence of cannabis use increased among young
adults in Western Europe and North America (Der et al, 1990). 



7.6.4.2 Exacerbation of schizophrenia 

There is reason to be concerned about the effects of cannabis on
psychotic symptoms among individuals with schizophrenia. Cannabis is
psychoactive drug that is probably psychotomimetic in high doses, and
its use seems to be relatively common among schizophrenic patients, as
indicated above. There is also anecdotal clinical evidence that
schizophrenic patients who use cannabis and other drugs experience
exacerbations of symptoms (Weil, 1970), and have a worse clinical
course, with more frequent psychotic episodes, than those who do not
(Knudsen and Vilmar, 1984; Perkins et al, 1986; Turner and Tsuang,
1990). 

However, there have been very few controlled studies of the
relationship between cannabis use and the clinical outcome of
schizophrenia. Negrete et al (1986) conducted a retrospective study
using clinical records of symptoms and treatment seeking among 137
schizophrenic patients with a disorder of at least six months
duration, and three visits to their psychiatric service during the
previous six months. The proportion of cannabis users among their
patients was the same as in the Canadian population, but heavy users
were over-represented, and the proportion of former users who had
stopped using was higher than in the general population. Negrete et al
(1986) compared the prevalence of hallucinations, delusions and
hospitalisations among the active users (N=25), the past users (n=51),
and those who had never used cannabis (N=61). The crude comparison
showed higher rates of continuous hallucinations and delusions, and of
hospitalisations among active users. This pattern of results persisted
after statistical control for differences in age and sex between the
three user groups. 

Negrete et al argued that cannabis use exacerbated schizophrenic
symptoms. They rejected the alternative hypothesis that patients with
a poorer prognosis were more likely to use cannabis, because they
found that past cannabis users experienced fewer symptoms, and
reported a high rate of adverse effects when using (91 per cent). They
also discounted the possibility that these were toxic psychoses,
because in all cases the minimum duration of symptoms had been six
months. They left open the mechanism by which cannabis use exacerbated
schizophrenic symptoms, suggesting three possibilities: that cannabis
disorganises psychological functioning; that it causes a toxic
psychosis that accentuates schizophrenic symptomatology; or that it
interferes with the therapeutic action of anti-psychotic medication.

More recently, Cleghorn et al (1991) have provided supportive
evidence. They compared the symptom profiles of schizophrenic patients
with histories of substance abuse of varying severity (none, moderate,
and severe), among whom cannabis was the most heavily used drug.
Comparisons with a subset of the patients who were maintained on
neuroleptic drugs revealed that the drug abusers had a higher
prevalence of hallucinations, delusions and positive symptoms. 

These studies provide a slender basis upon which to draw conclusions
about the effects of cannabis use on schizophrenic symptoms. One can
only agree with the conclusion of Turner and Tsuang (1990) that &quot;the
impact of substance abuse on the course and outcome of schizophrenia
remains largely undefined&quot; (p93), and that it will remain so until
large prospective studies in general population and clinical samples
recommended by Turner and Tsuang (1990) have been conducted. Until
such research has been undertaken, prudence would demand that
schizophrenic patients, and others at risk of schizophrenia by virtue
of family history, personality, or marginal social functioning, should
be strongly discouraged from using cannabis and other psychoactive
drugs, especially the psychostimulants amphetamine and cocaine.

7.6.5   Conclusions

There is reasonable evidence that heavy cannabis use, and perhaps
acute use in susceptible individuals, can produce an acute psychosis
in which confusion, amnesia, delusions, hallucinations, anxiety,
agitation and hypomanic symptoms predominate. The evidence for a toxic
cannabis psychosis comes from laboratory studies of the effects of THC
on normal volunteers and clinical observations of psychotic symptoms
in heavy cannabis users, which seem to comprise a toxic psychotic
syndrome and which remit rapidly following abstinence from cannabis.
There is also an argument by analogy with the fact that heavy chronic
amphetamine use has been shown to induce a paranoid psychosis
(Angrist, 1983).

There is little support for the hypothesis that cannabis use can cause
a chronic psychosis which persists beyond the period of intoxication.
Such a possibility is difficult to study because of the likely rarity
of such psychoses, and the near impossibility of distinguishing them
from individuals with schizophrenia and manic depressive psychoses who
also abuse cannabis (Negrete, 1983). 

The occurrence of a chronic residual state, or &quot;amotivational
syndrome&quot;, in chronic heavy cannabis users is not well supported by
research evidence. At best, a prima facie case has been made by
clinical observations, that withdrawal, lethargy, and apathy occur
among a minority of chronic, heavy users. This syndrome has proved
difficult to study in the laboratory, difficult to distinguish from
the effects of chronic intoxication (Negrete, 1988), and it so far
been impossible to rule out confounding effects of pre-existing
disease, malnutrition, personality disorder, and lifestyle.

There is strongly suggestive evidence that chronic cannabis use may
precipitate a latent psychosis in vulnerable individuals. This is
still strongly suggestive rather than established beyond reasonable
doubt, because in the best study conducted to date (Andreasson et al,
1987) the use of cannabis was not documented at the time of diagnosis,
there was a possibility that cannabis use was confounded by
amphetamine use, and there remains a question about the ability of the
study to reliably distinguish between schizophrenia and acute cannabis
or other drug-induced psychoses. 

Even if the relationship between cannabis use and schizophrenia is a
causal one, its public health significance should not be overstated.
It is most likely to indicate that cannabis use can precipitate
schizophrenia in vulnerable individuals, since the estimated
attributable risk of cannabis use is small, and the incidence of
schizophrenia has declined during the period in which cannabis use has
increased among young adults. 

The substantial prevalence of cannabis use among young adults in
Western societies makes the relationships between cannabis use and
psychosis deserving of further research. What are required are
case-control studies of people with schizophrenia and normals, and
case-control studies of psychotic individuals who do and do not have a
documented history of recent heavy cannabis use. Mueser et al (1990)
provide detailed suggestions for the types of controls that ought to
be incorporated in such studies. If the results of the case control
studies warrant it, prospective studies should be done. Longitudinal
studies like that undertaken by Andreason et al (1987) would be most
desirable, but can probably only be undertaken in exceptional
circumstances. Turner and Tsuang (1990) provide detailed suggestions
for prospective studies which would clarify the contribution of
cannabis and other drug use to the precipitation and exacerbation of
schizophrenia and other psychoses.  



References

Allebeck, P. (1991) Cannabis and schizophrenia: is there a causal
association? In G.G. Nahas and C. Latour (Eds) Physiopathology of
Illicit Drugs: Cannabis, Cocaine, Opiates Oxford: Pergamon Press.

Allebeck, P., Adamsson, C., Engstrom, A. and Rydberg, U. (1993)
Cannabis and schizophrenia: a longitudinal study of cases treated in
Stockholm county. Acta Psychiatrica Scandinavica, 88, 21-24.

Andreasson, S., Allebeck, P, and Rydberg, U. (1989) Schizophrenia in
users and nonusers of cannabis. Acta Psychiatrica Scandinavica, 79,
505-510.

Andreasson, S., Allebeck, P, Engstrom, A. and Rydberg, U. (1987)
Cannabis and schizophrenia: A longitudinal study of Swedish
conscripts. Lancet, 2, 1483-1486.

Angrist, B. (1983) Psychoses induced by central nervous system
stimulants and related drugs. In I. Creese (ed) Stimulants:
Neurochemical, Behavioral and Clinical Perspectives. New York: Raven
Press.

Anthony, J and Helzer, J.E. (1991) Syndromes of drug abuse and
dependence. In L.N. Robins and D.A. Regier (eds) Psychiatric Disorders
in America. New York: Free Press, MacMillan.

Arndt, S., Tyrrell, G., Flaum, M. and Andreasen, N (1992) Comorbidity
of substance abuse and schizophrenia: the role of premorbid
adjustment. Psychological Medicine, 22, 379-388.

Beaubruhn, M.  and Knight, F. (1973) Psychiatric assessment of 30
chronic users of cannabis and 30 matched controls. American Journal of
Psychiatry, 130, 309-311.

Bell, D. (1973) The experimental reproduction of amphetamine
psychosis. Archives of General Psychiatry, 29, 35-40.

Bernardson, G. and Gunne, L.M. (1972) Forty-six cases of psychosis in
cannabis abusers. International Journal of Addictions, 7, 9-16.

Bland, R.C., Newman, S and Orn, H. (1987) Schizophrenia: lifetime
co-morbidity in a community sample. Acta Psychiatrica Scandinavica,
75, 383-391.

Breakey, W.R., Goodell, H., Lorenz, P and McHugh, P.R. (1974)
Hallucinogenic drugs as precipitants of schizophrenia. Psychological
Medicine, 4, 255-261.

Brill, H. and Nahas, G.G. (1984) Cannabis intoxication and mental
illness. In G.G. Nahas Marihuana in Science and Medicine. New York:
Raven Press.

Carney, M.W.P., Bacelle, L., and Robinson, B. (1984) Psychosis after
cannabis use. British Medical Journal, 288, 1047.

Chaudry, H.R., Moss, H.B., Bashir, A. and Suliman, T. (1991) Cannabis
psychosis following bhang ingestion. British Journal of Addiction, 86,
1075-1081.

Chopra, G.S. and Smith, J.W. (1974) Psychotic reactions following
cannabis use in East Indians. Archives of General Psychiatry, 30,
24-27.

Cleghorn, J.M., Kaplan, R.D., Szechtman, B., Szechtman, H., Brown,
G.M. and Franco, S. (1991) Substance abuse and schizophrenia: effect
on symptoms but not on neurocognitive function. Journal of Clinical
Psychiatry, 52, 26-30.

Cohen, S. and Johnson, K. (1988) Psychosis from alcohol or drug abuse.
British Medical Journal, 297, 1270-1271.

Connell, P.H. (1959) Amphetamine Psychosis. Maudlsey Monograph Number
5, Institute of Psychiatry, London: Oxford University Press. 

Der, G., Gupta, S. and Murray, R.M. (1990) Is schizophrenia
disappearing? Lancet, 1, 513-516.

Dixon, L., Haas, G., Wedien, P.J., Sweeney, J. and Frances, A.J.
(1990) Acute effects of drug abuse in schizophrenic patients: clinical
observations and patients' self-reports. Schizophrenia Bulletin, 16,
69-79.

Dixon, L., Haas, G., Wedien, P.J., Sweeney, J. and Frances, A.J.
(1991) Drug abuse in schizophrenic patients: clinical correlates and
reasons for use. American Journal of Psychiatry, 148, 224-230.

Drummond, L. (1986) Cannabis psychosis: a case report. British Journal
of Addiction, 81, 139-140.

Edwards, G. (1976) Cannabis and the psychiatric position. In J.D.P.
Graham (ed) Cannabis and Health. London: Academic Press.

Edwards, G.(1983)  Psychopathology of a drug experience. British
Journal of Psychiatry, 143, 509-512.

Feinstein, A.R. (1985) Clinical Epidemiology. Philadelphia: W.B.
Saunders.

Gawin, F.H. and Ellinwood, E.H. (1988) Cocaine and other stimulants:
Actions, abuse and treatment. New England Journal of Medicine, 318,
1173-1182.

Georgotas, A. and Zeidenberg, P. (1979) Observations on the effects of
four weeks of heavy marijuana smoking on group interaction and
individual behavior. Comprehensive Psychiatry, 20, 427-432.

Ghodse, A.H.(1986) Cannabis psychosis. British Journal of Addiction,
81, 473-478. 

Goldberg, L. (1968a) Drug abuse in Sweden. Part I. Bulletin On
Narcotics, 20, (1) 1-31. (a)

Goldberg, L. (1968b) Drug abuse in Sweden. Part II. Bulletin On
Narcotics, 20, (2) 9-36. (b)

Grinspoon, L. and Hedblom, P. (1975) The Speed Culture: Amphetamine
Abuse in America. Cambridge, Massachussets: Harvard University Press.

Halikas, J.A., Goodwin, D.W. and Guze, S.B. (1971) Marihuana effects:
a survey of reguabis administered during
pregnancy: First
Association, 217, 692-694.

Hendin, H., Haas, A.P., Singer, P., Eller, M. and Ulman, R. (1987)
Living High: Daily Marijuana Use Among Adults. New York: Human
Sciences Press.

Imade, A.G.T. and Ebie, J (1991) A retrospective study of symptom
patterns of cannabis-induced psychosis. Acta Psychiatrica
Scandinavica, 83, 134-136.

Inghe, G. (1969) The present state of abuse and addiction to stimulant
drugs in Sweden.  (pp 187-214) In F. Sjoqvist and M. Tottie (eds)
Abuse of Central Stimulants. New York: Raven Press.

Johnson, B.A., Smith, B.L. and Taylor, P. (1988) Cannabis and
schizophrenia. Lancet, 1, 592-593.

Johnson, V. (1988) A longitudinal assessment of predominant patterns
of drug use among adolescents and young adults. In G. Chesher, P.
Consroe, and  R. Musty (eds) Marijuana: An International Research
Report. Canberra: Australian Government Publishing Service.

Jones, R.T. (1984) Marijuana: Health and treatment issues. Psychiatric
Clinics of North America, 7, 703-712.

Kandel, D. and Faust, R. (1975) Sequence and stages in patterns of
adolescent drug use. Archives of General Psychiatry, 32, 923-932.

Kolansky, H. and Moore, W.T. (1971) Effects  of marihuana on
adolescents and young adults. Journal of the American Medical
Association, 216, 486-492.

Knudsen, P. and Vilmar, T. (1984) Cannabis and neuroleptic agents in
schizophrenia. Acta Psychiatrica Scandinavica, 69, 162-174.

Mathers, D.C., Ghodse, A.H., Caan, A.W., and Scott, S.A. (1991)
Cannabis use in a large sample of acute psychiatric admissions.
British Journal of Addiction, 86, 779-784.

McGlothin, W.H. and West, L.J. (1968) The marijuana problem: An
overview. American Journal of Psychiatry, 125, 370-378.

Mendelson, J.H., Rossi, M.A., Meyer, R.E. (Eds). (1974). The Use of
Marihuana: A psychological and physiological inquiry. New York: Plenum
Press.

Millman, R.B. and Sbriglio, R. (1986) Patterns of use and
psychopathology in chronic marijuana users. Psychiatric Clinics of
North America, 9, 533-545.

Mueser, K.T., Yarnold, P.R., Levinson, D.F., Singh, H. Bellack, A.S.,
Kee, K., Morrison, R.L. and Yadalam, K.G. (1990) Prevalence of
substance abuse in schizophrenia: demographic and clinical correlates.
Schizophrenia Bulletin, 16, 31-56.

National Academy of Science, Institute of Medicine. (1982) Marijuana
and Health. Washington, DC: National Academy Press.

Negrete, J (1983) Psychiatric aspects of cannabis use. In K.O. Fehr
and H. Kalant (eds) Cannabis and Health Hazards. Toronto: Addiction
Research Foundation.

Negrete, J (1988) What's happened to the cannabis debate? British
Journal of Addiction, 83, 359-372.

Negrete, J (1989) Cannabis and schizophrenia. British Journal of
Addiction, 84, 349-351. 

Negrete, J.C., Knapp, W.P., Douglas, D. and Smith, W.B. (1986)
Cannabis affects the severity of schizophrenic symptoms: results of a
clinical survey. Psychological Medicine, 16, 515-520.

Onyango, R.S. (1986) Cannabis psychosis in young psychiatric
inpatients. British Journal of Addiction, 81, 419-423. 

Perkins, K.A., Simpson, J and Tsuang, M.T. (1986) Ten-year follow-up
of drug abusers with acute or chronic psychosis. Hospital and
Community Psychiatry, 37, 481-484.

Rolfe, M., Tang, C.M., Sabally, S., Todd, J.E., Sam, E.B. and Hatib
N'Jie, A.B. (1993) Psychosis and cannabis abuse in Gambia: A
case-control study. British Journal of Psychiatry, 1993, 163, 798-801.

Rottanburg, D., Robins, A.H., Ben-Arie, O., Teggin, A. and Elk, R.
(1982) Cannabis-associated psychosis with hypomanic features. Lancet,
2, 1364-1366.

Schneier, F.R. and Siris, S.G. (1987) A review of psychoactive
substance use and abuse in schizophrenia: patterns of drug choice.
Journal of Nervous and Mental Disorders, 175, 641-652.

Smith, D.E. (1968) Acute and chronic toxicity of marijuana. Journal of
Psychedelic Drugs, 2, 37-47.

Stefanis, C., Boulougouris, J. and Liakos, A. (1976) Clinical and
psychophysiological effects of cannabis in long-term users. In M
Braude and S. Szara (eds) The Pharmacology of Marihuana. New York:
Raven Press.

Tennant, F.S. and Groesbeck, C.J. (1972) Psychiatric effects of
hashish. Archives of General Psychiatry, 27, 133-136. 

Thacore, V.R. and Shukla, S.R.P. (1976) Cannabis psychosis and
paranoid schizophrenia. Archives of General Psychiatry, 33, 383-386.

Thomas, H. (1993) Psychiatric symptoms in cannabis users. British
Journal of Psychiatry, 163, 141-149.

Thornicroft, G. (1990) Cannabis and psychosis: Is there
epidemiological evidence for association. British Journal of
Psychiatry, 157, 25-33.

Tsuang, M.T., Simpson, J and Kronfol, Z. (1982) Subtypes of drug abuse
with psychosis. Archives of General Psychiatry, 39, 141-147.

Tunving, K. (1985) Psychiatric effects of cannabis use. Acta
Psychiatrica Scandinavica, 73, 209-217.

Turner, W.M. and Tsuang, M.T. (1990) Impact of substance abuse on the
course and outcome of schizophrenia. Schizophrenia Bulletin, 16,
87-372. 

Weil, A. (1970) Adverse reactions to marihuana. New England Journal of
Medicine, 282, 997-1000.

Weller, M.P.I., Ang, P.C., Latimer-Sayer, D.T. and Zachary, A. (1988)
Drug abuse and mental illness. Lancet, 1, 977.


</font>
</pre>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-13</DOCNO>
<DOCOLDNO>IA087-000627-B016-241</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch8.htm 206.61.184.43 19970122051815 text/html 64068
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:18:09 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:01:38 GMT
Content-length: 63850
</DOCHDR>
<html>

<head>
<title>The health and psychological consequences of cannabis use:
chapter 8 </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<h1></h1>
</body>

<body bgcolor="#ffffff">

<p>The health and psychological consequences of cannabis use
chapter 8 </p>

<h3>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
</h3>

<hr>

<pre>
<font size="2">8. The therapeutic effects of cannabinoids



8.1 Historical background

Cannabis has had a long history of medical and therapeutic use in
India and the Middle East (Grinspoon and Bakalar, 1993; Mechoulam,
1986; Nahas, 1984) where it has been variously used as an analgesic,
anti-convulsant, anti-spasmodic, anti-emetic, and hypnotic. Cannabis
was introduced to British medicine in the mid-nineteenth century by
O'Shaugnessy (1842) who had gained clinical experience with the drug
while an Army surgeon in India (Mechoulam, 1986; Nahas, 1984). He
recommended its use for the relief of pain, muscle spasms, and
convulsions occurring in tetanus, rabies, rheumatism and epilepsy
(Nahas, 1984). Partly as the result of his advocacy, cannabis came to
be widely used as an analgesic, anti-convulsant and anti-spasmodic
throughout the middle part of the 19th century in Britain and the USA.


The medical use of cannabis declined around the turn of the present
century. Because the active constituents of cannabis were not isolated
until the second half of the twentieth century, cannabis continued to
be used in the form of natural preparations which varied in purity
and, hence in effectiveness. The use of cannabis was largely
supplanted by other pharmaceutically purer drugs, which could be given
in standardised doses to produce more dependable effects. These
included the opiates, aspirin, chloral hydrate, and the barbiturates
(Mechoulam, 1986; Nahas, 1984). In the early part of the century, the
medical use of such crude cannabis preparations was further
discouraged by laws which treated cannabis as a &quot;narcotic&quot; drug and
severely restricted its availability. It finally disappeared from the
American pharmacopoeia in the early 1940s after the passage of the
Marijuana Tax Act (Grinspoon and Bakalar, 1993), although it continued
to be used in Australia into the 1960s (Casswell, 1992).

THC, the major psychoactive ingredient of cannabis, was not isolated
until 1964 (Goani and Mechoulam, 1964), shortly before cannabis
achieved widespread popularity as a recreational drug among American
youth. Its widespread recreational use, and its symbolic association
with a rejection of traditional social values, undoubtedly hindered
pharmaceutical research into its therapeutic uses. Consequently, the
rediscovery of some of its traditional therapeutic uses was largely
serendipitous, as was the discovery of some newer uses. For example,
its value as an anti-emetic agent in the treatment of nausea caused by
cancer chemotherapy seems to have been rediscovered by young adults
who had used cannabis recreationally prior to undergoing chemotherapy
for leukemia (Grinspoon, 1990). 

From the mid-1970s some clinical research on the therapeutic value of
cannabis and cannabinoids was undertaken. On the whole, however, this
research has been very thin and uneven, and, consequently, many of the
claims for the therapeutic efficacy of cannabinoids rely heavily, and,
in the case of rare medical conditions, solely upon anecdotal
evidence, that is, the testimonies of individuals who claim to have
derived medical benefit from its use (e.g. Grinspoon and Bakalar,
1993; Randall, 1990), and small numbers of cases reported by
physicians (e.g. Consroe et al, 1975; Meinck et al, 1989). 

Evidence will be reviewed for the best-supported therapeutic uses of
cannabinoids. The review begins with the evidence on the effectiveness
of cannabinoids as anti-emetic drugs for nausea caused by cancer
chemotherapy, and as agents to control intra-ocular pressure in
glaucoma. Briefer reviews are provided of the evidence in favour of
other putative therapeutic uses of cannabinoids which are less well
supported by clinical evidence, chief among which are its uses as an
anti-convulsant, an anti-spasmodic, and an analgesic agent. The value
and limitations of the largely anecdotal evidence of efficacy in these
latter conditions will also be briefly considered. The review will
include a discussion of the controversy in the United States about
&quot;marijuana rescheduling&quot; which has coloured much recent discussion of
the issue. This controversy concerns the vexatious issue of whether
smoked cannabis should be available for medical use in addition to
synthetic cannabinoids such as THC. 



8.2 Cannabinoids as anti-emetic agents

Profound nausea and vomiting can be such serious complications of
chemotherapy and radiotherapy for cancer that patients may discontinue
potentially life-saving treatment (Institute of Medicine, 1982).
Although various types of drugs (e.g. the phenothiazines) have been
shown to be effective in controlling nausea and vomiting in cancer
patients, substantial minorities of patients do not benefit from these
drugs. The seriousness of the problem of chemotherapy-induced nausea,
and the incomplete success of existing treatments, prompted
oncologists in the late 1970s and early 1980s to take a particular
interest in the anti-emetic properties of cannabinoids (Institute of
Medicine, 1982). 



8.2.1 Clinical trials

One of the earliest trials of the effectiveness of THC as an
anti-emetic was prompted by patient reports that smoking marijuana
relieved nausea and vomiting (Sallan et al, 1975). In this study, 22
patients (10 males and 12 females, average age 30 years) with a
variety of neoplasms were studied. In 20 patients, the nausea and
vomiting had proven resistant to existing anti-emetic drugs. A
randomised placebo-controlled trial with crossover was used, in which
patients were randomly assigned to receive oral THC (10mg per m2) and
placebo in one of four different orders (THC-placebo-THC; THC-
placebo-placebo; placebo-THC-placebo; placebo-THC-THC). Outcome was
assessed by grading patients' self-reports of nausea and vomiting
after THC and placebo into three categories: complete response if
there was vomiting after placebo but not after THC; partial response
if there was a greater than 50 per cent reduction in nausea and
vomiting after THC compared to placebo; and no response if there was a
less than 50 per cent reduction in nausea and vomiting.

Ten patients completed all three courses of THC and placebo and
vomited on at least one trial. After excluding one trial because of a
variation in the chemotherapy dose, there were 29 trails available for
analysis, 14 of placebo and 15 of THC. All 14 placebo trials resulted
in no response, while in the 15 THC trials there were five complete
responses, seven partial responses, and three no responses. This
difference was statistically significant when full and partial
responses were combined. Most patients (13/16) reported a &quot;high&quot; after
receiving THC, an experience which was correlated with the anti-emetic
effect. The most common side-effect was somnolence which curtailed
activities for two to six hours in a third of patients. Only two
patients experienced any symptoms of toxicity, (both after receiving
20mg doses of THC), namely, visual distortions and hallucinations and
depression lasting several hours. Sallan et al reported &quot;preliminary&quot;
observations from several patients that smoking marijuana produced an
equivalent anti-emetic effect to oral THC.

A trial by Chang et al (1979) largely supported the findings of Sallan
et al. In this study 15 patients with osteogenic sarcoma (10 males and
five females, average age 24 years) served as their own controls in
the course of monthly high dose methotrexate therapy. They were
assigned to receive three THC and three placebo trials in randomised
order during six treatment sessions. THC (10mg per m2 of body area)
and placebo were administered orally five times at three hourly
intervals, beginning two hours before chemotherapy. If the patients
vomited, the remaining doses of either THC or placebo were
administered by smoking a cigarette using a standardised smoking
technique. The effect of THC and placebo were assessed by nursing
staff who rated various endpoints (e.g. number of vomiting and
retching episodes, volume of emesis, degree and duration of nausea)
without being aware of which treatment patients had received. Patient
response was graded into three categories: excellent (greater then 80
per cent reduction after THC by comparison with placebo in each of
these endpoints); fair (greater than 30 per cent and less than 80 per
cent reduction), and no response (less than 30 per cent reduction).

The results showed that eight patients had an excellent response, six
a fair response, and one had no response. On all endpoints THC
produced a statistically significant reduction in nausea and vomiting
by comparison with placebo. There was also a dose-response
relationship between blood levels of THC and the incidence of nausea
and patient reports of feeling &quot;high&quot;. Generally, higher THC blood
levels were achieved when marijuana was smoked than when THC was taken
orally. There were few side effects reported, with sedation being the
most common (12/15 patients). Four patients experienced five dysphoric
reactions in the course of 281 THC drug doses (2 per cent), none of
which lasted more than 30 minutes, and all of which were successfully
managed with simple reassurance.

In a second phase of the study, four patients who had an excellent
response to THC in the first phase were retested under double-blind
conditions using two placebo trials in the next 10 treatments. A small
number of patients who had a fair response were also studied using an
increased dose of THC. All patients showed a reduction in the average
anti-emetic benefit of THC, decreasing from excellent to fair in the
case of previous excellent responders, and from fair to no response in
the case of the fair responders. Chang et al hypothesised that the
decline in effect reflected either the development of tolerance to the
effects of THC, or the development of conditioned nausea and vomiting
that was resistant to the anti-emetic effects of THC. 

Since these early studies, a large number of controlled clinical
studies have been conducted which compared the effectiveness of THC
with either a placebo or with other anti-emetic drugs (see Carey et
al, 1983; Poster et al, 1981; Levitt, 1986 for reviews). The results
of this literature have sometimes been unfairly described as
&quot;confused&quot; (e.g. Carey et al, 1983; Nahas, 1984). This description
betrays an unreasonably high expectation of the consistency of results
from studies which have generally used small samples of heterogenous
patients who have received various forms of chemotherapy. It also
ignores the fact that the cross-over studies comparing the anti-emetic
effects of THC with placebo have generally reported greater
anti-emetic effects for THC than placebo (Poster et al, 1981); the
single exception to this finding was a study which had a sample size
of only eight patients. 

Comparisons of the effectiveness of oral THC with that of existing
anti-emetic agents have been less consistent than the results of
comparisons with placebo. Nonetheless, the results have generally
indicated that THC is at least equivalent in effectiveness to the
widely used anti-emetic drug prochlorperazine (Carey et al, 1983;
Levitt, 1986). The inconsistencies in this case arise because some
studies have shown THC to be superior, probably because of the
practice in some trials of enlisting patients whose nausea had
previously proven resistant to prochlorperazine (Carey et al, 1983). 

The equivalence of THC and prochlorperazine has been supported by the
results of one of the largest and best conducted studies (Ungerleider
et al, 1982). In this study 214 patients with a variety of forms of
cancer (carcinomas, sarcomas, lymphomas and leukemias) were recruited
if they had already undergone chemotherapy and experienced nausea and
vomiting, or they were to receive a form of chemotherapy which had a
high emetic potential. Patients were randomly assigned to receive a
paired trial of either oral THC followed by prochlorperazine or vice
versa. The dose of THC was dependent on body surface area (7.5mg if
less than 1.4m2, 10mg for 1.4 to 1.8m2, and 12.5mg for greater than
1.8m2). Separate analyses were conducted on three groups of patients:
patients who received their cancer chemotherapy on a single day some
weeks apart (N=98); patients who received their chemotherapy on a
daily basis over several successive days (N=41); and patients who
discontinued the trial after a single episode of either THC or
prochlorperazine. Outcomes were patient self-ratings of nausea and
vomiting, and a variety of mood states and behaviours.

The results showed that there &quot;were no statistically significant
differences in the anti-nausea/anti-emetic effect of THC and
prochlorperazine&quot; (p640) in any of the three patient groups, even
though there were differences between patients in the single- and
multiple-day chemotherapy regimens in the time course of the nausea.
There were differences in mood and behaviour between the THC and
prochlorperazine trials, with patients reporting greater impairment of
concentration and less social interaction after receiving THC. There
were also more side effects from THC than prochlorperazine, with
sedation, sleepiness and mental clouding being the most common. There
was no difference in the frequency of panic attacks between the two
drugs. Despite these differences in side effects there was a small
patient preference in favour of THC as an anti-emetic, with 41 per
cent experiencing less nausea on THC, 31 per cent experiencing less
nausea on prochlorperazine, and 29 per cent reporting no difference in
effectiveness. The effectiveness of THC was not related to age or
prior experience with marijuana, but it was related to the experience
of side effects, with patients experiencing them reporting less
nausea.

Given the wide variety of patients who have been studied in terms of
age and type of cancer, the wide variety of chemotherapeutic agents
that have been used to treat their cancers, and the variety of
different anti-emetics with which THC has been compared, the fact that
findings of these studies are generally positive for THC is more
impressive than the apparent differences in outcome. The positive
results from the controlled trials also seem to be borne out by
clinical experience with cannabinoids in managing cancer patients. A
recent survey of a large sample of American oncologists, for example,
found that 44 per cent of oncologists had recommended marijuana to at
least one cancer patient, and 64 per cent of these physicians reported
that it was successful controlling nausea in at least half of their
patients. Overall, just under half of the oncologists in the sample
(44 per cent) believed that cannabinoids could be safely used in the
treatment of nausea caused by chemotherapy and radiotherapy (Dobin and
Kleiman, 1991). A similar proportion (48 per cent) reported that they
would prescribe marijuana for their patients if it was legal.

The general conclusion on the available literature is that THC is
superior to placebo, and equivalent in effectiveness to other
widely-used anti-emetic drugs, in its capacity to reduce the nausea
and vomiting caused by some chemotherapy regimens in some cancer
patients. There are a number of issues that remain to be resolved in
deciding upon the clinical role of cannabinoids as anti-emetic agents
in cancer chemotherapy. These issues include: the types of nausea
against which it may be most effective, and hence the types of
patients for which they are most appropriately prescribed; the degree
of patient tolerance of the psychotropic side effects of THC and other
cannabinoids; the potential seriousness of possible THC induced
immunosuppression in patients who are already immunologically
compromised; the most effective dosing schedules for THC as an
anti-emetic; the potential use of THC in combination with other
anti-emetic drugs; and the extent to which the motivation for the use
of THC may have been reduced by the availability of newer anti-emetic
drugs that are more effective than prochlorperazine (the main
anti-emetic drug in the 1980s). 



8.2.2 Which patients?

Which patients with what types of nausea are the most suitable for
treatment with cannabinoids as anti-emetics? Patients with various
forms of cancer have been the most extensively investigated patient
group, but the numbers of different types of cancer have been too
small to allow convincing analyses of differences in patient response.
The same point can be made about types of chemotherapy regimens; they
have varied widely in these studies, and have often not been reported,
but there has been no systematic analysis of the effectiveness of
cannabinoids in controlling emesis produced by different agents. It is
uncertain to what extent the cannabinoids may be effective against
nausea from other causes. The mechanisms that produce nausea are not
well understood but there are believed to be one or more protective
mechanisms located in the brain stem that can be triggered by a
variety of emetic agents. This raises the possibility that
cannabinoids may be therapeutically useful against nausea from a
variety of causes. 

8.2.3   Side effects

The psychoactive effects of cannabis which are prized by recreational
users - euphoria, relaxation, drowsiness - are not always welcomed by
older patients, most of whom are cannabis-naive. In some studies a
substantial minority of such patients have discontinued the use of THC
because of the unwelcome dysphoria and somnolence (Levitt et al,
1986). This has not been a universal experience, so further research
is required to discover to what extent this has been the result of
unnecessarily large doses, or poor patient preparation for these
effects, and failure to adequately manage them by reassurance. What
does seem to be the case is that the experience of some psychological
effects of THC, including the &quot;high&quot;, is necessary for the occurrence
of a clinically significant anti-emetic effect. This fact has led to
the search, so far unsuccessful, for cannabinoid derivatives of THC
which possess its anti-emetic properties but not its psychoactive
ones. The recent discovery of the cannabinoid ligand and receptor, and
receptor subtypes (see pp7-8) has encouraged researchers to believe
that this may be an achievable goal (Iversen, 1993).

A potentially more serious side effect of therapeutic THC is its
possible immunosuppressive effect. Any such effect would limit its use
as an anti-emetic in the treatment of cancer, since cancer patients
experience immune suppression as a side effect of their treatment.
There are several reasons why this may be less serious an issue that
it seems at first glance. First, there are doubts about the existence
of any immunosuppressive effect of cannabinoids (see Section 6.2 on
the immune system, pp62-68), and the effect is small in those studies
which report one. Second, the clinical significance of any such
effects is doubtful in the use of THC in cancer chemotherapy. Such use
would be intermittent, and relatively short-term, and the possible
gain in increased life expectancy from being able to complete a course
of cancer chemotherapy is such that most patients would be prepared to
take the risk, in the same way that they chose to undergo the highly
toxic chemotherapy in the first place. 

8.2.4   Unresolved clinical issues

If THC has a place in the management of nausea from cancer treatment
(Poster et al, 1981), and perhaps other causes, a number of clinical
issues remain to be resolved (Levitt, 1986). Foremost among these is
the best way in which to administer the drug. Should it be given well
in advance of treatment at low doses to ensure a stable blood level,
or should it be given in larger doses shortly before chemotherapy or
radiotherapy? This issue has not been systematically studied (Levitt,
1986).

An additional question is whether there is any clinical benefit to be
derived from combining THC with existing anti-emetic agents. There is
suggestive evidence that there might be, since the mechanisms of
action, while not well understood, appear to be different, raising the
possibility that there may be positive synergistic effects from the
combination of THC and other anti-emetics. One single-blind study of
the combination of dronabinol and prochlorperazine, for example,
suggested that the combination of these drugs may have a superior
anti-nausea effect to either drug used alone (Plasse et al, 1991).
Clearly, more research is warranted on this issue, especially as it
may enable cannabinoids to be used as anti-emetics at lower doses with
fewer unwanted psychotropic effects. 

It seems surprising that the desirability of undertaking research on
dosing and combined use of cannabinoids was highlighted by Poster et
al in 1981 and by the Institute of Medicine in 1982. Yet very little
research has been done, and THC has not been routinely incorporated
into the management of nausea caused by cancer chemotherapy. One of
the likely reasons has been the American controversy about the
rescheduling of marijuana under the Controlled Substances Act, which
some argue has discouraged clinical research on cannabinoids (see
below). Another reason has been that the motivation for further
research on the anti-emetic properties of THC has been removed by the
recent development of newer anti-emetic drugs which are superior to
prochlorperazine (Iversen, 1993), the &quot;gold standard&quot; drug when the
major controlled trials were conducted on cannabis in the 1970s and
1980s. In the absence of trials comparing THC with these newer drugs,
its comparative efficacy is unknown, although given its approximate
equivalence to prochlorperazine it is likely to be inferior to the
newer drugs.



8.3 Cannabinoids as anti-glaucoma agents

Glaucoma is the leading cause of blindness in the United States,
affecting two million people and producing 300,000 new cases each year
(Adler and Geller, 1986). It is a condition &quot;which is generally
characterised by an increase in intraocular pressure ... that
progressively impairs vision and may lead to absolute blindness&quot;
(Adler and Geller, 1986, p54). Although its causes are not understood,
it is believed to involve an obstruction to the outflow of the aqueous
humour in the eye leading to a gradual increase in intraocular
pressure (IOP) which, if untreated, may damage the optic nerve,
resulting in blindness. Its incidence increases over the age of 35,
especially among individuals who are myopic (i.e. short-sighted).
Although various drugs are available which reduce IOP, all possess
unwanted side-effects and patients may become tolerant to their
therapeutic effects. 

The effects of cannabis in reducing IOP were discovered
serendipitously by researchers and patients in the early and middle
1970s. Hepler and his colleagues (1971, 1976) observed a substantial
decrease in IOP while researching the effects of cannabis intoxication
on pupil dilation. They demonstrated that both cannabis and oral THC
produced substantial reductions in IOP in both normal volunteers and
patients with glaucoma (Hepler and Petrus, 1976; Hepler et al, 1976).
Subsequent research identified THC as the agent responsible for
producing this effect (Adler and Geller, 1986). 

Around the same time, patients with glaucoma who had used cannabis
recreationally also discovered its therapeutic effects. One such
patient, Robert Randall, used cannabis daily to control his glaucoma.
When arrested for possession and cultivation of cannabis, he
successfully used the defence of &quot;medical necessity&quot; arguing, with the
support of his physicians, that he would go blind if he stopped his
cannabis use. He subsequently was given legal access to cannabis for
medical purposes (Randall Affidavit, in Randall, 1988). 

Although there have been a number of case reports of the successful
use of cannabis in the management of glaucoma (e.g. Grinspoon and
Bakalar, 1993; Randall, 1990), there have not been any controlled
clinical studies of its effectiveness and safety in the long-term
management of glaucoma. Informed clinical opinion has been that THC is
an effective anti-glaucoma agent when used acutely, but there are
doubts about its effectiveness with chronic use because of the
development of tolerance to its effects on IOP (Jones et al, 1981).
Ophthalmologists who are opposed to the clinical use of THC point to a
number of major disadvantages. First, because THC is not
water-soluble, it cannot, unlike other anti-glaucoma agents, be
applied topically to the eye to ensure that enough is absorbed to
produce a clinically significant reduction in IOP. Second, as a
consequence, THC must be absorbed systemically in order to produce a
therapeutic effect on IOP, which means that patients must experience
the psychoactive effects of THC in order to derive its therapeutic
benefits against glaucoma. Third, because glaucoma is a chronic
condition, THC or cannabis would need to be taken in substantial doses
on a daily basis over long periods of time, if not for the remainder
of adult life. There has been an understandable concern about the
health risks of chronic daily cannabis use (e.g. Hepler, 1990;
American Academy of Ophthalmology, 1990). 

The position adopted by the American Academy of Ophthalmology has been
to insist that cannabis has no accepted medical use in the management
of glaucoma, and cannot have such medical use until a large controlled
trial has been conducted into its safety and effectiveness in daily
chronic use. There has been no evidence that the Academy has any
interest in, or has given any encouragement to, the conduct of such a
trial. Consequently, its position is that THC and other cannabinoids
should not be used be in the management of glaucoma. 

A contrary position has been taken by Randall, who has argued that
patients should be allowed to make the choice between the uncertain
health risks of chronic cannabis use and the more certain risks to
sight of poorly controlled glaucoma:

        &quot;People with life- and sense-threatening diseases are routinely
confronted by stark choices ... [between] the devastating consequences
of a debilitating, progressive disease ... [and] often highly damaging
biological and mental consequences of the toxic chemicals required to
check the progression of disease. .. Viewed in this medical context,
marihuana is more benign and far less damaging that the synthetic
toxins routinely prescribed by physicians&quot; (cited in Grinspoon and
Bakalar, 1993, p153)



8.4 Cannabinoids and neurological disorders



8.4.1 Anti-convulsant

Historically one of the commonest medical uses of cannabis
preparations has been as an anti-convulsant. O'Shaughnessy (1842), for
example, recommended the use of cannabis to control seizures in
epilepsy, tetanus and rabies (Nahas, 1984). Animal studies have
provided some support for this use in showing that THC has dual
effects on convulsions, i.e. they can produce convulsions in
susceptible animals, and suppress the maximum severity of convulsions
from a variety of causes, while cannabidiol (CBD) appears to be a
potent anti-convulsant (Chesher and Jackson, 1974; Consroe and Snider,
1986; Institute of Medicine, 1982).

Despite this animal evidence, there is very limited evidence on the
therapeutic effects of cannabinoids in humans with epilepsy. There are
a small number of case studies of individuals with epilepsy in which
the recreational use of cannabis appeared to enhance the
anti-convulsant effects of more traditional anti-convulsant medication
(e.g. Consroe et al, 1975; Grinspoon and Bakalar, 1993). There is a
single randomised placebo controlled study of the administration of
CBD in 15 patients with epilepsy that was not well controlled by
conventional anti-convulsants. Four of the eight patients who received
CBD in addition to their usual anti-convulsant drugs were free of
seizures throughout the study period, and three were improved. By
contrast, only one out of seven patients in the placebo condition
showed any clinical improvement (Cunha et al, 1980). Despite this
suggestive evidence of efficacy in epilepsy, CBD has not been widely
used in clinical management. Perhaps this is not surprising given the
absence of evidence of its efficacy, the existence of other effective
anti-convulsant drugs, and concerns about the safety of chronic use in
the management of a chronic disease. It is perhaps more surprising
that there has been no further research on the anti-convulsant
properties of CBD, especially as it has no psychoactive side effects
(Nahas, 1984).



8.4.2 Anti-spasmodic

Cannabinoids have been used in an empirical way in the management of
some patients with movement disorders, a variety of syndromes that
have in common a deficit in non-pyramidal motor control function,
which is expressed in usually one or more of the non-epileptic,
abnormal involuntary movements, such as those found in Parkinson's
disease, Huntington's disease, multiple sclerosis, and spasticity.
Although a number of drugs may be of benefit in the management of
these conditions, they are not always effective, and may produce
troublesome side-effects (Consroe and Snider, 1986). 

There has been some animal evidence which indicates that THC and its
analogues produce a broad spectrum of neurological effects, which
include alterations in motor function, and changes in muscle tone and
reflexes. The acute motor effects in normal humans - ataxia,
tremulousness and subjective weakness - also suggest a potential for
therapeutic effects in some movement disorders (Consroe and Snider,
1986). 

The evidence that cannabinoids have therapeutic effects in patients
with movement disorders is largely anecdotal. Grinspoon and Bakalar
(1993), for example, present four case histories of individuals with
multiple sclerosis whose condition improved while they smoked
marijuana, and deteriorated after they stopped smoking. Meinck et al
(1989) report a case history of a young man with multiple sclerosis
with severe limb and gait ataxia who complained of erectile impotence.
After smoking marijuana his gait improved sufficiently to be able to
walk unaided, and he was able to achieve and sustain an erection. When
cannabis was withdrawn under medical supervision, the patient's motor
function deteriorated to the point where he was unable to walk without
assistance. 

There has been one controlled study by Clifford (1983) who examined
the effects of THC on tremor in eight patients (four male and four
female) with advanced multiple sclerosis who had ataxia and tremor.
Five patients reported subjective benefit from THC and there was
objective evidence of benefit in two of these cases. Single-blind
placebo challenge in these cases produced evidence that their clinical
condition deteriorated when given placebo and improved with the
reinstatement of THC. 

Grinspoon and Bakalar (1993) described several case histories of
individuals with paraplegia and quadriplegia who reported that
cannabis use helped to reduce muscle spasm. The experiences of these
individuals were supported by similar reports obtained from a survey
of 43 individuals with spinal cord injuries, 22 of whom reported that
they used cannabis to control their muscle spasm. 

The only controlled trial of a cannabinoid in a movement disorder has
been an evaluation of the effects of CBD on severity of chorea in
patients with advanced Huntington's disease (Consroe et al, 1991).
This study was prompted by the authors' observation that CBD had
improved the condition of an individual with Huntington's disease
(Sandyck et al, 1988). In this study 19 Huntington's patients were
enrolled in a double-blind controlled trial in which they received six
weeks administration of CBD or placebo in a cross-over design. The
outcome was the severity of chorea, as assessed by blind clinical
ratings, patient self-report, and a variety of measures of motor
function. Although the study had sufficient statistical power to
detect a relatively small clinical benefit, there was no evidence of
improvement in chorea on any of the clinical, self-report or motor
measures. In the light of Consroe et al's failure to replicate the
earlier favourable single case, further controlled trials are
warranted before any of the cannabinoids can be routinely used in
treating movement disorders. 



8.5 Cannabinoids as anti-asthmatic agents 

Smoked cannabis, and to a lesser extent oral THC, have an acute
bronchodilatory effect in both normal persons and persons with asthma
(Tashkin et al, 1975; Tashkin et al, 1976). Tashkin et al (1975), for
example, compared the bronchodilator effect of smoked cannabis with
that of a standard clinical dose of the bronchodilator isoproterenol
in relieving experimentally induced asthma in asthmatic patients. They
found that smoking a 2 per cent-THC cannabis cigarette produced a
bronchodilator nearly equivalent to that of a clinical dose of
isoproterenol. 

Despite this early suggestion of a therapeutic effect in asthma,
cannabinoids have not been used therapeutically, nor have they been
extensively investigated as anti-asthmatic agents other than by
Tashkin and his colleagues (Tashkin, 1993). A major obstacle to
therapeutic use has been the route of administration. Oral THC
produces a smaller bronchodilator effect after a substantial delay,
and when used as an inhalant produces irritation and reflex
bronchoconstriction. Hence, smoking marijuana has been the most
dependable way of delivering a clinically effective dose of THC. There
is an understandable concern among clinical researchers that smoking
is an unsuitable mode of administering any drug, and an especially
inappropriate way to administer a drug to patients with asthma,
because it would inevitably involve the delivery of other noxious
chemicals that would nullify its therapeutic value in the short term,
and carry an increased risk of other respiratory disease and possibly
cancer in the long term (Tashkin, 1993). The unwanted psychotropic
effects from marijuana smoking have also been a barrier to its use as
an anti-asthmatic drug. Some investigators (e.g. Graham, 1986) have
nonetheless argued that the suitability of THC as a spray should be
further investigated because of the possible hazards of the chronic
use of the more widely-used beta-blocker antagonists. The recent
discovery of the cannabinoid receptor and ligand may prompt a
re-examination of this question. 



8.6 Cannabinoids as analgesics

There is some animal evidence that THC has an analgesic effect which
operates via a different mechanism from that of the opioid drugs
(Segal, 1986). There is a small amount of human experimental studies
which have reported mixed evidence of an analgesic effect (Nahas,
1984). There has been little clinical evidence beyond historical use
for various forms of chronic pain, including migraine, dysmenorrhoea,
and neuralgia, and the small number of case histories of its use in
chronic pain, dysmenorrhoea, labour pain, and migraine reported by
Grinspoon and Bakalar (1993).

Only one double-blind controlled cross-over study has been reported.
This study compared the analgesic effect of THC and codeine in
patients with cancer pain (Noyes et al, 1975). The findings suggested
that 20mg of THC was of equivalent analgesic effect to 120mg of
codeine. However, neither drug produced substantial analgesia in these
patients, and the majority of patients found the psychotropic effects
of 20mg of THC sufficiently aversive that they discontinued its use.
Clearly, much more basic pharmacological and animal investigation is
required before cannabinoids or their derivatives have any clinical
use as analgesics. Nevertheless, such investigations may be worth
pursuing because of the dependence potential of the more potent opioid
analgesics, and the likelihood that any cannabinoid mediated analgesic
effect operates by a different mechanism to that of the opioids.



8.7 Other possible therapeutic uses 

A variety of other therapeutic uses have been suggested, although few
have been investigated in any depth. In the late 1940s, for example,
there were some investigations of the therapeutic uses of the
euphoriant properties of cannabis, as a possible anti-depressant agent
in the form of synhexil, a synthetic cannabis analogue. The results in
one uncontrolled study were positive, but these were not replicated in
later studies using lower doses (Nahas, 1984; Grinspoon and Bakalar,
1993). None of these suggestions have been further investigated,
probably because of the potential for THC to produce dysphoric and
other unwanted psychotropic side effects.



8.8 Cannabis and AIDS

One of the areas of greatest contemporary interest in the therapeutic
uses of cannabinoids and cannabis has been their possible roles as an
anti-nausea agent, an appetite stimulant and an analgesic in patients
with AIDS (Randall, 1989). The development of this interest seems to
have replicated the earlier discovery of the anti-emetic effects of
cannabis in young cancer patients in the 1970s. AIDS patients often
experience nausea and weight loss, either while receiving cytotoxic
drugs to suppress HIV, or as a direct effect of the AIDS spectrum
diseases. Many patients have been recreational cannabis users, and so
have reported that the smoking of marijuana produces a diminution in
their nausea, an increased appetite, reduced pain, and general
improvements in well being. AIDS advocacy groups have accordingly
argued that marijuana should be made legally available to AIDS
patients (e.g. Randall, 1991).

So far the bulk of evidence for these therapeutic claims has been
provided by case reports (see Randall, 1989). There has been one small
uncontrolled study of 10 symptomatic AIDS patients which suggested
that dronabinol (synthetic THC) may be effective in reducing nausea
and stimulating appetite (Plasse et al, 1991). The evidence of its
anti-emetic properties in cancer patients seems to support its
potential application in AIDS treatment, and is deserving of further
investigation.

A potential concern with the use of cannabinoids in HIV positive
individuals and AIDS patients is the possible immunosuppressive
effects of cannabinoids. Although, as argued above, this effect is
likely to be small and of limited concern when used intermittently in
cancer patients, it is of potentially greater significance in AIDS
patients, since cannabis would be used regularly by patients with a
major immune system disorder. Even a small impairment in immunity may
have major consequences for HIV and AIDS affected individuals. Recent
epidemiological evidence does something to allay this concern. A large
prospective cohort study of HIV/AIDS in homosexual and bisexual men
recently failed to find any relationship between cannabis use, or any
other psychoactive drug use, and the rate at which HIV positive men
developed clinical AIDS (Kaslow et al, 1989). Nonetheless, the issue
of immunosuppression needs to be explicitly investigated in any
research which is undertaken into the therapeutic uses of cannabinoids
in the treatment of AIDS. 



8.9 The limitations of anecdotal evidence

Much of the case for the therapeutic uses of cannabinoids as other
than anti-emetic agents depends upon anecdotal evidence from case
histories. Such evidence has justifiably come to be distrusted as
evidence of therapeutic effectiveness in clinical medicine, especially
in the case of chronic conditions which have a fluctuating course of
remission and exacerbation. In such diseases, it is difficult to
exclude alternative explanations of any apparent relationship between
the use of a drug (e.g. THC) and an improvement in a patient's
condition. Among the alternative explanations that are most difficult
to exclude in a single case or even a succession of single cases is
simple coincidence: that is, there may be no relationship between the
use of the drug and improvement; the apparent relationship between the
two may have arisen because the use of the drug preceded an
improvement in the patient's condition that would have occurred in its
absence. This is especially likely to occur in a chronic condition
with a fluctuating course. In addition, the well-known placebo effect
which is observed in many conditions may explain the apparent benefits
of a drug or other treatment. It is for these reasons that this review
has relied upon evidence from controlled clinical trials in appraising
the therapeutic uses of cannabinoids. 

Grinspoon and Bakalar (1993) have attempted to defend anecdotal
evidence of therapeutic efficacy of cannabinoids. They argue that a
double standard has been used in the appraisal of the safety and
efficacy of cannabinoids: anecdotal evidence of harm has been readily
accepted while anecdotal evidence of benefit has been discounted.
Although at first glance &quot;double standards&quot; may seem to describe the
behaviour of the regulatory authorities, it is defensible to use
different standards of proof when evaluating the benefits and the
costs of therapeutic drugs. It is reasonable to err on the side of
caution by requiring stronger evidence of benefit from putatively
therapeutic drugs in order to ensure that the possible risks incurred
by their therapeutic use do not outweigh their benefits. Moreover,
this behaviour is not peculiar to the therapeutic appraisal of
cannabinoids; it is standard practice in the therapeutic appraisal of
all drugs. Medical practitioners are encouraged to report cases
histories of possible adverse effects of prescribed drugs. Such
reports are treated as a noisy but necessary way of detecting rare but
serious side effects of drugs that have not been detected in clinical
trials or animal studies. 



8.10 The politics of therapeutic cannabinoid use

A puzzle in the field of cannabinoid therapeutics is that despite the
positive appraisal of the therapeutic potential of cannabinoids as
anti-emetics and anti-glaucoma agents, they have not been widely used.
Nor has the detailed type of clinical pharmacological research been
undertaken on optimal methods of clinical use in those areas where the
cannabinoids do have therapeutic potential (e.g. as anti-emetics).
Part of the reason for this is that research on the therapeutic use of
these compounds has become a casualty of the debate in the United
States about the legal status of cannabis. This emerges from an
inspection of the arguments recently advanced for and against an
application to the United States Drug Enforcement Agency to change the
status of marijuana under the Controlled Substances Act, 1970 from a
schedule I drug which has no accepted medical use to a schedule II
drug which has an accepted medical use (see Randall, 1988, 1989,
1990).

The proponents of rescheduling (National Organisation for the Reform
of Marijuana Laws, Alliance for Cannabis Therapeutics, and Cannabis
Corporation of America) have argued that marijuana should be available
for medical use, as smoking is the most effective mode of delivering
THC for some therapeutic purposes. The opponents of rescheduling (Drug
Enforcement Agency, International Chiefs of Police, The National
Federation of Parents for a Drug Free Youth) have countered that
marijuana has no therapeutic use, since its few uses are better met,
either by other more effective drugs which do not have the
psychoactive effects of THC, or by the oral delivery of synthetic
cannabinoids. They have been supported by medical researchers and
practitioners who argue for the therapeutic superiority of
pharmaceutically pure drugs which can be given in defined doses (e.g.
Levitt, 1986; Mechoulam, 1988; Nahas, 1984). 

Medical researchers who have supported the rescheduling of marijuana
(e.g. Grinspoon and Bakalar, 1993; Merritt, 1988; Mikuriya, 1990;
Morgan, 1990; Weil, 1988) have argued that smoked cannabis is superior
to oral synthetic cannabinoids in effectiveness and has a lower risk
of producing unwanted psychoactive side-effects. Apart from the
unsuitability of oral medication for patients who are vomiting, their
main arguments in favour of smoking as a route of THC administration
are similar to the reasons recreational users often give for
preferring smoking to the oral use of cannabis. The greater
bioavailability of THC via smoking produces a more dependable
therapeutic effect, which is more easily controlled because users have
a greater ability to titrate their dose, and hence, to maximise the
desired effects while minimising the unpleasant effects. An additional
argument sometimes used is that there may be other cannabinoids
present in the crude plant product which modulate the undesired side
effects, including the unpleasant dysphoric effects of THC (Grinspoon
and Bakalar, 1993). There is also suggestive evidence that smoked
cannabis is as effective as oral THC, and may be preferred by patients
because of the greater control they have over dose (Chang et al,
1979). 

Opponents of marijuana rescheduling argue that the undesirable
psychoactive side effects of THC disqualify it from widespread medical
use, whatever the route of administration. Most also believe that
smoking is a medically unacceptable route of administration of THC
because it is unsuitable for very young and very old patients, there
is a risk of infection with micro-organisms which may contaminate the
plant material, and there is the danger that chronic smoke inhalation
may produce or exacerbate bronchitis, and expose the user to
carcinogens (e.g. Levitt, 1986; Mechoulam, 1988; Nahas, 1984). 

The proponents of rescheduling respond that none of these are
compelling reasons for rejecting smoked marijuana for therapeutic
purposes until more potent and specific therapeutic cannabinoids have
been identified and synthesised. Smoking, they point out, would not be
a compulsory method of administration; only an option for those
patients who preferred it, as would the use of cannabinoids if
patients did not like their psychoactive effects. The contamination of
micro-organisms reported with blackmarket cannabis can be overcome,
they argue, by standardising dose and using an anti-microbial
treatment, as has been done by National Institute on Drug Abuse (NIDA)
in preparing cannabis cigarettes for research (Randall, 1988). The
risks of bronchitis and respiratory tract cancers, it is argued, are
small with the intermittent and time-limited smoking of cannabis that
would occur in the course of cancer chemotherapy. In any case,
proponents of rescheduling argue, it is probably a risk that many
patients with a life-threatening illness may be prepared to run, as
shown by their preparedness to take highly toxic and carcinogenic
anti-cancer agents. 

Weil (1988) has argued that some opponents have used double standards
in appraising the risks of marijuana smoking. According to Weil, the
most common psychoactive effects of marijuana (euphoria, somnolence
and dysphoria) are minor, non-life-threatening and self-limiting
effects that can be easily managed, and are of much less severity than
the side effects of many other widely-used therapeutic drugs. Medical
witnesses for the government, he claims, &quot;do not contrast marijuana's
supposed adverse effects with the known adverse effects of drugs
routinely prescribed for the treatment of conditions like cancer,
glaucoma and multiple sclerosis. Instead, ... [they] compare marijuana
to some abstract, unobtainable standard of perfection&quot; (p437).

Merritt (1988) has made a similar point in criticising the arguments
raised against the therapeutic use of marijuana to manage glaucoma: &quot;
... each drug family used in glaucoma therapy is capable of producing
a lethal response, even when properly prescribed and used .. [p470]
[but] these drugs are all deemed &quot;safe&quot; for use in glaucoma therapy ..
because their adverse consequences are considered less threatening to
the patient than blindness&quot; (p472). Yet marijuana is excluded from
therapeutic use because of a possible risk of cancer from long-term
daily smoking. &quot;I cannot see&quot;, observes Merritt, &quot;how an alleged case
of marijuana-induced lung cancer which results in death is
significantly different in result from an acute adverse reaction to a
myotic drug which results in respiratory failure, except, of course,
that the patient with cancer is likely to outlive the patient who is
unable to draw in a breath of air&quot; (p474).

Although the debate about the rescheduling of marijuana has been
ostensibly about the safety and efficacy of marijuana use, it has been
driven by the debate about the legal status of recreational marijuana
use. For example, some of the groups advocating the therapeutic use of
cannabis have also been proponents of cannabis legalisation (e.g.
NORML), thereby fuelling the fears of opponents of cannabis use that
success in the campaign for marihuana rescheduling will be the thin
edge of a wedge to legalise cannabis. Other proponents of legalisation
(e.g. Grinspoon and Bakalar, 1993) have turned this reasoning around,
by arguing for the legalisation of cannabis as a way of making
cannabis available for therapeutic purposes.

On the other side of the argument are those opponents of marijuana use
who fear that the admission that marijuana, or any of its
constituents, may have a therapeutic use will send the &quot;wrong message&quot;
to youth. This has led to the denial that cannabinoids have any
therapeutic effects, and to attempts to stifle all scientific inquiry
into any such effects. For example, Mr Bernstein representing the
National Federation of Parents for a Drug Free Youth had the following
to say in his summing up against Rescheduling marijuana before Judge
Young (1989):

&quot;If marijuana were to be rescheduled to Schedule II, what kind of
message are we sending to a nation that is engaged in a battle for
it's very survival because of epidemic drug abuse? ... will not the
message be that marijuana is good for cancer, good for glaucoma, good
for spasticity and a host of other illnesses? Now to all of this who
are the most vulnerable? The answer is, of course, our young people.
Their reaction will be that if it is good for all of these things, it
can't be bad for me. We then have another youngster trying marijuana,
the gateway drug and probably starting down the road that leads to
nowhere but destruction&quot; (in Randall, 1989, p395). 

It is unfortunate that a connection has been forged between the
debates about the legal status of cannabis as a recreational drug and
the use of cannabinoids for therapeutic use. Any such connection is
spurious, since there is a world of difference between the use of
controlled doses of a purified drug under medical supervision and the
recreational use of crude preparations of a drug. In a rational world,
clinical decisions about whether to use pure cannabinoid drugs should
not be abrogated because crude forms of the drug may be abused by
those who use it recreationally. As a community we do not allow this
type of thinking to deny us the use of opiates for analgesia. Nor
should it be used to deny access to any therapeutic uses of
cannabinoids derivatives that may be revealed by pharmacological
research. 



8.11 Conclusions

The following provisional conclusions can be drawn on the available
evidence. First, there is good evidence for the therapeutic potential
of THC as an anti-emetic agent. Although uncertainty exists about the
most optimal method of dosing and the advantages and disadvantages of
different routes of administration, there is sufficient evidence to
justify it being made available in pure synthetic form to cancer
patients. In the light of the recent development of more effective
anti-emetic agents, it remains to be seen how widely used the
cannabinoids will be. Second, there is reasonable evidence for the
potential efficacy of THC in the treatment of glaucoma, especially in
cases which have proved resistant to existing anti-glaucoma agents.
Further research is clearly required, but this should not prevent its
use under medical supervision in poorly controlled cases, provided
patients make informed decisions about its use in the light of
information about the possible health risks of long-term use. Third,
there is sufficient suggestive evidence of the potential usefulness of
various cannabinoids as analgesic, anti-asthmatic, anti-spasmodic, and
anti-convulsant agents to warrant further basic pharmacological and
experimental investigation, and perhaps clinical research into their
effectiveness. 

Despite the basic and clinical research work which was undertaken in
late 1970s and early 1980s, the cannabinoids have not been widely used
therapeutically, nor have further investigations been conducted along
the lines suggested in the positive evaluations made by the Institute
of Medicine (1982). This seems largely attributable to the fact that
clinical research on the therapeutic use of cannabinoids has been
discouraged by regulation and a lack of funding in the United States,
where most cannabis research has been conducted. The discouragement of
therapeutic research, in turn, derives from the fact that THC, the
most therapeutically effective cannabinoid, has the psychoactive
effects sought by recreational users. In opposing the therapeutic uses
of cannabinoids, some researchers have used double standards in
appraising efficacy and safety, setting unreasonably high standards in
assessing the evidence on the comparative therapeutic safety and
efficacy of cannabinoids and existing agents. The application of the
same demanding standards to existing agents for the candidate
diseases, and more generally, to existing psychoactive drugs that are
widely used in medical practice, would denude the pharmacopoeia. The
recent discovery of the cannabinoid receptor may help to overcome some
of the resistance to research into the therapeutic uses of
cannabinoids, by holding out the prospect that the psychoactive
effects of the cannabinoids can be disengaged from their other
therapeutically desirable effects.



References

Adler, M.W. and Geller, E.B. (1986) Ocular effects of cannabinoids. In
R. Mechoulam (ed) Cannabinoids as Therapeutic Agents. Boca Raton,
Florida: CRC Press.

American Academy of Ophthalmology. (1990) &quot;The use of marijuana in the
treatment of glaucoma&quot;, June 21, 1987, reproduced In R Randall (ed)
Cancer Treatment and Marijuana Therapy. Washington, DC: Galen Press.

Carey, M.P., Burish, T.G. and Brenner, D.E. (1983)
Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems
and issues. Annals of Internal Medicine, 
99, 106-114.

Casswell, A. (1992) Marijuana as medicine. Medical Journal of
Australia, 156, 497-498.

Chang, A.E., Shiling, D.J., Stillman, R.C., Goldberg, N.H., Seipp,
C.A., Barofsky, I., Simon, R.M. and Rosenberg, S.A. (1979)
Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients
receiving high-dose methotrexate. Annals of Internal Medicine, 
91, 819-824.

Chesher, G.B. and Jackson, D.M. (1974) Anticonvulsant effects of
cannabinoids in mice: drug interactions within cannabinoids, and
cannabinoid interactions with phenytoin. Psychopharmacologia, 37,
255-264.

Clifford, D.B. (1983) Tetrahydrocannabinol for tremor in multiple
sclerosis. Annals of Neurology, 13, 669-671.

Consroe, P.F., Wood, G and Buchsbaum, H. (1975) Anticonvulsant nature
of marihuana smoking. Journal of the American Medical Association,
234, 306-307.

Consroe, P. and Snider, S.R. (1986) Therapeutic potential of
cannabinoids in neurological disorders. In R. Mechoulam (ed)
Cannabinoids as Therapeutic Agents. Boca Raton, Florida: CRC Press.

Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk,
R., Kennedy, K. and Schram, K. (1991) Controlled trial of cannabidiol
in Huntington's disease. Pharmacology, Biochemistry and Behavior, 40,
701-708.

Cunha, J.M., Carlini, E.A., Pereira, A.E., Ramos, O.L., Pimentel, C.,
Gagliardi, R., Sanvito, W.L., Lander, N. and Mechoulam, R. (1980)
Chronic administration of cannabidiol to healthy volunteers and
epileptic patients. Pharmacology, 21, 175-185.

Dobin, R.E. and Kleiman, M.A.R. (1991) Marijuana as antiemetic
medicine: A survey of oncologists' experiences and attitudes. Journal
of Clinical Oncology, 9, 1314-1319.

Goani, Y. and Mechoulam, R. (1964) Isolation, structure and partial
synthesis of an active constituent of hashish. Journal of the American
Chemical Society, 86, 1646-1647. 

Graham, J.D.P. (1986) The bronchodilator action of cannabinoids. In R.
Mechoulam (ed) Cannabinoids as Therapeutic Agents. Boca Raton,
Florida: CRC Press.

Grinspoon, L. (1990) Testimony In The Matter of Marihuana
Rescheduling. In R Randall (ed) Cancer Treatment and Marijuana
Therapy. Washington, DC: Galen Press.

Grinspoon, L. and Bakalar, J.B. (1993) Marihuana, the Forbidden
Medicine. New Haven: Yale University Press.

Hepler, R.S., and Petrus, R.J. (1971) Marihuana smoking and
intraocular pressure. Journal of the American Medical Association,
217, 1392.

Hepler, R.S., and Petrus, R.J. (1976) Experiences with administration
of marihuana to glaucoma patients. In Cohen, S. and R Stillman (Eds)
The Therapeutic Potential of Marihuana. New York: Plenum Medical Book
Company.

Hepler, R.S., Frank, I.M. and Petrus, R. (1976) Ocular effects of
marihuana smoking. In M Braude and S. Szara (eds) The Pharmacology of
Marihuana. New York: Raven Press.

Hepler, R.S. (1990) Testimony in The Matter of the Marihuana
Rescheduling. In R Randall (ed) Cancer Treatment and Marijuana
Therapy. Washington DC: Galen Press.

Institute of Medicine. (1982) Marijuana and Health. Washington DC:
Institute of Medicine, National Academy Press.

Iversen, L.L. (1993) Medical uses of marijuana? Nature, 365, 12-13.

Jones, R.T., Benowitz, N. and Herning, R.I. (1981) The clinical
relevance of cannabis tolerance and dependence. Journal of Clinical
Pharmacology, 21, 143S-152S.

Kaslow, R.A., Blackwelder, W.C., Ostrow, D.G., Yerg, D., Palenick, J.,
Coulson, A.H. and Valdiserri, R.O. (1989) No evidence for a role of
alcohol or other psychoactive drugs in accelerating immunodeficiency
in HIV-1-positive individuals: A report from the Multicenter AIDS
Cohort Study. Journal of the American Medical Association, 261,
3424-3429.

Levitt, M. (1986) Cannabinoids as antiemetics in cancer chemotherapy.
In R. Mechoulam (ed) Cannabinoids as Therapeutic Agents. Boca Raton,
Florida: CRC Press.

Mechoulam, R. (1986) The pharmacohistory of cannabis sativa. In R.
Mechoulam (ed) Cannabinoids as Therapeutic Agents. Boca Raton,
Florida: CRC Press.

Mechoulam, R. (1988) Direct testimony. In Randall, R (ed) Marijuana
Medicine and the Law. Washington DC: Galen Press.

Meinck, H.M., Schonle, P.W. and Conrad, B. (1989) Effect of
cannabinoids on spasticity and ataxia in multiple sclerosis. Journal
of Neurology, 236, 120-122.

Merritt, J (1988) Affidavit. In R Randall (ed) Marijuana Medicine and
the Law. Washington, DC: Galen Press.

Mikuriya, T.H. (1990) Testimony. In R Randall (ed) Cancer Treatment
and Marijuana Therapy. Washington, DC: Galen Press.

Morgan, J.P. (1990) Testimony. In R Randall (ed) Cancer Treatment and
Marijuana Therapy. Washington, DC.: Galen Press.

Nahas, G.G. (1984) The medical use of cannabis. In G.G. Nahas (ed)
Marihuana in Science and Medicine. New York: Raven Press.

Noyes, R., Brunk, F., Avery, D.H. and Canter, A. (1975) The analgesic
properties of delta-9-tetrahydrocannabinol and codeine. Clinical
Pharmacology and Therapeutics, 
18, 84-89.

Plasse, T.F., Gorter, R.W., Krasnow, S.H., Lane, M., Shapard, K.V. and
Wadleigh, R. (1991) Recent clinical experience with Dronabinol.
Pharmacology, Biochemistry and Behavior, 40, 695-700.

Poster, D.S., Penta, J.S., Bruno, S. and Macdonald, J.S. (1981)
Delta-9-tetrahydrocannabinol in clinical oncology. Journal of the
American Medical Association, 245, 2047-2051.

Randall, R (1988) (ed) Marijuana Medicine and the Law. Washington DC:
Galen Press.

Randall, R (1989) (ed) Marijuana Medicine and the Law, Volume II.
Washington DC: Galen Press.

Randall, R (1990) (ed) Cancer Treatment and Marijuana Therapy.
Washington DC: Galen Press.

Randall, R (1991) (ed) Marijuana and AIDS: Pot, Politics and PWAs in
America. Washington DC: Galen Press.

Sallan, S.E., Zinberg, N.E., and Frei, E. (1975) Antiemetic effect of
delta-9-tetrahydrocannabinol in patients receiving cancer
chemotherapy. New England Journal of Medicine, 293, 795-797.

Sandyk. R., Consroe, P., Stern, P., and Biklen, D. (1988) Preliminary
trial of cannabidiol in Huntington's disease. In G. Chesher, P.
Consroe and R. Musty (eds) Marijuana: An International Research
Report. Canberra: Australian Government Publishing Service.

Segal, M. (1986) Cannabinoids and analgesia. In R. Mechoulam (ed)
Cannabinoids as Therapeutic Agents. Boca Raton, Florida: CRC Press.

Tashkin, D.P., Shapiro, B.J. and Lee, Y.E. (1975) Effects of smoked
marijuana in experimentally induced asthma. American Review of
Respiratory Disease, 112, 377-386.

Tashkin, D.P., Shapiro, B.J. and Frank, I.M. (1976) Acute effects of
marihuana on airway dynamics in spontaneous and experimentally induced
bronchial asthma. In M Braude and S. Szara (eds) The Pharmacology of
Marihuana. New York: Raven Press.

Tashkin, D.P. (1993) The pulmonary effects of cannabis. Paper
presented to conference on &quot;Cannabis and Health&quot;, Wellington, New
Zealand, October, 1993.

Ungerleider, J.T., Andrysiak, T., Fairbanks, L., Goodnight, J., Sarna,
G. and Jamison, K. (1982) Cannabis and cancer chemotherapy: A
comparison of oral delta-9-THC and prochlorperazine. Cancer, 50,
636-645.

Young, F.L. (1989) In the matter of Marijuana Rescheduling Petition.
Opinion and recommended ruling, findings of fact, conclusions of law
and decision of Administrative Law Judge. In R Randall (ed) Marijuana
Medicine and the Law, Volume II. Washington, DC: Galen Press.

Weil, A. (1988) Affidavit. In R Randall (ed) Marijuana Medicine and
the Law. Washington, DC: Galen Press.



</font>
</pre>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-14</DOCNO>
<DOCOLDNO>IA087-000627-B016-271</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/medical/ch9.htm 206.61.184.43 19970122051825 text/html 26457
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:18:18 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:01:24 GMT
Content-length: 26239
</DOCHDR>
<html>

<head>
<title>The health and psychological consequences of cannabis use:
chapter 9 </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<h1></h1>
</body>

<body bgcolor="#ffffff">

<p>The health and psychological consequences of cannabis use </p>

<h3>National Drug Strategy<br>
Monograph Series No. 25 <br>
<br>
</h3>

<hr>

<pre>
<font size="2">9. An overall appraisal of the health and psychological effects of
        cannabis 



9.1 Summary 

The following is a summary of the major adverse health and
psychological effects of acute and chronic cannabis use, grouped
according to the degree of confidence in the view that the
relationship between cannabis use and the adverse effect is a causal
one.



9.1.1 Acute effects 

The major acute psychological and health effects of cannabis
intoxication are:

        anxiety, dysphoria, panic and paranoia, especially in naive
        users;

        cognitive impairment, especially of attention and memory for the
        duration of intoxication; 

        psychomotor impairment, and probably an increased risk of
        accidental injury or death if an intoxicated person attempts to drive
        a motor vehicle or operate machinery; 

        an increased risk of experiencing psychotic symptoms among those
        who are vulnerable because of a personal or family history of
        psychosis; and

        an increased risk of low birth weight babies if cannabis is used
        during pregnancy.



9.1.2 Chronic effects

The major health and psychological effects of chronic cannabis use,
especially daily use over many years, remain uncertain. On the
available evidence, the major probable adverse effects appear to be:

        respiratory diseases associated with smoking as the method of
        administration, such as chronic bronchitis, and the occurrence of
        histopathological changes that are precursors to the development of
        malignancy;

        development of a cannabis dependence syndrome, characterised by
        an inability to abstain from or to control cannabis use; and

        subtle forms of cognitive impairment, most particularly of
        attention and memory, which persist while the user remains chronically
        intoxicated, and may or may not be reversible after prolonged
        abstinence from cannabis.


The following are the major possible adverse effects of chronic, heavy
cannabis use which remain to be confirmed by controlled research:

        an increased risk of developing cancers of the aerodigestive
        tract, i.e. oral cavity, pharynx, and oesophagus;

        an increased risk of leukemia among offspring exposed in utero;
        and

        a decline in occupational performance marked by underachievement
        in adults in occupations requiring high level cognitive skills, and
        impaired educational attainment in adolescents.

        birth defects occurring among children of women who used cannabis
        during their pregnancies.



9.1.3 High risk groups

A number of groups can be identified as being at increased risk of
experiencing some of these adverse effects. 



Adolescents

        Adolescents with a history of poor school performance may have
        their educational achievement further limited by the cognitive
        impairments produced by chronic intoxication with cannabis.

        Adolescents who initiate cannabis use in the early teens are at
        higher risk of progressing to heavy cannabis use and other illicit
        drug use, and to the development of dependence on cannabis.



Women of childbearing age

        Pregnant women who continue to smoke cannabis are probably at
        increased risk of giving birth to low birth weight babies, and perhaps
        of shortening their period of gestation.

        Women of childbearing age who continue to smoke cannabis at the
        time of conception or while pregnant possibly increase the risk of
        their children being born with birth defects. 



Persons with pre-existing diseases

Persons with a number of pre-existing diseases who smoke cannabis are
probably at an increased risk of precipitating or exacerbating
symptoms of their diseases. These include: 

        individuals with cardiovascular diseases, such as coronary artery
        disease, cerebrovascular disease and hypertension; 

        individuals with respiratory diseases, such as asthma,
        bronchitis, and emphysema; 

        individuals with schizophrenia, who are at increased risk of
        precipitating or of exacerbating schizophrenic symptoms; and

        individuals who are or have been dependent upon alcohol and other
        drugs, who are probably at an increased risk of developing dependence
        on cannabis.



9.1.4 A caveat



As has been stressed throughout this document, there is uncertainty
surrounding many of these summary statements about the adverse health
effects of acute, and especially chronic, cannabis use. To varying
degrees, these statements depend upon inferences from animal research,
laboratory studies, and clinical observations about the probable ill
effects. In some cases, the inferences depend upon arguments from what
is known about the adverse health effects of other drugs, such as
tobacco and alcohol. In very few cases are there sufficient studies
which provide the detailed evidence that epidemiologists would require
to make informed judgments about the health effects of cannabis; the
interpretation of what epidemiological evidence is available is
complicated by difficulties in quantifying degree of exposure to
cannabis, and in excluding alternative explanations (including other
drug use) of associations observed between cannabis use and adverse
health outcomes. These interpretative problems are especially obvious
in the case of many of the alleged psychological outcomes of cannabis
use in adolescence, since many of these putative &quot;consequences&quot; (e.g.
poor school performance, deviant behaviour) also antedate the use of
cannabis. Nevertheless, these statements provide the best available
basis for making societal decisions about what policies ought to be
adopted towards cannabis use.



9.2  Two special concerns

Two issues which have hitherto been ignored require brief discussion.
These are the possible health implications of: the storage of THC in
body tissue; and any increases in the average potency of cannabis
products (as indexed by THC content) that may have occurred in recent
decades.



9.2.1 Storage of THC    

There is good evidence that with repeated dosing of cannabis at
frequent intervals, THC can accumulate in fatty tissues in the human
body where it may remain for considerable periods of time (see above
pp34-35). Attitudes towards this fact are strongly coloured by the
perceiver's views about cannabis use: those who are opposed to its use
usually regard this as a cause for major concern; proponents of
cannabis use largely ignore it. There is no evidence to make a
confident judgment one way or the other. The storage of cannabinoids
would be serious cause for concern if THC were a highly toxic
substance which remained physiologically active while stored in body
fat. The evidence that THC is a highly toxic substance is weak,
although it does have a bewildering variety of biological effects
(Martin, 1986). Its degree of activity while stored has not been
investigated. One potential health implication of THC storage is that
the release of stored cannabinoids into blood may produce unexpected
symptoms of cannabis intoxication. The release of stored THC has been
suggested as an explanation of &quot;flashback experiences&quot; (e.g. Negrete,
1988; Thomas, 1993). Such experiences have been rarely reported by
cannabis users (e.g. Edwards, 1983), and even in these cases
interpretation of their significance is complicated by the fact that
those who have reported such experiences have typically used other
hallucinogenic drugs. Whatever the uncertainties about health
implications of THC storage, all potential users of cannabis should be
aware that it occurs.



9.2.2 Increases in the potency of cannabis 

Cohen (1986) has been credited (Mikuriya and Aldrich, 1988) with
initiating the recent claim that the existing medical literature on
the health effects of cannabis underestimates its adverse effects
because it was based upon research conducted on less potent forms of
marijuana (O.5 per cent to 1.0 per cent THC) than those that became
available in the USA in the past decade (3.5 per cent THC in
1985-1986). This claim has been repeated often in the popular and
scientific media, and supported by anecdotal evidence that samples
containing up to 40 per cent THC have been seized by the police. An
alleged &quot;ten-fold&quot; increase in potency has contributed to recent
concerns about the health effects of cannabis, because of the
assumption that increases in average potency necessarily mean
substantial increases in the health risks of cannabis use. In
Australia this concern has been recently raised by the discovery of
hydroponically cultivated clones of cannabis plants that produce high
levels of THC, and by reports of the importation of high THC producing
strains of cannabis from New Guinea. 

There are a number of points to be made about this issue. First, the
evidence for an increase in potency is not as clear as Cohen (1986)
claimed, or as it seems from the data reported by ElSohy and ElSohy
(1989). The inference that these data demonstrate that potency has
increased depends upon the assumption that the samples analysed are
representative of cannabis consumed. Mikuriya and Aldrich (1988), for
example, have contested this assumption. They cite the results of
chemical analyses conducted on cannabis samples in California during
the middle 1970s in which the average potency was well within the
ranges reported in samples seized by the US Drug Enforcement Agency in
the middle 1980s. They also argue that the analyses of the DEA samples
from the middle 1970s underestimated THC potency because the samples
were not properly stored, allowing their average THC content to be
degraded. 

Second, even if we allow that there probably has been a small increase
in the THC potency of cannabis products in the USA, there is at
present no evidence of a similar increase in Australia. There is good
evidence from police samples analysed in New Zealand over the past
decade that average potency has not increased there (Bedford, 1993).
Press reports of increased potency have often been misleading in that
they have been based upon individual samples of highly concentrated
cannabis extracts, such as hash oil, which have never had a major
share of the cannabis market.

Third, the use of average potency can be also be potentially
misleading, since the average ignores differences between cannabis
users in preferences for cannabis products of varying potency. There
probably has always been a market for more potent products among the
heavier, and hence, more THC-tolerant, cannabis users. Marijuana
probably remains the majority preference of cannabis users, although
this is an issue worthy of investigation.

Fourth, it is not obvious that more potent forms of cannabis
inevitably have more adverse effects on users' health than less potent
forms. Indeed, it is conceivable that increased potency may have
little or no adverse effect if users are able to titrate their dose to
achieve the desired state of intoxication, as some have argued they do
(e.g. Kleiman, 1992; Mikuyira and Aldrich, 1988). If users were able
to titrate their dose, the use of more potent cannabis products would
reduce the amount of cannabis material that was smoked, which would
marginally reduce the risks of developing respiratory diseases. 

Fifth, even if users do not titrate their dose of THC, (or if they do
so inefficiently), any increase in the average dose received would not
inevitably have an adverse impact on users' health. The effect would
depend upon the type of health effect in question, and the relative
experience of users. Higher average doses may produce an increase in
the risk of minor adverse psychological effects of acute use,
especially among naive users. This could be a desirable outcome if it
discouraged further experimentation with the drug. Among experienced
cannabis users, an increased average dose may increase the risks of
accidents among those who drive while intoxicated, especially if
combined with alcohol. Higher average doses may also increase the risk
of regular users developing dependence.

All considered then, it is far from established that the average THC
potency of cannabis products has substantially increased over recent
decades. If potency has increased, it is even less certain that the
average health risks of cannabis use have materially changed as a
consequence, since users may titrate their dose to achieve the desired
effects. Even if the users are inefficient in titrating their dose of
THC, it is far from certain that the probability of adverse health
effects will be thereby increased. Nevertheless, given these concerns
about THC potency, it would be preferable to conduct research on the
issue rather than to rely upon inferences about the likely effects of
increased cannabis potency. Studies of the ability of experienced
users to titrate their dose of THC would contribute to an evaluation
of this issue, as would the inclusion in sample surveys of questions
about the form and perceived potency of cannabis products used. 



9.3 A comparative appraisal of health risks: alcohol, tobacco and
cannabis use

The probable and possible adverse health and psychological effects of
cannabis need to be placed in comparative perspective to be fully
appreciated. A useful standard for such a comparison is what is known
about the health effects of alcohol and tobacco, two other widely used
psychoactive drugs. Cannabis shares with tobacco, smoking as the usual
route of administration, and resembles alcohol in being used for its
intoxicating and euphoriant effects.

Considerable care must be exercised in making such comparisons.
Firstly, the quantitative risks of tobacco and alcohol use are much
better known than the health risks of cannabis, since alcohol and
tobacco have been consumed by substantial proportions of the
population, and there have been 40 years of scientific studies of the
health consequences of their use. Cannabis, by contrast, has been much
less widely used, and for a shorter period, in Western society; it has
been primarily used by healthy young adults, and there have been few
studies of its adverse health effects. 

Secondly, the prevalence of use of alcohol and tobacco is much higher
than that of cannabis. For example, the proportions of the Australian
population who are at least weekly users of alcohol, tobacco and
cannabis are: 61 per cent, 29 per cent, (Department of Health, Housing
and Community Services, 1992), and 11 per cent (Donnelly and Hall,
1994) respectively. Any overall comparison of the health consequences
of the three drug types that was based upon existing patterns of use
would unfairly disadvantage alcohol and tobacco. Any attempt to adjust
for the differences in prevalence (e.g. by estimating the health
effects if the prevalence of cannabis use was the same as those for
alcohol and tobacco) would involve making controversial assumptions,
so no such attempt has been made.

The very different prevalence of use of alcohol, tobacco and cannabis,
and the fact that we know a great deal more about the adverse effects
of alcohol and tobacco use, precludes any quantitative comparison of
the current health consequences of these drugs. Nevertheless, a
qualitative comparison of the probable health risks of cannabis with
the known health risks of alcohol and tobacco serves the useful
purpose of reminding us of the risks we currently tolerate with our
favourite psychoactive drugs. 

In undertaking this qualitative comparison, we have avoided the
necessity to comprehensively review the vast literatures on the health
effects of alcohol and tobacco by using the following authorities as
the principal sources of evidence for our assertions about their
health risks: Anderson et al (1993); Holman et al's (1988) compendium
of the health effects of alcohol and tobacco; the Institute of
Medicine (1987); the International Agency for Research into Cancer
(1990); Roselle et al (1993); and the Royal College of Physicians
(1987).



9.3.1 Acute effects



Alcohol. The major risks of acute cannabis use are similar to the
acute risks of alcohol intoxication in a number of respects. First,
both drugs produce psychomotor and cognitive impairment, especially of
memory and planning. The impairment produced by alcohol increases
risks of various kinds of accident, and the likelihood of engaging in
risky behaviour, such as dangerous driving, and unsafe sexual
practices. It remains to be determined whether cannabis intoxication
produces similar increases in accidental injury and death, although on
balance it probably does.

Second, there is good evidence that substantial doses of alcohol taken
during the first trimester of pregnancy can produce a foetal alcohol
syndrome. There is suggestive but far from conclusive evidence that
cannabis used during pregnancy may have similar adverse effects. 

Third, there is a major health risk of acute alcohol use that is not
shared with cannabis. In large doses alcohol can cause death by
asphyxiation, alcohol poisoning, cardiomyopathy and cardiac infarct.
There are no recorded cases of fatalities attributable to cannabis,
and the extrapolated lethal dose from animal studies cannot be
achieved by recreational users.



Tobacco. The major acute health risks that cannabis shares with
tobacco are the irritant effects of smoke upon the respiratory system,
and the stimulating effects of both THC and nicotine on the
cardiovascular system, both of which can be detrimental to persons
with cardiovascular disease.



9.3.2 Chronic effects



Alcohol. There are a number of risks of heavy chronic alcohol use,
some of which may be shared by chronic cannabis use. First, heavy use
of either drug increases the risk of developing a dependence syndrome
in which users experience difficulty in stopping or controlling their
use. There is strong evidence of such a syndrome in the case of
alcohol and reasonable evidence in the case of cannabis. A major
difference between the two is that it is uncertain whether a
withdrawal syndrome reliably occurs after dependent cannabis users
abruptly stop their cannabis use, whereas the abrupt cessation of
alcohol use in severely dependent drinkers produces a well defined
withdrawal syndrome which can be potentially fatal. 

Second, there is reasonable clinical evidence that the chronic heavy
use of alcohol can produce psychotic symptoms and psychoses in some
individuals. There is suggestive evidence that chronic heavy cannabis
use may produce a toxic psychosis, precipitate psychotic illnesses in
predisposed individuals, and exacerbate psychotic symptoms in
individuals with schizophrenia.

Third, there is good evidence that chronic heavy alcohol use can
indirectly cause brain injury - the Wernicke-Korsakov syndrome - with
symptoms of severe memory defect and an impaired ability to plan and
organise. With continued heavy drinking, and in the absence of vitamin
supplementation, this injury may produce severe irreversible cognitive
impairment. There is good reason for concluding that chronic cannabis
use does not produce cognitive impairment of comparable severity.
There is suggestive evidence that chronic cannabis use may produce
subtle defects in cognitive functioning, that may or may not be
reversible after abstinence. 

Fourth, there is reasonable evidence that chronic heavy alcohol use
produces impaired occupational performance in adults, and lowered
educational achievements in adolescents. There is suggestive evidence
that chronic heavy cannabis use produces similar, albeit more subtle
impairments in occupational and educational performance of adults. 

Fifth, there is good evidence that chronic, heavy alcohol use
increases the risk of premature mortality from accidents, suicide and
violence. There is no comparable evidence for chronic cannabis use,
although it is likely that dependent cannabis users who frequently
drive while intoxicated with cannabis increase their risk of
accidental injury or death.

Sixth, alcohol use has been accepted as a contributory cause of cancer
of the oropharangeal organs in men and women. There is suggestive
evidence that chronic cannabis smoking may also be a contributory
cause of cancers of the aerodigestive tract.



Tobacco. The major adverse health effects shared by chronic cannabis
and tobacco smokers are chronic respiratory diseases, such as chronic
bronchitis, and probably, cancers of the aerodigestive tract (i.e. the
mouth, tongue, throat, oesophagus, lungs). The increased risk of
cancer in the aerodigestive tract is a consequence of the shared route
of administration by smoking. It is possible that chronic cannabis
smoking also shares the cardiotoxic properties of tobacco smoking,
although this possibility remains to be investigated. 

It should be stressed that this section only describes the adverse
health effects of alcohol and tobacco for which there is some evidence
that chronic heavy cannabis use may also cause. It does not,
therefore, provide an exhaustive inventory of all the adverse health
effects of either chronic alcohol or tobacco use. Among the major
additional adverse health effects of chronic heavy alcohol use which
are not shared by cannabis are: liver cirrhosis, peripheral
neuropathy, and gastritis. 



9.4 Implications for harm reduction 

The simplest health advice to anyone who wishes to avoid the probable
acute and chronic adverse health effects of cannabis is to abstain
from using the drug. This advice is especially apt for persons with
any of the diseases (e.g. cardiovascular) or conditions (e.g.
pregnancy) which would make them more vulnerable to the adverse
effects of cannabis. 

Current cannabis users should be aware of the following risks of using
the drug. First, the risk of being involved in a motor vehicle
accident is likely to be increased when cannabis users drive while
intoxicated by cannabis. The combination of alcohol and cannabis
intoxication will substantially increase this risk. Second, the
chronic smoking of cannabis poses significant risks to the respiratory
system, apart from any specific effects of THC. Third, the respiratory
risks of cannabis smoking are amplified if deep inhalation and
breath-holding are used to maximise the absorption of THC in the
lungs. This technique greatly increases the delivery and retention of
particulate matter and tar. Fourth, daily or near daily use of
cannabis is to be avoided, as it has a high risk of producing
dependence. 


References

Anderson P., Cremona, A., Paton, A., Turner, C. and Wallace, P. (1993)
The risk of alcohol. Addiction, 88, 1493-1508. 

Bedford, K. (1993) THC levels in New Zealand cannabis and cannabis
products. Paper presented at Conference on Cannabis and Health,
Wellington, New Zealand, October, 1993.

Cohen, S. (1986) Marijuana research: selected recent findings. Drug
Abuse and Alcoholism Newsletter, 15, 1-3.

Department of Health Housing and Community Services (1993) Statistics
on Drug Abuse in Australia, 1992. Canberra: Australian Government
Publishing Service.

Donnelly, N. and Hall, W. (1994) Patterns of Cannabis Use in
Australia. Paper prepared for National Task Force on Cannabis.
National Drug Strategy Monograph Series No. 27. Canberra: Australian
Government Publishing Service.

Edwards, G. (1983) Psychopathology of a drug experience. British
Journal of Psychiatry, 143, 139-142.

ElSohy, M.A. and ElSohy, H.N. (1989) Marijuana: Analysis and detection
of use through urinalysis. In K.K. Redda, C.A. Walker and G. Barnett
(eds) Cocaine, Marijuana, Designer Drugs. Boca Raton, Florida: CRC
Press.

Holman, C.D., Armstrong, B. et al (1988) The Quantification of
Drug-Caused Morbidity and Mortality in Australia. Prepared for the
Commonwealth Department of Community Services and Health. Canberra:
Australian Government Publishing Service.

Institute of Medicine (1987) Causes and Consequences of Alcohol
Problems: An Agenda for Research. Washington DC: National Academy
Press.

International Agency on Cancer (1990) Cancer: Causes, Occurrence and
Control. (Ed) L. Tomatis. Lyon: International Agency on Cancer.

Kleiman, M.A.R. (1992) Against Excess: Drug Policy for Results. New
York, Basic Books.

Martin, B.R. (1986) The cellular effects of cannabinoids.
Pharmacological Reviews, 38, 
45-74.

Mikuriya, T. and Aldrich, M.R. (1988) Cannabis 1988, old drug, new
dangers: the potency question. Journal of Psychoactive Drugs, 20,
47-55.

Negrete, J (1988) What's happened to the cannabis debate? British
Journal of Addiction, 83, 359-372.

Roselle, G., Mendenhall, C.L. and Grossman, C.J. (1993) Effects of
alcohol on immunity and cancer. In R. Yirmiya and A.N. Taylor (eds)
Alcohol, Immunity, and Cancer. Baton Rouge: CRC Press.

Royal College of Physicians (1987) A Great and Growing Evil: The
medical consequences of alcohol abuse. London: Tavistock.

Thomas, H. (1993) Psychiatric symptoms in cannabis users. British
Journal of Psychiatry, 163, 141-149.


</font>
</pre>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-15</DOCNO>
<DOCOLDNO>IA086-000614-B046-88</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/Library/studies/nc/ncmenu.htm 206.61.184.43 19970122022026 text/html 14835
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 02:20:22 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:58:26 GMT
Content-length: 14617
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Marihuana, A Signal of Misunderstanding - Table of
Contents</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="61536" -->

<h1>The Report of the National Commission on Marihuana and Drug
Abuse </h1>

<h2>Marihuana: A Signal of Misunderstanding </h2>

<p><b>Commissioned by President Richard M. Nixon, March, 1972</b>
</p>

<hr>

<p><b><u>Table of Contents</u></b> </p>

<h3>The Report </h3>

<p>Letter of Transmittal </p>

<p><a href="misintro.htm">Introduction</a> </p>

<p><a href="mis2.htm"><b>I. Marihuana and the Problem of
Marihuana</b></a><b><u> </u></b></p>

<ul>
    <li>Origins of the Marihuana Problem <ul>
            <li>Visibility </li>
            <li>Perceived Threats </li>
            <li>Symbolism </li>
        </ul>
    </li>
    <li>The Need for Perspective <ul>
            <li>Historical Perspective </li>
            <li>Cultural Perspective <ul>
                    <li>The Search for Meaning </li>
                    <li>Skepticism </li>
                    <li>The Limits of Rationality </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Formulating Marihuana Policy <ul>
            <li>Scientific Oversimplification </li>
            <li>Philosophical Oversimplification </li>
            <li>Sociological Oversimplification </li>
            <li>Legal Oversimplification </li>
        </ul>
    </li>
    <li>The Report </li>
</ul>

<p><a href="ncchap2.htm"><b>II. Marihuana Use and Its Effects</b></a><b><u>
</u></b></p>

<ul>
    <li>The Marihuana User </li>
    <li>Demographic Characteristics </li>
    <li>Patterns of Use </li>
    <li>Profiles of Users <ul>
            <li>Experimental Users </li>
            <li>Intermittent Users </li>
            <li>Moderate and Heavy Users </li>
            <li>Very Heavy Users </li>
        </ul>
    </li>
    <li>Becoming a Marihuana User <ul>
            <li>Parental Influence </li>
            <li>Situational Factors and Behavioral Correlates </li>
            <li>Social Group Factors </li>
            <li>The Dynamics of Persistent Use </li>
        </ul>
    </li>
    <li>Becoming a Multidrug User <ul>
            <li>Epidemiologic Studies </li>
            <li>Profiles and Dynamics </li>
            <li>Sociocultural Factors </li>
        </ul>
    </li>
    <li>Effects of Marihuana on the User <ul>
            <li>Botany and Chemistry </li>
            <li>Factors Influencing Drug Effect <ul>
                    <li>Dosage </li>
                    <li>Method of Use </li>
                    <li>Metabolism </li>
                    <li>Set and Setting </li>
                    <li>Tolerance </li>
                    <li>Reverse Tolerance </li>
                    <li>Duration of Use </li>
                    <li>Patterns of Use </li>
                    <li>Definition of Dependence </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Effects Related to Pattern Use </li>
    <li>Immediate Drug Effects <ul>
            <li>Subjective Effects </li>
            <li>Bodv Function </li>
            <li>Mental Function </li>
            <li>The Intoxicated State </li>
            <li>Unpleasant Reactions </li>
            <li>Anxiety States </li>
            <li>Psychosis </li>
            <li>Conclusions </li>
        </ul>
    </li>
    <li>ShortTerm Effects </li>
    <li>Long Term Effects </li>
    <li>Very Long Term Effects <ul>
            <li>Tolerance and Dependence </li>
            <li>General Body Function </li>
            <li>Social Functioning </li>
            <li>Mental Functioning </li>
            <li>Motivation and Behavioral Change </li>
        </ul>
    </li>
    <li>Summary </li>
</ul>

<p><a href="ncc3.htm"><b>III. Social Impact of Marihuana Use</b></a><b><u>
</u></b></p>

<ul>
    <li>Marihuana and Public Safety <ul>
            <li>Marihuana and Crime <ul>
                    <li>The Issue of Cause and Effect </li>
                    <li>Marihuana and Violent Crime </li>
                    <li>Marihuana and Non Violent Crime </li>
                    <li>A Sociocultural Explanation </li>
                </ul>
            </li>
            <li>Marihuana and Driving </li>
        </ul>
    </li>
    <li>Marihuana, Public Health and Welfare <ul>
            <li>A Public Health Approach <ul>
                    <li>The Population at Risk </li>
                    <li>Confusion and Fact </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Assessment of Perceived Risks <ul>
            <li>Lethality </li>
            <li>Potential for Genetic Damage </li>
            <li>Immediate Effects </li>
            <li>Effects of LongTerm, Heavy Use </li>
            <li>Addiction Potential </li>
            <li>Progression to Other Drugs </li>
        </ul>
    </li>
    <li>Preventive Public Health Concerns <ul>
            <li>Summary </li>
        </ul>
    </li>
    <li>Marihuana and the Dominant Social Order <ul>
            <li>The Adult Marihuana User </li>
            <li>The Young Marihuana User </li>
        </ul>
    </li>
    <li>The World of Youth </li>
    <li>Why Society Feels Threatened <ul>
            <li>Dropping Out </li>
            <li>Dropping Down </li>
            <li>Youth and Radical Politics </li>
            <li>Youth and the Work Ethic </li>
        </ul>
    </li>
    <li>The Changing Social Scene </li>
</ul>

<p><a href="ncchp4.htm"><b>IV. Social Response to Marihuana Use </b></a></p>

<ul>
    <li>The Initial Social Response </li>
    <li>The Change </li>
    <li>The Current Response <ul>
            <li>The Criminal Justice System <ul>
                    <li>Law Enforcement Behavior </li>
                    <li>Law Enforcement Opinion </li>
                </ul>
            </li>
            <li>The Non Legal Institutions <ul>
                    <li>The Family </li>
                    <li>The Schools </li>
                    <li>The Churches </li>
                    <li>The Medical Community </li>
                    <li>Summary </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>The Public Response </li>
</ul>

<p><a href="ncrec.htm"><b>V. Marihuana and Social Policy</b></a><b><u>
</u></b></p>

<ul>
    <li><a href="ncrec1.htm">Drugs in a Free Society </a><ul>
            <li>Drugs and Social Responsibility </li>
        </ul>
    </li>
    <li><a href="ncrec2.htm">A Social Control Policy for
        Marihuana</a> <ul>
            <li>Approval of Use </li>
            <li>Elimination of Use </li>
            <li>Discouragement or Neutrality </li>
        </ul>
    </li>
    <li>Implementing the Discouragement Policy <ul>
            <li>The Role of Law in Effective Social Control </li>
            <li>Total Prohibition </li>
            <li>Regulation </li>
            <li>Partial Prohibition </li>
            <li>Recommendations for Federal Law </li>
            <li>Recommendations for State Law </li>
            <li>Discussion of Federal Recommendations </li>
            <li>Discussion of State Recommendations </li>
            <li>Discussion of Potential Objections </li>
        </ul>
    </li>
    <li>A Final Comment </li>
</ul>

<hr>

<p><a href="ncaddend.htm"><b>Addendum</b></a><b> </b></p>

<p>Ancillary Recommendations </p>

<p>Legal and Law Enforcement Recommendations </p>

<p>Medical Recommendations </p>

<p>Other Recommendations </p>

<p><b>Index of Contributors, Contractors and Consultants<br>
</b></p>

<hr>

<h3>The Appendix </h3>

<p>The Technical Papers of the First Report of the National
Commission on Marihuana and Drug Abuse, March, 1972 </p>

<p><a href="nc1let.htm">Letter of Transmittal </a></p>

<p><a href="ncstaff.htm">Members and Staff</a> </p>

<p><a href="nc1p.htm">Preface</a> </p>

<h3>Part One -- Biological Aspects </h3>

<h4>I. History of Marihuana Use: Medical and Intoxicant </h4>

<ul>
    <li><a href="nc1a.htm">History of the Medical Use</a> </li>
    <li><a href="nc1b.htm">History of the Intoxicant Use</a> </li>
</ul>

<h4>II. Biological Effects of Marihuana </h4>

<ul>
    <li><a href="nc1c.htm">Botanical and Chemical Considerations</a>
    </li>
    <li><a href="nc1d.htm">Factors Influencing
        Psychopharmacological Effect</a> </li>
    <li><a href="nc1e.htm">Acute Effects of Marihuana (Delta 9
        THC)</a> </li>
    <li><a href="nc1f.htm">Effects of Short-Term or Subacute Use</a>
    </li>
    <li><a href="nc1g.htm">Effects of Long-Term Cannabis Use</a> </li>
    <li><a href="nc1h.htm">Investigations of Very Heavy, Very
        Long-Term Cannabis Users</a> </li>
</ul>

<h4>III. Behavioral and Biological Concomitants of Chronic
Marihuana Smoking by Heavy and Casual Users </h4>

<h3>Part Two -- Social Aspects </h3>

<h4>I. Marihuana Use in American Society </h4>

<ul>
    <li>Surveys of Marihuana Use </li>
    <li>The Incidence and Prevalence of Marihuana Use </li>
    <li>The Future of Marihuana </li>
    <li>Why People Use Marihuana </li>
    <li>Becoming a Marihuana User </li>
    <li>Circumstances of First Marihuana Use </li>
    <li>The Marihuana User </li>
    <li>The Patterns of Marihuana Use </li>
    <li>Marihuana Use and the User: 1972 </li>
</ul>

<h4>II. Marihuana and the Use of Other Drugs </h4>

<ul>
    <li>Empirical Data on the Escalation Process </li>
    <li>Youth Drug Use Survey </li>
    <li>Summary </li>
</ul>

<h4>III. Marihuana and Public Safety </h4>

<ul>
    <li><a href="nc1i.htm">Problems in Assessing the Effects of
        Marihuana</a> </li>
    <li><a href="nc1j.htm">Marihuana and Violence</a> </li>
    <li><a href="nc1k.htm">Marihuana and Sexual Behavior</a> </li>
    <li><a href="nc1l.htm">Marihuana and (Non-Violent) Crime</a> </li>
    <li><a href="nc1m.htm">Summary and Conclusions: Marihuana and
        Crime</a> </li>
    <li><a href="nc1n.htm">Marihuana and Driving</a> </li>
</ul>

<h3>Part Three -- Legal Aspects </h3>

<h4>I. Control of Marihuana, Alcohol and Tobacco </h4>

<ul>
    <li><a href="nc2.htm">History of Marihuana Legislation</a> </li>
    <li><a href="nc2a.htm">History of Alcohol Prohibition</a> </li>
    <li><a href="nc2b.htm">History of Tobacco Regulation</a> </li>
</ul>

<h4>II. The Legal Status of Marihuana </h4>

<ul>
    <li>International Control </li>
    <li>The Control of Marihuana Under Federal Law </li>
    <li>Control of Marihuana at the State Level </li>
    <li>The Role of Ancillary Offenses and Constructive
        Possession in Controlling Marihuana </li>
    <li>Marihuana Control at the Local Level </li>
    <li>Analysis of Statutes Requiring Physicians to Report Drug
        Addiction </li>
</ul>

<h4>III. Trafficking Patterns of Marihuana and Hashish </h4>

<ul>
    <li>Marihuana Traffic From Mexico </li>
    <li>Marihuana Traffic From Jamaica </li>
    <li>The Growing Hashish Traffic </li>
</ul>

<h3>Part Four -- Response of the Criminal Justice System to
Marihuana Use </h3>

<h4>Introduction </h4>

<h4>I. Enforcement Behavior at the State Level </h4>

<h4>Enforcement Behavior at the Federal Level </h4>

<ul>
    <li>General Trends </li>
    <li>Federal Enforcement of the Marihuana Laws: 1970 </li>
</ul>

<h4>III. Opinion Within the Criminal Justice System </h4>

<ul>
    <li>Prosecutorial Opinion </li>
    <li>Opinion of Court Officials </li>
</ul>

<h3>Part Five -- National Survey </h3>

<h4>I. A Nationwide Study of Beliefs, Information and Experiences
</h4>

<ul>
    <li>Main Report </li>
    <li>Methods and Procedures </li>
</ul>

<h3>Part Six -- Social Policy Aspects </h3>

<h4>I. The Constitutional Dimensions of Marihuana Control </h4>

<ul>
    <li>Substantive Limitations on the Criminal Law </li>
    <li>Federal Preemption of Marihuana Control </li>
</ul>

<h4>II. Models and Statutory Schemes for Controlling Marihuana </h4>

<ul>
    <li>Law and Social Policy </li>
    <li>Legal Implementations of Marihuana Control Policies </li>
    <li>Formulating a Legal Scheme </li>
    <li>Implementation of Alcohol Prohibition </li>
</ul>

<h4>Marihuana and Education </h4>

<ul>
    <li>Drug Programs in American Education </li>
    <li>State Departments of Education Survey </li>
    <li>Commission Visits </li>
    <li>Drug Education Programs of Special Interest </li>
    <li>Marihuana Education in State Programs </li>
    <li>Surveys of College Drug Courses </li>
    <li>The Federal Government and Drug Education </li>
</ul>

<h4>Research Needs and Directions </h4>

<ul>
    <li>Biomedical </li>
    <li>Psychosocial </li>
    <li>Legal and Law Enforcement </li>
</ul>

<hr>

<p><b>Index of Contributors, Contractors and Consultants</b> </p>

<p><b>Research Papers Prepared for the Commission <br>
</b></p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="61536" -->

<p><br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-16</DOCNO>
<DOCOLDNO>IA088-000636-B009-64</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/shrthist.htm 206.61.184.43 19970122100009 text/html 12615
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:59:59 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:39:15 GMT
Content-length: 12397
</DOCHDR>
<html>

<head>
<title>A Short History of the Drug Laws </title>
<meta name="GENERATOR"
content="Internet Assistant for Microsoft Word 2.0z Beta">
</head>

<body>

<p> </p>
</body>

<body bgcolor="#ffffff">

<p><img src="../graphics/blueline.gif" align="BOTTOM"> </p>

<h1>A Short History of the Drug Laws </h1>

<p> <b>by the National Clearinghouse for Alcohol and Drug
Information </b> </p>

<p> <img src="../graphics/blueline.gif" align="BOTTOM"> </p>

<p> ------begin quote------- </p>

<p> The history of nonmedical drug use, and the development of
policies in response to drug use, also extends back to the early
settlement of the country. Like alcohol, the classification of
certain drugs as legal, or illegal, has changed over time. These
changes sometimes had racial and class overtones. </p>

<p> According to Mosher and Yanagisako, for example, Prohibition
was in part a response to the drinking practices of European
immigrants, who became the new lower class. Cocaine and opium
were legal during the 19th century, and were favored drugs among
the middle and upper classes. Cocaine became illegal after it
became associated with African Americans following
Reconstruction. Opium was first restricted in California in 1875
when it became associated with Chinese immigrant workers.
Marijuana was legal until the 1930s when it became associated
with Mexicans. LSD, legal in the 1950s, became illegal in 1967
when it became associated with the counterculture. </p>

<p> ------begin quote------- </p>

<p> ------begin full text---------- </p>

<p> Historical Overview of Prevention </p>

<p> Alcoholic beverages have been a part of the Nation's past
since the landing of the Pilgrims. According to Alcohol and
Public Policy: Beyond the Shadow of Prohibition, a publication
commissioned by NIAAA and prepared by the National Academy of
Sciences, the colonists brought with them from Europe a high
regard for alcoholic beverages, which were considered an
important part of their diet. Drinking was pervasive because
alcohol was regarded primarily as a healthy substance with
preventive and curative powers, not as an intoxicant. Alcohol was
also believed to be conducive to social as well as personal
health. It played an essential role in rituals of conviviality
and collective activity, such as barn raisings. While drunkenness
was condemned and punished, it was viewed only as an abuse of a
God-given gift. </p>

<p> The first temperance movement began in the early 1800s in
response to dramatic increases in production and consumption of
alcoholic beverages, which also coincided with rapid demographic
changes. Agitation against ardent spirits and the public disorder
they spawned gradually increased during the 1820s. In addition,
inspired by the writings of Benjamin Rush, the concept that
alcohol was addicting, and that this addiction was capable of
corrupting the mind and the body, took hold. The American Society
of Temperance, created in 1826 by clergymen, spread the
anti-drinking gospel. By 1835, out of a total population of 13
million citizens, 1.5 million had taken the pledge to refrain
from distilled spirits. The first wave of the temperance movement
(1825 to 1855) resulted in dramatic reductions in the consumption
of distilled spirits, although beer drinking increased sharply
after 1850. </p>

<p> The second wave of the temperance movement occurred in the
late 1800s with the emergence of the Women's Christian Temperance
Movement, which, unlike the first wave, embraced the concept of
prohibition. It was marked both by the recruitment of women into
the movement and the mobilization of crusades to close down
saloons. The movement set out to remove the destructive
substance, and the industries that promoted its use, from the
country. The movement held that while some drinkers may escape
problems of alcohol use, even moderate drinkers flirted with
danger. </p>

<p> The culmination of this second wave was the passage of the
18th Amendment and the Volstead Act, which took effect in 1920.
While Prohibition was successful in reducing per capita
consumption and some problems related to drinking, its social
turmoil resulted in its repeal in 1933. </p>

<p> Since the repeal of Prohibition, the dominant view of alcohol
problems has been that alcoholism is the principal problem. With
its focus on treatment, the rise of the alcoholism movement
depoliticized alcohol problems as the object of attention, as the
alcoholic was considered a deviant from the predominant styles of
life of either abstinence or &quot;normal&quot; drinking. The
alcoholism movement is based on the belief that chronic or
addictive drinking is limited to a few, highly susceptible
individuals suffering from the disease of alcoholism. The disease
concept of alcoholism focuses on individual vulnerability, be it
genetic, biochemical, psychological, or social/cultural in
nature. Under this view if the collective problems of each
alcoholic are solved, it follows that society's alcohol problem
will be solved. </p>

<p> Nevertheless, the pre-Prohibition view of alcohol as a
special commodity has persisted in American society and is an
accepted legacy of alcohol control policies. Following Repeal,
all States restricted the sale of alcoholic beverages in one way
or another in order to prevent or reduce certain alcohol
problems. In general, however, alcohol control policies
disappeared from the public agenda as both the alcoholism
movement and the alcoholic beverage industry embraced the view,
&quot;the fault is in the man and not in the bottle.&quot; </p>

<p> This view of alcoholism problems has also been the dominant
force in contemporary alcohol problem prevention. Until recently
the principal prevention strategies focused on education and
early treatment. Within this view education is intended to inform
society about the disease and to teach people about the early
warning signs so that they can initiate treatment as soon as
possible. Efforts focus on &quot;high risk&quot; populations and
attempt to correct a suspect process or flaw in the individual,
such as low self esteem or lack of social skills. The belief is
that the success of education and treatment efforts in solving
each alcoholic's problem will solve society's alcohol problem as
well. </p>

<p> Contemporary alcohol problem prevention began in the 1970s as
new information on the nature, magnitude, and incidence of
alcohol problems raised public awareness that alcohol can be
problematic when used by any drinker, depending upon the
situation. There was a renewed emphasis on the diverse
consequences of alcohol use--particularly trauma associated with
drinking driving, fires, and violence, as well as long term
health consequences. </p>

<p> The history of nonmedical drug use, and the development of
policies in response to drug use, also extends back to the early
settlement of the country. Like alcohol, the classification of
certain drugs as legal, or illegal, has changed over time. These
changes sometimes had racial and class overtones. According to
Mosher and Yanagisako, for example, Prohibition was in part a
response to the drinking practices of European immigrants, who
became the new lower class. Cocaine and opium were legal during
the 19th century, and were favored drugs among the middle and
upper classes. Cocaine became illegal after it became associated
with African Americans following Reconstruction. Opium was first
restricted in California in 1875 when it became associated with
Chinese immigrant workers. Marijuana was legal until the 1930s
when it became associated with Mexicans. LSD, legal in the 1950s,
became illegal in 1967 when it became associated with the
counterculture. </p>

<p> By the end of the 19th century concern had grown over the
indiscriminate use of these drugs, especially the addicting
patent medicines. Cocaine, opium, and morphine were common
ingredients in various potions sold over the counter. Until 1903,
cocaine was an ingredient of Coca-Cola(R). Heroin, which was
isolated in 1868, was hailed as a nonaddicting treatment for
morphine addiction and alcoholism. States began to enact control
and prescription laws and, in 1906, Congress passed the Pure Food
and Drug Act. It was designed to control opiate addiction by
requiring labels on the amount of drugs contained in products,
including opium, morphine, and heroin. It also required accurate
labeling of products containing alcohol, marijuana, and cocaine. </p>

<p> The Harrison Act (1914) imposed a system of taxes on opium
and coca products with registration and record-keeping
requirements in an effort to control their sale or distribution.
However, it did not prohibit the legal supply of certain drugs,
especially opiates. </p>

<p> Current drug laws are rooted in the 1970 Controlled
Substances Act. Under this measure drugs are classified according
to their medical use, their potential for abuse, and their
likelihood of producing dependence. The Act contains provisions
for adding drugs to the schedule, and rescheduling drugs. It also
establishes maximum penalties for the criminal manufacture or
distribution of scheduled drugs. </p>

<p> Increases in per capita alcohol consumption as well as
increased use of illegal drugs during the 1960s raised public
concern regarding alcohol and other drug problems. Prevention
issues gained prominence on the national level with the creation
of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)
in 1971 and the National Institute on Drug Abuse (NIDA) in 1974.
In addition to mandates for research and the management of
national programs for treatment, both Institutes included
prevention components. </p>

<p> To further prevention initiatives at the Federal level, the
Anti-Drug Abuse Act of 1986 created the U.S. Office for Substance
Abuse Prevention (OSAP), which consolidated alcohol and other
drug prevention activities under the Alcohol, Drug Abuse, and
Mental Health Administration (ADAMHA). The ADAMHA block grant
mandate called for States to set aside 21 percent of the alcohol
and drug funds for prevention. In a 1992 reorganization, OSAP was
changed to the Center for Substance Abuse Prevention (CSAP), part
of the new SAMHSA, retaining its major program areas, while the
research institutes of NIAAA and NIDA transferred to NIH. </p>

<p> The Office of National Drug Control Policy (ONDCP) was
established by the Anti-Drug Abuse Act of 1988. Its primary
objective was to develop a drug control policy that included
roles for the public and private sector to &quot;restore order
and security to American neighborhoods, to dismantle drug
trafficking organizations, to help people break the habit of drug
use, and to prevent those who have never used illegal drugs from
starting.&quot; In early 1992 underage alcohol use was included
among the drugs to be addressed by ONDCP. </p>

<p> While Federal, State, and local governments play a
substantial role in promoting prevention agendas, much of the
activity takes place at grass roots community levels. In addition
to funding from CSAP's &quot;Community Partnerships&quot; grant
program, groups receive support from private sources, such as The
Robert Wood Johnson &quot;Fighting Back&quot; program. </p>

<p> While alcohol and other drug problems continue to plague the
Nation at intolerably high levels, progress is being made.
National surveys document a decline in illicit drug use and a
leveling off of alcohol consumption. And indicators of problem
levels, such as alcohol-involved traffic crashes, show
significant declines. </p>

<p> <b>References</b> </p>

<p> A Promising Future: Alcohol and Other Drug Problem Prevention
Services Improvement. CSAP Prevention Monograph 10 (1992) BK191 </p>

<p> National Household Survey on Drug Abuse: Main Findings 1990
(1991) BKD67 </p>

<p> Mosher, J.F. and Yanagisako, K.L. &quot;Public Health, Not
Social Warfare: A Public Health Approach to Illegal Drug
Policy,&quot; Journal of Public Health Policy 12(3):278-322, 1991
<br>
</p>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> <br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-17</DOCNO>
<DOCOLDNO>IA086-000614-B048-24</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/Library/studies/duapip/pipmenu.htm 206.61.184.43 19970122023024 text/html 23916
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 02:30:18 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 07:12:42 GMT
Content-length: 23698
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Drug Use In America: Problem in Perspective - Table of
Contents</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include"
u-include="../../../../_private/scmj_sig_of_mis_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="../nc/ncmenu.htm">Marihuana, A Signal of
Misunderstanding</a></p>

<p>&nbsp;</p>
<!--webbot bot="Include" endspan i-checksum="54773" -->

<h1>The Report of the National Commission on Marihuana and Drug
Abuse </h1>

<h2>Drug Use In America: Problem in Perspective </h2>

<p><b>Commissioned by President Richard M. Nixon, March, 1972</b>
</p>

<p>&nbsp;</p>

<hr>

<p><b><u>Table of Contents</u></b> </p>

<p>Letter of Transmittal </p>

<p>Introduction </p>

<hr>

<h2><a href="pip1.htm">Chapter One -- Defining the Issues </a></h2>

<ul>
    <li>Definitional Confusion: What is Drug Abuse? <ul>
            <li>&quot;Drug&quot;-The All-Purpose Concept </li>
            <li>Drug Abuse: Synonym for Social Disapproval </li>
            <li>The Roots of a &quot;Problem&quot; </li>
        </ul>
    </li>
    <li>The Social Response: False Premises and the Perpetuation
        of a Problem <ul>
            <li>The Assumptions and Premises of Present Policy </li>
        </ul>
        <ul>
            <li>Elimination of Non-Medical Drug Use </li>
            <li>Risk-Taking and Health </li>
            <li>Motivation for Mood Alteration </li>
            <li>Drugs and Individual Responsibility </li>
        </ul>
    </li>
    <li>An Overview of the Present Response <ul>
            <li>Risk-Education </li>
            <li>Coercion </li>
            <li>Sickness </li>
            <li>Perpetuating the Problem </li>
        </ul>
    </li>
    <li>Defining the Problem <ul>
            <li>The Meaning of Drug Use <ul>
                    <li>The Incidence of Drug Use </li>
                    <li>Drug Using Behavior </li>
                    <li>Drug-Related Risk <ul>
                            <li>Risks to Individual Health </li>
                            <li>Drug-Induced Behavior </li>
                            <li>Dependence Liability </li>
                        </ul>
                    </li>
                </ul>
            </li>
            <li>Evaluating the Social Consequences of Drug Use </li>
            <li>Defining America's Drug Problem </li>
            <li>The Limits of Social Control </li>
        </ul>
    </li>
    <li>The Commission's Role </li>
</ul>

<hr>

<h2>Chapter Two </h2>

<p><b>Drug Using Behavior in the United States</b> </p>

<ul>
    <li>I. Drug Use in the General Population <ul>
            <li>Tobacco and Alcohol </li>
            <li>Use of Proprietary and Ethical Psychoactive
                Substances <ul>
                    <li>Incidence and Prevalance </li>
                    <li>Demographic Characteristics </li>
                    <li>Motivations for Use </li>
                    <li>Multi-Drug Use <ul>
                            <li>Alcohol, Ethical and Proprietary
                                Psychoactive Drugs </li>
                            <li>Marihuana and Ethical and
                                Proprietary Psychoactive Drugs </li>
                            <li>Concurrent Drug Usage </li>
                        </ul>
                    </li>
                </ul>
            </li>
            <li>Illicit Drug Use in the General Population <ul>
                    <li>Marihuana </li>
                    <li>LSD, Other Hallucinogens </li>
                    <li>Glue, Other Inhalants </li>
                    <li>Cocaine </li>
                    <li>Heroin </li>
                    <li>Multi-Drug Use </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>II. Drug Use Among Students <ul>
            <li>Survey Methodology </li>
            <li>Comparative National Survey Student Data </li>
            <li>Incidence of Student Drug Use <ul>
                    <li>Alcohol </li>
                    <li>Marihuana </li>
                    <li>Inhalants </li>
                    <li>Hallucinogens </li>
                    <li>Stimulants </li>
                    <li>Depressants </li>
                    <li>Opiates </li>
                </ul>
            </li>
            <li>Patterns of Student Drug Use <ul>
                    <li>Present and Future Drug Involvement </li>
                    <li>Frequency and Intensity of Drug Use </li>
                    <li>Duration of Student Drug Use </li>
                    <li>Multi-Drug Use </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>III. A Typology of Drug-Using Behavior <ul>
            <li>Experimental Use </li>
            <li>Social-Recreational Use </li>
            <li>Circumstantial-Situational Use </li>
            <li>Intensified Drug Use </li>
            <li>Compulsive Drug Use </li>
        </ul>
    </li>
    <li>IV. Psychosocial and Institutional Influences on
        Drug-Using Behavior <ul>
            <li>Broad Cultural Influences </li>
            <li>Drugs and Youth <ul>
                    <li>Experimentation, Availability and Need </li>
                    <li>Personal Dissatisfaction and the Search
                        for &quot;Something of Value&quot; </li>
                    <li>Age and Responsibility </li>
                    <li>The Impact of Extended Education </li>
                    <li>Institutional Sources of Identity </li>
                </ul>
            </li>
            <li>Mood Alteration in America </li>
            <li>Factors Bearing on Drug Dependence </li>
            <li>A Final Note </li>
        </ul>
    </li>
</ul>

<hr>

<h2>Chapter Three </h2>

<p><a href="pip3.htm"><b>The Social Impact of Drug Dependence and
Drug-Induced Behavior</b></a><b> </b></p>

<ul>
    <li>I. Drug Dependence <ul>
            <li>Terminological Confusion <ul>
                    <li>Addiction </li>
                    <li>Habituation </li>
                    <li>The Search for Precision </li>
                    <li>Drug Dependence </li>
                    <li>Excising &quot;Addiction&quot; </li>
                </ul>
            </li>
            <li>Toward a Functional Understanding of Drug
                Dependence <ul>
                    <li>Psychological Dependence: The Primary
                        Reinforcer </li>
                    <li>The Pharmacological Component:
                        Reinforcement Potential </li>
                    <li>Psycho-Social Components </li>
                    <li>The Development of Dependence:
                        Conditioning </li>
                    <li>The Dependence Continuum </li>
                    <li>Measuring the Degree of Dependence:
                        Psychological Components </li>
                    <li>Physical Dependence: The Secondary
                        Reinforcer </li>
                    <li>Summary </li>
                </ul>
            </li>
            <li>Evaluating the Social Impact of Drug Dependence <ul>
                    <li>Dependence, Health and Behavior </li>
                    <li>The Vulnerability Factor </li>
                    <li>The Relevance of Social Response </li>
                </ul>
            </li>
            <li>Present Social Impact <ul>
                    <li>Alcohol </li>
                    <li>Heroin </li>
                    <li>Barbiturates </li>
                    <li>Amphetamines and Related Stimulants </li>
                    <li>Cocaine </li>
                    <li>Hallucinogens </li>
                    <li>Cannabis </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>II. Drug Induced Behavior <ul>
            <li>Impact on Perception </li>
            <li>Impact on Memory </li>
            <li>Alteration of Mental States </li>
            <li>Impairment of Psychomotor Function </li>
            <li>Summary </li>
        </ul>
    </li>
    <li>III.Impact on Public Safety <ul>
            <li>Drugs and Crime <ul>
                    <li>Drugs and Their Criminogenic Effects <ul>
                            <li>Alcohol </li>
                            <li>Marihuana </li>
                            <li>Barbiturates </li>
                            <li>Amphetamines </li>
                            <li>Opiates </li>
                            <li>Cocaine </li>
                            <li>Hallucinogens </li>
                            <li>Other Psychoactive Substances </li>
                            <li>Summary </li>
                        </ul>
                    </li>
                </ul>
            </li>
            <li>Psychosocial Characteristics of Drug-Dependent
                Persons: Implications for Public Safety </li>
            <li>Social and Demographic Characteristics <ul>
                    <li>Age </li>
                    <li>Educational Status </li>
                    <li>Income, Occupation and Employment Status </li>
                    <li>Home Environment and Marital Status </li>
                    <li>Psychological Characteristics </li>
                </ul>
            </li>
            <li>Problems in Inferring Causation </li>
            <li>The Costs of Heroin Dependence <ul>
                    <li>Cost to the Heroin-Dependent Person </li>
                    <li>Cost to Society from Criminal Activity </li>
                    <li>Criminal Justice Costs: Processing the
                        Drug-Dependent Person </li>
                </ul>
            </li>
            <li>The Effect of Drug Treatment on Crime <ul>
                    <li>Current Research Findings </li>
                    <li>A Realistic Appraisal </li>
                </ul>
            </li>
            <li>Drugs and Driving <ul>
                    <li>Research Limitations </li>
                    <li>Research Findings <ul>
                            <li>Alcohol </li>
                            <li>Marihuana </li>
                            <li>Other Psychoactive Substances </li>
                        </ul>
                    </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>IV. Impact on Public Health and Welfare <ul>
            <li>Public Health and Welfare: A Preventive Concept </li>
            <li>Assessing the Public Health and Welfare Impact of
                Drug Use <ul>
                    <li>The Population of Heavy Alcohol Users </li>
                    <li>Economic Loss </li>
                    <li>Death <ul>
                            <li>Alcohol </li>
                            <li>Heroin </li>
                            <li>Barbiturates </li>
                        </ul>
                    </li>
                    <li>Medical Complications of Chronic Drug Use
                    </li>
                    <li>Impact on the Family Structure </li>
                    <li>Compensatory Social Costs </li>
                </ul>
            </li>
            <li>Framing a Public Health Response </li>
        </ul>
    </li>
</ul>

<hr>

<h2>Chapter Four </h2>

<p><b>Toward a Coherent Social Policy</b> </p>

<ul>
    <li>The Process </li>
    <li>Goals and Premises <ul>
            <li>Drugs and Social Responsibility </li>
            <li>Irresponsible Use </li>
            <li>Discouragement and Social Tolerance </li>
            <li>Responsible Decision Making </li>
            <li>Risks and Perceived Advantages </li>
            <li>Designing a Differential Response to Drug Use </li>
        </ul>
    </li>
    <li>I. The Availability Decision <ul>
            <li>Models of Availability </li>
            <li>The Calculus: An Overview <ul>
                    <li>Relative Social Cost </li>
                    <li>Efficacy of Controls </li>
                    <li>Cost of Controls </li>
                    <li>The Social Context of the Availability
                        Decision </li>
                </ul>
            </li>
            <li>The Present System <ul>
                    <li>Availability Not Limited As To Purpose of
                        Consumption </li>
                    <li>Availability Limited As To Purpose of
                        Consumption </li>
                    <li>Substances Not Available For Consumption </li>
                </ul>
            </li>
            <li>Specific Recommendations <ul>
                    <li>Opiates </li>
                    <li>Cocaine </li>
                    <li>Amphetamines </li>
                    <li>Barbiturates </li>
                    <li>Non-Barbiturate Sedatives </li>
                    <li>Minor Tranquilizers </li>
                    <li>Hallucinogens </li>
                    <li>Marihuana </li>
                    <li>Alcohol </li>
                </ul>
            </li>
            <li>Implementing Restrictions on Availability <ul>
                    <li>The Role of International Agreements </li>
                    <li>Federal Enforcement Policy </li>
                    <li>State Enforcement Policy </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>II. The Consumption-Intervention Decision <ul>
            <li>An Overview of the Possession Offense </li>
            <li>Deviance, Deterrence and Symbolism <ul>
                    <li>Philosophical Conflict </li>
                    <li>Constitutionality </li>
                    <li>Functional Overview </li>
                    <li>Deterrence </li>
                    <li>Social Costs of Enforcement </li>
                    <li>Possession and Supply </li>
                    <li>Symbolism </li>
                </ul>
            </li>
            <li>Sickness and Treatment <ul>
                    <li>Origins of the Cult of Curability </li>
                    <li>Addiction and Treatment: The Early Days </li>
                    <li>The Therapeutic Premise Takes Hold </li>
                    <li>Therapeutic Intervention Comes Under
                        Attack </li>
                    <li>Harnessing the Therapeutic Response </li>
                    <li>Involuntary &quot;Civil&quot; Commitment:
                        The Problems of a Therapeutic Response </li>
                    <li>Therapy and the Criminal Process </li>
                </ul>
            </li>
            <li>Dangerousness and Prevention <ul>
                    <li>Crime and the Public Safety </li>
                    <li>Contagion and the Public Health and
                        Welfare </li>
                    <li>The Appropriate Role of Preventive
                        Intervention </li>
                </ul>
            </li>
            <li>Conclusion: The Possession Offense and Its
                Enforcement <ul>
                    <li>Functional Enforcement </li>
                    <li>Role of the Police </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>III. Defining the Government's Role <ul>
            <li>Governmental Competence </li>
            <li>General Guidelines </li>
            <li>Analyzing the Government Response <ul>
                    <li>An Overview of the Government Response </li>
                    <li>The Special Action Office: A Stopgap </li>
                    <li>Failures of the Present System <ul>
                            <li>Identification of the Nature and
                                Extent of Drug Use </li>
                            <li>Definition of goals and
                                objectives for drug-related
                                functions </li>
                            <li>Effective planning </li>
                            <li>Affective control of resource
                                allocation </li>
                            <li>Coordination among federal
                                agencies </li>
                            <li>Drug-related functions within
                                agencies whose primary mission is
                                not solving drug problems </li>
                            <li>Evaluation of programs in terms
                                of their effectiveness </li>
                            <li>Evaluation of programs in terms
                                of efficiency </li>
                            <li>Separation of drug and alcohol
                                activities </li>
                        </ul>
                    </li>
                </ul>
            </li>
            <li>Reorganizing the Governmental Response <ul>
                    <li>Bringing the Drug Effort Under Control </li>
                    <li>The Structure of the Unified Approach </li>
                    <li>Organization of Response at the Community
                        Level </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>IV. Treatment and Rehabilitation <ul>
            <li>An Overview of the Present Response <ul>
                    <li>Uncertainty About the Illness </li>
                    <li>Uncertainty About the Objective of
                        Treatment </li>
                    <li>Diversity of Method </li>
                </ul>
            </li>
            <li>History of the Treatment of Opiate Dependence <ul>
                    <li>1870-1900: The Early Years </li>
                    <li>1900-1915: Years of Optimism </li>
                    <li>1915-1930: Confidence Wanes </li>
                    <li>1930-1960: The Dry Years </li>
                    <li>The Sixties: Society Turns to Therapy
                        Again </li>
                </ul>
            </li>
            <li>Present Methods and Models of Treatment <ul>
                    <li>Hospitalization </li>
                    <li>Ambulatory Drug-Free Treatment </li>
                    <li>Therapeutic Communities </li>
                    <li>Methadone Maintenance </li>
                    <li>Antagonist Treatment </li>
                    <li>Multi-Modality Programs </li>
                    <li>Treatment for Non-Opiate Drug Dependence </li>
                </ul>
            </li>
            <li>The Role of the Law in Treatment <ul>
                    <li>Legal Controls as Therapy <ul>
                            <li>Civil Procedures </li>
                            <li>Criminal Procedures </li>
                        </ul>
                    </li>
                </ul>
            </li>
            <li>Legal Control of the Treatment Process </li>
            <li>Heroin Maintenance </li>
            <li>Conclusions and Recommendations on Treatment of
                Dependence <ul>
                    <li>Federal Funding and Services </li>
                    <li>Federal Evaluation </li>
                    <li>State Treatment Programs </li>
                    <li>The Role of the Legal System in State
                        Programs </li>
                    <li>Uniformity of State Law </li>
                    <li>Emergency Treatment of Drug Users </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>V. Prevention <ul>
            <li>The Information-Education Explosion </li>
            <li>Goals of Information-Education Prevention </li>
            <li>Information Policy </li>
            <li>Education </li>
            <li>Training </li>
            <li>The Media and Drug Use Prevention </li>
            <li>Other Prevention Strategies and Techniques </li>
            <li>Summary and Conclusion </li>
        </ul>
    </li>
    <li>VI. Research <ul>
            <li>A New Interest in Research </li>
            <li>The Need for a Directed Research Plan <ul>
                    <li>Incidence, Frequency and Intensity of
                        Drug Use </li>
                    <li>Etiology and Consequences of Drug Use </li>
                    <li>The Role of the Criminal Justice System </li>
                    <li>Efficacy of Treatment </li>
                    <li>Other Areas </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>VII. The Private Response <ul>
            <li>The Health Professions </li>
            <li>Pharmaceutical Industry </li>
            <li>Alcohol Industry </li>
            <li>Legal Profession </li>
            <li>Industry </li>
            <li>Colleges and Universities </li>
            <li>Mass Media </li>
            <li>The Religious Community </li>
            <li>The Family </li>
        </ul>
    </li>
</ul>

<hr>

<h2>Chapter Five </h2>

<p><b>Looking Ahead</b> </p>

<ul>
    <li>The Immediate Future: The Goal of the Commission's
        Recommendations <ul>
            <li>Changing Attitudes </li>
            <li>Filling the Informational Gaps </li>
            <li>Unifying the Government Response </li>
            <li>Developing the Private Response </li>
            <li>Improving Controls on Availability </li>
            <li>Rationalizing Consumption Controls </li>
            <li>Expanding Treatment, Rehabilitation and
                Prevention Services </li>
        </ul>
    </li>
    <li>The Immediate Future </li>
    <li>Policy Making Over the Long Term <ul>
            <li>Confronting the Basic Question </li>
            <li>Reappraisal: The Need for Evaluation </li>
        </ul>
    </li>
</ul>

<hr>

<p>Sources </p>

<p>Bibliography </p>

<p>Consultants </p>

<p>Contractors and Contributors </p>

<p>Research Papers Prepared for Commission </p>

<p>Recommendations </p>

<p>Index of First Year Recommendations </p>

<p>Index of Second Year Recommendations<br>
</p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../../_private/scmj_sig_of_mis_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="../nc/ncmenu.htm">Marihuana, A Signal of
Misunderstanding</a></p>

<p>&nbsp;</p>
<!--webbot bot="Include" endspan i-checksum="54773" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-18</DOCNO>
<DOCOLDNO>IA088-000636-B009-303</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/studies.htm 206.61.184.43 19970122100312 text/html 49952
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 10:03:00 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 19-Jan-97 10:56:02 GMT
Content-length: 49736
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Major Studies of Drugs and Drug Policy - Titles and
Summaries</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="33179" -->

<h1>Major Studies of Drugs and Drug Policy </h1>

<p><b>This page will contain full-text copies of the major
studies of drugs and drug policy as they become available and as
we have resources to scan them and put them on the web. Readers
who wish to fund the addition of new research to the web should
see </b><a href="../../support/support.htm"><b>How You Can
Support the Schaffer Library</b></a><b>.</b></p>

<p><b>We are currently seeking copies of any reports for which we
do not yet have full text. These reports are marked with <img
src="../../../images/dot_red.GIF" width="20" height="16"></b></p>

<p><b>We also invite submissions of major reports which are not
yet listed here.</b> </p>

<p><a href="../../library/studies/majortoc1.htm"><font size="4">&nbsp;Major
Studies Table of Contents</font></a><font size="4"> - Titles only</font></p>

<hr>

<table border="3" bordercolor="#000080">
    <tr>
        <td><b>Year</b></td>
        <td><b>Country</b></td>
        <td><b>Title</b> </td>
    </tr>
    <tr>
        <td width="61"><strong>1894</strong></td>
        <td width="71"><strong>India</strong></td>
        <td width="451"><a href="inhemp/ihmenu.htm"><strong>Indian
        Hemp Drugs Commission Report</strong></a><strong> </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This 3,281-page, seven-volume classic report on
            the marijuana problem in India by British and
            concluded: &quot;Viewing the subject generally, it
            may be added that moderate use of these drugs is the
            rule, and that the excessive use is comparatively
            exceptional. The moderate use produces practically no
            ill effects.&quot; Nothing of significance in the
            report's conclusions has been proven wrong in the
            intervening century </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1905</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Report of the
        Committee Appointed by the Philippine Commission to
        Investigate The Use of Opium and the Traffic
        Therein...Bureau of Insular Affairs, War Dept.,
        Philippines </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1926</strong></td>
        <td width="71"><strong>England</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Departmental Committee
        on Morphine and Heroin Addiction, Report </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>(The Rolleston Report): This landmark study by a
            distinguished group of British doctors appointed by
            the government codified existing practices regarding
            the maintenance of addicts on heroin and morphine by
            individual doctors and recommended that they continue
            without police or medical society interference. In
            coming to this conclusion, these physicians displayed
            a humane regard for the addicts in their care,
            perhaps due to their view of the nature of narcotic
            addiction: &quot;Me condition must be regarded as a
            manifestation of disease and not as a mere form of
            vicious indulgence.&quot; The British addiction
            experts took pains to state that they did not agree
            with the opinions of &quot;some eminent physicians,
            especially in the United States&quot; that addicts
            &quot;could always be cured by sudden
            withdrawal.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1928</strong></td>
        <td><strong>US</strong></td>
        <td><a href="op/opmenu.htm"><strong>The Opium Problem</strong></a><strong>
        by Charles E. Terry and Mildred Pellens </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61">1<strong>929</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Panama Canal Zone
        Military Investigations (US Military, 1916-29) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>After an exhaustive study of the smoking of
            marijuana among American soldiers stationed in the
            zone, the panel of civilian and military experts
            recommended that &quot;no steps be taken by the Canal
            Zone authorities to prevent the sale or use of
            Marihuana.&quot; The committee also concluded that
            &quot;there is no evidence that Marihuana as grown
            and used [in the Canal Zone] is a 'habit-forming'
            drug.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1930</strong></td>
        <td><strong>US</strong></td>
        <td><strong>Wickersham Commission Report on Alcohol
        Prohibition </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1944</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="lag/lagmenu.htm"><strong>The
        LaGuardia Committee Report</strong></a><strong> Mayor's
        Committee on Marihuana, The Marihuana Problem in the City
        of New York commissioned by Mayor Fiorello LaGuardia,
        written by the New York Academy of Medicine, and
        published by the City of New York in 1944 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This study is viewed by many experts as the best
            study of any drug viewed in its social, medical, and
            legal context. The committee covered thousands of
            years of the history of marijuana and also made a
            detailed examination of conditions In New York City.
            Among its conclusions: &quot;The practice of smoking
            marihuana does not lead to addiction in the medical
            sense of the word.&quot; And: &quot;The use of
            marihuana does not lead to morphine or heroin or
            cocaine addiction, and no effort is made to create a
            market for those narcotics by stimulating the
            practice of marihuana smoking.&quot; Finally:
            &quot;The publicity concerning the catastrophic
            effects of marihuana smoking in New York City is
            unfounded.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1961</strong></td>
        <td width="71"><strong>England</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Interdepartmental
        Committee, Drug Addiction, (The First Brain Report) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>When the Brain Committee first met at the
            invitation of the minister of health, its mission was
            to review the advice given by the Rolleston Committee
            in 1926. That advice had been to continue to allow
            doctors to treat addicts with maintenance doses of
            powerful drugs when the doctors deemed it medically
            helpful for the patient. Brain I reiterated that
            advice and in this first report recommended no
            changes of any significance on the prescribing powers
            of doctors. This report expanded on one important
            point alluded to in Rolleston-the authenticity of the
            existence of &quot;stabilized addicts.&quot; </p>
            <p>While many American experts doubt their existence,
            this report explained, &quot;careful scrutiny of the
            histories of more than a hundred persons classified
            as addicts reveals that many of them who have been
            taking small and regular doses for years show little
            evidence of tolerance and are often leading
            reasonably satisfactory lives.&quot; Six &quot;case
            histories of known stabilized addicts&quot; were
            included in an appendix. They were mature, older
            patients, functioning normally on what would be huge
            doses of drugs by American standards. &quot;Mr.
            F.,&quot; for example, a clerical worker, was
            receiving the equivalent of 200 milligrams of
            morphine tablets each day. It is likely that these
            patients and their doctors would be dealt with as
            criminals in the United States. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1961</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Drug Addiction: Crime
        or Disease? Joint Committee of the American Bar
        Association and the American Medical Association on
        Narcotic Drugs, Interim and Final Reports, 1961: </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This report was the result of the only major
            combined study of drug policy made by two of the most
            important professional societies in the country.
            Chaired by attorney Rufus King of Washington, D.C..
            the committee presented a direct challenge to the
            tough policies of Federal Bureau of Narcotics
            Director Harry Anslinger, a philosophical ancestor of
            the previous &quot;drug czar,&quot; William Bennett.
            The blue-ribbon committee included a senior federal
            judge and was advised by Indiana University's Alfred
            Lindesmith, one of the most distinguished addiction
            scholars in history. The report observed, &quot;Drug
            addiction is primarily a problem for the physician
            rather than the policeman, and it should not be
            necessary for anyone to violate the criminal law
            solely because he is addicted to drugs.&quot; The
            report concluded that drug addiction was a disease,
            not a crime, that harsh criminal penalties were
            destructive, that drug prohibition ought to be
            reexamined, and that experiments should be conducted
            with British-style maintenance clinics for narcotic
            addicts. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1965</strong></td>
        <td width="71"><strong>England</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Interdepartmental
        Committee, Drug Addiction, Second Report, (The Second
        Brain Report) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Brain II has been consistently misinterpreted by
            leading American scholars and officials. It did not
            recommend the dismantling of the British prescription
            system nor the compulsory registration of addicts, as
            has been claimed. Instead, Brain II urged that </p>
            <ol>
                <li>doctors who wished to prescribe
                    &quot;restricted drugs&quot; to addicts for
                    the purpose of maintenance be required to
                    obtain a special license from the Home
                    Office; </li>
                <li>treatment centers be established for treating
                    addicts who were to be regarded as sick and
                    not criminal; and </li>
                <li>doctors and other medical personnel be
                    mandated to &quot;notify&quot; the Home
                    Office when they encountered an addict in the
                    course of their professional work.
                    Originally, the category of restricted drugs
                    included heroin and cocaine; now, dipipanone
                    has been added. </li>
            </ol>
            <p>The core of the British system remains, however,
            and in recent years has been reinvigorated.
            Approximately 200 doctors with special licenses are
            free to prescribe all drugs, including the restricted
            medicines, for maintenance of addicts. Also, any
            doctor, unlike those in the U.S., may prescribe all
            of the other drugs for maintenance, including, for
            example, injectable morphine and methadone. Brain II
            in the end was aimed at controlling a few
            overprescribing doctors, not at adopting the American
            system of treating addicts as the enemy. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1968</strong></td>
        <td width="71"><strong>England</strong></td>
        <td width="451"><a href="wootton/wootmenu.htm"><strong>Advisory
        Committee on Drug Dependence, Cannabis</strong></a><strong>,
        (The Wootton Report) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This study report on marijuana and hashish was
            prepared by a group that included some of the leading
            drug abuse experts of the United Kingdom. These
            impartial experts worked as a subcommittee under the
            lead of Baroness Wootton of Abinger. The basic tone
            and substantive conclusions were similar to all of
            the other great commission reports. The Wootton group
            specifically endorsed the conclusions of the Indian
            Hemp Drugs Commission and the La Guardia Committee.
            Typical findings included the following: </p>
        </blockquote>
        <blockquote>
            <ol>
                <li>There is no evidence that in Western society
                    serious physical dangers are directly
                    associated with the smoking of cannabis. </li>
                <li>It can clearly be argued on the world picture
                    that cannabis use does not lead to heroin
                    addiction. </li>
                <li>The evidence of a link with violent crime is
                    far stronger with alcohol than with the
                    smoking of cannabis. </li>
                <li>There is no evidence that this activity ...
                    is producing in otherwise normal people
                    conditions of dependence or psychosis,
                    requiring medical treatment. </li>
            </ol>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1970</strong></td>
        <td width="71"><strong>Canada</strong></td>
        <td width="451"><a href="ledain/NONMED1.HTM"><strong>Canadian
        Government Commission</strong></a><strong> of Inquiry
        into the Non-Medical Use of Drugs, Interim Report, (The
        Le Dain Report) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>The distinguished Canadian experts on this
            governmental commission were led by law school dean,
            later Supreme Court Justice, Gerald Le Dain. The
            report was similar to the other great commission
            reports in terms of its non-martial, calm approach to
            the facts and in its belief that marijuana use did
            not constitute a great threat to the public welfare.
            The official governmental commission was remarkable
            in the extent to which its report portrayed casual
            drug users as decent, thoughtful citizens whose views
            deserved the fullest possible hearing by the
            government in the process of developing drug control
            strategies. </p>
        </blockquote>
        <blockquote>
            <p>A mother of four and school teacher was quoted in
            the report as saying: &quot;When I smoke grass I do
            it in the same social way that I take a glass of wine
            at dinner or have a drink at a party. I do not feel
            that is one of the great and beautiful experiences of
            my life; I simply feel that it is pleasant, and I
            think it ought to be legalized.&quot; The commission
            did not ask for that change immediately but instead
            recommended that serious consideration be given to
            legalization of personal possession in the near
            future. The report also urged that police and
            prosecutors go easy on casual users and keep them out
            of jail as often as possible. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1970</strong></td>
        <td><strong>US</strong></td>
        <td><a href="vlr/vlrtoc.htm"><strong>The Forbidden Fruit
        and the Tree of Knowledge</strong></a><strong>: An
        Inquiry into the Legal History of American Marihuana
        Prohibition by Professors Richard J. Bonnie &amp; Charles
        H. Whitebread, II, Virginia Law Review, Volume 56,
        October 1970 Number 6 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This is the most definitive history of the
            marijuana laws. See <a
            href="../../History/whiteb1.htm">The History of the
            Non-Medical Use of Drugs</a> for the author's short
            version of this history. </p>
        </blockquote>
        <blockquote>
            <p>The authors concluded that the marijuana laws were
            motivated by three major factors.</p>
        </blockquote>
        <blockquote>
            <ol>
                <li>The first state marijuana prohibition law
                    came in Utah in 1915 and was enacted into law
                    along with a number of other Mormon religious
                    prohibitions. </li>
            </ol>
            <ol>
                <li>The early state marijuana laws in the
                    Southwest and West were passed because
                    &quot;All Mexicans are crazy and marijuana is
                    what makes them crazy.&quot; That is, they
                    were the result of racial prejudice against
                    newly arrived Mexican immigrants. </li>
                <li>The other early state marijuana laws were
                    passed out of the fear that opiate addicts,
                    who had been deprived of legal access to
                    opiates by the Harrison Tax Act of 1914,
                    would turn to marijuana. In other words, they
                    were afraid that opiate use would lead to
                    marijuana. </li>
            </ol>
            <p>The first Federal prohibition on marijuana was
            passed for reasons which can only be described as
            &quot;nonsense,&quot; including the racial reasons
            listed above, as well as allegations that marijuana
            caused young lovers to elope. Interested readers may
            want to review the original source documents under <a
            href="../../hemp/taxact/taxact.htm">Marihuana Tax Act
            of 1937</a>. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1972</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="cu/cumenu.htm"><strong>The
        Consumers Union Report on Licit and Illicit Drugs</strong></a><strong>,
        by Edward M. Brecher and the Editors of Consumer Reports
        Magazine </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This is a landmark study, a &quot;must-read&quot;,
            used as a basic textbook at major universities. This
            web page will ultimately include chapter by chapter
            summaries of the main points of this book. It is
            certainly one of the first books which should be read
            by people who want to know about this subject </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1972</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>The Koerner Commission
        Report, State of Ohio </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1972</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="dwda/dwdamenu.htm"><strong>Dealing
        With Drug Abuse: A Report to the Ford Foundation</strong></a><strong>,
        by the Drug Abuse Survey Project. </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1972</strong></td>
        <td><strong>US</strong></td>
        <td><a href="nc/ncmenu.htm"><strong>Marihuana: A Signal
        of Misunderstanding</strong></a><strong>, National
        Commission on Marihuana and Drug Abuse </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This commission was directed by Raymond P. Shafer,
            former Republican governor of Pennsylvania, and had
            four sitting, elected politicians among its eleven
            members. The commission also had leading addiction
            scholars among its members and staff and was
            appointed by President Nixon in the midst of the
            drug-war hysteria at that time. While the commission
            supported much existing policy, it produced two
            reflective reports, this being the final
            comprehensive document, which recommended research,
            experimentation, and humane compromise. The first
            recommendations of the commission were: </p>
        </blockquote>
        <blockquote>
            <ol>
                <li>Possession of marihuana for personal use
                    would no longer be an offense, but marihuana
                    possessed in public would remain contraband
                    subject to summary seizure and forfeiture. </li>
                <li>Casual distribution of small amounts of
                    marihuana for no remuneration, or
                    Insignificant remuneration not involving
                    profit, would no longer be an offense. </li>
            </ol>
            <p>The recommendations in this reports were endorsed
            by (among others) the American Medical Association,
            the American Bar Association, The American
            Association for Public Health, the National Education
            Association, and the National Council of Churches. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1973</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="duapip/pipmenu.htm"><strong>Drug
        Use in America: Problem in Perspective</strong></a><strong>,
        National Commission on Marihuana and Drug Abuse </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1977</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>The Nation's Toughest
        Drug Law: Evaluating the New York Experience, by the
        Joint Committee on New York Drug Law Evaluation, of the
        Association of the Bar of the City of New York </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This commission was formed to review the
            Rockefeller drug laws, the toughest in the nation.
            The report basically concluded that tougher sentences
            had provided little, if any, benefit. Instead, they
            had increased the incentive for drug sellers to
            commit violence and had clogged the criminal justice
            system. The report also found that tougher penalties
            had done nothing material to reduce drug use but had
            instead exacerbated some of the existing problems
            with drug abuse. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1980</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="fada/fadamenu.htm"><strong>The
        Facts About Drug Abuse</strong></a><strong>, The Drug
        Abuse Council </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>A 1972 report to the Ford Foundation,
            &quot;Dealing With Drug Abuse,&quot; concluded that
            current drug policies were unlikely to eliminate or
            greatly affect drug abuse. This conclusion led to the
            creation and joint funding by four major foundations
            of a broadly based, independent national Drug Abuse
            Council. The council reviewed and assessed laws,
            programs, and projects-federal, state, and local,
            private and governmental-related to use and misuse of
            psychoactive drugs. In its final report, the
            council's board of directors offered a set of
            observations considered central to the process of
            reaching mom consistent, coherent, and responsible
            approaches to drug use and misuse. </p>
            <ol>
                <li>Psychoactive substances have been available
                    throughout recorded history and will remain
                    so. To try to eliminate them completely is
                    unrealistic. </li>
                <li>The use of psychoactive drugs is pervasive,
                    but misuse is much less frequent, and the
                    failure to make the distinction between use
                    and misuse creates the impression that all
                    use is misuse and leads to addiction. </li>
                <li>There is a clear relationship between drug
                    misuse and pervasive societal ills such as
                    poverty, racial discrimination, and
                    unemployment, and we can expect drug misuse
                    so long as these adverse social conditions
                    exist. </li>
                <li>The price of an effective strategy to
                    eliminate drug misuse through the criminal
                    law would be perceived by many Americans as
                    too high in terms of invasions of privacy and
                    abrogations of individual liberties. </li>
                <li>Drug laws and policies attend insufficiently
                    to the problems of people misusing drugs and
                    too much to the properties of drugs
                    themselves, as though the drugs were somehow
                    inherently to blame. </li>
                <li>Too many Americans have unrealistic
                    expectations about what drug policies and
                    programs can accomplish. </li>
                <li>We have a regrettable tendency to blame our
                    drug problems on others, failing to recognize
                    that our drug problems are products of our
                    own national experience. </li>
            </ol>
            <p>The council's directors then offered a set of
            suggestions, Principal among them are the following, </p>
            <ol>
                <li>Treatment for drug dependence should be
                    available chiefly because people need help,
                    rather than as a crime control or behavior
                    control method. </li>
                <li>There should be a major study of the effects
                    of drug laws and their enforcement on
                    personal decisions to use or not use illicit
                    drugs. </li>
                <li>Legislative efforts to decriminalize at both
                    state and federal levels the possession of
                    small amounts of marijuana for personal use
                    should continue. </li>
                <li>The report ends with the recommendation:
                    &quot;... that serious consideration be given
                    to the use of state and local option as a
                    means of attempting solutions appropriate in
                    one place but not in others. Local options
                    could encourage greater flexibility and
                    ingenuity rather than reliance on an
                    unrealistic, rigid homogeneity in national
                    drug policy. We need to respond to the
                    diversity of people who use and misuse drugs,
                    base all our policies on a consistent set of
                    principles seeking to discourage misuse, and
                    keep our seemingly innate drug-using behavior
                    within reasonable limits through means. which
                    do not themselves produce more harm than they
                    prevent. </li>
            </ol>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1982</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>An Analysis of
        Marihuana Policy, National Research Council of the
        National Academy of Science </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>The NAS Committee on Substance Abuse and Habitual
            Behavior was composed of some of the leading American
            experts on medicine, addiction treatment, law,
            business, and public policy. These experts reviewed
            all of the available evidence on every aspect of the
            marijuana question. The committee then recommended
            that the country experiment with a system that would
            allow states to set up their own methods of
            controlling marijuana as is now done with alcohol.
            Under this approach, federal criminal penalties would
            be removed, and each state could decide to legalize
            the drug and impose regulations concerning hours of
            sale, age limits, and taxation. </p>
            <p>In the same vein as all the previous major
            objective studies, this report stated that excessive
            marijuana use could cause serious harm, that such use
            was rare, and that, on balance, the current policy of
            total prohibition was socially and personally
            destructive. The report placed great emphasis on
            building up public education and informal social
            controls, which often have a greater impact on drug
            abuse than the criminal law. Regarding the
            possibility of disaster for our youth under
            legalization, the report observed: </p>
            <p>There is reason to believe that widespread
            uncontrolled use would not occur under regulation.
            Indeed, regulation might facilitate patterns of
            controlled use by diminishing the &quot;forbidden
            fruit&quot; aspect of the drug and perhaps increasing
            the likelihood that an adolescent would be introduced
            to the drug through families and friends, who
            practice moderate use, rather than from their
            heaviest-using, most drug-involved peers, </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1988</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a
        href="http://www.commonlink.com/~olsen/MEDICAL/YOUNG/young.html"><strong>DEA
        Docket No. 86-22</strong></a><strong>, DEA Chief
        Administrative Law Judge ruling on medical marijuana </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This is the ruling of the DEA's own Chief
            Administrative Law Judge which arose as the result of
            a suit against the Federal Government, seeking to
            reschedule marijuana for medical purposes. Before
            issuing his ruling, Judge Francis Young heard two
            years of testimony from both sides of the issue and
            accumulated fifteen volumes of research. This was
            undoubtedly the most comprehensive study of medical
            marijuana done to date. Judge Young concluded that
            marijuana was one of the safest therapeutically
            active substances known to man, that it had never
            caused a single human death, and that the Federal
            Government's policy toward medical marijuana is
            &quot;unconscionable.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1989</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>AIDS and Drug Misuse,
        Part 1, Advisory Council on the Misuse of Drugs, 1988;
        Part 2, 1989 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>&quot;The spread of HIV is a greater danger to
            individual and public health than drug misuse,&quot;
            declared the leading drug abuse and health experts of
            the United Kingdom who sit on this distinguished
            quasi-governmental advisory group. This concept
            operated as the guiding principle in this commission
            report, one part issued in 1988, another in 1989. In
            stark contrast to the Bush administration's war
            plans, the British council provided a comprehensive
            health plan that seeks to prevent the use of drugs,
            as is the American goal. However, the plan has
            realistic goals regarding drug abusers; abstinence in
            the American mode, where possible, but above all
            else, health and life. Thus, the Advisory Council
            accepted the lessons of the &quot;harm
            reduction&quot; programs of the Liverpool area and
            recommended that they be spread to the entire United
            Kingdom. Some of these lessons involve needle
            exchanges and prescribed drugs for addicts. </p>
            <p>The report even went beyond the Liverpool
            experience when these leading British experts quietly
            observed, &quot;We believe that there is a place for
            an expansion of residential facilities where drug
            misusers may gain better health, skills, and
            self-confidence whilst in receipt of prescribed
            drugs.&quot; Thus, while the United States is
            planning more prison space for drug addicts, the
            United Kingdom is contemplating more hostels where
            addicts could be taught to live more healthy, more
            self-confident and more productive lives in the
            community. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1989</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><a href="../forum.htm"><strong>Report
        of the Research Advisory Panel </strong></a><strong>for
        the State of California </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This panel, appointed by the state legislature of
            California to regulate all research on controlled
            substances, reviewed drug policy and recommended that
            &quot;the legislature act to redirect this, state
            away from the present destructive pathways of drug
            control.&quot; The report noted that we had followed
            a path of prohibition over the last fifty years and
            concluded that this policy &quot;has been manifestly
            unsuccessful in that we are now using more and a
            greater variety of drugs, legal and illegal.&quot; In
            addition, the failure of prohibition has resulted in
            &quot;societal overreaction (that] has burdened us
            with ineffectual, inhumane, and expensive treatment,
            education and enforcement efforts.&quot; They
            recommended a move toward the formulation of
            &quot;legislation aiming at regulation and
            decriminalization&quot; and the winding down of the
            war on drugs. </p>
            <p>The Research Advisory Panel made three specific
            recommendations for initial legislative action. These
            were </p>
            <ol>
                <li>permit the possession of syringes and
                    needles; </li>
                <li>permit the cultivation of marijuana for
                    personal use; and </li>
                <li>in order to project an attitude of
                    disapproval of all drug use, take a token
                    action in forbidding the sale or consumption
                    of alcohol in state-supported institutions
                    devoted in part or whole to patient care or
                    educational activity. </li>
            </ol>
            <p>The panel recommended immediate and innovative
            action, concluding it is &quot;incontrovertible that
            whatever policies we have been following over the
            past generations must not be continued unexamined and
            unmodified since our actions to date have favored the
            development of massive individual and societal
            problems.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1991</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>&quot;The Twin
        Epidemics of Substance Use and HIV&quot; The National
        Commission on AIDS </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This indictment of current drug policy focuses on
            the relationship between the spread of HIV and drug
            use. The commission criticized the federal
            government's failure to recognize that these are twin
            epidemics and found that the &quot;strategy of
            interdiction and increased prison sentences has done
            nothing to change the stark statistics&quot; showing
            spread of AIDS by drug users. The commission singled
            out the Office of National Drug Control Policy for
            ignoring AIDS and &quot;neglecting the real public
            health and treatment measures which could and must be
            taken to halt the spread.&quot; </p>
            <p>The commission put forward five recommendations: </p>
            <ol>
                <li>Expand drug treatment so that all who apply
                    for treatment can be accepted into treatment
                    programs. </li>
                <li>Remove legal barriers to the purchase and
                    possession of injection equipment. </li>
                <li>The federal government must take the lead in
                    developing and maintaining programs to
                    prevent HIV transmission related to licit and
                    illicit drugs. </li>
                <li>Research and epidemiologic studies on the
                    relationships between licit and illicit drug
                    use and HIV transmission should be greatly
                    expanded and funding should be increased, not
                    reduced or merely held constant. </li>
                <li>All levels of government and the private
                    sector need to mount a serious and sustained
                    attack on the social problems of poverty,
                    homelessness, and lack of medical care that
                    promote licit and illicit drug use in
                    American society. </li>
            </ol>
        </blockquote>
        <blockquote>
            <p>The National Commission on AIDS could be described
            as the echo of the British Advisory Council on the
            misuse of drugs in its report on AIDS and drug
            misuse, as it made virtually the same policy
            recommendations. The commission concluded that
            &quot;the federal government must recognize that HIV
            and substance use is one of the issues of paramount
            concern within the 'war on drugs.' Any program which
            does not deal with the duality of the HIV/drug
            epidemic is destined to fail.&quot; The commission
            urged the federal government to move away from a law
            enforcement approach in controlling drugs toward a
            public health approach, which to date has &quot;been
            seriously neglected.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1994</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="../nylawyer.htm"><strong>A Wiser
        Course: Ending Drug Prohibition</strong></a><strong>, A
        Report of the Special Committee on Drugs and the Law of
        the Association of the Bar of the City of New York </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>The Bar of the City of New York studied the issue
            of drugs and drug policy for about five years and
            concluded that the only reasonable way to correct the
            current problems would be to repeal the Federal laws
            on these drugs in their entirety and allow the states
            to develop their own programs, similar to the
            situation with alcohol. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1994</strong></td>
        <td width="71"><strong>Australia</strong></td>
        <td width="451"><a href="aus/cannabis.htm"><strong>Legislative
        Options for Cannabis</strong></a><strong>. Australian
        Government </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td>1<strong>994</strong></td>
        <td><strong>US</strong></td>
        <td><a href="ota/otatoc.htm"><strong>Technologies for
        Understanding</strong></a><strong> and Preventing
        Substance Abuse and Addiction -- US Government Office of
        Technology Assessment -- October 18, 1994 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1996</strong></td>
        <td><strong>Australia</strong></td>
        <td><a href="dac/dacmenu.htm"><strong>Drugs and our
        Community</strong></a><strong> - Report of the Premier's
        Drug Advisory Council, Melbourne: Victorian Government,
        March, 1996 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1996</strong></td>
        <td><strong>US</strong></td>
        <td><a href="nycla/nycla.htm"><strong>Report and
        Recommendations of the Drug Policy Task Force</strong></a><strong>,
        New York County Lawyers Association</strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>The recommendations are:</p>
            <ol>
                <li>Pursue Alternative Models in Establishing
                    Future Drug Policy </li>
                <li>Provide Immediate Sentencing Relief and
                    Additional Judicial Discretion in Criminal
                    Prosecution of Drug Cases </li>
                <li>Reduce the Harms Associated With Substance
                    Abuse and Drug Prohibition </li>
                <li>Concentrate Law Enforcement Resources on
                    Reducing Violent Crime and Prosecution of
                    Violent Criminal Offenders </li>
                <li>Reshape the Drug Policy Debate -- Return to
                    Objective Analysis and Realistic Goals </li>
                <li>Implement Public Education Campaign on Drug
                    Use and Substance Abuse </li>
                <li>Decriminalize Marijuana </li>
                <li>Reverse Encroachments on Civil Rights and
                    Restore &quot;Due Process of Law&quot; </li>
                <li>Provide Alternative Social and Economic
                    Opportunity for Inner City Youth </li>
                <li>End War on Youth and Inner City Communities
                    -- Restore Confidence and Integrity in
                    Government </li>
            </ol>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td>1996</td>
        <td>Australia</td>
        <td><a href="redfern/rftoc.htm">Beyond Prohibition</a> -
        Report of the <font size="2"><strong>Redfern Legal Centre
        Drug Law Reform Project</strong></font><strong> - </strong><font
        size="2"><strong>September 1996</strong></font><strong> </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This recent report from Australia explores
            specific options for alternatives to the current drug
            prohibition.</p>
        </blockquote>
        </td>
    </tr>
</table>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_navbar.htm" tag="BODY" startspan
-->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="33179" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-19</DOCNO>
<DOCOLDNO>IA031-000655-B037-177</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlrintro.htm 206.61.184.43 19970122112351 text/html 5854
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:23:39 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:48:52 GMT
Content-length: 5637
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Legal History of American Marijuana Prohibition -
Introduction</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><font size="2"><b>THE FORBIDDEN FRUIT AND THE TREE OF
KNOWLEDGE: AN INQUIRY INTO THE LEGAL HISTORY OF AMERICAN
MARIJUANA PROHIBITION</b></font> </p>

<p><font size="2"><i>Richard J. Bonnie* &amp; Charles H.
Whitebread, II**</i></font> </p>

<h1>1. INTRODUCTION</h1>

<hr>

<p>Law may be rooted in fiction as well as fact. Indeed, a public
policy conceived in ignorance may be continuously reaffirmed,
ever more vehemently, so long as its origins remain obscure or
its fallacy unexposed. Yet once a spark of truth ignites the
public opinion process, the authority of time will not stay the
flames of controversy. In stable times the policy may soon be
reversed or modified to comport with reality. In volatile times,
however, a single controversy may lose its urgency. Fueled by
flames generated by related public issues, the fire may spread;
truth may again be consumed in the explosive collision of
competing cultural ideologies. </p>

<p>So it has been with marijuana.' Suppressed for forty years
without significant public attention, the &quot;killer weed&quot;
has suddenly surfaced as the preferred euphoriant of millions of
Americans. Hardly a day passes without public exposure to
propaganda from one side or the other. Hardly a day passes
without arrests of newsworthy figures for violations of marijuana
laws. Before legislatures and courts, the law is attacked and
defended with equal fervor. Sociological, medical and police
testimony regarding the drug's effects is delivered feverishly to
an attentive public. </p>

<p>Yet, apart from some expedient peripheral actions, little has
been done. Detailed studies have been commissioned, but there has
been no significant reconsideration of basic assumptions. Because
the marijuana issue has become ensnared in broader social
polemics, it has been stalemated. Stability and change, defiance
and repression, hippieism and middle-Americanism, &quot;law and
order&quot; and protest politics define the cultural milieu of
which the marijuana issue is viewed as but a symptom. </p>

<p>This Article is motivated by twin concerns: that the flagrant
disregard of marijuana laws bespeaks a growing disenchantment
with the capacity of our legal system rationally to order
society, and that the assimilation of the marijuana issue into
larger social conflicts has consigned the debate to the public
viscera instead of the public mind. Through a historical analysis
of the marijuana laws we hope to refocus the debate. An
understanding of the origins of the laws might modulate the
challengers' hostile accusations and at the same time promote in
legislators an awareness of their own responsibility. </p>

<p>For the purposes both of description and evaluation, law is
inseparable from the process by which it is adopted and the
values it manifests. Accordingly, our history focuses both on the
public policy formation process and on evolving patterns of our
culture. With respect to policy, formation, marijuana's legal
history is a significant illustration of the interaction of the
public opinion, legislative and judicial processes, and, in a
broader sense, the relation between folkways and gateways. With
respect to its value-content, the evolution of marijuana policy
reflects quite precisely emerging cultural attitudes toward
pluralism, privacy and individual pursuit of pleasure in an
increasingly mechanized and depersonalized technological society.
</p>

<hr>

<p>1Throughout its tumultuous history, the common name of the
cannabis drug has been spelled in numerous ways-marihuana,
meriguana, marijuana, marijuana. We will use the last spelling
because it appears most often in modern publications and conforms
more nearly to the Spanish. <br>
<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-20</DOCNO>
<DOCOLDNO>IA031-000655-B037-215</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlr1.htm 206.61.184.43 19970122112412 text/html 102087
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:23:56 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:46:57 GMT
Content-length: 101868
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Antecedents: Criminalization of Narcotics and Alcohol</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><b>THE FORBIDDEN FRUIT AND THE TREE OF KNOWLEDGE: AN INQUIRY
INTO THE LEGAL HISTORY OF AMERICAN MARIJUANA PROHIBITION</b> </p>

<p><i>Richard J. Bonnie &amp; Charles H. Whitebread, II<br>
</i></p>

<p><b>II. THE ANTECEDENTS: CRIMINALIZATION OF NARCOTICS And
ALCOHOL </b></p>

<hr>

<p>The restrictive public policy with respect to marijuana,
initiated in the late twenties and thirties and perpetuated to
the present day, has never been an isolated phenomenon. At each
stage of its development marijuana policy has been heavily
influenced by other social issues because the drug has generally
been linked with broader cultural patterns. Particularly at its
inception, nationwide anti-marijuana legislation and its fate in
the courts were inseparably linked with the earlier
anti-narcotics and prohibition experiences. In fact, the facility
with which marijuana policy was initiated directly related to the
astoundingly sudden and extreme alteration of public narcotics
and alcohol policy between 1900 and 1920. </p>

<p>In 1906 there were only three dry states, and judicial
precedent abounded for the proposition that the right to possess
alcohol for private consumption was an inalienable right. Yet, by
1917, twenty states had enacted prohibitionary legislation and
most others were contemplating it. Two years later the eighteenth
amendment and the Volstead Act had been enacted, and it was a
federal crime to possess alcohol even for the purpose of drinking
it within the home. Similarly, in 1900 only a handful of states
in any way regulated traffic in narcotic drugs-opium, cocaine,
morphine and heroin-even though all but heroin had been available
for a decade or more. Yet, by 1914, all states had enacted some
type of prohibitionary legislation, and the national government
had enacted the Harrison Narcotic Act. </p>

<p>There were many major differences between the temperance and
anti-narcotics movements. The temperance movement was a matter of
vigorous public debate; the anti-narcotics movement was not.
Temperance legislation was the product of a highly organized
nationwide lobby; narcotics legislation was largely ad hoc.
Temperance legislation was designed to eradicate known evils
resulting from alcohol abuse; narcotics legislation was largely
anticipatory. </p>

<p>On the other hand, there were striking similarities between
the two movements. Both were first directed against the evils of
large scale use and only later against all use. Most of the
rhetoric was the same: These euphoriants produced crime,
pauperism and insanity. Both began on the state level and later
secured significant congressional action. Both ultimately found
favor with the courts, provoking interchangeable dissenting
opinions. </p>

<p>We do not propose to unearth new truths about the events of
this period. However, we do believe that a familiarity with the
political and judicial response to the alcohol and narcotics
problems is essential to an understanding of the eventual
suppression of marijuana. We believe further that an
understanding of the relation between public opinion and any
sumptuary law is germane to a discussion of the predicament of
current marijuana legislation. Finally, since much of the current
debate about marijuana is focused on its harmful effects as
compared with those of narcotics and alcohol, the evolution of
public policy in those areas is particularly material.<br>
</p>

<p><i>A. A Review of the Temperance Movement</i> </p>

<p>Although aggressive prohibition campaigns had been mounted in
every state in 1851-69,1 and again in 1880-90, in 1903 only Maine
(1884), Kansas (1880) and North Dakota (1889) were completely dry
states.2 Ernest Cherrington, the chronicler par excellence of the
Prohibition movement, blamed the failure of the first thrust in
part on the intervention of the slavery question, which siphoned
the moral fervor of the people from the temperance movement .4
The failure of the second campaign he attributed to the inability
of the prohibition activists to compete politically with growing
liquor interests that dominated state and local governments.5 </p>

<p>By 1906, however, the progress of the anti-saloon arm of the
temperance movement in local option contests&quot; and the
adoption of alcohol prohibition by the people of Oklahoma in a
provision of their constitution ratified upon admission to
statehood 7 signalled a new crusade for state prohibitionary
legislation. The Oklahoma vote so &quot;electrified the moral
forces of other states&quot; 8 that by 1913 six additional states
had enacted statewide prohibition, and half of the remaining
states were contemplating action.9 </p>

<p>Perhaps the most significant development during this period
occurred on the national level. The Supreme Court had earlier
declared the police powers of the states, under which state
prohibition laws were enacted, impotent to prevent importation of
liquor from a wet state, of which there were still many, into a
dry state and to stay the sale and delivery of such liquor to the
buyer while in the original package.&quot; </p>

<p>After a congressional attempt to deal with the decision in
1890 aborted in the courts,&quot; the buyer of liquor shipped in
interstate commerce still had the right to receive and therefore
to use such liquor. But in 1913 Congress, by the Webb-Kenyon Act,
12 filled the gap by prohibiting the shipment of liquor from one
state to another to be used in violation of the laws of the
latter; dry states could thus enforce their prohibition laws The
mere passage of this law, according to against imported liquor.13
</p>

<p>Cherrington, committed Congress to a policy that recognized
the liquor traffic as an outlaw trade and indicated congressional
desire to assist the dry states. 14 </p>

<p>By November 1913, the tide had decidedly turned. More than
half the population and 71 percent of the area of the United
States were under prohibitionary laws.&quot;, Accordingly, the
Fifteenth National Convention of the Anti-Saloon League of
America unanimously endorsed immediate passage of National
Constitutional Prohibition, whereupon the National Temperance
Council was formed to combine the forces of the various
temperance organizations toward this end. 16 </p>

<p>By April 4, 1917, when a joint resolution was introduced in
the Senate proposing an amendment to the Constitution prohibiting
the manufacture, sale or transportation of intoxicating liquors
within the United States for beverage purposes, 17 eighty percent
of the territory of the United States was dry.&quot; Adopted by
the constitutional majorities of both houses on December 18,
1917, the eighteenth amendment was ratified by the thirty-sixth
state on January 16, 1919, and became effective on January 16,
1920.19 The Volstead Act,&quot; passed on October 28, 1919,
pursuant to section 2 of the eighteenth amendment, outlawed
possession of intoxicating liquor and therefore went
significantly beyond the amendment itself. </p>

<p>The National Commission on Law Observance and Enforcement (the
Wickersham Commission) attributed the passage of the eighteenth
amendment not to public opposition to use of intoxicating
beverages,&quot; although this was indeed the view of many of the
leaders of the movement, but rather to antipathy to three major
related evils: excessive consumption, political corruption and
licensed saloons .22 </p>

<p>Excessive use increased with the commercialization of
production and distribution, and the expansion of saloons. Public
resentment against the corrupting influence of the large liquor
dealers in local politics, especially in the larger cities,
tended to focus public attention on removing a cancer from the
body politic. Finally, the institution that most strongly aroused
public sentiment against liquor traffic was the licensed saloon,
itself the symbol of intemperance and corruption. Owned or
controlled by the large brewers or wholesalers, centers of
political activity, homes of commercialized vice, the saloons
were the betes noires of middle-American public opinion. </p>

<p>Because public opinion was largely opposed only to the
socio-political consequences of massive liquor traffic, the
enforcement of total abstinence under the eighteenth amendment
became increasingly difficult. By 1931 it was an accepted fact
that the upper and middle classes were &quot;drinking in large
numbers in quite frank disregard of the declared policy&quot; of
the Volstead Act.&quot; </p>

<p>The difficulties of securing compliance in such circumstances
were aggravated by an inadequately designed enforcement strategy,
24, public resentment of the lawless tactics of prohibition
agents, 25 and the lack of any sustained attempt at public
education.26 For twelve years, however, millions of dollars were
spent by federal and state governments in a fruitless effort to
secure compliance with the law. Contemporary legal observers were
particularly incensed by the dilution of constitutional
protections, especially those provided by the fourth amendment,
which was sanctioned by the courts in response to the &quot;felt
needs&quot; of securing compliance through enforcement alone.27 </p>

<p>Although many plans were advanced for changing the prohibition
laws to mitigate the lawlessness rampant during this period, as
late as 1931 even its most vigorous opponents felt that repeal of
the eighteenth amendment was politically unfeasible.28 By 1932,
however, public opinion had become so inflamed that the
Democratic National Convention included repeal in the party
platform.&quot;' Proposed by Congress on February 20, 1933, the
twenty-first amendment was ratified by the thirty sixth state on
December 5, 1933.<br>
</p>

<p><i>B. Anti-Narcotics Legislation to 1914</i> </p>

<p>For our purposes, the major feature of temperance history is
the responsiveness of the political process to public opinion.
Whether or not a majority of Americans ever favored prohibition
and whether or not the thrust of public opinion was ever
accurately assessed, the public opinion process was attuned to
the question for half a century. The alleged evils of alcohol
abuse were matters of public knowledge; the proper governmental
response was a subject of endless public debate; enactment and
repeal of Prohibition were attended by widespread public
participation. </p>

<p>In contrast, the early narcotics legislation was promulgated
largely in a vacuum. Public and even professional ignorance of
the effects of narcotic drugs contributed both to the dimensions
of the problem and the nature of the legislated cure. The initial
legislation was attended by no operation of the public opinion
process, and instead generated a new public image of narcotics
use. Only after this creation of a public perception occurred did
the legislative approach comport with what we shall call latent
public opinion. <br>
</p>

<p><i>1. Narcotics Use at the Turn of the Century: A Growing
Problem <br>
</i></p>

<p>Although estimates have varied widely regarding the number of
persons regularly using cocaine, opium, morphine and heroin
during the pre-criminalization period, a sufficiently accurate
figure can be drawn from a composite of contemporary surveys30
conducted between 1878 and 1924 .31 Estimates range from 182,215
(1884) to 782,118 (1913). We can safely estimate that there were
between one-quarter and one-half million Americans addicted to
narcotics around the turn of the century, comprising at least one
percent of the population.&quot; </p>

<p>This rather large addict population included more females than
males,33 more whites than blacks,&quot; and was confined neither
to particular geographical regions nor to areas of high
population concentrations Its most significant characteristic was
its predominantly middle-class composition. Such attributes
contrast starkly with the overwhelmingly black, lower-class male
addict population that today inhabits our major urban centers. </p>

<p>Nineteenth century narcotics addiction was generally
accidental. It is widely believed that medical addicts far
outnumbered &quot;kicks&quot; or pleasure&quot; addicts.37
Medical addiction stemmed from many sources. The first was
overmedication. Civil War hospitals used opium and morphine
freely and many veterans returned addicted to the drugs.&quot;
Overmedication continued long after peace had been restored, due
to the ready availability of these drugs with and sometimes
without prescription. Since physicians were free to dispense
these drugs as painkillers, persons given morphine first for
legitimate therapeutic purposes often found themselves addicted.
39 This problem was exacerbated by the absence of restrictions
upon druggists in refilling prescriptions containing extensive
amounts of morphine and other opiates40 and by the introduction
of the hypodermic syringe.&quot; The danger of overmedication
increased in 1884 when cocaine was first introduced into the
practice of medicine, and again in 1898 when an advance in German
chemistry produced heroin, a partially synthetic morphine
derivative. 42 For a time recommended as a treatment for morphine
addiction ,43 heroin was also widely used for medicinal purposes.
</p>

<p>A second source of accidental addiction was the use and
popularity of patent medicines. Exotically labeled elixirs were
advertised as general cures for- ills ranging from snake bite to
melancholia. By containing up to thirty or forty percent morphine
or opiates by volume, most patent medicines fulfilled their
cure-all promises. However, a heavy price was exacted for such
cures. In the absence of a requirement that contents be printed
on the label, many an unsuspecting person became addicted without
ever knowing the medicine that worked so well contained dangerous
narcotics.44 </p>

<p>Thus, careless prescription, incessant dispensation and hidden
distribution of harmful drugs, the addictive effects of which
were unknown until too late, fostered a large addict population
which continued to increase in the early twentieth century. The
increase in narcotics consumption, and therefore addiction, is
well illustrated by the fact that 628,177 pounds of opiates were
brought into this country in 1900, three times the amount
imported thirty years earlier.&quot; Governmental and medical
default explains the innocent nature of nineteenth century
narcotics addiction and therefore its predominantly middle-class,
nationwide character. </p>

<p>Not all addiction was accidental and private. It has been
suggested that both medical knowledge and governmental regulation
occurred only when each narcotic drug achieved a significant
degree of &quot;street&quot; use. Our research supports this
thesis, especially when &quot;street&quot; use is identified with
the poor and with racial minorities. For example, opium, the drug
first determined addictive and first identified with &quot;
pleasure&quot; use, was the earliest prohibited. Legislation was
first passed in the west coast states with newly immigrated
Chinese populations among whom its use was prevalent. Heroin
early achieved a widespread nonmedical or &quot;street&quot; use,
especially in large urban centers among lower-class males.&quot;'
</p>

<p>Nevertheless, addiction, even to opium, was predominantly
involuntary until 1900. Professional attention was not focused
directly on! Street&quot; use until after two developments had
significantly reduced the: possibility of medical addiction.
First, the passage of the Pure Food and Drug Act48 in 1906 led to
the demise of the patent medicine industry,: one of the primary
causes of medical addiction. The labeling requirements of the
Act, coupled with the later regulation of the production and
distribution of the opiates, protected the public from the
dangers of ignorance and virtually put the patent medicine
industry out of business.49 Second, the discovery of new
nonaddictive pain killers and anesthetics reduced the likelihood
of post-operative addiction since physicians no longer needed to
rely so heavily on morphine and opium. preparations to reduce and
control pain.<br>
</p>

<p>2. State Legislative Response Before 1914 </p>

<p>Although many states regulated narcotics indirectly through
their general &quot;poison laws&quot; before 1870,50 the first
anti-narcotics legislation did not appear until the last quarter
of the nineteenth century. Most of the early legislation focused
primarily on crime prevention&quot; and public education
regarding the dangers of drug use.&quot; The spread of opium
smoking, especially in the western states with high oriental
populations,53 provoked legislation in eighteen states between
1877 and 1911 designed to eradicate the practice either by
preventing the operation of opium dens or by punishing the
smoking of opium altogether. 54 As the addictive qualities of
opium, cocaine, morphine and later heroin became known, primarily
through observation of &quot;street&quot; use, concerned
physicians finally began to agitate for stricter regulation than
that provided by the &quot;poison laws,&quot; even though such
laws included opium and cocaine. Nevada enacted the first law
prohibiting the retail sale of opiates for nonmedical purposes in
1877.55 In 1887, Oregon prohibited sale of cocaine without a
prescription,&quot;&quot; and seven states followed suit by the
turn of the century57 as did thirty-nine more by 1914.58 However,
only twenty-nine states had included opiates in their
prohibitionary legislation by 1914.59 </p>

<p>With the exception of the Oregon schemes nineteenth century
narcotic laws did not attempt to restrict or prohibit possession
of narcotics, and were directed solely at distribution and sale.
By 1913, only six states had prohibited the mere possession of
restricted drugs by unauthorized persons .61 Three additional
states prohibited possession with intent illegally to dispense
such drugs .62 <br>
</p>

<p>3. Watershed: The Passage of the Harrison Act </p>

<p>The first national legislation designed to regulate narcotics
distribution, the 1909 &quot;Act to Prohibit Importation and Use
Of Opium&quot;' 63 barred the importation of opium at other than
specified ports and for other than medicinal use. The law further
required the keeping of import records. The main force behind the
passage of this statute was a desire to bring the United States
into line with other nations that had signed international
conventions against the use of the drug. 64 However, as state
anti-narcotics legislation began to take on crusade proportions,
pressure was generated for federal regulation of the importation
of opium for medicinal purposes and of the interstate trade in
cocaine, morphine and heroin. Consequently, the Harrison Act,
until this year the foundation of federal law controlling
narcotic drugs, was passed in 1914.65 </p>

<p>The Harrison Act, a taxing measure, required registration and
payment of an occupational tax by all persons who imported,
produced, dealt in, sold or gave away opium, cocaine or their
derivatives. The Act required all legitimate handlers of these
narcotics to file returns setting forth in detail their use of
the drugs. Each legitimate handler was required to use a special
order form in making any transfer of narcotics. Since the Act
also provided that only legitimate users could register and no
one but a registered user could obtain the specified form, any
transfer by an illegitimate user was a violation of the Act. For
those failing to comply with its registration requirements, the
original Harrison Act provided penalties of not more than $2,000
in fines or more than five years imprisonment, or both. </p>

<p>The passage of the Harrison Act was the culmination of
increasing concern in the medical profession66 about the freedom
with which physicians prescribed and druggists dispensed
addictive drugs, primarily morphine and heroin. During the period
of little or no regulation, the innocent addicts were regarded as
victims of an unfortunate sickness in need of treatment; usually
they could find a friendly physician or druggist willing to
sustain their habits. The passage of the Harrison Act, however,
by imposing a stamp of illegitimacy on most narcotics use,
fostered an image previously associated primarily with opium that
of the degenerate dope fiend with immoral proclivities. As the
regulation of physicians and druggists became more stringent,
especially after the Supreme Court held that prevention of
withdrawal was not a legitimate medical use that a prescription
to an unregistered person,67 this image fulfilled itself. All
addicts, whether accidental or pleasure-seeking, were shut off
from their supply and had to turn underground to purchase the
drugs. Inflated underground prices often provoked criminal
activity and this activity in turn evoked in the public a moral
response,, cementing the link between iniquity and. drug
addiction.68 </p>

<p>The early clinical experiments dealing with narcotics
addiction were inevitable victims of enforcement of the
Act.&quot; The concept that underlay the clinical effort-that
addiction was a medical problem to be dealt with by sustaining
the addict cheaply while trying to induce gentle withdrawal-was
antithetical to the attitude provoking the criminal
classification of unlawful possessors of narcotic drugs.&quot;
Clinics were run .in such cities as New York, Shreveport and
Jacksonville,&quot; but by 1923 all were closed, thus removing
still another legitimate source of supply for the addict. Again,
the crimes committed to enable these people to tap I the illicit
sources increased public hysteria and misunderstanding 72 about
the link between the opiates and crime. </p>

<p>Another result of the physicians' resignation to pressure was
that addicts to the opiates began to commit petty crimes in order
to secure the drugs which could prevent their suffering. These
inevitable law-induced crimes greatly accentuated the general
public belief that opiates had some inherent sinister property
which could change normal people into moral perverts and
criminals. </p>

<p>In addition to redefining the public conception of narcotic
addiction in a way that would not be seriously challenged for
half a century, the Harrison Act also provided a strange model
for the administration of narcotics laws which would
significantly affect future developments' Drafted as a tax law
rather than an outright criminal statute, the Act was intended to
do indirectly what Congress believed it could not do
directly-regulate possession and sale of the opiates. Indeed,
congressional caution was justified. A five-to-four decision by
the Supreme Court in the 1903 Lottery Case73 suggested what later
became fact-the Court, as self-appointed arbiter of the federal
system, would plant the tenth amendment in the path of
congressional regulation of &quot;local&quot; affairs. That
direct regulation of medical practice was indeed considered
beyond congressional power under the commerce clause is clearly
indicated in contemporary opinions. First, in its 1918 decision
in Hammer V. Dagenhart,74 the Court held the Child Labor Act
unconstitutional. Second, the Court ultimately upheld the
Harrison Act as a valid exercise of the taxing power 75 only by a
five-to-four margin. Finally, there is some fairly explicit
language about congressional regulation of medical practice in
subsequent Harrison Act opinions.76 </p>

<p>This indirect regulation of narcotics traffic under the
pretext of raising revenue had a number of significant
consequences. First, since the Act could not penalize users or
addiction directly, there was an immediate need for complementary
residual state legislation in order to deal effectively with the
drug problem. Second, the enforcement of the Act was necessarily
assigned to the Internal Revenue Service in the Treasury
Department. </p>

<p>The first enforcement agency for the Harrison Act was the
Narcotics Division of the Prohibition Unit of the Internal
Revenue Service created in 1920.77 This division was incorporated
in the Prohibition Bureau which was created in 1927 .78 In 1930,
the enforcement of the narcotics laws was severed from the Bureau
of Prohibition and established as the separate Bureau of
Narcotics in the Treasury Department .79 The existence of this
separate agency anxious to fulfill its role as crusader against
the evils of narcotics has done as much as any single factor to
influence the course of drug regulation from 1930 to 1970.&quot;
Although the impact of the Bureau on the passage of the Uniform
Narcotic Drug Act and the Marihuana Tax Act will be explained in
detail in subsequent sections, it is important here to note that
the existence of a separate bureau having responsibility only for
narcotics enforcement and for educating the public on drug
problems inevitably led to a particularly prosecutorial view of
the narcotics addict. Moreover, this creation of the Bureau
separate from the newly created FBI in the justice Department
unnecessarily bifurcated federal law enforcement operations in
this area. </p>

<p>C. The Judicial Role and the Constitutional Framework: </p>

<p>The Police Power and Intoxicant Prohibition to 1920 </p>

<p>It is not novel to suggest that the fate of contemporary
constitutional challenges to marijuana prohibition depends in
part on a judicial reading of public opinion as well as on the
availability of a constitutional peg on which to hang an
&quot;activist&quot; judicial inquiry. Since contextual pressure
and analytical conflict were also central elements of the
'Judicial response to alcohol and narcotics prohibition between
1850 and 1920, it is worthwhile to trace that response. </p>

<p>As in today's court battles over marijuana laws, the clash
then was between two polar constitutional concepts-the police
powers of the state and allegedly &quot;fundamental&quot;
personal constitutional rights. The conflict opened on state
constitutional grounds and was continued in the realm of the
fourteenth amendment. On the issues of alcohol and
&quot;hard&quot; narcotics, the police power was triumphant. In
the light of the comparisons drawn in current constitutional
arguments among marijuana , alcohol and narcotics, an inquiry
into the long struggle is informative. </p>

<p>1. Phase One: Prohibition of Sale and Manufacture of Alcohol </p>

<p>During the first wave of prohibitionist legislation in the
1850's, thirteen en states outlawed manufacture&quot; and sale of
intoxicating beverages.&quot; The constitutionality of such laws
under the commerce clause of the Federal Constitution had been
presaged in the License Case83 in 1847, where in six separate
opinions the Supreme Court upheld Massachusetts, New Hampshire
and Rhode Island laws regulating wholesale and retail sales of
liquor. Chief Justice Taney's famous dictum stated: </p>

<blockquote>
    <p>And if any State deems the retail and internal traffic in
    ardent spirits injurious to its citizens, and calculated to
    produce idleness, vice, or debauchery, I see nothing, in the
    constitution of the United States to prevent it from
    regulating and restraining the traffic, or from prohibiting,
    it altogether, if it thinks proper.84 </p>
</blockquote>

<p>Armed with this pronouncement, the courts of eight states
rebuffed challenges under their own constitutions.&quot; Some of
these decisions gave scant attention to the constitutional
argument but simply defined the police power broad terms86 and
perhaps cited the Taney dictum. </p>

<p>However, the rationale and rhetoric of those decisions
squarely rejecting the constitutional objections merit a detailed
comparison with that of two decisions, in New York88 and
Indiana89, declaring the statutes void. </p>

<p>Even the opponents of the laws acknowledged the potential
public evils of intemperance90crime, pauperism and vice-the
eradication of which was the objective of prohibitionary
legislation. Yet they argued that the means employed to
accomplish this end-prevention of sale was beyond the police
power. Alcohol had admittedly beneficial use91 and was harmful
only when abused.92 In order to eliminate it from channels of
commerce, thereby depriving its owners of a -fundamental incident
of ownership-the right to sell93 -a more pernicious character had
to be shown. 94 Accordingly, the public benefit did not justify
the restriction of private rights. The criminalization of sale of
alcohol beverages constituted a deprivation of
&quot;property&quot; without due process;95 or, failing that, it
constituted an infringement of the inalienable right of 1ife,
liberty And the pursuit of happiness rooted in the precepts of
natural justice that the people reserved to themselves when they
entered into the social compact.96 New York, in Wynehamer v.
People,97 accepted .the due process argument, at least with
respect to alcohol lawfully acquired, and Indiana endorsed the
inalienable rights argument in Beebe v. State.98 </p>

<p>The virtues of judicial restraint were vehemently defended in
the decisions rejecting these arguments: The courts uniformly
refused to interfere with the discretionary exercise of the
police power in the absence of a specific constitutional
prohibition. The Vermont Supreme Court view was typical: </p>

<blockquote>
    <p>The legislature in passing the law in question doubtless
    supposed that the traffic and drinking of intoxicating
    liquors went hand in hand ... and that, by cutting off the
    one, the other would also fall with it. Whether the drinking
    of intoxicating liquors tends to produce intemperance and
    whether the intemperance is a gangrene, tending to corrupt
    the moral health of the body politic, and to produce misery
    and lamentation; and whether the law in question is well
    calculated to cut off or mitigate the evils supposed to flow
    directly from intemperance and indirectly from the traffic in
    intoxicating liquors, were questions to be settled by the
    lawmaking power; and their decision in this respect is final
    and not to be reviewed by us.99 </p>
</blockquote>

<p>Under this view, societal self-protection, the essence of the
police power, is broadly defined.100 So long as the legislature
determines that the use of alcoholic beverages exerts an adverse
effect on public, health, safety or morals, the courts may
question neither the factual determination nor the means employed
to restrict that use. In answer to the argument that the courts
have a special obligation to review the relation between means
and ends where personal liberties are curtailed, these courts
disavowed any power &quot;to annul a legislative Act upon higher
grounds than those of express constitutional restriction,&quot;
101 or, after assuming for sake of argument the existence of such
power, they declined to exercise It.102 In response to the
argument accepted by Judge Comstock in Wynehamer v. New York-that
prohibition of sale of legally acquired alcohol was a deprivation
of property without due process of law-most courts distinguished
Wynehamer on its facts,103 held that no essential
&quot;property&quot; right had been violated,&quot;&quot; or
construed &quot;due process&quot; to refer only to due procedure
and not to the &quot;power ... to create and define an
offense.&quot; 105 </p>

<p>Two polar conceptions of the scope of 'Judicial review clashed
over a subject of intense public interest. The immediate question
was settled in favor of the constitutionality of prohibiting
manufacture and sale of alcoholic beverages; in fact, the Indiana
court itself disavowed its contrary decision in Beebe three years
after rendering it.106 However, the jurisprudential dialogue107
had merely begun. Today, Wynehamer is regarded as the initial
step, on the road to the vested rights conception of due process.
Similarly, Beebe is the philosophical ancestor of all challenges
to prohibition of intoxicants alcohol, narcotics, and
marijuana.108 </p>

<p>With the passage of the fourteenth amendment, the Supreme
Court was called upon to determine whether prohibitionary
exercises of the state police powers were now limited by federal
law. The battle fought in the 1850's on state constitutional
grounds was refought in the 1870's and 80's on federal
territory-with the same outcome. In a series of cases culminating
in Mugler v. Kansas,109 it slowly became settled that the
manufacturer or seller of intoxicating liquors had no
constitutional rights under either the privileges and immunities
or due process clauses that could prevent the operation of the
police power of the state, regardless whether the liquor was
bought or manufactured before passage of the law or even whether
it was manufactured solely for personal use.110 </p>

<p>Thus, as a matter of both state and federal constitutional
law, the courts required no more, and probably less, than that
legislation be designed to retard a public evil-here pauperism
and crime-and be rationally related to that end.&quot;' Absent a
specific constitutional limitation, it did not concern the courts
that such regulations affronted personal liberty and property
rights. The theoretical Justification of incidental curtailment
of private liberties in the public interest was that the
legislature must conduct the balancing; if the balance is
unsound, the law will be repealed. Indeed, the courts were
probably willing to indulge that presumption as a practical
matter since the passage of the prohibition laws was preceded by
vigorous public debate. In fact, the public opinion process did
work in reaction to these curtailments of private liberty, and
most such laws were subsequently repealed&quot;' in the ensuing
decade. </p>

<p>2. Phase Two: Probibition of Sale of Opium </p>

<p>As noted above, the first prohibitionary narcotics legislation
was enacted on the west coast in the 1880's in order to prohibit
sale and distribution of opium for nonmedical purposes. The
racial overtonesof this legislation were self-consciously
acknowledged by the initial Oregon and Nevada decisions.
Sustaining the conviction of an alien for selling opium in Ex
parte Yung Jon,&quot;' the Oregon district court noted: </p>

<blockquote>
    <p>Smoking opium is not our vice, and therefore it may be
    that this legislation proceeds more from a desire to vex and
    annoy the &quot;Heathen Chinee&quot; in this respect, than to
    protect the people from the evil habit. But the motives of
    legislators cannot be the subject of judicial investigation
    for the purpose of affecting the validity of their acts. 114 </p>
</blockquote>

<p>The opium laws were attacked on precisely the same grounds as
had been the alcohol prohibition legislation. The Nevada court
had no trouble in State v. Ah Chew;115 it simply cited the
License Cases, the Delaware decision sustaining prohibition of
alcohol sale, and distinguished Wynebamer as holding only that
the sale of lawfully acquired property could not be prohibited.
Within this framework, the result was obvious: </p>

<p>It is not denied that the indiscriminate use of opium . . .
tends in a much greater degree to demoralize the persons using
it, to dull the moral senses, to foster vice and produce crime,
than the sale of intoxicating drinks. If such is its tendency, it
should not have unrestrained license to produce such disastrous
results.... Under the police power . . . in the interest of good
morals, the good order and peace of society, for the prevention
of crime, misery and want, the legislature has authority to place
such restrictions upon sale or disposal of opium a,, will
mitigate, if not suppress, its evils to society.116 </p>

<p>The Oregon court, in the Yung Jon decision five years later,
did not take the easy way out. The court was apparently not
disposed to imply that sale of previously owned alcohol and
cigarettes could be prohibited, and thus reject outright the
Wynebamer conception of due process;117 instead it chose to hold
that sale of opium for nonmedical purposes was not an incident of
ownership and, since the law did not prohibit sale for medical
purposes, no property right was deprived. Not as cautious as his
brethren, Judge Deady inquired more actively into the nature of
opium before upholding the legislation. Whether a legislative act
is &quot;prohibitory&quot; (and by implication whether it
violates the due process clause) &quot;must depend on
circumstances, and particularly the character of the article, and
the uses and purposes to which it has generally been applied in
the community.&quot; 118 He then noted that opium was primarily a
medicinal drug; that although used in the East for centuries as
an intoxicant, that use was new in the United States and confined
primarily to the Chinese; that it was classed as a poison and was
less easily detected than alcoholic intoxication, &quot;which it
is said to replace where law and custom have made the latter
disreputable;&quot; and that its &quot;evil effects&quot; were
manifest upon the nervous and digestive systems, resembling
delirium tremens. Thus, there was no longstanding regard of opium
as a legitimate article of property except for medical use.
Accordingly, the act does not in effect prohibit the disposition
of the drug, but allows it under such circumstances, and on such
conditions, as will, according to the general practice and
opinions of the country, prevent its improper and harmful use.119
</p>

<p>Thus, whatever the judicial propensity to limit the police
power in the interest of property rights, prohibition of traffic
in opium-worse than alcohol and confined to aliens-violated no
implied or express constitutional limitations.<br>
</p>

<p>3. Phase Three: Prohibition of Possession of Alcohol to 1915 </p>

<p>At this stage of constitutional jurisprudence, criminalization
of possession or consumption of alcohol or narcotics was arguably
a deprivation of property without due process of law. The first
wave of prohibition cases had held only that the right to sell
even previously acquired liquor was not an essential element of
ownership. They had not held that the state could forbid the
essential attribute of ownership-the right to use. In fact, many
courts had expressly noted that alcohol was still a legitimate
article of property.120 </p>

<p>Until 1915 the weight of authority was that it was beyond the
police power to prohibit mere possession of alcoholic beverages
unless the quantity Justified an inference that they were held
for sale. A few cases so held ;121 many courts so stated in
dictum, while holding the laws either in conflict with particular
constitutional provisions regarding the &quot;sale&quot; of
liquor&quot;122 or in excess of the power of municipal
corporations;&quot; and many contemporary commentators so stated
.124 </p>

<p>Although the due process rationale was sometimes employed, 125
the preferred approach was &quot;inherent&quot; limitation. In
his 1904 treatise, Police Power, Ernst Freund premised the
&quot;inherent&quot; limitation of noninterference with purely
private conduct not on any inalienable natural right but on the
requirement that interference be justified on grounds of the
public welfare.&quot;' This and the &quot;practical difficulties
of enforcement, coupled with the constitutional prohibition of
unreasonable searches,&quot; 127 would sufficiently deter
legislative abuse. </p>

<p>Absent the addition of a natural rights notion, however, this
decisional frame becomes ambivalent on the dispositive question
in an adjudication questioning such legislative
&quot;abuse&quot;: Can the mere &quot;policy&quot; of
nonintervention with private conduct a more rigorous judicial
inquiry into the relation between the prohibited private acts and
the alleged public evil? If it cannot, the constitutional attack
on prohibition of possession is no stronger than that on
prohibition of sale. If it can, is not the judicial role subject
to the same charge of usurpation as it would be if the courts
employed a pure natural rights approach? </p>

<p>In any event, when the courts first confronted possession
prohibition, the rhetoric was varied-due process, 128 natural
rights&quot;' and private liberty&quot;&quot;-but the approach
was the same-a refusal to accept the legislative findings as to
the relation between private act and public harm and a refusal to
defer to the legislative balance of private liberty and public
need. For example, in one of the leading cases, Commonwealth v.
Campbell,&quot;' the Court of Appeals of Kentucky cited Cooley,
Mill, and Blackstone for the proposition that </p>

<p>[i]t is not within the competency of government to invade the
privacy of the citizen's life and to regulate his conduct in
matters in which he alone is concerned, or to prohibit him any
liberty the exercise of which will not directly injure
society.132 </p>

<p>Noting next that defendant was &quot;not charged with having
the liquor in his possession for the purpose of selling it, or
even giving it to another&quot; and that &quot;ownership and
possession cannot be denied when that ownership and possession is
not in itself injurious to the public,&quot; 133 the court
concluded that </p>

<p>the right to use liquor for one's own comfort, if the use is
without direct injury to the public, is one of the citizen's
natural and inalienable rights .... We hold that the police
power-vague and wide and undefined as it is-has limits . . . 134 </p>

<p>The key to this reasoning, of course, is the court's
insistence that the injury be direct as measured according to a
Judicial yardstick. Although the court devoted little attention
to the question, it implicitly rejected arguments that the only
way to exorcize the public evils attending excessive use and
adequately to enforce prohibitions against sale was to prevent
any private use at all. The court impliedly held that the posited
connection, albeit rational, was &quot;remote&quot; or
&quot;indirect&quot; or &quot;unreasonable&quot; and therefore
entitled to no deference. 135<br>
</p>

<p>4. Phase Four: Prohibition of Possession of Narcotics </p>

<p>This active 'Judicial role in alcohol cases should be compared
with the courts' simultaneous refusals to second-guess
legislative &quot;findings&quot; with regard to the
criminalization of possession of opium. In a series of cases
decided in Washington, Oregon and California136 in 1890, 1896 and
1911 respectively, courts held that the relation between
narcotics use and public harm was to be drawn by the legislature.
</p>

<p>In answer to the argument, accepted in the alcohol cases, that
despite the absence of explicit constitutional limitations the
police power of prohibition was inherently limited to acts which
&quot;involve direct and immediate injury to another,&quot; 137
the courts replied in predictable fashion: The state may prevent
a weak man from doing injury to himself if it determines that
such injury may cause the individual to become a &quot;burden on
society;&quot; &quot;' the state could find that excessive use of
opium, an active poison, would debase the moral and economic
welfare of' the society by causing ill health, pauperism and
insanity;... the state could find that the potential for and
evils attending excessive use demand a prohibition also of
nondeleterious moderate use.&quot;' Accordingly, in the words of
the Supreme Court of Washington, </p>

<p>[i]t is for the legislature to place on foot the inquiry as to
just in what degree the use is injurious; to collate all the
information and to make all the needful and necessary
calculations. These are questions of fact with which the court
cannot deal. The constitutionality of laws is not thus to be
determined .141 </p>

<p>The California court had more difficulty with the argument
that punishment of possession of alcohol had been held beyond the
police power. Despite its rhetoric regarding the wide bounds of
legislative fact-finding, the court actually made its own
determination that public injury from private abuse was more
likely with narcotics than alcohol. The lower court had said so
overtly: </p>

<p>But liquor is used daily in this and other countries as a
beverage, moderately and without harm, by countless thousands ...
; whereas it appears there is no such thing as moderation in the
use of opium. Once the habit is formed the desire for it is
insatiable, and its use is invariably disastrous. 142 </p>

<p>The California Supreme Court shied away: </p>

<p>We do not understand this to have been intended to declare an
established or conceded fact. So interpreted, the expression
would be, perhaps unduly sweeping. But the validity of
legislation which would be necessary or proper under a given
state of facts does not depend upon the actual existence of the
supposed facts. It is enough if the law-making body may
rationally believe such facts to be established. If the belief
that the use of opium, once begun, almost ]Inevitably leads to
excess may be entertained by reasonable men-and we do not doubt
that it may-such belief affords a sufficient 'Justification for
applying to opium restrictions which might be unduly burdensome
in the case of other substances, as, for example, intoxicating
liquors, the use of which may fairly be regarded as less
dangerous to their users or to the public. 143 </p>

<p>What the court said is unobjectionable. What it did not say,
however, is significant. This reasoning implies that if the
legislature should determine that the potential for excessive use
of alcohol-and consequently for the public evils of pauperism,
crime and insanity-is great enough to prohibit all use, that
judgment would have to stand. Probably not intending so to
suggest, the court really held that it thought that opium use was
more likely adversely to affect the public welfare than alcohol
use; accordingly, paternal criminal legislation was
&quot;reasonable&quot; in the former case and not in the latter,
even though they were identically &quot;Indirect.&quot; It
helped, perhaps, that the legislature was not telling the and his
white, middle-class colleagues that they shouldn't smoke opium,
and that the objective was merely to prevent a few &quot;Heathen
Chinee&quot; from hurting themselves through their stupidity and
from spreading their nasty habit to the whites.&quot;' </p>

<p>The only astounding thing about the opium possession cases is
that there was at least one dissenting opinion. In the Washington
case, Ah Lim v. Territory,145 judge Scott, for himself and
another judge, insisted on either a more conclusive demonstration
that the private act of smoking opium &quot;directly and clearly
affected the public in some manner&quot; or a more narrowly drawn
statute. He catalogued the alleged public justifications: </p>

<p>That smoking or inhaling opium injures the health of the
individual, and in this way weakens the state; that it tends to
the increase of pauperism. That it destroys the moral sentiment
and leads to the commission of crime. In other words, that it has
an injurious effect upon the individual, and, consequently,
results indirectly in an injury to the community. 146 </p>

<p>After noting the insufficiency of all of the 'Justifications
including the argument that the moderate desires of some must be
sacrificed to prevent abuse by others, 147 then concluded: </p>

<p>[The Act] is altogether too sweeping in its terms. I make no
question but that the habit of smoking opium may be repulsive and
degrading. That its effect would be to shatter the nerves and
destroy the intellect; and that it may tend to the increase of
pauperism and crime. But there is a vast difference between the
commission of a single act, and a confirmed habit. There is a
distinction to be recognized between the use and abuse of any
article or substance.... If this act must be held valid it is
hard to conceive of any legislative action affecting the personal
conduct, or privileges of the individual citizen. that must not
be upheld. . . . The prohibited act cannot affect the public in
any way except through the primary personal injury to the
individual, if it occasions him any injury. It looks like a new
and extreme step under our government in the field of
legislation, if it really was passed for any of the purposes upon
which that character of legislation can be sustained, if at all.
148 </p>

<p>The sanctity of &quot;the personal conduct or privileges of
the individual &quot; had suffered first blow. The knockout was
only a few citizen rounds away.<br>
</p>

<p>5. Phase Five: Prohibition of Possession of Alcohol After 1915
</p>

<p>The year 1915 was the watershed year for prohibitionists in
the courts. </p>

<p>By 1913, the tide had finally turned in the state
legislatures, many of which prohibited possession of more than a
certain quantity of alcoholic beverages. The first of these
statutes to reach the courts was that of Alabama in Southern
Express Co. v. Whittle.149 </p>

<p>Overruling its earlier decision in Eidge v. City of
Bessemer,150 one of the leading cases during the earlier phase,
the Alabama court swept away all restraints on the police power.
So long as the legislation was directed at some legitimate
purpose and was not arbitrary, the court should not interfere.151
Whether or not the Supreme Court had so intended, the Alabama
court, like other state courts, relied heavily on justice
Harlan's opinion in Mugler v. Kansas,152 and gave its legislature
a blank check when exercising police powers: </p>

<p>If the right of common law to manufacture an intoxicating
liquor for one's own personal use, out of one's own materials by
the application of one's own personal effort, may be forbidden by
appropriate legislation under the police power, as was expressly
ruled in Mugler v. Kansas . . . . it cannot be logically or
soundly asserted that the receipt or possession of more than a
specified quantity at one time may not be forbidden by a statute
. . . . 153 </p>

<p>The alleged sanctity of private conduct gave the court little
pause; this was just I one of a number of instances </p>

<blockquote>
    <p>where ancillary prohibitions of acts and conduct, innocent
    in themselves, have been sustained and confirmed as an
    exercise of the police power of the state; and so upon the
    theory that some valid legislative purpose might be more
    certainly made effective, or that evasions of the laws might
    be prevented or hindered of accomplishment.154 </p>
</blockquote>

<p>Though the Alabama court did not do so, it could have cited
the opium possession cases as authority. Most courts did. </p>

<p>The Alabama decision was quickly followed in Idaho155 and in
nine other states.156 When the Idaho case, Crane v. Campbell,157
came before the Supreme Court, Justice McReynolds dealt the
knockout blow: </p>

<blockquote>
    <p>As the state has the power . . . to prohibit [sale and
    manufacture], it may adopt such measures as are reasonably
    appropriate or needful to render exercise of that power
    effective. And, considering the notorious difficulties always
    attendant upon efforts to suppress traffic in liquors, we are
    unable to say that the challenged inhibition of their
    possession was 'arbitrary and unreasonable or without proper
    relation to the legitimate legislative purposes 158 </p>
</blockquote>

<p>The principle noted by Freund,159 that the police power did
not easily extend to matters of private conduct, was ignored: </p>

<blockquote>
    <p>[I] t clearly follows from our numerous decisions
    upholding prohibition legislation that the right to hold
    intoxicating liquors for personal use is not one of those
    fundamental privileges of a citizen of the United States
    which no State may abridge. A contrary view would be
    incompatible with the undoubted power to prevent manufacture,
    gift, sale, purchase or transportation of such articles-the
    only feasible ways of getting them. An assured right of
    possession would necessarily imply some adequate method to
    obtain not subject to destruction at the will of the State.
    160 </p>
</blockquote>

<p>Given the restrictive interpretation of the privileges and
immunities clause161 and the refusal to extend substantive due
process outside the economic area, 162 there was no existing
federal constitutional pigeonhole for &quot;private conduct&quot;
as a principle of constitutional limitation. And on the state
level the courts ignored the &quot;'intrinsic limitation&quot;
argument and discarded the direct-indirect yardstick in the wake
of the temperance movement. </p>

<p>The commentators were outraged. Again and again the courts
were indicted for interpreting constitutional precepts to
correspond with public opinion.163 The retreat on the temperance
question coincided perfectly with the final success of the
Prohibition movement. And the commentators were quite justified
in so noting. </p>

<p>It was merely icing on the cake when the Supreme Court upheld
the provision of the Volstead Act164 outlawing possession of
intoxicating liquor. The Court predictably rebuffed165 an
argument that it was beyond congressional power under section 2
of the eighteenth amendment to prohibit possession for personal
consumption of liquor owned before the passage of the Act.166 </p>

<p>6. A Postscript on the Police Power: The Cigarette Cases </p>

<p>Interestingly, the legislative solicitude for the health of
the citizenry during the period under discussion also extended to
the prohibition of cigarette smoking in several jurisdictions. In
1897, the General Assembly of Tennessee made it a misdemeanor to
sell, give away or otherwise dispose of cigarettes or cigarette
paper.167 The Supreme Court of Tennessee upheld the statute under
the police power on the grounds that cigarettes were not
legitimate articles of commerce, being &quot;inherently bad and
bad only.&quot; 168 The United States Supreme Court affirmed in
Austin v. Tennessee,169 primarily on the authority of the alcohol
and opium cases, noting that there need be only a rational basis
for the legislative determination that the commodity is harmful
to 'justify its prohibition.170 The Court did not even mention
any objection based on deprivation of property rights or personal
liberty. </p>

<p>The issue was posed more directly in Kentucky and Illinois
cases171 regarding the validity of local ordinances prohibiting
smoking of cigarettes &quot;within the corporate limits&quot; in
one case and &quot;in any street, alley, avenue ... park ... or
[other] public place&quot; in the other. Both courts held the
ordinances unreasonable interferences with personal liberty.172 </p>

<p>The argument that the ordinances were calculated to insure the
public safety by preventing fire hazards was held to be too
remote and the argument accepted in Austin regarding potential
injury to the smoker's health apparently was not made or at least
went unacknowledged by both courts. </p>

<p>These decisions, rendered in. 1911 and 1914, were probably
consistent, under a direct-indirect injury to society theory,
with Austin and with the alcohol and narcotics cases up to that
time. The post-1915 alcohol possession cases, however, undermined
any such distinction. insofar as it authorized a more active
judicial inquiry into the relationship between the private
conduct and the public need. At least at this stage of its
development it may be fruitless to seek out a &quot;neutral
principle&quot; beyond common sense regarding the undefined
constitutional limitations on the police power. Professor Brooks
Adams noted in 1913 that the scope of the police power could not
be determined in advance by abstract reasoning. Hence. as, each
litigation arose, the judges could follow no rule but the rule of
common sense, and the Police Power, translated into plain English
presently came to signify whatever, at the moment, the judges
happened to think reasonable. Consequently, they began guessing
at the drift of public opinion, as it percolated to them through
the medium of their education and prejudices. Sometimes they
guessed right and sometimes wrong, and when they guessed wrong
they were cast aside, as appeared dramatically enough in the
temperance agitation .173 </p>

<p>And justice Holmes noted: </p>

<blockquote>
    <p>It may be said in a general way that the police power
    extends to all the great public needs. It may be put forth in
    aid of what is sanctioned by usage, or held by the prevailing
    morality or strong and preponderant opinion to be greatly and
    immediately necessary to the public welfare.174 </p>
</blockquote>

<p>Whether the development of the Judicial response to exercises
of the police power at the time was the result of the changing
public opinion or a changing analytical framework, trends in that
response were evident. It remains to be seen whether any trends
are evident today to indicate how marijuana users will fare in
the future.<br>
</p>

<hr>

<h2>Footnotes and References </h2>

<p><font size="2">1 E. </font>CHERRINGTON, THE EVOLUTION OF
PROHIBITION IN THE UNITED STATES OF AMERICA <font size="2">135-45
(1920) [hereinafter cited </font>as CHERRINGTON1. </p>

<p>21d. at 176-84.<br>
</p>

<p>31d. at 180-81; Safely, Growth of State Power Under Federal
Constitution to Regulate Traffic in Intoxicating Liquors, 3
LOWAL. BULL. 221, 222 (1917). <br>
</p>

<p>4 CHERRINGTON139. </p>

<p> Id. at 181-82.<br>
</p>

<p>6 Id. at 280.<br>
</p>

<p>7 Id. at 280-81.<br>
</p>

<p>8 Id. at 281.<br>
</p>

<p> Id. at 284.<br>
</p>

<p>10 Leisy v. Hardin, 135 U.S. 100 (1890).<br>
</p>

<p>11Four months after Leisy Congress enacted the &quot;Wilson
Law,&quot; designed to make all intoxicating liquors subject
&quot;upon arrival&quot; to the laws of the state into which they
were sent. Act of Aug. 8, 1890, ch. 728, 26 Stat. 313. In Rhodes
v. Iowa, 170 U.S. 412 (1898), however, the Supreme Court held
that &quot;upon arrival&quot; meant after delivery to the
consignee. Thus the right to receive the liquor and the attendant
enforcement problems remained. </p>

<p>12Act of Mar. 1, 1913, ch. 90, 37 Stat. 699. </p>

<p>13 The Act was upheld in Clark Distilling Co. v. Western Md.
Ry., 242 U.S. 311 (1917). </p>

<p>14 CHERRINGToN, 285-86. </p>

<p>15 Id. at 320. </p>

<p>115 Id. at 321-22. </p>

<p>17 See H.R. Doc. No. 722, 71st Cong., 3d Sess. 5 (1931)
thereinafter cited as WICKERSHAM COMMISSION J. </p>

<p>18 <i>Id.</i> </p>

<p><i>Is </i>Id. at 8. </p>

<p>20 Act of Oct. 28, 1919, ch. 85, 41 Stat. 305.<br>
<br>
21 In 1904 Ernst Freund had noted, quoting from an article on
&quot;personal liberty&quot; in <i>the Cyclopedia of Temperance
and Prohibition: </i></p>

<p>Even the advocates of prohibition concede that the state has
no concern with the private use of liquor. &quot;The opponents of
prohibition misstate the case by saying that the state has no
right to declare what a man shall cat or drink. The state does
not venture to make any such declaration.... It is not the
private appetite or home customs of the citizen that the state
undertakes to manage, but the liquor traffic. . . . If by
abolishing the saloon the state makes it difficult for men to
gratify their private appetites, there is no just reason for
complaint.&quot;<br>
</p>

<p>E. FREuND, PoLicE POWER 484 (1904). </p>

<p>22 WICKERSHAM CommissioN 6-7. </p>

<p>23 Id. at 21. In 1929 President Hoover had devoted a major
part of his inaugural address to the &quot;disregard and
disobedience&quot; of the eighteenth amendment. He attributed to
the ordinary citizen &quot;a large responsibility&quot; for a
&quot;dangerous expansion in the criminal elements.&quot;
Attempting to generate moral support for the law, he chastised
the citizenry: </p>

<p>No greater national service can be given by men and women of
goodwill-who, I know, are not unmindful of the responsibilities
of citizenship-than that they should, by their example, assist in
stamping out crime and outlawry by refusing participation in and
condemning all transactions with illegal liquor. Our whole<br>
</p>

<hr>

<p>missing piece<br>
<br>
</p>

<hr>

<p>28 F. BLACK, <i>supra </i>note 27, at 149-50. </p>

<p>29 R. CHilds, MAKING REPEAL WORK 12 (1947). </p>

<p>30 The earliest surveys employ a methodology much less
sophisticated than those conducted after 1914. The later studies,
however, suffer from a time lag which inevitably detracts from
accuracy. In any event, taken together, these surveys adequately
describe the contours of the phenomenon under consideration. </p>

<p>31 The earliest attempt at a compilation of addiction figures
was undertaken by O. Marshall in 1878. Marshall, The <i>Opium
Habit in Michigan, </i>1878 MICH. STATE BD. OF<br>
HEALTH ANN. REP. 61-73. From questionnaires sent to doctors,
Marshall found 1,313 users of opium or morphine and concluded
therefrom that there were 7,763 addicts in the state. Dr. Charles
Terry later concluded that, if Marshall's figures were
representative, total incidence of addiction in the United States
in 1878 was 251,936. C. TERRY &amp; M. PELLENS, THE OPIUM PROBLEM
15 (1928) [hereinafter cited as TERRY &amp; PELLENS]. Marshall
was unable fully to take into account the fact that the incidence
of drug abuse in the cities was much higher than that in the
rural areas he studied; accordingly, his figures probably
underestimate the extent of addiction in the state. </p>

<p>In a similar study of Iowa in 1884, J. M. Hull found 5,732
addicts which, if representative, would reflect a national addict
population of 182,215. Hull, <i>The Opium Habit, </i>1885 IOWA
STATE BD. OF HEALTH BIENNIAL REP. <i>535-45, quoted in </i>TERRY
&amp; PELLENs 16-18. </p>

<p>In 1900 the author of a Vermont study sent 130 questionnaires
to various druggists in an attempt to determine the monthly sales
of various drugs. His 116 replies indicate that 3,300,000 doses
of opium were sold every month, or enough for every person in
Vermont over the age of 21 to receive 11/2 doses per day.
Grinnel, <i>A Review of Drug Consumption and Alcohol as Found in
Proprietary Medicine, </i>23 MEDico-LEGAL J. 426 <i>(1905),
quoted in </i>TERRY &amp; PELLENs 21-23. </p>

<p>Perhaps the best pre-1914 estimate was made by Dr. Charles
Perry who, as Health Officer of Jacksonville, Florida, compiled
data for that city in 1913. He found that 541 persons, or .81% of
the city's population, used opium or some preparation thereof in
1913. Nationwide, this incidence would be 782,118. 1913
JACKSONVILLE, FLA, BD. OF HEALTH ANN. <i>REP., quoted in </i>TERRY
&amp; PELLENs 25. </p>

<p>A researcher in 1915 found 2,370 registered addicts in
Tennessee and put the national addict population at between
269,000 and 291,670. Brown, <i>Enforcement of the Tennessee
Anti-Narcotic Law, 5 </i>Am. J. PUB. HEALTH 323-33 (1915), <i>quoted
in </i>TERRY &amp; PELLENs 27-29. </p>

<p>The first post-Harrison Act study, and perhaps the most
reliable of all research during this period, was done by Lawrence
Kolb and A. G. DuMez of the United States Public Health Service.
Utilizing previously computed statistics together with
information regarding the supply of narcotics imported into the
United States, these authors concluded the addict population
never exceeded 246,000. KOLB &amp; DUMEz, THE PREVALENCE AND
TREND OF DRUG ADDICTION IN THE UNITED STATES AND FACTORS
INFLUENCING IT 1-20 (39 Public Health Reports No. 21) (May 23,
1924). </p>

<p>At the same time the Narcotic Division of the Prohibition Unit
of the IRS estimated that there were more than 500,000 drug
addicts in America. Narcotic Division of the Prohibition Unit,
Bureau of Internal Revenue, Release (May 4, 1924), <i>quoted in </i>TERRY
&amp; PELLENs 42 n.25. </p>

<p>For more recent estimates of drug addiction in America, see W.
ELDRIDGE, NARCOTICS AND THE LAW 49-103 (2d rev. ed. 1967); A.
LINDESMITH, THE ADDICT AND THE LAW 99-134 (1965); ARTHUR D.
LITTLE, INC., DRUG ABUSE AND LAW ENFORCEMENT 1l-21 (1967). </p>

<p>32 <i>But see </i>M. NYSWANDER, THE DRUG ADDICT AS A PATIENT
1-13 (1956) (the author suggests that perhaps I to 4% of American
adult population was addicted in 1890). 33 Of the 1,313 addicts
in Marshall's Michigan study, 803 were females and only<br>
510 males. TERRY &amp; PELLENS 11. In the Florida study, there
were 228 men and 313 women. Id. at 25. Of the 2,370 registered
addicts in the Tennessee study, 784 were men and 1,586 women. Id.
at 27. A modern observer has concluded that there were at least
as many and probably twice as many women addicts as men.
O'Donnell, <i>Patterns of Drug Abuse and Their Social
Consequences, </i>in DRUGS &amp; YouTH 62, 64 (J. Whittenborn ed.
1969). For the last thirty years, male addicts have probably
outnumbered female addicts by four or five to one. <i>Id.</i> </p>

<p>34 Of the 228 men included in the Florida study, 188 were
white and 40 black; of the women 219 were white and 94 black.
TERRY &amp; PELLENs 25. At that time the white and black
populations in Jacksonville were equal. Of those covered in the
Tennessee study, 90% were white. Id. at 28. </p>

<p>35 The Michigan, Iowa and Vermont studies covered primarily
rural areas. </p>

<p><i>36 See, e.g., </i>Eberle, <i>Report of Committee on
Acquirement of Drug Habits, Am. </i>J. PHARMACY, Oct. 1903, at
474-88. &quot;While the increase is most evident with the lower
classes, the statistics of institutes devoted to the cure of
habitues show that their patients are principally drawn from
those in the higher walks of life.&quot; <i>Id, quoted in </i>TERRY
&amp; PELLENs 23. </p>

<p>37 <i>See, e.g., O'Donnell, supra </i>note 3 3, at 64. </p>

<p>38 TERRY &amp; PELLENs 69. </p>

<p>39Stanley, <i>Morpbinism, 6 </i>J. Crim. L. &amp; CRIMINOLOGY
586, 588 (1915). </p>

<p>40 See the resolution of the Narcotics Control Association of
California, 13 J. CRIM. L. &amp; CRIMINOLOGY 126-27 (1922),
calling for stricter laws regulating prescriptions and
prescription order forms. </p>

<p>41 TERRY &amp; PELLENs 66. </p>

<p>47<br>
</p>

<p>42 Brill, Recurrent Patterns in the History of Drug Dependence
and Some Interpretations, in DRUGS AND YOUTH 18 (J. Whittenborn
ed. 1969). </p>

<p>43 TERRY &amp; PELLENs 76-82. </p>

<p>44 See S. ADAms, THE GREAT AMERICAN FRAUD (1913). </p>

<p>45 TERRY &amp; PELLENs 44. </p>

<p>46 Id. at 84-87. </p>

<p>47 See H. KANE, OPIUM-SMOKING IN AMERICA AND CHINA (1882), in
which the author supports the contention that by approximately
1890 narcotic addiction had become widespread among the
respectable and professional classes. He states: </p>

<p>The practice [opium smoking] spread rapidly and quietly among
this class of gamblers and prostitutes until the latter part of
1875, at which time the authorities became cognizant of the fact,
and finding, upon investigation, that many women and young girls,
as also young men of respectable family, were being induced to
visit the dens .... </p>

<p>Quoted in TERRY &amp; PELLENs 73. </p>

<p>48Ch. 3915, 34 Stat. 768 (1906). </p>

<p>49 &quot;The peak of the patent medicine industry was reached
just prior to the passage of the federal Pure Food and Drug Act
in 1906.&quot; TERRY &amp; PELLENs 75. </p>

<p>50 U.S. TREASURY DEPT, STATE LAWS RELATING TO THE CONTROL oF
NARCOtic DRUGS AND THETREATMENT OFDRUG ADDICTION 1 (1931)
[hereinafter cited as STATE LAWS]. </p>

<p>51 The first drug legislation enacted in eight states outlawed
the administering Of 2 narcotic drug to any person with the
intent to facilitate the commission of a felony. These states
were California (1872), Idaho (1887), New York (1897), North
Dakota (1883), Pennsylvania (1901), South Dakota (1883), Utah
(1876) and Wisconsin (1901). Id. at 1-2. </p>

<p>52 Twenty-two states made such legislation their first laws
concerning the drug problem. Id. at 2. </p>

<p>53 Id. at 3-4. </p>

<p>54 States with such legislation were Arizona (1883),
California (1881), Georgia (1895), Idaho (1887), Maryland (1886),
Missouri (1911), Montana (1881), Nevada (1877), New Mexico
(1887), North Dakota (1879), Ohio (1885), Pennsylvania (1883),
South Dakota (1879), Utah (1880), Wisconsin (1891) and Wyoming
(1882). <i>Sec id., </i>Pt. III. </p>

<p><i>55 Id. </i>at S. </p>

<p>56 <i>Id. at </i>5, <i>2 5 1.</i> </p>

<p>57 Arizona (1899), Arkansas (1899), Colorado (1897), Illinois
(1897), Mississippi (1900), Montana (1889) and New York (1893).
Id., Pt. 111. </p>

<p><i>58 See id.</i> </p>

<p>59 <i>Id.</i> </p>

<p><i>60 </i>Id. at 251. </p>

<p>61 California (1909), Maine (1887), South Carolina (1911),
Tennessee (1913), Wm Virginia (1911) and Wyoming (1903). <i>Id., </i>Pt.
III. </p>

<p>62 Maryland (1912), Ohio (1913) and Virginia (1908). Id. </p>

<p>I&quot; Act of Feb. 9, 1909, ch. 100, 35 Stat. 614, <i>aS </i>amended,
21 U.S.C. S 173 (1964). This act was revised by Act of Jan. 17,
1914, ch. 9, 38 Stat. 275, in the same wave of reform that
produced the Harrison Act. </p>

<p>64 Hearings on the Importation and Use of Opium Before the
House Comm. on Ways and Means, 61st Cong., 2d Sess. passim
(1910). </p>

<p>65 38 Stat. 785 (1914), as amended, 26 U.S.C. S 4701-36
(1964). </p>

<p>66 See, eg., Stanley, supra note 39, at 587; Fixes Blame for
Dope Fiend Evil, Boston Herald, Jan. 5, 1917. </p>

<p>67 Webb V. United States, 249 U.S. 96 (1919). </p>

<p>68 See Weber, Drugs and Crime, 44 A.B.A. REP. 527 (1919).
Kolb, Factors That Have Influenced the Management and Treatment
of Drug Addicts, in NARCOTIC DRUG ADDICTION PROBLEMS 23, _26 (R.
Livingston ed. 1958) states: </p>

<p>See generally T. Duster, THE LEGISLATION OF MORALITY 3-28
(1970). <br>
</p>

<p>69 See generally A. LiNDEsmITH, supra note 31, at 135-61;
King, Narcotic Drug Laws and Enforcement Policies, 22 LAW &amp;
CONTEMP. PROB. 113, 124-26 (1957); King, The Narcotics Bureau and
the Harrison Act, 62 YALE L.J. 736 (1953); Note, Narcotics
Regulation, 62 YALE L.J. 751, 784-87 (1953). </p>

<p>70 For a savage attack on the clinic system by a well-known
supporter of the law enforcement model of the Harrison Act, see
Stanley, Narcotic Drugs and Crime, 12 J. Crim. L. &amp;
CRIMINOLOGY 110 (1921). </p>

<p>71 Lindesmith reports that for a brief period of time from
1919 to 1923 some forty clinics of this type existed in the
United States. A. Lindesmith, supra note 31, at 136, </p>

<p>72 The closing of the New York Clinic in 1919 was an
especially potent factor in promoting hysteria about heroin. More
than 7,400 addicts, about 90 percent Of whom were users of
heroin, were thrown on the streets of the city. Driven to commit
crimes, including those of narcotic violations, many of these
addicts were arrested. The increased number of arrests was widely
interpreted as an indication of moral deterioration due to
narcotics instead of evidence of maladministration of what could
have been a useful law. There were, of course, physicians who
dissented both as to the wisdom of closing the clinics and as to
the harmful effect of the drugs. Many of those who persisted in
helping their patients were arrested. Kolb, supra note 68, at 27.
</p>

<p>73 188 U.S. 3.21 (1903). </p>

<p>74 247 U.S. 251 (1918). </p>

<p>75 United States v. Doremus, 249 U.S. 86 (1919). The four
dissenters asserted that &quot;the statute was a mere attempt by
Congress to exert a power not delegated, that is, the reserved
police power of the States.&quot; Id. at 95. It is interesting to
note, however, that a subsequent congressional attempt to
regulate child labor through the taxing power was also
invalidated. Bailey v. Drexel Furniture Co., 259 U.&amp; 20
(1922).<br>
</p>

<p>76 justice McReynolds stated for the Court in Linder v. United
States, 268 U.S. 5, 18 (1925): Obviously, direct control of
medical practice in the States is beyond the power of the Federal
Government. Incidental regulation of such practice by Congress
through a taxing act cannot extend to matters plainly
inappropriate and unnecessary to reasonable enforcement of a
revenue measure. </p>

<p>The Court also held that the Harrison Act did not apply to
mere possession of opium. In reaching this conclusion the Court
pointed out that any congressional attempt to punish as a crime
possession of any article produced in a state would raise the
'gravest questions of power. United States v. Jin Fuey Moy, 241
U.&amp; 394, 401 (1916). </p>

<p>77 Schmeckebier, The Bureau of Prohibition, in BROOKINGS INST.
FOR GOVT RESEARCH, SERVICE MONOGRAPH No. 57, at 143 (1929). </p>

<p>78 An Act to Create a Bureau of Customs and 2 Bureau of
Prohibition in the Department of the Treasury, ch. 348, 44 Stat.
1381 (1927). </p>

<p>79 Act of June 14, 1930, ch. 488, 46 Star. 585. </p>

<p>80 See generally King, The Narcotics Bureau and the Harrison
Act, 62 YALE L.J. 736 (1953). </p>

<p>81 The primary objective of prohibitionary legislation was to
suppress all traffic in intoxicating beverages. Accordingly, most
states prohibited both manufacture and sale. However, New
Hampshire's law, in effect from 1855 through 1903, forbade only,
sale. </p>

<p>82 Sixteen states passed prohibitionary legislation for the
whole territory of the state. However, twelve of them had
repealed this legislation by 1903, and a thirteenth, Maine, had
repealed its statute before 1884 when prohibition was embodied in
a constitutional amendment. E. FREuND, POLICE POWER 202, 203
(1904). </p>

<p>83 46 U.S. (5 How.) 504 (1847). </p>

<p>84 Id. at 577. </p>

<p>85 State v. Paul, 5 R.I. 185 (1858); State v. Wheeler, 25
Conn. 290 (1856); State v Allmond, 7 De]. 612 (1856); People v.
Gallagher, 4 Mich. 244 (1856); Santo v. State' 2 Iowa 165 (1855);
Lincoln v. Smith, 27 Vt. 328 (1855); People v. Hawley, 3 Mich.
330 (1854); Commonwealth v. Kendall, 66 Mass. (12 Cush.) 414
(1853); Jones v. People, 14-111. 196 (1852). </p>

<p>86 State v. Paul, 5 R.I. 185 (1858); Commonwealth v. Kendall,
66 Mass. (I 2 Cush.) 414 (1853); Jones v. People, 14 III. 196
(1852). </p>

<p>87 State v. Wheeler, 25 Conn. 290 (1856); State v. Allmond, 7
De]. 612 (1856); Santo v. State, 2 Iowa 165 (1855); Lincoln v.
Smith, 27 Vt. 328 (1855). </p>

<p>88 Wynehamer v. People, 13 N.Y. 378 (1856). 89 Beebe v. State,
6 Ind. 501 (1855). </p>

<p>90 Dissenting in People v. Gallagher, 4 Mich. 244 (1856),
justice Pratt noted' &quot;That intemperance is a great evil, no
sane man can doubt.&quot; Id. at 284. The Iowa court asserted: </p>

<p>There is no statistical or economical proposition better
established, nor one to which a more general assent is given by
reading and intelligent minds, than this, that the use of
intoxicating liquors as a drink, is the cause. of more want,
pauperism, suffering, crime and public expense, than any other
cause-and perhaps it should be said, than all other causes
combined. </p>

<p>Santo v. State, 2 Iowa 165, 190 (1855). </p>

<p>91 Dissenting in People v. Gallagher, 4 Mich. 244 (1856) ,
justice Pratt stated: &quot;Spiritous liquors are necessary in
the prosecution of many of the most valuable arts,' as well as
for mechanical, manufacturing and medicinal purposes.&quot; Id.
at 260. </p>

<p>92 The Indiana Court noted &quot;as a matter of general
knowledge . . . that the use of beer &amp;c. as a beverage, is
not necessarily hurtful, any more than the use of lemonade or ice
cream.... It is the abuse, and not the use, of all these
beverages that is hurtful.&quot; Beebe v. State, 6 Ind. 501,
519-20 (1855). </p>

<p>93 Justice Pratt reasoned: </p>

<p>Liquors, then, whether produced by fermentation or
distillation, do legally constitute property of use and value;
and the owner of this species of personal property, when lawfully
acquired, is, upon every principle, . . . entitled to the
possession and use of it. This legally includes the right of
keeping, selling or giving it away, as the owner may deem proper.
This is a natural primary right incident to ownership . . . . </p>

<p>People v. Gallagher, 4 Mich. 244, 263 (1856); accord,
Wynehamer v. People, 13 N.Y. 378, 396-98 (1856) (Comstock, J.). </p>

<p>94 Said the Indiana Court: </p>

<p>[T]he legislature enacted the law in question upon the
assumption that the manufacture and sale of beer . . . were
necessarily destructive to the community, and in acting upon that
assumption, in our judgment, has unwarrantably invaded the right
to private property, and its use as a beverage and article of
traffic. </p>

<p>. . . We repeat, the manufacture and sale and use of liquors
are not necessarily hurtful, and this the Court has a right to
judicially inquire into and act upon in deciding upon the
validity of the law in question-in deciding . . . whether it is
an indirect invasion of a right secured to the citizen by the
Constitution. Beebe v. State, 6 Ind. 501, 520-21 (1855) (emphasis
added). </p>

<p>95 In an opinion often cited as the first to invoke the
substantive construction of &quot;due process of law,&quot; judge
Comstock in Wynchamer v. People, 13 N.Y. 378, 392-93, 398 (1856),
stated: </p>

<p>To say that &quot;the law of the land&quot; or &quot;due
process of law&quot;, may mean the very act of legislation which
deprives the citizen of his rights, privileges or property, leads
to a simple absurdity. The Constitution would then mean, that no
person shall be deprived of his property or rights unless the
legislature shall pass a law to effectuate the wrong, and this
would be throwing the restraint entirely away. The true
interpretation of these constitutional phrases is, that where
rights are acquired by the citizen under existing law, there is
no power in any branch of the government to take them away. </p>

<p>When a law annihilates the value of property, and strips it of
its attributes, by which alone it is distinguished as property,
the owner is deprived of it according to the plainest
interpretation, and certainly within the spirit of a
constitutional provision intended expressly to shield private
rights from the exercise of arbitrary power. </p>

<p>96 The Indiana court held the prohibitionary legislation in
contravention of a provision in the state constitution declaring
that &quot;all men are endowed by their Creator with certain
inalienable rights; that among these are life, liberty and the
pursuit of happiness.&quot; Beebe v. State, 6 Ind. 501, 510
(1855). Dissenting in People v. Gall2gher, 4 Mich. 244, 258
(1856), Justice Pratt conducted an identical natural rights
inquiry without the benefit of Thomas Jefferson's penmanship. </p>

<p>97 13N.Y. 379 (1856). </p>

<p>98 6 Ind. 501 (1855). </p>

<p>99 Lincoln v. Smith, 27 Vt. 328, 337-38 (1855). </p>

<p>100 See State v. Guerney, 37 Me. 156, 161 (1853). </p>

<p>101 State v. Allmond, 7 Del. 612, 639 (1856); see Lincoln v.
Smith, 27 Vt. 328, 338-39 (1855). </p>

<p>102 People v. Gallagher, 4 Mich. 244, 255 (1856); State v.
Wheeler, 25 Conn. 290, 297-98 (1856). </p>

<p>103 State v. Wheeler, 25 Conn. 290, 297 (1856); State v.
Allmond, 7 Del. 612, 642 (1856). </p>

<p>104 State v. Allmond, 7 Del. 612, 692 (1856). </p>

<p>105 State v. Paul, 5 R.I. 185, 197 (1858); Lincoln v. Smith,
27 Vt. 328, 360 (1855). </p>

<p>106 Meshmeier v. State, II Ind. 482 (1858). </p>

<p>107 In People v. Gallagher, 4 Mich. 244 (1856), the majority
stated: </p>

<p>The legislature has said that . . . no man shall sell liquors
to be used as a beverage, because by so doing, he inflicts injury
on the public; but, says the defendant, irrespective of the evil,
this right to sell liquors is a natural right, and you have no
power to pass a law infringing that right. How does he prove it?
Not by any adjudged cases; there are none, nor by anything in the
constitution preserving to him this right; but it is to be
determined by the nature and character of the right. . . . [The
manner in which the determination is to be made is] a question
very suitable and proper for the discussion and deliberation of a
legislative body, but one which cannot be entertained by this
court. </p>

<p>Id. at 257. judge Pratt replied: </p>

<p>If the doctrine is true that the legislature can, by the
exercise of an implied discretionary power, pass any law not
expressly inhibited by the constitution, then it is certain that
a hundred laws may be enacted by that body, invading directly
legitimate business pursuits, impairing and rendering worthless
trades and occupations, and destroying the substantial value of
private property, to the amount of millions of dollars. . . . But
who, I ask, believes that the legislature possesses the power, or
that the people, in their sovereignty, ever intended to confer on
that body such unlimited omnipotence? As appears to me, no man of
reason and reflection can believe it. </p>

<p>Id. at 277-79 (dissenting opinion). </p>

<p>108 Mere possession or consumption of alcohol was not
prohibited during this phase of temperance legislation. Many of
the courts were careful to allude to this feature and to note
that forfeiture could result only from illegal
possession-possession with intent to sell in violation of the
law. See, e.g., Santo v. State, 2 Iowa 165 (1855); Commonwealth
v. Kendall, 66 Mass. (12 Cush.) 414 (1853). </p>

<p>109 123 U.S. 623 (1887). </p>

<p>110 In Bartemeyer v. Iowa, 85 U.S. (18 Wall.) 129 (1873), the
Supreme Court held that the prohibition of traffic in
intoxicating drinks violates no privilege and immunity of United
States citizenship; the Court avoided the question whether a law
prohibiting sale of liquor owned before the law was passed was a
deprivation of property without due process. Four years later, in
Beer Co. v. Massachusetts, 97 U.S. 25 (1877), the Court sustained
a prohibition law against a challenge under the obligation of
contracts clauses but still deferred consideration of the
Wynehamer question. In upholding the seizure and forfeiture of
liquors belonging to the petitioner, justice Bradley stated: If
the public safety or the public morals require the discontinuance
of any manufacture or traffic, the hand of the legislature cannot
be stayed from providing for its discontinuance, by any
incidental inconvenience which individuals or corporations may
suffer. All rights are held subject to the police power of the
State. 97 U.S. at 32. </p>

<p>Finally, in Mugler v. Kansas, 123 U.S. 623 (1887), Wynebamer
was slain. The Court sustained a conviction for selling beer
manufactured before the passage of the law. The Court even held
that, in order to make effective its regulations against sale,
the State might forbid manufacture for personal use. Id. at 662.
The only constitutional inhibitions remaining after Mugler
emanated from the commerce power. For a discussion of the gradual
elimination of these restrictions by congressional action, see
Safely, Growth of State Power Under Federal Constitution to
Regulate Traffic in Intoxicating Liquors, 3 IOWA L. BuLL. 221,
229-34 (1917). </p>

<p>111 In Mugler, justice Harlan stated: </p>

<p>There is no justification for holding that the State, under
the guise merely of police regulations, is here aiming to deprive
the citizen of his constitutional rights. . . . If, therefore, a
state deems the absolute prohibition of the manufacture and sale,
within her limits, of intoxicating liquors for other than
medical, scientific, and manufacturing purposes, to be necessary
to the peace and security of society, the courts cannot, without
usurping legislative functions, override the will of the people
as thus expressed by their chosen representatives. They have
nothing to do with the mere policy of legislation. 123 U.S. at
662. </p>

<p>112 See note 82 supra. </p>

<p>113 28 F. 308 (D. Ore. 1886). The prisoner had been convicted
in an Oregon court and was being heard on petition for habeas
corpus. </p>

<p>114 Id. at 312. </p>

<p>115 16 Nev. 50 (1881). </p>

<p>116 Id. at 55-56. </p>

<p>117 The Supreme Court rejected it one year later in Mugler v.
Kansas, 123 U.S. 623 (1887). </p>

<p>118 Ex parte Yung Jon, 28 F. 308, 311 (D. Ore. 1886). </p>

<p>119 Id. In defining property essentially in terms of habits of
the community, judge Deady was leaving room for the
&quot;natural&quot; rights argument with regard to alcohol and
tobacco: </p>

<p>True, we permit the indiscriminate use of alcohol and tobacco,
both of which are classed by science as poisons, and doubtless
destroy many lives annually. But the people of this country have
been accustomed to the manufacture and use of these for many
generations, and they are produced and possessed under the common
and long-standing impression that they are legitimate articles of
property, which the owner is entitled to dispose of without any
unusual restraint. . . . On the other hand, the use of opium,
otherwise than as this act allows, as a medicine, has but little,
if any, place in the experience or habits of the people of this
country, save among a few aliens. </p>

<p>Id. at 311-12 (emphasis added). </p>

<p>120 State v. Wheeler, 25 Conn. 290 (1856); Lincoln v. Smith,
27 Vt. 328 (1855); Commonwealth v. Kendall, 66 Mass. (12 Cush.)
414 (1853); cf. State v. Clark, 28 N.H. 176, 181 (1854)
(ordinance that prohibited using or keeping intoxicating liquors
in any refreshment saloon or restaurant, &quot;not
unreasonable,&quot; since it did not &quot;profess to prohibit
either the use or sale of liquor altogether&quot;). </p>

<p>121 Ex parte Wilson, 6 Okla. Crim. 451, 119 P. 596 (1911);
Titsworth v. State, 2 Okla. Crim. 268, 101 P. 288 (1909); State
v. Williams, 146 N.C. 618, 61 S.F. 61 (1908); Ex parte Brown, 38
Tex. Crim. 295, 42 S.W. 554 (1897) (alternative holding). Contra,
Cohen v. State, 7 Ga. App. 5, 65 S.E. 1096 (1909); Easley Town
Council v. Pegg, 63 S.C. 98, 41 S.E. 18 (1902). </p>

<p>122 Commonwealth v. Campbell, 133 Ky. 50, 117 SAN,. 383
(1909); Ex parte Brown, 38 Tex. Crim. 295, 42 S.W. 554 (1897);
State v. Gilman, 33 W. Va. 146, 10 S.E. 293 (1889). </p>

<p>123 Eidge v. City of Bessemer, 164 Ala. 599, 51 So. 246
(1909); Sullivan v. City of Oneida, 61 Ill. 242 (1871). But see
Town of Selma v. Brewer, 9 Cal. App. 70, 98 P. 61 (Dist. Ct. App.
1908). </p>

<p>124 H. BLACK, INTOXICATING LIQUORS 50 (1892); E. FREUND,
POLICE POWER 484 (1904); H. JOYCE, THE LAW RELATING T0
INTOXICATING LIQUORS  85 (1910); Rogers, &quot;Life, Liberty
and Liquor&quot;: A Note on the Police Power, 6 VA. L. Rev. 156,
174 (1919). </p>

<p>125 E.g., State v. Williams, 146 N.C. 618, 61 S.E. 61 (1908). </p>

<p>126 F. FREUND, P0LICE: POWER 486 (1904): </p>

<p>Under these circumstances it seems impossible to speak of a
constitutional right of private consumption. There seems to be no
direct judicial authority for declaring private acts exempt from
the police power, and the universal tolerance With regard to them
should be ascribed to policy. Like am, other exercise of the
police power, control of private conduct would have to justify
itself on grounds of the public welfare. </p>

<p>127 Id. </p>

<p>128 E.g., State v. Williams, 146 N.C. 618, 61 S.E. 61 (1908). </p>

<p>129 E.g., State v. Gilman, 33 W. Va. 146, 10 S.E. 283 (1889). </p>

<p>130 E.g., Eidge v. City of Bessemer, 164 Ala. 599, 51 So. 246
(1909); Commonwealth v. Campbell, 133 Ky. 50, 117 S.W. 383
(1909). </p>

<p>131 133 Ky. 50, 117 S.W. 383 (1909). </p>

<p>132 Id. at 58, 117 S.W. at 385 (emphasis added). </p>

<p>133 Id. at 63, 117 S.W. at 387. </p>

<p>134 Id. 63-64,117 S.W. at 387. </p>

<p>135 Similarly, in State v. Gilman, 33 W. Va. 146, 10 S.E. 283
(1889), the court stated: </p>

<p>It can hardly be questioned that the right to possess property
is [an inalienable] right, and that that right embraces the
privilege of a citizen to keep in his possession property for
another. It is not denied that the keeping of property which is
injurious to the lives, health, or comfort of all persons may be
prohibited under the police power. . . . [I]t must, of course, be
within the range of legislative action to define the mode and
manner in which every one may so use his own as not to injure
others. But it does not follow that every statute enacted
ostensibly for the promotion of these ends is to be accepted as a
legitimate exercise of the police Power of the State . . . . </p>

<p>The keeping of liquors in his possession by a person, whether
for himself or for another, unless he does so for the illegal
sale of it, or for some other improper purpose , can by no
possibility injure or affect the health, morals, or safety of the
public; and, therefore, the statute prohibiting such keeping in
possession is not a legitimate exertion of the police power. </p>

<p>Id. at 148-49, 10 S.E. it 284 (emphasis added); accord, Ex
parte Brown, 38 Tex. Crim. 795, 42 S.W. 554 (1897). </p>

<p>In Ex parte Wilson, 6 Okla. Crim. 451, 119 P. 596 (1911), the
Court, after quoting extensively from Commonwealth v. Campbell,
noted, &quot;The only conclusion that we can legitimately arrive
at is that the act in question is not within a reasonable
exercise of the police powers of the state-is unconstitutional
and void.&quot; 6 Okla. Crim. at 475, 119 P. at 606 (emphasis
added). Finally, the Alabama Supreme Court stated, in striking
down a local ordinance prohibiting possession by beverage dealers
of alcoholic beverages: </p>

<p>[The ordinance] can be justified only, if at all, on the
ground that it sustains some reasonable relation to the
prohibition law in the way of preventing evasions of that law by
trick, artifice, or subterfuge under guise of which that 12W is
violated. But it has no such relation. It undertakes to prohibit
the keeping if) any quantity and for any purpose, however
innocent, of intoxicating liquors and beverages in places which
are innocent in themselves. Eidge v. City of Bessemer, 164 Ala.
599, 606, 51 So. 246, 249 (1909). </p>

<p>136 Ex parte Yun Quong, 159 Cal. 508, 114 P. 835 (1911); Luck
v. Sears, 29 Ore. 421, 44 P. 693 (1896); Ah Lim v. Territory, I
Wash. 156, 24 P. 588 (1890). </p>

<p>137 Ah Lim v. Territory, I Wash. 156, 163, 24 P. 588, 589
(1890). </p>

<p>138 If the state concludes that a given habit is detrimental
to either the moral, mental or physical well being of one of its
citizens to such an extent that it is liable to become a burthen
upon society, it has an undoubted right to restrain the citizen
from the commission of that act; and fair and equitable
consideration of the rights of other citizens make it not only
its right, but its duty, to restrain him. Id. at 164, 24 P. at
590; accord, Ex parte Yun Quong, 159 Cal. 508, 515, 114 P. 835,
837 (1911); Luck v. Sears, 29 Ore. 421, 426, 44 P. 693, 694
(1896). </p>

<p>139 Ex parte Yun Quong, 159 Cal. 508, 515, 114 P. 835, 837
(1911); Luck v. Sears, 29 Ore. 421, 425, 44 P. 693, 694 (1896). </p>

<p>140 But it is urged . . . that a moderate use of opium . . .
is not deleterious and consequently cannot be prohibited. We
answer that this is a question of fact which can only be inquired
into by the legislature. </p>

<p>Ah Lim v. Territory, I Wash. 156, 164, 24 P. 588, 590 (1890).
The dissent argued that moderate use by some could not be
punished to prevent excessive use by others. Id. at 172-74, 24 P.
at 592-93. <br>
</p>

<p>141 Id. at 165, 24 P. at 590. [W]hether [opiums] nature and
character is such that for the protection of the public its
possession by unauthorized persons should be prohibited is a
question of fact and of public policy, which belongs to the
legislative department to determine. Luck v. Sears, 29 0re. 421,
426, 44 P. 693, 694 (1896). </p>

<p>142 Ex parte Yun Quong, 159 Cal. 508, 514, 114 P. 835, 838
(1911) (quoting lower court opinion) (citations omitted). </p>

<p>143 Id. at 515, 114 P. at 838 (emphasis added). </p>

<p>144 &quot;It must be conceded that its indiscriminate use
would have a very deleterious and debasing effect upon our race
Id. at 514, 114 P. at 838. </p>

<p>145 l Wash. 156, 24 P. 588 (1890). </p>

<p>146 Id. at 168, 24 P. at 591. </p>

<p>147 Individual desires are too sacred to be ruthlessly
violated where only acts are involved which do not clearly result
in an in jury, to society, unless, possibly thus rendered
necessary in order to prevent others from like actions which to
them are injurious. </p>

<p>Id. at 173, 24 P. at 592. He concluded, however, that the
statute was too broad and that this question need not be reached.
</p>

<p>148 Id. at 174-75, 24 P. at 593, </p>

<p>149 194 Ala. 406, 69 So. 652 (1915). </p>

<p>150 164 Ala. 599, 51 So. 246 (1909). </p>

<p>151 It is the peculiar function of the lawmakers to ascertain
and to determine when the welfare of the people requires the
exercise of the state's police powers, and what are appropriate
measures to that end, subject only to the power and authority of
the courts to see, when assured to the requisite certainty, that
the measures of police so adopted do not arbitrarily violate
rights protected by the organic laws. 194 Ala. at 421, 69 So. at
656. </p>

<p>152 123 U.S. 623 (1887), quoted in 194 Ala. at 428-33, 69 So.
at 659-60. </p>

<p>153 194 Ala. at 433, 69 So. at 660. </p>

<p>154 Id. at 434, 69 So. at 660. </p>

<p>155 Ex parte Crane, 27 Idaho 671, 151 P. 1006 (1915), aff'd
suh nom. Crane v. Campbell, 245 U.S. 304 (1917). </p>

<p>156 Ex parte Zwissig, 42 Nev. 360, 178 P. 20 (1919); Fitch v.
State, 102 Neb. 361, 167 N.W. 417 (1918); State v. Brown, 40 S.D.
372, 167 N.W. 400 (1918); Liquor Transportation Cases, 140 Tenn.
582, 205 S.W. 423 (1918); State v. Certain Intoxicating Liquors,
51 Utah 569, 172 P. 1050 (1918); Delaney v. Plunkett, 146 Ga.
547, 91 S.E. 561 (1917); State v. Carpenter, 173 N.C. 767, 92
S.E. 373 (1917); City of Seattle v. Brookins, 98 Wash. 290, 167
P. 940 (1917); Brennan v. Southern Express Co., 106 S.C. 102, 90
S.E. 402 (1916) (dictum). </p>

<p>157 245 U.S. 304 (1917). </p>

<p>158 Id. at 307-08 (citations omitted). </p>

<p>159 See text at note 126 supra. </p>

<p>160 245 U.S. at 308. </p>

<p>161 Eg., Slaughter House Cases, 83 U.S. (16 Wall.) 36 (1873). </p>

<p>162 Substantive due process was slowly being watered down even
in the economic area during this time. See, e.g., Muller v.
Oregon, 208 U.S. 412 (1908). </p>

<p>163 E.g., Bronaugh, Limiting or Prohibiting the Possession, of
Intoxicating Liquors for Personal Use, 23 LAW NoTEs 67 (1919);
Rogers, &quot;Life, Liberty &amp; Liquor&quot;: A Note on the
Police Power, 6 VA. L. REV. 156 (1919); Safely, Growth of State
Power Under Federal Constitution to Regulate Traffic in
Intoxicating Liquors, 3 IOWA L, Bull 221 (1917); Vance, The Road
to Confiscation., 25 YALE I.J. 285 (1916). </p>

<p>164 Ch. 85, 41 Stat. 305 (1919). </p>

<p>165 Cornell v. Moore, 257 U.S. 491 (1922). </p>

<p>166 This argument was accepted in United States v. Dowling,
278 F. 630 (S.D. Fla. 1922). </p>

<p>167, Law of Feb. 11, 1897, ch. 30, [1897] Tenn. Acts 156. </p>

<p>168 Austin v. State, 101 Tenn. 563, 48 S.W. 305 (1898), aff'd,
179 U.S. 343 (1900). 169 179 U.S. 343 (1900). </p>

<p>170 The primary issue before the Court was whether the statute
infringed the exclusive power of Congress to regulate interstate
commerce. Id. at 344. However, before turning to the
&quot;original package&quot; questions, the Court first had to
conclude that the statute was a legitimate exercise of the police
power, for only then could an indirect interference with
interstate commerce be sustained. Id. at 349. The Court noted on
this point: </p>

<p>Cigarettes do not seem until recently to have attracted the
attention of the public as more injurious than other forms of
tobacco; nor are we now prepared to take judicial notice of any
special injury resulting from their use or to indorse the opinion
of the Supreme Court of Tennessee that &quot;they are inherently
bad and bad only.&quot; At the same time we should be shutting
our eyes to what is constantly passing before them were we to
affect an ignorance of the fact that a belief in their
deleterious effects, particularly upon young people, has become
very general and that communications are constantly finding their
way into the public press denouncing their use as fraught with
great danger to the youth of both sexes. Without undertaking to
affirm or deny their evil effects, we think it within the
province of the legislature to say how far they may be sold, or
to prohibit their sale entirely . . . provided . . . there be no
reason to doubt that the act in question is designed for the
protection of the public health. </p>

<p>Id. at 348-49; cf. Gundling City of Chicago, 177 U.S. 183
(1900) (affirming validity of licensing sale of cigarettes </p>

<p>171 City of Zion v. Behrens, 262 111. 510, 104 N.E. 836
(1914); Hershberg v. City of Barbourville, 142 Ky. 60. 133 S.W.
985 (1911). <br>
</p>

<p>172 In the broad language in which the ordinance is enacted it
is apparently an attempt on the part of the municipality to
regulate and control the habits and practices of the citizen
without any reasonable basis for so doing. The ordinance is an
unreasonable interference with the private rights of the citizen
. . . . 262 Ill. at 513, 104 N.E. at 837-38. </p>

<p>The ordinance is so broad as to prohibit one from smoking a
cigarette in his own home or on any private premises in the city.
To prohibit the smoking of cigarettes in [such circumstances] is
an invasion of his right to control his own personal indulgences.
142 Ky. at 61, 133 S.W. at 986 (1911). By holding that the
ordinance applied in the home, the Kentucky court avoided the
question raised in the Illinois case. The reasoning would appear
to compel the same result, however. </p>

<p>173 B. ADAMS, THE THEORY OF. SOCIAL REVOLUTIONS 94 (1913). </p>

<p>174 Noble State Bank v. Haskell, 219 U.S. 104, III (1911).<br>
</p>

<hr>

<p><a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>

<p><a href="../studies.htm">Major Studies of Drugs and Drug
Policy</a> </p>

<p><a href="../../../LIBRARY/studies/vlr/vlrtoc.htm">Forbidden
Fruit and the Tree of Knowledge - Table of Contents</a> <br>
</p>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-21</DOCNO>
<DOCOLDNO>IA031-000655-B037-244</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlr2.htm 206.61.184.43 19970122112430 text/html 49059
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:24:17 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:48:21 GMT
Content-length: 48841
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Genesis of Marijuana Prohibition</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><b>THE FORBIDDEN FRUIT AND THE TREE OF KNOWLEDGE: AN INQUIRY
INTO THE LEGAL HISTORY OF AMERICAN MARIJUANA PROHIBITION</b> </p>

<p><i>Richard J. Bonnie &amp; Charles H. Whitebread, II</i></p>

<p><font size="5"><b>III. THE GENESIS OF MARIJUANA PROHIBITION</b></font>
</p>

<hr>

<p>&nbsp;</p>

<p>Until the inclusion of marijuana in the Uniform Narcotic Drug
Act in 1932 and the passage of the Marihuana Tax Act in 1937,
there was no &quot;national&quot; public policy regarding the
drug. However, as early as 1914 the New York City Sanitary Laws
included cannabis in a prohibited drug list and in 1915 Utah
passed the first state statute prohibiting sale or possession of
the drug. By 1931 twenty-two states had enacted such legislation.
In the succeeding section, we shall delve into the circumstances
surrounding the passage of several of these early laws and the
ensuing judicial acquiescence in the legislative value judgments
concerning marijuana. We conclude that the legislative action and
approval were essentially kneejerk responses uninformed by
scientific study or public debate and colored instead by racial
bias and sensationalistic myths. </p>

<hr>

<p><b>A. Initial State Legislation 1914-1931</b> </p>

<p>As indicated above, the Harrison Act, a regulatory measure in
the garb of a taxing statute, left many gaps unfilled in the
effort to prohibit illegal or nonmedical use of opiates and
cocaine. Although Commissioner Anslinger of the Federal Bureau of
Narcotics stated in 1932 that few states had responded to the
Harrison Act,1 most states had in fact enacted or reenacted
narcotics laws in the period from 1914 to 1931.2 In so doing,
twenty-one states had also restricted the sale of marijuana as
part of their general narcotics articles, one state had
prohibited its use for any purpose, and four states had outlawed
its cultivation.3 Our objective in this section is to determine
why these states chose to include cannabis in their lists of
prohibited drugs. </p>

<p>The first consideration was the increasing public awareness of
the narcotics problem. As noted above, the Harrison Act
engendered a shift in public perception of the narcotics addict.
With ever-increasing frequency and venom, he was portrayed in the
public media as the criminal &quot;dope fiend.&quot; This
hysteria, coupled with the actual increases in drug-related
criminal conduct due to the closing of the clinics,4 was the
basis for a good many of the post-Harrison Act narcotic
statutes.5 Other forces such as lurid accounts in the media,6
publications of private narcotics associations 7 and the
effective separation of the addict and his problems from the
medical profession8 all pressed legislatures into action to deal
more effectively with what was perceived as a growing narcotics
problem. </p>

<p>Despite the increasing public interest in the narcotics
problem during this period, we can find no evidence of public
concern for, or understanding of, marijuana, even in those states
that banned it along with the opiates and cocaine. Observers in
the middle and late 1930's agreed that marijuana was at that time
a very new phenomenon on the national scene.9 The perplexing
question remains-why did some states include marijuana in their
prohibitive legislation a decade before it achieved any notice
whatsoever from the general public and the overwhelming majority
of legislators? </p>

<p>From a survey of contemporary newspaper and periodical
commentary we have concluded that there were three major
influences. The most prominent was racial prejudice. During this
period, marijuana legislation was generally a regional phenomenon
present in the southern and western states. Use of the drug was
primarily limited to Mexican-Americans who were immigrating in
increased numbers to those states. These movements were well
noted in the press accounts of passage of marijuana legislation.
A second factor was the assumption that marijuana, which was
presumed to be an addictive drug, would be utilized as a
substitute for narcotics and alcohol then prohibited by national
policy. This factor was particularly significant in the New York
law, the forerunner of nationwide anti-marijuana legislation.
Finally, there is some evidence that coverage of the drug by the
Geneva Conventions in 1925 was publicized in this country and may
have had some influence. </p>

<p><b>1. Rationale in the West: Class Legislation</b> </p>

<p>Geometric increases in Mexican immigration after the turn of
the century naturally resulted in the formation of sizeable
Mexican-American minorities in each western state.10 It was
thought then11 and is generally assumed now12 that use of
marijuana west of the Mississippi was limited primarily to the
Mexican segment of the population. We do not find it surprising,
therefore, that sixteen of these states prohibited sale or
possession of marijuana before 1930.13 Whether motivated by
outright prejudice or simple discriminatory disinterest, the
result was the same in each legislature-little if any public
attention, no debate, pointed references to the drug's Mexican
origins, and sometimes vociferous allusion to the criminal
conduct inevitably generated when Mexicans ate &quot;the killer
weed.&quot; </p>

<p>In Utah, for example, the nation's first statewide prohibition
of marijuana 14 in 1915 was attended by little publicity. The
combination of increasing Mexican immigration15 and the
traditional aversion of the Mormons to euphoriants of any kind16
led inevitably to the inclusion of marijuana in the state's
omnibus narcotics and pharmacy bill. Similarly, when the New
Mexico and Texas legislatures passed marijuana legislation in
1923, the former by separate statute17 and the latter by
inclusion,18 newspaper reference was minimal despite coverage in
both states of legislative action.19 The longest of the Santa Fe
New Mexican references noted: </p>

<blockquote>
    <p>The Santa Fe representative, however, had better luck with
    his bill to prevent sale of marihuana, cannabis indica,
    Indian hemp or hashish as it is variously known. This bill
    was passed without any opposition. Marihuana was brought into
    local prominence at the penitentiary board's investigation
    last summer when a convict testified he could get marihuana
    cigarets anytime he had a dollar. The drug produces
    intoxication when chewed or smoked. Marihuana is the name
    commonly used in the Southwest and Mexico.20 </p>
</blockquote>

<p>In its only direct reference to marijuana, the Austin Texas
Statesman stated: </p>

<blockquote>
    <p>The McMillan Senate Bill amended the anti-narcotic law so
    as to make unlawful the possession for the purpose of sale of
    any marihuana or other drugs. Marihuana is a Mexican herb and
    is said to be sold on the Texas-Mexican border .21 </p>
</blockquote>

<p>The discriminatory aspects of this early marijuana
legislation, suggested only obliquely by origin and apparent
disinterest in Utah, New Mexico and Texas, are directly confirmed
in Montana and Colorado. Montana newspapers gave relatively
&quot;full&quot; coverage to a proposal to exclude marijuana from
the general narcotics law and to create a separate marijuana
statute.22 On seven different days from January 14 to February
10, 1929 (the date of the bill's passage), the Montana Standard
succinctly noted the progress of the bill through the
legislature. The giveaway appeared on January 27 when the paper
recorded the following: </p>

<blockquote>
    <p>There was fun in the House Health Committee during the
    week when the Marihuana bill came up for consideration.
    Marihuana is Mexican opium, a plant used by Mexicans and
    cultivated for sale by Indians. &quot;When some beet field
    peon takes a few rares of this stuff,&quot; explained Dr.
    Fred Fulsher of Mineral County, &quot;He thinks he has just
    been elected president of Mexico so he starts out to execute
    all his political enemies. I understand that over in Butte
    where the Mexicans often go for the winter they stage
    imaginary bullfights in the 'Bower of Roses' or put on
    tournaments for the favor of 'Spanish Rose' after a couple of
    whiffs of Marijuana. The Silver Bow and Yellowstone
    delegations both deplore these international
    complications&quot; Everybody laughed and the bill was
    recommended for passage.23 </p>
</blockquote>

<p>The same year, a change in Colorado's marijuana law was
precipitated by less comic apprehensions of the drug's evil
effects. On April 7, 1929, a girl was murdered by her Mexican
step-father. The story was lead news in the Denver Post every day
until April 16, probably because the girl's mother was white. On
the 16th it was first mentioned that this man might have been a
marijuana user. Headlined &quot;Fiend Slayer Caught in Nebraska
[;] Mexican Confesses Torture of American Baby,&quot; and
subheaded &quot;Prisoner Admits to Officer He is Marihuana
Addict,&quot; the story, relates in full the underlying events: </p>

<blockquote>
    <p>&quot;You smoke marihuana?&quot; </p>
</blockquote>

<blockquote>
    <p>&quot;Yes &quot; </p>
</blockquote>

<blockquote>
    <p>The Mexican said he had been without the weed for two days
    before the killing of his step-daughter .24 </p>
</blockquote>

<p>On April 17, the story on the Mexican included the following: </p>

<blockquote>
    <p>He repeated the story he had told the Sidney Chief of
    Police regarding his addiction to marihuana saying that his
    supply of the weed had become exhausted several days before
    the killing and his nerves were unstrung.25 </p>
</blockquote>

<p>With regard to the legislative news there is no mention at any
time of a bill to regulate marijuana; however, on April 21, the
Denver Post noted the Governor had signed a bill increasing
penalties for sale, possession or production of marijuana.26 </p>

<p>The reader should note that public perception of marijuana's
ethnic origins and crime-producing tendencies often went hand in
hand, especially in the more volatile areas of the western
states. Stories such as the one appearing in the Denver Post,
where defendants charged with violent crimes attempted to blame
their actions on the effects of marijuana were primarily
responsible for the drug's characterization as a &quot;killer
weed.&quot; In any event, from this brief survey of marijuana
prohibition in the western states, we have concluded that its
Mexican use pattern was ordinarily enough to warrant its
prohibition, and that whatever attention such legislative action
received was attended by sensationalist descriptions of crimes
allegedly committed by Mexican marijuana users. </p>

<hr>

<p><b>2. Rationale in the East: Substitution</b> </p>

<p>The first significant27 instance of marijuana regulation
appeared in the 1914 amendments to the New York City Sanitary
Laws. The inclusion by the New York legislature of marijuana in
Its general narcotics statute in 1927 was the precursor of
nationwide legislation .28 For these reasons, we have chosen New
York as the most likely source of information regarding the.
rationale for marijuana prohibition in Maine, Massachusetts,
Michigan, Ohio, Rhode Island and Vermont, all of which had acted
before 1931.29 </p>

<p>In January 1914 the New York legislature passed its first
comprehensive statute-The Boylan Bill-regulating the sale and use
of habit forming drugs&quot;' and did not include marijuana among
its list of prohibited narcotics. It appears that the Board of
Health of New York City then amended its Sanitary Code adding
&quot;Cannabis indica, which is the Indian hemp from which the
East Indian drug called hashish is manufactured,&quot;31 to the
City's list of prohibited drugs. Violation of this provision of
the City Sanitary Code was a misdemeanor punishable by a small
fine and/or a jail term of up to six months. On July 29, 1914, an
article reporting the amendment appeared in the New York Times
wherein the drug was described: </p>

<blockquote>
    <p>This narcotic has practically the same effect as morphine
    and cocaine, but it was not used in this country to any
    extent while it was easy to get the more refined narcotics.32
    </p>
</blockquote>

<p>The next day the editors of the Times commented: </p>

<blockquote>
    <p>[T]he inclusion of cannabis indica among the drugs to be
    sold only on prescription is only common sense. Devotees of
    hashish are now hardly numerous enough here to count, but
    they are likely to increase as other narcotics become harder
    to obtain.33 </p>
</blockquote>

<p>From these observations, it would appear (1) that there were
few marijuana users at the time; and (2) that use of the drug was
expected to increase as a direct result of the restriction of
opiates and cocaine. </p>

<p>Despite New York City's early classification of cannabis with
known narcotics, New York State did not prohibit sale and
possession of the drug for other than medicinal purposes until
1927.34 And this was true despite a great deal of activity on the
narcotics front from 1914 to 1927, when the legislature acted
four different times.35 Throughout all this tumult and in the
variety of narcotics proposals suggested or enacted,36 marijuana
or cannabis was not classified among the restricted drugs until
the drafting of the 1927 Act. This act37 defined cannabis as a
&quot;habit-forming drug,&quot; 38 and accordingly punished as
misdemeanors39 the control, sale, distribution, administration
and dispensing40 of cannabis except for medical purposes. The
penalty provision of the statute did not discriminate among types
of offenses, first or subsequent violations, or the prohibited
narcotic drugs.41 </p>

<p>There is no apparent indication in the contemporary commentary
of the reasons for inclusion of marijuana in the New York laws.
When the 1927 law was passed, public concern was focused on the
general need to reduce narcotic addiction; none of the
commentators were concerned about marijuana.42 While there were
numerous articles in the media dealing with the problems of the
opiates, morphine, cocaine and heroin, only four articles about
marijuana appeared in the major New York newspaper during the
entire period from 1914 until 1927. In 1923 the New York Times
noted that the &quot;latest habit forming drug ... marihuana,
which is smoked in a cigarette&quot; was exhibited at a women's
club meeting.43 In 1925 the same paper reported that the drug had
been banned in Mexico.44 One year later, the paper reported the
results of testing in Panama on the effects of marijuana. The
article noted that as a result of these tests the study group
concluded marijuana smoking was relatively safe; thus, it was
&quot;recommended that no steps be taken by the authorities of
the Canal Zone to prevent the sale or use of marijuana and that
no special legislation on that subject was needed.&quot; 45
Finally, in July 1927, the Times reported that a Mexican family
was said to have gone insane from eating marijuana.46 Perhaps the
clearest indication of the absence of notice given the marijuana
section of the 1927 Act is that none of the articles discussing
the Act after its passage refer to marijuana .47 </p>

<p>It is likely, then, that the inclusion of cannabis in the
state law was motivated primarily by the same fear that had
provoked the Sanitary Law Amendment in 1914. Use, though still
slight, was expected to increase. Throughout the entire New York
experience the main argument was preventive: Marijuana use must
be prohibited to keep addicts from switching to it as a
substitute for the drugs which had become much more difficult to
obtain after the enactment of the Harrison Act, and for alcohol
after Prohibition.48 Accordingly, the passage of the Harrison and
Volstead Acts were direct causes of the preventive inclusion of
marijuana among prohibited drugs. In fact, it has been observed
that marijuana use did increase during this period .49 </p>

<p>Another factor that may have influenced the passage of the
1927 Act was the Second Opium Conference at Geneva in 1925,50
which included Indian hemp within the Convention against Opium
and other Dangerous Drugs, even though the United States had
withdrawn in 1925 from the League of Nations deliberations on
controlling and regulating the international traffic in dangerous
drugs.51 </p>

<hr>

<p><b>3. The International Scene</b> </p>

<p>The first mention of marijuana on the international front came
with the preliminary negotiations for the Hague Conference of
1912. In preparing for this Conference, which represented an
attempt to deal with the international opium traffic, the
government of Italy proposed that the production and traffic in
Indian hemp drugs be included as part of the agenda of the
Conference.52 During the Conference itself, there was no mention
of the drug, and the Convention did not include cannabis in its
provisions. In addition to the Convention, however, the delegates
signed a closing protocol: </p>

<blockquote>
    <p>2. The Conference considers it desirable to study the
    question of Indian hemp from the statistical and scientific
    point of view, with the object of regulating its abuses,
    should the necessity thereof be felt, by internal legislation
    or by an international agreement .53 </p>
</blockquote>

<p>It was not until just before the Geneva Conference of 1925
that the proposal was mentioned again. In 1923 the following
resolution was passed by the Advisory Committee on Traffic in
Opium and Other Dangerous Drugs of the League of Nations: </p>

<blockquote>
    <p>IV. With reference to the proposal of the Government of
    the Union of South Africa that Indian hemp should be treated
    as one of the habit-forming drugs, the Advisory Committee
    recommends the Council that, in the first instance, the
    Governments should be invited to furnish to the League
    information as to the production and use of, and traffic in,
    this substance in their territories, together with their
    observations on the proposal of the Government of the Union
    of South Africa .54 </p>
</blockquote>

<p>At the 1925 meeting in Geneva, the Egyptians led the way in
proposing that hashish be included within the Convention.55 An
Egyptian delegate presented a paper on the effects and use of
hashish in Egypt. Mr. El Guindy's study is so typical of the
so-called scientific or empirical evidence that has been
presented to justify the drug's prohibition that the following
excerpt must be included. In stating that the real danger of
hashish is that it will produce insanity, the Egyptian delegate
presented the following: </p>

<blockquote>
    <p>The illicit use of hashish is the principal cause of most
    of the cases of insanity occurring in Egypt. In support of
    this contention, it may be observed that there are three
    times as many cases of mental alienation among men as among
    women, and it is an established fact that men are much more
    addicted to hashish than women.56 </p>
</blockquote>

<p>The Egyptian proposal was referred to a subcommittee for study
and later in the Conference this group reported that the use of
Indian hemp drugs should be limited to medical and scientific
purposes. The proceedings contain no record of what medical or
scientific evidence might have been brought forward to support
the inclusion of the Indian hemp drugs in the Convention.57
Nevertheless, they were the subject of Chapters IV and V of the
Convention.58 </p>

<hr>

<p><b>4. Conclusion</b> </p>

<p>The early laws against the cannabis drugs were passed with
little public attention. Concern about marijuana was related
primarily to the fear that marijuana use would spread, even among
whites, as a substitute for the opiates and alcohol made more
difficult to obtain by federal legislation. Especially in the
western states, this concern was identifiable with the growth of
the Mexican-American minority. It is clear that no state
undertook any empirical or scientific study of the effects of the
drug. Instead they relied on lurid and often unfounded accounts
of marijuana's dangers as presented in what little newspaper
coverage the drug received. It was simply assumed that cannabis
was addictive and would have engendered the same evil effects as
opium and cocaine. Apparently, legislators in these states found
it easy and uncontroversial to prohibit use of a drug they had
never seen or used and which was associated with ethnic
minorities and the lower class. </p>

<hr>

<p align="center"><b>B. Judicial Corroboration</b> </p>

<p>Two significant conclusions appear from a study of the few
cases59 involving convictions for marijuana offenses under the
initial wave of state laws. First, the argument regarding a
private conduct limitation on the police power had been so
discredited it was not even made. Second, the courts, like the
legislatures, relied on nonscientific materials to support the
proposition that marijuana was an addictive, mind-destroying drug
productive of crime and insanity. </p>

<p>In only one case was there a serious constitutional challenge
to the validity of the legislation. Appealing a Louisiana
conviction for possession of five hundred plants of marijuana,
the defendant in State v. Bonoa60 argued not that the state could
not punish mere possession but rather that the statute was
overbroad, since aside from its use as an intoxicant the
marijuana plant was employed in the manufacture of hemp line, in
the preparation of useful drugs and for the production of bird
seed for canaries. Defendant's contention was that only
possession, sale or use for deleterious purposes could be
prohibited. </p>

<p>The court's reply was that the drug's deleterious properties
outweighed its uses, especially since &quot; [t]he Marijuana
plant is not one of the crops of this state.&quot; 61 Defendant
also offered the reductio ad absurdum argument that if possession
of the marijuana plant may be prohibited simply because
intoxicating resin may be extracted from the flowering tops, then
the possession of corn or grapes may be prohibited because
whiskey and wine may be made from them, or possession of poppies
because opium may be extracted from them. To this the court
replied that alcohol was less injurious than marijuana and that
both alcohol and opium were difficult to prepare from these
sources while the marijuana plant was easily converted into
tobacco and cigarettes. </p>

<p>The court's reasoning is admirable if we accept the basic
premise that the marijuana drug is deleterious. To support this
conclusion the court quoted from Solis Cohen Githens'
Pharmacotheraupeutics: </p>

<blockquote>
    <p>The first symptom is usually an exaltation of the mind . .
    . . The ideas are joyous Sleep follows . . . . When aroused
    from sleep . . . the mind passes into the same somnolent
    condition, which lasts for several hours and is followed by a
    sense of weakness and extreme mental depression. In certain
    eastern people . . . perhaps because of continued use, the
    somnolent action is replaced by complete loss of judgment and
    restraint such as is seen more often from alcohol. An Arab
    leader, fighting against the crusaders, had a bodyguard who
    partook of haschisch, and used to rush madly on their
    enemies, slaying everyone they met. The name of
    &quot;haschischin&quot; applied to them has survived as
    &quot;assassin.&quot; </p>
</blockquote>

<blockquote>
    <p>The habitual use of cannabis does not lead to much
    tolerance, nor do abstinence symptoms follow its withdrawal.
    It causes, however, a loss of mentality, resembling dementia,
    which can be recognized even in dogs.62 </p>
</blockquote>

<p>The court also quotes Rusby, Bliss &amp; Ballard, The
Properties and Uses of Drugs: </p>

<blockquote>
    <p>The particular narcosis of cannabis consists in the
    liberation of the imagination from all restraint . . . . Not
    rarely, in [the depression] state, an irresistible impulse to
    the commission of criminal acts will be experienced.
    Occasionally an entire group of men under the influence of
    this drug will rush out to engage in violent or bloody
    deeds.63 </p>
</blockquote>

<p>On these two sources, the entire opinion stands. The allegedly
deleterious consequences-criminal activity and insanity-are
supported only by the mythical etymology of the word
&quot;assassin.&quot; The marijuana user's purported propensity
toward crime, based on similar and often weaker authority, was
the primary rationale underlying passage of the Marihuana Tax
Act.64 So preposterous is this assertion that even the proponents
of criminalization-including the Cormmissioner of the Bureau of
Narcotics-later implicitly rejected it.65 </p>

<p>In any event, the courts were as willing to accept such
evidence as the legislatures. In a Utah case, State v. Navaro,66
where the court cited the acknowledged evils of marijuana to
repel a vagueness attack,67 it relied on another set of dubious
authorities. First, the court referred to the case of State v.
Diaz68 wherein a defendant in a first degree murder prosecution
tried to disprove the requisite mens rea by showing that he was
under the influence of marijuana at the time of the offense. Diaz
had claimed that &quot;his mind was an entire blank as to all
that happened to him and stated that after smoking the marijuana
he became 'very crazy.' To corroborate his assertion, defendant
summoned a physician whose testimony was summarized in Diaz in a
passage quoted in full in Navaro: </p>

<p>He stated that [marijuana] is a narcotic and acts upon the
central nervous system affecting the brain, producing
exhilarating effects and causing one to do things which he
otherwise would not do and especially induces acts of violence;
that violence is one of the symptoms of an excessive use of
marijuana. That the marihuana produces an &quot;I don't
care&quot; effect. A man having used liquor and marihuana might
deliberately plan a robbery and killing and carry it out and
escape, and then later fail to remember anything that had
occurred. 70 </p>

<p>Thus an attempt in an adversary setting by an accused to
escape criminal responsibility by blaming his offense on
marijuana intoxication became medical authority for the
scientific hypothesis that marijuana use causes crime. </p>

<p>The second source of support in Navaro for the allegedly
deleterious effects of marijuana was a 1932 article by Hayes and
Bowery (the latter a member of the Wichita, Kansas, Police
Department) entitled Marihuana .71 Calling for stricter penalties
for marijuana use, the authors stated that during the
exhilaration phase, the user is likely to have increased sexual
desires72 and to commit &quot;actions of uncontrollable violence,
or even murder.&quot; 73 For these propositions, they cited
newspaper accounts of crimes the causes of which the reporter
attributed to marijuana74 and police testimony to the same
effect.75 For example, the Chief Detective of the Los Angeles
Police Department was quoted as saying: </p>

<blockquote>
    <p>In the past we have had officers of this department shot
    and killed by Marihuana addicts and <i>have traced the act of
    murder directly to the influence of Marihuana, with no other
    motive</i>. Numerous assaults have been made upon officers
    and citizens with intent to kill by Marihuana addicts which
    were directly traceable to the influence of Marihuana.76 </p>
</blockquote>

<p>It should be noted that Hayes and Bowery attributed the
violent impulse to the absence of restraint engendered during the
so-called exhilaration phase, while each of the authorities cited
by the Louisiana court in Bonoa attributed the same impulse to
the sufferings experienced during the &quot;depression&quot;
phase.77 </p>

<p>The authors also asserted that habitual use leads to a
&quot;loss of mental activity, accompanied by a general dullness
and indolence, like that of chronic alcoholics or opium
caters,&quot; to &quot;destruction of brain tissues&quot; and
inevitably to insanity. For this proposition, the authors merely
said that &quot;seventeen to twenty per cent of all males
admitted to mental hospitals and asylums in India have become
insane through the use of this drug.&quot;78 </p>

<p>Finally the court cited an article by Eugene Stanley, the
District Attorney of New Orleans, entitled Marihuana as a
Developer of Crimiinals.79 The title conveys the message. We will
return to Mr. Stanley in the succeeding section.80 </p>

<p>The nonchalance with which Utah and Louisiana courts cited
sensationalistic, nonscientific sources to support the
proposition that marijuana produced crime and insanity suggests
how widely accepted this hypothesis was among decision-makers,
both judicial and legislative, prior to 1931. Given the
prevalence of this attitude, the noninvolvement of the middle
class, and the precedent established in the earlier alcohol and
narcotics cases, it is not surprising that constitutional
challenges were either not made or easily rebuffed. Nor is it
surprising that challenges regarding the ambiguity of the word
&quot;marijuana&quot; were unsuccessful.81 The courts, like the
legislatures, assumed marijuana caused crime and insanity, and
assumed that had public opinion crystallized on the question, it
would have favored the suppression of a drug with such evil
effects.<br>
</p>

<hr>

<h2>Footnotes and References </h2>

<p>1 Anslinger, The Reason for Uniform State Narcotic
Legislation, 21 GEO. L.J. 52, 53 (1932). </p>

<p>2 STATE Laws 35-327. </p>

<p>3 Id. at 14. </p>

<p>4 For a discussion of the change in the public image of
addicts and the closing of clinical experiments, see p. 988
supra. </p>

<p>5 See TERRY &amp; PELLENS 877-919. </p>

<p>6 See, eg., text at notes 24-25 infra. For somewhat more
clinical discussions, see TERRY &amp; PELLENS 877-919. </p>

<p>7 See Weber, Drugs and Crime, 10 J. CRIM. L. &amp; CRIMINOLOGY
370 (1919). </p>

<p>8 A. LINDESMITH, THE ADDICT AND THE LAW 3-3S (1965); King,
Narcotic Drug Laws and Enforcement Policies, 22 LAW &amp;
CONTEMP. PROB. 113, 120-26 (1957). </p>

<p>9 Hearing on H.R. 6385 Before the House Comm. on Ways and
Means, 75th Cong, 1st Sess. 20 (1937) [hereinafter cited as Tax
Act Hearings]. </p>

<p>10 The Bureau of Immigration recorded the entry of 590,765
Mexicans into the United States between 1915 and 1930. Of these,
upwards of 90% in each year were to be resident in the 22 states
west of the Mississippi, and more than two-thirds were to reside
in Texas alone. Information compiled from Tables, Immigrant
Aliens, By States of Intended Future Residence and Race or
Peoples, published yearly for each fiscal year from 1915 to 1930
in COMM'R GEN. OF IMMIGRATION ANN. REP. </p>

<p>11 Tax Act Hearings 20, 3 3. </p>

<p>12 THE MARIHUANA PAPERs at xiv (D. Solomon ed. 1966). 13 Id.
at xv. </p>

<p>14 At its 1915 session, the Utah legislature passed an omnibus
narcotics and pharmacy bill which included under it the cannabis
drugs. Ch. 66,  7, 8, [1915] Utah Laws 77. The law forbade
sale and possession of the named drugs, and provided for medical
use under a system of prescriptions and order blanks.
Interestingly, clinical treatment of addicts was allowed. Id. at
77-80. The law also prohibited possession of opium and marijuana
pipes. Id. at 80. Violations were misdemeanors punishable by
fines and/or imprisonment for terms up to six months, but third
offenders faced prison terms from one to five years. The statute
made no distinction between sale and possession, nor among the
various drugs. The law was revised in 1927. Ch. 65, [1927]1 Utah
Laws 107. </p>

<p>15 See note 10 supra. </p>

<p>16 See THE DOCTRINE AND COVENANTS OF THE CHURCH OF JESUS
CHRIST OF LATTER-DAY SAINTS, CONTAINING THE REVELATIONS GIVEN TO
JOSEPH SMITH, THE PROPHET  89, at 154 (192 1) (PP, P 5, 7, wine
or strong drink) (P 8, tobacco) (P 9, hot drinks) (revelations
given through Joseph Smith the Prophet, at Kirtland, Ohio,
February, 27, 1833, known as the Word of Wisdom). </p>

<p>17 The statute made importation of cannabis illegal and
established a presumption of importation whenever a person was
found to possess the drug. Ch. 42,   1-2, [1923] N.M. Laws
58-59. Violations were punishable by fine and/or imprisonment
from one to three years. Cultivation, sale or giving away
cannabis except for use by physicians and pharmacists was also
prohibited, and violations were punishable on first offense by
one to three years in prison and on subsequent offenses by three
to five years imprisonment. Id.  3, 4. </p>

<p>18 The Texas general narcotics statute, ch. 150, [1919] Tex.
Gen. Laws 277-79, as amended, ch. 61, [1919] Tex. Special Sess.
Laws 156-57, similar in format to the Utah statute and the
Harrison Act, included &quot;any drug or preparation known or
sold under the Spanish name of 'Marihuana........... Id. at 278.
Unlike the Utah and New Mexico statutes, Texas prohibited only
selling, furnishing or giving away marijuana. Except for the
exempted medical purposes, such divestment of any of the listed
narcotics could have resulted in a fine and/or imprisonment from
one month to one year. Id. at 279. </p>

<p>19 The Santa Fe New Mexican, hometown paper of the bill's
sponsor, made only one mention of marijuana at the time of
passage, and that was to note that the drug was being smuggled
into the state prisons. Santa Fe New Mexican, Feb. 1, 1923. </p>

<p>The Austin Texas Statesman gave heavy coverage to legislative
news at this time because the legislature was in special session
called by the Governor to deal with a budgetary problem. </p>

<p>20 Santa Fe New Mexican, Jan. 31, 1923. The statute was passed
on February 27, 1923; during the period from January 20 to
February 28, there were only three other references to marijuana.
The newspaper first noted the bill in a one sentence report that
a ban on sale of marijuana was to be discussed. Id., Jan. 20,
1923. Finally, in articles entitled &quot;A Day In The
Legislature,&quot; the progress of the bill (H.B. 56) was noted
on February 21 and 27 in simple lists of bills enacted. Id., Feb.
21, 27, 1923. So inconsequential was the bill that it was not
even mentioned in two stories describing the activities of the
legislature for that session. Id., Feb. 27, 1923, at 1, col. 1. </p>

<p>21 Austin Texas Statesman, June 19, 1923. Despite heavy
coverage of legislative news and of narcotics generally, the El
Paso Times made no reference to marijuana between June 10 and
June 25. The Texas Statesman mentioned the &quot;McMillan
Bill&quot; only two other times, each time without direct
reference to marijuana. </p>

<p>22 Unlike most states that passed laws early in the 1920's
against marijuana use, Montana in 1927 passed a statute which
merely amended the first section of its general narcotic law,
Rev. Code of Mont. ch. 227, S 3186 (1921), to include marijuana.
Ch. 91,  1, [ 1927] Mont. Laws 324. The new law, ch. 6, [1929]
Mont. Laws 5, made use, sale or possession without a prescription
a misdemeanor. </p>

<p>23 The Montana Standard, Jan. 27, 1929, at 3, col. 2. 24
Denver Post, April 16, 1929, at 2, col. 1. </p>

<p>25 Id., April 17,1929, at 2, col. 1. </p>

<p>26 Id., April 21, 1929. Ch. 95, (1927] Colo. Laws 309,
penalized possession, sale, gift, or cultivation of any of the
cannabis drugs as a misdemeanor. Offenses carried a fine and/or
imprisonment in the county jail for not less than one or more
than six months. The new law, ch. 93, [1929] Colo. Laws 331,
increased the penalties for second offenders to one to five year
terms in the penitentiary. </p>

<p>27 Although Commissioner Anslinger stated in the 1937 Tax Act
Hearings that the District of Columbia had no law regulating
marijuana, Dr. Woodward of the AMA refuted the Commissioner's
statement by citing a 1906 provision which limited the sale of
cannabis to pharmacists and regulated sale of the drug by such
pharmacists to the public. Tax Act Hearings 92-93. The D.C.
provision, Act of May 7, 1906, ch. 2084,  13, 34 Star. 175, is
typical of early attempts to deal with the drug under the general
poison laws, but it is noteworthy in its treatment of marijuana
separately from opiates. </p>

<p>28 See pp. 10 30-3 3 infra. </p>

<p>29 In 1913, Maine prohibited the sale of cannabis indica
without a prescription. STATE LAWS 137. Massachusetts passed a
similar law in 1917, id. at 150, and Michigan forbade possession
in 1929, id. at 161. A 1923 Ohio law prohibited sale or
possession with intent to sell, id. at 242; Rhode Island
prohibited sale in 1918, id. at 263; and Vermont barred sale
without a prescription in 1915, id. at 296. </p>

<p>31 Ch. 363, [1914] N.Y. Laws 1120. The first narcotics
legislation in New York was enacted in 1893. Ch. 661, art. XII,
208, 11893] N.Y. Laws 1561. The 1893 law provided that no
prescription containing opium, morphine, cocaine or chloral could
be filled more than once. Two years later, the legislature
enacted a provision requiring that the effect of narcotics on the
human system be taught in the public schools. Ch. 1041, 1,
[18951 N.Y. Laws 972. In 1897, a law was passed making it a
felony to possess any narcotic &quot;with intent to administer
the same or cause the same to be administered to another&quot;
without his consent. Ch. 42,  1, [1897] N.Y. Laws 21. The first
provision aimed at the sale of narcotics was passed in 1907 and
provided that the sale or distribution of cocaine without a
prescription was unlawful. Ch. 424, @ 1, [ 1907] N.Y. Laws 879.
This provision was subsequently amended to provide for the
keeping of records of sales and of transactions between dealers.
Ch. 470,  2, [1913] N.Y. Laws 984; ch. 131,  1, [1910] N.Y.
Laws 231; ch. 277,  1, [1908] N.Y. Laws 764. </p>

<p>31 N.Y. Times, July 29, 1914, at 6, col. 2. </p>

<p>32 Id. </p>

<p>33 Id., July 30, 1914, at 8, col. 4. </p>

<p>34 Ch. 672, [1927] N.Y. Laws 1695-1703. </p>

<p>35 The 1914 act was amended by the Whitney Act in 1918 which
also provided for the repeal of the 1914 act. Ch. 639, [1918]
N.Y. Laws 2026. In 1921 an act was passed that in effect repealed
all the legislation relating to the narcotics problem. Ch. 708,
[1921] N.Y. Laws 2496. The measure made no provision for other
laws on the subject. This surprising move was made in the
interests of economy, N.Y. Times, Jan. 6, 1921, at 1, col. 8, and
with the belief that the drug problem could be better handled by
local authorities working in concert with federal agencies. See
id., Jan. 9, 1921, S 2, at 1, col. 7; id., May 22, 1921, S 2, at
11, col. 3, An act making illegal the sale of cocaine without a
prescription was enacted in 1923. Ch. 130, [1923] N.Y. Laws 160.
The possession of opium or cocaine without a prescription was
outlawed in 1926. Ch. 650,  2, [1926] N.Y. Laws 1198. </p>

<p>36 As late as 1918, a legislative committee that had
exhaustively studied the narcotics problem in New York did not
mention the use of marijuana and concluded: &quot;The drugs which
are the sources of the difficulty are cocaine and eucaine with
their salts and derivatives and opium and its derivatives,
codeine, morphine and heroin.&quot; JOINT LEGISLATIVE COMM. TO
INVESTIGATE THE LAWS IN RELATION TO THE DISTRIBUTION AND SALE OF
NARCOTIC DRUGS, FINAL REPORT, NEW YORK SENATE Doc. No. 35 (1918).
quoted in TERRY &amp; PELLENs 833. </p>

<p>37 The Act of April 5, 1927, repealed both the 1923 and 1926
laws and replaced them with a comprehensive narcotic control
scheme. Ch. 672, [1927] N.Y. Laws 1695. This act contained
provisions relating to the control and use of narcotic drugs and
treatment of addicts; it also exempted certain preparations from
its coverage. The act furnished the model for the Uniform
Narcotic Drug Act. See pp. 1030-31 infra. </p>

<p>Subsequently, in 1929, unlawful sale of narcotics was made a
felony and all other violations of the 1927 act were made
misdemeanors. Ch. 377, [19291 N.Y. Laws 881. </p>

<p>38 Ch. 672, S 421(14), [ 1927] N.Y. Laws 1697. </p>

<p>39 Id. S 443, at 1702, </p>

<p>40 Id. 5 423, at 1697. </p>

<p>41 See id.  443, at 1702. </p>

<p>42 See N.Y. Times, Mar. 25, 1927, at 4, col. 6. </p>

<p>43 Id., Jan. 11, 1923, at 24, col. 1. </p>

<p>44 Id., Dec. 29, 1925, at 10, col. 7. </p>

<p>45 Id., Nov. 21, 1926,  2, at 3, col. 1. </p>

<p>46 Id., July 6, 1927, at 10, col. 6. </p>

<p>47 See id., Mar. 25, 1927, at 4, col. 6; id., April 6, 1927,
at 13, col. 2. </p>

<p>48 See Simon, From Opium to Hasheesh, Sci Am., Nov. 1921, at
14-15. See also N.Y. Times, Jan. 11, 1923, at 24, col. 1. A
similar argument was made with respect to cocaine: </p>

<p>Cocaine in particular is greatly in demand. When prohibition
is in force, persons, especially drinkers from compulsion of
habit who have been robbed of their daily drink, will naturally
resort to cocaine . . . . </p>

<p>Weber, supra note 7, at 372. </p>

<p>49 B. RENBORG, INTERNATIONAL DRUG CONTROL 216 (1947): </p>

<p>As the campaign against the illicit traffic in opium,
morphine, and cocaine drugs made progress and gradually resulted
in diminution of the supplies on the illicit market, a marked
increase in the illicit traffic and the use of Indian hemp drugs
was noticed. more particularly on the North American Continent
(the problem of marihuana) and in Egypt (the hashish problem). </p>

<p>50 See Second Geneva Opium Conference, Convention, Protocol
and Final Act, quoted in W. WILLOUGHBY, OPIUM AS AN INTERNATIONAL
PROBLEM 534-70 (1925). </p>

<p>51 Id. at 344-46. </p>

<p>52 Wright, The International Opium Conference, 6 Am. J. INT'L
L. 865, 871 (1912). </p>

<p>53 Addendum and Final Protocol of The international Opium
Conf., The Hague, 1912, quoted in W. WILLOUGHBY, supra note 50,
at 492. </p>

<p>54 ADVISORY Comm. ON TRAFFIC in OPIUM AND OTHER DANGEROUS
DRUGs, REPORT To COUNCIL ON THE WORK OF THE SIXTH SESSION (1924),
quoted in W. WILLOUGHBY, supra note 50, at 374. </p>

<p>55 See W. WILLOUGHBY, supra note 50, at 2 SI. </p>

<p>56 Quoted in id. at 378. Mr. El Guindy concludes by saying:
&quot;Generally speaking, the proportion of cases of insanity
caused by the use of hashish varies from 3 to 60 percent of the
total number of cases occurring in Egypt.&quot; Id. at 379. </p>

<p>57 There are no records of these subcommittee hearings, so we
can only surmise that the quality of the evidence might have been
about as bad as that presented in the floor report of the
Egyptian delegation. </p>

<p>58 Geneva Convention of 1925, quoted in W.WILLOUGHBY, supra
note 50, at 539. Moreover, the Convention defines Indian hemp as
follows: </p>

<p>&quot;Indian hemp&quot; means the dried flowering or fruiting
tops of the pistillate plant Cannabis sativa L. from which the
resin has not been extracted, under whatever name they may be
designated in commerce. </p>

<p>Id. at 535 </p>

<p>59 In an extensive surveyof cases appearing in the Fourth
Decennial Digest for the years 1926 to 1936, we could find only
eight cases dealing with marijuana under laws enacted prior to
the Uniform Narcotic Drug Act. In chronological order: Gonzales
v. State, 108 Tex. Crim. 253, 299 S.W.. 901 (1927); State v.
Franco, 76 Utah 202, 289 P. 100 (1930); State v. Bonoa, 172 La.
955, 136 So. 15 (1931); Santos v. State, 122 Tex. Crim. 69, 53
S.W.2d 609 (1932); Baker v. State, 123 Tex. Crim. 209, 58 S.W.2d
534 (1933); Horton v. State, 123 Tex. Crim. 237, 58 S.W.2d 833
(1933); State v. Navaro, 83 Utah 6, 26 P.2d 955 (1933); People v.
Torres, 5 Cal. App. 2d 580, 43 P.2d 374 (Dist. Ct. App. 1935). </p>

<p>60 172 La. 955, 136 So. 15 (1931). </p>

<p>61 Id. at 964, 136 So. at 18. </p>

<p>62 id. at 961-62, 136 So. at 17-18. </p>

<p>63 id. at 962-63, 136 So. at 18. </p>

<p>64 See pp 1055-57 infra. </p>

<p>65 See pp. 1072 infra. </p>

<p>66 see Utah 6, 26 P.2d 955 (1933) </p>

<p>67 Appellant, convicted on an information charging
&quot;possession of marijuana,&quot; contended that the statue
prohibited only possession of the flowering tops and leaves of
the marijuana plant. The court held that marijuana was the
popular name for the drug, not just the plant, and that the
information accordingly charged an offense. For this proposition,
it cited dictionaries, other state statutes, articles, cases and
texts. It is the court's familiarity with the articles describing
the allegedly evil effects of the drug with which we are
concerned. </p>

<p>68 76 Utah 463, 290 P. 727 (1930).<br>
</p>

<p>69 Id. at 469, 290 P. at 729<br>
</p>

<p>70 83 Utah at 12, 26 P.2d at 957, quoting 76 Utah at 469-470,
290 P. at 729 </p>

<p>71 Hayes &amp; Bowery, Marihuana, 23 J. CRim. L. &amp;
CRIMINOLOGY 1086 (1932). </p>

<p>72 Id. at 1087, 1089. </p>

<p>73 Id. at 1088. </p>

<p>74 Id. at 1093. </p>

<p>75 Id. at 1088, 1090-91. </p>

<p>76 Id. at 1088 (emphasis added). </p>

<p>77 Compare text at note 72 supra with text at notes 62-63
supra. 78 Hayes &amp; Bowery, supra note 71, at 1090. </p>

<p>79 Stanley, Marihuana as a Developer of Criminals, 2 Am. J.
Police Sci. 252 (1931),cited in State v Navaro, 83 Utah 6, 14-15,
26 P.2d 955, 958 (1933). </p>

<p>80 See p. 1044 infra. </p>

<p>81 E.g., State v. Navaro, 83 Utah 6, 15, 26 P2d 955, 959
(1933); State v. Bonoa, 172 La. 955, 959, 136 So. 15, 17 (1931 ).
The Texas court was somewhat stricter in a series of cases
charging simply sale or possession of &quot;narcotic drugs&quot;
without specifying marijuana. On the same day, the court reversed
convictions in Baker v. State, 123 Tex. Crim. 209. 58 S.W.2d 534
(1933) (possession); Baker v. State, 123 Tex. Crim. 212, 58
S.W.2d 535 (1933) (sale or possession); and Horton v. State, 123,
Tex. Crim. 237, 58 S.W.2d 833, (1933) (possession). On the other
hand the Court held that an indictment charging &quot;possession
of marijuana&quot; is sufficient even though it does not allege
that marijuana is a narcotic drug. Santos v. State 122 Tex. Crim.
69, 53 S.W.2d 609 (1932).<br>
<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-22</DOCNO>
<DOCOLDNO>IA031-000655-B037-267</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlr3.htm 206.61.184.43 19970122112445 text/html 63786
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:24:32 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:48:10 GMT
Content-length: 63568
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Passage of the Uniform Narcotic Drug Act: 1927-1937</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><b>THE FORBIDDEN FRUIT AND THE TREE OF KNOWLEDGE: AN INQUIRY
INTO THE LEGAL HISTORY OF AMERICAN MARIJUANA PROHIBITION</b> </p>

<p><font size="2"><i>Richard J. Bonnie &amp; Charles H.
Whitebread, II</i></font> </p>

<p><b>IV. PASSAGE OF THE UNIFORM NARCOTIC DRUG ACT: </b></p>

<p><b>1927-1937</b> </p>

<hr>

<p>Our conclusions to this point bear summarization. During the
first two decades of the twentieth century, state as well as
national policy was steadfastly opposed to manufacture, sale and
consumption of narcotics and alcohol except for medical purposes.
Constitutional objections ions were uniformly ignored, in the
narcotics cases primarily because the nexus between the private
conduct and public harm was in fact a close one, and in the
alcohol cases primarily because the legislation was in response
to full operation of the public opinion process, to which the
courts were willing to defer. </p>

<p>We have also found that public opinion had not crystallized
against intoxicants generally, although public policy was moving
rapidly in that direction. Ultimately, the mere existence of that
public policy even in the form of criminal law-was not sufficient
to convert a public antipathy toward the evils of commercial
alcohol traffic into opposition to moderate use of alcohol. On
the question of private use, the public policy was unenforceable
and eventually abandoned. However, with respect to narcotics, the
public policy, also expressed through the criminal law,
effectively converted narcotics use, in the public view, from a
medical problem to a legal-moral problem. Sympathy for
unfortunate victims turned into moral indictment. Because other
laws and medical advances had reduced the number of accidental
addicts, the number of addicts decreased; in this sense the
public policy was successful. However, to the extent that this
police, effectively ostracized a group of users from the rest of
society, drove them to criminal activity to sustain their habit,
and engendered a moralistic public image, the stage was set for
many ensuing problems the consequences of which have only
recently become matters of public debate. </p>

<p>Ancillary to these developments during this period was the
classification of marijuana in some half the states as an
addictive drug that produced the same evils as the opiates and
cocaine--crime, pauperism and insanity. The users, few in number,
were primarily Mexicans. But as Mexican immigration increased and
the legitimate supply of narcotics and alcohol disappeared, a
fear developed, particularly in the western states, that
marijuana use would increase, particularly among the white youth.
As a result, some twenty-two states restricted marijuana use to
medical channels. The private conduct objection having
evaporated, the courts uncritically affirmed the legislative
classification, accepting on faith nonscientific opinion that
marijuana was a &quot;killer weed.&quot; </p>

<p>Even though the public opinion process did not operate on the
issue during this period, the decision-makers in all probability
thought that their actions comported with latent public
attitudes. If indeed marijuana caused crime and insanity, of
course the public would oppose its use, as it presumably did use
of opium and cocaine. Because the users were few in number and
confined primarily to a suppressed social and economic minority,
there was no voice which could be beard to challenge these
assumptions. To put it another way, the middle class had
successfully frustrated alcohol prohibition because the public
opinion process came to reflect its view that the law should not
condemn intoxication. Yet because marijuana use was primarily a
lower class phenomenon, the middle class was generally unaware of
the proposed legislation. </p>

<p>The public opinion process did not operate and decision-makers
remained uninformed about the drug. Quickly and with neither
consideration nor dissent, the laws were enacted, thus
establishing a deliberative format followed often in the
succeeding debates. </p>

<p>Although the groundwork had been laid, denigration of the
&quot;loco-weed&quot; was primarily a regional phenomenon until
1932. Nationalization ensued in two fell swoops in the 1930's.
First, cannabis was included in an optional provision of the
Uniform Narcotic Drug Act proposed in 1932. Second, Congress
enacted the Marihuana Tax Act in 1937. In the following sections
we shall scrutinize these two watershed developments. </p>

<hr>

<p><b>A. Origins of the Uniform Law</b> </p>

<p>As we have suggested, the Harrison Act's masquerade as a
revenue measure required residual state legislation in order to
effectuate full prohibition of the narcotics trade in America.1
After its passage most states obediently marched to the tune
played in Washington. By 1931 every state had restricted the sale
of cocaine and, with the exception of two, the opiates.2
Thirty-six states had enacted legislation prohibiting
unauthorized possession of cocaine3 and thirty-five prohibited
unauthorized possession of the opiates and other restricted
drugs.4 Eight states also prohibited possession of hypodermic
syringes.5 Perhaps the most significant feature of the state
response to the Harrison Act was the sharp increase in penalties
between 1914 and 1931.6 Even those penalties, however, seem light
in comparison with the current penalties.7 </p>

<p>On the other hand, some influential legislators thought that
the Federal Act was sufficient to deal with the problem.8 And
there was a considerable lack of uniformity regarding the
offenses prohibited and the penalties imposed by the several
states. Finally, there was little attention devoted to
development of enforcement patterns within and among the states.9
</p>

<p>With such a variety of state legislation, it is not surprising
that little data is available on the enforcement of these laws.
Since the Uniform Crime Statistics, currently the most reliable
source for enforcement data, were first compiled in 1932, there
are no figures on the number of drug arrests by state authorities
in the 1920's. One commentator asserts: </p>

<blockquote>
    <p>As of June 30, 1928, of the 7738 prisoners in federal
    penitentiaries, 2529 were sentenced for narcotics offenses,
    1156 for prohibition law violations, and 1148 for
    stolen-vehicle transactions. Data are not available for
    approximately the same number in state institutions at this
    time.10 </p>
</blockquote>

<p>Despite the significant degree of federal enforcement activity
evidenced by the above data, state law enforcement agencies
seldom involved themselves with narcotics.11 Perhaps the best
evidence of the lax enforcement of state narcotic laws from 1914
to 1927 is the 1921 call for more effective enforcement of the
1917 Massachusetts anti-narcotic law by the Medical Director of
the Boston Municipal Court: </p>

<blockquote>
    <p>Our laws aiming at the suppression of morphinism could
    perhaps be better, but, no matter whether they be improved or
    not, they will not have their maximal efficiency without
    adequate appropriations for their enforcement. Even with the
    insufficient funds now available, more could be reached. I
    understand, for instance, that there is no special police
    force (white squads) entrusted with the detection and arrest
    of cases of V.D.L. [Violation of the Drug Law.] and that
    officers are very much hankered by not being allowed to
    follow suspected persons outside their particular
    districts.12 </p>
</blockquote>

<p>The general lack of uniformity in anti-narcotic legislation,13
the weakness of state enforcement procedures, 14 and the growing
hysteria about dope fiends and criminality15 converged in several
requests beginning as early as 1927 for a uniform state narcotic
law.16 </p>

<p>The drafting process of the Uniform Narcotic Drug Act must
also be viewed against the backdrop of two larger movements: </p>

<p>(1) the trend toward the creation and dissemination of uniform
state laws by the National Commissioners on Uniform State Laws, a
group to which each state sent two representatives appointed by
the governor; and </p>

<p>(2) the general concern in the late 20's and early 30's about
controlling interstate crime, manifested, for example, in the
creation of the nearly autonomous Federal Bureau of Investigation
in 1930. </p>

<p>Because the concepts of states rights and narrowly construed
federal power held shelf sway in this period, appeal to the
National Commissioners was the inevitable recourse for those
pressing for uniform and-narcotic regulations. </p>

<hr>

<p><b>B. Drafting the Law</b> </p>

<p>A committee of Commissioners in conjunction with Dr. William
C. Woodward, Executive Secretary of the Bureau of Legal Medicine
and Legislation of the American Medical Association, prepared and
submitted at the 1925 meeting of the Commissioners the First
Tentative Draft.17 The Committee report stated: &quot;It occurs
to your committee that the New York Act should be taken as a
basis for framing a Uniform Act, and the draft submitted herewith
is largely a copy of the New York Act.&quot; 18 It appears that
the First Draft was drawn up by the Chairman of the Committee
alone.19 It was never presented on the floor of the full meeting
but was recommitted for further study. 20 The First Draft
included the following definitions: </p>

<blockquote>
    <p>(12) &quot;Cannabis indica&quot; or &quot;cannabis
    sativa&quot; shall include any compound, manufacture, salt,
    derivative or preparation thereof and any synthetic
    substitute for any of them identical in chemical composition.
    </p>
</blockquote>

<blockquote>
    <p>(13) &quot;Habit forming drugs&quot; shall mean coca
    leaves, opium, cannabis indica or cannabis sativa.21 </p>
</blockquote>

<p>Nowhere in the Committee report or in the Proceedings does
there appear an explanation of the inclusion of cannabis under
the prohibited or regulated drugs. </p>

<p>The Second Tentative Draft was presented in 1928,22 and again
the draft was not discussed at the Conference but recommitted for
further study.23 The Second Draft was an exact copy of the 1927
New York statute.24 It retained cannabis in the class of
&quot;habit forming drugs .&quot; 25 The lack of concern on the
part of the Commissioners themselves for the whole narcotics
matter is reflected in the remarks of the President of the
Conference in introducing a brief statement to the Conference by
Dr. Woodward: </p>

<blockquote>
    <p>President Miller: In view of the importance of the act I
    think it would not be amiss to listen to the Doctor for a few
    minutes, that he may point out to us why it is important. In
    some of the states we do not recognize the importance because
    it has not been called to our attention.26 </p>
</blockquote>

<p>Moreover, the statements of Dr. Woodward point out that one of
the major forces supporting the drafting of the Uniform Act was
the AMA. The doctors not only wanted to protect the public from
drug addiction but also sought uniformity among state laws
&quot;in order that the profession may have a better
understanding of its obligations and duties and of its rights in
the use of narcotic drugs. &quot; 27 </p>

<p>Two Third Drafts were submitted. The initial one closely
resembled the first two Tentative Drafts and was presented in
1929.28 Again, it was recommitted for further study.29 The second
Third Tentative Draft30 was the first to remove cannabis from the
definition of &quot;habit forming drugs&quot; and to include only
a supplemental provision for dealing with the drug.31 The
explanation for this change from the first two drafts is
contained in this note following the supplemental section: </p>

<blockquote>
    <p>Note: Because of the many objections raised to the
    inclusion of cannabis indica, cannabis americana and cannabis
    sativa in the general list of habit-forming drugs, no mention
    is made of them in other sections of this act. The foregoing
    section is presented in order to meet an apparent demand for
    some method of preventing the use of such drugs for the
    production and maintenance of undesirable drug addiction. It
    may be adopted or rejected, as each state sees fit, without
    affecting the rest of the act.32 </p>
</blockquote>

<p>Judge Deering, the Chairman of the Committee on the Uniform
Narcotic Drug Act, recommended recommission for further study
because the committee had not yet had a chance to consult with
the newly created Bureau of Narcotics. At the time of this
conference (August 14, 1930) no one had yet been appointed to
fill the office of Commissioner of the Bureau.33 </p>

<p>After receiving suggestions from the newly appointed
Commissioner Anslinger, the Committee presented a Fourth
Tentative Draft to the national conference in September 1931.34
The section dealing with marijuana was identical to that included
in the 1930 revised version of the Third Tentative Draft.35 The
national conference directed the Committee to return the next
year with a Fifth Tentative or Final Draft:36 </p>

<p>The Fifth-and final-Tentative Draft was adopted by the
National Conference of Commissioners on October 8, 1932.37 There
were some major changes in the Uniform Act between the Fourth and
the Fifth Tentative Drafts with regard to the regulation of
marijuana. Although the marijuana provisions remained
supplemental to the main body of the Act, any state wishing to
regulate sale and possession of marijuana was instructed to
simply add cannabis to the definition of &quot;narcotic
drugs,&quot; in which case all the other provisions of the Act
would apply to marijuana as well as the opiates and cocaine.38 It
appears that the change from a supplemental section to a series
of amendments to the relevant sections of the Act was preferred
by the Narcotics Bureau.39 The only opposition to adoption of the
Final Draft came from some Commissioners who objected to tying
the uniform state law to the terms of the Federal Harrison Act.40
This last obstacle to adoption of the Act was overcome by the
argument that a number of states had already passed such
legislation so that the federalism problem should not stand in
the way; the Act was adopted 26-3.41 These floor arguments at the
national conference are a most important indication that no one
challenged or even brought up the issue of the designations of
the drugs to be prohibited. Moreover, this brief debate confirms
the notion that the Act received very little attention of any of
the Commissioners other than those sitting on the committee that
drafted it.42 </p>

<p>Examination of the annual proceedings of the Commissioners
immediately suggests several conclusions about the drafting and
proposal of the Uniform Narcotic Drug Act. (1) It was drafted in
conjunction with the American Medical Association and, after
1930, Commissioner Anslinger of the Federal Bureau of Narcotics.
(2) It was not one of the more controversial uniform laws and it
was given little consideration during the full meetings of the
Commissioners. (3) Impetus for the legislation, especially the
optional marijuana provisions, came from the Bureau of Narcotics
itself. (4) No scientific study of any kind was undertaken before
the optional marijuana section was proposed. (5)The first three
tentative drafts included marijuana within the general part of
the Act while the last two (including the one finally adopted by
the Commissioners) made marijuana the subject of a separate,
optional provision. (6) The model for all the drafts of the
Uniform Act was the 1927 New York State statute. </p>

<hr>

<p><b>C. Passage of the State Laws</b> </p>

<p>By 1937 every state had enacted some form of legislation
relating to marijuana, and thirty-five had enacted the Uniform
Act.43 The process by which a previously regional phenomenon
became nationwide closely parallels that which characterized the
earlier state-by-state developments. The major difference is that
the Bureau of Narcotics sought to insure passage of the Act in
each state through lobbying and testifying before the
legislatures and by propagandizing in channels of public opinion.
The Bureau's role has been overstated, however. The same factors
that combined to produce the earlier legislation were exacerbated
during the nationalization period, 1932-1937, and the legislation
probably would have passed just as easily without the efforts of
the Bureau. </p>

<p>Use of the drug was still slight and confined to
underprivileged or fringe groups who had no access either to
public opinion or to the legislators. The middle class had little
knowledge and even less interest in the drug and the legislation.
Passage of the Act in each state was attended by little
publicity, no scientific study and even more blatant ethnic
aspersions than the earlier laws. In short, the laws went
unnoticed by legal commentators, the press and the public at
large, despite the propagandizing efforts of the Bureau of
Narcotics. </p>

<hr>

<p><b>1. Use Patterns and Public Knowledge: 1931-1937</b> </p>

<p>As we noted earlier, marijuana use began in this country in
states near the Mexican border,44 &quot;marijuana&quot; in fact
being a Mexican label for the cannabis drug. Throughout the
1920's marijuana use was confined primarily to the
Mexican-American community; however, by the late 20's use of this
drug had spread to many of the larger cities and had become quite
popular among some elements in the Black ghettoes .45 jazz
musicians, dancers and others found the drug a cheap and readily
available euphoriant.46 </p>

<p>Nevertheless, use still remained slight even in 1934.
Commissioner Anslinger himself asserted in 1937: &quot;Ten years
ago we only heard about it [marijuana] throughout the Southwest .
. . . [I]t has only become a national menace in the last 3
years.&quot; 47 Still another commentator has written: </p>

<blockquote>
    <p>Only in the 1920's was there any significant usage even by
    the Mexican-American communities in border cities, and only
    in the mid and late 1920's did Negro, jazz musicians and
    &quot;degenerate&quot; bohemian sub-cultures start smoking
    marijuana. Even the most lurid Journalists did not claim
    marijuana &quot;seeped&quot; into society at large until the
    1930's and usually the mid-30's.48 </p>
</blockquote>

<p>As late as 1928, the arrest of one Harlem youth for possession
of a small amount of marijuana was news.&quot; Thus, we conclude
that the number of users was still small, although it may have
begun to grow around 1935, and that these users were still
concentrated regionally in the West and Southwest and
socioeconomically within the lower class Mexican-American and
Black communities. </p>

<p>At the same time, the overwhelming majority of middle-class
Americans in the 1930's knew nothing of marijuana use-they had
never seen marijuana and knew no one who used the drug. Prior to
1935 there was little, if any, attention given marijuana in major
national magazines50 and the leading national newspapers.51 That
few middle class Americans in this period knew anything of
marijuana or its effects is best illustrated by the fact that the
Bureau of Narcotics conducted a campaign to alert people to the
dangers of marijuana. The Bureau as early as 1932 began arousing
public opinion against marijuana by &quot;an educational campaign
describing the drug, its identification and its evil
effects.&quot; 52 In July 1936, the New York City police were
shown marijuana so that they would recognize it growing or in
dried, smokeable form .53 Thus, even policemen had to be shown
the plant as late as 1936 to permit effective enforcement of the
New York state law. We may accordingly infer that the level of
public familiarity with the drug was quite low indeed.54 </p>

<p>What little information filtered to the middle class was
generated by sporadic campaigns by local newspapers detailing the
potential evils of marijuana; the accounts, as before, were
sensationalistic and tended to exacerbate latent ethnic
prejudices. For example, a 1934 newspaper account linked crime in
the Southwest with marijuana smoking Mexican-Americans in the
region.55 In a 1935 letter to the editor of the New York Times, a
Sacramento, California, reader asserted: </p>

<blockquote>
    <p>Marijuana, perhaps now the most iinsidious of our
    narcotics, is a direct by-product of unrestricted Mexican
    immigration . . . . Mexican peddlers have been caught
    distributing sample marijuana cigarettes to school
    children.56 </p>
</blockquote>

<p>The writer went on to demand a quota on Mexicans permitted to
enter the country. In testifying in favor of the Marihuana Tax
Act, Commissioner Anslinger submitted a letter he had received
from the editor of a Colorado newspaper asking the Bureau to help
stamp out the marijuana menace. After describing an attack by a
Mexican-American, allegedly under the influence of marijuana, on
a girl of his region the writer stated: </p>

<blockquote>
    <p>I wish I could show you what a small marijuana cigaret can
    do to one of our degenerate Spanish-speaking residents.
    That's why our problem is so great; the greatest percentage
    of our population is composed of Spanish-speaking persons,
    most of whom are low mentally, because of social and racial
    conditions.57 </p>
</blockquote>

<p>Again, in the testimony at the hearings on the Marihuana Tax
Act the following is excerpted from an article included in the
record: </p>

<blockquote>
    <p>We find then that Colorado reports that the Mexican
    population there cultivates on an average of 2 to 3 tons of
    the weed annually. This the Mexicans make Into cigarettes,
    which they sell at two for 25 cents, mostly to white school
    students.58 </p>
</blockquote>

<p>Thus, not only did few middle-class Americans know about
marijuana and its use, but also what little
&quot;information&quot; was available provoked an automatic
adverse association of the drug with Mexican immigration, crime
and the deviant life style in the Black ghettos. Naturally, the
impending drug legislation, as had the earlier state legislation,
became entangled with society's views of these minority groups. </p>

<hr>

<p><b>2. Role of the Federal Bureau of Narcotics</b> </p>

<p>It has become quite fashionable among critics of existing
marijuana legislation to assert that the sole cause of the
illegal status of marijuana has been the crusading zeal of the
Federal Bureau of Narcotics and especially of its long-time head,
Harry J. Anslinger. Some observers have suggested that the
Bureau's activity was produced by bureaucratic exigencies and the
need to expand;59 others have said the Bureau was on a moral
crusade;60 still others have asserted that the Bureau believed
its own propaganda about the link between criminality and dope
fiends.61 While much of this may be true, it is clear that the
Bureau did not single-handedly conjure up the idea of banning
marijuana use. Since many states had already undertaken the
regulation of marijuana before the creation of the Bureau in
1930, we cannot credit the Bureau alone with the pressure to
outlaw the drug. </p>

<p>At the same time, it is certain that the Federal Bureau of
Narcotics' actions quickened the pace of the passage by state
legislators of the Uniform Narcotic Drug Act. The Bureau saw the
passage of state narcotics laws as one of its primary objectives.
To this end we have detailed how directly the Bureau was involved
in the creation of the Final Draft of the Uniform Act. After
approval of the Final Draft, the Bureau began a significant
campaign in the newspapers and legal journals to boost public
support for the Uniform Act.62 By detailing the inability of
federal enforcement agencies to deal with the burgeoning
narcotics traffic, the Bureau continued to press for passage of
the Uniform Act by creating a felt need in the public for such
legislation.63 Despite the efforts of the Bureau, the Uniform Act
went virtually unnoticed by legal commentators and periodicals,
and by the public media. </p>

<hr>

<p><b>3. Legislative Scrutiny and Media Coverage</b> </p>

<p>The Uniform Act was passed by the legislatures of most states
with out scientific study or debate and without attracting public
attention. </p>

<p>In examining in detail the passage of the Uniform Act in
Virginia and some other selected states, it will be clear that
public concern over marijuana succeeded the outlawing of the drug
and did not precede it. Our methodology to determine the extent
of public attention in a given state at the time of the passage
of the act was to review the newspapers of larger cities for the
two weeks before and after passage.64 </p>

<p>In Virginia the Uniform Narcotic Drug Act passed the House
88-0 on February 16, 1934,65 and was approved 34-0 by the Senate
on February 22.66 Although the Act as passed in Virginia
contained no marijuana provisions, the same legislature the next
month passed a bill (H.B. 236), prohibiting &quot;use of opium,
marijuana [and] loco weed ... in the manufacture of cigarettes,
cigars&quot; and other tobacco products.67 This law, which
amended a 1910 Virginia statute prohibiting the use of opium in
the manufacture of cigarettes,68 was the first mention of
marijuana, or any of its derivatives in the Virginia Code. </p>

<p>An examination of the Richmond Times-Dispatch, the newspaper
of the state capital and perhaps the most influential newspaper
in the state at that time, for the period surrounding the
enactment of these two provisions (February 1 to March 15, 1934)
shows clearly that little, if any, public attention attended
their passage. There is no mention at any time of H.B. 236.69 As
for H.B. 94 (the Uniform Act), the Times Dispatch reported on
February 7 that the bill had been introduced. This announcement
was buried among the list of all bills introduced and referred on
February 6.70 In a February 12 article dealing with
&quot;controversial&quot; bills before the House and Senate that
week no mention was made of H.B. 94. On March 6, the newspaper
recorded: &quot;Among the important bills passed were. . . . [far
down the list] the Scott bill, making the State narcotic law
conform to the Federal statute.&quot; 71 That is the sum of the
publicity received by the Uniform Act and the statute that first
regulated marijuana in any way in Virginia. </p>

<p>In 1936, the legislature passed a separate statute prohibiting
the sale and use of marijuana. This bill-S.B. 289-passed the
House and Senate unanimously.72 The Act prohibited, except for a
narrow medical exception, sale, possession, use and cultivation
of marijuana .73 The penalties for violation, interestingly, were
more severe than those for violation of the 1934 Uniform Act.
Looking again at the Times-Dispatch for the period from February
15 to March 19, 1936, we find only one brief article on the new
marijuana legislation. After the Senate passed the measure on
February 29, the following appeared: </p>

<blockquote>
    <p>Among the bills passed by the Senate was the Apperson
    measure prohibiting the cultivation, sale or distribution of
    derivatives of the plant cannabis sativa, introduced as an
    outgrowth of alleged traffic in marihuana cigarettes in
    Roanoke. It fixes punishment for violation of its provisions
    at from one to 10 years in the penitentiary, or by
    confinement in jail for 12 months and a fine of not more than
    $1,000 or both. </p>
</blockquote>

<blockquote>
    <p>Charges that school children were being induced to become
    addicts of marihuana cigarettes and that the weed was being
    cultivated in and near the city on a wide scale were laid
    before the Roanoke City Council last year. A youth who said
    he was a former addict of the drug testified before the
    Council that inhalation of one of the cigarettes would
    produce a 'cheap drunk' of several days' duration.74 </p>
</blockquote>

<p>No further mention of this statute was made after the House
passed it or after the Governor signed it into law. </p>

<p>In order to determine whether the lack of public attention in
Virginia was common to other states when the first prohibition of
marijuana took place, we have surveyed the leading newspapers of
several other states at the times encompassing passage of the
law. We tried to select states that had not previously regulated
use of the drug under the assumption that more publicity would
attend initial legislation than an amendment of existing law. </p>

<p>In New Jersey, Rhode Island, Oregon and West Virginia, for
example, the major newspapers of Newark, Providence, Salem and
Charleston 78 respectively, referred to the Uniform Act only once
and to marijuana not at all. In Kentucky, the Louisville Herald
Post printed only two short references to the Uniform Act,79 one
of which referred to marijuana: </p>

<blockquote>
    <p>[Congressman] Kramer added that boys and girls of school
    age are being led into the use of habit forming drugs by
    underworld leaders.......... Muggles&quot; or cigarettes made
    from marijuana, commonly called loco weed or hemp, are also
    tabooed under the new state law, it was learned.80 </p>
</blockquote>

<p>Typical of both legislative and newspaper concern about the
new law is the following Charleston Daily Mail comment: </p>

<blockquote>
    <p>A Narcotic Bill </p>
</blockquote>

<blockquote>
    <p>Inconspicuously upon the special calendar of the house of
    delegates rather far down upon it-is Engrossed S.B. No. 230,
    lodging specific powers in the hands of state authorities for
    the control of the traffic in narcotics. It has passed the
    Senate unanimously. It should pass the House, and its only
    danger of defeat there is the very real one that it will
    become lost in the shuffle of adjournment now but a few hours
    away. </p>
</blockquote>

<blockquote>
    <p>The bill goes under the name of the uniform narcotic drug
    act and it is just that. Identical measures for the control
    by the states of illicit traffic on drugs have been passed by
    other states, notably the Southern group. Its passage here
    would result in a broad territory in which there are
    corresponding laws .... 81 </p>
</blockquote>

<p>The editorial nowhere mentions marijuana. The bill itself
passed in the waning hours of the special session with no
subsequent attention given it. 82 </p>

<p>From our survey of these and other states, we have concluded
that with but one exception83 the Virginia experience was the
norm. (1) The laws prohibiting use, sale, possession, and
distribution of marijuana passed unnoticed by the media. There
was no public outcry for such legislation. (2) Quite often the
bill was buried beneath more controversial bills in a busy
legislative session. (3) In many states the Act was passed late
in the session along with myriad other
&quot;uncontroversial&quot; laws. (4) Finally, no state undertook
independent study to determine the medical facts about
marijuana-they relied on information supplied by the Federal
Bureau of Narcotics84 or a few lurid newspaper stories.85 </p>

<hr>

<p><b>4. Available Medical Opinion</b> </p>

<p>In conjunction with the fourth conclusion from our state case
histories of the passage of this Act, we should examine the
extent of medical knowledge that might have been available to
legislators had they wanted to conduct an independent evaluation
of the dangers of the hemp drugs. </p>

<p>There were five influential sources for information about the
effects of marijuana and hemp on humans. None of these were
conducted with the scientific precision characterizing modern
studies of drug effects. However, they each deserve mention here
either because they deserved attention then or because they
heavily influenced later commentators. </p>

<p>The first exhaustive study of the effects of cannabis and the
other hemp drugs was done by the British in India. Their Indian
Hemp Drugs Commission studied cannabis use among the native
population in India in 1893 and 1894,86 and submitted its
conclusions in a 500-page report. The Commission received
evidence from 1,193 witnesses, including 335 doctors, and studied
the relevant drug-related judicial proceedings and the intake
records of every mental hospital in British India. As a result
they concluded: </p>

<blockquote>
    <p>In regard to the moral effects of the drugs, the
    Commission are of opinion that their moderate use produces no
    moral injury whatever. There is no adequate ground for
    believing that it injuriously affects the character of the
    consumer. Excessive consumption, on the other hand, both
    indicates and intensifies moral weakness or depravity.
    Manifest excess leads directly to loss of self-respect, and
    thus to moral degradation. In respect to his relations with
    society, however, even the excessive consumer of hemp drugs
    is ordinarily inoffensive. His excesses may indeed bring him
    to degraded poverty which may lead him to dishonest
    practices; and occasionally, but apparently very rarely
    indeed, excessive indulgence in hemp drugs may lead to
    violent crime. But for all practical purposes it may be laid
    down that there is little or no connection between the use of
    hemp drugs and crime.87 </p>
</blockquote>

<p>It is quite clear, however, that the Indian Hemp Drug
Commission88 Report was not disseminated in the United States
until 1969 . </p>

<p>On the other hand, periodic reports of the Panama Canal Zone
Governor's Committee to study the physical and moral effects of
the use of marijuana were available to legislators before the
passage of the Uniform Act. After an investigation extending from
April to December 1925, the Committee reached the following
conclusions: </p>

<p>There is no evidence that marijuana as grown here is a
&quot;habit-forming&quot; drug in the sense in which the term is
applied to alcohol, opium, cocaine etc. or that it has any
appreciable deleterious in influence on the individual using
it.89 </p>

<p>In 1933, a similar Panama Canal Zone committee reported: </p>

<blockquote>
    <p>Delinquencies due to marijuana smoking which result in
    trial by military court are negligible in number when
    compared with delinquencies resulting from the use of
    alcoholic drinks which also may be classed as stimulants and
    intoxicants.90 </p>
</blockquote>

<p>About the time that the final Governor's Committee Report from
the Canal Zone was completed, a New Orleans physician, Dr.
Fossier, completed a study from which he concluded that marijuana
was a highly dangerous drug with habit-forming properties.91 This
piece would have remained relatively unnoticed due to the
obscurity of the journal in which it was published had it not
been picked up by the New Orleans District Attorney, Eugene
Stanley, and made the basis for his own article-Marihuana as a
Developer of Criminals92 which appeared in a law enforcement
journal. Mr. Stanley stated: </p>

<blockquote>
    <p>It is an ideal drug to cut off inhibitions quickly. . . . </p>
</blockquote>

<blockquote>
    <p>At the present time the underworld has been quick to
    realize the value of this drug in subjugating the will of
    human derelicts to that of a master mind. Its use sweeps away
    all restraint, and to its influence may be attributed many of
    our present day crimes. It has been the experience of the
    Police and Prosecuting Officials in the South that
    immediately before the commission of many crimes the use of
    marihuana cigarettes has been indulged in by criminals so as
    to relieve themselves from the natural restraint which might
    deter them from the commission of criminal acts, and to give
    them the false courage necessary to commit the contemplated
    crime.93 </p>
</blockquote>

<p>Mr. Stanley's article, based on no empirical data whatsoever,
was widely used by courts to corroborate early legislation and by
lobbyists to justify the later prohibitive legislation against
the hemp drugs.94 </p>

<p>In 1933 the following colloquy appeared in the Journal of the
American Medical Association: </p>

<blockquote>
    <p>Effects of Cannabis </p>
</blockquote>

<blockquote>
    <p>To the Editor:-I have been hearing about the smoking of
    cigarets dipped into or medicated with fluid extract of
    Cannabis americana. I can find nothing about the use of the
    drug by addicts. What is its immediate effect? What are its
    late effects? What is the minimum lethal dose? In what way
    does it differ from or resemble &quot;muggles&quot; in its
    action? While in Louisiana I was told that the use of
    marihuana causes dementia. Is this true' Please omit name. </p>
</blockquote>

<blockquote>
    <p>M.D., Illinois. </p>
</blockquote>

<blockquote>
    <p>ANSWER.-The effect of Cannabis americana is the same as
    that of Cannabis indica- and, of the effect of the latter,
    the books are so full that it is hardly necessary to detail
    them here. It must suffice here to say that cannabis, at the
    height of its action, usually produces hallucinations, with
    or without euphoria, and that these are followed by a deep
    sleep. Its most marked after-effect is the liability to the
    establishment of a craving for the drug, the habitual use of
    which undermines the intellectual qualities and the social
    value of the victim and leads to general physical
    deterioration. It is stated that smokers nearly always become
    imbecile in time. The minimum lethal dose is unknown, no
    fatalities having been reported in man. In view of the fact
    that one dose may kill one dog that has no marked effect on
    another, one must admit the possibility of a lethal effect on
    man. In view of what has been said, it must be admitted that
    &quot;marihuana,&quot; which is merely another name for
    Cannabis indica, may cause dementia.95 </p>
</blockquote>

<p>The reply contains no indication how or where the persons who
answered the question got their data. It seems clear from the
nature of the response that the medical community was quite
uncertain as to the effects of the drug in 1933. </p>

<p>In 1934, Dr. Walter Bromberg, senior psychiatrist at Bellevue
Hospital, reported that marijuana was not a habit-forming drug
and was far less responsible for crime than other drugs such as
alcohol. In this study, Bromberg drew his data from examination
of 2,216 inmates convicted of felonies.96 Dr. Bromberg pointed
out that marijuana users tend to be passive in comparison to
users of alcohol and that the hemp drugs should lead to crime
only in cases of use by already psychopathic types. 97 </p>

<p>This then was the extent of medical evidence available to
laymen and legislators alike at the time the Uniform Narcotic
Drug Act and the fast prohibitions of marijuana were enacted in
most states. We can conclude the following from our brief review
of the medical literature. (1) Little was really known about the
effects of marijuana use-there were few studies and what studies
there were had serious methodological flaws. (2) Even if the
studies we record had been adequate methodologically, they
appeared generally in obscure medical not widely read by laymen.
(3) Of these studies, most found marijuana relatively harmless
especially in contrast to use of alcohol. (4) None of these
studies were considered in either the formulation or the passage
of the Uniform Act in the states examined. And what is more
astounding is that instead of consulting medical opinion,
legislators relied on lurid newspaper accounts of marijuana,
often provided by defendants in criminal prosecutions whose
motivation was to use marijuana to escape criminal
responsibility. </p>

<hr>

<p><b>5. Provisions of the Uniform Narcotic Drug Act and
Supplemental Virginia Marijuana Statute</b> </p>

<p>Having studied the circumstances surrounding passage of the
Uniform Act and similar legislation in several states between
1932 and 1937, we shall briefly summarize the provisions of those
laws. </p>

<p>(a) Classification and Offenses.-The Virginia legislature made
no changes in the Uniform Act as drafted by the Commissioners and
did not include the supplementary marijuana provisions in passing
that Act.98 In 1936, Virginia passed special marijuana
legislation99. which defined cannabis exactly as did the
definitional provision of the Uniform Act. Both the special
marijuana statute in Virginia and the Uniform Act prohibited
possession, transfer and cultivation of the drug100 but did not
refer to the more specific acts that later came to be separated
and punished more heavily, such as sale to a minor and possession
of more than a certain amount. </p>

<p>(b) Penalties.-The Uniform Act contained no specific penalties
for its violations; the matter of supplying the appropriate
penalties was left to each state. Virginia punished first
violations of its Uniform Act by a fine not exceeding $100 and/or
imprisonment in jail not exceeding one year, and second and
subsequent offenses by a fine not exceeding $1,000 and/or
imprisonment for not more than five years in the penitentiary.101
The penalties for violation of Virginia's 1936 marijuana statute
were stiffer than for violation of its Uniform Act. Each offense
was punishable by imprisonment in the penitentiary for from one
to ten years or by confinement in jail for not more than twelve
months and/or by a fine up to $1,000, in the discretion of the
court or jury.102 </p>

<p>An analysis of penalties for violation of the marijuana
statutes enacted in other states at about the same time indicates
Virginia's penalties were atypically harsh. In New Jersey, for
instance, the penalty for unlawful possession and sale of
marijuana was that attaching to a high misdemeanor.103 In Rhode
Island the penalty for unlawful possession was a fine of not more
than $1,000 or imprisonment for not more than threeyears or
both.104 For unlawful selling, Rhode Island provided a fine of
not more than $2,000 or imprisonment for not more than five years
or both.105 In Kentucky the penalty for a first offense violation
was a fine of not less than $100 and not more than $500 or jail
for not less than thirty days nor more than one year or both. For
second and subsequent offenses the statute required imprisonment
in the penitentiary for not less than one nor more than five
years.106 Finally, West Virginia penalized a first offender by a
fine not exceeding $100 or jail for not exceeding one year or
both, and subsequent offenders by fine not exceeding $1,000 or
imprisonment in the penitentiary not exceeding five years or
both.107 </p>

<p>This comparison indicates that Virginia penalties could be
more severe than the average. Moreover, Virginia did not
distinguish in penalty between possession and sale of the drug,
and violation of Virginia's separate marijuana law could be more
heavily penalized than violation of the Uniform Act. </p>

<hr>

<h2>Footnotes and References </h2>

<p>1. See p. 989 supra </p>

<p>2. STATE LAWS 13. </p>

<ol>
    <li>Id at 8. </li>
    <li>Id. </li>
    <li>Id at 21 </li>
    <li>For example, compare ch. 337 [1929] NY Laws 881 with ch.
        363 [1914] NY Laws 1120 </li>
    <li>See Appendix A, Tables II, III </li>
    <li>For example, in 1921 New York had repealed its general
        narcotics provision, ch. 708 [1921] NY Laws 2496. See
        note 35 at 1017-18 supra. Governor Miller of New York at
        that time stated: </li>
</ol>

<blockquote>
    <p>Being unable to resolve that conflict of opinion, I have
    deemed it the safest course to leave the subject to be
    governed by the Federal statute until such time at least as
    it shall more clearly appear in what way that statute might
    be wisely supplemented by the state.<br>
    </p>
</blockquote>

<p>48. REPORT OF THE NEW YORK STATE BAR ASSOCIATION 133 [1925]
(emphasis original) Commissioner Anslinger felt that the states
had failed to do their part during this period: </p>

<p>Notwithstanding the limited power of the Federal Government,
state officers immediately became imbued with the erroneous
impression that the problem of preventing abuse of narcotic drugs
was one now [after the Harrison Act] exclusively cognizable by
the National Government, and that the Federal Law alone,
enforced, of course, by Federal agencies only, should represent
all the control necessary over the illicit narcotic drug traffic.
</p>

<p>Anslinger, The Reason for Uniform State Narcotic Legislation,
21 GEO. L.J. 52, 53 (1932). </p>

<p>9 TERRY &amp; PELLENS 969-91. See also 1928 HANDBOOK OF THE
NATIONAL CONFERENCE OF COMMISSIONERS ON UNIFORM STATE LAWS AND
PROCEEDINGs 77-78 (handbooks hereinafter cited as 19- HANDBOOK]. </p>

<p>10 King, The Narcotics Bureau and the Harrison Act, 62 YALE
L.J. 736, 738 n.12 (1953). See also Schmeckbier, The Bureau of
Prohibition in BROOKINGS INST. FOR GOVT RESEARCH, SERVICE
MONOGRAPH.No. 57, at 143 (1929). </p>

<p>11 See JOINT LEGISLATIVE COMM. TO INVESTIGATE THE LAWS IN
RELATION TO THE DISTRIBUTION AND SALE OF NARCOTIC DRUGS, FINAL
REPORT, NEWYORK SENATE Doc. No. 3 (1918): </p>

<p>No fixed policy exists for the enforcement of the State
statutes except in the larger cities of the State but their
enforcement has been left to the desultory or spasmodic efforts
of local police officials . . . . </p>

<p>Quoted in TERRY &amp; PELLENS 834. See also FT. BECKER,
OUTSIDERS 137-38 (1963). </p>

<p>12 Sandoz, Report on Morphinism to the Municipal Court of
Boston, 13 J. CRIM. L. &amp; CRIMINOLOGY 10, 54 (1922) (emphasis
original) </p>

<p>13 See STATE LAWS 31-34. </p>

<p>14 Id. at 28. </p>

<p>15 See SPECIAL COMMITTEE TO INVESTIGATE THE TRAFFIC IN
NARCOTIC DRUGS, U.S. TREASURY DEP'T, REPORT (1919) </p>

<p>16 H. ANSLINGER &amp; W. TOMPKINS, THE TRAFFIC IN NARCOTICS
159 (1953). </p>

<p>17. 1925 HANDB00K 977-85. </p>

<p>18 Id. at 975. </p>

<p>19 Id. at 305. </p>

<p>20 Id. </p>

<p>21 Id. at 978. </p>

<p>22 1928 HANDBOOK 323-33. </p>

<p>23 Id. at 75-78. </p>

<p>24 Ch. 672, [1927] N.Y. Laws 1695-1703. </p>

<p>25 1928 HANDBOOK 325. </p>

<p>26 Id. at 76-77. </p>

<p>27 Id. at 77. </p>

<p>28 1929 HANDBOOK 332-40. </p>

<p>29 Id. at 83. </p>

<p>30 1930 HANDBOOK 485-97. </p>

<p>31 The provision, which made an exemption for medicinal or
scientific use, read in part as follows: </p>

<p>Section 12. (Cannabis Indica, Cannabis Americana and Cannabis
Sativa.) No person shall plant, cultivate, produce, manufacture,
possess, have under his control, sell, prescribe, administer,
dispense or compound cannabis indica, cannabis americans, or
cannabis sativa, or any preparation or derivative thereof, or
offer the same for sale, administering dispensing or compounding
. . . . </p>

<p>Id. at 493. </p>

<p>32 Id. There is no evidence of what objections had been
raised. The authors feel certain that the dissenters were
birdseed and hemp growers who also objected to the passage of the
Marihuana Tax Act. See pp. 1054, 1059 infra. </p>

<p>33 1930 HANDBOOK 126-27. </p>

<p>34 1931 HANDBOOK 390-402. </p>

<p>35 Id. at 398-99. </p>

<p>36 Id. at 127-28. </p>

<p>37 1932 HANDBOOK 95-107. </p>

<p>38 Id. at 326. </p>

<p>39 See Tennyson, Uniform State Narcotic Law, I FED. B. Assn
J., Oct. 1932, at 55; Illicit Drug Traffic, 2 FED. B. ASS'N J.
208-09 (1935) (indicating that the simple amendments for
marijuana were designed by the Bureau so that other drugs could
be added in the same way). </p>

<p>40 1932 HANDBOOK 95-107. </p>

<p>41 Id. at 107. </p>

<p>42 From our own computations, the total time spent by all the
Commissioners discussing this Act from 1927 to 1932 could not
have exceeded one hour. Moreover, the small number of states
present at the time of the roll call, as compared with the 48
that voted on the Uniform Machine Gun Act the day before,
indicates that concern for this Act was less than overwhelming. </p>

<p>43 Tax, Act Hearings 25-26. </p>

<p>44 See H. BECKER, OUTSIDERS 135 (1963). </p>

<p>45 NEW YORK CITY MAYOR'S COMMITTEE ON MARIHUANA, REPORT,
reprinted in THE MARIHUANA PAPERS 277-307 (D. Solomon Ed. 1966)
[hereinafter cited as LAGUARDIA REPORT]. </p>

<p>46 id. at 292-94. The following exchange from the Hearings on
the Marihuana Tax Act indicates the low cost of the drug in 1937:
</p>

<p>Mr. Thompson: What is the price of marijuana? </p>

<p>Mr. Anslinger: The addict pays anywhere from 10 to 25 cents
per cigarette. In illicit traffic the bulk price would be around
$20 per pound. Legitimately, the bulk is around $2 per pound. </p>

<p>Tax Act Hearings 27. </p>

<p>47 Tax Act Hearings 20. </p>

<p>48 Mandel, Hashish, Assassins and the Love of God, 2 ISSUES IN
CRIMINOLOGY I49 (1966). </p>

<p>49 N.Y. Times, Oct. 7, 1928,  2, at 4, col. 6. </p>

<p>50 There is only one article even vaguely related to marijuana
listed prior to 1935 Our Home Hasheesh Crop, LITERARY DIGEST,
Apr. 3, 1926, at 64. See H. BECKER, OUTSIDERS 141 (1963). </p>

<p>51 From 1923 to 1935 there were only thirteen short articles
related in any way to marijuana in the New York Times, even
though New York City had banned marijuana as early as 1914 and
the state legislature had acted in 1927. </p>

<p>52 BUREAU OF NARCOTICS, U.S. TREASURY DEP'T, TRAFFIC IN OPIUM
AND OTHER DANGEROUS DRUGS 59 (1937). See also H. BECKER,
OUTSIDERS 140 (1963). </p>

<p>53 N.Y. Times, July 24, 1936, at 6, col. 3. </p>

<p>54 In 1923 the New York Times, in a short article, reported:
&quot;The latest habit forcing drug . . . marijuana, which is
smoked in a cigarette-was exhibited&quot; at a women's club
meeting. N.Y. Times, Jan. 11, 1923, at 24, col. 1. </p>

<p>55 N.Y. Times, Sept. 16, 1934,  4, at 6, col. 3. </p>

<p>56 Id., Sept. 15, 1935, s 4, at 9, col. 4. </p>

<p>57 Tax Act Hearings 32. </p>

<p>58 Gomila, Marijuana-A More Alarming Menace to Society Than
All Other Habit Forming Drugs, quoted in Tax Act Hearings 32-33.
See also Gusfield, On Legislating Morals: The Symbolic Process of
Designating Deviance, 56 CALIF. L. REv. 54, 69 (1968). 59
Dickson, Bureaucracy and Morality: An Organizational Perspective
on a Moral Crusade, 16 SOCIAL PROB. 143 (1968). </p>

<p>60 H. BECKER, OUTSIDERS 137-45 (1963); see T. DUSTER, THE
LEGISLATION OF MORALITY 17-19 (1970). </p>

<p>61 King, The Narcotics Bureau and the Harrison Act, 62 YALE
L.J. 736, 737-39 (1953). </p>

<p>62 E.g., Anslinger, The Reason for Uniform State Narcotic
Legislation, 21 GEo. L.J. 52 (1932); Tennyson, Uniform State
Narcotic Law, I FED. B. ASS'N J., Oct. 1932. at 55 (Mr. Tennyson
was Legal Advisor, Bureau of Narcotics). </p>

<p>63 See, e.g., N.Y. Times, Sept. 16, 193 1, at 37, col. 2. </p>

<p>64 It seems that if there were any public concern at all about
the Uniform Act and its adoption, it should appear at those times
in mention of the bill, marijuana or narcotic drugs in general.
We used the papers of the larger cities under the assumption that
they would usually contain the fullest and most accurate account
of the business of state legislatures. </p>

<p>65 VA. HOUSE JOUR. 324 (1934). </p>

<p>66 VA. SENATE JOUR. 300-01 (1934). </p>

<p>67 Any manufacturer or manufacturers of cigarettes who shall
employ opium, marihuana, loco weed, or any other sedative,
narcotic or hypnotic drug, like chemical or substance, either in
the tobacco used or paper wrappers of cigarettes, cigars, tobacco
or any otherwise undiluted foodstuff or beverage, other than that
advertised, sold and used as a drug or medicine, shall be guilty
of a misdemeanor, and upon conviction shall be fined not less
than one hundred dollars nor more than one thousand dollars, or
confined in jail not less than six months nor more than twelve
months, or both, for each offense. Ch. 268, [1934] Va. Acts of
Assembly 411 (H.B. 236). </p>

<p>68 Ch. 246, [1910] Va. Acts of Assembly 358 (codified as
amended VA. CODE ANN. 18.1-345,-346 (Supp. 1970)). </p>

<p>69 On March 11, 1934, the day after the prohibition of use of
opium in cigarettes was amended to include marijuana, the
Richmond Times-Dispatch did not mention the action, and an
article entitled &quot;Bills Passed by Assembly&quot; did not
mention any marijuana or narcotic laws. Richmond Times-Dispatch,
Mar. 11, 1934, at 4, col. 2. A March 12, six-column article,
entitled &quot;Vital Measures Passed in Busy 1934 Assembly&quot;
also did not mention either the narcotics legislation or the
marijuana amendment. id., Mar. 12, 1934, at 1, col. 2. </p>

<p>70 Id., Feb. 7, 1934, at 4, col. 1. </p>

<p>71 Id., Mar. 6,1934, at 2, col. 5. </p>

<p>72 VA. HOUSE JOUR. 827 (1936); VA. SENATE JOUR. 498 (1936). </p>

<p>73 Ch. 212, [19361 Va. Acts of Assembly 361. </p>

<p>74 Richmond Times-Dispatch, Mar. 1, 1936, at 12, col. 3. </p>

<p>75 The Newark Star Ledger was surveyed from May 20 to June 10,
193 3, a period surrounding the passage of the statute, ch. 186,
[1933] N.J. Acts 397, on June 5, 1933. On the day of the signing
of the bill, there appeared a short article noting that the
Uniform Narcotic Drug Act had become law. Newark Star Ledger,
June 5, 1933, at 2. 76 The statute, ch. 2096, [1934] R.I. Acts
101, was approved April 26, 1934. The Providence journal was
surveyed from April 10 to April 28, 1934, and on April 12 there
appeared five sentences on the Uniform Act. providence journal,
Apr. 12, 1934, at R. On April 21, the law was described in a
short article summarizing the business of the legislative
session. Id., Apr. 21, 1934, at 7. Neither article mentioned
marijuana. </p>

<p>77 The Salem Oregon Statesman in the period from February 8 to
February 28, 1935, had only one article dealing with drugs. Salem
Oregon Statesman, Feb. 21, 1935, at 2, col. 2. </p>

<p>78 The Uniform Act was passed in West Virginia on March 8,
1935. Ch. 46, [1935] W. Va. Acts 179. The Charleston Daily Mail,
which carried detailed legislative news, was surveyed from March
I to March 20, 1935. On March 1, the legislature reconvened under
a special calendar including the Uniform Act. During this period,
the Act attracted little attention except for an editorial on
March 7. Charleston Daily Mail, Mar. 7, 1935, at 10, co]. 1. The
bill was mentioned in passing in two other stories on upcoming
legislation, and in a report that a federal judge criticized West
Virginia's failure to enact the Act. Id., Mar. 6, 1935, at 6,
col. 4. </p>

<p>79 The Louisville Herald Post was surveyed from April 15 to
June 15, 1934. The marijuana section of the Uniform Act became
effective on June 14, 1934. Ch. 142, [1934] Ky. Acts 562. The
only reference to the Act was Louisville Herald Post. June 6,
1934, at 10. </p>

<p>80 Id. </p>

<p>81 Charleston Daily Mail, Mar. 7,1935, at 10, col. 1. </p>

<p>82 Id., Mar. 11, 1935, at 1, col. 1, reports: &quot;In the
confusion of the closing hours Saturday night the legislature
passed many bills, many of them unread and unprinted and not
understood.&quot; </p>

<p>83 In Missouri, the passage of the Uniform Act was attended by
pressure on the legislature stemming from a hysteria campaign in
the St. Louis Star Times which contained 5 major articles urging
the outlawing of marijuana and presenting lurid case studies of
the evils of the drug. These articles were quoted in the Tax Act
Hearings. See St. Louis Star Times, Jan. 17-Feb. 19, 1935. </p>

<p>84 See, e.g., N.Y. Times, Sept. 16, 1931, at 37, col. 2
(recording Commissioner Anslinger's statements on the need for
uniform state laws to regulate marijuana). </p>

<p>85 In the Missouri case, the legislature, in response to the
scare stories in the St. Louis Star Times, took only 10 days to
present the law, hold quick hearings, and unanimously pass the
anti-marijuana legislation. </p>

<p>86 INDIAN HEMP DRUGS COMMISSION 1893-94, REPORT: MARIJUANA (J.
Kaplan ed. 1969). </p>

<p>87 Id. at 264. </p>

<p>88 Id. at vi. </p>

<p>89 Quoted in Marijuana Smoking in Panama, 73 THE MILITARY
SURGEON 274 (1933). </p>

<p>90 Id. at 279. </p>

<p>91 Fossier, The Marijuana Menace, 84 NEW ORLEANS MEDICAL &amp;
SURGICAL J. 247 (1931). </p>

<p>92 Stanley, Marihuana as a Developer of Criminals, 2 Am. J.
POLICE Sci. 252 (1931). </p>

<p>93 Id. at 256. </p>

<p>94 See Tax Act Hearings 23-24, 37. </p>

<p>95 100 JA.M.A. 601 (1933). </p>

<p>96 Bromberg, Marijuana Intoxication: A Clinical Study of
Cannabis Sativa Intoxication, </p>

<p>97 Am. J. PSYCHIATRY 303 (1934). </p>

<p>97 Id. at 309; see Facts and Fancies About Marijuana, LITERARY
DIGEST, Oct. 24, 1936, at 7-8. This presentation begins by
digesting Dr. Bromberg's article for laymen: </p>

<p>It is clear from this study [of 2,216 criminals convicted of
felonies] that in this region the drug is a breeder of crime only
when used by psychopathic types in whom the drug allows the
emergence of aggressive, sexual or antisocial tendencies. . . .
It is quite probable that alcohol is more responsible as an agent
for crime than is marihuana. </p>

<p>The article continues: </p>

<p>The following facts stand out in social and medical reports: </p>

<p>1. Marihuana is not a habit-forming drug, as is heroin or
opium. </p>

<p>2. It prolongs sensations; it is in high favor as an
aphrodisiac. </p>

<p>3. It is the most inexpensive of drugs; marihuana cigarettes
usually selling at from three to twenty-five cents each. </p>

<p>The article then describes the effects of marijuana: </p>

<p>After smoking from one to three &quot;reefers,&quot; if one
has not been told what to expect, the first effects of the drug
pass almost unnoticed-nothing, perhaps, but a slight twitching of
muscles of the neck, back or legs. The mind remains calm and
clear. Suddenly, without apparent cause, a chance remark . . .
sends the subject into a spasm of violent laughter. </p>

<p>Becoming calm again, while the drug continues to exert its
weird effects, the smoker finds ideas crowding through his brain
with bewildering rapidity; those around him become slow-dull. Nor
is the language of his own tongue swift enough to keep pace with
his lightning thoughts. </p>

<p>Soon the self-esteem of the smoker begins to grow in like
proportion. . . . </p>

<p>Paradoxically, trifling discomforts become unbearable evils;
the flare of a match near-by brings a resentment that is
immediately transformed into an overwhelming desire for revenge.
But before the &quot;reefer man&quot; could possibly climb to his
feet, or even reach a hand for a gun or knife, new thoughts have
come crowding in.... </p>

<p>Above all other distinguishing effects of marihuana
intoxication is the fact that all normal conceptions of time and
space are lost. </p>

<p>As in the split-second dream that seems to last the night
through, time seems of interminable length; the clock stands
still for days. </p>

<p>Vision, too, takes on new concepts. Inconsiderable distances
become tremendous.... </p>

<p>Yet, throughout the intoxication, there is constant awareness
that the strange fancies rushing through the mind are not
natural, but purely the effects of the drug; unlike the
opium-cater, he is acutely conscious of those about him. He has
many of the sensations of the gay &quot;drunk&quot; at the ball. </p>

<p>Describing a pot-party: </p>

<p>There is little noise; windows are shut, keeping the smell of
smoking weeds away from what might be curious nostrils. </p>

<p>Nor is there any of the yelling, dashing about, playing of
crude jokes or physical violence that often accompany alcoholic
parties; under the effects of marihuana, one has a dread of all
these things. </p>

<p>98 Ch. 86, [1934] Va. Acts of Assembly 81. </p>

<p>99 Ch. 212, [1936] Va. Acts of Assembly 361. </p>

<p>100 Id. </p>

<p>101 Ch. 86, S 20, [1934] Va. Acts of Assembly 90. </p>

<p>102 Ch. 212,  I (c), [ 1936] Va. Acts of Assembly 362. The
penalty for violation of ch. 268, [1934] Va. Acts of Assembly
411, which prohibited the use of marijuana in the manufacture of
cigars and cigarettes, was confinement in jail for from 6 to 12
months and/or a fine of from $100 to $1000. </p>

<p>103 Ch. 186,  12, [1933] N.J. Laws 41 1. </p>

<p>104 Ch. 2096, S 14, [19341 R.I. Acts III. </p>

<p>105 Id.  15. </p>

<p>106 Ch. 142, [1934] Ky. Acts 562. </p>

<p>107 Ch. 46,  2 3, [1935] W. Va. Acts 192.<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-23</DOCNO>
<DOCOLDNO>IA031-000655-B037-297</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlr4.htm 206.61.184.43 19970122112459 text/html 44103
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:24:48 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:47:55 GMT
Content-length: 43885
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Passage of the Marihuana Tax Act of 1937</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><b>THE FORBIDDEN FRUIT AND THE TREE OF KNOWLEDGE: AN INQUIRY
INTO THE LEGAL HISTORY OF AMERICAN MARIJUANA PROHIBITION</b> </p>

<p><font size="2"><i>Richard J. Bonnie* &amp; Charles H.
Whitebread, II**</i></font> </p>

<p><b>V. PASSAGE OF THE MARIHUANA TAX ACT OF 1937</b> </p>

<hr>

<p>The first assertion of federal authority over marijuana use
was the Marihuana Tax Act, passed in 1937. The obvious question,
from a historical point of view, is why such legislation was
thought to be necessary, especially after the brushfire passage
of the Uniform Act and related legislation in every state in the
previous few years. Enforcement difficulty and public hysteria
are two reasons which have been propounded for the federal
action. We subscribe to a third, one which we rejected with
respect to the uniform acts-Congress was hoodwinked by the
Federal Bureau of Narcotics. </p>

<hr>

<p><b>A. State Enforcement of the Uniform Law</b> </p>

<p>One of the primary arguments in support of the Marihuana Tax
Act was that the legislation was required to permit and
facilitate adequate enforcement of the Uniform Narcotic Drug
Act.1 Initial examination of enforcement statistics after passage
of the Uniform Act suggests that marijuana seizures and arrests
in most states rose dramatically. </p>

<p>However, we should be careful to note at the outset the
inadequacies of most drug statistics, which, especially during
this period, do not permit conclusive analysis regarding the
extent of enforcement. </p>

<p>Reporting officials frequently do not differentiate among the
drugs. Different jurisdictions employ different measures of
enforcement-number of arrests, convictions, kilograms of the drug
seized, or number of seizures; even where the same measures are
used, statistics are often compiled for different time frames. In
addition, changes in the definitions in the laws-such as a change
from considering cannabis as only the flowering top of the plant
to considering it the whole plant-can wildly distort the
statistics from year to year. To add to the confusion,
enforcement agencies can manipulate the data for their own uses;
if they must appear to be attacking the drug problem or to need
more resources, they can change radically the statistical
appearance of the enforcement problem by using, for example,
arrests as their enforcement measure. Finally, the mere passage
of prohibitive legislation will in itself be reflected in the
enforcement data. This is especially important for our study of
enforcement patterns in the states before passage of the
Marihuana Tax Act. As one commentator has explained: </p>

<blockquote>
    <p>A point that should be obvious but that is sometimes
    overlooked is that there are no official statistics relating
    to violations of a drug, law until the drug law is enacted.
    To compare official preenactment and postenactment data is to
    compare nothing to something, and naturally drug use will
    appear to rise.2 </p>
</blockquote>

<p>For all these reasons, the drug statistics from the period of
the 1930's must be used somewhat hesitantly to support any
contention about the extent of state enforcement before the
enactment of Marihuana Tax Act. With this caveat in mind, we
shall proceed, nevertheless, to do so. </p>

<p>Although Commissioner Anslinger testified at the hearings on
the Tax Act that state officials frequently asked for federal
assistance 3 it appears from the Federal Bureau's own statistics
that state and municipal agencies were proceeding with vigor to
stamp out marijuana use.4 We do not have fully accurate data, but
there are indications that both New York and Louisiana were
moving against marijuana use. In 1934, the New York police
discovered a large field of marijuana growing near the Brooklyn
Bridge. In making a related raid, the police also seized 1,000
marijuana cigarettes.5 In 1935, the police burned a marijuana
crop found growing on the grounds of the Welfare Island
penitentiary.6 Throughout 1936, the narcotics division of the New
York police found and destroyed several marijuana crops growing
in and around the city.7 Fragmentary figures are available on law
enforcement in Louisiana which indicate there were 219 arrests on
marijuana charges in New Orleans alone from 1930 until April of
1936.8 In Louisiana as a whole for 1936 over 1,195 pounds of bulk
marijuana were seized.9 </p>

<p>This evidence suggests that state authorities in areas where
marijuana use had become common at all were dealing fairly
effectively with the trade in the drug. Although some states may
have hoped that passage of a federal law dealing with marijuana
would reduce the enforcement burden on state and local police and
bring additional federal services and money,10 the law cannot
really be justified as filling an enforcement void. Nevertheless,
this was one of the most effective arguments advanced by
Commissioner Anslinger in the halls of Congress. </p>

<hr>

<p><b>B. Public Hysteria or Continued Public Ignorance?</b> </p>

<p>Some observers have attributed passage of the Tax Act to
public hysteria.11 In support of this contention they show that
there was a marked increase in the number of titles dealing with
marijuana in the Readers' Guide to Periodical Literature from
1936 until 1939, compared with the total absence of articles on
this subject in preceding years.12 It should be noted, however,
that only seven articles treating marijuana or hashish appeared
from 1920 to August 1937, when the Tax Act was passed.13 With
respect to medical opinion, the AMA Journal presented an article
opposing the enactment of the Tax Act and arguing, as did their
representative at the Tax Act hearings, 14 that existing state
laws were sufficient if properly enforced.15 </p>

<p>It seems the national media and medical opinion were far from
hysterical at the time the Tax Act passed. There were a few local
newspaper campaigns against the drug, but they tended to peak
about two years before the passage of the Act and were isolated
instances of public support for the Uniform Narcotic Drug Act.16
Moreover, these atypical state scares did not draw national
attention. </p>

<p>In fact, whatever publicity the &quot;marijuana problem&quot;
received during this period was attributable to Commissioner
Anslinger and his office, who conducted an active educational
campaign for federal legislation. They prepared press stories on
the dangers of the drug and traveled around the country
disseminating propaganda.17 Despite these efforts, however,
public knowledge of the marijuana proposals was minimal at best.
The New York Times contained nine references to marijuana from
January 1936 until it reported on August 3, 1937,18
&quot;President Roosevelt signed today a bill to curb traffic in
the narcotic, marihuana, through heavy taxes on
transactions.&quot; </p>

<p>As in prior years, marijuana was still not a matter of public
attention, and the so-called &quot;problem&quot; and the federal
proposal to cure it went virtually unnoticed by most of the
American public. At the same time, however, the
&quot;educational&quot; campaign conducted by the Bureau to
inform the Congress of the dimensions of the &quot;problem&quot;
was highly successful. In this sense, the Bureau itself created
the &quot;felt need&quot; for federal legislation; the Bureau-and
not public hysteria which it was unable to arouse-was the major
force behind the Tax Act. We assign to the Bureau the
instrumental role with respect to passage of the Tax Act even
though we did not do so with respect to the Uniform Act. So
successful were the Commissioner's efforts in the Congress that
the hearings before the House Ways and Means Committee and the
floor debate on the bill are near comic examples of dereliction
of legislative responsibility. </p>

<hr>

<p><b>C. The Tax Act Hearings</b> </p>

<hr>

<p><b>Note from Cliff Schaffer:</b> Interested readers may refer
to the full text of the hearings for the <a
href="../../../hemp/taxact/taxact.htm">Marihuana Tax Act</a>, and
related documents, also on this site. </p>

<hr>

<p>Although the Marihuana Tax Act was modeled after the Harrison
Act, marijuana was not simply included in the earlier act
primarily for three reasons. First, the importation focus of the
Harrison Act was inappropriate for marijuana because there were
domestic producers.20 </p>

<p>Second, since cannabis had been removed from the United States
Pharmacopoeia and had no recognized medicinal uses, the variety
of medical exceptions in the Harrison Act were inapplicable.21
Third, even though the Supreme Court had upheld the Harrison
Act's prohibition against purchase by unregistered persons of the
designated drugs, there was some uncertainty whether the earlier
5-4 decision22 would be followed. Accordingly, the Marihuana Tax
Act imposed a prohibitive tax of $100 an ounce on the designated
transactions, rather than prohibit the purchases directly.23 </p>

<p>The brief three days of hearings on the Act24 present a case
study in legislative carelessness. At no time was any primary
empirical evidence presented about the effects of the drug, and
the participating congressmen seem never to have questioned the
assumed evils. Furthermore, the only real concerns seem to have
been that farmers would be inconvenienced by having to kill a
plant which grew wild in many parts of the country, and that the
birdseed, paint and varnish, and domestic hemp industries would
be damaged by passage of the law.25 Finally, the one witness
appearing in opposition to the bill, Dr. William C. Woodward,
legislative counsel of the American Medical Association and an
early and respected participant in the drafting of the Uniform
Narcotic Drug Act,26 was roundly insulted for his audacity in
daring to question the wisdom of the Act. </p>

<p>We reproduce in the following few pages some of the dialogue
from the hearings, to give the reader the flavor of these
ramshackle proceedings, and to allow him to understand more fully
the pyramiding of absurdity represented by the amendments of the
1950's. From the hearings we extract contemporary perception of
use patterns and harmful effects of marijuana, the quality of
medical and other evidence presented, and a short glimpse at how
the witnesses were treated by the committee. </p>

<p><b>1. Who Were Users?</b> </p>

<p>The record of the hearings indicates quite clearly that the
Federal Narcotics Bureau was anxious for the committeemen to
believe marijuana use was a relatively new phenomenon that was on
the increase in America.27 Once again, marijuana use and the
Mexican minority were closely linked: &quot;The Mexican laborers
have brought seeds of this plant into Montana and it is fast
becoming a terrible menace, particularly in the counties where
sugarbeets are grown.&quot;28 Again, also, marijuana was
presented as the agent by which the underworld class hoped to
enslave American youth.29 The youth of the marijuana users was
contrasted with the increasing age of the usual opiate addict.
Perhaps most interestingly for later developments, Commissioner
Anslinger succinctly noted that heroin addicts and marijuana
users came from totally different classes and that the use of one
drug was unrelated to use of the other: </p>

<blockquote>
    <p><b>Mr. Anslinger.</b> This drug is not being used by those
    who have been using heroin and morphine. It is being used by
    a different class, by a much younger group of people. The age
    of the morphine and heroin addict is increasing all the time,
    whereas the marihuana smoker is quite young. </p>
</blockquote>

<blockquote>
    <p><b>Mr. Dingell. </b>I am just wondering whether the
    marihuana addict graduates into a heroin, an opium or cocaine
    user. </p>
</blockquote>

<blockquote>
    <p><b>Mr. Anslinger.</b> No sir; I have not heard of a case
    of that kind. I think it is an entirely different class. The
    marihuana addict does not go in that direction30 </p>
</blockquote>

<p>The hearings shed no more light on who was using the drug and
in what numbers. </p>

<hr>

<p><b>2. What's Wrong with Marijuana?</b> </p>

<p>If the proceedings did not shed light on the patterns of
usage, this in no way was an obstacle to unanimity on the evils
of the drug-insanity, criminality and death. Three major sources
were relied on to support this consensus (1) a variety of horror
stories from newspapers cited by Mr. Anslinger and others about
atrocious criminal acts committed by individuals under the
influence of the drug;31 (2) studies by Eugene Stanley, the
District Attorney of New Orleans, linking the drug and the
population of the Louisiana jails;32 and (3) some inconclusive
experimentation on dogs.33 As we noted earlier, the newspaper
stories about crimes committed under the influence of marijuana
have two things in common: The reports are unsubstantiated, and
many of the accused invoked their use of marijuana as a defense
to the charge .34 </p>

<p>The New Orleans report concluded: &quot;After an exhaustive
research on marijuana from its earliest history to the present
time, this drug is in our judgment the one that must be
eliminated entirely.&quot; 35 What was this exhaustive research?
It appears to have been nothing but quotations from the most
hysterical series of newspaper articles to appear at that time36
and reports of the number of marijuana addicts to be found in the
prison population.37 The relation of these figures to the
conclusion that the drug must be regulated was never established.
</p>

<p>The Stanley study38 was even less well documented and even
more outrageous in its description of the effects of marijuana
use. &quot;It is an ideal drug to quickly cut off
inhibitions.&quot; 39 For this proposition Stanley relied on the
story of the Persian &quot;Assassins&quot; who allegedly
committed acts of terror while under the influence of hashish.
Although Stanley included in his list of references the Indian
Hemp Drugs Commission Report, it is clear he made little effort
to catalogue the then available data but contented himself with a
number of bold and undocumented assertions. In reading the
hearings, one continues to expect some report of a medical or
scientific survey, and instead one finds these two reports by New
Orleans law enforcers. The contrary conclusions of the Canal Zone
studies were not even mentioned. </p>

<p>Finally, a scientific study of the effects of marijuana was
presented, but, in keeping with the overall tone of the hearings,
this was the most preposterous evidence of all. The Treasury
Department presented a pharmacologist who had tested the effects
of the cannabis drugs on dogs. 40 He concluded that
&quot;[c]ontinuous use will tend to cause the degeneration of one
part of the brain.&quot; 41. </p>

<p>One paragraph later, however, this scientist stated:
&quot;Only about 1 dog in 300 is very sensitive to the
test.&quot;42 Later in the doctor's testimony, after he had
stated over and over the potential evils found from the testing
on dogs, he was unable to make the crucial link between a dog's
response to the drug and the human response. More incredibly, as
the following exchange points out, the doctor really had no
knowledge of what effect the drug had on the dogs, since he was
not familiar with the psychology of dogs: </p>

<blockquote>
    <p><b>Mr. McCormack</b>. Have you experimented upon any
    animals whose reaction to this drug would be similar to that
    of human beings. </p>
</blockquote>

<blockquote>
    <p><b>Dr. Munch.</b> The reason we use dogs is because the
    reaction of dogs to this drug, closely resembles the reaction
    of human beings. </p>
</blockquote>

<blockquote>
    <p><b>Mr. McCormack. </b>And the continued use of it, as you
    have observed the reaction on dogs, has resulted in the
    disintegration of the personality? </p>
</blockquote>

<blockquote>
    <p><b>Dr. Munch.</b> Yes. So far as I can tell, not being a
    dog psychologist .... 43 </p>
</blockquote>

<p>Dr. Woodward, the sole witness representing the American
Medical Association, noted the inadequacy of these medical
statistics. We include his statement on that point in full: </p>

<blockquote>
    <p>That there is a certain amount of narcotic addiction of an
    objectionable character no one will deny. The newspapers have
    called attention to it so prominently that there must be some
    grounds for their statements. It has surprised me, however,
    that the facts on which these statements have been based have
    not been brought before this committee by competent primary
    evidence. We arc referred to newspaper publications
    concerning the prevalence of marihuana addiction. We are told
    that the use of marihuana causes crime. </p>
</blockquote>

<blockquote>
    <p>But yet no one has been produced from the Bureau of
    Prisons to show the number of prisoners who have been found
    addicted to the marihuana habit. An informal inquiry shows
    that the Bureau of Prisons has no evidence on that point. </p>
</blockquote>

<blockquote>
    <p>You have been told that school children are great users of
    marihuana cigarettes. No one has been summoned from the
    Children's Bureau to show the nature and extent of the habit,
    among children. </p>
</blockquote>

<blockquote>
    <p>Inquiry of the Children's Bureau shows that they have had
    no occasion to investigate it and know nothing particularly
    of it. </p>
</blockquote>

<blockquote>
    <p>Inquiry of the Office of Education-and they certainly
    should know something of the prevalence of the habit among
    the school children of the country, if there is a prevalent
    habit-indicates that they have had no occasion to investigate
    and know nothing of it. </p>
</blockquote>

<blockquote>
    <p>Moreover, there is in the Treasury Department itself, the
    Public Health Service, with its Division of Mental Hygiene.
    The Division of Mental Hygiene was, in the first place, the
    Division of Narcotics. It was converted into the Division of
    Mental Hygiene, I think, about 1930. That particular Bureau
    has control at the present time of the narcotics farms that
    were created about 1929 or 1930 and came into operation a few
    years later. No one his been summoned from that Bureau to
    give evidence on that point. </p>
</blockquote>

<blockquote>
    <p>Informal inquiry by me indicates that they have had no
    record of any marihuana or Cannabis addicts who have even
    been committed to those farms. </p>
</blockquote>

<blockquote>
    <p>The Bureau of the Public Health Service has also a
    division of pharmacology. If you desire evidence as to the
    pharmacology, of Cannabis, that obviously is the place where
    you can get direct and primary evidence, rather than the
    indirect hearsay evidence. 44 </p>
</blockquote>

<p>Dr. Woodward's testimony clearly manifests the deficiencies of
the hearings, for at no time did the congressional committee hear
primary sources of competent medical evidence before labeling
cannabis the producer of crime and insanity. </p>

<hr>

<p><b>3. How Dare You Dissent!</b> </p>

<p>Following the testimony of the Treasury Department and its
witnesses, the only witnesses who came forward were
representatives of legitimate industries that feared the Tax Act
would damage their businesses, because manufacture of their
products required some part or parts of the cannabis plant.45
These witnesses were assured that the Tax Act would have little
if any impact on their operations .46 </p>

<p>The one witness who opposed the adoption of the Act was
roundly accused of obstructionism and bad faith. Dr. Woodward,
one of the chief drafters of the Uniform Narcotic Drug Act,
appeared on behalf of the AMA to suggest that, if there was to be
any regulation of the cannabis drugs at all, it should be added
to the Harrison Act and not be the subject of this separate, and
he felt inadequately considered, legislative proposal.47 We have
already examined Dr. Woodward's skepticism on the dangers of the
drug. He added to this a thinly veiled attack on the lack of
cooperation the AMA had received from the Federal Bureau of
Narcotics.48 Finally, he advocated either assisting state
enforcement of their existing laws dealing with the drug or at
most including marijuana as a regulated and taxed drug under the
Harrison Act. </p>

<p>Either because of antipathy to the AMA or because of the
audacity of these suggestions, the Committee members savagely
attacked both Dr. Woodward and the AMA. Witness the following
exchange, starting with the doctor's answer to questions why, he
had not proposed marijuana legislation </p>

<blockquote>
    <p><b>Dr. Woodward. </b>In the first place, it is not a
    medical addiction that is involved and the data do not come
    before the medical society. You may absolutely forbid the use
    of Cannabis by any physician, or the disposition of Cannabis
    by any pharmacist in the country, and you would not have
    touched your Cannabis addiction as it stands today, because
    there is no relation between it and the practice of medicine
    or pharmacy. It is entirely outside of the those two
    branches. </p>
</blockquote>

<blockquote>
    <p><b>The Chairman.</b> If the statement that you have made
    has any relation to the question that I asked, I just do not
    have the mind to understand it; I am sorry. </p>
</blockquote>

<blockquote>
    <p><b>Dr. Woodward.</b> I say that we do not ordinarily come
    directly to Congress if a department can take care of the
    matter. I have talked with the Commissioner, with
    Commissioner Anslinger. </p>
</blockquote>

<blockquote>
    <p><b>The Chairman. </b>If you want to advise us on
    legislation, you ought to come here with some constructive
    proposals, rather than criticism, rather than trying to throw
    obstacles in the way of something that the Federal Government
    is trying to do. It has not only an unselfish motive in this,
    but the), have a serious responsibility. </p>
</blockquote>

<blockquote>
    <p><b>Dr. Woodward. </b>We cannot understand yet, Mr.
    Chairman, why this bill should have been prepared in secret
    for 2 years without any intimation, even, to the profession,
    that it was being prepared .49 </p>
</blockquote>

<p>After accusing Dr. Woodward of obstruction, evasion and bad
faith, the Committee did not even thank him for his testimony.50 </p>

<hr>

<p><b>D. Congressional &quot;Deliberation&quot; and Action</b> </p>

<p>We noted earlier that the marijuana &quot;problem&quot; and
the proposed federal cure were virtually unnoticed by the general
public. Unable to arouse public opinion through its educational
campaign, the Bureau of Narcotics nevertheless pushed the
proposed legislation through congressional committees. The
Committee members were convinced by meaningless evidence that
federal action was urgently needed to suppress a problem that was
no greater and probably less severe than it had been in the
preceding six years when every state had passed legislation to
suppress it. The Committee was also convinced, incorrectly, that
the public was aware of the evil and demanded federal action. </p>

<p>The debate on the floor of Congress shows both the low public
visibility of the legislation and the nonchalance of the
legislators. The bill passed the House of Representatives in the
very late afternoon of a long session; many of the members were
acquainted neither with marijuana nor with the purpose of the
Act. When the bill first came to the House floor late on June 10,
1937, one congressman objected to considering the bill at such a
late hour, whereupon the following colloquy occurred: </p>

<blockquote>
    <p><b>Mr. DOUGHTON. </b>I ask unanimous consent for the
    present consideration of the bill (H.R. 6906) to impose an
    occupational excise tax upon certain dealers in marihuana, to
    impose a transfer tax upon certain dealings in marihuana, and
    to safeguard the revenue therefrom by registry and recording.
    </p>
</blockquote>

<blockquote>
    <p>The Clerk read the title of the bill. </p>
</blockquote>

<blockquote>
    <p><b>Mr. SNELL.</b> Mr. Speaker, reserving the right to
    object, and notwithstanding the fact that my friend, Reed, is
    in favor of it, is this a matter we should bring up at this
    late hour of the afternoon? I do not know anything about the
    bill. It may be all right and it may be that everyone is for
    it, but as a general principle, I am against bringing up any
    important legislation, and I suppose this is important, since
    it comes from the Ways and Means Committee, at this late hour
    of the day.<br>
    </p>
</blockquote>

<blockquote>
    <p><b>Mr. RAYBURN.</b> Mr. Speaker, if the gentleman will
    yield, I may say that the gentleman from North Carolina has
    stated to me that this bill has a unanimous report from the
    committee and that there is no controversy about it. </p>
</blockquote>

<blockquote>
    <p><b>Mr. SNELL. </b>What is the bill? </p>
</blockquote>

<blockquote>
    <p><b>Mr. RAYBURN</b>. It has something to do with something
    that is called marihuana. I believe it is a narcotic of some
    kind. </p>
</blockquote>

<blockquote>
    <p><b>Mr. FRED M. VINSON. </b>Marihuana is the same as
    hashish. </p>
</blockquote>

<blockquote>
    <p><b>Mr. SNELL.</b> Mr. Speaker, I am not going to object
    but I think, it is wrong to consider legislation of this
    character at this time of night.51 </p>
</blockquote>

<p>On June 14 when the bill finally emerged on the House floor,
four representatives in one way or another asked that the
proponents explain the provisions of the Act. Instead of a
detailed analysis, they received a statement of one of the
members of the Ways and Means Committee repeating uncritically
the lurid criminal acts Anslinger had attributed to marijuana
users at the hearings. After less than two pages of debate. the
Act passed without a roll call.52 When the bill returned as
amended from the Senate, the House considered it once again, and
adopted as quickly as possible the Senate suggestions, which were
all minor.53 The only question was whether the AMA agreed with
the bill. Mr. Fred Vinson not only said they did not object when
in fact their committee witness had dissented strenuously, but he
also claimed that the bill had AMA support. After turning Dr.
Woodward's testimony on its head, he also called him by another
name, Wharton.54 </p>

<p>In summary, the Act passed the Congress with little debate and
even less public attention. Provoked almost entirely by the
Federal Bureau of Narcotics and by a few hysterical state law
enforcement agents hoping to get federal support for their
activities, the law was tied neither to scientific study nor to
enforcement need. The Marihuana Tax Act was hastily drawn, heard,
debated and passed; it was the paradigm of the uncontroversial
law. </p>

<hr>

<p><b>E. Provisions of the Act</b> </p>

<p>Except for the three differences noted above, the Marihuana
Tax Act is modeled directly after the earlier federal tax act
regulating the opiates -the Harrison Act. As with that Act, the
enforcement of the new marijuana tax was left to the Bureau of
Narcotics in the Treasury Department. Thus, as a result of the
1937 statute, the jurisdiction of the Bureau was increased
substantially.55 </p>

<p>The Marihuana Tax Act deals specifically with the seeds, resin
and most other parts and derivatives of the plant Cannabis Sativa
L. The Act requires persons importing, producing,56 selling or in
any other way dealing with the drug to pay an occupational tax
and to register with the Internal Revenue Service. In addition,
all transferees of marijuana are required to file a written order
form and to pay a transfer tax, $1 per ounce if registered and a
prohibitive $100 per ounce if not registered . 57 Possession of
the drug without a written order form constitutes presumptive
evidence of noncompliance with the Act. It is also unlawful for a
transferor to transfer the drug to a person who has not secured
the order form and paid the tax. As originally enacted, section
12 of the Act assessed a fine of not more than $2,000 and/or
imprisonment for not more than five years for violation of each
provision of the Act.<br>
</p>

<hr>

<h2>Footnotes and References </h2>

<p>1 The best example of this argument is contained in
Commissioner Anslinger's statement to the congressional committee
hearings on the Marihuana Tax Act: </p>

<p align="center"><b>STATE LAWS</b> </p>

<p>All of the States now have some type of legislation directed
against the traffic in marijuana for improper purposes. There is
no legislation in effect with respect to the District of Columbia
dealing with marijuana traffic. There is unfortunately a loophole
in much of this State legislation because of a too narrow
definition of this term. Few of the States have a special
narcotic law enforcement agency and, speaking generally,
considerable training of the regular peace officers will be
required together with increased enforcement facilities before a
reasonable measure of effectiveness under the State laws can be
achieved. </p>

<p align="center"><b>NEED FOR FEDERAL LEGISLATION</b> </p>

<p>Even in States which have legislation controlling in some
degree the marijuana traffic, public officials, private citizens,
and the press have urged or suggested the need for national
legislation dealing with this important problem. A partial list
of States wherein officials or the press have urged the need for
Federal legislation on the subject are Colorado, Kansas, New
Mexico, Louisiana, and Oklahoma. </p>

<p>The uniform State narcotic law has now been adopted by some 35
States, many of these including cannabis or marijuana within the
scope of control by that law. However, it has recently been
learned that the legislative definition of cannabis in most of
these laws is too narrow, and it will be necessary to have the
definition amplified in amendatory legislation in most of the
States, to accord with the definition in the pending Federal
bill. As is the case at present with respect to opium, coca
leaves, and their respective alkaloids, the uniform State law
does not completely solve the enforcement problem with respect to
marijuana but it will provide the necessary supplement to the
Federal act and permit cooperation of State and Federal forces,
each acting within its respective sphere, toward suppression of
traffic for abusive use, no matter in what form the traffic is
conducted. The Bureau of Narcotics, under the Marijuana Taxing
Act, would continue to act as an informal coordinating agency in
the enforcement of the Uniform State law, exchanging information
as between the respective State authorities in the methods of
procedure and attempting to secure true uniformity in the
enforcement of the act in the various States which have adopted
it. </p>

<p><i>Tax Act Hearings 31.<br>
</i></p>

<p>2 Mandel, Problems with Official Drug Statistics, 21 STAN. L.
REV. 991, 1002 (1969). This article is the most complete
discussion of the present inadequacies of all official drug
statistics. </p>

<p>3 Tax Act Hearings 26-27. </p>

<p>4 The FBN statistics for 1935 through 1937 on quantities (in
pounds) of harvested marijuana seized by state and municipal
authorities in the major states are as follows:<br>
</p>

<table border="2">
    <tr>
        <td width="148"></td>
        <td width="148">1935</td>
        <td width="148">1936 </td>
        <td width="148">1937</td>
    </tr>
    <tr>
        <td width="148">Louisiana</td>
        <td width="148">20</td>
        <td width="148">1,196 </td>
        <td width="148">30</td>
    </tr>
    <tr>
        <td width="148">Mississippi</td>
        <td width="148">5</td>
        <td width="148">1,309 </td>
        <td width="148">*</td>
    </tr>
    <tr>
        <td width="148">New York</td>
        <td width="148">372,000</td>
        <td width="148">1 </td>
        <td width="148">*</td>
    </tr>
    <tr>
        <td width="148">Ohio</td>
        <td width="148">17,314</td>
        <td width="148">431 </td>
        <td width="148">86</td>
    </tr>
    <tr>
        <td width="148">Texas</td>
        <td width="148">216</td>
        <td width="148">463 </td>
        <td width="148">20</td>
    </tr>
    <tr>
        <td width="148">All other states</td>
        <td width="148">2,232</td>
        <td width="148">1,972</td>
        <td width="148">120</td>
    </tr>
    <tr>
        <td width="148">TOTALS</td>
        <td width="148">391,787</td>
        <td width="148">5,372 </td>
        <td width="148">256</td>
    </tr>
</table>

<p>BUREAU OF NARCOTICS, U.S. TREASURY DEP'T, TRAFFIC IN OPIUM AND
OTHER DANGEROUS DRUGS 63 (1935) [hereinafter cited as TRAFFIC IN
Opium]; id. at 90 (1936); id. at 81 (1937); Part of the erratic
quality of these figures may stem from failure to weigh only the
dried flowering tops of the plants seized. For example, 256
pounds seized in 1937 may represent a larger quantity of total
plants than 391,787 pounds seized in 1935. See Mandel, supra note
2, at 999.<br>
</p>

<p>5 N.Y. Times, Oct. 18, 1934, at 4, col. 4. The article goes on
to refer to &quot;mariajuana [sic], or loco weed, which produces
a pleasant, relaxed sensation when smoked, and eventually drives
the habitual user insane </p>

<p>6 Id., July 17, 1935, at 8, Col. 8. </p>

<p>7 See id., Aug. 19, 1936, at 16, col. 3; id., July 28, 1936,
at 11, col. 6. </p>

<p>8 See Tax Act Hearings 3 S. </p>

<p>9 TRAFFIC IN OPIUM 90 (1936). </p>

<p>10 See Tax Act Hearings 26. </p>

<p>11 See, eg., THE MARIHUANA PAPERS at xv (D. Solomon ed. 1966).
See also H. BECKER, OUTSIDERS 140-42 (1963). </p>

<p>12 Becker's survey of marijuana-related articles in the
Readers' Guide to Periodical Literature between January 1925 and
March 1951 indicates no articles written before July 1935, four
articles written between July 1935 and June 1937, and seventeen
written between July 1937 and June 1939. H. BECKER, OUTSIDERS 141
(1963). </p>

<p>13 The Readers' Guide citations are: Anslinger &amp; Cooper,
Marihuana: Assassin of Youth, Am. MAGAZINE, July 1937, at 18;
Parry, Menace: Marihuana, 36 Am. MERCURY 487 (1935); Simon, From
Opium to Hash Eesh, Sci. Am., Nov. 1921, at 14; Wolf, Uncle Sam
Fights a New Drug Menace, POPULAR SCI, May 1936, at 14; Facts and
Fancies About Marihuana, LITERARY DIGEST, Oct. 24, 1936, at 7;
Marihuana Menaces Youth, Sci. Am., Mar. 1936, at 150; Our Home
Hasheesh, Crop, LITERARY DiGEST, .Apr. 3, 1926, at 64. </p>

<p>14 See text at notes 47-50 infra. </p>

<p>15 108 JA.M.A. 1543-44 (1937). </p>

<p>16 See St. Louis Star-Times, Jan. 17-Feb. 19, 1935. </p>

<p>17 See, e.g., N.Y. Times, Jan. 3, 1937, S 6, at 6, col. 4. The
article reported a meeting between Anslinger and the chairwoman
of the New York Federation of Women's Clubs. After the meeting,
the chairwoman started an all out campaign against marijuana,
focusing on lobbying for the nationwide passage of state
legislation, and on an educational program aimed at educating
high school students on the dangers of the drug, Another New York
Times article described the appearance of a representative of the
Federal Bureau of Narcotics at a meeting of the national Parents
and Teachers Association held in Richmond, Virginia, urging the
members of the association to help fight the menace of marijuana
which produced in its users &quot;a temporary sense of complete
irresponsibility which led to sex crimes and other 'horrible'
acts of violence.&quot; N.Y. Times, May 4, 1937, at 26, col. 1. </p>

<p>18 Id., July 24, 1936, at 6, col. 3; id., July 29, 1936, at
II, col. 6; id., Aug. 14, 1936. at 12, co]. 3; id., Aug. 19,
1936, at 16, col. 3; id., Oct. 4, 1936, S 1, at 3, col. 3; id.,
Oct. 28, 1936, at 27, col, 6; id., Jan. 3, 1937,  6, at 6, col.
4; id., Mar. 22, 1937, at 24, col. 1; id., May 4, 1937, at 26,
col. 1. </p>

<p>19 Id., Aug. 3, 1937, at 4, col. 5.<br>
</p>

<p>20 Compare Tax Act Hearings 13-14 (testimony of Clinton
Hester, Office of the General Counsel of the Treasury Department)
with State v. Bonoa, 172 La. 955, 136 So. 15 (1931). It should be
asked whether the information at congressional disposal changed
so drastically between 1937 and 1956 as to justify the statutory
presumption enacted at that time, 21 U.S.C. 5 176a (1964),
providing that possession of marijuana was presumptive evidence
of knowing concealment of illegally imported marijuana. </p>

<p>21 Tax Act Hearings 13-14. Earlier state statutes,
particularly Virginia's, had taken great pains to outline medical
exemptions from the marijuana prohibition. See p. 1040 supra. </p>

<p>22 United States v. Doremus, 249 U.S. 86 (1919). </p>

<p>23 Tax Act Hearings 13-14. </p>

<p>24 The hearings, including all material not actively discussed
but merely read into the record, cover only 124 pages. </p>

<p>25 Tax Act Hearings 77-86; see State v. Bonoa, 172 La. 955,
136 So. 15 (1931). </p>

<p>26 See pp. 1030-32 supra. </p>

<p>27 See Tax Act Hearings 30-3 1. </p>

<p>28 Id. at 45. </p>

<p>29 Quoting Dr. Walter Bromberg, Mr. Anslinger stated: </p>

<p>Young men between the ages of 16 and 25 are frequent smokers
of marihuana; even boys of 10 to 14 are initiated (frequently in
school groups); to them as to others, marihuana holds out the
thrill. Since the economic depression the number of marihuana
smokers was increased by vagrant youths coming into intimate
contact with older psychopaths. </p>

<p>Tax Act Hearings 24. See also id. at 32-35, 39, 45. </p>

<p>30 Id. at 24. </p>

<p>31 Id. at 22-23. </p>

<p>32 Id. at 32-37. </p>

<p>33 Id. at 50-52. </p>

<p>34 See id. at 22-23. It is entirely likely that some of these
particularly lurid stores were the product of desperate
defendants, who, upon being caught red-handed in the commission
of crime, sought mitigation of their penalties by claiming to be
under the influence of the drug. See Bromberg, Marijuana: A
Psychiatric Study, 113 J.A.M.A. 4 (1939). Bromberg cautions,
&quot;The extravagant claims of defense attorneys and the press
that crime is caused by addiction to marihuana demands [sic]
careful scrutiny, at least in this jurisdiction [New York
County).&quot; Id. at 10. </p>

<p>35 Tax Act Hearings 35. </p>

<p>36 A good example is the series run by the St, Louis
Star-Times in early 1935 which featured such articles as the one
entitled &quot;Young Slaves to Dope Cigaret Pay Tragic Price for
Their Folly&quot; on Jan. 18, 1935. </p>

<p>37 See Gomila &amp; Gomila, Marihuana-A More Alarming Menace
to Society Than All Other Habit-Forming Drugs, quoted in Tax Act
Hearings 32, 34. Mr. F. R. Gomila was public safety director of
New Orleans. </p>

<p>38 Stanley, Marihuana as a Developer of Criminals, 2 Am. J.
Police Sci. 252 (1931), quoted in Tax Act Hearings 37-42, is
based on, and indeed is nearly a word-for-word paraphrase of,
Fossier's article in the New Orleans Medical journal, supra note
91 at P. 1044. As we have seen, Fossier, in reaching his
conclusions, overlooked the Panama Canal Zone study. </p>

<p>39 Tax Act Hearings 39. </p>

<p>40 0ne assumes the drug was thought to be too dangerous to
risk experimentation on people. </p>

<p>41 Tax Act Hearings 48. </p>

<p>42 Id. </p>

<p>43 Id. at 51. </p>

<p>44 Id. at 92. </p>

<p>45 Thus, the following witnesses appeared: Hon. Ralph E.
Lozier, General Counsel of the National Institute of Oilseed
Products; Raymond G. Scarlett of the birdseed industry; and
Joseph B. Hertzfeld, Manager, Feed Department, The Philadelphia
Seed Co. </p>

<p>46 See id. at 74. </p>

<p>47 Id. at 87-121. </p>

<p>48 Id. at 87-88 (&quot;During the past 2 years I have visited
the Bureau of Narcotics probably 10 or more times. Unfortunately,
I had no knowledge that such a bill as this was proposed until
after it had been introduced&quot;). </p>

<p>49 Id. at 116. </p>

<p>50 See id. at 121. There is sonic indication in Fred Vinson's
questioning of Dr. Woodward that one cause of the hostility
directed at the witness was the growing disfavor with which the
New Deal Congress viewed the fairly conservative AMA. Vinson was
particularly pointed when he said that the AMA was trying to
obstruct here as it had with the Health Care provisions of the
Social Security Act, Id. it 102-04. </p>

<p>51 81 CONG. REC. 5575 (1937). </p>

<p>52 Id. at 5689-92. </p>

<p>53 Id. at 7624-25. </p>

<p>54 Id. at 7625. </p>

<p>55 See Dickson, Bureaucracy and Morality: An Organizational
Perspective an a Moral Crusade, 16 SOCIAL PROD. 143 (1968)
(relating this expansion of the Bureau's area of enforcement to
their solid support for the need of such federal legislation). </p>

<p>56 Section 4 (b) of the Act (now INT. REV. CODE Of 1954, 
4755 (a) (2) ) gives rise to a presumption that one is a producer
of marijuana within the terms of the Act if marijuana is found
growing on his property. </p>

<p>57 The Act does not prohibit possession or purchase of
marijuana per se.<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-24</DOCNO>
<DOCOLDNO>IA031-000655-B038-25</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlr5.htm 206.61.184.43 19970122112510 text/html 62411
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:25:01 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:47:45 GMT
Content-length: 62193
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>A New Rationale - The &quot;Stepping Stone&quot; Theory</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><b>THE FORBIDDEN FRUIT AND THE TREE OF KNOWLEDGE: AN INQUIRY
INTO THE LEGAL HISTORY OF AMERICAN MARIJUANA PROHIBITION</b> </p>

<p><font size="2"><i>Richard J. Bonnie &amp; Charles H.
Whitebread, II</i></font> </p>

<p><b>VI. THE 1950's: HARSHER PENALTIES AND A NEW RATIONALE-THE
&quot;STEPPING STONE&quot; THEORY</b> </p>

<hr>

<p>&nbsp;</p>

<p>The 1950's witnessed the advent of an extremist legislative
policy with respect to drugs generally and marijuana in
particular. For the first time in our national history, there was
public interest in narcotic drugs. Apparently there had been an
increase in narcotic drug abuse in the late 40's, and the public
mind was ripe for the FBN propaganda. In the paranoid atmosphere
of the times, the call for harsher penalties was soothing.
Unfortunately, marijuana was caught in the turbulence of this
era. Although the pharmacological facts about the drug were
beginning to emerge, congressional furor was aroused by the novel
assertion, rejected by Commissioner Anslinger in 1937, that use
of marijuana led to use of harder drugs. This new plateau of
misinformation was to provide the base for continual escalation
of penalties and proliferation of offenses throughout the decade.
</p>

<hr>

<p><b>A. The Boggs Act and Its Progeny: The First Escalation</b> </p>

<p>In 1951 Congress passed the next major piece of federal
narcotics legislation-the Boggs Act .2 The importance of this
legislation is that provided much harsher penalties for all drug
violators. Also, for the first time on the federal level,
marijuana and other narcotics were lumped together as a result of
the Act's provision for uniform penalties for violators of either
the Narcotic Drugs Import and Export Act3 or the Marihuana Tax
Act.4 This indiscriminate treatment of marijuana as just another
narcotic drug flew in the face of contemporary testimony
challenging the assumption that the hemp drugs were addictive,
crime-producing, and likely to lead to insanity and death. New
testimony that marijuana was unlikely to be addictive was buried
under the new rationale for harsh penalties against offenders of
the marijuana laws-that the drug inevitably is the stepping stone
to heroin addiction. Eventually, the states followed the federal
lead in striking out against drug violators with the same
mindless fervor that characterized their anti-communist
campaigns. </p>

<hr>

<p><b>1. The Problem: Increased Narcotics Use</b> </p>

<p>The hearings before the Subcommittee of the House Ways and
Means Committee and the floor debate show that the primary reason
for passage of the Boggs Act was the increase in narcotic use in
the period 1948-1951. Testimony and evidence from a wide variety
of sources indicated an abrupt and substantial increase in
addiction, especially among teenagers, between 1947 and 1951.5
Young people under 21 who had rarely been addicts suddenly became
a predominant group involved in addiction and narcotics crimes.6
Representative Boggs, speaking during the congressional debates
on his bill, enunciated a concern which was reflected in many
other quarters. After noting that there had been a 24 percent
increase in arrests for narcotics violations between 1949 and
1950 and a 77 percent increase between 1948 and 1950,
Representative Boggs stated: </p>

<blockquote>
    <p>The most shocking part about these figures is the fact
    that there has been an alarming increase in drug addiction
    among younger persons. In the first- 6 months of 1946, the
    average age of addicted persons committed . . . at Lexington,
    Ky. was 37.5 years. Only 3 patients were under the age of 21.
    During the first 6 months of 1950, only 4 years later, the
    average had dropped to 26.7 years, and 766 patients were
    under the age of 21.... [I]n New York City alone it has been
    estimated that 1 out of every 200 teenagers is now addicted
    to some type of narcotics.7 </p>
</blockquote>

<p>Later he said, &quot;We need only to recall what we have read
in the papers in the past week to realize that more and more
younger people are falling into the clutches of unscrupulous dope
peddlers . . . .&quot; 8 </p>

<p>Representative Boggs then proceeded to insert in the record
eleven newspaper and magazine articles dated between May 2 and
July 16, 1951.9 The Washington Evening Star of July 16 (the day
of the debate) carried a story on the results of a mayor's
committee report on drug addiction in New York City. According to
the newspaper, &quot;between 45,000 and 90,000 persons in New
York City are using illicit dope.... Based on the city's
population of 7,835,099, that would be 1 out of every 87 or 1 out
of 174 persons.&quot; The paper indicated that the report showed
an increase in addiction among teenagers, and it called for
&quot;more severe penalties for dope sellers, and for wholesale
revisions of Federal and State penal statutes relating to
sale.&quot; </p>

<p>An article in Time magazine of June 25, 1951, inserted by Mr.
Boggs, related New York City School Superintendent William
Jansen's statement that one out of every 200 high school students
in the city was a user of habit forming drugs. The article went
on to describe the alarming increases in dope consumption&quot;
in other major cities and the ease with which school children
obtained narcotics. Another article, in the Washington Evening
Star of June 12, 1951, contained statements by a member of the
staff of the Attorney General of New York to the effect that
between 5,000 and 15,000 of New York City's 300,000 high school
students were drug addicts. To supplement the stock figures,
these articles included the testimony of witnesses who described
their own acts of prostitution and thievery, the loss of
educational opportunities, the death of addicts from &quot;hot
shots,&quot; the horrors of withdrawal, and a wide variety of
other aspects of drug abuse. </p>

<p>This evidence of increasing use of narcotics, especially among
the young, and the fear that narcotics use would continue to
spread, presented a problem that Congress felt needed a quick and
effective solution. </p>

<hr>

<p><b>2. The Solution: Harsher Penalties</b> </p>

<p>In the same way that the congressional hearings,
investigations and debates reflect the impetus for enactment of
the Boggs Act, they also reveal the official and public consensus
as to the solution-harsher penalties. Perhaps Commissioner
Anslinger best described the prevailing climate when he stated: </p>

<blockquote>
    <p>Short sentences do not deter. In districts where we get
    good sentences the traffic does not flourish.... </p>
</blockquote>

<blockquote>
    <p>There should be a minimum sentence for the second offense.
    The commercialized transaction, the peddler, the smuggler,
    those who traffic in narcotics, on the second offense if
    there were a minimum sentence of 5 years without probation or
    parole, I think it would just about dry up the traffic.10 </p>
</blockquote>

<p>This statement before the Committee was quoted by
Representative Boggs during the congressional debate on his bill,
along with the Kefauver Committee's recommendation that
&quot;mandatory penalties of imprisonment of at least 5 years
should be provided for second offenders.&quot; 11 Representative
Boggs indicated that his bill was to incorporate the Kefauver
Committee recommendations of mandatory minimum sentences for drug
peddlers and had as its principal purpose ... to remove the power
of suspension of sentence and probation in the cases of second
and subsequent offenders against the narcotics and marijuana
laws, and to provide minimum sentences .... 12 </p>

<p>Moreover, Representative Boggs and others supported the
mandatory minimum sentences because they felt some federal had
been lax in enforcing the narcotic laws 13 and because they
believed harsher penalties had reduced crimes, particularly
kidnapping and the white slave trade, in other areas.14
Representative Edwin Arthur Hall of New York urged substitution
of his bill, which provided for minimum sentences of 100 years
for dope peddlers.15 Although there was some opposition to the
Boggs Act, notably by Representative Celler, who thought that the
mandatory minimum sentence provision would be unjust for
addicts,16 the majority opinion was clearly that mandatory
minimum sentences were necessary to insure punishment of
peddlers.17 In response to Mr. Celler's contention that young
addicts could be subjected to long prison terms because of the
loss of judicial discretion in sentencing, Representative Jenkins
stated: </p>

<blockquote>
    <p>The enforcing officers will always have sympathy for the
    unfortunate consumer, especially if he is harmless. These
    enforcing officers are going to protect the little boys and
    little girls. They are not going to drag the high school boys
    and girls before the criminal courts until they know that
    they are collaborating with the peddlers18 </p>
</blockquote>

<p>Mr. Boggs presented a more reasonable justification for
mandatory minimums: </p>

<blockquote>
    <p>[I]t is not the intention of this legislation to affect a
    teen-ager or any such person who has possession of narcotics.
    But the gentleman also knows that if we try to make a
    distinction between possession and peddling that we
    immediately open the law to all types of abuses.19 </p>
</blockquote>

<p>The Act as passed provided uniform penalties for violations of
the Narcotic Drugs Import and Export Act and the Marihuana Tax
Act. The penalties prescribed were: </p>

<p>First offense 2 - 5 years </p>

<p>Second offense 5 - 10 years </p>

<p>Third and subsequent offenses 10 - 20 years </p>

<p>Fine for all offenses $2,000.00 </p>

<p>The relatively low fines reflected a congressional belief that
monetary penalties were an insignificant deterrent.20 An
essential provision of the Act removed judicial discretion in
sentencing by providing that upon conviction for a second or
subsequent offense the imposition or execution of the sentence
could not be suspended nor probation granted. As in the nontax
predecessors of the Boggs Act since 1909 and the Marihuana Tax
Act, possession of a narcotic drug was sufficient for conviction
unless the defendant could explain the possession to the
satisfaction of the jury.21 </p>

<hr>

<p><b>3. Marijuana and the Boggs Act</b> </p>

<p>Congressional and public attention was clearly focused on hard
narcotics use, primarily the opiates. Judging from the recorded
proceedings, especially the floor debate in the House, marijuana
seems to have been along for the ride, much as it had been during
enactment of the Uniform Narcotic Drug Act. However, here there
was a conscious decision to include marijuana violations in the
new penalty provisions. Underlying this decision were
determinations that marijuana use had also increased during the
later 1940's, that it too was spreading to white teenagers, and
that the drug's dangers, warranted the harsh treatment
contemplated by the Act. </p>

<p>(a) Increased Use.-To test the allegation of an increase in
marijuana use during this period, we have used the seizure and
enforcement figures used by the proponents of the legislation.
These figures tend to sustain the hypothesis that marijuana
traffic increased from 1948 to 1951, following a decline
throughout the early 40's. However, the figures are also
consistent with other hypotheses, for example that improved
enforcement techniques and increased state-federal cooperation
had increased arrests. </p>

<p>Federal agents of the Narcotics Bureau began vigorously
enforcing the Marihuana Tax Act almost as soon as President
Roosevelt signed it into law. From October 1 to December 31,
1937, alone, the FBN made 369 seizures totaling 229 kilograms of
the drug.22 </p>

<p>Moreover, state officials made extensive seizures either in
conjunction with FBN agents or in pursuance of their newly-passed
state controls over marijuana's Marijuana seizures by federal
authorities hit their low point in 1945 when only 257 kilograms
were taken, 128 of which were seized by the FBN and the rest by
United States Customs agents .24 At this time the FBN had
approximately 180 agents.25 This low seizure figure suggests a
decrease in marijuana use throughout the early 1940 's.26 </p>

<p>Beginning in about 1948, however, the arrest and seizure 27
figures rose dramatically, the arrest figures rising 33 percent
from 1947 to 1948. These figures tend to corroborate the
Commissioner's assertion that there was a drastic increase in
narcotics use between 1948 and 1951 28 and to justify the
simultaneous calls for amendment of the narcotics and marijuana
laws.29 On the other hand, these figures could reflect increased
or I improved enforcement. For example, in 1949 the FBN had begun
to encourage the largest cities to form special narcotics squads
to deal especially with the drug problem.30 By 1951, however,
only New York and Los Angeles had formed the separate police
detail the FBN had requested .31 Thus even if one were tempted to
try to correct for improvements in the law enforcement machinery,
the seizure figures for the late 40's and 50's do sustain the
notion that the traffic in marijuana increased from 1948 to 1951.
</p>

<p>(b) Youthful Users.-As with the hard narcotics, Congress was
especially alarmed by the alleged spread of marijuana to white
teenagers and school children. Militating against this
proposition is evidence that marijuana use was not widespread
among the young as late as 1944. In that year, the famous La
Guardia Report reached the following conclusions among others:
Marijuana use was widespread in the Borough of Manhattan but
tended to be limited to certain areas, notably Harlem; the
majority of marijuana smokers were Negroes and Latin-Americans,
and marijuana smoking was not widespread among school children
.32 </p>

<p>The La Guardia study portrays marijuana use in this period as
a rather casual adjunct to ghetto life. Since it was not costly,
this euphoriant was well within the reach of ghetto residents. It
appears that throughout the early 40's marihuana use in the West
as well as in the East continued to be associated with the ethnic
minorities, especially in the inner city.33 </p>

<p>The fear that marihuana use would spread to white teenagers is
one that has recurred since the earliest legislative cognizance.
In fact, it was probably a factor in the early opium laws .34 We
have been unable to confirm whether the fear was justified at
this time, but in light of the documentation of increased
narcotics use among the young, we shall presume the same use
patterns to be true of marihuana. </p>

<p>(c) The Danger: A New Rationale.-The FBN had begun its
educational campaign for harsher marihuana penalties immediately
after passage of the Tax Act.&quot; In the early years, the
campaign was particularly effective with judges. For example, in
one of the first cases under the Tax Act, a Colorado judge
stated: </p>

<blockquote>
    <p>I consider marihuana the worst of all narcotics-far worse
    than the use of morphine or cocaine. Under its influence men
    become beasts, just as was the case with [the defendant].
    Marihuana destroys life itself. I have no sympathy With those
    who sell this weed. In the future I will impose the heaviest
    penalties. The Government is going to enforce this new law to
    the letter.36 </p>
</blockquote>

<p>The crime, pauperism and insanity rationale was accepted
unquestioningly as late as 1951.37 Under this rationale, harsher
penalties were certainly as imperative for marijuana offenders as
they were for opiate offenders. However, in a paper filed as an
exhibit to the hearings38 on the Boggs Act, Dr. Harris Isbell,
Director of Research at the Public Health Service hospital in
Lexington, Kentucky, exploded the traditional rationale. He
stated that marijuana was not physically addictive.39 Although he
postulated a definition of addiction which amounts to nothing
more than chronic intoxication 40 and noted the possibility of
&quot;temporary psychoses&quot; in &quot;predisposed
individuals,&quot; Isbell's description of marijuana was
extraordinarily favorable. Before the Kefauver Committee he
testified: </p>

<blockquote>
    <p>Marijuana smokers generally are mildly intoxicated,
    giggle, laugh, bother no one, and have a good time. They do
    not stagger or fall, and ordinarily will not attempt to harm
    anyone. </p>
</blockquote>

<blockquote>
    <p>It has not been proved that smoking marijuana leads to
    crimes of violence or to crimes of a sexual nature. Smoking
    marijuana has no unpleasant after-effects, no dependence is
    developed on the drug, and the practice can easily be stopped
    at any time. In fact, it is probably easier to stop smoking
    marijuana cigarettes than tobacco cigarettes. </p>
</blockquote>

<blockquote>
    <p>In predisposed individuals, marijuana may precipitate
    temporary psychoses and is, therefore, not an innocuous
    practice with them.41 </p>
</blockquote>

<p>Dr. Isbell's statements that marijuana does not cause a
physical dependence were supported by other doctors, 42 prison
officials,43 and perhaps most significantly by the statement of a
number of narcotics addicts .44 </p>

<p>Despite this testimony the legislators approved greatly
increased penalties for marijuana users. The crucial reason for
this severe treatment can be seen in the following colloquy
during the House subcommittee hearings: </p>

<blockquote>
    <p>Mr. Boggs. From just what little I saw in that
    demonstration, I have forgotten the figure Dr. Isbell gave,
    but my recollection is that only a small percentage of those
    marijuana cases was anything more than a temporary degree of
    exhilaration .... </p>
</blockquote>

<blockquote>
    <p>Mr. Anslinger. The danger is this: Over 50 percent of
    those young addicts started on marijuana smoking. They
    started there and graduated to heroin; they took the needle
    when the thrill of marijuana was gone.45 </p>
</blockquote>

<p>Many others -doctors ,46 crime prevention experts,47 police
and narcotics bureau officials48 -testified to the link between
marijuana use and ultimate heroin addiction. Representative Boggs
himself summed up this novel danger of marijuana in one of the
few statements even to mention marijuana in House floor debate: </p>

<blockquote>
    <p>Our younger people usually start on the road which leads
    to drug addiction by smoking marijuana. They then graduate
    into narcotic drugs-cocaine, morphine, and heroin. When these
    younger persons become addicted to the drugs, heroin, for
    example, which costs from $8 to $15 per day, they very often
    must embark on careers of crime . . . and prostitution . . .
    in order to buy the supply which they need.49 </p>
</blockquote>

<p>The passage of this new Federal Act marked a significant shift
in rationale for the illegal status of marijuana; that status
became more entrenched by the indiscriminate lumping of marijuana
with the other narcotic drugs. </p>

<hr>

<p><b>4. The State Response: Mindless Escalation</b> </p>

<p>While the Boggs Act was still pending in Congress, the Bureau
of Narcotics encouraged the states to modify their existing
narcotic and marijuana legislation to enact &quot;penalties
similar to those provided for in the Boggs bill [which] would be
of material assistance in the fight against the narcotic
traffic.&quot; 50 Seventeen states (including Virginia) and the
Territory of Alaska responded by passing &quot;little Boggs
Acts&quot; by 1953, and eleven other states increased their
penalties by 1956. </p>

<p>In 1951, seven states and the Territory of Alaska passed
penalty provisions similar to those contained in the Boggs
Act.,51 In addition, nine other states amended their drug laws to
provide for more severe penalties, but the provisions were
neither uniform nor identical to those provided for under the
federal measure. 52 In 1952, four more states, including
Virginia, amended the penalty provisions of their drug laws to
bring them in line with the Boggs Act.53 Six more states followed
suit in 1953.54 Finally, in 1955 and 1956 two states, Ohio and
Louisiana respectively, enacted penalty provisions which were
substantially more severe than those passed previously in any
Jurisdiction.55 </p>

<p>The Virginia &quot;little Boggs Act&quot; was signed into law
on April 1, 1952 ,56 after having passed both houses
unanimously.57 The measure was regarded as routine, and as one of
the &quot;less controversial&quot; proposals to come before the
legislature during the 1952 session.58 It cleared the House on a
day when bills were being passed &quot;at the rate of about one a
minute during some periods&quot; 59 and won Senate approval
during the final rush to complete business in the waning hours of
the 1952 General Assembly. </p>

<p>The Act produced three basic changes in Virginia's scheme of
narcotics control. It added marijuana to those drugs whose sale
was forbidden under the state's version of the Uniform Narcotic
Drug Act; it created the new substantive crime of sale to a
minor; and it provided for harsher penalties for violations of
the drug laws.60 </p>

<p>Prior to 1952, the Virginia anti-marijuana provision was
separate from those provisions governing the sale of
&quot;hard&quot; drugs. But the 1952 Act repealed this provision
and included marijuana under the state's general narcotic control
law. As a result, a person illegally selling marijuana became
subject to the same penalties imposed upon a person legally
vending such drugs as heroin, morphine and cocaine .61 </p>

<p>The heart of the 1952 Act was the provision for stiffer
penalties for the violation of Virginia's general narcotic laws
prohibiting the sale of drugs without a prescription. For the
first offense, the penalty was imprisonment in the penitentiary
for not less than three nor more than five years plus a fine of
not more than $1,000. For the second offense, the penalty was
imprisonment for not less than five nor more than ten years and a
fine of not more than $2,000. For the third and succeeding
offenses, the penalties were fines of not more than $3,000 and
imprisonment for not less than ten nor more than twenty years. </p>

<p>The 1952 Act also made it a felony to sell, barter, peddle,
exchange or otherwise dispense marijuana or any other narcotic
drug to a minor. Any person found guilty of such offense was
subject to imprisonment for a term of not less than ten years nor
more than thirty years, no part of which could be suspended, and
a fine of not more than $ 1,000 for the first offense, $2,000 for
the second offense and $3,000 for the third and subsequent
offenses. Such a provision exemplifies the increased
sophistication of anti-narcotic legislation during the 1950's.
Thus, the continued escalation of penalties for drug law
violators was followed in Virginia. Moreover, despite the public
concern and attention in the national media, in Virginia it is
plain that the 1952 amendments to the narcotic laws passed
virtually unnoticed in the press .62 </p>

<hr>

<p><b>B. The Late 1950's: Another Escalation of the Penalties</b>
</p>

<p>Whether because use had decreased or because the propagandists
had accomplished their main mission, the narcotics problem
dropped almost entirely from public view after the Boggs Act was
passed. Nevertheless, state and federal police authorities, armed
with data suggesting that the strengthening of the drug laws had
at least halted the increase in drug use, pressed for further
increases in penalties in order entirely to root out the drug
menace. 63 Without significant debate or public interest,
Congress responded by passing the Narcotic Control Act of 1956
.64 </p>

<p>Although the legislators paid even less attention to marijuana
than they had in 1951, the precedent there established of
classifying marijuana with hard narcotics resulted in a
proliferation of marijuana offenses and a further increase in
penalties. In some ways, this legislation represents the
high-water mark of uninformed public policy regarding marijuana.
In almost every respect, the provisions of the Act and the
legislative motivation bear absolutely no rational relation to
marijuana's pharmacology and to the drug's actual use and traffic
patterns. </p>

<hr>

<p><b>I. Provisions of the Narcotic Control Act of 1956</b> </p>

<p>Public Law 728, an act intended to make more effective control
of the narcotic drugs and marijuana, was approved on July 18,
1956. It amended the Internal Revenue Code of 1954 and the
Narcotic Drugs Import and Export ACt65 primarily in the direction
of increasing still further the penalties for violation of those
acts and proliferating the scope of federal control over the use,
possession and sale of narcotic drugs and marijuana. </p>

<p>The new law raised the potential fine for all narcotics and
marijuana offenses to $20,000 66 and increased the mandatory
minimum sentences for offenses in the prescription, registration
and possession categories to two, five and ten years for
successive offenses.67 No distinction was made between addicts
and traffickers with regard to these types of violations.
Violations of the sale, transfer and smuggling provisions of the
Act carry a minimum sentence of five years for first offenses and
ten years for all subsequent offenses. 68 In this connection the
Act created a new offense by prohibiting illegal importation of
marijuana and forbidding knowing receipt, concealment, purchase,
sale, and facilitation of transportation or concealment of such
illegally, imported marijuana .69 Simple possession was by
statute sufficient evidence of guilt to convict.70 This
provision, now 21 U.S.C.  176a, paralleled a similar
importation provision for narcotics originally passed in 1909. </p>

<p>In addition, any sale or transfer of any drug by an adult to a
was made punishable by a minimum ten-year sentence.71 Finally,
the Act made suspension, probation and parole unavailable to all
offenders except those convicted of a first offense for
possession, prescription or registration.72 </p>

<p>In addition to the increases in offenses and penalties, the
law contained wide variety of provisions relating to enforcement.
Customs and Narcotics Bureau agents were authorized to carry
weapons and to make arrests without a warrant on belief that a
drug violation had been committed .73 The Government was allowed
to appeal unfavorable decisions suppressing evidence74 and to
compel testimony from witnesses by a grant of immunity.75 In a
concession to those legislators who favored a wiretapping
provision, the new law created a category of offense based on the
use of communications instrumentalities in violation of the drug
laws.76 This provision carried penalties of a minimum two-year
sentence and up to a $5,000 fine. The Act required that citizens
who are drug users and drug law violators must register with the
immigration authorities upon entering or leaving the United
States .77 The Act also amended the Immigration and Nationality
Act to provide for deportation of alien drug users and drug law
violators .78 </p>

<hr>

<p><b>2. Marijuana-Along for the Ride</b> </p>

<p>The Narcotic Control Act of 1956 was premised on the same
beliefs as was the Boggs Act. Few if any of the legislators
recognized that marijuana was in any way different from the
physically addictive narcotics.79 The stepping stone concept was
now so widely accepted that only once during the extensive
congressional debates on the House and Senate versions of the
bill was the subject of marijuana as a separate substance even
raised. In a statement reflecting both ignorance of the basic
characteristics of marijuana and naive acceptance of the stepping
stone concept, Senator Daniel, Chairman of the Senate
subcommittee that investigated the drug problem, described
marijuana: </p>

<blockquote>
    <p>That is a drug which starts most addicts in the use of
    drugs. Marihuana, in itself a dangerous drug, can lead to
    some of the worst crimes committed by those who are addicted
    to the habit. Evidently, its use leads to the heroin habit
    and then to the final destruction of the persons addicted.80 </p>
</blockquote>

<p>Because Congress bought the FBN's propaganda lock, stock and
barrel, it is not surprising that there was no dissent from the
proposition that harsher penalties were the means to eliminate
illicit use and sale of all drugs.81 </p>

<hr>

<p><b>3. Trafficking Patterns</b> </p>

<p>The 1956 Act reflected an unsupported conception of the nature
of the marijuana traffic. Under the assumption that
&quot;peddlers&quot; of all drugs, marijuana included, are
controlled by organized crime, the Act assessed extremely heavy
penalties for sale, especially to minors. For example, the House
Ways and Means Committee report noted that &quot;narcotic
traffickers ... are in most cases well organized professional
racketeers.&quot; 82 Similarly, in recommending prohibition of
probation or suspension of sentence for first-offender peddlers,
the House subcommittee had asserted that if the first offender
peddler problem was not solved, there would eventually be
&quot;large scale recruiting of our youth by the upper echelon of
traffickers.&quot; 83 </p>

<p>While the reference to organized crime was undoubtedly valid
with respect to hard drugs, the assumption that marijuana traffic
was controlled by large-scale racketeers was completely
unsupported. The marijuana distribution pattern today is far
different than the distribution pattern for &quot;hard&quot;
drugs. On college campuses today, the marijuana seller is likely
to be a smoker who has a small amount he wants to sell. Unless
one is to believe that organized crime has abdicated a
distribution role to &quot;amateurs,&quot; it is difficult to
imagine that it controlled the distribution of marijuana in 1956.
Accordingly, the 1956 Act's widely divergent treatment of sale
and use of marijuana may not have been justified at the time of
enactment, and it certainly makes little sense today. </p>

<hr>

<p><b>4. Origin and Use</b> </p>

<p>A related misconception about the marijuana trade concerns the
new importation offenses. Underlying the presumption of knowing
concealment of smuggled marijuana arising from possession are two
findings that the mainstay of marijuana traffic is imported from
Mexico and that possessors are likely to be aware of that fact.
Even in 1956, such findings were dubious.84 As to the presumption
of importation, Commissioner Anslinger's estimate that 90 percent
of all marijuana seized by federal authorities had been smuggled
from Mexico85 was grossly misleading. The Federal Bureau of
Narcotics had practically abandoned the responsibility for
marijuana control to increasingly effective state narcotics
squads and to the Customs agents.86 Of course, federal figures
taken alone would suggest a high percentage of importation.
Furthermore, the Commissioner's conclusion was inconsistent with
an essential premise of the Tax Act87 and with other materials
before the Congress,88 all of which emphasized the large degree
of domestic cultivation. </p>

<p>As to the possessor's knowledge, the underlying assumption
again was that there was an organized trade pattern so that each
user knew where his drug came from. As we know, marijuana was
then a casual adjunct to ghetto life. It was a social, rather
than an economic, phenomenon limited almost exclusively to
unemployed or menially employed members of racial minorities in
the center cities.89 As applied to such a class of people, the
presumption is farcical.90 </p>

<hr>

<p><b>5. Enforcement Patterns</b> </p>

<p>Although the proliferation of federal offenses suggests on its
face that state enforcement was inadequate to cope with marijuana
trade or that increased use of the drug presaged increased
narcotics addiction, nothing could be farther from the truth.
Considering marijuana alone, the 1956 legislation was passed in
response to no need at all. The enforcement statistics confirm
our hypothesis that marijuana was simply &quot;along for the
ride.&quot; </p>

<p>First, as we noted above, federal arrests declined continually
after 1952.91 Although attributable in part to increased state
enforcement92 and to a conscious FBN decision to concentrate on
narcotics, the figures do suggest a decline in or at least a
stabilization of marijuana use by the middle fifties, even in
areas in which narcotics use continued unabated. Second, the
class of users does not seem to have changed at all during this
period. Arrest statistics still indicate that use was centered in
the ghetto areas of major cities93 in California, Texas,
Louisiana, Michigan, New York, and Illinois.94 However, because
statistics were not refined according to race, age, sex and often
even the drug used,95 we cannot state categorically that there
was no change in use patterns. 96 </p>

<hr>

<p><b>6. The Epitome of Irrationality: Virginia's 1958 Amendment</b>
</p>

<p>In 1958, Virginia's Uniform Drug Act was further amended to
make the &quot;possession of illegally acquired narcotic drugs
[which included marijuana] in any quantity greater than
twenty-five grains, if in solid form, or eight ounces, if in
liquid form,&quot; a crime punishable by a fine of not more than
$5,000 and imprisonment for not less than twenty nor more than
forty years .97 The effect of this enactment was to provide a
penalty for illegal possession that was more than twice as severe
as the penalty for unlawful sale and one and one-half times more
stringent than that for sale to a minor. It is incredible that
despite the extreme <a name="last">harshness of this penalty, the
measure passed both houses of the General Assembly with but one
dissenting vote, and no mention was made of it in the Richmond
Times-Dispatch during the period of February 14 to April 7, 1958.</a>
</p>

<p>In conclusion, the Federal Narcotic Control Act of 1956 and
subsequent state legislation reflect the same basic congressional
and public misconceptions about the nature and dangers of
marijuana that characterized the early fifties. Even more
unchanged, and in fact strengthened by results under the Boggs
Act, was the assumption that the key to the solution of the
narcotic drug problem was the imposition of harsher penalties on
both users and traffickers in illicit drugs. Classification of
marijuana with narcotic drugs was now a foregone conclusion. In
fact, legislators seemed less aware that marijuana was a distinct
substance than they had been in 1951. </p>

<hr>

<h2>Footnotes and References </h2>

<p>1 Between 1937 and 1951, the Uniform Narcotic Drug Act was
amended to change the definition of cannabis from the flowering
or fruiting tops of just the female plant to include the
corresponding parts of the male plant. See 1942 HANDBOOK 172-73. </p>

<p>2 Act of Nov. 2, 1951, ch. 666, 65 Stat. 767. </p>

<p>3 21 U.S.C.  174 (1964). </p>

<p>4 26 U.S.C.   4741-76 (1964). </p>

<p>5 Hearings Before the Special Senate Committee to Investigate
Organized Crime in Interstate Commerce, 82d Cong., 1st Sess., pt.
14, exhibit 1, at .131, 240-41, 266 (1951) [hereinafter cited as
Kefauver Committee Hearings). Senator Kefauver stated at the June
26, 1951, session of the hearings: </p>

<p>Illegal drug use has reached epidemic proportions, according
to information secured by this committee from different parts of
the country. One of the most alarming aspects is the reported
increase in addiction among the younger generation, some of
school age. </p>

<p>Id., pt. 14, at 235. See also N.Y. Times, June 19, 1951, at
25, col. I (&quot;the present wave of juvenile addiction struck
us with hurricane force in 1948 and 1949, and in a short time had
the two Federal hospitals bursting at the seams&quot;) (statement
of Commissioner Anslinger). </p>

<p>6 A 57 year-old addict witness, who had started smoking opium
around 1912, stated that he had never seen significant use of
drugs by young people until recently and theorized that marijuana
was the cause. Kefauver Committee Hearings, pt. 14, at 382. 7 97
CONG. REC. 8197 (195 1). </p>

<p>8 Id. at 8198. </p>

<p>9 Id. at 8198-8204. </p>

<p>10 Id. at 8198 (as quoted by Representative Boggs). See also
Kefauver Committee Hearings, pt. 14, at 430-31 (testimony of
Commissioner Anslinger). </p>

<p>11 97 CONG. REC. 8198 (1951). </p>

<p>12 Id. at 8196. </p>

<p>13 See id. at 8197, 8207. One of the most critical statements
on this point came from Representative Harrison of Virginia who,
after noting that narcotics laws violations had been increasing
&quot;only&quot; in those jurisdictions where federal judges had
failed to impose adequate sentences on recidivists, stated:
&quot;Where the judiciary is abusing its discretion, it is the
duty of the law-making body to limit the discretion in order that
the public may be protected.&quot; Id. at 8211. </p>

<p>14 Id. at 8207. </p>

<p>15 Id. at 8209. </p>

<p>16 Id. at 8210. </p>

<p>17 Representative Celler suggested that harsh mandatory
sentences would have &quot;two results: grand juries will refuse
to indict and petit juries will refuse to convict.&quot; Id. at
8206. </p>

<p>18 Id. at 8207. </p>

<p>19 Id. at 8206. </p>

<p>20 Id. at 8197. </p>

<p>21 Representative Keating Questioned the constitutionality of
the provision. Id. at 8206. Apparently Keating accepted
Representative Harrison's statement that the language had been in
the statutory predecessors for years and had been passed on by
the Supreme Court. Id. at 8211. </p>

<p>22 TRAFFIC IN Opium 80 (1937). For a full and effective
discussion of the flaws in these drug statistics from 1937 until
the mid 1940's due to a confusion over what parts of the
marijuana plant were to be weighed in determining how much of the
drug had been seized, see Mandel, Problems with Official Drug
Statistics, 21 STAN. L. REV. 991, 998-99 (1969). </p>

<p>23 The following figures are available from 1936 to 1941.
After 1941 the FBN ceased publication of the number of seizures
by state and municipal authorities: </p>

<table border="1">
    <tr>
        <td width="98">Year</td>
        <td width="98">Number of seizures</td>
        <td width="98">Amount seized</td>
    </tr>
    <tr>
        <td width="98">1935</td>
        <td width="98">unreported</td>
        <td width="98">195+ tons </td>
    </tr>
    <tr>
        <td width="98">1936</td>
        <td width="98">377</td>
        <td width="98">386 tons </td>
    </tr>
    <tr>
        <td width="98">1937</td>
        <td width="98">335</td>
        <td width="98">116 Kg. </td>
    </tr>
    <tr>
        <td width="98">1939</td>
        <td width="98">289</td>
        <td width="98">22,807 Kg. </td>
    </tr>
    <tr>
        <td width="98">1940</td>
        <td width="98">433</td>
        <td width="98">71,129 Kg. </td>
    </tr>
    <tr>
        <td width="98">1941</td>
        <td width="98">193</td>
        <td width="98">19 Kg. </td>
    </tr>
</table>

<p>TRAFFIC IN Opium 63 (1935); id. at 57 (1936); id. at 81
(1937); id. at 80 (1939); id. at 73 (1940); id. at 38 (1941). The
great discrepancy in these numbers may be one reason the FBN
ceased their publication in 1941. </p>

<p>24 Id. at 80 (1945). </p>

<p>25 Hearings on Dep'ts of Treasury and Post Office
Appropriations for 19S1 Before a Subcomm. of the House Comm. on
Appropriations, 81st Cong., 2d Sess., pt. 1, at 128 (1950). </p>

<p>26 The figures on the amount seized by federal agents from
1939-1945 are as follows: </p>

<table border="1">
    <tr>
        <td width="197">Year</td>
        <td width="197">FBN No. of Kgs. Seized </td>
        <td width="197">Customs No. of Kgs. Seized</td>
    </tr>
    <tr>
        <td width="197">1939</td>
        <td width="197">419</td>
        <td width="197">63 </td>
    </tr>
    <tr>
        <td width="197">1940</td>
        <td width="197">495</td>
        <td width="197">100 </td>
    </tr>
    <tr>
        <td width="197">1941</td>
        <td width="197">396</td>
        <td width="197">12 </td>
    </tr>
    <tr>
        <td width="197">1942</td>
        <td width="197">289</td>
        <td width="197">44 </td>
    </tr>
    <tr>
        <td width="197">1943</td>
        <td width="197">150</td>
        <td width="197">168 </td>
    </tr>
    <tr>
        <td width="197">1944</td>
        <td width="197">247</td>
        <td width="197">78 </td>
    </tr>
    <tr>
        <td width="197">1945</td>
        <td width="197">128</td>
        <td width="197">129 </td>
    </tr>
</table>

<p>TRAFFIC IN Opium 78 (1939); id. at 72 (1940); id. at 37
(1941); id. at 49 (1942); id. at 42 (1943); id. at 34 (1944); id.
at 23 (1945). </p>

<p>27 The figures for the period 1946-1951 are as follows: </p>

<p>Year Seized </p>

<table border="1">
    <tr>
        <td width="148"></td>
        <td width="148"></td>
        <td colspan="2" width="295">No. of Arrests for<p>Violations
        of Marijuana Laws </p>
        </td>
    </tr>
    <tr>
        <td width="148">Year</td>
        <td width="148">No. of Kgs. Seized</td>
        <td width="148">FBN</td>
        <td width="148">Customs</td>
    </tr>
    <tr>
        <td width="148">1946</td>
        <td width="148">293</td>
        <td width="148">331 </td>
        <td width="148">953</td>
    </tr>
    <tr>
        <td width="148">1947</td>
        <td width="148">307</td>
        <td width="148">466 </td>
        <td width="148">911</td>
    </tr>
    <tr>
        <td width="148">1948</td>
        <td width="148">422</td>
        <td width="148">1023 </td>
        <td width="148">1278</td>
    </tr>
    <tr>
        <td width="148">1949</td>
        <td width="148">384</td>
        <td width="148">1165 </td>
        <td width="148">1643</td>
    </tr>
    <tr>
        <td width="148">1950</td>
        <td width="148">323</td>
        <td width="148">933 </td>
        <td width="148">1490</td>
    </tr>
    <tr>
        <td width="148">1951</td>
        <td width="148">447</td>
        <td width="148">558 </td>
        <td width="148">1177</td>
    </tr>
</table>

<p>TRAFFIC IN Opium 23, 27 (1946); id. at 23, 29 (1947); id. at
23, 28 (1948); id. at 22, 26 (1949); id. at 29, 33 (1950); id. at
25. 29 (1951). </p>

<p>28 See Teen-Age Dope Addicts New Problem?, U.S. NEWS &amp;
WoRLD REPORT, June 29, 1951, at 18 (interview with Commissioner
Anslinger). </p>

<p>29 See text at note 10 supra. </p>

<p>30 See Teen-Age Dope Addicts New Problem?, supra note 28, at
19. </p>

<p>31 Anslinger, The Facts About Our Teen-Age Addicts, READERS
Digest, Oct. 1951, at 139. </p>

<p>32 The conclusions of the <a href="../lag/lagmenu.htm">La
Guardia Report</a> are discussed in THE MARIHUANA PAPERS 277-410
(D. Solomon ed. 1966). The thirteen conclusions on the sociology
of marijuana use are so significant we include them in full: </p>

<p>From the foregoing study the following conclusions are drawn: </p>

<p>1. Marihuana is used extensively in the Borough of Manhattan
but the problem is not as acute as it is reported to be in other
sections of the United States. </p>

<p>2. The introduction of marihuana into this area is recent as
compared to other localities. </p>

<p>3. The cost of marihuana is low and therefore within the
purchasing power of most persons. </p>

<p>4. The distribution and use of marihuana is centered in
Harlem. </p>

<p>5. The majority of marihuana smokers are Negroes and
Latin-Americans. </p>

<p>6. The consensus among marihuana smokers is that the use of
the drug creates a definite feeling of adequacy. </p>

<p>7. The practice of smoking marihuana does not lead to
addiction in the medical sense of the word. </p>

<p>8. The sale and distribution of marihuana is not under the
control of any single organized group. </p>

<p>9. The use of marihuana does not lead to morphine or heroin or
cocaine addiction and no effort is made to create a market for
these narcotics by stimulating the practice of marihuana smoking.
</p>

<p>10. Marihuana is not the determining factor in the commission
of major crimes. </p>

<p>11. Marihuana smoking is not widespread among school children.
</p>

<p>12. Juvenile delinquency is not associated with the practice
of smoking marihuana. </p>

<p>13. The publicity concerning the catastrophic effects of
marihuana smoking in New York City is unfounded. Id. at 307. </p>

<p>33 The New York trend was also typical of Los Angeles.
California Division of Narcotic Enforcement, Marijuana-Our Newest
Narcotic Menace, April 11 1940, at 12. See also Note, Youth and
Narcotics, 1 U.C.L.A. L. Rev. 445, 453 (1954) (reporting a
breakdown by race of narcotics arrests by the Oakland police
department). </p>

<p>34 For example, in 1895 New York had passed a statute, ch.
1041, 5 1, [1895 ] N.Y. Laws 972, requiring instruction in public
schools on the effect of narcotics. </p>

<p>35 For full accounts of the FBN &quot;educational
campaigns&quot; up through the present day, see TRAFFIC IN Opium
from 1937 to the present. For the full exposition of the FBN's
position on the drug user as a criminal before he becomes an
addict, see Recidivism on Narcotic Law Violators, in Traffic in
Opium for each year. </p>

<p>36 Judge J. Foster Svmes of Denver, Colorado, quoted in
TRAFFIC IN OPIUM 57 (1937). </p>

<p>37 See, e.g., G. CREIGHTON, NARCOTICS: THEIR LEGITIMATE AND
ILLICIT USE (I 95 1). </p>

<p>38 Hearings an H.R. 3490 before the Subcomm. on Narcotics of
the House Comm. on Ways and Means. 82d Cong., 1st Sess. 147
(1951) [hereinafter cited as Boggs Act Hearings). </p>

<p>39 Dr. Isbell's paper stated: </p>

<p>Any definition [of addiction] which makes dependence an
essential feature will also not include intoxications with such
substances as cocaine, marijuana, and amphetamine. because
dependence on these substances is no more marked than is
dependence on tobacco and coffee and yet, in some ways,
intoxication with cocaine or marijuana is more harmful than is
addiction to morphine. Furthermore, definitions which exclude
cocaine and marijuana from the list of addicting drugs would
cause endless confusion because, in common parlance and legally,
both drugs arc regarded as addicting. </p>

<p>Id. at 147-48. </p>

<p>40 Id. at 148. </p>

<p>41 Kefauver Committee Hearings, pt. 14, at 119. </p>

<p>42 Id. at 136. See also Boggs Act Hearings I 01. </p>

<p>43 Boggs Act Hearings 96 </p>

<p>44 Kefauver Committee Hearings, pt. 14, at 73, 101, 109
(statements of three addicts). See also id. at 190, 204 for
statements by addicts to the effect that upon Moving from
marijuana to hard drugs they did not know that the Latter were
addictive. The implication is clear that marijuana is not
addictive. See id. at 91. </p>

<p>45 Boggs Act Hearings 206. </p>

<p>46 Kefauver Committee Hearings, pt. 14, at 133. 47 Boggs Act
Hearings 105. </p>

<p>48 Kefauver Committee Hearings, pt. 14, at 449; Boggs Act
Hearings 62. </p>

<p>49 97 CONG. REC. 8197-98 (1951). The linkage of marijuana use
to heroin was also supplied by sonic of the testimony by addicts
themselves. Of 27 addicts interviewed in part 14 of the Kefauver
Committee Hearings, 15 testified that they had started their drug
use with marijuana. This figure is misleading because a
substantial majority of the 12 who had not used marijuana were
addicts because of illness or were older addicts who had begun
using drugs before marijuana was readily available. See Kefauver
Committee Hearings, pt. 14, at 11, 29, 54, 62, 71, 84, 93, 99,
104, 108, 153, 157, 160, 162, 167, 171, 182, 189, 194, 203, 211,
216, 220, 367, 380, 432, 436. Approximately 5 of the addict
witnesses indicated that marijuana did in fact lead to the use of
the harder drugs but only one gave definite reasons why he
thought this transition inevitably took place. One male addict,
after stating that the average age of marijuana smokers was 13 or
14, stated: </p>

<p>You would very seldom find a person smoking marijuana who does
just that, he keeps on, and he gets to the point where he does
not have the same drive or feeling that he first had, and it is
like a stepping stone, he graduates to heroin. Kefauver Committee
Hearings, pt. 14, at 199-200. </p>

<p>Note that among many of these addicts curiosity and peer group
pressure was the primary factor in starting them into the use of
hard drugs. Id. at 12, 32, 94, 109, 254. Moreover, Representative
Boggs introduced some mystery into his statements during the
House debates by stating: </p>

<p>A study in February of 1950 of 602 case reports indicates that
53 percent . . . started their addiction to drugs by reason of
association with other addicts, and 7 percent of them started on
marijuana. </p>

<p>97 CONG. REC. 8197 (1951). This study is cited on the same
page with Representative Boggs' statement that our young people
usually start on the road to drug addiction by smoking marijuana.
</p>

<p>50 TRAFFIC IN Opium 6 (1950). </p>

<p>51 Alabama, Indiana, Maryland, New Jersey, Oklahoma, Tennessee
and West Virginia. Id. at 8 (1951). </p>

<p>52 Connecticut, Illinois, Louisiana, Michigan, New York,
Pennsylvania, Utah, Washington and Wisconsin. Id. at 8-9. </p>

<p>53 Colorado, Georgia, Kentucky and Virginia. Id. at 6 (1952). </p>

<p>54 Delaware, Iowa, Minnesota, Nebraska, Pennsylvania and
Wyoming. Id. at 9 (1953). 55 The Ohio law, approved June 16,
1955, provided for imprisonment of any one found guilty of
illegally selling narcotic drugs for a period of not less than
twenty nor more than forty years. Id. at 7 (1955). The Louisiana
measure, adopted the following year, provided severe prison
sentences without parole, probation or suspension for the illegal
sale, possession or administration of a narcotic drug. Sentences
ranged from a five year minimum to a ninety-nine year maximum.
Id. at 28 (1956). </p>

<p>56 Ch. 451, [1952) Va. Acts of Assembly 736. </p>

<p>57 The bill, H.B. 132, passed the House 65-0 on February 23,
1952, and the Senate 34-0 on March 7, 1952. </p>

<p>58 Richmond Times-Dispatch, Mar. 2, 1952, 5 2, at 1, col. 6. </p>

<p>59 Id., Feb. 24, 1952,  2, at 5, col. 3. The House passed
fifty bills and advanced thirty-five more during its session of
February 23, 1952. Id. </p>

<p>60 Ch. 212, [1936] Va. Acts of Assembly 361. </p>

<p>61 Ch. 451, [1952] Va. Acts of Assembly 736. </p>

<p>62 See also Proffit, An Analysis of the Missouri Narcotic Drug
Laws, 17 Mo. L. REV. 252 (1952), in which the author shows that
narcotic hysteria was closely linked to the general hysteria and
&quot;Red Scare&quot; of the early fifties: &quot;The opinion has
been advanced that the recent upsurge in consumption [of drugs]
is fostered by Communists in an effort to undermine the morals of
our youth.&quot; Id. at 252-53. He cites a Missouri official who
so testified before a state legislative committee. For more of
the same, see W. OURSLER &amp; L. SMITH, NARCOTICS: AMERICA'S
PERIL 266 (1952). The Missouri case parallels the Virginia data
in that great public concern is expressed about the possible
spread of narcotics addiction but little if any separate notice
was given marijuana. Everywhere the narcotics evil was linked by
veiled references to international communism, especially that of
China, the traditional home of the opium habit. </p>

<p>63 Hearings on Illicit Narcotics Traffic Before the Subcomm.
on Improvements in the Federal Criminal Code of the Senate Comm.
on the judiciary, 84th Cong., 1st Sess. 57 (1955) [hereinafter
cited as Daniel Committee Hearings]; see H. ANSLINGER &amp; W.
OURSLER, THE MURDERERS (1962). </p>

<p>64 Ch. 629, 70 Stat. 567. </p>

<p>65 Ch. 202, 42 Stat. 596 (1922). </p>

<p>66 Ch. 629,   103, 105-06, 108, 70 Stat. 568, 570, 571
(codified at 26 U.S.C.  7237 (1964); 21 U.S.C.  174, 176a,
184a (1964)). </p>

<p>67 Id.  103, 70 Stat. 568 (codified at 26 U.S.C.  7237
(1964)). </p>

<p>68 Id. </p>

<p>69 Id.  106, 70 Stat. 570 (codified at 21 U.S.C.  176a
(1964)). </p>

<p>70 Id. (declared unconstitutional in Leary v. United States,
395 U.S. 6 (1969)) </p>

<p>71 Id.  103, 70 Stat. 568 (codified at 26 U.S,C.  7237 (b)
(1) (1964)). The statute also provided that a seller peddling
heroin to a minor may be subject to a sentence of life
imprisonment imposed by a court, or to a death sentence imposed
by a jury. Id.  107, 70 Star. 571 (codified at 21 US.C.  176b
(1964)). </p>

<p>72 Id. S 103, 70 Stat. 569 (codified at 26 U.S.C. 7237(d)
(Supp. 111, 1966)). </p>

<p>73 Id.  104, 70 Star. 570 (codified at 26 U.S.C.  7607
(1964)). </p>

<p>74 Id.  201, 70 Star. 573 (codified at 18 U.SC. S 1404
(1964)). </p>

<p>75 Id., 70 Star. S74 (codified at 18 U.S.C. S 1406 (1964)). </p>

<p>76 Id., 70 Star. 573 (codified at 18 U.S.C. 5 1403 (1964) ). </p>

<p>77 id., 70 Stat. 574 (codified at 18 U.S.C.  1407 (1964)). </p>

<p>78 Id. S 301, 70 Stat. 575 (codified at 8 U.S.C.  1182(a)
(5), (23) (1964)). </p>

<p>79 The House Subcommittee on Narcotics, which produced what
became the essentials of the Narcotic Control Act of 1956,
revealed its knowledge of the distinction between marijuana and
narcotics solely by a footnote to the major heading
&quot;Narcotics&quot; which stated in fine print that the term
narcotics included marijuana. See U.S. CODE CONG. &amp; Am News
3294 (1956). </p>

<p>80 102 GONG. REC. 9015 (1956). </p>

<p>81 Representative Boggs, father of the Boggs Act and Chairman
of the Subcommittee on Narcotics of the House Ways and Means
Committee, stated that '[e]ffective steps to eliminate the
unlawful drug traffic requires ... the imposition of severe
punishment by the courts.&quot; Id. at 10689. The subcommittee,
which had set out to determine the effect of the Boggs Act on
narcotics traffic, U.S. CODE CONG. &amp; AD. News 3291 (1956),
began its recommendations with calls for further increases in the
penalties for narcotics law violations. Id. at 3309. In fact, the
subcommittee felt that this was the only way to eliminate the
drug menace, and recommended that educational programs on the
evils of narcotics not be instituted in the schools for fear of
exciting the curiosity of young people. Id. at 3305. Both the
House Ways and Means Committee report and the subcommittee report
are filled with statements to the effect that harsher penalties
are the most effective weapons in the war against illicit
narcotics. Id. at 3281-3303 passim. The Ways and Means Committee
conclusion was succinct: &quot;Experience with the Boggs law . .
. has clearly demonstrated the efficacy of severe punishment in
reducing the illicit commerce in drugs.&quot; Id. at 3286. </p>

<p>Finally, Senator Daniel, speaking for the Senate subcommittee
investigating the drug situation in the United States, found
&quot;it absolutely necessary for the Congress of the United
States to strengthen the hands of our law enforcement officers
and provide higher penalties if we are to stop the narcotics
traffic in this country.&quot; 102 CONG. Rec. 9014 (1956). His
subcommittee also recommended the kind of across-the-board
increases in penalties that the Act eventually contained. </p>

<p>82 U.S. CODE CONG. &amp; AD. News 3283 (1956); see id. at
3302. </p>

<p>83 Id. at 3304. </p>

<p>84 In holding unconstitutional the presumption of knowledge
that marijuana was smuggled, the Supreme Court in Leary v. United
States, 395 U.S. 6 (1969), relied on the change in use patterns
from 1959 to 1967. We think the presumption was unconstitutional
when passed in 1956, both as to importation and knowledge. </p>

<p>85 Daniel Committee Hearings 18. </p>

<p>86 The decline in the number of FBN arrests and seizures is
directly related to the increase in local and state enforcement
personnel. This thesis is supported by data from California where
statewide arrests soared while federal arrests remained stable.
Bureau of Criminal Statistics, California Dep't of Justice, Crime
in California (1956). See also A. LiNDESMITH, THE ADDICT AND THE
LAW 238 (1963). One commentator has suggested that except for the
years immediately after the passage of the Marihuana Tax Act,
when the Bureau wanted to concentrate on its newly acquired
enforcement field, the FBN arrest data show clearly its emphasis
on the hard narcotics. Mandel, Problems with Official Drug
Statistics, 21 STAN. L. REV. 991, 1019-20 (1969). </p>

<p>87 See note 20 at p. 1053 supra. </p>

<p>88 Written materials inserted into the record of the Senate
hearings included the testimony of an experienced federal Customs
official that high quality marijuana was being grown near the
Texas cities of Laredo and Brownsville. Daniel Committee Hearings
3488-89. In addition, the Attorney General of Ohio noted that
marijuana may grow unnoticed along roadsides and vacant lots in
many parts of the country.&quot; Id. at 4814. Also, a bulletin
issued by the Philadelphia Police Academy recited that
&quot;[plenty of marijuana is found growing in this city.&quot;
Id. at 599. </p>

<p>89 Blum, Mind-Altering Drugs and Dangerous Behavior: Dangerous
Drugs, in THE PRESIDENT'S COMMISSION ON LAW ENFORCEMENT AND
ADMINISTRATION OF JUSTICE, TASK FORCE REPORT: NARCOTICS AND DRUG
ABUSE 21, 24 (1967); Bouquet, Cannabis, 3 U.N. BULL. ON
NARCOTICS, Jan. 1951, at 22, 32-33. </p>

<p>90 This is especially true with respect to the young and black
minorities. The presumption has validity only as applied to
recently immigrated Mexicans. Cf. Chein, The Status of
Sociological and Social Psychological Knowledge Concerning
Narcotics, in NARCOTIC DRUG ADDICTION PROBLEMS 146, 155 (R.
Livingston ed. 1963). Mr. Chein reports a shift in drug use from
1930-1960 from old to young and a continued increase in the
percentage of drug users who are Black or Spanish-speaking. </p>

<p>91 The number of federal arrests for marijuana violations fell
from 1288 in 1952 to 169 in 1960. TRAFFIC IN Opium 26 (1952); id.
at 69 (1960). </p>

<p>92 By 1954, many major states and cities had special narcotics
squads. See Daniel Committee Hearings 13 -14, 1 10. </p>

<p>93 Cf. TRAFFIC IN Opium 66 (1956); id. at 41 (1959). The FBN
charts show clearly the extraordinary incidence of drug abuse
among Blacks, Mexican-Americans and other minority communities. </p>

<p>94 Daniel Committee Hearings, exhibit 7, at 267-71. Local
arrests in those six states accounted for 2,822 of the 3,205
marijuana arrests made by local law enforcers in 1954. </p>

<p>95 For example, the statistics in TRAFFIC IN Opium seldom even
distinguish among the drugs involved, and the FBI Uniform Crime
Statistics frequently report all drug related arrests together,
with no delineation of the type of drug used or the nature of the
offender. </p>

<p>96 Chein, supra note 90, at 152, suggests that whatever
patterns of drug use existed in the fifties were merely
continuations of patterns observed in the thirties. </p>

<p>97 Ch. 535, (19581 Va. Acts of Assembly 675.<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-25</DOCNO>
<DOCOLDNO>IA031-000655-B038-54</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlr7.htm 206.61.184.43 19970122112537 text/html 42800
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:25:19 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:47:31 GMT
Content-length: 42582
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Marijuana Users in the Courts: 1930-1965</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><b>THE FORBIDDEN FRUIT AND THE TREE OF KNOWLEDGE: AN INQUIRY
INTO THE LEGAL HISTORY OF AMERICAN MARIJUANA PROHIBITION</b> </p>

<p><font size="2"><i>Richard J. Bonnie &amp; Charles H.
Whitebread, II</i></font> </p>

<h2>VII. MARIJUANA USERS IN THE COURTS: 1930-1965</h2>

<hr>

<p>&nbsp;</p>

<p>Having studied the evolution of legislative hostility to
marijuana from a regional phenomenon with racial overtones to a
nationwide paranoia, it is worthwhile to consider the fate of
marijuana users in the courts during this evolutionary period.
After the courts had summarily rejected the substantive
constitutional arguments, appeals in marijuana cases tended to
focus on three contentions particularly germane to drug
violations: procedural objections arising from interrelated
statutory schemes on the state and federal levels punishing
essentially the same conduct; objections to police conduct
intrinsic to victimless crimes; and objections to sufficiency of
evidence at trial. Like their legislative colleagues, state and
federal translated what they knew of the drug's mythical effects
into overt hostility. Coupled with the traditionally conservative
treatment afforded the rights of criminal defendants, especially
in state prosecutions, this judicial hostility produced
ever-lengthening sentences and few reversals. </p>

<hr>

<p><font size="4"><b>A. Statutory Fantasies: The Complications of
Federal Legislation</b></font> </p>

<p><b>1. Quadruple &quot;Jeopardy&quot; and the &quot;Killer
Weed&quot;</b> </p>

<p>When Congress passed the Marihuana Tax Act in 1937, marijuana
had already been included in the Uniform Narcotic Drug Act and
every state had enacted some form of marijuana prohibition.1 In
addition to its ostensible revenue-raising function, the Act was
obviously designed both to deter further use of the drug 2 and to
facilitate enforcement of the state laws.3 The statute assured
the availability to state prosecutors of the order forms filed
with the IRS at the time of payment of the tax. 4 Congress had
thought that the order forms and registration requirements would
develop an &quot;adequate means of publicizing dealings in
marihuana in order to tax and control the traffic
effectively.&quot;5 </p>

<p>Thus, after 1937, possession of marijuana without filing the
transfer form and paying the federal tax constituted a violation
of both state and federal law;- yet filing the form and paying
the tax would probably not have eliminated the buyer's exposure
to prosecution under state law. Indeed, compliance would probably
have readily identified the buyer to state officials. To this
unfairness the courts paid no heed, noting that exposure to state
and federal prosecution for the same act did not constitute
double jeopardy7 and that the fifth amendment did not protect
defendants from prosecution for violation of state law.8 </p>

<p>After passage of the 1956 federal narcotic drug legislation9
possession of marijuana constituted at least one, and often two,
additional crimes. First, the Narcotic Drugs Import and Export
Act was amended10 in 1956 to punish directly illegal
importation11 of marijuana or other dealings in the drug with
knowledge that it had been illegally imported. Since mere
possession was sufficient evidence to convict under the Act, 12
possession without registration and order form now constituted
three crimes, and compliance with the filing and tax provisions
would have exposed the defendant to liability under state law and
under the importation provision if the original importation was
illegal. Again the courts saw no fifth amendment violation.13
Second, another provision of the 1956 package required every
person addicted to or using narcotics or convicted of a violation
of the narcotics or marijuana laws punishable by over one year's
imprisonment to register upon leaving the country. 14 Designed to
aid the Government in identifying potential smugglers. the
statute was upheld, as a strict liability offense, 15 against a
multitude of constitutional challenges. 16 Since penalties for
marijuana possession almost uniformly exceeded one year's
imprisonment during this period, a first offense possession
conviction by either sovereign triggered the registration
provision. </p>

<p><b>2. Statutory Presumptions</b> </p>

<p>Because the federal statutes punished sale and possession of
marijuana only indirectly, each had to bridge the gap between
those acts and the technical crimes-tax violations and
importation-related acts. As a bootstrap from the federal taxing
power to a federal police power, Congress chose presumptions.
Thus, under the Marihuana Tax Act, possession plus failure to
produce the required forms was presumptive evidence of the
criminal act-failure to pay the tax17 -and the courts had no
trouble upholding this provision. 18 In addition, under the
Import and Export Act possession of marijuana constituted
presumptive evidence of illegal importation and of defendant's
knowledge of such importation.19 </p>

<p>Against a rash of attacks on the rationality of this
presumption, the lower federal courts20 noted that the Supreme
Court had upheld the same statutory language in the original
Federal Import and Export Act with respect to opium 21 and that
there was sufficient general knowledge that most marijuana was
imported from Mexico to make the presumption rational. Although
the Ninth Circuit at one time indicated that a defendant could
rebut the presumption by showing that the marijuana in his
possession was manicured and therefore more likely to have been
domestically grown,22 that court later held that such proof was
insufficient and that the defendant must also show actual
domestic production. 23 </p>

<p><b>B. Attacks on State Legislation</b> </p>

<p>Most attacks on the state statutes focused on the vagueness of
statutory terms-marijuana, however spelled, or cannabis or Indian
Hemp24 -both as a scientific matter and in terms of common
experience.25 Predictably, however, few state courts were of a
mind to inhibit legislative proscription of the &quot;killer
weed.&quot; Due in part to greatly exaggerated conceptions about
the effects of the drug26 and in part to the ease with which the
mature plant is processed for the outlawed purposes,27 the courts
construed these statutory definitions as broadly as possible 28
despite the traditional rule of strict construction of criminal
statutes. </p>

<p>With the progressive increase in the severity of penalties
which accompanied adoption of the Uniform Act in the 1930's and
1940's and the surge of amendments in the 1950's in the wake of
the Boggs Act.29 Some problems of application arose.
Interestingly enough. some courts, applied the lesser penalty
where one of two penalties could be imposed.30 Similarly many
courts tended to impose minimum sentences until the late 1950's
when they , too, lost all sense of proportion.31 </p>

<p><b>C. Procedural Defenses and Entrapment</b> </p>

<p>Statutory attacks during this period tended to reflect the
complicated interrelation of state and federal law and the
scientific imprecision of legislative drafting. These attacks
were usually rebuffed, and defendants, caught in a squeeze of
judicial and legislative hostility, had few, if any, viable
defenses based on whether or not they had violated the regulatory
scheme. Both state and federal statutes merely required the
prosecution to prove that the particular defendant was found in
possession of a substance which when chemically tested was found
to be marijuana. There were few tricky problems of proof, and the
prosecution usually had a clear case. If these offenders were
caught dead to rights on the merits, the energetic attorney had
to look elsewhere for his defense. </p>

<p>Fortunately, the exigencies of police practice in the field of
narcotics law enforcement provided a defendant's attorney with a
new area of attack-procedural irregularities in the arrest and
apprehension of his client. The possession and sale of marijuana
epitomize the crime without a victim; neither seller nor buyer is
apt to complain of the transaction. In order to promote vigorous
law enforcement in this area, the police have had to use a series
of undercover agents, surprise raids and often questionable
search and arrest techniques. Because of the nature of the
conduct they are trying to stifle, the police must intrude into a
private social relationship where none of the parties wants it-
thus, the police have found it essential to employ highly
secretive and often patently deceitful practices. It is no
coincidence that the vast developments in the law of criminal
procedure-especially in the fourth amendment area-have been
outgrowths primarily of narcotics and marijuana cases. </p>

<p><b>1. Search and Seizure</b> </p>

<p>Today the major remedy for an illegal search is exclusion of
the seized items as evidence. Some states and the federal courts
have used this exclusionary rule since early in the twentieth
century. However, before the 1961 decision in Mapp v. 0hio32
required all states to adopt this remedy, many state courts did
not exclude illegally seized evidence. In jurisdictions without
the rule, it scarcely helped the victim of an illegal search to
raise the point. So, for example, in a 1945 Louisiana case, the
court permitted introduction of marijuana seized without a
warrant from defendant's room while he was out of town .33 </p>

<p>Because of the scope permitted the searching officer, things
were not much better in jurisdictions adhering to the
exclusionary rule. In states using the rule before Mapp, the
crucial issue when the lawfulness of a search was questioned was
whether or not the search was reasonable under the
circumstances.34 One might expect, in view of the judicial
hostility toward marijuana defendants, that the reasonableness
standard provided sufficient leeway for circumvention of the
exclusionary rule in more than a few cases.35 Other end runs
around the rule were developed in the federal system and in the
states purporting to apply the rule to evidence seized in an
illegal search. First, courts upheld searches if there was
arguably an untainted source for seizure of the evidence. For
example, a court might admit marijuana seized in a concededly
illegal search where a police officer saw the marijuana before
beginning the illegal search .36 Second, in order to have
standing to assert the inadmissibility of seized items, one had
to admit the narcotics in question belonged to hirn.37 Third,
courts often permitted searches pursuant to a warrant to extend
far beyond the items named in the warrant 38 under what came to
be known as the contraband theory. This theory reasoned that
certain items could never lawfully be possessed and belonged only
to the government; thus any seizure of these items was
permissible.39 </p>

<p><b>2. Entrapment</b> </p>

<p>In order for federal and state agents to detect narcotics
traffic and use, it is essential that they infiltrate the drug
culture. Obtaining this inside information may often involve
police use of special employees - informers-or may require that
the police become directly involved in the commission of the
criminal act .40 Many defendants in narcotics cases have claimed
that they were forced into sales or purchases of narcotics by the
police or their agents. These charges led to the affirmative
defense of entrapment, first recognized in federal courts by the
Supreme Court in Sorrels v. United States.41 Since that time, the
principles of the defense, as stated in that decision, were
reaffirmed by the Supreme Court in Sherman v. United States .42
In Sherman, a government informer induced the defendant, who was
trying to quit his use of narcotics and was undergoing treatment
at a narcotics rehabilitation center, to resume his use and
supply the informer. The Court held that the conduct of the
police informer constituted entrapment. </p>

<p>The entrapment defense would seem the ideal defense tactic in
marijuana cases, because so often the defendant has been
apprehended due to some police informer or police trick .43
However, the theoretical and practical outlines of the defense
narrowly restrict its scope and make it rarely successful.
Moreover, because it may entail an admission that defendant
committed the act charged 44 it is usually the last resort. </p>

<p>From the beginning there have been two conflicting views of
the entrapment defense. The majority view has considered
entrapment an exception to the given criminal statute on the
ground that the legislature could not have intended entrapment to
fall within the statutory definitions of the crime. With this as
the theoretical justification of the defense, the inquiry focuses
on the innocence of the defendant but for the police conduct. The
practical question is whether the police merely supplied an
opportunity for a person with a preexisting prediliction to the
criminal act. In the majority view this question of fact is to be
resolved by the jury. 45 </p>

<p>Throughout the years a substantial minority position has
contended that the entrapment defense should be considered a
police control mechanism. Under this view, the focus is on the
police and their conduct rather than on the character of the
defendant. This rationale is premised on the court's supervisory
powers over tile administration of justice, and the question of
entrapment is one of law to be decided by the not by the jury.46 </p>

<p>The focus of the defense on the character of the defendant and
the use of usually unsympathetic juries to decide the issue have
greatly hindered the successfulness of the entrapment defense.
Since the defense must be raised affirmatively, the defendant
bears a heavy burden in proving that he would not have committed
the crime but for the police inducement. Thus, in Gilmore v.
United States47 the defendant was unable to carry the burden of
proving that he would not have otherwise committed the marijuana
offense. A government agent approached the defendant and
requested marijuana, but the jury found no entrapment and the
court could not declare that there was entrapment as a matter of
law. </p>

<p>With the entrapment defense, as with illegal searches, the
court has a known lawbreaker before it and for this reason is
reluctant to free him unless there is an overwhelming reason to
dismiss the charges, As a California court stated, It is not the
entrapment of a criminal upon which the law frowns . . . . &quot;
48 The focus upon the defendant and his mental state, rather than
a focus on the government enforcement practices and their
possible effect of creating a particular crime, places an
incredible burden on the defendant to try to convince the jury
that he is otherwise blameless. The use of informers and special
agents who become friendly with those suspected of dealing in
marijuana, and the use of this friendship to try to purchase
marijuana, often by supplying the cash,49 are bound to have a
detrimental effect on the lay enforcement officers as well as to
assure a slight increase in the supply of marijuana which would
otherwise not have entered the trade. Nevertheless, the defense
as presently structured remains virtually impossible for the
defendant to raise with any real hope of success.<br>
</p>

<p><b>D. The Pro Forma Trial<br>
</b></p>

<p>When the marijuana defendant had exhausted his motions for
dismissal or suppression of the evidence and was brought to
trial, he was usually in deep trouble, faced with judicial
hostility, lax methods of identification, and loose standards of
proof. Convictions were rarely reversed for any reason and
especially not for insufficient evidence. And penalties, no
matter how harsh, were never set aside. </p>

<p>The first line of defense in the marijuana trial often
involved the defendant's claim that the substance seized from him
was not really marijuana. In general, the state had no difficulty
proving the substance to be marijuana. In the important case,
expert evidence of chemical tests may have been introduced,50 but
more commonly courts permitted the testimony of police
officers,51 undercover agents and other lay witnesses52 to be
sufficient to create a question of fact for the jury to decide.
53 Thus, when chemical evidence was not introduced, juries were
strongly inclined to believe the policeman or a disinterested
prosecution witness as against the defendant.54 </p>

<p>This ease of identification combined with the uncritical
acceptance of uncorroborated testiniony,55 produced what amounted
in fact to a very low standard of proof. Thus, in a California
case, People v. Janisse,56 the conviction was upheld on the
testimony of teenage boys, though the defendant's co-workers
testified for an alibi. The evidence of rookie police officers
who later failed their civil service exams57 has been accepted
over the word of the defendant. Finally, even the testimony of
witnesses who stand to benefit only from the conviction of the
defendant has been accepted without corroboration, whether the
benefit was indirect58 or direct.59 The wisdom of allowing such
testimony by itself to be legally sufficient for a conviction is
doubtful. </p>

<p>Although in theory the state must prove the defendant's
possession was knowing,60 through the use of circumstantial
evidence the state usually encountered few problems in meeting
its burden of proof. The state was permitted to use
circumstantial evidence to link the defendant to a quantity of
marijuana, but where only circumstantial evidence existed there
must have been an instruction to the that all other reasonable
inferences of innocence had been overcome.61 For example,
behavior such as running away from police, if marijuana was found
along the path run, was sufficient to link the defendant to
possession 62 though mere proximity without other guilty behavior
was not enough to prove possession. 63 </p>

<p>Finally, judicial hostility to the &quot;morally
depraved&quot; marijuana user was so strong that often judges
condoned inflammatory statements by the prosecution to the jury
about the nature of the drug and its users. Indeed, some judges
themselves often participated in these highly emotional
statements. For example, one judge in instructing a jury
announced: </p>

<blockquote>
    <p>Marijuana is a vicious, demoralizing substance that robs a
    person of morality honor, integrity, decency, and all the
    virtues that are the foundation of good character and good
    citizenship. The Government is constantly engaged in an
    effort to stamp out traffic in this and in narcotic drugs.
    Officers of the Government are employed in this effort
    usually and are entitled to credit for their loyalty and
    integrity.64<br>
    </p>
</blockquote>

<p>In the same way, direct aspersions toward a defendant's
character were tolerated .65 For instance, courts overlooked
prosecution comments that the defendant sold his drugs near a
'junior high school&quot; or that drug use among teenagers must
be stopped .66 </p>

<p>In sum, then, defendants in marijuana cases had great
difficulties at trial during this period. Easy identification
methods, jury acceptance of uncorroborated testimony, use of
circumstantial evidence to prove defendant's possession was
knowing, and the 'judicial participation in inflammatory
statements to the jury made defense success at trial a virtual
impossibility.<br>
</p>

<hr>

<h2>Footnotes<br>
</h2>

<p>1 See p. 1034 supra.<br>
<br>
2 See, e.g., Hearings on H.R. 006 Before a Subcomm. of the Senate
Comm. on Finance, 75th Cong., 1st Sess. 5-7 (1937); H.R. REP. No.
792, 75th Cong., 1st Sess. 1-3 (1937). </p>

<p>3 See Leary v. United States, 395 U.S. 6, 26-27 (1969). 4 26
U.S.C.  4773 (1964). </p>

<p>4 H.R. REP. No. 792, 75th Cong., 1st Sess. 2 (1937); S. REP.
No. 900, 7Sth Cong., 1st Sess. 3 (1937). </p>

<p>5 With minor exceptions, the Marihuana Tax Act requires all
transactions in marijuana to be carried out by written order
form. 26 U.S.C.  4741-44 (1964). It is unlawful for a
transferor to transfer except by such form obtained by the
transferee, 26 U.S.C. S 4742 (1964), and for the transferee to
acquire, transport or conceal marijuana without filing the
transfer form, registering with the IRS and paying the applicable
transfer tax. 26 U.S.C.  4744 (a) (1964). For heretofore
unregistered persons, that tax is $100 an ounce. 26 U.S.C. 
4741 (1964). Since marijuana was excised from the United States
Pharmacopoeia, there have been few legitimate transactions by
registered persons. THE PRESIDENTS COMMISSION ON LAW ENFORCEMENT
AND ADMINISTRATION OF JUSTICE, REPORT: THE CHALLENGE OF CRIME IN
A FREE SOCIETY 214 (1967). Since .the tax is otherwise
prohibitive, the Act is in effect almost entirely a criminal law;
the crime is having anything to do with marijuana-possession,
sale, acquisition or importation-since proof of possession
coupled with failure, after reasonable notice and demand by the
Secretary of the Treasury or his delegate, to produce the
transfer form is &quot;presumptive evidence&quot; of guilt. 26
U.S.C.  4744(a) (1964). </p>

<p>7 Cf. Abbate v. United States, 359 U.S. 187 (1959); Bartkus v.
Illinois, 359 U.S. 121 (1959); United States v. Lanza, 260 U.S.
377 (1922). One state court held, as an interpretation of state
legislative policy rather than under constitutional compulsion,
that acquittal of a federal marijuana possession charge would
constitute a defense to the same state charge. State v. Wortham,
63 Ariz. 148, 160 P.2d 352 (1945). </p>

<p>8 See Leary v. United States, 383 F.2d 851, 870 (5th Cir.
1967), revd, 395 U.S. 6 (1969); Haynes v. United States, 339 F.2d
30, 31-32 (5th Cir.), cert. denied, 380 U.S. 924 (1965). </p>

<p>9 See pp. 1077-78 supra. </p>

<p>10 21 U.S.C.  176a (1964). </p>

<p>11 Importation &quot;contrary to law` was that in violation of
the Marihuana Tax Act, 26 U.S.C. S 4755 (1964), or the Customs
Act, 19 U.S.C. S 1496-97 (1964). </p>

<p>12 See note 19 infra and accompanying text. </p>

<p>13 See, e.g., Rule v. United States, 362 F.2d 215 (5th Cir.
1966), cert. denied, 385 U.S. 1018 (1967). </p>

<p>14 18 U.S.C.  1407 (1964). </p>

<p>15 Application of the statute was particularly harsh. Even
though defendant, found guilty of a drug offense and sent to the
California Youth Authority for several months, had been told upon
release that his record was clean, the court held that he had
violated the statute by failing to register. Adams v. United
States, 299 F.2d 327 (9th Cir. 1962). </p>

<p>16 See Palma v. United States, 261 F.2d 93 (5th Cir. 1958');
Reyes v. United States, 258 F.2d 774 (9th Cir. 1958); United
States v. Eramdjian, 155 F. Supp. 914 (S.D. Cal. 1957). The
courts struggled mightily with arbitrariness, vagueness, right to
travel, self incrimination, and equal protection arguments, but
upheld the statute. But cf. Russell v. United States, 306 F.2d
402 (9th Cir. 1962) (gun registration requirement
unconstitutional since it required admission of presumptively
unlawful possession). </p>

<p>17 26 U.S.C. S 4744 (a) (1964). </p>

<p>18 E.g., Manning v. United States, 274 F.2d 926 (5th Cir.),
rcv'd on other grounds on rehearing, 280 F.2d 422 (5th Cir.
1960). </p>

<p>This provision was early interpreted not to require government
agents to request the transfer form at the time of arrest, the
courts holding that possession of the form was an affirmative
defense. E.g., Hill v. United States, 261 F.2d 483 (9th Cir.
1958); Hensley v. United States, 160 F.2d 257 (D.C. Cir.), cert.
denied, 331 U.S. 817 (1947). </p>

<p>19 21 U.S.C.  176a (1964). </p>

<p>20 Leary v. United States, 383 F.2d 851, 869 (5th Cir. 1967),
rev'd, 395 U.S. 6 (1969); Borne v. United States, 332 F.2d 565
(5th Cir. 1964); United States v. Gibson, 310 F.2d 79 (2d Cir.
1962); Claypole v. United States, 280 F.2d 768 (9th Cir. 1960);
Butler v. United States, 273 F.2d 436 (9th Cir. 1959); Caudillo
v. United States, 253 F.2d 513 (9th Cir.), cert. denied, 357 U.S.
931 (1958). </p>

<p>21 Yee Hem v. United States, 269 U.S. 178 (1925). </p>

<p>22 Caudillo v. United States, 253 F.2d 513 (9th Cir.), cert.
denied, 357 U.S. 931 (1958). Implying that the presumption of
importation was a rule of evidence, not of substantive law, the
court noted that imported marijuana was ordinarily composed of
mixed twigs and stems since the growers waited until maturity
before harvesting. In the United States, on the other hand,
growers avoided police detection by picking individual leaves
before the plant matured, Since appellant possessed mixed twigs
and stems, the court upheld application of the presumption; the
clear suggestion, however, was that the presumption would not be
applied to manicured marijuana. </p>

<p>23 Costello v. United States, 324 F.2d 260 (9th Cir. 1963),
cert. denied, 376 U.S. 930 (1964). </p>

<p>24 Use of the Latin word &quot;cannabis&quot; was challenged
as an unconstitutionally vague definition of the prohibited
substance in People v. Oliver, 66 Cal. App. 2d 431, 152 P.2d 329
(Dist. Ct. App. 1944), on the basis of an early holding that the
use of Latin to define a sex crime was unconstitutionally vague,
Ex parte Lockett, 179 Cal. 581, 178 P. 134 (1919) (fellatio and
cunnilingus). -In rejecting the vagueness argument, the court
held that &quot;cannabis&quot; was later explained in the statute
by the use of the word &quot;marijuana&quot; and that the two
words were synonymous. See People v. Martinez, 117 Cal. App. 2d
701, 256 P.2d 1028 (Dist. Ct. App. 1953) (&quot;Indian Hemp&quot;
not unconstitutionally vague); cf. People v. Johnson, 147 Cal.
App. 2d 417, 305 P.2d 82 (Dist. Ct. App. 1957)
(&quot;lophophora&quot; not unconstitutionally vague reference to
peyote). </p>

<p>25A related issue was whether the charge of possession of
&quot;marijuana&quot; was specific enough where there were
statutory exceptions to protect the bird seed and hemp
industries. The general rule was that the state need not allege
that the parts possessed were not within the statutory
exceptions. E.g., Simpson v. State, 129 Fla. 1279 176 So. 515
(1937). Contra, People v. Sowrd, 370 111. 140, 18 N.E.2d 176
(1938'). </p>

<p>26See, e.g., Simpson v. State, 129 Fla. 127, 131, 176 So. 515,
517 (1937) (marijuana causes erotic hallucinations, loss of
sense, false conviction, loss of values, a general weakening of
powers, making it dangerous to mind and body). In Commonwealth v.
LaRosa, 42 Pa. D. &amp; C. 34, 36-37 (Fayette County Dist. Ct.
1941), the court stated: </p>

<p>The deleterious, even vicious, qualities of the plant which
render it highly dangerous to the mind and body, upon which it
operates to destroy the will, to produce imaginary delectable
situations, and gradually to weaken the physical powers, reside
in a sticky resin of great narcotic power that pervades the
entire plant .... 27 State v. Bonoa, 172 La. 955, 136 So. 15
(1931). </p>

<p>28 See State v. Hall, 41 Wash. 2d 446, 249 P.2d 769 (1952);
Commonwealth v. LaRosa, 42 Pa. D. &amp; C. 34 (Fayette County
Dist. Ct. 1941). LaRosa held that the statute, passed two years
earlier, created a duty to cut down marijuana plants before they
could seed and that defendant had no right to plant marijuana
even if he meant to cut the plants before maturity. Defendant's
conviction for possession of two thousand mature plants and one
hundred fifty thousand immature plants was accordingly affirmed. </p>

<p>29 See pp. 1074-75 supra. </p>

<p>30 E.g., State v. Economy, 61 Nev. 394, 130 P.2d 264 (1942). </p>

<p>31 This was particularly true in the Southwest, where use
cases were more numerous and appeals more frequent. Indicative of
this trend are the following Texas cases in chronological order:
Gonzales v. State, 108 Tex. Crim. 253, 299 S.W. 901 (1928) ($25
fine); Baker v. State, 123 Tex. Crim. 209, 58 S.W.2d 534 (1933)
(5-year sentence reversed); Horton v. State, 123 Tex. Crim. 237,
58 S.W.2d 833 (1933) (2-year sentence reversed); Spangler v.
State, 135 Tex. Crim. 36, 117 S.W.2d 63 (1938) 1-year sentence
affirmed); Ramirez v. State, 135 Tex. Crim. 442, 125 S.W.2d 597
(1938) (3-year sentence affirmed) (possession of a crop of 300
plants); Fawcett v. State, 137 Tex. Crim. 14, 127 S.W.2d 905
(1939) (2-year sentence reversed); Anderson v. State, 137 Tex.
Crim. 461, 131 S.W.2d 961 (1939) (5-year sentence affirmed)
(defendant tried to dispose of marijuana in station house);
Martinez v. State, 138 Tex. Crim. 51, 134 SW.2d 276 (1939)
(6-year sentence reversed); Carrizal v. State, 138 Tex. Crim.
103, 134 S.W.2d 287 (1939) (2-year sentence affirmed); Lufkin v.
State, 144 Tex. Crim. 501, 164 S.W.2d 709 (1942) (2-year
affirmed); Cornelius v. State, 158 Tex. Crim. 356, 256 S.W.2d 102
(1953) (2-year sentence affirmed); Sparks v. State, 159 Tex.
Crim. 111, 261 S.W.2d 571 (1953) (2-year sentence reversed); Rao
v. State, 160 Tex. Crim. 416, 271 S.W.2d 426 (1954) (2-10 year
sentence); Brewer v. State, 161 Tex. Crim. 28, 274 S.W.2d 411
(1954) (8-year sentence affirmed); Torres v. State, 161 Tex.
Crim. 480, 278 SW.2d 853 (1955) (3-year sentence affirmed); Gomez
v. State, 162 Tex. Crim. 30, 280 SW.2d 279 (1955) (5-25 year
sentence affirmed); McWhorter v. State, 163 Tex. Crim. 318, 291
SW.2d 329 (1956) (2-3 year sentence affirmed); Crosco v. State,
164 Tex. Crim. 257, 298 S.W.2d 134 (1957) (2-year sentence
affirmed); Garcia v. State, 166 Tex. Crim. 482, 316 S.W.2d 734
(1958) (life sentence affirmed); Sherr2d v. State, 167 Tex. Crim.
119, 318 SW.2d 900 (1958) (13-year sentence reversed); Leal v.
State, 169 Tex. Crim. 222, 332 S.W.2d 729 (1959) (75-year
sentence affirmed) (one prior conviction); King v. State, 169
Tex. Crim. 34, 335 S.W.2d 378 (1959) (7-year sentence affirmed);
Locke v. State, 169 Tex. Crim. 361, 334 S.W.2d 292 (1960)
(15-year sentence affirmed); Massiate v. State, 365 S.W.2d 802
(Tex. Crim. App. 1963) (life sentence affirmed) (two prior
burglary convictions). </p>

<p>32 367 U.S. 643 (1961). </p>

<p>33 State v. Shotts, 207 La. 898, 22 So. 2d 209, cert. denied,
326 U.S. 730 (1945). </p>

<p>34 See, e.g., United States v. Rabinowitz, 339 U.S. 56 (1950).
The Court here upheld the search of a one-room office on the
grounds that the search was incident to a lawful arrest, and said
that the scope of such searches must turn on the reasonableness
of the search considering all the underlying circumstances. </p>

<p>35 Cf. Anderson v. State, 137 Tex. Crim. 461, 131 S.W.2d 961
(1939). See also Lea) v. State, 169 Tex. Crim. 222, 332 S.W.2d
729 (1959), holding it reasonable for a policeman to search
defendant's shorts where he suspected from an informer's tip that
the &quot;out of the ordinary bulge&quot; in defendant's pants
concealed marijuana. </p>

<p>36 Ramirez v. State, 135 Tex. Crim. 442, 125 SW.2d 597 (1938).
Eventually, courts began to allow the admission of illegally
seized evidence if there was any untainted source whatsoever.
Thus, where defendant testified that the police had found
marijuana in a dresser drawer in his house, the court permitted
the state to introduce the marijuana based on the untainted
source of defendant's own statements in court. Rao v. State, 160
Tex. Crim, 416, 271 S.W_2d 426 (1954). </p>

<p>37 See Connolly v. Medalie, 58 F.2d 629 (2d Cir. 1932). In
that case judge Learned Hand wrote: </p>

<p>Men just wince at admitting that they were the owners, or in
possession, of contraband property; may wish at once to secure
the remedies of a possessor, and avoid the perils of the part;
but equivocation will not serve. If they come as victims, they
must take on that role, with enough detail to cast them without
question. The petitioners at bar shrank from that predicament;
but they were obliged to choose one horn of the dilemma. </p>

<p>Id. at 630 </p>

<p>38 See King v. State, 169 Tex. Crim. 34, 335 SAV.2d 378
(1959). Here the Texas court held, with one dissent, that a
search warrant for the premises of the husband authorized a
search of the wife's bag in the house; her conviction for the
materials found in the bag was affirmed, </p>

<p>In the field of search incident to an arrest, courts went even
farther. Thus, a Texas court affirmed a conviction based upon the
arrest and search of a defendant, even though the police officer
admitted he had arrested the defendant solely for the purpose of
searching him. The officer ostensibly arrested the defendant for
a knife fight, but later admitted that he had arrested him
because he suspected him of possession of marijuana. The court
noted that the defendant was unable to give any authority for his
contention that the state should be bound by the officer's
statement as to the purpose of the arrest. Gonzales v. State, 160
Tex. Crim. 548, 272 S.W.2d 524 (1954). </p>

<p>39 It had been held that contraband may be seized in a search
incident to arrest although the items taken had no relationship
to the crime for which the arrest was made. Harris v. United
States, 331 U.S. 145 (1947). overruled, Chimel v. California, 395
U.S. 752 (1969). </p>

<p>40 THE PRESIDENT'S COMMISSION ON LAW ENFORCEMENT AND
ADMINISTRATION OF JUSTICE, TASK FORCE REPORT: NARCOTICS AND DRUG
ABUSE 8. See also MASS PRODUCTION JUSTICE AND THE CONSTITUTIONAL
IDEAL 52-53 (C. Whitebread ed. 1970). </p>

<p>41 287 U.S. 435 (1932). </p>

<p>42 356 U.S. 369 (1958). </p>

<p>43 See A. LITTLE, DRUG ABUSE AND LAW ENFORCEMENT (1967). </p>

<p>44 See Henderson v. United States, 237 F.2d 169, 172 (1956);
State v. Taylor, 375 S.W.2d 58, 62 (Mo. 1964). But see People v.
Perez, 62 Cal. 2d 769, 401 P.2d 934, 44 Cal. Rptr. 326 (1965)
(Traynor, C.J.). </p>

<p>45 Sherman v. United States, 356 U.S. 369, 377 &amp; n.8
(1958) (Warren, GJ.). </p>

<p>46 Id. it 378 (Frankfurter, J., concurring); Sorrells v.
United States, 287 U.S. 435, 453-59 (1932) (Roberts, J.,
dissenting). </p>

<p>47 228 F.2d 121 (5th Cir. 1955), See also United States v.
Davis 272 F.2d 149 (7th Cit. 1959). Davis was not strictly an
entrapment case; the government agents had arranged for the
transportation of a hag of marijuana front Texas to Chicago. The
defendant argued that the agents' activities were illegal, and
for that reason, the government was estopped from prosecuting him
and that the evidence was inadmissible. The trial court found
that the defendant had arranged for the deal and instructed the
jury to acquit if the agents had illegally caused the
importation. As in Gilmore, the jury was not willing to condemn
the police, </p>

<p>48 People v. Branch, 119 Cal. App. 2d 490, 494, 260 P.2d 27,
30 (Dist. Ct. App. 1953), where the police had their witness call
the defendant and ask to buy some marijuana and then accompanied
the witness to the defendant's home. </p>

<p>49 See People v. Williams, 146 Cal. App. 2d 656, 304 P.2d 100
(1956); Commonwealth v. Jones, 46 Dauph. 300 (Dauphin County,
Pa., Dist. Ct. 1938). </p>

<p>50 See, e.g., People v. Agajanian, 97 Cal. App. 2d 399, 218
P.2d 114 (Dist. Ct. App. 1950); People v. Oliver, 66 Cal. App. 2d
431, 152 P.2d 329 (Dist. Ct. App. 1944); Valdez v. State, 135
Tex. Crim. 201, 117 S.W.2d 459 (1938). </p>

<p>51 McWhorter v. State, 163 Tex. Crim. 318, 291 S.W.2d 329
(1956). </p>

<p>52 People v. Sanchez, 197 Cal. App. 2d 617, 17 Cal. Rptr. 230
(Dist. Ct. App. 1961); People v. Haggard, 181 Cal. App. 2d 38, 4
Cal. Rptr. 898 (Dist. Ct. App. 1960); People v. Janisse, 162 Cal.
App. 2d 117, 328 P.2d 11 (Dist. Ct. App. 1958). Even minors who
receive the marijuana from the defendant are competent to
identify the substance. People v. Sanchez, supra. </p>

<p>53 See Hernandez v. State, 137 Tex. Crim. 343, 129 S.W.2d 301
(1938). </p>

<p>54 See, e.g., cases cited at note 52 supra. </p>

<p>55See, e.g., People v. Ballejos, 216 Cal. App. 2d 286@ 30 Cal.
Rptr. 725 (Dist. Ct. App. 1963); People v. Johnson, 99 Cal. App.
2d 559, 222 P.2d 58 (Dist. Ct. App. 1950). overruled, People v.
Perez, 62 Cal. 2d 769, 401 P.2d 934, 44 CA Rptr. 326 0965)
(Traynor, C.J.). See also People v. Sanchez, 197 C21. App, 2d
617, 17 Cal, Rptr. 230 (Dist. Ct. App. 1961); People v. Alinnns,
110 Cal. .@,\pp. 2d 310, 242 P.2d 331 (Dist. Ct. App.), ccrt.
dcnied, 344 U.S. 846 (1952). </p>

<p>56 162 CA App. 2d 117, 328 P.2d 11 Misr. Ct. App. 1958) (it
was not too improbable that defendant would have given marijuana
away to a near stranger). But see People v. MacCagnan, 129 Cal.
App, 2d 100, 276 P.2d 679 (Dist. Ct. App. 1954) (evidence of the
price admitted to show the unlikelihood that defendant was given
the marijuana). </p>

<p>57 People v. Gebron, 124 C21. App, 2d 675, 208 P.2d 1068
(Dist. Ct. App. 1954). </p>

<p>58 People v. Mimms, 110 Ca]. App. 2d 310, 242 P.2d 331 (Dist.
Ct. App.), cert. denied, 344 U.S. 846 (1952). </p>

<p>59 People V. JA7irlSton, 46 Ca]. 2d 151, 293 P.2d 40 (1956)
(witnesses against defendant for sale to minor were due to go on
trial themselves); People v. Ballejos, 216 Cal. App. 2d 286, 30
Cal Rptr. 725 (Dist, Ct. App. 1963) (agent alleged to be paid by
government if successful was only witness against defendant). </p>

<p>60 See People v. Carrasco, 159 Cal. App. 2d 63, 32i P.2d 129
(Dist. Ct. App. 1958), People v. Antista, 129 Cal. App. 2d 47,
276 P.2d 177 (Dist. Ct. App. 1954) (defendant never reported
having previously used marijuana and apartment used by many other
persons); People v. Candiotto, 128 Cal. App. 2d 347, 275 P.2d 500
(Dist. Ct. App. 1954); People v. Savage, 128 Cal. App. 2d 123,
274 P.2d 905 (Dist. Ct. App. 1954) (maid found marijuana wrapped
in napkins two days after a party held to be insufficient
evidence) (trial judge held to be prejudiced); Fawcett V. State,
137 Tex. Crim. 14, 127, S.W.2d 905 (1939) (reversed for failure
to give instruction on ignorance as a defense). </p>

<p>61 Gonzales v. People, 128 Colo. 522, 264 P.2d 508 (1953);
State v. Walker, 54 N.M. 302, 223 P.2d 943 (1950). </p>

<p>62 Perez v. State, 34 Ala. App. 406, 40 So. 2d 344 (Ct. App.
1949) (paper in apartment matched paper on marijuana). See also
People v. Rodriguez, 151 Cal. App. 2d 598, 312 P.2d 272 (Dist.
Ct. App. 1957) (defendant knowingly helping owner move marijuana
is sufficient for possession). </p>

<p>63 People v. Miller, 162 Cal. App. 2d 96, 328 P.2d 506 (Dist.
Ct. App. 1958) (reversible error to introduce marijuana found
down the street from the defendant's apartment without further
proof of defendant's ownership) - In Sherrad v. State, 167 Tex.
Crim. 119, 318 S.W.2d 900 (1958), defendant's conviction was
reversed for the failure of the prosecutor to connect the payment
to the defendant with the later payment to another defendant who
made delivery of the marijuana to the agent. The court noted that
defendant had been charged as the principal, and that no proof of
any conspiracy had been made. See also People v. Vasquez, 135
Cal. App. 2d 446, 287 P.2d 385 (Dist. Ct. App. 1955) (defendant
chargeable with transporting, not possession, where he told
co-defendant to throw marijuana away and co-defendant did not do
so). </p>

<p>64 Lake v. United States, 302 F.2d 452 (8th Cir. 1962). </p>

<p>65 See, e.g., People v. Sykes, 44 Cal. 2d 166, 280 P.2d 769,
cert. denied, 349 U.S. 934 (1955) (evidence of defendant's
activities as a pimp admissible in a trial on charge of marijuana
sale to minor in order to prove that there was a plot to
subjugate both the body and mind of the minor) (Traynor, CJ,
dissented, stating that the evidence was prejudicial and of no
probative value); Escamilla v. State, 162 Tex. Crim. 346, 285
SW.2d 216 (1955) (permissible for prosecutor to call defendant a
peddler and then to withdraw statement); People v. Salo, 73 Cal.
App. 2d 685, 167 P.2d 269 (Dist. Ct. App. 1946); Medina v. State,
149 Tex, Crim. 249, 193 S.W.2d 196 (1946) (no error to call
defendant a dealer in marijuana in possession trial). </p>

<p>66 Torres v. State, 161 Tex. Crim. 480, 278 S.W.2d 85 3 (195
5). </p>

<p>67 People v. Head, 108 Cal. App. 2d 734, 239 P.2d 506 (Dist.
Ct. App. 1952).</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-26</DOCNO>
<DOCOLDNO>IA031-000655-B038-73</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlr8.htm 206.61.184.43 19970122112548 text/html 44984
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:25:38 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:47:20 GMT
Content-length: 44766
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>The Public Discovers The Truth About Marijuana</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><b>THE FORBIDDEN FRUIT AND THE TREE OF KNOWLEDGE: AN INQUIRY
INTO THE LEGAL HISTORY OF AMERICAN MARIJUANA PROHIBITION</b> </p>

<p><font size="2"><i>Richard J. Bonnie &amp; Charles H.
Whitebread, II</i></font> </p>

<p><b>VIII. THE PUBLIC DISCOVERS THE TRUTH ABOUT MARIJUANA</b></p>

<hr>

<p>&nbsp;We need not belabor the point, but sometime after 1965
the wisdom of the marijuana laws suddenly became dinner-table
conversation in most American middle-class homes along with the
Indochina war and campus dissent. Many sons and daughters, and
even mothers and fathers, of the middle class had tried the drug,
and those who had not were certainly familiar with
&quot;pot&quot; and the law. The medical profession finally
commenced a research effort to determine who was right-the user
who said the drug was a harmless pleasant euphoriant or the
lawmakers, who by their actions had condemned it as a noxious
cause of crime, addiction and insanity. <br>
</p>

<p>A. Marijuana and the Masses </p>

<p>Although marijuana arrests arid seizures hit their all-time
low point in 1960,1 the middle and late sixties witnessed a
revolution in marijuana use. Vast numbers of people have recently
adopted the drug as their principal euphoriant; however, by all
estimates, the new users are the sons and daughters of the middle
class, not the ethnic minorities and ghetto residents formerly
associated with marijuana.2 Student marijuana use is now so
common that it has been associated in the public eye with the
overall campus life style.3 Accompanying the growth of widespread
marijuana use on campus has been an increasing experimentation
with the drug by intellectuals, professors, young professionals
and members of several other social groups who would never have
considered using the drug ten years ago.4 </p>

<p>Dr. Stanley F. Yolles, former Director of the National
Institute of Mental Health, testifying before a Senate
subcommittee, said, &quot;A conservative estimate of persons in
the United States, both Juvenile and adult, who have used
marihuana, at least once, is about 8 million and may be as high
as 12 million people.&quot;5 Other estimates have run as high as
twenty to twenty-five million users.6 This vast increase in the
number of people using marijuana seems to have begun in the early
and middle sixties. It is likely that this new use pattern was
initially precipitated by the publicity surrounding the LSD
experimentation of Doctors Alpert and Leary at Harvard in 1963.7
As a growing segment of the academic fringe began to preach
consciousness-expansion, students began to find marijuana
available on campus. From that point the phenomenon snowballed.
As more novice marijuana users reported no ill effects from its
use, more students tried it, and in turn those who used and
enjoyed the drug began to &quot;turn on&quot; those who had not.
By 1970, some campuses reported that over seventy percent of the
student body were users.8 More recently, marijuana use spread
beyond the student subculture; reportedly its use has become
common even among young professionals on Wall Street.9 Moreover,
since it is readily available and widely used in Vietnam,
marijuana has become popular with many soldiers.10 </p>

<p>3 See, e.g., R. DEBoLD&amp; R. LEAF, LSD,MAN AND SOCIETY
(1967); R. GOLDSTEIN, ONE IN SEVEN: DRUGS ON CAMPUS (1966); K.
KENNISTON, THE UNCOMMITrED: ALIENATED YOUTH INAMERICAN SOCIETY
(1967); D, LOURIA, THEDRUG SCENE (1968); L. SIMMONS &amp; B.
WINEGRAD, IT'S HAPPENING (1967). </p>

<p>4 See Malabre, Drugs on the Job, Wall St. J., May 4, 1970, at
1, Col. 6. This article deals not only with drug use by
professionals but also details the increasing trend of drug use
on the job. </p>

<p>5 Hearings Before the Subcomm. to Investigate juvenile
Delinquency of the Senate Comm. on the Judiciary, 91st Cong., 1St
Sess. 267 (1969) [hereinafter cited as Narcotics Legislation
Hearings]. </p>

<p>6 Id. at 268. </p>

<p>7 See R. DEBOLD &amp; R. LEAF, LSD, MAN AND SOCIETY 130-31
(1967). </p>

<p>8 TIME, Sept. 26, 1969, at 69; Yale Daily News, Jan. 14, 1970.
</p>

<p>9 Malabre, supra note 4. </p>

<p>10 D. LOURIA, THE DRUG SCENE 10 (1968). </p>

<p>The general public is clearly aware that there has been both a
vast increase in the number of users and a shift from lower- to
middle-class use of the drug. These great changes in the nature
of marijuana use have had important social consequences. First,
with the sharp rise in the number of users and the tendency of
marijuana users to share common life styles and often political
opinions, the drug has become associated ill the past few years
with a major counter-culture, Many proponents of that
counter-culture have contended that the illegal status of
marijuana -which puts large numbers of people oil the wrong side
of the criminal law-is the most significant unifying and
recruiting agent for the New Left and the other political and
social causes of the late sixties.&quot; Some New Left leaders
have gone so far as to oppose reduction in the penalties for
marijuana possession because they feel severe penalties aid their
recruiting ends by making marijuana users outraged against a
society that overacts so strongly to a nonexistent danger.&quot;
We feel the general disrespect for marijuana laws may be causing
a dangerous disrespect for all laws in a sizeable segment of the
population. The credibility of government suffers on all issues
when its handling of the use of this drug seems to so many so far
removed from reality. This opinion is supported by the increasing
medical evidence that the dangers of tile drug are de minimus. </p>

<p>Secondly, the new middle-class use of marijuana has induced
the first significant medical inquiry into the nature of the
drug; has spawned increasing numbers of challenges to the
constitutionality of marijuana laws and penalties, and has
spurred the passage of more lenient legislation. </p>

<p>One commentator has stated: </p>

<p>Nobody cared when it was a ghetto problem. Marijuana -well, it
was used by jazz musicians or the lower class, so you didn't care
if they got 2-to-20 years. But when a nice, middle-class girl or
boy in college gets busted for the same thing, then the whole
community sits up and takes notice. And that's the name of the
game today. The problem has begun to come home to roost-in all
strata of society, in suburbs, in middle-class homes, in the
colleges, suddenly, the punitive, vindictive approach was
touching- all classes of society. And now the most exciting thing
that's really happening is the change in attitude by the people.
Now we have a willingness to examine the problem, as to whether
it's an experimentation, or an illness rather than &quot;an
evil.&quot; With this change I think we can come to a more
rational approach to methods of drug control.13 </p>

<p>Without doubt, the new class of users has successfully
demanded more favorable attention from the legislatures and the
courts than the lower class could have attracted. In fact, even
the slightest circumscription of the reach of a state marijuana
law is now national news.14 </p>

<p>A third result of the widespread use of marijuana has been a
substantial challenge to the traditional picture of the national
marijuana trade. Over the past three decades, law enforcement
officials continued to convince legislators that the traffic in
marijuana was controlled by professional criminals.15 Confronted
with this portrait of the marijuana trade, legislators naturally
stereotyped the &quot;seller&quot; as the vicious criminal
pushing his wares for high profit and felt that extraordinarily
harsh penalties were justified for sellers.16 From several recent
studies it appears that the structure of marijuana traffic bears
little or no relation to the traditional stereotype. In a recent
survey of 204 users it was found that 44 percent had sold to
friends at least once. Many casual users sell to leave themselves
enough profit to cover the amount of their own use. 17 The study
further finds that even at the very top, profits are too small
and the product too bulky to interest the criminal class that
probably underwrites sales of heroin and other &quot;hard
drugs.&quot; 18 Thus even at the top, amateurs-composed generally
of the students, young professionals and soldiers who constitute
the users-are the main source of the drug.19 It is also important
to note that marijuana is typically sold by the ounce20 rather
than by the cigarette as was traditionally assumed. Thus, even
the relatively casual experimenter was likely to have at least an
ounce of the drug in his possession. </p>

<p><font size="4"><b>B. Enforcement of the Marijuana Laws:
1960-1970</b></font> </p>

<p>As a result of the rapid spread of marijuana use, full
enforcement of the marijuana laws has become impossible.21 By
1967 the Federal Bureau of Narcotics had 299 agents, roughly 50
more than in 1956.22 In the same period the use of marijuana
probably increased 1,000 fold. It seems obvious from both FBN
statistics and the best available state and local statistics that
two enforcement patterns emerged in the sixties: concentration on
&quot;sellers&quot; and selective enforcement. </p>

<p>Since 1960 the FBN and major state and municipal narcotic
squads have concentrated on the larger sellers. In the early
sixties this trend was less pronounced,23 but by 1968 the
Commissioner of the FBN said that 75 percent of federal marijuana
arrests were of dealers and that even the remaining 25 percent
were sellers but were charged with possession as a result of plea
bargains. Statistics from California show the same concentration
on sellers nevertheless the California bureau found that most of
these sellers were young and first offenders.26 Thus, at least by
1968 it became clear that sellers were quite often neophytes. </p>

<p>At the same time that the police have abandoned full
enforcement for concentration on dealers, enforcement of the laws
has remained necessarily haphazard and somewhat selective. Since
marijuana use has become so common, there are certain student and
hippy communities in which the police could arrest nearly
everyone. Here the problem of selective enforcement necessarily
arises-the police arrest those they dislike for other reasons,
either political disagreement or suspicion of use of other drugs.
This inevitable practice, although perhaps not consciously
planned, has brought outcry from some victimized communities.27
This policy-if not a policy by the police at least a perception
by the hippies-of selective enforcement has provided them
increased impetus toward the anti-establishment life style they
have adopted. Their attitude is aggravated when the police engage
in particularly aggressive tactics, such as use of informers, to
trap the offenders. 28 </p>

<p>By 1970, the unenforceability of the marijuana laws was most
clearly evidenced by the failure of President Nixon's Operation
Intercept which was designed to seal off the Mexican border and
the supply of marijuana coming into the United States from
Mexico.29 Both national and international tensions led to the
failure of the &quot;Noble Experiment.&quot; By now, the
marijuana trade is so scattered and at the same time so
fragmented (with no real hierarchy in the trade) that the
unenforceability of these laws has reached Prohibition
proportions.<br>
</p>

<p><b>C. Emergence of Medical Opinion</b> </p>

<p>One of the most significant causes of widespread middle-class
use of marijuana was the lack of any medical proof of the
allegedly evil effects of its use. In fact, what authoritative
studies had been conducted up to this time were inconsistent with
the assumptions underlying anti-marijuana legislation. In this
situation, users viewed themselves as experimenters with a mild
euphoriant, not criminals endangering themselves or society at
large. The inevitable consequence was increased medical inquiry
into the effects of the drug, beginning in about 1967.31 </p>

<p>Concurrently, the National Institute of Mental Health
significantly Increased its funding for grants and contracts for
marijuana research.32 </p>

<p>Despite this intensified inquiry, uncertainty about the
effects of the drug persists. There are several major research
obstacles responsible for continued absence of reliable research.
After outlining the impediments to conclusive findings, we shall
extract from the existing studies the present state of medical
knowledge. </p>

<p><b>1. Research Obstacles</b> </p>

<p>The major obstacle is the nature of the marijuana plant
itself. Marijana is a derivative of the plant Cannabis Sativa,
commonly denoted the hemp plant. It is classified as a dioecious
plant, that is, the male reproductive parts are on one individual
plant and the female parts are on another. The differentiation of
the male and female plants is exceedingly significant because the
chemical compounds responsible for the euphoric effect of
marijuana are found primarily in the sticky resin that covers the
unfertilized female flowers and adjacent leaves. The male plant
may contain a small amount of this active resin, but it is grown
mainly for hemp fiber.33 </p>

<p>The hemp plant yields three rough grades of intoxicating
substances, the least potent of which is &quot;marijuana.&quot;
34 Yet, because the classifications are imprecise, confusion is
engendered by attributing to &quot;marijuana&quot; the effects
produced by the excessive use of the more potent forms of
cannabis.35 In addition, the psychic potency of the plant differs
depending upon where the marijuana is grown, 36 and upon
cultivation variables such as occurrence of fertilization and
time of harvesting: </p>

<p><br>
</p>

<blockquote>
    <p>If the male plants are not removed and fertilization
    occurs, the female plants which carry the main intoxicating
    properties are considerably weakened in that respect. In
    addition, unless harvesting is carried out immediately before
    the blossoming of the flowers there is further weakening and
    variation in the potency of the produce.37 </p>
</blockquote>

<p>It is interesting to note in this connection that the
marijuana used in the United States is among the weakest in the
world.38 These factors frustrate the creation of a standardized
dosage in any given experiment and preclude the comparison of the
results of independent studies.39 </p>

<p>In addition to the problems engendered by the great variance
in potency and dosage, meaningful marijuana research also
inhibited by differences in means of consumption. Since
standardized doses are generally considered impossible if the
drug is smoked,40 most studies, including the La Guardia Report,
are based upon oral administration of marijuana to the subjects.
Yet smoking is the method of consumption among nearly all
American users. Furthermore, standardized dosage is not even
assured by the oral method since &quot;little is known about the
gastrointestinal absorption of the highly water-soluble
cannabinals in man.&quot; 41 Finally, &quot;there is considerable
indirect evidence from users that the quality of the intoxication
is different when marijuana or its preparations are ingested
rather than smoked. In particular, ingestion seems to cause more
powerful effects . . . . &quot; 42 </p>

<p>2. Current Medical Knowledge </p>

<p>It is perhaps best to begin with the medical data concerning
the traditional allegations about marijuana. </p>

<p>(a) The Myths.-First, it is universally accepted among medical
authorities that marijuana is not physically habit-forming.43
Although some researchers have asserted that a psychological
dependence may result from continued use of the drug, this
hypothesis has not been established and its relevance has been
questioned. One authority has noted that &quot;habituation to
marihuana is not as strong as to tobacco or to alcohol.&quot; 44
Another has commented that &quot;[a] psychological dependence and
desire for the drug may occur, but this is inconsistent and is
not uncontrollable.... Perhaps the dependence is even less than
the dependence on cigarettes.&quot; 45 </p>

<p>Second, there is no evidence whatsoever that the use of
marijuana has a direct relationship to the commission of crime.
One commentator has noted that &quot; during the high the
marihuana user may say things he would not ordinarily say, but he
generally will not do things that are foreign to his nature. If
he is not normally a criminal, he will not commit a crime under
the influence of the drug.&quot; 46 In fact, it is entirely
likely that the characteristic passive reaction to the use of
marijuana tends to inhibit criminality. A recent study has shown
that juvenile &quot;potheads&quot; tend to be nonaggressive and
to stay away from trouble.47 Similarly, there is no scientific
evidence for the proposition that marijuana is an aphrodisiac. It
has been suggested to the contrary that the most potent form of
cannabis, pure ganja, has the reverse effect, being taken by
Indian priests to quell the libido.48 </p>

<p>Finally, the evidence is at best inconclusive regarding the
contention that use of marijuana leads to the use of
&quot;hard&quot; narcotics. Some of the early studies claiming to
have established a valid connection were scientifically
unreliable. One authority has observed in this regard: </p>

<p><br>
</p>

<blockquote>
    <p>Supposedly scientific studies of this problem have been
    conducted in the past, such as the one done in a deprived
    area of a large city where the use of heroin was widespread,
    and indicating that many users of marijuana went on to the
    use of more hazardous drugs. I am sure that without previous
    marijuana, the use of such drugs in that environment would be
    just as high, and that if such a study were done on a college
    population, it would be found that the subsequent use of
    &quot;hard&quot; drugs would be negligible.49 </p>
</blockquote>

<p>Referring to a presidential task force investigation, another
authoritv has commented: </p>

<p><br>
</p>

<blockquote>
    <p>It is true that the Federal study showed that among heroin
    users about 50% had had experience with marijuana- the study
    also found, however, that most of the heroin addicts had been
    users of alcohol and tobacco. There is no evidence that
    marijuana is more likely than alcohol or tobacco to lead to
    the use of narcotics.50 </p>
</blockquote>

<p>On the basis of the available information, most authorities
have concluded that there is no scientific basis for the theory
that the use of marijuana is a causal factor in the use of
&quot;hard&quot; narcotics.51 In any event, as a matter of common
sense, it would appear that the phenomenon in dispute is very
complex, including both individual personality features and
environmental factors. As one commentator put it &quot;Several of
the studies indicate that the precious statistics have been
misleading and exaggerated.&quot; Whether or not the proposition
can be scientifically established, there is probably a slightly
greater chance that an individual who has used marijuana could go
on to opiates, but statistically this is not . . . an important
social consideration.&quot;52 </p>

<p>Thus, it appears that none of the traditional allegations
about marijuana has been scientifically established, that its
alleged addictive qualities have been disproved, and that the
overwhelming weight of authority disputes its allegedly crime
producing and stepping stone tendencies. We will now briefly
survey the medically recognized effects of the drug, physical,
psychomotor and psychological. </p>

<p>(b) Physical Effects.-The acute physical effects of marijuana
are the subject of much debate. Various studies have reached
different conclusions. Nearly all authorities, however, are in
agreement that the bodily symptoms accompanying the
&quot;high&quot; are very slight. The most commonly noted effects
are a slight rise in blood pressure, conjunctival vascular
congestion, slight elevation in blood sugar, urinary frequency
and an increase in pulse rate.53 In general, these acute symptoms
are relatively short-lived, and there are no known lasting
physical effects.54 On the other hand, there is evidence that
prolonged smoking could lead to &quot;marijuana bronchitis,&quot;
and that communal smoking has the tendency to encourage the
spread of communicable diseases. </p>

<p>(c) Psychomotor Effects.-Varying results have also been
reported in studies of the acute effects of marijuana upon
psychomotor functions. Although the researchers have sometimes
found some slight impairment in performance tests,55 there is
apparently no general depressing or stimulating effect on the
nervous system and no influence on speech and coordination.56 In
the most recent study, Doctors Well, Zinberg and Nelson of the
Boston University School of Medicine found that marijuana users
are able to compensate nearly 100 percent for whatever adverse
effects may result on ordinary psychomotor performance. 57 </p>

<p>Such findings suggest that marijuana is not likely to be a
causal factor in driving accidents, a hypothesis that is
supported by a recent simulated driving test comparing the
performance of subjects under the influence of marijuana and
alcohol.58 There seems to be no contention in the medical field
that there are any lasting effects from marijuana in the
psychomotor area. The Well study reported that noticeable effects
&quot;were diminished between 30 minutes and I hour, and they
were largely dissipated 3 hours after the end of smoking. No
delayed or persistent effects beyond 3 hours were observed or
reported.&quot; 59 </p>

<p>(d) Psychological Effects.-The acute psychological effects of
the use of marijuana are more complex. At the outset, it can be
stated with certainty that &quot;marijuana is definitely
distinguishable from other hallucinogenic drugs such as LSD, MIT,
mescaline, peyote, and psilocybin. Although it produces some of
the same effects, it is far less potent than these other drugs.
It does not alter consciousness to nearly so great an extent as
they do nor does It lead to increasing tolerance to the drug
dosage.&quot; 60 Furthermore, the subjective effects of cannabis
are dependent upon the personality of the user, his expectations,
and the circumstances under which the drug is taken, as well as
learning to smoke marijuana properly.61 </p>

<p>There is general agreement about the pleasurable psychological
effects. Users uniformly experience greatly enhanced
perception-whether real or delusory-of visual, auditory, taste
and touch effects, increased sense of humor or hilarity, feelings
of well-being or wonderment, and distorted time and space
perceptions.62 In this connection, it is interesting to note that
even the pleasurable phenomena are dependent on individual
circumstances, particularly ivlicii the drug is taken for the
first time. Many, if not most, people do not become
&quot;high&quot; on their first exposure to marijuana, even if it
is smoked correctly.63 The probable explanation for this curious
phenomenon is that repeated exposure to marijuana reduces
psychological inhibition, as part of, or as a result of, a
learning process.64 </p>

<p>Medical knowledge is most tentative with reference to adverse
psychological effects. Recent studies, however, have vehemently
disputed an earlier tendency to attribute psychoses and severe
panic reactions to marijuana use.65 As Dr. Well has noted: </p>

<p><br>
</p>

<blockquote>
    <p>Because reliable information about the acute effects of
    marijuana has been as scarce within the medical profession as
    without, many of these reactions have been misinterpreted and
    incorrectly treated. For example, simple panic states, which
    doubtless would be properly diagnosed in other circumstances,
    are often called &quot;toxic psychoses&quot; when doctors
    elicit immediate histories of marijuana use.66 </p>
</blockquote>

<p>Medical experts now generally agree that the possibility of
depression, panic and psychoses depends entirely on the
circumstances of use and the personality of the user.67 In his
most recent study, Dr. Weil concluded that &quot;serious adverse
reactions are uncommon in the 'normal' population,&quot;68 but
noted three exceptions. First, simple depressive reactions which
rarely occur in regular users may occur in novices who approach
their initial use ambivalently.69 Second, the most frequent
adverse reaction is apprehension, more often described as
anxiety, and sometimes reaching a degree of panic. Again, such
reactions are closely related to the attitude of the user and to
the social setting.70 The social setting also influences the
frequency of panic reactions, suggesting again that this
phenomenon correlates with the degree of reluctance with which
people approach initial use of the drug: </p>

<p><br>
</p>

<blockquote>
    <p>In a community where marijuana has been accepted as a
    recreational intoxicant, they may be extremely rare (for
    example, one per cent of all responses to the drug). On the
    other hand, at a rural Southern college, where
    experimentation with the drug may represent a much greater
    degree of social deviance, 25 per cent of persons trying it
    for the first time may become panicked.71 </p>
</blockquote>

<p>The panicked person normally believes that he is either dying
or losing his mind, and simple reassurance will end most such
reactions.72 The reaction normally is short-lived, but it may be
prolonged by an attitude encouraging the underlying fears.73 In
short, &quot;panic reactions . . . seem more nonpharmacologic
than pharmacologic.&quot;74 </p>

<p>Third, psychotic reactions occur rarely, if at all, in normal
users,75 and occur mainly in persons with a low psychosis
threshold or a history of psychosis76 or hallucinogenic drug
experimentation.77 Even in such cases, marijuana is a precipitant
rather than a primary cause of this type of reaction 78 which
lasts at most a day or two.79 <br>
</p>

<hr>

<h2>Footnotes </h2>

<p>1 TRAFFIC IN Opium 69 (1960). </p>

<p>2 In reporting the marijuana arrests of Robert Kennedy, Jr.,
and R. Sargent Shriver, Jr., Walter Cronkite noted that
&quot;This case is not unusual; more and more parents across the
nation find themselves going to court with their children on drug
charges. It's becoming an incident of modern living.&quot; CBS
Evening News, Aug. 6, 1970, See also J. Rosevear, Pot: A HANDBOOK
OF MARIHUANA 117-31 (1967); TRAFFIC IN OPIUM 2, 40 (1966). </p>

<p>11 Perhaps the best statement the authors have yet encountered
to this effect was made by Jerry Rubin, one of the Chicago Seven,
in Charlottesville, Virginia, on May 6, 1970, when he said:
&quot;Smoking pot miles you a criminal and a revolutionary-as
soon as you take your first puff. you are an enemy of
society&quot; See also J. Rubin. Do It! (1970). </p>

<p>12 Wash. Post, Feb. 24, 1970, at III, col. 3. </p>

<p>13 N.Y. Times, Feb. 15, 1970,  6 (Magazine), at 14
(statement of Dr. Stanley Yolles). </p>

<p>14 See, e.g., Wash. Post, May 16, 1970, at A3, col. 8
(reporting a Minnesota Supreme Court decision holding that
possession of small amount of marijuana does not necessarily
justify conviction). This case is discussed at P. 1122 infra. </p>

<p>15 N.Y. Times, Oct. 19, 1969,  4, at 8, col. 2. </p>

<p>16 Narcotics Legislation Hearings 4 (statement of Senator
Dodd). </p>

<p>17 Goode, The Marijuana Market, 12 Colum. F., Winter 1969, at
7. </p>

<p>18 Id. at 8. </p>

<p>19 Hearings Before the Subcomm. to Investigate Juvenile
Delinquency of the Senate Comm. on the judiciary, 90th Cong., 2d
Sm. 4510 (1968) [hereinafter cited as Juvenile Delinquency
Hearings]. At these hearings, former Commissioner of the Bureau
of Narcotics, Henry Giordano, stated: &quot;We have not seen any
evidence of criminal syndicates such as the Mafia being involved
[in the marijuana trade].&quot; Id. </p>

<p>20 Goode, supra note 17, at 4, 5. See also Leary, the
Politics, Ethics, and Meaning of Marijuana, in The MARIHUANA
PAPERS 121 (D. Solomon ed. 1966). </p>

<p>21 See Los Angeles Times Dec. 4, 1967, s. 2 at 6, col. 1
(statement by Los Angeles Police Chief). </p>

<p>22 See Mandel, Problems with Official Drug Statistics, 21
Stan. L. Rev. 991, 1021 n. 114 (1969). </p>

<p>23 See TRAFFIC IN OPIUM 72 (1960); id. at 65 (1961) id at 78
(1963) </p>

<ol>
    <li>Hearings on Depts of Treasury and Post Office and the
        Executive Offic Appropriations for 1969 Before a Subcomm.
        Of the Hose Comm. On Appropriations, 90<sup>th</sup>
        Cong. 2d sess., pt. 1, at 624 (1968) </li>
</ol>

<p>25 The state of California has kept excellent statistics since
1959. In 1968. as a typical year of the late sixties, the police
seized over 30,000,000 grams of marijuana of all kinds in only
10,000 arrests. The larger amount seized relative to the number
of arrests seems to indicate the concentration on dealers. BUREAU
OF CRIMINAL STATISTICS, DEPT OF JUSTICE, STATE OF CALIFORNIA,
DRUG ARRESTS AND DISPOSITIONS IN CALIFORNIA 41, 43 (1968) </p>

<p>26 Id. at 37-39. </p>

<p>27 See Fort, Social Problems of Drug Use and Drug Policies, 56
CALIF. L. Rev. 17, 23 (1968). See also H. BECKER, OUTSIDERS 159
(1963); T. DUSTER, T14E LEGISLATION OF MORALITY: LAW, DRUGS AND
MORAL JUDGMENT (1970). </p>

<p>28 See LITTLE, DRUG ABUSE AND LAW ENFORCEMENT 1313 -15 (1967);
Project, Marijuana Laws: An Empirical Study of Enforcement and
Administration in Los Angeles County, 15 U.C.L.A. L. Rev. 1507,
1522-31 (1968). </p>

<p>29 TIME, Sept. 26, 1969, at 70. </p>

<p>30 One commentator has charged that those most knowledgeable
about marijuana have &quot;dodged&quot; the topic. Kaplan, The
Special Case of Marihuana (Or, It's the Doctor's Fault), 9 J.
CLINICAL PHARMACOLOGY 349, 351 (1969). </p>

<p>31 At the end of 1968 there existed only four known studies on
human subjects conducted by Americans. See Weil, Zinberg &amp;
Nelson, Clinical and Psychological Effects of Marihuana in Man,
162 SCIENCE 1234, 1235 (1968) [hereinafater cited as Weil Study].
The previous lack of concern with marijuana call also be observed
by 211 examination of the number of articles appearing in medical
periodicals. During the decade between 1942 and 1951, only six
articles dealing with the subject are listed in the index for
medical journals. Eleven reports were noted as being published in
the next ten years. From 1962 to 1966, an average of three
materials per year were available. It was not until 1967 that the
subject became of sufficient interest to occupy the time of a
reasonable number of medical authors. In that year, eleven
articles appeared in medical periodicals. By 1968, this number
had increased to 30, and in 1969 more than 60 articles dealing
with the topic of human marijuana consumption have appeared. In
other words, more than three times the number of articles
appeared in the last three years than in the 25 preceding years. </p>

<p>32 In Fiscal year 1967, NIMH obligated $786,000 for marihuana
research grants and contracts. Comparable figures for 1968 and
1969 respectively were S1,239,000 and $1,330,000. In Fiscal year
1970, if funds are available, the institute proposes to obligate
$2,550,000 to support grant and contract studies of marihuana,
which means that there will have been a more than three-fold
increase for support of these studies in the last four
years.&quot; Statement by Dr. Roger 0. Egcberg, Assistant
Secretary for Health and Scientific Affairs, M.S. Dep't of HEW,
before the Select Committee oil Crime, U.S. House of
Representatives (mimeographed press release). </p>

<p>33 Weil Study 1234. </p>

<p>34 The three substances are charas-pure unadulterated resin
that has been scraped from the leaves and flowering tops of the
female plant; hashish or ganja-an agglomeration of female
flowering tops and stems with whatever resin is attached to their
surfaces, thought to contain about 40% resin; and marijuana-a low
potency preparation consisting of dried mature leaves and
flowering tops of both male and female plants, thought to contain
between 5 and 8% resin. Schwarz, Toward a Medical Understanding
of Marihuana, 14 CAN. PSYCHIATRIC ASS'N J. 591, 592 (1969). </p>

<p>35 As long as the term marihuana is used indiscriminately to
refer to cannabis of all kinds and potencies, confusion will
continue. . . . In this country some of the vigorous opponents of
marihuana seem to foster this confusion by attributing to any use
of marihuana the effects produced primarily by the excessive use
of the more potent forms of cannabis in an attempt to preserve a
strongly negative public image of marihuana. </p>

<p>H. NOWLIS, DRUGS ON THE COLLEGE CAMPUS 93 (1969). </p>

<p>36 &quot;The major botanical feature of the plant is the
extreme variability in its appearance, characteristics and
properties when grown in different geographical and climatic
condition.&quot; Schwarz, supra note 34, at 591. In the United
States and Mexico, for example, the production of the more potent
forms is relatively uncommon, and there appears to be no demand
for them. J. ROSEVEAR, POT: A HANDBOOK OF MARIHUANA 31-33 (1967).
</p>

<p>37 Schwarz, supra note 34, at 592. </p>

<p>38 Zunin, Marijuana: The Drug and the Problem, 134 MILITARY
MED. 104, M. 7 (1969). According to the author, several factors
contribute to this phenomenal: (1) The amount of resin found in
the flowering tops markedly decreases as the plants are grown in
more temperate areas. It is estimated that the resin content of
Indian cannabis is 20%; Mexican 15% or less; that grown in
Kentucky 8%; and that found in Wisconsin 6% or less. </p>

<p>(2) The activity of the resin in the female is greatly reduced
if fertilized by the male. In this country, because of an
inability to distinguish between the two plants, inattention to
cultivation and lack of knowledge, the female plants are
fertilized. (3) The resinous content is highest prior to
&quot;going to seed&quot; of the female plant. The marijuana in
this country has gone to seed prior to harvesting. </p>

<p>(4) The male plant contains little or no resin content. In
this country, the male plant is indiscriminately mixed with the
female plant in the final preparation. </p>

<p>(5) The most active portion of the plant is the flowering top.
In this country, preparations of marijuana are composed primarily
of leaves, twigs, and seeds which are crushed. </p>

<p>(6) The potency of marijuana decreases with time. It is
reduced at the end of one year, markedly reduced at the end of
two years, and nonexistent at the end of three years. In
addition, it keeps better in cold, dry climates. Most of the
marijuana in the United States is several months to several years
old by the time it has been harvested and has passed through the
smuggling operation. </p>

<p>39 Given the above variations in the plant and in its products
and extracts, together with the continuing ignorance of its
chemistry it is not surprising that it is virtually impossible to
make direct comparisons between the various studies on the
effects on human beings who are even more individually variable. </p>

<p>Schwarz, supra note 34, at 593. </p>

<p>Recently. what is believed to be the active ingredient in
marijuana has been isolated and synthesized. However, this
substance denominated (THC), is only available for research in
very limited quantities. Weil Study Furthermore, it has not been
proven that THC is the sole ingredient contributing to the
effects caused by marijuana. </p>

<p>40 &quot;[M]any pharmacologists dismiss the possibility of
giving marihuana by smoking because, they sav, the dose cannot he
standardized.&quot; Weil Study 1235. </p>

<p>41 Id. </p>

<p>42 Id. </p>

<p>43 &quot;-There is now an abundance of evidence that marihuana
is not an addictive drug. Cessation of its use produces no
withdrawal symptoms, nor does a user feel any need to increase
the dosage as he becomes accustomed to the drug.&quot; Grinspoon,
Marihuana 221 Sci. Am. 17, 21 (1969). </p>

<p>44 Id. </p>

<p>45 Zunin, supra note 38, at 108. </p>

<p>46 Grinspoon, supra note 43, at 22. </p>

<p>47 McGlothlin &amp; West, The Marihuana Problem: An Overview,
125 Am. J. PSYSH. 370, 372-73 (1968). This supports the finding
of the La Guardia Report that marijuana is not a direct causal
factor in criminal misconduct, but that the &quot;high&quot;
leads to sociable attitudes. </p>

<p>48 THE MARIHUANA PAPERS 44 (D. Solomon ed. 1966). Since
marijuana has a tendency to produce drowsiness, it is difficult
to see how it could lead to an act of violent sex. J. ROSEVEAR,
supra note 36, at 61. See also La Guardia Report, in THE
MARIHUANA PAPERS 296-97 (D. Solomon ed. 1966). </p>

<p>49 Radoosky, Marijuana Foolishness, 280 NEW ENG. J. MED. 712
(1969). </p>

<p>50 Grinspoon, supra note 43, at 21-23. </p>

<p>51 THE PRESIDENT'S COMMISSION ON LAW ENFORCEMENT AND
ADMINISTRATION OF JUSTICE, TASK FORCE REPORT: NARCOTICS AND DRUG
ABUSE 13-14 (1967); Council on Mental Health and Committee on
Alcoholism and Drug Dependence, Dependence on Cannabis
(Marijuana), 201 JAM.A. 368-71 (1967). </p>

<p>52 Zunin, supra note 38, at 108. </p>

<p>53 L. GOODMAN &amp; A. GILMAN, THE PHARMACOLOGICAL BASIS OF
THERAPEUTICS ch. 16 (3d ed. 1965). Nausea, vomiting and diarrhea
have also been reported, but it is felt that these symptoms are
mainly the result of oral administration. Grinspoon, supra note
43, at 20. Increased appetite and dryness of the mouth are also
said to be common. </p>

<p>54 Usually the reports of chronic ill effects are to be found
in Eastern studies of individuals using the stronger hashish or
pure resinous substances over prolonged periods of time and are
complicated by the immeasurable effects of many other social,
economic, personality and cultural factors. Schwarz, supra note
34, at 595. </p>

<p>55 Tests by Robert S. Morrow in the 1930's revealed that even
large doses of marijuana did not affect performances on tests of
the speed of tapping or the quickness of response to simple
stimuli. Grinspoon, supra note 43, at 20. &quot;The drug did
affect steadiness of the hand and body and the reaction time for
complex stimuli.&quot; Id. The most recent study in this area was
done by Andrew Weil, Norman Zinberg and Judith Nelson of the
Boston University School of Medicine. Their conclusions were that
regular users of marijuana may show some slight degree of
impairment in performance tests, but that the aptitude of the
subjects may even improve slightly after smoking marijuana. Weil
Study 1242. Marijuana-naive subjects tended to show some
impairment in performance. Id. </p>

<p>56 N.Y. Times, May 11, 1969, 6 (Magazine), ' at 92, Col. 2. </p>

<p>57 We were struck by the difficulty of recognizing when a
subject is high unless he tells you that he is . . . . It seems
possible to ignore the effects of marihuana on consciousness, to
adapt to them, and to control them to a significant degree. Id. </p>

<p>58 Comparison of tbe Effects Of Marijuana and, Alcohol On
Simulated Driving Performance 164 SCIENCE 851 (1969) (concluding
that subjects under a &quot;social marijuana high&quot; showed no
significant differences from control subjects in accelerator,
brake, signal, steering, and total errors). In addition,
&quot;unlike alcohol drinkers, most pot smokers studiously avoid
driving while high.&quot; J. ROSEVEAR, supra note 36, at 135. </p>

<p>59 Weil Study 1238. </p>

<p>60 Grinspoon, supra note 43, at 19. </p>

<p>61 H. NOWLIS, DRUGS ON THE COLLEGE CAMPUS 96-101 (1969). </p>

<p>62 L. GOODMAN &amp; A. GILMAN, supra note 53, at ch. 16;
Dependence on Cannabis (Marijuana), supra note 51, at 368-71. </p>

<p>63 Weil Study 1241; Wash. Post, May 24, 1970, at A26, col. 1. </p>

<p>64 &quot;The subjective responses of our subjects indicate
that they had imagined a marihuana effect to be much more
profoundly disorganizing than what they, experienced.&quot; Weil
Study 1241. This subjective control over the effects extended as
far as the reporting of no effects when in actuality the subject
had received a large dose. Id. 65 Grinspoon, supra note 43, at
23-24. </p>

<p>66 Weil, Adverse Reactions to Marijuana, 282 NEW ENG. J. MED.
997 (1970). </p>

<p>67 See, e.g., Schwarz, supra note 34, at 595; Weil, supra note
66. </p>

<p>68 Weil, supra note 66, at 997. </p>

<p>69 Marihuana depressions I have seen have occurred mainly in
obsessive-compulsive persons who are ambivalent about trying the
drug or who invested the decision to experience marihuana with
great emotional meaning. In interviewing these patients, I have
thought that they used marihuana as an excuse for letting
themselves be depressed, not that their depressions were
psycho-pharmacological. </p>

<p>Id. at 998. </p>

<p>70 Dr. Weil has stated that &quot;panic reactions occurred
most often among novice users of marijuana-frequently older
persons who are ambivalent about trying the drug in the first
place.&quot; N.Y. Times, May 1, 1970, at 18C, col. 2.<br>
</p>

<p>71 Id. These panic reactions may emulate acute psychoses in
hospital emergency wards &quot;where the patient may feel
overwhelmed, helpless and unable to communicate his
distress.&quot; Weil, supra note 66, at 998. </p>

<p>72 Id. </p>

<p>73 N.Y. Times, May 1, 1970, at 18C, col. 3. </p>

<p>74 Weil, supra note 66, at 1000. </p>

<p>75 Dr. Weil is of the opinion that &quot;all adverse reactions
to marihuana should be considered panic reactions until proven
otherwise,&quot; id. at 998, and that he has never seen a toxic
psychosis following the smoking of marijuana by a normal user.
Id. at 9199. </p>

<p>716 Id. at 1000. </p>

<p>7-7 Id. at 999-1000. </p>

<p>78 H. Nowlis, DRUGS ON THE COLLEGE CAMPUS 96-101 (1969);
Schwarz, supra note 34 at 595. </p>

<p>79 McGlothlin &amp; West, The Marijuana Problem: An Overview,
125 Am. J. Psych. 370,372 (1968).<br>
<br>
</p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-27</DOCNO>
<DOCOLDNO>IA031-000655-B038-97</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/vlr/vlr9.htm 206.61.184.43 19970122112605 text/html 45637
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:25:54 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:47:08 GMT
Content-length: 45419
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Marijuana Legislation Clashes with Judicial Skepticism
1965-70 </title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_vlr_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->

<p><b>THE FORBIDDEN FRUIT AND THE TREE OF KNOWLEDGE: AN INQUIRY
INTO THE LEGAL HISTORY OF AMERICAN MARIJUANA PROHIBITION</b> </p>

<p><font size="2"><i>Richard J. Bonnie &amp; Charles H.
Whitebread, II</i></font> </p>

<p><br>
</p>

<p>IX. MARIJUANA LEGISLATION CLASHES WITH JUDICIAL SKEPTICISM AND
EMERGING VALUES - PIECEMEAL JUDICIAL RESPONSE: 1965-1970<br>
</p>

<p>The dramatic increase in marijuana use during the latter
1960's and the consequent increase in prosecution1 were matters
of high public visibility. Judicial response at both the trial
and appellate levels was influenced by a combination of powerful
forces, none of which had been present in the preceding years.
The 1960's saw a revolution in the law of criminal procedure, and
in few areas were police practices more suspect than in the
enforcement of the drug laws. The latter part of the decade
witnessed widespread dissent against the political and legal
systems; this protest milieu gave an added dimension to marijuana
use as more and more people smoked, oftentimes overtly, in order
to defy a seemingly ignorant law. Faced with this unusual
conjunction of widespread political and social eccentricity, the
courts-institutional protectors of political deviants-were
inevitably pressed into institutional sympathy for social
deviants. A third force was the revitalized judicial interest in
the value of privacy in a highly automated, technological
society; more and more people went to the courts to question
longstanding governmental prohibitions against essentially
private decisions and acts-homosexuality, abortion, contraception
and drugs. Together with the well-publicized medical skepticism
about the soundness of the nation's drug laws, particularly those
regulating marijuana, these forces moved the courts to scrutinize
enforcement practices and consider a new wave of constitutional
objections to state and federal marijuana legislation.<br>
</p>

<h2>A. Multiple Offenses: Untying the Statutory Knots</h2>

<h3>1. Federal Developments<br>
</h3>

<p>In the major decision during this period, the United States
Supreme Court voided the federal provisions most often employed
to prosecute the possessor (buyer) of marijuana. In the first arm
of Leary v. United States,2 the Court held that the Fifth
Amendment relieves unregistered buyers of any duty to pay the
transfer tax and to file the written order form as required by
the Marihuana Tax Act.3 The Court reasoned that, since filing
such a form would expose a buyer to liability under state law,
under the occupational tax provisions of the Tax Act, and perhaps
under the marijuana provision of the Import and Export Act,4 the
filing provisions violated the fifth amendment guarantees against
self-incrimination. On the other hand, the Court held in a later
case that the fifth amendment does not relieve the marijuana
seller of the duty to confine his sales to transferees who are
willing to comply with the order form requirements.5 Similarly,
the Eighth Circuit recently held6 that Leary does not compel
invalidation of Tax Act section 4755(b), which prohibits the
interstate transportation of marijuana, because a conviction
under that section is not really a conviction for falling to
register and pay the occupational tax and, even if it were,
registration under section 4753 is not necessarily incriminating
as was the written order form requirement struck down in Leary .7
</p>

<p>The second arm of Leary reversed the long line of decisions8
upholding the presumption of knowing concealment of illegal
importation arising from possession under section 176a of the
Import and Export Act.9 The Court held that, in light of the case
with which marijuana was domestically cultivated and the number
of users, the presumption of know1edge could not rationally be
drawn from possession.10 it could not be said &quot;with
substantial assurance that the presumed fact [knowing concealment
of illegally imported marijuana] is more likely than not to flow
from the proved fact [possession] on which it is made to
depend.&quot;11 Although there is authority to the contrary,12
the Ninth Circuit has held this part of Leary retroactive,
thereby invalidating all prior Section 176a convictions in which
the defendant did not admit knowledge and the was instructed as
to the applicability of the statutory presumption .13 </p>

<p>A serious dispute remains as to what the Government will have
to prove in subsequent prosecutions under section 176a. Assuming
that the entire provision does not violate the privilege against
self-incrimination,14 it is likely that the prosecution will have
to prove actual knowledge of illegal importation in the future.15
Since it is highly improbable that such proof will be
forthcoming, section 176a has probably been rendered useless as
applied to possessors. It should be clear that the entire series
of decisions under the Tax Act and section 176a has an air of
unreality about them because Congress probably has Article I
power directly to prohibit possession and sale of marijuana and
has now exercised that power in the Comprehensive Drug Abuse
Prevention and Control Act of 1970.16 This new legislation,
although stopping short in some respects, discards many of the
fictions perpetuated by earlier legislation. The Leary decision
was at least partially responsible for forcing Congress to
rationalize the federal role in the drug field, particularly with
respect to marijuana. </p>

<p>Another manifestation of judicial dissatisfaction with the
extreme nature of existing drug legislation is the apparent
reversal of the trend of decisions upholding the strict liability
of one-time drug offenders, users and addicts for failure to
register when leaving the country.17 The Ninth Circuit held the
phrase &quot;uses narcotic drugs&quot; unconstitutionally
vague.18 Taking a more direct approach, the Second Circuit found
knowledge of the registration requirement to be an element of the
crime.19 Thus construed, the statute precludes any due process
challenge to the sufficiency of the notice.20 Although a
self-incrimination issue remains, 21 the Second Circuit's
decision removed the most serious defect in the statute, one that
had become intolerable as the number of marijuana convictions
escalated in the late 1960's.<br>
</p>

<h3>2. State Developments<br>
</h3>

<p>The erosion of the archaic federal criminal statutes for
marijuana-related offenses has been accompanied by a similar,
albeit limited, development on the state level. The major issue
in state litigation concerns so-called &quot;drug-proximity&quot;
offenses which are generally employed as plea-bargaining tools or
to prevent the release of a suspect when evidence was 1 illegally
seized or when the evidence is insufficient to secure a
conviction under the substantive drug offense. Typical ancillary
offenses are loitering in the common areas of a building for the
purpose of unlawfully using or possessing any narcotic drug;22
loitering in public by a user, addict or convicted drug offender
without lawful employment;23 presence in an establishment where
narcotic drugs are dispensed;24 and presence of a user or drug
offender in a private place where drugs are kept.25 </p>

<p>The decisional trend seems to point to the unconstitutional
vagueness of simple loitering and vagrancy statutes.26 Because of
the nexus between narcotics and crime, however, the courts are
struggling to redefine narcotics-proximity statutes to avoid the
vagueness objection.27 It might appear that where &quot;good
account&quot; provisions give the arresting police officer too
much discretion the statute will fal1.28 On the other hand,
courts generally avoid vagueness objections based on lack of
notice by reading in knowledge elements wherever neccssary.29
Because of the tenuous relation between marijuana and crime, the
courts should construe &quot;narcotics&quot; in such statutes not
to include marijuana. </p>

<p>Similar restriction of marijuana-related offenses has been
accomplished by holding that charges of possession and sale will
not both lie where the only possession is incident to sale,30 and
by tightening the requirements of specificity in the indictment
regarding the proscribed parts of the plant.31 </p>

<h2>B. Procedural Objections to Enforcement Practices<br>
</h2>

<p>The law of criminal procedure underwent a major revolution in
the 1960's. The Bill of Rights was applied piece by piece to the
states through the fourteenth amendment. The Supreme Court
focused its concern on protecting the rights of the criminal
defendant. The earlier philosophy had been that, so long as the
defendant's rights at trial were guaranteed, the Court should
not, and did not need to, intrude into the pretrial stages of the
criminal process. For a variety of reasons it became clear in the
1960's that in a system where between 75 and 90 percent of all
defendants bargain and enter guilty pleas, rights must be assured
well before trial if they are to have any real meaning to the
average person caught in the net of the criminal process. Thus,
step by step the Court began to regulate police practices-search,
arrest and interrogation techniques-and the conduct of the early
stages of the criminal process. This substantial change in
attitude meant that more marijuana defendants could successfully
raise procedural objections.<br>
</p>

<h3>1. Search and Seizure<br>
</h3>

<p>The most important development for the marijuana offender has
been the close judicial scrutiny of police searches as a result
of Supreme Court rulings under the fourth amendment. More
stringent standards have been established for the police to
obtain search warrants32 and the proper scope of searches
incident to a lawful arrest has been narrowed substantially. 33 </p>

<p>Although courts have refused to exclude any evidence that was
in plain sight when seized, such as a bag of marijuana in a
school satchel voluntarily opened by a student,34 or marijuana
thrown out of window by a defendant trying to dispose of it,35
they have narrowed the permissible time and area in which a car
may be searched .36 </p>

<p>Moreover, the difficult standing problem posed by the
requirement that one had to admit possession or ownership of the
seized property in order successfully to challenge the search was
alleviated in cases involving group arrests by permitting all
those on the premises to challenge a given search.37 </p>

<p>The new requirements for procuring search warrants led to a
number of technical defense victories. For example, searches of
defendants' residences were successfully challenged in two
Montana marijuana cases38 because the warrants were issued by a
justice of the peace, rather than by a district judge, as
required by the state law. These holdings were premised on the
sanctity of private residences, and they suggest a growing
reluctance to countenance &quot;reasonable&quot; warrantless
searches, especially of the home. Similarly, Maryland struck down
the fruits of a search of defendant's guests and their
automobiles on the ground that the permissible search was limited
to the areas described in the warrant.39 An Illinois court has
held that property not included in the warrant must be returned
to the defendant.40 This return to a more stringent view of
particularity requirements of warrants stands in stark contrast
to the willingness of courts to overlook these requirements in
the late fifties.41 </p>

<p>Likewise, courts now scrutinize more closely police claims of
probable cause for expanding the area of the search. A California
court held that even though defendant was lawfully arrested,
search of his luggage in a friend's apartment was justified
neither by the friend's consent nor by the officer's having seen
the defendant swallow something.42 The search was especially
unjustifiable since the defendant had been arrested in his
automobile. In another California case, the presence of peculiar
odors did not constitute probable cause for the search of a
footlocker.43 </p>

<p>An airline had detained the footlocker since it corresponded
to a police description. The officers had smelled the marijuana
and then searched the footlocker before sending it on its way and
tracing it. The California Supreme Court held that the smell
alone was not sufficient cause to search without a warrant. </p>

<p>Despite judicial narrowing of the scope of searches with or
without a warrant, the easing of the standing requirements, and
the closer scrutiny on the probable cause issue, courts continue
to permit police to enter dwellings without knocking or by force
where circumstances indicate such action is reasonable and
necessary. For example, a California court upheld a marijuana
search, even though the police entered without knocking, because
the police heard people running around inside yelling, &quot;It's
the police,&quot; and thought they heard a shot fired.44 The
court held that the statutory knocking requirement was subject to
exception when there was danger of destruction of evidence and
danger to the police. Closely related to no-knock entry is
forcible entry, upheld in an Illinois case45 where the police
broke into the defendant's residence when he did not immediately
respond to their knocks. The necessity for forced entry is
essentially the same as for unannounced entry, but forced entry
adds the danger of causing fright and damage. </p>

<p>Another search area that has not been substantially
liberalized is that of the border search. Customs officials have
a much more extensive right to search than their police
colleagues. Mere suspicion is sufficient to justify a border
search.46 Even though the jurisdiction of customs agents ends
once entry into the country is completed,, the courts have
allowed border guards great discretion in determining what
constitutes completed entry. In Thomas v. United States.47 the
Fifth Circuit held admissible evidence seized an hour and a half
after the appellant had entered the United States because he was
only six blocks from the border. Although there is an inevitable
problem of how far the jurisdiction of the customs agent extends,
Thomas suggests c1early that it is not limited to border
crossings. <br>
</p>

<h3>2. Entrapment</h3>

<p>Although the majority opinions in Sorrells v. United States48
and Sherman v. United States,49 remain the leading statements on
entrapment, some courts have recently permitted expansion of the
defense. In California a defendant may plead not guilty and still
raise the entrapment defense in some cases. The court in People
v. Perez stated: </p>

<p>To compel a defendant to admit his guilt as a condition of
invoking the defense of entrapment would compel him to relieve
the prosecution of its burden of proving his guilt beyond a
reasonable doubt at the risk of not being able to meet his burden
of proving entrapment.50 </p>

<p>The defendant must, however, still raise the defense at trial
to be determined as a matter of fact by the jury.51 There is no
right to raise the defense in a pretrial motion to suppress the
evidence.52 Most courts continue to focus on the moral
culpability of the accused53 in determining whether or not
entrapment has been successfully shown. Recent Arkansas,54 and
Nevada55 cases, however, suggest that the courts are increasingly
concerned about the conduct of law enforcement agents, especially
in marijuana cases.<br>
</p>

<h3>3. Other Prosecution Practices</h3>

<p>Several major abuses, although judicially recognized, remain
largely uncorrected. Long delay between offense and arrest is
common in narcotics offenses because the police desire to expose
the full extent of distribution and to maintain a cover for the
undercover agent as long as possible. Yet any substantial delay
prejudices the defendant since the prosecution continues to
gather evidence while the defendant may forget exact
circumstances and possibly exculpating facts. Judicial response
has been inconsistent, focusing primarily on the purposefulness
of the delay.56 In light of the recent rejuvenation of the speedy
trial requirement by the Supreme Court,57 there is some hope that
this abuse may be corrected. </p>

<p>A more serious abuse with which state and federal prosecutors
have been charged is politically-motivated discretionary
enforcement.58 Although the courts can do little to remedy this
state of affairs, it forms the basis for one of our basic
contentions: The political-social overtones of the marijuana
problem may inhibit a rational political and prosecutorial
response and at the same time may provoke a protective judicial
response. One judge, particularly expert with regard to
contemporary drug problems acknowledged the partial truth of the
charges of political prosecution against Hippies, long-hairs and
draft-card burning college students.59 To the extent that other
trial and appellate Judges recognize these prosecutorial
tendencies, we can expect some judicial compensation either in
fact-finding, in sentencing, or in response to substantive
challenges to the law. It is our contention, of course, that such
judicial reaction has already begun.<br>
</p>

<h3>C. Sufficiency of the Evidence</h3>

<p>The ease of identifying marijuana in conjunction with the use
of uncorroborated testimony and circumstantial evidence continues
to require of the prosecution only a very low burden of proof.
Nevertheless, appellate decisions are gradually beginning to
tighten these requirements, and active judicial hostility at
trial has all but disappeared. </p>

<p>Although the use of uncorroborated testimony to convict
continues to be upheld by the courts,60 an Illinois appellate
court has reversed a conviction because of the behavior of the
testifying officer.61 Noting that the officer had repeatedly
pressured the defendant to become an informer, the court held
that the uncorroborated testimony of this officer was not
sufficient to support a conviction. The court did not make clear
whether it exercised a weight of the evidence review of the trial
judge's fact-finding, or whether it applied an exclusionary
evidence rule pursuant to its inherent powers over the
administration of criminal justice. Whatever the case, judicial
perspective in the clash between marijuana defendant and police
officer has clearly shifted. </p>

<p>The amount of marijuana required to uphold a conviction is
undergoing substantial change. The California Supreme Court held
in People, v. Leal62 that to be sufficient for conviction, the
amount of narcotics must be enough for sale or consumption, the
rule generally applied where the statute does not specify a
minimum quantity.63 In Eckroth v. State64 a Florida court ruled
that the taking of a drug from a passing pipe is not sufficient
to constitute possession where the defendant did not own the
pipe, the drug or the premises. Similarly, in a case that
received national publicity,65 the Minnesota Supreme Court field
that if the state defines marijuana as a narcotic, it cannot
punish possession of what could be native cannabis in amounts too
scanty to produce a &quot;narcotic&quot; effect. Accordingly,
exiguous traces of the drug found in the crevices of defendant's
brief case left in his mistress' car did not constitute an amount
sufficient for conviction .66 </p>

<p>Other problems remain unsolved. Circumstantial evidence
continues to link defendants to seized marijuana. Constructive
possession was found where the defendant's daughter was the
actual possessor67 and the fact that marijuana was found where an
informer said she had seen defendant smoking it the previous day
was sufficient to support the defendant's conviction.68 There is
a split as to whether a conviction can be upheld where the
defendant gratuitously brings the buyer and seller together.
Massachusetts upheld the conviction for possession where the
defendant's only contact with the marijuana was passing it to the
state's agent,69 ruling that the facilitation of the sale added
enough to the act of passing to allow the court to find
possession. In a similar case, however, a New York court held
that there was not present the required involvement or concert of
action to uphold a conviction for sale.70 Nevertheless, courts
have refused conviction on numerous occasions in which the
defendant was not linked exclusively with the marijuana that was
found71 and have generally required an outside linking factor
before upholding the possession.72 However, the element that can
tip the scales in favor of conviction is often unrelated to the
possible possession of the marijuana. For example, a California
court73 upheld the finding of possession of marijuana discovered
along with a purse the defendants had stolen. The defendants
contended that the marijuana was not theirs and must have been in
the purse when stolen. That the defendants were thieves probably
played more heavily in the conviction than any evidence of their
connection with marijuana. </p>

<p>Where marijuana is found on the premises of the individual,
possession is presumed, although the courts have read in a
defense of ignorance of the presence of the marijuana.74
Nevertheless, in a New Hampshire case75 the court upheld a
possession conviction premised on the defendant's knowledge of
presence of the drug on the premises even though the court
apparently believed the defendant's story that it belonged to a
third party. Ordinarily there is direct corroborating evidence to
indicate the defendant's knowledge.76 </p>

<p>Along with the gradual thaw on these points in state courts,
the late sixties witnessed a total absence of the outrageous
judicial participation in inflammatory statements about the
dangers of the drug and its users which we saw was typical of the
late fifties. To the contrary, the appellate opinions, at least,
are replete with skeptical references to the inclusion of
marijuana in the narcotics classification .77<br>
</p>

<h3>D. Sanction</h3>

<p>Nowhere has judicial disenchantment with the drug laws,
especially marijuana, been greater than in the area of
punishment. Preference for civil treatment of drug abuse,78
disgust with severe mandatory sentencing that deprives the
Judiciary of its traditional function of weighing the culpability
of the individual offender, 79 and skepticism about a statutory
scheme which catches the user or small scale distributor and
misses the major trafficker80 have all found their way into
judicial opinions. </p>

<p>This dissatisfaction with legislative inaction in the area of
de-escalating punishment has already begun to provoke remedial81
judicial action. In a landmark decision82 receiving national
attention,83 the Supreme Court of New Jersey recently held that
any prison sentence imposed for first-offense possession of
marijuana for personal use &quot;should be suspended,&quot;84
While the court based its holding on the judiciary's statutory
authority to suspend sentences in &quot;the best interests of the
public as well as of the defendant,&quot;85 and on the appellate
court's power to review for abuse of discretion trial court
sentencing decisions, it appears that the true locus of the
opinion is the Eighth Amendment. That is, the court really
determined that any prison sentence for first-offense possession
of marijuana for personal use is unreasonably excessive.
Accordingly, the decision will be discussed in more detail in the
following section.86<br>
</p>

<hr>

<h2>Footnotes:</h2>

<p>1 See pp. 1096-1 101 supra. See also People v. Patton, 264
Cal. App. 2d 637, 70 Cal. Rpt. 484 (Dist. Ct. App. 1968), where
the arresting officer testified that he had made about 1,000
marijuana arrests.<br>
</p>

<p>2 395 U.S. 6 (1969). </p>

<p>3 Although Leary involved only the concealment and
transportation provision, 26 U.S.C.  4744 (a) (2) (1964), the
Eighth Circuit has held, correctly, that Leary also covers the
acquiring provision,  4744(a) (1), &quot;since a person
obviously would have to acquire the marijuana to knowingly
transport or conceal it.&quot; United States v. Young, 422 F.2d
302, 304 (8th Cir.), cert. denied, 398 U.S. 914 (1970). </p>

<p>4 Because the &quot;danger of incrimination under state
law&quot; was &quot;so plain,&quot; the Court did not pursue the
additional question of a buyer's exposure to liability under the
Import and Export Act. 395 U.S. at 16 n.14. </p>

<p>5 Minor vs. United States, 396 U.S. 87 (1969) </p>

<p>6 United States v. Young, 422 F.2d, 302 (8<sup>th</sup> Cir.)
, cert. Denied, 398 U.S. 914 (970) </p>

<p>7 &quot;Although we need not reach the question, we feel that
the Fifth Amendment is not violated by the insubstantial hazards
of incrimination posed by section 4753. Id. at 306 </p>

<p>8 See p. 1086, supra </p>

<p>9 Anticipating the Leary decision on the  176a presumption
was United States v. Adams, 293 F. Supp. 776 (S.D.N.Y. 1968). </p>

<p>10 395 U.S. at 52 53. Having found the &quot;knowledge&quot;
presumption unconstitutional, the court avoided consideration of
the &quot;illegal importation&quot; presumption. Id at 38. The
knowledge presumption has also be held invalid as applied to
hashish. United States v. Maestri, 424 F.2d 1066 (9<sup>th</sup>
Cir. 1970) ; cf. United States v. Cepelis, 426 F.2d 134 (9<sup>th</sup>
Cir. 1970) (remanded for factual determination as to whether
Leary applies to hashish.) </p>

<p>In Turner v. United States, 396 U.S. 398 (1970), the Court
upheld the presumption in 21 U.S.C.  174 (1964) (direct
ancestor of  176a as applied to heroin but declared it
irrational as applied to cocaine. It has been held that Turner is
retroactive, United States v. Vallejo, 312 F. Supp. 244 (S.D.N.Y.
1970). </p>

<p>11 395 U.S. at 30. </p>

<p>12 Rivera-Vargas v. United States, 307 F. Supp. 1075 (D.P.R.
1969). </p>

<p>13 United States v. Scott, 425 F.2d 55 (9th Cit. 1970). We
think the Ninth Circuit is right, at least with respect to
convictions secured after marijuana achieved high public
visibility in the 1960's. Since the number of people still
incarcerated for earlier convictions is minimal, complete
retroactive effect is in order. Essential to the Leary decision
was a determination that the presumption was factually
unsupportable; it therefore constituted a material flaw in the
fact-finding process and seriously impaired the right to jury
trial. </p>

<p>14 Absent the written order form requirement of the Marihuana
Tax Act, we do not see how prosecution under  176a involves the
fifth amendment at all. Neither did the Ninth Circuit. Id. at 61.
</p>

<p>15 See United States v. Martinez, 425 F.2d 1300 (9th Cit.
1970); McClain v. United States, 417 F.2d 489 (9th Cit. 1969). A
mere inference of importation is clearly not enough to sustain a
conviction since it would nullify Leary. Cf. United States v.
Ramos, 282 F. Supp. 354 (S.D.N.Y. 1968) (where Government failed
to prove possession beyond reasonable doubt, court could not
infer knowledge of importation). It is difficult to see how the
Government could raise an inference of knowledge without proving
actual knowledge. If, however, such can be done, it is clear that
the defendant has a right to prove that the marijuana was not
imported. United States v. Espinoza, 406 F.2d 733 (2d Cir.),
cert. denied, 395 U,S. 908 (1969) (retrial ordered for failure of
trial judge to allow defendant to prove that marijuana came from
California), </p>

<p>16 Pub. L. No. 91-513 (Oct. 27, 1970). See also Leary v.
United States, 395 U.S. 6, 54 (1969) (&quot;We are constrained to
add that nothing in what we hold today implies any constitutional
disability in Congress to deal with the marijuana traffic by
other means&quot;). </p>

<p>17 See P. 1085 supra. </p>

<p>18 Weissman v. United States, 373 F.2d 799 (9th Cir. 1967).
Struggling to confine its holding, the court distinguished an
apparently contradictory case, United States v. Eramdjian, 155 F.
Supp. 914 (S.D. Cal. 1957), on the ground that it involved
&quot;addiction&quot; rather than use of narcotic drugs. </p>

<p>19 United States v. Mancuso, 420 F.2d 556 (2d Cir. 1970). </p>

<p>20 See Lambert v. California, 355 U.S. 225 (1957) (application
of city ordinance requiring convicted felons to register within
five days after arrival in city where there is no actual notice
or knowledge of ordinance is unconstitutional). 21 The Mancuso
court did not discuss the issue. </p>

<p>22 N.Y. PENAL LAW  1533 (5) (McKinney 1967). </p>

<p>23 D.C.CODE ANN.  22-3302 (1967). </p>

<p>24 Id.  22-1515(a). </p>

<p>25 Id.  3 3 -416 (a). </p>

<p>26 e.g.. Wheeler v. Goodman, 306 F. Supp. 58 (W.D.N.C. 1969),
appeal docketed, 38 U.S.L.W. 3409 (U.S. Apr. 21, 1970) (No. 1273,
1969 Term; renumbered No. 102, 1970 Term); Lazarus v. Faircloth,
301 F. Supp. 266 (S.D. Fla.) appeal docketed, 38 U.S.L.W. 3225
(U.S. Dec. 16, 1969) (No. 630, 1969 Term; renumbered No. 43, 1970
Term; Broughton v. Brewer, 298 F. Supp. 260 (S.D. Ala. 1969). </p>

<p>27 In People v. Pagnotta, 25 N.Y.2d 333, 253 N.E.2d 202, 305
N.YS.2d 484 (1969), the New York Court of Appeals upheld a
statute making it illegal to loiter about any &quot;stairway,
staircase, hall, roof, elevator, cellar, courtyard, or any
passageway of a building for the purpose of unlawfully using or
possessing any narcotic drug.&quot; The court distinguished the
ordinary vagrancy and loitering cases on the ground that the
conduct punished in the narcotics vagrancy statute is directly
related to the commission of crime against others: </p>

<p>[P] rotection of innocent citizens from drug users is a very
crucial problem. As has recently been pointed out by several
newspaper articles, in some of our poorer urban areas where drug
use is high, innocent citizens are often beaten, robbed and even
murdered by drug addicts .... It is completely reasonable and
proper for the Legislature to protect these citizens from
accidentally stumbling into the midst of such miscreants in the
common areas of buildings. </p>

<p>Id. at 338, 253 N.E.2d at 206, 305 N.Y.S.2d at 489. </p>

<p>28 Ricks v. District of Columbia, 414 F.2d 1097, 1104-05 (D.C.
Cit. 1968). But cf. United States v. McClough, 263 A.2d 48 (D.C.
Ct. App. 1970) (upholding statute prohibiting presence in an
establishment where defendant knows narcotics are being
dispensed). </p>

<p>29 e.g., United Stares v. McClough, 263 A.2d 48 (D.C. Ct. App.
1970) (reading scienter provision into statute prohibiting prior
drug users or offenders from being &quot;found in any place . . .
building, structure . . . in which any illicit narcotic drugs are
kept&quot;); cf. People v, Brim, 257 Cal. App. 2d 839, 65 Cal.
Rptr. 265 (Dist. Ct. App. 1968) (interpreting statute outlawing
knowingly being in a place where narcotics are being used as
charging defendant with intentional involvement with the unlawful
use of marijuana). </p>

<p>30 State v. Duplain, 102 Ariz. 100, 425 P.2d 570 (1967);
People v. Theobald, 231 Cal. App. 2d 351, 41 Cal. Rptr. 758
(Dist. Ct. App. 1964). </p>

<p>31 See, e.g., State v. Haddock, 101 Ariz. 240, 418 P.2d 577
(1966) (seeds contain no cannibin, therefore no crime charged);
State v. Curry, 97 Ariz. 191, 398 P.2d 899 (1965) (marijuana
refers to the p2its of the plant containing cannabin). Contra,
State v. Ringo, 5 Conn. Cir. 134, 246 A.2d 208 (Cir. Ct. 1968)
(possession of seed, residue in pipes and a small package of
marijuana); Commonwealth v. Cunningham, 35 Pa. D. &amp; C.2d 527
(0. &amp; T. Allegheny 1964) (possession of marijuana seeds); cf.
State v. Everidge, 77 N.M. 505, 424 P.2d 787 (1967) (defendant
required to raise defense that marijuana possessed was within
statutory exception); State v. Mudge, 69 Wash. 2d 861, 420 P.2d
863 (1966) (same). </p>

<p>32 Spinelli v. United States, 393 U.S. 410 (1969); Aguilar v.
Texas, 378 U.S. 108 (1964). </p>

<p>33 Chimel v. California, 395 U.S. 752 (1969) (search incident
to a lawful arrest limited to an area within immediate control of
the suspect). See also Terry v. Ohio, 392 U.S. 1 (1968). </p>

<p>34 People v. Bloom, 270 Cal. App. 2d 731, 76 Cal. Rptr. 137
(Dist. Ct. App. 1969). </p>

<p>35 State NT. Garcia, 76 N.M. 171, 413 P.2d 210 (1966). </p>

<p>36 Preston v. United States, 376 U.S. 364 (1964). See also
Cooper v. California, 386 U.S. 58 (1967). The holdings in both
these cases are probably limited by Chimel. </p>

<p>37 Jones N7. United States, 362 U.S. 257 (1960). </p>

<p>38 State v. Kurland, 151 Mont. 569, 445 P.2d 570 (1968); State
v. Langan, 151 Mont. 558, 445 P.2d 565 (1968). </p>

<p>39 Haley v. State, 7 Md. App. 18, 253 A.2d 424 (1969). </p>

<p>40 People v. Hartfield, 94 111. App. 2d 421, 237 N.E.2d 193
(1968). </p>

<p>41 See pp. 1089-91 supra. </p>

<p>42 People v. Cruz, 61 Cal. 2d 861, 395 P.2d 889, 40 Cal. Rptr.
841 (1964); accord, People v. Patton, 264 Cal. App. 2d 637, 70
Cal. Rptr. 484 (Dist. Ct. App. 1968). In Cruz the court stated
that it was reasonable for the officers to try to dislodge the
suspected marijuana from the defendant's mouth. </p>

<p>43 People v. McGrew, 103 Cal. 3d 404, 462 P.2d 1, 82 Cal.
Rptr. 47 3 ( 1 969), relying on People v. Marshall, 69 Cal. 2d
51, 412 11.2d 665, 69 Cal. Rptr. 585 (1968) (&quot; 'In plain
smell,' therefore, is plainly not the equivalent of 'in plain
view'&quot; </p>

<p>44 People V. Clay, 273 Cal. App. 2d 279, 78 Cal. Rptr. 56
(Dist. Ct. App. 1969) </p>

<p>45) People v. Hartfield, 94 111. App. 2d 421, 237 N.F.2d 193
(1968). </p>

<p>46 United States v. Glaziou, 402 F.2d 8 (2d Cir. 1968), cert.
denicd, 393 U.S.1121 (1969); Henderson v. United States, 390 F.2d
805 (9th Cir. 1967). </p>

<p>47 372 F.2d 252 (5th Cir. 1967). The customs agents had
searched the defendants belongings at the time he had entered the
country arid had not discovered the marihuana and heroin he
possessed. They came into town and searched the defendant when
they were notified by an informer that he was carrying the
contraband. </p>

<p>48 287 U.S. 435 (1952) </p>

<p>49 356 U.S.369 (1958) </p>

<p>6062 Cal. 2d 769, 776, 401 P.2d 934, 938, 44 Cal. Rptr. 326,
330 (1965). The decision overturned a long series of precedents.
That all justices concurred is indicative of the sentiment for
change. The court required the prosecution to disclose the
identity of the informant because he was essential to the
defenses of entrapment and lack of knowledge. The decision was
immediately implemented in People v. Marsden, 234 Cal. App. 2d
796, 44 Cal. Rptr. 728 (Dist. Ct. App. 1965). There, defendant
was repeatedly requested to furnish marijuana to a government
agent and finally purchased and gave the agent one marijuana
cigarette. The court noted that the case was close to entrapment
as a matter of law. </p>

<p>51 People v. Oatis, 264 Cal. App. 2d 324, 70 Cal. Rptr. 524
(Dist. Ct. App. 1968), cert. denied, 393 U.S. 1108 (1969). </p>

<p>52 State v. Folsom, 463 P.2d 381 (Ore. 1970). </p>

<p>53 Commonwealth v. Harvard, 253 N.E.2d 346 (Mass. 1969);
Glosen v. Sheriff, 451 P.2d 841 (Nev. 1969). </p>

<p>54 Peters v. State, 450 S.W.2d 276 (Ark. 1970). Here the
defendant gave some marijuana free of charge to the agent after
repeated requests. The marijuana had been left in the defendant's
shop by others. In remanding the case for consideration by the
jury whether entrapment existed the court stated: </p>

<p>Perhaps, neither the persistent solicitation, the use of an
alias, the misrepresentation of the purposes for which [the
agent] wanted to acquire the marijuana nor the use of friends of
appellant for an entree, standing alone, would have been
sufficient to raise a fact question as to entrapment, but when
taken together along with the total lack of evidence that [the
defendant] had possessed or sold marijuana before, there was such
an issue. Id. at 278. </p>

<p>55 Froggatt v. State, 467 P.2d 1011 (Nev. 1970) (reversed for
failure to give entrapment<br>
instruction where policeman placed marijuana in defendant's car
and then Defendant sold it to another officer). </p>

<p>56 Compare Jordan v. United States, 416 F.2d 338 (9th Cir.
1969), cert. denied, 397 U.S. 920 (1970) (since three-month delay
was not purposeful, defendant must show actual prejudice), with
Ross v. United States, 349 F.2d 210 (D.C. Cir. 1965) (charges
dismissed since seven-month delay found purposeful). </p>

<p>57 Smith v. Hooey 393 U.S. 374 (1969). </p>

<p>58 E.g., J. KAPLAN, MARIJUANA THE, NEW PROHIBITION 40-42
(1970). </p>

<p>59 Oliver, Assessment of Current Legal Practices from the
Viewpoint of the Courts, in DRUGS AND Youth 229 (J. Wittenborn
ed. 1969). Judge Oliver tried to minimize the seriousness of the
problem, However: </p>

<blockquote>
    <p>I think that as judge I must be interested in what might
    appear to be a pattern of discriminatory law enforcement, but
    I . . . consider much of this talk must be viewed with the
    same critical eye which most other talk about drug abuse must
    be viewed. </p>
</blockquote>

<p>Id. at 233. </p>

<p>60 See, e.g., Winfield v. State, 248 Ind. 95, 223 N.E.2d 576
(1967). </p>

<p>61 People v. Quintana, 91 Ill. App. 2d 95, 234 N.E.2d 406
(1968). The court was greatly displeased with the continuing
misbehavior of the officer: &quot;[The 5-8 previous arrests and
shakedowns] were a high-handed display of police power which
completely disregarded the defendant's constitutional
rights.&quot; Id. at 98, 234 N.F.2d at 408. </p>

<p>62 64 Cal. 2d 504, 413 P.2d 665, 50 Cal. Rptr. 777 (1966)
(heroin). </p>

<p>63 People v. Villalobos, 245 Cal, App. 2d 561, 54 Cal. Rptr.
60 (Dist. Ct. App. 1966) (50 milligrams insufficient); see Tuttle
v. State, 410 S.W.2d 780 (Tex. Crim. App. 1967) (63 milligrams
sufficient, enough to make a very small cigarette); People v.
Hokuf, 245 Cal. App. 2d 394, 53 Cal. Rptr. 828 (Dist. Ct. App.
1966) (reversible error for the court not to instruct the jury
that fragments of marijuana cannot support conviction). But see
Franklin v. State, 8 Ind. App. 134, 258 A.2d 767 (1969) (heroin),
in which the court upheld a conviction for possession where the
defendant went to the hospital with an overdose. Although
recognizing that once the drug is inside the body there is no
possession because there is no control, the court felt that prior
possession and self-administration could be inferred. The
decision should do much to discourage addicts from receiving any
medical treatment that might expose them to criminal penalties. </p>

<p>64 227 So. 2d 313 (Fla. Dist. Ct. App. 1969). </p>

<p>65 See P. 1099 &amp; note 14 supra. </p>

<p>66 State v. Resnick, 177 NW.2d 418 (Minn. 1970). </p>

<p>67 People v. Thomas, 76 Ill. App. 2d 42, 221 NE. 2d. 800
(1966). </p>

<p>68 State v. Mantell, 71 Wash. 2d 768, 430 P.2d 980 (1967). </p>

<p>69 Commonwealth v. Harvard, 253 N.F.2d 346 (Mass. 1969). </p>

<p>70 People v. Hingerton, 27 App. Div. 2d 754, 277 N.Y.S.2d 754
(1967). </p>

<p>71 See, e.g., State v. Oare, 249 Ore. 597, 439 P.2d 885 (1968)
(one marijuana cigarette found in bathroom with two people, Home
owner convicted); People v. Van Syoc, 269 Cal. App. 2d 370, 75
Cal. Rptr. 490 (Dist. Ct. App. 1969) (marijuana found on
righthand side of the dashboard in defendant's car while parked
in public lot), People v. Evans, 72 Ill. App. 2d 146, 218 N.E.2d
781 (1966) (marijuana found under bar where defendant had been
sitting). </p>

<p>72 State v. Faircloth, 181 Neb. 333, 148 NW.2d 187 (1967)
(defendant had dufflebag<br>
full of marijuana between his legs in automobile); People v.
Blunt, 241 Cal. App. -Id 200, 50 Cal. Rptr. 440 (Dist. Ct. App.
1966) (defendant only one who had sat in back of police car where
Marijuana found). </p>

<p>73 People v. Irvin, 264 Cal. App. 2d 747, 70 Cal. Rptr. 892
(Dist. Ct. App. 1968). </p>

<p>74 See Commonwealth v. Buckley, 354 Mass. 508, 238 N.F.2d 335
(1968); People v. Mitchell, 51 Misc. 2d 82, 272 N.Y.S.2d 523
(Sup. Ct. 1967). Contra. State v. Givens, 74 Wash. 2d 48, 442
P.2d 628 (1968). </p>

<p>75 State v. Colcord, 109 N.H. 231, 248 A.2d 80 (1968). </p>

<p>76 The evidence of fragments of marijuana on the defendant
often provides this evidence, See, e.g., People v. Slade, 264
Cal. App. 2d 188, 70 Cal. Rptr. 321 (Dist. Ct. App. 1968); People
v. Haynes, 253 Cal. App. 2d 1060, 61 Cal. Rptr. 859 (Dist. Ct.
App. 1967), cert. denied, 392 U.S. 914 (1968); People v. Hurta,
238 Cal. App. 2d 162, 47 Cal. Rptr. 580 (Dist. Ct. App. 1965). </p>

<p>77 See 1131-32 infra. </p>

<p>78 E.g., Oliver, supra note W.<br>
</p>

<p>79 See, e.g., United Sates v. Kleinhalzer, 306 F. Supp. 311
(E.D.N.Y. 1969) (Weinstein, J.); Oliver, supra note 59, at 230: </p>

<p>In most other areas of the law, however, legislatures have
freely granted judges the power and discretion within quite
flexible limitations, to determine appropriate sentences for all
particular defendants before them that may or may not, dependent
upon the particular case, include commitment to a penal
institution. . . . </p>

<p>In the field of drug abuse, quite contrary to that experience,
mandatory prison sentences apparently reflect a legislative
conviction that all drug offenders are so alike that sending all
to prison is, in fact, a real solution to what must have been
viewed as a relatively simple problem. They also seem to reflect
a certainty and righteousness that can hardly be said to be
justified by our present scientific knowledge. </p>

<p>80 For example, in Aguilar v. United States, 363 F. 2d 379 (9<sup>th</sup>
Cir. 1966), the court affirming the smuggling conviction of a
Mexican mechanic driving a car containing marijuana back to the
United States, noted: </p>

<p>Here was a young man with a previous clean record, and there
was no indication he was a user of narcotics or inside a
narcotics ring. Apparently he was a victim of his personal
economics. When the law gets no closer than this to the real
rascal, one must wonder about the policy of it, although it be
beyond our function. </p>

<p>Id. at 381. See also Oliver, supra note 59, at 233 </p>

<p>81 What Justice Jackson said about adjudicative mood when the
death penalty hangs in the balance is equally appropriate with
regard to harsh marijuana penalties: </p>

<p>When the penalty is death, we, like state judges, are tempted
to strain the evidence and even, in close cases, the law in order
to give a doubtfully condemned man another chance. </p>

<p>Stein v. New York, 346 U.S. 156, 196 (1953) </p>

<p>82 State v. Ward, No. A-9 (N.J. Oct. 26, 1970) </p>

<p>83 N.Y. Times, Oct. 27. 1970, at 1, Col. 4 </p>

<p>84 State v. Ward, No. A-9 (N.J. Oct. 26, 1970) </p>

<p>85 N.J. Stat. Ann. Section 2a:168-1 (1969) </p>

<p>86 See pp. 1138-39 infra.<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_vlr_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="vlrtoc.htm">The Forbidden Fruit and the Tree of
Knowledge</a></p>
<!--webbot bot="Include" endspan i-checksum="19264" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-28</DOCNO>
<DOCOLDNO>IA088-000636-B009-324</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/nc/ncmenu.htm 206.61.184.43 19970122100330 text/html 14835
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 10:03:17 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:58:26 GMT
Content-length: 14617
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Marihuana, A Signal of Misunderstanding - Table of
Contents</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="61536" -->

<h1>The Report of the National Commission on Marihuana and Drug
Abuse </h1>

<h2>Marihuana: A Signal of Misunderstanding </h2>

<p><b>Commissioned by President Richard M. Nixon, March, 1972</b>
</p>

<hr>

<p><b><u>Table of Contents</u></b> </p>

<h3>The Report </h3>

<p>Letter of Transmittal </p>

<p><a href="misintro.htm">Introduction</a> </p>

<p><a href="mis2.htm"><b>I. Marihuana and the Problem of
Marihuana</b></a><b><u> </u></b></p>

<ul>
    <li>Origins of the Marihuana Problem <ul>
            <li>Visibility </li>
            <li>Perceived Threats </li>
            <li>Symbolism </li>
        </ul>
    </li>
    <li>The Need for Perspective <ul>
            <li>Historical Perspective </li>
            <li>Cultural Perspective <ul>
                    <li>The Search for Meaning </li>
                    <li>Skepticism </li>
                    <li>The Limits of Rationality </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Formulating Marihuana Policy <ul>
            <li>Scientific Oversimplification </li>
            <li>Philosophical Oversimplification </li>
            <li>Sociological Oversimplification </li>
            <li>Legal Oversimplification </li>
        </ul>
    </li>
    <li>The Report </li>
</ul>

<p><a href="ncchap2.htm"><b>II. Marihuana Use and Its Effects</b></a><b><u>
</u></b></p>

<ul>
    <li>The Marihuana User </li>
    <li>Demographic Characteristics </li>
    <li>Patterns of Use </li>
    <li>Profiles of Users <ul>
            <li>Experimental Users </li>
            <li>Intermittent Users </li>
            <li>Moderate and Heavy Users </li>
            <li>Very Heavy Users </li>
        </ul>
    </li>
    <li>Becoming a Marihuana User <ul>
            <li>Parental Influence </li>
            <li>Situational Factors and Behavioral Correlates </li>
            <li>Social Group Factors </li>
            <li>The Dynamics of Persistent Use </li>
        </ul>
    </li>
    <li>Becoming a Multidrug User <ul>
            <li>Epidemiologic Studies </li>
            <li>Profiles and Dynamics </li>
            <li>Sociocultural Factors </li>
        </ul>
    </li>
    <li>Effects of Marihuana on the User <ul>
            <li>Botany and Chemistry </li>
            <li>Factors Influencing Drug Effect <ul>
                    <li>Dosage </li>
                    <li>Method of Use </li>
                    <li>Metabolism </li>
                    <li>Set and Setting </li>
                    <li>Tolerance </li>
                    <li>Reverse Tolerance </li>
                    <li>Duration of Use </li>
                    <li>Patterns of Use </li>
                    <li>Definition of Dependence </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Effects Related to Pattern Use </li>
    <li>Immediate Drug Effects <ul>
            <li>Subjective Effects </li>
            <li>Bodv Function </li>
            <li>Mental Function </li>
            <li>The Intoxicated State </li>
            <li>Unpleasant Reactions </li>
            <li>Anxiety States </li>
            <li>Psychosis </li>
            <li>Conclusions </li>
        </ul>
    </li>
    <li>ShortTerm Effects </li>
    <li>Long Term Effects </li>
    <li>Very Long Term Effects <ul>
            <li>Tolerance and Dependence </li>
            <li>General Body Function </li>
            <li>Social Functioning </li>
            <li>Mental Functioning </li>
            <li>Motivation and Behavioral Change </li>
        </ul>
    </li>
    <li>Summary </li>
</ul>

<p><a href="ncc3.htm"><b>III. Social Impact of Marihuana Use</b></a><b><u>
</u></b></p>

<ul>
    <li>Marihuana and Public Safety <ul>
            <li>Marihuana and Crime <ul>
                    <li>The Issue of Cause and Effect </li>
                    <li>Marihuana and Violent Crime </li>
                    <li>Marihuana and Non Violent Crime </li>
                    <li>A Sociocultural Explanation </li>
                </ul>
            </li>
            <li>Marihuana and Driving </li>
        </ul>
    </li>
    <li>Marihuana, Public Health and Welfare <ul>
            <li>A Public Health Approach <ul>
                    <li>The Population at Risk </li>
                    <li>Confusion and Fact </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>Assessment of Perceived Risks <ul>
            <li>Lethality </li>
            <li>Potential for Genetic Damage </li>
            <li>Immediate Effects </li>
            <li>Effects of LongTerm, Heavy Use </li>
            <li>Addiction Potential </li>
            <li>Progression to Other Drugs </li>
        </ul>
    </li>
    <li>Preventive Public Health Concerns <ul>
            <li>Summary </li>
        </ul>
    </li>
    <li>Marihuana and the Dominant Social Order <ul>
            <li>The Adult Marihuana User </li>
            <li>The Young Marihuana User </li>
        </ul>
    </li>
    <li>The World of Youth </li>
    <li>Why Society Feels Threatened <ul>
            <li>Dropping Out </li>
            <li>Dropping Down </li>
            <li>Youth and Radical Politics </li>
            <li>Youth and the Work Ethic </li>
        </ul>
    </li>
    <li>The Changing Social Scene </li>
</ul>

<p><a href="ncchp4.htm"><b>IV. Social Response to Marihuana Use </b></a></p>

<ul>
    <li>The Initial Social Response </li>
    <li>The Change </li>
    <li>The Current Response <ul>
            <li>The Criminal Justice System <ul>
                    <li>Law Enforcement Behavior </li>
                    <li>Law Enforcement Opinion </li>
                </ul>
            </li>
            <li>The Non Legal Institutions <ul>
                    <li>The Family </li>
                    <li>The Schools </li>
                    <li>The Churches </li>
                    <li>The Medical Community </li>
                    <li>Summary </li>
                </ul>
            </li>
        </ul>
    </li>
    <li>The Public Response </li>
</ul>

<p><a href="ncrec.htm"><b>V. Marihuana and Social Policy</b></a><b><u>
</u></b></p>

<ul>
    <li><a href="ncrec1.htm">Drugs in a Free Society </a><ul>
            <li>Drugs and Social Responsibility </li>
        </ul>
    </li>
    <li><a href="ncrec2.htm">A Social Control Policy for
        Marihuana</a> <ul>
            <li>Approval of Use </li>
            <li>Elimination of Use </li>
            <li>Discouragement or Neutrality </li>
        </ul>
    </li>
    <li>Implementing the Discouragement Policy <ul>
            <li>The Role of Law in Effective Social Control </li>
            <li>Total Prohibition </li>
            <li>Regulation </li>
            <li>Partial Prohibition </li>
            <li>Recommendations for Federal Law </li>
            <li>Recommendations for State Law </li>
            <li>Discussion of Federal Recommendations </li>
            <li>Discussion of State Recommendations </li>
            <li>Discussion of Potential Objections </li>
        </ul>
    </li>
    <li>A Final Comment </li>
</ul>

<hr>

<p><a href="ncaddend.htm"><b>Addendum</b></a><b> </b></p>

<p>Ancillary Recommendations </p>

<p>Legal and Law Enforcement Recommendations </p>

<p>Medical Recommendations </p>

<p>Other Recommendations </p>

<p><b>Index of Contributors, Contractors and Consultants<br>
</b></p>

<hr>

<h3>The Appendix </h3>

<p>The Technical Papers of the First Report of the National
Commission on Marihuana and Drug Abuse, March, 1972 </p>

<p><a href="nc1let.htm">Letter of Transmittal </a></p>

<p><a href="ncstaff.htm">Members and Staff</a> </p>

<p><a href="nc1p.htm">Preface</a> </p>

<h3>Part One -- Biological Aspects </h3>

<h4>I. History of Marihuana Use: Medical and Intoxicant </h4>

<ul>
    <li><a href="nc1a.htm">History of the Medical Use</a> </li>
    <li><a href="nc1b.htm">History of the Intoxicant Use</a> </li>
</ul>

<h4>II. Biological Effects of Marihuana </h4>

<ul>
    <li><a href="nc1c.htm">Botanical and Chemical Considerations</a>
    </li>
    <li><a href="nc1d.htm">Factors Influencing
        Psychopharmacological Effect</a> </li>
    <li><a href="nc1e.htm">Acute Effects of Marihuana (Delta 9
        THC)</a> </li>
    <li><a href="nc1f.htm">Effects of Short-Term or Subacute Use</a>
    </li>
    <li><a href="nc1g.htm">Effects of Long-Term Cannabis Use</a> </li>
    <li><a href="nc1h.htm">Investigations of Very Heavy, Very
        Long-Term Cannabis Users</a> </li>
</ul>

<h4>III. Behavioral and Biological Concomitants of Chronic
Marihuana Smoking by Heavy and Casual Users </h4>

<h3>Part Two -- Social Aspects </h3>

<h4>I. Marihuana Use in American Society </h4>

<ul>
    <li>Surveys of Marihuana Use </li>
    <li>The Incidence and Prevalence of Marihuana Use </li>
    <li>The Future of Marihuana </li>
    <li>Why People Use Marihuana </li>
    <li>Becoming a Marihuana User </li>
    <li>Circumstances of First Marihuana Use </li>
    <li>The Marihuana User </li>
    <li>The Patterns of Marihuana Use </li>
    <li>Marihuana Use and the User: 1972 </li>
</ul>

<h4>II. Marihuana and the Use of Other Drugs </h4>

<ul>
    <li>Empirical Data on the Escalation Process </li>
    <li>Youth Drug Use Survey </li>
    <li>Summary </li>
</ul>

<h4>III. Marihuana and Public Safety </h4>

<ul>
    <li><a href="nc1i.htm">Problems in Assessing the Effects of
        Marihuana</a> </li>
    <li><a href="nc1j.htm">Marihuana and Violence</a> </li>
    <li><a href="nc1k.htm">Marihuana and Sexual Behavior</a> </li>
    <li><a href="nc1l.htm">Marihuana and (Non-Violent) Crime</a> </li>
    <li><a href="nc1m.htm">Summary and Conclusions: Marihuana and
        Crime</a> </li>
    <li><a href="nc1n.htm">Marihuana and Driving</a> </li>
</ul>

<h3>Part Three -- Legal Aspects </h3>

<h4>I. Control of Marihuana, Alcohol and Tobacco </h4>

<ul>
    <li><a href="nc2.htm">History of Marihuana Legislation</a> </li>
    <li><a href="nc2a.htm">History of Alcohol Prohibition</a> </li>
    <li><a href="nc2b.htm">History of Tobacco Regulation</a> </li>
</ul>

<h4>II. The Legal Status of Marihuana </h4>

<ul>
    <li>International Control </li>
    <li>The Control of Marihuana Under Federal Law </li>
    <li>Control of Marihuana at the State Level </li>
    <li>The Role of Ancillary Offenses and Constructive
        Possession in Controlling Marihuana </li>
    <li>Marihuana Control at the Local Level </li>
    <li>Analysis of Statutes Requiring Physicians to Report Drug
        Addiction </li>
</ul>

<h4>III. Trafficking Patterns of Marihuana and Hashish </h4>

<ul>
    <li>Marihuana Traffic From Mexico </li>
    <li>Marihuana Traffic From Jamaica </li>
    <li>The Growing Hashish Traffic </li>
</ul>

<h3>Part Four -- Response of the Criminal Justice System to
Marihuana Use </h3>

<h4>Introduction </h4>

<h4>I. Enforcement Behavior at the State Level </h4>

<h4>Enforcement Behavior at the Federal Level </h4>

<ul>
    <li>General Trends </li>
    <li>Federal Enforcement of the Marihuana Laws: 1970 </li>
</ul>

<h4>III. Opinion Within the Criminal Justice System </h4>

<ul>
    <li>Prosecutorial Opinion </li>
    <li>Opinion of Court Officials </li>
</ul>

<h3>Part Five -- National Survey </h3>

<h4>I. A Nationwide Study of Beliefs, Information and Experiences
</h4>

<ul>
    <li>Main Report </li>
    <li>Methods and Procedures </li>
</ul>

<h3>Part Six -- Social Policy Aspects </h3>

<h4>I. The Constitutional Dimensions of Marihuana Control </h4>

<ul>
    <li>Substantive Limitations on the Criminal Law </li>
    <li>Federal Preemption of Marihuana Control </li>
</ul>

<h4>II. Models and Statutory Schemes for Controlling Marihuana </h4>

<ul>
    <li>Law and Social Policy </li>
    <li>Legal Implementations of Marihuana Control Policies </li>
    <li>Formulating a Legal Scheme </li>
    <li>Implementation of Alcohol Prohibition </li>
</ul>

<h4>Marihuana and Education </h4>

<ul>
    <li>Drug Programs in American Education </li>
    <li>State Departments of Education Survey </li>
    <li>Commission Visits </li>
    <li>Drug Education Programs of Special Interest </li>
    <li>Marihuana Education in State Programs </li>
    <li>Surveys of College Drug Courses </li>
    <li>The Federal Government and Drug Education </li>
</ul>

<h4>Research Needs and Directions </h4>

<ul>
    <li>Biomedical </li>
    <li>Psychosocial </li>
    <li>Legal and Law Enforcement </li>
</ul>

<hr>

<p><b>Index of Contributors, Contractors and Consultants</b> </p>

<p><b>Research Papers Prepared for the Commission <br>
</b></p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="61536" -->

<p><br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-29</DOCNO>
<DOCOLDNO>IA086-000619-B005-89</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/history/history.htm 206.61.184.43 19970122033255 text/html 9736
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 03:32:49 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 19-Jan-97 10:58:19 GMT
Content-length: 9521
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Historical Research on Drugs -- Legalization,
Decriminalization</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../_private/schaffer_style.htm"
background="../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../_private/schaffer_logo.htm" tag="BODY" startspan
-->

<p align="center"><img src="../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="28886" --><!--webbot
bot="Include" u-include="../../_private/sch_History_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../toc.htm">Contents</a> | <a
href="../../feedback.htm">Feedback</a> | <a
href="../../search.htm">Search</a> </p>

<p><a href="../../index.htm">DRCNet Library</a> | <a
href="../index.HTM">Schaffer Library</a>&nbsp;| <a
href="history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="64902" -->

<h1>Historical Research on Drug Policy </h1>

<p>The history of our drug policy is one of the more fascinating
chapters in the development of America as we are today. This
section will continue to grow and I invite everyone to make
submissions of their favorite historical documents on the
subject. By the way, folks, in case anyone asks, we are firmly
committed to publishing all of the historical information,
regardless of which side it may favor. </p>

<hr>

<p><img src="golddot1.gif" width="22" height="22"><a
href="../LIBRARY/histdrug.htm">The History of the Drug Laws</a> </p>

<p><a href="whiteb1.htm">The History of the Marijuana Laws</a> in
the United States by Charles Whitebread - A Speech to the
California Judges Association 1995 annual conference An
excellent, and funny history of how we got our current drug laws.
</p>

<p><a href="ophs.htm">The History of the Opium and Cocaine Laws </a>by
David F. Musto, MD </p>

<p><a href="../LIBRARY/studies/vlr/vlrtoc.htm">The Forbidden
Fruit and the Tree of Knowledge:</a> An Inquiry into the Legal
History of American Marijuana Prohibition by Professor Richard J.
Bonnie &amp; Professor Charles H. Whitebread, II -- The first
major study ever done of the legal history of the marihuana laws.
</p>

<p><b>From the National Commission on Marihuana and Drug Abuse,
1972</b> </p>

<ul>
    <li><a href="../LIBRARY/studies/nc/nc2.htm">History of
        Marihuana Legislation</a> </li>
    <li><a href="../LIBRARY/studies/nc/nc2a.htm">History of
        Alcohol Prohibition</a> </li>
    <li><a href="../LIBRARY/studies/nc/nc2b.htm">History of
        Tobacco Regulation</a> </li>
</ul>

<p><a href="histsum.htm">A Summary of Historical Events </a></p>

<p><a href="baum1.htm">Excerpts from Smoke and Mirrors</a>, by
Dan Baum - A history of the drug war in modern times. </p>

<hr>

<h2>Other Historical Links </h2>

<p><img src="golddot1.gif" width="22" height="22"><a
href="http://www.hempbc.com/">Hemp BC</a> - Hemp, British
Columbia - lots of good historical information on hemp in Canada.
</p>

<p><img src="golddot1.gif" width="22" height="22"><a
href="http://www.paranoia.com/~foucault/Babel/">Drug Culture
Throughout History </a>- An interesting collection of information
regarding the history of drugs, from the earliest times to the
current day. </p>

<hr>

<h2>Historical Articles </h2>

<p><a href="drug_law_timeline.htm">Drug Law Timeline</a> - Some
significant events in the history of our drug laws</p>

<p><a href="soldis.htm">The Mythical Roots of US Drug Policy:</a>
Soldier's Disease and Addicts in the Civil War by Jerry Mandel </p>

<p><a href="prohibit.htm">American Prohibitionists and Violence,
1865-1920</a> - by Richard Hamm </p>

<p><a href="../Library/szasz1.htm">The Pure Food and Drugs Act of
1906 </a>by Thomas M. Szasz</p>

<p><a href="murd3.htm">Hemp Around Their Necks</a> -- Chapter 3
of Harry Anslinger's 1961 book &quot;The Murderers&quot;. </p>

<blockquote>
    <p>Among other things he tells how the La Guardia Committee
    Report gave children a signal to light up as many reefers as
    they want. </p>
</blockquote>

<p><a href="../heroin/twaino1.htm">The Gentle, Inoffensive
Chinese</a> -- from Volume II, Chapter XIII of Roughing It, by
Mark Twain, 1871. This is included here to help give readers an
understanding of the racial feelings which were behind the
earliest anti-opium smoking laws.</p>

<p><a href="dequinc1.htm">Confessions of an English Opium Eater</a>
by Thomas de Quincey -- This is the famous essay on opium from
the early 1800's. </p>

<p><a href="canada1.htm">Panic and Indifference</a>, The Politics
of Canada's Drug Laws. P.J. Giffen, Shirley Endicott and Sylvia
Lambert. A few samples from a book which is an excellent
discussion of the history of Canada's drug laws. </p>

<p><a href="nyt1.htm">Experts Discount Marijuana as Big Factor In
Crime </a>but Drive on It Will Be Pressed </p>

<blockquote>
    <p>This is an article from the New York Times, January 12,
    1945, reporting the conclusions of the La Guardia Committee
    Report on marijuana. The committee found that the fears about
    marijuana were &quot;unfounded&quot; but the politicians
    swore to keep up the fight anyway. </p>
</blockquote>

<p><a href="../history/opium_joint.htm">An &quot;Opium
Joint&quot; Raided</a>. The New York Times September 28, 1891, p.
2. </p>

<blockquote>
    <p>A quaint article about the opium problem in the 19th
    century. </p>
</blockquote>

<p><a href="../history/opiumchina1899.htm">Alcohol and Opium
Compared: </a>Opinions of over 100 Physicians on the use of Opium
in China -- Compiled by William Hector Park, M.D., American
Presbyterian Mission Press, Shanghai, 1899 </p>

<p><a href="saved1867.htm">What Shall They Do to Be Saved?, </a>Harper's
magazine 35, Aug. 1867, pp. 377-87. </p>

<p>An article about the evils of opium addiction. </p>

<p><a href="../history/demon1883.htm">The Demon of the Orient </a>Allen
S. Williams, New York: &quot;Published by the Author,&quot; 1883
Chapter IV. An American's Palace Joint Another chapter of the
evils of opium. </p>

<p><a href="../history/opiumwarfare1909.htm">The Warfare Against
Opium-Smoking in America</a> Outdoor, Feb. 6, 1909, vol. 91, p275
</p>

<p><a href="../history/opiumhabit1888.htm">How the Opium Habit is
Acquired </a>by Virgil G. Eaton The Popular Science Monthly 33,
Sept. 1888, 663-67 </p>

<p><a href="../history/ent_turk.htm">An Enterprising Turk</a>,
The New York Times July 1, 1890, p. 8 This is a story about how a
Turk decided to sell diluted opium and was quickly driven out of
business by public exposure. </p>

<p><a href="../history/landopium1896.htm">In The Land of Opium</a>.
- The Immense Areas Given to the Growth of the Poppy - The New
York Times March 29, 1896, p. 28 </p>

<blockquote>
    <p>The Drug's History Traced from the Plant to the Pipe--The
    Scenes in the Indian Fields--Processes Through Which the
    Opium Goes--The Monopoly of Finishing for Smoking in the
    Hands of Chinese--View of a Lucknow Smoking Den. </p>
</blockquote>

<p><a href="../history/sanfranopium1892.htm">The San Francisco
Opium Joints </a>-- The Review of Reviews 5 June (1892), p. 604 </p>

<blockquote>
    <p>A lurid description of the San Francisco opium dens. It is
    worth noting that San Francisco had passed ordinances
    outlawing opium smoking in opium dens some 17 years before
    this article was written. </p>
</blockquote>

<p><a href="../history/opium_ind1898.htm">The Opium Industry in
America </a>by C.F. HOLDER Scientific American 1898, p. 147 This
is a review of the opium industry as it existed in the late 19th
century. </p>

<p><a href="szasz1.htm">Are The Drug Laws Constitutional? </a>A
Historical Perspective From &quot;Our Right To Drugs&quot; by
Thomas Szasz, Praeger Publishers, NY (1992): </p>

<p><a href="1600BC.htm">Evidence Found of Ancient Marijuana Use</a>:
Albany (NY) Times Union, 20 May 1993 attributed to Newsday </p>

<p><a href="mrsin.htm">From Mr Sin to Mr Big </a>by Desmond
Manderson This is a synopsis of a history of the drug laws in
Australia. It is a good demonstration of the racism behind the
drug laws. </p>

<p><a href="../GOVPUBS/guns1.htm">A Brief History of Federal
Firearms Enforcement</a>, Frederick S. Calhoun. Ph.D.. Historian,
Federal Law Enforcement Training Center </p>

<p><a href="om/ommenu.htm">The Opium Monopoly</a> by Ellen N. La
Motte - 1920 - An account of the opium trade in Asia in the first
part of the Twentieth Century </p>

<p><a href="../lincoln.htm">The Lincoln Quote</a> - Some
commentary on a quote attributed to Abraham Lincoln.</p>

<hr>
<!--webbot bot="Include"
u-include="../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../toc.htm">Contents</a> | <a
href="../../feedback.htm">Feedback</a> | <a
href="../../search.htm">Search</a> </p>

<p><a href="../../index.htm">DRCNet Library</a> | <a
href="../index.HTM">Schaffer Library</a>&nbsp;| <a
href="history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="64902" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-30</DOCNO>
<DOCOLDNO>IA087-000632-B024-214</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/GOVPUBS/GOVPUBS.HTM 206.61.184.43 19970122094424 text/html 15321
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:44:14 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:16:53 GMT
Content-length: 15103
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Government Publications Related to Drugs and Drug Policy</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../_private/schaffer_style.htm"
background="../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../_private/schaffer_logo.htm" tag="BODY" startspan
-->

<p align="center"><img src="../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="28886" --><!--webbot
bot="Include" u-include="../../_private/sch_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../toc.htm">Contents</a> | <a
href="../../feedback.htm">Feedback</a> | <a
href="../../search.htm">Search</a> </p>

<p><a href="../../index.htm">DRCNet Library</a> | <a
href="../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../Library/studies/studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="37375" -->

<h1>Government Publications on Drugs and Drug Policy </h1>

<hr size="4">

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="../Library/studies/studies.htm">The Biggest Studies of Drug
Policy</a>. </p>

<p>Revised and Updated. This is a list of the major studies of
drug policy done over the last 100 years or so. Quite an
interesting place to start your reading. </p>

<p><a href="crimebil.htm">Excerpt from the 1994 Crime Bill</a> </p>

<p>Calling for the establishment of a commission to study the
drug problem. This clause was inserted into the Crime Bill as a
result of the Resolution for a Federal Commission on Drug Policy
(Hoover Resolution). </p>

<p><a href="drugcorr.htm">Drug Corruption and the Federal
Government </a>- A list of current Congressional Reports on the
topic. </p>

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="http://www.unicor.gov/">UNICOR</a> - Prison Industries Web
Site </p>

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="http://www.webcom.com/~pinknoiz/covert/druglaw.html">The
Contras and Cocaine</a> - Selections from the Kerry Committee
Document on Drugs, Law Enforcement, and Foreign Policy. </p>

<hr>

<h2>Contents </h2>

<h3>Department of Justice Reports </h3>

<hr>

<h4>DOJ Reports </h4>

<p><a href="psycviol.htm">Psychoactive Substances and Violence -
DOJ Report</a> - Feb, 1994 </p>

<p>This Department of Justice report was a search and summary of
all of the existing evidence on the relationship between drugs
and violence. The report found that alcohol was the only drug
which had any real connection to drug-induced violence. Nearly
all of the violence associated with illegal drugs was a result of
the fact that the drugs are illegal, not as a result of
pharmacological effects. </p>

<p><a href="retri94.htm">Past and Future Directions </a>of the
D.A.R.E. Program: An Evaluation Review, (380K - big file) Draft
Final Report by Research Triangle Institute September 1994 </p>

<p>This is the study done by the Research Triangle Institute to
evaluate the effectiveness of the DARE drug-education program in
the schools. The basic conclusion was that DARE was highly
popular with both police and the school officials, but had no
real effect on long-term drug use. </p>

<p><a href="pidcms.htm">PREVENTING ILLEGAL DIVERSION OF CHEMICALS</a>:
NIJ Research in Brief, November 1993 </p>

<p><a href="dcourt1.htm">Drug Courts: </a>Information on a New
Approach to Address Drug-Related Crime </p>

<p><a href="cjstcha.htm">A Criminal Justice System Strategy</a>
for Treating Cocaine-Heroin Abusing Offenders in Custody </p>

<p><a href="hairt.txt">TESTING HAIR FOR ILLICIT DRUG USE </a>NIJ,
Research in Brief, January 1993 </p>

<p><a href="doff90.htm">DRUG OFFENSES ACCOUNT </a>FOR A LARGER
PERCENTAGE OF JAIL INMATES - Dept. of Justice Press Release1990 </p>

<p><a href="DRUGCRT.HTM" drugcrt.html">Drug Courts: Proposed Rule
</a>by the U.S. Department of Justice, Office of Justice Programs
</p>

<p><a href="dojpr1.htm">THE NATION'S PRISON POPULATION </a>GREW
ALMOST 9 PERCENT LAST YEAR - Press Release 8-9-95 </p>

<p><a href="dojpr2.htm">STATE AND FEDERAL PRISON </a>POPULATION
TOPS ONE MILLION </p>

<p><a href="dojpr3.htm">THE NATION'S CORRECTIONAL </a>POPULATION
TOPS 5 MILLION - 8/27/95 </p>

<p><a href="denf90.htm">Drug Enforcement by Police</a>, 1990 </p>

<p><img src="../graphics/starbult.gif" width="29" height="29"><a
href="fedconvs.htm">Federal Convictions of Public Officials, 1970
- 1988</a> Chart -- Excerpted from THE ECONOMICS OF PROHIBITION,
by Mark Thornton. Reference Source: USDoJ &quot;Report to
Congress on the Activities and Operations of the Public Integrity
Section&quot; </p>

<p><a href="JLCROWD.HTM">System-Wide Strategies to Relieve Jail
Overcrowding</a></p>

<hr>

<h4>Bureau of Justice Statistics Reports </h4>

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="http://gopher.usdoj.gov/bop/">Bureau of Prisons Home Page</a>
</p>

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="http://gopher.usdoj.gov/bop/facts.html">Bureau of Prisons
Facts Page </a>-- Basic stats about the Federal prison system
(does not include stats on state prisons or jails. </p>

<p><a href="crimhi93.htm">Highlights of the Crime Problem</a>,
1993 </p>

<p><a href="fax1994.htm">DRUGS AND CRIME FACTS, 1994</a> </p>

<p><a href="prsn90.htm">Prisoners in 1990 </a></p>

<p><a href="prsnr92.htm">Prisoners in 1992</a> </p>

<p><a href="jailin92.htm">Jail Inmates </a>1992 </p>

<p><a href="prs94as.htm">Prisoners in 1994</a> </p>

<p><a href="jails1.htm">Jails and Jail Inmates 1993-94</a>:
Census of Jails and Survey of Jails </p>

<p><a href="denfcpr.htm">Drug Enforcement and Treatment in
Prisons</a>, 1990 </p>

<p><a href="corr93.htm">Correctional Populations in the United
States </a>1980 - 1993 Executive Summary </p>

<p><a href="violent.txt">Violent Crime: National Crime
Victimization Survey</a> -- April 1994, NCJ-147486 </p>

<hr>

<h4>Drug Enforcement Administration Reports </h4>

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="http://www.usdoj.gov/dea/deahome.html">DEA Home Page </a>-
Not much there, really. Just their copy of the publication below.
</p>

<p><a href="../ACTIVIST/how2men.htm">How to Hold Your Own In A
Drug Legalization Debate</a>, by the DEA, November, 1994 </p>

<p>This booklet was the result of the DEA's emergency conference
in August, 1994, in which they tried desperately to find some way
to keep from getting their butts kicked when they engaged in
public debates on drug policy. It is a direct response to the <a
href="../ACTIVIST/strats.htm">Persuasive Strategies, </a>and
borrows from the Persuasive Strategies on several occasions. </p>

<p><a href="../ACTIVIST/how2men.htm">Reply to the DEA's book </a>&quot;How
To Hold Your Own In a Drug Legalization Debate&quot; </p>

<p>In this section, I go through the arguments the DEA has raised
in their book and examine them in detail against the Federal
Government's own evidence on the subject. In addition to missing
the point, the DEA is not telling the truth. </p>

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="deacht1.htm">DEA Charts on Worldwide Cocaine and Heroin
Production and Seizures </a>-- These are the official DEA charts
of worldwide cocaine and heroin production and seizures. </p>

<p><a href="usdta.htm">U.S. DRUG THREAT ASSESSMENT: 1993 DRUG
INTELLIGENCE REPORT </a>- DEA - September, 1993 This is a rather
long document which is a comprehensive summary of the DEA's view
of the threat from drugs. </p>

<p><a href="cocccp.htm">COCA CULTIVATION AND COCAINE PROCESSING:
AN OVERVIEW </a>-- DEA - September 1993 This report is the DEA's
overview of the cocaine industry. </p>

<p><a href="deaseal.htm">The DEA Official Seal </a>-- This is a
GIF file of the DEA's official seal. </p>

<p><a href="const1.htm">International Drug Trafficking </a>Organizations
in Mexico - Statement by: Thomas A. Constantine, Administrator,
Drug Enforcement Administration, Before the: Senate Foreign
Relations Committee - August 8, 1995 </p>

<hr>

<h3>National Institute on Drug Abuse </h3>

<p><a href="http://www.drcnet.org/library/exchange1/review.htm">The
Facts on Needle Exchange </a>- Previously unreleased Federal
Government documents, plus background materials, on the facts
about needle exchange programs. </p>

<p><a href="nidaviol.txt">Drugs and Violence</a><b>:</b> Causes,
Correlates, and Consequences, <b><u>(Very Big -- 600K!)</u></b>
NIDA Research Monograph 103 - 1990, For a shorter analysis, with
essentially the same results, see Psychoactive Substances and
Violence, above. </p>

<hr>

<h3>National Clearinghouse on Alcohol and Drug Information </h3>

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="http://www.health.org/">NCADI Home Page</a> </p>

<p>Contains information such as the Drug Abuse Warning Network
(DAWN) Reports, the Household Survey on Drug Abuse, and other
information. While the information contained in these surveys is
significant, it needs to be viewed carefully in light of the
problems which are encountered with any attempt to collect
information on illegal activities. In addition, when such
information is reported to the media, the government officials
releasing the information will tend to make up press reports
which are misleading, to say the least, when compared with the
full text of the reports. Readers of these reports should read
them carefully to determine the difference between the press
release and the details of the report, and they should also refer
to the problems in collecting accurate data, discussed in the GAO
report, Drug Use Measurement. </p>

<hr>

<h3><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="gao/gaomen1.htm">General Accounting Office Document Page </a></h3>

<hr>

<h3>Other Government Publications </h3>

<p><a href="Needle1.htm">The Clinton Administration's Internal
Reviews of Needle Exchange Research</a></p>

<p><a href="respond.txt">RESPONDING TO DRUG USE AND VIOLENCE</a>:
HELPING PEOPLE, FAMILIES, AND COMMUNITIES A Directory and
Resource Guide of Public and Private Sector Drug Control Grants </p>

<p><a href="dprmar.txt">MARIJUANA USE GOING THROUGH THE ROOF </a></p>

<p>This is a press release on the recent rise in marijuana use. </p>

<p><a href="drgcnt.txt">PRESS BRIEFING </a>BY DIRECTOR OF
NATIONAL DRUG CONTROL POLICY, DR. LEE BROWN February 9, 1994 --
Lee Brown touting the Clinton Administration's new plan for the
same old failures. Typical political BS. </p>

<p><a href="drgpol.txt">AIDS CZAR KRISTINE GEBBIE </a>COMMENDS
DRUG CZAR FOR NATIONAL DRUG STRATEGY - February 9, 1994 </p>

<p>No sooner had Lee Brown spoken the words than other officials
rushed forth to praise him for his wisdom. Ms. Gebbie quit the
Clinton Administration shortly thereafter because she couldn't
find anyone who cared about the AIDS problem. </p>

<p><a href="drgstr.txt">REMARKS BY THE PRESIDENT IN DRUG STRATEGY
ANNOUNCEMENT </a>-- February 9, 1994 -- The President thought Lee
Brown's plan was a good idea too. </p>

<p><a href="drugfr.txt">POLICE PRACTICES: DRUG FREE BLOCK PLAN </a>By
Deputy Chief Charles W. Bennett, Jr. and Captain A. Christine
Bailor, M.P.A., Richmond, VA Police Department Originally
published in the July '94 issue of FBI Law Enforcement Bulletin </p>

<p>This is another one of those hare-brained plans to stamp out
drugs in the community. Among other things, the police get
together with the neighborhood residents and get them to sign a
contract vowing to be drug-free. Oh well, it made them feel
productive for a while. </p>

<p><a href="selcom89.htm">LEGALIZATION OF ILLICIT DRUGS: </a>IMPACT
AND FEASIBILITY (A Review of Recent Hearings) REPORT OF THE
SELECT COMMITTEE ON NARCOTICS ABUSE AND CONTROL, 1989 </p>

<p>These are the hearings on legalization held by Congressman
Charles Rangel in 1989. It is a good example of the thinking and
arguments being used at that time. Most notable is the fact that
no real research was done, just some collecting of opinions, and
many of the members of the committee said their mind was made up
before they heard the evidence. </p>

<p><a href="anahord.htm">A Proposed Anaheim Ordinance </a></p>

<p>This is a proposed ordinance for the city of Anaheim,
California which would have barred people from city parks if they
had ever been convicted of a drug offense. Just another dumb idea
from our politicians. This one later fell to a combined lawsuit
by the ACLU and NORML. Contributed by Jim Rosenfield. </p>

<p><a href="solom1.htm">DRUGS AND THE INFORMATION SUPERHIGHWAY </a><u>by
HON. GERALD B.H. SOLOMON OF NEW YORK in the House of
Representatives, Thursday, October 6, 1994 </u></p>

<p>A speech by Gerald Solomon. He is upset because people are
using the internet to promote drug policy reform. Free speech
must be stopped before it ruins America. </p>

<p><a href="solom2.htm">DRUG DECRIMINALIZATION IN HOLLAND </a>HAS
INCREASED CRIME AND ADDICTION by HON. GERALD B.H. SOLOMON OF NEW
YORK in the House of Representatives Thursday, March 2, 1995 </p>

<p>Another diatribe, full of misinformation, by Gerald Solomon.
What he doesn't know about the subject has filled libraries. </p>

<p><a href="../ACTIVIST/hremail.htm">US HOUSE OF REPRESENTATIVES </a>-
CONSTITUENT ELECTRONIC MAIL SYSTEM </p>

<p>How to contact your elected representatives through e-mail.
Now all you have to do is get them to listen. </p>

<p><a href="../ACTIVIST/hradd.txt">The U.S. House of
Representatives Member Directory </a></p>

<p><a href="guns1.htm">A BRIEF HISTORY </a>OF FEDERAL FIREARMS
ENFORCEMENT, Frederick S. Calhoun. Ph.D. Historian, Federal Law
Enforcement Training Center </p>

<p><a href="amhab/ahmenu.htm">America's Habit: </a>Drug Abuse,
Drug Trafficking, &amp; Organized Crime -- President's Commission
on Organized Crime, 1986 </p>

<p><a href="dtest1.htm">REMARKS BY THE PRESIDENT</a> ON
PRESIDENT'S DIRECTIVE ON DRUG TESTING </p>

<p><a href="pr01.htm">White House Press Release on Drugs 10-23-95</a>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../_private/sch_navbar.htm" tag="BODY" startspan
-->

<p><a href="../../toc.htm">Contents</a> | <a
href="../../feedback.htm">Feedback</a> | <a
href="../../search.htm">Search</a> </p>

<p><a href="../../index.htm">DRCNet Library</a> | <a
href="../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../Library/studies/studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="37375" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-31</DOCNO>
<DOCOLDNO>IA030-000641-B026-95</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/omintro.htm 206.61.184.43 19970122140914 text/html 14015
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:08:59 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:40:38 GMT
Content-length: 13797
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly -- Introduction</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY</h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<p><b>INTRODUCTION</b> </p>

<p>&nbsp;</p>

<hr>

<p>&nbsp;</p>

<p>We first became interested in the opium traffic during a visit
to the Far East in 1916. Like most Americans, we had vaguely
heard of this trade, and had still vaguer recollections of a war
between Great Britain and China, which took place about
seventy-five years ago, known as the Opium War. From time to time
we had heard of the opium trade as still flourishing in China,
and then later came reports and assurances that it was all over,
accompanied by newspaper pictures of bonfires of opium and opium
pipes. Except for these occasional and incidental memories, we
had neither knowledge of, nor interest in the subject. On our way
out to Japan, in the July of 1916, we met a young Hindu on the
boat, who was outspoken and indignant over the British policy of
establishing the opium trade in India, as one of the departments
of the Indian Government. Of all phases of British rule in India,
it was this policy which excited him most, and which caused him
most ardently to wish that India had some form of
self-government, some voice in the control and management of her
own affairs, so that the country could protect itself from this
evil. Without this, he declared, his country was powerless to put
a stop to this traffic imposed on it by a foreign government, and
he greatly deplored the slow, but steady demoralization of the
nation which was in consequence taking place. As he produced his
facts and figures, showing what this meant to his people-this
gradual undermining of their moral fiber and economic efficiency
we grew more and more interested. That such conditions existed
were to us unheard of, and unbelievable. It seemed incredible
that in this age, with the consensus of public opinion sternly
opposed to the sale and distribution of habit-forming drugs, and
with legislation to curb and restrict such practices incorporated
in the laws of all ethical and civilized governments, that here,
on the other side of the world, we should come upon opium traffic
conducted as a government monopoly. Not only that, but conducted
by one of the greatest and most highly civilized nations of the
world, a nation which we have always looked up to as being in the
very forefront of advanced, progressive and humane ideals. So
shocked were we by what this young Hindu told us, that we flatly
refused to believe him. We listened to what he had to say on the
subject, but thinking that however earnest he might be, however
sincere in his sense of outrage at such a policy, that he must of
necessity be mistaken. We decided not to take his word for it,
but to look into the matter for ourselves. </p>

<p>We did look into the matter. During a stay in the Far East of
nearly a year, in which time we visited Japan, China, Hong Kong,
French IndoChina, Siam and Singapore, we looked into the matter
in every country we visited. Wherever possible we obtained
government reports, and searched them carefully for those
passages giving' statistics concerning the opium trade-the amount
of opium consumed, the number of shops where it was sold, and the
number of divans where it was smoked. We found these shops
established under government auspices, the dealers obtaining
their supplies of opium from the government, and then obtaining
licenses from the government to retail it. In many countries, we
visited these shops and divans in person, and bought opium in
them freely, just as one goes to a shop to buy cigarettes. We
found a thorough and complete establishment of the opium traffic,
run by the government, as a monopoly. Revenue was derived through
the sale of opium, through excise taxes upon opium, and through
license fees paid by the keepers of opium shops and divans* -A
complete, systematic arrangement, by which the foreign government
profited at the expense of the subject peoples under its rule. In
European countries and in America, we find the governments making
every effort to repress the sale of habit-forming drugs. Here, in
the Far East, a contrary attitude prevails. The government makes
every effort to encourage and extend it. </p>

<p>Two notable exceptions presented themselves. </p>

<p>One was Japan. There are no opium shops in Japan, and the
Japanese Government is as careful to protect its people from the
evils and dangers of opium as any European country could be. It
must be remembered, however, that Japan is a free and independent
country. It has never been conquered by a European country, and
perhaps one explanation as to why the Japanese are a powerful,
virile people, is because Japan is the one Oriental nation that
has never been dominated by a European power, and in consequence,
never drugged. </p>

<p>The other exception is our own possession of the Philippines,
which although a subject country, has never had the opium traffic
established as part of the machinery of an alien government. </p>

<p>On our return to America, we were greatly exercised over these
facts which we had unearthed. We continued our researches as to
the opium traffic in the New York Public Library, and in the
Library of Congress, in Washington, in both of which places there
is a rich and abundant literature on the subject. We obtained
ready access to official blue books and government reports,
issued by the British Government, and it is from these sources
that the material in this book is largely drawn. We were somewhat
hampered in our investigations by the fact that because of the
war, these blue books have not always been of recent date, some
of them being two or three years old. For this reason, it has not
always been possible to give the most recent figures as to opium
consumption and distribution in the various countries. However,
we feel that we have obtained enough information to uphold our
case, and in any event, there is no doubt that the opium traffic,
as fostered by the British Government, still continues. In
looking over the list of British colonies where it is
established, we may find here and there a diminution in the
amount of opium consumed, but this is probably due to the
exigencies of war, to the lack of shipping and transportation,
rather than to any conscientious scruples or moral turnover;
because the revenue derived from the opium trade is precious. In
some instances, as in the case of the Straits Settlements, the
local British Government derives from forty to fifty percent of
its revenue from this source. Yet, taken in relation to the
whole, it is not large. However valuable it may be, however large
the percentage in the case of any particular colony, it can
surely never be large enough to compensate for the stigma
attached.- It is a blot upon the honor of a great nation to think
that she deliberately runs her colonies on opium: No revenue,
whether large or small, can be justified when coming from such a
source as this. </p>

<p>In all these blue books and official reports, the question of
the Opium Monopoly, as it is called, is dealt with freely. There
is no attempt to hide or suppress the facts. The subject is
reported frankly and fully. It is all there, for any one to read
who chooses. How then, does it happen that we in America know
nothing about Great Britain's Opium Monopoly? That the facts are
new to us and come to us as a shock? One is because of our
admiration for Great Britain. Those who know and there are a
few-hesitate to state them. Those who know, feel that it is a
policy unworthy of her. We hesitate to call attention to the
shortcomings of a friend. There are other reasons also for this
conspiracy of silence-fear of international complications, fear
of endangering the good feeling between the two countries,
England and America. Consequently England has been able to rely
upon those who know the facts to keep silent, either through
admiration or through fear. Also the complete ignorance of the
rest of us has been an additional safeguard. Therefore, for
nearly a century, she has been running her Opium Monopoly
undisturbed. It began as a private industry, about the time of
the East India Company, but later on passed out of the hands of
private individuals into the department of Opium Administration,
one of the branches of the colonial government&quot; But, loyal
as we have been all these years, we can remain silent no longer.
The time is now rapidly approaching when the two countries,
England and America, are to become closely united. How can we
become truly united, however, when on such a great moral question
as this we stand diametrically opposed? </p>

<p>There is still another reason why we should break silence. The
welfare of our own country is now at stake. The menace of opium
is now threatening America, and our first duty is to ourselves.
Little by little, surreptitiously, this drug has been creeping in
over our borders, and to-day many thousands of our young men and
young women are drug addicts, habituated to the use of one of the
opium derivatives, morphia or heroin. The recent campaign against
drug users, conducted by the New York Department of Health, has
uncovered these addicts in great numbers; has brought them before
us, made us see, in spite of ourselves, that thousands of them
exist and that new ones are being created daily. The question
arises, how do they obtain the drug? It was the fortune of the
writer to be present during the first week of the opening of the
Health Department Clinic for Drug Addicts, and her work consisted
in taking the histories of these pitiful, abject wrecks of men
and women who swarmed to the clinic in hundreds, seeking supplies
of the drug which they could not obtain elsewhere. The history of
these patients was almost invariably the same-there was a
monotony in their tragic, pathetic recital as to how they became
victims, how they first became acquainted with the drug. As a
rule, they began in extreme youth, generally between fifteen and
twenty years of age, one boy having begun at the age of thirteen.
In nearly every case they had tried it as a lark, as an
experiment. At &quot;parties,' they said, when some one of the
company would pass round a box full of heroin, inviting them to
snuff it. To snuff it, these children, very much as a small boy
goes behind the barn to try his first cigarette. In many
instances those who produced the box were peddlers, offering it
as a gift at first, knowing that after a dose or two the fatal
habit would be formed and another customer created. These
peddlers doubtless obtained their supplies from smugglers. But
that takes us back to our argument, namely, the part played by
that great nation which grows and distributes opium to the world.
For that nation produces an oversupply of opium, far more than is
needed by the medical profession for the relief of pain. Opium is
not profitable in its legitimate use. It is only profitable
because of the demands of addicts, men and women deliberately
debauched, either through the legalized machinery of colonial
governments, or through the illegal activities of smugglers. A
moral sentiment that will balk at this immense over-production,
the sole object of which is to create drug victims, is the only
weapon to fight it. In giving this book to the public, we are
calling upon that moral sentiment. We feel that we shall number
among our staunchest supporters that great body of men and women
in England who have for years been vainly fighting the opium
traffic. No more bitter opponents of this policy are to be found
than amongst the English people themselves. From time to time, in
Parliament, sharp debates have arisen as to the advisability of
continuing it, and some of the greatest men in England have been
steadfastly opposed. The great Gladstone has described it as
&quot;morally indefensible.&quot; The time has now come for us,
people of both countries, to unite to stop it.<br>
</p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-32</DOCNO>
<DOCOLDNO>IA030-000641-B026-124</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om1.htm 206.61.184.43 19970122140925 text/html 8884
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:09:15 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:46 GMT
Content-length: 8667
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Great Britain's Opium Monopoly</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>I - GREAT BRITAIN'S OPIUM MONOPOLY</h2>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"><br>
</p>

<p>In a book shop in Shanghai, we came upon a small book with an
arresting title, &quot;Drugging a Nation,&quot; by Samuel Merwin.
It was published in 1908, eight years before we chanced upon it,
shabby and shop worn, its pages still uncut. The people of
Shanghai, the great International Settlement of this largest city
and most important seaport of China, did not have to read it.
They knew, doubtless, all that its pages could disclose. We,
however, found it most enlightening. In it there is this
description of the British Opium Monopoly: </p>

<p>&quot;In speaking of it as a 'monopoly' I am not employing a
cant word for effect. I am not making a case. That is what it is
officially styled in a certain blue book on my table which bears
the title, 'Statement Exhibiting the Moral and Material Progress
of India during the year 1905-'6,' and which was ordered by the
House of Commons to be printed, May 10, 1907. . . . Now to get
down to cases, just what this Government Opium Monopoly is, and
just how Goes it work? An excerpt from the rather ponderous blue
book will tell us. It may be dry but it is official and
unassailable. It is also short. </p>

<p>&quot;'The opium revenue'-thus the blue book-'is partly raised
by a monopoly of the production of the drug in Bengal and the
United provinces, and partly by the levy of a duty on all opium
imported from native states. . . . In these two provinces, the
crop is grown under the control of a government department, which
arranges the total area which is to be placed under the crop,
with a view to the amount of opium required.' </p>

<p>&quot;So much for the broader outline. Now for a few of the
details: 'The cultivator of opium in these monopoly districts
receives a license, and is granted advances to enable him to
prepare the land for the crop, and he is required to deliver the
whole of the product at a fixed price to opium agents, by whom it
is dispatched to the government factories at Patna and Ghazipur.'
</p>

<p>&quot;The money advanced to the cultivator bears no interest.
The British Indian government lends money without interest in no
other cases. Producers of crops other than opium are obliged to
get along without free money. </p>

<p>&quot;When it has been manufactured, the opium must be
disposed of in one way and another; accordingly: 'The supply of
prepared opium required for consumption in India is made over to
the Excise Department . . . the chests of &quot; provision &quot;
opium, for export, are sold at monthly sales, which take place at
Calcutta.' For the meaning of the curious term, 'provision opium'
we have only to read on a little further. 'The opium is received
and prepared at the government factories, where the out-turn of
the year included 8,774 chests of opium for the Excise
Department, about three hundred pounds of various opium
alkaloids, thirty maunds of medical opium; and 51,770 chests of
provision opium for the Chinese market.' There are about <b>i4o </b>pounds
in a chest. . . . Last year the government had under poppy
cultivation 654,928 acres. And the revenue to the treasury,
including returns from auction sales, duties and license fees,
and deducting all 'opium expenditures' was nearly <font size="1">$22,000,000.
</font></p>

<p>As the blue book states, this opium is auctioned off once a
month. At that point, the British Government, as a government,
washes its hands of the business. Who buys the opium at these
government auctions, and what afterwards becomes of it? &quot;The
men who buy in the opium at these monthly auctions and afterwards
dispose of it are a curious crowd of Parsees, Mohammedans,
Hindoos and Asiatic Jews. Few British names appear in the opium
trade to-day. British dignity prefers not to stoop beneath the
taking in of profits; it leaves the details of a dirty business
to dirty hands. This is as it has been from the first. The
directors of the East India Company, years and years before that
splendid corporation relinquished the actual government of India,
forbade the selling of its specially-prepared opium direct to
China, and advised a trading station on the coast whence the drug
might find its way 'without the company being exposed to the
disgrace of being engaged in illicit commerce.&quot;' </p>

<p>&quot;So clean hands and dirty hands went into partnership.
They are in partnership still, save that the most nearly
Christian of governments has officially succeeded the company as
party of the first part.&quot; </p>

<p>You will say, if the British Government chooses to deal in
opium, that is not our concern. It is most emphatically our
concern. Once a month, at these great auction sales, the British
Government distributes thousands of pounds of opium, which are
thus turned loose upon the world, to bring destruction and ruin
to the human race. The buyers of this opium are not agents of the
British Government. They are merely the distributors, through
whom this drug is directed into the channels of trade.' The
British Government derives a certain portion of its revenue from
the sale of opium, therefore depends upon these dealers to find a
market for it. ' They are therefore, as distributors, the
unofficial agents of the British Government, through whom it is
sold legitimately, or smuggled around the world. In seeking to
eradicate the drug evil, we must face the facts, and recognize
clearly that the source of supply is the British Government,
through whose agents, official and unofficial, it is distributed.
</p>

<p>America, so they tell us, is now menaced by the drug evil. Now
that prohibition is coming into effect, we are told that we are
now confronted by a vice more terrible, far more deteriorating
and dangerous. If that is true, then we must recognize our danger
and guard against it. Some of the opium and morphia which reaches
this country is smuggled in; the rest is imported by the big
wholesale drug houses. There is an unlimited supply of it. As we
have seen, the British Government encourages poppy production,
even to the extent of lending money <i>without interest </i>to
all those who are willing to raise this most profitable crop. The
monopoly opium is sold once a month to the highest bidders, and
some of these highest bidders are unscrupulous men who must find
their markets how and where they can. That fact, of course, is of
no moment to the British Government. It is of deepest concern to
Americans, however. To the north of us we have the Dominion of
Canada. To the south, the No-Man's Land of Mexico. At the present
moment, the whole country is alarmed at the growing menace of the
drug habit, which is assuming threatening proportions.<br>
</p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-33</DOCNO>
<DOCOLDNO>IA030-000641-B026-142</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om2.htm 206.61.184.43 19970122140933 text/html 6063
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:09:24 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:11 GMT
Content-length: 5846
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Indian Opium Monopoly</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>II -- THE INDIAN OPIUM MONOPOLY </h2>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"> </p>

<p><font size="1">LET </font>us quote from another dry official
record, of unimpeachable veracity-the Statesman's YearBook, for
1916. On page 140<b>, </b>under the heading of The British
Empire: India and Dependencies, we read: &quot;Opium. In British
territory the cultivation of the poppy for the production of
opium is mainly restricted to the United Provinces, and the
manufacture of the opium from this region is a State monopoly. A
limited amount is also grown in the Punjab for local consumption
and to produce poppy seeds. In the monopoly districts the
cultivator receives advances from Government to enable him to
prepare the land for the crop, and he is bound to sell the whole
of the produce at a fixed price to Government agents, by whom it
is despatched to the Government factory at Ghazipur to be
prepared for the market. The chests of manufactured opium are
sold by auction in Calcutta at monthly sales. A reserve is kept
in hand to supply the deficiencies of bad seasons, and a
considerable quantity is distributed by the Indian excise
departments. Opium is also grown in many of the Native States of
Rajaputana and Central India. These Native States have agreed to
conform to the British system. No <font size="1">6 </font>opium
may pass from them into British territory for consumption without
payment of duty. </p>

<p>&quot;The bulk of the exports of opium from India has been to
China. By arrangements with that country, the first one being in
I907, the exports from India have been limited, and provision
made for the cessation of the export to China when the native
Chinese production of opium shall be suppressed. The trade with
China is now practically suspended.&quot; </p>

<p>The important things to notice in the above statement are
these: The growing of poppies, the manufacture of opium, and the
monthly auction sales continue. Also, the opium trade with China
is practically at an end. The history of the opium traffic in
China is a story complete in itself and will be dealt with in
another chapter. At present, we must notice that the trade with
China is practically suspended, but that the British Government
is still auctioning off, once a month at Calcutta, great
quantities of opium. Where does this opium go--who are the
consumers? If not to China, then where? </p>

<p>The same reliable authority, the Statesman's Year-Book for
1918<b>, </b>has this to say on the subject. On page 130 we read:
&quot; Opium: In British territory the cultivation of the poppy
for the production of opium is practically confined to the United
Provinces, and the manufacture of opium from this region is a
State monopoly. The bulk of the exported opium is at<b> </b>present
either sent to the United Kingdom, or supplied direct to the
Governments of consuming countries in the Far East; a certain
quantity is also sold by auction in Calcutta at monthly sales.
Opium is also grown in many of the Native States of Rajputana and
Central India, which have agreed to conform to the British
system.&quot; The following tables, taken from most reliable
authority, give some idea of the exports to the &quot;consuming
countries of the Far East.&quot; Note that Japan began buying
opium in 1911-12<font size="1">2. </font>We shall have something
to say about the Japanese smuggling later. Also note that it was
in 1907<b> </b>that Great Britain and China entered into
agreement, the outcome to be the suppression of the opium trade
in China. But see the increasing imports into the treaty ports;
up till almost the very last moment British opium being poured
into China. In the second table, observe the increasing
importation into England, (United Kingdom), synchronous with the
increased exports to Japan, which will be discussed later.<br>
</p>

<p><img src="img00001.gif" align="bottom" width="292"
height="535"> </p>

<p><img src="img00002.gif" align="bottom" width="292"
height="536"> <br>
</p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-34</DOCNO>
<DOCOLDNO>IA030-000641-B026-154</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om3.htm 206.61.184.43 19970122140941 text/html 11024
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:09:33 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:06 GMT
Content-length: 10806
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Japan as an Opium Distributor</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<p>III -- JAPAN AS AN OPIUM DISTRIBUTOR </p>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"> </p>

<p><font size="1">IN </font>an article which appeared in the <i>New
York Times, </i>under date of February 14, 1919<b>, </b>we read:
&quot;A charge that the Japanese Government secretly fosters the
morphia traffic in China and other countries in the Far East is
made by a correspondent in the <i>North China Herald </i>in its
issue of December 21st<b> </b>last. The correspondent asserts
that the traffic has the financial support of the Bank of Japan,
and that the Japanese postal service in China aids, although
'Japan is a signatory to the agreement which forbids the import
into China of morphia or of any appliances used in its
manufacture or application.' </p>

<p>&quot;Morphia no longer can be purchased in Europe, the
correspondent writes. The seat of industry has been transferred
to Japan, and morphia is now manufactured by the Japanese
themselves. Literally, tens of millions of yen are transferred
annually from China to Japan for the payment of Japanese morphia.
. . . </p>

<p>&quot;In South China, morphia is sold by Chinese peddlers,
each of whom carries a passport certifying that he is a native of
Formosa, and therefore entitled to Japanese protection. Japanese
drug stores throughout China carry large stocks of morphia.
Japanese medicine vendors look to morphia for their largest
profits. Wherever Japanese are predominant, there the trade
flourishes. Through Dairen, morphia circulates throughout
Manchuria and the province adjoining; through Tsingtao, morphia
is distributed over Shantung province, Anhui, and Kiangsu, while
from Formosa morphia is carried with opium and other contraband
by motor-driven fishing boats to some point on the mainland, from
which it is distributed throughout the province of Fukien and the
north of Kuangtung. Everywhere it is sold by Japanese under
extra-territorial protection.&quot; </p>

<p>The article is rather long, and proves beyond doubt the
existence of a well-organized and tremendous smuggling business,
by means of which China is being deluged with morphia. In the
body of the article we find this paragraph: </p>

<p>&quot;While the morphia traffic is large, there is every
reason to believe that the opium traffic upon which Japan is
embarking with enthusiasm, is likely to prove even more
lucrative. In <i>the Calcutta opium sales, Japan has become one
of the considerable purchasers of Indian </i>opium. . . . <i>Sold
by the Government of India, this opium is exported under permits
applied for by the Japanese Government, </i>is shipped to Kobe,
and from Kobe is transshipped to Tsingtao. Large profits are made
in this trade, in which are interested some of the leading firms
of Japan.&quot; </p>

<p>This article appears to be largely anti-Japanese. In fact,
more anti-Japanese than anti-opium. Anti Japanese sentiment in
America is played upon by showing up the Japanese as smugglers of
opium. The part the British Government plays in this traffic is
not emphasized. &quot;In the Calcutta opium sales, Japan has
become one of the considerable purchasers of Indian opium . . .
sold by the Government of India.&quot; We are asked to condemn
the Japanese, who purchase their stocks of opium as individuals,
and who distribute it in the capacity of smugglers. We are not
asked to censure the British Government which produces,
manufactures and sells this opium as a State monopoly. We are
asked to denounce the Japanese and their nefarious smuggling and
shameful traffic, but the source of supply, which depends upon
these smugglers as customers at the monthly auctions, is above
reproach. A delicate ethical distinction. </p>

<p>However, there is no doubt that the Japanese are ardent
smugglers. In an article in the March, 1919<b>, </b>number of
&quot;Asia&quot; by Putnam Weale, we find the following bit: *
&quot;At all ports where Japanese commissioners of Maritime
Customs (in China) hold office, it is undeniable that centres of
contraband trade have been established, opium and its derivatives
being so openly smuggled that the annual net import of Japanese
morphia (although this trade is forbidden by International
Convention) is now said to be something like 20<b> </b>tons a
year-sufficient to poison a whole nation.&quot; </p>

<p><font size="1">* &quot; A Fair Chance for Asia,&quot; by
Putnam Weale, page 227.</font> </p>

<p>Mr. Weale is an Englishman, therefore more anti-Japanese than
anti-opium. We do not recall any of his writings in which he
protests against the opium trade as conducted by his Government,
nor the part his Government plays in fostering and encouraging
it. </p>

<p>However, there are other Englishmen who see the situation in a
more impartial light, and who are equally critical of both Great
Britain and Japan. In his book, Trade Politics and Christianity
in Africa and the East,&quot; by A. J. Macdonald, M. A., formerly
of Trinity College, Cambridge, we find the facts presented with
more balance. Thus, on page 229: &quot;. . . In the north of
China another evil is springing up. The eradication of the opium
habit is being followed by the development of the morphia
traffic. . . . The morphia habit in northern China, especially
Manchuria, is already widespread. The Chinese Government is alert
to the evil, but their efforts to repress it are hampered by the
action of traders, mainly Japanese, who elude the restrictions
imposed by the Chinese and Japanese Governments. . . . China is
being drenched with morphia. It is incredible that anything
approaching the amount could possibly be devoted to legitimate
purposes. It is said that in certain areas coolies are to be seen
covered all over with needle punctures.' An injection of the drug
can be obtained for three or four cents. In Newchang 2,000<b> </b>Victims
of the morphia habit died in the winter of 1914-15. Morphia
carries off its victims far more rapidly than opium. . . .
Morphia is not yet manufactured in any appreciable quantities in
the East, and certainly even Japan cannot yet manufacture the
hypodermic injectors by means of which the drug is received. The
bulk of the manufacture takes place in England, Germany and
Austria. . . . In this traffic, two firms in Edinburgh and one in
London are engaged. The trade is carried on through Japanese
agents. The Board of Trade returns show that the export of
morphia from Great Britain to the East has risen enormously
during the last few years. </p>

<p>1911 - 5.5 tons </p>

<p>1912 - 7.5 tons </p>

<p>1913 - 11.25 </p>

<p>1914 -- 14 </p>

<p>The freedom which allows three British firms to supply China
with morphia for illicit purposes is a condemnation of English
Christianity. </p>

<p>This book of Mr. Macdonald's was published in 1916<b>. </b>Mr.
Weale's article was published in 1919<b>, </b>in which he speaks
of an importation of about twenty tons of morphia. Apparently the
three British firms which manufacture morphia, two in Edinburgh
and one in London are still going strong. Japan, however, appears
to be growing impatient with all this opprobrium cast upon her as
the distributor of drugs, especially since much of the outcry
against this comes from America. Our own country seems to be
assisting in this traffic in a most extensive manner. The Japan
Society Bulletin No. 60 calls attention to this:<br>
</p>

<p>NEW TURN IN MORPHIA TRAFFIC </p>

<p>The morphia traffic in China has taken a new turn, according
to the <i>Japan Advertiser. </i>It quotes Putnam Weale to the
effect that whilst in recent years the main distributors have
been Japanese, the main manufacturers have been British. The
morphia has been exported in large quantities from Edinburgh to
Japan, but as the result of licensing the exports of this drug
from Great Britain, the shipments to Japan dropped from <font
size="1">6oo,229 </font>ounces in 1917 to one-fourth that amount
in 1918<b>. </b><i>The Japan Chronicle, </i>speaking from
&quot;absolutely authentic information,&quot; states that 113,000
ounces of morphia arrived in Kobe from the United States in the
first five months of 1919<b>. </b>These figures are not given as
the total shipments received in Kobe, but merely as the quantity
of which <i>The Chronicle </i>has actual knowledge. It states
further that this morphia is being transhipped in Kobe harbor to
vessels bound for China. Dr. Paul S. Reinsch, who has resigned
his post as Minister to China, has stated that he will use every
resource in his power to stop the shipment from America of
morphia intended for distribution in China, in defiance of the
international convention which prohibits the sale of the drug in
that country. </p>

<p>If sufficient publicity is cast upon the distributors,
Japanese, English and American, public sentiment may in time take
cognizance of the source of all this mischief, namely, the
producer.<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-35</DOCNO>
<DOCOLDNO>IA030-000641-B026-187</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om4.htm 206.61.184.43 19970122141009 text/html 8241
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:09:58 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:02 GMT
Content-length: 8024
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - Singapore</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>IV -- SINGAPORE</h2>

<hr>

<p>In January, 1917, we found ourselves at Singapore, a British
dependency, situated at the end of the Malay Peninsula, and one
of the greatest seaports of the Orient. We were stopping at the
Hotel de l' Europe, a large and first class hotel. The first
morning at breakfast, the waiter stood beside us, waiting for our
order. He was a handsome young Malay, dressed in white linen
clothes, and wearing a green jade bracelet on one wrist. We gave
him our order and he did not move off. He continued to stand
quietly beside our chairs, as in a trance. We repeated the
order-one tea, one coffee, two papayas. He continued to stand
still beside us, stupidly. Finally he went away. We waited for a
long time and nothing happened. At last, after a long wait, he
returned and set before us a teapot filled with hot water.
Nothing else. We repeated again-tea, coffee, papayas. We said it
two or three times. Then he went away and came back with some
tea. We repeated again, coffee and fruit. Eventually he brought
us some coffee. Finally, after many endeavors, we got the fruit.
It all took a long time. We then began to realize that something
was the matter with him. He could understand English well enough
to know what orders we were giving him, but he seemed to forget
as soon as he left our sight. We then realized that he was
probably drugged. It was the same thing every day. In the morning
he was stupid and dull, and could not remember what we told him.
By evening his brain was clearer, and at dinner he could remember
well enough. The effects of whatever he had been taking had
apparently worn off during the day. </p>

<p>We learned that the opium trade was freely indulged in, at
Singapore, fostered by the Government. Singapore is a large city
of about 300,000 inhabitants, a great number of which are
Chinese. It has wide, beautiful streets, fine government
buildings, magnificent quays and docks-a splendid European city
at the outposts of the Orient. We found that a large part of its
revenue is derived from the opium traffic-from the sale of opium,
and from license fees derived from shops where opium may be
purchased, or from divans where it may be smoked. The customers
are mainly Chinese. </p>

<p>I wanted to visit these Government-licensed opium shops and
opium dens. A friend lent me two servants, as guides. We three
got into rickshaws and went down to the Chinese quarter, where
there are several hundred of these places, all doing a
flourishing business. It was early in the afternoon, but even
then, trade was brisk. The divans were rooms with wide wooden
benches running round the sides, on which benches, in pairs,
sharing a lamp between them, lay the smokers. They purchased
their opium on entering, and then lay down to smoke it. The
packages are little, triangular packets, each containing enough
for about six smokes. Each packet bears a label, red letters on a
white ground, &quot;Monopoly opium.&quot; </p>

<p>In one den there was an old man-but you can't tell whether a
drug addict is old or not, he looked as they all do, gray and
emaciated-but as he caught my eye, he laid down the needle on
which he was about to cook his pill, and glanced away. I stood
before him, waiting for him to continue the process, but he did
not move. </p>

<p>&quot;Why doesn't he go on?&quot; I asked my guide. &quot;He
is ashamed to have you see him,&quot; came the reply. </p>

<p>&quot;But why should he be ashamed?&quot; I asked, &quot;The
British Government is not ashamed to sell to him, to encourage
him to drug himself, to ruin himself. Why should he be
ashamed?&quot; </p>

<p>&quot;Nevertheless, he is,&quot; replied the guide. &quot;You
see what he looks like-what he has become. He is not quite so far
gone as the others-he is a more recent victim. He still feels
that he has become degraded. Most of them do not feel that way
after a while.&quot; </p>

<p>So we went on and on, down the long street. There was a
dreadful monotony about it all. </p>

<p>House after house of feeble, emaciated, ill wrecks, all
smoking Monopoly Opium, all contributing, by their shame and
degradation, to the revenues of the mighty British Empire. </p>

<p>That evening after dinner, I sat on the wide verandah of the
hotel, looking over a copy of the &quot;Straits Times.&quot; One
paragraph, a dispatch from London, caught my eye. &quot; Chinese
in Liverpool. Reuter's Telegram. London, January 17, 1917
Thirty-one Chinese were arrested during police raids last night
on opium dens in Liverpool. Much opium was seized. The police in
one place were attacked by a big retriever and by a number of
Chinese, who threw boots and other articles from the
house-top.&quot; </p>

<p>Coming fresh from a tour of the opium-dens of Singapore, I
must say that item caused some mental confusion. It must also be
confusing to the Chinese. It must be very perplexing to a Chinese
sailor, who arrives in Liverpool on a ship from Singapore, to
find such a variation in customs. To come from a part of the
British Empire where opium smoking is freely encouraged, to Great
Britain itself where such practices are not tolerated. He must
ask himself, why it is that the white race is so sedulously
protected from such vices, while the subject races are so eagerly
encouraged. It may occur to him that the white race is valuable
and must be preserved, and that subject races are not worth
protecting. This double standard of international justice he must
find disturbing. It would seem, at first glance, as if subject
races were fair game-if there is money in it. Subject races,
dependents, who have no vote, no share in the government and who
are powerless to protect themselves-fair game for exploitation. </p>

<p>Is this double-dealing what we mean when we speak of &quot;our
responsibility to backward nations, 1) or of &quot;the sacred
trust of civilization&quot; or still again when we refer to
&quot;the White Man's burden &quot; ? </p>

<p>Pondering over these things as I sat on the hotel verandah, I
finally reached the conclusion that to print such a dispatch as
that in the &quot; Straits Times&quot; was, to say the least,
most tactless. </p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p><br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-36</DOCNO>
<DOCOLDNO>IA030-000641-B026-206</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om5.htm 206.61.184.43 19970122141021 text/html 5031
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:10:11 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:40:58 GMT
Content-length: 4814
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Straits Settlement Opium Commission</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>V -- THE STRAITS SETTLEMENTS OPIUM COMMISSION<br>
</h2>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"> </p>

<p>FROM time to time, certain people in England apparently have
qualms as to Great Britain's opium traffic, and from time to time
questions are raised as to whether or not such traffic is morally
defensible. In February, 1909, apparently in answer to such
scruples and questionings on the part of a few, a very
interesting report was published, &quot;Proceedings of the
Commission appointed to Enquire into Matters Relating to the Use
of Opium in the Straits Settlements and the Federated Malay
States. Presented to both Houses of Parliament by Command of His
Majesty.&quot; This document may be found in the New York Public
Library and is well worth careful perusal. </p>

<p>This Commission consisted of about a dozen men, some English,
some natives of the Straits Settlements. They apparently made an
intensive and exhaustive study of the subject, carefully
examining it from every angle. Countless witnesses appeared
before them, giving testimony as to the effects of opium upon the
individual. This testimony is interesting, in that it is of a
contradictory nature, some witnesses saying that moderate opium
indulgence is nothing worse than indulgence in alcoholic
beverages, and like alcohol, only pernicious if taken to excess.
Other witnesses seemed to think that it was most harmful. The
Commission made careful reports as to the manner of licensing
houses for smoking, the system of licensing opium farms, etc.,
and other technical details connected with this extensive
Government traffic. Finally, the question of revenue was
considered, and while the harmfulness of opium smoking was a
matter of divided opinion, when it came to revenue there was no
division of opinion at all. As a means of raising revenue, the
traffic was certainly justifiable. It was proven that about fifty
per cent of the revenues of the Straits Settlements and the
Federated Malay States came from the opium trade, and, as was
naively pointed out, to hazard the prosperity of the Colony by
lopping off half its revenues, was an unthinkable proceeding. </p>

<p>The figures given are as follows. </p>

<p>1898. Revenue derived from 0pium....45.9 percent </p>

<p>1899 44.8 </p>

<p>1900 43.3 </p>

<p>1901 53.2 </p>

<p>1902 48.3 </p>

<p>1903 47.1 </p>

<p>1904 59.1 </p>

<p>1905 46. </p>

<p>1906 53.3 </p>

<p>There was one dissenting voice as to the conclusions reached
by this Opium Commission, that of a Bishop who presented a
minority report. But what are moral scruples against cold facts
that there's money in the opium trade? </p>

<p>This Commission made its report in 1909. But the opium
business is apparently still flourishing in the Straits
Settlements. Thus we read in the official Blue Book for 1917,
&quot;Colony of the Straits Settlements &quot; that of the total
revenue for the year, $18,672,104, that $9,182,000 came from
opium. What per cent is that?<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-37</DOCNO>
<DOCOLDNO>IA030-000641-B026-222</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om6.htm 206.61.184.43 19970122141031 text/html 6267
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:10:22 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:40:54 GMT
Content-length: 6050
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Opium in Siam</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>VI --OPIUM IN SIAM</h2>

<hr>

<p>BANGKOK, Siam, January, 1917- Siam, an independent kingdom. As
a matter of fact, &quot;protected&quot; very sternly and
thoroughly by Great Britain and France, so that its
&quot;independence&quot; would about cover an oyster cracker.
However, it is doubtless protected &quot;benevolently&quot; for
what protectorate is anything but benevolent? The more rigorous
the protectorate, the more benevolent its character. The Peace
Conference seems to have given us a new word in
&quot;mandatory.&quot; We do not know as yet what adjective will
be found to qualify mandatory, but it will doubtless be fitting
and indicative of idealism-of sorts. Therefore, all will be well.
Our suspicions will be lulled. It is high time that a substitute
was found for &quot;benevolent protectorate.&quot; </p>

<p>The particular form of benevolence noted in Siam was the total
inability of the Siamese to exclude British opium. They are
allowed, by the benevolent powers, to impose an import duty on
all commodities imported except opium. That is free. The treaty
between Siam and Great Britain in 1856 says so. We rather fancy
that Great Britain had more to say about this in 1856 than Siam
but maybe not. Anyway poor old Siam, an independent kingdom, is
bound to receive as much opium as may be imported, and is quite
powerless, by the terms of this treaty, to enact laws to exclude
it. In the last year or two, the Government of Siam has been
obliged to put the opium traffic under government control, in
order to minimize the worst evils in connection with it, although
to restrict and regulate an evil is a poor substitute for the
ability to abolish it. </p>

<p>All this, you will see, is rather tough on the Siamese, but
good business for the British Empire. </p>

<p>However, opium is not bad for one. There are plenty of people
to testify to that. We Americans have a curious notion to the
contrary, but then, we Americans are so hysterical and gullible.
An Englishman whom we met in Bangkok told me that opium was not
only harmless, but actually beneficial. He said once that he was
traveling through the jungle, into the interior somewhere. He had
quite a train of coolies with him, carrying himself and his
baggage through the dense forests. By nightfall, he found his
coolies terribly exhausted with the long march. But he was in a
hurry to press on, so, as he expressed it, he gave each of them a
&quot;shot&quot; of morphia, whereupon all traces of fatigue
vanished. They forgot the pain of their weary arms and legs and
were thus enabled to walk all night. He said that morphia
certainly knocked a lot of work out of men-you might say, doubled
their capacity for endurance. </p>

<p>The night we left Bangkok, we got aboard the boat at about
nine in the evening. The hatch was open, and we looked into the
hold upon a crowd of coolies who had been loading sacks of rice
aboard the ship. There they lay upon the rice sacks, two or three
dozen of them, all smoking opium. Two coolies to a lamp. I rather
wondered that a lamp did not upset and set the boat on fire, but
they are made of heavy glass, with wide bottoms, so that the
chances of overturning them are slight. So we leaned over the
open hatch, looking down at these little fellows, resting and
recuperating themselves after their work, refreshing themselves
for the labor of the morrow. </p>

<p>Opium is wonderful, come to think of it. But why, since it is
so beneficial and so profitable, confine it to the downtrodden
races of the world? Why limit it to the despised races, who have
not sense enough to govern themselves anyway? </p>

<p>The following figures are taken from the Statistical Year
Books for the Kingdom of Siam: </p>

<p>Foreign trade and navigation of the port of Bangkok, imports
of opium: </p>

<p>1911-12 1,270 chests of opium </p>

<p>1912-13 1,775 </p>

<p>1913-14 1,186 </p>

<p>1 914-15 2,000 Imported from India and Singapore. </p>

<p>1915-16 2,000 </p>

<p>1916-17 1,100 </p>

<p>1917-18 1,850 </p>

<p>Also, from the same source, we find the number of retail opium
shops: </p>

<p>1912-13 2,985 </p>

<p>1913-14 3,075 </p>

<p>1914-15 3,132 </p>

<p>1915-16 3,104 </p>

<p>1916-17 3,111<br>
</p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-38</DOCNO>
<DOCOLDNO>IA030-000641-B026-245</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om7.htm 206.61.184.43 19970122141047 text/html 7351
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:10:33 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:40:50 GMT
Content-length: 7134
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - Hong Kong</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>VII -- HONGKONG</h2>

<hr>

<p>&nbsp;</p>

<p>The Crown Colony of Hongkong was ceded by China to Great
Britain in January, 1841; the cession was confirmed by the treaty
of Nanking in August, 1842; and the charter bears date April 5,
1843. Hongkong is the great center for British commerce with
China and Japan, and a military and naval station of first-class
importance.&quot; </p>

<p>Thus the Statesman's Year Book. This authority, however, omits
to mention just exactly how this important piece of Chinese
territory came to be ceded to Great Britain. It was the reward
that Great Britain took unto herself as an &quot;indemnity&quot;
following the successful prosecution of what is sometimes spoken
of as the first opium war-a war of protest on the part of China
against Great Britain's insistence on her right to deluge China
with opium. China's resistance was in vain-her efforts to stem
the tide of opium were fruitless-the might, majesty, dominion and
power of the British Empire triumphed, and China was beaten. The
island on which Hongkong is situated was at that time a blank
piece of land; but strategically well placed-ninety miles south
of the great Chinese city of Canton, the market for British
opium. </p>

<p>The opposite peninsula of Kowloon, on the mainland, was ceded
to Great Britain by treaty in 1861, and now forms part of
Hongkong. By a convention signed at Peking in June, 1898, there
was also leased to Great Britain for 99 years a portion of
Chinese territory mainly agricultural, together with the waters
of Mirs Bay and Deep Bay, and the island of Lan-tao. Its area is
356 square miles, with about 81,000 inhabitants, exclusively
Chinese. Area of Old Kowloon is 3 square miles. Total area of
colony, 391 square miles. </p>

<p>The population of Hongkong, excluding the Military and Naval
establishments, and that portion of the new territory outside New
Kowloon, was according to the 1911 census, 366,145 inhabitants.
Of this number the Chinese numbered 354,187. </p>

<p>This colony is, of course, governed by Great Britain, and is
not subject to Chinese control. Here is situated a Government
opium factory, and the imports of Indian opium into Hongkong for
the past several years are as follows: </p>

<p>1903-4 3,576,431 pounds sterling </p>

<p>1904-5 4,036,436 </p>

<p>1905-6 3,775,82.6 </p>

<p>1906-7 3,771,409 </p>

<p>1907-8 3,145,403 </p>

<p>1908-9 2,230,755 </p>

<p>1909-10 3,377,222 </p>

<p>1910-11 3,963,264 pounds sterling </p>

<p>1911-12 3,018,858 </p>

<p>1912-13 2,406,084 </p>

<p>1913-14 1,084,093 </p>

<p>1914--15 110,712 </p>

<p>These figures are taken from &quot;Statistical Abstract
Relating to British India, 1905-6 to 1915,&quot; and &quot;
Statistical Abstract Relating to British India, 1903-4 to
1912-13.&quot; The falling off in imports of opium noticed in
1914-15 may be due to the war, lack of shipping, etc., or to the
fact that the China market was due to close on April 1, 1917. The
closing of the China market 400,000,000 of people destined no
longer to have opium supplied to them (except illegally, by
smuggling, etc.) is naturally a big blow to the British opium
interests. That is where the menace to the rest of the world
comes in. Opium has been proved such a profitable commodity, that
if one market is shut off, others must be found as substitutes.
The idea of closing the trade altogether naturally does not
appeal to those who profit by it. Therefore, what we should hail
at first sight as a welcome indication of a changed moral
sentiment, is in reality but the pause which proceeds the casting
about for new markets, for finding new peoples to drug. </p>

<p>The Colonial Report No. 972, Hongkong Report for 1917, gives
the imports and exports of opium: Page 7- </p>

<p>&quot;The imports and exports of certified opium during the
year as follows: </p>

<p>Imports......... 7 chests </p>

<p>Export.......... 224 chests </p>

<p>Of these, however, the imports all come from Shanghai, and of
the total export Of 224 chests, 186 went to Shanghai.&quot; </p>

<p>Opium received from other sources than Shanghai makes a better
showing. &quot; Seven hundred and forty chests of Persian opium
imported during the year, and seven hundred and forty-five
exported to Formosa. Nine hundred and ten chests of uncertified
Indian opium were imported: Four hundred and ten chests by the
Government Monopoly, and the remaining five hundred for the Macao
opium farmer.&quot; </p>

<p>Macao is a small island off the coast of China, near Canton-a
Portuguese settlement, owned by Portugal for several centuries,
where the opium trade is in full blast. But somehow, one does not
expect so much of Portugal. The most significant feature of the
above paragraph, however, lies in the reference to the
importation of Persian opium. &quot; Seven hundred and forty
chests of Persian opium imported.&quot; Query, who owns Persia? </p>

<p>Nevertheless, in spite of this poor showing, in spite of the
decrease in opium importation as compared with the balmy days,
all is not lost. The Crown Colony of Hongkong still continues to
do an active trade. In the Colonial Office List for 1917, on page
218, we read: &quot;Hongkong. Revenue: About one-third of the
revenue is derived from the Opium Monopoly.&quot;<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-39</DOCNO>
<DOCOLDNO>IA030-000641-B026-268</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om8.htm 206.61.184.43 19970122141059 text/html 4617
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:10:49 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:40:47 GMT
Content-length: 4400
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - Sarawak</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>VIII -- SARAWAK<br>
</h2>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"> </p>

<p>NEAR British North Borneo. Area, 42,000 square miles, many
rivers navigable. The government of part of the present territory
was obtained in 1842 by Sir James Brooke from the Sultan of
Brunei. Various accessions were made between 1861, 1885, and
188o. The Rajah, H. H. Sir Charles Johnson Brooke, G. C.M.G.,
nephew to the late Rajah, born June 3, 1829, succeeded in 1868.
Population estimated at 500,000, Malays, Dyaks, Kayans, Kenyahs,
and Muruts, with Chinese and other settlers. </p>

<p>Thus the Statesman's Year Book, to which we would add a
paragraph from an article in the National Geographic Magazine for
February, 1919. Under the title: &quot;Sarawak: The Land of the
White Rajahs&quot; we read: &quot;With the recent death of Sir
Charles Brooke, G. C. M. G., the second of the white rajahs of
Sarawak, there came to an end one of the most useful and unusual
careers among the many that have done credit to British rule in
the Far East. For nearly 49 years he governed, as absolute
sovereign, a mixed population of Chinese, Malays, and numerous
pagan tribes scattered through the villages and dense jungles of
an extensive territory on the northwest coast of Borneo. </p>

<p>&quot; Constant solicitude for the welfare of his people won
the sympathy and devotion which enabled this white man, supported
by an insignificant army and police, to establish the peaceful
occupations of civilization in place of barbarous tyranny and
oppression.&quot; </p>

<p>How thoroughly this &quot;civilizing&quot; process was
accomplished may be judged somewhat by turning to the Colonial
Office List for 19I7, where on page 436 we read: &quot;Sarawak:
The principal sources of revenue are the opium, gambling, pawn
shops, and arrack, producing: </p>

<p>1908 $483,019 </p>

<p>1909 460,416 </p>

<p>1910 385,070 </p>

<p>1911 420,151 </p>

<p>1912 426,867 </p>

<p>1913 492,455 </p>

<p>In the Statesman's Year Book for 1916 we find the total
revenue for this well-governed little colony as follows, given
however in pounds sterling, instead of dollars, as in the above
table. Thus: </p>

<p>Revenue-1910 221,284 pounds sterling </p>

<p>1911I 159,456 </p>

<p>1912 175,967 </p>

<p>1913 210,342 </p>

<p>1914 208,823 </p>

<p>It would seem as if forty-nine years of constant solicitude
for the welfare of a people, establishing the peaceful
occupations of civilization, might have resulted in something
better than a revenue derived from opium, gambling, pawn shops
and arrack. </p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p><br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-40</DOCNO>
<DOCOLDNO>IA030-000641-B026-287</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om9.htm 206.61.184.43 19970122141105 text/html 10494
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:10:57 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:40:43 GMT
Content-length: 10276
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - Shanghai</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>IX -- SHANGHAI<br>
</h2>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"><br>
</p>

<p>IN the New York Library there is an interesting little book,
about a quarter of an inch thick, and easy reading. It is
entitled: &quot;Municipal Ethics: Some Facts and Figures from the
Municipal Gazette, 1907-1914. An Examination of the Opium License
policy of the Shanghai Municipality. In an Open Letter to the
Chairman of the Council, by Arnold Foster, Wuchang. For 42 years
Missionary to the Chinese.&quot; </p>

<p>Shanghai, being a Treaty Port, is of two parts. The native or
Shanghai city, under the control and administration of the
Chinese. And the foreign concessions, that part of the city under
the control and administration of foreigners. This is generally
known as the International Settlement (also called the model
settlement), and the Shanghai Municipal Council is the
administrative body. Over this part the Chinese have no control.
In 1907, when China began her latest fight against the opium
evil, she enacted and enforced drastic laws prohibiting opium
smoking and opium selling on Chinese soil, but was powerless to
enforce these laws on &quot;foreign&quot; soil. In the foreign
concessions, the Chinese were able to buy as much opium as they
pleased, merely by stepping over an imaginary line, into a
portion of the town where the rigid anti-opium laws of China did
not apply. </p>

<p>Says Mr. Arnold, in his Open Letter: &quot;It will be seen
that the title of the pamphlet, Municipal Ethics, describes a
situation which is a complex one. It concerns first the actual
attitude of the Shanghai Municipal Council towards the Chinese
national movement for the suppression of the use of opium. This,
we are assured by successive Chairmen of the Council, has been
one of &quot;sincere sympathy...... the greatest sympathy,&quot;
and more to the same effect. Certainly no one would have guessed
this from the facts and figures reproduced in this pamphlet from
the columns of the &quot; Municipal Gazette.&quot; </p>

<p>&quot;The second element in the ethical situation is the
actual attitude of the Council not only towards the Chinese
national movement, but also towards its own official assurances,
protestations and promises. </p>

<p>&quot;It is on this second branch of the subject before us
that I specially desire to focus attention, and for the facts
here stated that I would bespeak the most searching examination.
The protestations of the Council as to its own virtuous attitude
in regard to opium reform in China are made the more emphatic,
and also the more open to criticism, by being coupled with some
very severe insinuations made at the time, as to the insincerity
and unreliability of the Chinese authorities in what they were
professing, and in what they were planning to do in the same
matter of opium reform. It so happens, as the event proves, that
these sneers and insinuations were not only quite uncalled for,
but were absolutely and utterly unjust. When a comparison is
instituted between (a) 'official pronouncements' made two years
ago by the Chinese authorities as to what they then intended to
do for the suppression of the opium habit, and (b) the 'actual
administrative results' that in the meanwhile have been
accomplished, the Chinese have no cause to be ashamed of the
verdict of impartial judges. What they have done may not always
have been wise, it may sometimes have been very stern, but the
outcome has been to awaken the astonishment and admiration of the
whole civilized world! When, on the other hand, a comparison is
instituted between (a) the fine professions and assurances of the
Shanghai Municipal Council made six or seven years ago as to its
own attitude towards the 'eradication of the opium evil' and (b)
the 'actual administrative results' of the Council's own
proceedings, the feelings awakened are of very different order.
Here, not to mention any other consideration, two hard facts
stare one in the face: First, in October, 1907, there were
eighty-seven licensed opium shops in the International
Settlement. In May, 1914, there were six hundred and sixty-three.
In 1907 the average monthly revenue from opium licenses, dens and
shops combined, was Taels 5,450- In May, 1914, the revenue from
licenses and opium shops alone was Taels 10,995. The Council will
not dispute these figures.&quot; </p>

<p>At the beginning of the anti-opium campaign in 1907, there
were 700 dens (for smoking) in the Native City, and 1600 in the
International Settlement. The Chinese closed their dens and shops
at once. In the Settlement, the dens were not all closed until
two years later, and the number of shops in the Settlement
increased by leaps and bounds. Table I shows an outline of the
Municipal opium-shop profits concurrent with the closing of the
opium houses-and subsequently: </p>

<p>Year Month Dens Shops Monthly revenue, shops only </p>

<p>1908 Jan. 1436 87 Taels, 338 </p>

<p>Oct. 1005 131 623 </p>

<p>1909 Jan. 599 166 1,887 </p>

<p>Oct. 297 231 2,276 </p>

<p>1910 Oct. Closed 306 5,071 </p>

<p>1911 Oct. 348 5,415 </p>

<p>1912 Nov. 402 5,881 </p>

<p>1913 Dec. 560 8,953 </p>

<p>1914 March 628 10,111 </p>

<p>April 654 10,772 </p>

<p>Mr. Arnold quotes part of a speech made by the Chairman of the
Municipal Council, in March, 1908. The Chairman says in part:
&quot;The advice which we have received from the British
Government is, in brief, that we should do more than keep pace
with the native authorities, we should be in advance of them, and
where possible, encourage them to follow us.&quot; It must have
been most disheartening to the native authorities, suppressing
the opium traffic with the utmost rigor, to see their efforts
defied and nullified by the increased opportunities for obtaining
opium in that part of Shanghai over which the Chinese have no
control. A letter from a Chinese to a London paper, gives the
Chinese point of view: &quot;China . . . is obliged to submit to
the ruthless and heartless manner in which British merchants,
under the protection of the Shanghai 'Model Settlement' are
exploiting her to the fullest extent of their ability.&quot; </p>

<p>There is lots of money in opium, however. The following tables
compiled by Mr. Arnold show the comparison between the amount
derived from opium licenses as compared with the amount derived
from other sorts of licenses. </p>

<p>1913. Wheelbarrows Taels, 38,670 </p>

<p>Carts 22,944 </p>

<p>Motor cars 12,376 </p>

<p>Cargo boats.... . . .. 5,471 </p>

<p>Chinese boats 4,798 </p>

<p>Steam launches.... . 2,221 </p>

<p>Total, 86,480 </p>

<p>Opium shops 86,386 Opium, 86,3 86 </p>

<p>Another table shows the licensed institutions in Shanghai
representing normal social life (chiefly of the Chinese) as
compared with revenue from opium shops: </p>

<p>1913. Tavern Taels, 16,573 </p>

<p>Foreign liquor seller.. 19,483 </p>

<p>Chinese wine shop.... 28,583 </p>

<p>&quot;&quot; tea shop.... 9,484 </p>

<p>&quot;&quot; theater. . . . . 8,74 </p>

<p>&quot;&quot; club 3,146 </p>

<p>Total.. 85,983 </p>

<p>Opium shops 86,386 </p>

<p>Treaty Ports are those cities in China, in which the foreign
powers have extra-territorial holdings, not subject to Chinese
jurisdiction. Shanghai is one of them, the largest and most
important. The Statistical Abstract Relating to British India for
I903-4 to I912-I3 shows the exports of British opium into these
Treaty Ports. </p>

<p>1903-4 1,610,296 pounds sterling </p>

<p>1904-5 1,504,604 </p>

<p>1905-6 1,130,372 </p>

<p>1906-7 1,031,065 </p>

<p>1907-8 1,215,142 </p>

<p>1908-9 2,703,871 </p>

<p>1909-10 1,234,432 </p>

<p>1910-11 2,203,670 </p>

<p>1911-12 3,64,887 </p>

<p>1912-13 3,242,902 </p>

<p>It was in 1907 that China began her great fight against the
opium evil, and enacted stringent laws for its prohibition on
Chinese soil. On page 15 of his little book, Mr. Arnold quotes
from Commissioner Carl, of Canton: &quot;The 1912 figure (for the
importation of foreign opium) is the largest on record since
1895. The great influx of Chinese into the foreign concessions,
where the antiopium smoking regulations cannot be enforced by the
Chinese authorities, and where smoking can be indulged in without
fear of punishment, no doubt accounts for the unusual increase
under foreign opium.&quot; <br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-41</DOCNO>
<DOCOLDNO>IA030-000641-B027-9</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om10.htm 206.61.184.43 19970122141122 text/html 11978
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:11:12 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:41 GMT
Content-length: 11760
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - India</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>X -- INDIA </h2>

<hr>

<p>INDIA is the source and fount of the British opium trade, and
it is from Indian opium that the drug is chiefly supplied to the
world. As we have said before, it is a government monopoly.
Cultivators, who wish to plant poppies, may borrow money from the
Government free of interest, the sole condition being that the
crop be sold back to the Government again. It is manufactured
into opium at the Government factory at Ghazipur, and once a
month, the Government holds auctions at Calcutta, by means of
which the drug finds its way into the trade channels of the
world-illicit and otherwise.* </p>

<p>*This description of the Opium Department is to be found in
Statistics of British India, Financial Statistics, Vol. 11, 8th
Issue, page 159: </p>

<p>OPIUM. The region in which the poppy was cultivated in 1916-17
for the manufacture of &quot;Bengal opium&quot; comprises 32
districts of the United Provinces of Agra and Ouhd. The whole
Department has, with effect from the 29th September, 1910, been
under the control of one Opium Agent, with headquarters at
Ghazipur. At Ghazipur there is a Government factory where the
crude opium is manufactured into the form in which it passes into
consumption. The cultivation of the poppy and the manufacture of
opium are regulated by Act XIII of 1857, as amended by Act I of
1911, and are under the general control of the Lieutenant
Governor and the Board of Revenue of the United Provinces, and
the immediate supervision of the Opium Agent at Ghazipur. The
possession, transport, import and export of opium are regulated
by rules framed under the Indian Opium Act. Cultivation is
permitted only under licenses granted under the authority of the
Opium Agent. The area to be cultivated is fixed by the license,
and the cultivator is bound to sell the whole of his production
to the Opium Department at the rate fixed by Government..........
Advances, on which no interest is charged, are given to licensed
cultivators at the time of executing the agreement and from time
to time (though ordinarily no more than two advances are given)
until final delivery. In March, April and May the opium is made
over to the officers of the Department, and weighed and tested,
and as soon as possible afterwards each cultivator's accounts are
adjusted, and the balance due is paid him. After weighment the
opium is forwarded to the Government factory at Ghazipur, where
it is manufactured in 3 forms-(a) opium intended for export to
foreign countries, departmentally known as &quot;provision
opium&quot;(b) opium intended for consumption in India and Burma,
departmentally known as &quot;excise opium&quot; and (c) medical
opium for export to London. Provision opium is made up in the
form of balls or cakes, each weighing 3.5 lbs., and is packed in
chests, each chest containing forty cakes, weighing 140 1/7 lbs.
It is generally of 71' efficiency. Excise opium is made up in
cubical packets, each weighing one seer, 60 of which are packed
in a case. It is of higher consistency than the &quot;provision
opium.&quot; Medical opium is made up into cakes weighing 2 lbs.
Provision opium is sold by public auction in Calcutta. A
notification is published annually, generally about the month of
June, stating the number of chests which will be put up for sale
in each month of the next calendar year, and the quantities so
notified are not altered without three months notice. Sales are
conducted month by month by the Bengal Government; 7,000 chests
were notified for sale in 1917 for shipment to non-China markets.
The number of chests actually sold was 4,615. In addition to
this, 4,500 chests were sold to the Government of the Straits
Settlements, 2,200 to the Government of Netherland Indies, and 00
to the Government of Hongkong. The duty levied by Government on
each chest may be taken to be the difference between the average
price realized and the average cost. </p>

<p>The following facts are taken from &quot; Statistics of
British India. Financial Statistics, Volume II,Eighth
Issue,&quot; to be found at the New York Public Library: </p>

<p>AREA UNDER POPPY CULTIVATION </p>

<p>Acreage: </p>

<p>1910-11 362,868 </p>

<p>1911-12 200,672 </p>

<p>1912-13 178,263 </p>

<p>1913-14 144,561 </p>

<p>1914-15 164,911 </p>

<p>1915-16 167,155 </p>

<p>1916-17 204,186 </p>

<p>In the hey-day of the China trade, 613,996 acres were under
cultivation in the years 1905-6, consequently this is a drop in
the extent of acreage. But, as we have said before, the closing
of the China market simply means that other outlets must be
found, and apparently they are being found, since from I914
onwards, the acreage devoted to poppy planting is slowly
increasing again. </p>

<p>The opium manufactured in the Government factory is of three
kinds-provision opium for export; excise opium, for consumption
in India, and medical opium, for export to London. It is this
latter form of opium which, according to Mr. MacDonald, in his
&quot;Trade Politics and Christianity in Africa and the
East&quot; is being manufactured into morphia by three British
firms, two in Edinburgh and one in London, which morphia the
Japanese are buying and smuggling into North China. </p>

<p>The &quot;Statistics of British India&quot; shows the
countries into which Indian opium has been exported: we will take
the figures for the last five years, which show the number of
chests sent out. </p>

<p><img src="img00003.gif" align="bottom" width="195"
height="543"> <br>
</p>

<p>In some countries we see a falling off, as in China.
Cochin-China, the French colony, shows a considerable
increase--the little Annarnites, Tonquinese, Cambodgians and
other inhabitants of this colony of the French Republic being
shown what's what. Mauretius, a British Colony five hundred miles
off the coast of Madagascar, in the Indian ocean, seems to be
coming on. The falling off in shipments to the United Kingdom may
possibly have been due to the war and the scarcity of ships.
&quot;Other countries&quot; seem to be holding their own. With
the end of the war, the increase in ships, and general trade
revival, we may yet see compensation for the loss of China. With
the increase of drug addicts in the United States, it may be that
in time America will no longer be classed under &quot;other
countries&quot; but will have a column all to itself. </p>

<p>In another table we find a comparison as to the number of
chests of provision or export opium and of excise opium, or that
intended for consumption in India. Thus: <br>
</p>

<p><img src="img00004.gif" align="bottom" width="350"
height="144"> </p>

<p>Each chest contains roughly about one hundred and forty
pounds. <br>
</p>

<p>REVENUE </p>

<p>The revenue of India is derived from various sources, and is
classified under eight heads. Thus: for 1916-17-<br>
</p>

<p><img src="img00005.gif" align="bottom" width="349"
height="383"> </p>

<p>Out of these eight classifications, opium comes fourth on the
list. </p>

<p>But in addition to the direct opium revenue, we must add
another item, Excise, which is found under the third heading,
taxation. In the &quot;India Office List for i9i8&quot; we find
&quot;Excise&quot; explained as follows: Page 383: &quot;Excise
and Customs: Excise duties in India are levied with the two fold
object of raising revenue and restricting the use of intoxicants
and narcotics.&quot; In the same book, on page 385, we also read:
&quot;Excise and Customs Revenues: The total of the excise and
customs revenues on liquors and drugs in i 9 i 5-i 6 was in round
figures ten million pounds. This total gives an average of rather
more than ninepence a head on the whole population of British
India as the revenue charge on drink and drugs during the
year.&quot; </p>

<p>These excise duties are collected on spirits, beer, opium and
intoxicating drugs, such as ganja, charas, and bhang, all forms
or preparations of Indian hemp (Cannabis Indica), known in some
countries as hashish. In 1917-18 there were 17,369 drug shops
throughout India. The excise duties collected from these sources
was pretty evenly distributed. Excise revenue for a period of
years is as follows:<br>
</p>

<p><img src="img00006.gif" align="bottom" width="334"
height="194"> </p>

<p>The &quot;Statistics of British India for 1918&quot; has this
to say on the subject of Excise (page 218): &quot;Revenue: During
the ten years ending with 1916-17 the net receipts from Excise
duties increased . . . at the rate of 47 per cent. The receipts
from opium (consumed in India, not exported) being at the rate of
44 per cent. The net receipts from liquors and from drugs other
than opium . . . the increase at the rate Of 48 per cent. This
large increase is due not merely to the expansion of consumption,
but also to the imposition of progressively higher rates of duty
and the increasingly extensive control of the excise
administration. The revenue from drugs, (excluding opium) has
risen in ten years . . . the increase being at the rate of 67 per
cent.&quot; </p>

<p>A national psychology that can review these figures with
complacency, satisfaction and pride is not akin to American
psychology. A nation that can subjugate 300,000,000 helpless
people, and then turn them into drug addicts-for the sake of
revenue is a nation which commits a cold blooded atrocity
unparalleled by any atrocities committed in the rage and heat of
war. The Blue Book shows no horror at these figures. Complacent
approval greets the increase of 44 per cent of opium consumption,
and the increase of 67 per cent in the use of other habit-forming
drugs. Approval, and a shrewd appreciation of the possibilities
for more revenue from &quot;progressively higher rates of
duty,&quot; knowing well that drug addicts will sell soul and
body in order to procure their daily supply.<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-42</DOCNO>
<DOCOLDNO>IA030-000641-B027-21</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om11.htm 206.61.184.43 19970122141131 text/html 3944
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:11:22 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:37 GMT
Content-length: 3727
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly -- Turkey and Persia</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>XI -- TURKEY AND PERSIA </h2>

<hr>

<p>NEXT to India, the greatest two opium-producing countries in
the world are Turkey and Persia. The Statesman's Year Book for
1918 has this to say about it. On page 1334: &quot;The principal
exports from Turkey into the United Kingdom..... in two years
were:<br>
</p>

<p><img src="img00007.gif" align="bottom" width="333"
height="115"> </p>

<p>These are the only articles mentioned in this list of chief
exports. There are others, doubtless, but the Statesman's Year
Book is a condensed and compact little volume, dealing only with
the principal things exported. In i9i5 we therefore notice that
the opium export was second on the list, being exceeded by but
one other, dried fruit. In i9i6, the third year of the war, the
opium export is decidedly less, as are all the other articles
exported, except dried fruit and wool-which were articles
probably more vital to the United Kingdom at that time even than
opium. </p>

<p>PERSIA </p>

<p>THE same authority, the Statesman's Year Book for 1918, gives
a table on page 1162, showing the value of the chief exports from
Persia. The values are given in thousands of kran, sixty kran
equaling one pound sterling. <br>
<img src="img00008.gif" align="bottom" width="333" height="46"> </p>

<p>Since the war, both Turkey and Persia are more or less under
control of the British Empire, which gives Great Britain virtual
control of the world's output of opium. With this monopoly of the
opium-producing countries, and with a million or so square miles
added to her immense colonial Empire, one wonders what use Great
Britain will make of the mandatory powers she has assumed over
the lives and welfare of all these subject peoples! Will she find
these helpless millions ready for her opium trade? Will she
establish opium shops, and opium divans, and reap half the costs
of upkeep of these newly acquired states by means of this
shameful traffic?<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-43</DOCNO>
<DOCOLDNO>IA030-000641-B027-44</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om12.htm 206.61.184.43 19970122141138 text/html 3761
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:11:30 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:33 GMT
Content-length: 3544
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - Mauretius</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<p><b>XII - MAURETIUS</b> </p>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"> </p>

<p>ANOTHER British colony is Mauretius, acquired by conquest in
1810, and formally ceded to Great Britain by the Treaty of Paris
in 1814. This island is in the Indian Ocean, 500 miles east of
Madagascar, with an area of about 720 square miles. The
population is about 377,000, of which number 258,000 are Indian,
and 3,000 Chinese. Opium appears to be sold in the colony, since
the Blue Book mentions that licenses are required for opium
sellers. As far as we can discover, by perusal of these
Government Reports, the sale of opium is not conducted by the
Government itself, as in India, the Straits Settlements,
Hongkong, etc., but is carried on by private dealers who obtain
licenses before they can open opium shops. A part of the revenue,
however, is derived from opium; thus, according to the Blue Book
for the Colony of Mauretius for 1915, page V 73, we read that the
imports of opium for the year amounted to 1,353 kilos, with a
duty collected of 54,126 rupees. The Blue Book for 1916 shows a
gratifying increase. Thus, the import of crude opium from India
amounted to 5,690 kilos, with a duty collected of 227,628 rupees.
(See page V 64-) </p>

<p>Statistics for British India, Eighth Issue, gives these
figures: </p>

<p>OPIUM EXPORTED TO MAURETIUS </p>

<p>1912-13 -- 10 chests </p>

<p>1913-14 -- 19 </p>

<p>1914-15 -- 23 </p>

<p>1915-16 -- 65 </p>

<p>1916-17. -- 120 </p>

<p>This is a poor little colony, but has its possibilities. The
consumption of opium appears to be increasing steadily in a most
satisfactory manner. Congratulations all round. </p>

<p><img src="img00009.gif" align="bottom" width="341" height="89"><br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p><br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-44</DOCNO>
<DOCOLDNO>IA030-000641-B027-67</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om13.htm 206.61.184.43 19970122141147 text/html 6493
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:11:39 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:30 GMT
Content-length: 6276
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - British North Borneo</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>XIII - BRITISH NORTH BORNEO</h2>

<hr>

<p>BRITISH North Borneo occupies the northern part of the island
of Borneo. Area, about 31,000 square miles, with a coast line of
over 800 miles. Population (1911 census), 208,000, consisting
mainly of Mohammedan settlers on the coast and aboriginal tribes
inland. The Europeans numbered 355; Chinese 26,000; Malays,
1,612; East Indians about 5,000 and Filipinos 5,700. The number
of natives cannot be more than approximately estimated, but is
placed at about 170,000. The territory is under the jurisdiction
of the British North Borneo Company, being held under grants from
the Sultans of Brunei and Sulu (Royal Charter in 1881). </p>

<p>Like many other British colonies, opium is depended upon for
part of the revenue. The Statesman's Year Book for 1916 observes
on page 107: &quot;Sources of revenue: Opium, birds' nests, court
fees, stamp duty, licenses, import and export duties, royalties,
land sales, etc. No public debt.&quot; </p>

<p>In this frank manner, our attention is called to opium, which
appears first on the list of sources o revenue. </p>

<p>Going over the files of the Government reports, we will begin
with the &quot;Supplement to the Official Gazette for British
North Borneo. Administration Report for the Year 1910.&quot;
Published June 1, 1911. On page 3 we read: Customs and Trade: The
import and export trade of the state shows a healthy expansion. .
. . It is interesting to note that imports show an increase at
every station. Out of the 47 headings of Tariff, there are only 7
which show decreases. . . . The largest increases appear under
cloth, $147,106; opium, $132,692, and iron ware, $218,620. . . .
The general all round increases . . . are of course due to the
demand for supplies of all kinds in connection with the opening
of rubber estates.&quot; </p>

<p>The Supplement to the Official Gazette, Report for 1912
(published in December, 1913) is also a report of general
prosperity. Page 4: &quot;Trade: The volume of trade for the year
1912 was $11,139,122, giving an increase over 1911 of 18 per
cent. . . . Imports: As in 1911, all stations show an increase of
imports. Out Of 47 headings, 33 show increases, 12 show
decreases, and 2 remain stationary. Increases: There was an
increase under rice, flour and grain . . . the increase under
other headings include sundries, opium, machinery, etc.&quot; </p>

<p>The next Government Report is not so happy. Opium imports show
no &quot;healthy expansion.&quot; Thus, the Supplement to the
Official Gazette, Report for 1913 (published 1 February, 1915)
says on page 4: &quot;Other decreases in imports were opium,
$108,18o. The decrease in opium was due to the abolition of the
Opium Farm, which also held the Labuan Farm, and opium was
therefore no longer imported from Labuan for use in the West
Coast and the Interior.&quot; </p>

<p>Still more bad news as to opium, in the report for 1914,
(published 1 February, 1916). All imports drop. Page 4 records
&quot;Decrease in imports. . . . Railway and telegraph material,
rice, flour, grain and opium.&quot; In this year the opium
imports only amount to $58,464. This general falling off in all
imports may have been due to the war. But the opium situation was
apparently growing serious. On page 17 of this same report we
read that &quot;Thirty-two ordinances were passed by the Council
and became laws during the year. Among them the Opium and
Chandu.&quot; </p>

<p>The brevity and meagerness of these official reports often
leave one puzzled as to their meaning. The Supplement to the
Official Gazette for 1915 (published October, 1916), shows still
more discouraging news as to opium. Imports that year amounted to
only $31,299. But, in spite of this discouragement, hope still
remains. The same report shows optimism under the head of Excise.
&quot;Excise: $627,225, against $467,078, an increase in the net
revenue of $160,147, due to Government taking over the sole
control of the sale of chandu (smoking opium) and the collection
of other Excise duties, formerly farmed.&quot; </p>

<p>This explains the Ordinance passed by the Council the
preceding year, regarding Opium and Chandu. Since the Government
has taken over 44 sole control of the sale of chandu &quot; and
will collect the excise duties systematically and thoroughly, we
may still hope for some future report which will show once more a
&quot;healthy expansion&quot; in the opium revenue. </p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-45</DOCNO>
<DOCOLDNO>IA030-000641-B027-85</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om14.htm 206.61.184.43 19970122141155 text/html 4798
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:11:46 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:26 GMT
Content-length: 4581
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - British Guiana</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>XIV - BRITISH GUIANA</h2>

<hr>

<p>SITUATED in South America. Area, 89,480 square miles.
Population at census of 1911, excluding aborigines in the
unfrequented parts of the colony, 296,000. The Statesman's Year
Book, which gives us these brief facts, has very little to say
about this British colony in our Western Hemisphere, and gives no
dates or information as to how and when it was acquired. The
Government reports are also meager and unsatisfactory, and there
is no wealth of detail as to exports and imports. The country,
however, is rich in gold, mining having commenced in i886.
Diamonds have also been discovered. </p>

<p>The chief sources of revenue, however, are customs, excise and
licenses. With the word &quot;excise&quot; we have come to have
unpleasant associations. From &quot;The Statistical Abstract for
British Self-Governing Dominions, Colonies, Possessions and
Protectorates&quot; we find a table showing the imports of opium
into the various countries under British rule. The opium imports
into British Guiana are as follows: </p>

<p>1910 1,251 pounds sterling </p>

<p>1911 1,270 </p>

<p>1912 2,474 </p>

<p>1913 4,452 </p>

<p>1914 5,455 </p>

<p>1915 4,481 </p>

<p>These figures would seem to indicate that even on the Western
Hemisphere the taste for opium may be cultivated. It need not
necessarily be confined to the Oriental peoples. The population
of much of South America is a mixed lot, the result of mixed
breeding between Spanish settlers, Indians, native tribes of all
sorts. All this jumble, including the aborigines referred to,
might, with a little teaching become profitable customers of the
Opium Monopoly. Time and a little effort, given this fertile
field, ought to produce a &quot;healthy expansion&quot; in the
opium trade. </p>

<p>And that this insidious habit is indeed taking hold, in at
least one more country in South America, one may infer from the
following paragraph which appeared in the New York Times, 4
October, 1919: </p>

<p>DRUG EVIL IN ARGENTINA </p>

<p>Buenos Aires Opens Fight on Use of Narcotics </p>

<p>The city government of Buenos Aires, Argentina, has begun a
determined fight to wipe out the drug evil by the enactment of
stringent laws governing the sale of narcotics. This step was
taken after an investigation by the authorities had disclosed
that not only was the narcotic habit strong among the poor, but
that it was spreading throughout virtually every class in the
city. </p>

<p>Until the passage of the laws druggists were permitted to sell
cocaine, morphine and opium to any purchaser. The new laws forbid
the sale of these drugs except in filling prescriptions prepared
by registered physicians. The city also has established
dispensaries for the treatment of drug addicts.<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-46</DOCNO>
<DOCOLDNO>IA030-000641-B027-112</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om15.htm 206.61.184.43 19970122141220 text/html 13157
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:12:07 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:22 GMT
Content-length: 12939
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>History of the Opium Trade in China</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>XV -- HISTORY OF THE OPIUM TRADE IN CHINA</h2>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"> </p>

<p>IN a vague way, we are familiar with the &quot;opium
evil&quot; in China, and some of us have hazy ideas as to how it
came about. The China Year Book for 1916 has this to say on the
subject: &quot;The poppy has been known in China for 12
centuries, and its medicinal use for 9 centuries. . . . It was
not until the middle of the 17th century that the practice of
mixing opium with tobacco for smoking purposes was introduced
into China. This habit was indulged in by the Dutch in Java, and
by them taken to Formosa, whence it spread to Amoy and the
mainland generally. There is no record to show when opium was
first smoked by itself, but it is thought to have originated
about the end of the 18th century. Foreign opium was first
introduced by the Portuguese from Goa at the beginning of the
18th century. In 1729, when the foreign import was 200 chests,
the Emperor Yung Ching issued the first anti-opium edict,
enacting severe penalties on the sale of opium and the opening of
opium-smoking divans. The importation, however, continued to
increase, and by 1790 it amounted to over 4,000 chests annually.
In 1796 opium smoking was again prohibited, and in 1800 the
importation of foreign opium was again declared illegal. Opium
was now contraband, but the fact had no effect on the quantity
introduced into the country, which rose to 5,000 chests in 1820;
16,000 chests in 1830; 20,000 chests in 1838, and 70,000 chests
in 1858.&quot; </p>

<p>The China Year Book makes no mention of the traders who
carried these chests of opium into China. The opium came from
India, however, and the increase in importation corresponds with
the British occupation of India, and the golden days of the East
India Company. &quot;Opium was now contraband, but that fact had
no effect on the quantity introduced into the country,&quot;
smuggled in wholesale by the enterprising British traders. </p>

<p>China was powerless to protect herself from this menace,
either by protests or prohibition. And as more and more of the
drug was smuggled in, and more and more of the people became
victims of the habit, the Chinese finally had a tea-party, very
much like our Boston Tea Party, but less successful in outcome.
In 1839, in spite of the fact that opium smoking is an easy habit
to acquire and had been extensively encouraged, the British
traders found themselves with 20,000 chests of unsold opium on
their store-ships, just below Canton. The Chinese had repeatedly
appealed to the British Government to stop these imports, but the
British Government had turned a persistently deaf ear. Therefore
the Emperor determined to deal with the matter on his own
account. He sent a powerful official named Lin to attend to it,
and Lin had a sort of Boston Tea Party, as we have said, and
destroyed some twenty thousand chests of opium in a very drastic
way. Mr. H. Wells Williams describes it thus: &quot;The opium was
destroyed in the most thorough manner, by mixing it in parcels Of
200 chests, in trenches, with lime and salt water, and then
drawing off the contents into an adjacent creek at low
tide.&quot; </p>

<p>After this atrocity, followed the first Opium War, when
British ships sailed up the river, seized port after port, and
bombarded and took Canton. Her ships sailed up the Yangtsze, and
captured the tribute junks going up the Grand Canal with revenue
to Peking, thus stopping a great part of China's income. Peace
was concluded in 1843, and Great Britain came out well. She
recompensed herself by taking the island of Hongkong; an
indemnity Of 21 million dollars, and Canton, Amoy, Foochow,
Ningpo and Shanghai were opened up as &quot;treaty
ports&quot;-for the importation of opium and the
&quot;open-door&quot; in general. </p>

<p>Mr. Wells, in his &quot;Middle Kingdom&quot; describes the
origin of this first war with England: &quot;This war was
extraordinary in its origin as growing chiefly out of a
commercial misunderstanding; remarkable in its course as being
waged between strength and weakness, conscious superiority and
ignorant pride; melancholy in its end as forcing the weaker to
pay for opium within its borders against all its laws, thus
paralyzing the little moral power its feeble government could
exert to protect its subjects. . . . It was a turning point in
the national life of the Chinese race, but the compulsory payment
of six million dollars for the opium destroyed has left a stigma
upon the English name.&quot; </p>

<p>He also says, &quot;The conflict was now fairly begun; its
issue between the parties so unequally matched --one having
almost nothing but the right on its side, the other assisted by
every material and physical advantage-could easily be
foreseen&quot; and again, after speaking of it as being unjust
and immoral, he concludes &quot;Great Britain, the first
Christian power, really waged this war against the pagan monarch
who had only endeavored to put down a vice harmful to his people.
The war was looked upon in this light by the Chinese; it will
always be so looked upon by the candid historian, and known as
the Opium War.&quot; </p>

<p>Within fifteen years after this first war, there was another
one, and again Great Britain came off victorious. China had to
pay another indemnity, three million dollars, and five more
treaty ports were opened up. By the terms of the Treaty of
Tientsin, the sale of opium in China was legalized in 1858. </p>

<p>From a small pamphlet, &quot;Opium: England's Coercive Policy
and Its Disastrous Results in China and India&quot; by the Rev.
John Liggins, we find the following: &quot;As a specimen of how
both wars were carried on, we quote the following from an English
writer on the bombardment of Canton: 'Field pieces loaded with
grape were planted at the end of long, narrow streets crowded
with innocent men, women and children, to mow them down like
grass till the gutters flowed with their blood.' In one scene of
carnage, the Times correspondent recorded that half an army of
10,ooo men were in ten minutes destroyed by the sword, or forced
into the broad river. &quot; The Morning Herald &quot; asserted
that &quot;a more horrible or revolting crime than this
bombardment of Canton has never been committed in the worst ages
of barbaric darkness.&quot; </p>

<p>Naturally, therefore, after the termination of these two wars,
China gave up the struggle. She had fought valiantly to protect
her people from opium, but the resources of a Christian nation
were too much for her. Seeing therefore that the opium trade was
to be forced upon her, and that her people were doomed to
degradation, she decided to plant poppies herself. There should
be competition at least, and the money should not all be drained
out of the country. Thus it came about that after 1858 extensive
tracts of land were given over to poppy production. Whole
provinces or parts of provinces, ceased to grow grain and other
necessities, and diverted their rich river bottoms to the raising
of opium. Chinese opium, however, never supplanted Indian opium,
being inferior to that raised in the rich valley of the Ganges.
The country merely had double quantities of the drug, used
straight or blended, to suit the purse or taste of the consumer. </p>

<p>Then, in 1906, the incredible happened. After over a hundred
years of steady demoralization, with half her population opium
addicts, or worse still, making enormous profits out of the
trade, China determined to give up opium. In all history, no
nation has ever set itself such a gigantic task, with such a
gigantic handicap. China, a country of immense distances, with
scant means of communication; with no common language, a land
where only the scholars can read and write, suddenly decided to
free herself from this vice. The Emperor issued an edict saying
that in ten years' time all opium traffic must cease, and an
arrangement was made with Great Britain whereby this might be
accomplished. To the honor of America be it said that we assisted
China in this resolution. We agreed to see her through. </p>

<p>A bargain was then made between China and Great Britain, in
1907, China agreeing to diminish poppy cultivation year by year
for a period of ten years, and Great Britain agreeing to a
proportional decrease in the imports of Indian opium. A three
years' test was first agreed to, a trial of China's sincerity and
ability, for Great Britain feared that this was but a ruse to cut
off Indian opium, while leaving China's opium alone in the field.
At the end of three years, however, China had proved her ability
to cope with the situation. Thus, for a period of ten years, both
countries have lived up to their bargain, the amount of native
and foreign opium declining steadily in a decreasing scale. April
1, 1917, saw the end of the accomplishment. </p>

<p>China's part was most difficult. In the remote, interior
provinces, poppies were grown surreptitiously, connived at by
corrupt officials who made money from the crops. However, drastic
laws were enacted and severe penalties imposed upon those who
broke them. If poppy cultivation could not be stopped, England
would not hold to her end of the bargain. Not only was there a
nation of addicts to deal with, but these could obtain copious
supplies of opium from the foreign concessions, over which the
Chinese had no control. We shall show, in another article, to
what extent this was carried on. Yet somehow, in some manner, the
impossible happened. Year by year, little by little, one province
after another was freed from poppy cultivation, until in 1917,
China was practically free from the native-grown drug, and
foreign importation had practically ended. </p>

<p>In this manner, first by large smuggling, then by two opium
wars, was China drugged with opium. And in this manner, and to
this extent, has she succeeded in freeing herself from the curse.
But in one way, she is not free. She has no control over the
extra-territorial holdings of European powers, for in each treaty
port are the foreign concessions already mentioned-German,
Austrian, British, French, Russian. And in these concessions,
opium may be procured. Simply by crossing an imaginary line, in
such cities as Shanghai and Hongkong, can the Chinese buy as much
opium as they choose. China will never be rid of this menace till
she is rid of these extraterritorial holdings. Opium shops,
licensed by foreign governments, are always ready to supply her
people with the forbidden drug. </p>

<p>We say that the China market is closed. So it is, in one way.
But the British Opium Monopoly is not ended. The year 1917 saw a
tremendous blow dealt to the British opium dealers, but other
markets will be found. There are other countries than China whose
inhabitants can be taught this vice. The object of this
discussion is to consider these other countries, and to see to
what extent the world is menaced by this possibility. </p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-47</DOCNO>
<DOCOLDNO>IA030-000641-B027-126</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/HISTORY/om/om16.htm 206.61.184.43 19970122141232 text/html 18020
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 14:12:22 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:41:17 GMT
Content-length: 17802
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The Opium Monopoly - Conclusion</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<h1>THE OPIUM MONOPOLY </h1>

<p><b>BY ELLEN N. LA MOTTE</b> </p>

<h2>XVI -- CONCLUSION</h2>

<p><img src="../../graphics/blueline.gif" align="bottom"
width="562" height="19"> </p>

<p>THERE are many people who advocate the use of opium, and who
defend the policy of the Opium Monopoly. They argue that it is
not harmful-if taken in moderation. They even assert that it is
no more objectionable than alcohol or tobacco. Leaving out of
account, therefore, the consensus of opinion of the medical
profession as to the evils of habit-forming drugs, and accepting
the theory that opium is harmless, we should then like to ask why
the use of opium is so carefully restricted to the peoples of
subject states, who have no voice in their own affairs? Why
should the benefits of opium be confined to Oriental races, and
why should not the white race be given the same opportunities for
indulgence? Is there any reason for this discrimination? As a
source of revenue, it certainly has advantages. Yet curiously
enough, those European countries which derive much profit through
the sale of opium to their subject races, seem to have an
aversion to introducing it to their people at home. And there is
a further coincidence in the fact that none of the self-governing
colonies of European countries-Australia, New Zealand and
Canada-permit this traffic. It appears to be only the subject
peoples, whose well-being has become the White Man's Burden, who
receive the blessings of this peculiar form of altruism. Is it
because the white race is worth preserving, worth protecting, and
because subject nations are fair game for exploitation of any
kind? </p>

<p>Another argument advanced by advocates of Government opium is
that the Oriental peoples are &quot;different&quot;-that opium
does them no harm. Every writer on the subject of opium in China,
produces evidence to show the shocking results upon that country,
during the hey-dey of the deluge. The complete moral degradation,
and economic ruin of thousands of helpless individuals. Nor do we
think the medical profession would agree with this assumption
that opium is harmless to Orientals, because they are
&quot;different.&quot; Their only real difference lies in their
helplessness to protect themselves from foreign aggression. </p>

<p>Another argument advanced by the upholders of the Monopoly is
that the Orientals have always been users of opium, that they
like it, it suits them, it would be unfair to deprive them of it.
We have seen to what extent the Chinese liked it, and how it was
forced upon them by two wars. Not until they were completely
crushed, and had to accept the terms of the conquerer, did they
submit. It can hardly, therefore, be called a vice indigenous to
the Chinese. Japan is another Oriental nation that disproves this
argument. As we have said before, there are no opium shops in
Japan, and the sale of opium is not conducted by the Japanese
Government. On the contrary, the Japanese have the same fear of
this drug that a European nation has, and exercises the same
precautions to protect its people. But, as we have said before,
Japan is the only Oriental nation that has not been subjugated by
a European nation, and therefore has never had opium thrust upon
her. She is the only country in the Far East that has managed to
preserve her sovereignty, and has never been subject to certain
blighting influences of European culture. </p>

<p>Another exception to this assumption that the Orientals cannot
do without opium lies in the Philippines. When America acquired
those islands some twenty years ago, our first act was to
eliminate the opium traffic, which had been established there by
our predecessors. It had been in existence for decades, but we
immediately set about to abolish it. Root and branch we did away
with it, and shed no crocodile tears as to the &quot; hardship
&quot; this would be to the people who had come under our
protection. We wished no revenue coming from such a source as
this. Yet we might have cut in half the cost of our Philippine
budget had we followed the example set by other nations. We have
seen that certain British colonies, Hongkong and the Straits
Settlements, for example, derive from one-third to one-half of
their upkeep expenses from this traffic. But we refrained from
treating our Filipinos in this manner. We are called
sentimentalists out in the East-at such times as we are not
called money-getters. To-day, the Philippines are very nearly
ready for self government. Would they have been so nearly ready
had we continued to drug them as they had been drugged before we
took possession? Drugged peoples are usually docile and
submissive-perhaps that is the secret of much of the successful
colonizing, about which we hear so much. </p>

<p>But let us leave aside the question of the Orientals, and
whether or no opium is good for them. We recognize quite clearly
that it is not good for ourselves, for Americans. We recognize
that fact quite as clearly as England realizes that it is not
good for the inhabitants of the British Isles. Quite as clearly
as France, while setting up opium shops in her colony of
Indo-China, refuses to establish them in Paris or Marseilles.
America is unique in the fact that although we have colonial
possessions, we do not have a double standard of morality. We
attempt to throw around our colonies the same safeguards that we
throw around ourselves at home. But the question arises, how
successful are we in protecting ourselves at home? Not
particularly so, according to the daily press. </p>

<p>How great the danger to ourselves was recognized some
thirty-seven years ago by an Episcopal missionary to China, the
Rev. John Liggins. In 1882 he published a small book, already
referred to, entitled: &quot;England's Coercive Opium Policy and
Its Disastrous Results in China and India.&quot; The preface to
this unheeded warning runs thus. &quot;Our aim in this sketch is
to present, as briefly as possible, the most important facts and
testimonies concerning a traffic which is as disgraceful to
England as it is ruinous to China and hurtful to India. . . . It
is also of the highest importance that the people throughout our
wide domain should be aroused concerning the new, fascinating and
deadly foe which has entered our country through the Golden Gate,
and which already numbers its victims by the thousands, and will
soon do so by the tens of thousands.&quot; </p>

<p>The Rev. Mr. Liggins saw it coming-that danger which is almost
ready to overwhelm us to-day. He recognized clearly that the
Opium Monopoly of that great nation which rules nearly one-third
of the world-the British Empire would in time reach further and
further afield for new victims. It is too lucrative a trade to be
confined to only a few countries. Markets must not only be
created and legalized in subject states, but new ones added in
outside countries, through smuggling. All too fatally easy of
accomplishment, and so profitable, financially, as to be worth
any risk and effort. The prediction as to our own danger, made in
i882, seems to be abundantly realized. </p>

<p>The number of drug addicts in America to-day are fairly
startling. The number is variously estimated in New York City
alone as from ten thousand to one hundred thousand. It is said
that there may be a million in the country. Yet these figures are
the merest guesswork, by no means substantiated. Certain it is
that the campaign of the New York Health Department has uncovered
thousands of them, and any other city that chose to do so, could
produce facts equally startling. </p>

<p>The laws on our statute books concerning the prescription of
narcotic drugs are powerless to deal with the situation. It is
shooting into the air to try to &quot;regulate&quot; this
condition. It is as thoroughly well &quot;regulated&quot; as it
can ever be by the Harrison Anti-Narcotic Act, a Federal Law
whose enforcement is in the hands of the Internal Revenue
Department. By the provisions of this Act, every pound of opium
or its derivatives that comes into this country, legitimately, is
accounted for, and its distribution, both wholesale and retail,
made a matter of record. Thus, the Board of Trade returns show
the amount imported by the big wholesale drug houses. These must
account for their sales to the retail drug stores, and the
amounts must tally. The drug stores can only sell narcotic drugs
on a physician's prescription, and the prescriptions are kept on
file, and the quantity sold must correspond to the quantity
called for by these prescriptions, as well as to the amount
obtained from the wholesale drug house. In prescribing narcotics,
the physician is obliged to write his prescription in
triplicate--one copy for his own protection, one copy for the
local druggist, and one copy to be filed with the health
department. Nor is he allowed to prescribe narcotics for an
addict without decreasing the dosage. His prescription cannot
call for thirty grains of morphia day after day, it must show, in
a chronic case of this kind, a daily diminution of the amount
prescribed, thus indicating a desire to get the patient off the
drug, eventually. All these records are kept on file, open to
inspection whenever an accounting is demanded, consequently any
leak can be instantly accounted for. This Harrison Act is as
comprehensive and as nearly perfect as possible, yet it does not
cover the situation. By this means, violations can be detected,
whether on the part of an unscrupulous physician or druggist, or
even the wholesale house, but these violations are only
occasional. The root of the evil remains untouched. </p>

<p>At one time, it was believed that carelessness on the part of
the physician was chiefly responsible for creating drug addicts,
but the recent campaign against violators of the Harrison Act
seems to have completely exonerated him of this charge. For one
patient who becomes a drug addict while under a doctor's care,
through the accidental misuse of morphia, there are a hundred who
form the habit through other ways. It is not the occasional,
accidental victim, given morphia for the relief of pain, which is
creating our thousands of drug users. It is not the occasional
unscrupulous physician who is responsible. If this was all, we
could easily cope with these unwitting abuses, or even deliberate
instances of misuse. But the question goes deeper than this. </p>

<p>The Opium Monopoly was not established for any humane or
altruistic purpose. It was not established to provide the medical
profession with a drug for the relief of pain, to ease the agony
of the injured and wounded, or to calm the last days of those
dying with an incurable disease. This, which may be called the
legitimate use of opium, is not the object of the Opium Monopoly.
Used only in this manner, there would be no money in it. It is
only when opium is produced in quantities far in excess of the
legitimate needs of the world that it becomes worth while-to the
Opium Monopoly. That Monopoly was established not to relieve pain
and suffering, but with the deliberate intention of creating pain
and suffering, by creating drug victims by the thousand. It is
these hundreds of thousands of customers that are profitable. The
menace to America lies in the large amounts of opium which are
smuggled into the country for this purpose. Boys and girls o
sixteen and seventeen first acquire this habit through curiosity,
through association with what they call &quot;bad company,&quot;
peddlers who first offer it free, as a gift, well knowing that
after a few doses the fatal habit will be formed. Where do these
vendors obtain their supplies? </p>

<p>The daily papers often contain suggestive paragraphs. Thus the
&quot; New York Times,&quot; under date of February 28, 1919:
&quot; Seize Opium in Schenectady. Opium, valued by Federal
officials at $10,000 was seized in Schenectady, and four Chinamen
were arrested in a raid on Chinese places of business on Centre
street today. The Federal officials expressed the belief that
opium had been smuggled, and that Schenectady is the distributing
point for this part of the State.&quot; </p>

<p>An item in the &quot;Seattle Union Record,&quot; of June 24,
1919, gives us cause for further consideration. </p>

<p>BRITISH DRUG SHIP HELD BY UNITED STATES </p>

<p>FINE OF $49,265 ASSESSED FOR BRINGING &quot;DOPE&quot; TO
AMERICA </p>

<p>LINER ALLOWED TO MOVE UNDER BOND </p>

<p>NO ARRESTS MADE, THOUGH BOOZE IS FOUND ABOARD </p>

<p>No arrests were made up to Tuesday noon in connection with the
enormous seizure of opium, cocaine and liquor on the Blue Funnel
liner Cyclops, although the investigation is being continued by
federal officials. </p>

<p>The ship has been seized and a fine of $49,265 has been
assessed against her for having drugs not listed in the ship's
manifest. </p>

<p>United States District Attorney Robert C. Saunders filed a
libel Monday night against the Cyclops, the boat being seized
later by the customs service. Bond was fixed at $100,00, or twice
the fine. The Fidelity Surety Company filed the bond Monday. The
ship was released Tuesday morning. </p>

<p>A civil libel suit may be filed against Capt. W. Duncan,
holding him responsible for the liquor found on the ship. Captain
Duncan, questioned Monday by customs officials, claimed to know
nothing about the contraband. </p>

<p>The result of Monday's checking of the opium and cocaine
showed that the seizure amounted to 778 tins of opium, 670 ounces
of cocaine and 16 ounces of morphine. </p>

<p>A small paragraph in a New York paper, dated June 12, 1919,
reads thus: &quot;Two New Yorkers jailed for smuggling opium.
Pleas of guilty to charges of opium smuggling were entered in the
Federal Court today by Albertus Schneitzer and Maxwell Auerbach,
of New York. They were fined $500 each, and sent to Atlanta
penitentiary, the former for two years, and the latter for one
year. The men were arrested in connection with the seizure of
opium on the Canadian border.&quot; </p>

<p>We cannot grapple with our problem unless we face the facts;
if we ignore the source of supply and distribution, and the
reasons for this immense overproduction of opium on the part of
the British Opium Monopoly. The anti-narcotic laws on our statute
books are powerless to protect us. With Canada, a British
province, to the north, and all Mexico on the south, what chance
have we against such exposure? Of what use to send two smugglers
to the penitentiary, when at the Calcutta opium sales, once a
month opium is auctioned off under the auspices of the British
Government, to be disposed of as the buyers may see fit? Much of
it, as we have seen, goes to those helpless states and colonies
which have no control over their own affairs, where the opium
traffic is conducted under the administration of the alien
government. Much of the rest of it goes out for smuggling
purposes, to be distributed in devious, roundabout, underhand
channels throughout the world. We are coming in for our share in
this distribution. </p>

<p>We feel that our country is in grave peril. Our politicians
and our diplomats have been too careful all these years, to speak
of this business, through fear of offending a powerful nation.
But we feel that the time has now come to speak. England has been
relying upon our silence to &quot;get away with it.&quot; Upon
our ignorance, and upon that silence which gives consent. But in
this new, changed world, reborn out of the blood and agony of the
great war, is it not time to practice some of the decencies which
we have proclaimed so loudly? </p>

<p>As we have said before, no stronger opponents of this policy
are to be found than among a section of the people of England
itself. We look to them to join us, in this great issue, and we
feel that we shall not look in vain. </p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_History_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../history.htm"><font size="3">Historical Research</font></a></p>
<!--webbot bot="Include" endspan i-checksum="50318" -->

<p><br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-48</DOCNO>
<DOCOLDNO>IA087-000627-B012-218</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/moscone/sum1.htm 206.61.184.43 19970122050254 text/html 21213
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:02:27 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:56:50 GMT
Content-length: 20995
</DOCHDR>
<html>

<head>
<title>Savings in California Marijuana Law Enforcement Costs
Attributab </title>
<meta name="GENERATOR"
content="Internet Assistant for Word 2.0z Beta">
</head>

<body>

<p> <img src="../../graphics/blueline.gif" align="BOTTOM"> </p>

<h1>Savings in California Marijuana Law Enforcement Costs </h1>

<p> <b>Attributable to the Moscone Act of 1976-A Summary</b> </p>

<p> <b>MICHAEL R. ALDRICH, PH.D.* &amp; TOD MIKURIYA, M.D.**</b> </p>

<p> *Curator, Fitz Hugh Ludlow Memorial Library, P.O. Box 640346,
San Francisco, California 94164 </p>

<p> &quot;Psychiatrist and Substance Abuse Therapist, Berkeley,
California </p>

<p> <img src="../../graphics/blueline.gif" align="BOTTOM"> </p>

<p> The fiscal costs of California marijuana law enforcement
began to escalate dramatically in the mid- 1960's as mainly
young, White, middle-class marijuana offenders flooded the
criminal justice system, replacing older, nonWhite heroin addicts
as the typical drug offenders in the state (Aldrich, Mikuriya
&amp; Brownell 1986: 2-9). California marijuana arrests leaped
tenfold from 1962 (3,743) to 1967 (37,514), with corresponding
increases in the number and cost of court dispositions,
incarcerations in county jails and state prisons, and probation
and parole caseloads. As shown in Table I, by 1972 there were
approximately 76,561 marijuana-related arrests, of which 73,061
were felony arrests, mostly for possession offenses. By 1974
there were nearly 100,000 felony marijuana-related arrests, and
these comprised one quarter of all the felony arrests in the
state (Aldrich, Mikuriya &amp; Brownell 1986). </p>

<p> The steep increase in the number of arrests, the change in
drug-offender characteristics, and the felony status of marijuana
possession offenses led legislators to adopt several different
strategies to cope with the burden on the criminal justice
system. These included the so-called wobbler bills of 1968 and
1969, which allowed first offense felony marijuana possession
cases to be disposed of as misdemeanors, and since 1972, a
diversion program that has allowed charges to be dropped against
first offenders if they complete a drug abuse treatment program
(Brownell 1988). Nevertheless, the cost of marijuana law
enforcement continued to explode, from approximately eight
million dollars in 1960 to over $100 million a year in 1972
(California Senate Select Committee 1974: 97-118). </p>

<p> The crux of the problem faced by legislators was that
possession of marijuana was a felony offense. In terms of law
enforcement time, personnel. and budgets, a felony offense
receives top priority. It frequently involves the following:
investigation by more than one officer; transporting, booking,
and incarcerating the offender; hours of paperwork; and time
spent in court by the arresting officers. In addition, a felony
drug offense often involves the use of paid informants, gathering
evidence and reliable witnesses, a budget for drug purchases,
undercover work, and interagency cooperation. Even under the
wobbler provisions of Penal Code Section 17, a felony charge
required adjudication in a lower court or Superior Court,
investigation of the defendant's prior criminal record, and some
expenditure of public funds at every level of the criminal
justice system. This may include the cost of grand juries, public
defenders, prosecutors, judges, bailiffs, juries, hearings,
trials, appeals, county jails, state prisons, and/or probation
and parole systems, depending on how each case proceeds (Aldrich,
Mikuriya &amp; Brownell 1986; Calof 1968). </p>

<p> On the other hand, a misdemeanor offense generally requires
less expenditure of time and money by law enforcement agencies,
can often be adjudicated in the lower courts, and punishes the
convicted offender with a fine, probation or a year or less in
county jail rather than a year or more in state prison. A
citation offense, which involves giving the offender a ticket
with a fixed bail that can be forfeited as a fine, is the least
expensive offense category because it can be disposed of with a
minimum of police </p>

<p> TABLE I </p>

<p> CALIFORNIA MARIJUANA ARRESTS 1972-1986* </p>

<pre>
Year Felony Misdemeanor Total
1972 73,061 3,500 76,561
1973 88,110 3,500 91,610
1974 99,597 3,500 103,097
1975 85,757 3,500 89,257
Average
1974-75 92,677 3,500 96,177
1976 19,284 34,110 53,394
1977 17,262 34,110 51,371
1978 17,397 35,424 52,821
1979 19,263 32,796 52,059
1980 20,509 38,270 58,779
1981 20,771 43,791 64,562
1982 20,737 42,904 63,641
1983 19,920 43,803 63,723
1984 21,350 42,219 63,569
1985 24,182 43,181 67,363
Average
1976-85 20,068 39,133 59,201
1986 19,938 30,105 50,043
</pre>

<p> *Data provided by Bureau of Criminal Statistics and Special
Services, California Department of Justice. Misdemeanor marijuana
arrest figures were not recorded by the Bureau between 1972
through 1977, and am estimated based an the averages of the three
preceding years and the two following years. al. 19 87). </p>

<p> It was this reality-based observation of the criminal justice
system that Senator George Moscone, then Majority Leader of the
State Senate, recognized when designing California's unique
misdemeanor citation system for possession of marijuana in small
amounts (Brownell 1988; Aldrich et al. 1987; Atkeson 1987; Budman
1977; Uelman 1976; Moscone 1974); and it is this reality that is
recognized in the present article in-estimating the savings
attributable to that law. At present (under the Moscone Act),
almost all misdemeanor marijuana offenses are citable, and are
valued in this article at one third the cost of felony marijuana
arrests. </p>

<h2>METHODS</h2>

<p> The methods utilized are presented in detail, with annual
tables and formulas used for calculations, by Aldrich and
colleagues (1987) and Aldrich, Mikuriya and Brownell (1986).
California marijuana arrest data from 1960 through 1985, and
court dispositions and law enforcement expenditures from 1972
through 1985 were obtained from the Bureau of Criminal Statistics
and Special Services of the California Department of Justice. </p>

<p> Marijuana arrest expenditures were calculated according to a
method designed by Post, a former legislative analyst (California
Senate Select Committee 1974: 99) who determined that
approximately one quarter of police time is devoted to the
detection and apprehension of criminals, and therefore that
arrest expenditures are approximately one quarter of all law
enforcement expenditures. Weighting felony arrests at dime times
as expensive as misdemeanor arrests, the average cost per felony
was determined by dividing total arrest expenditures by the
number of felony arrests plus one third of the number of
misdemeanor arrests. Felony marijuana arrest expenditures from
1972 through 1985 were then calculated by multiplying the number
of felony marijuana arrests by the cost per felony arrest for
each year. The average cost per misdemeanor arrest was obtained
by dividing the cost per felony arrest by three, and misdemeanor
marijuana arrest expenditures were calculated by multiplying the
number of marijuana arrests by the cost per misdemeanor arrest
for each year. Total marijuana arrest expenditures for each year
were obtained by adding felony and misdemeanor marijuana arrest
expenditures (Aldrich et al. 1987). </p>

<p> The method used to calculate the cost of marijuana
court-disposition relies on a time-weighting technique used by
the Judicial Council of California (1985: 112ff) to determine the
number of judgeships needed in the state. This technique
recognizes the wide variance in judicial time needed to dispose
of different types of cases, and gives a much more accurate
picture of court costs than would be obtained using raw numbers
of dispositions. In 1984, for instance, criminal case
dispositions were 10 percent of the total dispositions filed in
Superior Court, but took up 33 percent of Superior Court time.
For comparison, juvenile delinquency cases were also 10 percent
of Superior Court dispositions, but took up only seven percent of
its time (Judicial Council of California 1985: 114). Using
timeweights and budgets published annually by the Judicial
Council, the costs, of adult felony marijuana cases were
calculated by ascertaining the costs of criminal cases in the
lower courts and Superior Courts, along with court-related costs
in each, for each year from 1972 through 1985, and then
multiplying the result by the percentage of those cases that
involved marijuana. </p>

<p> Annual prison and parole population counts and expenditures
were obtained from the California Department of Corrections,
dividing the latter by the former to determine per capita costs.
These costs were then multiplied by the number of prisoners and
parolees whose most serious convicted offense was a marijuana
charge (also provided by the Department of Corrections) to
determine the cost of marijuana-related prison and parole for
each year from 1974 through 1985. </p>

<p> The State and Local Government Implicit Price Deflation a
federal index available from the Commission on State Finance that
is frequently employed by state agencies for budget analysis, was
used to adjust marijuana law enforcement expenditures for
inflation. Savings attributable to the Moscone Act (expressed in
1986 dollars) were calculated by subtracting the
inflation-adjusted arrest, disposition, prison and parole
expenditures for each year after the law took effect (January 1,
1976) from a baseline average of these expenditures in the two
years (1974 and 1975) immediately before the law took effect. </p>

<h2>RESULTS</h2>

<p> As shown in Table I and Figure 1, the major ongoing effect.
of the Moscone Act has been to reduce felony marijuana arrests
from 92,677 a year (the average for 1974 and 1975) to 20,068 a
year (the average for 1976 through 1985). Thus the new law saved
California the expenses of 72,609 felony arrests every year for a
decade, a 78 percent decrease in felony marijuana arrest
expenditures. </p>

<p> At the same time, making possession a citable misdemeanor
caused a tenfold increase in misdemeanor marijuana arrests: from
an average of 3,500 per year for 1974 and 1975 to an, average of
39,113 per year from 1976 through 1985-an average increase of
35,613. However, these misdemeanor citations were not nearly as
expensive to issue or to adjudicate. The cumulative effect was to
cut total marijuana-related arrests by 39 percent over the
decade: from an average of 96,177 for 1974 and 1975 to an average
of 59,128 from 1976 through 1985-an average decrease of 37,049
marijuana arrests per year. </p>

<p> The massive reduction in felony arrests, in tandem with a
more modest increase in misdemeanor arrests, produced an
extraordinary drop in statewide law enforcement expenditures
since 1976, as shown in Table IL Total expenditures (in 1986
dollars) on marijuana arrests, court dispositions, prisoners and
parolees dropped from an average of $157.6 million for 1974 and
1975 to an average of $61.8 million per year during the following
decade. </p>

<p> As shown in Table 111, the State of California has saved
nearly half a billion dollars ($464,552,353 or $46 million below
100 in 1980. This resulted in considerable savings in prison and
parole expenditures (see Table II), which totaled more than $52
million since 1976 (see Table HD. </p>

<h2>SUMMARY, DISCUSSION AND CONCLUSIONS</h2>

<p> The State of California has saved a minimum of one billion
dollars since 1976 as a result of making possession of an ounce
or less of marijuana a citable misdemeanor instead of a felony.
The present study considered savings from 1976 through 1985 in
four major areas: arrest costs, court costs, prison costs and
parole costs. Together they amounted to a total savings of $958
million, or nearly $ 100 million per year (see Table III). When
these savings are compared with the $100 million a year being
spent on marijuana law enforcement in 1971 and 1972 (California
Senate Select Committee 1974: 118) and the average of $157.6
million spent in 1974 and 1975 (see Table 11), it is evident that
the Moscone Act has been quite successful in achieving two of its
main objectives: (1) reducing law enforcement expenditures
related to possession of small amounts of marijuana to a minimum;
and (2) relieving an overwhelming burden on the state judicial
system. </p>

<p> One billion dollars should be considered a minimum estimate
of savings because the present study did not include savings in
the cost of county jails, prosecutors, public defenders,
probation departments, misdemeanor court dispositions, juvenile
facilities, or peripheral parts of the criminal justice system
involved with marijuana law enforcement, such as the cost of
collecting statistics. Nor were any savings in expenditures by
individual arrestees or defendants considered. Savings are also
underestimated because the total amount of fines paid for
marijuana misdemeanor citations is not recorded. If all of the
40,671 people cited for possession of an ounce or less of
marijuana in 1985 (Aldrich et al. 1987: 1) paid a $100 fine, that
revenue amounts to more than four million dollars per year. </p>

<p> When the Moscone Act was being debated in the California
Legislature in 1974, some opponents of the bill were concerned
that reducing penalties for possession for an ounce or less of
marijuana to a maximum $100 fine would be a &quot;green
light&quot; for drug users across the state (Budman 1977).
Senator Moscone pointed out that a 1974 study of marijuana use in
Oregon, which had passed a similar statute in 1973, had found no
increase in statewide use of the drug, while 40 percent of the
marijuana smokers surveyed reported a decrease in their use
(California Senate Select Committee: 6-7). A follow-up survey in
Oregon in 1976 (Drug Abuse Council 1977) showed only a very
slight (three percent) increase in the number currently using
marijuana, and also reported that fear of prosecution </p>

<p> so<img src="../../graphics/at-work.gif" align="BOTTOM"> </p>

<h2>ENFORCEMENT COSTS</h2>

<p> mum $100 fine) of these offenses with alternative fine/jail/
prison penalties would obliterate the citation system and all the
savings brought about by using this system. Either of these
legislative changes would at least triple, and more likely
quadruple, statewide marijuana law enforcement and criminal
justice system expenditures in every future year (Aldrich et al.
1987). </p>

<p> It is rare that taxpayers can congratulate lawmakers for
saving a considerable amount of money in any area of law
enforcement The present system is accomplishing the purposes for
which it was designed by Senator Moscone, by keeping possession
of small amounts of marijuana a criminal offense while
significantly reducing the criminal justice expenditures related
to that offense. </p>

<h2>ACKNOWLEDGMENTS</h2>

<p> The authors gratefully acknowledge the editorial assistance
of Gordon Brownell, Michael Rossman and Jerry Mandel at various
stages of this ongoing study, and wish to thank the following for
providing the data on which it is based: Charlotte Rhea and
Quinton Hegner, Department of Criminal Statistics; Joe Doyle,
Administrative Office of the Courts; Linda Greule, Phyllis
Marquez and Doug Jenks, Department of Corrections; and Greg
Geeting, Commission on State Finance. </p>

<h2>REFERENCES</h2>

<p> Aldrich, M.R.; Mikuriya, T.H. &amp; Brownell, G.S. 1986.
Preliminary Report: Fiscal Costs of California Marijuana Law
Enforcement 1960-1984. Part 1: Arrest Costs. Berkeley,
California: Medi-Comp Press. </p>

<p> Aldrich, M.R.; Mikuriya, T.H.; Brownell, G.S. &amp; Mandel,
J.S. 1987. Fiscal savings in California marijuana law
enforcement, 1976-1985, attributable to the Moscone Act of 1976,
with comments on the effects of refelonization and Senate Bill
218. Testimony to the California Senate Judiciary Committee,
April 7. </p>

<p> Atkcson, L 1987. The California battle for marijuana.
Unpublished manuscript </p>

<p> Brownell. G.S. 1988. Marijuana and the law in California: A
historical and political overview. Journal of Psychoactive Drugs
Vol. 20(l). </p>

<p> Budman, K. 1977. A First Report of the Impact of California's
New Marijuana Law (SB 95) (Requested by the California
Legislature). Office of Narcotics and Drug Abuse, California
Health and Welfare Agency, January. </p>

<p> California Senate Select Committee on Control of Marijuana.
1974. </p>

<p> Final Report, Marijuana: Beyond Misunderstanding. Sacramento:
</p>

<p> California Legislature. </p>

<p> Calof, L. 1968. The cost of enforcing the marijuana laws in
California. In: Aldrich, M.R.; Mikuriya, T.H. &amp; Brownell G.S.
1986. PreliminaryReport:Fiscal Costs of California Marijuana Law
Enforcement </p>

<p> 1960-1984. Part 1: Arrest Costs. Berkeley, California:
Medi-Comp Press. </p>

<p> Drug Abuse Council. 1,977. Marijuana survey-state of Oregon.
News release, Washington, D.C., January 28. </p>

<p> Judicial Council of California. 1985. Annual Report to the
Governor and the Legislature. San Francisco: Administrative Off
ice of the Courts. </p>

<p> Mandel,J. 1987.Are lower penalties a green light for drug
users? JournaI of Psychoactive Drugs Vol. 19(4): 383-385. </p>

<p> Moscone, G. 1974. SB 95 (Moscone) as amended February 4,
Health and Safety Code. Marijuana Infractions. History, Digest,
Purpose, Comment Sacramento: California Legislature. </p>

<p> Uelman, G.F. 1976. California's new marijuana law: A sailing
guide for uncharted waters. California State Bar Journal Vol.
51(l): 27-86. </p>

<p> ALDRICH &amp; MIKURIYA </p>

<p> ENFORCEMENT COSTS </p>

<p> TABLE III </p>

<p> SAVINGS IN 1986 DOLLARS ATTRIBUTABLE TO THE MOSCONE ACT OF
1976* </p>

<p> Arrest Court Prison/Parole Total </p>

<pre>
Savings Savings Savings Savings
Year
1976 51,148,242 30,136,901 4,454,199 85,739,342
1977 52,579,256 46,659,085 5,465,589 104,703,930
1978 50,929,077 48,672,621 6,222,817 105,824,515
1979 52,289,278 50,617,968 7,006,126 109,913,372
1980 47,723,509 47,254,261 7,198,048 102,175,818
1981 45,462,251 45,032773 6,896,320 97,391,344
1982 43,563,228 43,059,6055 6,439,267 93,062,100
1983 42,958,451 41,234,833 6,082,368 90,275,652
1994 41,229,931 42,270,836 3,909,809 87,410,576
1985 36,669,130 46,443,643 &lt;1,303.923&gt; 81,808,850
Total
1976-85 464,552,353 441,382,526 52,370,620 958,305,499
Average savings per year (10-year period): $95.8 million per year.
*From Aldrich et al. 1987. Court disposition savings pertain only to adult felony dispositions because data on adult misdemeanor dispositions are unavailable and juvenile divsiion data are limited. Adult felony dispositions(1973-1974) were not reported to the Bureau of Criminal Statistics and Special Services, and estimates were made based on annual increments between 1972 -and 1975.
TABLE IV
MARIJUANA FELONS IN PRISON AND ON PAROLE 1972-1985*
In Prison On Parole Total
Year (n) (n) (n)
1972 636 1,061 1,697
1973 668 873 1,541
1974 605 661 1,266
1975 317 462 779
1976 198 349 547
1977 146 216 362
1978 121 104 225
1979 101 85 186
1980 98 80 178
1981 119 69 188
1982 157 76 233
1983 191 167 358
1984 327 234 561
1985 618 396 1,014
*Aldrich et al. 1987. Data provided by the California Department of Corrections.
ALDRICH &amp; MIKURIYA
ENFORCEMENT COSTS
TABLE II
MARIJUANA LAW ENFORCEMENT EXPENDITURES 1974-1985
(INFLATION-ADJUSTED IN 1986 DOLLARS)*
Arrest Court Prison Parole Total
Year ($) ($) ($) ($) ($)
1974 84,365,805 65,465,904 8,452,864 2,651,780 160,927,353
1975 75,904,642 71,169,219 5,874,307 1,430,688 154,378,856
Average
1974-75 80,135,224 68,313,062 7,163,586 2,041,234 157,653,106
1976 28,986,982 38,176,161 3,489,715 1,260,906 71,913,764
1977 27,555,968 21,653,977 2,929,779 809,452 52,949,176
1978 29,206,147 19,640,441 2,398,912 583,091 51,828,591
1979 27,845,946 17,695,094 1,813,040 385,754 47,739,834
1980 32,411,715 21,058,801 1,702,828 303,944 55,477,288
1981 34,672,973 23,280,289 2,013,524 294,976 60,261,762
1982 36,571,996 25,253,457 2,462,066 304,487 64,592,006
1983 37,176,773 27,078,229 2,609,865 512,587 67,377,454
1984 38,905,293 26,042,226 4,628,388 666,623 70,242,530
1985 43,466,094 21,869,419 9,259,076 1,249,667 75,844,256
Total
1976-85 336,799,887 241,748,094 33,307,193 6,371,487 618,226,661
Average
1976-85 33,679,988 24,174,809 3,330,719 637,149 61,822,666
</pre>

<p> *From Aldrich et &amp;I. 1987. </p>

<hr>

<p> <a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-49</DOCNO>
<DOCOLDNO>IA087-000627-B012-251</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/moscone/summary.htm 206.61.184.43 19970122050314 text/html 16722
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:03:05 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:56:56 GMT
Content-length: 16504
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Fiscal Costs of California Marijuana Law Enforcement 1960
- 1984 </title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_hemp_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->

<h1>Summary --</h1>

<h1><a name="OLE_LINK1">FISCAL COSTS OF CALIFORNIA MARIJUANA LAW
ENFORCEMENT 1960 - 1984</a></h1>

<p><b>by</b> </p>

<p><b>Michael R. Aldrich, Ph.D.</b> </p>

<p><b>Tod H. Mikuriya, M.D.</b> </p>

<p><b>Gordon S. Brownell, J.D.</b> </p>

<p><img src="../../graphics/blueline.gif" width="562" height="19">
</p>

<p>Copyright 1986, MEDI-COMP PRESS, 1168 Sterling Avenue,
Berkeley, California 94708 </p>

<p>PRELIMINARY ONLY NOT FOR PUBLICATION JUNE 15, 1986 </p>

<p>DEDICATED To the Memory of GEORGE R. MOSCONE Who Designed the
Legislation </p>

<h2>SUMMARY OF PRELIMINARY REPORT</h2>

<ul>
    <li>1. This is not a study of marijuana users or their
        behavior, but a study of the activity of police, courts,
        and prisons. </li>
    <li>2. In 1974 we did a study for the California Senate which
        showed that it was costing about $100 million a year
        (1972) to enforce the marijuana laws. This compares with
        1960, when only about $8 million was spent for this. </li>
    <li>3. THREE MAIN REASONS for escalation of costs in 1960s: <ul>
            <li>1) A MAJOR CHANGE IN DRUG OFFENDER
                CHARACTERISTICS. In 1960 the typical person
                arrested for drugs in California was a
                26-year-old Hispanic heroin addict from Los
                Angeles, with a long criminal record. By 1967 the
                typical drug offender was a 19-year-old white
                marijuana smoker with no criminal record, often a
                middle-class youth -from the suburbs. </li>
            <li>2) ARREST VOLUME. In 1962 there were 3,743
                marijuana arrests in the state. In 1967 there
                were ten times as many (37,514). By 1972 there
                were 76,561, of which 73,000 were felony arrests.
                By 1974 there were nearly 100,000 felony
                marijuana arrests statewide. </li>
            <li>3) FELONY STATUS of POSSESSION OFFENSES. The most
                frequent marijuana offense was possession of a
                small amount, and it was a felony. By 1974,
                one-fourth of all the felony arrests in
                California were for marijuana. </li>
            <li>This meant that: POLICE RESOURCES, formerly
                concentrated on Los Angeles heroin addicts, now
                had to be spread statewide to a much more diverse
                and less visible populations and many departments
                had to add narcotics officers to their staff. The
                sheer volume of arrests greatly increased law
                enforcement costs statewide. </li>
            <li>Also: COURT COSTS, especially in Superior Court
                where felonies are adjudicated, rose dramatically
                as thousands of felony marijuana possession cases
                created a logjam in the courts. Prosecutors and
                judges found it difficult to send 19-yearold
                first offenders to prison for possession, and
                conviction rates fell. </li>
            <li>In sum, thousands of young people were arrested
                on -felony charges each year. All had to be
                processed through the criminal justice system,
                and criminal justice agency costs skyrocketed. </li>
            <li>One-fourth of the felony arrests in California
                were for marijuana and it was costing the state
                $100 million a year to process marijuana
                offenders. </li>
            <li>This was the situation the Moscone Law of 1975
                was designed to alleviate. </li>
        </ul>
    </li>
    <li>4. There were several legislative attempts to deal with
        this problem by allowing felony marijuana possession
        cases to be processed in the lower courts. These were
        TEMPORARILY successful in reducing congestion in Superior
        Courts, but could not solve the essential problem, that
        thousands of young people were being fed into the
        criminal justice system because possession was still
        classified as a felony. </li>
    <li>5. Two important influences on legislative policy during
        this period were the 1972 RECOMMENDATION OF THE NATIONAL
        COMMISSION on Marihuana and Drug Abuse that marijuana
        possession be decriminalized, and the 1972 CALIFORNIA
        MARIJUANA INITIATIVE, which would have decriminalized
        possession avid cultivation for personal use. CMI was
        defeated statewide, but garnered 34% of the vote,
        providing new impetus to repeal felony penalties for
        possession. </li>
    <li>6. THE MOSCONE ACT. After two years of hearings and a
        thorough investigation by a Senate Select Committee
        chaired by Senate Majority Leader George Moscone, a
        compromise was reached among legislators who would not
        accept complete legalization of marijuana. The essence of
        the Moscone Act (passed in 1975, took effect Pages
        January 1, 1976) was to reduce possession of small
        amounts 25-27 of marijuana FROM A FELONY TO A NEW TYPE OF
        MISDEMEANOR, in which a citation is issued to the
        offender rather than arrest and booking; and for which
        the MAXIMUM PENALTY is a $100 fine instead of jail or
        prison. </li>
    <li>7. The EFFECT OF THE MOSCONE ACT ON LAW ENFORCEMENT COSTS
        in California is what we are examining in our new study.
        We have not completed the DISPOSITIONS part of our study
        yet, but this is a preliminary report on its effect in
        regard to the COSTS OF MAKING ARRESTS. </li>
    <li>S. GRAPH MJFM6084 - CALIFORNIA MARIJUANA ARRESTS 1960-84.
        This graph shows the effect of the Moscone Act on
        marijuana 29-31 arrests. FELONY arrests fell dramatically
        from about 100,000 in 1974 to about 20,000 in 1976-- a
        drop of about 8O,000. </li>
    <li>MISDEMEANOR marijuana arrests leaped from about 3500 in
        1972 to about 35,000 in 1978. (Unfortunately misdemeanor
        marijuana arrests were not recorded between 1972 and 1977
        so we can't be more precise about the number of
        misdemeanor or total marijuana arrests for those years.) </li>
    <li>So the CUMULATIVE effect of the Moscone Act was to reduce
        total marijuana arrests from more than 100,000 a year to
        below 64,000 in the 1980s-- a reduction of at least
        36,OOO arrests a year. </li>
</ul>

<h3>EFFECTS OF THE MOSCONE ACT ON MARIJUANA ARREST COSTS</h3>

<ul>
    <li>9. The method we have used to calculate marijuana arrest
        costs was invented in 1972 by A. ALAN POST, then the
        Legislative Analyst for the State of California. After
        consultation with law enforcement agencies Post
        determined that about one-fourth of a police officer's
        time is devoted to investigating and making arrests.
        Therefore one-fourth of law enforcement budgets were
        expended on making arrests. </li>
    <li>Thus, the percentage of total arrests which were for
        marijuana could be applied to one-fourth of state law
        enforcement expenditures., for a reasonable approximation
        of the cost of making marijuana arrests. </li>
    <li>The law enforcement costs included in this calculation
        are the expenditures of county and state police,
        sheriffs' departments and the California Highway Patrol. </li>
    <li>These law enforcement ARREST costs should not be confused
        with the total amount of money spent in processing
        offenders through the criminal justice system. It does
        not include the costs of prosecution public defenders,
        the courts, or penal institutions. In 19729 for instance
        the arrest costs were only $13.2 million of the total
        $100 million expended. </li>
    <li>10. GRAPH ARRCOSTS- ACTUAL MARIJUANA ARREST EXPENDITURES
        73-84. In 1972, there were 76,561 marijuana arrests. The
        cost of making these arrests was $13.2 MILLION, or about
        $173 per arrest. By 1974, with nearly 100,000 felony
        marijuana arrests, the cost had risen to $18.4 MILLION,
        or $185 per arrest. </li>
    <li>11. Then we discovered that the Moscone Act, which was
        passed in July 1975 but did not take effect until
        January, 1976, had a surprising effect even before it
        officially took effect. Its passage sent a message to
        police around the state that possession was no longer
        going to be considered a felony, and marijuana arrests
        dropped sharply -for the last six months of 1975. </li>
    <li>This caused a slight $129000 drop in 1975 marijuana
        arrest costs, but because law enforcement expenditures in
        general were rising while the number of marijuana arrests
        was falling, the cost per marijuana arrest rose to $214. </li>
    <li>12. Then in 1976, directly as a result of the new law,
        marijuana arrest expenditures fell to $4.5 MILLION, or
        $235 per arrest. That same year, 1976, statewide felony
        arrests dropped by about 75,000. Most of this decrease
        was marijuana arrests. </li>
    <li>13. The nosedive in arrest costs continued in 1977, down
        to $4.3 MILLION. The costs of misdemeanor marijuana
        arrests are not included because the arrest statistics
        are not available. Still, a savings of $14 million a year
        ($28 million in two years) in felony arrest costs is a
        considerable achievement for a single legal change. </li>
    <li>14. In 1978, when misdemeanor marijuana arrests again
        began to be counted, arrest costs rose to $14.9 MILLION,
        or $282 per arrest. This was still lower than the $18
        million a year being spent before the Moscone Act. It
        took another two years until 1980, for arrest costs to
        pass their pre-Moscone level. </li>
    <li>15. IN THE 1980s, California marijuana arrests have
        levelled off at about 64,000 a year, of which about
        20-22,000 are felonies (mostly sale) and about 42-44,000
        are misdemeanors. Even though arrests have levelled off,
        law enforcement costs in general have continued to rise
        because of inflation and many other reasons, including
        the continued expansion of police forces and all other
        criminal justice agencies. </li>
    <li>16. Thus by 1984, marijuana arrest costs have risen to
        about $30.5 MILLION a year, or nearly $500 ($480.24) per
        arrest. This is a 131 PERCENT RISE in actual expenditures
        since 1972 when marijuana arrest costs were $13.2
        million. </li>
    <li>17. INFLATION-ADJUSTED MARIJUANA ARREST EXPENDITURES. </li>
    <li>In order to understand the real savings attributable to
        the Moscone Act, it is necessary to account for
        inflation. We have done this by using the &quot;State and
        Local Government Implicit Price Deflator&quot; which is
        routinely used by government agencies in budget analysis.
    </li>
    <li>18. GRAPH INFARRCO (inflation-adjusted arrest costs). </li>
    <li>As the graph shows in 1974 dollars, marijuana arrest
        costs have still not risen above their pre-Moscone level.
        1984 inflation-adjusted expenditures on marijuana arrests
        were about $14 million, 24 percent below the $18 million
        spent in 1974 and just slightly more than was spent in
        1975. </li>
    <li>In fact, the 1984 inflation-adjusted expenditures are
        only slightly more than the $13.2 million actually
        expended in 1972. </li>
    <li>19. Graph PRISPOP - MARIJUANA FELONS IN PRISON. </li>
    <li>Although we have not completed the Dispositions part of
        our study the California Department of Corrections has
        made available to us the total number of marijuana felons
        in prison each year between 1972 and 1984. </li>
    <li>This graph shows one of the most dramatic effects of the
        the Moscone Act-- a massive drop in the number of people
        in state prison for felony marijuana offenses. </li>
    <li>In 1973 there were 668 such prisoners, the highest number
        in California history. </li>
    <li>In 1980, largely because the Moscone Act and other
        measures had reduced the number of felony marijuana
        offenders being fed into prison through Superior Court,
        the number of marijuana prisoners dropped to only 98--
        the lowest number in recent state history. </li>
    <li>Recently (1984), with about 21,000 felony marijuana
        arrests being made for sale, possession for sale and
        cultivation each year, the number of marijuana felons in
        prison has risen to 327 -- exactly ten more than there
        were in 1975. </li>
    <li>Thus the Moscone Act did the same for marijuana prisoner
        populations that it did for arrest costs-- it contained
        them at just above their 1975 level (when the law was
        passed). </li>
</ul>

<h3>CONCLUSIONS</h3>

<ul>
    <li>20. The net effect of the Moscone Act was to reduce
        inflation-adjusted marijuana arrest expenditures by 24
        percent from 1974 to 1984, and to contain marijuana
        arrest costs at about their 1975 level (when the bill was
        passed). There is no other crime in the state for which
        this can be said. </li>
    <li>21. The most important single effect of the Moscone Act
        was to reduce the number of felony marijuana arrests by
        about 80,000 a year. This reduction was permanent and
        represents a considerable savings to the taxpayer. </li>
    <li>Cumulatively, it means that about 720,000 felony
        marijuana arrests and dispositions did not have to be
        paid for during the nine-year period 1976 - 1984, nor an
        additional 80,000 per year since then. </li>
    <li>In 1984 dollars, with every marijuana arrest costing
        about $500, that means the Moscone Act saved the
        taxpayers around $360 MILLION between 1976 and 1984 in
        felony arrest costs. </li>
    <li>(This does not include any prosecutor public defender,
        court disposition.., or penal institution costs.) </li>
    <li>22. It is rare that a single legal change has such an
        immediate and drastic effect on arrests and enforcement
        costs in a state. </li>
</ul>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-50</DOCNO>
<DOCOLDNO>IA087-000627-B012-274</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/moscone/chap1.htm 206.61.184.43 19970122050325 text/html 27195
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:03:18 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:57:36 GMT
Content-length: 26977
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>California Drug and Marijuana Arrests, 1960-67</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_hemp_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->

<p><b>A Fiscal Analysis of Marijuana Decriminalization</b></p>

<p><b>CHAPTER 1. </b></p>

<h1>REASONS FOR ESCALATING ENFORCEMENT COSTS: </h1>

<p><b>CALIFORNIA DRUG AND MARIJUANA ARRESTS, 1960-67</b> </p>

<p><img src="../../graphics/blueline.gif" width="562" height="19">
</p>

<h2>LEGISLATIVE HISTORY</h2>

<p>Marijuana has been illegal in California since 1915, when the
State Legislature made it unlawful to possess or sell the
flowertops, leaves, extracts, tinctures or any narcotic
preparations of hemp, Indian hemp or &quot;loco weed&quot; except
when prescribed by a physician. Originally these were misdemeanor
offenses punishable by a $100- $400 fine or 50-1830 days in jail,
but subsequent legislation gradually increased penalties to the
felony level (Source 1). </p>

<p>A felony is defined in California law as an offense for which
confinement in state prison is either an alternative or the sole
penalty. By 1939, possession or sale of any amount (or any part)
of the plant Cannabis sativa L. drew up to a year in county jail
or up to six years in prison. </p>

<p>In 1953-54 minimum mandatory sentences were established for
cannabis crimes, with &quot;escalator clauses&quot; punishing
repeat offenders more severely. Most marijuana offenses were
felonies with minimums of one to ten years in prison for
possession,) or five to life for sale. Practically the only
marijuana misdemeanors were &quot;use of marijuana&quot; (a crime
since 1949), and &quot;maintaining premises where narcotics are
used.&quot; These were punished by a mandatory 90 days to one
year in jail. </p>

<p>A U.S. Supreme Court decision in the Robinson case in 1962,
however, held that addiction or use of drugs per se was not a
crime, leaving &quot;use of marijuana&quot; exclusively a
juvenile offense thereafter. California's delinquent tendency
laws allow juveniles to be punished for offenses such as using
marijuana, or being a runaways which would not be crimes if they
were committed by adults (Source 2). </p>

<p>The marijuana laws covering most of the first eight-year
(1960-67) period of this study were established in 1961. Simple
possession of any amount of marijuana drew a minimum 1-10 years
in prison, with no parole until a year had been served. An
offender with any prior felony conviction got 2-20 years, and
with two priors five years to life in prison. </p>

<p>Possession of marijuana for sales a new offense in 1961, drew
two to ten years in prison (5-15 with any prior; 10-life with two
priors). Sale of marijuana was punished by a mandatory five or
ten years to life, with no possibility of parole until three
years had been served (Source I). </p>

<p>By putting virtually all marijuana offenses in the same felony
class as heroin% murder, rapes and arson, legislators placed
marijuana offenders in the most expensive law enforcement
judicial, and correctional categories. Malting any crime a felony
sends a message to the police and Courts that this offense has
top priority in terms of time and money spent pursuing and
prosecuting the offender. This was feasible as long as there were
only a few thousand marijuana arrests per year.., but when
arrests started doubling and tripling it soon became evident that
treating marijuana like heroin was going to be a very expensive
proposition indeed. </p>

<h2>THE BCS INDIVIDUAL REPORTING SYSTEM, 1959-67</h2>

<p>California has one of the best statistical databases on drug
offenders in the world today because the 1959 State Legislature
appropriated funds to establish a unit within the Justice
Department's Bureau of Criminal Statistics to keep track of every
known drug law violator from the point of arrest through the
final disposition. </p>

<p>Information such as the age, sex, race, drug usage, prior
criminal record, and probation or parole status of each new
offender was recorded on a 5x8 card at the time of his or her
drug arrest. Subsequent events (disposition and sentence) in
processing the offender through the criminal justice system were
recorded on this same card., along with any later criminal
involvements (Source 3). </p>

<p>This was the first attempt in any state to gather information
about individual drug offenders from all available sources.
Federal agencies as well as city, county and state agencies
contributed data from police arrest reports, rap sheets, court
records, jail and prison files, juvenile hall and California
Youth Authority records, and probation and parole reports. A
total of 120,248 persons were included in these files between
1960 and 1967 (Source 3i, p.7). These persons accumulated a total
of 214,809 drug arrests during this time, of which 91,529 were
marijuana arrests (Table 1). </p>

<p>The wealth of detail on drug offenders preserved by the
Individual Reporting System allows us to determine why
enforcement costs skyrocketed. The eight-year period 1960-67 has
been chosen because thereafter the method of recording arrests no
longer included detailed offender characteristics. </p>

<h2>CHANGES IN DRUG OFFENDER CHARACTERISTICS 1960-67</h2>

<p>Changes in drug arrest patterns and drug offender
characteristics in the early 1960s were the primary reasons for
the sudden escalation of drug law enforcement costs in California
during the ensuring years. A brief survey of these changes
between 1960 and 1967 will help us understand why enforcement
costs rose so drastically. Fuller detail can be found in Sources
3 and 4i, and in the RACE67 appendix to this report. </p>

<p>1960 was the first full calendar year of the Individual
Reporting System, and in many ways reflects the narcotics scene
of the late 1950s. Drug arrests were split about evenly between
heroin offenders and a quite different group of marijuana or
dangerous drug offenders (see Table 1). The replacement of the
first group by the second is essentially what caused the costs of
law enforcement to rise. </p>

<p>The chief concern of law enforcement was heroin arrests, which
were nearly half (48 percent) of all drug arrests. There were
twice as many heroin arrests as marijuana arrests among adults,
with dangerous drug arrests taking third place (Table 1). Police
priority was given to heroin and marijuana offenses because most
were felonies while dangerous drug offenses were practically all
amphetamine and barbiturate misdemeanors. </p>

<p>Nearly three-fourths (74.1 percent) of heroin arrests were for
simple use of the drug-- a felony. Forty percent of heroin
offenders were Hispanic; about a third were white, and a fourth
were black (Race67). </p>

<p><b>TABLE 1. CALIFORNIA DRUG ARRESTS 1960-67</b> </p>

<p>By Offense Category and Percentage of All Drug Arrests </p>

<hr>

<pre>
YEAR ALLDRUG    MJ   MJ%      HEROIN H%      D.DRS. DD%     OTHER 0%
1960	19265	5155	27	9295	48	4048	21	767	4
1961	15185	3794	21	8307	46	5239	29	848	5
1962	17613	3743	21	6022	34	6771	38	1077	6
1963	19226	5518	30	6064	33	5443	30	1201	7
1964	21729	7560	35	7701	35	5216	24	1252	6
1965	24374	10002	41	6164	25	6881	28	1327	5
1966	33622	18243	54	6482	19	7071	21	1826	5
1967	61792	37514	61	8469	14	12367	20	3442	6
</pre>

<hr>

<pre>
TOTAL    214809    91529 43% 58504 27%           53036   25% 11740      5.5%
</pre>

<hr>

<p>Note: Percentages may not total 100% due to rounding. </p>

<p>Source: Drug Arrests and Dispositions in California 1969, p.l.
</p>

<p>The typical adult heroin offender in 1960 was a male heroin
addict of Mexican descent from Los Angeles. He was 25 years of
age or older, and had a lengthy criminal record for drugs and
crimes against property. Seven out of ten heroin offenders had
already served prison or jail sentences at the time of their 1960
arrest (Source 4). </p>

<p>Juveniles in the early 1960s, however, had many more marijuana
and dangerous drug arrests than heroin arrests. In 1961 juvenile
drug offenders were 39 percent Mexican descent, 37 percent white,
22 percent black, and 1.6 percent &quot;other&quot; races (RACE67
Appendix). </p>

<p>The main reason for these ethnic distributions in the early
Sixties was that Los Angeles County, with its large Hispanic and
black populations was responsible for about 70 percent of all
drug arrests in the state. There was considerable variation
between Los Angeles and the rest of the state in ethnicity of
arrests. &quot;A much higher percentage of whites was arrested
outside Los Angeles County. The percentage of Negroes arrested in
Los Angeles County was substantially higher than in the rest of
the state&quot; (Source 3c, p.20). </p>

<p>The establishment of the California Rehabilitation Center
(CRC) for narcotics addicts in 1961, and the U. S. Supreme Court
decision in the Robinson case in 1962, had the cumulative effect
of greatly reducing the number of arrests for heroin addiction or
use in the next few years. Since these were about three-fourths
of all heroin arrests, the percentage of drug arrests which were
for heroin steadily declined (Sources 3b-3i). </p>

<p>Meanwhile, arrests for marijuana and dangerous drugs started
to climb. A surge of dangerous drug arrests in 1961-62 was the
first sign that drug arrest patterns were about to change
radically. Dangerous drug arrests exceeded heroin arrests for the
first time in 1962 (Table 1). </p>

<p>In 1960, felony marijuana arrests were only 3.72 percent of
all the felony arrests in California (MJSPRD line 43), and
marijuana arrests were about one-fourth (27 percent) of all drug
arrests in the state (Table 1). Seventy percent of marijuana
arrests were made in Los Angeles. Whites accounted for nearly
half (48.5 percent) of adult marijuana arrests, blacks for 28
percent, and Hispanics for 22 percent (RACE67). </p>

<p>The typical adult marijuana or dangerous offender in 1960 was
a white male under 25 years of age from Los Angeles. He had never
been arrested before on a drug charge, but was likely to have
been arrested for some crime against property. One out of seven
adult marijuana offenders in 1960 progressed to heroin
involvement within five years (Source 4). </p>

<p>In 1963 the number of marijuana arrests began to rise rapidly.
In 1964 marijuana and heroin arrests were each about 35 percent
of all drug arrests, and in 1965 marijuana arrests surpassed
heroin arrests both in number and as a percentage of drug arrests
(Table 1). </p>

<p>For the first time in California history, whites were involved
in more than half of all drug and all marijuana arrests in 1965.
The Los Angeles component of statewide drug arrests steadily
declined, from 70 per-cent in 1960 to 64 percent in 1965 and only
50 percent in 1967 (RACE67). </p>

<p>The Bureau of Criminal Statistics noted in 1966 that &quot;a
new segment of California's population is entering the drug
picture. Here there is an indication that an important component
of the new segment is made up of persons of Caucasian descent ...
The proportion of white (adult) arrestees has risen to 56 percent
from 44 percent in 1960... This development appears to stem in
part from the influx of large numbers of novice users into the
drug arrest population&quot; (Source 3h, p.14). </p>

<p>This trend was even more pronounced in 1967, when whites
became 64.5 percent of adult drug arrests, 70.9 percent of
juvenile drug arrests, and 66 percent of all drug arrests. The
surge in white arrests occurred in all categories. Many
amphetamine-barbiturate offenses were raised to felony level in
1965, and LSD and similar hallucinogens were made illegal in
1966, which caused dangerous drug arrests to double between 1965
and 1967 (Table 19 and Sources 3h, pp.1-49 and 3i, pp.1-39 12). </p>

<p>The most significant increase however, was in marijuana
arrests, where the proportion of white offenders in 1967 rose to
68 percent for adults, 72.9 percent for juveniles) and 64 percent
of all marijuana arrests, with concomitant decreases of about 5
percent each in black and Hispanic marijuana arrests (Source 3i,
p.12). </p>

<p>Marijuana arrests doubled between 1966-1967 and became 61
percent of all drug arrests in the state, compared with 27
percent in 1960. Despite the explosion of dangerous drug arrests
in 1967, they constituted only about 20 percent of all drug
arrests-- down slightly from 21 percent in 1960. And heroin
arrests, which had been 48 percent of drug arrests in 1960, were
now only 14 percent of all drug arrests in California (Table 1). </p>

<p>Accompanying the increase in white offenders was a continuing
rise in the proportion of offenders who had never been arrested
on drug or criminal charges before. In 1965, 53 percent of adult
drug arrestees were first offenders; in 1967 they were 61
percent. The highest proportion of these were new marijuana
offenders-- 67 percent of adult marijuana arrests in 1965 were
initial arrests, rising to 71 percent in 1967 (Sources 3g, P.8;
3h, p.9; 3i, p.7). </p>

<p>The median (average) age of marijuana offenders fell from 24
years old in 1961 to 22 in 1965 and 19 in 1967. This drove down
the median age of all drug offenders from 26 in 1961 to 20 in
1967. About 85 percent of drug offenders were male (Sources 3g,
p.11; 3h, p.14; 3i, pp.12-13). </p>

<p>Thus by 1967 the typical person arrested for drugs in
California was no longer an aging Hispanic heroin addict with a
lengthy criminal record, but a young white pot smoker who had
usually not been involved with drugs or crime before. This change
was permanent, at least through 1985, and had great impact on the
costs of drug law enforcement in California. </p>

<p>Generally an ethnic-minority heroin addict does not have the
financial resources available to a first-time white marijuana
offender, with which to fight a felony case through the criminal
justice system. It was not the change in skin color, but the
changes in drug of choice, place of arrest, and financial
circumstances of the average drug offender that caused the costs
of law enforcement to skyrocket. The single most important
influence on these costs was the rising number of white felony
marijuana arrests, which by 1967 were 42 percent of all drug
arrests in California (RACE67). </p>

<h2>MARIJUANA ARREST ANALYSIS, 1960-67</h2>

<p>The following analysis of marijuana arrest patterns will be
helpful in understanding the predominant role of these arrests in
increasing the costs of law enforcement in California. The
frequency counts (Tables 1, 2, and 3) and the MJSPRD table on
which this analysis is based may be found in the reference table
section at the back of this report. </p>

<p>Marijuana arrests increased tenfold between 1962 (3743) and
1967 (37514). As can be seen in graph DRMJ6067 above, it was.
this rise in marijuana arrests which fueled the statewide surge
in drug arrests, so the drug arrest curve generally matches the
marijuana arrest curve. </p>

<p>Graph %AMJAD67 shows that marijuana arrests rose from 27
percent of all drug arrests in 1960 to 61 percent in 1967. This
important change in the typical offender's drug of choice
occurred in 1965, when marijuana arrests surpassed heroin
arrests, and was solidified when marijuana arrests surpassed
non-marijuana arrests in 1966 (graph DAD672 below). </p>

<p>95 to 99 percent of California marijuana arrests were felonies
at this time. Most misdemeanor marijuana arrests were of
juveniles, for use of marijuana. A few adults each year were
arrested for maintaining premises. </p>

<p>Adults were arrested for marijuana far more frequently than
juveniles, contrary to the public impression that most marijuana
arrests are of juveniles (Table 3, graph MJ6067) However, the
rate of increase for juvenile arrests was much greater than for
adult arrests.., and the average marijuana offender was only 19
years old by 1967 (Source 3i, p.13). </p>

<p>Adult marijuana arrests increased vastly in number, but
declined as a percentage of all marijuana arrests, from 92
percent in 1962 to 71 percent in 1967 (graph %AJMJ67). Juvenile
arrests rose from 8 to 29 percent. </p>

<p>Possession of any amount of marijuana was a felony, and was
the most frequent marijuana offense, ranging from 77 percent in
1962 to 84 percent in 1967. When possession for sale is included
possession arrests were nearly 90 percent of all marijuana
arrests by 1967 (Table 3, graphs above). </p>

<p>Non-possession offenses were 19.5 percent (1962) to 11 percent
(1967) of marijuana arrests. The most common non-possession
felony was sale of marijuana; the least common -felonies were
cultivation of marijuana and sale of some other substance in lieu
of marijuana. </p>

<h2>SUMMARY: REASONS FOR RISING ENFORCEMENT COSTS</h2>

<p>The following are the most important reasons for -the
escalation of marijuana law enforcement costs in California.
Unless otherwise stated, the data given are for 1967. </p>

<p>1. ARREST VOLUME: There were ten times as many marijuana
arrests in 1967 (37,514) as there were in 1962 (3,743), and still
rising. </p>

<p>2. FELONY STATUS: Virtually all marijuana offenses (99
percent) were classified as felonies, which put them into the
costliest &quot;top priority&quot; law enforcement judicial and
correctional classes. </p>

<p>3. MOSTLY POSSESSION: Eighty-four percent of felony marijuana
arrests were for simple possession (Table 3). The minimum
mandatory penalty for simple possession was 1-10 years in state
prison. </p>

<p>4. PERCENTAGE OF STATEWIDE FELONY ARRESTS: Felony marijuana
arrests were 18.23 percent of all felony arrests, compared with
only 3.72 percent in 1960 (MJSPRD line 43). It was the easiest
felony bust in the state for police to make, and this too
contributed to the sharp rise in arrests. </p>

<p>5. %AMJAD: Marijuana arrests were 61 percent of all drug
arrests, compared with 27 percent in 1960 (Table 1, and MJSPRD
line 53). </p>

<p>6. PLACE OF ARREST: Drug arrests, particularly marijuana
arrests., spread statewide instead of being concentrated in Los
Angeles. Los Angeles County made 70 percent of drug arrests and
66 percent of marijuana arrests in 1960, declining to 50 and 48
percent in 1967. &quot;Areas which previously had little illegal
drug activity... now found it necessary to add highly specialized
narcotic officers to their law enforcement staffs&quot; (Source
3h, p.12). </p>

<p>7. DRUG OF CHOICE: The typical drug offender in California was
no longer a heroin addict, scrambling to support an expensive
habits but a marijuana smoker with better financial resources
available. </p>

<p>B. RACE AND FINANCIAL CONDITION: White people, who received
fewer than half of all drug arrests in 1960, now accounted for
twothirds (66 percent) of all drug arrests and for 70 percent of
all marijuana arrests. Whites in general have better financial
resources than ethnic minorities with which to fight a felony
case. </p>

<p>9. CRIMINAL RECORD: the typical drug offender no longer had a
criminal record. This meant that he or she was harder to convict,
and often that he or she would fight a first offense with all
available resources. With more defendants fighting their cases,,
costs rose across the board, especially in Superior Court. </p>

<p>10. AGE: The typical drug offender was now 19 years old, and
prosecutors and judges found it increasingly difficult to send
19-year-old first offenders to state prison for simple
possession. In 1960, 93 percent of all drug offenders were
convicted as charged; by 1967 this had fallen to 70 percent
overall, with only 48 percent of marijuana offenders convicted as
charged (Source 3i, p.29). </p>

<p>In sums the underlying reason for the rise in enforcement
costs was a radical change in offender characteristics. The
typical Californian arrested for drugs was no longer an
ethnic-minority heroin addicts but a young white marijuana user.
The arrest statistics themselves thus reveal a major
sociocultural change in California, directly connected to the
rise of white marijuana and dangerous drug (psychedelic) arrests.
This was the rise of the youthful counterculture. </p>

<p>Social commentary on the predominantly white counterculture is
beyond the scope of this papers but it should be pointed out that
black and Hispanic marijuana and dangerous drug arrests show
increases parallel to the white increases but more modest (RACE67
annual tables). Whether this was due to countercultural influence
and assimilations to increased availability of these drugs, or to
other factors, cannot be ascertained from the statistics. </p>

<p>Likewise, it is difficult to be more specific about the costs
of arresting and prosecuting heroin addicts (usually repeat
of-fenders) versus marijuana smokers (usually first offenders).
The key question here would be whether the cost of repeated
incarceration of those financially unable to defend themselves is
more or less than the cost of fruitless prosecution of those who
can. The former calculation would have to include the capital
costs of correctional facilities for addicts (including prisons,
jails, and the CRC)-- and capital expenditures are not included
in the enforcement cost statistics collected by BCS. Other
variables such as how many white and nonwhite offenders were able
to hire lawyers, are also not available. </p>

<p>Nevertheless, it is generally true that a white marijuana
offender has better financial resources with which to fight a
felony charge than an ethnic-minority heroin addict does, and
this is reflected in the declining conviction rates for drug
offenders (see item 10 on page 8). </p>

<p>This fact, coupled with the extraordinary increase in arrest
volume (marijuana arrests leaping beyond 37,000 a year and still
rising), led to increased costs at every stage of the criminal
justice system, including expanded police forces, the need for
more public defenders, huge caseloads in probation and parole
departments and a major logjam in the courts. </p>

<p>Because the law continued to treat marijuana like heroin (as a
felony)$ enforcement costs started exploding the moment this
change occurred in 1965. The resulting rise in enforcement costs
will be examined in the next chapter. </p>

<h2>SOURCES</h2>

<p>1. Letter to Senator Arlen Gregorio (titled &quot;Marijuana -
#17361&quot;), from Peter Melnicoe, Deputy Legislative Counsel,
Office of the Legislative Counsel of California (George H.
Murphy)* Sacramento, January 18, 1974. Printed as an appendix to
the Moscone Report (&quot;Marijuana: Beyond
Misunderstanding%&quot; Final Report of the California
Legislature Senate Select Committee on Control of Marijuana),
Sacramento, May 1974. </p>

<p>2. &quot;While all (juvenile) narcotic arrests have been
grouped Linder the heading, major offenses (felonies), it is very
difficult to identify in detail the exact nature of these
offenses. The Bureau of Criminal Statistics publishes a separate
series of reports on narcotic arrests each year which indicates
that about one-half of the juvenile arrests fall into a felony
category and the other half either in a misdemeanor category or
in an area of delinquency not defined by the Penal Code. The fact
that an adult has admitted the use of marijuana or dangerous
drugs is not a criminal offense defined by the Penal Code;
however% a ,juvenile who has admitted to the use of such
substances can be filed on in the juvenile court as a
delinquent.&quot; -- Crime and Delinquency in California 1965
(Sacramento: BCS, 1966), p.143. </p>

<p>3. A detailed history of the Individual Reporting System drug
offender study and its methodology may be found in its first
report (#3a below), and as appendices to the BCS reports for 1960
through 1963 (#3b-#3e). Retroactive revisions of data are
discussed in the reports for 1965 (#3g) through 1967 (#3i). See
also Michael R. Aldrich, &quot;Legislative and Reporting-System
Changes Relevant to Statistics on Cost of Enforcing California
Marijuana Laws,&quot; in the Moscone Report, Sacramento, 1974. </p>

<p>3a. Narcotic Arrests in California July 1, 1959- June 30,
1960. Sacramento: Bureau of Criminal Statistics, 1960. </p>

<p>3b. Narcotic Arrests and Their Dispositions in California,
1960. </p>

<p>3c. Narcotic Arrests and Dispositions in California, 1961. </p>

<p>3d. Drug Arrests and Dispositions in California, 1962. </p>

<p>3e. Drug AT-rests and Dispositions in California, 1963. </p>

<p>3f. Drug Arrests and Dispositions in California, 1964. </p>

<p>3g. Drug Arrests and Dispositions in California, 1965. </p>

<p>3h. Drug Arrests and Dispositions in California, 1966. </p>

<p>3i. Drug Arrests and Dispositions in California, 1967. </p>

<p>4. &quot;Follow-Up Study of 1960 Adult Drug Offenders,&quot;
Sacramento: Bureau of Criminal Statistics, 1968. See also RACE67
file appended to this Study and, for an interesting comparison,
the &quot;Five Year Follow-Up of 1966 Juvenile Drug
Arrestees,&quot; Sacramento: BCS, 1973. </p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-51</DOCNO>
<DOCOLDNO>IA087-000627-B012-305</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/moscone/chap2.htm 206.61.184.43 19970122050335 text/html 23829
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:03:27 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:57:28 GMT
Content-length: 23611
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Fiscal Costs of California Marijuana Law Enforcement,
1960-1972 </title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_hemp_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->

<p>A Fiscal Analysis of Marijuana Decriminalization</p>

<p><b>CHAPTER II. </b></p>

<h1>FISCAL COSTS OF CALIFORNIA MARIJUANA LAW ENFORCEMENT,
1960-1972 </h1>

<p><img src="../../graphics/blueline.gif" width="562" height="19">
</p>

<p>The fact that nearly one-fifth of all California felony
arrests pertain to marijuana charges indicates that marijuana
enforcement costs constitute a significant portion of all
California law enforcement and correctional expenditures. </p>

<p>Legislative Analyst A. Alan Post, 1972 (Source la). </p>

<h2>THE BCS SUMMARY REPORTING SYSTEM, 1968-77</h2>

<p>One of the first casualties of the explosion of drug arrests
was the BCS Individual Reporting System drug offender study. By
1967, almost one-fourth of the entire BCS staff was involved in
collecting drug statistics (Source 1d, p.1). As the number of
arrests continued to rise, -the Bureau was forced to resort to a
less accurate system of summary estimates rather than keeping
track of thousands of individual offenders. </p>

<p>The Summary Reporting System began in 1968, ay-id involved
making estimates of the total number- of drug offenders -from a
30 percent sample of police drug arrest summaries and rap sheets.
When drug arrests again increased in 1969, the sample was reduced
to 20 percent (Sources 2a, pp. :13-19; 2b, p.5). </p>

<p>This immediately downgraded the value and precision of the
statistical database. A sample is an averaging device and doesn't
give very reliable information on individuals, particularly in a
rapidly changing population of drug offenders. Although a random
sample can eflect the number of people arrested in each general
drug category with some precision, characteristics such as the
age, sex, race, or criminal record of offenders were
progressively lost because there is no way to check, whether the
sample accurately reflects these individual traits in the drug
offender population as a whole. </p>

<p>Police summary forms had spaces -for the general offense
charged-how many were arrested for marijuana--- but did not
contain specific offenses, i.e. how many were arrested for
possession. Thus frequency counts (like Table 2), which are very
valuable to legislators -trying to determine the efficacy of
specific laws, could no longer be obtained from the database
(Source 1d, p.2). This meant, for example, that it was impossible
to determine how many dangerous drug arrests were for LSD, or how
many marijuana arrests were for cultivation. </p>

<p>Rap sheets -from the Criminal Identification and Investigation
bureau, part of the sample used by BCS, are based on
-fingerprints. Juveniles are often not fingerprinted:
consequently juvenile drug offenders are under-represented in the
sample. Another-- problem is that &quot;booking offenses shown on
rap sheets are poor indicators of actual offenses&quot; described
in arrest reports (Source 2c,., p.6). </p>

<p>In addition, use of the summary system led BCS to revise their
data retroactively each year--- meaning, for instance, that the
number of drug arrests in 1968 was reported differently almost
every year after that (Sources 2a, pp.43-44, 46, 61-63; 2b and
2c, p.1; 2d, p.3; 2e, p.4). To solve this problem we have
arbitrarily chosen the final estimates for these years given in
Crime and Delinquency in California, 1972 (Source 3e). </p>

<p>Finally, USE- Of the summary system meant that some
information previously reported had to be dropped. First to go
were statistics on Federal offenses in California, which have not
been collected since 1968. Then in 1972 BCS stopped reporting
misdemeanor marijuana arrests; this continued until 1978, and
injured the database permanently because the total number of
marijuana arrests each year between 1972 and 1977 cannot be
ascertained precisely. </p>

<h2>DRUG ARRESTS A MAJOR FACTOR IN RISING ENFORCEMENT COSTS</h2>

<p>California criminal justice agency expenditures rose by 67
percent -from fiscal 1967-68 to fiscal 1971-72 (Source 3e, p.62).
Much of this extraordinary increase in enforcement costs must be
attributed to the explosion in drug arrests, especially marijuana
arrests (graph DRMJ6072). </p>

<p>Drug arrests were the prime contributor to sudden rises in
statewide felony arrests. &quot;Adults arrested for felony crimes
increased by about 30,000 in 1969 over 1968, of which drug
arrests accounted for 20,000, or about 67 percent of the
increase. In 1972, total -felony arrests increased 11,000 over
1971, with drug arrests making Lip nearly all the rise...&quot;
(Source 3e, p.29). </p>

<p>Felony marijuana arrests were only 3.72 percent of all felony
arrests in 1960. By 1972 over one-fifth (21.19 percent) of the
felony arrests in California were for marijuana (Table 4: line 43
MJSPRD). Misdemeanor marijuana arrests were negligible, less than
one percent of misdemeanors. </p>

<p>During this same five years (1968-72), -the number- of drug
offenders increased by 96 percent compared to a 23 percent
increase in non-drug offenders. Also, more drug arrestees were
prosecuted; complaints filed by the police against drug offenders
rose by 123 percent, compared to 34 percent for non-drug
offenders (Source 3e, p.39). </p>

<p>The result was that massive numbers of drug offenders were
funneled through police stations, county jails, lower and
superior courts, and probation and parole departments each year.
All the trends shown in the previous chapter continued, insofar
as can be determined from the database: these offenders were
mostly white, Mostly Young (19 to 20), and mostly arrested on
felony charges of possession of marijuana (Source 2a, p.28). </p>

<p><b>TABLE 4. DRUG AND MARIJUANA ARRESTS 1960, 1967-72</b> </p>

<hr>

<pre>
ARRESTS          1960      1967      1968       1969      1970       1971       1972
</pre>

<hr>

<pre>
FELONY	(42)    132379    203233    258740     299574    315232     332693     344762
Fel. Drug(40)   15768     48120     79221      106344   118314     119184      127699
% Drug/Fel      11.91     23.68     30.62       35.50    37.53      35.82       37.04
Marijuana (39)   4921     37049     47949       51414    64880      61199       73061
% MJ/Fel (43)	  3.72	    18.23     18.53       17.16    20.58      18.40       21.19
MISDEMEANOR(48)611458    717015    697514       770583  808518     806428      860158
Misd. Drug(46)   3497     13672     15517        16827   17850      18377       17889
% Drug/Misd.     0.57      1.91      2.22        2.18     2.21       2.28        2.O8
Marijuana (45)    234       465      2388        3762     4141       3398        3500
% MJ/Misd(49)    0.04      0.06      0.34        0.49     0.51       0.42         0.41
FEL &amp; MISD.(54)743837    920248    956254     1070157  1123750    1139121      1154325
Total Drug (52) 19265     61792     94738      123171   136164     137561       145588
% Drug/FM        2.59      6.71      9.91       11.51    12.12      12.08         12.61
Total Marij (51) 5155     37514     50327       55176    69021      64597         76561
% MJ/F&amp;M(55)     0.69      4.08      5.26       5.16      6.14       5.67       6.63
</pre>

<hr>

<p>Source: MJSPRD and its Sources. Numbers in parentheses refer
to MJSPRD lines. </p>

<h2>COSTS OF MARIJUANA LAW ENFORCEMENT 1960-72</h2>

<p>The following is a brief summary of all previous studies of
the costs of California marijuana law enforcement. In general,
the- method of these studies was to apply cost-per-unit estimates
to the number of offenders in each stage of the criminal justice
process from arrest to final dispositions For greater detail,
Consult Source </p>

<p>In 1968 Stanford law student, Lawrence Calof wrote the
definitive first study of these costs. Taking the 1966 marijuana
arrest and disposition data and applying fiscal 1967-68 budget
-figures, Calof arrived at a &quot;hybrid&quot; estimate of
$29,783,418.56 for -the 18,243 adult and juvenile marijuana
arrests and the dispositions of 14,209 adult -felony offenders.
This averages out to approximately $1,630 per arrest, or $2,100
per adult disposition (Source la, p.114; see Calof appendix). </p>

<p>To estimate the costs at each stage of the disposition
process, Calof relied not only on published budgets, but also on
numerous interviews with officials at each stage, and a sample of
Los Angeles superior court dispositions. The interviews were
necessary to form a realistic assessment of the amounts of time
spent in the prosecution of marijuana offenders. Then he
calculated the costs of taking a single offender through the
system in Los Angeles, where more than 60 percent of marijuana
arrests were made (Calof appendix). </p>

<p>Calof's study is especially valuable in reflecting the costs
of adult felony prosecution before &quot;The Wobbler&quot; took
effect. However-, Calof excluded the costs of juvenile court
proceedings, and misdemeanor proceedings in lower- court-----
because at the time these were insignificant Thus Calof's
estimate must be regarded as conservative, a minimum figure. </p>

<p>His professor at Stanford Law School, John Kaplan, used the
Calof method to calculate the 1968 enforcement costs in his book
&quot;Marijuana The New Prohibition&quot; (1970). He arrived at a
figure of about $72 million for the 50,327 marijuana arrests that
year, with emphasis in adult felony dispositions for which the
most information was available- (Source 4). </p>

<p>U.C. L. A. researcher William McGlothlin, using a variation of
the Calof method, estimated approximately $43.1 million for the
cost of 1969 marijuana dispositions. Dr. MCGlothlin excluded
certain costs which Calof had included (appeals, state narcotics
bureau, motions to suppress evidence), and used significantly
lower cost/unit estimates for court dispositions and commitments
(Source la, p.114). However, McGlothlin, not a lawyer, made no
attempt to interview criminal justice agency or court officials
about the actual costs involved at each stage, and his estimates
are not as realistic as Calof's. As at result his cost estimate
for 1969 is, in our opinion, much too low. </p>

<p>Tod H. Mikuriya, M.D., a consultant to the National Commission
on Marihuana and Drug Abuse, estimated 1970 marijuana enforcement
cost, at $106 million. This figure was obtained by multiplying
Calof's estimate by the percentage increase in marijuana arrests
in 1970 over 1966 (Source la, p.115). </p>

<h3>THE A. ALAN POST METHOD OF DETERMINING ARREST COSTS</h3>

<p>Perhaps not coincidentally, a different method of assessing
the costs Of Marijuana arrests for 1971 gave approximately the
same $106 million figure obtained for 1970, even though the
number of marijuana arrests in 1971 declined by 3,681 from the
previous year (Source la, p.115; Table 5). </p>

<p>This new method was invented by Legislative Analyst A. Alan
Post, and was based on the fact that the overwhelming majority of
marijuana arrests are made by local police and sheriff's
departments. &quot;It was determined that approximately 25
percent of a police Officer's time is devoted to the detection
and apprehension of criminals. Therefore, it was concluded that
25 percent of the county's law enforcement budget is expended on
criminal activity. The percentage of total marijuana arrests of
the total arrests was computed for each county. This percentage
was applied to that activity. Thus, a rough approximation was
constructed of what it Costs California County law enforcement
agencies to effect marijuana arrests&quot; (Source la, pp. 98-99
and letter from Wayne Knutila of BCS to the Moscone Committee
Feb. 7, 1974, are appendix in Source 1). </p>

<p>This method revealed that in 1971, local police and sheriff's
departments spent approximately $8.9 million at the arrest stage
alone, an average of $138 per marijuana arrest. Using the same
method, county law enforcement expenditures on marijuana arrests
in 1972 were calculated at approximately $11 million, or $144 per
arrest (Source la. P.99). </p>

<p>However these figures did not, include the costs of the
California Highway Patrol, 63 per-cent of whose felony arrests in
1972 involved marijuana and other drug arrests. Adding CHP
expenditures on marijuana arrests brought the cost per arrest to
$166 in 1971 and $171 in 1972 (Source lap P.100). </p>

<p>Thus for 1971, using the Post method for arrest costs and
taking into account a significant reduction in disposition costs
caused by increasing use of The Wobbler and P.C. Section 17
(discussed below), total costs of marijuana law enforcement were
calculated at approximately $106,859,808. The 1971 estimate
proved comparable to the 1970 figure by a different method of
calculation (Source la, pp.115-117). This is further evidence
that the McGlothlin estimate for 1969 was too low. </p>

<p>To determine costs in 1972 for the Moscone Committee, two
separate evaluation techniques were used. First, the Calof method
was applied to the 1972 marijuana arrest/disposition statistics
and budgets. This produced an estimate of $95,239,536 for 1972
(Source. lb). </p>

<p>The second approach was to apply the A. Alan Post arrest costs
and Calof unit Costs to updated information, including revised
correctional Costs, supplied by every major criminal justice
agency in the state. This produced an estimate of $105,762,049
spent on marijuana Offenders by these agencies in 1972 (Source
1c). </p>

<p>The two different evaluation methods again produced comparable
results-- $95 million and $106 million-- as total marijuana
enforcement costs in 1972. We rounded this off to $100 million as
an average. This estimate is conservative, a minimum figure,
because it did not include the costs of 20,697 unknown adult
dispositions, 84310 commitments from lower court, or any juvenile
dispositions (Source la., p.113). </p>

<h3>INFLUENCE OF &quot;THE WOBBLER&quot; AND P.C. SECTION 17 ON
COSTS</h3>

<p>A close scrutiny of dispositions revealed that the major
influence on reducing the fiscal costs of processing marijuana
offenders through the courts had been Section 17 of the Penal
Code. The number of adult felony marijuana offenders in lower
courts increased sharply between 1969 and 1971, and by 1972 more
(12,346) felony marijuana cases were disposed of in lower courts
than in superior court (8,884). (Source la, p. 101.) </p>

<p>Nevertheless, superior Court dispositions nearly doubled from
1968 to 1971, because of vast increases in the number of arrests
(Source 3e, p.40, and Table 5). It took three years for the
&quot;Wobbler&quot; and Section 17 PC to relieve the congestion
in superior court. 1972 at last saw a drop of over 6,000 superior
court dispositions, largely attributable to -filing felonies as
misdemeanors in lower courts (Source 3e, p.40). </p>

<p>This reduction in superior court costs is responsible for the
slight drop in estimated enforcement costs in 1972 compared to
1971 (Table 6). Because off reduced superior court costs, We
included McGlothlin's low estimate to indicate that the cost per
arrest/disposition declined to $1,342 between 1969 and 1972, a
considerable savings (Source la,, p.117). </p>

<p>However, in 1972 there was an unexpected jump of 11,000 more
felony drug arrests, accompanied by a leveling off in lower-
court dispositions. &quot;After three years of sharp
increases,&quot; BCS reported &quot;this short boom in lower
court terminations is over. The number of felony complaints
terminated in lower courts in 1972 increased about 2000, or only
4 percent Over 1971 . The leveling-off of lower court
terminations in 1972 may indicate that the use of P.C. Section
17b5... has -reached its full potential.&quot; (Source 3e.,
p.36). </p>

<p>Another problem presented itself when 1972 dispositions were
examined. Of the 41,927 marijuana complaints filed in 1972, 8,884
were processed as felonies in Superior Court and 12,346 as
misdemeanors in lower courts leaving a serious lacuna of some
20,697 complaints unaccounted for in the BCS record books. The
apparent leveling off of enforcement costs at about $100 million
a year might as easily be the result of not having information on
the dispositions of 49 percent of the complaints filed, as of
hypothetical savings from the use of P.C. Section 17 (Source la,
pp. 101, 117). </p>

<p>In SUM, the &quot;Wobbler&quot; and P.C. Section 17 were
political compromises of limited Success. Their main effect was
to contain enforcement costs which would have been appreciably
higher without them. By allowing most -felony marijuana
possession cases to be processed in lower Courts without actually
taking possession out of the felony category, congestion in the
superior courts was reduced, with concomitant fiscal savings. </p>

<p>On the Other hand, as superior courts handled fewer (marijuana
cases, lower courts handled many more than they had in the past,
and lower-court costs began increasing as the number of marijuana
arrests continued to rise. It became evident that simply
re-shuffling offenders from superior to lower courts could
mitigate, but would not solve, the cost problem. </p>

<p>As shown in Table 6 and graph COST6072, the costs Of marijuana
law enforcement rose from about $8 million in 1960 to $100
million in 1972. It cost California taxpayers about $577 million
to punish about 400,000 people between 1960 and 1972, an average
$44.4 million a year. These estimates are conservative because
they do not include costs of many adult dispositions or any
juvenile dispositions (Source la, p.113). </p>

<p>Marijuana arrests increased tenfold between 1962 and 1967,
while enforcement costs increased ninefold (Table 6). For the
entire thirteen-year period from 1960 to 1972, marijuana arrests
increased 1385 percent, while-, enforcement costs increased 1090
percent (Table 6). </p>

<p>And what was the result of these massive Cost increases? The
Depar tment of Corrections informed the Moscone Committee that as
of December- 31, 1973, there were 621 felons in state prison
whose most serious commitment offense was violation of some law
pertaining to marijuana. In Addition, there were 858 marijuana
offenders on parole as of that date (Source la., p.109). </p>

<p>Thus Californians were spending $100 million a year to put
about 1500 people in prison or on parole. This comes to more than
$66,000 for each convicted adult felony offender. </p>

<p>One clear fact emerged from the weight of evidence presented
to the Moscone Committee: despite all attempts to reduce them,
the -fiscal costs of marijuana law enforcement continued to
increase slightly or suddenly, year after year. </p>

<p>TABLE 6. CALIFORNIA MARIJUANA LAW ENFORCEMENT COSTS, 1960-72 </p>

<hr>

<pre>
YEAR      MJ ARRESTS COST OF ENFORCEMENT SOURCE/UNIT COSTS RELEVANT LAWS
1960	5,155	$ 3,402,650	Calof- $1630	All arrests,
1961	3,794	6,184,220		prosecution,
1962	3,743	6,101,090		commitments
1963	5,518	8,994,340		handled as
1964	7,560	12,322,800		felonies.
1965	10,002	16,303,260		Avg. cost per
1966	18,243	29,147,418		arrest, $1630
1967	37,514	61,147,820		disp., $2100.
1968	50,327	$ 72,074,860	Kaplan    $1432	&quot;Wobbler&quot; and
1969	55,176	43,100,000	McGlothlin .- $ 7 8 1	P.C. Sec. 17:
1970	69,021	106,028,968	Mikuriya- $1536	Avg. cost/arr
1971	64,597	106,859,808	Extrapol-- $1654	1968-72 $1356
1972	76,561	100,000,000	Aldrich- $1306	1969-72 $1342
</pre>

<hr>

<pre>
TOTAL 407,211 577,303,234   Avg. $1417.70 or $44,407,941/yr.
</pre>

<hr>

<p>Source-. Moscone Report (Source la), p. 117. </p>

<h2>SOURCES</h2>

<p>(Moscone Report) California Senate Select Committee on Control
of Marijuana (George Moscone, Chairman), Final Report, Marijuana:
Beyond Misunderstanding. Sacramento, May 1974. </p>

<p>la. Michael R. Aldrich, Ph.D., &quot;Fiscal Costs of
California Marijuana Law Enforcement,&quot; Chapter 8, pp.
97-118. The quote from A. Alan Post is on page 97. </p>

<p>lb. Tod H. Mikuriya, M.D., Barbara Schneider, Michael R.
Aldrich, and Gordon Brownell, &quot;Selected California
Statistics Concerning the Enforcement of Marijuana Laws ...
February 13, 1974.&quot; An appendix to the Moscone Report. </p>

<p>1c. Michael R. Aldrich, Barbara Schneider, Tod H. Mikuriya,
M.D., and Gordon Brownell, &quot;Costs of California Marijuana
Law </p>

<p>Enforcement: A Preliminary Study.&quot; Appendix, 7pp. </p>

<p>Id. Michael R. Aldrich, &quot;Previous Marijuana Enforcement
Cost Estimates,&quot; February, 1974. Appendix, 4pp. </p>

<p>le. Michael R. Aldrich, &quot;Legislative and Reporting-System
Changes </p>

<p>Relevant to Statistics on Cost of En-forcing California
Marijuana Laws,&quot; Feb. 1974. Appendix, 5pp. </p>

<p>2. Drug Arrests and Dispositions in California. Sacramento:
Bureau of </p>

<p>Criminal Statistics. Usually published a year after, date. </p>

<p>2a. D.A.D. 1968. 2b. D.A.D. 1969. 2c. D.A.D. 1970. </p>

<p>2d. D.A.D. 1971. 2e. D.A.D. 1972. </p>

<p>3. Crime and Delinquency in California. Sacramento: Bureau of
Criminal </p>

<p>Statistics. Usually published a year after date. </p>

<p>3a. CD 1968. 3b. CD 1969. 3c. CD 1970. </p>

<p>3d. CD 1971. 3e. CD 1972. </p>

<p>4. John Kaplan, Marijuana-- The New Prohibition. New York and
Cleveland: World Publishing Cc.., 1970, pp.29-30. For a full
discussion of the processing of Marijuana offenders through the
stages of the criminal justice system, see &quot;Marijuana Laws:
An Empirical Study of Enforcement and Administration in Los
Angeles County,&quot; UCLA Law Review 15 (1968), pp. 1499-1582. </p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-52</DOCNO>
<DOCOLDNO>IA087-000627-B012-335</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/moscone/chap3.htm 206.61.184.43 19970122050356 text/html 14362
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:03:45 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:57:21 GMT
Content-length: 14144
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Legislative Changes in California Marijuana Laws in the
1970S </title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_hemp_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->

<p><font size="5">A Fiscal Analysis of Marijuana
Decriminalization</font></p>

<p><b>CHAPTER III</b> </p>

<h1><a name="OLE_LINK2">LEGISLATIVE CHANGES IN CALIFORNIA
MARIJUANA LAWS IN 1970S</a></h1>

<p><img src="blueline.gif" width="562" height="19"> </p>

<h2>I. 1972: Prelude to Decriminalization </h2>

<p>Following the enactment of The Wobbler and the revisions in
Section 17 of the Penal Code, California's marijuana laws were to
remain unchanged until 1972, when certain events occurring
outside of the Legislature heralded the beginning of a
noncriminal approach to marijuana possession and use in the
state. </p>

<p>The first external force to impact upon the Legislature was
the Final Report of the National Commission on Marijuana and
Health, appointed by President Nixon to study all aspects of
marijuana in American society and to recommend public policy
approaches and guidelines. The Commission was A conservative body
of thirteen members, nine of whom were appointed by the President
and two each by the U.S. Senate and House of Representatives, and
it was widely assumed that the Commission would reinforce and
rubber-stamp the harsh &quot;War on Drugs&quot; approach toward
marijuana and drug use which the White House had been advocating.
Thus, the Commission's Final Report made headlines across the
country when it recommended decriminalizing marijuana possession
and use. </p>

<p>Decriminalization was a term essentially coined and
popularized by the National Commission. Decriminalization
entailed a public policy of discouragement of marijuana use,. by
keeping cultivation, sale and other non-possessory offenses
illegal, while removing criminal penalties for simple use and
possession of the substance. In essence, it aimed at eliminating
the harsh social consequences brought about by labeling marijuana
users &quot;criminal&quot; while concentrating the resources and
sanctions of the criminal law on commercial traffickers. The
report of the National Commission was to become the Bible of the
marijuana law reform movement for the remainder of the '70s. </p>

<p>The second major event to force a re-examination by the
Legislature of the state's marijuana laws was the 1972 California
Marijuana Initiative, which appeared on the November ballot that
year as Proposition 19. Founded by Foster City attorney Leo
Paoli, Proposition 19 was a measure which proposed totally
removing criminal penalties for the adult possession and
cultivation of marijuana for personal use. Though defeated, the
measure garnered 34% of the vote and provided new impetus for
legislative efforts to repeal felony penalties for marijuana
possession. </p>

<p>Significantly, the California Legislature passed two major
bills in 1972 affecting marijuana penalties, both of which were
clearly influenced by the statewide demonstration for marijuana
law reform symbolized by Proposition 19. </p>

<p>The first, Penal Code 1000, commonly known as the &quot;drug
diversion program,&quot; was sponsored by, among others,
then-State Senator George Deukmejian, in order to provide a
mechanism for diverting first-offenders from the criminal justice
system. Under P.C. 1000, individuals charged with various drug
possession offenses could have all criminal charges against them
dismissed, provided they agreed to participate in a drug
education and/or treatment program. Supported by liberals and
conservatives alike, the drug diversion bill was signed into law
by Governor Ronald Reagan. </p>

<p>Also passing the Legislature in late 1972, following the vote
on Proposition 19, was a bill sponsored by Beverly Hills
Assemblyman Alan Sieroty which would have repealed the wobbler
and made possession of marijuana for personal use a straight
misdemeanor. The Sieroty bill was vetoed by Governor Reagan.
Another Sieroty misdemeanor bill passed both houses of the
Legislature in 1974, but was also vetoed by Governor Reagan. </p>

<p>The impact of Proposition 19 was also noticed by Senate
Democratic leader George R. Moscone, who represented San
Francisco, which was the only county to pass Proposition 19.
Recognizing that a penalty reduction bill had no chance of
enactment as long as Ronald Reagan was governor, Senator Moscone
instead proposed the appointment of a state commission, analogous
to the National Commission on Marijuana and Health, to study
California's marijuana laws and recommend appropriate public
policy changes. Originally proposed as a state commission,
Moscone realized that Governor Reagan would be able to block the
formation of such a commission. Thus came into being,
alternatively, the California Senate Select Committee on the
Control of Marijuana. </p>

<p>The Select Committee, commonly referred to as the Moscone
Committee after its chairman, conducted the first major study
into marijuana law enforcement in the state, with particular
emphasis on the social and fiscal costs of the laws. Among its
findings were the facts that in the early 1970s, statewide
marijuana arrests were approaching almost 100,000 annually, with
enforcement costs averaging well over $100,000 million per year. </p>

<p>Finding that the overwhelming majority of marijuana offenses
(approximately 90%) were for simple possession, the Moscone
Committee recommended in its Final Report a serious re-ordering
of law enforcement priorities by the Legislature. The Final
Report of the Select Committee noted that: </p>

<p>&quot;The marijuana laws as they pertain to simple possession
for private adult use should be amended to abolish the felony
offense. The Legislature should adopt a program of
decriminalization, making simple possession of marijuana for
private adult use an infraction, if anything.&quot; </p>

<h2>1975: Enactment of Senate Bill 95</h2>

<p>Following an unsuccessful attempt in 1974 to implement the
decriminalization recommendations of the Select Committee, which
was essentially a &quot;trial run&quot; with no expectation of
actual success, Senator Moscone introduced Senate Bill 95 which
was heard and enacted by the Legislature in 1975. This bill was
signed into law on July 9, 1975 by Governor Edmund G. Brown, Jr.,
making California the fifth state (out of an eventual total of
eleven) to end the arrest and jailing of persons charged with
possession of small amounts of marijuana for personal use. </p>

<p>As originally introduced, S.B. 95 would have made possession
of not more than three ounces of marijuana an infraction,
punishable by a maximum fine of $100.00. There was political
resistance, however, to both the three-ounce standard and also to
labeling the offense an infraction, which opponents of S.B. 95
contended sent too &quot;permissive&quot; a message to the
public. The bill was therefore amended by the author in the
Senate Judiciary Committee to make possession of one ounce or
less a citable misdemeanor, rather than an infraction, in order
to split law enforcement opposition to the bill and pick up the
necessary votes to pass the measure out of committee. </p>

<p>The amendment changing the offense from an infraction to a
misdemeanor resulted in a change of label more than anything
else, in that an infraction was also a crime in California, and
S.B. 95 created essentially a new category of low misdemeanor
which was sui generis and was treated like an infraction in all
critical respects. Possession of an ounce or less became a
mandatory citable misdemeanor offense, punishable by fine only,
not to exceed $100.00, -with no arrest, booking or jail. </p>

<p>Under S.B. 95, possession of more than one ounce of marijuana
also became a misdemeanor, punishable by imprisonment in the
county jail for not more than six months, by a fine of not more
than $500.00, or by both such fine and imprisonment. In such
instances, the arresting officer has the discretion of either
issuing a citation or taking the defendant into custody. </p>

<p>S.B. 95 also revised the penalties for both furnishing without
consideration and transporting not more than one ounce of
marijuana, treating such offenses as simple possession, rather
than as felonies. Giving away or transporting more than one ounce
of marijuana, as well as cultivation, sale and possession of-any
amount with intention to sell remained as felonies under S.B. 95.
</p>

<p>Prior California law did not distinguish among various forms
of marijuana based on form or potency, treating the natural
cannabis plant, synthetic THC and hashish as the same substance.
S. B. 95 distinguished between &quot;marijuana&quot; and
&quot;concentrated cannabis&quot;, the latter referring to the
separated resin, whether crude or purified, obtained from
marijuana. As to concentrated cannabis, essentially hashish or
hash oil, the prior wobbler penalties remain in effect. This
legislative distinction was brought about by law enforcement
opposition to eliminating felony penalties for possession of
hashish or hash oil. </p>

<p>One of the critical reforms embodied in S.B. 95, which
resulted directly from the legislative &quot;trade-off&quot;
which came about when the bill was amended to make possession of
small amounts of marijuana a citable misdemeanor rather than an
infraction, was a new record.-purging provision unlike anything
in existing California law. This provision ended the prospect of
life-long criminal records for individuals arrested and/or
convicted of marijuana possession and other marijuana misdemeanor
offenses and contained retroactive provisions for offenses
occurring prior to January 1, 1976, when S.B. 95 took effect. </p>

<p>Under these provisions as later amended S.B. 95 required the
destruction of records of any court or public agency pertaining
to an arrest or conviction for possessing marijuana, other than
concentrated cannabis, or for giving away or transporting not
more than one ounce of ordinary marijuana where the arrest and/or
conviction occurred after January 1, 1976, in which case such
records could not be kept beyond two years from the date of
conviction, or from the date of arrest if there was no
conviction. No civil or collateral disabilities or penalties
could attach to an individual as a result of a prior marijuana
misdemeanor offense, once the records are destroyed or two years
had passed. </p>

<p>The penalty provisions of S.B. 95 are non-recidivist, in that
repeat offenders are not subject to any greater penalties than
first offenders. S.B. 95 provided, however, that individuals
convicted more than three times within a two year period shall be
subject to the provisions of P.C. Section 1000.1 and 1000.2 (the
drug diversion program). No jail penalties or increased fines can
be assessed against repeat offenders. </p>

<p>In summary, in addition to repealing various minor marijuana
offenses, S.B. 95 adopted six major forms affecting California's
marijuana laws, which together have had a major impact on the
fiscal costs of marijuana law enforcement in the state and in
reducing the legal, social and fiscal costs of marijuana law
enforcement: </p>

<ol>
    <li>No arrest or booking for individuals apprehended in
        possession of small amounts of marijuana; </li>
</ol>

<ol>
    <li>No jail or incarceration for persons convicted of
        possession of small amounts of marijuana; </li>
    <li>Furnishing of small amount of marijuana for no
        consideration is treated as simple possession, not sale; </li>
    <li>Transportation of small amounts of marijuana is treated
        as simple possession, not felony transportation; </li>
    <li>Elimination of life-long criminal records for marijuana
        possession arrests and convictions, and placing a
        two-year limit on the retention of such records and the
        use of such records. against individuals arrested and
        convicted of specified offenses; </li>
    <li>Abolition of recidivist penalties for simple possession,
        giving and away and transporting small amounts of
        marijuana. </li>
</ol>

<p>The actual fiscal savings brought about by S.B. 95, and the
impact which this reform legislation has had on California's
criminal justice system, have been dramatic, as evidenced by the
analysis set forth in this study. </p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-53</DOCNO>
<DOCOLDNO>IA087-000627-B013-25</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/moscone/chap4.htm 206.61.184.43 19970122050442 text/html 11392
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:04:33 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:57:16 GMT
Content-length: 11174
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Marijuana Arrest Costs 1972-1984</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_hemp_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->

<p><font size="5">A Fiscal Analysis of Marijuana
Decriminalization</font></p>

<p><b>CHAPTER IV. </b></p>

<h1>MARIJUANA ARREST COSTS 1972-1984</h1>

<p><img src="blueline.gif" width="562" height="19"> </p>

<p>The following graph (Source: MJSPRD) shows at a-glance the
effect of the Moscone Act on marijuana arrests. Felony marijuana
arrests fell by about 80,000, from nearly 100,000 in 1974 to less
than 20,000 in 1976. Misdemeanor marijuana arrests were not
recorded between 1972 and 1977, but leaped tenfold from about
3,500 in 1972 to 35,424 in 1978. By 1984, total marijuana arrests
were leveling off at below 64,000 a year, so the cumulative
effect of the Moscone Act was to reduce total marijuana arrests
by at least 36,000 a year. </p>

<p><img src="mjfm6084.gif" width="374" height="370"> </p>

<h2>EFFECT OF THE MOSCONE ACT ON MARIJUANA ARRESTS</h2>

<p>In 1974 felony marijuana arrests peaked at nearly 100,000
(99,597), representing about one-fourth (24.75 percent) of the
felony arrests in the state (Table 7) and over two-thirds (69.21
percent) of the state's felony drug arrests (line 41 MJSPRD).
This was the situation the Moscone Act was designed to alleviate.
</p>

<p>The Moscone Act had an effect even before it officially went
into effect on January 1, 1976. Its immediate effect upon passage
in July 1975 was to reduce the number of felony marijuana arrests
by 13,840 from their 1974 level, and by another whopping 66,473
arrests in 1976. In two years felony marijuana arrests dropped
from nearly 100,000 to fewer than 20,000 (Table 7). </p>

<p>This caused 1976 statewide felony arrests to fall
precipitously by about 75,OOO from their 1974 level (Table 7). </p>

<p>That is, felony marijuana arrests fell from 25 percent of
statewide felony arrests in 1974 to a mere 6 percent in 1976
(line 43 MJSPRD), and from 7.22 percent of total
felony-misdemeanor arrests in 1974 to only 1.41 percent in 1976
(Table 7). </p>

<p>The reduction of felony marijuana arrests was permanent and
remains the most important effect of the Moscone Act. Felony
marijuana arrests crept past 20,000 in 19809 and have leveled off
at about 21,000 a year since then (Table 7). </p>

<p>This loss of about 80,000 felony marijuana ay-rests each year
from 1976 to 1984 represents a considerable savings to the
taxpayer. Cumulatively, it means that about 720,000 felony
arrests and dispositions did not have to be paid for during the
nine-year period. </p>

<p>TABLE 7. CALIFORNIA MARIJUANA ARRESTS 1972-84 </p>

<hr>

<p>MJSPRD LINE 54 42 39 55 43 45 51 </p>

<hr>

<pre>
YEAR F-M ARRESTS FEL.ARR. FEL.MJ %MJFMA %FMJFA MISD.MJ TOTAL MJ 
</pre>

<hr>

<pre>
1972 1154325 344762 73061 6.63 21.19 Est.3500 76561
1973 1280177 358024 Betio 6.88 f 24.61 n/a n/a
1974 1380204 402421 99597 7.22 f 24.75 n/a n/a
1975 1353720 393658 85757 6.33 f 21.78 n/a n/a
1976 1366988 327535 19284 1.41 f 5.89 n/a n/a
1977 1410587 327215 17262 1.22 f 5.28 n/a n/a
1978 1399724 334647 17397 3.77 5.20 35424 52821
1979 1460608 357632 19263 3.56 5.39 32796 52059
1980 1561658 372190 20509 3.76 5.51 38270 58779
1981 1666569 386195 20771 3.87 5.38 43791 64562
1982 1658240 386995 20737 3.84 5.36 42904 63641
1983 1668027 373609 19920 3.82 5.33 43803 63723
1984 1697231 384861 21350 3.75 5.55 42219 63569
</pre>

<hr>

<p>Source: MJSPRD and its sources. </p>

<p>135) The other major effect of the Moscone Act was to increase
the number of misdemeanor marijuana arrests, though the exact
amount of the increase cannot be ascertained because misdemeanor
marijuana arrests were not recorded in the base year period
(1972-77). It is also difficult to know precisely what
misdemeanor marijuana arrests were recorded from 1978 onwards,
because the Moscone Act allows the issuance of a citation for
possession offenses and the offender need not appear at the
police station or in court where the arrest would be recorded
(see Chapter III). </p>

<p>However, with the available information it can be stated that
the overall effect of the Moscone Act was to reduce total
marijuana arrests by at least 36,000 a year. This is based on the
fact that in 1974 there were about 100,000 felony marijuana
arrests, plus an unknown number of misdemeanor arrests, while in
1984 there were 21,350 felony marijuana arrests, plus 42,219
misdemeanor marijuana arrests, for a total of 63,569 marijuana
arrests (Table 7). 100,000 felony arrests minus 63,500 total
arrests indicates a reduction of at least 36,413 arrests each
year. </p>

<h2>EFFECT OF THE MOSCONE ACT ON MARIJUANA ARREST COSTS</h2>

<p>Table 8 below summarizes the ARRCOST file appended to this
report. The A. Alan Post method (see Chapter II) was used to
calculate actual marijuana arrest expenditures, and the State and
Local Government implicit Price Deflator (see INFLATE appendix)
was used to adjust for inflation. </p>

<p>TABLE S. MARIJUANA ARREST COSTS 1972-84 </p>

<hr>

<pre>
FISCAL NUMBER ACTUAL MJ ARR. COST PER INFLATION-ADJ. IA COST/ 
YEAR MJ ARR. EXPENDITURES MJ ARREST EXPENDITURES MJ ARREST 
</pre>

<hr>

<pre>
71/72 76,561 $13,220,270 $172.66 $15,214,567 $ 198.72
72/73 88,110 fel $15,540,785 $176.38 $17,374,438 $197.19
73/74 99,597 fel $18,380,911 $184.55 $18,380,911 $184.55
74/75 85,757 fel $18,368,236 $214.19 $14,335,488 $167.16
75/76 19,284 fel $ 4,526,727 $234.74 $ 3,772,119 $195.61
76/77 179262 fel $ 4,324,924 $250.55 $ 3,381,480 $195.89
77/78 52,821 $14,887,136 $281.84 $10,835,750 $205.14
78/79 52,059 $14,787,243 $284.05 $ 9,937,320 $190.89
79/80 58,779 $19,352,917 $329.25 $11,858,474 $201.75
80/8l 64,562 $23,228,001 $359.78 $12,991,204 $201.22
81/82 63,641 $26,318,198 $413.54 $13,651,710 $214.51
82/83 63,723 $28,473,506 $446.83 $13,847,971 $217.32
83/84 63,569 $30,528,638 $480.24 $13,979,108 $219.90
</pre>

<hr>

<p>Source: MJSPRD, ARRCOST and INFLATE appendices. </p>

<p>For the years immediately surrounding the Moscone Act
(1973-77), including the base year 1974, misdemeanor marijuana
arrest statistics are not available and the cost of making felony
marijuana arrests is shown in Table 8 for those years. If
misdemeanor arrests were included, the total arrests and total
expenditures would be higher for those years, but the cost per
arrest would probably be lower. </p>

<p>Between 1972 and 1984, actual expenditures for marijuana
arrests rose 131 percent, from $13.2 million in 1972 to $30.5
million in 1984 (Table B). Let's look at that in two periods, the
short-term effect through 1979 and the long-term effect through
1984. </p>

<p>The immediate effect of the Moscone Act was to reduce total
marijuana arrests (felony and misdemeanor combined) from over
100,000 in 1974 to about 52,000 in 1979. As a result, actual
marijuana arrest expenditures were held to approximately $14.8
million in fiscal 1978/79, a bit lower than their fiscal 1972/73
levels (Table 8). </p>

<p>The 1979 cost of $284.05 per marijuana arrest compares with
1974's $184.55 figure. However, in 1974 dollars the 1979 cost per
arrest was only $190.89. Thus, when adjusted for inflation, a
major result of the Moscone Act was a mere $6.34 increase in the
cost per arrest (Table 8). </p>

<p>This means that during a time when statewide law enforcement
costs in general were rising sharply due to inflation increasing
arrest volume, and other factors, the Moscone Act held the line
on marijuana arrest costs. To be precise, it was the best
cost-containment measure passed by the Legislature in the 1970s:
the same containment of actual and inflation adjusted
expenditures cannot be discerned for any other type of crime. </p>

<p>The 1984 cost per marijuana arrest was $480.24, compared with
$172.68 in 1972 and $184.55 in 1974. This is a 178 percent rise
in expenditures per marijuana arrest since 19729 caused by
reducing the number of marijuana arrests while law enforcement
costs in general continued to rise (Table 8). </p>

<p>However, when adjusted for inflation and expressed in 1974
dollars, the cost of marijuana arrests in 1984 was $13,979,105
(line 13) or $219.90 per arrest. This is only slightly higher
than the $13,220,270 spent on marijuana arrests in 1972, and is
24 percent lower than the $18,380,911 spent in the base fiscal
year 1973/74. </p>

<p>Thus the net effect of the Moscone Act was to reduce inflation
adjusted marijuana arrest expenditures by 24 percent from 1974 to
1984, and to contain marijuana arrest costs at just above their
1972 level. Again, there is no other crime in the state for which
this can be said. </p>

<p>Nevertheless, actual expenditures for marijuana arrests have
been rising steadily in the Eighties, from about $20 million in
1980 to over $30 million in 1984. Total marijuana arrests seem to
have leveled off at about 639000 a year, but expenditures keep
rising due to inflation and generally increased law enforcement
costs. </p>

<p>In sum, it costs the taxpayers an average of about $500 every
time someone is arrested for marijuana in California, regardless
of whether that is a felony or misdemeanor arrest. This figure
includes only the cost of making an arrest, not the cost of
processing the offender later. This cost per marijuana arrest can
be expected to continue to rise. </p>

<p><img src="fig4_1.gif" width="381" height="321"> </p>

<p><img src="fig4_2.gif" width="409" height="373"> </p>

<hr>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-54</DOCNO>
<DOCOLDNO>IA087-000627-B013-66</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/moscone/chap5.htm 206.61.184.43 19970122050547 text/html 26110
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:05:18 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:57:11 GMT
Content-length: 25892
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Adult Felony Marijuana Dispositions</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_hemp_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->

<p><font size="5">A Fiscal Analysis of Marijuana
Decriminalization</font></p>

<h1>CHAPTER V. ADULT FELONY MARIJUANA DISPOSITIONS</h1>

<p>&nbsp;</p>

<hr>

<p>The following graph clearly shows the buildup of marijuana
cases in California's superior and lower Courts until 1977, when
the Moscone Act, in tandem with Penal Code Section 17, and PC
1000, took marijuana possession dispositions out of the court
system. </p>

<p><img src="fig5_1.gif" width="367" height="348"> </p>

<p><img src="fig5_1a.gif" width="407" height="67"> </p>

<p>This part of our report is far from complete. The Bureau of
Criminal Statistics has provided us with adult felony marijuana
disposition data for the years 1976 to 1984, which is presented
here. 'There is no data available on adult misdemeanor
dispositions, and the juvenile disposition data is limited. </p>

<p>The adult felony marijuana dispositions are collected by a
system known as OBTS-- the Offender Based Transaction Statistics
program, which has been on line in California since 1978. Before
that, the information is less than complete because some counties
weren't using OBTS yet. </p>

<p>Even the OBTS data, however, is thought to be about 30 percent
underreported. This applies to all adult felony dispositions
including those for felony marijuana offenders. Despite this, it
is possible to calculate the costs of these dispositions by using
the percentage of all dispositions which were for marijuana
instead of the raw figures themselves. </p>

<p>The other figures needed for this calculation are Accurate,
across the board Court expenditures including direct trial costs
and other court related expenditures. Only the California
Judicial Council collects this information in combined form, and
that has only been in the last few years. We have used this
information to determine an approximate court-cost per adult
felony marijuana disposition for fiscal years 1982/83 and
1983/84. </p>

<p>The data collected by the Bureau of Criminal Statistics
divides these expenditures into Court costs (for Superior,
Municipal, and Justice courts) and &quot;Court-Related
Costs&quot; which are not divided by court. This makes it hard to
assign court-related costs to superior or lower court, and we're
still reforming on a method by which to do this. Then we will be
able to ascertain total Court expenditures on marijuana
dispositions for other years. </p>

<p>In the DISPTREE charts on the -following three pages, the
-figures used determine court costs are those in lines 8 and 39,
because those are the dispositions that made it into a court.
Line 1, the total adult felony marijuana dispositions, includes
those released by the police (line 2), those that were turned
over to another jurisdiction (line 3), those on whom a complaint
was requested by a prosecutor (line 4), and those whose complaint
was denied by a Court (line 5). </p>

<p>Since only those on whom a complaint was filed (line 6) made
it into courts it is accurate to use only the actual court
dispositions (lines 8 and 39) in computing Court Costs. However,
this does not include the costs of police dispositions,
prosecutors, or public de-fenders. </p>

<p>Actual court expenditures on adult felony marijuana
dispositions were approximately 16.4 million dollars in fiscal
1992/83, and approximately $18.6 million in fiscal 1983/84. This
works out to a Superior Court cost of $2112 per marijuana case, a
Lower Court cost of $1491 per marijuana case, and a combined
average cost of $1701 per marijuana case. </p>

<p>Inflation-adjusted expenditures have -riot been calculated
yet. </p>

<p>132) DISPTREE OBTS ADULT FELONY MARIJUANA DISPOSITIONS,
1976-1984 </p>

<p>1976 % 1977 % 1978 % </p>

<p>1. TOTAL AD.FEL.MJ. DISPOSITIONS 8862 100 19317 100 8201 100 </p>

<p>2. Released by Police 255 2.9 254 1.3 377 4.6 </p>

<p>3. Indictments/ Warrants (SC/LC) 592 6.7 350 1.8 498 6.1 </p>

<p>4. COMPLAINT Requested (Pros.) 8015 90.4 18713 96.9 7326 89.3 </p>

<p>5. Complaint Denied 1239 14.0 1401 7.3 1243 15.2 </p>

<p>6. COMPLAINT GRANTED (To L.C.) 6776 76.5 17312 89.6 6083 74.2 </p>

<p>7. </p>

<p>5. LOWER COURT DISPOSITIONS 7293 82.3 17602 91.1 6526 79.6 </p>

<p>9. MISDEMEANOR Complaints 4097 46.2 13841 71.6 3337 40.7 </p>

<p>10. Not Convicted 1863 21.0 8102 41.9 1328 16.2 </p>

<p>11. Dismissed 1850 20.9 8025 41.5 1319 16.1 </p>

<p>12. Acquitted 12 0.1 75 0.4 9 0.1 </p>

<p>13. Juv. Court 1 0.0 2 0.0 0 0 </p>

<p>14. CONVICTED (Misd.) 2234 25.2 5738 29.7 2009 24.5 </p>

<p>15. Guilty Plea (Misd.) 2103 23.7 5449 28.2 1858 22.7 </p>

<p>16. CYA 0 0 2 0.0 0 0 </p>

<p>17. Probation 631 7.1 1835 9.5 535 6.5 </p>

<p>18. Prob. w/ Jail 280 3.2 603 3.1 287 3.5 </p>

<p>19. Jail 276 3.1 642 3.3 253 3.1 </p>

<p>20. Fine 1008 11.4 2480 12.8 920 11.2 </p>

<p>21. Other 39 0.4 176 0.9 14 0.2 </p>

<p>22. FELONY Complaints 3196 36.1 3762 19.5 3189 38.9 </p>

<p>23. Not convicted 1008 11.4 1119 5.8 1109 13.5 </p>

<p>24. Dismissed 998 11.3 1110 5.7 1108 13.5 </p>

<p>25. Acquitted 9 0.1 a 0.0 1 0.0 </p>

<p>26. JUV. Court 2 0.0 1 0.0 0 0 </p>

<p>27. CONVICTED (Fel.) 705 8.0 795 4.1 725 8.8 </p>

<p>28. Guilty Plea (Fel.) 678 7.7 763 3.9 674 19.2 </p>

<p>29. CYA 0 0 0 0 0 0 </p>

<p>30. Probation 241 2.7 333 1.7 266 3.2 </p>

<p>31. Prob. w/ Jail 244 2.8 222 1.1 252 3.1 </p>

<p>32. Jail 86 1.0 68 0.4 SC) 1.0 </p>

<p>33. Fine 130 1.5 159 0.8 126 1.5 </p>

<p>34. Other 4 0 13 0.1 1 0.0 </p>

<p>35. To Superior Court 1483 16.7 1848 9.6 1355 16.5 </p>

<p>36. Held to Answer 1352 15.3 1662 8.6 1214 14.8 </p>

<p>37. Guilty Plea (S.C.) 131 1.5 186 1.0 141 1.7 </p>

<p>38. </p>

<p>39. SUPERIOR COURT DISPOSITIONS 1558 17.6 1907 9.9 1410 17.2 </p>

<p>40. Not Convicted 303 3.4 520 2.7 260 3.2 </p>

<p>41. Dismissed 284 3.2 484 2.5 236 2.9 </p>

<p>42. Acquitted 18 0.2 35 0.2 24 0.3 </p>

<p>43. Not guilty-Insane 0 0 0 0 0 0 </p>

<p>44. Juv. Court 1 0.0 1 0.0 0 0 </p>

<p>45. CONVICTED 1255 14.2 1387 7.2 1150 14.0 </p>

<p>46. Guilty Plea (inc. NG-To-G) 1013 11.4 1138 5.9 947 11.6 </p>

<p>47. Prison 59 0.7 49 0.3 42 0.5 </p>

<p>48. CYA 7 0.1 15 0.1 1 0.0 </p>

<p>49. Probation 376 4.2 458 2.4 326 4.0 </p>

<p>50. Probation w/ Jail 727 19.2 753 3.9 727 8.9 </p>

<p>51. Jail 38 0.4 39 0.2 27 0.3 </p>

<p>52. Fine 38 0.4 58 0.3 23 0.3 </p>

<p>53. CRC 10 0.1 10 0.1 3 0.0 </p>

<p>54. Other 0 0 2 0.0 1 0.0 </p>

<p>55. </p>

<p>56. TOTAL CONVICTIONS (14+27+45) 4497 50.7 7920 41.0 3884 47.4
</p>

<p>57. Total Guilty Pleas(15+28+46) 3794 42.8 7350 38.1 3479 42.4
</p>

<p>58. Total Incarcerated (18,19, 1710 19.3 2376 12.3 1668 20.3 </p>

<p>31,32,47,50,51) </p>

<p>NO Death sentences, NO not-guilty-insanity. I think line 46
includes line 37 </p>

<p>198) DISPTREE. OBTS ADULT FELONY MARIJUANA DISPOSITIONS,
1979-1981 </p>

<p>1979 % 1980 % 1981 % </p>

<p>1. TOTAL AD.FEL.MJ. DISPOSITIONS 9034 100 10889 100 11767 100 </p>

<p>2. Released by Police 598 6.6 809 7.4 933 7.9 </p>

<p>3. Indictments/ Warrants (SC/LC) 537 5.9 550 5.1 688 5.9 </p>

<p>4. COMPLAINT Requested (Pr-cis.) 7899 87.4 9530 87.5 10146
86.2 </p>

<p>5. Complaint Denied 1489 16.5 1873 17.2 2070 17.6 </p>

<p>6. COMPLAINT GRANTED (To L.C.) 6410 71.0 7657 70.3 8076 68.6 </p>

<p>7. </p>

<p>B. LOWER COURT DISPOSITIONS 6934 76.8 8200 75.3 8758 74.4 </p>

<p>9. MISDEMEANOR Complaints 3713 41.1 4277 39.3 3807 32.4 </p>

<p>10. Not Convicted 1395 15.4 1609 14.8 1363 11.6 </p>

<p>11. Dismissed 1375 15.2 1600 14.7 1353 11.5 </p>

<p>12. Acquitted 19 0.2 9 0.1 1.0 0.1 </p>

<p>13. Juv. Court 1 0.0 0 0 0 0 </p>

<p>14. CONVICTED (Misd.) 2318 25.7 2668 24.5 2444 20.8 </p>

<p>15. Guilty Plea (Misd.) 2139 23.7 2433 22.3 2205 18.7 </p>

<p>16. CYA 1 0.0 1 0.0 0 0 </p>

<p>17. Probation 614 6.8 714 6.6 721 6.1 </p>

<p>15. Prob. w/ Jail 398 4.4 464 4.3 388 3.3 </p>

<p>19. Jail 266 2.9 374 3.4 346 2.9 </p>

<p>20. Fine 998 11.0 1081 9.9 955 8.1 </p>

<p>21. Other 41 0.5 34 0.3 34 0.3 </p>

<p>22. FELONY Complaints 3221 35.7 3923 36.0 4951 42.1 </p>

<p>23. Not convicted 1012 11.2 1126 10.3 1379 11.7 </p>

<p>24. Dismissed 1007 11.1 1118 10.3 1377 11.7 </p>

<p>25. Acquitted 4 0.0 5 0.0 1 0.0 </p>

<p>26. JUV. Court 1 0.0 3 0.0 1 0.0 </p>

<p>27. CONVICTED (Fel.) 728 8.1 1025 9.4 1243 10.6 </p>

<p>28. Guilty Plea (Fel.) 674 7.5 956 8.8 1157 9.8 </p>

<p>29. CYA 0 0 0 0 0 0 </p>

<p>30. Probation 288 3.2 356 3.3 357 3.0 </p>

<p>31. Prob. w/ Jail 265 2.9 427 3.9 556 4.7 </p>

<p>32. Jail 82 0.9 98 0.9 141 1.2 </p>

<p>33. Fine Be 1.0 141 1.3 184 1.6 </p>

<p>34. Other 5 0.1 3 0.0 5 0.0 </p>

<p>35. To Superior Court 1481 16.4 1772 16.3 2329 19.8 </p>

<p>36. Held to Answer 1325 14.7 1465 13.5 1868 15.9 </p>

<p>37. Guilty Plea (S.C.) 156 1.7 307 2.8 461 3.9 </p>

<p>38. </p>

<p>39. SUPERIOR COURT DISPOSITIONS 1494 16.5 1779 16.3 2335 19.8 </p>

<p>40. Not Convicted 246 2.7 230 2.1 293 2.5 </p>

<p>41. Dismissed 229 2.5 202 1.9 283 2.4 </p>

<p>42. Acquitted 17 0.2 28 0.3 10 0.1 </p>

<p>43. Not guilty-Insane 0 0 0 0 0 0 </p>

<p>44. Juv. Court 0 0 0 0 0 0 </p>

<p>45. CONVICTED 1248 13.8 1549 14.2 2042 17.4 </p>

<p>46. Guilty Plea (inc. NG-To-G) 1014 11.2 1294 11.9 1739 14.8 </p>

<p>47. Prison 59 0.7 59 0.5 101 0.9 </p>

<p>48. CYA 3 0.0 12 0.1 15 0.2 </p>

<p>49. Probation 374 4.1 382 3.5 462 3.9 </p>

<p>50. Probation w/ Jail 751 8.3 1036 9.5 1388 11.8 </p>

<p>51. Jail 25 0.3 29 0.3 48 0.4 </p>

<p>52. Fine 35 0.4 28 0.3 21 0.2 </p>

<p>53. CRC 0 0 3 0.0 4 0.0 </p>

<p>54. Other (inc.MDSO) 1 0.0 0 0 0 0 </p>

<p>55. </p>

<p>56. TOTAL. CONVICTIONS (14+27+45) 4294 47.5 5242 48.1 5729
48.7 </p>

<p>57. Total Guilty Pleas(15+28+46) 3827 42.4 4683 43.0 5101 43.4
</p>

<p>58. Total Incarcerated (18,19, 1846 20.4 2487 22.8 2968 25.2 </p>

<p>31,32,47,50,51) </p>

<p>No Death sentences, No not-guilty-insanity. I think line 46
includes line 37 </p>

<p>Adfel MJ Complaints filed (12276) in CJP 79 p.61 differ a lot
from this data </p>

<p>264) DISPTREE. OBTS ADULT FELONY MARIJUANA DISPOSITIONS,
1982-84 </p>

<p>1982 % 1983 % 1984 % </p>

<p>1. TOTAL AD.FEL.MJ. DISPOSITIONS 12030 100 12332 100 11356 100
</p>

<p>2. Released by Police 644 5.4 568 4.6 580 5.1 </p>

<p>3. Indictments/ Wary-ants (SC/LC) 1 0.0 4 0.0 1 0.0 </p>

<p>4. COMPLAINT Requested (Pros.) 11385 94.6 11760 95.4 10775
94.9 </p>

<p>5. Complaint Denied 3552 29.5 4116 33.4 3522 31.0 </p>

<p>6. COMPLAINT GRANTED (To L.C.) 7833 65.1 7644 62.0 7253 63.9 </p>

<p>7. </p>

<p>B. LOWER COURT DISPOSITIONS 7833 65.1 7644 62.0 7253 63.9 </p>

<p>9. MISDEMEANOR Complaints 2548 21.2 1813 14.7 1279 11.3 </p>

<p>10. Not Convicted 1081 9.0 948 7.7 585 5.2 </p>

<p>11. Dismissed 10783 9.0 944 7.7 584 5.1 </p>

<p>12. Acquitted 3 0.0 2 0.0 1 0.0 </p>

<p>13. Juv. Court 0 0 2 0.0 0 0 </p>

<p>14. CONVICTED (Misd.) 1467 12.2 865 7.0 694 6.1 </p>

<p>15. Guilty Plea (Misd.) n/a n/a n/a </p>

<p>16. CYA 0 0 0 0 0 0 </p>

<p>17. Probation 496 4.1 304 2.5 238 2.1 </p>

<p>18. Prob. w/ Jail 410 3.4 298 2.4 258 2.3 </p>

<p>19. Jail 246 2.0 151 1.2 121 1.1 </p>

<p>20. Fine 305 2.5 103 0.8 74 0.7 </p>

<p>21. Other 10 0.1 9 0.1 3 0.0 </p>

<p>22. FELONY Complaints 5285 43.9 5831 47.3 5974 52.6 </p>

<p>23. Not convicted 1403 11.7 1479 12.0 1427 12.6 </p>

<p>24. Dismissed 1399 11.6 1471 11.9 1415 12.5 </p>

<p>25. Acquitted 3 0.0 4 0.0 4 0.0 </p>

<p>26. Juv. Court 1 0.0 4 0.0 4 0.0 </p>

<p>27. CONVICTED (Fel.) 1015 8.4 999 8.1 842 7.4 </p>

<p>2B. Guilty Plea (Fel.) n/a n/a n/a </p>

<p>29. CYA 0 0.0 0 0 0 0 </p>

<p>30. Probation 341 2.8 364 3.0 293 2.6 </p>

<p>31. Prob. w/ Jail 491 4.1 499 4.0 431 3.83 </p>

<p>32. Jail 116 1.0 115 0.9 92 0.88 </p>

<p>33. Fine 66 0.5 21 0.2 25 0.2 </p>

<p>34. Other 1 0.0 0 0 1 0.0 </p>

<p>35. To Superior Court 2867 23.8 3353 27.2 3705 32.6 </p>

<p>36. Held to Answer 2131 17.7 2241 18.2 2455 21.6 </p>

<p>37. Guilty Plea (S.C.) 736 6.1 1112 9.0 1250 11.0 </p>

<p>38. </p>

<p>39. SUPERIOR COURT DISPOSITIONS 2868 23.8 3357 27.2 3706 32.6 </p>

<p>40. Not Convicted 327 2.7 299 2.4 292 2.6 </p>

<p>41. Dismissed 299 2.5 272 2.2 278 2.4 </p>

<p>42. Acquitted 27 0.2 26 0.2 11 0.1 </p>

<p>43. Not guilty-Insane 0 0 0 0 0 0 </p>

<p>44. Juv. Court 1 0.0 1 0.0 3 0.0 </p>

<p>45. CONVICTED 2541 21.1 3058 24.8 3414 30.1 </p>

<p>46. Guilty Plea (inc. NG-To-G) n/a n/a n/a </p>

<p>47. Prison 106 0.9 134 1.1 221 1.9 </p>

<p>48. CYA 8 0.1 3 0.0 6 0.1 </p>

<p>49. Probation 577 4.8 698 5.7 607 5.3 </p>

<p>50. Probation w/ Jail 1753 14.6 2117 17.2 2503 22.0 </p>

<p>51. Jail 87 0.7 97 0.8 65 0.6 </p>

<p>52. Fine a 0.1 7 0.1 a 0.1 </p>

<p>53. CRC 2 0.0 2 0.0 2 0.0 </p>

<p>54. Other (inc.MDSO) 0 0 0 0 2 0.0 </p>

<p>55. </p>

<p>56. TOTAL CONVICTIONS (14+27+45) 5023 41.8 4922 39.9 4950 43.6
</p>

<p>57. Guilty Pleas(15+28+46) not available from OBTS TREES after
1982. </p>

<p>58. Total Incarcerated (18,19, 3209 26.7 3411 27.7 3691 32.5 </p>

<p>31,32,47,50,51) Note DROP in convictions, incarcerations. </p>

<p>No Death sentences, No not-guilty-insanity. Guilty pleas n/a
in OBTS trees. </p>

<p>334) COSTS OF ADULT FELONY MARIJUANA ARREST DISPOSITIONS,
1983-84 </p>

<p>The method used to calculate the costs of marijuana
dispositions relies on the time-weighting technique which the
Judicial Council of California uses to determine the number- of
judgeships needed in the state (Source la). This technique
recognizes the wide variance in judicial time needed to dispose
of different types of cases, and gives a much more accurate
picture of court dispositions than would be obtained from using
the raw numbers of dispositions. </p>

<p>In fiscal 1983/84, for example, there were 781,471 cases filed
in superior court. Of these, only about IC) percent (74,412) were
criminal cases. However, these criminal cases tool, up 33
per-cent of superior court time. For comparison juvenile
delinquency cases were also about IC) percent of filings, but
took up only 7 percent of superior court time because most were
sent to juvenile court (Source la!, pp. 105, 114). </p>

<p>With this in mind, the costs of felony marijuana dispositions
can be worked out by ascertaining the costs of criminal cases in
superior and lower courts, and then multiplying the result by the
percentage of those cases which were for marijuana. </p>

<p>The figures for court expenditures in fiscal 1982/83 and
1983/849 and the percentage of time spent on criminal cases, come
-from the annual reports of the California Judicial Council
(Source 1). However, the Council does not have specific
information on the number of marijuana dispositions processed
through the courts, and for this we must rely on Bureau of
Criminal Statistics data (Sources 2 and 3). </p>

<p>BCS can provide information on adult felony marijuana
dispositions back to 1976, and for comparability we will
therefore use BCS data on total adult felony arrest dispositions.
However, due to underreporting of disposition information to BCS,
only about 70 percent of adult felony dispositions are recorded
each year (Sources 2 and 3). And this does not include any adult
misdemeanor dispositions or juvenile dispositions. </p>

<p>Thus, we are comparing expenditures that are 100 percent
reported with dispositions that are only 70 percent reported. The
difficulty is mitigated somewhat by the fact that the percentages
of total adult felony dispositions which were for marijuana
(lines 6, 14 and 20 in the tables) would remain approximately the
same if the disposition information was reported 100 percent.
Since the calculation of marijuana expenditures relies on these
percentages rather than on the raw number of dispositions, the
result should be as accurate as possible with available
information. </p>

<p>In the lower courts, the categories of criminal cases which
include marijuana offenses are felony preliminary hearings,
felonies reduced to misdemeanors, and Group A misdemeanors. These
are the criminal cases used to determine the percentages of
Municipal court time in line 10. Justice Court percentages are
unavailable; by using Municipal Court percentages we have in
effect transferred the relatively few marijuana cases in Justice
Court into Municipal Court. </p>

<p>ADULT FELONY MARIJUANA DISPOSITION EXPENDITURES, l982/83 </p>

<p>1982/83 SUPERIOR COURT SOURCE </p>

<hr>

<p>1. S.C. Expenditures $314,800,000 lb, p. 52 </p>

<p>2. S.C. Criminal Case Time Percentage 33% lb, p.124 </p>

<p>3. S.C. Criminal Case Expenditures $103,884,000 (#I X #2) </p>

<p>4. S.C. Ad. Fel. Dispositions (83) 52,874 2, p. 13 </p>

<p>5. S.C. Ad. Fel. MJ Dispositions 3,357 3, p. 3 </p>

<p>6. S.C. % MJ of Ad. Fel. Dispositions 6.35% (#5 / #4) </p>

<p>7. S.C. Ad. Fel. MJ Disp. Expenditures $ 6,596,634 (#6 X #3) </p>

<p>5. S.C. Cost per Ad. Fel. MJ Disposition $1965.04 (#7 / #5) </p>

<p>1982/83 LOWER COURTS SOURCE </p>

<hr>

<p>9. L.C. Expenditures $263,100,000 lb, p. 52 </p>

<p>9a. Municipal Court Expenditures $245,200,000 lb, p. 52 </p>

<p>9b. Justice Court Expenditures $ 17,900,000 lb, p. 52 </p>

<p>10. M.C. Criminal Case Time Percentages* 45% (#10a + #10b) </p>

<p>l0a. M.C. Felony Cases 19% lbp p.157 </p>

<p>10b. M.C. Group A Misdemeanor Cases 26% lb, p.157 </p>

<p>11. L.C. Criminal Case Expenditures $118,395,000 (#I0 X #9) </p>

<p>Ila. L.C. Felony Expenditures $ 49,989,000 (#10a X #9) </p>

<p>Ilb. L.C. A-Misd Expenditures $ 68,406,000 (#10b X #9) </p>

<p>12. L.C. Ad. Fel. Dispositions (83) 92,063 2p p. 13 </p>

<p>13. L.C. Ad. Fel. MJ Dispositions (83) 7,644 3, P. 3 </p>

<p>13a. L.C. Felony MJ Complaints 5,831 3, p. 3 </p>

<p>13b. L.C. Misdem MJ Complaints 1,813 3, p. 3 </p>

<p>14. % MJ of L.C. Ad. Fel. Dispositions 88.30% (#13 / #12) </p>

<p>15. L.C. MJ Disposition Expenditures $ 9,826,785 (#14 X #11) </p>

<p>16. L.C. Cost per Ad. Fel. MJ Disposition $1285.56 (#15 / #13)
</p>

<p>Note: Only Municipal Court time-percentages are used here
because Justice </p>

<p>Court data is unavailable; the percentages should be
approximately equal. </p>

<p>1982/83 RECAPITULATION: SUPERIOR AND LOWER COURTS SOURCE </p>

<hr>

<p>17. SCLC Criminal Case Expenditures $222,279,000 (#3 + #11) </p>

<p>18. SCLC Ad. Fel. Dispositions (yr) 144,937 (#4 + #12) </p>

<p>19. SCLC Ad. Fel. MJ Dispositions 11,001 (#5 + #13) </p>

<p>20. % MJ of SCLC Ad. Fel. Dispositions 7.59% (#19 / #18) </p>

<p>21. SCLC Ad. Fel. MJ Disp. Expenditures $ 16,423,419 (#7 +
#15) </p>

<p>22. AVG SCLC Cost per Ad. Fel. MJ Disp. $1492.90 (#21 / #19) </p>

<p>ABBREVIATIONS USED </p>

<p>S.C. = Superior Court Mi = Marijuana Ad. Fel. = Adult Felony </p>

<p>L.C. = Lower Court AVG = Average Disp. = Disposition </p>

<p>M.C. = Municipal Court SCLC = Superior and Lower Courts
Combined </p>

<p>464) ADULT FELONY MARIJUANA DISPOSITION EXPENDITURES, 1983/84 </p>

<p>1983/84 SUPERIOR COURT SOURCE </p>

<hr>

<p>1. S.C. Expenditures $360,650,000 la, p. 48 </p>

<p>2. S.C. Criminal Case Time Percentage 33% la, p.114 </p>

<p>3. S.C. Criminal Case Expenditures $120,216,667 (#I X #2) </p>

<p>4. S.C. Ad. Fel. Dispositions (84) 56,963 2, p. 13 </p>

<p>5. S.C. Ad. Fel. MJ Dispositions 3,706 3, P. 3 </p>

<p>6. S.C. % MJ of Ad. Fel. Dispositions 6.51% (#5 / #4) </p>

<p>7. S.C. Ad. Fel. MJ Disp. Expenditures $ 7,826,105 (#6 X #3) </p>

<p>B. S.C. Cost per Ad. Fel. MJ Disposition $2111.74 (#7 / #5) </p>

<p>1983/84 LOWER COURTS SOURCE </p>

<hr>

<p>9. L.C. Expenditures $310,060,000 la, p. 48 </p>

<p>9a. Municipal Court Expenditures $289,510,000 la, p. 48 </p>

<p>9b. Justice Court Expenditures $ 20,550,000 la, p. 48 </p>

<p>IC). M.C. Criminal Case Time Percentages* 47% (#10a + #10b) </p>

<p>10a. M.C. Felony Cases 20% la, p.147 </p>

<p>10b. M.C. Group A Misdemeanor Cases 27% la, p.147 </p>

<p>11. L.C. Criminal Case Expenditures $145,728,200 (#10 X #9) </p>

<p>l1a. L.C. Felony Expenditures $ 62,012,000 (#10a X #9) </p>

<p>Ilb. L.C. A--Misd Expenditures $ 83,716,200 (#10b X #9) </p>

<p>12. L.C. Ad. Fel. Dispositions (84) 97,757 2, p. 13 </p>

<p>13. L.C. Ad. Fel. MJ Dispositions 7,253 3, p. 3 </p>

<p>13a. L.C. Felony MJ complaints 5,974 3, p. 3 </p>

<p>13b. L.C. Misdem MJ complaints 1,279 3, p. 3 </p>

<p>14. % MJ of L.C. Ad. Fel. Dispositions 7.42% (#13 / #12) </p>

<p>15. L.C. MJ Disposition Expenditures $ 10,813,032 (#14 X #11) </p>

<p>16. L.C. Cost per Ad. Fel. MJ Disposition $1490.84 (#15 / #13)
</p>

<p>*Note: Only Municipal Court time-percentages are used here
because Justice </p>

<p>Court data is unavailable; the percentages should be
approximately equal. </p>

<p>1983/84 RECAPITULATION: SUPERIOR AND LOWER COURTS SOURCE </p>

<hr>

<p>17. SCLC Criminal Case Expenditures $265,944,867 (#3 + #11) </p>

<p>18. SCLC Ad. Fel. Dispositions (84) 154,720 (#4 + #12) </p>

<p>19. SCLC Ad. Fel. MJ Dispositions 10,959 (#5 + #13) </p>

<p>20. % MJ of SCLC Ad. Fel. Dispositions 7.08% (#19 / #18) </p>

<p>21. SCLC Ad. Fel. MJ Disp. Expenditures $ 18,639,137 (#7 +
#15) </p>

<p>22. AVG SCLC Cost per Ad. Fel. MJ Disp. $1700.81 (#21 / #19) </p>

<p>ABBREVIATIONS USED </p>

<p>S.C. = Superior Court Mi = Marijuana Ad. Fel. = Adult Felony </p>

<p>L.C. = Lower Court AVG = Average Disp. = Disposition </p>

<p>M.C. = Municipal Court SCLC = Superior ay-id Lower Courts
Combined </p>

<p>533) SOURCES </p>

<p>1. Judicial Council of California, Annual Reports to the
Governor and the Legislature. San Francisco: Administrative
Office of the Courts. </p>

<p>la. 1985 Final Report. Weighting is described pp. 112 et seq.
lb. 1984 Final Report. </p>

<p>IC. 1983 Final Report. </p>

<p>Id. 1982 Final Report. </p>

<p>2. Criminal Justice Profile 1984, pp. 12-14. Sacramento:
Bureau of Criminal Statistics, 1985. </p>

<p>3. DISPTREE file appended to this report. It is derived from
OBTS (Offender-Based Transaction Statistics) Disposition Trees
for Adult Felony Marijuana Dispositions, with data limitation
notes., 1976-1984. Sacramento: Bureau of Criminal Statistics,
1985. </p>

<p>NOTE: EXPENDITURES NOT INCLUDED IN THIS CALCULATION: </p>

<p>1. Prosecutor (District Attorney) costs </p>

<p>2. Public Defender costs </p>

<p>3. Probation services expenditures </p>

<p>4. Adult Misdemeanor Arrest Dispositions </p>

<p>5. Juvenile Felony Arrest Dispositions </p>

<p>6. Juvenile Misdemeanor- Arrest Dispositions </p>

<p>7. Adult Felony Arrest Dispositions that did riot reach a
court because dismissed by police. </p>

<p>e. Adult Felony Arrest Dispositions that did -riot reach a
court except to have the complaint requested by a prosecutor be
denied. </p>

<p>9. None of the expenditures have been inflation-adjusted yet. </p>

<p>NOTE- EXPENDITURES WHICH ARE INCLUDED IN THIS CALCULATION: </p>

<p>&quot;These costs represent the total operational costs of the
trial Courts. The only category of costs not included are capital
</p>

<p>Outlay expenditures for Such purposes as site acquisition and
construction of new court facilities.&quot; -- Source la, p. 43. </p>

<p>(Thus the expenditures recorded by the Judicial Council
include county budgets for superior, municipal and justice
courts, the </p>

<p>County clerks office, bailiffs, court-appointed private
attorneys., and indirect county costs attributable to court
activities Such as personnel or purchasing offices whose costs
are attributed to the courts by local prorated budget estimates.
In addition, certain state contributions to trial courts such as
superior court judges' salaries, block grants, judges' retirement
funds, and reimbursement for specific legislative mandates.
--Ibid.) </p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-55</DOCNO>
<DOCOLDNO>IA087-000627-B013-101</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/hemp/moscone/chap6.htm 206.61.184.43 19970122050637 text/html 8735
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:06:15 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:57:04 GMT
Content-length: 8518
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Prison and Parole Costs (Marijuana)</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_hemp_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->

<p><font size="5">A Fiscal Analysis of Marijuana
Decriminalization</font></p>

<h1>CHAPTER VI. PRISON AND PAROLE COSTS </h1>

<p>&nbsp;</p>

<hr>

<h2>INFLUENCE OF THE MOSCONE ACT ON PRISON POPULATIONS</h2>

<p>It is difficult to distinguish the roles of PC Section 17 and
the &quot;Wobbler,&quot; PC 1000 (drug diversion), the Moscone
Act, and the Determinate Sentencing Act of 1976 in reducing
prison populations for all had some effect. Nevertheless it is
possible to follow their cumulative impact chronologically. It
should be remembered that by definition, a -felony is a crime for
which a possible sentence is a year or more in prison. Most if
not all felony offenders reach prison via the Superior Court
pipeline. </p>

<p>Section 17 PC allowed certain felonies, including many
Marijuana possession cases, to be disposed of in lower courts.
This began the process of clearing the congestion in Superior
Court, but increased the workload in the lower courts. PC 1000,
the 1973 drug diversion program, also took first offenders out of
the courts, jails and prisons by allowing their charges to be
dismissed upon completion of a drug treatment program. </p>

<p>As a result the number of felony offenders disposed of in
Superior Court began diminishing, with the direct effect of
reducing the number of felony marijuana offenders in prison from
668 in 1973, to 605 in 1974 and 317 in 1975 (Source 1). </p>

<p>The Moscone Act, effective January 1, 1976, augmented this
process by taking the most common marijuana offense-- possession
of a small amount out of Superior Court entirely. Moreover, this
did not increase the lower court workload. As explained in a
previous chapter, the new law provided that individuals
apprehended for possession of less than an ounce need not be
formally arrested or booked on the misdemeanor charge. This
provision meant that marijuana possession offenders did not have
to appear even in lower courts. And since the maximum penalty for
this offense was a $100 fine (not incarceration), jail as well as
prison populations fell. </p>

<p>As a result, felony marijuana offenders in prison again fell
to only 198 in 1976. Thus!. before the Determinate Sentencing
Act, the combined three laws had reduced marijuana felon
populations by 70 percent between 1973 and 1976, simply by
emptying the Superior Court pipeline of felony marijuana
possession cases. </p>

<p>The Determinate Sentencing Act occasioned a one-time,
across-the-board release of felons from prison (Source 1). This
is reflected in the drop in marijuana felons from 198 in 1976 to
146 in 1977. The law's long-term effect was to decrease the
number of trials in Superior Court and to increase the number Of
guilty pleas (Source 2). </p>

<p>Acting in tandem, these legislative changes continued to
reduce the marijuana felon population to 121 in 1978, 101 in
1979, and 98 in 1980. Starting with 668 marijuana felons in 1973,
this represents an enormous 85 percent drop in the number of
marijuana prisoners. </p>

<p>Then in 1981, as felony arrests for sale and cultivation of
marijuana climbed and leveled off at about 21,000 a year, the
number of marijuana felons in prison again began to rise,
reaching 327 by 1984. Overall, the result of the Moscone Act and
these other influences was to reduce the marijuana prison
population to about half its 1972 level. </p>

<h2>FELONY MARIJUANA OFFENDER PRISON AND PAROLE COSTS</h2>

<p>The California Department of Corrections keeps close track of
the per capita costs of convicted felons in prison or on parole.
Since it costs no more for a marijuana offender than for any
other inmate or parolee, it is easy to determine the costs of
adult felony marijuana offenders by Multiplying the number of
such of-fenders in prison or on parole by the per capita costs
each year. All statistics for this calculation were provided by
the Department of Corrections (Source 1). </p>

<p>FISCAL MJ FELONS PER CAP MJ PRISON MJ FELONS PER CAP MJ PAROLE
</p>

<p>YEAR IN PRISON COSTS COSTS ON PAROLE COSTS COSTS </p>

<p>----------------------------------------------------------------------------
</p>

<p>77/78 (77) 146 $10,400 $1,518,400 (77) 216 $ 792 $171,072 </p>

<p>78/79 (78) 121 $10,058 $1,217,018 (78) 104 $ 854 $88,816 </p>

<p>79/80 (79) 101 $11,304 $1,141,704 (79) 85 $1,285 $109,225 </p>

<p>80/81 (80) , 98 $12,646 $1,239,308 (80) 880 $1,408 $112,640 </p>

<p>81/82 (81) 119 $12,706 $1,512,014 (81) 69 $1,103 $76,107 </p>

<p>82/83 (82) 157 $12,706 $1,994,842 (82) 76 $ 837 $63,612 </p>

<p>83/84 (83) 191 $12,948 $2,473,068 (83) 167 $1,393 $232,631 </p>

<p>84/85 (84) 327 $14,344* $4,690,488 (84) 234 $1,847 $432,198 </p>

<p>NOTES: *1984/85 Institution and Parole per capita costs are
estimated. The Population counts are as of December 31 each year.
Felons counted are those with marijuana as their most serious
offense. </p>

<p>In 1973, the 668 marijuana offenders in prison were about 3
percent </p>

<p>of the total prison population of 22,486. In 1980 the 98
Marijuana felons were less than half of one percent (0.4
per-cent) of the prison population, and by 1984 the 327 marijuana
felons were 0.76 percent of that population. </p>

<p>By reducing the number of marijuana felons significantly
compared to their 1972-74 levels, the Moscone Act and the other
laws mentioned above saved the taxpayers consider-able sums of
money. Nevertheless it should be noticed that the cost of keeping
327 marijuana offenders in prison in 1984 was nearly 5 million
dollars. </p>

<p><img src="fig6_1.gif" width="595" height="197"> </p>

<h2>SOURCES</h2>

<p>1. Total and Marijuana Felon prison populations for 1972-84,
and Per Capita Institution and Parole Costs for fiscal 1977/78 to
1985/86 were provided by Phyllis Marquez and Linda Greutle,
Estimates Unit, California Department of Corrections
(Sacramento)., in January 1986. Ms. Greule alerted us to the
possible influence of the Determinate Sentencing Act in addition
to the Moscone Act in reducing prison populations, as well. </p>

<p>2. Judicial Council of California, 1985 Annual Report to the
Governor and the Legislature (San Francisco, 1986), p. 21. The
Judicial Council reports since 1977 have followed the influence
of the Determinate Sentencing Act closely. </p>

<p>MRA NOTE: in the later version of this report, look in the
Prison.CDC file folder for a study Linda Greule sent on the
aver-age time served before parole by marijuana prisoners. </p>

<p>Also: do a comparative cost estimate like the one in my
PRISON.CDC -file. </p>

<p>Also; check sources Suggested by Linda Greule for per capita
costs before 1977-- take it back to at least 1972. PRISON.CDC
-file again. </p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_hemp_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../hempmenu.htm">Hemp (Marijuana)</a></p>
<!--webbot bot="Include" endspan i-checksum="49632" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-56</DOCNO>
<DOCOLDNO>IA087-000625-B008-195</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/MISC/misc.htm 206.61.184.43 19970122040151 text/html 8053
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 04:01:35 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 05:14:52 GMT
Content-length: 7836
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Miscellaneous Items on Drugs and Drug Policy</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../_private/schaffer_style.htm"
background="../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../_private/schaffer_logo.htm" tag="BODY" startspan
-->

<p align="center"><img src="../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="28886" --><!--webbot
bot="Include" u-include="../../_private/sch_misc_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../toc.htm">Contents</a> | <a
href="../../feedback.htm">Feedback</a> | <a
href="../../search.htm">Search</a> </p>

<p><a href="../../index.htm">DRCNet Library</a> | <a
href="../index.HTM">Schaffer Library</a>&nbsp;| <a
href="misc.htm"><font size="3">Miscellaneous Statements on Drug
Policy</font></a></p>
<!--webbot bot="Include" endspan i-checksum="49651" -->

<h1>Miscellaneous Items on Drugs and Drug Policy</h1>

<p>Items not elsewhere classified</p>

<hr>

<p><img src="../graphics/golddot1.gif" width="22" height="22"><a
href="http://turnpike.net/~jnr/wodarts.htm">War on Drugs Articles
</a>- A collection of articles about the War on Some Drugs. </p>

<p><a href="sciurin.htm">The &quot;Scientific&quot; Justification
for Urine Testing - Part 1</a></p>

<p><a href="sciurin2.htm">The &quot;Scientific&quot;
Justification for Urine Testing - Part 2</a></p>

<blockquote>
    <p><font size="3">By John Morgan, Medical professor and
    acting Chairman of Pharmacology, City University of New York
    Medical School, KANSAS LAW REVIEW, 1988</font></p>
</blockquote>

<p><a href="testneg.htm"><font size="3">Test Negative A look at
the &quot;evidence&quot; justifying illicit-drug tests</font></a><font
size="3">, by John Morgan, SCIENTIFIC AMERICAN March 1990, p. 18 </font></p>

<p><a href="forensic.htm"><font size="3">Federal Panel Says Value
of Workplace Testing Unproven</font></a><font size="3">--
Forensic Drug Abuse Advisor Vo. 7 (1) January 1995, p.6</font></p>

<p><a href="testscam.htm">The Drug Test Scam </a>by Ian Goddard</p>

<p><a href="uromancy.htm"><font size="3">Urinalysis or Uromancy?
The Untold Costs of Drug Testing Abuse</font></a><font size="3">
by Dale Gieringer, Ph.D.,</font></p>

<blockquote>
    <p><font size="3">A paper for the Drug Policy Foundation
    Published in &quot;Strategies for Change: New Directions in
    Drug Policy (1992)</font></p>
</blockquote>

<p><a href="metanal.htm"><font size="3">Meta-Analysis of
Adolescent Crime and Substance Use, 1981-1995</font></a><font
size="3"> by Gordon E. Kenney, Ph.D. The University of Memphis
Memphis, Tennessee</font></p>

<p><a href="amtest.htm"><font size="3">1994 American Management
Survey on Workplace Drug Testing</font></a></p>

<p><a href="drinkwater.htm"><font size="3">Simple Way to Beat
Urine Tests - Just Drink Water</font></a><font size="3">, Report
from American Academy of Forensic Sciences, Forensic Drug Abuse
Advisor, Vol. 6, Issue 3, March 1994</font></p>

<p><a href="../LIBRARY/testmny.htm">Testimony of Marc Mauer</a>,
Assistant Director, The Sentencing Project </p>

<blockquote>
    <p>Before the Subcomittee on Legislation and National
    Security and the Subcommittee on Government Information,
    Justice and Agriculture of the House Government Operations
    Committee, May 2, 1990, Washington, D.C. </p>
</blockquote>

<p><a href="../GovPubs/CJSREFRM.HTM">Criminal Justice System
Reform</a> by Judge Thomas M. Stark</p>

<p><a href="downshow.htm">America Held Prisoner</a>, by Hugh
Downs - A radio show by Hugh Downs, about the author of these web
pages. </p>

<p><a href="pcpviol.htm">PCP and Violence </a>- excerpted from :
Drug Abuse and Drug Abuse Research, an annual report to congress
by the U.S. Dept. of Health and Human Services, pg. 153. (1991) </p>

<p><a href="mariju1.htm">Marijuana - The Insidious Drug </a>A
summary of some of the major points in Pot Safari and Marijuana
Alert by Peggy Mann, McGraw Hill. A modern version of Reefer
Madness. </p>

<p><a href="../LIBRARY/dolrcost.htm">The Dollar Cost of
Punishment </a>This file contains miscellaneous notes and
references regarding the costs of punishing people for drug
offenses. Lots of interesting tidbits. Originally posted on
DRCNet. </p>

<p><a href="../LIBRARY/slikker.htm">A Review of the Scientific
Literature Re Amotivational Syndrome </a></p>

<p>This is an excellent synopsis of the information regarding the
&quot;amotivational syndrome&quot; and marijuana. Complete with
citations for further reference. Contributed by Brian of DRCNet. </p>

<p><a href="../GOVPUBS/solom1.htm">DRUGS AND THE INFORMATION
SUPERHIGHWAY </a><u>by HON. GERALD B.H. SOLOMON OF NEW YORK in
the House of Representatives, Thursday, October 6, 1994 </u></p>

<p>A speech by Gerald Solomon. He is upset because people are
using the internet to promote drug policy reform. Free speech
must be stopped before it ruins America. </p>

<p><a href="../GOVPUBS/solom2.htm">DRUG DECRIMINALIZATION IN
HOLLAND</a> HAS INCREASED CRIME AND ADDICTION by HON. GERALD B.H.
SOLOMON OF NEW YORK in the House of Representatives Thursday,
March 2, 1995 Another diatribe, full of misinformation, by Gerald
Solomon. What he doesn't know about the subject has filled
libraries. </p>

<p><a href="../LIBRARY/southam1.htm">Drug Laws in South America</a>
- A synopsis of the drug laws in various South American
countries. </p>

<p><a href="../LIBRARY/marij.htm">Pharmacology of Marijuana: Just
Another Sedative </a>by Frederick H. Meyers, M.D., Professor of
Pharmacology, University of California, San Francisco, Ca. This
is an excellent document discussing the effects and pharmacology
of marijuana. </p>

<p><a href="../LIBRARY/forum.htm">The Drug Policy Foundation's
Forum on Legislative Policy</a> State Capitol, January 27, 1992
by Frederick H. Meyers, M.D., Professor of Pharmacology,
University of California, San Francisco, CA This paraphrases the
report of the Research Advisory Panel. </p>

<p><a href="lionsmj1.htm">Facts About Marijuana </a>Marijuana:
Drug of Deception, A publication of the Lions Club </p>

<p><a href="beergood.htm">Beer Versus Drugs </a>Why beer is good
and the illegal drugs are bad - from Anheuser-Busch. </p>

<p><a href="econ1.htm">Three articles on the Drug Problem</a>,
From the Economist May 15 -21, 1993 </p>

<p><a href="abc0406.htm">ABC News WAR ON DRUGS</a>: SEARCHING FOR
SOLUTIONS: A Summary by Jim Hoffman </p>

<p><a href="../LIBRARY/urchild.htm">Your Child and Stimulants </a>by
the Netherlands Institute on Alcohol and Drugs. </p>

<p>This file consists of excerpts from a publication directed at
parents in the Netherlands. Contributed by Mario Lap. </p>

<p><a href="../Library/drugbib1.htm">Drug Bibliography</a> -- A
listing of articles and other materials on drugs. The latest
article listed is 1990. (Note: This file is more than 300K)</p>

<hr>
<!--webbot bot="Include"
u-include="../../_private/sch_misc_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../toc.htm">Contents</a> | <a
href="../../feedback.htm">Feedback</a> | <a
href="../../search.htm">Search</a> </p>

<p><a href="../../index.htm">DRCNet Library</a> | <a
href="../index.HTM">Schaffer Library</a>&nbsp;| <a
href="misc.htm"><font size="3">Miscellaneous Statements on Drug
Policy</font></a></p>
<!--webbot bot="Include" endspan i-checksum="49651" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-57</DOCNO>
<DOCOLDNO>IA087-000632-B018-23</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/library/studies/studies.htm 206.61.184.43 19970122092148 text/html 49952
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:21:39 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 19-Jan-97 10:56:02 GMT
Content-length: 49736
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Major Studies of Drugs and Drug Policy - Titles and
Summaries</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../_private/schaffer_style.htm"
background="../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="1994" --><!--webbot
bot="Include" u-include="../../../_private/sch_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="33179" -->

<h1>Major Studies of Drugs and Drug Policy </h1>

<p><b>This page will contain full-text copies of the major
studies of drugs and drug policy as they become available and as
we have resources to scan them and put them on the web. Readers
who wish to fund the addition of new research to the web should
see </b><a href="../../support/support.htm"><b>How You Can
Support the Schaffer Library</b></a><b>.</b></p>

<p><b>We are currently seeking copies of any reports for which we
do not yet have full text. These reports are marked with <img
src="../../../images/dot_red.GIF" width="20" height="16"></b></p>

<p><b>We also invite submissions of major reports which are not
yet listed here.</b> </p>

<p><a href="../../library/studies/majortoc1.htm"><font size="4">&nbsp;Major
Studies Table of Contents</font></a><font size="4"> - Titles only</font></p>

<hr>

<table border="3" bordercolor="#000080">
    <tr>
        <td><b>Year</b></td>
        <td><b>Country</b></td>
        <td><b>Title</b> </td>
    </tr>
    <tr>
        <td width="61"><strong>1894</strong></td>
        <td width="71"><strong>India</strong></td>
        <td width="451"><a href="inhemp/ihmenu.htm"><strong>Indian
        Hemp Drugs Commission Report</strong></a><strong> </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This 3,281-page, seven-volume classic report on
            the marijuana problem in India by British and
            concluded: &quot;Viewing the subject generally, it
            may be added that moderate use of these drugs is the
            rule, and that the excessive use is comparatively
            exceptional. The moderate use produces practically no
            ill effects.&quot; Nothing of significance in the
            report's conclusions has been proven wrong in the
            intervening century </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1905</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Report of the
        Committee Appointed by the Philippine Commission to
        Investigate The Use of Opium and the Traffic
        Therein...Bureau of Insular Affairs, War Dept.,
        Philippines </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1926</strong></td>
        <td width="71"><strong>England</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Departmental Committee
        on Morphine and Heroin Addiction, Report </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>(The Rolleston Report): This landmark study by a
            distinguished group of British doctors appointed by
            the government codified existing practices regarding
            the maintenance of addicts on heroin and morphine by
            individual doctors and recommended that they continue
            without police or medical society interference. In
            coming to this conclusion, these physicians displayed
            a humane regard for the addicts in their care,
            perhaps due to their view of the nature of narcotic
            addiction: &quot;Me condition must be regarded as a
            manifestation of disease and not as a mere form of
            vicious indulgence.&quot; The British addiction
            experts took pains to state that they did not agree
            with the opinions of &quot;some eminent physicians,
            especially in the United States&quot; that addicts
            &quot;could always be cured by sudden
            withdrawal.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1928</strong></td>
        <td><strong>US</strong></td>
        <td><a href="op/opmenu.htm"><strong>The Opium Problem</strong></a><strong>
        by Charles E. Terry and Mildred Pellens </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61">1<strong>929</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Panama Canal Zone
        Military Investigations (US Military, 1916-29) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>After an exhaustive study of the smoking of
            marijuana among American soldiers stationed in the
            zone, the panel of civilian and military experts
            recommended that &quot;no steps be taken by the Canal
            Zone authorities to prevent the sale or use of
            Marihuana.&quot; The committee also concluded that
            &quot;there is no evidence that Marihuana as grown
            and used [in the Canal Zone] is a 'habit-forming'
            drug.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1930</strong></td>
        <td><strong>US</strong></td>
        <td><strong>Wickersham Commission Report on Alcohol
        Prohibition </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1944</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="lag/lagmenu.htm"><strong>The
        LaGuardia Committee Report</strong></a><strong> Mayor's
        Committee on Marihuana, The Marihuana Problem in the City
        of New York commissioned by Mayor Fiorello LaGuardia,
        written by the New York Academy of Medicine, and
        published by the City of New York in 1944 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This study is viewed by many experts as the best
            study of any drug viewed in its social, medical, and
            legal context. The committee covered thousands of
            years of the history of marijuana and also made a
            detailed examination of conditions In New York City.
            Among its conclusions: &quot;The practice of smoking
            marihuana does not lead to addiction in the medical
            sense of the word.&quot; And: &quot;The use of
            marihuana does not lead to morphine or heroin or
            cocaine addiction, and no effort is made to create a
            market for those narcotics by stimulating the
            practice of marihuana smoking.&quot; Finally:
            &quot;The publicity concerning the catastrophic
            effects of marihuana smoking in New York City is
            unfounded.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1961</strong></td>
        <td width="71"><strong>England</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Interdepartmental
        Committee, Drug Addiction, (The First Brain Report) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>When the Brain Committee first met at the
            invitation of the minister of health, its mission was
            to review the advice given by the Rolleston Committee
            in 1926. That advice had been to continue to allow
            doctors to treat addicts with maintenance doses of
            powerful drugs when the doctors deemed it medically
            helpful for the patient. Brain I reiterated that
            advice and in this first report recommended no
            changes of any significance on the prescribing powers
            of doctors. This report expanded on one important
            point alluded to in Rolleston-the authenticity of the
            existence of &quot;stabilized addicts.&quot; </p>
            <p>While many American experts doubt their existence,
            this report explained, &quot;careful scrutiny of the
            histories of more than a hundred persons classified
            as addicts reveals that many of them who have been
            taking small and regular doses for years show little
            evidence of tolerance and are often leading
            reasonably satisfactory lives.&quot; Six &quot;case
            histories of known stabilized addicts&quot; were
            included in an appendix. They were mature, older
            patients, functioning normally on what would be huge
            doses of drugs by American standards. &quot;Mr.
            F.,&quot; for example, a clerical worker, was
            receiving the equivalent of 200 milligrams of
            morphine tablets each day. It is likely that these
            patients and their doctors would be dealt with as
            criminals in the United States. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1961</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Drug Addiction: Crime
        or Disease? Joint Committee of the American Bar
        Association and the American Medical Association on
        Narcotic Drugs, Interim and Final Reports, 1961: </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This report was the result of the only major
            combined study of drug policy made by two of the most
            important professional societies in the country.
            Chaired by attorney Rufus King of Washington, D.C..
            the committee presented a direct challenge to the
            tough policies of Federal Bureau of Narcotics
            Director Harry Anslinger, a philosophical ancestor of
            the previous &quot;drug czar,&quot; William Bennett.
            The blue-ribbon committee included a senior federal
            judge and was advised by Indiana University's Alfred
            Lindesmith, one of the most distinguished addiction
            scholars in history. The report observed, &quot;Drug
            addiction is primarily a problem for the physician
            rather than the policeman, and it should not be
            necessary for anyone to violate the criminal law
            solely because he is addicted to drugs.&quot; The
            report concluded that drug addiction was a disease,
            not a crime, that harsh criminal penalties were
            destructive, that drug prohibition ought to be
            reexamined, and that experiments should be conducted
            with British-style maintenance clinics for narcotic
            addicts. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1965</strong></td>
        <td width="71"><strong>England</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>Interdepartmental
        Committee, Drug Addiction, Second Report, (The Second
        Brain Report) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Brain II has been consistently misinterpreted by
            leading American scholars and officials. It did not
            recommend the dismantling of the British prescription
            system nor the compulsory registration of addicts, as
            has been claimed. Instead, Brain II urged that </p>
            <ol>
                <li>doctors who wished to prescribe
                    &quot;restricted drugs&quot; to addicts for
                    the purpose of maintenance be required to
                    obtain a special license from the Home
                    Office; </li>
                <li>treatment centers be established for treating
                    addicts who were to be regarded as sick and
                    not criminal; and </li>
                <li>doctors and other medical personnel be
                    mandated to &quot;notify&quot; the Home
                    Office when they encountered an addict in the
                    course of their professional work.
                    Originally, the category of restricted drugs
                    included heroin and cocaine; now, dipipanone
                    has been added. </li>
            </ol>
            <p>The core of the British system remains, however,
            and in recent years has been reinvigorated.
            Approximately 200 doctors with special licenses are
            free to prescribe all drugs, including the restricted
            medicines, for maintenance of addicts. Also, any
            doctor, unlike those in the U.S., may prescribe all
            of the other drugs for maintenance, including, for
            example, injectable morphine and methadone. Brain II
            in the end was aimed at controlling a few
            overprescribing doctors, not at adopting the American
            system of treating addicts as the enemy. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1968</strong></td>
        <td width="71"><strong>England</strong></td>
        <td width="451"><a href="wootton/wootmenu.htm"><strong>Advisory
        Committee on Drug Dependence, Cannabis</strong></a><strong>,
        (The Wootton Report) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This study report on marijuana and hashish was
            prepared by a group that included some of the leading
            drug abuse experts of the United Kingdom. These
            impartial experts worked as a subcommittee under the
            lead of Baroness Wootton of Abinger. The basic tone
            and substantive conclusions were similar to all of
            the other great commission reports. The Wootton group
            specifically endorsed the conclusions of the Indian
            Hemp Drugs Commission and the La Guardia Committee.
            Typical findings included the following: </p>
        </blockquote>
        <blockquote>
            <ol>
                <li>There is no evidence that in Western society
                    serious physical dangers are directly
                    associated with the smoking of cannabis. </li>
                <li>It can clearly be argued on the world picture
                    that cannabis use does not lead to heroin
                    addiction. </li>
                <li>The evidence of a link with violent crime is
                    far stronger with alcohol than with the
                    smoking of cannabis. </li>
                <li>There is no evidence that this activity ...
                    is producing in otherwise normal people
                    conditions of dependence or psychosis,
                    requiring medical treatment. </li>
            </ol>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1970</strong></td>
        <td width="71"><strong>Canada</strong></td>
        <td width="451"><a href="ledain/NONMED1.HTM"><strong>Canadian
        Government Commission</strong></a><strong> of Inquiry
        into the Non-Medical Use of Drugs, Interim Report, (The
        Le Dain Report) </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>The distinguished Canadian experts on this
            governmental commission were led by law school dean,
            later Supreme Court Justice, Gerald Le Dain. The
            report was similar to the other great commission
            reports in terms of its non-martial, calm approach to
            the facts and in its belief that marijuana use did
            not constitute a great threat to the public welfare.
            The official governmental commission was remarkable
            in the extent to which its report portrayed casual
            drug users as decent, thoughtful citizens whose views
            deserved the fullest possible hearing by the
            government in the process of developing drug control
            strategies. </p>
        </blockquote>
        <blockquote>
            <p>A mother of four and school teacher was quoted in
            the report as saying: &quot;When I smoke grass I do
            it in the same social way that I take a glass of wine
            at dinner or have a drink at a party. I do not feel
            that is one of the great and beautiful experiences of
            my life; I simply feel that it is pleasant, and I
            think it ought to be legalized.&quot; The commission
            did not ask for that change immediately but instead
            recommended that serious consideration be given to
            legalization of personal possession in the near
            future. The report also urged that police and
            prosecutors go easy on casual users and keep them out
            of jail as often as possible. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1970</strong></td>
        <td><strong>US</strong></td>
        <td><a href="vlr/vlrtoc.htm"><strong>The Forbidden Fruit
        and the Tree of Knowledge</strong></a><strong>: An
        Inquiry into the Legal History of American Marihuana
        Prohibition by Professors Richard J. Bonnie &amp; Charles
        H. Whitebread, II, Virginia Law Review, Volume 56,
        October 1970 Number 6 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This is the most definitive history of the
            marijuana laws. See <a
            href="../../History/whiteb1.htm">The History of the
            Non-Medical Use of Drugs</a> for the author's short
            version of this history. </p>
        </blockquote>
        <blockquote>
            <p>The authors concluded that the marijuana laws were
            motivated by three major factors.</p>
        </blockquote>
        <blockquote>
            <ol>
                <li>The first state marijuana prohibition law
                    came in Utah in 1915 and was enacted into law
                    along with a number of other Mormon religious
                    prohibitions. </li>
            </ol>
            <ol>
                <li>The early state marijuana laws in the
                    Southwest and West were passed because
                    &quot;All Mexicans are crazy and marijuana is
                    what makes them crazy.&quot; That is, they
                    were the result of racial prejudice against
                    newly arrived Mexican immigrants. </li>
                <li>The other early state marijuana laws were
                    passed out of the fear that opiate addicts,
                    who had been deprived of legal access to
                    opiates by the Harrison Tax Act of 1914,
                    would turn to marijuana. In other words, they
                    were afraid that opiate use would lead to
                    marijuana. </li>
            </ol>
            <p>The first Federal prohibition on marijuana was
            passed for reasons which can only be described as
            &quot;nonsense,&quot; including the racial reasons
            listed above, as well as allegations that marijuana
            caused young lovers to elope. Interested readers may
            want to review the original source documents under <a
            href="../../hemp/taxact/taxact.htm">Marihuana Tax Act
            of 1937</a>. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1972</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="cu/cumenu.htm"><strong>The
        Consumers Union Report on Licit and Illicit Drugs</strong></a><strong>,
        by Edward M. Brecher and the Editors of Consumer Reports
        Magazine </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This is a landmark study, a &quot;must-read&quot;,
            used as a basic textbook at major universities. This
            web page will ultimately include chapter by chapter
            summaries of the main points of this book. It is
            certainly one of the first books which should be read
            by people who want to know about this subject </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1972</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>The Koerner Commission
        Report, State of Ohio </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1972</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="dwda/dwdamenu.htm"><strong>Dealing
        With Drug Abuse: A Report to the Ford Foundation</strong></a><strong>,
        by the Drug Abuse Survey Project. </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1972</strong></td>
        <td><strong>US</strong></td>
        <td><a href="nc/ncmenu.htm"><strong>Marihuana: A Signal
        of Misunderstanding</strong></a><strong>, National
        Commission on Marihuana and Drug Abuse </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This commission was directed by Raymond P. Shafer,
            former Republican governor of Pennsylvania, and had
            four sitting, elected politicians among its eleven
            members. The commission also had leading addiction
            scholars among its members and staff and was
            appointed by President Nixon in the midst of the
            drug-war hysteria at that time. While the commission
            supported much existing policy, it produced two
            reflective reports, this being the final
            comprehensive document, which recommended research,
            experimentation, and humane compromise. The first
            recommendations of the commission were: </p>
        </blockquote>
        <blockquote>
            <ol>
                <li>Possession of marihuana for personal use
                    would no longer be an offense, but marihuana
                    possessed in public would remain contraband
                    subject to summary seizure and forfeiture. </li>
                <li>Casual distribution of small amounts of
                    marihuana for no remuneration, or
                    Insignificant remuneration not involving
                    profit, would no longer be an offense. </li>
            </ol>
            <p>The recommendations in this reports were endorsed
            by (among others) the American Medical Association,
            the American Bar Association, The American
            Association for Public Health, the National Education
            Association, and the National Council of Churches. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1973</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="duapip/pipmenu.htm"><strong>Drug
        Use in America: Problem in Perspective</strong></a><strong>,
        National Commission on Marihuana and Drug Abuse </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1977</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>The Nation's Toughest
        Drug Law: Evaluating the New York Experience, by the
        Joint Committee on New York Drug Law Evaluation, of the
        Association of the Bar of the City of New York </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This commission was formed to review the
            Rockefeller drug laws, the toughest in the nation.
            The report basically concluded that tougher sentences
            had provided little, if any, benefit. Instead, they
            had increased the incentive for drug sellers to
            commit violence and had clogged the criminal justice
            system. The report also found that tougher penalties
            had done nothing material to reduce drug use but had
            instead exacerbated some of the existing problems
            with drug abuse. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1980</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="fada/fadamenu.htm"><strong>The
        Facts About Drug Abuse</strong></a><strong>, The Drug
        Abuse Council </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>A 1972 report to the Ford Foundation,
            &quot;Dealing With Drug Abuse,&quot; concluded that
            current drug policies were unlikely to eliminate or
            greatly affect drug abuse. This conclusion led to the
            creation and joint funding by four major foundations
            of a broadly based, independent national Drug Abuse
            Council. The council reviewed and assessed laws,
            programs, and projects-federal, state, and local,
            private and governmental-related to use and misuse of
            psychoactive drugs. In its final report, the
            council's board of directors offered a set of
            observations considered central to the process of
            reaching mom consistent, coherent, and responsible
            approaches to drug use and misuse. </p>
            <ol>
                <li>Psychoactive substances have been available
                    throughout recorded history and will remain
                    so. To try to eliminate them completely is
                    unrealistic. </li>
                <li>The use of psychoactive drugs is pervasive,
                    but misuse is much less frequent, and the
                    failure to make the distinction between use
                    and misuse creates the impression that all
                    use is misuse and leads to addiction. </li>
                <li>There is a clear relationship between drug
                    misuse and pervasive societal ills such as
                    poverty, racial discrimination, and
                    unemployment, and we can expect drug misuse
                    so long as these adverse social conditions
                    exist. </li>
                <li>The price of an effective strategy to
                    eliminate drug misuse through the criminal
                    law would be perceived by many Americans as
                    too high in terms of invasions of privacy and
                    abrogations of individual liberties. </li>
                <li>Drug laws and policies attend insufficiently
                    to the problems of people misusing drugs and
                    too much to the properties of drugs
                    themselves, as though the drugs were somehow
                    inherently to blame. </li>
                <li>Too many Americans have unrealistic
                    expectations about what drug policies and
                    programs can accomplish. </li>
                <li>We have a regrettable tendency to blame our
                    drug problems on others, failing to recognize
                    that our drug problems are products of our
                    own national experience. </li>
            </ol>
            <p>The council's directors then offered a set of
            suggestions, Principal among them are the following, </p>
            <ol>
                <li>Treatment for drug dependence should be
                    available chiefly because people need help,
                    rather than as a crime control or behavior
                    control method. </li>
                <li>There should be a major study of the effects
                    of drug laws and their enforcement on
                    personal decisions to use or not use illicit
                    drugs. </li>
                <li>Legislative efforts to decriminalize at both
                    state and federal levels the possession of
                    small amounts of marijuana for personal use
                    should continue. </li>
                <li>The report ends with the recommendation:
                    &quot;... that serious consideration be given
                    to the use of state and local option as a
                    means of attempting solutions appropriate in
                    one place but not in others. Local options
                    could encourage greater flexibility and
                    ingenuity rather than reliance on an
                    unrealistic, rigid homogeneity in national
                    drug policy. We need to respond to the
                    diversity of people who use and misuse drugs,
                    base all our policies on a consistent set of
                    principles seeking to discourage misuse, and
                    keep our seemingly innate drug-using behavior
                    within reasonable limits through means. which
                    do not themselves produce more harm than they
                    prevent. </li>
            </ol>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1982</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>An Analysis of
        Marihuana Policy, National Research Council of the
        National Academy of Science </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>The NAS Committee on Substance Abuse and Habitual
            Behavior was composed of some of the leading American
            experts on medicine, addiction treatment, law,
            business, and public policy. These experts reviewed
            all of the available evidence on every aspect of the
            marijuana question. The committee then recommended
            that the country experiment with a system that would
            allow states to set up their own methods of
            controlling marijuana as is now done with alcohol.
            Under this approach, federal criminal penalties would
            be removed, and each state could decide to legalize
            the drug and impose regulations concerning hours of
            sale, age limits, and taxation. </p>
            <p>In the same vein as all the previous major
            objective studies, this report stated that excessive
            marijuana use could cause serious harm, that such use
            was rare, and that, on balance, the current policy of
            total prohibition was socially and personally
            destructive. The report placed great emphasis on
            building up public education and informal social
            controls, which often have a greater impact on drug
            abuse than the criminal law. Regarding the
            possibility of disaster for our youth under
            legalization, the report observed: </p>
            <p>There is reason to believe that widespread
            uncontrolled use would not occur under regulation.
            Indeed, regulation might facilitate patterns of
            controlled use by diminishing the &quot;forbidden
            fruit&quot; aspect of the drug and perhaps increasing
            the likelihood that an adolescent would be introduced
            to the drug through families and friends, who
            practice moderate use, rather than from their
            heaviest-using, most drug-involved peers, </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1988</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a
        href="http://www.commonlink.com/~olsen/MEDICAL/YOUNG/young.html"><strong>DEA
        Docket No. 86-22</strong></a><strong>, DEA Chief
        Administrative Law Judge ruling on medical marijuana </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This is the ruling of the DEA's own Chief
            Administrative Law Judge which arose as the result of
            a suit against the Federal Government, seeking to
            reschedule marijuana for medical purposes. Before
            issuing his ruling, Judge Francis Young heard two
            years of testimony from both sides of the issue and
            accumulated fifteen volumes of research. This was
            undoubtedly the most comprehensive study of medical
            marijuana done to date. Judge Young concluded that
            marijuana was one of the safest therapeutically
            active substances known to man, that it had never
            caused a single human death, and that the Federal
            Government's policy toward medical marijuana is
            &quot;unconscionable.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1989</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>AIDS and Drug Misuse,
        Part 1, Advisory Council on the Misuse of Drugs, 1988;
        Part 2, 1989 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>&quot;The spread of HIV is a greater danger to
            individual and public health than drug misuse,&quot;
            declared the leading drug abuse and health experts of
            the United Kingdom who sit on this distinguished
            quasi-governmental advisory group. This concept
            operated as the guiding principle in this commission
            report, one part issued in 1988, another in 1989. In
            stark contrast to the Bush administration's war
            plans, the British council provided a comprehensive
            health plan that seeks to prevent the use of drugs,
            as is the American goal. However, the plan has
            realistic goals regarding drug abusers; abstinence in
            the American mode, where possible, but above all
            else, health and life. Thus, the Advisory Council
            accepted the lessons of the &quot;harm
            reduction&quot; programs of the Liverpool area and
            recommended that they be spread to the entire United
            Kingdom. Some of these lessons involve needle
            exchanges and prescribed drugs for addicts. </p>
            <p>The report even went beyond the Liverpool
            experience when these leading British experts quietly
            observed, &quot;We believe that there is a place for
            an expansion of residential facilities where drug
            misusers may gain better health, skills, and
            self-confidence whilst in receipt of prescribed
            drugs.&quot; Thus, while the United States is
            planning more prison space for drug addicts, the
            United Kingdom is contemplating more hostels where
            addicts could be taught to live more healthy, more
            self-confident and more productive lives in the
            community. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1989</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><a href="../forum.htm"><strong>Report
        of the Research Advisory Panel </strong></a><strong>for
        the State of California </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This panel, appointed by the state legislature of
            California to regulate all research on controlled
            substances, reviewed drug policy and recommended that
            &quot;the legislature act to redirect this, state
            away from the present destructive pathways of drug
            control.&quot; The report noted that we had followed
            a path of prohibition over the last fifty years and
            concluded that this policy &quot;has been manifestly
            unsuccessful in that we are now using more and a
            greater variety of drugs, legal and illegal.&quot; In
            addition, the failure of prohibition has resulted in
            &quot;societal overreaction (that] has burdened us
            with ineffectual, inhumane, and expensive treatment,
            education and enforcement efforts.&quot; They
            recommended a move toward the formulation of
            &quot;legislation aiming at regulation and
            decriminalization&quot; and the winding down of the
            war on drugs. </p>
            <p>The Research Advisory Panel made three specific
            recommendations for initial legislative action. These
            were </p>
            <ol>
                <li>permit the possession of syringes and
                    needles; </li>
                <li>permit the cultivation of marijuana for
                    personal use; and </li>
                <li>in order to project an attitude of
                    disapproval of all drug use, take a token
                    action in forbidding the sale or consumption
                    of alcohol in state-supported institutions
                    devoted in part or whole to patient care or
                    educational activity. </li>
            </ol>
            <p>The panel recommended immediate and innovative
            action, concluding it is &quot;incontrovertible that
            whatever policies we have been following over the
            past generations must not be continued unexamined and
            unmodified since our actions to date have favored the
            development of massive individual and societal
            problems.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1991</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><b><img src="../../../images/dot_red.GIF"
        width="20" height="16"></b><strong>&quot;The Twin
        Epidemics of Substance Use and HIV&quot; The National
        Commission on AIDS </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This indictment of current drug policy focuses on
            the relationship between the spread of HIV and drug
            use. The commission criticized the federal
            government's failure to recognize that these are twin
            epidemics and found that the &quot;strategy of
            interdiction and increased prison sentences has done
            nothing to change the stark statistics&quot; showing
            spread of AIDS by drug users. The commission singled
            out the Office of National Drug Control Policy for
            ignoring AIDS and &quot;neglecting the real public
            health and treatment measures which could and must be
            taken to halt the spread.&quot; </p>
            <p>The commission put forward five recommendations: </p>
            <ol>
                <li>Expand drug treatment so that all who apply
                    for treatment can be accepted into treatment
                    programs. </li>
                <li>Remove legal barriers to the purchase and
                    possession of injection equipment. </li>
                <li>The federal government must take the lead in
                    developing and maintaining programs to
                    prevent HIV transmission related to licit and
                    illicit drugs. </li>
                <li>Research and epidemiologic studies on the
                    relationships between licit and illicit drug
                    use and HIV transmission should be greatly
                    expanded and funding should be increased, not
                    reduced or merely held constant. </li>
                <li>All levels of government and the private
                    sector need to mount a serious and sustained
                    attack on the social problems of poverty,
                    homelessness, and lack of medical care that
                    promote licit and illicit drug use in
                    American society. </li>
            </ol>
        </blockquote>
        <blockquote>
            <p>The National Commission on AIDS could be described
            as the echo of the British Advisory Council on the
            misuse of drugs in its report on AIDS and drug
            misuse, as it made virtually the same policy
            recommendations. The commission concluded that
            &quot;the federal government must recognize that HIV
            and substance use is one of the issues of paramount
            concern within the 'war on drugs.' Any program which
            does not deal with the duality of the HIV/drug
            epidemic is destined to fail.&quot; The commission
            urged the federal government to move away from a law
            enforcement approach in controlling drugs toward a
            public health approach, which to date has &quot;been
            seriously neglected.&quot; </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1994</strong></td>
        <td width="71"><strong>US</strong></td>
        <td width="451"><a href="../nylawyer.htm"><strong>A Wiser
        Course: Ending Drug Prohibition</strong></a><strong>, A
        Report of the Special Committee on Drugs and the Law of
        the Association of the Bar of the City of New York </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>The Bar of the City of New York studied the issue
            of drugs and drug policy for about five years and
            concluded that the only reasonable way to correct the
            current problems would be to repeal the Federal laws
            on these drugs in their entirety and allow the states
            to develop their own programs, similar to the
            situation with alcohol. </p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td width="61"><strong>1994</strong></td>
        <td width="71"><strong>Australia</strong></td>
        <td width="451"><a href="aus/cannabis.htm"><strong>Legislative
        Options for Cannabis</strong></a><strong>. Australian
        Government </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td>1<strong>994</strong></td>
        <td><strong>US</strong></td>
        <td><a href="ota/otatoc.htm"><strong>Technologies for
        Understanding</strong></a><strong> and Preventing
        Substance Abuse and Addiction -- US Government Office of
        Technology Assessment -- October 18, 1994 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1996</strong></td>
        <td><strong>Australia</strong></td>
        <td><a href="dac/dacmenu.htm"><strong>Drugs and our
        Community</strong></a><strong> - Report of the Premier's
        Drug Advisory Council, Melbourne: Victorian Government,
        March, 1996 </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>Summary not yet available.</p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td><strong>1996</strong></td>
        <td><strong>US</strong></td>
        <td><a href="nycla/nycla.htm"><strong>Report and
        Recommendations of the Drug Policy Task Force</strong></a><strong>,
        New York County Lawyers Association</strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>The recommendations are:</p>
            <ol>
                <li>Pursue Alternative Models in Establishing
                    Future Drug Policy </li>
                <li>Provide Immediate Sentencing Relief and
                    Additional Judicial Discretion in Criminal
                    Prosecution of Drug Cases </li>
                <li>Reduce the Harms Associated With Substance
                    Abuse and Drug Prohibition </li>
                <li>Concentrate Law Enforcement Resources on
                    Reducing Violent Crime and Prosecution of
                    Violent Criminal Offenders </li>
                <li>Reshape the Drug Policy Debate -- Return to
                    Objective Analysis and Realistic Goals </li>
                <li>Implement Public Education Campaign on Drug
                    Use and Substance Abuse </li>
                <li>Decriminalize Marijuana </li>
                <li>Reverse Encroachments on Civil Rights and
                    Restore &quot;Due Process of Law&quot; </li>
                <li>Provide Alternative Social and Economic
                    Opportunity for Inner City Youth </li>
                <li>End War on Youth and Inner City Communities
                    -- Restore Confidence and Integrity in
                    Government </li>
            </ol>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td>1996</td>
        <td>Australia</td>
        <td><a href="redfern/rftoc.htm">Beyond Prohibition</a> -
        Report of the <font size="2"><strong>Redfern Legal Centre
        Drug Law Reform Project</strong></font><strong> - </strong><font
        size="2"><strong>September 1996</strong></font><strong> </strong></td>
    </tr>
    <tr>
        <td colspan="3"><blockquote>
            <p>This recent report from Australia explores
            specific options for alternatives to the current drug
            prohibition.</p>
        </blockquote>
        </td>
    </tr>
</table>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../_private/sch_navbar.htm" tag="BODY" startspan
-->

<p><a href="../../../toc.htm">Contents</a> | <a
href="../../../feedback.htm">Feedback</a> | <a
href="../../../search.htm">Search</a> </p>

<p><a href="../../../index.htm">DRCNet Library</a> | <a
href="../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="33179" -->
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-58</DOCNO>
<DOCOLDNO>IA031-000655-B038-236</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/library/studies/nc/misintro.htm 206.61.184.43 19970122112719 text/html 7777
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:27:12 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:58:21 GMT
Content-length: 7560
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Marihuana: A Signal of Misunderstanding -- Introduction</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include"
u-include="../../../../_private/scmj_sig_of_mis_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="ncmenu.htm">Marihuana, A Signal of Misunderstanding</a></p>

<p>&nbsp;</p>
<!--webbot bot="Include" endspan i-checksum="38989" -->

<p><b>National Commission on Marihuana and Drug Abuse</b> </p>

<h2>Marihuana: A Signal of Misunderstanding </h2>

<h1>Introduction </h1>

<p>&nbsp;</p>

<hr>

<p>&nbsp;</p>

<p>This is the first of two Reports by the National Commission on
and Drug Abuse. Public Law 91-513 requires that we report to the
President, Congress and the public initially on marihuana and
then on the broader issue of drug abuse in the United The second
Report will include a review of the marihuana issue with
particular attention to studies which have been conducted in the
interim. </p>

<p>In large measure, the marihuana issue is a child of the
sixties, the visual and somewhat pungent symbol of dramatic
changes which have permanently affected our nation in the last
decade. Some have that our mandate has placed the cart before the
horse, and that we should have focused first on the wider social
issue and assessed marihuana's impact on society within that
context. much thought and investigation, we now believe that
Congress was wise in focusing this Commission's attention first
on marihuana. separating it from the rest of the drug
controversy, we have been better able to analyze the unique
position marihuana occupies in our society. </p>

<p>Our mandate was a broad one, covering, for example, the nature
and scope of use, the effects of the drug, the relationship of
marihuana use to other behavior and the efficacy of existing law.
Realizing that marihuana had never before in the American
experience been the subject of a concentrated, authoritative
governmental study, we launched a comprehensive research and
fact-finding effort. We sought.. to evaluate and supplement
existing material, to fill knowledge voids. and to assess the
so-called truths commonly posed in the marihuana debate. </p>

<p>Soon after funds became available on March 22, 1971, we
commissioned more than 50 projects, ranging from a study of the
effects of marihuana on man to a field survey of enforcement of
the marihuana laws in six metropolitan jurisdictions. Of
particular importance in our fact-finding effort were the
opinions and attitudes of all groups in our society. </p>

<p>Through formal and informal hearings, recorded in thousands of
pages of transcripts, we solicited all points of view, including
those of public officials, community leaders, professional
experts and students. We commissioned a nationwide survey of
public beliefs, information and experience referred to in this
Report as the National Survey. In addition, we conducted separate
surveys of opinion among', district attorneys, judges, probation
officers, clinicians, university health officials and free clinic
personnel. </p>

<p>This inquiry focused on the American experience. However, we
have been well aware from the outset that the scope of marihuana
use in the United States differs considerably from that in other
countries where the drug has been used for centuries.
Accordingly, the Commission sought to put the American experience
in perspective by seeing the situation first hand in India,
Greece, North Africa, Jamaica, Afghanistan, and other countries. </p>

<p>Because of our initial concentration on marihuana, certain
issues common to marihuana and other drugs have been deferred for
more complete coverage in the second Report. For example, a
detailed analysis of educational programs about marihuana and its
use will be considered when we evaluate drug education programs
in general. </p>

<p>Further, we do not discuss the rehabilitation of the problem
marihuana user since no such specialized programs exist; we found
the subject is best approached from a broader perspective of
rehabilitation programs for problem users of all non-narcotic
drugs. An examination of federal and state organizational
response to the drug issue, as well as an in-depth study of
general law enforcement strategies, have both been undertaken and
will continue, but will not be reported fully until the second
year. </p>

<p>Officers of the Federal Government have set a high priority on
fuller understanding of the marihuana issue and appropriate
governmental action. President Nixon has frequently expressed his
personal and official commitment to providing a rational and
equitable public response to the use and misuse of drugs.
Similarly, Congress has shown its concern in passing the
Comprehensive Drug Abuse Prevention and Control Act of 1970. In
appointing this Commission, both the President and Congress have
recognized the need for an independent, nonpartisan appraisal of
the nature of marihuana and the consequences of its use, for a
similar appraisal of the abuse of all drugs, and for appropriate
recommendations for public policy as a result of both studies. </p>

<p>The Commission decided early in its deliberations to write a
Report that was complete but not overly technical so that the
reader could understand the points discussed without analyzing
detailed studies. Some. studies and supporting data are included
in an Appendix to the Report, which is published separately. For
the researcher and others interested in greater detail, the
Appendix provides the necessary technical data. </p>

<p>This Report focuses on marihuana, the popular name for a
mixture of stems, leaves and flowering tops of the Indian hemp
plant, Cannabis Sativa L. This Report presents the most
significant information gathered to date about the drug and its
users, concluding with the Commission's recommendations
concerning the most appropriate public response to marihuana
usage in our society.<br>
</p>

<hr>

<p>&nbsp;</p>
<!--webbot bot="Include"
u-include="../../../../_private/scmj_sig_of_mis_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="ncmenu.htm">Marihuana, A Signal of Misunderstanding</a></p>

<p>&nbsp;</p>
<!--webbot bot="Include" endspan i-checksum="38989" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-59</DOCNO>
<DOCOLDNO>IA031-000655-B038-274</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/library/studies/nc/mis2.htm 206.61.184.43 19970122112746 text/html 70753
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:27:28 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:56:02 GMT
Content-length: 70535
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Marihuana and the Problem of Marihuana</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include"
u-include="../../../../_private/scmj_sig_of_mis_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="ncmenu.htm">Marihuana, A Signal of Misunderstanding</a></p>

<p>&nbsp;</p>
<!--webbot bot="Include" endspan i-checksum="38989" -->

<p><b>The National Commission on Marihuana and Drug Abuse</b> </p>

<p><b>Marihuana: A Signal of Misunderstanding</b> </p>

<h1>I -- marihuana and the problem of marihuana</h1>

<p>&nbsp;</p>

<hr>

<p>&quot;There are no whole truths; all truths are half -truths.
It is trying to treat them as whole truths that plays the
devil.&quot; </p>

<p>Alfred North Whitehead (1953) </p>

<hr>

<p>We are a nation of problem-solvers. We are restless and
impatient with perceived gaps between the way things are and the
way we think ought to be. Understandably, such an impulse toward
self-correction never leaves us wanting for social problems to
solve. Although it is a prerequisite to social progress, this
problem-solving orientation misdirects our attention. In order to
maximize public awareness we are apt to characterize situations
as being far worse than they really are. Because any activity is
commonly regarded as a move toward a solution, rhetoric and
stopgap legislation sometimes substitute for rational reflection.
We become so impressed with social engineering that we overlook
inherent human limitations. </p>

<p>Since the mid-sixties, American society has been increasingly
agitated by what has been defined as a marihuana problem. The
typical sequences of &quot;a national problem&quot; have
resulted: exaggeration, polarization and the inevitable demand
for a. solution. The appointment of this Commission and the
publication of this Report reflect the escalation of marihuana
use into the realm of social problem. Since the beginning of our
official life, we have grappled with the threshold question: Why
has the use of marihuana reached problem status in the public
mind? </p>

<hr>

<h2>Origins of the Marihuana Problem </h2>

<p>Marihuana has been used as an intoxicant in various parts of
the world for centuries and in this country for 75 years. Yet use
of the drug has been regarded as a problem of major proportions
for less than a decade. We will not find the reasons for
contemporary social concern in pharmacology texts or previous
governmental reports, for we are dealing with two separate
realities: a drug with certain pharmacologic properties and
determinable, although variable, effects on man; and a pattern of
human behavior, individual and group, which has, as a behavior,
created fear, anger, confusion, and uncertainty among a large
segment of the contemporary American public. The marihuana
behavior pattern is the source of the marihuana controversy. </p>

<p>The most apparent feature of the behavior is that it is
against the law. But inconsistency between behavior and the legal
norm is not sufficient, in itself, to create a social problem.
Marihuana, has been an illegal substance for several decades; and
the widespread violation of laws against gambling and adultery
have not excited the public to the same extent as has
marihuana-smoking in recent years. </p>

<p>At the same time, we suspect that illegality may play an
important role in problem definition where drugs are concerned.
Alcohol is of proven danger to individual and societal health and
the public is well aware of its dangers, yet use of this drug has
not been accorded the same problem status. Marihuana's illegality
may have been a necessary condition for the marihuana problem,
but the increased violation of the legal proscription does not by
itself explain the phenomenon. </p>

<p>The Commission believes that three interrelated factors have
fostered the definition of marihuana as a major national problem.
First, the illegal behavior is highly visible to all segments of
our society. Second, use of the drug is perceived to threaten the
health and morality not only of the individual but of the society
itself. Third, and most important, the drug has evolved in the
late sixties and early seventies, as a symbol of wider social
conflicts and public issues. </p>

<p><b>VISIBILITY</b> </p>

<p>More than anything else, the visibility of marihuana use by a
segment of our population previously unfamiliar with the drug is
what stirred public anxiety and thrust marihuana into the problem
area. Marihuana usage in the United States has been with us for a
very long period of time, dating back to the beginning of the
century. For decades its use was mainly confined to the
underprivileged socioeconomic groups in our cities and to certain
insulated social groups, such as jazz musicians and artists. As
long as use remained confined to these groups and had a
negligible impact on the dominant social order, the vast majority
of Americans remained unconcerned. From the other side, the
insulated marihuana user was in no position to demand careful
public or legislative scrutiny. </p>

<p>However, all this changed markedly in the mid-1960's. For
various reasons, marihuana use became a common form of recreation
for many middle and upper class college youth. The trend spread
across the country, into the colleges and high schools and into
the affluent suburbs as well. Use by American servicemen in
Vietnam was frequent. In recent years, use of the drug has
spanned every social class and geographic region. </p>

<p>The Commission-sponsored National Survey, &quot;A Nationwide
Study of Beliefs, Information and Experiences,&quot; indicated
that some 24 million Americans have tried marihuana at least once
and that at least 8.3 million are current users. </p>

<p>Other surveys uniformly indicate that more than 40% of the
U.S. college population have tried marihuana, and in some
universities the figure is much higher. Also, use of the drug has
become almost as common among young adults out of college, and
among older teenagers in high school. The National Survey
indicates that 39%, of young adults between 18 and 25 years of
age have tried marihuana. The stereotype of the marihuana user as
a marginal citizen has given way to a composite picture of large
segments of American youth, children of the dominant majority and
very much a part of the mainstream of American life. </p>

<p>Public confusion, anger, and fear over this development became
increasingly apparent during the mid and late 1960's. Such mass
deviance was a problem and the scope of the problem was augmented
by frequent publicity. The topic of the usage of marihuana by the
young received considerable attention from newspapermen and
television reporters. The drug's youthful users abetted the media
in this regard by flaunting their disregard of the law, Few of us
have not seen or heard of marihuana being used en masse at rock
concerts, political demonstrations and gatherings of campus
activists. </p>

<p>In addition, new scientific and medical interest in marihuana
and its use was stimulated by the sudden public interest. For the
first time in the American experience, the drug became the
subject of intensive scrutiny in the laboratories and clinics.
Unfortunately, this research was conducted in the spotlight of
public controversy. Isolated findings and incomplete information
have automatically been presented to the public, with little
attempt made to place such findings in a larger perspective or to
analyze their meanings. </p>

<p>Any new marihuana research has had ready access to the news
spotlight and often has been quickly assimilated into the
rhetoric of the marihuana, debate. Science has become a weapon in
a propaganda battle. Because neither the reporters nor the public
have the expertise to evaluate this information, the result has
been an array of conflicting anecdotal reports, clinical studies
on limited populations, and surveys of restricted utility. </p>

<p>Visibility, intense public interest, and fishbowl research are
all important components of the marihuana problem. </p>

<p><b>PERCEIVED THREATS</b> </p>

<p>Although marihuana is taken by most users for curiosity or
pleasure, the non-using public still feels seriously affected by
use of the drug. Several decades ago it was popularly asserted
that the drug brought about a large variety of social and
individual ills, including crime and insanity. As a result it was
prohibited by federal law in 1937. The marihuana explosion of the
mid-sixties occurred within the context of 30 years of instilled
fear. Although based much more on fantasy than on proven fact,
the marihuana &quot;evils&quot; took root in the public mind, and
now continue to color the public reaction to the marihuana
phenomenon. Even beyond the violation of law, the widespread use
of marihuana, is seen as a threat to society in other ways. And
the threats grow proportionately as the controversy swells. </p>

<p>It has been astutely observed that any statement frequently
repeated in public assumes the status of fact. With so many
people continually arguing about marihuana, the public has
understandably become alarmed and confused. </p>

<p>On the basis of the National Survey, we have tried to identify
the ways in which the public feels threatened by marihuana use.
Essentially these threats fall into three general categories:
threats to the public safety, threats to the public health, and
threats to the dominant social order. </p>

<p>In terms of public safety, the concern is with the
relationship between marihuana and aggressive behavior, crime and
juvenile delinquency. Threats to the public health usually refer
initially to the impact of marihuana on the user. Lethality,
psychosis, addiction potential and effects of chronic long-term
use, are major concerns. Additionally, the fear exists that
marihuana leads to the use of more dangerous drugs, especially
LSD and heroin. </p>

<p>The threat which marihuana use is thought to present to the
dominant social order is a major undercurrent of the marihuana
problem. Use of the drug is linked with idleness, lack of
motivation, hedonism and sexual promiscuity. Many see the drug as
fostering a counterculture which conflicts with basic moral
precepts as well as with the operating functions of our society.
The &quot;dropping out&quot; or rejection of the established
value system is viewed with alarm. Marihuana becomes more than a
drug; it becomes a symbol of the rejection of cherished values. </p>

<p><b>SYMBOLISM</b> </p>

<p>The symbolic aspects of marihuana are the, most intangible of
the items to which the Commission must address itself, and yet
they may be at the heart of the marihuana problem. Use of
marihuana was, and still is, age-specific. It was youth-related
at a time in American history when the adult society was alarmed
by the implications of the youth &quot; movement&quot;: defiance
of the established order, the adoption of new life styles, the
emergence of &quot;street people,&quot; campus unrest, drug use,
communal living, protest politics, and even political radicalism.
In an age characterized by the so-called generation gap,
marihuana symbolizes the cultural divide. </p>

<p>For youth, marihuana became a convenient symbol of
disaffection with traditional society, an allure which
supplemented its recreational attraction. Smoking marihuana may
have appealed to large numbers of youth who opposed certain
policies or trends, but who maintained faith in the American
system as a whole. In ;a time when symbolic speech is often
preferred to the literal form, marihuana was a convenient
instrument of mini-protest. It was also an agent of group
solidarity, as the widely-publicized rock concerts so well
illustrate. </p>

<p>For the adult society, the decade of the sixties was a
distressing time. The net effect of racial unrest, campus
disruption, political assassination, economic woes and an
unpopular war was widespread uneasiness. Attending a general fear
that the nation was witnessing its own disintegration was a
desire to shore up our institutions and hold the line. That line
was easy to define where drugs, particularly marihuana, were
concerned. </p>

<p>Use of drugs, including marihuana, is against the law. For
many, marihuana symbolized disorder in a society frustrated by
increasing lawlessness. Insistence on application of the law
tended also to harden views, thereby escalating still further the
use of marihuana as a symbolic issue. </p>

<p>The social conflicts underlying the drug's symbolic status
have dissipated somewhat in the past few years; and in some ways,
the Commission has similarly noted a partial deflation of the
marihuana problem and of the emotionalism surrounding it. We are
hopeful that our attempt to clarify the scientific and normative
dimensions of marihuana use will further deemphasize, the problem
orientation and facilitate rational decision-making. </p>

<h2>The Need for Perspective </h2>

<p>This Commission has the task of exploring the marihuana
controversy from as many vantage points as possible in its
attempt to make sound, realistic and workable policy
recommendations. Because we are dealing essentially with a
complex social concern rather than a simple pharmacologic
phenomenon, any social policy decision must discuss the realities
of marihuana as a drug, marihuana use as a form of behavior, and
marihuana as a symbol. </p>

<p>Particularly important is the determination of the longevity
of the behavior. Are we dealing with a behavior that is becoming
rooted in our culture or are we experiencing an aberration, a fad
that will in time, of its own accord, pass away? </p>

<p>The vortex of the marihuana controversy is the present, but
the prudent policy planner must not be blinded by the deluge of
recent statistics. It is important that we scan the past for
clues about the meaning of certain behavior and the promise
offered by various social policy responses. We are convinced that
a wider historical understanding will also go a long way toward
deflating marihuana as a problem. </p>

<h3>HISTORICAL PERSPECTIVE </h3>

<p>When viewed in the context of American society's ambivalent
response to the non-medical use of drugs, the marihuana problem
is not unique. Both the existing social policy toward the drug
and its contemporary challenge have historical antecedents and
explanations. Somewhat surprisingly, until the last half of the
19th century, the only drugs used to any significant extent for
non-medical purposes in this country were alcohol and tobacco. </p>

<p>American opinion has always included some opposition to the
nonmedical use of any drug, including alcohol and tobacco. From
colonial times through the Civil War, abstentionist outcries
against alcohol and tobacco sporadically provoked prohibitory
legislation. One 18th century pamphleteer advised against the use
of any drink &quot;which is liable to steal away a man's senses
and render him foolish, irascible, uncontrollable and
dangerous.&quot; Similarly, one 19th century observer attributed
delirium tremens, perverted sexuality, impotency, insanity and
cancer to the smoking and chewing of tobacco. </p>

<p>Despite such warnings, alcohol and tobacco use took deep root
in American society. De Tocqueville noted what hard drinkers the
Americans were, and Dickens was compelled to report that &quot;in
all the public places of America, this filthy custom [tobacco
chewing] is recognized.&quot; Nonetheless, the strain in our
culture opposed to all non-medical drug use persisted and in the
late 19th century gained ardent adherents among larger segments
of the population. </p>

<p>Beginning in earnest around 1870, abstentionists focused the
public opinion process on alcohol. As science and politics were
called to the task, public attention was drawn to the liquor
problem. &quot;Liquor is responsible for 19% of the divorces, 25%
of the poverty, 25% of the insanity, 37% of the pauperism, 45% of
child desertion and 50% of the crime in this country,&quot;
declared the Anti-Saloon League. &quot;And this,&quot; it was
noted, &quot;is a very conservative estimate.&quot; </p>

<p>The Temperance advocates achieved political victory during the
second decade of the 20th century. By 1913, nine states were
under statewide prohibition, and in 31 other states local option
laws operated, with the ultimate effect that more than 50% of the
nation's population lived under prohibition. Four years later,
Congress approved the 18th Amendment and on January 16, 1919,
Nebraska became the 36th state to ratify the Amendment, thus
inscribing national Prohibition in the Constitution. </p>

<p>Although on a somewhat smaller scale and with lesser results,
public attention was simultaneously attracted to a growing
tobacco problem. Stemming partly from the immediate popularity of
cigarette-smoking, a practice introduced after the Civil War, and
partly from riding the coattails of abstentionist sentiment,
anti-tobacconists achieved a measure of success which had
previously eluded them. The New York Time editorialized in 1885
that: </p>

<blockquote>
    <p>The decadence of Spain began when the Spaniards adopted
    cigarettes and if this pernicious habit obtains among adult
    Americans, the ruin of the Republic is close at hand. . . . </p>
</blockquote>

<p>Between 1895 and 1921, 14 states banned the sale of
cigarettes. </p>

<p>Although though there has been some posthumous debate about
the efficacy of alcohol Prohibition as a means of reducing
excessive or injurious use, the experiment failed to achieve its
declared purpose: elimination of the practice of alcohol
consumption. The habit was too ingrained in the society to be
excised simply by cutting off legitimate supply. </p>

<p>In addition, the 18th Amendment never commanded a. popular
consensus; in fact, the Wickersham Commission, appointed by
President Hoover in 1929 to study Prohibition, attributed the
Amendment's enactment primarily to public antipathy toward the
saloon, the large liquor dealers and intemperance rather than to
public opposition to use of the drug. </p>

<p>Subsequent observers have agreed that Prohibition was
motivated primarily by a desire to root out the institutional
evils associated with the drug's distribution and excessive use;
only a minority of its supporters opposed all use. And in this
respect, Prohibition succeeded. Upon repeal, 13 years after
ratification, liquor was back, but the pre-Prohibition saloon and
unrestrained distribution had been eliminated from the American
scene. </p>

<p>Both the scope of the alcohol habit and the ambivalence of
supporting opinion are manifested in the internal logic of
Prohibition legislation. The legal scheme was designed to cut off
supply, not to punish the consumer. Demand could be eliminated
effectively, if at all, only through educational efforts. Only
five states prohibited possession of alcohol for personal use in
the home. Otherwise, under both federal and state law, the
individual remained legally free to consume alcohol. </p>

<p>The anti-tobacco movement was not propelled by the
institutions outrage or the cultural symbolism surrounding the
alcohol problem It never succeeded on a national scale. Local
successes were attributable to the temporary strength of the
abstentionist impulse, together with the notion that
tobacco-smoking was a stepping-stone to alcohol use Lacking the
consensus necessary to reverse a spreading habit, tobacco
&quot;prohibition&quot; never extended to possession. Insofar as
the anti-tobacco movement was really a coattail consequence of
alcohol Prohibition, is not surprising that all 14 states which
had prohibited sale repealed their proscriptions by 1927. </p>

<p>By the early 1930's, the abstentionist thrust against alcohol
and tobacco had diminished. State and federal governments
contented themselves with regulating distribution and extracting
revenue. When the decade ended, the general public no longer
perceived alcohol and tobacco use as social problems. The two
drugs had achieved social legitimacy. </p>

<p>A comparison between the national flirtation with alcohol and
tobacco prohibition and the prohibition of the non-medical use of
other drugs is helpful in analyzing the marihuana issue. In 1900,
only a handful of states regulated traffic in
&quot;narcotic&quot; drugs--opium, morphine, heroin and cocaine
even though, proportionately, more persons probably were addicted
to those drugs at that time than at any time since. Estimates
from contemporary surveys are questionable, but a conservative
estimate is a quarter of a million people, comprising at least 1%
of the population. This large user population in 1900 included
more females than males, more whites than blacks, was not
confined to a particular geographic region or to the cities, and
was predominantly middle class. </p>

<p>This 19th century addiction was generally accidental and well
hidden. It stemmed in part from over-medication, careless
prescription practices, repeated refills and hidden distribution
of narcotic drugs in patent medicines. Society responded to this
largely invisible medical addiction in indirect, informal ways.
Self -regulation by the medical profession and pharmaceutical
industry, stricter prescription practices by the state
governments and regulation of labeling by the Federal Government
in 1906 all combined in the early years of the new century to
reduce the possibility of this accidental drug addiction. </p>

<p>About this same time, during the late 19th and early 20th
centuries, attention within the law enforcement and medical
communities was drawn to another use of narcotics----the
&quot;pleasure&quot; or &quot;street&quot; use of these drugs by
ethnic minorities in the nation's cities. Society reacted to this
narcotics problem by enacting criminal legislation, prohibiting
the non-medical production, distribution or consumption of these
drugs. Within a very few years, every state had passed
anti-narcotics legislation, and in 1914 the Federal Government
passed the Harrison Narcotics Act. </p>

<p>The major differences between the temperance and
anti-narcotics movements must be, emphasized. The temperance,
movement was a matter of vigorous public debate; the
anti-narcotics movement was not. Temperance legislation was the
product of a highly organized nation-wide lobby; narcotics
legislation was largely ad hoc. Temperance legislation was
designed to eradicate known problems resulting from alcohol
abuse; narcotic--, legislation was largely anticipatory.
Temperance legislation rarely restricted private activity;
narcotics legislation prohibited all drug-related behavior,
including possession and use. </p>

<p>These divergent policy patterns reflect the clear-cut
separation in the public and professional minds between alcohol
and tobacco on the one hand, and &quot;narcotics&quot; on the
other. Use of alcohol and tobacco were indigenous American
practices. The intoxicant use of narcotics was not native,
however, and the users of these drugs were either alien, like the
Chinese opium smokers, or perceived to be marginal members of
society. </p>

<p>As to the undesirability and immorality of nonmedical use of
narcotics, there was absolutely no debate. By causing its users
to be physically dependent, the narcotic drug was considered a
severe impediment to individual participation in the economic and
political systems. Use, it was thought, automatically escalated
to dependence and excess, which led to pauperism, crime and
insanity. From a sociological perspective, narcotics use was
thought to be prevalent among the slothful and immoral
populations, gamblers, prostitutes, and others who were already
&quot;undesirables.&quot; Most important was the threat that
narcotics posed to the vitality of the nation's youth. </p>

<p>In short, the narcotics question was answered in unison: the
nonmedical use of narcotics was a cancer which had to be removed
entirely from the social organism. </p>

<p>Marihuana smoking first became prominent on the American scene
in the decade following the Harrison Act. Mexican immigrants and
West Indian sailors introduced the practice in the border and
Gulf states. As the Mexicans spread throughout the West and
immigrated to the major cities, some of them carried the
marihuana habit with them. The practice also became common among
the same urban populations with whom opiate use was identified. </p>

<p>Under such circumstances, an immediate policy response toward
marihuana quite naturally followed the narcotics pattern rather
than the alcohol or tobacco pattern. In fact, marihuana was
incorrectly classified as a &quot;narcotic&quot; drug in
scientific literature and statutory provisions. By 1931, all but
two states west of the Mississippi and several more in the East
had enacted prohibitory legislation making it a criminal offense
to possess or use the drug. </p>

<p>In 1932, the National Conference of Commissioners on Uniform
State Laws included an optional marihuana, provision in the
Uniform Narcotic Drug Act, and by 1937 every state, either by
adoption of the Uniform Act or by separate legislation, had
prohibited marihuana use. In late 1937, the Congress adopted the
Marihuana Tax Act, superimposing a, federal prohibitory scheme on
the state scheme. </p>

<p>Not once during this entire period was any comprehensive
scientific study undertaken in this country of marihuana, or its
effects. The drug was assumed to be a 'narcotic' to render the
user psychologically dependent, to provoke violent crime, and to
cause insanity. Although media attention was attracted to
marihuana use around 1935, public awareness was low and public
debate non-existent. As long as use remained confined to
insulated minorities throughout the next quarter century, the
situation remained stable. When penalties for narcotics
violations escalated in the 1950's, marihuana penalties went
right along with them, until a first-offense possessor was a
felon subject to lengthy incarceration. </p>

<p>With this historical overview in mind, it is not surprising
that the contemporary marihuana experience has been characterized
by fear and confusion on one side and outrage and protest on the
other. As scientific and medical opinion has become better known,
marihuana has lost its direct link with the narcotics in the
public mind and in the statute books. </p>

<p>But extensive ambivalence remains about the policies for
various drugs. Marihuana's advocates contend that it is no more
or less harmful than alcohol and tobacco and should therefore be
treated in similar fashion. The drug's adversaries contend that
it is a stepping-stone to the narcotics and should remain
prohibited. At the present time public opinion tends to consider
marihuana less harmful than the opiates and cocaine and more
harmful than alcohol and tobacco. </p>

<p>Interestingly, while marihuana. is perceived as less harmful
than before, alcohol and tobacco are regarded as more harmful
than before. In some ways, the duality which previously
characterized American drug policy has now been supplanted by an
enlightened skepticism as to the variety of approaches to the
non-medical use of various drugs. </p>

<p>Despite this shift in attitudes, however, the use of alcohol
and tobacco is not considered a major social problem by many
Americans, while marihuana use is still so perceived. </p>

<p>This remains true despite the fact that alcoholism afflicts
nine million Americans. According to the National Institute on
Alcohol Addiction and Alcoholism of the National Institute of
Mental Health: alcohol is a factor in half (30,000) of the
highway fatalities occurring each year; an economic cost to the
nation of $15 billion occurs as a result of acoholism and alcohol
abuse; one-half of the five million yearly arrests in the United
States are related to the misuse of alcohol (1.5 million offenses
for public drunkenness alone) ; and one-half of all homicides and
one-fourth of all suicides are alcohol related, accounting for a
total of 11,700 deaths annually. </p>

<p>Similarly, tobacco smoking is not considered a major public
concern despite its link to lung cancer and heart disease.
According to the Surgeon General in The Health Consequences of
Smoking, 1972: </p>

<blockquote>
    <p>cigarette smoking is the, major &quot;cause&quot; of lung
    cancer in men and a significant &quot;cause&quot; of lung
    cancer in women; the risk of developing lung cancer in both
    men and women is directly related to an individual's exposure
    as measured by the number of cigarettes smoked, duration of
    smoking, earlier initiation, depth of inhalation, and the
    amount of &quot;tar&quot; produced by the cigarette; and data
    from numerous prospective and retrospective studies indicate
    that cigarette smoking is a significant risk factor
    contributing to the development of coronary heart disease
    (CHD) including fatal CHD and its most severe expression,
    sudden and unexpected death. </p>
</blockquote>

<h3>CULTURAL PERSPECTIVE </h3>

<p>Realizing the importance of social change in understanding the
issues surrounding the use of marihuana and other drugs, the
Commission decided early that an objective appraisal of cultural
trends was vital for the, development of policy recommendations.
Since neither the increase in marihuana use nor its attendant
controversy is an isolated phenomenon, we sought a wider cultural
perspective. To this end, the Commission sponsored a wide-ranging
seminar on &quot;Central Influences on American Life.&quot; With
the cooperation of the Council for Biology in Human Affairs of
the Salk Institute, we elicited a three-day conversation among 13
exceptionally thoughtful and perceptive observers of American
life.* </p>

<p>*The participants included Jacques Barzun, as moderator, Mary
Bingham, Claude T. Bissell, Kenneth Boulding, Robert R. Bowie,
Theodore Caplow, Jay W. Forrester, T. George Harris. Rollo May,
Jay Saunders Redding, Jonas Salk, Ernest van den Haag, and Leroy
S. Wehrle. </p>

<p>It is well beyond both our mandate and our competence to
attempt a definitive presentation of the status of the American
ethical system However, we shall try to suggest some of the more
salient influence in our changing society, recognizing that only
against the backdrop of society's fears, aspirations and values
can a rational response to marihuana be formulated. Although we
are not prepared to identify specific causal connections between
these social trends and marihuana use, we do believe that some of
the major points raised in the discussion of cultural change
provide essential background in understanding the marihuana
problem. </p>

<h2>The Search for Meaning </h2>

<p>One overriding influence in contemporary America is the
declining capacity of our institutions to help the individual
find his place in society. As one of the participants at the
Seminar observed: </p>

<blockquote>
    <p>A society is stable, peaceful, happy, not when it has rid
    itself of the tensions-because you never get rid of the
    tensions, because people's drives will be satisfied in ways
    that clash and so on-but when a very high proportion of the
    people feel fulfillment of some sort within the context which
    the society normally provides. The long-term problem now, for
    many many people, not just young people, is that this
    condition is not met. </p>
</blockquote>

<p>Another noted: </p>

<blockquote>
    <p>What is wrong with our social system, it seems to me, is
    that it no longer inspires in people a feeling of purpose,
    meaningfulness and so on. </p>
</blockquote>

<p>A number of institutional trends have joined to deprive the
individual of a sense of communal inspiration. Perhaps most
important is the economic element. Whereas the individual's
economic achievement formerly gave his life broad social meaning
and inspired his existence, automation and technological advance
have tended to depersonalize the individual's role in the
economy. Instead of the economic system being dependent on
individual productivity, the individual is increasingly dependent
on the system. As his work dwindles in significance to the total
society, it diminishes in meaning for him. Moreover, as more and
more of our people share the nation's affluence, Horatio Alger's
example is no longer needed to climb the economic ladder. </p>

<p>A particularly emphatic manifestation of the declining
economic demand on the individual is the institutionalization of
leisure time. Whereas the economy used to require long hours of
work, now it barely requires more than a five-day week. Expanding
vacation time and reduced work-weeks tend to diminish the
strength of the work ethic. The implications of enforced leisure
time are only now becoming apparent, and the concept of
&quot;idle hands are the devil's plaything&quot; has to be
reexamined in terms of acceptable forms of non-work behavior.
This new time component, allowing for the assertion of
individuality, has produced both privileges and problems. </p>

<p>In the last decade we have seen the beginnings of the
institutionalization of this leisure ethic. A leisure-time
industry has sprung up to organize this time period for the
individual. Many Americans, due to the nature of their jobs in an
automated economic system, find little personal satisfaction in
their work, and many are now searching for individual fulfillment
through the use of free time. Where meaning is not found in
either work or recreational pursuits, the outcome is likely to be
boredom and restlessness. Whether generated by a search for
individual fulfillment, group recreation or sheer boredom, the
increased use of drugs, including marihuana, should come as no
surprise. </p>

<p>Another social development which has chipped away at
individual identity is the loss of a vision of the future. In an
age where change is so rapid, the individual has no concept of
the future. If man could progress from land transportation to the
moon in 60 years, what, lies ahead? Paralleling the loss of the
technological horizon is the loss of a vision of what the future,
in terms of individual and social goals, ought to look like. Are
times moving too fast for man to be able to plan or -to adjust to
new ways and new styles? This sense of the collapsing time frame
was best summed up by one of the Seminar participants: </p>

<blockquote>
    <p>.... there are great forces that have developed over the
    last several decades that cause one to lose sight of the
    distant future. Let me contrast a rural farm family of
    several decades ago which settled a farm. They expected their
    children to live there, they can imagine their grandchildren
    living there-there is an image of the future. There is really
    no one who [now] has any image of where his great
    grandchildren will he or what they will do. This comes about
    because of the nature of industrial society; it comes about
    because we have retirement plans instead of looking after
    one's own old age. There area whole set of these [factors]. </p>
</blockquote>

<blockquote>
    <p>Now the morality, the ethics get tied into it because
    ethics are really a long-time horizon concept. It's something
    you engage in because it's contrary to immediate reward and
    immediate gratification and so you look to some distant
    future. But as one loses sight of any future then I think the
    ethics and morality creep up to the very near term also . . .
    We have no one who has got an image of this country two
    hundred years from now, who is trying to create a structure
    that be believes will exist that long. So a number of these
    things . . . tie together in terms of the long-term goals and
    how they have shifted. In any of our systems there tend to be
    a conflict between the short-term and the long-term goals. If
    the long-term goals are lost sight of then the short-term
    expediencies seem to be the things that well up. </p>
</blockquote>

<p>To the extent that planning for the future no longer gives the
individual his inspiration, he must look to the present. Such a
climate is conducive to pleasure-seeking, instant gratification
and an entire life-perspective which our society has always
previously disclaimed A third force depriving the individual of a
presumed place in society is the loss of a sense of community, a
sense of belonging. Mobility, mass living and rapid travel all
conspire to destroy the smaller community. The family moves from
place to place and then separates with each child going his own
way. This global thinking leaves little time for home-town
concern. </p>

<p>The dissipation of geographic roots parallels a social
uprooting. As one of our Seminar participants noted: </p>

<blockquote>
    <p>When you grow up with a, small number of people with whom
    you have to live for a while, it does something which isn't
    done now. It forces you to face yourself. It forces you to
    ask what kind of pet-son you are, because you can't get away
    with it with a group you're going to have to live with. They
    know what you really are. The mobility has the effect of
    making it possible for people to live playing parts for
    years. It seems to me we see it among the youngsters: role
    playing as distinguished from being somebody. . . . </p>
</blockquote>

<p>All of these social trends have their most potent impact on
young people who are just beginning to develop their values,
beliefs and commitments. The adult society has found it easier to
adjust to the emergence of the leisure value. Having experienced
it as a gradual process, they see it as a reward for previous
toil. For many of our young, however, a substantial segment of
leisure time may be considered an essential part of living; they
have known no other experience. Similarly, an adult society,
increasingly influenced toward the present, at least has
developed an historical perspective. Also, adult values were
internalized at a time when a future vision was possible. For
many of the young, however, the present weighs more, heavily.
This notion is best reflected in the vociferous youth response to
the Vietnam conflict, the embodiment of a war fought for the
future, </p>

<p>Finally, all of these cultural changes have occurred,
especially for the young, in an environment of affluence. The
successful economic system has maximized individual freedom. But
the individual has been given unlimited choices at exactly the
time when a, value system within which to make such choices is in
doubt. Because he has no sense of direction, the result is
restlessness, boredom and an increase in the likelihood of
present-oriented choices. Self-destructive drug-taking is one
form such behavior may take. One of our Seminar participants
observed in this connection: </p>

<blockquote>
    <p>It seems to me that you've got this affluence. So that
    while most of us grew up with the feeling that the channels
    within which we were going to have to move and make choices
    were very narrow, channels for these youngsters look
    absolutely open. It's an absolutely a, la carte menu-it's the
    biggest a la, carte menu you can imagine. [This occurs] in a
    situation in which this sense of radical change is going on
    so fast that you can't master it, together with a feeling
    that the society is being operated by very large
    organizations which you can't get a grip on, giving one a
    sense of helplessness, of not knowing where to take hold. All
    these things inherently are disorienting to youngsters and
    don't give them a, feeling of challenge, [but rather] a doubt
    as to the meaning of their own lives, of the significance of
    their being here, [a sense of] being atoms. So then they do
    act like children in the sense of behaving violently to call
    attention to themselves. They do a whole lot of other things
    which, it seems to me, are the sort of things you often see
    when people feel their lives have no meaning. </p>
</blockquote>

<p><b>Skepticism</b> </p>

<p>Another major influence in contemporary American life with
substantial relevance to the marihuana problem is the uneasy
relationship between the individual and society's institutions,
particularly the state. For 50 years, there has been a continuing
upward flow of power to large institutional units, whether they
be corporate conglomerates, labor unions, universities or the
Government. We have created a society which &quot;requires the
individual to lean on society,&quot; observed one of our Seminar
participants, &quot;in ways that formerly he did not have to do.
He used to lean on the clan, on the family, on the village. We
have used bureaucracy to deal with these problems.&quot; For
many, the Federal Government epitomizes this development,
bureaucratizing a social response to the most human of needs. </p>

<p>We suspect that the implications of this trend for the
individual, although inevitable, became more visibly apparent in
the 1960's. Mass institutions must deal through rules; the
individual becomes a number. &quot;Intuitively, [the individual]
feels that bureaucracies must make man into an object in order to
deal with him.&quot; So we have a depersonalization at exactly
the time that many individuals are casting about for identity and
fulfillment. </p>

<p>Simultaneously, technological advance poses the awesome
prospect of 1984: the intrusion of the omnipresent state into the
private affairs of the individual. Computerized data-banks and
electronic surveillance are perceived as restrictions on
individuality at a time when the desire for personal privacy is
ascendant. </p>

<p>Another cultural feature of governmental bureaucracy during
the sixties has been failure to match expectations. Government
promises the elimination of poverty, the dissipation of racial
discrimination, the excision of drug abuse, and creates rising
expectations. But government is often ill-equipped or unable to
perform such monumental tasks. As individual helplessness
increases, as the &quot;responsibility&quot; of the bureaucracy
enlarges, those in need often feel that the gap between public
declaration and performance must be the result of a conspiracy to
fail. And for the rest of us, there is the credibility gap. The
net result is a loss of confidence in society's institutions.
Viewed from this perspective, youthful dissent, cynicism and
disobedience of the 1960's were not such surprising consequences.
</p>

<p>Still another significant feature of institutional life in
contemporary America is the lag between purpose and
implementation. That is, some of our social institutions have not
yet begun to deal with the consequences of the social and
economic changes which have occurred over the last several
decades. The best example, and the one most germane to the youth,
is the educational system. Two generations ago, the labor force
could assimilate the large majority of the nation's youth.
Neither a high school nor a college education was prerequisite to
occupational choice or achievement. Increased educational
attainment was presumed to be limited to either the privileged or
the able and would be rewarded by certain careers. </p>

<p>Today, however, the labor force grows more quickly than the
system is able to assimilate it, and the educational system now
serves as custodian as well as teacher. Although we sincerely
wish to achieve the democratic ideal of a highly educated
populace, we also keep our children in school as long as possible
because we have nothing else for them to do. The trend is
strikingly apparent even in the last 20 years.<br>
</p>

<table border="1">
    <tr>
        <td></td>
        <td colspan="2"><b>Percent enrolled in school</b></td>
    </tr>
    <tr>
        <td><b>Age</b></td>
        <td><b>1950</b></td>
        <td><b>1970</b></td>
    </tr>
    <tr>
        <td>14-15</td>
        <td>94.7</td>
        <td>98.1</td>
    </tr>
    <tr>
        <td>16-17</td>
        <td>71.3</td>
        <td>90.0</td>
    </tr>
    <tr>
        <td>18-19</td>
        <td>29.4</td>
        <td>47.7</td>
    </tr>
    <tr>
        <td>20-24</td>
        <td>9.0</td>
        <td>21.5</td>
    </tr>
</table>

<p>This custodial function confronts educators with a dilemma.
Attrition is not in society's best interest; thus, single-minded
devotion to the highest levels of achievement would be
dysfunctional. In a sense, because the system no longer wants to
turn away its subjects, the notion of failure has lost its
meaning. As one of the Seminar participants observed: </p>

<blockquote>
    <p>I think one of the problems is that there is no longer a
    penalty for failure. We-the educators-have had to lower
    standards in order to accommodate these people who need no
    longer fear failure. Of course this has been a cyclical
    thing, a wheel within a wheel. [If ] there is no longer a
    penalty for failure, then there is no longer the need to
    acquire. </p>
</blockquote>

<p>The changing function of education has been felt in both the
secondary schools and in our institutions of higher learning.
Numerous high school graduates cannot read. Colleges and junior
colleges have sprung up overnight to accommodate the population,
but many provide classrooms with little specific purpose. Only
slowly is the educational system beginning to come to grips with
its role in a changed society. At the university level, many
educators have been appalled at sacrifices which have ensued from
the custodial feature; rote learning, they contend, has
supplanted citizen and character education. </p>

<p>Uncertainty about the role of the educational system has not
escaped the students, particularly at the college level. Many of
our youth, pressed into longer attendance, question its need or
desirability. The demand for &quot;relevance&quot; is but another
reflection of the search for meaning, for an understandable role
in society. Drug use has perhaps provided an outlet for some
members of this restless generation, uncertain of its place. </p>

<p><b>The Limits of Rationality</b> </p>

<p>The social response to the individual's search for meaning has
fostered an ambivalence, an unwillingness to act, a paralysis. In
large measure, according to one Seminar member, this default of
authority reveals the intensity of the search: </p>

<blockquote>
    <p>In the same way we are getting universities that can't
    teach, families that can't socialize and police forces that
    can't catch criminals. In every case, the same issue is
    involved: the subject of authority questions the legitimacy
    of authority and the exerciser of it is unable to find-very
    often doesn't even try to find-a defense, because he feels in
    himself a sympathy, as do so many parents, with the
    challenge. </p>
</blockquote>

<p>To a significant extent, society is waiting, hoping that the
impulse for change will settle around certain fundamental
attributes of the American ethic. At the present time, however,
no consensus about the nature of these fundamentals exists. We
are all looking for values that have deep roots, as we attempt to
sort out the durable from the ephemeral. </p>

<p>All of the participants at our Central Influences Seminar
agreed that the unique feature of this search was its a rational
quality. As one observer put it: </p>

<blockquote>
    <p>We have been discussing the question of how we change a
    society. I don't think it's changed by rational intention. As
    I understand societies, historically and our own, what really
    is required to change it is something on a deeper level that
    involves myth, ritual, sacrament-a number of these functions
    that have always been related to societies. On these you
    can't just suddenly make up your mind and then prescribe. </p>
</blockquote>

<blockquote>
    <p>Regarding our problem of authority, you cannot really ask
    the question: why can't these people hang onto their
    authority? They can't hang onto it because what gave them
    authority is something not of themselves, but part of the
    society, part of a ritual, a sacrament: a way of behaving in
    the group which gave them authority, [whether] professorial,
    parental or policy authority. In each one of these cases,
    what we see is not the diminishing of these men so much but
    rather the developing emptiness, the lack of the particular
    ethic that gave them authority to start with. This is why we
    are in a terrible dilemma. </p>
</blockquote>

<blockquote>
    <p>What is essentially lacking is a system of ethics,
    morality or religion that gives birth -to the myths, the
    rituals, the sacraments that are its expression. These touch
    human beings on the unconscious level. These are the ways we
    see the world. They are not our conscious thought, but the
    ways we form ourselves, form each other, love each other or
    hate each other-in terms not so much of rational intention as
    a deeper unconscious-conscious and unconscious-which is my
    definition of a myth; much more of a feeling level, a living
    level. That is what is not present now. </p>
</blockquote>

<blockquote>
    <p>What we need, below and above all of our deliberations, is
    the growth and development of an ethical system. We just do
    not have this now. </p>
</blockquote>

<p>As we move into the 1970's, our society is collectively
engaged in the task -of determining what America means, and how
each individual should find fulfillment in `a changing age. From
this wider perspective of flux emerges an uncertainty about what
the increased prevalence of marihuana use means for the
individual and the total society. </p>

<h2>Formulating Marihuana Policy </h2>

<p>Present symbolism, past implications, and future apprehensions
all combine to give marihuana many meanings. These diverse
notions of what marihuana means constitute the marihuana problem.
In this atmosphere, the policy-maker's position is precarious
insofar as no assumption is beyond dispute. Accordingly, the
Commission has taken particular care to define the process by
which a social policy decision should be reached. </p>

<p>In studying the arguments of past and present observers to
justify a particular kind of marihuana policy, we conclude that a
major impediment to rational decision-making in this area is
oversimplification. As suggested earlier, many ingredients are
included in the marihuana mix-medical, legal, social,
philosophical, and moral. Many observers have tended to isolate
one element, highlight it and then extrapolate social policy from
that one premise. In an area where law, science and morality are
so intertwined, we must beware of the tendency toward such
selectivity. </p>

<p><b>SCIENTIFIC OVERSIMPLIFICATION</b> </p>

<p>It is wrong to assume, as many have done, that a particular
statement of marihuana's effects compels a given social policy or
legal implementation. An accurate statement of the effects of the
drug is obviously an important consideration, but it is
conclusive only if the effects are extreme one way or the other.
For example, if the use of a particular drug immediately causes
the user to murder anyone in his presence, we have no doubt that
a vigorous effort to eliminate use of that drug would be in
order. On the other hand, if the effects of the drug are purely
benign, presenting no danger whatsoever to the user or society,
no reason would exist to suppress it. </p>

<p>We know of no psychoactive substance, including marihuana,
which falls at either of these extremes. Thus, it begs the issue
to contend, as some have done, that because we don't know enough
about the effects of heavy, chronic use, we should maintain the
status quo. We know a lot about the adverse effects of alcoholism
and heavy cigarette smoking, and yet no responsible observer
suggests that we should adopt total prohibition for these drugs.
Similarly, previous estimates of marihuana's role in causing
crime and insanity were based quite erroneous information; but to
infer from this that marihuana should be considered totally
benign and hence made freely available is also not logical. Both
approaches are simplistic; both approaches fail to take into
account the social context in which the drug is used and the
dynamic factors affecting the role that marihuana use may or may
not play in the future. </p>

<p>A similar manifestation of scientific oversimplification is
the focus on causality. Many opponents of marihuana use feel
compelled to establish a causal connection between marihuana use
and crime, psychosis, and the use of other drugs, while, their
adversaries focus the dispute on negating such relationships. The
Commission believes that this tendency misses the mark. </p>

<p>The policy-maker's task is concerned primarily with the
effects of marihuana on human behavior. For both philosophical
and practical reasons, proof of causal relationships is next to
impossible. At the same time, however, the extent to which
marihuana use is associated with certain behaviors and whether
any significant relationships exist can offer important clues. </p>

<p>We must be cautious when dealing with such data. Yet we cannot
afford to paralyze the decision-making process simply because
absolute &quot;proof &quot; is lacking. Spokesmen on both sides
of the marihuana debate should focus not on causation but instead
on the relevance of the association between various behavioral
effects and marihuana use. </p>

<p><b>PHILOSOPHICAL OVERSIMPLIFICATION</b> </p>

<p>Some partisans stoutly maintain that the state has no right to
interfere with essentially private conduct or that the state has
no right to protect the individual from his own folly. Some of
the greatest minds of the Western world have struggled over such
philosophical issue always with the same outcome: a recognition
of the need to draw a line between the individual and his social
surroundings. That is, everything an individual does, in private
or not, potentially may affect others. The issue is really to
determine when the undesirable effect upon others is likely
enough or direct enough for society to take cognizance of it and
to deal with it. Coupled with this is the further question of
whether the nature of the behavior and its possible effect is
such that society should employ coercive measures. </p>

<p>Advocates of liberalization of the marihuana laws commonly
contend either that the decision to use marihuana is a private
moral decision or that any harm flowing from use of the drug
accrues only to the user. Defenders of the, present restrictions
insist that society not only has the right but is obligated to
protect the existing social order and to compel an individual to
abstain from a behavior which may impair his productivity.
Unfortunately, the issue is not so simple and the line often
drawn between the private conduct and behavior affecting the
public health and welfare, is not conclusive or absolutely
definable. </p>

<p>For example, a, decision to possess a firearm, while private
is considered by many to be of public magnitude, requiring
governmental control. A decision to engage in adulterous conduct,
although generally implemented in private, may have public
consequences if society believes strongly in the desirability of
the existing family structure. Similarly, excessive alcohol
consumption, in addition to its adverse effects on individual
health, may impair familial stability and economic productivity,
matters with which the total society is concerned. </p>

<p>So, while we agree with the basic philosophical precept that
society may interfere with individual conduct only in the public
interest, using coercive measures only when less restrictive
measures would not suffice this principle merely initiates
inquiry into a rational social policy but does not identify it.
We must take a careful look at this complicated question of the
social impact of private behavior. And we must recognize at the
outset the inherent difficulty in predicting effects on public
health and welfare, and the strong conflicting notions of what
constitutes the public interest. </p>

<p>Again and again during the course of our hearings, we have
been startled by the divergence of opinion within different
segments of our population. Sometimes the disagreement is quite
vehement, and relates to the underlying social concerns of
particular groups. For example, we were told repeatedly by
leaders of the urban black communities that they wanted to purge
all drug use from their midst, marihuana included, and that the
&quot;legalization&quot; of marihuana would be viewed as part of
a design to keep the black man enslaved. </p>

<p>On the other hand, we were informed repeatedly by the activist
student element that the pre-sent social policy regarding
marihuana was merely a tool for suppression of political dissent,
and until the law was changed, there could be no hope of
integrating the dissident population into the mainstream of
American society. </p>

<p>Such statements reemphasize the degree to which marihuana is
regarded as a symbol of a larger social concern. </p>

<p>The conflicting notions of the public interest by different
segments of the population reinforced in the Commission's
deliberations the realization that we have been called upon to
recommend public policy for all segments of the population, for
all of the American people. The public good cannot be defined by
one segment of the population, the old or the young, users or
non-users of marihuana, ethnic minorities or white majority. At
the same time, the fears of each of these groups must be taken
into consideration in arriving at the basic social objectives of
the Commission's public policy recommendation. Where such fears
are real, they must be confronted directly; where they are
imagined, however, they must be put in perspective and,
hopefully, laid to rest. </p>

<p><b>SOCIOLOGICAL OVERSIMPLIFICATION</b> </p>

<p>Public debate and decision-making in our society suffer from
the glorification of statistical data. After a particular social
phenomenon, such as marihuana use, has been defined as a problem,
armies of social scientific researchers set out to analyze and
describe the problem. A sophisticated computer technology
instantly translates millions of bits of data into correlations,
probabilities and trends. The most striking findings are then fed
to a data-hungry public. The result is data overload. </p>

<p>Descriptive information about the nature and scope of
marihuana use as a behavior is an essential component of the
policy-maker's knowledge-base. However, such information does not
in itself have social policy implications. The policy-maker must
define goals and evaluate means; only after he asks the right
questions will statistical data suggest useful answers.
Unfortunately, a tendency exists in the marihuana debate to
assign prescriptive meanings to descriptive data without testing
the underlying assumptions. Further, the data have often been
accumulating in a fragmented way. No overall plan was devised
beforehand; the result has been an ad hoc use of available data
triggered by individual research interests rather than by
long-term policy needs. </p>

<p>What does it mean that 24 million people have tried marihuana?
Some have suggested that it means marihuana ought to be
legalized. But does it mean the same thing if 15 million tried
the drug once and have decided not to use it again? And does it
mean the same thing if popular interest in the drug turns out to
be a passing fancy, which wanes as suddenly as it waxed? </p>

<p>On the other side of the controversy, what does it mean that a
substantial percentage of the public would favor increased
penalties for marihuana use? The prescriptive implications of a
democratic impulse may be offset by a preference for individual
freedom of choice. Also, this segment of public opinion may have
been influenced by incorrect information, such as unwarranted
belief in marihuana's lethality or addiction potential. So,
although the policy-maker must be aware of political realities,
he must not allow his function to be supplanted by public opinion
polls. This is an area which requires both awareness of public
attitudes and willingness to assert leadership based on the best
information available. </p>

<p><b>LEGAL OVERSIMPLIFICATION</b> </p>

<p>Perhaps the major impediment to rational decision-making is
the tendency to think only in terms of the legal system in
general and of the criminal justice system in particular. This
thinking is certainly understandable, given the history of
marihuana's involvement with the criminal law. Nonetheless, the
law does not exist in a social vacuum, and legal alternatives can
be evaluated only with reference to the values and policies which
they are designed to implement and the social context in which
they are designed to operate. </p>

<p>Legal fallacies are apparent on both sides of the marihuana
controversy. Many of the persons opposed to marihuana use look
exclusively to the law for social control. This reliance on the
law is stronger today because many of our fellow citizens are
uneasy about the diminishing effectiveness of our other
institutions, particularly when the non-legal institutions have
been relatively lax in controlling drug related behavior.
Increasing reliance is placed upon the legal system to act not
only as policeman, but as father confessor, disciplinarian,
educator, rehabilitator and standard-bearer of our moral code.
Little or no thought is given to what impact this over-reliance
on the law has on the viability of other social institutions, not
to mention it's effect on the legal process. </p>

<p>A society opposed to marihuana use need not implement that
policy through the criminal law. Non-legal institutions, such as
the church, the school and the family, have great potential for
molding individual behavior. Accordingly, the policy-maker must
delicately assess the capacity of the legal system to accomplish
its task and must consider the mutual impact of legal and
non-legal institutions in achieving social objectives. </p>

<p>We recognize the short-sightedness of an absolute assumption
that the criminal law is the necessary tool for implementing a
social policy opposed to marihuana use. But equally short-sighted
is the opposing contention which attempts to analyze the law
separately from its underlying social policy objective. This
argument assumes that if the law isn't working, or if the costs
of enforcing the law outweigh its benefits, the law should,
therefore, be repealed. </p>

<p>If society feels strongly enough about the impropriety of a
certain behavior, it may choose to utilize the criminal law even
though the behavior is largely invisible and will be minimized
only through effective operation of other agencies of social
control. Laws against incest and child-beating are good examples.
In weighing the costs and benefits of a particular law, one must
provide a scale and a system of weights. The scale is the
normative classification of behavior, and the system of weights
is the largely subjective evaluation of the importance of the
values breached by the behavior. This weighing process is what is
open to dispute. </p>

<p>In sum, no law works alone. Where an unquestioned consensus
exists about the undesirability of a particular behavior and all
social institutions are allied in the effort to prevent it, as is
the case with murder and theft, the law can be said to
&quot;work&quot; even though some murders and thefts may still be
committed. Where society is ambivalent about its attitude toward
the behavior and other institutions are not committed to its
discouragement, the law cannot be said to be working, even though
many people may not engage in the behavior because it is against
the law. </p>

<p>The question is whether the social policy, which the law is
designed to, implement, is being achieved to a satisfactory
extent. To determine the role of law regarding marihuana, we must
first look to society's values and aspirations, and then define
the social policy objective. If we seek to discourage certain
marihuana-related behavior, we must carefully assess the role of
the legal system in achieving that objective. </p>

<h2>The Report </h2>

<p>In this Chapter, we have tried to put the marihuana problem in
perspective. In the remainder of this Report, we explore several
aspects of the phenomenon of marihuana use, its effects, its
social impact and its social meaning, assessing their relative
importance in the formulation of social policy. </p>

<p>In Chapter II, we consider the effects of the drug on the
individual user, with particular attention to the size of the
user population for whom various effects are relevant. The
Commission emphasizes that this material is related only
indirectly to its policy-making function. The social policy
planner is concerned not about the effects on the individual per
se, but about the impact of any adverse effect on his behavior
and on the larger society and about the meaning of this behavior
in the larger social perspective. The material in Chapter II
serves primarily to educate and inform. </p>

<p>In Chapter III, the Commission evaluates the various threats
which marihuana use is perceived to present to the public safety,
public health, and dominant social order. This Chapter is
designed to assess the social impact of marihuana use, the
initial step in the policy making process. </p>

<p>In Chapter IV, we consider what role marihuana use plays and
will play in the life of American society. This is the dynamic
element of marihuana use and is the most intangible of the
marihuana realities, but is particularly important from a
policy-planning perspective. This consideration is the one most
overlooked by contemporary observers and participants in the
marihuana debate. </p>

<p>Because social meaning is not a directly measurable entity, we
must examine the ways in which society responds to the behavior
and whether such responses, both formal and informal, are fluid
or. static. After analyzing public opinion, law enforcement
behavior and the reactions of medical, educational, and other
segments of the population, we then discuss what marihuana use
has come to mean and is likely to mean in the future.
Particularly important in this highly speculative endeavor is the
wider cultural perspective which we described earlier in this
Chapter. </p>

<p>In Chapter V, we bring this information to bear on a
policy-making process. After establishing the philosophical
framework, we explore the spectrum of social policy options,
choosing the one we judge most suitable to the present time. Then
we consider the range of legal alternatives for implementing this
chosen policy, and select the one we believe to be most
appropriate for achieving it. </p>

<p>In an addendum to the Report, we present some ancillary
recommendations. Some of these recommendations flow from our
basic premise, others are a result of independent evaluation by
the Commission of other areas of concern. </p>

<p>We ask the reader to set his preconceptions aside as we have
tried to do, and discriminate with us between marihuana, the
drug, and marihuana, the problem. We hope that our conclusions
will be acceptable to the entire public, but barring that, we
hope at the least that the areas of disagreement and their
implications will be brought into sharper focus.<br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/scmj_sig_of_mis_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="ncmenu.htm">Marihuana, A Signal of Misunderstanding</a></p>

<p>&nbsp;</p>
<!--webbot bot="Include" endspan i-checksum="38989" -->

<p><br>
<br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-60</DOCNO>
<DOCOLDNO>IA031-000655-B038-313</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/library/studies/nc/ncchap2.htm 206.61.184.43 19970122112805 text/html 104889
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:27:52 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:53:45 GMT
Content-length: 104670
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Marihuana Use and Its Effects</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include"
u-include="../../../../_private/scmj_sig_of_mis_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="ncmenu.htm">Marihuana, A Signal of Misunderstanding</a></p>

<p>&nbsp;</p>
<!--webbot bot="Include" endspan i-checksum="38989" -->

<p><b>The National Commission on Marihuana and Drug Abuse</b> </p>

<p><b>Marihuana - A Signal of Misunderstanding.</b> </p>

<p><b>Chapter II</b> </p>

<h1>marihuana use and its effects<br>
</h1>

<hr>

<p>&quot;Facts are stubborn things; and whatever may be our
wishes, our inclinations, or the dictates of our passions, they
cannot alter the state of facts and evidence.&quot; John Adams
(1770) <br>
</p>

<hr>

<p>The ultimate objective of the Commission is to evaluate the
total impact of actual and potential marihuana use on
contemporary American society. This endeavor involves three
phases: first, an evaluation of the nature and scope of
contemporary American marihuana use; second, a careful
reevaluation of the pharmacological effects of the drug on the
human body with special emphasis on the drug's capacity to alter
or modify behavior; and third, an evaluation of the impact of
marihuana use on society. This chapter deals with the first and
second phases, and Chapter Three deals with the third.<br>
</p>

<p align="center"><b>The Marihuana User <br>
</b></p>

<p>Cannabis has been used widely for many centuries in
nonindustrialized countries of Asia and Africa. Today, as in
earlier years, use of drug is concentrated primarily among lower
socioeconomic groups. in these countries, the practice is
estimated to be confined to a tenth of the lower socioeconomic,
male population. Although such use of the drug is
well-established, it offers little direct comparison with the
American experience. </p>

<p>Although the commercial, industrial and therapeutic value of
the hemp plant was widely recognized and exploited in the United
States from the earliest days of its history, knowledge and use
of its intoxicating and psychoactive properties remained largely
unknown until about 1900. </p>

<p>At that time, the custom of smoking marihuana was generally
limited to groups of Mexican itinerant workers in the border
states of the Southwest. By 1910, marihuana use began to emerge
in other southern states and cities, particularly New Orleans,
and in the port cities along the Mississippi River. In time,
these cities became distribution centers for enterprising
sailors. From there, marihuana use spread cross-country to other
urban centers, mining camps, railroad construction sites, farm
labor camps, &quot;bohemian&quot; communities of artists and jazz
musicians, and various other groups outside the mainstream of
American society.<br>
</p>

<p>Recently, of course, use of the drug has spread to young,
white, middle class groups and especially to high school and
college populations.<br>
</p>

<p align="center"><font size="2"><b>DEMOGRAPHIC CHARACTERISTICS <br>
</b></font></p>

<p>On the basis of the Commission-sponsored National Survey, we
have concluded that contemporary marihuana use is pervasive,
involving all segments of the U.S. population. The Survey
estimated that about 24 million Americans over the age of 11
years (15% of the adults 18 and over, and 14% of the 12-17 year
olds) have used marihuana at least once, referred to in this
Report as ever-users. Until recently twice as many males as
females had used it; the most up-to-date studies of high school
students, college-age individuals, and young adults carried out
by the Commission indicate that this sex differential appears to
be diminishing. In many youthful populations use is almost
equally distributed between males and females. </p>

<p>Marihuana use does not appear to vary significantly by race.
With respect to the religious affiliation of the users, Jews and
Catholics appear to be slightly overrepresented as compared to
Protestants. </p>

<p>Usage is highest in cities, towns, and suburbs but not
uncommon in rural areas. States in the Northeast and West have
considerably higher rates of use than have the North Central
states, which in turn have significantly higher rates than those
in the South. </p>

<p>Use is found in all socioeconomic groups and occupations,
though slightly more predominant among persons with above-average
incomes. A New York survey of the state's general population
indicated that ever-use as well as regular use is almost equally
prevalent among <font size="2">sales workers, clerical workers,
skilled, semiskilled and unskilled workers, managers, owners,
professionals and technical workers.</font> </p>

<p>At the same time, the incidence of use seems to vary according
to educational attainment. Among all adults not now in school, 5%
of those with an eighth grade education or less have used the
drug, contrasted with 11% of those who completed some high
school, 14% of those who graduated from high school, 25% of those
who completed some college and 21 % of those who graduated from
college. </p>

<p>Age is presently one of the most significant correlates of
marihuana use. Among the total population, those who have tried
or used marihuana at least once, termed ever-users, are heavily
concentrated in the 16-25 age bracket. Of all the ever-users,
about half are in this group. At the same time, however, we
should emphasize that use is by no means confined to teenagers
and young adults. <br>
</p>

<p>The proportion of individuals in different age groups who have
used marihuana is indicated in Figure 1.<br>
<br>
<img src="img00001.gif" align="bottom" width="1343" height="973"><br>
</p>

<p>The incidence of use is greatest among young people: 27% of
the 16-17 year olds, 40% of the 18-21 year olds, and 38% of the
22-25 year olds have tried marihuana; at the low extremes, 6% of
the 12-13 year olds and 6% of the over-50 generation have used
the drug. </p>

<p>Among those now in school, incidence also seems to rise with
increasing school level: Ever-users represent 44% of those
persons now in college or graduate school; 30% of high school
juniors and seniors; 17% of freshmen and sophomores; and 8% of
students in junior high school.<br>
</p>

<p>At the same time, the use of the drug among adults is by no
means confined to college students. Even among the 18-25 year
olds, 75% of the ever-users are not now in school. </p>

<p>The initial patterns of contemporary marihuana use appear to
be shifting; there is a trend toward increased use among college
students as well as non-college students. Non-student users now
span social class, income level and occupational classification.
In addition, the proportion -of users increases during the teens,
peaks during the young adult years and then falls off rapidly
(Figure 1). </p>

<p>Having described the incidence of any use of marihuana ever,
and demographic characteristics of the 24 million Americans who
have tried the drug, we recognize the need to place this
information into perspective. The policymaker must also be
concerned with the patterns of use: frequency, amount consumed at
each smoking, and duration of use. </p>

<p><font size="2"><b>PATTERNS OF USE<br>
</b></font></p>

<p>The most striking of the use patterns revealed in the National
Survey is that 41 % of the adults and 45 % of the youth who have
ever used marihuana reported that they no longer use the drug.
Twenty-nine percent of the adults and 43% of the youth reported
that they are still using marihuana (see Table 1). When asked why
they bad terminated use, the overwhelming majority of adults
(61%) specified, among other reasons, that they had simply lost
interest in the drug.<br>
</p>

<p><font size="2"><b>Table I.-EXPERIENCE WITH MARIHUANA<br>
</b></font></p>

<p><font size="2"><b>Percent of ever-users<br>
</b></font></p>

<p><font size="2"><b>Frequency</b> <b>Adults</b> <b>Youth</b> <b>Designation</b></font>
</p>

<p><font size="2"><b>(18 and</b> <b>(12-17)</b></font> </p>

<p><font size="2"><b>over)<br>
</b></font></p>

<p><font size="2"><b>Have used marihuana but no longer</b> <b>41</b>
<b>45</b></font> </p>

<p><font size="2">u <b>se.</b> <b>lExperimenters.</b></font> </p>

<p><font size="2"><b>Once a month or less</b> <b>9</b> <b>15<br>
</b></font></p>

<p><font size="2"><b>2-3 times pet month</b> <b>8</b> <b>10</b> <b>Intermittent
users.</b></font> </p>

<p><font size="2"><b>Once per week</b> <b>4</b> <b>9 @<br>
</b></font></p>

<p><font size="2"><b>Several times per week</b> <b>5</b> <b>4
Moderate users.</b></font> </p>

<p><font size="2"><b>Once daily</b> <b>1</b> <b>1 1<br>
</b></font></p>

<p><font size="2"><b>More than once daily</b> <b>2</b> <b>4 Heavy
users.</b></font> </p>

<p><font size="2"><b>No answer</b> <b>30</b> <b>12 <br>
<br>
</b></font></p>

<p>These data indicate that at least 41% of the adults and 45% of
the youth have used marihuana but have -discontinued use; 9% of
the adults and 15% of the youth use the drug sporadically, once
a, month or less. These persons can be characterized as
experimental marihuana users.* </p>

<p>To ensure an understanding of this section of the Report, some
definitions are required at this juncture. In this report, the
Commission employs the following designations:<br>
</p>

<p align="center"><font size="2"><i>Frequency of Use <br>
</i></font></p>

<p><font size="2">Experimental-At least one trial to once a month
or less.</font> </p>

<p><font size="2">Intermittent-Two to 10 times monthly.</font> </p>

<p><font size="2">Moderate-11 times monthly to once, daily.</font>
</p>

<p><font size="2">Heavy-Several times daily.</font> </p>

<p><font size="2">Very Heavy-Almost constant intoxication with
potent preparations; brain rarely drug free. <br>
</font></p>

<p align="center"><font size="2"><i>Duration of Use</i></font> </p>

<p><font size="2">Short Term-Less than two years.</font> </p>

<p><font size="2">Long Term-Two to 10 years.</font> </p>

<p><font size="2">Very Long Term-Over 10 years. <br>
</font></p>

<p>Twelve percent of the adults and 19% of the youth who have
ever used marihuana can be designated intermittent users; they
continue to use the drug more than once a month, but less than
several times a week, probably on weekends. Six percent of the
adults and five percent of the youth are moderate users who
continue to use marihuana several times a week to once daily. </p>

<p>Finally, 2% of the adults and 4% of the youth who have ever
used marihuana are heavy users: they use the drug several times
daily. A very small fraction of these heavy users may be very
heavy users, who are intoxicated most of their waking hours and
probably use very potent preparations of the drug. </p>

<p>In addition to frequency, duration of use is an important
variable in discussing use patterns and especially when
considering drug effects. Most users in this country have smoked
the drug over a short term, that is, less than two years. Others
have used the drug over a long term, two to 10 years. Very few
Americans can be considered very long term users, that is, over
10 years. </p>

<p>Another important element of use is the amount of marihuana
used on each occasion. Most intermittent and moderate users
average about one-half to one cigarette per occasion, usually at
night. Most heavy users smoke at least one to two cigarettes an
occasion, with a few using as many as five consecutively. </p>

<p>As this brief description of use patterns suggests, marihuana
use and the marihuana user do not fall into simple, distinct
classifications. Although it is possible to sketch profiles of
various marihuana-using populations, no valid stereotype of a
marihuana user or non-user can be drawn. The spectrum of
individuals who use or have used marihuana varies according to
frequency, intensity and duration of use. It is meaningless to
talk of &quot;the marihuana user&quot; or &quot;marihuana
use&quot; without first clarifying descriptive data.<br>
</p>

<p>*All respondents for the National Survey were asked to
complete a self administered questionnaire. This instrument
covered many sensitive areas, including a series of items on
personal experience with marihuana and other drugs. Given the
nature of the questions, the contractor took every precaution to
insure that the interviewee responded honestly and that his
responses were kept strictly confidential. Even the interviewer
who orally administered the rest of the Survey was not permitted
to view the written instrument. </p>

<p>One of the inevitable costs of such confidentiality is the
risk that a certain percentage of respondents would not complete
one or more of the questions. Where a significant number of
questions remained unanswered, the questionnaire was not
tabulated at all. However, in 30%, of the otherwise complete
questionnaires, the adult respondents who had ever used the drug
did not answer the question, &quot;On the average, about how
often do you use marihuana at the present time?&quot; </p>

<p>Concerned about the meaning of this non-response rate, the,
Commission directed the contractor to conduct a detailed analysis
comparing the non-respondents with all respondents and with those
individuals who had never used marihuana at all. On the basis of
this analysis, we are confident that the overwhelming majority,
if not all, of the non-respondents are experimenters. </p>

<p>In the flrst place, the demographic characteristics of the
non-respondents coincide closely with those of the non-users and
less frequent users. Very few of the young adults, where more
frequent use is concentrated, failed to respond. </p>

<p>Secondly, the non-respondents are disproportionately located
in the geographic regions where use was least prevalent and least
frequent. For example, 50% of the ever-users in the North Central
region failed to respond, compared to 71% in the West. Yet only
5% of the ever-users in the North Central region continue to use
the drug more than once a week, compared to 21% in the West; and
less than .5% of the ever-users in the North Central region use
the drug more than once a day, as compared to 4% in the West. <br>
</p>

<p align="center"><font size="2"><b>PROFILES OF USERS <br>
</b></font></p>

<p>Several studies by the Commission and many other recent
college and high school surveys have elucidated a variety of
personality types or categories of marihuana users. These
profiles relate primarily to the patterns depicted above and to
the meaning of marihuana use for various individuals. Essentially
we will describe a continuum with much overlapping among the
categories. The reader should understand that group
identification is at best a hazardous occupation; the traits
described are not exclusive to marihuana users. A much larger
number of individuals who have not used the drug can be similarly
described. <br>
</p>

<p><font size="2"><b>Experimental Users<br>
</b></font></p>

<p>The first and by far the largest group has been designated as
&quot;experimenters&quot; because of their extremely infrequent
or non-persistent marihuana usage. Experimentation with the drug
is motivated primarily by curiosity and a desire to share a
social experience. These experimenters are characteristically
quite conventional and practically indistinguishable from the
non-user in terms of life style, activities, social integration,
and vocational or academic performance. </p>

<p>Disciplined, optimistic, and self-confident, experimenters
appear to be as conventional, responsible, goal-oriented and
orderly as non-users.<br>
</p>

<p>Intermittent Users<br>
</p>

<p>The intermittent users are motivated to use marihuana for
reasons similar to those of the experimenters. They use the drug
irregularly and infrequently but generally continue to do so
because of its socializing and recreational aspects. For the
intermittent user, marihuana often contributes to the
establishment and solidification of close social relations among
users similarly inclined. The individual has a sense of belonging
to an intimate group. </p>

<p>Investigations of behavioral aspects of marihuana smoking
clearly demonstrate that marihuana smoking is a social activity,
believed by intermittent users to enhance the enjoyment of shared
activities, especially music, art, films and food. </p>

<p>In a Commission-sponsored study to determine the effects of
repeat doses of marihuana, under free access conditions, the
subjects smoked almost exclusively in groups. A certain number of
these individuals tended to share much of their leisure time in
common activities, and marihuana, smoking was the focal activity
around which other types of social interactions revolved, such as
conversation, watching TV, listening to music and playing games.
The intermittent users studied exhibited an increased sense of
well-being, relaxation, and friendliness during these activities.
They were more inclined to seek and emphasize the social rather
than personal effects of the drug. </p>

<p>Intermittent marihuana users, like the experimenters, are
generally conventional in most respects. They are more liberal
politically and socially and they tend to stress education for
personal improvement rather than for recognition or high grades.
Like many non-users, these individuals are likely to be
self-expressive, intellectually and culturally oriented,
creative, and flexible. Placing a high value on experimentation
and responsible, independent decision-making, they often manifest
a desire to search for new experiences, resulting in some
behaviors which depart from the norms of the larger society.
Often accompanying their search is a sense of uncertainty about
the future.<br>
</p>

<p>Moderate and Heavy Users </p>

<p>The final groups of marihuana users are the moderate and heavy
users. This range is wide and includes individuals who use
marihuana more than 10 times a month to several times a day.
Practically all of the American research effort to date has
focused on the large majority of individuals who use less often,
that is, the experimental and intermittent users. Consequently,
not enough is known about characteristics and behavior of the
moderate and the heavy users, so it is difficult to distinguish
accurately between the two groups. We suspect however that the
moderate users share traits with both the intermittent and the
heavy users. Having already discussed the intermittent group, we
will now turn to the characteristics of the heavy group. </p>

<p>Heavy users seem to need the drug experience more often. Their
initial and continued marihuana use is motivated not only by
curiosity and an urge to share a social experience but also by a
desire for &quot;kicks,&quot; &quot;expansion of awareness and
understanding,&quot; and relief of anxiety or boredom. </p>

<p>Generally, the heavy marihuana user's life style, activities,
values and attitudes are unconventional and at variance with
those of the, larger society. These individuals are more
pessimistic, insecure, irresponsible, and nonconforming. They
find routine especially distasteful. Their behavior and mood are
restless and uneven. </p>

<p>Heavy users place particularly strong emphasis on impulsive
response in the interest of pleasure-seeking, immediate
gratification, and individual expression. They tend to evidence
social and emotional immaturity, are especially indifferent to
rules and conventions, and are often resistant to authority.
However, several surveys have also revealed that they tend to be
curious, socially perceptive, skillful and sensitive to the needs
of others, and possess broadly based, although unconventional,
interests. </p>

<p>The Boston free-access study permitted the Commission to
observe a group of individuals whose life styles, activities,
values and attitudes are representative of a segment of the
unconventional youthful subculture. The month-long period of
controlled study during the fall prevented the participation of
individuals who were married, steadily employed, or enrolled in
school. </p>

<p>Individuals who smoked marihuana once a week or less were
sought by the researchers but were exceedingly unusual among the
population available for the study. Consequently, the group
studies contrasted with the student and full-time working
populations in which weekly marihuana use is more common. For
this reason, the intermittent users studied appeared to be
similar to, rather than different from, the moderate and heavy
users studied. Both groups had used marihuana for an average of
five years. </p>

<p>Under the study's confined conditions, participants tended to
smoke more marihuana than they did &quot;on the outside.&quot;
The intermittent users, who by our definition averaged eight
times a month under outside conditions, averaged three cigarettes
a day during the study. The range was from one-half to six
cigarettes daily. </p>

<p>The moderate and heavy users, who &quot;on the outside&quot;
averaged 33 times a month, now averaged six-and-a-half cigarettes
a day. The range was three-and-a-half to eight cigarettes. In
discussing the Boston study, we will call this group
&quot;daily&quot; users. </p>

<p>Smoking usually occurred at night, sometimes during the
afternoon and only occasionally upon awakening. The intermittent
and heavy users usually smoked one cigarette a session. The daily
users were more likely to smoke more than one a session. A few
individuals in the daily group could have been considered
constantly intoxicated on a few occasions during the 21 -day
period. </p>

<p>The mean age of the subjects studied was 23. Based on IQ
testing, they were superior intellectually, although they had
completed, on the average, only two-and-a-half years of college.
Their job histories were rather erratic, characteristic of a
pattern of itinerant living. The intermittent users -were from a
middle or upper class background, while the daily users generally
shared a lower socioeconomic status. Broken homes and instances
of alcohol or drug abuse were more common in the family
backgrounds of the daily users. </p>

<p>Alcohol was rarely used by the subjects. Use of hallucinogens
and amphetamines was significantly more widespread and had begun
earlier in the daily user group. In contrast to the intermittent
group, the daily users almost uniformly reported that marihuana
smoking produced relaxation, noting <b>also </b>increased
alteration <b>in </b>perception or psychedelic-like effects.
Similarly, they reported an increased sense of well-being,
friendliness, carefreeness and decreased hostility. Additionally,
the daily users appeared to demonstrate a moderate psychological
dependence <b>on </b>the marihuana experience while the
intermittent users demonstrated little or no psychological
dependence. </p>

<p>Analysis of social-behavioral aspects of daily users'
marihuana smoking clearly demonstrated that it is a pivotal
social activity around which conversation, other personal
interactions, and much of the users' lives revolve. Smoking
almost exclusively occurred in groups and was the focal activity
around which these groups formed. The daily users exhibited a
readiness to take part in but not to initiate a smoking session. </p>

<p>In contrast to the intermittent users, all the daily users in
a group smoked when marihuana was made available. Marihuana
smoking appeared to be a primary means of reinforcing group
solidarity. Yet these users were more inclined to seek the
personal effects of the drug rather than the socializing effects
sought by the intermittent users. </p>

<p>The social adjustment of the daily users, when judged from a
traditional psychiatric standpoint, was impaired. Individuals
tended to be more withdrawn and to interact less with each other
than the intermittent users, regardless of the type of activity
or state of intoxication. However, the daily users did appear to
accommodate themselves better than the intermittent users to the
effects of the intoxication on social interaction.<br>
</p>

<p>Despite a relatively high level of scholastic attainment and
superior intelligence, many of the subjects were performing well
below their intellectual capability, usually working at menial,
mechanical or artisan tasks. They were not oriented toward
achieving the traditional goals of the larger society. </p>

<p>Nonetheless, during the period of the Boston study, the
subjects could not be characterized as displaying a general
lassitude and indifference, carelessness in personal hygiene or
lack of productive activity, all supposed to be characteristic of
very heavy use. Even during the periods of heaviest marihuana
smoking, they maintained a high level of interest and
participation in a variety of personal activities, such as
writing, reading, keeping up on current world events, and
participating in athletic and aesthetic endeavors. </p>

<p>Additionally, all of the subjects maintained a desire to
complete all aspects of the research study. Although they could
be labeled 'underachievers&quot; in terms of the traditional
standards of the larger society, these individuals were motivated
to pursue actively the interests and activities of their <b>own </b>subculture.
</p>

<p>Generally, most studies which have been undertaken indicate
that individuals who are heavy marihuana users cannot find a
place for themselves in conventional society. Their heavy
marihuana use may reflect and perhaps perpetuate their
unconventionality while providing social acceptance in one of the
non-conventional subcultures.<br>
</p>

<p><font size="2"><b>Very Heavy Users<br>
</b></font></p>

<p>The Commission's analysis of frequency, quantity and duration
of marihuana use suggest that the United States is at the present
time in a fortunate position. All of the studies available to the
Commission have indicated that only a minute number of Americans
can be designated as very heavy marihuana users. These studies
uniformly indicate that chronic, constant intoxication with very
potent cannabis preparations is exceedingly rare in this country.
</p>

<p>The Commission believes that important distinctions must be
made between the daily (moderate and heavy) American marihuana
user and the very heavy hashish or charas user in other parts of
the world where cannabis is widely cultivated and its use deeply
ingrained. Many of the North African and Asian users do not
employ the drug only as an intoxicant in the western sense.
Instead, it is frequently used in &quot;folk medical
practice,&quot; in religious rites and as a work adjunct
particularly in those occupations which are physically demanding,
monotonous, unintellectual, and offer little possibility of
advancement. </p>

<p>In these countries, very heavy use is typically associated
with young males from a lower socioeconomic background.
Nonetheless, use is more widespread among all ages and elderly
chronic users are not uncommon. </p>

<p>Generally, these very heavy users consume high amounts of very
potent preparations continually throughout the day so that they
are rarely drug-free. These individuals evidence strong
psychological dependence on the drug, requiring compulsive
drug-taking. Clear-cut behavioral changes occur in these extreme
cases. The very heavy User tends to lose interest in all
activities other than drug use. A common element of the
behavioral pattern is lethargy and social deterioration. Not
surprisingly, these users have been held in low esteem and very
heavy use has been subject to societal disapproval in almost all
countries.<br>
</p>

<p align="center"><font size="2"><b>BECOMING A MARIHUANA USER<br>
</b></font></p>

<p>Our attempt to classify marihuana users is primarily for
descriptive purposes. It does not imply that all individuals who
resemble any of the categories are necessarily marihuana users.
Nor is it implied that all marihuana users fit neatly or
precisely into these slots. There is no &quot;typical&quot;
marihuana user, just as their is no typical American. The most
notable statement that can be made about the vast majority of
marihuana users-experimenters and intermittent users-is that they
are essentially indistinguishable from their non-marihuana using
peers by any fundamental criterion other than their marihuana
use. </p>

<p>But if most users and non-users of marihuana essentially are
indistinguishable, why have some people chosen to use the drug
and others not, and why have some people continued to use it and
others not? An important part of the explanation is that use of
marihuana, like all human behavior, occurs within specific social
and cultural settings. The individual's biological
characteristics and personality probably play an important role
in determining the pattern his use will take. However, the
cultural and social setting play a larger role in determining
whether be will use it at all. </p>

<p>Numerous studies have demonstrated that the young person who
chooses to use marihuana differs in some important sociological
respects from his peer who does not choose to do so. These
differences relate to his willingness to experiment with a drug,
especially a forbidden one. in short, the process of becoming a
marihuana user is not a &quot; seduction of the, innocent&quot;
as is often portrayed. Based on interrelated familial, social and
cultural factors, persons, especially young persons, who may
choose to use marihuana can be predicted statistically.<br>
</p>

<p><font size="2"><b>Parental Influence<br>
</b></font></p>

<p>The decision to use marihuana is related to parental life
style. </p>

<p>Parents provide the most important example of acceptable
drug-taking behavior for their children. That marihuana users
frequently have medicine-taking, cigarette-smoking, or
liquor-drinking parents has been demonstrated. In a series of
Canadian studies, grade and high school students who said their
mothers took tranquilizers daily were three times more likely to
try marihuana than the students who did not so report. </p>

<p>Beyond the influence of a drug-taking example, parents have
the primary influence on their childrens' acquisition of skills,
values and attitudes necessary to be mature and responsible
adults. Many parents have oriented their children toward becoming
independent, competent, educated, and adaptive adults. </p>

<p>Simultaneously, many young people observe in their parents'
lives the trend toward shorter work periods, earlier retirement
and increased emphasis on leisure time activities. It appears
that the incidence of adolescent marihuana use is strongly
correlated with this trend toward increased leisure time.<br>
</p>

<p><font size="2"><b>Situational Factors and Behavioral
Correlates </b></font></p>

<p>All studies of the ever user, including the
Commission-sponsored National Survey, have established that
marihuana smoking is significantly correlated with a number of
demographic variables. Males, college students, and residents of
metropolitan areas, especially in the Northeast and West, are
generally overrepresented in proportion to their percentage of
the total population. </p>

<p>Among the behaviors statistically correlated with marihuana,
use are radical politics, visits to psychiatrists, sexual
freedom, and separate residences from parents. The most
significant behavior seems to be use of legal drugs, especially
alcohol and tobacco. Young people who choose to experiment with
marihuana are fundamentally the same people, socially and
psychologically, as those who use alcohol and tobacco. For
example, in a study of high school youngsters, only 3% of all the
nonsmokers in the sample had ever tried marihuana, compared with
50% of all the current cigarette smokers. Similarly, for alcohol
drinking outside the family setting, only 2% of all the
nondrinkers had tried marihuana, as compared to 27% of the
drinkers. The National Survey tends to confirm the close
association between marihuana use and cigarette smoking and
alcohol use. Among all the adults sampled in the Survey, 71% had
smoked cigarettes and 39% are current smokers. Similarly, of
adult non-marihuana users, 70% have smoked cigarettes and 38% are
current smokers. These percentages increase somewhat for
marihuana users: 87 have smoked cigarettes and 54% are current
cigarette smokers. </p>

<p>In regard to alcohol consumption, 40% of all the adults
sampled indicated that they had not consumed beer or bard liquor
in the 30 days prior to the survey. Marihuana users tended to
have consumed alcohol more often than non-marihuana users (Table,
2).<br>
</p>

<p><font size="2"><b>Table 2.-LIQUOR CONSUMPTION DURING 30-DAY
PERIOD <br>
</b></font></p>

<p><font size="2"><b>1-4</b> <b>5-10</b> <b>11 or</b> <b>No</b></font>
</p>

<p><font size="2"><b>0 days</b> <b>days</b> <b>days</b> <b>more</b>
<b>answer</b></font> </p>

<p><font size="2"><b>days<br>
</b></font></p>

<p><font size="2"><b>Percent of nonmarihuana users. .</b> <b>45</b>
<b>19</b> <b>6</b> <b>7</b> <b>21</b></font> </p>

<p><font size="2"><b>Percent of marihuana users</b>...... <b>26</b>
<b>30</b> <b>12</b> <b>8</b> <b>24<br>
<br>
</b></font></p>

<p><font size="2"><b>Social Group Factors<br>
</b></font></p>

<p>One of the most influential factors in determining behavior in
contemporary America among adolescents and young adults is peer
group influence. Knowing other people who use marihuana
predisposes the individual to use marihuana, and having
marihuana-using friends provides the social opportunity for the
curious. Ile individual who is already part of a, social group
which uses marihuana indicates by this choice that his attitudes
and values are already to some degree compatible with illicit
drug use. </p>

<p>Social peer groups are especially influential upon individuals
who have not yet become &quot;successful&quot; adults, such as
adolescents, college students and young adults, who spend a great
deal of time and effort competing for status in situations where
status opportunities are minimal. The social peer group provides
an opportunity for achieving status among equals by demonstrating
competence and autonomy. Outstanding performance in athletics,
organizations or academics demonstrates competence but not
autonomy because these activities are adult-oriented and
controlled. Additionally, only a relative few are able to excel. </p>

<p>Opportunity to prove oneself is more readily available in the
peer group. Often, adolescents participate in forms of delinquent
behavior, termed symbolic infractions, in order to demonstrate
autonomy and competence to their peers. These include joy-riding,
vandalism, sexual promiscuity, underage drinking, violation of
rules of decorum and dress, and purposeless confrontation with
authority. </p>

<p>Marihuana use has recently been added to the list of
infractions and offers several advantages for adolescents and
young adults. Most important, it provides a shared group
experience which offers the, shy, lonely, socially awkward
neophyte a means of entrance to the group, complete with its own
ceremonial initiation. Repetition of the behavior serves to
increase closeness and commitment to the group. Usually the
experience is pleasurable and the individual is able to control
his level of intoxication. This delinquency is viewed as
relatively harmless to oneself and others, although its symbolic
impact on parents and authority is often greater than that of
other common infractions. </p>

<p>Therefore, a, subtle process of acquiring attitudes favorable
to drug use, of having friends and acquaintances who define the
marihuana experience in acceptable and pleasurable terms, and of
having a social belief system which prepares one to accept the
conversion process to begin with, are all powerful complementary
factors which direct a young person toward marihuana use. At this
point, the use of marihuana provides further opportunities for
acquiring new marihuana using friends and entering the social
milieu of marihuana, users.<br>
</p>

<p><font size="2"><b>The Dynamics of Persistent Use<br>
</b></font></p>

<p>The cultural and social factors sketched above, in combination
with the individual's somatic and psychic characteristics,
determine the pattern of his drug behavior once he has chosen to
experiment with it. The majority of individuals who reach this
point progress no further and often discontinue marihuana use.
The most common explanation for discontinuing use is loss of
interest; the effect lost its novelty and became boring. Other
less common reasons are fear of legal hazards, social pressure,
and concerns over physical and mental drug effects. Among the
infrequently noted reasons are: interference with other
activities; replacement by alcohol; unavailability; cost;
unpleasant experiences; fear of moral transgression; or
progression to other forms of non-drug interests such as yoga,
transcendental meditation, agrarian communes, esoteric religion
and restrictive diets. </p>

<p>For those who continue use, psychosocial factors are important
determinants of the use patterns. Many marihuana users are
strongly committed to traditional society in which they desire to
rise socially. They have chosen to participate fully in the
traditional adult-oriented activities and the formal
achievement-reward system. Their peer groups consist primarily of
similarly oriented individuals. The infrequent use of marihuana
by these persons is a social activity for fun and satisfies
curiosity. </p>

<p>Those individuals who continue to use marihuana more
frequently appear to be different types of people and oriented
toward a different part of the social system. Most of them
maintain stable career orientations and continue to function
within the broader society. But they feel more burdened by the
traditional system of social controls and more removed from
contemporary society's institutions. These individuals tend to
turn away from more traditional adult-oriented reward systems and
intensify their peer-group orientation. Their interests and
activities emphasize an informal &quot;in-crowd,&quot;
out-of-school or work orientation. The meaning of marihuana use
by this peer group emphasizes the ideological character of usage.
In contrast to the infrequent type of user, these individuals
seem to build their self-identity around the marihuana-using peer
group.<br>
</p>

<p align="center"><font size="2"><b>BECOMING A MULTIDRUG USER<br>
</b></font></p>

<p>The more one smokes marihuana, the more involved his
interpersonal relationships are likely to become with his peers
who share the experience with him. As he spends more time with
this group, he begins to sever his contacts with conventional
individuals and conventional routines. He may eventually view
himself as a drug user and be willing to experiment with other
drugs which are approved by his peer group. Only ;a small portion
of the marihuana users who reach this stage are likely to become
persistent, frequent users of these other drugs. The majority
appear to experiment only.<br>
</p>

<p><font size="2"><b>Epidemiologic Studies<br>
</b></font></p>

<p>The Commission's studies have confirmed the association
between marihuana usage and the consumption of other drugs for
curiosity and pleasure. This association holds for all drugs,
including over-thecounter and prescription pain relievers,
tension relievers, sleeping pills, and stimulants as well as
hashish, methamphetamines, cocaine, LSD and mescaline, and
heroin. The National Survey showed that current marihuana users
are about twice as likely to have used any illicit drugs than are
those who have ceased using marihuana (Table 3).<br>
</p>

<p align="center"><font size="1">Table 3.-ILLICIT DRUG USE BY
ADULTS<br>
</font></p>

<p><font size="1">Have used Currently</font> </p>

<p><font size="1">but no using</font> </p>

<p><font size="1">Substance Never used marihuana longer use
marihuana</font> </p>

<p><font size="1">marihuana (percent)</font> </p>

<p><font size="1">(percent)<br>
<br>
</font></p>

<p><font size="1">Hashish Less than 0.5 percent 28 63<br>
</font></p>

<p><font size="1">LSD or mescaline Less than 0.5 percent 11 28</font>
</p>

<p><font size="1">Methamphetamine Less than 0.5 percent 10 23</font>
</p>

<p><font size="1">Cocaine Less than 0.5 percent 4 10</font> </p>

<p><font size="1">Heroin Less than 0.5 percent 1 4<br>
</font></p>

<p>The Commission additionally has contracted a study of 105
selected, middle class, young, working adults from California,
who are marihuana smokers. Of this sample, 11% were daily
marihuana users and 47% used it several times a week; 33% used it
several times a month; 6% used it once to several times a year;
and 3% had used it but were not currently using marihuana. The
study indicates that while most of the subjects were frequent
marihuana users, the incidence of other drug use was relatively
low (Table 4).<br>
</p>

<p><font size="1"><b>Table 4.-FREQUENCY OF OTHER DRUG USE BY
MARIHUANA USERS<br>
</b></font></p>

<p><font size="1"><b>Percent who use marihuana</b></font> </p>

<p><font size="1"><b>Percent</b></font> </p>

<p><font size="1"><b>Substance</b> <b>who</b> <b>Once to</b> <b>Several</b>
<b>Several</b></font> </p>

<p><font size="1"><b>never</b> <b>several</b> <b>times</b> <b>times</b>
<b>Daily</b></font> </p>

<p><font size="1"><b>used</b> <b>times</b> <b>a month</b> <b>a
week</b></font> </p>

<p><font size="1"><b>marihuana</b> <b>a year <br>
</b></font></p>

<table>
    <tr>
        <td width="84"></td>
        <td width="84"></td>
        <td width="84"></td>
        <td width="84"></td>
        <td width="84"></td>
        <td width="84"></td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Hashish</b></font></td>
        <td width="84"><font size="1"><b>42</b></font> </td>
        <td width="84"><font size="1"><b>31</b></font></td>
        <td width="84"><font size="1"><b>21</b></font> </td>
        <td width="84"><font size="1"><b>5</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>LSD</b></font></td>
        <td width="84"><font size="1"><b>96</b></font> </td>
        <td width="84"><font size="1"><b>4</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Mescaline</b></font></td>
        <td width="84"><font size="1"><b>79</b></font> </td>
        <td width="84"><font size="1"><b>19</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>2</b></font> </td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Psilocybin</b></font></td>
        <td width="84"><font size="1"><b>96</b></font> </td>
        <td width="84"><font size="1"><b>4</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>STP, DMT</b></font></td>
        <td width="84"><font size="1"><b>100</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Heroin</b></font></td>
        <td width="84"><font size="1"><b>98</b></font> </td>
        <td width="84"><font size="1"><b>2</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Codeine</b></font></td>
        <td width="84"><font size="1"><b>87</b></font> </td>
        <td width="84"><font size="1"><b>11</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>2</b></font> </td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Amphetamines</b></font></td>
        <td width="84"><font size="1"><b>89</b></font></td>
        <td width="84"><font size="1"><b>7</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>4</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Barbiturates</b></font></td>
        <td width="84"><font size="1"><b>86</b></font></td>
        <td width="84"><font size="1"><b>10</b></font> </td>
        <td width="84"><font size="1"><b>4</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Cocaine</b></font></td>
        <td width="84"><font size="1"><b>75</b></font> </td>
        <td width="84"><font size="1"><b>19</b></font></td>
        <td width="84"><font size="1"><b>2</b></font> </td>
        <td width="84"><font size="1"><b>4</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
    </tr>
    <tr>
        <td width="84"><font size="1"><b>Glue</b></font></td>
        <td width="84"><font size="1"><b>100</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
        <td width="84"><font size="1"><b>0</b></font></td>
        <td width="84"><font size="1"><b>0</b></font> </td>
    </tr>
</table>

<p>With the exception of marihuana and hashish, no drug was used
by more than 25% of this population and this use was almost
exclusively experimental. Interestingly, the more exotic drugs,
mescaline and cocaine were more frequently used (21% and 25% of
this sample respectively) than the common dangerous drugs: LSD
(4%), heroin (2%), codeine (11%), barbiturates (14%), and
amphetamines (11%). </p>

<p>Among high school students, marihuana, is normally the, first
illicit drug used, although several recent studies have suggested
that a significant number of students initiate illicit use, with
other drugs. Of the marihuana users, a majority have used no
other illicit drug, and they tend to be experimental or
intermittent users of marihuana. </p>

<p>The more frequently the adolescent uses marihuana, the more
likely he is to experiment with other drugs. For example, in one
recent study of San Diego high school students of predominantly
white middle socioeconomic background, 80% of the students who
used marihuana weekly or more often had used other drugs, and 50%
of this group had used LSD. In contrast, 33% of the less than
weekly users bad used other drugs. <br>
</p>

<p><font size="1"><b>Profiles and Dynamics<br>
</b></font></p>

<p>The personality profile of the heavy marihuana user discussed
earlier includes elements propelling him toward heavy involvement
in the multiple-drug-using-subculture. Heavy drug use by these
individuals may reflect and aggravate a total alienation and
disaffiliation from American society and its institutions. This
group hopes to find in drug use more than simple, fun or relief
from boredom. The heavy use of drugs represents a shift into the
drug subculture and an adoption of a totally new life style. Some
observers feel that this shift provides a new identity which
allows the individual to counteract his apathy and search for
meaning in a society he views as unloving, lonely, and
meaningless. He seeks to become involved with what he describes
as the exciting, relevant, &quot;real&quot; experience of life.
Additionally, he believes drug use provides new feelings and
awareness needed to overcome barriers between himself, others,
and the natural world. </p>

<p>The drug culture as a community also helps to meet the needs
of the individual. It provides a ready supply of drugs, unites
common experiences and secrets that enhance the drug experience,
and protects the individual against undesired experiences and
against &quot;the outside world.&quot; Most important, the
culture instills self-confidence by reassuring the individual
that he has been wise in choosing this new identity. </p>

<p>Frequently, these are individuals who express feelings of
loneliness, isolation and over-protection from their home and
family. One frequent pattern involves an intimate, dominating
mother and a distant, unemotional father. In some cases, the
drug-use ritual and the, sense of community closeness offered by
the drug subculture appear to satisfy certain personal needs.
Additionally, joining the subculture provides a release from
sheltered life, a test of competence, an opportunity to
participate, and a chance to express anger. When the anger is
turned inward instead of directed at society and family, drug use
becomes a form of passive, self-destructiveness. <br>
</p>

<p><font size="2"><b>Sociocultural Factors<br>
</b></font></p>

<p>After the individual views himself as a drug user and has
become immersed in the drug-using subculture, the drugs he
chooses to experiment with and his pattern of use are determined
primarily by non-drug factors well beyond the simple properties
of the psychoactive chemical. These factors are predominantly
socioeconomic and sociocultural, although psychic and somatic
factors also play a role in determining who will continue and how
intensively. </p>

<p>The availability of a distribution system which stocks the
other drugs is essential. Most often, contact with this
distribution system is increased by having friends or
acquaintances who use or sell other drugs. However, much of the
marihuana selling takes place, at the customer level between
friends, and involves little profit and relatively small
quantities of the drug. The marihuana user who only buys has
little contact with the professional multidrug dealing system.
However, the user-buyer-seller of marihuana is more involved with
the multidrug system, uses more himself and has more friends who
use and sell other drugs. This factor of being a seller rather
than only a buyer-user is influential in determining the degree
of an individual's involvement with and commitment to the use of
other drugs. </p>

<p>Marihuana use does not itself determine which drugs the
heavily involved user will choose to use. Generally, the
selection of other drugs is influenced by the social group. For
example, blacks and whites have roughly equal rates of trying and
using marihuana, but their choice of other drugs and the styles
of drug use are quite different and distinctive, due to their
frequently different sociocultural backgrounds. Additionally, one
recent study of white high school and college students revealed
different patterns of further drug use among males and females.
Men and women used marihuana in equal numbers, but the men who
used other drugs tended to use hallucinogens while the women
tended to use amphetamines. </p>

<p>An extensive survey of drug use among 3,500 liberal arts
undergraduates attending 14 campuses in the New York area
demonstrated the racial character of drug use among this
population (Table 5).<br>
</p>

<p><font size="2"><b>Table 5.-RACIAL CHARACTER OF DRUG USE<br>
</b></font></p>

<p><font size="2"><b>Meth-</b> <b>Amphet-</b> <b>Hallu-</b></font>
</p>

<p><font size="2"><b>Percentage tried drugs</b> <b>Heroin</b> <b>Cocaine</b>
<b>amphet-</b> <b>amine</b> <b>cinogens</b></font> </p>

<p><font size="2"><b>mine<br>
<br>
</b></font></p>

<p><font size="2"><b>Blacks................ 9</b> <b>16</b> <b>5</b>
<b>9</b> <b>13</b></font> </p>

<p><font size="2"><b>Whites................ 4</b> <b>7</b> <b>11</b>
<b>19</b> <b>21<br>
</b></font></p>

<p>According to recent studies, heroin usage is not common among
white marihuana users. Heroin is most strongly linked to
marihuana use in black and Spanish-speaking ghettos where many
feel they have little chance of personal advancement and
self-fulfillment. In such communities, a segment of the
population constructs new illegitimate but accessible avenues for
social coping. For some this involves the hustle (non-violent
stealing) and the excitement of obtaining and using heroin and
cocaine. They regard marihuana as a &quot;cool&quot; drug and use
it for its social and calming effects. </p>

<p>In contrast, studies have demonstrated that the psychedelics
are more often used by the white, middle to upper middle class,
collegeeducated populations. The typical use of these drugs in
high school college and working populations is episodic and
experimental, and is usually discontinued rather rapidly in
contrast with marihuana use, which for many persons is of long
duration. In many instances, psychedelic drug use begins almost
simultaneously with marihuana. </p>

<p>For a few, drug use becomes an ideologic focus, reflecting
disillusionment with society and rejection of the
&quot;establishment.&quot; These and other motives, including
mere pleasure-seeking, lead to continued use of LSD and other
hallucinogens. Marihuana is viewed as a dilute LSD and is often
used to enhance or prolong the effects of that drug. Sometimes it
is encountered after first LSD use. </p>

<p>Methamphetamine, or &quot;speed,&quot; use is more
characteristic of those lower socioeconomic white, youth who are
not school or work oriented. Living for the moment is the
characteristic attitude of the speed scene. The speed user views
marihuana as he does alcohol and uses it for fun or for its
calming effects. </p>

<p>For these three groups of illicit drug users, marihuana use
has different meanings and is secondary in importance to the use
of the other drugs. Whether or not marihuana leads to other drug
use depends on the individual, on the social and cultural setting
in which the drug use takes places, and on the nature of the drug
market. Its use, however, is neither inevitable nor necessary. <br>
</p>

<p align="center">The Effects of Marihuana on the User<br>
</p>

<p>The previous section has attempted to paint a broad picture of
the marihuana user. This section will deal with the, drug and its
effects on these individuals. </p>

<p>The meaning of drug often varies with the context in which it
is used. The physician would define a drug as any substance used
as a medicine in the treatment of physical or mental disease.
Today, due to the influence of many factors, the layman may focus
on the negative connotations of drugs, such as the stupefying,
poisoning, habit-forming misuse of the opiate drugs. The
considerably wider and more scientific definition of a drug which
will be used in this section is: any chemical substance which has
an action on living tissues.<br>
</p>

<p><font size="2"><i>A psychoactive drug </i></font><font
size="1"><i>is </i></font><font size="2"><i>any substance capable
of modifying mental performance and individual behavior by
inducing functional or pathological changes in the central
nervous system. <br>
</i></font></p>

<p>As defined, psychoactive drugs exert their major effect on the
state of the mind including emotions, feelings, sensibility,
consciousness and thinking. The definition implies neither
positive nor negative meanings. Chemical substances are not
inherently good or bad. All substances, including medicines and
foods, which man has chosen to consume have certain desired
effects (whether therapeutically beneficial or pleasurable) and
undesired effects (whether detrimental or unpleasant). For
example, eating food is certainly a necessary and pleasurable
activity. However, obesity plays an important role in many
diseases, including diabetes, high blood pressure and heart
attacks, and tends to limit physical activities. </p>

<p>The classification of any drug effect as either beneficial or
harmful often greatly depends on the values the classifier places
on the expected effects. This is especially relevant with respect
to the psychoactive drugs such as tranquilizers, stimulants,
coffee, cigarettes, alcohol, marihuana and other licit or illicit
drugs. For all of these drugs, the weights of benefit and harm
are difficult to determine when viewed merely in terms of their
stated effects. <br>
</p>

<p align="center"><font size="2"><b>BOTANY AND CHEMISTRY <br>
</b></font></p>

<p>Marihuana refers to a preparation derived from a plant,
cannabis sativa L. The preparation contains varying quantities of
the flowers and their resinous secretions, leaves, small stems
and seeds. These plant parts contain many chemical substances.
The chemical substance which produces the major drug effects is
tetrahydrocannabinol (THC). According to current information, the
amount of THC present determines the potency of the preparation.
Hereinafter, any reference to drug content or drug effect of
marihuana will, for all practical purposes, mean that of
tetrahydrocannabinol. </p>

<p>The drug content of the plant parts is variable, generally
decreasing in the following sequence: resin, flowers, leaves.
Practically no drug is found in the stems, roots or seeds. The
potency and resulting drug effect of marihuana fluctuates,
depending on the relative proportions of these plant parts in the
marihuana mixture. </p>

<p>Most marihuana available in this country comes from Mexico and
has a THC content of less than 1%. Marihuana of American origin
often contains less than two-tenths of 1% THC. Marihuana
originating in Jamaica and Southeast Asia often has a 2% to 4%
THC content. </p>

<p>Marihuana is the least potent preparation of the plant.
Jamaican ganja, containing primarily the flower tops and the
small leaves or bracts, has a THC content of about 4% to 8%
depending on the mixture. Indian ganja is less potent. The most
potent preparation is hashish (charas) which is composed of only
the drug-rich resinous secretions of the flowers. Generally, the
THC content of hashish is 5 % to 12 %.<br>
</p>

<p>FACTORS INFLUENCING DRUG EFFECT<br>
</p>

<p>A number of variable factors exert an important influence on
the psychopharmacologic effects of marihuana in man, as is true
for all drugs. Failure to take these factors into consideration
probably accounts for a large part of the inconsistency and
controversy surrounding the description of the drug effect.<br>
</p>

<p><font size="2"><b>Dosage</b></font> </p>

<p>The dosage or quantity of the drug (tetrahydrocannabinol)
consumed is the most important variable. As with most drugs, the
larger the dose taken, the greater the physical and mental effect
will be and the longer the effect will last. The effect of a high
dose of marihuana on an individual would be quite different from
the effect of a low, usual &quot;social&quot; dose.<br>
</p>

<p><font size="2"><b>Method of Use<br>
</b></font></p>

<p>The method of use has a bearing upon the drug effect. The
method is directly related to both dosage and time lapse before
the drug effect is felt. Injection directly into a vein delivers
the total dose immediately, producing a rapid, maximal response
of minimal duration. Smoking and inhalation cause rapid but less
efficient delivery of the dose; variable quantity of the drug is
destroyed during burning or escapes into the air and does not
reach the lungs. Oral ingestion produces different effects,
according to the system in which the drug is dispersed.
Generally, oral ingestion diminishes the drug effect, but
prolongs it.<br>
</p>

<p><font size="2"><b>Metabolism<br>
</b></font></p>

<p>Another factor which influences the effect of the drug is
metabolism. During the metabolic process, the body cells,
principally in the liver and lungs, chemically alter drug
substances, changing their activity and providing for their
elimination from the body. Increasing evidence indicates that
marihuana is first changed by the body in a way that activates or
enhances the drug effect and is subsequently altered in a way
that inactivates the drug prior to its removal from the body. </p>

<p>The rate and direction of these metabolic steps can
significantly influence the effect of marihuana. For instance,
individuals with extensive exposure to marihuana or other drugs
metabolize more rapidly, and perhaps differently, from those
individuals with no drug exposure.<br>
</p>

<p><font size="2"><b>Set and Setting<br>
</b></font></p>

<p>An important variable in discussing the effect of marihuana on
the user is the social and emotional environment; that is, the
individual's &quot;set&quot; and &quot;setting.&quot; </p>

<p>&quot;Set&quot; refers to a combination of factors that create
the &quot;internal environment&quot; of the individual, including
personality, life style, and philosophy, past drug experiences,
personal expectations of drug effect, and mood at the time of the
drug experience. </p>

<p>&quot;Setting&quot; refers to the external environment and
social context in which the individual takes the drug. These
factors are most influential when drugs are taken at low dosages
and, like marihuana, produce minimal physical and subtle
subjective mental effects. The effect of marihuana generally will
be quite different for an intermittent social adult smoker from
that of a youth deeply involved in the youthful drug subculture.
These factors partially account for the belief of a marihuana
user that he is experiencing a &quot;high&quot; in certain
experiments even when he is given a non-marihuana substance
(placebo) but is told it is marihuana. <br>
</p>

<p><font size="2"><b>Tolerance<br>
</b></font></p>

<p>Another important factor that determines the immediate effect
of any drug is tolerance. Tolerance has two different
connotations. The first, initial tolerance, is a measure of the
amount of a drug which a subject must receive on first exposure
to produce a designated degree of effect. A variety of innate and
environmental factors contributes to initial tolerance among
individuals. Different individuals require varying amounts of the
drug to attain the same physical and mental effect. </p>

<p>The second connotation, which shall be referred to when we use
the word tolerance, is that of an acquired change in tolerance.
That is, within the same individual, as a result of repeated
exposure to the drug, the same dose of the drug may produce a
diminishing effect so that an increased amount of the drug is
required to produce the same specified degree of effect. </p>

<p>Tolerance develops at differential rates to given effects of
the same drug. If tolerance has developed to one specific effect,
it has not necessarily developed to other specific effects. </p>

<p>By definition, the development of tolerance is neither
beneficial nor detrimental. If tolerance develops rapidly to the
desired mental effect of a &quot;high&quot; but slowly to the
behavioral or physical effects, rapid increase in dose would be
necessary in order to have the desired effect, and progressive
behavioral and physical disruption would be seen. This is the
pattern for amphetamines. </p>

<p>However, if tolerance develops slowly or not at all to the
desired mental effects but more rapidly to the behaviorally or
physically disruptive effects, no dosage increase or only a
slight one would be necessary and the unpleasant and undesired
effects would progressively diminish. </p>

<p>With regard to marihuana, present indications are that
tolerance does develop to the behaviorally and physically
disruptive effects, in both animals and man, especially at high
frequent doses for prolonged time periods. Studies in foreign
countries indicate that very heavy prolonged use of very large
quantities of hashish leads to the development of tolerance to
the mental effects, requiring an increase in intake to reach the
original level of satisfaction. However, for the intermittent use
pattern and even the moderate use pattern, little evidence exists
to indicate the development of tolerance to the desired
&quot;high,&quot; although the high may persist for a shorter
time period. During the Boston free-access study, no change was
apparent in the level of the high produced by a relatively large
dose of the drug over a 21-day period of moderate to heavy
smoking. <br>
</p>

<p>The fact that some individuals smoke more of the drug than
others may merely reflect a desire for a different level of
&quot;high.&quot; There is a tendency to develop a tolerance to
the physical effects and behaviorally disruptive effects,
especially the depressant effects, in heavy daily users. The
development of such behavioral tolerance of this nature may
explain the fact that experienced marihuana smokers describe a
lower occurrence rate of undesirable drug effects. The
development of tolerance may also explain why these smokers
exhibit normal behavior and competent performance of ordinary
tasks, while not appearing intoxicated to others even though they
are at their usual level of intoxication.<br>
</p>

<p><font size="2"><b>Reverse Tolerance<br>
</b></font></p>

<p>Repeated exposure to marihuana has been said to cause an
individual to need lesser amounts of the drug to achieve the same
degree of intoxication. This &quot;reverse tolerance&quot; may be
related to one's learning to get high or to the recognition of
the subtle intoxication at low doses. Or perhaps, such tolerance
reflects an increase in the body's ability to change the drug to
an active chemical. To date, the existence of &quot;reverse
tolerance&quot; has not been substantiated in an experimental
setting.<br>
</p>

<p><font size="2"><b>Duration of Use<br>
</b></font></p>

<p>Tolerance development is only one of a variety of occurrences
which possibly are related to repetitive use of marihuana. Any
discussion of drug effect must also take into account the time
period over which the drug use occurs. Immediate effects of a
single drug experience must be contrasted with effects of
short-term use and the effects of longterm use in order to detect
any cumulative effects or more subtle, gradually occurring
changes. </p>

<p>This issue of an individual's change over a period of years is
quite complex; a multitude of factors other than marihuana use
may affect his life. As previously defined, short-term refers to
periods of less than two years, long-term to periods of two to 10
years, and very long-term to periods greater than 10 years. Most
of the American experience involves short-term and long-term use,
with low doses of weak preparations of the drug.<br>
</p>

<p><font size="2"><b>Patterns of Use<br>
</b></font></p>

<p>The drug effect of marihuana can be realistically discussed
only within the context of who the user is, how long he has used
marihuana, how much and how frequently he uses it, and the,
social setting of his use. <br>
</p>

<p>In general, for virtually any drug, the heavier the pattern of
use, the greater the risk of either direct or indirect damage.
For purposes of this discussion, the patterns of use developed in
the first section of this chapter will be utilized. Because
frequency of use is presently the, primary determinant of use
patterns in this country, we employ similar designations: </p>

<p><font size="2">(1) The <i>experimenter </i>who uses marihuana,
at most a few times over a short term and then generally ceases
to use it, or uses once a month or less;</font> </p>

<p><font size="2">(2) The <i>intermittent user </i>who uses
marihuana, infrequently, that is more than once monthly but less
than several times a week;</font> </p>

<p><font size="2">(3) <i>The moderate user </i>who uses it from
several times a week to once daily, generally over a long term;</font>
</p>

<p><font size="2">(4) The <i>heavy user </i>who uses it several
times a day over a long term and;</font> </p>

<p><font size="2">(5) The <i>very heavy user </i>who is
constantly intoxicated with high tetrahydrocannabinol content
preparations, usually hashish, over a very long term.</font> </p>

<p>Again, these classifications are not intended to be rigid but
are designed to facilitate a discussion of the many usage
patterns. <br>
</p>

<p><font size="2"><b>Definition of Dependence <br>
</b></font></p>

<p><font size="2">Before describing the effect of marihuana, on
the user, two additional definitions are required. They concern
the concept of <i>dependence </i>which has so clouded public and
professional consideration of psychoactive drugs. Throughout the
remainder of this report, we refer Separately to psychological
and physical dependence, defined as follows:</font> </p>

<p><font size="2"><i>Psychological dependence </i>is the repeated
use of psychoactive drugs leading to a conditioned pattern of
drug-seeking behavior. The intensity of dependence varies with
the nature of the drug, the method, frequency, and duration of
administration, the mental and physical attributes of the
individual, and the characteristics of the physical and social
environment. Its intensity is at its peak when drug-seeking
becomes a compulsive and undeviating pattern of behavior.</font> </p>

<p><font size="2"><i>Physical dependence </i>is the state of
latent hyper-excitability which develops in the central nervous
system of higher mammals following frequent and prolonged
administration of the morphine-like analgesics, alcohol,
barbiturates, and other depressants. Such dependence is not
manifest subjectively or objectively during drug administration.
Specific symptoms and signs, the abstinence syndrome, occur upon
abrupt termination of drug administration; or with morphinelike
agonists by administering the specific antagonists.<br>
</font></p>

<p align="center"><font size="2"><b>EFFECTS RELATED TO PATTERN
USE<br>
</b></font></p>

<p>Set out below is a brief summary of effects of marihuana,
related to frequency and duration of use. The remainder of the
Chapter discusses the effects of immediate, short-term, long-term
and very long-term use of the drug.<br>
</p>

<p><font size="2">Experimenters and</font> </p>

<p><font size="2">intermittent users ------ Little or no
psychological dependence.</font> </p>

<p><font size="2">Influence on behavior related largely to</font>
</p>

<p><font size="2">conditioning to drug use and its social</font> </p>

<p><font size="2">value to the user.</font> </p>

<p><font size="2">No organ injury demonstrable.</font> </p>

<p><font size="2">Moderate users ------------ Moderate
psychological dependence in-</font> </p>

<p><font size="2">creasing with duration of use.</font> </p>

<p><font size="2">Behavioral effects minimal in stable per-</font>
</p>

<p><font size="2">sonalities, greater in those with emo-</font> </p>

<p><font size="2">tional instability.</font> </p>

<p><font size="2">Probably little if any organ injury.</font> </p>

<p><font size="2">Duration of use increases probability of</font>
</p>

<p><font size="2">escalation of all effects including shift</font>
</p>

<p><font size="2">from moderate to heavy use.<br>
</font></p>

<p><font size="2">Heavy users -------------- American &quot;pot
head.&quot;</font> </p>

<p><font size="2">Strong psychological dependence.</font> </p>

<p><font size="2">Detectable behavior changes.</font> </p>

<p><font size="2">Possible organ injury (chronic diminution of
pulmonary function).</font> </p>

<p><font size="2">Effects more easily demonstrable with long-term
use. <br>
</font></p>

<p><font size="2">Very heavy users ---------- Users in countries
where the use of cannabis has been indigenous for centuries.</font>
</p>

<p><font size="2">Very strong psychological dependence to point
of compulsive drug seeking and use.</font> </p>

<p><font size="2">Clear-cut behavioral changes.</font> </p>

<p><font size="2">Greater incidence of associated organ injury.<br>
</font></p>

<p align="center"><font size="2"><b>IMMEDIATE DRUG EFFECTS<br>
</b></font></p>

<p>The immediate effects are those which occur during the drug
intoxication or shortly following it. The user is aware of some
of these effects, for they often cause him to use the drug. At
the same time, many changes may occur in his body which can be
measured by others but are not obvious to him.<br>
</p>

<p><font size="2"><b>Subjective Effects<br>
</b></font></p>

<p>A description of an individual's feelings and state of
consciousness as affected by low doses of marihuana is difficult;
the condition is not similar to usual waking states and is the
result of a highly individual experience. Perhaps the closest
analogies are the experience of day dreaming or the moments just
prior to falling asleep. The effect is not constant and a
cyclical waxing and waning of the intensity of the intoxication
occurs periodically. </p>

<p>At low, usual &quot;social&quot; doses, the intoxicated
individual may experience an increased sense of well-being;
initial restlessness and hilarity followed by a dreamy, carefree
state of relaxation; alteration of sensory perceptions including
expansion of space and time; and a more vivid sense of touch,
sight, smell, taste, and sound; a feeling of hunger, especially a
craving for sweets; and subtle changes in thought formation and
expression. To an unknowing observer, an individual in this state
of consciousness would not appear noticeably different from his
normal state. </p>

<p>At higher, moderate doses, these same reactions are
intensified but the changes in the individual would still be
scarcely noticeable to an observer. The individual may experience
rapidly changing emotions, changing sensory imagery, dulling of
attention, more altered thought formation and expression such as
fragmented thought, flight of ideas, impaired immediate memory,
disturbed associations, altered sense of self-identity and, to
some, a perceived feeling of enhanced insight. </p>

<p>At very high doses, psychotomimetic phenomena may be
experienced. These, include distortions of body image, loss of
personal identity, sensory and mental illusions, fantasies and
hallucinations. </p>

<p>Nearly all persons who continue to use marihuana describe
these usual effects in largely pleasurable terms. However, others
might call some of these same effects unpleasant or undesirable. </p>

<p>As discussed earlier, a wide range of extra-drug factors also
influences marihuana's effects. The more the individual uses
marihuana and the longer he has been using it, the more likely
the experiences will be predominantly pleasurable, and the less
likely the effects will be unpleasant. An increasing
sensitization to those effects viewed as pleasant occurs as the
user has more experience with the drug. </p>

<p>Persons subject to unpleasant reactions may eliminate
themselves from the using group although the occasional
experience of an unpleasant effect does not always discourage
use.<br>
</p>

<p><font size="2"><b>Body Function<br>
</b></font></p>

<p>A large amount of research has been performed in man and
animals regarding the immediate effect of marihuana on bodily
processes. No conclusive evidence exists of any physical damage,
disturbances of bodily processes or proven human fatalities
attributable solely to even very high doses of marihuana.
Recently, animal studies demonstrated a relatively large margin
of safety between the psychoactive dose and the physical and
behavioral toxic and lethal dose. Such studies seemed to indicate
that safe human study could be undertaken over a wide dose range.
</p>

<p>Low to moderate doses of the drug produce minimal measurable
transient changes in body functions. Generally, pulse rate
increases, recumbent blood pressure increases slightly, and
upright blood pressure decreases. The eyes redden, tear secretion
is decreased, the pupils become slightly smaller, the fluid
pressure within the eye lessens and one study reports that the
eyeball rapidly oscillates (nystagmus). </p>

<p>A minimal decrement in maximum muscle strength, the presence
of a fine hand tremor, and a decrease in hand and body steadiness
have also been noted. Decreased sensitivity to pain and
overestimation of elapsed time may occur. </p>

<p>The effects of marihuana on brain waves are still unclear and
inconsistent. Generally, the intoxication produces minimal,
transient changes of rapid onset and short duration. Sleep time
appears to increase, as does dreaming. </p>

<p>Investigation of the effects of marihuana on a wide variety of
other bodily function indices has revealed few consistently
observed changes. </p>

<p>These few consistently observed transient effects on bodily
function seem to suggest that marihuana is a rather unexciting
compound of negligible immediate toxicity at the doses usually
consumed in this country. The substance is predominantly a
psychoactive drug. The feelings and state of consciousness
described by the intoxicated seem to be far more interesting than
the objective state noted by an observer.<br>
</p>

<p><font size="2"><b>Mental Function<br>
</b></font></p>

<p>Marihuana, like other psychoactive substances, predominantly
affects mental processes and responses (cognitive tasks) and thus
the motor responses directed by mental processes (psychomotor
tasks). Generally, the degree of impairment of cognitive and
psychomotor performance is dose-related, with minimal effect at
low doses. The impairment varies during the period of
intoxication, with the maximal effect at the peak intoxication.
Performance of simple or familiar tasks is at most minimally
impaired, while poor performance is demonstrated on complex,
unfamiliar tasks. Experienced marihuana users commonly
demonstrate significantly less decrement in performance than
drug-naive, individuals. </p>

<p>The greater his past marihuana experience, the better the
intoxicated individual is able to compensate for drug effect on
ordinary performance at usual doses. Furthermore, marked
individual variation in performance is noted when all else is
held constant. The effect of marihuana on cognitive and
psychomotor performance is therefore highly individualized and
not easily predictable. Effects on emotional reactions and on
volition are equally variable and are difficult to measure under
laboratory conditions, but can be significant.<br>
</p>

<p><font size="2"><b>The Intoxicated State<br>
</b></font></p>

<p>Studies of intoxicated persons have suggested possible
explanations for the subtle effects on mental processes produced
by marihuana, Generally, a temporary episodic impairment of
short-term memory occurs. These memory voids may be filled with
thoughts and perceptions extraneous to organized -mental
processes. Past and future may become obscured -as the individual
focuses on filling the present momentary memory lapse. His sense
of self -identity may seem altered if he cannot place himself in
his usual time frame. </p>

<p>This altered state of mind may be regarded by the individual
as pleasant or unpleasant. The important factors of dosage and
set and setting play a most important role in this determination.
When the nature of the drug-taking situation and the
characteristics of the individual are optimal. the user is apt to
describe his experience as one of relaxation, sensitivity,
friendliness, carefreeness, thoughtfulness, happiness,
peacefulness, and fun. For most marihuana users who continue to
use the drug, the experience is overwhelmingly pleasurable. <br>
</p>

<p><font size="2"><b>Unpleasant Reactions<br>
</b></font></p>

<p>However, when these circumstances are not optimal, the
experience may be unpleasant and an undesirable reaction to the
marihuana intoxication occurs. In these instances, anxiety,
depression, fatigue or cognitive loss are experienced as a
generalized feeling of ill-being and discomfort. A heavy sluggish
feeling, mentally and physically, is common in inexperienced
marihuana smokers who overshoot the desired high or in persons
who might orally ingest too large a dose. Dizziness, nausea,
incoordination, and palpitations often accompany the &quot;too
stoned&quot; feeling.<br>
</p>

<p><font size="2"><b>Anxiety States<br>
</b></font></p>

<p>&quot;Novice anxiety reactions&quot; or feelings of panic
account for a majority of unpleasant reactions to marihuana. When
the distortion of self image and time is recognized by the
individual as drug-induced and temporary, the experience is
viewed as pleasurable. Anxiety -and panic result when these
changes cause the individual to fear that the loss of his
identity and self-control may not end, and that he is dying or
&quot;losing his mind.&quot; These anxiety and panic reactions
are transient and usually disappear over a few hours as the
drug's effects wear off, or more quickly with gentle friendly
reassurance. </p>

<p>The large majority of these, anxiety reactions occur in
individuals who are experimenting with marihuana. Most often
these individuals have an intense underlying anxiety surrounding
marihuana use, such as fears of arrest, disruption of family and
occupational relations, and possible bodily or mental harm. Often
they are older and have relatively rigid personalities with less
desire for new and different experiences. </p>

<p>The incidence of these anxiety reactions may have decreased as
marihuana use has become acceptable to wider populations, as the
fears of its effects have lessened and as users have developed
experience in management of these reactions.<br>
</p>

<p><font size="2"><b>Psychosis<br>
</b></font></p>

<p>Rare cases of full-blown psychotic episodes have been
precipitated by marihuana. Generally, the individuals had
previous mental disorders or had poorly developed personalities
and were marginally adjusted to their life situation. Often the
episode occurred at times of excessive stress. These episodes are
characteristically temporary. Psychotherapy and sometimes
medications are useful in prompt control and treatment of this
psychological reaction. In addition, rare nonspecific toxic
psychoses have occurred after extremely high doses. This state of
nonspecific drug intoxication or acute brain syndrome is
self-limited and clears spontaneously as the drug is eliminated
from the body.<br>
</p>

<p><b>Conclusions<br>
</b></p>

<p>In summary, the immediate effect of marihuana on normal mental
processes is a subtle alteration in state of consciousness
probably related to a change in short-term memory, mood, emotion
and volition. This effect on the mind produces a varying
influence on cognitive and psychomotor task performance which is
highly individualized, as well as related to dosage, time,
complexity of the task and experience of the user. The effect on
personal, social and vocational functions is difficult to
predict. In most instances, the marihuana intoxication is
pleasurable. In rare cases, the experience may lead to unpleasant
anxiety and panic, and in a predisposed few, to psychosis.<br>
</p>

<p align="center"><font size="2"><b>SHORT-TERM EFFECTS <br>
</b></font></p>

<p>The effect of an enormous daily oral dose of the drug (up to
about one hundred thousand times the minimal behaviorally
effective human dose) was recently studied in rats and monkeys
for three months. A severe, generalized nervous system depression
was evident the first few days. Evidence of cumulative toxicity
was observed at these doses. Severe central -nervous system
depression produced fatalities in some rats in the first few days
until tolerance developed. Later, extreme hyperactivity
developed. </p>

<p>The monkeys experienced severe central nervous system
depression and one group showed mild hyperactivity, but all
rapidly returned to normal behavior after the development of
tolerance to these effects. Minimal dose-related toxic effects on
bodily organs were noted at autopsy at the conclusion of the
experiment. These non-specific findings of unknown meaning
included bypocellularity of the bone marrow and spleen and
hypertrophy of the adrenal cortex. </p>

<p>A 28-day study employing intravenous administration of from
one to ten thousand times the minimal effective human dose to
monkeys produced -similar findings clinically. In the high dose
groups delayed deaths from acute hemorrhagic pneumonia were
possibly caused by accumulation of clumps of THC in the lung
producing irritation similar to that seen at the injection sites.
No other organ pathology was noted. These animal studies
illustrated that the margin of safety between active dose and
toxic dose was enormous. </p>

<p>A few studies have recently been carried out to observe the
effect of a few weeks of daily marihuana smoking in man. The
amount smoked was a relatively large American dose. Frequency of
use was once to several times daily. </p>

<p>During the 21-day Boston free-access study, no harmful effects
were observed on general bodily functions, motor functions,
mental functions, personal or social behavior or work
performance. Total sleep time and periods of sleep were
increased. Weight gain was uniformly noted. </p>

<p>No evidence of physical dependence or signs of withdrawal were
noted. In the heaviest smokers, -moderate psychological
dependence was suggested by an increased negative mood after
cessation of smoking. </p>

<p>Tolerance appeared to develop to the immediate effects of the
drug on general bodily functions (pulse rate) and
psychomotor-cognitive performance (time estimation, short-term
memory, and shootinggallery skill) but not to the
&quot;high.&quot; Marihuana intoxication did not significantly
inhibit the ability of the subjects to improve with practice
through time on these psychological-motor tasks. </p>

<p>Neither immediate nor short-term (21 day) high-dose marihuana
intoxication decreased motivation to engage in a variety of
social and goal-directed behaviors. No consistent alteration that
could be related to marihuana smoking over this period of time
was observed in work performance of a simple task, participation
in aspects of the research study, or interest and participation
in a variety of personal activities, such as writing, reading,
interest and knowledge of current world events, or participation
in athletic or aesthetic activities. </p>

<p>Marihuana smoking appeared to affect patterns of social
interactions. Although use of the drug was found to be a group
social activity around which conversation and other types of
social behavior were centered, it was not uncommon for some or
all of the smokers to withdraw from the social interaction and
concentrate on the subjective drug experience. </p>

<p>During the first part of the smoking period, both intermittent
and daily users demonstrated a marked decrement in total
interaction. Total interaction continued to diminish among
intermittent users but increased above presmoking levels among
the daily users during the later parts of the smoking period. The
quality of the interaction was more convivial and less
task-oriented when marihuana was available to the group. </p>

<p>Additionally, an assessment of the effect of marihuana on
risktaking behavior revealed that daily users tended to become
more conservative when engaging in decision-making under
conditions of risk. </p>

<p><font size="2"><b>LONG-TERM EFFECTS<br>
</b></font></p>

<p>Our knowledge about marihuana is incomplete, but certain
behavior characteristics appear to be emerging in regard to long
term American marihuana use which, for the most part, is
significantly less than 10 years. These impressions were
confirmed in the Boston free-access study. The group of American
young adults studied averaged five years (range 2-17 years) of
intermittent or daily use, of marihuana. </p>

<p>No significant physical, biochemical, or mental abnormalities
could be attributed solely to their marihuana smoking. Some
abnormality of pulmonary function was demonstrated in many of the
subjects which could not be correlated-with quantity, frequency
or duration of smoking marihuana and/or tobacco cigarettes. (One
other investigation recently completed uncovered no abnormalities
in lung or heart functioning of a group of non-cigarette smoking
heavy marihuana users). Many of the subjects were in fair to poor
physical condition, as judged by exercise tolerance. </p>

<p>The performance of one-fifth of the subjects on a battery of
tests sensitive to brain function was poorer on at least one,
index than would have been predicted on the basis of their IQ
scores and education. But a definite relationship between the
poor test scores and prior marihuana or hallucinogen use could
not be proven. </p>

<p>In the past few years, observers have noted various social,
psychological and behavioral changes among young high school and
college age Americans including many who have used marihuana
heavily for a number of years. These changes are reflected by a
loss of volitional goal direction. These individuals drop out and
relinquish traditional adult roles and values. They become
present rather than future oriented, appear alienated from
broadly accepted social and occupational activity, and experience
reduced concern for personal hygiene and nutrition. </p>

<p>Several psychiatrists believe they have detected clinically
that some heavy marihuana-using individuals appear to undergo
subtle changes in personality and modes of thinking, with a
resulting change in life style. In adopting this new life style,
a troubled youth may turn toward a subculture where drug use and
untraditional behavior are acceptable. </p>

<p>This youthful population resembles in many respects the
marihuana smoker described in the Boston study. No evidence
exists to date to demonstrate that marihuana use alone caused
these behavioral changes either directly or indirectly. Many
individuals reach the same point without prior marihuana use or
only intermittent or moderate use; and many more individuals use
marihuana as heavily but do not evidence these changes. For some
of these young people, the drop out state is only a temporary
phase, preceding a personal reorganization and return to a more
conventional life style. </p>

<p>If heavy, long-term marihuana use is linked to the formation
of this complex of social, psychological and behavioral changes
in young people, then it is only one of many contributing
factors. <br>
</p>

<p><font size="2">VERY LONG-TERM EFFECTS OF HEAVY AND VERY HEAVY
USE <br>
</font></p>

<p>Knowledge of the effects of very heavy, very long-term use of
marihuana by man is still incomplete. The Commission has
extensively reviewed the world literature as well as ongoing
studies in Jamaica and Greece, and carefully observed very heavy,
very long-term using populations in countries in other parts of
the world, such as Afghanistan and India. These populations smoke
and often drink much stronger drug preparations, hashish and
ganja, than are commonly used in America. From these
investigations, some observable consequences are becoming much
clearer.<br>
</p>

<p>Tolerance and Dependence<br>
</p>

<p>Some tolerance does occur with prolonged heavy usage; large
drug doses are necessary for the desired effects. Abrupt
withdrawal does not lead to a specific or reproducible abstinence
syndrome and physical dependence has not been demonstrated in man
or in animals. The very heavy users studied did evidence strong
psychological dependence, but were able to cease use for short
periods of time. In these users, <br>
</p>

<p>withdrawal does induce, symptoms characteristic of
psychological dependence. The anxiety, restlessness, insomnia,
and other non-specific symptoms of withdrawal are very similar in
kind and intensity to those experienced by compulsive cigarette
smokers. </p>

<p>Although the distress of withdrawal exerts a very strong
psychogenic drive to continue use, fear of withdrawal is, in most
cases, not adequate to inspire immediate criminal acts to obtain
the drug. <br>
</p>

<p><font size="2"><b>General Body Function<br>
</b></font></p>

<p>In the Jamaican study, no significant physical or mental
abnormalities could be attributed to marihuana use, according to
an evaluation of medical history, complete physical examination,
chest x-ray, electrocardiogram, blood cell and chemistry tests,
lung, liver or kidney function tests, selected hormone
evaluation, brain waves, psychiatric evaluation, and
psychological testing. There was no evidence to indicate that the
drug as commonly used was responsible for producing birth defects
in offspring of users. This aspect is also being studied further.
</p>

<p>Heavy smoking, no matter if the substance was tobacco or
ganja, was shown to contribute to pulmonary functions lower than
those found among persons who smoked neither substance. All the
ganja smokers studied also smoked tobacco. In Jamaica, ganja is
always smoked in a mixture with tobacco; and many of the subjects
were heavy cigarette smokers, as well. </p>

<p>In a study of a Greek hashish-using population preliminary
findings revealed poor dentition, enlarged livers, and chronic
bronchitis. Further study is required to clarify the relationship
of these to hashish use, alcohol or tobacco use, or general life
style of this user population.<br>
</p>

<p><font size="2"><b>Social Functioning<br>
</b></font></p>

<p>Similarly, the Jamaican and Greek subjects did not evidence
any deterioration of mental or social functioning which could be
attributed solely to heavy very long-term cannabis use. </p>

<p>These individuals appear to have used the drug without
noticeable behavioral or mental deviation from their lower
socioeconomic group norms, as detected by observation in their
communities and by extensive sociological interviews,
psychological tests and psychiatric examination. </p>

<p>Overall life style was not different from non-users in their
lower socioeconomic community. They were alert and realistic,
with average intelligence based on their education. Most
functioned normally in their communities with stable families,
homes, jobs, and friends. These individuals seem to have survived
heavy long-term cannabis use without major physical or behavioral
defects.<br>
</p>

<p><font size="2"><b>Mental Functioning<br>
</b></font></p>

<p>The incidence of psychiatric hospitalizations for acute
psychoses and of use of drugs other than alcohol is not
significantly higher than among the non-using population. The
existence of a specific longlasting, cannabis-related psychosis
is poorly defined. If heavy cannabis use produces a, specific
psychosis, it must be quite rare or else exceedingly difficult to
distinguish from other acute or chronic psychoses. </p>

<p>Recent studies suggest that the occurrence of any form of
psychosis in heavy cannabis users is no higher than in the
general population. Although such use is often quite, prevalent
in hospitalized mental patients, the drug could only be
considered a. causal factor in a, few cases. Most of these were,
short-term reactions or toxic overdoses. In addition, a
concurrent use of alcohol often played a role in the, episode
causing hospitalization. </p>

<p>These findings are somewhat surprising in view of the
widespread belief that cannabis attracts the mentally unstable,
vulnerable individual. Experience in the United States has not
involved a level of heavy marihuana, use comparable to these
foreign countries. Consequently, such long-lasting psychic
disturbances possibly caused by heavy cannabis use have not been
observed in this country. <br>
</p>

<p><font size="2"><b>Motivation and Behavioral Change<br>
</b></font></p>

<p>Another controversial form of social-mental deterioration
allegedly related to very long-term very heavy cannabis use is
the &quot;amotivational syndrome.&quot; It supposedly affects the
very heavy using population and is described world-wide as a,
loss of interest in virtually all activities other than cannabis
use, with resultant lethargy, amorality, instability and social
and personal deterioration. The reasons for the occurrence of
this syndrome are varied and hypothetical; drug use is only one
of many components in the socioeconomic and psychocultural
backgrounds of the individuals. </p>

<p>Intensive studies of the Greek and Jamaican populations of
heavy long-term cannabis users appear to dispute the sole
causality of cannabis in this syndrome. The heavy ganja and
hashish using individuals were from lower socioeconomic groups,
and possessed average intelligence but had little education and
small chance of vocational advancement. Most were married and
maintained families and households. They were all employed, most
often as laborers or small businessmen, at a level which
corresponded with their education and opportunity. </p>

<p>In general, their life styles were dictated by socioeconomic
factors and did not appear to deteriorate as a result of cannabis
use. The Jamaicans were working strenuously and regularly at
generally uninteresting jobs. In their culture, cannabis serves
as a work adjunct. The users believe the drug provides energy for
laborious work and helps them to endure their routine tasks.<br>
</p>

<p>In contrast, others have described Asian and African
populations where heavy to very heavy hashish or charas smoking
for a very long time is associated with clear-cut behavioral
changes. In these societies, the smokers are mostly jobless,
illiterate persons of the lowest socioeconomic backgrounds. They
generally begin to use the drug in their early teens and continue
its use up to their 60's. </p>

<p>The users prefer to smoke in groups of two to 20, generally in
a quiet place out of the reach of non-smokers. Weakness,
malnutrition and sexual difficulties, usually impotence, a-re
common. Some of them report sleep disturbances. </p>

<p>Most users who have used the drug for 20 to 30 years are lazy
and less practical in most of their daily acts and reluctant to
make decisions. However, their ability to perform non-complicated
tasks is as good as non-smokers. </p>

<p>Although the smokers think they become faster in their daily
work, a general slowness in all their activities is noticed by
others. This user population is typically uncreative. They make
little if any significant contribution to the social, medical or
economic improvement of their community. </p>

<hr>

<p><b>SUMMARY<br>
</b></p>

<p>Once existing marihuana, policy was cast into the realm of
public debate, partisans on both sides of the issue
over-simplified the question of the effects of use of the, drug
on the individual. Proponents of the prohibitory legal system
contended that marihuana, was a, dangerous drug, while opponents
insisted that it was a harmless drug or was less harmful than
alcohol or tobacco. </p>

<p>Any psychoactive drug is potentially harmful to the
individual, depending on the intensity, frequency and duration of
use. Marihuana is no exception. Because the particular hazards of
use differ for different drugs, it makes no sense, to compare the
harmfulness of different drugs. One may compare, insofar as the
individual is concerned, only the harmfulness of specific
effects. Is heroin less harmful than alcohol because, unlike
alcohol, it directly causes no physical in-jury? Or is heroin
more harmful than alcohol because at normal doses its use is more
incapacitating in a behavioral sense? </p>

<p>Assessment of the relative dangers of particular drugs is
meaningful only in a wider context which weighs the possible
benefits of the drugs, the comparative scope of their use, and
their relative impact on society at large. We consider these
questions in the next Chapter, particularly in connection with
the impact on public health. </p>

<p>Looking only at the effects on the individual, there, is
little proven danger of physical or psychological harm from the
experimental or intermittent use of the natural preparations of
cannabis, including the resinous mixtures commonly used in this
country. The risk of harm lies instead in the heavy, long-term
use of the drug, particularly of the most potent preparations. </p>

<p>The experimenter and the intermittent users develop little or
no psychological dependence on the drug. No organ injury is
demonstrable. </p>

<p>Some moderate users evidence a degree of psychological
dependence which increases in intensity with prolonged duration
of use. Behavioral effects are lesser in stable personalities but
greater in those with emotional instability. Prolonged duration
of use does increase the probability of some behavioral and
organic consequences including the possible shift to a heavy use
pattern. </p>

<p>The heavy user shows strong psychological dependence on
marihuana and often hashish. Organ injury, especially diminuation
of pulmonary function, is possible. Specific behavioral changes
are detectable. All of these effects are more apparent with
long-term and very long-term heavy use than with short-term heavy
use. </p>

<p>The very heavy users, found in countries where the use of
cannabis has been indigenous for centuries, have a compulsive
psychological dependence on the drug, most commonly used in the
form of hashish. Clear-cut behavioral changes and a greater
incidence of associated biological injury occur as duration of
use increases. At present, the Commission is unaware of any
similar pattern in this country. <br>
</p>

<hr>

<p><a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> <br>
<br>
</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B23-61</DOCNO>
<DOCOLDNO>IA031-000655-B039-18</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/library/studies/nc/ncc3.htm 206.61.184.43 19970122112818 text/html 105438
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 11:28:07 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 06:54:07 GMT
Content-length: 105219
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Social Impact of Marihuana Use</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include"
u-include="../../../../_private/scmj_sig_of_mis_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a> </p>

<p><a href="ncmenu.htm">Marihuana, A Signal of Misunderstanding</a></p>

<p>&nbsp;</p>
<!--webbot bot="Include" endspan i-checksum="38989" -->

<p><b>National Commission on Marihuana and Drug Abuse</b> </p>

<p><b>Marihuana: A Signal of Misunderstanding</b> </p>

<p><b>Chapter III</b> </p>

<h1>Social Impact of marihuana use<br>
</h1>

<hr>

<p>&nbsp; </p>

<p><font size="2">&quot;Man is a creature who lives not upon
bread alone but principally by catchwords.&quot; -Robert Louis
Stevenson,</font> </p>

<p><font size="2"><i>Virginia Puerisque (1881) <br>
</i></font></p>

<hr>

<p>Implicit in existing social and legal policy toward marihuana
is the view that society suffers in some way from use of the
drug. When the widespread practice of marihuana smoking appeared
in the United States in the early decades of the 20th century,
the medical, law enforcement, newspaper, and legislative
communities immediately indicted the drug. They assumed that the
drug posed serious dangers to individual health; but more
importantly, they viewed it as a menace to the public order.
Crime, insanity and idleness were thought to be the inevitable
consequences of its use. </p>

<p>That some of these original fears were unfounded and that
others were exaggerated have been clear for many years. Yet, many
of these early beliefs continue to affect contemporary public
attitudes and concerns. Consequently, one of the Commission's
most important tasks is to evaluate carefully all data relevant
to the social impact of marihuana use. We must determine whether
and in what respects social concern is justified. What is myth
and what is reality? </p>

<p>The literature pertaining to -the presumed effects and
consequences of marihuana use still reveals a wide diversity of
opinion about social impact. Careful scrutiny is inhibited by the
prevalence of hearsay, rhetoric and undocumented assertions about
the effects and consequences of marihuana use. Nonetheless,
evidence is mounting and a number of significant trends have
recently emerged. In the previous Chapter we explored the
evidence regarding the nature and scope of contemporary marihuana
use, and the effects of the drug on the individual user. Now we
must consider the impact on society of behavior resulting from
use of marihuana. </p>

<p>In dealing with the behavioral consequences of marihuana, use,
the Commission has made, a concerted effort to review and
evaluate the enormous body of existing popular and scientific
literature, and has itself initiated new empirical research,
including national surveys, retrospective studies and controlled
laboratory experiments. </p>

<p>Awareness of the difficulties involved in investigating an
inherently complex social phenomenon and applying its research
findings to policy decisions has fostered particular sensitivity
to the quality of previous and Commission-sponsored research. As
such, considerable attention was given to such basic research
questions as: </p>

<p>What behavioral effects are most relevant in assessing the
consequences of marihuana use? </p>

<p>What measures produce the most valid data concerning given
effects? </p>

<p>What reliance should be placed on various research techniques,
such as self-reporting, controlled experiments, clinical
observations and statistical relationships? </p>

<p>What generalizations can be made from particular populations
studied? </p>

<p>What are the limits of given data in terms of inference.
interpredation and attribution of cause?<br>
</p>

<p>With respect to the Commission's own research program, the
process of selection and allocation of resources was indeed
difficult, and some areas of inquiry have undoubtedly been either
neglected or shortchanged. Nonetheless, we believe that the
studies undertaken and information gathered will add
significantly to our understanding of the conditions and
circumstances under which marihuana use is likely to affect
adversely the public safety, public health and welfare, and
dominant social order.<br>
</p>

<p align="center"><b>Marihuana and Public Safety<br>
</b></p>

<p>The belief that marihuana is causally linked to crime and
other antisocial conduct first assumed prominence during the
1930's as the result of a concerted effort by governmental
agencies and the press to alert the American populace to the
dangers of marihuana use. Newspapers all over the country began
to publish lurid accounts of &quot;marihuana atrocities.&quot; In
the absence of adequate understanding of the effects of the drug,
these largely unsubstantiated stories profoundly influenced
public opinion and gave birth to the stereotype of the marihuana
user as physically aggressive, lacking in self-control,
irresponsible, mentally ill and, perhaps most alarming,
criminally inclined and dangerous. The combination of the
purported effects of the drug itself plus the belief that it was
used by unstable individuals seemed to constitute a significant
danger to public safety. </p>

<p>Now, more than 30 years later, many observers are skeptical
about the existence of a cause-effect relationship between
marihuana use and antisocial conduct.<br>
</p>

<p align="center"><font size="2"><b>MARIHUANA AND CRIME <br>
</b></font></p>

<p>Over the years, there have been several hypotheses about the
relationship between marihuana and antisocial conduct. The
earliest view was that marihuana causes or leads to the
commission of aggressive and violent criminal acts such as
murder, rape and assault. These acts are committed, it has been
argued, because marihuana allegedly produces a relaxation of
ordinary inhibitions, a weakening of impulse control and a
concomitant increase in aggressive tendencies while the user is
under its influence. </p>

<p>Marihuana's alleged criminogenic role is not always limited to
violent or aggressive behavior. Some commentators also postulate
that marihuana leads to or causes non-violent forms of criminal
or delinquent conduct, ranging from sexual promiscuity to grand
larceny. Underlying this second causal hypothesis are the
assumptions that marihuana frequently impairs judgment, distorts
reality and diminishes, at least temporarily, the user's sense of
personal and social responsibility. Regular or heavy use over an
extended period of time is felt to interfere, perhaps
irreversibly, with the orderly development of psychosocial and
moral maturity. </p>

<p>As indicated above, however, a growing uncertainty prevails
about ,the existence of a causal link between marihuana use and
antisocial conduct. In fact, recent surveys, including several
sponsored by the Commission, suggest that large segments of the
professional public, particularly the law enforcement and
criminal justice communities, are no longer willing to assert a,
cause-effect relationship but observe, instead, the existence of
a statistical association. <br>
</p>

<p><font size="2"><b>The Issue of Cause and Effect<br>
</b></font></p>

<p>The controversy over the cause-effect relationship between
marihuana use and criminal, violent or delinquent behavior poses
a number of serious problems for the investigators Proponents and
opponents of the causal view tend to rely on different kinds of
evidence and to call upon different types of experts, thereby
differing substantially in the kinds of information they accept
as relevant, reliable or valid. </p>

<p>Practitioners, such as police and probation officers for
example, frequently cite case examples in which apprehended
offenders are found to be in possession of marihuana at the time
of arrest. The mere presence of the drug or the fact that an
offender is a known user of marihuana is sometimes deemed
sufficient to establish a causal link between the marihuana and
the offense.* </p>

<p>Empiricists, on the other hand, would deny that the simple
presence of the drug constitutes a satisfactory demonstration of
a causal relationship between marihuana use and the crime in
question. They would defer, instead, to the results of empirical
studies designed explicitly to test the assertion. Essentially,
they emphasize that even if some offenders do use marihuana, an
equal or larger number of offenders do not, and there are
certainly large numbers of marihuana users in the
population-at-large who never engage in the kinds of antisocial
conduct deemed to be related to or caused by the use of the drug.
</p>

<p>Proving any positive and direct relationship, be it causal or
otherwise, between two inherently complex social phenomena is
fraught with enormous difficulties. The relationship of marihuana
use to crime, violence, aggression or juvenile delinquency
presents no exception. Before examining the evidence with respect
to the existence of a causal connection, certain basic
considerations deserve at least brief mention here. </p>

<p>To prove, the existence of a positive and direct relationship,
one would be required to demonstrate that the alleged offender
was, indeed, a marihuana, user; that he was under the influence
of the drug at the time he committed the offense; and that the
crime was directly attributable to the effects of the marihuana.
The kinds of evidence necessary to establish these facts are not
easy to obtain. </p>

<p>First, evidence of the use of marihuana by the accused is
generally dependent upon either direct admission of use, hearsay
evidence, or inferences derived from knowledge of possession
(that is, the offender was found to have marihuana on his person
or in his possession at the time of arrest). </p>

<p>Second, because no chemical tests presently exist outside the
laboratory to identify the presence of marihuana in the body of
the accused, it is difficult if not impossible to prove that the
offender was definitely under the influence of marihuana when he
committed the offense. </p>

<p>Third, in order to prove that the marihuana represented the
significant contributory or precipitating variable, all other
factors possibly related to the offense would have to be examined
and excluded. </p>

<p>The problems of validation are further compounded by
additional variations in behavior attributable to: (a) the
pharmacological potency of the drug; (b) possible adulteration of
the marihuana; (c) the interaction of marihuana with other drugs
simultaneously ingested; (d) differing individual response to
similar dosage levels; (e) the time-action function; (f) the
cumulative effect of marihuana use; and (g) various social,
psychological and situational variables such as set and setting,
individual expectations, personal predispositions or preexisting
impulse disorders. </p>

<p>Despite the inherent complexities of the issue and the
difficulties in securing reliable and valid evidence, a
relatively large body of research is now available pertaining to
the criminogenic effects of marihuana upon the individual and the
nature and extent to which the drug constitutes a danger to
public safety. In the following section, we present the available
evidence and assess the strength and direction of the alleged
relationships between marihuana use and violent or aggressive
behavior and also non-violent forms of criminal and delinquent
behavior.<br>
</p>

<p>*In the widely publicized Licata case of the 1930's. for
example, a 16-year-old cannabis user was charged with the ax
murder of his family and the offense was directly attributed to
the effects of marihuana. There was, however. no precise
information available regarding the use of marihuana in relation
to the crime. Nor. in the various accounts of the case, was there
generally any reference to the fact that several of the boy's
relatives had previously been committed to mental institutions;
that the police hall, about one year prior to the offense (and
presumably before the youth's alleged use of marihuana) attempted
to commit him for his bizarre behavior; or that shortly after the
crime, the boy began to exhibit the symptoms of paranoid
schizophrenia.<br>
</p>

<p><font size="2"><b>Marihuana and Violent Crime <br>
</b></font></p>

<p>As indicated earlier, the belief that marihuana causes or
leads to the commission of violent or aggressive acts first
emerged during the 1930's and became deeply embedded in the
public mind. Until recently, however, these beliefs were
generally based on the anecdotal case examples of law enforcement
authorities, a few clinical observations and several
quasi-experimental studies of selected populations comprised of
military offenders, convicted or institutionalized criminals or
delinquents and small groups of college students. Few efforts
were made to compare the incidence of violent or aggressive
behavior in representative samples of both user and non-user
populations. </p>

<p>Even in these early observations and investigations, however,
no substantial evidence existed of a causal connection between
the use of marihuana and the commission of violent or aggressive
acts. Indeed, if any relationship was indicated, it was not a
positive and direct causal connection but in inverse or negative
statistical correlation. </p>

<p>Rather than inducing violent -or aggressive behavior through
its purported effects of lowering inhibitions, weakening impulse
control and heightening aggressive tendencies, marihuana was
usually found to inhibit the expression of aggressive impulses by
pacifying the user, interfering with muscular coordination,
reducing psychomotor activities and generally producing states of
drowsiness lethargy, timidity and passivity. </p>

<p>In fact, only a small proportion of the marihuana users among
any group of criminals or delinquents known to the authorities
and appearing in study samples had ever been arrested or
convicted for such violent crimes as murder, forcible rape,
aggravated assaultor armed robbery. When these marihuana-using
offenders were compared with offenders who did not use marihuana,
the former were generally found to 'have committed less
aggressive behavior than the latter. </p>

<p>In an effort to accumulate data on the relationship between
marihuana use and aggressive or violent criminal behavior, the
Commission sponsored several studies designed to assess the
purported causal relationship. </p>

<p>First, the Commission wanted to tap the unique experience of
the law enforcement and criminal justice communities.
Representative samples of prosecuting attorneys, judges,
probation officers and court clinicians were asked their opinions
about the relationship between marihuana use and the commission
of aggressive or violent criminal acts. When asked to evaluate
the statement that &quot;most aggressive acts or crimes of
violence committed by persons who are known users of marihuana
occur when the offender is under the influence of
marihuana,&quot; three-quarters of the judges, probation officers
and clinicians indicated either that the statement was probably
untrue or that they were unsure of its accuracy. Of these three
groups, a greater proportion of clinicians (76.5%) thought the
statement false than did the probation officers (60%)and judges
(44.2%). </p>

<p>In a separate mail survey of the chief prosecuting attorneys
in the 50 states-the group which has often supported the causal
hypothesis-52% of the respondents stated that they either did not
believe or were uncertain of the truth of the proposition that
use of marihuana leads to aggressive behavior. </p>

<p>We have already noted that only a small fraction of the
offender populations in past studies were found to have been
arrested for crimes of violence. Similarly, in a
Commission-sponsored study of 1,776 16to-21-year-olds arrested in
five New York counties for marihuana law violations between 1965
and 1969, onlv a small percentage bad either previously or
subsequently come to the attention of authorities for such
offenses as assault or robbery. In fact, less than 1% of the
offenders in this sample had been arrested for these offenses
prior to their first marihuana arrest, and less than 3% were
known to the Federal Bureau of Investigation for these offenses
subsequent to their marihuana violation. </p>

<p>Perhaps more important than professional opinion or the
incidence of violent offenses in an offender population, however,
is the determination of the extent to which marihuana use is
related to violent or aggressive behavior in the general
population. </p>

<p>In a Commission-sponsored survey, face-to-face interviews were
conducted with a representative sample of 559 West Philadelphia
residents in order to ascertain the extent of marihuana use in
this heterogeneous population and the relative involvement of
marihuana users and nonusers in violent criminal behavior. In
corroboration of the earlier findings, the researchers found no
significant differences in the proportions of users and
non-users; who stated that they had committed any of the
aggressive or violent crimes enumerated. </p>

<p>Further, no findings indicated that marihuana was generally or
frequently used immediately prior to the commission of offenses
in the very small number of instances in which these offense's
did occur. In contrast, however, the aggressive and violent
offenders in this sample did report with significantly greater
frequency the use of alcohol within 24 hours of the offense in
question. </p>

<p>These findings should be considered in fight of an earlier
West Coast study of disadvantaged minority-group youthful
marihuana users, many of whom were raised in a combative and
aggressive social milieu similar to that found in several of the
West Philadelphia sampled neighborhoods. The data show that
marihuana users were much less likely to commit aggressive or
violent acts than were those who preferred amphetamines or
alcohol. They also show that most marihuana users were able to
condition themselves to avoid aggressive behavior even in the
face of provocation. In fact, marihuana was found to play a
significant role in youth's transition from a &quot;rowdy&quot;
to a &quot;cool,&quot; non-violent style. </p>

<p>The Commission is aware of the claim that a few emotionally
unstable or impulsive individuals have become particularly
aggressive or impulsive under the influence of marihuana. As we
have noted, some newspaper accounts have attributed sensational
homicides or sexual assaults to marihuana-induced transitory
psychotic states on the part of the user. No evidence exists,
however, to indicate that marihuana was responsible for
generating or creating excessive aggressiveness or impulsivity in
individuals having no prior history of impulse or personality
disorder. The most that can be said is that in those rare
instances, marihuana may have aggravated a preexisting condition.
</p>

<p>In sum, the weight of the evidence is that marihuana does not
cause violent or aggressive behavior, if anything, marihuana
generally serves to inhibit the expression of such behavior.
Marihuana-induced relaxation of inhibitions is not ordinarily
accompanied by an exaggeration of aggressive tendencies. </p>

<p>No evidence exists that marihuana use will cause or lead to
the commission of violent or aggressive behavior by the large
majority of psychologically and socially mature individuals in
the general population.<br>
</p>

<p><font size="2"><b>Marihuana and Non-Violent Crime<br>
</b></font></p>

<p>A second hypothesis reflecting the statements of significant
numbers of government officials is that marihuana plays a major
role in the commission of other, essentially non-violent, forms
of criminal and delinquent behavior. </p>

<p>In general, those espousing this more general cause-effect
relationship assume that the drug frequently produces, in
addition to the lowering of inhibitions, impairment of judgment,
distortion of reality and at least temporary reduction of a sense
of personal and social responsibility. Indeed, the earlier
stereotype of the marihuana user was that of an immoral,
physically debilitated, psychologically unstable and criminally
marginal man whose state of severely and irreversibly
underdeveloped psychosocial and moral maturity was said to derive
directly from his continued use of marihuana. </p>

<p>As indicated earlier, neither the inherent complexities of the
issue nor the previously inconclusive empirical evidence has
deterred the formulation and expression of strong opinions about
the relationship of marihuana use to crime and delinquency.
Opinion in this area, quite apart from the empirical evidence,
has long assumed critical importance in the development of social
policy. </p>

<p>The Commission has addressed the issue in three different
ways. One was to assess the state of current public and
professional opinion relative to the general proposition that
marihuana causes or leads to the commission of criminal or
delinquent acts. A second approach was to review the professional
literature addressed to the issue, and a third was to initiate
empirical investigations of our own. </p>

<p>The opinion surveys found that substantial numbers of persons
raised serious questions about the existence of a causal
relationship between marihuana use and criminal or delinquent
behavior. Confusion and uncertainty about the existence of such a
relationship have been expressed by both youth and adults,
including practicing professionals in the criminal justice
system. </p>

<p>Recent data suggest that some of this confusion may be the
result of a fairly widespread misconception about the addiction
potential of marihuana. To the extent that persons believe
marihuana users are physically dependent on the -drug, they may
assume that, like the heroin user, the marihuana user commits his
offenses in order to support what is perceived as a drug habit;
and that, like the heroin model, offenses are committed more
often in the desperate attempt to obtain the drug rather than
under its influence following use. There is no evidence that this
is the case, even for those who use the drug heavily. </p>

<p>In the Commission-sponsored National Survey, the respondents
were asked whether they agreed or disagreed with the statement
that &quot;many crimes are committed by persons who are under the
influence of marihuana.&quot; Fifty-six percent of the adult
population and 41% of the youth indicated agreement. As in the
Survey generally, there was a significant difference of opinion
according to age in the adult population. While 69% of the
over-50 age group agreed with this statement, only about
one-third of the 18-to-25 age group and the 14-to-17-yearolds
agreed. One of every four youth respondents and 18% of the adults
said they were &quot;not sure&quot; of the existence of such a
relationship between marihuana use and crime. </p>

<p>Much greater consensus exists, even between generations,
regarding the association of alcohol and crime. While 56% of all
adults expressed their belief that many crimes are committed by
persons under the influence of marihuana, 69% of these same
adults believed that alcohol was related in the same way. Only 7%
felt unsure about the alcohol crime relationship, in contrast to
18% who expressed uncertainty about the relationship between
crime and marihuana. </p>

<p>The Commission also surveyed opinion within the criminal
justice community. A sample of 781 judges, probation officers and
court clinicians replied to a questionnaire which asked
respondents to indicate whether or not their professional
experience led them to believe that &quot;use of marihuana causes
or leads to antisocial behavior in the sense that it leads one to
commit other criminal or delinquent acts.&quot; Of all
respondents, 27% believed this to be the case. Within each
professional group, 34% of the judges, 18% of the probation
officers and 2% of the clinicians indicated their agreement. </p>

<p>On the assumption that some, proportion, however small, of
marihuana users might ultimately be arrested for non-drug
offenses, these officials were also asked to assess the relative,
truth of the statement that &quot;most non-drug offenses
committed by persons who are known users of marihuana or are
found to have marihuana on their person or in their possession
occur when the offender is under the influence of
marihuana.&quot; Seventy-one percent of the responding judges,
75% of the probation officers and 85% of the court clinicians
either thought the statement false or were unsure of its
accuracy. </p>

<p>Respondents likewise rejected, however, the proposition that
these crimes perpetrated by marihuana users occur when the
offender is attempting to obtain the drug rather than while under
its influence; 65.6% of the judges, 64.6% of the probation
officers and 78.3% of the court clinicians either denied or were
unsure of the truth of this proposition. </p>

<p>In short, marihuana, is not generally viewed by participants
in the criminal justice community as a major contributing
influence in the commission of delinquent or criminal acts. </p>

<p>This increasing professional skepticism is buttressed by the
weight of research findings. A comprehensive review of the
literature revealed that in the various offender populations
studied for this purpose, only a small percentage were marihuana
users. In only a handful of cases did researchers report that
criminal conduct followed the use of marihuana. Generally, the
rate of self -reported, non-drug crime did not significantly
differ between users and non-users. </p>

<p>Both of the Commission-sponsored studies (the New York and
Philadelphia studies referred to earlier) corroborated this
research consensus. In the Philadelphia study, for example, less
than 10% of the sample were known to the police, and there were
no significant differences among marihuana users and non-users in
the sample who reported the commission of major criminal acts
when statistical controls were applied. Further, most of the
first offenses committed by users occurred prior to their use of
marihuana, and only in rare instances did the offenses
immediately follow (within 24 hours) upon the use of marihuana
(five cases out of 741 first offenses and 19 cases out of 516
most recent offenses). </p>

<p>Likewise, the New York study revealed that about one-fifth of
-the marihuana law violators arrested between 1965 and 1969 were
found to have previous arrest records. Of those with previous
arrests, the great majority of offenses (86%) involved traffic
violations and minor violations of the vagrancy statutes. In but
10% of the cases the previous arrests were for assault, robbery,
burglary or larceny. </p>

<p>In essence, neither informed current professional opinion nor
empirical research, ranging from the 1930's to the present, has
produced systematic evidence to support the thesis that marihuana
use, by itself, either invariably or generally leads to or causes
crime, including acts of violence,, juvenile delinquency or
aggressive behavior. Instead the evidence suggests that
sociolegal and cultural variable's account for the apparent
statistical correlation between marihuana use and crime or
delinquency.<br>
</p>

<p><font size="2"><b>A Sociocultural Explanation <br>
</b></font></p>

<p>The persistent belief that some relationship exists between
marihuana use and crime is not without statistical support.
Undoubtedly, the marihuana user of the 1920's and 1930's was
overrepresented in the nation's jails and penitentiaries and in
the general crime and delinquency statistics. Especially during
the late 1920's and early 1930's when the nation was preoccupied
with lawlessness, the translation of this statistical correlation
into a causal hypothesis is not surprising. </p>

<p>The increasing incidence of use in the mid-sixties by white,
affluent, middle class, high school youth, college students and
adults has occasioned a reevaluation of the marihuana user and a
reexamination of the crime issue. The overwhelming majority of
the new marihuana offenders have had no previous arrests, and
come from the normally low risk, middle and upper socioeconomic
population groups. </p>

<p>Recent public opinion surveys suggest that considerable social
disapproval is attached to the &quot;hippie&quot; life style,
unconventional mode of dress and apparent disregard for the law
displayed by many of these individuals. Nonetheless, fewer
persons are now willing to classify as criminal those marihuana
users whose only contact with the law has been as a result of
their marihuana use. Perceptions have undergone a change as a
result of the increased usage of marihuana among youth of the
dominant social class. Nonetheless, a statistical association
remains. </p>

<p>First, the majority of both marihuana users and offenders
other than actual marihuana law violators fall into the
14-to-25-year age group. Second, the majority of those arrested
for marihuana law violations as well as other delinquent or
criminal acts were, and to a much lesser degree, still are, drawn
from the same &quot;high risk&quot; populations, such as minority
groups, socially and economically disadvantaged, young, male,
inner-city residents. </p>

<p>Third, various offender populations subjected to study often
included a number of marihuana users, although it was not the
marihuana violations per se but other, more serious criminal
conduct that originally brought most of them to the attention of
the authorities. Finally, during the past five years, marihuana
law violators have increasingly swelled the crime and delinquency
statistics; in most cases, their only contact with the law has
been for these marihuanaspecific offenses. </p>

<p>The Philadelphia study corroborated this continuing
statistical association. The simple relationship between using
marihuana and committing offenses was positive and statistically
significant, and there was also a high correlation between
frequency of smoking marihuana and committing offenses. These
direct associations were reduced to insignificance, however, upon
further analysis of the data, and other explanations for the
coincidence of marihuana use and crime became evident. These
included: race, education, age, the use of other drugs, and
having drug-using friends. </p>

<p>We conclude that some users commit crimes more frequently than
non-users not because they use marihuana but because they happen
to be the kinds of people who would be expected to have a higher
crime rate, wholly apart from the use of marihuana. In most
cases, the differences in crime rate between users and non-users
are dependent not on marihuana use per se but on these other
factors. </p>

<p>In summary, although the available evidence suggests that
marihuana use may be statistically correlated with the incidence
of crime and delinquency, when examined in isolation from the
other variables, no valid evidence was found to support the
thesis that marihuana' by itself, either inevitably, generally or
even frequently causes or precipitates the commission of crime,
including acts of violence, or juvenile delinquency. <br>
</p>

<p>Within this framework, neither the marihuana user nor the drug
itself can be said to constitute a danger to public safety. For,
as two researchers have so cogently stated for the Commission,
&quot;Whatever an individual is, in all of his cultural, social
and psychological complexity, is not going to vanish in a puff of
marihuana smoke.&quot;<br>
</p>

<p align="center"><font size="2"><b>MARIHUANA AND DRIVING <br>
</b></font></p>

<p>Within the context of public safety another issue which merits
attention is the extent to which drivers under the influence of
marihuana constitute a hazard on the nation's streets and
highways. Although in recent years increasing attention has been
given to this issue, at present little empirical evidence exists
to inform discussion. </p>

<p>To assess the actual and potential impact of marihuana on
traffic safety, a number of basic research questions must be
answered. </p>

<p>the extent to which marihuana, users actually drive while
under the influence of the drug </p>

<p>the extent to which marihuana users driving while
&quot;high&quot; commit traffic violations and are involved in
traffic accidents </p>

<p>the amounts of marihuana consumed immediately prior to the
commission of traffic violations or the involvement in traffic
accidents and the drug's role in these events </p>

<p>the nature and extent to which marihuana actually impairs
psychomotor skills, judgment and driving performance<br>
</p>

<p>To date, the generalizations made concerning the effects of
marihuana on driving behavior have generally been based on
statistical studies of traffic violations and accidents and
inferences drawn from more general studies of the physiological
and psychological consequences of marihuana use, such as changes
in pulse rate, reaction time, neuromuscular coordination, time
estimation and spatial perceptions. </p>

<p>Such studies pose serious limitations in the nature,
reliability and validity of the data. The basic problems derive
from difficulties in identifying and attributing cause. A major
obstacle in such retrospective analysis is the inability to
separate the effects of marihuana from those possibly engendered
by the use of other drugs, such as alcohol, tranquilizers and
amphetamines. Finally, conclusive analysis is impossible until a
reliable technique is developed for measuring the level of
marihuana present in the body of the driver at the time of his
violation or accident. </p>

<p>Prospective experimental studies of actual reactions to road
conditions and traffic emergency situations would undoubtedly
provide the most reliable and valid data, but such studies would
themselves endanger the public and have not been undertaken.
Researchers have relied, therefore, on controlled laboratory
simulator studies and direct interviews with those who have
admitted to driving while under the influence of marihuana.<br>
</p>

<p>With respect to the simulator studies , the available evidence
suggests that while, in some cases, marihuana has produced
interference with certain motor or mental abilities which affect
driving behavior, these effects were generally believed to be
readily overcome by the exercise of extreme caution by the driver
and a significant reduction in speed. </p>

<p>The few driving simulator tests completed to date have
generally revealed no significant correlations between marihuana
use and driving disabilities. Comparison of the simulator scores
of users and nonusers, however, did reveal small but
nonsignificant differences in the number of speedometer errors
made. </p>

<p>These simulator studies also examined the comparative effects
of alcohol and marihuana on driving scores. The findings of one
study, though controversial, suggested that intoxication
resulting from low doses of marihuana was less detrimental to
driving performance than was the presence of alcohol at the
legally prohibited blood level of .10%. </p>

<p>The methodological limitations of the study raise serious
questions about the reliability and validity of the findings. As
one critic has noted, &quot;It does not follow automatically that
lack of effect of a drug on the simulated task will correlate
with lack of effect on the actual task.&quot; Further , the use
of dissimilar doses of alcohol and marihuana has led another
critic to assert that &quot;finding that a heavy dose of alcohol
caused more impairment than a mild dose of marihuana is neither
surprising nor helpful in assessing the relative effects of the
two drugs in the relative doses in which they are normally
used.&quot; </p>

<p>Recent research has not yet proven that marihuana use
significantly impairs driving ability or performance. The
Commission believes, nonetheless, that driving while under the
influence of any psychoactive drug is a serious risk to public
safety; the acute effects of marihuana intoxication, spatial and
time distortion and slowed reflexes may impair driving
performance. That the risk of injury may be greater for alcohol
than for marihuana matters little. </p>

<p>Obviously, Much more research needs to be undertaken in this
area. Hopefully, recent studies sponsored by the National
Institute of Mental Health and other agencies will soon provide
the concrete information that is needed.<br>
</p>

<p>Marihuana, Public Health and Welfare<br>
</p>

<p>As the feared threat to public safety through violent crime
has diminished in recent years, policy-makers and the public have
begun increasingly to view marihuana and other illicit drug use
as a public health concern. The National Survey indicates that
American adults regard drug abuse as the third most pressing
problem of the day, closely following the economy and Vietnam.
However, public attitudes reflect considerable confusion about
the facts concerning marihuana and drugs in general. </p>

<p>This confusion has resulted from too little understanding of
the motives for drug use as well as inadequate knowledge of the
classification of drugs according to their main effects. Legal
penalties have frequently mirrored this confusion, and the
resulting inconsistencies cause, many young people to lose
confidence in adult authority. Even in the medical profession,
much uncertainty is evident, and for most of the general public
there is no clear authority to whom they can turn for guidance.<br>
</p>

<p align="center"><font size="2">A PUBLIC HEALTH APPROACH <br>
</font></p>

<p>The Commission broadly defines public health concerns as all
health problems which affect people en masse and are thereby
difficult to treat on a traditional physician-to-patient basis.
This category would include social and economic dependence and
incapacity. A health problem which spreads to other susceptible
members of the society cannot be controlled by the individual
physician. This view coincides with the concept of preventive
medicine, recognizing that all public health problems must be
dealt with on both an individual and societal level. </p>

<p>To illustrate, the increasing incidence of deaths due to lung
cancer subsequent to chronic, heavy tobacco usage is a major
public health concern. In this instance, prevention of smoking
and ascertaining the cause of the malignancies, rather than the
individual treatment of each case by a physician, define the
public health dimension. A major concern exists because the
population at risk is large and growing, and the risk of harm is
great. </p>

<p>In addition to the risk of large numbers of the populace being
affected, the issue of contagion must also be examined. Unlike
infectious diseases such as influenza and smallpox, where the
person affected &quot; catches&quot; the ailment unintentionally,
those individuals who use marihuana choose to come into contact
with it. The contagion model is relevant only insofar as social
pressure from proselytizing friends and social contacts play a
role in spreading the use of the, drug. This dimension exists
with marihuana, as well as alcohol and tobacco. </p>

<p>After assessing the potential harm to the individual and
society, the size of the population at risk and the contagion
aspect, society must determine the nature of the control
mechanism used to deal with the problem, and how nine]) of its
health resources, manpower and facilities will be allocated to
meet the perceived threat to the public health. Therefore, an
analysis of the relative risk of marihuana use must be
undertaken. We must examine not only the effects of the drug on
the individual but also determine which groups are at risk and
why.<br>
</p>

<p>Practically all substances consumed by man are potentially
dangerous to the physical or mental health of the individual if
used irresponsibly or by particularly sensitive persons. Certain
substances are sufficiently complex in their effects that
societal control is necessary to reduce risk, for example,
fluorides added to the water supply, prescription drugs, and food
additives. The degree of concern and control varies, depending on
relative public health dangers. <br>
</p>

<p><font size="2"><b>The Population At Risk <br>
</b></font></p>

<p>Before the dangers can be assessed, the population at risk
must be defined. Viewing the public health picture on a large
scale, the United States in 1972 may still be considered
fortunate with regard to marihuana usage. While it is the third
most popular recreational drug, behind alcohol and tobacco, it
has not been institutionalized and commercialized. </p>

<p>Most of the Americans who have used marihuana have been merely
experimenting with it. As noted in Chapter 1, there are 24
million Americans who have tried marihuana at one time or
another, with 8.3 million still using it. Of those who have quit,
most say they have simply lost interest in it. The same Survey
shows that experience with marihuana peaks in the
18-to-25-year-old group and falls off sharply thereafter. A fact
of some significance is that at least 71% of all adults (18-years
and older) and 80% of youth (12-to-17-years) have never used
marihuana at all.* </p>

<p>The Survey also indicates that the majority of those youth and
adults who continue to use marihuana do so intermittently, that
is, between one and 10 times a month. These individuals are
classified as intermittent marihuana smokers who use the drug for
its socializing effects. They are, for the most part, ordinary
Americans who are either in school or are employed. </p>

<p>About 2% of those who have ever used marihuana, or 500,000
people, now use the drug heavily. They use the drug several times
a day. These individuals use marihuana for its personal drug
effects in addition to its socializing effects. Generally, their
life styles, values, attitudes, behaviors and activities are
unconventional. Marihuana plays an important role in their lives.
Because the risk of psychological, and perhaps physical, harm
from marihuana increases with the frequency quantity and duration
of its use, these heavy marihuana users constitute the greatest
at-risk population in the United States today. </p>

<p>The heavy marihuana user presents the greatest potential
concern to the, public health. It is the Commission's opinion
that these heavy marihuana users constitute a source of contagion
within American society. They actively proselytize others into a
drug-oriented way of life. The effectiveness of peer group
pressure has been described earlier in Chapter II </p>

<p>We anticipate that this at-risk population would increase in
number should a policy of institutionalized availability be
adopted toward marihuana. Although marihuana is readily available
illicitly in the United States today, a policy permitting its
legal distribution could be expected to bring about an increase
in users, with some percentage of them becoming heavy users. It
is the availability of the drug, coupled -with a governmental
policy of approval or neutrality, that could escalate this group
into a public health and welfare concern. While this is
speculative, it is a concern which cannot be dismissed. The
experience with the rise in the use of tobacco and alcohol makes
clear the probable consequences of commercial exploitation. </p>

<p>Another concern of the Commission is the experience of other
countries which have large heavy user populations. While the
pattern of behavior in one country is not automatically similar
to a pattern of behavior in another country, the existence of
heavy user populations constitutes a serious public health
concern which must be avoided in this country. The availability
of the drug alone does not seem to determine increased usage;
supply and governmental inaction appear to tip the balance toward
increased use. The proportion of our population susceptible to
this pattern of use is conjectural but good preventive public
health requires limiting the number to an irreducible minimum. <br>
</p>

<p>*In the self-administered instrument, several separate
questions were utilized to elicit the respondent's experience
with marihuana. This technique permitted an analysis of
consistency of responses, and also minimized the possibility of
nonresponse. Nevertheless, 14% of the adults and 6% of the youth
did not respond to enough of these questions to ascertain whether
they had ever tried marihuana or not. <br>
</p>

<p>Percentage who- Adult Youth </p>

<p>Ever used ------------------------------------- 15 14 </p>

<p>Never used ------------------------------------ 71 so </p>

<p>No response ----------------------------------- 14 6<br>
</p>

<p><font size="2"><b>Confusion and Fact <br>
</b></font></p>

<p>One of the primary sources of confusion surrounding the use of
marihuana and other psychoactive drugs is the ambiguity of the
term &quot;drug abuse.&quot; In many quarters the excessive use
of any drug is considered drug abuse, regardless of the effect of
the drug on the individual or his behavior. In order to clarify
this issue the Commission defines psychoactive drug abuse as
follows: <br>
</p>

<p><font size="2"><i>Drug abuse is the use of psychoactive drugs
in a way likely to induce mental dysfunction and disordered
behavior. <br>
</i></font></p>

<p>It should be emphasized that demonstrable pathology of organ
systems, including the brain, is not a necessary characteristic
of psychoactive drug abuse. There are numerous non-psychoactive
drugs which can induce extensive organ pathology but do not
modify behavior; such drugs leave their imprint primarily on the
individual, not on society. The Commission believes that many of
the perplexing issues relating to psychoactive drugs, including
marihuana, can be clarified if drug abuse refers only to the
impact of drug-induced behavior on society. </p>

<p>Three types of such drug-induced behavior are considered
unacceptable in most organized societies: (1) aggressiveness
leading to violence; (2) loss of psychomotor control; (3) mental
or physical disorder leading to social and economic incapacity or
dependency. </p>

<p>This is not to say that society is unconcerned about the
harmful effects of psychoactive drugs on the individual, or that
such effects do not merit the attention of public health
officials. Cigarette smoking, although affecting primarily the
individual, is surely a matter of public health concern. We
believe, however, that the term drug abuse, with its attendant
societal disapprobation, should be reserved for drug taking which
has a more direct effect on society through disordered behavior. </p>

<p>Beyond the confusion surrounding the term drug abuse, a
rational evaluation of the public health impact of marihuana use
is also inhibited by extensive misinformation about the drug.
Recently, a great deal of research has increased significantly
our knowledge about marihuana. Further research data are
necessary before ;a conclusive statement about marihuana and
public health can be made. However, enough is known today to
discuss some of the public perceptions in detail. And sufficient
data are presently available to allow for rational
decision-making.<br>
</p>

<p align="center"><font size="2"><b>ASSESSMENT OF PERCEIVED RISKS<br>
</b></font></p>

<p>The Commission believes that marihuana. is perceived by the
American public to present the following risks to the public
health:<br>
</p>

<p>lethality </p>

<p>potential for genetic damage or teratogenicity </p>

<p>immediate adverse physical or mental effects </p>

<p>long-term physical or mental effects including psychosis and
&quot;amotivation&quot; syndrome </p>

<p>&quot;addiction&quot; potential </p>

<p>* progression to other stronger drugs, especially heroin<br>
</p>

<p><font size="2"><b>Lethality<br>
</b></font></p>

<p>The Commission's National Survey revealed that 48% of adults
believe that some people have died from marihuana use. A careful
search of the literature and testimony of the nation's health
officials has not revealed a single human fatality in the United
States proven to have resulted solely from ingestion of
marihuana. Experiments with the drug in monkeys demonstrated that
the dose required for overdose death was enormous and for all
practical purposes unachievable by humans smoking marihuana. This
is in marked contrast to other substances in common use, most
notably alcohol and barbiturate sleeping pills. </p>

<p>Of comparative note, 89% of all adults in the same Survey
believe that some people have died from using alcohol. This
indicates that public opinion regarding alcohol and its potential
lethality is more accurate than it is for marihuana. At the same
time, factual knowledge regarding the inherent danger in using a
substance, for example alcohol, seemingly does not deter many
persons from using it irresponsibly.<br>
</p>

<p><font size="2"><b>Potential For Genetic Damage <br>
</b></font></p>

<p>The thalidomide tragedies of the 1950's have taught us to
ponder carefully the possibility of genetic damage subsequent to
any drug use. The much publicized controversy regarding LSD and
subsequent genetic damage has led investigators to study
marihuana and its possible genetic effects. Although a number of
studies have been performed, at present no reliable evidence
exists indicating that marihuana causes genetic defects in man. </p>

<p>Early findings from studies of chronic (up to 41 years), heavy
(several ounces per day) cannabis users in Greece and Jamaica
also failed to find such evidence. In all its studies, the
Commission found no evidence of chromosome damage or teratogenic
or mutagenic effects due to cannabis at doses commonly used by
man. However, since fetal damage cannot be ruled out, the use of
marihuana like that of many other drugs, is not advisable during
pregnancy.<br>
</p>

<p><font size="2"><b>Immediate Effects<br>
</b></font></p>

<p>The intoxicant effects of marihuana on the mental function of
the user does have potential health significance both for the
individual and others with whom he may come in contact. Because
marihuana is a psychoactive drug, it is important to examine the
acute toxic effects which may occur in certain predisposed
individuals and which increase with the potency of the
preparation. </p>

<p>The Commission has reviewed numerous clinical studies
describing acute panic reactions and transient psychotic-like
episodes which occur as acute effects of the drug intoxication.
In addition, a predisposed individual might experience
aggravation of a latent psychotic state or other underlying
instability. Although severe abnormal psychological states are
rare when compared to the total number of marihuana users, lesser
problems are not rare, and they may endanger both the individual
and those around him at the time of their occurrence. The
individual contemplating use is not capable of predicting whether
he is predisposed by his particular circumstances to an
undesirable mental reaction. The undesirable consequences
occurring while an individual is involved in complex tasks such
as driving or operating machinery or tasks requiring fine
psychomotor precision and judgment are all too imaginable. </p>

<p>From a public health point of view, the immediate effects of
marihuana intoxication on the individual's organs or bodily
functions are of little significance. By and large these effects,
which have been carefully outlined in Chapter 11 of the Report,
are transient and have little or no permanent effect upon the
individual.<br>
</p>

<p><font size="2"><b>Effects Of Long-Term, Heavy Use<br>
</b></font></p>

<p>To determine the long-term chronic effects of heavy marihuana
use, the Commission has carefully reviewed the world literature
and contemporary studies of heavy, chronic (up to 41 years)
cannabis users in the world. In addition, lower socioeconomic
populations in Afghanistan, Greece, and Jamaica have been
examined.<br>
</p>

<p><font size="2"><b><i>Effects On The Body <br>
</i></b></font></p>

<p>These recent studies in Greece and Jamaica report minimal
physical abnormalities in the cannabis users as compared with
their non-using peers. </p>

<p>Minimal abnormalities in pulmonary function have been observed
in some cases of heavy and very heavy smokers of potent marihuana
preparations (ganja or hashish). However, one study concluded the
cause was smoking in general no matter what the substance. The
other study could not express any conclusion because of the
absence of a control population. Such decrements in normal
pulmonary capacity may represent early warning signals in the
development of chronic lung disease. They must be considered in
any program of early prevention of disease and future disability.
</p>

<p>No objective evidence of specific pathology of brain tissue
has been documented. This fact contrasts sharply with the
well-established brain damage of chronic alcoholism.<br>
</p>

<p><font size="2"><b><i>Effects On The Mind <br>
</i></b></font></p>

<p>No outstanding abnormalities in psychological tests,
psychiatric interviews or coping patterns have been conclusively
documented in studies of cannabis users in other countries of the
world. Further research in this important area is necessary
before definite conclusions can be drawn relating or linking
marihuana to mental dysfunction because available psychological
tests do not measure certain higher mental functions very
accurately.<br>
</p>

<p>Cannabis use has long been known to precipitate short-term
phychotic-like episodes in predisposed individuals or those who
take excessive doses. Some observers report that the prevalence
of shortterm psychoses as well as the psychotic episodes of
longer duration in heavy cannabis users are compatible with the
prevalence rate of psychosis in the general population and,
therefore, may not be attributable to cannabis use. In fact, some
believe that in populations under stress where marihuana is
widely used, occurrence of the acute psychotic-like episodes
occur less often than one would expect in such a population.
Other researchers have disagreed with these conclusions, and the
matter is still controversial. <br>
</p>

<p><font size="2"><b><i>Effects On Motivation <br>
</i></b></font></p>

<p>The Commission is deeply concerned about another group of
behavioral effects that have been described in other nations as
being associated with the heavy, long-term use of cannabis. This
behavioral condition has been termed the &quot;amotivational
syndrome.&quot; An extreme form has been reported in populations
of lower socioeconomic males in several developing nations. These
reports describe lethargy, instability, social deterioration, a
loss of interest in virtually all activities other than drug use.
This state of social and economic disability also results in
precipitation and aggravation of psychiatric disorders (overt
psychotic behavior) and possible somatic complications among very
heavy, very long-term users of high potency cannabis products.
However, in the populations so far observed in Jamaica, Greece,
and Afghanistan, physical and psychosocial deterioration was not
reported. The life styles of these populations appeared to be
conditioned by cultural and socioeconomic factors. Some
researchers believe cannabis' may serve to keep these individuals
stratified at this lower socioeconomic level. </p>

<p>The occurrence of a similar, though less intense, syndrome has
been identified recently with heavy marihuana use among young
persons in the Western world, including the United States. Some
clinicians have described the existence of a complex of subtle
social, psychological and behavioral changes related to a loss of
volitional goal direction in certain individuals, including some
long-term heavy users of marihuana. Such persons appear to orient
only to the present. They appear, alienated from generally
accepted social and occupational activities, and they tend to
show a reduced concern for personal hygiene and nutrition. </p>

<p>Some clinicians believe that this picture is directly caused
by the action of marihuana. However , other behavioral scientists
believe that among impressionable adolescents, marihuana-induced
suggestibility may facilitate the rapid adoption of new values
and behavior patterns, particularly when the drug is taken in a
socially alienated subculture that advocates and strongly
reinforces such changes. </p>

<p>Whichever interpretation one accepts, the fact is apparent
that the chronic, heavy use of marihuana may jeopardize social
and economic adjustments of the adolescents We believe this is
one concern which merits further research and evaluation. On the
basis of past studies, the chronic, heavy use of marihuana, seems
to constitute a high-risk behavior, particularly among
predisposed adolescents. This consideration is especially
critical when we consider the adolescent who is in the throes of
a normally turbulent emotional process. The Commission has
reviewed numerous reported studies and heard the testimony of
several clinicians dealing with heavy users of marihuana who
exhibit this particular behavior pattern. Although the United
States does not, at the present time, have a large number of such
persons within its population, the incidence is too frequent to
ignore. Expanded epidemiologic studies are imperative to obtain a
better understanding of this complex behavior.<br>
</p>

<p><font size="2">Addiction Potential<br>
</font></p>

<p>Unfortunately, fact and fancy have become irrationally mixed
regarding marihuana's physiological and psychological properties.
Marihuana clearly is not in the same chemical category as heroin
insofar as its physiologic and psychological effects are
concerned. In a word, cannabis does not lead to physical
dependence. No torturous withdrawal syndrome follows the sudden
cessation of chronic, heavy use of marihuana. Although evidence
indicates that heavy, long-term cannabis users may develop
psychological dependence, even then the level of psychological
dependence is no different from the syndrome of anxiety and
restlessness seen when an American stops smoking tobacco
cigarettes.<br>
</p>

<p><font size="2">Progression To Other Drugs<br>
</font></p>

<p>As noted in Chapter 11, to say marihuana leads to any other
drug avoids the real issue and reduces a complex set of variables
to an oversimplified premise of cause and effect. If any one
statement can characterize why persons in the United States
escalate their drug use patterns and become polydrug users, it is
peer pressure. Indeed, if any drug is associated with the use of
other drugs, including marihuana, it is tobacco, followed closely
by alcohol. Study after study which the Commission reviewed
invariably reported an association between the use of tobacco,
and, to a lesser extent, of alcohol with the use of marihuana and
other drugs. </p>

<p>The fact should be emphasized that the overwhelming majority
of marihuana users do not progress to other drugs. They either
remain with marihuana or foresake its use in favor of alcohol. In
addition, the largest number of marihuana users in the United
States today are experimenters or intermittent users, and 2% of
those who have ever used it are presently heavy users. Only
moderate and heavy use of marihuana is significantly associated
with persistent use of other drugs. </p>

<p>Some persons in our society are interested in experimenting
with a series of drugs, and there is no uniformity regarding
which drug these multidrug users take first. In some cases, the
drug used is a matter of preference; in others, a matter of
availability; and in further instances, it matter of group
choice. </p>

<p>Citizens concerned with health issues must consider the
possibility of marihuana use leading to use of heroin, other
opiates, cocaine or hallucinogens. This so-called stepping-stone
theory first received widespread acceptance in 1951 as a result
of testimony at Congressional hearings. At that time, studies of
various addict populations repeatedly described most heroin users
as marihuana users also. The implication of these descriptions
was that a causal relationship existed between marihuana and
subsequent heroin use. When the voluminous testimony given at
these hearings is seriously examined, no verification is found of
a causal relationship between marihuana use and subsequent heroin
use. </p>

<p>Again, we must avoid polarity on this issue. To assume that
marihuana use is unrelated to the use of other drugs would be
inaccurate. As mentioned earlier, the heavy or very heavy
marihuana users are frequently users of other drugs. The
stepping-stone theory holds that the adolescent begins the use of
illicit drugs with marihuana, and later proceeds to heroin in the
search for greater thrills. The opposing viewpoint holds that the
large majority of marihuana users never become heroin addicts and
denies the validity of a causal relationship. </p>

<p>In the National Survey, among the adult respondents, 70%
thought that marihuana makes people want to try stronger drugs
such as heroin; 56% of the youth in the 12-to-17-year-old
category agreed with the same statement. These perceptions
contrast with another finding in the same Survey which revealed
that 4% of current marihuana users have tried heroin. On the
other hand, very few respondents perceived alcohol and tobacco to
be precipitants of other drug use. </p>

<p>Studies of the escalation process demonstrate that the rates
of progression vary from one group to another and from one
segment of the population to another. There is no set proportion
of marihuana users who &quot;escalate&quot; to the use of other
drugs. The other drugs which some marihuana smokers use vary
according to the social characteristics of the population in
question. Within some groups, heroin may be the choice; in other
groups, it may be LSD. </p>

<p>Marihuana use per se does not dictate whether other drugs will
be used; nor does it determine the rate of progression, if and
when it, occurs, or which drugs might be used. As discussed in
Chapter 11, the user's social group seems to have the strongest
influence on whether other drugs will be used; and if so, which
drugs will be used.<br>
</p>

<p>PREVENTIVE PUBLIC HEALTH CONCERNS <br>
</p>

<p>The hallmark of a good health care delivery system is
preventing as much illness as possible. This objective is
achieved by means of immunizations, regular routine checkups, and
educational programs. </p>

<p>Education programs regarding marihuana have been notably
ineffective, partly due to an exaggeration of the effects of
using the drug and partly because the effects of the opiates and
marihuana have been compared inaccurately. As a result, many
persons have developed a conscious or unconscious denial of
nearly all dangers associated with marihuana use. Some educators
believe that drug programs merely sharpen the curiosity of
children and tempt them to use drugs which they otherwise would
not use. Others believe that the responsibility should not be
lodged with the schools but rather with the home or the
community. </p>

<p>Because of the uncertainty about the efficacy of these,
programs, education programs dealing with drug usage simply do
not exist in the school systems of a number of major cities; in
others, token programs are offered in response to the demand that
something be done. Health educators have the responsibility to
help this vulnerable group of Americans become aware of all
options so that they are able to make enlightened choices. </p>

<p>The educational role of physicians and other clinical health
personnel should not be underestimated. The National Survey shows
that the public believes young people should receive information
concerning marihuana first from schools and second from family
physicians. The health professional has a unique position as both
teacher and confidant to an individual struggling with a
&quot;drug abuse&quot; problem. Honest, sincere, and confidential
guidance from a physician may prevent later difficulties to both
the individual and the society. The Commission believes that
action must be taken to inform and support the physician in his
role as confidant and counsellor to those seeking assistance. </p>

<p>Considering the current patterns of marihuana use in the
United States, the need for treatment and/or rehabilitation does
not appear necessary for the vast majority of persons who are
experimenting with the drug or using it intermittently. Rather,
these persons need to be realistically educated regarding the
potential hazards they face. To this end, a comparison of the
personal and public health risks of marihuana and those of
heroin, cocaine, amphetamines, and other drugs would be useful. <br>
</p>

<p>A concern for public health also requires thoughtful
consideration of the consequences of any change in public policy.
We have objectively appraised the present scope of public health
concerns concluding that the most serious risk lies with the
population of heavy users, which is, at this time, quite small in
this country. </p>

<p>Now, we must soberly consider the likely effect of adoption of
a social policy of neutrality or approval toward marihuana use.
Any legal policy which institutionalizes availability of the drug
carries with it a likely increase in the at-risk population. This
factor is not necessarily conclusive in itself , but it does
weigh heavily for the policymaker. Even though the proportion of
heavy users in the total using population might not increase if
such a social or legal policy were adopted, the absolute number
of heavy users would probably increase. Thus, we would have an
increase in the at-risk segment of the populace. A greater stress
would thereby be placed on the general health care delivery
system in all the areas of health concern described earlier. </p>

<p>Regardless of emerging social policy, greater emphasis must be
placed on educating our youth regarding the prospective dangers
inherent in expanded marihuana use. This anticipatory guidance
can serve to defuse or at least forestall a potentially serious
social phenomenon.<br>
</p>

<p><font size="2"><b>Summary<br>
</b></font></p>

<p>From what is now known about the effects of marihuana, its use
at the present level does not constitute a major threat to public
health. However, this statement should not lead to complacency.
Marihuana is not an innocuous drug. The clinical findings of
impaired psychological function, carefully documented by medical
specialists, legitimately arouse concern. These studies identify
marihuana-related problems which must be taken into account in
the development of public policy. Unfortunately, these
marihuana-related problems, which occur only in heavy, long-term
users, have been over generalized and overdramatized. </p>

<p>Two percent of those Americans who have ever used marihuana
are now heavy users and constitute the highest risk group. Strong
evidence indicates that certain emotional changes have taken
place among predisposed individuals as a result of prolonged,
heavy marihuana use. The clinical reports in the literature
describing transient psychoses, other psychiatric difficulties,
and impairment of cognitive function subsequent to use of
marihuana and of other drugs do not prove causality but cannot be
ignored. </p>

<p>The causes of these emotional difficulties are much too
complex to justify general conclusions by the public or the
press. The mass media have frequently promoted such clinical
reports to appear as far reaching events affecting the entire
population. The clinician sees only the troubled Population of
any group. In evaluating a public health concern, the essential
element is the proportion of affected persons in the general
group. The people responsible for evaluating public health
problems must concern themselves with the proportion of people
out of the total population who are affected by any specific
condition. The highest risk groups should be identified as the
source of primary concern. A recognition that a majority of
marihuana users are not now a matter of public health concern
must be made so that public health Officials may concentrate
their attention where it will have maximum impact. </p>

<p>The concept of relative risk is crucial to an evaluation of
the impact of marihuana on public health. We believe that
experimental or intermittent use of this drug carries minimal
risk to the public health, and should not be given overzealous
attention in terms of a public health response. We are concerned
that social influences might cause those who would not otherwise
use the drug to be exposed to this minimal risk and the potential
escalation of drug-using patterns. For this group, we must
deglorify, demythologize, and deemphasize the use of marihuana
and other drugs. </p>

<p>The Commission reemphasizes its concern about the small
minority of heavy, long-term marihuana users who are exposed to a
much greater relative risk of impaired general functioning in
contemporary America. Public health officials should concentrate
their efforts on this group. Fortunately, the group has to date
not grown sufficently in size to warrant its being considered a
major public health concern. </p>

<p>We retiterate, too, the public health implications of an
increase in the at-risk population. We suspect that such an
increase is most likely if a sudden shift in social policy
significantly increased availability of the drug. One of the
factors we consider in Chapter V when evaluating the various
social policy options and legal implementations is the effect of
each policy on incidence and patterns of use. Regardless of how
heavy this particular variable will weigh in that process, we
must state that a significant increase in the at-risk population
could convert what is now a minor public health concern in this
country to one of major proportions.<br>
</p>

<p><b>Marihuana And The Dominant Social Order<br>
</b></p>

<p>For more than 30 years it has been widely assumed that the
marihuana user constitutes a threat to the well-being of the
community and the nation. Originally, the users were considered
to be &quot;outsiders&quot; or marginal citizens. Included were
such people as hustlers, prostitutes, itinerant workers, merchant
seamen, miners and ranchhands, water-front day laborers and
drifters, many of whom were drawn from the lower socioeconomic
segments of the population. </p>

<p>Concerns about marihuana use expressed in the 1930's related
primarily to a perceived inconsistency between the life styles
and values of these individuals and the social and moral order.
Their potential influence on the young was especially worrisome.
When marihuana was first prohibited, a recurrent fear was that
use might spread among the youth. And in the late 1930's and
1940's, the attraction of young people to jazz music was thought
to be in part related to marihuana use by this
&quot;outsider&quot; population. </p>

<p>Throughout this early period, American society, in reaction to
its fear of the unfamiliar, translated rumor about the
criminality and immorality of the marihuana user into
&quot;unquestioned fact&quot; which, in turn, was translated into
social policy. </p>

<p>From the mid-thirties to the present, however, social
perceptions have undergone significant change in response to the
emergence of new and challenging social problems. As marihuana,
use has spread to include the affluent, middle class, white high
school and college-age youth as well as minority group members of
lower socioeconomic circumstances in urban core areas, the
concept of marginality has become blurred. </p>

<p>Also, as the use of marihuana has increased, those individuals
formerly labeled as marginal and threatening have been replaced
by a more middle class, white, educated and younger population of
marihuana smokers. A stereotyped user no longer exists, and
therefore, the question now properly focuses on who poses a
threat to the dominant order.<br>
</p>

<p><font size="2"><b>The Adult Marihuana User <br>
</b></font></p>

<p>Despite the fact that substantial numbers of adults use
marihuana, society does not appear to feel greatly threatened by
this group, probably because included in the group are a
considerable number of middle class individuals who are regularly
employed and whose occupational and social status appear to be
similar to those of peers and colleagues who do not use
marihuana. </p>

<p>In the course of its fact-finding effort, the Commission has
met with several groups of socially and economically
&quot;successful&quot; marihuana users in the professions of law,
medicine, banking, education and business. In most cases, these
persons, in their external appearances, seemed to be mature and
responsible adults whose social attitudes and behavior did not
mark them as radical ideologues or essentially irresponsible
individuals. </p>

<p>For the most part, use of marihuana by adults has been found
to be more directly related to the facilitation of social
interaction (much like the adult use of alcohol in social
gatherings) than to any other factor. Although their marihuana
smoking behavior is illegal, most adult users are not ordinarily
considered by their peers to be criminal nor is their use
generally likely to result in arrest. </p>

<p>Because the adult user generally maintains low visibility, is
primarily a recreational user, is not usually involved in radical
political activity and maintains a life style largely
indistinguishable from his non-using neighbors, he is not
ordinarily viewed as a threat to the dominant social order. In
short, aside from his use of marihuana, the adult recreational
user is not generally viewed as a significant social problem.<br>
</p>

<p><font size="2"><b>The Young Marihuana User <br>
</b></font></p>

<p>The widespread use of marihuana by millions of young people of
college and high school age has been viewed by many as a direct
threat to the stability and future of the social order. </p>

<p>Many parents, adults in general, and government officials have
expressed concern that young people who use marihuana often
reject the essential values and traditions upon which the society
is founded. Some have suggested that youthful marihuana use is,
in itself, an indication of the rejection of responsibility and a
sign of reckless hedonism which may well interfere with an
orderly maturation process. Others see youthful marihuana use as
part of a pattern of conduct which produces dropping out,
underachievement and dependency. </p>

<p>In short, the mass character of youthful marihuana use has
been frequently interpreted as a rejection of the
institutionalized principles of law and a lack of concern for
individual social responsibility, which threatens the social and
political institutions. </p>

<p>Implicit in this view is the assumption that a young person
who uses marihuana in spite of the law cannot be expected to
assume an individually and socially responsible, adult role. The
strength of this fear is drawn largely from the vocal and visible
&quot;counterculture&quot; to which marihuana is often tied. Not
surprisingly, the concerns posed by an alternate youthful life
style are extended to the drug itself. </p>

<p>Threats to the social order are often seen, for example, in
the character of youthful leisure time activities, such as
attendance at rock concerts, occasioned by the high mobility and
affluence of today's youth. They are also seen in the new modes
of speech and dress and in the seemingly casual manner of their
day-to-day living. Equally troublesome for many, however, is the
idea of intentional intoxication for purposes of recreation. </p>

<p>Such conduct and the more casual attitude toward sexual
relationships as well as participation in radical politics have
provoked increasing concern throughout the adult society. The
National Survey illustrates the extent to which the older adult
perceives youthful marihuana use as part of a much larger pattern
of behavior which bodes ill for the future of the nation.<br>
</p>

<p>First, the older the adult respondent, the more likely he was
to picture the marihuana user as leading an abnormal life. Only
9% of the over-50 generation agreed with the statement that
&quot;most people who use marihuana lead a normal life.&quot;
Nineteen percent of the 35to-49 age group and 29% of the
26-to-34-year-olds were of the same belief. Conversely, half of
the young adults (18-to-25) considered most marihuana users
normal. This fact is not surprising since many of their
contemporaries are marihuana users. </p>

<p>Second, the marihuana user, as envisioned by adults, is
typically a youthful dropout from society. He doesn't like to be
with other people, is uninterested in the world around him, is
usually lazy and has an above-average number of personal
problems. </p>

<p>Third, the less optimistic the adult respondent was about the
nation's youth, the more likely he was to oppose alteration of
the marihuana laws and to envision major social dislocations if
the laws were changed. Fifty-seven percent of the adult
population in general agreed with the statement, &quot;if
marihuana were legal, it would lead to teenagers becoming
irresponsible and wild.&quot; Among those adults who most
disapproved of youthful behavior in general, 74% agreed with the
quoted statement. Similarly, 84% of the non-approving adults
favored stricter laws on marihuana. </p>

<p>As we discussed in Chapter I, marihuana's symbolic role in a
perceived generational conflict has brought marihuana use into
the Category of a social problem. Today's youthful marihuana user
is seen as a greater threat to the social order than either the
marginal user of earlier times or the adult user of the present.
Since the concerns about marihuana today relate mostly to youth,
the remainder of this section will focus on these youth-related
issues. <br>
</p>

<p align="center"><font size="2"><b>'THE WORLD OF YOUTH <br>
</b></font></p>

<p>Youth of today are better fed, better housed, more mobile,
more affluent, more schooled and probably more bored with their
lives than any generation which has preceded them. </p>

<p>Adults have difficulty understanding why such privileged young
people should wish to offend by their language and appearance and
spend so much effort trying to discredit those institutions of
society which have made possible the privileges which those youth
enjoy. Many adults perceive the present level of youthful
discontent to be of a greater intensity than has been true of
past generations. </p>

<p>Marihuana has become both a focus and a symbol of the
generation gap and for many young people its use has become, an
expedient means of protest against adult values. </p>

<p>Adults in positions of authority, parents, teachers, policy
officials, judges, and others often view marihuana use as the
sign of youth's rejection of moral and social values and of the
system of government under which they live. The problem is that
both youth and adults tend to make pronouncements and are
frequently unable to reason together in logical fashion. Instead
they overstate their positions in such a way that effective
resolution of their differences becomes very difficult. </p>

<p>In effect, each group takes the rhetoric of the other at face
value. For youth, however, marihuana use plays many roles, only
one of which is a symbolic assault on adult authority and values.
</p>

<p>Marihuana use, for many young people, has become a part of a
ritual. It takes on the aspect of participating in a shared
experience which, for some if not all, is enjoyable in itself.
For many, it becomes an even more interesting experience because
it is forbidden. </p>

<p>Some of the rituals concerned with the purchase, storage,
preparation, and use of marihuana take on a mystique similar to
the time of Prohibition when people went through certain rituals
necessary to get a drink in a speak-easy. The three knocks and
&quot;Joe sent me&quot; cues have been replaced by the
not-so-secret handshakes, the new vocabulary of youth and other
exclusionary devices to delineate the &quot;in&quot; group. </p>

<p>The use of marihuana is attractive to many young people for
the sense of group unity and participation which develops around
the common use of the drug. This sense tends to be intensified by
a sense of &quot;common cause&quot; in those circumstances where
users are regarded as social or legal outcasts. </p>

<p>They know, too, that many of their peers who share the
marihuana experience and also share the designation of lawbreaker
are, in reality, productive and generally affirmative individuals
who are interested neither in promoting the downfall of the
nation nor in engaging in acts which would harm the general
well-being of the community. </p>

<p>In short, many youth have found marihuana use to be a
pleasurable and socially rewarding experience. They have found
that the continuance of this behavior has brought them more
pleasure than discomfort, more reward than punishment. </p>

<p>Youth have increasingly come to see law enforcement activity
directed at marihuana use as an unreasonable and unjustifiable
rejection of their generation. Most of these youth have grown up
with a positive image of the police as protectors of society.
Now, many are confronted with the possibility of police intrusion
into their private lives and the threat of a criminal record. The
unfortunate result, in many instances, has been a blanket
rejection and distrust of both the agents and institutions of
government. </p>

<p>In part, marihuana use as a social behavior is an unintended
byproduct of the formal and informal educational process. Some
persons even suggest that youthful drug usage is a
&quot;success&quot; in terms of the educational and socialization
process. Our society values independence of thought,
experimentation, and the empirical method, often reinforcing this
attitude by such advertising cliches as &quot;make up your own
mind,&quot; &quot;be your own man...... judge for yourself.&quot;
</p>

<p>Although experimentation with regard to drugs should not be
considered a &quot;success, the Commission does believe that the
educational efforts necessary to discourage this curiosity, which
may be valuable in other matters, have not succeeded. We
understand why teenagers and young adults encouraged over the
years to make up their own minds have not been restrained by
exaggerated accounts of marihuana's harmful effects, or by the
more recent assertions that a true evaluation of marihuana uses
requires more research. The Scottish verdict of &quot;not
proven&quot; does little to restrain youthful curiosity. </p>

<p>In the previous Chapter, we emphasized the difference between
the vast majority of experimenters and intermittent users and the
small group of moderate and heavy users who generally use drugs
other than marihuana as well. The former do not differ
significantly from non-users on many indices of social
integration. Various studies indicate that they maintain normal
patterns of living and social interaction, and are employed,
competent citizens. </p>

<p>On the other hand, there undoubtedly are a number of persons
who have used marihuana and have exercised poor judgment,
performed inadequately, or behaved irresponsibly while under the
drug's influence, thus jeopardizing themselves or others. The
fact remains, however, that a certain number of these persons
were immature and irresponsible individuals even prior to
marihuana use, who would be expected to have poor or impaired
judgment whether or not marihuana was involved. </p>

<p>The marihuana user is not, for the most part, a social
isolationist or a severely disturbed individual in need of
treatment or confinement. Most users, young or old, demonstrate
an average or above-average degree of social functioning,
academic achievement and job performance. Their general image of
themselves and their society is not radically different from that
of their non-marihuana-using peers. The majority of both groups
tends to demonstrate equal interest in corporate concerns. </p>

<p>Based upon present evidence, it is unlikely that marihuana
users will become less socially responsible as a result of their
marihuana use or that their patterns of behavior and values will
change significantly.<br>
</p>

<p align="center"><font size="2"><b>WHY SOCIETY FEELS THREATENED<br>
</b></font></p>

<p>Society appears to be concerned about marihuana use primarily
because of its perceived relationship to other social problems.
We noted in the discussion of marihuana and public health that
the focus of social concern should be the heavy users and the
possibility that their numbers will increase. Here we consider
the perceived impact of marihuana use upon the institutions and
proclaimed goals of the society.<br>
</p>

<p><font size="2"><b>Dropping Out <br>
</b></font></p>

<p>Many parents have a genuine fear that marihuana use leads to
idleness and &quot;dropping out.&quot; During the 1960's,
marihuana use, as well as the use of other psychoactive drugs,
became equated with unconventional youth life styles. When a
number of young people adopted unconventional life styles, many
adults tended to view long hair, unkempt appearance and drugs as
symbols of counterculture. </p>

<p>They concluded that anyone who allowed his hair to grow or
gave little attention to his clothing or appearance was probably
a drug user with little or no motivation to achieve and no
interest in conventional goals. </p>

<p>A number of researchers and clinicians have observed the use
of marihuana or hashish in other societies, particularly among
poor, lower class males. Some have observed that many of these
individuals are generally unmotivated and ordinarily appear to
show little aspiration or motivation to improve their way of
life, regardless of whether they are judged by the standards of
the more prosperous members of their own society or by middle
class standards of contemporary American society. </p>

<p>One of the problems with this type of analysis is that it
fails to perceive the social and cultural realities in which the
phenomenon takes place. In the Middle East and in Asia where
hashish is used, the societies, in all instances, are highly
stratified with people in the lower classes having virtually no
social or economic mobility. Poverty, deprivation and disease
were the conditions into which these people were born and in
which they remain, regardless of whether they use cannabis. In
this context, a person's resignation to his status in life is not
likely to be caused or greatly influenced by the effects of
cannabis. Any society will always have a certain number of
persons who, for various reasons, are not motivated to strive for
personal achievement or participate fully in the life of the
community. Therefore, the determination is difficult to make
whether cannabis use influences a person to drop out and, if it
does, to what extent. </p>

<p>Some individuals possess particular personality as well as
psychosocial characteristics which in specified instances could
produce amotivation or dropping out. However, little likelihood
exists that the introduction of a single element such as
marihuana use would significantly change the basic personality
and character structure of the individual to any degree. An
individual is more likely to drop out when a number of
circumstances have joined at a given point in his lifetime,
producing pressures with which he has difficulty in coping. These
pressures often coincide with situations involving painful or
difficult judgments resulting from a need to adjust to the
pressures of the social environment. </p>

<p>Many young people, particularly in the college population, are
shielded in their earlier years from experiences which might be
emotionally stressful or unpleasant. Some young people, so
sheltered, are neither equipped to make mature and independent
judgments nor prepared to enjoy the new-found freedom of the
university or college in a mature and responsible way. Some of
these students are often unable to cope with social or academic
adversity. After being sheltered for so long, some of these young
people may be easily attracted to experiences which promise new
excitement and to fall under the influence of a peer group whose
values and living patterns may be inimical to a productive,
healthy and continuous process of personal growth and maturity.
In these instances, marihuana serves as the medium by which these
individuals encounter social and psychological experiences with
which they are ill-equipped to cope. </p>

<p>Certain numbers of these young people have demonstrated what
is described as amotivation long before the smoking of marihuana
became fashionable. Adolescence is often a particularly difficult
period of searching in many directions at the same time. In
addition to seeking a concept of &quot;self&quot; the adolescent
is, at the same time, attempting to comprehend the nature of the
world around him and to identify his status and role in society. </p>

<p>Different individuals, with different backgrounds,
socialization patterns, belief systems and levels of emotional
maturity cope with the period of transition from childhood to
adulthood in different ways., For a small number, dropping out
might be one of these coping mechanisms whether or not they use
marihuana. For others, the response to the difficult adjustments
of adolescence takes other forms, some of which are more,
acceptable, &quot;normal&quot; and easier for adults to
understand. </p>

<p>The young person who does not find it possible to cope with
the pressures of his adolescent developmental period in ways
convenient to the understanding of adult society should not be
rejected, stigmatized or labeled. He requires both support and
understanding and the opportunity to participate in roles which
have meaning for him and in ways in which he feels comfortable.
For a certain number of young people, marihuana and the mystique
of the experience eases this passage by helping them share their
feelings, doubts, inadequacies and aspirations with peers with
whom they feel safe and comfortable. <br>
</p>

<p><font size="2"><b>Dropping Down<br>
</b></font></p>

<p>Apart from the concern over youthful dropping out and
idleness, there is also widespread concern about &quot;dropping
down&quot; or underachieving. </p>

<p>Parents frequently express fear that marihuana will undermine
or interfere with academic and vocational career development and
achievement by focusing youthful interests on the drug and those
associated with the drug subculture. Some parents make
considerable sacrifices for their children to go to school, and
the fears that marihuana might undermine the academic, emotional
and vocational development of their young are quite
understandable. </p>

<p>The Commission reviewed a number of studies related to
marihuana use by high school and college youth. No conclusive
evidence was found demonstrating that marihuana by itself is
responsible for academic or vocational failure or &quot;dropping
down,&quot; although it could be one of many contributory
reasons. Many studies reported that the majority of young people
who have used marihuana received average or above-average grades
in school. </p>

<p>In part, underachievement is related to a view of what one
individual judges to be the achievement capacity of another. This
judgment is often made without concern for what the individual
himself feels about his potential, his interests and his goals.
Perceptions about achievement also frequently fail to take into
consideration the individual feelings about the goals of his
peers and the values of the larger society, including the
relative prestige and status attached to various academic
programs, occupations and professions. <br>
</p>

<p><font size="2"><b>Youth and Radical Politics <br>
</b></font></p>

<p>Aside from the issue of unconventional life styles and the
concerns evoked by them, the other major concern of the sixties
which related to youth and drugs was radical politics. </p>

<p>During the latter half of the decade, youthful anti-war groups
were organized on many of the nation's college campuses and high
schools. These groups could be divided into two segments. The
largest segment consisted of concerned, sometimes confused,
frustrated and well-meaning petition signers and demonstrators.
Within this large group there was a small coterie of individuals
who constantly sought to turn the demonstration into a
confrontation and to protest for peace by means of violence. The
second segment consisted of organizations of individuals whose
stated purpose was to undermine the social and political
stability of the society through violent means. </p>

<p>What must be clearly understood, however, is that among the
young people, and some not so young, who protested against the
war in Vietnam, only a minority were bent on violence and
manipulated and corrupted these otherwise peaceful demonstrations
for their own purposes. </p>

<p>At the various gatherings, a number of the young people
protesting in these mass groups did smoke marihuana. We will
never know how many were initiated to marihuana use during the
course of these peace demonstrations. The fact remains, however,
that in the large campins, such as those in Washington, marihuana
was involved in two ways. First, there was the &quot;normal&quot;
use in which the smoking was part of the social experience.
Individuals came together and smoked, in part, to acknowledge and
strengthen group solidarity. Second, another quite different
aspect of the marihuana use at these gatherings said, in effect,
&quot;we know it's illegal but go and arrest all of us for doing
it. . . .&quot; This aspect can perhaps best be characterized as
a symbolic challenge to authority. </p>

<p>Unfortunately, however, the media, particularly television and
some of the news magazines, sometimes portrayed the image of a
group of young people plotting the overthrow of the nation by
violent means while under the influence of marihuana. In those
relatively few instances where explosives and other violent means
were employed, the evidence points to a cold and calculated plan
which was neither conceived nor executed under the influence of
marihuana. </p>

<p>As a result of these protests and demonstrations, therefore,
radical politics has been seen by many as a mechanism through
which large numbers of young people would be introduced to
marihuana as well as to other drugs. Radical political activity
or mass political protest is viewed by some as a threat to the
welfare of the nation and is assumed to be aided and encouraged
by our enemies. </p>

<p>The involvement of large numbers of youth in political
activism and the concomitant public concern about drug use have
beclouded the issue of marihuana use and have led to a broadening
of the concerns about marihuana on the part of adults. </p>

<p>Some of the radical movement's leaders abetted this tendency
by pointing out the alleged irrationality and unfairness of the
marihuana laws to recruit members to their ranks. Not surprising
is the fact that 45% of the adult respondents in the National
Survey felt that marihuana is often promoted by people who are
enemies of the United States. Nor is it surprising that this
belief is a function of age. While 22% of all young people
(12-to-17 years of age) and 26% of young adults (18-to-25 years)
identified marihuana with national enemies, more than one-half
(58%) of those persons 50 years and older did so.<br>
</p>

<p><font size="2"><b>Youth and the Work Ethic <br>
</b></font></p>

<p>Of the many issues related to youth and the use of marihuana,
one that greatly troubles many adults, is youthful attitudes
toward work. The work ethic in our society is based on a belief
that work is a good and necessary activity in and of itself. </p>

<p>The traditional view holds that work is not only a right and
moral act but that it keeps people from mischief and from wasting
time on harmful recreational pleasures. The rationale for this
thesis is that work in American society has served as the primary
means by which persons acquired the treasured symbols of society.
</p>

<p>In fact, throughout much of our history, with the exception of
the small number who inherited or married wealth, no ethical
alternative to work existed. In recent years, the increased
emphasis placed upon leisure time activities has resulted in
shorter work weeks, longer vacation periods and more paid
holidays. </p>

<p>Among the concerns of the adults about today's youthful
attitudes toward work and leisure are that young people seem to
enjoy their recreational pursuits so much that they forget that
to a considerable degree their enjoyment is paid for by the labor
of others. </p>

<p>Many young people do not express the same level of concern as
their parents did about preparing themselves for a career and
&quot;getting ahead in the world.&quot; In part, this attitude is
attributable to the fact that increasingly, the results of this
labor are not tangible, material goods. Service occupations
generally do not produce such tangible products, and even in
manufacturing industries the individual worker is usually too
remote from the product to feel any pride or interest in it. In
both instances, the traditional symbol of the &quot;manhood&quot;
of work, a tangible product, is no longer present. </p>

<p>In sum, society has become increasingly disturbed by certain
attitudes of today's youth which seem to stress pleasure, fun,
and enjoyment without a counterbalancing concern for a
disciplined and sustained work effort. Nevertheless, the number
of young people who view work as unimportant is small when
compared to the total number of young people. The Commission has
found no evidence to suggest that the majority of youth are
unwilling or incapable of productive and disciplined work
performance. In fact, the great majority of young people are
performing their tasks in industry, the professions and education
quite effectively. </p>

<p>Although many young people delay entry into the work force to
enjoy the fruits of our prosperous society, this delay does not
mean they will not one day contribute their best efforts to the
continued growth and advancement of the nation.<br>
</p>

<p><font size="2"><b>The Changing Social Scene <br>
</b></font></p>

<p>The present confusion about the effects of youthful marihuana
use upon the dominant social order is caused by a variety of
interrelated social concerns, many of them emotionally charged
issues, including anti-war demonstrations, campus riots, hippie
life styles, the rising incidence of crime and delinquency and
the increased usage of all illicit drugs. The focus of concern
about marihuana is aggravated by the data overload mentioned in
Chapter 1, by the outpouring of incidental information about the
drug and its effects in a form and volume far beyond the capacity
of the readers or listeners to assimilate or interpret. Rather
than informing the public, much of the data disseminated has
produced frustration and misinterpretation of the information
presented. </p>

<p>Adult society, including parents and policy-makers, finds it
difficult to comprehend and account for many of the attitudes and
behavior of the young, including the use of marihuana. In many
cases the adults are still influenced by the myths of an earlier
period which overstated the dangers of the drug. At a time of
great social change and turbulence, the tendency to depend on the
&quot;traditional wisdom,&quot; and its moral justification, is a
strong one. </p>

<p>Just as youth must try to understand and appreciate the
strengths of the institutions of our society, adults must try to
understand the times through the eyes of their children. Where
marihuana is concerned, society must try to understand its role
in the lives of those who use it. The key to such understanding
lies in the changes which have taken place in society within
recent years and the effects these changes have had on succeeding
generations of youth. The increased use of marihuana is only one
of these effects. </p>

<p>One focal point in discussion between generations is the
contrast between the use of marihuana and the use of alcohol.
Many young people perceive that marihuana is less dangerous than
alcohol in terms of its addiction potential and long-term
physical and psychological consequences. Many believe also that
marihuana - and other psychoactive drugs make it possible to
expand their perceptions and see this as a perfectly legitimate
objective. </p>

<p>Viewed against the background of the profound changes of
recent years in the fields of economics, politics, religion,
family life, housing patterns, civil rights, employment and
recreation, the use of marihuana by the nation's youth must be
seen as a relatively minor change in social patterns of conduct
and as more of a consequence of than a contributor to these major
changes. </p>

<p>When the issue of marihuana use is placed in this context of
society's larger concerns, marihuana does not emerge as a major
issue or threat to the social order. Rather, it is most
appropriately viewed as a part of the whole of society's concerns
about the growth and development of its young people. </p>

<p>In view of the magnitude and nature of change which our
society has experienced during the past 25 years, the thoughtful
observer is not likely to attribute any of the major social
problems resulting from this change to marihuana use. Similarly,
it is unlikely that marihuana will affect the future strength,
stability or vitality of our social and political institutions.
The fundamental principles and values upon which the society
rests are far too enduring to -go up in the smoke of a marihuana
cigarette.<br>
</p>

<hr>

<p><a href="http://cliffcompaq/druglibrary/schaffer/index.htm">Cliff
Schaffer's Home Page</a> <br>
</p>
</body>
</html>
</DOC>
